PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Raman, MCC; Johnson, KA; Yard, BA; Lowther, J; Carter, LG; Naismith, JH; Campopiano, DJ				Raman, Marine C. C.; Johnson, Kenneth A.; Yard, Beverley A.; Lowther, Jonathan; Carter, Lester G.; Naismith, James H.; Campopiano, Dominic J.			The External Aldimine Form of Serine Palmitoyltransferase STRUCTURAL, KINETIC, AND SPECTROSCOPIC ANALYSIS OF THE WILD-TYPE ENZYME AND HSAN1 MUTANT MIMICS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY SENSORY NEUROPATHY; 8-AMINO-7-OXONONANOATE SYNTHASE; 5-AMINOLEVULINATE SYNTHASE; CRYSTAL-STRUCTURE; BASE SYNTHESIS; YEAST LCB1; 1ST STEP; ENZYME; SPTLC1; IDENTIFICATION	Sphingolipid biosynthesis begins with the condensation of L-serine and palmitoyl-CoA catalyzed by the PLP-dependent enzyme serine palmitoyltransferase (SPT). Mutations in human SPT cause hereditary sensory autonomic neuropathy type 1, a disease characterized by loss of feeling in extremities and severe pain. The human enzyme is a membrane-bound hetereodimer, and the most common mutations are located in the enzymatically incompetent monomer, suggesting a "dominant" or regulatory effect. The molecular basis of how these mutations perturb SPT activity is subtle and is not simply loss of activity. To further explore the structure and mechanism of SPT, we have studied the homodimeric bacterial enzyme from Sphingomonas paucimobilis. We have analyzed two mutants (N100Y and N100W) engineered to mimic the mutations seen in hereditary sensory autonomic neuropathy type 1 as well as a third mutant N100C designed to mimic the wild-type human SPT. The N100C mutant appears fully active, whereas both N100Y and N100W are significantly compromised. The structures of the holoenzymes reveal differences around the active site and in neighboring secondary structure that transmit across the dimeric interface in both N100Y and N100W. Comparison of the L-Ser external aldimine structures of both native and N100Y reveals significant differences that hinder the movement of a catalytically important Arg(378) residue into the active site. Spectroscopic analysis confirms that both N100Y and N100W mutants subtly affect the chemistry of the PLP. Furthermore, the N100Y and R378A mutants appear less able to stabilize a quinonoid intermediate. These data provide the first experimental insight into how the most common disease-associated mutations of human SPT may lead to perturbation of enzyme activity.	[Johnson, Kenneth A.; Carter, Lester G.; Naismith, James H.] Univ St Andrews, Scottish Struct Prote Facil, EaStChem, Edinburgh KY16 9RH, Midlothian, Scotland; [Johnson, Kenneth A.; Carter, Lester G.; Naismith, James H.] Univ St Andrews, Ctr Biomol Sci, Edinburgh KY16 9RH, Midlothian, Scotland; [Campopiano, Dominic J.] Univ Edinburgh, Sch Chem, EaStChem, Edinburgh EH9 3JJ, Midlothian, Scotland	University of St Andrews; University of St Andrews; University of Edinburgh	Naismith, JH (corresponding author), Univ St Andrews, Scottish Struct Prote Facil, EaStChem, Edinburgh KY16 9RH, Midlothian, Scotland.	naismith@st-andrews.ac.uk; Dominic.Campopiano@ed.ac.uk	Carter, Lester/G-6561-2014; Naismith, James Henderson/AAB-8614-2020; Naismith, James Henderson/H-3408-2012	Naismith, James Henderson/0000-0001-6744-5061; Naismith, James Henderson/0000-0001-6744-5061; Campopiano, Dominic/0000-0001-8573-6735	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F009739/1, BBS/B/14434]; Scottish Structural Proteomics Facility (SSPF); Biotechnology and Biological Sciences Research Council [BB/F008503/1, BBS/B/14434, BB/F009739/1] Funding Source: researchfish; Medical Research Council [G0500367] Funding Source: researchfish; BBSRC [BB/F009739/1, BB/F008503/1] Funding Source: UKRI; MRC [G0500367] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scottish Structural Proteomics Facility (SSPF); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Biotechnology and Biological Sciences Research Council (BBSRC) Grants BB/F009739/1 and BBS/B/14434 (to D.J.C. and J.H.N.) and the Scottish Structural Proteomics Facility (SSPF).	Alexeev D, 2006, ORG BIOMOL CHEM, V4, P1209, DOI 10.1039/b517922j; Alexeev D, 1998, J MOL BIOL, V284, P401, DOI 10.1006/jmbi.1998.2086; Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792; Auer-Grumbach M, 2004, DRUG TODAY, V40, P385, DOI 10.1358/dot.2004.40.5.850487; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bejaoui K, 2001, NAT GENET, V27, P261, DOI 10.1038/85817; Bejaoui K, 2002, J CLIN INVEST, V110, P1301, DOI 10.1172/JCI200216450; BUEDE R, 1991, J BACTERIOL, V173, P4325, DOI 10.1128/JB.173.14.4325-4332.1991; Chen JK, 1999, CHEM BIOL, V6, P221, DOI 10.1016/S1074-5521(99)80038-6; Dawkins JL, 2001, NAT GENET, V27, P309, DOI 10.1038/85879; DUNATHAN HC, 1966, P NATL ACAD SCI USA, V55, P712, DOI 10.1073/pnas.55.4.712; DYCK P, 1993, NEURONAL ATROPHY DEG; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERREIRA GC, 1995, J BIOENERG BIOMEMBR, V27, P151, DOI 10.1007/BF02110030; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Gable K, 2002, J BIOL CHEM, V277, P10194, DOI 10.1074/jbc.M107873200; Gable K, 2000, J BIOL CHEM, V275, P7597, DOI 10.1074/jbc.275.11.7597; Han GS, 2006, J BIOL CHEM, V281, P39935, DOI 10.1074/jbc.M609365200; Han GS, 2004, J BIOL CHEM, V279, P53707, DOI 10.1074/jbc.M410014200; Hanada K, 1997, J BIOL CHEM, V272, P32108, DOI 10.1074/jbc.272.51.32108; Hanada K, 2000, J BIOL CHEM, V275, P8409, DOI 10.1074/jbc.275.12.8409; Hanada K, 1998, J BIOL CHEM, V273, P33787, DOI 10.1074/jbc.273.50.33787; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Hornemann T, 2008, CHEM PHYS LIPIDS, V154, pS62, DOI 10.1016/j.chemphyslip.2008.05.170; HORNEMANN T, 2008, CHEM PHYS LIPIDS, V154, pPO111; Hornemann T, 2007, BIOCHEM J, V405, P157, DOI 10.1042/BJ20070025; Hornemann T, 2006, J BIOL CHEM, V281, P37275, DOI 10.1074/jbc.M608066200; Houlden H, 2006, BRAIN, V129, P411, DOI 10.1093/brain/awh712; Houlden H, 2004, CURR OPIN NEUROL, V17, P569, DOI 10.1097/00019052-200410000-00007; Hunter GA, 1999, BIOCHEMISTRY-US, V38, P3711, DOI 10.1021/bi982390w; Ikushiro H, 2004, BIOCHEMISTRY-US, V43, P1082, DOI 10.1021/bi035706v; Ikushiro H, 2001, J BIOL CHEM, V276, P18249, DOI 10.1074/jbc.M101550200; Ikushiro H, 2008, J BIOL CHEM, V283, P7542, DOI 10.1074/jbc.M706874200; Ikushiro H, 2007, J BACTERIOL, V189, P5749, DOI 10.1128/JB.00194-07; JORDAN PM, 1972, ENZYMES; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kerbarh O, 2006, CHEM COMMUN, P60, DOI 10.1039/b511837a; Kobayashi T, 2006, BIOL PHARM BULL, V29, P1526, DOI 10.1248/bpb.29.1526; McCampbell A, 2005, HUM MOL GENET, V14, P3507, DOI 10.1093/hmg/ddi380; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Merrill AJ., 2006, SPHINGOLIPID BIOL; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagiec MM, 1996, GENE, V177, P237, DOI 10.1016/0378-1119(96)00309-5; NAGIEC MM, 1994, P NATL ACAD SCI USA, V91, P7899, DOI 10.1073/pnas.91.17.7899; Nicholson GA, 1996, NAT GENET, V13, P101, DOI 10.1038/ng0596-101; RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9; Schmidt A, 2001, BIOCHEMISTRY-US, V40, P5151, DOI 10.1021/bi002204y; Verhoeven K, 2004, NEUROLOGY, V62, P1001, DOI 10.1212/01.WNL.0000115388.10828.5C; Webster SP, 2000, BIOCHEMISTRY-US, V39, P516, DOI 10.1021/bi991620j; WILLIAMS RD, 1984, ARCH BIOCHEM BIOPHYS, V228, P282, DOI 10.1016/0003-9861(84)90069-9; Yard BA, 2007, J MOL BIOL, V370, P870, DOI 10.1016/j.jmb.2007.04.086; ZAMAN Z, 1973, BIOCHEM J, V135, P257, DOI 10.1042/bj1350257; Zhang JS, 2002, J BIOL CHEM, V277, P44660, DOI 10.1074/jbc.M203584200; Zitomer NC, 2009, J BIOL CHEM, V284, P4786, DOI 10.1074/jbc.M808798200	56	48	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17328	17339		10.1074/jbc.M109.008680	http://dx.doi.org/10.1074/jbc.M109.008680			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19376777	hybrid, Green Published			2022-12-25	WOS:000266962400068
J	Saito, N; Robert, M; Kochi, H; Matsuo, G; Kakazu, Y; Soga, T; Tomita, M				Saito, Natsumi; Robert, Martin; Kochi, Hayataro; Matsuo, Goh; Kakazu, Yuji; Soga, Tomoyoshi; Tomita, Masaru			Metabolite Profiling Reveals YihU as a Novel Hydroxybutyrate Dehydrogenase for Alternative Succinic Semialdehyde Metabolism in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTROPHORESIS-MASS-SPECTROMETRY; BETA-HYDROXYACID DEHYDROGENASES; GAMMA-HYDROXYBUTYRATE; CLOSTRIDIUM-AMINOBUTYRICUM; RAT-BRAIN; 2 GENES; ENZYME; METHYLGLYOXAL; METABOLOMICS; TRANSAMINASE	The search for novel enzymes and enzymatic activities is important to map out all metabolic activities and reveal cellular metabolic processes in a more exhaustive manner. Here we present biochemical and physiological evidence for the function of the uncharacterized protein YihU in Escherichia coli using metabolite profiling by capillary electrophoresis time-of-flight mass spectrometry. To detect enzymatic activity and simultaneously identify possible substrates and products of the putative enzyme, we profiled a complex mixture of metabolites in the presence or absence of YihU. In this manner, succinic semialdehyde was identified as a substrate for YihU. The purified YihU protein catalyzed in vitro the NADH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. Moreover, a yihU deletion mutant displayed reduced tolerance to the cytotoxic effects of exogenous addition of succinic semialdehyde. Profiling of intracellular metabolites following treatment of E. coli with succinic semialdehyde supports the existence of a YihU-catalyzed reduction of succinic semialdehyde to gamma-hydroxybutyrate in addition to its known oxidation to succinate and through the tricarboxylic acid cycle. These findings suggest that YihU is a novel gamma-hydroxybutyrate dehydrogenase involved in the metabolism of succinic semialdehyde, and other potentially toxic intermediates that may accumulate under stress conditions in E. coli.	[Saito, Natsumi; Robert, Martin; Kochi, Hayataro; Matsuo, Goh; Kakazu, Yuji; Soga, Tomoyoshi; Tomita, Masaru] Keio Univ, Inst Adv Biosci, Yamagata 9970017, Japan; [Soga, Tomoyoshi; Tomita, Masaru] Human Metabolome Technol Inc, Yamagata 9970052, Japan	Keio University	Saito, N (corresponding author), 403-1 Nipponkoku, Yamagata 9970017, Japan.	natsumi@ttck.keio.ac.jp	Robert, Martin/B-3970-2009; Soga, Tomoyoshi/B-8105-2014	Robert, Martin/0000-0002-7082-5142; Soga, Tomoyoshi/0000-0001-9502-2509	Japan Society for the Promotion of Science (JSPS); Yamagata prefectural government; Tsuruoka city	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Yamagata prefectural government; Tsuruoka city(Tsuruoka City Government)	This work was supported by a grant-in-aid for scientific research from the Japan Society for the Promotion of Science (JSPS) (to M. R.) and research funds from the Yamagata prefectural government and Tsuruoka city.	ADAMS MJ, 1994, STRUCTURE, V2, P651, DOI 10.1016/S0969-2126(00)00066-6; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andriamampandry C, 1998, BIOCHEM J, V334, P43, DOI 10.1042/bj3340043; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Baran R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-530; BARTSCH K, 1990, J BACTERIOL, V172, P7035, DOI 10.1128/jb.172.12.7035-7042.1990; Breitkreuz KE, 2003, J BIOL CHEM, V278, P41552, DOI 10.1074/jbc.M305717200; Busch K, 2000, BIOCHEMISTRY-US, V39, P10110, DOI 10.1021/bi000589e; Chen LF, 2007, TRENDS BIOTECHNOL, V25, P343, DOI 10.1016/j.tibtech.2007.06.001; COOPER RA, 1984, ANNU REV MICROBIOL, V38, P49, DOI 10.1146/annurev.mi.38.100184.000405; Cusa E, 1999, J BACTERIOL, V181, P7479, DOI 10.1128/JB.181.24.7479-7484.1999; De Biase D, 1999, MOL MICROBIOL, V32, P1198, DOI 10.1046/j.1365-2958.1999.01430.x; DONNELLY MI, 1981, EUR J BIOCHEM, V113, P555, DOI 10.1111/j.1432-1033.1981.tb05098.x; FERGUSON GP, 1993, MOL MICROBIOL, V9, P1297, DOI 10.1111/j.1365-2958.1993.tb01259.x; Fuhrer T, 2007, J BACTERIOL, V189, P8073, DOI 10.1128/JB.01027-07; Gerhardt A, 2000, ARCH MICROBIOL, V174, P189, DOI 10.1007/s002030000195; Gibson DL, 2006, J BACTERIOL, V188, P7722, DOI 10.1128/JB.00809-06; Goto S, 2002, NUCLEIC ACIDS RES, V30, P402, DOI 10.1093/nar/30.1.402; Grant AW, 2003, FEMS MICROBIOL LETT, V218, P93, DOI 10.1111/j.1574-6968.2003.tb11503.x; HARDMAN JK, 1962, METHOD ENZYMOL, V5, P778, DOI 10.1016/S0076-6879(62)05312-4; Hawes JW, 1996, FEBS LETT, V389, P263, DOI 10.1016/0014-5793(96)00597-2; Karp PD, 2002, NUCLEIC ACIDS RES, V30, P56, DOI 10.1093/nar/30.1.56; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Ko J, 2005, J BACTERIOL, V187, P5782, DOI 10.1128/JB.187.16.5782-5789.2005; LETTIERI JT, 1979, J PHARMACOL EXP THER, V208, P7; MAITRE M, 1975, EUR J BIOCHEM, V52, P157, DOI 10.1111/j.1432-1033.1975.tb03983.x; MAREK LE, 1988, J BACTERIOL, V170, P991, DOI 10.1128/jb.170.2.991-994.1988; Marvel CS, 1929, J AM CHEM SOC, V51, P260, DOI 10.1021/ja01376a032; MISRA K, 1995, BIOCHEM J, V305, P999, DOI 10.1042/bj3050999; Misra K, 1996, MOL CELL BIOCHEM, V156, P117, DOI 10.1007/BF00426333; Njau RK, 2001, CHEM-BIOL INTERACT, V130, P785, DOI 10.1016/S0009-2797(00)00234-9; Njau RK, 2000, J BIOL CHEM, V275, P38780, DOI 10.1074/jbc.M007432200; Ohashi Y, 2008, MOL BIOSYST, V4, P135, DOI 10.1039/b714176a; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Rost B, 2002, J MOL BIOL, V318, P595, DOI 10.1016/S0022-2836(02)00016-5; Saito N, 2006, J PROTEOME RES, V5, P1979, DOI 10.1021/pr0600576; Schaub J, 2006, BIOTECHNOL PROGR, V22, P1434, DOI 10.1021/bp050381q; Schomburg I, 2002, NUCLEIC ACIDS RES, V30, P47, DOI 10.1093/nar/30.1.47; Soga T, 2002, ANAL CHEM, V74, P2233, DOI 10.1021/ac020064n; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Soga T, 2007, J CHROMATOGR A, V1159, P125, DOI 10.1016/j.chroma.2007.05.054; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Tian WD, 2003, J MOL BIOL, V333, P863, DOI 10.1016/j.jmb.2003.08.057; Totemeyer S, 1998, MOL MICROBIOL, V27, P553, DOI 10.1046/j.1365-2958.1998.00700.x; VALENTIN HE, 1995, EUR J BIOCHEM, V227, P43, DOI 10.1111/j.1432-1033.1995.tb20358.x; Van Cauwenberghe OR, 1999, PHYTOCHEMISTRY, V52, P575, DOI 10.1016/S0031-9422(99)00301-5; van der Werf MJ, 2007, ANAL BIOCHEM, V370, P17, DOI 10.1016/j.ab.2007.07.022; Wang C, 2006, MOL MICROBIOL, V62, P45, DOI 10.1111/j.1365-2958.2006.05351.x; Winder CL, 2008, ANAL CHEM, V80, P2939, DOI 10.1021/ac7023409; WOLFF RA, 1995, PROTEIN EXPRES PURIF, V6, P206, DOI 10.1006/prep.1995.1026	52	51	52	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16442	16451		10.1074/jbc.M109.002089	http://dx.doi.org/10.1074/jbc.M109.002089			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19372223	Green Published, hybrid			2022-12-25	WOS:000266730900041
J	Cai, CX; Weisleder, N; Ko, JK; Komazaki, S; Sunada, Y; Nishi, M; Takeshima, H; Ma, JJ				Cai, Chuanxi; Weisleder, Noah; Ko, Jae-Kyun; Komazaki, Shinji; Sunada, Yoshihide; Nishi, Miyuki; Takeshima, Hiroshi; Ma, Jianjie			Membrane Repair Defects in Muscular Dystrophy Are Linked to Altered Interaction between MG53, Caveolin-3, and Dysferlin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTANT CAVEOLIN-3; SKELETAL-MUSCLE; T-TUBULE; OVEREXPRESSION; TRAFFICKING; MUTATIONS; APOPTOSIS; LIGAND; DAMAGE; HEART	Defective membrane repair can contribute to the progression of muscular dystrophy. Although mutations in caveolin-3 (Cav3) and dysferlin are linked to muscular dystrophy in human patients, the molecular mechanism underlying the functional interplay between Cav3 and dysferlin in membrane repair of muscle physiology and disease has not been fully resolved. We recently discovered that mitsugumin 53 (MG53), a muscle-specific TRIM (Tri-partite motif) family protein (TRIM72), contributes to intracellular vesicle trafficking and is an essential component of the membrane repair machinery in striated muscle. Here we show that MG53 interacts with dysferlin and Cav3 to regulate membrane repair in skeletal muscle. MG53 mediates active trafficking of intracellular vesicles to the sarcolemma and is required for movement of dysferlin to sites of cell injury during repair patch formation. Mutations in Cav3 (P104L, R26Q) that cause retention of Cav3 in Golgi apparatus result in aberrant localization of MG53 and dysferlin in a dominant-negative fashion, leading to defective membrane repair. Our data reveal that a molecular complex formed by MG53, dysferlin, and Cav3 is essential for repair of muscle membrane damage and also provide a therapeutic target for treatment of muscular and cardiovascular diseases that are linked to compromised membrane repair.	[Cai, Chuanxi; Weisleder, Noah; Ko, Jae-Kyun; Ma, Jianjie] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Phys & Biophys, Piscataway, NJ 08854 USA; [Ma, Jianjie] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Med, Piscataway, NJ 08854 USA; [Komazaki, Shinji] Saitama Med Sch, Dept Anat, Saitama 3500495, Japan; [Sunada, Yoshihide] Kawasaki Med Sch, Dept Internal Med, Kurashiki, Okayama 7010192, Japan; [Nishi, Miyuki; Takeshima, Hiroshi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, Kyoto 6068501, Japan	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Saitama Medical University; Kawasaki Medical School; Kyoto University	Ma, JJ (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Phys & Biophys, 675 Hoes La, Piscataway, NJ 08854 USA.	maj2@umdnj.edu	Cai, Chuanxi/AAW-1488-2020; Weisleder, Noah L/A-7098-2013	Weisleder, Noah L/0000-0002-2619-8022; Weisleder, Noah/0000-0003-2710-3088; Takeshima, Hiroshi/0000-0003-4525-3725	National Institutes of Health [RO1-HL069000, RO1-AG028856, K99/R00-AR054793]; Ministry of Education, Science, Sports and Culture of Japan; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K99AR054793, R00AR054793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028856] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-HL069000 and RO1-AG028856 ( to J.M. and H. T.) and National Institutes of Health K99 Award K99/R00-AR054793 ( to N.W.). This work was also supported by grants from the Ministry of Education, Science, Sports and Culture of Japan ( to H. T.) and the American Heart Association ( to C. C.).	Bansal D, 2004, TRENDS CELL BIOL, V14, P206, DOI 10.1016/j.tcb.2004.03.001; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Cai CX, 2009, J BIOL CHEM, V284, P3314, DOI 10.1074/jbc.M808866200; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Date T, 2003, J MOL CELL CARDIOL, V35, P811, DOI 10.1016/S0022-2828(03)00139-1; Fee DB, 2004, MUSCLE NERVE, V30, P375, DOI 10.1002/mus.20092; Galbiati F, 2000, P NATL ACAD SCI USA, V97, P9689, DOI 10.1073/pnas.160249097; Galbiati F, 2001, J BIOL CHEM, V276, P21425, DOI 10.1074/jbc.M100828200; Galbiati F, 1999, J BIOL CHEM, V274, P25632, DOI 10.1074/jbc.274.36.25632; Galbiati F, 2001, TRENDS MOL MED, V7, P435, DOI 10.1016/S1471-4914(01)02105-0; Glover L, 2007, TRAFFIC, V8, P785, DOI 10.1111/j.1600-0854.2007.00573.x; Guglieri M, 2008, CURR OPIN NEUROL, V21, P576, DOI 10.1097/WCO.0b013e32830efdc2; Hagiwara Y, 2000, HUM MOL GENET, V9, P3047, DOI 10.1093/hmg/9.20.3047; Han R, 2007, CURR OPIN CELL BIOL, V19, P409, DOI 10.1016/j.ceb.2007.07.001; Han R, 2007, J CLIN INVEST, V117, P1805, DOI 10.1172/JCI30848; Hernandez-Deviez DJ, 2008, J BIOL CHEM, V283, P6476, DOI 10.1074/jbc.M708776200; Hernandez-Deviez DJ, 2006, HUM MOL GENET, V15, P129, DOI 10.1093/hmg/ddi434; Klinge L, 2007, FASEB J, V21, P1768, DOI 10.1096/fj.06-7659com; Ko JK, 2005, AM J PHYSIOL-CELL PH, V288, pC1273, DOI 10.1152/ajpcell.00517.2004; McNally EM, 1998, HUM MOL GENET, V7, P871, DOI 10.1093/hmg/7.5.871; McNeil AK, 2006, J BIOL CHEM, V281, P35202, DOI 10.1074/jbc.M606406200; McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665; Minetti C, 1998, NAT GENET, V18, P365, DOI 10.1038/ng0498-365; Miyake K, 1995, J CELL BIOL, V131, P1737, DOI 10.1083/jcb.131.6.1737; Nishi M, 1999, J CELL BIOL, V147, P1473, DOI 10.1083/jcb.147.7.1473; Ohsawa Y, 2004, HUM MOL GENET, V13, P151, DOI 10.1093/hmg/ddh014; Pouvreau S, 2007, P NATL ACAD SCI USA, V104, P5235, DOI 10.1073/pnas.0700748104; Setsuta K, 2004, CIRC J, V68, P747, DOI 10.1253/circj.68.747; Smythe GM, 2003, J CELL SCI, V116, P4739, DOI 10.1242/jcs.00806; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; Sunada Y, 2001, HUM MOL GENET, V10, P173, DOI 10.1093/hmg/10.3.173; Towler MC, 2004, TRAFFIC, V5, P129, DOI 10.1111/j.1600-0854.2003.00164.x; Weisleder N, 2006, J CELL BIOL, V174, P639, DOI 10.1083/jcb.200604166; Yeh CH, 2006, SHOCK, V26, P262, DOI 10.1097/01.shk.0000225863.56714.96	34	194	207	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15894	15902		10.1074/jbc.M109.009589	http://dx.doi.org/10.1074/jbc.M109.009589			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19380584	hybrid, Green Published			2022-12-25	WOS:000266501000057
J	Foley, DA; Swartzentruber, KG; Colley, KJ				Foley, Deirdre A.; Swartzentruber, Kristin G.; Colley, Karen J.			Identification of Sequences in the Polysialyltransferases ST8Sia II and ST8Sia IV That Are Required for the Protein-specific Polysialylation of the Neural Cell Adhesion Molecule, NCAM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEVELOPMENTALLY-REGULATED MEMBER; POLYSIALIC ACID SYNTHESIS; AMINO-ACIDS; DIFFERENTIAL BIOSYNTHESIS; LINKED OLIGOSACCHARIDES; RECOGNITION DOMAIN; BRAIN DEVELOPMENT; ALPHA-HELIX; WILMS TUMOR; RAT-BRAIN	The polysialyltransferases ST8Sia II and ST8Sia IV polysialylate the glycans of a small subset of mammalian proteins. Their most abundant substrate is the neural cell adhesion molecule (NCAM). An acidic surface patch and a novel alpha-helix in the first fibronectin type III repeat of NCAM are required for the polysialylation of N-glycans on the adjacent immunoglobulin domain. Inspection of ST8SiaIV sequences revealed two conserved polybasic regions that might interact with the NCAM acidic patch or the growing polysialic acid chain. One is the previously identified polysialyltransferase domain (Nakata, D., Zhang, L., and Troy, F. A. (2006) Glycoconj. J. 23, 423-436). The second is a 35-amino acid polybasic region that contains seven basic residues and is equidistant from the large sialyl motif in both polysialyltransferases. We replaced these basic residues to evaluate their role in enzyme autopolysialylation and NCAM-specific polysialylation. We found that replacement of Arg(276)/Arg(277) or Arg(265) in the polysialyltransferase domain of ST8Sia IV decreased both NCAM polysialylation and autopolysialylation in parallel, suggesting that these residues are important for catalytic activity. In contrast, replacing Arg(82)/Arg(93) in ST8Sia IV with alanine substantially decreased NCAM-specific polysialylation while only partially impacting autopolysialylation, suggesting that these residues may be particularly important for NCAM polysialylation. Two conserved negatively charged residues, Glu(92) and Asp(94), surround Arg(93). Replacement of these residues with alanine largely inactivated ST8Sia IV, whereas reversing these residues enhanced enzyme autopolysialylation but significantly reduced NCAM polysialylation. In sum, we have identified selected amino acids in this conserved polysialyltransferase polybasic region that are critical for the protein-specific polysialylation of NCAM.	[Foley, Deirdre A.; Swartzentruber, Kristin G.; Colley, Karen J.] Univ Illinois, Dept Biochem & Mol Genet, Coll Med, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Colley, KJ (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Coll Med, 900 S Ashland Ave,M-C 669, Chicago, IL 60607 USA.	karenc@uic.edu			National Institutes of Health [RO1 GM63843]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063843] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM63843 ( to K. J. C.).	Angata K, 2000, J BIOL CHEM, V275, P18594, DOI 10.1074/jbc.M910204199; Angata K, 2004, J BIOL CHEM, V279, P25883, DOI 10.1074/jbc.M401562200; Angata K, 1997, J BIOL CHEM, V272, P7182, DOI 10.1074/jbc.272.11.7182; BARANSKI TJ, 1991, J BIOL CHEM, V266, P23365; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; Close BE, 2001, GLYCOBIOLOGY, V11, P997, DOI 10.1093/glycob/11.11.997; Close BE, 2003, J BIOL CHEM, V278, P30796, DOI 10.1074/jbc.M305390200; Close BE, 2000, J BIOL CHEM, V275, P4484, DOI 10.1074/jbc.275.6.4484; Close BE, 1998, J BIOL CHEM, V273, P34586, DOI 10.1074/jbc.273.51.34586; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; Curreli S, 2007, J BIOL CHEM, V282, P30346, DOI 10.1074/jbc.M702965200; DATTA AK, 1995, J BIOL CHEM, V270, P1497, DOI 10.1074/jbc.270.4.1497; Datta AK, 1998, J BIOL CHEM, V273, P9608, DOI 10.1074/jbc.273.16.9608; DRICKAMER K, 1993, GLYCOBIOLOGY, V3, P2, DOI 10.1093/glycob/3.1.2; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; FINNE J, 1983, BIOCHEM BIOPH RES CO, V112, P482, DOI 10.1016/0006-291X(83)91490-0; Geremia RA, 1997, GLYCOBIOLOGY, V7, pR5; Glaser F, 2001, PROTEINS, V43, P89, DOI 10.1002/1097-0134(20010501)43:2<89::AID-PROT1021>3.3.CO;2-8; Gluer S, 1998, J PEDIATR SURG, V33, P1516, DOI 10.1016/S0022-3468(98)90488-2; Hildebrandt H, 1998, CANCER RES, V58, P779; Hildebrandt H, 1998, J NEUROCHEM, V71, P2339; JAMES WM, 1987, BIOCHEM BIOPH RES CO, V148, P817, DOI 10.1016/0006-291X(87)90949-1; JANIN J, 1988, J MOL BIOL, V204, P155, DOI 10.1016/0022-2836(88)90606-7; Jeanneau C, 2004, J BIOL CHEM, V279, P13461, DOI 10.1074/jbc.M311764200; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kapitonov D, 1999, GLYCOCONJUGATE J, V16, P337, DOI 10.1023/A:1007091926413; Kapitonov D, 1999, GLYCOBIOLOGY, V9, P961, DOI 10.1093/glycob/9.10.961; Kiss JZ, 2001, BRAIN RES REV, V36, P175, DOI 10.1016/S0165-0173(01)00093-5; Kitazume-Kawaguchi S, 2001, J BIOL CHEM, V276, P15696, DOI 10.1074/jbc.M010371200; KOJIMA N, 1995, FEBS LETT, V360, P1, DOI 10.1016/0014-5793(95)00059-I; KOMMINOTH P, 1991, AM J PATHOL, V139, P297; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LIVINGSTON BD, 1993, J BIOL CHEM, V268, P11504; LIVINGSTON BD, 1988, J BIOL CHEM, V263, P9443; Ma BY, 2003, P NATL ACAD SCI USA, V100, P5772, DOI 10.1073/pnas.1030237100; Meiler J, 2003, P NATL ACAD SCI USA, V100, P12105, DOI 10.1073/pnas.1831973100; Mendiratta SS, 2006, J BIOL CHEM, V281, P36052, DOI 10.1074/jbc.M608073200; Mendiratta SS, 2005, J BIOL CHEM, V280, P32340, DOI 10.1074/jbc.M506217200; MENGELING BJ, 1995, P NATL ACAD SCI USA, V92, P502, DOI 10.1073/pnas.92.2.502; Miller E, 2008, J BIOL CHEM, V283, P1985, DOI 10.1074/jbc.M708160200; Muhlenhoff M, 1996, EMBO J, V15, P6943, DOI 10.1002/j.1460-2075.1996.tb01086.x; Nakata D, 2006, GLYCOCONJUGATE J, V23, P423, DOI 10.1007/s10719-006-6356-5; NAKAYAMA J, 1995, P NATL ACAD SCI USA, V92, P7031, DOI 10.1073/pnas.92.15.7031; NELSON RW, 1995, J BIOL CHEM, V270, P17171, DOI 10.1074/jbc.270.29.17171; Nishikawa A, 1997, J BIOL CHEM, V272, P19408, DOI 10.1074/jbc.272.31.19408; Oltmann-Norden I, 2008, J BIOL CHEM, V283, P1463, DOI 10.1074/jbc.M708463200; Ong E, 1998, GLYCOBIOLOGY, V8, P415, DOI 10.1093/glycob/8.4.415; PELKONEN S, 1989, J VIROL, V63, P4409, DOI 10.1128/JVI.63.10.4409-4416.1989; Phillips GR, 1997, DEV BRAIN RES, V102, P143, DOI 10.1016/S0165-3806(97)00069-2; ROTH J, 1988, AM J PATHOL, V133, P227; ROTH J, 1988, P NATL ACAD SCI USA, V85, P2999, DOI 10.1073/pnas.85.9.2999; ROTHBARD JB, 1982, J BIOL CHEM, V257, P1064; Sato C, 2000, J BIOL CHEM, V275, P15422, DOI 10.1074/jbc.275.20.15422; SCHEIDEGGER EP, 1995, J BIOL CHEM, V270, P22685, DOI 10.1074/jbc.270.39.22685; Sevigny MB, 1998, GLYCOBIOLOGY, V8, P857, DOI 10.1093/glycob/8.9.857; Steenbergen SM, 2006, J BACTERIOL, V188, P6195, DOI 10.1128/JB.00466-06; Steet R, 2005, J BIOL CHEM, V280, P33318, DOI 10.1074/jbc.M505994200; Suzuki M, 2005, GLYCOBIOLOGY, V15, P887, DOI 10.1093/glycob/cwi071; Tanaka F, 2000, CANCER RES, V60, P3072; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Yabe U, 2003, J BIOL CHEM, V278, P13875, DOI 10.1074/jbc.M300458200; YANG PF, 1992, J CELL BIOL, V116, P1487, DOI 10.1083/jcb.116.6.1487; YANG PF, 1994, J BIOL CHEM, V269, P23039; ZUBER C, 1992, J BIOL CHEM, V267, P9965	66	42	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15505	15516		10.1074/jbc.M809696200	http://dx.doi.org/10.1074/jbc.M809696200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19336400	Green Published, hybrid			2022-12-25	WOS:000266501000019
J	Kulkarni, MM; McMaster, WR; Kamysz, W; McGwire, BS				Kulkarni, Manjusha M.; McMaster, W. Robert; Kamysz, Wojciech; McGwire, Bradford S.			Antimicrobial Peptide-induced Apoptotic Death of Leishmania Results from Calcium-dependent, Caspase-independent Mitochondrial Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; ANTI-INFLAMMATORY AGENT; MELITTIN HYBRID PEPTIDE; DONOVANI PROMASTIGOTES; ENDOPLASMIC-RETICULUM; FLUFENAMIC ACID; PROTOZOAN; PARASITE; CYTOTOXICITY; AMASTIGOTES	alpha- and theta-defensin-, magainin-, and cathelicidin-type antimicrobial peptides (AMPs) can kill the pathogenic protozoan Leishmania. Comparative studies of a panel of AMPs have defined two distinct groups: those that induce nonapoptotic (Class I) and apoptotic (Class II) parasite killing based on their differential ability to induce phosphatidyl serine exposure, loss of mitochondrial membrane potential and decreased ATP production, induction of caspase-3/7 and -12 activity, and DNA degradation. Class II AMPs cause rapid influx of the vital stain SYTOX and an increase in intracellular Ca2+, whereas Class I AMPs cause a slow accumulation of SYTOX and do not affect intracellular Ca2+ levels. Inhibitors of cysteine or caspase proteases diminished fast influx of SYTOX through the surface membrane and DNA degradation but do not ablate the annexin V staining or the induction of apoptosis by Class II AMPs. This suggests that the changes in surface permeability in AMP-mediated apoptosis are related to the downstream events of intracellular cysteine/caspase activation or the loss of ATP. The activation of caspase-12-like activity was Ca2+-dependent, and inhibitors of voltage-gated and nonspecific Ca2+ channels diminished this activity. Flufenamic acid, a nonspecific Ca2+ inhibitor, completely ablated AMP-induced mitochondrial dysfunction and cell death, indicating the importance of dysregulation of Ca2+ in antimicrobial peptide-induced apoptosis.	[McGwire, Bradford S.] Ohio State Univ, Div Infect Dis, Ctr Microbial Interface Biol, Med Ctr, Columbus, OH 43210 USA; [McMaster, W. Robert] Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada; [Kamysz, Wojciech] Med Univ Gdansk, Fac Pharm, PL-80416 Gdansk, Poland	University System of Ohio; Ohio State University; University of British Columbia; Fahrenheit Universities; Medical University Gdansk	McGwire, BS (corresponding author), Ohio State Univ, Div Infect Dis, Ctr Microbial Interface Biol, Med Ctr, Biomed Res Tower,Rm 1012,460 W 12th Ave, Columbus, OH 43210 USA.	Brad.McGwire@osumc.edu		Kamysz, Wojciech/0000-0001-5335-3043	Ohio State University; American Heart Association; Canadian Institutes of Health [7399]	Ohio State University(Ohio State University); American Heart Association(American Heart Association); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported, in part, by the funding from the Ohio State University, American Heart Association Beginning Grant in-Aid and Scientist Development Grant awards (to B. S. M.), and Canadian Institutes of Health Grant MOP 7399 (to W. R. M.).	Arnoult D, 2002, CELL DEATH DIFFER, V9, P65, DOI 10.1038/sj.cdd.4400951; Bellm L, 2000, EXPERT OPIN INV DRUG, V9, P1731, DOI 10.1517/13543784.9.8.1731; BoseDasgupta S, 2008, CELL DEATH DIFFER, V15, P1629, DOI 10.1038/cdd.2008.85; Chen CY, 2001, CELL GROWTH DIFFER, V12, P297; Chicharro C, 2001, ANTIMICROB AGENTS CH, V45, P2441, DOI 10.1128/AAC.45.9.2441-2449.2001; Das M, 2001, J CELL SCI, V114, P2461; Diaz-Achirica P, 1998, BIOCHEM J, V330, P453, DOI 10.1042/bj3300453; Eichler T, 2006, TOXICOL SCI, V90, P392, DOI 10.1093/toxsci/kfj106; Ge YG, 1999, ANTIMICROB AGENTS CH, V43, P782, DOI 10.1128/AAC.43.4.782; Holzmuller P, 2002, INFECT IMMUN, V70, P3727, DOI 10.1128/IAI.70.7.3727-3735.2002; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jordani MC, 2000, MOL CELL BIOCHEM, V210, P153, DOI 10.1023/A:1007185825101; Joshi PB, 2002, MOL BIOCHEM PARASIT, V120, P33, DOI 10.1016/S0166-6851(01)00432-7; KIDERLEN AF, 1990, J IMMUNOL METHODS, V127, P11, DOI 10.1016/0022-1759(90)90334-R; Kulkarni MM, 2006, MOL MICROBIOL, V62, P1484, DOI 10.1111/j.1365-2958.2006.05459.x; Lee N, 2007, EUKARYOT CELL, V6, P1745, DOI 10.1128/EC.00123-07; MCDOUGALL P, 1983, BIOCHEM PHARMACOL, V32, P2595, DOI 10.1016/0006-2952(83)90024-2; MCDOUGALL P, 1988, BIOCHEM PHARMACOL, V37, P1327, DOI 10.1016/0006-2952(88)90790-3; McGwire BS, 2003, J INFECT DIS, V188, P146, DOI 10.1086/375747; Moreno SNJ, 2003, CURR OPIN MICROBIOL, V6, P359, DOI 10.1016/S1369-5274(03)00091-2; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Paris C, 2004, ANTIMICROB AGENTS CH, V48, P852, DOI 10.1128/AAC.48.3.852-859.2004; Sen N, 2004, J BIOL CHEM, V279, P52366, DOI 10.1074/jbc.M406705200; Sen N, 2004, CELL DEATH DIFFER, V11, P924, DOI 10.1038/sj.cdd.4401435; Sudhandiran G, 2003, J BIOL CHEM, V278, P25120, DOI 10.1074/jbc.M301975200; Van Zandbergen G, 2007, AUTOIMMUNITY, V40, P349, DOI 10.1080/08916930701356960; van Zandbergen G, 2006, P NATL ACAD SCI USA, V103, P13837, DOI 10.1073/pnas.0600843103; Yang L, 2000, BIOPHYS J, V79, P2002, DOI 10.1016/S0006-3495(00)76448-4; Zangger H, 2002, CELL DEATH DIFFER, V9, P1126, DOI 10.1038/sj.cdd.4401071; Zong WX, 2003, J CELL BIOL, V162, P59, DOI 10.1083/jcb.200302084	30	68	73	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15496	15504		10.1074/jbc.M809079200	http://dx.doi.org/10.1074/jbc.M809079200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19357081	Green Published, hybrid			2022-12-25	WOS:000266501000018
J	Levinger, L; Hopkinson, A; Desetty, R; Wilson, C				Levinger, Louis; Hopkinson, Angela; Desetty, Rohini; Wilson, Christopher			Effect of Changes in the Flexible Arm on tRNase Z Processing Kinetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER SUSCEPTIBILITY GENE; POLYADENYLATION FACTOR CPSF-73; TRANSFER-RNA; SUBSTRATE RECOGNITION; THERMOTOGA-MARITIMA; ZINC PHOSPHODIESTERASE; CRYSTAL-STRUCTURE; CLEAVAGE SITE; Z CATALYSIS; CCA	tRNAs are transcribed as precursors and processed in a series of reactions culminating in aminoacylation and translation. Central to tRNA maturation, the 3' end trailer can be endonucleolytically removed by tRNase Z. A flexible arm (FA) extruded from the body of tRNase Z consists of a structured alpha alpha beta beta hand that binds the elbow of pre-tRNA. Deleting the FA hand causes an almost 100-fold increase in K-m with little change in k(cat), establishing its contribution to substrate recognition/binding. Remarkably, a 40-residue Ala scan through the FA hand reveals a conserved leucine at the ascending stalk/hand boundary that causes practically the same increase in K-m as the hand deletion, thus nearly eliminating its ability to bind substrate. K-m also increases with substitutions in the GP(alpha 4-alpha 5) loop and at other conserved residues in the FA hand predicted to contact substrate based on the co-crystal structure. Substitutions that reduce k(cat) are clustered in the beta 10-beta 11 loop.	[Levinger, Louis; Hopkinson, Angela; Desetty, Rohini; Wilson, Christopher] CUNY York Coll, Dept Biol, Jamaica, NY 11451 USA	City University of New York (CUNY) System; York College NY (CUNY)	Levinger, L (corresponding author), 94-20 Guy R Brewer Blvd, Jamaica, NY 11451 USA.	louie@york.cuny.edu			National Institutes of Health [S06GM08153, R15CA120072, SC3GM084764]; Professional Staff Congress-City University of New York; NATIONAL CANCER INSTITUTE [R15CA120072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM084764, S06GM008153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Professional Staff Congress-City University of New York; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants S06GM08153, R15CA120072, and SC3GM084764. This work was also supported by grants from the Professional Staff Congress-City University of New York.	AEBI M, 1990, J BIOL CHEM, V265, P16216; Chen Y, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-12; de la Sierra-Gallay IL, 2006, NAT STRUCT MOL BIOL, V13, P376, DOI 10.1038/nsmb1066; de la Sierra-Gallay IL, 2005, NATURE, V433, P657, DOI 10.1038/nature03284; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dominski Z, 2005, CELL, V123, P37, DOI 10.1016/j.cell.2005.08.002; Dominski Z, 2007, CRIT REV BIOCHEM MOL, V42, P67, DOI 10.1080/10409230701279118; Dubrovsky EB, 2004, NUCLEIC ACIDS RES, V32, P255, DOI 10.1093/nar/gkh182; Fechter P, 1998, FEBS LETT, V436, P99, DOI 10.1016/S0014-5793(98)01096-5; Hoelzle A, 2008, RNA, V14, P928, DOI 10.1261/rna.933208; Hopkinson A, 2008, RNA BIOL, V5, P104, DOI 10.4161/rna.5.2.6086; Ishii R, 2005, J BIOL CHEM, V280, P14138, DOI 10.1074/jbc.M500355200; Ishii R, 2007, ACTA CRYSTALLOGR F, V63, P637, DOI 10.1107/S1744309107033623; Karkashon S, 2007, BIOCHEMISTRY-US, V46, P9380, DOI 10.1021/bi700578v; Korver W, 2003, INT J CANCER, V104, P283, DOI 10.1002/ijc.10945; Kostelecky B, 2006, J BACTERIOL, V188, P1607, DOI 10.1128/JB.188.4.1607-1614.2006; Levinger L, 1998, J BIOL CHEM, V273, P1015, DOI 10.1074/jbc.273.2.1015; Mandel CR, 2006, NATURE, V444, P953, DOI 10.1038/nature05363; MCCLAIN WH, 1987, SCIENCE, V238, P527, DOI 10.1126/science.2443980; Minagawa A, 2004, J BIOL CHEM, V279, P15688, DOI 10.1074/jbc.M313951200; Minagawa A, 2008, J MOL BIOL, V381, P289, DOI 10.1016/j.jmb.2008.05.016; Mohan A, 1999, RNA, V5, P245, DOI 10.1017/S1355838299981256; Nashimoto M, 1997, NUCLEIC ACIDS RES, V25, P1148, DOI 10.1093/nar/25.6.1148; Pellegrini O, 2003, EMBO J, V22, P4534, DOI 10.1093/emboj/cdg435; Redko Y, 2007, NAT REV MICROBIOL, V5, P278, DOI 10.1038/nrmicro1622; Schiffer S, 2003, BIOL CHEM, V384, P333, DOI 10.1515/BC.2003.039; Schiffer S, 2002, EMBO J, V21, P2769, DOI 10.1093/emboj/21.11.2769; Schilling O, 2005, J BIOL CHEM, V280, P17857, DOI 10.1074/jbc.M500591200; Shi PY, 1998, RNA, V4, P276; Shibata HS, 2005, J BIOL CHEM, V280, P22326, DOI 10.1074/jbc.M502048200; Smith MM, 2004, DEV BIOL, V266, P151, DOI 10.1016/j.ydbio.2003.10.016; Spath B, 2005, J BIOL CHEM, V280, P35440, DOI 10.1074/jbc.M506418200; Takaku H, 2004, NUCLEIC ACIDS RES, V32, P4429, DOI 10.1093/nar/gkh774; Takaku H, 2003, NUCLEIC ACIDS RES, V31, P2272, DOI 10.1093/nar/gkg337; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; Vogel A, 2004, BIOCHEMISTRY-US, V43, P10379, DOI 10.1021/bi049703+; Yan H, 2006, J BIOL CHEM, V281, P3926, DOI 10.1074/jbc.M509822200; Zareen N, 2005, J MOL BIOL, V350, P189, DOI 10.1016/j.jmb.2005.04.073; Zareen N, 2006, RNA, V12, P1104, DOI 10.1261/rna.4206	39	7	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15685	15691		10.1074/jbc.M900745200	http://dx.doi.org/10.1074/jbc.M900745200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19351879	Green Published, hybrid			2022-12-25	WOS:000266501000037
J	Ooga, T; Ohashi, Y; Kuramitsu, S; Koyama, Y; Tomita, M; Soga, T; Masui, R				Ooga, Takushi; Ohashi, Yoshiaki; Kuramitsu, Seiki; Koyama, Yoshinori; Tomita, Masaru; Soga, Tomoyoshi; Masui, Ryoji			Degradation of ppGpp by Nudix Pyrophosphatase Modulates the Transition of Growth Phase in the Bacterium Thermus thermophilus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTROPHORESIS-MASS-SPECTROMETRY; SPOT GENE-PRODUCT; ESCHERICHIA-COLI; STRINGENT RESPONSE; BACILLUS-SUBTILIS; GUANOSINE 5'-DIPHOSPHATE-3'-MONOPHOSPHATE; CELL-DIVISION; HYDROLASE; (P)PPGPP; PROTEIN	A major bacterial alarmone, guanosine 3', 5'-bispyrophosphate (ppGpp), controls cellular growth under conditions of nutritional starvation. For most bacteria, intracellular ppGpp levels are tightly controlled by the synthesis/degradation cycle of RelA and SpoT activities. This study shows a novel ppGpp regulatory protein governing the cellular growth of Thermus thermophilus, Ndx8, a member of the Nudix pyrophosphatase family that degrades ppGpp to yield guanosine 3', 5'-bisphosphate. The ndx8-null mutant strain exhibited early stage growth arrest accompanied by the stationary phase-specific morphologies and global transcriptional modulation under nutritionally defined conditions. Several possible substrate compounds of Ndx8, which specifically accumulated in the ndx8 mutant cells, were identified by employing a capillary electrophoresis time-of-flight mass spectrometry-based metabolomics approach. Among them, the hydrolytic activity of Ndx8 for ppGpp was significant not only in vitro but also in vivo. Finally, the elimination of ppGpp synthetic activity suppressed the observed phenotype of the ndx8 mutation, suggesting that the function of Ndx8 as a growth regulator is involved in ppGpp accumulation, which is thought to act as a trigger of the growth phase transition. These results suggest a novel mechanism of ppGpp-mediated growth control by the functional relay between Ndx8 and SpoT activity as ppGpp scavengers.	[Ohashi, Yoshiaki; Tomita, Masaru; Soga, Tomoyoshi] Human Metabolome Technol Inc, Yamagata 9970052, Japan; [Ooga, Takushi; Kuramitsu, Seiki; Masui, Ryoji] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Osaka 5600043, Japan; [Ohashi, Yoshiaki; Tomita, Masaru; Soga, Tomoyoshi] Keio Univ, Inst Adv Biosci, Yamagata 9970052, Japan; [Kuramitsu, Seiki; Masui, Ryoji] RIKEN, SPring Ctr 8, Harima Inst, Mikazuki, Hyogo 6795148, Japan; [Koyama, Yoshinori] Natl Inst Adv Ind Sci & Technol, Inst Biol Resources & Funct, Tsukuba, Ibaraki 3058566, Japan	Osaka University; Keio University; RIKEN; National Institute of Advanced Industrial Science & Technology (AIST)	Ohashi, Y (corresponding author), Human Metabolome Technol Inc, Yamagata 9970052, Japan.	ohashi@humanmetabolome.com; rmasui@bio.sci.osaka-u.ac.jp	Soga, Tomoyoshi/B-8105-2014	Soga, Tomoyoshi/0000-0001-9502-2509	RIKEN Structural Genomics/Proteomics Initiative; National Project on Protein Structural and Functional Analyses, Ministry of Education, Culture, Sports, Science and Technology of Japan; Yamagata Prefecture and Tsuruoka City; Japan Society for the Promotion of Science for Young Scientists [19-601]	RIKEN Structural Genomics/Proteomics Initiative; National Project on Protein Structural and Functional Analyses, Ministry of Education, Culture, Sports, Science and Technology of Japan; Yamagata Prefecture and Tsuruoka City; Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by the RIKEN Structural Genomics/Proteomics Initiative, the National Project on Protein Structural and Functional Analyses, Ministry of Education, Culture, Sports, Science and Technology of Japan, a grant from Yamagata Prefecture and Tsuruoka City, and Japan Society for the Promotion of Science for Young Scientists Research Fellowship 19-601 ( to T. O.).	AKINYANJU J, 1979, FEBS LETT, V107, P173, DOI 10.1016/0014-5793(79)80489-5; Alsaker KV, 2005, J BACTERIOL, V187, P7103, DOI 10.1128/JB.187.20.7103-7118.2005; AMES BN, 1960, J BIOL CHEM, V235, P769; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Braeken K, 2006, TRENDS MICROBIOL, V14, P45, DOI 10.1016/j.tim.2005.11.006; Cartwright JL, 2000, J BIOL CHEM, V275, P32925, DOI 10.1074/jbc.M005015200; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; Chang DE, 2002, MOL MICROBIOL, V45, P289, DOI 10.1046/j.1365-2958.2002.03001.x; COCHRAN JW, 1974, J BIOL CHEM, V249, P353; Crosse AM, 2000, LETT APPL MICROBIOL, V31, P332, DOI 10.1046/j.1472-765x.2000.00822.x; DAI K, 1991, J BACTERIOL, V173, P3500, DOI 10.1128/jb.173.11.3500-3506.1991; DEBOER HA, 1977, FEBS LETT, V79, P19, DOI 10.1016/0014-5793(77)80341-4; Dunn CA, 1999, J BIOL CHEM, V274, P32318, DOI 10.1074/jbc.274.45.32318; Eymann C, 2002, J BACTERIOL, V184, P2500, DOI 10.1128/JB.184.9.2500-2520.2002; Fisher David I., 2004, BMC Biochemistry, V5, P7, DOI 10.1186/1471-2091-5-7; GALLANT J, 1976, CELL, V7, P75, DOI 10.1016/0092-8674(76)90257-9; GENTRY DR, 1993, J BACTERIOL, V175, P7982, DOI 10.1128/JB.175.24.7982-7989.1993; Hale CA, 1997, CELL, V88, P175, DOI 10.1016/S0092-8674(00)81838-3; Hashimoto Y, 2001, FEBS LETT, V506, P231, DOI 10.1016/S0014-5793(01)02926-X; HEINEMEYER EA, 1978, EUR J BIOCHEM, V89, P125, DOI 10.1111/j.1432-1033.1978.tb20904.x; Hogg T, 2004, CELL, V117, P57, DOI 10.1016/S0092-8674(04)00260-0; JOHNSON GS, 1979, J BIOL CHEM, V254, P5483; Kasai K, 2006, J BACTERIOL, V188, P7111, DOI 10.1128/JB.00574-06; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Larsen N, 2006, APPL ENVIRON MICROB, V72, P1173, DOI 10.1128/AEM.72.2.1173-1179.2006; Legler PM, 2000, BIOCHEMISTRY-US, V39, P8603, DOI 10.1021/bi000537p; Lemos JA, 2007, MOL MICROBIOL, V65, P1568, DOI 10.1111/j.1365-2958.2007.05897.x; Letek M, 2007, INT MICROBIOL, V10, P271, DOI 10.2436/20.1501.01.36; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; Maksel D, 2001, BIOCHEM J, V357, P399, DOI 10.1042/0264-6021:3570399; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Murphy H, 2003, METHOD ENZYMOL, V371, P596; Murray KD, 1996, J MOL BIOL, V259, P41; Nanamiya H, 2008, MOL MICROBIOL, V67, P291, DOI 10.1111/j.1365-2958.2007.06018.x; NISHINO T, 1979, J BACTERIOL, V140, P671, DOI 10.1128/JB.140.2.671-679.1979; OHandley SF, 1996, J BIOL CHEM, V271, P24649, DOI 10.1074/jbc.271.40.24649; Ohashi Y, 2008, MOL BIOSYST, V4, P135, DOI 10.1039/b714176a; Ojha AK, 2000, INFECT IMMUN, V68, P4084, DOI 10.1128/IAI.68.7.4084-4091.2000; PAO CC, 1979, J BIOL CHEM, V254, P688; PAO CC, 1980, J BIOL CHEM, V255, P1830; PAO CC, 1981, BIOCHIM BIOPHYS ACTA, V677, P358, DOI 10.1016/0304-4165(81)90247-6; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Raskin DM, 2007, P NATL ACAD SCI USA, V104, P4636, DOI 10.1073/pnas.0611650104; SALES M, 1982, MOL GEN GENET, V186, P263, DOI 10.1007/BF00331860; SARUBBI E, 1988, MOL GEN GENET, V213, P214, DOI 10.1007/BF00339584; SEYFZADEH M, 1993, P NATL ACAD SCI USA, V90, P11004, DOI 10.1073/pnas.90.23.11004; Shinkai A, 2007, J BACTERIOL, V189, P3891, DOI 10.1128/JB.01739-06; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soga T, 2007, J CHROMATOGR A, V1159, P125, DOI 10.1016/j.chroma.2007.05.054; SOMERVILLE CR, 1979, MOL GEN GENET, V169, P315, DOI 10.1007/BF00382277; TANAKA T, 1981, J BIOCHEM-TOKYO, V89, P677, DOI 10.1093/oxfordjournals.jbchem.a133245; Traxler MF, 2006, P NATL ACAD SCI USA, V103, P2374, DOI 10.1073/pnas.0510995103; Wang ZR, 2002, P NATL ACAD SCI USA, V99, P12663, DOI 10.1073/pnas.192445599; XIAO H, 1991, J BIOL CHEM, V266, P5980; Xu WL, 2000, BIOCHEM BIOPH RES CO, V273, P753, DOI 10.1006/bbrc.2000.2999	57	49	50	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15549	15556		10.1074/jbc.M900582200	http://dx.doi.org/10.1074/jbc.M900582200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19346251	hybrid, Green Published			2022-12-25	WOS:000266501000023
J	Wang, YC; Hu, XB; He, F; Feng, F; Wang, L; Li, W; Zhang, P; Li, D; Jia, ZS; Liang, YM; Han, H				Wang, Yao-Chun; Hu, Xing-Bin; He, Fei; Feng, Fan; Wang, Lin; Li, Wei; Zhang, Ping; Li, Duan; Jia, Zhan-Sheng; Liang, Ying-Min; Han, Hua			Lipopolysaccharide-induced Maturation of Bone Marrow-derived Dendritic Cells Is Regulated by Notch Signaling through the Up-regulation of CXCR4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC PROGENITOR CELLS; TRANSCRIPTION FACTOR; LINEAGE DECISION; DIFFERENTIATION; LIGAND; MONOCYTES; PRECURSORS; DELTA-1; RBP-J-KAPPA/SU(H); MACROPHAGES	Dendritic cells (DCs) are professional antigen presenting cells to initiate immune response against pathogens, but mechanisms controlling the maturation of DCs are unclear. Here we report that, in the absence of recombination signal binding protein-J kappa (RBP-J, the transcription factor mediating Notch signaling), lipopolysaccharide-stimulated monocyte-derived DCs are arrested at a developmental stage with few dendrites, low major histocompatibility complex II (MHC II) expression, and reduced motility and antigen presentation ability. RBP-J null DCs had lower expression of CXCR4. Transduction with a CXCR4-expressing lentivirus rescued developmental arrest of RBP-J-deficient DCs. Activation of Notch signaling in DCs up-regulated CXCR4 expression and increased the outgrowth of dendrites and the expression of MHC II. These effects were abrogated by a CXCR4 inhibitor. Therefore, Notch signaling is essential for DCs to transit from a dendrite(low)MHC IIlow immature state into a dendrite(high)MHC IIhigh mature state, during the lipopolysaccharide-induced DC maturation, most likely through the up-regulation of CXCR4.	[Liang, Ying-Min; Han, Hua] Fourth Mil Med Univ, Tangdu Hosp, Dept Hematol, Xian 710038, Peoples R China; [Wang, Yao-Chun; Hu, Xing-Bin; He, Fei; Feng, Fan; Wang, Lin; Li, Wei; Zhang, Ping; Li, Duan; Jia, Zhan-Sheng; Han, Hua] Fourth Mil Med Univ, Tangdu Hosp, Dept Med Genet & Dev Biol, State Key Lab Canc Biol, Xian 710038, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Liang, YM (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Hematol, Xian 710038, Peoples R China.	liangym@fmmu.edu.cn; huahan@fmmu.edu.cn	Hu, XB/U-8501-2019	han, hua/0000-0002-1872-9700	National Natural Science Foundation [30600544, 30830067, 30801050, 30800454]; Ministry of Science and Technology of China [2006AA02A111, 2009CB521706, 2007AA02Z441]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by the National Natural Science Foundation ( Grants 30600544, 30830067, 30801050, and 30800454) and the Ministry of Science and Technology of China ( Grants 2006AA02A111, 2009CB521706, and 2007AA02Z441).	Ardavin C, 2001, TRENDS IMMUNOL, V22, P691, DOI 10.1016/S1471-4906(01)02059-2; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; BHARDWAJ N, 1992, J EXP MED, V175, P267, DOI 10.1084/jem.175.1.267; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cheng PY, 2007, BLOOD, V109, P507, DOI 10.1182/blood-2006-05-025601; Cheng PY, 2003, BLOOD, V102, P3980, DOI 10.1182/blood-2003-04-1034; Cheng PY, 2001, J IMMUNOL, V167, P4458, DOI 10.4049/jimmunol.167.8.4458; Diao J, 2004, J IMMUNOL, V173, P1826, DOI 10.4049/jimmunol.173.3.1826; Dontje W, 2006, BLOOD, V107, P2446, DOI 10.1182/blood-2005-05-2090; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Honjo T, 1996, GENES CELLS, V1, P1, DOI 10.1046/j.1365-2443.1996.10010.x; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kabashima K, 2007, AM J PATHOL, V171, P1249, DOI 10.2353/ajpath.2007.070225; Kabashima K, 2007, BIOCHEM BIOPH RES CO, V361, P1012, DOI 10.1016/j.bbrc.2007.07.128; Kohara H, 2007, BLOOD, V110, P4153, DOI 10.1182/blood-2007-04-084210; Leon B, 2005, SEMIN IMMUNOL, V17, P313, DOI 10.1016/j.smim.2005.05.013; Leon B, 2004, BLOOD, V103, P2668, DOI 10.1182/blood-2003-01-0286; MACATONIA SE, 1986, IMMUNOLOGY, V59, P509; Moll H, 2003, CELL MICROBIOL, V5, P493, DOI 10.1046/j.1462-5822.2003.00291.x; Ohishi K, 2000, BLOOD, V95, P2847, DOI 10.1182/blood.V95.9.2847.009k19_2847_2854; Ohishi K, 2001, BLOOD, V98, P1402, DOI 10.1182/blood.V98.5.1402; Olivier A, 2006, BLOOD, V107, P2694, DOI 10.1182/blood-2005-03-0970; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Shi ZX, 2008, PROTEIN EXPRES PURIF, V59, P242, DOI 10.1016/j.pep.2008.02.004; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Weijzen S, 2002, J IMMUNOL, V169, P4273, DOI 10.4049/jimmunol.169.8.4273; Williams CK, 2008, CANCER RES, V68, P1889, DOI 10.1158/0008-5472.CAN-07-2181; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317	36	44	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15993	16003		10.1074/jbc.M901144200	http://dx.doi.org/10.1074/jbc.M901144200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19357083	Green Published, hybrid			2022-12-25	WOS:000266501000065
J	Zhu, JZ; Wu, XZ; Goel, S; Gowda, NM; Kumar, S; Krishnegowda, G; Mishra, G; Weinberg, R; Li, G; Gaestel, M; Muta, T; Gowda, DC				Zhu, Jianzhong; Wu, Xianzhu; Goel, Suchi; Gowda, Nagaraj M.; Kumar, Sanjeev; Krishnegowda, Gowdahalli; Mishra, Gourav; Weinberg, Rebecca; Li, Guangfu; Gaestel, Matthias; Muta, Tatsushi; Gowda, D. Channe			MAPK-activated Protein Kinase 2 Differentially Regulates Plasmodium falciparum Glycosylphosphatidylinositol-induced Production of Tumor Necrosis Factor-alpha and Interleukin-12 in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B-ZETA; MESSENGER-RNA STABILITY; GENE-EXPRESSION; TNF-ALPHA; RICH ELEMENT; PROINFLAMMATORY RESPONSES; INNATE IMMUNITY; NITRIC-OXIDE; MALARIA; INDUCTION	Proinflammatory responses induced by Plasmodium falciparum glycosylphosphatidylinositols (GPIs) are thought to be involved in malaria pathogenesis. In this study, we investigated the role of MAPK-activated protein kinase 2 (MK2) in the regulation of tumor necrosis factor-alpha(TNF-alpha) and interleukin (IL)12, two of the major inflammatory cytokines produced by macrophages stimulated with GPIs. We show that MK2 differentially regulates the GPI-induced production of TNF-alpha and IL-12. Although TNF-alpha production was markedly decreased, IL-12 expression was increased by 2-3-fold in GPI-stimulated MK2(-/-) macrophages compared with wild type (WT) cells. MK2(-/-) macrophages produced markedly decreased levels of TNF-alpha than WT macrophages mainly because of lower mRNA stability and translation. In the case of IL-12, mRNA was substantially higher in MK2(-/-) macrophages than WT. This enhanced production is due to increased NF-kappa B binding to the gene promoter, a markedly lower level expression of the transcriptional repressor factor c-Maf, and a decreased binding of GAP-12 to the gene promoter in MK2(-/-) macrophages. Thus, our data demonstrate for the first time the role of MK2 in the transcriptional regulation of IL-12. Using the protein kinase inhibitors SB203580 and U0126, we also show that the ERK and p38 pathways regulate TNF-alpha and IL-12 production, and that both inhibitors can reduce phosphorylation of MK2 in response to GPIs and other toll-like receptor ligands. These results may have important implications for developing therapeutics for malaria and other infectious diseases.	[Zhu, Jianzhong; Wu, Xianzhu; Goel, Suchi; Gowda, Nagaraj M.; Kumar, Sanjeev; Krishnegowda, Gowdahalli; Mishra, Gourav; Weinberg, Rebecca; Li, Guangfu; Gowda, D. Channe] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Gaestel, Matthias] Hannover Med Sch, Inst Biochem, D-30625 Hannover, Germany; [Muta, Tatsushi] Tohoku Univ, Grad Sch Life Sci, Lab Cell Recognit & Response, Sendai, Miyagi 9808578, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Hannover Medical School; Tohoku University	Gowda, DC (corresponding author), Penn State Univ, Coll Med, Dept Biochem & Mol Biol, 500 Univ Dr, Hershey, PA 17033 USA.	gowda@psu.edu	Gaestel, Matthias/A-6560-2013	Gaestel, Matthias/0000-0002-4944-4652; GOWDA, KRISHNE/0000-0002-6042-0520; Kumar, Sanjeev/0000-0002-4454-9914; Li, Guangfu/0000-0002-9817-568X	National Institutes of Health [AI41139]; NIAID; Pennsylvania Department of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041139] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Pennsylvania Department of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI41139 from NIAID. This work was also supported by the Pennsylvania Department of Health.	Amarante-Paffaro A, 2004, REPRODUCTION, V128, P207, DOI 10.1530/rep.1.00214; Ariyasinghe A, 2006, J PARASITOL, V92, P531, DOI 10.1645/GE-551R1.1; Artavanis-Tsakonas K, 2003, CLIN EXP IMMUNOL, V133, P145, DOI 10.1046/j.1365-2249.2003.02174.x; Becker C, 2001, J IMMUNOL, V167, P2608, DOI 10.4049/jimmunol.167.5.2608; BIRON CA, 1995, CURR OPIN IMMUNOL, V7, P485, DOI 10.1016/0952-7915(95)80093-X; Cao SJ, 2002, J IMMUNOL, V169, P5715, DOI 10.4049/jimmunol.169.10.5715; COT S, 1994, J INFECT DIS, V169, P1417, DOI 10.1093/infdis/169.6.1417; Coxon PY, 2003, CELL SIGNAL, V15, P993, DOI 10.1016/S0898-6568(03)00074-3; Dimopoulos G, 2001, CURR OPIN IMMUNOL, V13, P79, DOI 10.1016/S0952-7915(00)00186-2; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Frevel MAE, 2003, MOL CELL BIOL, V23, P425, DOI 10.1128/MCB.23.2.425-436.2003; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Gasque P, 2004, MOL IMMUNOL, V41, P1089, DOI 10.1016/j.molimm.2004.06.011; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Kang YJ, 2008, J IMMUNOL, V180, P5075, DOI 10.4049/jimmunol.180.7.5075; KARUNAWEERA ND, 1992, P NATL ACAD SCI USA, V89, P3200, DOI 10.1073/pnas.89.8.3200; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Kotlyarov A, 2002, BIOCHEM SOC T, V30, P959, DOI 10.1042/BST0300959; Kotlyarov A, 2002, MOL CELL BIOL, V22, P4827, DOI 10.1128/MCB.22.13.4827-4835.2002; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Lehner MD, 2002, J IMMUNOL, V168, P4667, DOI 10.4049/jimmunol.168.9.4667; Lukas SM, 2004, BIOCHEMISTRY-US, V43, P9950, DOI 10.1021/bi049508v; Malaguarnera L, 2002, LANCET INFECT DIS, V2, P472, DOI 10.1016/S1473-3099(02)00344-4; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Muta T, 2006, VITAM HORM, V74, P301, DOI 10.1016/S0083-6729(06)74012-2; Naik RS, 2003, J BIOL CHEM, V278, P2036, DOI 10.1074/jbc.M208976200; Naik RS, 2000, J EXP MED, V192, P1563, DOI 10.1084/jem.192.11.1563; Neininger A, 2002, J BIOL CHEM, V277, P3065, DOI 10.1074/jbc.C100685200; Ramos-Payan R, 2003, SCAND J IMMUNOL, V57, P439, DOI 10.1046/j.1365-3083.2003.01250.x; Rousseau S, 2008, J CELL SCI, V121, P149, DOI 10.1242/jcs.018671; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Sandler H, 2008, BIOCHEM SOC T, V36, P491, DOI 10.1042/BST0360491; Sanjabi S, 2000, P NATL ACAD SCI USA, V97, P12705, DOI 10.1073/pnas.230436397; SCHOFIELD L, 1993, J EXP MED, V177, P145, DOI 10.1084/jem.177.1.145; SCHOFIELD L, 1993, ANN TROP MED PARASIT, V87, P617, DOI 10.1080/00034983.1993.11812820; SHERMAN IW, 1998, MALARIA PARASITE BIO, P1; Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; STOKOE D, 1992, EMBO J, V11, P3985, DOI 10.1002/j.1460-2075.1992.tb05492.x; Su Z, 2000, INFECT IMMUN, V68, P4399, DOI 10.1128/IAI.68.8.4399-4406.2000; Sugimoto K, 2004, J CLIN INVEST, V114, P857, DOI 10.1172/JCI200420014; Trinh DV, 2008, J MOL BIOL, V379, P122, DOI 10.1016/j.jmb.2008.03.060; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamazaki S, 2005, J BIOL CHEM, V280, P1678, DOI 10.1074/jbc.M409983200; Zhang T, 2002, BIOCHEM SOC T, V30, P952, DOI 10.1042/BST0300952; Zhu JZ, 2005, J BIOL CHEM, V280, P8617, DOI 10.1074/jbc.M413539200	46	31	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15750	15761		10.1074/jbc.M901111200	http://dx.doi.org/10.1074/jbc.M901111200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19359247	Green Published, hybrid			2022-12-25	WOS:000266501000044
J	Teufel, DP; Bycroft, M; Fersht, AR				Teufel, D. P.; Bycroft, M.; Fersht, A. R.			Regulation by phosphorylation of the relative affinities of the N-terminal transactivation domains of p53 for p300 domains and Mdm2	ONCOGENE			English	Article						CBP; IHD; Mdm4; fluorescence anisotropy; phospho-peptides; transactivation	ACTIVATION DOMAINS; IN-VIVO; BINDING; PROTEIN; STABILIZATION; TRANSCRIPTION; COACTIVATORS; ACETYLATION; COMPLEX; CBP	The transcriptional activity of the tumour suppressor, p53, requires direct binding between its transactivation domain (TAD, 1-57) and the transcriptional coactivator, p300. We systematically assessed the role of TAD phosphorylation on binding of the p300 domains CH3, Taz1, Kix and IBiD. Thr18 phosphorylation increased the affinity up to sevenfold for CH3 and Taz1, with smaller increases from phosphorylation of Ser20, Ser15, Ser37, Ser33, Ser46 and Thr55. Binding of Kix and IBiD was less sensitive to phosphorylation. Strikingly, hepta-phosphorylation of all Ser and Thr residues increased binding 40- and 80-fold with CH3 and Taz1, respectively, but not with Kix or IBiD. Substitution of all phospho-sites with aspartates partially mimicked the effects of hepta-phosphorylation. Mdm2, the main negative regulator of p53, competes with p300 for binding to TAD. Binding of Mdm2 to TAD was reduced significantly only on phosphorylation of Thr18 (sevenfold) or by hepta-phosphorylation (24-fold). The relative affinities of Mdm2 and p300 for p53 TAD can thus be changed by up to three orders of magnitude by phosphorylation. Accordingly, phosphorylation of Thr18 and hepta-phosphorylation dramatically shifts the balance towards favouring the binding of p300 with p53, and is thus likely to be an important factor in its regulation. Oncogene (2009) 28, 2112-2118; doi:10.1038/onc.2009.71; published online 13 April 2009	[Fersht, A. R.] Univ Cambridge, Ctr Mrc, Dept Chem, MRC Ctr Prot Engn, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology; University of Cambridge	Fersht, AR (corresponding author), Univ Cambridge, Ctr Mrc, Dept Chem, MRC Ctr Prot Engn, Hills Rd, Cambridge CB2 0QH, England.	arf25@cam.ac.uk	Bycroft, Mark/D-9446-2017; Fersht, Alan R/B-2189-2008	Bycroft, Mark/0000-0002-0673-2216; Teufel, Daniel/0000-0002-6527-2117	Medical Research Council [MC_U105474168, U.1054.00.012(74168)] Funding Source: Medline; MRC [MC_U105474168] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ashcroft M, 1999, MOL CELL BIOL, V19, P1751; Bean LJH, 2002, J BIOL CHEM, V277, P1864, DOI 10.1074/jbc.M108881200; Blattner C, 1999, ONCOGENE, V18, P1723, DOI 10.1038/sj.onc.1202480; Bottger V, 1999, ONCOGENE, V18, P189, DOI 10.1038/sj.onc.1202281; Brown CJ, 2008, CELL CYCLE, V7, P608, DOI 10.4161/cc.7.5.5488; Chao C, 2006, EMBO J, V25, P2615, DOI 10.1038/sj.emboj.7601167; Chi SW, 2005, J BIOL CHEM, V280, P38795, DOI 10.1074/jbc.M508578200; Di Lello P, 2006, MOL CELL, V22, P731, DOI 10.1016/j.molcel.2006.05.007; Dornan D, 2001, EMBO REP, V2, P139, DOI 10.1093/embo-reports/kve025; Dornan D, 2003, J BIOL CHEM, V278, P13431, DOI 10.1074/jbc.M211460200; Johnson TM, 2006, CELL DEATH DIFFER, V13, P902, DOI 10.1038/sj.cdd.4401902; Knights CD, 2003, J BIOL CHEM, V278, P52890, DOI 10.1074/jbc.M300279200; Lai ZH, 2000, ARCH BIOCHEM BIOPHYS, V381, P278, DOI 10.1006/abbi.2000.1998; Lambert PF, 1998, J BIOL CHEM, V273, P33048, DOI 10.1074/jbc.273.49.33048; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Legge GB, 2004, J MOL BIOL, V343, P1081, DOI 10.1016/j.jmb.2004.08.087; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; Liu G, 2003, J BIOL CHEM, V278, P17557, DOI 10.1074/jbc.M210696200; LU H, 1995, P NATL ACAD SCI USA, V92, P5154, DOI 10.1073/pnas.92.11.5154; Marine JC, 2004, CELL CYCLE, V3, P900; Melcher K, 2000, J MOL BIOL, V301, P1097, DOI 10.1006/jmbi.2000.4034; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Polley S, 2008, J MOL BIOL, V376, P8, DOI 10.1016/j.jmb.2007.11.082; Saito S, 2003, J BIOL CHEM, V278, P37536, DOI 10.1074/jbc.M305135200; Sakaguchi K, 2000, J BIOL CHEM, V275, P9278, DOI 10.1074/jbc.275.13.9278; Schon O, 2002, J MOL BIOL, V323, P491, DOI 10.1016/S0022-2836(02)00852-5; Teufel DP, 2007, P NATL ACAD SCI USA, V104, P7009, DOI 10.1073/pnas.0702010104; Teufel DP, 2003, BIOCHEMISTRY-US, V42, P1451, DOI 10.1021/bi026852o; THUT CJ, 1995, SCIENCE, V267, P100, DOI 10.1126/science.7809597; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Wells M, 2008, P NATL ACAD SCI USA, V105, P5762, DOI 10.1073/pnas.0801353105; Xu Y, 2003, CELL DEATH DIFFER, V10, P1213, DOI 10.1038/sj.cdd.4401292; Zor T, 2002, J BIOL CHEM, V277, P42241, DOI 10.1074/jbc.M207361200	33	105	108	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 21	2009	28	20					2112	2118		10.1038/onc.2009.71	http://dx.doi.org/10.1038/onc.2009.71			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	448BI	19363523	Green Accepted			2022-12-25	WOS:000266235800005
J	Saccone, SF; Bierut, LJ; Chesler, EJ; Kalivas, PW; Lerman, C; Saccone, NL; Uhl, GR; Li, CY; Philip, VM; Edenberg, HJ; Sherry, ST; Feolo, M; Moyzis, RK; Rutter, JL				Saccone, Scott F.; Bierut, Laura J.; Chesler, Elissa J.; Kalivas, Peter W.; Lerman, Caryn; Saccone, Nancy L.; Uhl, George R.; Li, Chuan-Yun; Philip, Vivek M.; Edenberg, Howard J.; Sherry, Stephen T.; Feolo, Michael; Moyzis, Robert K.; Rutter, Joni L.			Supplementing High-Density SNP Microarrays for Additional Coverage of Disease-Related Genes: Addiction as a Paradigm	PLOS ONE			English	Article								Commercial SNP microarrays now provide comprehensive and affordable coverage of the human genome. However, some diseases have biologically relevant genomic regions that may require additional coverage. Addiction, for example, is thought to be influenced by complex interactions among many relevant genes and pathways. We have assembled a list of 486 biologically relevant genes nominated by a panel of experts on addiction. We then added 424 genes that showed evidence of association with addiction phenotypes through mouse QTL mappings and gene co-expression analysis. We demonstrate that there are a substantial number of SNPs in these genes that are not well represented by commercial SNP platforms. We address this problem by introducing a publicly available SNP database for addiction. The database is annotated using numeric prioritization scores indicating the extent of biological relevance. The scores incorporate a number of factors such as SNP/gene functional properties (including synonymy and promoter regions), data from mouse systems genetics and measures of human/mouse evolutionary conservation. We then used HapMap genotyping data to determine if a SNP is tagged by a commercial microarray through linkage disequilibrium. This combination of biological prioritization scores and LD tagging annotation will enable addiction researchers to supplement commercial SNP microarrays to ensure comprehensive coverage of biologically relevant regions.			Saccone, SF (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.	ssaccone@wustl.edu	Chesler, Elissa/K-4641-2019; Bierut, Laura Jean/W-6806-2019; Lerman, Caryn/AHC-5180-2022	Chesler, Elissa/0000-0002-5642-5062; Bierut, Laura Jean/0000-0002-9952-4810; Li, Chuan-Yun/0000-0002-8008-8430; Edenberg, Howard/0000-0003-0344-9690; Rutter, Joni/0000-0002-6502-2361; Sherry, Stephen/0000-0002-7982-076X; Philip, Vivek/0000-0001-5126-707X	NATIONAL CANCER INSTITUTE [P01CA089392, P50CA084718] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA013513, U01AA013499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020677, K02DA021237, ZIADA000401, R01DA019963, U01DA020830, Z01DA000537, K01DA015129, ZIADA000537, Z01DA000401] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIHLM200888] Funding Source: NIH RePORTER; NCI NIH HHS [CA084718, P01 CA089392, P50 CA084718, CA089392] Funding Source: Medline; NHGRI NIH HHS [HG004422, U01 HG004422] Funding Source: Medline; NIAAA NIH HHS [U01 AA013513, AA13499, U01 AA013499, AA13513] Funding Source: Medline; NIDA NIH HHS [DA020830, DA019963, K02 DA021237, DA021237, U01 DA020830, R01 DA019963, K01 DA015129, R01 DA020677, DA020677, DA015129, DA07079] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; CRADDOCK N, 2008, MOL PSYCHIAT; Fredette BJ, 1996, DEVELOPMENT, V122, P3163; HAWKS J, 2007, P NATL ACAD SCI US; HODGKINSON CA, 2008, ALCOHOL ALCOHOL; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Ivanov DB, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1174, DOI 10.1023/A:1012445316415; Kipmen-Korgun D, 2005, J CARDIOVASC PHARM, V45, P418, DOI 10.1097/01.fjc.0000157458.91433.86; Li CY, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040002; LI M, 2008, EUR J HUM GENET; Loots G, 2007, BIOINFORMATICS, V23, P122, DOI 10.1093/bioinformatics/btl546; Nielsen DA, 2008, MOL PSYCHIATR, V13, P417, DOI 10.1038/sj.mp.4002147; Philippova M, 2005, FASEB J, V19, P588, DOI 10.1096/fj.04-2430fje; Saccone SF, 2008, BIOINFORMATICS, V24, P1805, DOI 10.1093/bioinformatics/btn315; *SAS I, 2004, SAS REL 9 1 3; Takeuchi T, 2000, J NEUROCHEM, V74, P1489, DOI 10.1046/j.1471-4159.2000.0741489.x; Uhl GR, 2008, ARCH GEN PSYCHIAT, V65, P683, DOI 10.1001/archpsyc.65.6.683; WALL L, 1987, PEARL VERSION 5 8 5; Wang E, 2004, AM J HUM GENET, V74, P931, DOI 10.1086/420854; Wang ET, 2006, P NATL ACAD SCI USA, V103, P135, DOI 10.1073/pnas.0509691102	21	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2009	4	4							e5225	10.1371/journal.pone.0005225	http://dx.doi.org/10.1371/journal.pone.0005225			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VA	19381300	Green Submitted, gold, Green Published			2022-12-25	WOS:000265513800006
J	Estep, PW; Warner, JB; Bulyk, ML				Estep, Preston Wayne, III; Warner, Jason B.; Bulyk, Martha L.			Short-Term Calorie Restriction in Male Mice Feminizes Gene Expression and Alters Key Regulators of Conserved Aging Regulatory Pathways	PLOS ONE			English	Article							LIFE-SPAN EXTENSION; DIETARY RESTRICTION; MAMMALIAN TARGET; BODY-WEIGHT; DWARF MICE; GROWTH; RAPAMYCIN; STRESS; LONGEVITY; TOR	Background: Calorie restriction (CR) is the only intervention known to extend lifespan in a wide range of organisms, including mammals. However, the mechanisms by which it regulates mammalian aging remain largely unknown, and the involvement of the TOR and sirtuin pathways (which regulate aging in simpler organisms) remain controversial. Additionally, females of most mammals appear to live longer than males within species; and, although it remains unclear whether this holds true for mice, the relationship between sex-biased and CR-induced gene expression remains largely unexplored. Methodology/Principal Findings: We generated microarray gene expression data from livers of male mice fed high calorie or CR diets, and we find that CR significantly changes the expression of over 3,000 genes, many between 10- and 50-fold. We compare our data to the GenAge database of known aging-related genes and to prior microarray expression data of genes expressed differently between male and female mice. CR generally feminizes gene expression and many of the most significantly changed individual genes are involved in aging, hormone signaling, and p53-associated regulation of the cell cycle and apoptosis. Among the genes showing the largest and most statistically significant CR-induced expression differences are Ddit4, a key regulator of the TOR pathway, and Nnmt, a regulator of lifespan linked to the sirtuin pathway. Using western analysis we confirmed post-translational inhibition of the TOR pathway. Conclusions: Our data show that CR induces widespread gene expression changes and acts through highly evolutionarily conserved pathways, from microorganisms to mammals, and that its life-extension effects might arise partly from a shift toward a gene expression profile more typical of females.			Estep, PW (corresponding author), Longenity Inc, Lincoln, MA USA.	pestep@post.harvard.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR051287] Funding Source: NIH RePORTER; NIAMS NIH HHS [F32 AR051287] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Amador-Noguez D, 2004, AGING CELL, V3, P423, DOI 10.1111/j.1474-9728.2004.00125.x; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Bauer M, 2004, PHYSIOL GENOMICS, V17, P230, DOI 10.1152/physiolgenomics.00203.2003; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Berriz GF, 2003, BIOINFORMATICS, V19, P2502, DOI 10.1093/bioinformatics/btg363; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; BURGER JM, 2004, SCI AGING KNOWLEDGE, pPE30, DOI DOI 10.1126/SAGEKE.2004.28.PE30; Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598; Corradetti MN, 2005, J BIOL CHEM, V280, P9769, DOI 10.1074/jbc.C400557200; de Magalhaes JP, 2005, NUCLEIC ACIDS RES, V33, pD537, DOI 10.1093/nar/gki017; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Dhahbi JM, 2004, P NATL ACAD SCI USA, V101, P5524, DOI 10.1073/pnas.0305300101; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Fu CX, 2006, MECH AGEING DEV, V127, P905, DOI 10.1016/j.mad.2006.09.006; Fu CX, 2004, J NUTR, V134, P2965, DOI 10.1093/jn/134.11.2965; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; HOAG WG, 1963, ANN NY ACAD SCI, V108, P805, DOI 10.1111/j.1749-6632.1963.tb13421.x; *I LAB AN RES I, 1996, GUID CAR US LAB AN; INGRAM DK, 1982, MECH AGEING DEV, V20, P253, DOI 10.1016/0047-6374(82)90092-6; Jiang WQ, 2008, CANCER RES, V68, P5492, DOI 10.1158/0008-5472.CAN-07-6721; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaeberlein M, 2007, AGING CELL, V6, P731, DOI 10.1111/j.1474-9726.2007.00341.x; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kawauchi K, 2005, J IMMUNOL, V174, P5261, DOI 10.4049/jimmunol.174.9.5261; Kendziorski C, 2005, P NATL ACAD SCI USA, V102, P4252, DOI 10.1073/pnas.0500607102; Kennedy BK, 2007, CELL MOL LIFE SCI, V64, P1323, DOI 10.1007/s00018-007-6470-y; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Lane MA, 2001, ANN NY ACAD SCI, V928, P287; Li Y, 2002, J BIOL CHEM, V277, P11352, DOI 10.1074/jbc.M109062200; Liang HY, 2003, EXP GERONTOL, V38, P1353, DOI 10.1016/j.exger.2003.10.019; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Linford NJ, 2007, AGING CELL, V6, P673, DOI 10.1111/j.1474-9726.2007.00319.x; Liss B, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf088; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; Miller RA, 2002, AGING CELL, V1, P22, DOI 10.1046/j.1474-9728.2002.00006.x; Miller RA, 2002, MOL ENDOCRINOL, V16, P2657, DOI 10.1210/me.2002-0142; *NCBI, 2007, ENTR GEN; Novoradovskaya N, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-20; Okamura S, 2001, MOL CELL, V8, P85, DOI 10.1016/S1097-2765(01)00284-2; ORENTREICH N, 1993, J NUTR, V123, P269; PROMISLOW DEL, 1992, P ROY SOC B-BIOL SCI, V247, P203, DOI 10.1098/rspb.1992.0030; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Ramsey JJ, 2000, EXP GERONTOL, V35, P1131, DOI 10.1016/S0531-5565(00)00166-2; Redman LM, 2009, MOL CELL ENDOCRINOL, V299, P129, DOI 10.1016/j.mce.2008.10.014; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SEGALL PE, 1976, MECH AGEING DEV, V5, P109, DOI 10.1016/0047-6374(76)90012-9; Selman C, 2006, PHYSIOL GENOMICS, V27, P187, DOI 10.1152/physiolgenomics.00084.2006; Sharp ZD, 2005, J GERONTOL A-BIOL, V60, P293, DOI 10.1093/gerona/60.3.293; Shimokawa I, 2003, FASEB J, V17, P1108, DOI 10.1096/fj.02-0819fje; Sjogren K, 2002, Minerva Endocrinol, V27, P299; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Strand AD, 2002, HUM MOL GENET, V11, P2207, DOI 10.1093/hmg/11.19.2207; Suckow M. A., 2000, LAB MOUSE; Swindell WR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-353; Tsuchiya M, 2006, AGING CELL, V5, P505, DOI 10.1111/j.1474-9726.2006.00240.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Walford RL, 2002, J GERONTOL A-BIOL, V57, pB211, DOI 10.1093/gerona/57.6.B211; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; YUAN R, 2008, AGING STUDY LIFESPAN	73	62	68	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2009	4	4							e5242	10.1371/journal.pone.0005242	http://dx.doi.org/10.1371/journal.pone.0005242			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TU	19370158	Green Published, gold			2022-12-25	WOS:000265510600006
J	Hahn, CG; Banerjee, A; MacDonald, ML; Cho, DS; Kamins, J; Nie, ZP; Borgmann-Winter, KE; Grosser, T; Pizarro, A; Ciccimaro, E; Arnold, SE; Wang, HY; Blair, IA				Hahn, Chang-Gyu; Banerjee, Anamika; MacDonald, Matthew L.; Cho, Dan-Sung; Kamins, Joshua; Nie, Zhiping; Borgmann-Winter, Karin E.; Grosser, Tilo; Pizarro, Angel; Ciccimaro, Eugene; Arnold, Steven E.; Wang, Hoau-Yan; Blair, Ian A.			The Post-Synaptic Density of Human Postmortem Brain Tissues: An Experimental Study Paradigm for Neuropsychiatric Illnesses	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; GENE-EXPRESSION; RAT FOREBRAIN; PROTEIN; SCHIZOPHRENIA; MASS; IDENTIFICATION; FRACTION; PHOSPHORYLATION; ORGANIZATION	Recent molecular genetics studies have suggested various trans-synaptic processes for pathophysiologic mechanisms of neuropsychiatric illnesses. Examination of pre- and post-synaptic scaffolds in the brains of patients would greatly aid further investigation, yet such an approach in human postmortem tissue has yet to be tested. We have examined three methods using density gradient based purification of synaptosomes followed by detergent extraction (Method 1) and the pH based differential extraction of synaptic membranes (Methods 2 and 3). All three methods separated fractions from human postmortem brains that were highly enriched in typical PSD proteins, almost to the exclusion of pre-synaptic proteins. We examined these fractions using electron microscopy (EM) and verified the integrity of the synaptic membrane and PSD fractions derived from human postmortem brain tissues. We analyzed protein composition of the PSD fractions using two dimensional liquid chromatography tandem mass spectrometry (2D LC-MS/MS) and observed known PSD proteins by mass spectrometry. Immunoprecipitation and immunoblot studies revealed that expected protein-protein interactions and certain posttranscriptional modulations were maintained in PSD fractions. Our results demonstrate that PSD fractions can be isolated from human postmortem brain tissues with a reasonable degree of integrity. This approach may foster novel postmortem brain research paradigms in which the stoichiometry and protein composition of specific microdomains are examined.			Hahn, CG (corresponding author), Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA.	hahnc@mail.med.upenn.edu	Blair, Ian A/B-3320-2010; MacDonald, Matthew/X-2356-2019; Arnold, Steven E/J-7546-2012; Grosser, Tilo/A-1057-2007	Grosser, Tilo/0000-0001-8569-8396	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES016004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075916] Funding Source: NIH RePORTER; NIEHS NIH HHS [U01 ES016004, P30 ES0135080] Funding Source: Medline; NIMH NIH HHS [R01-MH-075916, R01 MH075916] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BEHAN A, 2008, MOL PSYCHIAT; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Chen XB, 2005, P NATL ACAD SCI USA, V102, P11551, DOI 10.1073/pnas.0505359102; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; COTMAN CW, 1974, J CELL BIOL, V63, P441, DOI 10.1083/jcb.63.2.441; Coyle JT, 2006, CELL MOL NEUROBIOL, V26, P365, DOI 10.1007/s10571-006-9062-8; Crecelius A, 2008, PROTEOMICS, V8, P1276, DOI 10.1002/pmic.200700728; Dosemeci A, 2006, BIOCHEM BIOPH RES CO, V339, P687, DOI 10.1016/j.bbrc.2005.11.069; Dosemeci A, 2007, MOL CELL PROTEOMICS, V6, P1749, DOI 10.1074/mcp.M700040-MCP200; Eastwood SL, 2004, INT REV NEUROBIOL, V59, P47; Harrison PJ, 2008, J PSYCHOPHARMACOL, V22, P308, DOI 10.1177/0269881108089818; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Harrison PJ, 2001, HIPPOCAMPUS, V11, P508, DOI 10.1002/hipo.1067.abs; Hashimoto R, 2007, DRUG TODAY, V43, P645, DOI 10.1358/dot.2007.43.9.1088821; Heresco-Levy U, 1998, EUR NEUROPSYCHOPHARM, V8, P141, DOI 10.1016/S0924-977X(97)00050-3; Honer WG, 2004, INT REV NEUROBIOL, V59, P175; Hunsucker SW, 2008, J NEUROCHEM, V105, P725, DOI 10.1111/j.1471-4159.2007.05183.x; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Jaffe H, 2004, BIOCHEM BIOPH RES CO, V321, P210, DOI 10.1016/j.bbrc.2004.06.122; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Leliveld SR, 2008, J NEUROSCI, V28, P3839, DOI 10.1523/JNEUROSCI.5389-07.2008; Lewis DA, 2002, NEUROPSYCHOPHARMACOL, V26, P143, DOI 10.1016/S0893-133X(01)00393-1; Lewis DA, 2006, ARCH NEUROL-CHICAGO, V63, P1372, DOI 10.1001/archneur.63.10.1372; Meador-Woodruff JH, 2003, ANN NY ACAD SCI, V1003, P75, DOI 10.1196/annals.1300.005; Mirnics K, 2001, TRENDS NEUROSCI, V24, P479, DOI 10.1016/S0166-2236(00)01862-2; Novikova SI, 2006, NEUROBIOL DIS, V23, P61, DOI 10.1016/j.nbd.2006.02.002; Okabe S, 2007, MOL CELL NEUROSCI, V34, P503, DOI 10.1016/j.mcn.2007.01.006; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Petersen JD, 2003, J NEUROSCI, V23, P11270; Phillips GR, 2005, J NEUROSCI RES, V81, P762, DOI 10.1002/jnr.20614; Phillips GR, 2003, J NEUROSCI, V23, P5096; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Price TS, 2007, MOL CELL PROTEOMICS, V6, P527, DOI 10.1074/mcp.T600049-MCP200; Seagar M, 1999, PHILOS T ROY SOC B, V354, P289, DOI 10.1098/rstb.1999.0380; Seagar M, 1998, J BIOENERG BIOMEMBR, V30, P347, DOI 10.1023/A:1021937605818; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Talbot K, 2006, HUM MOL GENET, V15, P3041, DOI 10.1093/hmg/ddl246; Tomita S, 2001, J CELL BIOL, V153, pF19, DOI 10.1083/jcb.153.5.F19; Trinidad JC, 2008, MOL CELL PROTEOMICS, V7, P684, DOI 10.1074/mcp.M700170-MCP200; Tsai GC, 2002, ANNU REV PHARMACOL, V42, P165, DOI 10.1146/annurev.pharmtox.42.082701.160735; Walikonis RS, 2000, J NEUROSCI, V20, P4069; Yoshimura Y, 2004, J NEUROCHEM, V88, P759, DOI 10.1046/j.1471-4159.2003.02136.x	47	59	60	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2009	4	4							e5251	10.1371/journal.pone.0005251	http://dx.doi.org/10.1371/journal.pone.0005251			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TU	19370153	Green Published, gold			2022-12-25	WOS:000265510600009
J	Kiselev, AO; Skinner, MC; Lampe, MF				Kiselev, Andrey O.; Skinner, Megan C.; Lampe, Mary F.			Analysis of pmpD Expression and PmpD Post-Translational Processing during the Life Cycle of Chlamydia trachomatis Serovars A, D, and L2	PLOS ONE			English	Article								Background: The polymorphic membrane protein D (PmpD) in Chlamydia is structurally similar to autotransporter proteins described in other bacteria and may be involved in cellular and humoral protective immunity against Chlamydia. The mechanism of PmpD post-translational processing and the role of its protein products in the pathogenesis of chlamydial infection have not been very well elucidated to date. Methodology/Principal Findings: Here we examined the expression and post-translational processing of the protein product of the pmpD gene during the life cycle of C. trachomatis serovars A, D, and L2. Each of these three serovars targets different human organs and tissues and encodes a different pmpD gene nucleotide sequence. Our quantitative real-time reverse transcription polymerase chain reaction results demonstrate that the pmpD gene is up-regulated at 12-24 hours after infection regardless of the Chlamydia serovar. This up-regulation is coincidental with the period of exponential growth and replication of reticulate bodies (RB) of Chlamydia and indicates a probable similarity in function of pmpD in serovars A, D, and L2 of Chlamydia. Using mass spectrometry analysis, we identified the protein products of post-translational processing of PmpD of C. trachomatis serovar L2 and propose a double pathway model for PmpD processing, with one cleavage site between the passenger and autotransporter domains and the other site in the middle of the passenger domain. Notably, when Chlamydia infected culture cells were subjected to low (28 degrees C) temperature, PmpD post-translational processing and secretion was found to be uninhibited in the resulting persistent infection. In addition, confocal microscopy of cells infected with Chlamydia confirms our earlier hypothesis that PmpD is secreted outside Chlamydia and its secretion increases with growth of the chlamydial inclusion. Conclusion/Significance: The results of this current study involving multiple Chlamydia serovars support the general consensus that the pmpD gene is maximally expressed at mid infection and provide new information about PmpD as an autotransporter protein which is post-translationally processed and secreted outside Chlamydia during normal and low temperature induced persistent chlamydial infection.			Kiselev, AO (corresponding author), Univ Washington, Dept Lab Med, Seattle, WA 98195 USA.	lampe@u.washington.edu						Alberts B., 1994, MOL BIOL CELL; BARBOUR AG, 1982, J BACTERIOL, V151, P420, DOI 10.1128/JB.151.1.420-428.1982; BEATTY WL, 1993, P NATL ACAD SCI USA, V90, P3998, DOI 10.1073/pnas.90.9.3998; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; Carlson JH, 2005, INFECT IMMUN, V73, P6407, DOI 10.1128/IAI.73.10.6407-6418.2005; Crane DD, 2006, P NATL ACAD SCI USA, V103, P1894, DOI 10.1073/pnas.0508983103; Dautin N, 2007, ANNU REV MICROBIOL, V61, P89, DOI 10.1146/annurev.micro.61.080706.093233; Dautin N, 2007, EMBO J, V26, P1942, DOI 10.1038/sj.emboj.7601638; Elwell C, 2005, CELL MICROBIOL, V7, P725, DOI 10.1111/j.1462-5822.2005.00508.x; Fadel S, 2008, J MED MICROBIOL, V57, P1058, DOI 10.1099/jmm.0.2008/001305-0; Goellner S, 2006, INFECT IMMUN, V74, P4801, DOI 10.1128/IAI.01487-05; Gomes JP, 2007, GENOME RES, V17, P50, DOI 10.1101/gr.5674706; Gomes JP, 2006, J BACTERIOL, V188, P275, DOI 10.1128/JB.188.1.275-286.2006; Gomes JP, 2004, J BACTERIOL, V186, P4295, DOI 10.1128/JB.186.13.4295-4306.2004; Goodall JC, 2001, EUR J IMMUNOL, V31, P1513, DOI 10.1002/1521-4141(200105)31:5<1513::AID-IMMU1513>3.0.CO;2-U; Henderson IR, 2001, TRENDS MICROBIOL, V9, P573, DOI 10.1016/S0966-842X(01)02234-X; Henderson IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3; Hendrixson DR, 1997, MOL MICROBIOL, V26, P505, DOI 10.1046/j.1365-2958.1997.5921965.x; Hogan RJ, 2003, MICROB PATHOGENESIS, V34, P11, DOI 10.1016/S0882-4010(02)00187-0; Hogan RJ, 2004, INFECT IMMUN, V72, P1843, DOI 10.1128/IAI.72.4.1843-1855.2004; Kari L, 2008, J INFECT DIS, V197, P449, DOI 10.1086/525285; Kiselev AO, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000568; Klos A, 2009, FEMS MICROBIOL LETT, V291, P120, DOI 10.1111/j.1574-6968.2008.01446.x; KUO D, 1994, BIOCHEMISTRY-US, V33, P8347, DOI 10.1021/bi00193a023; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE CK, 1978, ANTIMICROB AGENTS CH, V13, P441, DOI 10.1128/AAC.13.3.441; Maurer AP, 2007, PLOS PATHOG, V3, P752, DOI 10.1371/journal.ppat.0030083; Maniatis T., 1989, MOL CLONING LAB MANU; Mathews SA, 1999, FEBS LETT, V458, P354, DOI 10.1016/S0014-5793(99)01182-5; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Navarro-Garcia F, 2001, INFECT IMMUN, V69, P1053, DOI 10.1128/IAI.69.2.1053-1060.2001; Nicholson TL, 2003, J BACTERIOL, V185, P3179, DOI 10.1128/JB.185.10.3179-3189.2003; Niessner A, 2003, J INFECT DIS, V188, P108, DOI 10.1086/375827; Nunes A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r153; Nunes A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000878; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; SHACHTER J, 1999, CHLAMYDIA INTRACELLU; Shaw AC, 2002, PROTEOMICS, V2, P164, DOI 10.1002/1615-9861(200202)2:2<164::AID-PROT164>3.0.CO;2-U; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Stothard DR, 2003, INFECT IMMUN, V71, P1200, DOI 10.1128/IAI.71.3.1200-1208.2003; SUCHLAND RJ, 1991, J CLIN MICROBIOL, V29, P1333, DOI 10.1128/JCM.29.7.1333-1338.1991; Swanson KA, 2009, INFECT IMMUN, V77, P508, DOI 10.1128/IAI.01173-08; Thomson NR, 2008, GENOME RES, V18, P161, DOI 10.1101/gr.7020108; Turner DPJ, 2002, INFECT IMMUN, V70, P4447, DOI 10.1128/IAI.70.8.4447-4461.2002; Vandahl BBS, 2005, CELL MICROBIOL, V7, P825, DOI 10.1111/j.1462-5822.2005.00514.x; Wehrl W, 2004, MOL MICROBIOL, V51, P319, DOI 10.1046/j.1365-2958.2003.03838.x; Wilmouth RC, 1999, BIOCHEMISTRY-US, V38, P7989, DOI 10.1021/bi990098y	49	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2009	4	4							e5191	10.1371/journal.pone.0005191	http://dx.doi.org/10.1371/journal.pone.0005191			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TS	19367336	Green Submitted, Green Published, gold			2022-12-25	WOS:000265510400004
J	Gonthier, B; Koncina, E; Satkauskas, S; Perraut, M; Roussel, G; Aunis, D; Kapfhammer, JP; Bagnard, D				Gonthier, Bertrand; Koncina, Eric; Satkauskas, Saulius; Perraut, Martine; Roussel, Guy; Aunis, Dominique; Kapfhammer, Josef P.; Bagnard, Dominique			A PKC-Dependent Recruitment of MMP-2 Controls Semaphorin-3A Growth-Promoting Effect in Cortical Dendrites	PLOS ONE			English	Article								There is increasing evidence for a crucial role of proteases and metalloproteinases during axon growth and guidance. In this context, we recently described a functional link between the chemoattractive Sema3C and Matrix metalloproteinase 3 (MMP3). Here, we provide data demonstrating the involvement of MMP-2 to trigger the growth-promoting effect of Sema3A in cortical dendrites. The in situ analysis of MMP-2 expression and activity is consistent with a functional growth assay demonstrating in vitro that the pharmacological inhibition of MMP-2 reduces the growth of cortical dendrites in response to Sema3A. Hence, our results suggest that the selective recruitment and activation of MMP-2 in response to Sema3A requires a PKC alpha dependent mechanism. Altogether, we provide a second set of data supporting MMPs as effectors of the growth-promoting effects of semaphorins, and we identify the potential signalling pathway involved.			Gonthier, B (corresponding author), INSERM, U575, Strasbourg, France.	dominique.bagnard@inserm.fr	Satkauskas, Saulius/AAD-7045-2020; Bagnard, Dominique/I-6535-2013; Dominique, Aunis/W-1419-2019; Satkauskas, Saulius/Z-4144-2019	Satkauskas, Saulius/0000-0002-9001-7767; Bagnard, Dominique/0000-0002-5261-902X				Antonov A A, 1997, Aviakosm Ekolog Med, V31, P34; Bagnard D, 2001, J NEUROSCI, V21, P3332, DOI 10.1523/JNEUROSCI.21-10-03332.2001; Bagnard D, 2004, MOL CELL NEUROSCI, V25, P722, DOI 10.1016/j.mcn.2003.12.007; Bagnard D, 1998, DEVELOPMENT, V125, P5043; Blobel CP, 2000, CURR OPIN CELL BIOL, V12, P606, DOI 10.1016/S0955-0674(00)00139-3; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; Castellani V, 2000, NEURON, V27, P237, DOI 10.1016/S0896-6273(00)00033-7; Chang C, 2001, TRENDS CELL BIOL, V11, pS37, DOI 10.1016/S0962-8924(01)82222-4; da Rocha AB, 2000, PATHOBIOLOGY, V68, P113, DOI 10.1159/000055911; Falk J, 2005, NEURON, V48, P63, DOI 10.1016/j.neuron.2005.08.033; Fenstermaker V, 2004, J NEUROBIOL, V58, P403, DOI 10.1002/neu.10304; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Fujioka S, 2003, BIOCHEM BIOPH RES CO, V301, P304, DOI 10.1016/S0006-291X(02)03023-1; Galko MJ, 2000, SCIENCE, V289, P1365, DOI 10.1126/science.289.5483.1365; Good PF, 2004, J NEUROCHEM, V91, P716, DOI 10.1111/j.1471-4159.2004.02766.x; Gundlfinger A, 2003, J NEUROBIOL, V57, P95, DOI 10.1002/neu.10259; Hanbali M, 2004, J NEUROCHEM, V90, P1423, DOI 10.1111/j.1471-4159.2004.02601.x; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hehr CL, 2005, DEVELOPMENT, V132, P3371, DOI 10.1242/dev.01908; Husain S, 2005, INVEST OPHTH VIS SCI, V46, P1706, DOI 10.1167/iovs.04-0993; Kennedy TE, 2000, BIOCHEM CELL BIOL, V78, P569, DOI 10.1139/bcb-78-5-569; Kolodkin AL, 1998, PROG BRAIN RES, V117, P115; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Koncina E, 2007, ADV EXP MED BIOL, V621, P50, DOI 10.1007/978-0-387-76715-4_4; Li L, 2005, DIABETES, V54, P2227, DOI 10.2337/diabetes.54.7.2227; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; McAllister AK, 2002, NEURON, V33, P2, DOI 10.1016/S0896-6273(01)00577-3; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; Metzger F, 2003, CEREBELLUM, V2, P206, DOI 10.1080/14734220310016150; Metzger F, 2000, EUR J NEUROSCI, V12, P1993, DOI 10.1046/j.1460-9568.2000.00086.x; Mikule K, 2003, J BIOL CHEM, V278, P21168, DOI 10.1074/jbc.M211828200; Miyazaki N, 1999, NEUROSCI RES, V33, P269, DOI 10.1016/S0168-0102(99)00015-2; Nakamura F, 1998, NEURON, V21, P1093, DOI 10.1016/S0896-6273(00)80626-1; Oh LYS, 1999, J NEUROSCI, V19, P8464; Papadimitriou E, 2001, ENDOTHELIUM-J ENDOTH, V8, P181; Polleux F, 1998, SCIENCE, V282, P1904, DOI 10.1126/science.282.5395.1904; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; QATSHA KA, 1993, P NATL ACAD SCI USA, V90, P4674, DOI 10.1073/pnas.90.10.4674; RANASINGHE HS, 2008, NEUROSCIENCE; Reber M, 2007, ADV EXP MED BIOL, V621, P32, DOI 10.1007/978-0-387-76715-4_3; ROTH L, 2008, CELL MOL LIFE SCI; Sakai T, 1999, J BIOL CHEM, V274, P29666, DOI 10.1074/jbc.274.42.29666; Schimmelpfeng K, 2001, MECH DEVELOP, V106, P25, DOI 10.1016/S0925-4773(01)00402-6; Schrenk K, 2002, NEUROSCIENCE, V110, P675, DOI 10.1016/S0306-4522(01)00559-0; SCHWAMBORN JC, 2004, J BIOL CHEM; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Szklarczyk A, 2002, J NEUROSCI, V22, P920, DOI 10.1523/JNEUROSCI.22-03-00920.2002; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tsai CH, 2003, ORAL SURG ORAL MED O, V95, P710, DOI 10.1067/moe.2003.121; Vaillant C, 2003, MOL CELL NEUROSCI, V24, P395, DOI 10.1016/S1044-7431(03)00196-9; Vaillant C, 1999, J NEUROSCI, V19, P4994; Wimmer-Kleikamp SH, 2004, J CELL BIOL, V164, P661, DOI 10.1083/jcb.200312001; Wolman MA, 2004, J NEUROSCI, V24, P8428, DOI 10.1523/JNEUROSCI.2349-04.2004; Yang P, 2006, PROG NEUROBIOL, V79, P73, DOI 10.1016/j.pneurobio.2006.05.001; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807	57	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5099	10.1371/journal.pone.0005099	http://dx.doi.org/10.1371/journal.pone.0005099			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19352510	Green Published, gold, Green Submitted			2022-12-25	WOS:000265505700010
J	Vargesson, N; Laufer, E				Vargesson, Neil; Laufer, Ed			Negative Smad Expression and Regulation in the Developing Chick Limb	PLOS ONE			English	Article								The inhibitory or negative Smads, Smad6 and Smad7, block TGF beta superfamily signals of both the BMP and TGF beta classes by antagonizing the intracellular signal transduction machinery. We report the cloning of one Smad6 and two Smad7 (Smad7a and Smad7b) chick homologs and their expression and regulation in the developing limb. Smad6 and Smad7a are expressed in dynamic patterns reflecting the domains of BMP gene expression in the limb. Activation and inhibition of the BMP signaling pathway in limb mesenchyme indicates that negative Smad gene expression is regulated, at least in part, by BMP family signals.			Vargesson, N (corresponding author), Univ Aberdeen, Inst Med Sci, Sch Med Sci, Aberdeen, Scotland.	elaufer@columbia.edu		Laufer, Edward/0000-0002-4933-1017; Vargesson, Neil/0000-0001-8027-114X				Amthor H, 2002, DEV BIOL, V243, P115, DOI 10.1006/dbio.2001.0555; Benson DA, 1998, NUCLEIC ACIDS RES, V26, P1, DOI 10.1093/nar/26.1.1; Capdevila J, 1999, MOL CELL, V4, P839, DOI 10.1016/S1097-2765(00)80393-7; Capdevila J, 1998, DEV BIOL, V197, P205, DOI 10.1006/dbio.1997.8824; Dahn RD, 2000, SCIENCE, V289, P438, DOI 10.1126/science.289.5478.438; FRANCIS PH, 1994, DEVELOPMENT, V120, P209; Hamburger H, 1951, J MORPHOL, V88, P49; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Khokha MK, 2003, NAT GENET, V34, P303, DOI 10.1038/ng1178; Laufer E, 1997, NATURE, V388, P400, DOI 10.1038/41143; Laufer E, 1997, NATURE, V386, P366, DOI 10.1038/386366a0; Logan M, 1998, METHODS, V14, P407, DOI 10.1006/meth.1998.0595; MACKEM S, 1991, DEVELOPMENT, V112, P791; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, GENE DEV, V14, P627; Merino R, 1999, DEVELOPMENT, V126, P5515; Miyazono K, 2000, ADV IMMUNOL, V75, P115, DOI 10.1016/S0065-2776(00)75003-6; Montero JA, 2008, DEV BIOL, V321, P343, DOI 10.1016/j.ydbio.2008.06.022; Mowbray C, 2001, MECH DEVELOP, V108, P179, DOI 10.1016/S0925-4773(01)00479-8; Nakayama T, 1998, DEVELOPMENT, V125, P857; NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443; Nieto MA, 1996, METHOD CELL BIOL, V51, P219, DOI 10.1016/S0091-679X(08)60630-5; Park SH, 2005, J BIOCHEM MOL BIOL, V38, P9; Pizette S, 2001, DEVELOPMENT, V128, P4463; Pizette S, 2000, DEV BIOL, V219, P237, DOI 10.1006/dbio.2000.9610; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Robert B, 2007, DEV GROWTH DIFFER, V49, P455, DOI 10.1111/j.1440-169x.2007.00946.x; Suzuki T, 2008, P NATL ACAD SCI USA, V105, P4185, DOI 10.1073/pnas.0707899105; Topper JN, 1997, P NATL ACAD SCI USA, V94, P9314, DOI 10.1073/pnas.94.17.9314; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Vargesson N, 2001, DEV BIOL, V240, P499, DOI 10.1006/dbio.2001.0481; Verheyden JM, 2008, NATURE, V454, P638, DOI 10.1038/nature07085; Yamada M, 1999, DEV BIOL, V215, P48, DOI 10.1006/dbio.1999.9419; Yokouchi Y, 1996, DEVELOPMENT, V122, P3725; Zou HY, 1996, SCIENCE, V272, P738, DOI 10.1126/science.272.5262.738; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157; Zuzarte-Luis V, 2004, DEV BIOL, V272, P39, DOI 10.1016/j.ydbio.2004.04.015	38	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5173	10.1371/journal.pone.0005173	http://dx.doi.org/10.1371/journal.pone.0005173			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19352514	Green Published, Green Submitted, gold			2022-12-25	WOS:000265505700025
J	Virador, VM; Davidson, B; Czechowicz, J; Mai, A; Kassis, J; Kohn, EC				Virador, Victoria M.; Davidson, Ben; Czechowicz, Josephine; Mai, Alisha; Kassis, Jareer; Kohn, Elise C.			The Anti-Apoptotic Activity of BAG3 Is Restricted by Caspases and the Proteasome	PLOS ONE			English	Article								Background: Caspase-mediated cleavage and proteasomal degradation of ubiquitinated proteins are two independent mechanisms for the regulation of protein stability and cellular function. We previously reported BAG3 overexpression protected ubiquitinated clients, such as AKT, from proteasomal degradation and conferred cytoprotection against heat shock. We hypothesized that the BAG3 protein is regulated by proteolysis. Methodology/Principal Findings: Staurosporine (STS) was used as a tool to test for caspase involvement in BAG3 degradation. MDA435 and HeLa human cancer cell lines exposed to STS underwent apoptosis with a concomitant time and dose-dependent loss of BAG3, suggesting the survival role of BAG3 was subject to STS regulation. zVAD-fmk or caspase 3 and 9 inhibitors provided a strong but incomplete protection of both cells and BAG3 protein. Two putative caspase cleavage sites were tested: K (E) under barV (D) under bar (BAG3(E345A/D347A)) within the proline-rich center of BAG3 (PXXP) and the C-terminal L (E) under barA (D) under bar site (BAG3(E516A/D518A)). PXXP deletion mutant and BAG3(E345A/D347A), or BAG3(E516A/D518A) respectively slowed or stalled STS-mediated BAG3 loss. BAG3, ubiquitinated under basal growth conditions, underwent augmented ubiquitination upon STS treatment, while there was no increase in ubiquitination of the BAG3(E516A/D518A) caspase-resistant mutant. Caspase and proteasome inhibition resulted in partial and independent protection of BAG3 whereas inhibitors of both blocked BAG3 degradation. STS-induced apoptosis was increased when BAG3 was silenced, and retention of BAG3 was associated with cytoprotection. Conclusions/Significance: BAG3 is tightly controlled by selective degradation during STS exposure. Loss of BAG3 under STS injury required sequential caspase cleavage followed by polyubiquitination and proteasomal degradation. The need for dual regulation of BAG3 in apoptosis suggests a key role for BAG3 in cancer cell resistance to apoptosis.			Virador, VM (corresponding author), NCI, Mol Signaling Sect, Med Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA.	vvirador@helix.nih.gov	Virador, Victoria M./A-8173-2009		Intramural NIH HHS Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIASC009163, Z01SC009163] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Annunziata CM, 2007, CLIN CANCER RES, V13, P6585, DOI 10.1158/1078-0432.CCR-07-0327; Asher G, 2006, BIOESSAYS, V28, P844, DOI 10.1002/bies.20447; Basbous J, 2007, MOL CELL BIOL, V27, P3936, DOI 10.1128/MCB.01776-06; Beere H M, 2001, Sci STKE, V2001, pre1, DOI 10.1126/stke.2001.93.re1; Bendjennat M, 2003, CELL, V114, P599, DOI 10.1016/j.cell.2003.08.001; Bonelli P, 2004, LEUKEMIA, V18, P358, DOI 10.1038/sj.leu.2403219; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Coulson M, 2005, GENETICS, V171, P1799, DOI 10.1534/genetics.105.043265; Didelot C, 2006, HANDB EXP PHARM, V172, P171; Doong H, 2002, CANCER LETT, V188, P25, DOI 10.1016/S0304-3835(02)00456-1; Doong H, 2003, J BIOL CHEM, V278, P28490, DOI 10.1074/jbc.M209682200; Doong H, 2000, ONCOGENE, V19, P4385, DOI 10.1038/sj.onc.1203797; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Eichholtz-Wirth H, 2003, CANCER LETT, V194, P81, DOI 10.1016/S0304-3835(03)00009-0; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Frisch SM, 1999, CURR BIOL, V9, P1047, DOI 10.1016/S0960-9822(99)80455-2; Gao BX, 2006, J BIOL CHEM, V281, P29711, DOI 10.1074/jbc.M604596200; Han Z, 2000, CELL DEATH DIFFER, V7, P521, DOI 10.1038/sj.cdd.4400681; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Homma S, 2006, AM J PATHOL, V169, P761, DOI 10.2353/ajpath.2006.060250; Karran L, 2001, CRIT REV EUKAR GENE, V11, P269; Kassis JN, 2006, EXP CELL RES, V312, P2962, DOI 10.1016/j.yexcr.2006.05.023; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Lauber K, 2001, J BIOL CHEM, V276, P29772, DOI 10.1074/jbc.M101524200; Lee JH, 1999, ONCOGENE, V18, P6183, DOI 10.1038/sj.onc.1203043; Mollerup J, 2005, FEBS LETT, V579, P4187, DOI 10.1016/j.febslet.2005.06.045; Nicholson DW, 2003, SCIENCE, V299, P214, DOI 10.1126/science.1081274; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; Pochampally R, 1998, ONCOGENE, V17, P2629, DOI 10.1038/sj.onc.1202206; Romano MF, 2003, CELL DEATH DIFFER, V10, P383, DOI 10.1038/sj.cdd.4401167; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; TAKAYAMA S, 1995, CELL, V80, P279, DOI 10.1016/0092-8674(95)90410-7; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Thress K, 2001, EMBO J, V20, P1033, DOI 10.1093/emboj/20.5.1033; Widmann C, 1998, J BIOL CHEM, V273, P7141, DOI 10.1074/jbc.273.12.7141; Wu YH, 2004, J BIOL CHEM, V279, P19264, DOI 10.1074/jbc.M307049200; YOUN DY, 2008, AM J PHYSL ENDOCRINO	37	40	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5136	10.1371/journal.pone.0005136	http://dx.doi.org/10.1371/journal.pone.0005136			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19352495	Green Published, gold, Green Submitted			2022-12-25	WOS:000265505700023
J	Sudhakar, C; Nagabhushana, A; Jain, N; Swarup, G				Sudhakar, Cherukuri; Nagabhushana, Ananthamurthy; Jain, Nishant; Swarup, Ghanshyam			NF-kappa B Mediates Tumor Necrosis Factor alpha-Induced Expression of Optineurin, a Negative Regulator of NF-kappa B	PLOS ONE			English	Article								Optineurin is a ubiquitously expressed multifunctional cytoplasmic protein encoded by OPTN gene. The expression of optineurin is induced by various cytokines. Here we have investigated the molecular mechanisms which regulate optineurin gene expression and the relationship between optineurin and nuclear factor kappa B (NF-kappa B). We cloned and characterized human optineurin promoter. Optineurin promoter was activated upon treatment of HeLa and A549 cells with tumor necrosis factor alpha (TNF alpha). Mutation of a putative NF-kappa B-binding site present in the core promoter resulted in loss of basal as well as TNF alpha-induced activity. Overexpression of p65 subunit of NF-kappa B activated this promoter through NF-kappa B site. Oligonucleotides corresponding to this putative NF-kappa B-binding site showed binding to NF-kappa B. TNF alpha-induced optineurin promoter activity was inhibited by expression of inhibitor of NF-kappa B (kappa B alpha) super-repressor. Blocking of NF-kappa B activation resulted in inhibition of TNF alpha-induced optineurin gene expression. Overexpressed optineurin partly inhibited TNF alpha-induced NF-kappa B activation in Hela cells. Downregulation of optineurin by shRNA resulted in an increase in TNF alpha-induced as well as basal NF-kappa B activity. These results show that optineurin promoter activity and gene expression are regulated by NF-kappa B pathway in response to TNF alpha. In addition these results suggest that there is a negative feedback loop in which TNF alpha-induced NF-kappa B activity mediates expression of optineurin, which itself functions as a negative regulator of NF-kappa B.	[Sudhakar, Cherukuri; Nagabhushana, Ananthamurthy; Jain, Nishant; Swarup, Ghanshyam] Ctr Cellular & Mol Biol, Council Sci & Ind Res, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Sudhakar, C (corresponding author), Ctr Cellular & Mol Biol, Council Sci & Ind Res, Hyderabad 500007, Andhra Pradesh, India.	gshyam@ccmb.res.in		Swarup, Ghanshyam/0000-0002-8098-0509				Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Alward WLM, 2003, AM J OPHTHALMOL, V136, P904, DOI 10.1016/S0002-9394(03)00577-4; Anborgh PH, 2005, J BIOL CHEM, V280, P34840, DOI 10.1074/jbc.M504508200; Anto RJ, 2003, J BIOL CHEM, V278, P25490, DOI 10.1074/jbc.M301790200; Aung T, 2005, INVEST OPHTH VIS SCI, V46, P2816, DOI 10.1167/iovs.04-1133; Boye K, 2008, INT J CANCER, V123, P1301, DOI 10.1002/ijc.23617; Chalasani ML, 2007, INVEST OPHTH VIS SCI, V48, P1607, DOI 10.1167/iovs.06-0834; CHATURVEDI MM, 1994, J BIOL CHEM, V269, P14575; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; De Marco N, 2006, J BIOL CHEM, V281, P16147, DOI 10.1074/jbc.M601467200; Fiedler MA, 1998, AM J RESP CELL MOL, V19, P259, DOI 10.1165/ajrcmb.19.2.3149; Funayama T, 2004, INVEST OPHTH VIS SCI, V45, P4359, DOI 10.1167/iovs.03-1403; Fuse N, 2004, J GLAUCOMA, V13, P299, DOI 10.1097/00061198-200408000-00007; Gupta V, 2006, J CELL SCI, V119, P1703, DOI 10.1242/jcs.02885; Hattula K, 2000, CURR BIOL, V10, P1603, DOI 10.1016/S0960-9822(00)00864-2; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Jain N, 2005, J BIOL CHEM, V280, P36664, DOI 10.1074/jbc.M413261200; Jain N, 2007, FEBS J, V274, P4396, DOI 10.1111/j.1742-4658.2007.05969.x; Jono H, 2004, J BIOL CHEM, V279, P36171, DOI 10.1074/jbc.M406638200; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kroeber M, 2006, EXP EYE RES, V82, P1075, DOI 10.1016/j.exer.2005.11.004; Leung YF, 2003, INVEST OPHTH VIS SCI, V44, P3880, DOI 10.1167/iovs.02-0693; Li YG, 1998, MOL CELL BIOL, V18, P1601, DOI 10.1128/MCB.18.3.1601; Morton S, 2008, FEBS LETT, V582, P997, DOI 10.1016/j.febslet.2008.02.047; Mrowka R, 2008, FEBS J, V275, P3178, DOI 10.1111/j.1742-4658.2008.06471.x; Mukhopadhyay A, 2005, MOL VIS, V11, P792; Paliwal P, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-45; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; Rezaie T, 2005, INVEST OPHTH VIS SCI, V46, P2404, DOI 10.1167/iovs.04-1243; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Sarfarazi Mansoor, 2003, Ophthalmol Clin North Am, V16, P529; Schwamborn K, 2000, J BIOL CHEM, V275, P22780, DOI 10.1074/jbc.M001500200; Takahashi Y, 2007, NEUROPATH APPL NEURO, V33, P692, DOI 10.1111/j.1365-2990.2007.00862.x; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wang N, 2001, NAT MED, V7, P304, DOI 10.1038/85446; Weisschuh N, 2007, EXP EYE RES, V85, P450, DOI 10.1016/j.exer.2007.06.012; Willoughby CE, 2004, INVEST OPHTH VIS SCI, V45, P3122, DOI 10.1167/iovs.04-0107; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Zhu G, 2007, CURR BIOL, V17, P1438, DOI 10.1016/j.cub.2007.07.041	40	89	93	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5114	10.1371/journal.pone.0005114	http://dx.doi.org/10.1371/journal.pone.0005114			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340308	Green Published, gold, Green Submitted			2022-12-25	WOS:000265500700017
J	Almog, M; Korngreen, A				Almog, Mara; Korngreen, Alon			Characterization of Voltage-Gated Ca2+ Conductances in Layer 5 Neocortical Pyramidal Neurons from Rats	PLOS ONE			English	Article							ACTION-POTENTIAL INITIATION; CALCIUM-CHANNEL CURRENTS; T-TYPE; N-TYPE; TRANSMITTER RELEASE; APICAL DENDRITES; PROPAGATION; ACTIVATION; CELLS; FACILITATION	Neuronal voltage-gated Ca2+ channels are involved in electrical signalling and in converting these signals into cytoplasmic calcium changes. One important function of voltage-gated Ca2+ channels is generating regenerative dendritic Ca2+ spikes. However, the Ca2+ dependent mechanisms used to create these spikes are only partially understood. To start investigating this mechanism, we set out to kinetically and pharmacologically identify the sub-types of somatic voltage-gated Ca2+ channels in pyramidal neurons from layer 5 of rat somatosensory cortex, using the nucleated configuration of the patch-clamp technique. The activation kinetics of the total Ba2+ current revealed conductance activation only at medium and high voltages suggesting that T-type calcium channels were not present in the patches. Steady-state inactivation protocols in combination with pharmacology revealed the expression of R-type channels. Furthermore, pharmacological experiments identified 5 voltage-gated Ca2+ channel sub-types -L-, N-, R- and P/Q-type. Finally, the activation of the Ca2+ conductances was examined using physiologically derived voltage-clamp protocols including a calcium spike protocol and a mock back-propagating action potential (mBPAP) protocol. These experiments enable us to suggest the possible contribution of the five Ca2+ channel sub-types to Ca2+ current flow during activation under physiological conditions.	[Almog, Mara; Korngreen, Alon] Bar Ilan Univ, Leslie & Susan Gonda Interdisciplinary Brain Res, Ramat Gan, Israel; [Almog, Mara; Korngreen, Alon] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel	Bar Ilan University; Bar Ilan University	Almog, M (corresponding author), Bar Ilan Univ, Leslie & Susan Gonda Interdisciplinary Brain Res, Ramat Gan, Israel.	korngra@mail.biu.ac.il		Korngreen, Alon/0000-0002-2036-6160; Almog, Mara/0000-0002-6600-4966	Israeli Science Foundation [212/07]	Israeli Science Foundation(Israel Science Foundation)	This work was supported by a grant from the Israeli Science Foundation (212/07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenman CD, 1999, J NEUROPHYSIOL, V82, P1697, DOI 10.1152/jn.1999.82.4.1697; BARGAS J, 1994, J NEUROSCI, V14, P6667; BIRNBAUMER L, 1994, NEURON, V13, P505, DOI 10.1016/0896-6273(94)90021-3; Bourinet E, 2001, BIOPHYS J, V81, P79, DOI 10.1016/S0006-3495(01)75681-0; BROWN AM, 1993, J NEUROPHYSIOL, V70, P1530, DOI 10.1152/jn.1993.70.4.1530; Carrasco MA, 2006, CELL CALCIUM, V40, P575, DOI 10.1016/j.ceca.2006.08.021; COX DH, 1992, J NEUROSCI, V12, P906; CREUTZFELDT OD, 1977, NATURWISSENSCHAFTEN, V64, P507, DOI 10.1007/BF00483547; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P599, DOI 10.1113/jphysiol.1982.sp014394; Gasparini S, 1997, PFLUG ARCH EUR J PHY, V435, P99, DOI 10.1007/s004240050488; Gulledge AT, 2003, J NEUROSCI, V23, P11363; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; IKEDA SR, 1991, J PHYSIOL-LONDON, V439, P181, DOI 10.1113/jphysiol.1991.sp018663; Johnson SL, 2008, J PHYSIOL-LONDON, V586, P1029, DOI 10.1113/jphysiol.2007.145219; Korngreen A, 2000, J PHYSIOL-LONDON, V525, P621, DOI 10.1111/j.1469-7793.2000.00621.x; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; Larkum ME, 2003, J PHYSIOL-LONDON, V549, P471, DOI 10.1113/jphysiol.2002.037614; Larkum ME, 2001, J PHYSIOL-LONDON, V533, P447, DOI 10.1111/j.1469-7793.2001.0447a.x; Larkum ME, 1999, P NATL ACAD SCI USA, V96, P14600, DOI 10.1073/pnas.96.25.14600; Li LY, 2007, J NEUROSCI, V27, P13420, DOI 10.1523/JNEUROSCI.1709-07.2007; LORENZON NM, 1995, J NEUROPHYSIOL, V73, P1443, DOI 10.1152/jn.1995.73.4.1443; LORENZON NM, 1995, J NEUROPHYSIOL, V73, P1430, DOI 10.1152/jn.1995.73.4.1430; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; MARKRAM H, 1995, J PHYSIOL-LONDON, V485, P1; Mermelstein PG, 1999, J NEUROSCI, V19, P7268, DOI 10.1523/JNEUROSCI.19-17-07268.1999; MILLER RJ, 1987, SCIENCE, V235, P46, DOI 10.1126/science.2432656; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Randall AD, 1997, NEUROPHARMACOLOGY, V36, P879, DOI 10.1016/S0028-3908(97)00086-5; REUTER H, 1983, NATURE, V301, P569, DOI 10.1038/301569a0; SATHER W, 1992, J PHYSIOL-LONDON, V450, P643, DOI 10.1113/jphysiol.1992.sp019148; Scamps F, 1998, NEUROSCIENCE, V87, P719, DOI 10.1016/S0306-4522(98)00165-1; Schaefer AT, 2007, J PHYSIOL-LONDON, V579, P737, DOI 10.1113/jphysiol.2006.122564; SCHILLER J, 1995, J PHYSIOL-LONDON, V487, P583, DOI 10.1113/jphysiol.1995.sp020902; Schnee ME, 2003, J PHYSIOL-LONDON, V549, P697, DOI 10.1113/jphysiol.2002.037481; Serrano JR, 1999, J GEN PHYSIOL, V114, P185, DOI 10.1085/jgp.114.2.185; Sjostrom PJ, 2008, PHYSIOL REV, V88, P769, DOI 10.1152/physrev.00016.2007; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Suedof Thomas C., 2008, V184, P1; TAKAHASHI K, 1991, J PHARMACOL EXP THER, V256, P169; TAKAHASHI K, 1991, J NEUROPHYSIOL, V65, P148, DOI 10.1152/jn.1991.65.1.148; Tanabe M, 1998, J NEUROPHYSIOL, V80, P2268, DOI 10.1152/jn.1998.80.5.2268; Tarasenko AN, 1998, J PHYSIOL-LONDON, V509, P385, DOI 10.1111/j.1469-7793.1998.385bn.x; Taverna E, 2002, J CELL SCI, V115, P3909, DOI 10.1242/jcs.00072; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; Wang G, 1999, J NEUROSCI, V19, P9235; Wu LG, 1999, J NEUROSCI, V19, P726; Wu LG, 1998, P NATL ACAD SCI USA, V95, P4720, DOI 10.1073/pnas.95.8.4720; YE JH, 1993, BRAIN RES, V606, P111, DOI 10.1016/0006-8993(93)91577-F; Zamponi GW, 1998, P NATL ACAD SCI USA, V95, P4035, DOI 10.1073/pnas.95.7.4035; ZHANG JF, 1993, NEUROPHARMACOLOGY, V32, P1075, DOI 10.1016/0028-3908(93)90003-L; Zhu JJ, 2000, J PHYSIOL-LONDON, V526, P571, DOI 10.1111/j.1469-7793.2000.00571.x	56	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e4841	10.1371/journal.pone.0004841	http://dx.doi.org/10.1371/journal.pone.0004841			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337371	Green Published, Green Submitted, gold			2022-12-25	WOS:000265500600001
J	Stephen, ID; Coetzee, V; Smith, ML; Perrett, DI				Stephen, Ian D.; Coetzee, Vinet; Smith, Miriam Law; Perrett, David I.			Skin Blood Perfusion and Oxygenation Colour Affect Perceived Human Health	PLOS ONE			English	Article							FACIAL ATTRACTIVENESS; SEXUAL SELECTION; FLOW; AGE; PERCEPTION; IMMUNOCOMPETENCE; AVERAGENESS; PERFORMANCE; SYMMETRY; EXERCISE	Skin blood perfusion and oxygenation depends upon cardiovascular, hormonal and circulatory health in humans and provides socio-sexual signals of underlying physiology, dominance and reproductive status in some primates. We allowed participants to manipulate colour calibrated facial photographs along empirically-measured oxygenated and deoxygenated blood colour axes both separately and simultaneously, to optimise healthy appearance. Participants increased skin blood colour, particularly oxygenated, above basal levels to optimise healthy appearance. We show, therefore, that skin blood perfusion and oxygenation influence perceived health in a way that may be important to mate choice.	[Stephen, Ian D.; Coetzee, Vinet; Smith, Miriam Law; Perrett, David I.] Univ St Andrews, Sch Psychol, Percept Lab, St Andrews KY16 9AJ, Fife, Scotland	University of St Andrews	Stephen, ID (corresponding author), Univ St Andrews, Sch Psychol, Percept Lab, St Andrews KY16 9AJ, Fife, Scotland.	is77@st-andrews.ac.uk; dp@st-andrews.ac.uk	Coetzee, Vinet/F-2155-2011; Stephen, Ian/ABA-6218-2021	Coetzee, Vinet/0000-0003-1716-0804; Perrett, David/0000-0002-6025-0939; Stephen, Ian/0000-0001-9714-8295	BBSRC; Unilever Research	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Unilever Research(Unilever)	This work was supported by the BBSRC and Unilever Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundsen T, 2001, P NATL ACAD SCI USA, V98, P13155, DOI 10.1073/pnas.211439298; Armstrong N, 2001, EUR J APPL PHYSIOL, V85, P546, DOI 10.1007/s004210100485; Barber N, 1995, ETHOL SOCIOBIOL, V16, P395, DOI 10.1016/0162-3095(95)00068-2; Barton RA, 2005, NATURE, V437, pE10, DOI 10.1038/nature04307; Blount JD, 2003, SCIENCE, V300, P125, DOI 10.1126/science.1082142; Bourne GR, 2003, NATURWISSENSCHAFTEN, V90, P402, DOI 10.1007/s00114-003-0444-1; BURT DM, 1995, P ROY SOC B-BIOL SCI, V259, P137, DOI 10.1098/rspb.1995.0021; BUSSE W W, 1989, Drugs, V37, P1; Changizi MA, 2006, BIOL LETT-UK, V2, P217, DOI 10.1098/rsbl.2006.0440; Charkoudian N, 2003, MAYO CLIN PROC, V78, P603, DOI 10.4065/78.5.603; Charkoudian N, 1999, J APPL PHYSIOL, V87, P1719, DOI 10.1152/jappl.1999.87.5.1719; Drummond PD, 2000, PERS INDIV DIFFER, V29, P1123, DOI 10.1016/S0191-8869(99)00259-7; Drummond PD, 2001, PSYCHOPHYSIOLOGY, V38, P190, DOI 10.1111/1469-8986.3820190; Elliot AJ, 2008, J PERS SOC PSYCHOL, V95, P1150, DOI 10.1037/0022-3514.95.5.1150; FEATHER JW, 1988, PHYS MED BIOL, V33, P711, DOI 10.1088/0031-9155/33/6/005; Fink B, 2001, J COMP PSYCHOL, V115, P92, DOI 10.1037//0735-7036.115.1.92; Fink B, 2006, EVOL HUM BEHAV, V27, P433, DOI 10.1016/j.evolhumbehav.2006.08.007; Greenlees I, 2008, J SPORT SCI, V26, P569, DOI 10.1080/02640410701744446; HILL GE, 1990, ANIM BEHAV, V40, P563, DOI 10.1016/S0003-3472(05)80537-8; Hill RA, 2005, NATURE, V435, P293, DOI 10.1038/435293a; Hong GW, 2001, COLOR RES APPL, V26, P76, DOI 10.1002/1520-6378(200102)26:1<76::AID-COL8>3.0.CO;2-3; Johnson JM, 1998, MED SCI SPORT EXER, V30, P382, DOI 10.1097/00005768-199803000-00007; Jones BC, 2005, P ROY SOC B-BIOL SCI, V272, P347, DOI 10.1098/rspb.2004.2962; Jones BC, 2004, PERCEPTION, V33, P569, DOI 10.1068/p3463; Jones D., 2000, ADAPTATION HUMAN BEH, P133; Kilner R, 1997, P ROY SOC B-BIOL SCI, V264, P963, DOI 10.1098/rspb.1997.0133; LEARY MR, 1992, PSYCHOL BULL, V112, P446, DOI 10.1037/0033-2909.112.3.446; Little A.C., 2007, J EVOLUTIONARY PSYCH, V5, P161, DOI [10. 1556/JEP. 2007. 1008, DOI 10.1556/JEP.2007.1008, https://doi.org/10.1556/JEP.2007.1008]; LIU D, 1992, DIABETOLOGIA, V35, P287, DOI 10.1007/BF00400932; Maddox KB, 2002, PERS SOC PSYCHOL B, V28, P250, DOI 10.1177/0146167202282010; Massaro M, 2003, BEHAV ECOL SOCIOBIOL, V55, P169, DOI 10.1007/s00265-003-0683-3; Matts PJ, 2007, J AM ACAD DERMATOL, V57, P977, DOI 10.1016/j.jaad.2007.07.040; McGraw KJ, 2003, AM NAT, V162, P704, DOI 10.1086/378904; Muhe L, 1999, ARCH DIS CHILD, V81, P216, DOI 10.1136/adc.81.3.216; Muhe L, 2000, TROP MED INT HEALTH, V5, P805, DOI 10.1046/j.1365-3156.2000.00637.x; Negro JJ, 2006, COMP BIOCHEM PHYS A, V143, P78, DOI 10.1016/j.cbpa.2005.10.028; PANZA JA, 1990, NEW ENGL J MED, V323, P22, DOI 10.1056/NEJM199007053230105; Peters A, 2004, J EVOLUTION BIOL, V17, P1111, DOI 10.1111/j.1420-9101.2004.00743.x; Ponsonby AL, 1997, PEDIATRICS, V99, pE31, DOI 10.1542/peds.99.1.e3; Reybrouck T, 1999, CHEST, V115, P788, DOI 10.1378/chest.115.3.788; Rhodes G, 2007, PERCEPTION, V36, P1244, DOI 10.1068/p5712; Rhodes L, 1997, J REPROD FERTIL, V111, P51; RICHARDSON D, 1987, ARCH ENVIRON HEALTH, V42, P19, DOI 10.1080/00039896.1987.9935790; Roberts SC, 2005, EVOL HUM BEHAV, V26, P213, DOI 10.1016/j.evolhumbehav.2004.09.002; Russell R, 2003, PERCEPTION, V32, P1093, DOI 10.1068/p5101; Saks L, 2003, OECOLOGIA, V134, P301, DOI 10.1007/s00442-002-1125-z; Setchell JM, 2005, ETHOLOGY, V111, P25, DOI 10.1111/j.1439-0310.2004.01054.x; Setchell JM, 2006, P ROY SOC B-BIOL SCI, V273, P2395, DOI 10.1098/rspb.2006.3573; Sotchell JM, 2001, HORM BEHAV, V39, P177, DOI 10.1006/hbeh.2000.1628; SYMON D, 1995, CHIC SEX HIST SOC, P80; Symons D, 1979, EVOLUTION HUMAN SEXU; TANKERSLEY CG, 1991, J APPL PHYSIOL, V71, P236, DOI 10.1152/jappl.1991.71.1.236; THORNHILL R, 1993, HUM NATURE-INT BIOS, V4, P237, DOI 10.1007/BF02692201; Thornton MJ, 2002, EXP DERMATOL, V11, P487, DOI 10.1034/j.1600-0625.2002.110601.x; Waitt C, 2003, P ROY SOC B-BIOL SCI, V270, pS144, DOI 10.1098/rsbl.2003.0065; Waitt C, 2006, AM J PRIMATOL, V68, P738, DOI 10.1002/ajp.20264	56	139	140	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5083	10.1371/journal.pone.0005083	http://dx.doi.org/10.1371/journal.pone.0005083			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437PY	19337378	Green Submitted, Green Published, gold			2022-12-25	WOS:000265500600021
J	Hosokawa, N; Kamiya, Y; Kamiya, D; Kato, K; Nagata, K				Hosokawa, Nobuko; Kamiya, Yukiko; Kamiya, Daiki; Kato, Koichi; Nagata, Kazuhiro			Human OS-9, a Lectin Required for Glycoprotein Endoplasmic Reticulum-associated Degradation, Recognizes Mannose-trimmed N-Glycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; UBIQUITIN LIGASE COMPLEX; QUALITY-CONTROL; MISFOLDED GLYCOPROTEINS; SECRETORY PATHWAY; IDENTIFIES YOS9P; PROTEIN; DISLOCATION; HOMOLOG; ALPHA-1-ANTITRYPSIN	In the endoplasmic reticulum (ER), lectins and processing enzymes are involved in quality control of newly synthesized proteins for productive folding as well as in the ER-associated degradation (ERAD) of misfolded proteins. ER quality control requires the recognition and modification of the N-linked oligosaccharides attached to glycoproteins. Mannose trimming from the N-glycans plays an important role in targeting of misfolded glycoproteins for ERAD. Recently, two mammalian lectins, OS-9 and XTP3-B, which contain mannose 6-phosphate receptor homology domains, were reported to be involved in ER quality control. Here, we examined the requirement for human OS-9 (hOS-9) lectin activity in degradation of the glycosylated ERAD substrate NHK, a genetic variant of alpha 1-antitrypsin. Using frontal affinity chromatography, we demonstrated that the recombinant hOS-9 mannose 6-phosphate receptor homology domain specifically binds N-glycans lacking the terminal mannose from the C branch in vitro. To examine the specificity of OS-9 recognition of N-glycans in vivo, we modified the oligosaccharide structures on NHK by overexpressing ER alpha 1,2-mannosidase I or EDEM3 and examined the effect of these modifications on NHK degradation in combination with small interfering RNA-mediated knockdown of hOS-9. The ability of hOS-9 to enhance glycoprotein ERAD depended on the N-glycan structures on NHK, consistent with the frontal affinity chromatography results. Thus, we propose a model for mannose trimming and the requirement for hOS-9 lectin activity in glycoprotein ERAD in which N-glycans lacking the terminal mannose from the C branch are recognized by hOS-9 and targeted for degradation.	[Hosokawa, Nobuko; Nagata, Kazuhiro] Kyoto Univ, Inst Frontier Med Sci, Dept Mol & Cellular Biol, Kyoto 6068397, Japan; [Kamiya, Yukiko; Kato, Koichi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Kamiya, Yukiko; Kamiya, Daiki; Kato, Koichi] Nagaya City Univ, Grad Sch Pharmaceut Sci, Nagoya, Aichi 4678063, Japan; [Kato, Koichi] Ochanomizu Univ, Glycosci Inst, Tokyo 1128610, Japan	Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); Nagoya City University; Ochanomizu University	Hosokawa, N (corresponding author), 53 Kawahara Cho,Sakyo Ku, Kyoto 6068397, Japan.	nobuko@frontier.kyoto-u.ac.jp; kkatonmr@ims.ac.jp		Kato, Koichi/0000-0001-7187-9612; Kamiya, Yukiko/0000-0001-7582-3886	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [20107004, 19GS0314] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to N. H., K. K., and K. N.) and a grant from the Uehara Memorial Foundation (to N. H.).	Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Avezov E, 2008, MOL BIOL CELL, V19, P216, DOI 10.1091/mbc.E07-05-0505; Bernasconi R, 2008, J BIOL CHEM, V283, P16446, DOI 10.1074/jbc.M802272200; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Buschhorn BA, 2004, FEBS LETT, V577, P422, DOI 10.1016/j.febslet.2004.10.039; Cabral CM, 2001, TRENDS BIOCHEM SCI, V26, P619, DOI 10.1016/S0968-0004(01)01942-9; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; HAMMOND C, 1994, J CELL BIOL, V126, P41, DOI 10.1083/jcb.126.1.41; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Herscovics A, 2002, GLYCOBIOLOGY, V12, p14G; Herscovics A, 2001, BIOCHIMIE, V83, P757, DOI 10.1016/S0300-9084(01)01319-0; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Hosokawa N, 2003, J BIOL CHEM, V278, P26287, DOI 10.1074/jbc.M303395200; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Hosokawa N, 2008, J BIOL CHEM, V283, P20914, DOI 10.1074/jbc.M709336200; Hosokawa N, 2007, BIOCHEM BIOPH RES CO, V362, P626, DOI 10.1016/j.bbrc.2007.08.057; Jakob CA, 1998, J CELL BIOL, V142, P1223, DOI 10.1083/jcb.142.5.1223; Kamiya Y, 2005, J BIOL CHEM, V280, P37178, DOI 10.1074/jbc.M505757200; Kamiya Y, 2008, J BIOL CHEM, V283, P1857, DOI 10.1074/jbc.M709384200; Kanehara K, 2007, SEMIN CELL DEV BIOL, V18, P743, DOI 10.1016/j.semcdb.2007.09.007; KASAI K, 1986, J CHROMATOGR, V376, P33, DOI 10.1016/S0378-4347(00)80822-1; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; Lederkremer GZ, 2005, TRENDS BIOCHEM SCI, V30, P297, DOI 10.1016/j.tibs.2005.04.010; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Liu Y, 1999, J BIOL CHEM, V274, P5861, DOI 10.1074/jbc.274.9.5861; Mast SW, 2005, GLYCOBIOLOGY, V15, P421, DOI 10.1093/glycob/cwi014; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Munro S, 2001, CURR BIOL, V11, pR499, DOI 10.1016/S0960-9822(01)00302-5; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Szathmary R, 2005, MOL CELL, V19, P765, DOI 10.1016/j.molcel.2005.08.015; van Anken E, 2005, CRIT REV BIOCHEM MOL, V40, P191, DOI 10.1080/10409230591008161	38	156	157	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17061	17068		10.1074/jbc.M809725200	http://dx.doi.org/10.1074/jbc.M809725200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19346256	Green Published, hybrid			2022-12-25	WOS:000266962400044
J	Xu, YJ; Kelly, TJ				Xu, Yong-jie; Kelly, Thomas J.			Autoinhibition and Autoactivation of the DNA Replication Checkpoint Kinase Cds1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHK2 PROTEIN-KINASE; FORKHEAD-ASSOCIATED DOMAIN; FISSION YEAST; S-PHASE; DAMAGE CHECKPOINT; PHOSPHORYLATION; ACTIVATION; MRC1; AUTOPHOSPHORYLATION; OLIGOMERIZATION	Cds1 is the ortholog of Chk2 and the major effector of the DNA replication checkpoint in Schizosaccharomyces pombe. Previous studies have shown that Cds1 is activated by a two-stage mechanism. In the priming stage, the sensor kinase Rad3 and the mediator Mrc1 function to phosphorylate a threonine residue, Thr(11), in the SQ/TQ domain of Cds1. In the autoactivation stage, primed Cds1 molecules dimerize via intermolecular interactions between the phosphorylated Thr(11) in one Cds1 and the forkhead-associated domain of the other. Dimerization activates Cds1, probably by promoting autophosphorylation. To define the mechanisms for the autoactivation of primed Cds1 and the regulation of this process, we carried out genetic and biochemical studies to identify phosphorylatable residues required for checkpoint activation. Our data indicate that dimerization of Cds1 promotes trans-autophosphorylation of a number of residues in the catalytic domain, but phosphorylation of a highly conserved threonine residue (Thr(328)) in the activation loop is the only covalent modification required for kinase activation in vitro and in vivo. Autophosphorylation of Thr(328) and kinase activation in unprimed, monomeric Cds1 are strongly inhibited by the C-terminal 27-amino acid tail of the enzyme. This autoinhibitory effect may play an important role in preventing spontaneous activation of the replication checkpoint during normal cell cycles. The two-stage activation pathway and the autoinhibition mechanism, which are probably shared by other members of the Chk2 family, provide sensitivity, specificity, and noise immunity, properties required for the replication checkpoint.	[Xu, Yong-jie] Wright State Univ, Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA	University System of Ohio; Wright State University Dayton	Xu, YJ (corresponding author), 148 Diggs,3640 Col Glenn Hwy, Dayton, OH 45435 USA.	yong-jie.xu@wright.edu; tkelly@mskcc.org						Ahn J, 2004, DNA REPAIR, V3, P1039, DOI 10.1016/j.dnarep.2004.03.033; Ahn J, 2002, J BIOL CHEM, V277, P48418, DOI 10.1074/jbc.M208321200; Ahn JY, 2002, J BIOL CHEM, V277, P19389, DOI 10.1074/jbc.M200822200; Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Boddy MN, 1998, SCIENCE, V280, P909, DOI 10.1126/science.280.5365.909; Boddy MN, 2001, CURR BIOL, V11, pR953, DOI 10.1016/S0960-9822(01)00572-3; Campbell David G, 2002, J Biomol Tech, V13, P119; Chen P, 2000, CELL, V100, P681, DOI 10.1016/S0092-8674(00)80704-7; Furuya K, 2003, J CELL SCI, V116, P3847, DOI 10.1242/jcs.00790; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; Huse M, 2001, MOL CELL, V8, P671, DOI 10.1016/S1097-2765(01)00332-X; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Johnson DA, 2001, CHEM REV, V101, P2243, DOI 10.1021/cr000226k; Johnson LN, 2001, CHEM REV, V101, P2209, DOI 10.1021/cr000225s; Kass EM, 2007, J BIOL CHEM, V282, P30311, DOI 10.1074/jbc.M704642200; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Lee CH, 2001, J BIOL CHEM, V276, P30537, DOI 10.1074/jbc.M104414200; Li J, 2008, J BIOL CHEM, V283, P36019, DOI 10.1074/jbc.M804075200; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Liu QH, 2000, GENE DEV, V14, P1448; Lopez-Girona A, 2001, P NATL ACAD SCI USA, V98, P11289, DOI 10.1073/pnas.191557598; Lovly CM, 2008, MOL CELL BIOL, V28, P5874, DOI 10.1128/MCB.00821-08; MEISENHELDER JT, 1999, CURRENT PROTOCOLS MO; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MURAKAMI H, 1995, NATURE, V374, P817, DOI 10.1038/374817a0; Nakamura TM, 2004, MOL CELL BIOL, V24, P6215, DOI 10.1128/MCB.24.14.6215-6230.2004; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Oliver AW, 2007, TRENDS BIOCHEM SCI, V32, P351, DOI 10.1016/j.tibs.2007.06.004; Oliver AW, 2006, EMBO J, V25, P3179, DOI 10.1038/sj.emboj.7601209; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Saka Y, 1997, GENE DEV, V11, P3387, DOI 10.1101/gad.11.24.3387; Schwarz JK, 2003, MOL CANCER RES, V1, P598; Seo GJ, 2003, BIOCHEM BIOPH RES CO, V304, P339, DOI 10.1016/S0006-291X(03)00589-8; Sweeney FD, 2005, CURR BIOL, V15, P1364, DOI 10.1016/j.cub.2005.06.063; Tanaka K, 2004, J BIOL CHEM, V279, P32079, DOI 10.1074/jbc.M404834200; Tanaka K, 2001, NAT CELL BIOL, V3, P966, DOI 10.1038/ncb1101-966; Tanaka K, 2001, MOL CELL BIOL, V21, P3398, DOI 10.1128/MCB.21.10.3398-3404.2001; Usui T, 2007, P NATL ACAD SCI USA, V104, P2797, DOI 10.1073/pnas.0611259104; Wu XL, 2003, J BIOL CHEM, V278, P36163, DOI 10.1074/jbc.M303795200; Xu XZ, 2002, MOL CELL BIOL, V22, P4419, DOI 10.1128/MCB.22.12.4419-4432.2002; Xu YJ, 2006, GENE DEV, V20, P990, DOI 10.1101/gad.1406706; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhao H, 2003, MOL CELL BIOL, V23, P8395, DOI 10.1128/MCB.23.22.8395-8403.2003; Zou L, 2007, GENE DEV, V21, P879, DOI 10.1101/gad.1550307	49	16	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					16016	16027		10.1074/jbc.M900785200	http://dx.doi.org/10.1074/jbc.M900785200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19357077	Green Published, hybrid			2022-12-25	WOS:000266501000067
J	Mahut, B; Trinquart, L; Bokov, P; Le Bourgeois, M; Waernessyckle, S; Peiffer, C; Delclaux, C				Mahut, Bruno; Trinquart, Ludovic; Bokov, Plamen; Le Bourgeois, Muriel; Waernessyckle, Serge; Peiffer, Claudine; Delclaux, Christophe			Relationships between Specific Airway Resistance and Forced Expiratory Flows in Asthmatic Children	PLOS ONE			English	Article								Background: The earliest changes associated with airflow obstruction in asthmatic children are a proportionally greater reduction in FEF50% than in FEV1 using spirometry, and an increase in specific airway resistance (sRaw) using body plethysmography. Consequently, we hypothesized that sRaw could be better linked to FEF50% than to FEV1. The first aim was to assess the relationships between forced expiratory flows and sRaw in a large group of asthmatic children in a transversal study. We then performed a longitudinal study in order to determine whether sRaw of preschool children could predict subsequent impairment of forced expiratory flows at school age. Methodology: Pulmonary function tests (sRaw and forced expiratory flows) of 2193 asthmatic children were selected for a transversal analysis, while 365 children were retrospectively selected for longitudinal assessment from preschool to school age. Principal Findings: The transversal data showed that sRaw is differently related to FEF50% (21/sRaw) and to FEV1 (near linearly). These results were further explained by a simple one-compartment lung model, which justified the shape of the observed relationships. As hypothesized, sRaw correlated more strongly to FEF50% than to FEV1 (r = 0.64 versus 0.39, respectively; p<0.001). In the longitudinal part of the study, sRaw at preschool age correlated with subsequent FEF50% (% predicted) (-0.31, 95% CI, -0.40 to -0.22), but weakly with subsequent FEV1 (% predicted) (-0.09, 95% CI, -0.20 to 0). Conclusion: Specific Raw is more strongly related to FEF50% than to FEV1 and could be used in preschool children to predict subsequent mild airflow limitation.			Mahut, B (corresponding author), Cabinet La Berma, Antony, France.	christophe.delclaux@egp.aphp.fr	Trinquart, Ludovic/H-4961-2019	Trinquart, Ludovic/0000-0002-3028-4900				AEBISCHER CC, 1995, MONALDI ARCH CHEST D, V50, P140; Arets HGM, 2001, EUR RESPIR J, V18, P655, DOI 10.1183/09031936.01.00204301; Beydon N, 2007, AM J RESP CRIT CARE, V175, P1304, DOI 10.1164/rccm.200605-642ST; Bisgaard H, 2005, CHEST, V128, P355, DOI 10.1378/chest.128.1.355; Bisgaard H, 1995, EUR RESPIR J, V8, P2067, DOI 10.1183/09031936.95.08122067; BRISCOE WA, 1958, J CLIN INVEST, V37, P1279, DOI 10.1172/JCI103715; DAB I, 1976, PEDIATR RES, V10, P996, DOI 10.1203/00006450-197612000-00009; Delacourt C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001180; DUBOIS AB, 1956, J CLIN INVEST, V35, P327, DOI 10.1172/JCI103282; GUYATT AR, 1968, J APPL PHYSIOL, V24, P310, DOI 10.1152/jappl.1968.24.3.310; Lemaire F, 2006, AM J RESP CRIT CARE, V174, P363, DOI 10.1164/rccm.2603003; Macklem PT, 1998, AM J RESP CRIT CARE, V157, pS181, DOI 10.1164/ajrccm.157.5.rsaa-2; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Milligan G, 2005, J MOL NEUROSCI, V26, P161, DOI 10.1385/JMN:26:2-3:161; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; TAGER IB, 1986, AM REV RESPIR DIS, V134, P502; Taussig LM, 2003, J ALLERGY CLIN IMMUN, V111, P661, DOI 10.1067/mai.2003.162; Zapletal A, 1977, Cesk Pediatr, V32, P513	18	21	21	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2009	4	4							e5270	10.1371/journal.pone.0005270	http://dx.doi.org/10.1371/journal.pone.0005270			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TW	19381269	gold, Green Submitted, Green Published			2022-12-25	WOS:000265510800012
J	Deng, MQ; Gao, JT; Suraneni, P; Li, R				Deng, Manqi; Gao, Juntao; Suraneni, Praveen; Li, Rong			Kinetochore-Independent Chromosome Poleward Movement during Anaphase of Meiosis II in Mouse Eggs	PLOS ONE			English	Article								Kinetochores are considered to be the key structures that physically connect spindle microtubules to the chromosomes and play an important role in chromosome segregation during mitosis. Due to different mechanisms of spindle assembly between centrosome-containing mitotic cells and acentrosomal meiotic oocytes, it is unclear how a meiotic spindle generates the poleward forces to drive two rounds of meiotic chromosome segregation to achieve genome haploidization. We took advantage of the fact that DNA beads are able to induce bipolar spindle formation without kinetochores and studied the behavior of DNA beads in the induced spindle in mouse eggs during meiosis II. Interestingly, DNA beads underwent poleward movements that were similar in timing and speed to the meiotic chromosomes, although all the beads moved together to the same spindle pole. Disruption of dynein function abolished the poleward movements of DNA beads but not of the meiotic chromosomes, suggesting the existence of different dynein-dependent and dynein-independent force generation mechanisms for the chromosome poleward movement, and the latter may be dependent on the presence of kinetochores. Consistent with the observed DNA bead poleward movement, sperm haploid chromatin (which also induced bipolar spindle formation after injection to a metaphase egg without forming detectable kinetochore structures) also underwent similar poleward movement at anaphase as DNA beads. The results suggest that in the chromatin-induced meiotic spindles, kinetochore attachments to spindle microtubules are not absolutely required for chromatin poleward movements at anaphase.			Deng, MQ (corresponding author), Stowers Inst Med Res, Kansas City, MO USA.	MQD@stowers-institute.org; RLI@stowers-institute.org						Antonio C, 2000, CELL, V102, P425, DOI 10.1016/S0092-8674(00)00048-9; Biggins S, 2003, CURR BIOL, V13, pR449, DOI 10.1016/S0960-9822(03)00369-5; Brunet S, 1998, CURR BIOL, V8, P1231, DOI 10.1016/S0960-9822(07)00516-7; Brunet S, 1999, J CELL BIOL, V146, P1, DOI 10.1083/jcb.146.1.1; Caudron M, 2005, SCIENCE, V309, P1373, DOI 10.1126/science.1115964; CHATOT CL, 1989, J REPROD FERTIL, V86, P679, DOI 10.1530/jrf.0.0860679; Clarke PR, 2005, SCIENCE, V309, P1334, DOI 10.1126/science.1117842; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca JG, 2004, CURR BIOL, V14, pR921, DOI 10.1016/j.cub.2004.10.014; Deng MQ, 2007, DEV CELL, V12, P301, DOI 10.1016/j.devcel.2006.11.008; Deng MQ, 2005, DEV BIOL, V278, P358, DOI 10.1016/j.ydbio.2004.11.013; Desai A, 1998, J CELL BIOL, V141, P703, DOI 10.1083/jcb.141.3.703; Gaetz J, 2004, J CELL BIOL, V166, P465, DOI 10.1083/jcb.200404015; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; HAYS TS, 1990, J CELL BIOL, V110, P391, DOI 10.1083/jcb.110.2.391; Heald R, 2000, TRENDS CELL BIOL, V10, P1, DOI 10.1016/S0962-8924(99)01691-8; Heald R, 1999, CURR OPIN STRUC BIOL, V9, P268, DOI 10.1016/S0959-440X(99)80037-2; Heald R, 1997, J CELL BIOL, V138, P615, DOI 10.1083/jcb.138.3.615; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Hogan B, 1994, MANIPULATING MOUSE E; Khodjakov A, 1996, J CELL BIOL, V132, P1093, DOI 10.1083/jcb.132.6.1093; Kline-Smith SL, 2005, CURR OPIN CELL BIOL, V17, P35, DOI 10.1016/j.ceb.2004.12.009; LaFountain JR, 2001, MOL BIOL CELL, V12, P4054, DOI 10.1091/mbc.12.12.4054; LeMaire-Adkins R, 2000, GENETICS, V156, P775; Maddox P, 2003, J CELL BIOL, V162, P377, DOI 10.1083/jcb.200301088; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Mazumdar M, 2005, TRENDS CELL BIOL, V15, P349, DOI 10.1016/j.tcb.2005.05.006; McIntosh JR, 2008, CELL, V135, P322, DOI 10.1016/j.cell.2008.08.038; McIntosh JR, 2002, ANNU REV CELL DEV BI, V18, P193, DOI 10.1146/annurev.cellbio.18.032002.132412; Mitchison TJ, 2005, PHILOS T R SOC B, V360, P623, DOI 10.1098/rstb.2004.1616; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; PFARR CM, 1990, NATURE, V345, P263, DOI 10.1038/345263a0; SAWIN KE, 1991, J CELL BIOL, V112, P925, DOI 10.1083/jcb.112.5.925; SCHATTEN G, 1994, DEV BIOL, V165, P299, DOI 10.1006/dbio.1994.1256; Shimoda SL, 2002, CELL, V109, P9, DOI 10.1016/S0092-8674(02)00712-2; SKIBBENS RV, 1995, J CELL SCI, V108, P2537; STEUER ER, 1990, NATURE, V345, P266, DOI 10.1038/345266a0; Sullivan M, 2003, NAT CELL BIOL, V5, P249, DOI 10.1038/ncb940; SZOLLOSI D, 1972, J CELL SCI, V11, P521; Tanaka K, 2005, NATURE, V434, P987, DOI 10.1038/nature03483; Tanaka TU, 2002, CURR OPIN CELL BIOL, V14, P365, DOI 10.1016/S0955-0674(02)00328-9; Tomashov-Matar R, 2005, REPRODUCTION, V130, P467, DOI 10.1530/rep.1.00746; Vagnarelli P, 2008, FEBS LETT, V582, P1950, DOI 10.1016/j.febslet.2008.04.014; Van Hooser AA, 2001, CURR BIOL, V11, pR855, DOI 10.1016/S0960-9822(01)00515-2; Vernos I, 1996, CURR OPIN CELL BIOL, V8, P4, DOI 10.1016/S0955-0674(96)80041-X; Waters JC, 1996, MOL BIOL CELL, V7, P1547, DOI 10.1091/mbc.7.10.1547; Wittmann T, 1999, METHOD CELL BIOL, V61, P137; Yen TJ, 1996, CURR OPIN CELL BIOL, V8, P381, DOI 10.1016/S0955-0674(96)80014-7	48	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5249	10.1371/journal.pone.0005249	http://dx.doi.org/10.1371/journal.pone.0005249			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TN	19365562	Green Published, gold, Green Submitted			2022-12-25	WOS:000265509900021
J	Poshusta, TL; Sikkink, LA; Leung, N; Clark, RJ; Dispenzieri, A; Ramirez-Alvarado, M				Poshusta, Tanya L.; Sikkink, Laura A.; Leung, Nelson; Clark, Raynell J.; Dispenzieri, Angela; Ramirez-Alvarado, Marina			Mutations in Specific Structural Regions of Immunoglobulin Light Chains Are Associated with Free Light Chain Levels in Patients with AL Amyloidosis	PLOS ONE			English	Article							PRIMARY SYSTEMIC AMYLOIDOSIS; CLINICAL PRESENTATION; ORGAN INVOLVEMENT; CONSTANT-REGION; GENE USE; CELL; AGGREGATION; STABILITY; SURVIVAL; FEATURES	Background: The amyloidoses are protein misfolding diseases characterized by the deposition of amyloid that leads to cell death and tissue degeneration. In immunoglobulin light chain amyloidosis (AL), each patient has a unique monoclonal immunoglobulin light chain (LC) that forms amyloid deposits. Somatic mutations in AL LCs make these proteins less thermodynamically stable than their non-amyloidogenic counterparts, leading to misfolding and ultimately the formation of amyloid fibrils. We hypothesize that location rather than number of non-conservative mutations determines the amyloidogenicity of light chains. Methodology/Principal Findings: We performed sequence alignments on the variable domain of 50 kappa and 91 lambda AL light chains and calculated the number of non-conservative mutations over total number of patients for each secondary structure element in order to identify regions that accumulate non-conservative mutations. Among patients with AL, the levels of circulating immunoglobulin free light chain varies greatly, but even patients with very low levels can have very advanced amyloid deposition. Conclusions: Our results show that in specific secondary structure elements, there are significant differences in the number of non-conservative mutations between normal and AL sequences. AL sequences from patients with different levels of secreted light chain have distinct differences in the location of non-conservative mutations, suggesting that for patients with very low levels of light chains and advanced amyloid deposition, the location of non-conservative mutations rather than the amount of free light chain in circulation may determine the amyloidogenic propensity of light chains.			Poshusta, TL (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	Ramirezalvarado.marina@mayo.edu		Leung, Nelson/0000-0002-5651-1411; Ramirez-Alvarado, Marina/0000-0003-2325-6773; Dispenzieri, Angela/0000-0001-8780-9512	NCI NIH HHS [R01 CA111345, CA111345, P01 CA062242, CA062242] Funding Source: Medline; NIGMS NIH HHS [R01 GM071514, GM071514] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA111345, P01CA062242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071514] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abraham RS, 2007, J CLIN IMMUNOL, V27, P69, DOI 10.1007/s10875-006-9056-9; Abraham RS, 2003, BLOOD, V101, P3801, DOI 10.1182/blood-2002-09-2707; Arendt BK, 2008, BLOOD, V112, P1931, DOI 10.1182/blood-2008-03-143040; Baden EM, 2008, J BIOL CHEM, V283, P30950, DOI 10.1074/jbc.M804822200; Baden EM, 2008, J BIOL CHEM, V283, P15853, DOI 10.1074/jbc.M705347200; Branden C., 1999, INTRO PROTEIN STRUCT; Buxbaum JN, 2003, TRENDS BIOCHEM SCI, V28, P585, DOI 10.1016/j.tibs.2003.09.009; Comenzo RL, 1999, BRIT J HAEMATOL, V106, P744, DOI 10.1046/j.1365-2141.1999.01591.x; Comenzo RL, 2001, BLOOD, V98, P714, DOI 10.1182/blood.V98.3.714; Comenzo RL, 1998, BLOOD, V91, P3662; Dispenzieri A, 2006, BLOOD, V107, P3378, DOI 10.1182/blood-2005-07-2922; Dispenzieri A, 2008, BLOOD, V111, P4908, DOI 10.1182/blood-2008-02-138602; HURLE MR, 1994, P NATL ACAD SCI USA, V91, P5446, DOI 10.1073/pnas.91.12.5446; Kim YS, 2000, J BIOL CHEM, V275, P1570, DOI 10.1074/jbc.275.3.1570; KYLE RA, 1995, SEMIN HEMATOL, V32, P45; O'Nuallain B, 2007, BIOCHEMISTRY-US, V46, P1240, DOI 10.1021/bi0616605; Olsen KE, 1998, BIOCHEM BIOPH RES CO, V251, P642, DOI 10.1006/bbrc.1998.9508; Prokaeva T, 2007, ARTHRITIS RHEUM-US, V56, P3858, DOI 10.1002/art.22959; RADZICKA A, 1988, BIOCHEMISTRY-US, V27, P4538, DOI 10.1021/bi00412a047; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Schiffer M, 1996, AM J PATHOL, V148, P1339; Sikkink LA, 2008, AMYLOID, V15, P29, DOI 10.1080/13506120701815324; Stevens FJ, 2000, AMYLOID, V7, P200, DOI 10.3109/13506120009146835; STEVENS FJ, 1999, ANTIBODIES, P175; Wall J, 1999, BIOCHEMISTRY-US, V38, P14101, DOI 10.1021/bi991131j; Wally J, 1999, BBA-MOL BASIS DIS, V1454, P49, DOI 10.1016/S0925-4439(99)00019-8; WELSCHOF M, 1995, J IMMUNOL METHODS, V179, P203, DOI 10.1016/0022-1759(94)00286-6; Wetzel R, 1997, ADV PROTEIN CHEM, V50, P183, DOI 10.1016/S0065-3233(08)60322-8	28	53	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5169	10.1371/journal.pone.0005169	http://dx.doi.org/10.1371/journal.pone.0005169			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TN	19365555	Green Published, Green Submitted, gold			2022-12-25	WOS:000265509900004
J	Vadivel, K; Namasivayam, G				Vadivel, Kanagasabai; Namasivayam, Gautham			An Estimate of the Numbers and Density of Low-Energy Structures (or Decoys) in the Conformational Landscape of Proteins	PLOS ONE			English	Article							ORTHOGONAL LATIN SQUARES; MULTIPLE-MINIMA PROBLEM; NEAR-NATIVE FOLDS; ATOM FORCE-FIELD; STRUCTURE PREDICTION; PATHWAYS; FUNNELS; DETERMINANTS; MINIMIZATION; POTENTIALS	Background: The conformational energy landscape of a protein, as calculated by known potential energy functions, has several minima, and one of these corresponds to its native structure. It is however difficult to comprehensively estimate the actual numbers of low energy structures (or decoys), the relationships between them, and how the numbers scale with the size of the protein. Methodology: We have developed an algorithm to rapidly and efficiently identify the low energy conformers of oligo peptides by using mutually orthogonal Latin squares to sample the potential energy hyper surface. Using this algorithm, and the ECEPP/3 potential function, we have made an exhaustive enumeration of the low-energy structures of peptides of different lengths, and have extrapolated these results to larger polypeptides. Conclusions and Significance: We show that the number of native-like structures for a polypeptide is, in general, an exponential function of its sequence length. The density of these structures in conformational space remains more or less constant and all the increase appears to come from an expansion in the volume of the space. These results are consistent with earlier reports that were based on other models and techniques.			Vadivel, K (corresponding author), Univ Madras, Ctr Adv Study Crystallog & Biophys, Madras 600005, Tamil Nadu, India.	n_gautham@hotmail.com		Vadivel, Kanagasabai/0000-0003-3777-9540				Almog O, 2003, J MOL BIOL, V332, P1071, DOI 10.1016/j.jmb.2003.07.011; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Betancourt MR, 2001, J COMPUT CHEM, V22, P339, DOI 10.1002/1096-987X(200102)22:3<339::AID-JCC1006>3.0.CO;2-R; Bonneau R, 2001, ANNU REV BIOPH BIOM, V30, P173, DOI 10.1146/annurev.biophys.30.1.173; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; BRYNGELSON JD, 1987, P NATL ACAD SCI USA, V84, P7524, DOI 10.1073/pnas.84.21.7524; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Dinner AR, 1999, J PHYS CHEM B, V103, P7976, DOI 10.1021/jp990851x; Felts AK, 2002, PROTEINS, V48, P404, DOI 10.1002/prot.10171; FINNEY DJ, 1955, EXPT DESIGN ITS STAT, P45; FLOUDAS CA, 1999, DIMACS SERIES DISCRE, P141; Gilis D, 2004, J BIOMOL STRUCT DYN, V21, P725, DOI 10.1080/07391102.2004.10506963; Goldbeck RA, 1999, P NATL ACAD SCI USA, V96, P2782, DOI 10.1073/pnas.96.6.2782; GRIFFIN JF, 1986, P NATL ACAD SCI USA, V83, P3272, DOI 10.1073/pnas.83.10.3272; Hardin C, 2002, J COMPUT CHEM, V23, P138, DOI 10.1002/jcc.1162; Heikinheimo P, 2001, P NATL ACAD SCI USA, V98, P3121, DOI 10.1073/pnas.061612498; Herges T, 2005, STRUCTURE, V13, P661, DOI 10.1016/j.str.2005.01.018; HOLM L, 1992, J MOL BIOL, V225, P93, DOI 10.1016/0022-2836(92)91028-N; Huang ES, 1996, J MOL BIOL, V257, P716, DOI 10.1006/jmbi.1996.0196; Kanagasabai V, 2007, PROTEINS, V67, P908, DOI 10.1002/prot.21333; Keasar C, 2003, J MOL BIOL, V329, P159, DOI 10.1016/S0022-2836(03)00323-1; KOEHL P, 1995, NAT STRUCT BIOL, V2, P163, DOI 10.1038/nsb0295-163; Lazaridis T, 1999, J MOL BIOL, V288, P477, DOI 10.1006/jmbi.1999.2685; Levy Y, 2001, J CHEM PHYS, V114, P993, DOI 10.1063/1.1329646; LI ZQ, 1987, P NATL ACAD SCI USA, V84, P6611, DOI 10.1073/pnas.84.19.6611; Liu C.L, 1968, INTRO COMBINATORIAL, P359; Melo F, 2002, PROTEIN SCI, V11, P430, DOI 10.1002/pro.110430; Mirny LA, 2000, P NATL ACAD SCI USA, V97, P9978, DOI 10.1073/pnas.160271197; NEMETHY G, 1992, J PHYS CHEM-US, V96, P6472, DOI 10.1021/j100194a068; OLSZEWSKI KA, 1992, J PHYS CHEM-US, V96, P4672, DOI 10.1021/j100190a096; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Park B, 1996, J MOL BIOL, V258, P367, DOI 10.1006/jmbi.1996.0256; Petrey D, 2000, PROTEIN SCI, V9, P2181, DOI 10.1110/ps.9.11.2181; Plotkin SS, 2000, P NATL ACAD SCI USA, V97, P6509, DOI 10.1073/pnas.97.12.6509; Plotkin SS, 2002, Q REV BIOPHYS, V35, P111, DOI 10.1017/S0033583502003761; Samudrala R, 2000, PROTEIN SCI, V9, P1399, DOI 10.1110/ps.9.7.1399; Samudrala R, 1998, PROTEIN ENG, V11, P991, DOI 10.1093/protein/11.11.991; Samudrala R, 1998, J MOL BIOL, V279, P287, DOI 10.1006/jmbi.1998.1689; Samudrala R, 1998, J MOL BIOL, V275, P895, DOI 10.1006/jmbi.1997.1479; Samudrala R., 1999, PAC S BIOCOMPUT, V4, P505; Scheraga HA, 1999, J GLOBAL OPTIM, V15, P235, DOI 10.1023/A:1008328218931; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; SIPPL MJ, 1995, CURR OPIN STRUC BIOL, V5, P229, DOI 10.1016/0959-440X(95)80081-6; SOSNICK TR, 1994, NAT STRUCT BIOL, V1, P149, DOI 10.1038/nsb0394-149; Tsai J, 2003, PROTEINS, V53, P76, DOI 10.1002/prot.10454; Vengadesan K, 2004, BIOPOLYMERS, V74, P476, DOI 10.1002/bip.20021; Vengadesan K, 2004, J PHYS CHEM B, V108, P11196, DOI 10.1021/jp049581v; Vengadesan K, 2003, BIOPHYS J, V84, P2897, DOI 10.1016/S0006-3495(03)70017-4; WANG YH, 1995, P NATL ACAD SCI USA, V92, P709, DOI 10.1073/pnas.92.3.709; WEINER SJ, 1986, J COMPUT CHEM, V7, P230, DOI 10.1002/jcc.540070216; WEISSMAN JS, 1995, CHEM BIOL, V2, P255, DOI 10.1016/1074-5521(95)90044-6; WOLYNES PG, 1995, SCIENCE, V267, P1619, DOI 10.1126/science.7886447	53	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5148	10.1371/journal.pone.0005148	http://dx.doi.org/10.1371/journal.pone.0005148			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357778	Green Submitted, gold, Green Published			2022-12-25	WOS:000265505900014
J	Gomes, CM; Boesch, C				Gomes, Cristina M.; Boesch, Christophe			Wild Chimpanzees Exchange Meat for Sex on a Long-Term Basis	PLOS ONE			English	Article							TAI-NATIONAL-PARK; REPRODUCTIVE SUCCESS; FEMALE CHIMPANZEES; HUNTING BEHAVIOR; COOPERATION; EVOLUTION; ECOLOGY; FOREST	Humans and chimpanzees are unusual among primates in that they frequently perform group hunts of mammalian prey and share meat with conspecifics. Especially interesting are cases in which males give meat to unrelated females. The meat-for-sex hypothesis aims at explaining these cases by proposing that males and females exchange meat for sex, which would result in males increasing their mating success and females increasing their caloric intake without suffering the energetic costs and potential risk of injury related to hunting. Although chimpanzees have been shown to share meat extensively with females, there has not been much direct evidence in this species to support the meat-for-sex hypothesis. Here we show that female wild chimpanzees copulate more frequently with those males who, over a period of 22 months, share meat with them. We excluded other alternative hypotheses to exchanging meat for sex, by statistically controlling for rank of the male, age, rank and gregariousness of the female, association patterns of each male-female dyad and meat begging frequency of each female. Although males were more likely to share meat with estrous than anestrous females given their proportional representation in hunting parties, the relationship between mating success and sharing meat remained significant after excluding from the analysis sharing episodes with estrous females. These results strongly suggest that wild chimpanzees exchange meat for sex, and do so on a long-term basis. Similar studies on humans will determine if the direct nutritional benefits that women receive from hunters in foraging societies could also be driving the relationship between reproductive success and good hunting skills.			Gomes, CM (corresponding author), Max Planck Inst Evolutionary Anthropol, Leipzig, Germany.	gomes@eva.mpg.de						Baayen R. H., 2008, ANAL LINGUISTIC DATA; BATES D, 2007, LME4 PACKAGE LINEAR; BOESCH C, 1994, ANIM BEHAV, V48, P653, DOI 10.1006/anbe.1994.1285; BOESCH C, 1989, AM J PHYS ANTHROPOL, V78, P547, DOI 10.1002/ajpa.1330780410; Boesch C, 2000, CHIMPANZEES TAI FORE; Boesch C, 2006, COOPERATION IN PRIMATES AND HUMANS: MECHANISMS AND EVOLUTIONS, P139, DOI 10.1007/3-540-28277-7_8; Bolker B., 2007, ECOLOGICAL MODELS DA; CHIVERS DJ, 1980, J MORPHOL, V166, P337, DOI 10.1002/jmor.1051660306; Deschner T, 2003, ANIM BEHAV, V66, P551, DOI 10.1006/anbe.2003.2210; Field A., 2009, DISCOVERING STAT USI; Gilby IC, 2008, ANIM BEHAV, V75, P351, DOI 10.1016/j.anbehav.2007.06.008; Gilby IC, 2006, ANIM BEHAV, V72, P169, DOI 10.1016/j.anbehav.2006.01.013; Gilby IC, 2006, ANIM BEHAV, V71, P953, DOI 10.1016/j.anbehav.2005.09.009; GOMES CM, 2009, P R SOC B, V276; Goodall J., 1986, CHIMPANZEES GOMBE PA; GRAND TI, 1977, AM J PHYS ANTHROPOL, V47, P211, DOI 10.1002/ajpa.1330470204; Gurven M, 2006, CURR ANTHROPOL, V47, P185, DOI 10.1086/499552; Gurven M, 2004, BEHAV BRAIN SCI, V27, P543, DOI 10.1017/S0140525X04000123; Gurven Michael, 2006, Soc Biol, V53, P81; Hasegawa T., 1983, J ETHOL, V1, P75, DOI DOI 10.1007/BF02347833; Hawkes K, 2001, EVOL HUM BEHAV, V22, P113, DOI 10.1016/S1090-5138(00)00066-0; JONES NGB, 1987, SOC SCI INFORM, V26, P31; KAPLAN H, 1985, CURR ANTHROPOL, V26, P131, DOI 10.1086/203235; Lee Richard, 1968, MAN HUNTER; Lehmann J, 2009, ANIM BEHAV, V77, P377, DOI 10.1016/j.anbehav.2008.09.038; LOVEJOY CO, 1981, SCIENCE, V211, P341, DOI 10.1126/science.211.4480.341; Manly BFJ, 1997, RANDOMIZATION BOOTST; Mitani JC, 2001, ANIM BEHAV, V61, P915, DOI 10.1006/anbe.2000.1681; Muller MN, 2007, P ROY SOC B-BIOL SCI, V274, P1009, DOI 10.1098/rspb.2006.0206; Nishida T., 1968, Primates, V9, P167, DOI 10.1007/BF01730971; OATES JF, 1990, ECOLOGY, V71, P328, DOI 10.2307/1940272; Quinn G.P., 2002, EXPT DESIGNS DATA AN; *R DEVELOPMENTCORE, 2004, R LANG ENV STAT COMP; Smith EA, 2000, EVOL HUM BEHAV, V21, P245, DOI 10.1016/S1090-5138(00)00031-3; Smith EA, 2004, HUM NATURE-INT BIOS, V15, P343, DOI 10.1007/s12110-004-1013-9; STANFORD CB, 1994, BEHAVIOUR, V131, P1, DOI 10.1163/156853994X00181; Stanford Craig B., 1999, HUNTING APES MEAT EA; Stumpf RM, 2006, BEHAV ECOL SOCIOBIOL, V60, P749, DOI 10.1007/s00265-006-0219-8; TELEKI G, 1973, PREDATORY BEHAV WILD; Watts DP, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P244, DOI 10.1017/CBO9780511606397.024; Wittig RM, 2003, INT J PRIMATOL, V24, P847, DOI 10.1023/A:1024632923180; WRANGHAM RW, 1975, THESIS CAMBRIDGE U T; ZAHAVI A, 1995, J AVIAN BIOL, V26, P1, DOI 10.2307/3677205	43	157	159	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5116	10.1371/journal.pone.0005116	http://dx.doi.org/10.1371/journal.pone.0005116			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437RX	19352509	Green Published, Green Submitted, gold			2022-12-25	WOS:000265505700016
J	Dross, N; Spriet, C; Zwerger, M; Muller, G; Waldeck, W; Langowski, J				Dross, Nicolas; Spriet, Corentin; Zwerger, Monika; Mueller, Gabriele; Waldeck, Waldemar; Langowski, Joerg			Mapping eGFP Oligomer Mobility in Living Cell Nuclei	PLOS ONE			English	Article								Movement of particles in cell nuclei can be affected by viscosity, directed flows, active transport, or the presence of obstacles such as the chromatin network. Here we investigate whether the mobility of small fluorescent proteins is affected by the chromatin density. Diffusion of inert fluorescent proteins was studied in living cell nuclei using fluorescence correlation spectroscopy (FCS) with a two-color confocal scanning detection system. We first present experiments exposing FCS-specific artifacts encountered in live cell studies as well as strategies to prevent them, in particular those arising from the choice of the fluorophore used for calibration of the focal volume, as well as temperature and acquisition conditions used for fluorescence fluctuation measurements. After defining the best acquisition conditions, we show for various human cell lines that the mobility of GFP varies significantly within the cell nucleus, but does not correlate with chromatin density. The intranuclear diffusional mobility strongly depends on protein size: in a series of GFP-oligomers, used as free inert fluorescent tracers, the diffusion coefficient decreased from the monomer to the tetramer much more than expected for molecules free in aqueous solution. Still, the entire intranuclear chromatin network is freely accessible for small proteins up to the size of eGFP-tetramers, regardless of the chromatin density or cell line. Even the densest chromatin regions do not exclude free eGFP-monomers or multimers.	[Dross, Nicolas; Mueller, Gabriele; Waldeck, Waldemar; Langowski, Joerg] German Canc Res Ctr, Div Biophys Macromol, Heidelberg, Germany; [Spriet, Corentin] IRI, Parc Haute Borne, Villeneuve Dascq, France; [Zwerger, Monika] German Canc Res Ctr, Div Funct Cell Biol, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Universite de Lille - ISITE; Universite de Lille; Helmholtz Association; German Cancer Research Center (DKFZ)	Dross, N (corresponding author), German Canc Res Ctr, Div Biophys Macromol, Heidelberg, Germany.	jl@dkfz.de	Langowski, Jörg/A-1843-2011; Spriet, Corentin/ABE-4215-2021	Langowski, Jörg/0000-0001-8600-0666; Spriet, Corentin/0000-0002-5805-3426	DFG [La 500/13]; Region-Nord-Pas-de-Calais; ANR [05-MIIM-042]; CNRS MRCT; RT-MFM;  [GDR2588]	DFG(German Research Foundation (DFG)); Region-Nord-Pas-de-Calais(Region Hauts-de-FranceEuropean Commission); ANR(French National Research Agency (ANR)); CNRS MRCT(Centre National de la Recherche Scientifique (CNRS)); RT-MFM; 	This work was supported by DFG grant La 500/13 to JL and by grants from the Region-Nord-Pas-de-Calais, ANR-05-MIIM-042, CNRS MRCT, GDR2588 and RT-MFM to CS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beetz C, 2004, BIOCHEM BIOPH RES CO, V318, P1079, DOI 10.1016/j.bbrc.2004.03.195; BERLAND KM, 1995, BIOPHYS J, V68, P694, DOI 10.1016/S0006-3495(95)80230-4; Brown CM, 2008, J MICROSC-OXFORD, V229, P78, DOI 10.1111/j.1365-2818.2007.01871.x; Bulseco Dylan A, 2003, Methods Cell Biol, V72, P465, DOI 10.1016/S0091-679X(03)72022-6; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Curl CL, 2005, CYTOM PART A, V65A, P88, DOI 10.1002/cyto.a.20134; Digman MA, 2005, BIOPHYS J, V89, P1317, DOI 10.1529/biophysj.105.062836; DIGMAN MA, 2007, IMAGE ANAL MED MICRO, P207; DROSS N, 2008, Patent No. 2020080108950; Gao Y, 2007, APPL SPECTROSC, V61, P956, DOI 10.1366/000370207781745883; GENO G, 2005, BIOTECHNIQUES, V39, P818; Genove G, 2005, BIOTECHNIQUES, V39, P814, DOI 10.2144/000112056; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Gorisch S, 2005, HISTOCHEM CELL BIOL, V123, P217, DOI 10.1007/s00418-005-0752-y; Gorisch SM, 2005, J CELL SCI, V118, P5825, DOI 10.1242/jcs.02689; Gorisch SM, 2004, P NATL ACAD SCI USA, V101, P13221, DOI 10.1073/pnas.0402958101; Gorisch SM, 2003, EXP CELL RES, V289, P282, DOI 10.1016/S0014-4827(03)00265-9; Grunwald D, 2008, BIOPHYS J, V94, P2847, DOI 10.1529/biophysj.107.115014; Guigas G, 2008, BIOPHYS J, V94, P90, DOI 10.1529/biophysj.107.117044; HAYES L, PHILO SEDNTERP; Hess ST, 2002, BIOPHYS J, V83, P2300, DOI 10.1016/S0006-3495(02)73990-8; Jach G, 2006, NAT METHODS, V3, P597, DOI 10.1038/NMETH901; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Karpova TS, 2008, SCIENCE, V319, P466, DOI 10.1126/science.1150559; Kim SA, 2007, NAT METHODS, V4, P963, DOI 10.1038/NMETH1104; KOHLRAUSCH F, 1985, PRAKTISCHE PHYS; KOPPEL DE, 1976, BIOPHYS J, V16, P1315, DOI 10.1016/S0006-3495(76)85776-1; Mallengo G, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2940570; Medina MA, 2002, BIOESSAYS, V24, P758, DOI 10.1002/bies.10118; Monier K, 2000, NAT CELL BIOL, V2, P661, DOI 10.1038/35023615; MULLER CB, 2009, SOFT MATTER; Pack C, 2006, BIOPHYS J, V91, P3921, DOI 10.1529/biophysj.106.079467; Perche PY, 2000, CURR BIOL, V10, P1531, DOI 10.1016/S0960-9822(00)00832-0; Petrasek Z, 2008, BIOPHYS J, V94, P1437, DOI 10.1529/biophysj.107.108811; Politz JC, 1998, P NATL ACAD SCI USA, V95, P6043, DOI 10.1073/pnas.95.11.6043; Politz JCR, 2003, MOL BIOL CELL, V14, P4805, DOI 10.1091/mbc.E03-06-0395; Roth CM, 2007, ANAL CHEM, V79, P7340, DOI 10.1021/ac071039q; Sadoni N, 2001, CHROMOSOMA, V110, P39, DOI 10.1007/s004120000123; Schenk A, 2004, BIOPHYS J, V86, P384, DOI 10.1016/S0006-3495(04)74114-4; Schwille P, 1999, BIOPHYS J, V77, P2251, DOI 10.1016/S0006-3495(99)77065-7; SCOTT DW, 1979, BIOMETRIKA, V66, P605, DOI 10.1093/biomet/66.3.605; Seibel NM, 2007, ANAL BIOCHEM, V368, P95, DOI 10.1016/j.ab.2007.05.025; Seksek O, 1997, J CELL BIOL, V138, P131, DOI 10.1083/jcb.138.1.131; TEWES M, 1998, THESIS RUPRECHT KARL; Tini M, 2002, MOL CELL, V9, P265, DOI 10.1016/S1097-2765(02)00453-7; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Verschure PJ, 2003, EMBO REP, V4, P861, DOI 10.1038/sj.embor.embor922; Volkel P, 2007, BIOCHIMIE, V89, P1, DOI 10.1016/j.biochi.2006.07.009; Wachsmuth M, 2003, BIOPHYS J, V84, P3353, DOI 10.1016/S0006-3495(03)70059-9; Wachsmuth M, 2000, J MOL BIOL, V298, P677, DOI 10.1006/jmbi.2000.3692; WACHSMUTH M, 2001, FLUORESZENZFLUKTUATI; Wei XB, 2003, BIOPHYS J, V84, P1317, DOI 10.1016/S0006-3495(03)74947-9; Weidemann T, 2003, J MOL BIOL, V334, P229, DOI 10.1016/j.jmb.2003.08.063; Weidemann T, 2002, SINGLE MOL, V3, P49, DOI 10.1002/1438-5171(200204)3:1<49::AID-SIMO49>3.3.CO;2-K; REVERSIBLE ASS STRUC	55	111	113	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2009	4	4							e5041	10.1371/journal.pone.0005041	http://dx.doi.org/10.1371/journal.pone.0005041			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437QB	19347038	Green Published, Green Submitted, gold			2022-12-25	WOS:000265500900002
J	Fan, XC; Struhl, K				Fan, Xiaochun; Struhl, Kevin			Where Does Mediator Bind In Vivo?	PLOS ONE			English	Article								Background: The Mediator complex associates with RNA polymerase (Pol) II, and it is recruited to enhancer regions by activator proteins under appropriate environmental conditions. However, the issue of Mediator association in yeast cells is controversial. Under optimal growth conditions (YPD medium), we were unable to detect Mediator at essentially any S. cerevisiae promoter region, including those supporting very high levels of transcription. In contrast, whole genome microarray experiments in synthetic complete (SC) medium reported that Mediator associates with many genes at both promoter and coding regions. Principal Findings: As assayed by chromatin immunoprecipitation, we show that there are a small number of Mediator targets in SC medium that are not observed in YPD medium. However, most Mediator targets identified in the genome-wide analysis are false positives that arose for several interrelated reasons: the use of overly lenient cut-offs; artifactual differences in apparent IP efficiencies among different genomic regions in the untagged strain; low fold-enrichments making it difficult to distinguish true Mediator targets from false positives that occur in the absence of the tagged Mediator protein. Lastly, apparent Mediator association in highly active coding regions is due to a non-specific effect on accessibility due to the lack of nucleosomes, not to a specific association of Mediator. Conclusions: These results indicate that Mediator does not bind to numerous sites in the yeast genome, but rather selectively associates with a limited number of upstream promoter regions in an activator- and stress-specific manner.	[Fan, Xiaochun; Struhl, Kevin] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Fan, XC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	kevin@hms.harvard.edu			National Institutes of Health [GM 30186]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030186, R37GM030186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant GM 30186 from the National Institutes of Health to KS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrau JC, 2006, MOL CELL, V22, P179, DOI 10.1016/j.molcel.2006.03.023; APARICIO O, 2004, CURRENT PROTOCOLS MO; Bjorklund S, 2005, TRENDS BIOCHEM SCI, V30, P240, DOI 10.1016/j.tibs.2005.03.008; Boube M, 2002, CELL, V110, P143, DOI 10.1016/S0092-8674(02)00830-9; Chadick JZ, 2005, TRENDS BIOCHEM SCI, V30, P264, DOI 10.1016/j.tibs.2005.03.001; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Fan XC, 2006, NAT STRUCT MOL BIOL, V13, P117, DOI 10.1038/nsmb1049; GIARDINA C, 1995, MOL CELL BIOL, V15, P2737; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Kim YJ, 2005, TRENDS BIOCHEM SCI, V30, P245, DOI 10.1016/j.tibs.2005.03.010; KORNBERG RD, 2005, TRENDS BIOCHEM SCI, V30, P240; Kristjuhan A, 2004, EMBO J, V23, P4243, DOI 10.1038/sj.emboj.7600433; Kuras L, 2003, P NATL ACAD SCI USA, V100, P13887, DOI 10.1073/pnas.2036346100; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; Ng HH, 2002, GENE DEV, V16, P806, DOI 10.1101/gad.978902; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Proft M, 2005, EUKARYOT CELL, V4, P1343, DOI 10.1128/EC.4.8.1343-1352.2005; SCHNEIDER BL, 1995, YEAST, V11, P1265, DOI 10.1002/yea.320111306; Schwabish MA, 2004, MOL CELL BIOL, V24, P10111, DOI 10.1128/MCB.24.23.10111-10117.2004; Struhl K., 2007, EVALUATING TECHNIQUE, P29; Tanay A, 2006, GENOME RES, V16, P962, DOI 10.1101/gr.5113606; THOMPSON CM, 1995, P NATL ACAD SCI USA, V92, P4587, DOI 10.1073/pnas.92.10.4587; Wade JT, 2008, CURR OPIN GENET DEV, V18, P130, DOI 10.1016/j.gde.2007.12.008; Wade JT, 2004, NATURE, V432, P1054, DOI 10.1038/nature03175; Zhu XF, 2006, MOL CELL, V22, P169, DOI 10.1016/j.molcel.2006.03.032	29	53	54	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2009	4	4							e5029	10.1371/journal.pone.0005029	http://dx.doi.org/10.1371/journal.pone.0005029			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437QA	19343176	gold, Green Submitted, Green Published			2022-12-25	WOS:000265500800003
J	Zhang, YF; Li, H; Wang, XM; Gao, X; Liu, XL				Zhang, Yafeng; Li, Hai; Wang, Xiaoming; Gao, Xiang; Liu, Xiaolong			Regulation of T Cell Development and Activation by Creatine Kinase B	PLOS ONE			English	Article							NEGATIVE SELECTION; CD4(+)CD8(+) THYMOCYTES; PROTEIN; EXPRESSION; DIFFERENTIATION; APOPTOSIS; ENZYME; SIGNAL; BCL-2; MUSCLES	Creatine kinase catalyzes the reversible transfer of the N-phosphoryl group from phosphocreatine to ADP to generate ATP and plays a key role in highly energy-demanding processes such as muscle contraction and flagellar motility; however, its role in signal transduction (which frequently involves ATP-consuming phosphorylation) and consequent cell-fate decisions remains largely unknown. Here we report that creatine kinase B was significantly up-regulated during the differentiation of double-positive thymocytes into single-positive thymocytes. Ectopic expression of creatine kinase B led to increased ATP level and enhanced phosphorylation of the TCR signaling proteins. Consequentially, transgenic expression of creatine kinase B promoted the expression of Nur77 and Bim proteins and the cell death of TCR signaled thymocyte. In addition, the activation, proliferation and cytokine secretion of T cells were also enhanced by the expression of creatine kinase B transgene. In contrast, treatment of T cells with specific creatine kinase inhibitor or creatine kinase B shRNA resulted in severely impaired T cell activation. Taken together, our results indicate that creatine kinase B plays an unexpected role in modulating TCR-mediated signaling and critically regulates thymocyte selection and T cell activation.	[Zhang, Yafeng; Li, Hai; Wang, Xiaoming; Liu, Xiaolong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai, Peoples R China; [Gao, Xiang] Nanjing Univ, Model Anim Res Ctr, Nanjing, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Nanjing University	Zhang, YF (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai, Peoples R China.	liux@sibs.ac.cn	Li, Hai/AAI-9163-2021	Li, Hai/0000-0002-4762-9362	National Natural Science Foundation of China [30623003]; Ministry of Science and Technology [2006CB504303, 2007CB815802]; National High-Tech Research and Development Program of China [2007AA02Z167]; National Basic Research Program of China [2007CB914504]; Chinese Academy of Sciences [KSCX1-YW-R-43, 180KSCX2-YW-R-108]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	National Natural Science Foundation of China (30623003), the Ministry of Science and Technology (2006CB504303, 2007CB815802), National High-Tech Research and Development Program of China (2007AA02Z167), National Basic Research Program of China (2007CB914504) and Chinese Academy of Sciences (KSCX1-YW-R-43, 180KSCX2-YW-R-108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames A, 2000, BRAIN RES REV, V34, P42, DOI 10.1016/S0165-0173(00)00038-2; Amsen D, 1999, P NATL ACAD SCI USA, V96, P622, DOI 10.1073/pnas.96.2.622; Balasubramani M, 2006, CANCER RES, V66, P763, DOI 10.1158/0008-5472.CAN-05-3771; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Burklen TS, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/35936; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; Chang EJ, 2008, NAT MED, V14, P966, DOI 10.1038/nm.1860; Cheng AM, 1997, CURR OPIN IMMUNOL, V9, P528, DOI 10.1016/S0952-7915(97)80106-9; Debrincat MA, 2007, J BIOL CHEM, V282, P4728, DOI 10.1074/jbc.M609164200; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Huddleston HG, 2005, GYNECOL ONCOL, V96, P77, DOI 10.1016/j.ygyno.2004.08.047; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Ishikawa J, 2005, CLIN CHIM ACTA, V361, P135, DOI 10.1016/j.cccn.2005.05.028; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; KNOWLES JR, 1980, ANNU REV BIOCHEM, V49, P877, DOI 10.1146/annurev.bi.49.070180.004305; Koretzky GA, 2001, NAT REV IMMUNOL, V1, P95, DOI 10.1038/35100523; Kuiper JWP, 2008, PLOS BIOL, V6, P568, DOI 10.1371/journal.pbio.0060051; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; Liu XL, 2003, J EXP MED, V197, P363, DOI 10.1084/jem.20021698; Mahajan VB, 2000, P NATL ACAD SCI USA, V97, P12062, DOI 10.1073/pnas.97.22.12062; Meffert G, 2005, BMC GASTROENTEROL, V5, DOI 10.1186/1471-230X-5-9; Mulvaney PT, 1998, INT J CANCER, V78, P46, DOI 10.1002/(SICI)1097-0215(19980925)78:1<46::AID-IJC9>3.0.CO;2-X; Mustelin T, 2003, BIOCHEM J, V371, P15, DOI 10.1042/BJ20021637; Ohashi PS, 2003, CURR OPIN IMMUNOL, V15, P668, DOI 10.1016/j.coi.2003.09.013; Owen MJ, 1996, CURR OPIN IMMUNOL, V8, P191, DOI 10.1016/S0952-7915(96)80057-4; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; PUNT JA, 1994, J EXP MED, V179, P709, DOI 10.1084/jem.179.2.709; Qian DP, 1997, CURR OPIN CELL BIOL, V9, P205, DOI 10.1016/S0955-0674(97)80064-6; Rincon M, 2001, CURR OPIN IMMUNOL, V13, P339, DOI 10.1016/S0952-7915(00)00224-7; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; Shin JB, 2007, NEURON, V53, P371, DOI 10.1016/j.neuron.2006.12.021; Sprent J, 2002, IMMUNOL REV, V185, P126, DOI 10.1034/j.1600-065X.2002.18512.x; SPRENT J, 1995, CURR OPIN IMMUNOL, V7, P196, DOI 10.1016/0952-7915(95)80004-2; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Swainson L, 2005, P NATL ACAD SCI USA, V102, P12867, DOI 10.1073/pnas.0503603102; Tachikawa M, 2004, EUR J NEUROSCI, V20, P144, DOI 10.1111/j.1460-9568.2004.03478.x; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; VANDEURSEN J, 1993, CELL, V74, P621, DOI 10.1016/0092-8674(93)90510-W; Ventura-Clapier R, 1998, MOL CELL BIOCHEM, V184, P231, DOI 10.1023/A:1006840508139; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Wallimann T, 1998, MAGN RESON MATER PHY, V6, P116; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Yu Q, 2003, J EXP MED, V197, P475, DOI 10.1084/jem.20021765	50	53	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5000	10.1371/journal.pone.0005000	http://dx.doi.org/10.1371/journal.pone.0005000			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337362	Green Submitted, gold, Green Published			2022-12-25	WOS:000265500600007
J	Lamers, SL; Salemi, M; Galligan, DC; de Oliveira, T; Fogel, GB; Granier, SC; Zhao, L; Brown, JN; Morris, A; Masliah, E; McGrath, MS				Lamers, Susanna L.; Salemi, Marco; Galligan, Derek C.; de Oliveira, Tulio; Fogel, Gary B.; Granier, Sara C.; Zhao, Li; Brown, Joseph N.; Morris, Alanna; Masliah, Eliezer; McGrath, Michael S.			Extensive HIV-1 Intra-Host Recombination Is Common in Tissues with Abnormal Histopathology	PLOS ONE			English	Article								There is evidence that immune-activated macrophages infected with the Human Immunodeficiency Virus (HIV) are associated with tissue damage and serve as a long-lived viral reservoir during therapy. In this study, we analyzed 780 HIV genetic sequences generated from 53 tissues displaying normal and abnormal histopathology. We found up to 50% of the sequences from abnormal lymphoid and macrophage rich non-lymphoid tissues were intra-host viral recombinants. The presence of extensive recombination, especially in non-lymphoid tissues, implies that HIV-1 infected macrophages may significantly contribute to the generation of elusive viral genotypes in vivo. Because recombination has been implicated in immune evasion, the acquisition of drug-resistance mutations, and alterations of viral co-receptor usage, any attempt towards the successful eradication of HIV-1 requires therapeutic approaches targeting tissue macrophages.	[Lamers, Susanna L.; Salemi, Marco; de Oliveira, Tulio; Granier, Sara C.] BioInfoExperts, Thibodaux, LA USA; [Salemi, Marco; Brown, Joseph N.] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA; [Galligan, Derek C.; Morris, Alanna; McGrath, Michael S.] Univ Calif San Francisco, Dept Lab Med, Positive Hlth Program, San Francisco, CA 94143 USA; [de Oliveira, Tulio] Univ Western Cape, S African Natl Bioinformat Inst, Cape Town, South Africa; [Fogel, Gary B.] Nat Select Inc, San Diego, CA USA; [Zhao, Li] Shandong Univ, Dept Toxicol, Jinan, Peoples R China; [McGrath, Michael S.] Pathol Inc, Burlingame, CA USA; [Masliah, Eliezer] Univ Calif San Diego, Sch Med, Dept Pathol, San Diego, CA USA; [McGrath, Michael S.] AIDS & Canc Specimen Resource, San Francisco, CA USA	State University System of Florida; University of Florida; University of California System; University of California San Francisco; South African National Biodiversity Institute; University of the Western Cape; Shandong University; University of California System; University of California San Diego	Lamers, SL (corresponding author), BioInfoExperts, Thibodaux, LA USA.	mmcgrath@hemeonc.ucsf.edu			NIH [R01 MH073510-01]; SBIR [DMI-0349669]; West Coast AIDS and Cancer Specimen Resource Consortium [U01 CA066529-12]; Department of Pediatrics at the University of Florida, Gainesville [AI065265, HD32259]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032259, R55HD032259] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U01CA066529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073510] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SBIR; West Coast AIDS and Cancer Specimen Resource Consortium; Department of Pediatrics at the University of Florida, Gainesville; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The project was primarily funded through NIH R01 MH073510-01. Additional support was provided to S.L. Lamers through SBIR grant DMI- 0349669. Additional support was provided to M.S. McGrath through the West Coast AIDS and Cancer Specimen Resource Consortium U01 CA066529-12. Additional support for M. Salemi was provided by grants AI065265 and HD32259 and the Department of Pediatrics at the University of Florida, Gainesville. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Carvajal-Rodriguez A, 2007, INFECT GENET EVOL, V7, P476, DOI 10.1016/j.meegid.2007.02.001; Charpentier C, 2006, J VIROL, V80, P2472, DOI 10.1128/JVI.80.5.2472-2482.2006; Chen JB, 2005, J VIROL, V79, P9337, DOI 10.1128/JVI.79.14.9337-9340.2005; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; COFFIN JM, 1979, J GEN VIROL, V42, P1, DOI 10.1099/0022-1317-42-1-1; Cotter Bruno R, 2006, Curr HIV/AIDS Rep, V3, P126, DOI 10.1007/BF02696656; Forsman A, 2008, TRENDS MICROBIOL, V16, P555, DOI 10.1016/j.tim.2008.09.004; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Hansen AB, 2006, HIV MED, V7, P38, DOI 10.1111/j.1468-1293.2005.00334.x; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; HU WS, 1990, SCIENCE, V250, P1227, DOI 10.1126/science.1700865; Jung A, 2002, NATURE, V418, P144, DOI 10.1038/418144a; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Lamers S, 2004, BIOINFORMATICS, V20, P436, DOI 10.1093/bioinformatics/btg445; Lamers SL, 1996, AIDS RES HUM RETROV, V12, P1169, DOI 10.1089/aid.1996.12.1169; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Mack KD, 2003, JAIDS-J ACQ IMM DEF, V33, P308, DOI 10.1097/00126334-200307010-00004; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Meyerhans A, 2003, SWISS MED WKLY, V133, P451; Mild M, 2007, J VIROL, V81, P3369, DOI 10.1128/JVI.01295-06; Morris A, 1999, J VIROL, V73, P8720, DOI 10.1128/JVI.73.10.8720-8731.1999; Orenstein JM, 1997, SCIENCE, V276, P1857, DOI 10.1126/science.276.5320.1857; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Perez-Bercoff D, 2007, J VIROL, V81, P4540, DOI 10.1128/JVI.01620-06; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246; Rodrigo AG, 1999, P NATL ACAD SCI USA, V96, P2187, DOI 10.1073/pnas.96.5.2187; Rodrigo AG, 1997, AIDS RES HUM RETROV, V13, P737, DOI 10.1089/aid.1997.13.737; Salemi M, 2005, J VIROL, V79, P11343, DOI 10.1128/JVI.79.17.11343-11352.2005; SALEMI M, 2003, PHYLOGENETIC HDB PRA, P348; Salemi M, 2008, MOL PHYLOGENET EVOL, V49, P618, DOI 10.1016/j.ympev.2008.08.017; Salemi M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000950; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Samaras K, 2007, DIABETES CARE, V30, P113, DOI 10.2337/dc06-1075; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; SERAFINI S, 2008, ANTIVIRAL RES; Shriner D, 2004, GENETICS, V167, P1573, DOI 10.1534/genetics.103.023382; SMITH JM, 1992, J MOL EVOL, V34, P126; Swingler S, 2008, CELL HOST MICROBE, V4, P63, DOI 10.1016/j.chom.2008.05.015; Swingler S, 2007, PLOS PATHOG, V3, P1281, DOI 10.1371/journal.ppat.0030134; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Yu H, 1998, J BIOL CHEM, V273, P28384, DOI 10.1074/jbc.273.43.28384; Zhang CY, 2008, INFECT GENET EVOL, V8, P693, DOI 10.1016/j.meegid.2008.04.001; Zhuang JL, 2002, J VIROL, V76, P11273, DOI 10.1128/JVI.76.22.11273-11282.2002	52	36	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e5065	10.1371/journal.pone.0005065	http://dx.doi.org/10.1371/journal.pone.0005065			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333384	Green Submitted, Green Published, gold			2022-12-25	WOS:000265499900017
J	Chandrasekharan, BP; Kolachala, VL; Dalmasso, G; Merlin, D; Ravid, K; Sitaraman, SV; Srinivasan, S				Chandrasekharan, Bindu P.; Kolachala, Vasantha L.; Dalmasso, Guillaume; Merlin, Didier; Ravid, Katya; Sitaraman, Shanthi V.; Srinivasan, Shanthi			Adenosine 2B receptors (A(2B)AR) on enteric neurons regulate murine distal colonic motility	FASEB JOURNAL			English	Article						stool retention; stool frequency; nitric oxide	A2B; EXPRESSION; COLITIS; MOUSE; CELLS; RAT; INFLAMMATION; PROTECTS; TRANSIT	Delayed colonic emptying leading to constipation is a significant health concern. We investigated the role of adenosine 2B receptor (A(2B)AR) in modulating distal colonic motility using wild-type and A(2B)AR-knockout (A(2B)AR(-/-)) mice. Colon motility was assessed using stool characteristics and colonic transit. Distal colonic ganglia, isolated by laser capture microdissection, were tested for A(2B)AR expression by RTPCR. The distal colon contraction and relaxation responses were assessed by electrical field stimulation (EFS) in presence of A(2B)AR agonists, antagonists or inhibitors of nitric oxide (NO) and guanylate cyclase. Nitrite levels were measured in enteric neuronal cultures exposed to A(2B)AR agonists/antagonists. A(2B)AR(-/-) mice display increased stool retention, decreased stool frequency, delayed colonic emptyping, and decreased circular muscle relaxation. RT-PCR identified A(2B)AR expression in distal colonic ganglia. EFS studies revealed that enteric neuronal A(2B)AR is essential for distal colonic relaxation, and A(2B)AR antagonists can inhibit relaxation. Enteric neurons stimulated with A(2B)AR agonists produced more nitrite than cultures treated with antagonists. We demonstrate an essential role of A(2B)AR in regulating distal colon relaxation, as A(2B)AR activation is linked to NO signaling. Hence targeting the colonic A(2B)AR could represent a novel therapeutic strategy to treat constipation.-Chandrasekharan, B. P., Kolachala, V. L., Dalmasso, G., Merlin, D., Ravid, K., Sitaraman, S. V., Srinivasan, S. Adenosine 2B receptors (A(2B)AR) on enteric neurons regulate murine distal colonic motility. FASEB J. 23, 2727-2734 ( 2009)	[Chandrasekharan, Bindu P.; Kolachala, Vasantha L.; Dalmasso, Guillaume; Merlin, Didier; Sitaraman, Shanthi V.; Srinivasan, Shanthi] Emory Univ, Div Digest Dis, Atlanta, GA 30322 USA; [Ravid, Katya] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Ravid, Katya] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Emory University; Boston University; Boston University	Sitaraman, SV (corresponding author), Emory Univ, Div Digest Dis, Suite 246,Whitehead Res Bldg,615 Michael St, Atlanta, GA 30322 USA.	ssitar2@emory.edu; ssrini2@emory.edu	Dalmasso, Guillaume/N-2443-2018; Chandrasekharan, Bindu/CAA-0476-2022; chandrasekharan, bindu/AAU-5479-2021; Srinivasan, Shanthi/A-6133-2013	Dalmasso, Guillaume/0000-0002-3433-870X; Chandrasekharan, Bindu/0000-0003-2943-3902; Ravid, Katya/0000-0002-9918-3024	Crohn's and Colitis Foundation of America (CCFA); Ruth L. Kirstein National Research Service Award for Individual Postdoctoral Fellows [F32]; NIH [NIH-KO8 DK067045, RO3 DK078552, DK06411, RO1-DK-071594, HL 13262]; Digestive Diseases Research Center [DK064399]; Pax Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL013262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064399, R03DK078552, K08DK067045, R01DK080684, R01DK071594] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation of America (CCFA); Ruth L. Kirstein National Research Service Award for Individual Postdoctoral Fellows(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Diseases Research Center; Pax Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	B. C. and G. D. are supported by Crohn's and Colitis Foundation of America (CCFA) Research Fellowship Awards, and V. L. K. is supported by a Ruth L. Kirstein National Research Service Award for Individual Postdoctoral Fellows (F32). Authors are supported by the following NIH grants: NIH-KO8 DK067045 ( S. S.), RO3 DK078552 ( S. S.), DK06411 ( S. V. S.), RO1-DK-071594 ( D. M.), and a Digestive Diseases Research Center grant (DK064399). K. R., an established researcher with the American Heart Association, is supported by NIH HL 13262. The authors thank Pax Health ( New Haven, CT, USA), a division of Clinical Data, for supplying ATL-801. The authors thank Mr. Zinan Zhang for help with experiments related to whole-animal motility studies.	Anitha M, 2008, GASTROENTEROLOGY, V134, P1424, DOI 10.1053/j.gastro.2008.02.018; Anitha M, 2006, GASTROENTEROLOGY, V131, P1164, DOI 10.1053/j.gastro.2006.07.019; Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; BULT H, 1990, NATURE, V345, P346, DOI 10.1038/345346a0; Burnstock G, 2008, NEUROGASTROENT MOTIL, V20, P8, DOI 10.1111/j.1365-2982.2008.01107.x; Christofi FL, 2001, J COMP NEUROL, V439, P46, DOI 10.1002/cne.1334; Coates MD, 2006, NEUROGASTROENT MOTIL, V18, P464, DOI 10.1111/j.1365-2982.2006.00792.x; Compos-Neto A, 1998, J IMMUNOL, V160, P2037; de Lorijn F, 2005, GUT, V54, P1107, DOI 10.1136/gut.2004.051045; De Man JG, 2001, BRIT J PHARMACOL, V133, P695, DOI 10.1038/sj.bjp.0704115; Giaroni C, 2002, NEUROPHARMACOLOGY, V43, P1313, DOI 10.1016/S0028-3908(02)00294-0; Grenz A, 2008, PLOS MED, V5, P968, DOI 10.1371/journal.pmed.0050137; Kolachala V, 2005, CELL MOL LIFE SCI, V62, P2647, DOI 10.1007/s00018-005-5328-4; Kolachala V, 2005, J BIOL CHEM, V280, P4048, DOI 10.1074/jbc.M409577200; Kolachala VL, 2008, BRIT J PHARMACOL, V155, P127, DOI 10.1038/bjp.2008.227; Kolachala VL, 2008, GASTROENTEROLOGY, V135, P861, DOI 10.1053/j.gastro.2008.05.049; Mi T, 2008, J CLIN INVEST, V118, P1491, DOI 10.1172/JCI33467; MILLER MS, 1981, J PHARMACOL METHOD, V6, P211, DOI 10.1016/0160-5402(81)90110-8; Mizuta Y, 1999, AM J PHYSIOL-GASTR L, V277, pG275, DOI 10.1152/ajpgi.1999.277.2.G275; Nemeth ZH, 2005, J IMMUNOL, V175, P8260, DOI 10.4049/jimmunol.175.12.8260; RIVKEES SA, 1992, MOL ENDOCRINOL, V6, P1598, DOI 10.1210/me.6.10.1598; Toda N, 2005, PHARMACOL REV, V57, P315, DOI 10.1124/pr.57.3.4; Van Crombruggen K, 2007, NEUROPHARMACOLOGY, V53, P257, DOI 10.1016/j.neuropharm.2007.05.010; Van Crombruggen K, 2004, NEUROGASTROENT MOTIL, V16, P81; Xu Y, 2008, J BIOL CHEM, V283, P14213, DOI 10.1074/jbc.M708657200; Yaar R, 2005, J CELL PHYSIOL, V202, P9, DOI 10.1002/jcp.20138; Yang D, 2008, P NATL ACAD SCI USA, V105, P792, DOI 10.1073/pnas.0705563105; Yang D, 2006, J CLIN INVEST, V116, P1913, DOI 10.1172/JCI27933; Zizzo MG, 2006, BRIT J PHARMACOL, V148, P956, DOI 10.1038/sj.bjp.0706808	29	34	37	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2727	2734		10.1096/fj.09-129544	http://dx.doi.org/10.1096/fj.09-129544			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19357134	Green Published			2022-12-25	WOS:000268836700040
J	Zhang, HM; Astrof, NS; Liu, JH; Wang, JH; Shimaoka, M				Zhang, Hongmin; Astrof, Nathan S.; Liu, Jin-Huan; Wang, Jia-Huai; Shimaoka, Motomu			Crystal structure of isoflurane bound to integrin LFA-1 supports a unified mechanism of volatile anesthetic action in the immune and central nervous systems	FASEB JOURNAL			English	Article						allosteric modulation; conformational change; ferritin; halogen bond; stereoisomer	I-DOMAIN; GABA(A) RECEPTOR; OPTICAL ISOMERS; SERUM-ALBUMIN; BINDING; INHIBITION; PROTEINS; INFLAMMATION; REFINEMENT; ACTIVATION	Volatile anesthetics (VAs), such as isoflurane, induce a general anesthetic state by binding to specific targets (i.e., ion channels) in the central nervous system (CNS). Simultaneously, VAs modulate immune functions, possibly via direct interaction with alternative targets on leukocytes. One such target, the integrin lymphocyte function-associated antigen-1 (LFA-1), has been shown previously to be inhibited by isoflurane. A better understanding of the mechanism by which isoflurane alters protein function requires the detailed information about the drug-protein interaction at an atomic level. Here, we describe the crystal structure of the LFA-1 ligand-binding domain (I domain) in complex with isoflurane at 1.6 angstrom. We discovered that isoflurane binds to an allosteric cavity previously implicated as critical for the transition of LFA-1 from the low-to the high-affinity state. The isoflurane binding site in the I domain involves an array of amphiphilic interactions, thereby resembling a "common anesthetic binding motif" previously predicted for authentic VA binding sites. These results suggest that the allosteric modulation of protein function by isoflurane, as demonstrated for the integrin LFA-1, might represent a unified mechanism shared by the interactions of volatile anesthetics with targets in the CNS.-Zhang, H., Astrof, N. S., Liu, J.-H., Wang, J.-H., Shimaoka, M. Crystal structure of isoflurane bound to integrin LFA-1 supports a unified mechanism of volatile anesthetic action in the immune and central nervous systems. FASEB J. 23, 2735-2740 ( 2009)	[Astrof, Nathan S.; Shimaoka, Motomu] Childrens Hosp, Immune Dis Inst, Program Cellular & Mol Med, Boston, MA 02115 USA; [Zhang, Hongmin; Liu, Jin-Huan; Wang, Jia-Huai] Dana Farber Canc Inst, Boston, MA 02115 USA; [Zhang, Hongmin; Liu, Jin-Huan; Wang, Jia-Huai] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Zhang, Hongmin; Liu, Jin-Huan; Wang, Jia-Huai] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Astrof, Nathan S.; Shimaoka, Motomu] Harvard Univ, Sch Med, Dept Anesthesia, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Shimaoka, M (corresponding author), Childrens Hosp, Immune Dis Inst, Program Cellular & Mol Med, 3 Blackfan Circle, Boston, MA 02115 USA.	shimaoka@idi.harvard.edu	Zhang, Hongmin/S-9953-2017; Zhang, Hongmin/C-4503-2009	Zhang, Hongmin/0000-0003-4356-3615; Zhang, Hongmin/0000-0001-6357-4106	National Institutes of Health, [AI063421, HL048675]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063421] Funding Source: NIH RePORTER	National Institutes of Health,(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Koichi Yuki and Sulpicio G. Soriano ( Children's Hospital Boston and Harvard Medical School, Boston, MA, USA) for providing reagents and advice. This work was supported by grants from the National Institutes of Health, AI063421 ( M. S.) and HL048675 ( M. S., J. H. W.).	Auffinger P, 2004, P NATL ACAD SCI USA, V101, P16789, DOI 10.1073/pnas.0407607101; Bertaccini EJ, 2007, ANESTH ANALG, V104, P318, DOI 10.1213/01.ane.0000253029.67331.8d; Bhattacharya AA, 2000, J BIOL CHEM, V275, P38731, DOI 10.1074/jbc.M005460200; Chiang N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001879; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dickinson R, 2000, ANESTHESIOLOGY, V93, P837, DOI 10.1097/00000542-200009000-00035; DUSTIN ML, 1999, GUIDEBOOK EXTRACELLU, P228; Eckenhoff RG, 1997, PHARMACOL REV, V49, P343; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Franks NP, 1998, BIOPHYS J, V75, P2205, DOI 10.1016/S0006-3495(98)77664-7; FRANKS NP, 1991, SCIENCE, V254, P427, DOI 10.1126/science.1925602; HALL AC, 1994, BRIT J PHARMACOL, V112, P906, DOI 10.1111/j.1476-5381.1994.tb13166.x; Hayes JK, 2004, ANESTH ANALG, V98, P999, DOI 10.1213/01.ANE.0000104584.91385.1D; Hemmings HC, 2005, TRENDS PHARMACOL SCI, V26, P503, DOI 10.1016/j.tips.2005.08.006; Kallen J, 1999, J MOL BIOL, V292, P1, DOI 10.1006/jmbi.1999.3047; Kortagere S, 2008, J MOL GRAPH MODEL, V27, P170, DOI 10.1016/j.jmgm.2008.04.001; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; LIEN EJ, 1976, MOL PHARMACOL, V12, P598; Liu RY, 2005, FASEB J, V19, P567, DOI 10.1096/fj.04-3171com; McBride WT, 1996, ANAESTHESIA, V51, P465, DOI 10.1111/j.1365-2044.1996.tb07793.x; Mobert J, 1999, ANESTHESIOLOGY, V90, P1372, DOI 10.1097/00000542-199905000-00022; MOODY EJ, 1993, BRAIN RES, V615, P101, DOI 10.1016/0006-8993(93)91119-D; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PFEIFFER CC, 1956, SCIENCE, V124, P29, DOI 10.1126/science.124.3210.29; Qu AD, 1996, STRUCTURE, V4, P931, DOI 10.1016/S0969-2126(96)00100-1; QUINLAN JJ, 1995, ANESTHESIOLOGY, V83, P611, DOI 10.1097/00000542-199509000-00021; Shimaoka M, 2003, NAT REV DRUG DISCOV, V2, P703, DOI 10.1038/nrd1174; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Streiff JH, 2008, J CHEM INF MODEL, V48, P2066, DOI 10.1021/ci800206a; Xu Y, 1996, BIOPHYS J, V70, P532, DOI 10.1016/S0006-3495(96)79599-1; Yuki K, 2008, FASEB J, V22, P4109, DOI 10.1096/fj.08-113324	34	34	34	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2735	2740		10.1096/fj.09-129908	http://dx.doi.org/10.1096/fj.09-129908			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19332643	Green Published			2022-12-25	WOS:000268836700041
J	Zakharova, MY; Kuznetsov, NA; Dubiley, SA; Kozyr, AV; Fedorova, OS; Chudakov, DM; Knorre, DG; Shemyakin, IG; Gabibov, AG; Kolesnikov, AV				Zakharova, Maria Yu.; Kuznetsov, Nikita A.; Dubiley, Svetlana A.; Kozyr, Arina V.; Fedorova, Olga S.; Chudakov, Dmitry M.; Knorre, Dmitry G.; Shemyakin, Igor G.; Gabibov, Alexander G.; Kolesnikov, Alexander V.			Substrate Recognition of Anthrax Lethal Factor Examined by Combinatorial and Pre-steady-state Kinetic Approaches	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; KINASE-KINASE; ACTIVE-SITE; MECHANISM; INACTIVATION; GLYCOSYLASE; PROTEOLYSIS; PROTEASE; FAMILY	Lethal factor (LF), a zinc-dependent protease of high specificity produced by Bacillus anthracis, is the effector component of the binary toxin that causes death in anthrax. New therapeutics targeting the toxin are required to reduce systemic anthrax-related fatalities. In particular, new insights into the LF catalytic mechanism will be useful for the development of LF inhibitors. We evaluated the minimal length required for formation of bona fide LF substrates using substrate phage display. Phage-based selection yielded a substrate that is cleaved seven times more efficiently by LF than the peptide targeted in the protein kinase MKK6. Site-directed mutagenesis within the metal-binding site in the LF active center and within phage-selected substrates revealed a complex pattern of LF-substrate interactions. The elementary steps of LF-mediated proteolysis were resolved by the stopped-flow technique. Pre-steady-state kinetics of LF proteolysis followed a four-step mechanism as follows: initial substrate binding, rearrangement of the enzyme-substrate complex, a rate-limiting cleavage step, and product release. Examination of LF interactions with metal ions revealed an unexpected activation of the protease by Ca2+ and Mn2+. Based on the available structural and kinetic data, we propose a model for LF-substrate interaction. Resolution of the kinetic and structural parameters governing LF activity may be exploited to design new LF inhibitors.	[Zakharova, Maria Yu.; Dubiley, Svetlana A.; Kozyr, Arina V.; Chudakov, Dmitry M.; Gabibov, Alexander G.; Kolesnikov, Alexander V.] Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Moscow 117997, Russia; [Kuznetsov, Nikita A.; Fedorova, Olga S.; Knorre, Dmitry G.] Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, Novosibirsk 630090, Russia; [Shemyakin, Igor G.] State Res Ctr Appl Microbiol & Biotechnol, Obolensk 142279, Moscow Region, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Kolesnikov, AV (corresponding author), Inst Bioorgan Chem, Miklukho Maklaya 16-10,117997 GSP,V-437, Moscow, Russia.	koleso@ibch.ru	Fedorova, Olga/ABE-6637-2020; Knorre, Dmitriy/G-4250-2013; Dubiley, Svetlana/AAU-2812-2021; Kuznetsov, Nikita/CAA-3889-2022; Chudakov, Dmitriy M/G-7741-2014; Fedorova, Olga S./E-1291-2013; Kuznetsov, Nikita A/F-3245-2011; Kuznetsov, Nikita/AFU-9897-2022; Kolesnikov, Alexander V/O-1840-2016	Fedorova, Olga/0000-0002-4001-7187; Kuznetsov, Nikita/0000-0002-4016-198X; Chudakov, Dmitriy M/0000-0003-0430-790X; Fedorova, Olga S./0000-0002-4001-7187; Kuznetsov, Nikita A/0000-0002-4016-198X; Kuznetsov, Nikita/0000-0002-4016-198X; 	United States Civilian Research & Development Foundation [2496]; NATO [SfP 980870]; Russian Ministry of Science [02.512.11.2007, 02.512.11.2208]	United States Civilian Research & Development Foundation; NATO(NATO (North Atlantic Treaty Organisation)); Russian Ministry of Science	This work was supported by United States Civilian Research & Development Foundation Grant 2496, NATO Grant SfP 980870, and the Russian Ministry of Science Grants 02.512.11.2007 and 02.512.11.2208.	Allerberger F, 2002, LANCET, V359, P711, DOI 10.1016/S0140-6736(02)07793-0; CHEVRIER B, 1994, STRUCTURE, V2, P283, DOI 10.1016/S0969-2126(00)00030-7; Chopra AP, 2003, J BIOL CHEM, V278, P9402, DOI 10.1074/jbc.M211262200; Cummings RT, 2002, P NATL ACAD SCI USA, V99, P6603, DOI 10.1073/pnas.062171599; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Hammond SE, 1998, INFECT IMMUN, V66, P2374, DOI 10.1128/IAI.66.5.2374-2378.1998; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOLLAND DR, 1995, PROTEIN SCI, V4, P1955, DOI 10.1002/pro.5560041001; Huang C Y, 1979, Methods Enzymol, V63, P54; Jernigan DB, 2002, EMERG INFECT DIS, V8, P1019, DOI 10.3201/eid0810.020353; KOCHI SK, 1994, FEMS MICROBIOL LETT, V124, P343, DOI 10.1111/j.1574-6968.1994.tb07306.x; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Kuznetsov NA, 2007, J BIOL CHEM, V282, P1029, DOI 10.1074/jbc.M605788200; Kuznetsov NA, 2007, BIOCHEMISTRY-US, V46, P424, DOI 10.1021/bi060787r; Liang XD, 2004, J BIOL CHEM, V279, P52473, DOI 10.1074/jbc.M409105200; LOBB RR, 1980, BIOCHEMISTRY-US, V19, P5297, DOI 10.1021/bi00564a023; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Mock WL, 1996, BIOCHEMISTRY-US, V35, P7369, DOI 10.1021/bi952827p; Nakajima K, 1997, NUCLEIC ACIDS RES, V25, P2231, DOI 10.1093/nar/25.11.2231; *NOV, 1997, PET SYST MAN, V4, P49; NUSSEY SS, 2001, ENDOCRINOLOGY INTEGR, P173; Pannifer AD, 2001, NATURE, V414, P229, DOI 10.1038/n35101998; Rellos P, 2007, J BIOL CHEM, V282, P6833, DOI 10.1074/jbc.M609721200; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Scott WRP, 2000, STRUCTURE, V8, P1259, DOI 10.1016/S0969-2126(00)00537-2; SMITH MM, 1995, J BIOL CHEM, V270, P6440, DOI 10.1074/jbc.270.12.6440; Souslova EA, 2006, MICROSC RES TECHNIQ, V69, P207, DOI 10.1002/jemt.20278; Tonello F, 2003, J BIOL CHEM, V278, P40075, DOI 10.1074/jbc.M306466200; Tonello F, 2002, NATURE, V418, P386, DOI 10.1038/418386a; Turk BE, 2004, NAT STRUCT MOL BIOL, V11, P60, DOI 10.1038/nsmb708; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728	32	17	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					17902	17913		10.1074/jbc.M807510200	http://dx.doi.org/10.1074/jbc.M807510200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19359249	hybrid, Green Published			2022-12-25	WOS:000267712400002
J	Hilgenberg, LGW; Pham, B; Ortega, M; Walid, S; Kemmerly, T; O'Dowd, DK; Smith, MA				Hilgenberg, Lutz G. W.; Pham, Bryan; Ortega, Maria; Walid, Saif; Kemmerly, Thomas; O'Dowd, Diane K.; Smith, Martin A.			Agrin Regulation of alpha 3 Sodium-Potassium ATPase Activity Modulates Cardiac Myocyte Contraction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORTICAL-NEURONS; MONOCLONAL-ANTIBODIES; NA,K-ATPASE ALPHA; INTRACELLULAR NA+; SUBUNIT ISOFORMS; TYROSINE KINASES; PUMP FUNCTION; RAT; RECEPTOR; EXPRESSION	Drugs that inhibit Na, K-ATPases, such as digoxin and ouabain, alter cardiac myocyte contractility. We recently demonstrated that agrin, a protein first identified at the vertebrate neuromuscular junction, binds to and regulates the activity of alpha 3 subunit-containing isoforms of the Na, K-ATPase in the mammalian brain. Both agrin and the alpha 3 Na, K-ATPase are expressed in heart, but their potential for interaction and effect on cardiac myocyte function was unknown. Here we show that agrin binds to the alpha 3 subunit of the Na, K-ATPase in cardiac myocyte membranes, inducing tyrosine phosphorylation and inhibiting activity of the pump. Agrin also triggers a rapid increase in cytoplasmic Na+ in cardiac myocytes, suggesting a role in cardiac myocyte function. Consistent with this hypothesis, spontaneous contraction frequencies of cultured cardiac myocytes prepared from mice in which agrin expression is blocked by mutation of the Agrn gene are significantly higher than in the wild type. The Agrn mutant phenotype is rescued by acute treatment with recombinant agrin. Furthermore, exposure of wild type myocytes to an agrin antagonist phenocopies the Agrn mutation. These data demonstrate that the basal frequency of myocyte contraction depends on endogenous agrin-alpha 3 Na, K-ATPase interaction and suggest that agrin modulation of the alpha 3 Na, K-ATPase is important in regulating heart function.	[Smith, Martin A.] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA; [Ortega, Maria; Kemmerly, Thomas; O'Dowd, Diane K.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Smith, MA (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Joan Irvine Smith Hall,Rm 110, Irvine, CA 92697 USA.	masmith@uci.edu			National Institutes of Health [NS33213, NS27501]; American Heart Association Western States Affiliate; Howard Hughes Medical Institute (HHMI); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS027501, R01NS027501, R29NS027501, R01NS033213] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Western States Affiliate(American Heart Association); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS33213 (to M. A. S.) and NS27501 (to D. K. O'D.). This work was also supported by a grant-in-aid from the American Heart Association Western States Affiliate (to M. A. S.) and a Howard Hughes Medical Institute (HHMI) professor's grant (to D. K. O'D.).	Arystarkhova E, 1996, J BIOL CHEM, V271, P23407, DOI 10.1074/jbc.271.38.23407; Bers DM, 2003, CARDIOVASC RES, V57, P897, DOI 10.1016/S0008-6363(02)00656-9; BIROC SL, 1993, DEV BRAIN RES, V75, P119, DOI 10.1016/0165-3806(93)90071-H; Blaustein MP, 1998, CLIN EXP HYPERTENS, V20, P691, DOI 10.3109/10641969809053247; Bossuyt J, 2006, J BIOL CHEM, V281, P32765, DOI 10.1074/jbc.M606254200; Bozulic LD, 2005, INVEST OPHTH VIS SCI, V46, P618, DOI 10.1167/iovs.04-0809; Burgess RW, 2000, J CELL BIOL, V151, P41, DOI 10.1083/jcb.151.1.41; Cheusova T, 2006, J NEUROCHEM, V99, P450, DOI 10.1111/j.1471-4159.2006.04086.x; Crambert G, 2002, P NATL ACAD SCI USA, V99, P11476, DOI 10.1073/pnas.182267299; Despa S, 2005, CIRC RES, V97, P252, DOI 10.1161/01.RES.0000176532.97731.e5; Dostanic I, 2003, J BIOL CHEM, V278, P53026, DOI 10.1074/jbc.M308547200; Fuller W, 2004, FASEB J, V18, P197, DOI 10.1096/fj.03-0213fje; GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625; Glitsch HG, 2001, PHYSIOL REV, V81, P1791, DOI 10.1152/physrev.2001.81.4.1791; GODFREY EW, 1988, J CELL BIOL, V106, P1263, DOI 10.1083/jcb.106.4.1263; GOTTLIEB SS, 1992, CIRCULATION, V86, P420, DOI 10.1161/01.CIR.86.2.420; HALLAQ H, 1990, P NATL ACAD SCI USA, V87, P7834, DOI 10.1073/pnas.87.20.7834; HALLAQ H, 1989, J PHARMACOL EXP THER, V248, P716; Han F, 2006, CIRC RES, V99, P1376, DOI 10.1161/01.RES.0000251667.73461.fb; Harada K, 2006, J PHYSIOL SCI, V56, P113, DOI 10.2170/physiolsci.RP001905; Hilgenberg LGW, 2006, CELL, V125, P359, DOI 10.1016/j.cell.2006.01.052; Hilgenberg LGW, 1999, J NEUROSCI, V19, P7384, DOI 10.1523/JNEUROSCI.19-17-07384.1999; Hilgenberg LGW, 2004, J NEUROBIOL, V61, P289, DOI 10.1002/neu.20049; HOCH W, 1993, NEURON, V11, P479, DOI 10.1016/0896-6273(93)90152-H; Hoover CL, 2003, J CELL BIOL, V161, P923, DOI 10.1083/jcb.200301013; James PF, 1999, MOL CELL, V3, P555, DOI 10.1016/S1097-2765(00)80349-4; Jia LG, 2005, AM J PHYSIOL-HEART C, V288, pH1982, DOI 10.1152/ajpheart.00142.2004; Juhaszova M, 1997, ANN NY ACAD SCI, V834, P524, DOI 10.1111/j.1749-6632.1997.tb52310.x; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; LEVI AJ, 1994, PROG BIOPHYS MOL BIO, V62, P1, DOI 10.1016/0079-6107(94)90005-1; LUCCHESI PA, 1991, J BIOL CHEM, V266, P9327; Martin AO, 2005, J CELL BIOL, V169, P503, DOI 10.1083/jcb.200411054; Mitcheson JS, 1998, CARDIOVASC RES, V39, P280, DOI 10.1016/S0008-6363(98)00128-X; Ngo ST, 2007, INT J BIOCHEM CELL B, V39, P863, DOI 10.1016/j.biocel.2006.10.012; Pierre SV, 2006, CELL BIOCHEM BIOPHYS, V46, P303, DOI 10.1385/CBB:46:3:303; Quintas LEM, 2007, EUR J PHARMACOL, V565, P151, DOI 10.1016/j.ejphar.2007.03.017; Reif R, 2007, FASEB J, V21, P3468, DOI 10.1096/fj.07-8800com; Rhee MS, 2004, AM J PHYSIOL-CELL PH, V287, pC1229, DOI 10.1152/ajpcell.00111.2004; SCHENK DB, 1983, P NATL ACAD SCI-BIOL, V80, P5281, DOI 10.1073/pnas.80.17.5281; Schoner W, 2002, EUR J BIOCHEM, V269, P2440, DOI 10.1046/j.1432-1033.2002.02911.x; Smith MA, 2002, NEUROREPORT, V13, P1485, DOI 10.1097/00001756-200208270-00001; SWEADNER KJ, 1989, BIOCHIM BIOPHYS ACTA, V988, P185, DOI 10.1016/0304-4157(89)90019-1; Thompson CB, 1996, J BIOL CHEM, V271, P32653, DOI 10.1074/jbc.271.51.32653; Verdonck F, 2003, J MOL CELL CARDIOL, V35, P5, DOI 10.1016/S0022-2828(02)00280-8; Wang JN, 1996, J CLIN INVEST, V98, P1650, DOI 10.1172/JCI118960; Wang XQ, 2005, J NEUROCHEM, V93, P1515, DOI 10.1111/j.1471-4159.2005.03147.x; Zahler R, 1996, CIRC RES, V78, P870, DOI 10.1161/01.RES.78.5.870	47	18	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16956	16965		10.1074/jbc.M806855200	http://dx.doi.org/10.1074/jbc.M806855200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19376779	hybrid, Green Published			2022-12-25	WOS:000266962400033
J	Podzelinska, K; He, SM; Wathier, M; Yakunin, A; Proudfoot, M; Hove-Jensen, B; Zechel, DL; Jia, ZC				Podzelinska, Kateryna; He, Shu-Mei; Wathier, Matthew; Yakunin, Alexander; Proudfoot, Michael; Hove-Jensen, Bjarne; Zechel, David L.; Jia, Zongchao			Structure of PhnP, a Phosphodiesterase of the Carbon-Phosphorus Lyase Pathway for Phosphonate Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINUCLEAR ZINC PHOSPHODIESTERASE; METALLO-BETA-LACTAMASES; TRNASE-Z CATALYSIS; ESCHERICHIA-COLI; PYRROLOQUINOLINE QUINONE; STRINGENT RESPONSE; GLYOXALASE-II; TRANSFER-RNA; CRYSTAL-STRUCTURE; Z-ENZYMES	Carbon-phosphorus lyase is a multienzyme system encoded by the phn operon that enables bacteria to metabolize organophosphonates when the preferred nutrient, inorganic phosphate, is scarce. One of the enzymes encoded by this operon, PhnP, is predicted by sequence homology to be a metal-dependent hydrolase of the beta-lactamase superfamily. Screening with a wide array of hydrolytically sensitive substrates indicated that PhnP is an enzyme with phosphodiesterase activity, having the greatest specificity toward bis(p-nitrophenyl) phosphate and 2',3'-cyclic nucleotides. No activity was observed toward RNA. The metal ion dependence of PhnP with bis(p-nitrophenyl) phosphate as substrate revealed a distinct preference for Mn2+ and Ni2+ for catalysis, whereas Zn2+ afforded poor activity. The three-dimensional structure of PhnP was solved by x-ray crystallography to 1.4 angstrom resolution. The overall fold of PhnP is very similar to that of the tRNase Z endonucleases but lacks the long exosite module used by these enzymes to bind their tRNA substrates. The active site of PhnP contains what are probably two Mn2+ ions surrounded by an array of active site residues that are identical to those observed in the tRNase Z enzymes. A second, remote Zn2+ binding site is also observed, composed of a set of cysteine and histidine residues that are strictly conserved in the PhnP family. This second metal ion site appears to stabilize a structural motif.	[Podzelinska, Kateryna; Zechel, David L.; Jia, Zongchao] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; [He, Shu-Mei; Wathier, Matthew] Queens Univ, Dept Chem, Kingston, ON K7L 3N6, Canada; [Yakunin, Alexander; Proudfoot, Michael] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; [Hove-Jensen, Bjarne] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark	Queens University - Canada; Queens University - Canada; University of Toronto; University of Copenhagen	Zechel, DL (corresponding author), Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.	dlzechel@chem.queensu.ca; jia@post.queensu.ca	Yakunin, Alexander/J-1519-2014	Yakunin, Alexander/0000-0003-0813-6490; Zechel, David/0000-0002-1570-599X	Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institute for Health Research	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canadian Institute for Health Research.	Adams MA, 2008, J BACTERIOL, V190, P1072, DOI 10.1128/JB.01274-07; ANDERSEN PS, 1995, J BACTERIOL, V177, P2008, DOI 10.1128/jb.177.8.2008-2013.1995; Aravind L, 1999, In Silico Biol, V1, P69; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; Campos-Bermudez VA, 2007, BIOCHEMISTRY-US, V46, P11069, DOI 10.1021/bi7007245; Cheary R.W., 1996, PROGRAMS XFIT FOURYA; Crisp J, 2007, BIOCHEMISTRY-US, V46, P10664, DOI 10.1021/bi700707u; Crowder MW, 2006, ACCOUNTS CHEM RES, V39, P721, DOI 10.1021/ar0400241; de la Sierra-Gallay IL, 2006, NAT STRUCT MOL BIOL, V13, P376, DOI 10.1038/nsmb1066; de la Sierra-Gallay IL, 2005, NATURE, V433, P657, DOI 10.1038/nature03284; Errey JC, 2006, BIOCHEMISTRY-US, V45, P3033, DOI 10.1021/bi052297p; Garrity JD, 2004, J BIOL CHEM, V279, P920, DOI 10.1074/jbc.M309852200; Hogg T, 2004, CELL, V117, P57, DOI 10.1016/S0092-8674(04)00260-0; Hou ZL, 1999, J BIOL CHEM, V274, P17505, DOI 10.1074/jbc.274.25.17505; Hove-Jensen B, 2003, J BACTERIOL, V185, P2793, DOI 10.1128/JB.185.9.2793-2801.2003; HOVEJENSEN B, 1988, J BACTERIOL, V170, P1148, DOI 10.1128/jb.170.3.1148-1152.1988; Hu ZX, 2008, BIOCHEMISTRY-US, V47, P7947, DOI 10.1021/bi8004768; Huang JL, 2005, J MOL EVOL, V61, P682, DOI 10.1007/s00239-004-0349-4; Karkashon S, 2007, BIOCHEMISTRY-US, V46, P9380, DOI 10.1021/bi700578v; Kehres DG, 2003, FEMS MICROBIOL REV, V27, P263, DOI 10.1016/S0168-6445(03)00052-4; Kostelecky B, 2006, J BACTERIOL, V188, P1607, DOI 10.1128/JB.188.4.1607-1614.2006; Kuznetsova E, 2005, FEMS MICROBIOL REV, V29, P263, DOI 10.1016/j.femsre.2004.12.006; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Llarrull LI, 2007, J BIOL CHEM, V282, P18276, DOI 10.1074/jbc.M700742200; Magnusson OT, 2004, P NATL ACAD SCI USA, V101, P7913, DOI 10.1073/pnas.0402640101; Mazumder R, 2002, NUCLEIC ACIDS RES, V30, P5229, DOI 10.1093/nar/gkf645; METCALF WW, 1993, J BACTERIOL, V175, P3430, DOI 10.1128/jb.175.11.3430-3442.1993; Minagawa A, 2006, NUCLEIC ACIDS RES, V34, P3811, DOI 10.1093/nar/gkl517; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Patzer SI, 2001, J BACTERIOL, V183, P4806, DOI 10.1128/JB.183.16.4806-4813.2001; Podzelinska K, 2008, ACTA CRYSTALLOGR F, V64, P554, DOI 10.1107/S1744309108014656; Quinn JP, 2007, ENVIRON MICROBIOL, V9, P2392, DOI 10.1111/j.1462-2920.2007.01397.x; Rao NN, 1998, J BACTERIOL, V180, P2186, DOI 10.1128/JB.180.8.2186-2193.1998; Redko Y, 2007, NAT REV MICROBIOL, V5, P278, DOI 10.1038/nrmicro1622; Rizk SS, 2006, PROTEIN SCI, V15, P1745, DOI 10.1110/ps.062135206; Schilling O, 2005, BIOCHEM J, V385, P145, DOI 10.1042/BJ20040773; Schilling O, 2003, BIOCHEMISTRY-US, V42, P11777, DOI 10.1021/bi034672o; Shibata HS, 2006, BIOCHEMISTRY-US, V45, P5486, DOI 10.1021/bi051972s; SILVER S, 1970, J BACTERIOL, V104, P1299, DOI 10.1128/JB.104.3.1299-1306.1970; Spath B, 2007, CELL MOL LIFE SCI, V64, P2404, DOI 10.1007/s00018-007-7160-5; Spath B, 2008, ARCH MICROBIOL, V190, P301, DOI 10.1007/s00203-008-0368-4; Spath B, 2007, BIOCHEMISTRY-US, V46, P14742, DOI 10.1021/bi7010459; SPIRA B, 1995, J BACTERIOL, V177, P4053, DOI 10.1128/jb.177.14.4053-4058.1995; Toyama H, 1998, MICROBIOL-UK, V144, P183, DOI 10.1099/00221287-144-1-183; VELTEROP JS, 1995, J BACTERIOL, V177, P5088, DOI 10.1128/jb.177.17.5088-5098.1995; Vogel A, 2004, BIOCHEMISTRY-US, V43, P10379, DOI 10.1021/bi049703+; Vogel A, 2002, J BIOL CHEM, V277, P29078, DOI 10.1074/jbc.M112047200; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Yakovleva GM, 1998, APPL MICROBIOL BIOT, V49, P573, DOI 10.1007/s002530051215; Yakunin AF, 2004, J BIOL CHEM, V279, P36819, DOI 10.1074/jbc.M405120200	53	29	31	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17216	17226		10.1074/jbc.M808392200	http://dx.doi.org/10.1074/jbc.M808392200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19366688	Green Published, hybrid			2022-12-25	WOS:000266962400059
J	Pongratz, RL; Kibbey, RG; Kirkpatrick, CL; Zhao, XJ; Pontoglio, M; Yaniv, M; Wollheim, CB; Shulman, GI; Cline, GW				Pongratz, Rebecca L.; Kibbey, Richard G.; Kirkpatrick, Clare L.; Zhao, Xiaojian; Pontoglio, Marco; Yaniv, Moshe; Wollheim, Claes B.; Shulman, Gerald I.; Cline, Gary W.			Mitochondrial Dysfunction Contributes to Impaired Insulin Secretion in INS-1 Cells with Dominant-negative Mutations of HNF-1 alpha and in HNF-1 alpha-deficient Islets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE NUCLEAR FACTOR-1-ALPHA; PANCREATIC BETA-CELLS; MAGNETIC-RESONANCE; MALIC ENZYME; ISOLATED RAT; PROTON LEAK; EXPRESSION; METABOLISM; GLUCOSE; GENE	Maturity Onset Diabetes of the Young-type 3 (MODY-3) has been linked to mutations in the transcription factor hepatic nuclear factor (HNF)-1 alpha, resulting in deficiency in glucose-stimulated insulin secretion. In INS-1 cells overexpressing doxycycline-inducible HNF-1 alpha dominant-negative (DN-) gene mutations, and islets from Hnf-1 alpha knock-out mice, insulin secretion was impaired in response to glucose (15 mM) and other nutrient secretagogues. Decreased rates of insulin secretion in response to glutamine plus leucine and to methyl pyruvate, but not potassium depolarization, indicate defects specific to mitochondrial metabolism. To identify the biochemical mechanisms responsible for impaired insulin secretion, we used P-31 NMR measured mitochondrial ATP synthesis (distinct from glycolytic ATP synthesis) together with oxygen consumption measurements to determine the efficiency of mitochondrial oxidative phosphorylation. Mitochondrial uncoupling was significantly higher in DN-HNF-1 alpha cells, such that rates of ATP synthesis were decreased by approximately one-half in response to the secretagogues glucose, glutamine plus leucine, or pyruvate. In addition to closure of the ATP-sensitive K+ channels with mitochondrial ATP synthesis, mitochondrial production of second messengers through increased anaplerotic flux has been shown to be critical for coupling metabolism to insulin secretion. C-13-Isotopomer analysis and tandem mass spectrometry measurement of Krebs cycle intermediates revealed a negative impact of DN-HNF-1 alpha and Hnf-1 alpha knock-out on mitochondrial second messenger production with glucose but not amino acids. Taken together, these results indicate that, in addition to reduced glycolytic flux, uncoupling of mitochondrial oxidative phosphorylation contributes to impaired nutrient-stimulated insulin secretion with either mutations or loss of HNF-1 alpha.	[Pongratz, Rebecca L.; Kibbey, Richard G.; Zhao, Xiaojian; Shulman, Gerald I.; Cline, Gary W.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Kirkpatrick, Clare L.; Wollheim, Claes B.] Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva 4, Switzerland; [Pontoglio, Marco; Yaniv, Moshe] Inst Pasteur, CNRS, Dept Dev Biol, Unite Rech Associee 1644, F-75724 Paris, France	Yale University; Yale University; Howard Hughes Medical Institute; Yale University; University of Geneva; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Cline, GW (corresponding author), Yale Univ, Sch Med, Dept Internal Med, POB 208020, New Haven, CT 06520 USA.	gary.cline@yale.edu	Kirkpatrick, Clare L/M-1890-2018; Shulman, Gerald I./P-7176-2019	Kirkpatrick, Clare L/0000-0001-8564-8559; Shulman, Gerald I./0000-0003-1529-5668	National Institutes of Health [R01 DK-071071]; EuroDia [LSHM-CT-2006-518153]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059635, K08DK080142, R01DK071071, R01DK040936] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EuroDia; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK-071071 from USPHS (to G. W. C.). This work was also supported by EuroDia Grant LSHM-CT-2006-518153, a European Community-funded project under Framework Program 6 (to C. B. W.).	Abad MFC, 2004, J BIOL CHEM, V279, P11521, DOI 10.1074/jbc.M306766200; Affourtit C, 2006, BIOCHEM J, V393, P151, DOI 10.1042/BJ20051280; BUKOWIECKI L, 1979, BIOCHIM BIOPHYS ACTA, V583, P370, DOI 10.1016/0304-4165(79)90461-6; CAMPBELLBURK SL, 1987, BIOCHEMISTRY-US, V26, P7493, DOI 10.1021/bi00397a044; Cline GW, 2004, J BIOL CHEM, V279, P44370, DOI 10.1074/jbc.M311842200; Cline GW, 2001, J BIOL CHEM, V276, P20240, DOI 10.1074/jbc.M102540200; COHEN SM, 1978, NATURE, V273, P554, DOI 10.1038/273554a0; David G, 1999, J NEUROSCI, V19, P7495, DOI 10.1523/JNEUROSCI.19-17-07495.1999; Drew B, 2003, AM J PHYSIOL-REG I, V285, pR1259, DOI 10.1152/ajpregu.00264.2003; Du F, 2007, MAGN RESON MED, V57, P103, DOI 10.1002/mrm.21107; Dukes ID, 1998, J BIOL CHEM, V273, P24457, DOI 10.1074/jbc.273.38.24457; FAJANS SS, 1989, DIABETES METAB REV, V5, P579, DOI 10.1002/dmr.5610050705; GADIAN DG, 1979, BIOL APPLICATIONS MA, P463; Hagenfeldt-Johansson KA, 2001, ENDOCRINOLOGY, V142, P5311, DOI 10.1210/en.142.12.5311; Krauss S, 2003, J CLIN INVEST, V112, P1831, DOI 10.1172/JCI200319774; Krauss S, 2002, P NATL ACAD SCI USA, V99, P118, DOI 10.1073/pnas.012410699; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MACDONALD MJ, 1992, HORM METAB RES, V24, P158, DOI 10.1055/s-2007-1003284; MACDONALD MJ, 1985, DIABETES, V34, P246, DOI 10.2337/diabetes.34.3.246; MALLOY CR, 1990, AM J PHYSIOL, V259, pH987, DOI 10.1152/ajpheart.1990.259.3.H987; Papas KK, 1998, AM J PHYSIOL-ENDOC M, V275, pE1100, DOI 10.1152/ajpendo.1998.275.6.E1100; Papas KK, 2007, BIOTECHNOL BIOENG, V98, P1071, DOI 10.1002/bit.21486; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; PETROFF OAC, 1985, NEUROLOGY, V35, P781, DOI 10.1212/WNL.35.6.781; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; Pontoglio M, 1998, J CLIN INVEST, V101, P2215, DOI 10.1172/JCI2548; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; Shih DQ, 2001, DIABETES, V50, P2472, DOI 10.2337/diabetes.50.11.2472; Simpson NE, 2006, DIABETOLOGIA, V49, P1338, DOI 10.1007/s00125-006-0216-5; TELLER JK, 1992, J BIOL CHEM, V267, P10423; Thomas H, 2002, BIOL CHEM, V383, P1691, DOI 10.1515/BC.2002.190; Wang HY, 1998, EMBO J, V17, P6701, DOI 10.1093/emboj/17.22.6701; Wang HY, 2000, EMBO J, V19, P4257, DOI 10.1093/emboj/19.16.4257; Wiederkehr A, 2009, EMBO J, V28, P417, DOI 10.1038/emboj.2008.302; Yamagata K, 2002, DIABETES, V51, P114, DOI 10.2337/diabetes.51.1.114; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0; Zawalich WS, 2004, J ENDOCRINOL, V183, P309, DOI 10.1677/joe.1.05832	37	27	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16808	16821		10.1074/jbc.M807723200	http://dx.doi.org/10.1074/jbc.M807723200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19376774	hybrid, Green Published			2022-12-25	WOS:000266962400017
J	Li, ZY; Hassan, MQ; Jafferji, M; Aqeilan, RI; Garzon, R; Croce, CM; van Wijnen, AJ; Stein, JL; Stein, GS; Lian, JB				Li, Zhaoyong; Hassan, Mohammad Q.; Jafferji, Mohammed; Aqeilan, Rami I.; Garzon, Ramiro; Croce, Carlo M.; van Wijnen, Andre J.; Stein, Janet L.; Stein, Gary S.; Lian, Jane B.			Biological Functions of miR-29b Contribute to Positive Regulation of Osteoblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; OSTEOGENIC DIFFERENTIATION; HISTONE DEACETYLASE-4; MESSENGER-RNAS; ACTIVIN-A; TGF-BETA; COLLAGEN; MICRORNA; EXPRESSION; RUNX2	Bone tissue arises from mesenchymal cells induced into the osteoblast lineage by essential transcription factors and signaling cascades. MicroRNAs regulate biological processes by binding to mRNA 3'-untranslated region (UTR) sequences to attenuate protein synthesis. Here we performed microRNA profiling and identified miRs that are up-regulated through stages of osteoblast differentiation. Among these are the miR-29, miR-let-7, and miR-26 families that target many collagens and extracellular matrix proteins. We find that miR-29b supports osteoblast differentiation through several mechanisms. miR-29b decreased and anti-miR-29b increased activity of COL1A1, COL5A3, and COL4A2 3'-UTR sequences in reporter assays, as well as endogenous gene expression. These results support a mechanism for regulating collagen protein accumulation during the mineralization stage when miR-29b reaches peak levels. We propose that this mechanism prevents fibrosis and facilitates mineral deposition. Our studies further demonstrate that miR-29b promotes osteogenesis by directly down regulating known inhibitors of osteoblast differentiation, HDAC4, TGF beta 3, ACVR2A, CTNNBIP1, and DUSP2 proteins through binding to target 3'-UTR sequences in their mRNAs. Thus, miR-29b is a key regulator of development of the osteoblast phenotype by targeting anti-osteogenic factors and modulating bone extracellular matrix proteins.	[Li, Zhaoyong; Hassan, Mohammad Q.; Jafferji, Mohammed; van Wijnen, Andre J.; Stein, Janet L.; Stein, Gary S.; Lian, Jane B.] Univ Massachusetts, Sch Med, Dept Cell Biol & Canc Ctr, Worcester, MA 01655 USA; [Aqeilan, Rami I.; Garzon, Ramiro; Croce, Carlo M.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Aqeilan, Rami I.; Garzon, Ramiro; Croce, Carlo M.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University of Massachusetts System; University of Massachusetts Worcester; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Lian, JB (corresponding author), Univ Massachusetts, Sch Med, Dept Cell Biol & Canc Ctr, 55 Lake Ave N, Worcester, MA 01655 USA.	jane.lian@umassmed.edu	van Wijnen, Andre J./AAG-3578-2019; Young, Richard A/F-6495-2012; Hassan, Mohammad/GZA-7507-2022; Aqeilan, Rami/R-4443-2016; Garzon, Ramiro/E-3104-2011; Aqeilan, Rami/AAT-7785-2020; Li, zhao-yong/N-4288-2013	van Wijnen, Andre J./0000-0002-4458-0946; Young, Richard A/0000-0001-8855-8647; Hassan, Mohammad/0000-0002-1712-0004; Aqeilan, Rami/0000-0002-6034-023X; Li, zhaoyong/0000-0002-1502-4027	National Institutes of Health [AR039588, R37 DE012528]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049069, R01AR039588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE012528] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant AR039588 (to G. S. S.) and R37 DE012528 (to J.B.L.).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Banerjee C, 1997, J CELL BIOCHEM, V66, P1, DOI 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V; Beaudoing E, 2001, GENOME RES, V11, P1520, DOI 10.1101/gr.190501; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Bodine PVN, 2006, REV ENDOCR METAB DIS, V7, P33, DOI 10.1007/s11154-006-9002-4; BRENNER RE, 1993, EUR J PEDIATR, V152, P505, DOI 10.1007/BF01955060; Burger C, 2008, BIOPHYS J, V95, P1985, DOI 10.1529/biophysj.107.128355; Caunt CJ, 2008, J BIOL CHEM, V283, P6241, DOI 10.1074/jbc.M706624200; Choi JY, 1996, J CELL BIOCHEM, V61, P609, DOI 10.1002/(SICI)1097-4644(19960616)61:4<609::AID-JCB15>3.3.CO;2-Q; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Daniels DL, 2002, MOL CELL, V10, P573, DOI 10.1016/S1097-2765(02)00631-7; Deng ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P2001, DOI 10.2741/2819; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Eijken M, 2007, FASEB J, V21, P2949, DOI 10.1096/fj.07-8080com; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; FRANCESCHI RT, 1994, J BONE MINER RES, V9, P843; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; GERSTENFELD LC, 1993, J BONE MINER RES, V8, P1031; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; GLIMCHER MJ, 1989, ANAT REC, V224, P139, DOI 10.1002/ar.1092240205; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Ikenoue T, 1999, J CELL BIOCHEM, V75, P206, DOI 10.1002/(SICI)1097-4644(19991101)75:2<206::AID-JCB3>3.3.CO;2-K; Jeon EJ, 2006, J BIOL CHEM, V281, P16502, DOI 10.1074/jbc.M512494200; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Levy JB, 1996, ENDOCRINOLOGY, V137, P1159, DOI 10.1210/en.137.4.1159; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Luzi E, 2008, J BONE MINER RES, V23, P287, DOI 10.1359/JBMR.071011; LYNCH MP, 1995, EXP CELL RES, V216, P35, DOI 10.1006/excr.1995.1005; Ma L, 2008, CELL CYCLE, V7, P570, DOI 10.4161/cc.7.5.5547; Maeda S, 2004, EMBO J, V23, P552, DOI 10.1038/sj.emboj.7600067; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Natalizio BJ, 2002, J BIOL CHEM, V277, P42733, DOI 10.1074/jbc.M208070200; OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304; Park SY, 2008, NAT STRUCT MOL BIOL, V15, P224, DOI 10.1038/nsmb0308-224; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; QUARLES LD, 1992, J BONE MINER RES, V7, P683; Raucci A, 2008, J CELL PHYSIOL, V215, P442, DOI 10.1002/jcp.21323; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Sarathchandra P, 2000, J PATHOL, V192, P385; Sengupta S, 2008, P NATL ACAD SCI USA, V105, P5874, DOI 10.1073/pnas.0801130105; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Stein GS, 2008, J CELL BIOCHEM, V104, P2016, DOI 10.1002/jcb.21813; Stewart TL, 2005, CALCIFIED TISSUE INT, V77, P113, DOI 10.1007/s00223-004-0188-8; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Tuddenham L, 2006, FEBS LETT, V580, P4214, DOI 10.1016/j.febslet.2006.06.080; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Wenstrup RJ, 2006, J BIOL CHEM, V281, P12888, DOI 10.1074/jbc.M511528200; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006	65	458	498	0	66	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15676	15684		10.1074/jbc.M809787200	http://dx.doi.org/10.1074/jbc.M809787200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19342382	Green Published, hybrid			2022-12-25	WOS:000266501000036
J	Scolari, S; Engel, S; Krebs, N; Plazzo, AP; De Almeida, RFM; Prieto, M; Veit, M; Herrmann, A				Scolari, Silvia; Engel, Stephanie; Krebs, Nils; Plazzo, Anna Pia; De Almeida, Rodrigo F. M.; Prieto, Manuel; Veit, Michael; Herrmann, Andreas			Lateral Distribution of the Transmembrane Domain of Influenza Virus Hemagglutinin Revealed by Time-resolved Fluorescence Imaging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; GPI-ANCHORED PROTEINS; LIPID RAFT MICRODOMAINS; LIVING CELL-MEMBRANES; FRET MICROSCOPY; MATRIX PROTEIN; LIVE CELLS; TRANSPORT; SURFACE; GLYCOPROTEINS	Influenza virus hemagglutinin (HA) has been suggested to be enriched in liquid-ordered lipid domains named rafts, which represent an important step in virus assembly. We employed Forster resonance energy transfer (FRET) via fluorescence lifetime imaging microscopy to study the interaction of the cytoplasmic and transmembrane domain (TMD) of HA with a glycosylphosphatidylinositol (GPI)-anchored peptide, an established marker for rafts in the exoplasmic leaflet of living mammalian plasma membranes. Cyan fluorescent protein (CFP) was fused to GPI, whereas the HA sequence was tagged with yellow fluorescent protein (YFP) on its exoplasmic site (TMD-HA-YFP), avoiding any interference of fluorescent proteins with the proposed role of the cytoplasmic domain in lateral organization of HA. Constructs were expressed in Chinese hamster ovary cells (CHO-K1) for which cholesterol-sensitive lipid nanodomains and their dimension in the plasma membrane have been described (Sharma, P., Varma, R., Sarasij, R. C., Ira, Gousset, K., Krishnamoorthy, G., Rao, M., and Mayor, S. (2004) Cell 116, 577-589). Upon transfection in CHO-K1 cells, TMD-HA-YFP is partially expressed as a dimer. Only dimers are targeted to the plasma membrane. Clustering of TMD-HA-YFP with GPI-CFP was observed and shown to be reduced upon cholesterol depletion, a treatment known to disrupt rafts. No indication for association of TMD-HA-YFP with GPI-CFP was found when palmitoylation, an important determinant of raft targeting, was suppressed. Clustering of TMD-HA-YFP and GPI-CFP was also observed in purified plasma membrane suspensions by homoFRET. We concluded that the palmitoylated TMD-HA alone is sufficient to recruit HA to cholesterol-sensitive nanodomains. The corresponding construct of the spike protein E2 of Semliki Forest virus did not partition preferentially in such domains.	[Scolari, Silvia; Krebs, Nils; Plazzo, Anna Pia; Herrmann, Andreas] Humboldt Univ, Dept Biol Mol Biophys, D-10115 Berlin, Germany; [Engel, Stephanie; Veit, Michael] Free Univ Berlin, Fac Med Vet, Dept Immunol, D-12249 Berlin, Germany; [Engel, Stephanie; Veit, Michael] Free Univ Berlin, Fac Med Vet, Dept Mol Biol, D-12249 Berlin, Germany; [De Almeida, Rodrigo F. M.] Univ Lisbon, Fac Ciencias, Ctr Quim & Bioquim Mol & Neural Biophys, P-1749016 Lisbon, Portugal; [Prieto, Manuel] Inst Super Tecn, Ctr Quim Fis Mol, P-1049001 Lisbon, Portugal	Humboldt University of Berlin; Free University of Berlin; Free University of Berlin; Universidade de Lisboa; Universidade de Lisboa; Instituto Superior Tecnico	Herrmann, A (corresponding author), Humboldt Univ, Dept Biol, Invalidenstr 43, D-10115 Berlin, Germany.	andreas.herrmann@rz.hu-berlin.de	Veit, Michael/G-6492-2010; Prieto, Manuel/N-4448-2013; de Almeida, Rodrigo/D-8629-2012	Prieto, Manuel/0000-0003-3012-6598; de Almeida, Rodrigo/0000-0002-9748-7083; Veit, Michael/0000-0002-7638-1829	Deutsche Forschungsgemeinschaft [SPP 1175, SFB 740, TP C3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) (SPP 1175 and SFB 740, TP C3) (to A. H. and M. V.).	Baudin F, 2001, VIROLOGY, V281, P102, DOI 10.1006/viro.2000.0804; Borst JW, 2005, J FLUORESC, V15, P153, DOI 10.1007/s10895-005-2523-5; Briggs JAG, 2003, J GEN VIROL, V84, P757, DOI 10.1099/vir.0.18779-0; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Chang DK, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-2; COPELAND CS, 1986, J CELL BIOL, V103, P1179, DOI 10.1083/jcb.103.4.1179; de Almeida RFM, 2005, J MOL BIOL, V346, P1109, DOI 10.1016/j.jmb.2004.12.026; De Almeida RFM, 2006, MOL MEMBR BIOL, V23, P305, DOI 10.1080/09687860600703613; DOMS RW, 1993, VIROLOGY, V193, P545, DOI 10.1006/viro.1993.1164; Enami M, 1996, J VIROL, V70, P6653, DOI 10.1128/JVI.70.10.6653-6657.1996; Gautier I, 2001, BIOPHYS J, V80, P3000, DOI 10.1016/S0006-3495(01)76265-0; Gomez-Puertas P, 2000, J VIROL, V74, P11538, DOI 10.1128/JVI.74.24.11538-11547.2000; Grailhe R, 2006, CHEMPHYSCHEM, V7, P1442, DOI 10.1002/cphc.200600057; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Hess ST, 2007, P NATL ACAD SCI USA, V104, P17370, DOI 10.1073/pnas.0708066104; Hess ST, 2005, J CELL BIOL, V169, P965, DOI 10.1083/jcb.200412058; Hofman EG, 2008, J CELL SCI, V121, P2519, DOI 10.1242/jcs.028753; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Kenworthy AK, 2000, MOL BIOL CELL, V11, P1645, DOI 10.1091/mbc.11.5.1645; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Lackowicz JR, 2006, PRINCIPLES FLUORESCE; Leser GP, 2005, VIROLOGY, V342, P215, DOI 10.1016/j.virol.2005.09.049; Lin SS, 1998, J CELL BIOL, V142, P51, DOI 10.1083/jcb.142.1.51; Lu YE, 2000, J VIROL, V74, P7708, DOI 10.1128/JVI.74.17.7708-7719.2000; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501; Scheiffele P, 1999, J BIOL CHEM, V274, P2038, DOI 10.1074/jbc.274.4.2038; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Silvius JR, 2006, MOL MEMBR BIOL, V23, P5, DOI 10.1080/09687860500473002; Takeda M, 2003, P NATL ACAD SCI USA, V100, P14610, DOI 10.1073/pnas.2235620100; Tall RD, 2003, TRAFFIC, V4, P838, DOI 10.1046/j.1398-9219.2003.0138.x; TANAKA F, 1979, PHOTOCHEM PHOTOBIOL, V29, P1091, DOI 10.1111/j.1751-1097.1979.tb07825.x; Tatulian SA, 2000, BIOCHEMISTRY-US, V39, P496, DOI 10.1021/bi991594p; VEIT M, 1991, J VIROL, V65, P2491, DOI 10.1128/JVI.65.5.2491-2500.1991; WHITE J, 1982, NATURE, V300, P658, DOI 10.1038/300658a0; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang J, 2000, J VIROL, V74, P4634, DOI 10.1128/JVI.74.10.4634-4644.2000	40	63	63	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15708	15716		10.1074/jbc.M900437200	http://dx.doi.org/10.1074/jbc.M900437200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19349276	Green Published, hybrid			2022-12-25	WOS:000266501000040
J	Toivanen, PI; Nieminen, T; Viitanen, L; Alitalo, A; Roschier, M; Jauhiainen, S; Markkanen, JE; Laitinen, OH; Airenne, TT; Salminen, TA; Johnson, MS; Airenne, KJ; Yla-Herttuala, S				Toivanen, Pyry I.; Nieminen, Tiina; Viitanen, Lenita; Alitalo, Annamari; Roschier, Miia; Jauhiainen, Suvi; Markkanen, Johanna E.; Laitinen, Olli H.; Airenne, Tomi T.; Salminen, Tiina A.; Johnson, Mark S.; Airenne, Kari J.; Yla-Herttuala, Seppo			Novel Vascular Endothelial Growth Factor D Variants with Increased Biological Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; VEGF-D; GENE-TRANSFER; RECEPTOR SPECIFICITY; ANGSTROM RESOLUTION; SIGNAL-TRANSDUCTION; TYROSINE KINASES; ORF VIRUS; BINDING; ANGIOGENESIS	Members of the vascular endothelial growth factor (VEGF) family play a pivotal role in angiogenesis and lymphangiogenesis. They are potential therapeutics to induce blood vessel formation in myocardium and skeletal muscle, when normal blood flow is compromised. Most members of the VEGF/platelet derived growth factor protein superfamily exist as covalently bound antiparallel dimers. However, the mature form of VEGF-D (VEGF-D-Delta N Delta C) is predominantly a non-covalent dimer even though the cysteine residues (Cys-44 and Cys-53) forming the intersubunit disulfide bridges in the other members of the VEGF family are also conserved in VEGF-D. Moreover, VEGF-D bears an additional cysteine residue (Cys-25) at the subunit interface. Guided by our model of VEGF-D-Delta N Delta C, the cysteines at the subunit interface were mutated to study the effect of these residues on the structural and functional properties of VEGF-D-Delta N Delta C. The conserved cysteines Cys-44 and Cys-53 were found to be essential for the function of VEGF-D-Delta N Delta C. More importantly, the substitution of the Cys-25 at the dimer interface by various amino acids improved the activity of the recombinant VEGF-D-Delta N Delta C and increased the dimer to monomer ratio. Specifically, substitutions to hydrophobic amino acids Ile, Leu, and Val, equivalent to those found in other VEGFs, most favorably affected the activity of the recombinant VEGF-D-Delta N Delta C. The increased activity of these mutants was mainly due to stabilization of the protein. This study enables us to better understand the structural determinants controlling the biological activity of VEGF-D. The novel variants of VEGF-D-Delta N Delta C described here are potential agents for therapeutic applications, where induction of vascular formation is required.	[Yla-Herttuala, Seppo] Univ Kuopio, AI Virtanen Inst Mol Sci, Dept Biotechnol & Mol Med, FI-70211 Kuopio, Finland; [Toivanen, Pyry I.; Nieminen, Tiina] Ark Therapeut Oyj, FI-70210 Kuopio, Finland; [Viitanen, Lenita; Airenne, Tomi T.; Salminen, Tiina A.; Johnson, Mark S.] Abo Akad Univ, Dept Biochem & Pharm, FI-20520 Turku, Finland	University of Eastern Finland; Abo Akademi University	Yla-Herttuala, S (corresponding author), Univ Kuopio, AI Virtanen Inst Mol Sci, Dept Biotechnol & Mol Med, POB 1627, FI-70211 Kuopio, Finland.	seppo.ylaherttuala@uku.fi	Salminen, Tiina A/G-7492-2019; Salminen, Tiina A./AAM-5443-2021; Laitinen, Olli H/A-6618-2016	Salminen, Tiina A/0000-0002-4135-8020; Salminen, Tiina A./0000-0002-4135-8020; Laitinen, Olli H/0000-0002-3751-9952; Yla-Herttuala, Seppo/0000-0001-7593-2708; Jauhiainen, Suvi/0000-0002-0630-8175	Ark Therapeutics Group Plc.; Academy of Finland; ISB (National Graduate School in Informational and Structural Biology); Foundation of Abo Akademi; Sigrid Juselius Foundation; Leducq Foundation; Joe, Pentti, and Tor Borg Memorial Fund; Finnish Cultural Foundation; Magnus Ehrnrooth Foundation	Ark Therapeutics Group Plc.; Academy of Finland(Academy of Finland); ISB (National Graduate School in Informational and Structural Biology); Foundation of Abo Akademi; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Leducq Foundation(Leducq Foundation); Joe, Pentti, and Tor Borg Memorial Fund; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Magnus Ehrnrooth Foundation	This work was supported by Ark Therapeutics Group Plc., the Academy of Finland, the ISB (National Graduate School in Informational and Structural Biology), the Foundation of Abo Akademi ( Centre of Excellence in Cell Stress), the Sigrid Juselius Foundation, the Leducq Foundation, the Joe, Pentti, and Tor Borg Memorial Fund, the Finnish Cultural Foundation, and the Magnus Ehrnrooth Foundation.	Achen MG, 2000, EUR J BIOCHEM, V267, P2505, DOI 10.1046/j.1432-1327.2000.01257.x; Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548; Airenne KJ, 2000, GENE THER, V7, P1499, DOI 10.1038/sj.gt.3301269; Airenne KJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng102; ANISIMOV A, 2009, CIRC RES IN PRESS; Annex BH, 2005, CARDIOVASC RES, V65, P649, DOI 10.1016/j.cardiores.2004.09.004; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Bhardwaj S, 2003, HUM GENE THER, V14, P1451, DOI 10.1089/104303403769211664; Bjork A, 2003, J MOL BIOL, V334, P811, DOI 10.1016/j.jmb.2003.10.006; Byrne AM, 2005, J CELL MOL MED, V9, P777, DOI 10.1111/j.1582-4934.2005.tb00379.x; Christinger HW, 2004, J BIOL CHEM, V279, P10382, DOI 10.1074/jbc.M313237200; Culajay JF, 2000, BIOCHEMISTRY-US, V39, P7153, DOI 10.1021/bi9927742; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Fuh G, 1998, J BIOL CHEM, V273, P11197, DOI 10.1074/jbc.273.18.11197; Hagihara Y, 2007, J BIOL CHEM, V282, P36489, DOI 10.1074/jbc.M707078200; Holmes DIR, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-209; Iyer S, 2001, J BIOL CHEM, V276, P12153, DOI 10.1074/jbc.M008055200; Iyer S, 2006, J MOL BIOL, V359, P76, DOI 10.1016/j.jmb.2006.03.002; Jia HY, 2004, J BIOL CHEM, V279, P36148, DOI 10.1074/jbc.M401538200; Joukov V, 1997, EMBO J, V16, P3898, DOI 10.1093/emboj/16.13.3898; Joukov V, 1998, J BIOL CHEM, V273, P6599, DOI 10.1074/jbc.273.12.6599; Karpanen T, 2006, FASEB J, V20, P1462, DOI 10.1096/fj.05-5646com; Laitinen OH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni042; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; LYTTLE DJ, 1994, J VIROL, V68, P84, DOI 10.1128/JVI.68.1.84-92.1994; MAJUMDER K, 1992, GENE, V110, P89, DOI 10.1016/0378-1119(92)90448-X; McColl BK, 2007, FASEB J, V21, P1088, DOI 10.1096/fj.06-7060com; MILES AA, 1952, J PHYSIOL-LONDON, V118, P228, DOI 10.1113/jphysiol.1952.sp004789; Muller YA, 1997, STRUCTURE, V5, P1325, DOI 10.1016/S0969-2126(97)00284-0; MURRAYRUST J, 1993, STRUCTURE, V1, P153, DOI 10.1016/0969-2126(93)90029-G; Nagano N, 1999, FEBS LETT, V458, P69, DOI 10.1016/S0014-5793(99)01122-9; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; PAJUSOLA K, 1994, ONCOGENE, V9, P3545; Pieren M, 2006, J BIOL CHEM, V281, P19578, DOI 10.1074/jbc.M601842200; Rissanen TT, 2003, CIRC RES, V92, P1098, DOI 10.1161/01.RES.0000073584.46059.E3; Rissanen TT, 2002, FASEB J, V16, P100, DOI 10.1096/fj.02-0377fje; Rutanen J, 2003, CARDIOVASC RES, V59, P971, DOI 10.1016/S0008-6363(03)00518-2; Rutanen J, 2004, CIRCULATION, V109, P1029, DOI 10.1161/01.CIR.0000115519.03688.A2; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Stacker SA, 1999, J BIOL CHEM, V274, P32127, DOI 10.1074/jbc.274.45.32127; Stacker SA, 1999, J BIOL CHEM, V274, P34884, DOI 10.1074/jbc.274.49.34884; Suto K, 2005, J BIOL CHEM, V280, P2126, DOI 10.1074/jbc.M411395200; Suzuki Y, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni103; Tammela T, 2005, CARDIOVASC RES, V65, P550, DOI 10.1016/j.cardiores.2004.12.002; Tarsitano M, 2006, FASEB J, V20, P227, DOI 10.1096/fj.05-4147com; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; TISCHER E, 1991, J BIOL CHEM, V266, P11947; Vajanto I, 2002, J GENE MED, V4, P371, DOI 10.1002/jgm.287; Vlahakis NE, 2005, J BIOL CHEM, V280, P4544, DOI 10.1074/jbc.M412816200; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Wiesmann C, 1997, CELL, V91, P695, DOI 10.1016/S0092-8674(00)80456-0; Yamazaki Y, 2003, J BIOL CHEM, V278, P51985, DOI 10.1074/jbc.C300454200; Yla-Herttuala S, 2003, NAT MED, V9, P694, DOI 10.1038/nm0603-694	56	24	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					16037	16048		10.1074/jbc.M109.001123	http://dx.doi.org/10.1074/jbc.M109.001123			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19366703	hybrid, Green Published			2022-12-25	WOS:000266501000069
J	Forgber, M; Trefzer, U; Sterry, W; Walden, P				Forgber, Michael; Trefzer, Uwe; Sterry, Wolfram; Walden, Peter			Proteome Serological Determination of Tumor-Associated Antigens in Melanoma	PLOS ONE			English	Article								Proteome serology may complement expression library-based approaches as strategy utilizing the patients' immune responses for the identification pathogenesis factors and potential targets for therapy and markers for diagnosis. Melanoma is a relatively immunogenic tumor and antigens recognized by melanoma-specific T cells have been extensively studied. The specificities of antibody responses to this malignancy have been analyzed to some extent by molecular genetic but not proteomics approaches. We screened sera of 94 melanoma patients for anti-melanoma reactivity and detected seropositivity in two-thirds of the patients with 2-6 antigens per case detected by 1D and an average of 2.3 per case by 2D Western blot analysis. For identification, antigen spots in Western blots were aligned with proteins in 2-DE and analyzed by mass spectrometry. 18 antigens were identified, 17 of which for the first time for melanoma. One of these antigens, galectin-3, has been related to various oncogenic processes including metastasis formation and invasiveness. Similarly, enolase has been found deregulated in different cancers. With at least 2 of 18 identified proteins implicated in oncogenic processes, the work confirms the potential of proteome-based antigen discovery to identify pathologically relevant proteins.			Forgber, M (corresponding author), Humboldt Univ, Charite Univ Med, Dept Dermatol Venerol & Allergy, Berlin, Germany.	peter.walden@charite.de						Bacarese-Hamilton T, 2002, BIOTECHNIQUES, P24; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Califice S, 2004, INT J ONCOL, V25, P983; Caron M, 2007, MOL CELL PROTEOMICS, V6, P1115, DOI 10.1074/mcp.R600016-MCP200; Chan C, 1999, ELECTROPHORESIS, V20, P3467, DOI 10.1002/(SICI)1522-2683(19991101)20:17<3467::AID-ELPS3467>3.3.CO;2-0; Chen YT, 1998, P NATL ACAD SCI USA, V95, P6919, DOI 10.1073/pnas.95.12.6919; Chen YT, 1996, P NATL ACAD SCI USA, V93, P5915, DOI 10.1073/pnas.93.12.5915; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; Craven RA, 2006, PROTEOMICS, V6, P2853, DOI 10.1002/pmic.200500549; Cui JW, 2005, MOL CELL PROTEOMICS, V4, P1718, DOI 10.1074/mcp.M400165-MCP200; De Monte L, 2008, J PROTEOME RES, V7, P504, DOI 10.1021/pr070360m; Demine R, 2004, RAPID COMMUN MASS SP, V18, P907, DOI 10.1002/rcm.1420; Ehlken H, 2004, INT J CANCER, V108, P307, DOI 10.1002/ijc.11537; Forgber M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000040; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Ghoshal A, 2009, GLYCOCONJUGATE J, V26, P675, DOI 10.1007/s10719-008-9223-8; GORG A, 1988, ELECTROPHORESIS, V9, P531, DOI 10.1002/elps.1150090913; Gunawardana CG, 2007, CANCER LETT, V249, P110, DOI 10.1016/j.canlet.2007.01.002; GUNNING AP, 2008, FASEB J; Gure AO, 2000, INT J CANCER, V85, P726, DOI 10.1002/(SICI)1097-0215(20000301)85:5<726::AID-IJC21>3.0.CO;2-F; Hardouin J, 2007, ANN NY ACAD SCI, V1107, P223, DOI 10.1196/annals.1381.024; Hartmann TB, 2008, EXP DERMATOL, V17, P324, DOI 10.1111/j.1600-0625.2007.00637.x; Hartmann TB, 2005, INT J CANCER, V114, P88, DOI 10.1002/ijc.20762; Jager D, 2000, CANCER RES, V60, P3584; Jungblut PR, 2002, METHOD ENZYMOL, V358, P307; Kellner R, 2002, PROTEOMICS, V2, P1743, DOI 10.1002/1615-9861(200212)2:12<1743::AID-PROT1743>3.0.CO;2-U; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Krah Alexander, 2004, Methods Mol Med, V94, P19; Lee M, 2007, CANCER IMMUNOL IMMUN, V56, P783, DOI 10.1007/s00262-006-0239-2; Li C, 2006, PROTEOMICS, V6, P547, DOI 10.1002/pmic.200500256; Li C, 2005, PROTEOMICS, V5, P1125, DOI 10.1002/pmic.200401141; Lichtenfels R, 2003, BBA-PROTEINS PROTEOM, V1646, P21, DOI 10.1016/S1570-9639(02)00547-2; Looi KS, 2008, J PROTEOME RES, V7, P4004, DOI 10.1021/pr800273h; Mobley JA, 2004, J UROLOGY, V172, P331, DOI 10.1097/01.ju.0000132355.97888.50; Mourad-Zeidan AA, 2008, AM J PATHOL, V173, P1839, DOI 10.2353/ajpath.2008.080380; Nakahara S, 2005, APOPTOSIS, V10, P267, DOI 10.1007/s10495-005-0801-y; Neumann F, 2004, CANCER IMMUNOL IMMUN, V53, P589, DOI 10.1007/s00262-003-0492-6; Philip R, 2007, J PROTEOME RES, V6, P2509, DOI 10.1021/pr0606777; Pocza P, 2008, INT J CANCER, V122, P1972, DOI 10.1002/ijc.23296; Rattner JB, 1997, CLIN INVEST MED, V20, P308; Shimura T, 2005, CANCER RES, V65, P3535, DOI 10.1158/0008-5472.CAN-05-0104; Shoshan Stacy H., 2007, Cancer Biomarkers, V3, P141; Tomaino B, 2007, J PROTEOME RES, V6, P4025, DOI 10.1021/pr070281a; Tureci O, 1996, CANCER RES, V56, P4766; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P384, DOI 10.1074/mcp.R500009-MCP200; Unwin RD, 2003, PROTEOMICS, V3, P45, DOI 10.1002/pmic.200390008; Usener D, 2003, BRIT J DERMATOL, V149, P282, DOI 10.1046/j.1365-2133.2003.05410.x; Vereecken P, 2006, J INT MED RES, V34, P119, DOI 10.1177/147323000603400116; Yang F, 2007, J PROTEOME RES, V6, P751, DOI 10.1021/pr0602287; Zippelius A, 2007, CANCER IMMUNOL IMMUN, V56, P249, DOI 10.1007/s00262-006-0177-z; Zubieta MR, 2006, AM J PATHOL, V168, P1666, DOI 10.2353/ajpath.2006.050971	51	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2009	4	4							e5199	10.1371/journal.pone.0005199	http://dx.doi.org/10.1371/journal.pone.0005199			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TW	19381273	Green Submitted, gold, Green Published			2022-12-25	WOS:000265510800005
J	Fabre, V; Condemi, S; Degioanni, A				Fabre, Virginie; Condemi, Silvana; Degioanni, Anna			Genetic Evidence of Geographical Groups among Neanderthals	PLOS ONE			English	Article							POPULATION SIZE; DNA; SEQUENCE; REMAINS; SIMCOAL	The Neanderthals are a well-distinguished Middle Pleistocene population which inhabited a vast geographical area extending from Europe to western Asia and the Middle East. Since the 1950s paleoanthropological studies have suggested variability in this group. Different sub-groups have been identified in western Europe, in southern Europe and in the Middle East. On the other hand, since 1997, research has been published in paleogenetics, carried out on 15 mtDNA sequences from 12 Neanderthals. In this paper we used a new methodology derived from different bioinformatic models based on data from genetics, demography and paleoanthropology. The adequacy of each model was measured by comparisons between simulated results (obtained by BayesianSSC software) and those estimated from nucleotide sequences (obtained by DNAsp4 software). The conclusions of this study are consistent with existing paleoanthropological research and show that Neanderthals can be divided into at least three groups: one in western Europe, a second in the Southern area and a third in western Asia. Moreover, it seems from our results that the size of the Neanderthal population was not constant and that some migration occurred among the demes.			Fabre, V (corresponding author), Univ Mediterranee, CNRS, UMR6578, EFS,Lab Anthropol Bioculturelle, Marseille, France.	anna.degioanni@univmed.fr	Condemi, Silvana/ABE-2701-2021	Condemi, Silvana/0000-0002-6516-0879				Anderson CNK, 2005, BIOINFORMATICS, V21, P1733, DOI 10.1093/bioinformatics/bti154; BARYOSEF O, 1995, LIEGE E R A U L, V62, P247; BARYOSEF O, 1991, JJHEAMT ORIGINES HOM, P217; Beauval C, 2005, P NATL ACAD SCI USA, V102, P7085, DOI 10.1073/pnas.0502656102; Belle EMS, 2009, HEREDITY, V102, P218, DOI 10.1038/hdy.2008.103; Belle EMS, 2006, P NATL ACAD SCI USA, V103, P8012, DOI 10.1073/pnas.0509718103; BIRABEN JN, 1979, POPULATION, V34, P13, DOI 10.2307/1531855; Bocquet-Appel, 2008, PALEODEMOGRAPHIE 99; Bocquet-Appel JP, 2005, J ARCHAEOL SCI, V32, P1656, DOI 10.1016/j.jas.2005.05.006; Caramelli D, 2003, P NATL ACAD SCI USA, V100, P6593, DOI 10.1073/pnas.1130343100; Caramelli D, 2006, CURR BIOL, V16, pR630, DOI 10.1016/j.cub.2006.07.043; CONDEMI S, 2001, 15 CTHS; Condemi S, 1992, HOMMES FOSSILES SACC; Condemi S., 2007, BAR INT SERIES, V1603, P28; Currat M, 2004, PLOS BIOL, V2, P2264, DOI 10.1371/journal.pbio.0020421; CURRAT M, 2004, EFFETS EXPANSIONS PO; de Lumley M.A., 1973, ANTENEANDERTALIENS N; Dean D, 1998, J HUM EVOL, V34, P485, DOI 10.1006/jhev.1998.0214; Excoffier L, 1999, MOL BIOL EVOL, V16, P1357, DOI 10.1093/oxfordjournals.molbev.a026046; Excoffier L, 2000, J HERED, V91, P506, DOI 10.1093/jhered/91.6.506; GAMBIER D, 1997, GACECMW CONCEPTUAL I, P117; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; HAMBUCKEN A, 1997, ANTHR PREHIST, V108, P109; Krause J, 2007, NATURE, V449, P902, DOI 10.1038/nature06193; Krings M, 2000, NAT GENET, V26, P144, DOI 10.1038/79855; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Lalueza-Fox C, 2006, CURR BIOL, V16, pR629, DOI 10.1016/j.cub.2006.07.044; Mussi M., 2001, EARLIEST ITALY OVERV; Orlando L, 2006, CURR BIOL, V16, pR400, DOI 10.1016/j.cub.2006.05.019; Ovchinnikov IV, 2000, NATURE, V404, P490, DOI 10.1038/35006625; RAY N, 2003, MODELISATION DEMOGRA; Rosas A, 2006, P NATL ACAD SCI USA, V103, P19266, DOI 10.1073/pnas.0609662104; Schmitz RW, 2002, P NATL ACAD SCI USA, V99, P13342, DOI 10.1073/pnas.192464099; Serre D, 2004, PLOS BIOL, V2, P313, DOI 10.1371/journal.pbio.0020057; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tattersall I., 2006, P9; TILLIER AM, 2006, DIOGENE, V214, P132; Trinkaus E, 2003, J HUM EVOL, V45, P245, DOI 10.1016/j.jhevol.2003.08.003; Trinkaus E, 2006, CURR ANTHROPOL, V47, P597, DOI 10.1086/504165; Vandermeersch B., 1981, HOMMES FOSSILES QAFZ; Voight BF, 2005, P NATL ACAD SCI USA, V102, P18508, DOI 10.1073/pnas.0507325102; Voisin J.-L., 2006, P299, DOI 10.1007/978-1-4020-5121-0_17; WAGNER GA, 1997, WGAUBKW EUROPAS BEIT, P186; WOOD J, 1987, AM NAT, P165; ZILHAO J, 2002, AURIGNACIAN BEHAV MO, P52	45	78	81	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2009	4	4							e5151	10.1371/journal.pone.0005151	http://dx.doi.org/10.1371/journal.pone.0005151			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437TS	19367332	gold, Green Submitted, Green Published			2022-12-25	WOS:000265510400001
J	Gustafsson, L; Aits, S; Onnerfjord, P; Trulsson, M; Storm, P; Svanborg, C				Gustafsson, Lotta; Aits, Sonja; Onnerfjord, Patrik; Trulsson, Maria; Storm, Petter; Svanborg, Catharina			Changes in Proteasome Structure and Function Caused by HAMLET in Tumor Cells	PLOS ONE			English	Article								Background: Proteasomes control the level of endogenous unfolded proteins by degrading them in the proteolytic core. Insufficient degradation due to altered protein structure or proteasome inhibition may trigger cell death. This study examined the proteasome response to HAMLET, a partially unfolded protein-lipid complex, which is internalized by tumor cells and triggers cell death. Methodology/Principal Findings: HAMLET bound directly to isolated 20S proteasomes in vitro and in tumor cells significant co-localization of HAMLET and 20S proteasomes was detected by confocal microscopy. This interaction was confirmed by co-immunoprecipitation from extracts of HAMLET-treated tumor cells. HAMLET resisted in vitro degradation by proteasomal enzymes and degradation by intact 20S proteasomes was slow compared to fatty acid-free, partially unfolded alpha-lactalbumin. After a brief activation, HAMLET inhibited proteasome activity in vitro and in parallel a change in proteasome structure occurred, with modifications of catalytic (beta 1 and beta 5) and structural subunits (alpha 2, alpha 3, alpha 6 and beta 3). Proteasome inhibition was confirmed in extracts from HAMLET-treated cells and there were indications of proteasome fragmentation in HAMLET-treated cells. Conclusions/Significance: The results suggest that internalized HAMLET is targeted to 20S proteasomes, that the complex resists degradation, inhibits proteasome activity and perturbs proteasome structure. We speculate that perturbations of proteasome structure might contribute to the cytotoxic effects of unfolded protein complexes that invade host cells.			Gustafsson, L (corresponding author), Lund Univ, Dept Microbiol Immunol & Glycobiol, Inst Lab Med, Lund, Sweden.	Catharina_Svanborg@immunol.a-star.edu.sg	Onnerfjord, Patrik/R-3131-2019; Aits, Sonja/D-1496-2011	Onnerfjord, Patrik/0000-0002-2345-2937; Aits, Sonja/0000-0002-1321-0678; Storm, Petter/0000-0002-7655-3731; Gustafsson, Lotta/0000-0002-9826-9133				ACHARYA KR, 1991, J MOL BIOL, V221, P571; BREW K, 1968, P NATL ACAD SCI USA, V59, P491, DOI 10.1073/pnas.59.2.491; BRODBECK U, 1966, J BIOL CHEM, V241, P762; Chandra N, 1998, BIOCHEMISTRY-US, V37, P4767, DOI 10.1021/bi973000t; Ciechanover A, 2006, EXP BIOL MED, V231, P1197; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; EBNER KE, 1966, BIOCHEM BIOPH RES CO, V24, P232, DOI 10.1016/0006-291X(66)90725-X; EWBANK JJ, 1993, BIOCHEMISTRY-US, V32, P3677, DOI 10.1021/bi00065a022; Fischer W, 2004, CANCER RES, V64, P2105, DOI 10.1158/0008-5472.CAN-03-2661; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; GOLDBERG AL, 1995, SCIENCE, V268, P522, DOI 10.1126/science.7725095; GREGORI L, 1995, J BIOL CHEM, V270, P19702, DOI 10.1074/jbc.270.34.19702; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Gustafsson L, 2004, NEW ENGL J MED, V350, P2663, DOI 10.1056/NEJMoa032454; GUSTAFSSON L, 2005, THESIS LUND U LUND; HAKANSSON A, 1995, P NATL ACAD SCI USA, V92, P8064, DOI 10.1073/pnas.92.17.8064; Hedlund M, 1996, J EXP MED, V183, P1037, DOI 10.1084/jem.183.3.1037; Hill CP, 2002, CURR TOP MICROBIOL, V268, P73; Karpman D, 1998, INFECT IMMUN, V66, P636, DOI 10.1128/IAI.66.2.636-644.1998; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Kuwajima K, 1996, FASEB J, V10, P102, DOI 10.1096/fasebj.10.1.8566530; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Mossberg AK, 2007, INT J CANCER, V121, P1352, DOI 10.1002/ijc.22810; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; RAO KR, 1989, BIOCHEM BIOPH RES CO, V163, P1390, DOI 10.1016/0006-291X(89)91133-9; SAFAR J, 1994, BIOCHEMISTRY-US, V33, P8375, DOI 10.1021/bi00193a027; Satoh J, 2006, J NEUROSCI METH, V152, P278, DOI 10.1016/j.jneumeth.2005.09.015; Smith LJ, 1999, PROTEINS, V36, P77, DOI 10.1002/(SICI)1097-0134(19990701)36:1<77::AID-PROT7>3.0.CO;2-X; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Svensson M, 2000, P NATL ACAD SCI USA, V97, P4221, DOI 10.1073/pnas.97.8.4221; Svensson M, 2003, PROTEIN SCI, V12, P2794, DOI 10.1110/ps.0231003; Svensson M, 1999, J BIOL CHEM, V274, P6388, DOI 10.1074/jbc.274.10.6388; Watanabe N, 1996, PLANT CELL PHYSIOL, V37, P147, DOI 10.1093/oxfordjournals.pcp.a028925; WENZEL T, 1995, NAT STRUCT BIOL, V2, P199, DOI 10.1038/nsb0395-199; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Wu LC, 1996, BIOCHEMISTRY-US, V35, P859, DOI 10.1021/bi951408p	41	53	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2009	4	4							e5229	10.1371/journal.pone.0005229	http://dx.doi.org/10.1371/journal.pone.0005229			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TO	19365565	Green Submitted, Green Published, gold			2022-12-25	WOS:000265510000005
J	Sauzullo, I; Mengoni, F; Lichtner, M; Massetti, AP; Rossi, R; Iannetta, M; Marocco, R; Del Borgo, C; Soscia, F; Vullo, V; Mastroianni, CM				Sauzullo, Ilaria; Mengoni, Fabio; Lichtner, Miriam; Massetti, Anna Paola; Rossi, Raffaella; Iannetta, Marco; Marocco, Raffaella; Del Borgo, Cosmo; Soscia, Fabrizio; Vullo, Vincenzo; Mastroianni, Claudio Maria			In Vivo and In Vitro Effects of Antituberculosis Treatment on Mycobacterial Interferon-gamma T Cell Response	PLOS ONE			English	Article							LATENT TUBERCULOSIS INFECTION; SKIN-TEST; ELISPOT TEST; ASSAYS; DIAGNOSIS; GOLD; ENUMERATION; ESAT-6; INDIVIDUALS; EFFICACY	Background: In recent years, the impact of antituberculous treatment on interferon (IFN)-gamma response to Mycobacterium tuberculosis antigens has been widely investigated, but the results have been controversial. The objective of the present study was: i) to evaluate longitudinal changes of IFN-gamma response to M. tuberculosis-specific antigens in TB patients during antituberculous treatment by using the QuantiFERON-TB Gold (QFT-G) assay; ii) to compare the differences in T-cell response after a short or prolonged period of stimulation with mycobacterial antigens; iii) to assess the CD4+ and CD8+ T cells with effector/memory and central/memory phenotype; iv) to investigate the direct in vitro effects of antituberculous drugs on the secretion of IFN-gamma. Principal Findings: 38 TB patients was evaluated at baseline and at month 2 and 4 of treatment and at month 6 (treatment completion). 27 (71%) patients had a QFT-G reversion (positive to negative) at the end of therapy, while 11 (29%) TB patients remained QFT-G positive at the end of therapy. Among the 11 patients with persistent positive QFT-G results, six had a complete response to the treatment, while the remaining 5 patients did not have a resolution of the disease. All 27 patients who became QFT-G negative had a complete clinical and microbiological recovery of the TB disease. In these patients the release of IFN-gamma is absent even after a prolonged 6-day incubation with both ESAT-6 and CFP-10 antigens and the percentage of effector/memory T-cells phenotype was markedly lower than subjects with persistent positive QFT-G results. The in vitro study showed that antituberculous drugs did not exert any inhibitory effect on IFN-gamma production within the range of therapeutically achievable concentrations. Conclusions: The present study suggests that the decrease in the M. tuberculosis-specific T cells responses following successful anti-TB therapy may have a clinical value as a supplemental tool for the monitoring of the efficacy of pharmacologic intervention for active TB. In addition, the antituberculous drugs do not have any direct down-regulatory effect on the specific IFN-gamma response.			Sauzullo, I (corresponding author), Sapienza Univ, Dept Infect & Trop Dis, Rome, Italy.	claudio.mastroianni@uniroma1.it	MASTROIANNI, Claudio Maria/O-9741-2019; Iannetta, Marco/M-4619-2019; Iannetta, Marco/B-5596-2017	MASTROIANNI, Claudio Maria/0000-0002-1286-467X; Iannetta, Marco/0000-0002-6938-8627; Iannetta, Marco/0000-0002-6938-8627; Sauzullo, Ilaria/0000-0002-0060-0749; Massetti, Anna Paola/0000-0003-0520-8743				Aiken AM, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-66; Al-Attiyah R, 2003, FEMS IMMUNOL MED MIC, V38, P249, DOI 10.1016/S0928-8244(03)00166-4; Arend SM, 2007, AM J RESP CRIT CARE, V175, P618, DOI 10.1164/rccm.200608-1099OC; Carrara S, 2004, CLIN INFECT DIS, V38, P754, DOI 10.1086/381754; CORBETT EL, 2006, INT J TUBERC LUNG D, V10, pS231; Dheda K, 2007, J INFECTION, V55, P169, DOI 10.1016/j.jinf.2007.02.005; Dominguez J, 2009, DIAGN MICR INFEC DIS, V63, P43, DOI 10.1016/j.diagmicrobio.2008.09.010; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC; Ferrand RA, 2005, INT J TUBERC LUNG D, V9, P1034; Hill PC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000183; Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192; Hussain R, 2002, J IMMUNOL METHODS, V264, P95, DOI 10.1016/S0022-1759(02)00092-3; Jones S, 2007, INT J TUBERC LUNG D, V11, P1190; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Katiyar SK, 2008, INT J TUBERC LUNG D, V12, P1146; Kobashi Y, 2007, INTERNAL MED, V46, P1543, DOI 10.2169/internalmedicine.46.0088; Kobashi Y, 2009, J INFECTION, V58, P197, DOI 10.1016/j.jinf.2008.08.009; Lalvani A, 2004, CLIN INFECT DIS, V38, P757, DOI 10.1086/381763; Lalvani A, 2001, AM J RESP CRIT CARE, V163, P824, DOI 10.1164/ajrccm.163.4.2009100; Lalvani A, 2001, J INFECT DIS, V183, P469, DOI 10.1086/318081; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; Lalvani A, 2007, CHEST, V131, P1898, DOI 10.1378/chest.06-2471; Leyten EMS, 2007, CLIN VACCINE IMMUNOL, V14, P880, DOI 10.1128/CVI.00132-07; Leyten EMS, 2006, J CLIN MICROBIOL, V44, P1197, DOI 10.1128/JCM.44.3.1197-1201.2006; Manuel O, 2007, AM J TRANSPLANT, V7, P2797, DOI 10.1111/j.1600-6143.2007.02011.x; Mazurek GH, 2001, JAMA-J AM MED ASSOC, V286, P1740, DOI 10.1001/jama.286.14.1740; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2007, INFECTION, V35, P98, DOI 10.1007/s15010-007-6114-z; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2007, LANCET INFECT DIS, V7, P428, DOI 10.1016/S1473-3099(07)70086-5; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; Pathan AA, 2001, J IMMUNOL, V167, P5217, DOI 10.4049/jimmunol.167.9.5217; Richeldi L, 2006, AM J RESP CRIT CARE, V174, P736, DOI 10.1164/rccm.200509-1516PP; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sauzullo I, 2008, DIAGN MICR INFEC DIS, V62, P395, DOI 10.1016/j.diagmicrobio.2008.08.015; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Ulrichs T, 2000, INT J TUBERC LUNG D, V4, P1181; Vekemans J, 2001, INFECT IMMUN, V69, P6554, DOI 10.1128/IAI.69.10.6554-6557.2001; Wu-Hsieh BA, 2001, CLIN INFECT DIS, V33, P1336, DOI 10.1086/323044	40	41	44	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5187	10.1371/journal.pone.0005187	http://dx.doi.org/10.1371/journal.pone.0005187			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TN	19365543	Green Submitted, Green Published, gold			2022-12-25	WOS:000265509900015
J	Zcharia, E; Jia, J; Zhang, X; Baraz, L; Lindahl, U; Peretz, T; Vlodavsky, I; Li, JP				Zcharia, Eyal; Jia, Juan; Zhang, Xiao; Baraz, Lea; Lindahl, Ulf; Peretz, Tamar; Vlodavsky, Israel; Li, Jin-Ping			Newly Generated Heparanase Knock-Out Mice Unravel Co-Regulation of Heparanase and Matrix Metalloproteinases	PLOS ONE			English	Article								Background: Heparanase, a mammalian endo-beta-D-glucuronidase, specifically degrades heparan sulfate proteoglycans ubiquitously associated with the cell surface and extracellular matrix. This single gene encoded enzyme is over-expressed in most human cancers, promoting tumor metastasis and angiogenesis. Principal Findings: We report that targeted disruption of the murine heparanase gene eliminated heparanase enzymatic activity, resulting in accumulation of long heparan sulfate chains. Unexpectedly, the heparanase knockout (Hpse-KO) mice were fertile, exhibited a normal life span and did not show prominent pathological alterations. The lack of major abnormalities is attributed to a marked elevation in the expression of matrix metalloproteinases, for example, MMP2 and MMP14 in the Hpse-KO liver and kidney. Co-regulation of heparanase and MMPs was also noted by a marked decrease in MMP (primarily MMP-2,-9 and 14) expression following transfection and over-expression of the heparanase gene in cultured human mammary carcinoma (MDA-MB-231) cells. Immunostaining (kidney tissue) and chromatin immunoprecipitation (ChIP) analysis (Hpse-KO mouse embryonic fibroblasts) suggest that the newly discovered co-regulation of heparanase and MMPs is mediated by stabilization and transcriptional activity of beta-catenin. Conclusions/Significance: The lack of heparanase expression and activity was accompanied by alterations in the expression level of MMP family members, primarily MMP-2 and MMP-14. It is conceivable that MMP-2 and MMP-14, which exert some of the effects elicited by heparanase (i.e., over branching of mammary glands, enhanced angiogenic response) can compensate for its absence, in spite of their different enzymatic substrate. Generation of viable Hpse-KO mice lacking significant abnormalities may provide a promising indication for the use of heparanase as a target for drug development.			Zcharia, E (corresponding author), Hadassah Hebrew Univ, Med Ctr, Dept Oncol, Jerusalem, Israel.	vlodavsk@cc.huji.ac.il; jin-ping.li@imbim.uu.se			NCI NIH HHS [R01 CA106456, R01-CA106456] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA106456] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ala-Aho R, 2005, BIOCHIMIE, V87, P273, DOI 10.1016/j.biochi.2004.12.009; BARNER M, 1985, INT J CANCER, V35, P483, DOI 10.1002/ijc.2910350411; Basche M, 2006, CLIN CANCER RES, V12, P5471, DOI 10.1158/1078-0432.CCR-05-2423; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Brabletz T, 1999, AM J PATHOL, V155, P1033, DOI 10.1016/S0002-9440(10)65204-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Cohen CD, 2006, P NATL ACAD SCI USA, V103, P5682, DOI 10.1073/pnas.0511257103; Cohen I, 2007, CLIN CANCER RES, V13, P4069, DOI 10.1158/1078-0432.CCR-06-2546; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; DANIEL CW, 1995, DEV BIOL, V169, P511, DOI 10.1006/dbio.1995.1165; Davidson D, 2007, GYNECOL ONCOL, V104, P311, DOI 10.1016/j.ygyno.2006.08.045; Dempsey LA, 2000, TRENDS BIOCHEM SCI, V25, P349, DOI 10.1016/S0968-0004(00)01619-4; Doweck I, 2006, NEOPLASIA, V8, P1055, DOI 10.1593/neo.06577; Dredge Keith, 2004, Curr Opin Investig Drugs, V5, P668; Elkin M, 2001, FASEB J, V15, P1661, DOI 10.1096/fj.00-0895fje; Elkin M, 2000, FASEB J, V14, P2477, DOI 10.1096/fj.00-0292com; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Freeman C, 1998, BIOCHEM J, V330, P1341, DOI 10.1042/bj3301341; Galvis MLE, 2007, NAT CHEM BIOL, V3, P773, DOI 10.1038/nchembio.2007.41; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P23536, DOI 10.1074/jbc.M400554200; Hulett MD, 2000, BIOCHEMISTRY-US, V39, P15659, DOI 10.1021/bi002080p; Hulett MD, 1999, NAT MED, V5, P803, DOI 10.1038/10525; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Iozzo RV, 2001, J CLIN INVEST, V108, P349, DOI 10.1172/JCI13738; Kelly T, 2003, CANCER RES, V63, P8749; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Kram V, 2006, J CELL PHYSIOL, V207, P784, DOI 10.1002/jcp.20625; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Li JP, 2003, J BIOL CHEM, V278, P28363, DOI 10.1074/jbc.C300219200; Lin XH, 2000, MATRIX BIOL, V19, P303, DOI 10.1016/S0945-053X(00)00073-1; Lin XH, 1999, DEVELOPMENT, V126, P3715; Loo BM, 2001, J BIOL CHEM, V276, P16868, DOI 10.1074/jbc.M011226200; Mannello F, 2005, CURR CANCER DRUG TAR, V5, P285, DOI 10.2174/1568009054064615; McKenzie E, 2000, BIOCHEM BIOPH RES CO, V276, P1170, DOI 10.1006/bbrc.2000.3586; McParland BJ, 1998, BRIT J RADIOL, V71, P950, DOI 10.1259/bjr.71.849.10195010; Medhora M, 2003, AM J PHYSIOL-HEART C, V284, pH215, DOI 10.1152/ajpheart.01118.2001; Merry CLR, 2002, BBA-GEN SUBJECTS, V1573, P319, DOI 10.1016/S0304-4165(02)00399-9; Nadir Y, 2006, J THROMB HAEMOST, V4, P2443, DOI 10.1111/j.1538-7836.2006.02212.x; Naggi A, 2005, J BIOL CHEM, V280, P12103, DOI 10.1074/jbc.M414217200; Nobuhisa T, 2005, BIOCHEM BIOPH RES CO, V331, P175, DOI 10.1016/j.bbrc.2005.03.129; Ohkawa T, 2004, LAB INVEST, V84, P1289, DOI 10.1038/labinvest.3700159; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Parish CR, 2001, BBA-REV CANCER, V1471, pM99, DOI 10.1016/S0304-419X(01)00017-8; Pikas DS, 1998, J BIOL CHEM, V273, P18770, DOI 10.1074/jbc.273.30.18770; Purushothaman A, 2008, J BIOL CHEM, V283, P32628, DOI 10.1074/jbc.M806266200; Shteper PJ, 2003, ONCOGENE, V22, P7737, DOI 10.1038/sj.onc.1207056; Sternlicht MD, 2006, DIFFERENTIATION, V74, P365, DOI 10.1111/j.1432-0436.2006.00105.x; Takahashi M, 2002, ONCOGENE, V21, P5861, DOI 10.1038/sj.onc.1205755; Timpl R, 1996, BIOESSAYS, V18, P123, DOI 10.1002/bies.950180208; VANDENHOVEN MJ, 2007, KIDNEY INT; Vlodavsky I, 2001, J CLIN INVEST, V108, P341, DOI 10.1172/JCI200113662; VLODAVSKY I, 1983, CANCER RES, V43, P2704; VLODAVSKY I, 1992, INVAS METAST, V12, P112; Vlodavsky I, 2001, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1004s01; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; VLODAVSKY I, 1987, P NATL ACAD SCI USA, V84, P2292, DOI 10.1073/pnas.84.8.2292; Vlodavsky I, 1996, CANCER METAST REV, V15, P177, DOI 10.1007/BF00437470; VLODAVSKY I, 1993, BASEMENT MEMBRANES C, P327; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3; Wu BB, 2007, IMMUNITY, V26, P227, DOI 10.1016/j.immuni.2006.12.007; Zcharia E, 2005, AM J PATHOL, V166, P999, DOI 10.1016/S0002-9440(10)62321-8; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811	66	139	145	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2009	4	4							e5181	10.1371/journal.pone.0005181	http://dx.doi.org/10.1371/journal.pone.0005181			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437SB	19360105	Green Published, gold, Green Submitted			2022-12-25	WOS:000265506100004
J	Hsieh, PJ; Tse, PU				Hsieh, Po-Jang; Tse, Peter U.			Microsaccade Rate Varies with Subjective Visibility during Motion-Induced Blindness	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; PHYSIOLOGICAL CORRELATE; ATTENTIONAL MODULATION; NEURAL ACTIVITY; DISTINCT MODES; FILLING-IN; STRIATE; AREAS; REPRESENTATIONS; RESPONSES	Motion-induced blindness (MIB) occurs when a dot embedded in a motion field subjectively vanishes. Here we report the first psychophysical data concerning effects of microsaccade/eyeblink rate upon perceptual switches during MIB. We find that the rate of microsaccades/eyeblink rises before and after perceptual transitions from not seeing to seeing the dot, and decreases before perceptual transitions from seeing it to not seeing it. In addition, event-related fMRI data reveal that, when a dot subjectively reappears during MIB, the blood oxygen-level dependent (BOLD) signal increases in V1v and V2v and decreases in contralateral hMT+. These BOLD signal changes observed upon perceptual state changes in MIB could be driven by the change of perceptual states and/or a confounding factor, such as the microsaccade/eyeblink rate.			Hsieh, PJ (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, Moore Hall, Hanover, NH 03755 USA.	pjh@mit.edu			NIMH NIH HHS [R03 MH0609660-01] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bonneh YS, 2001, NATURE, V411, P798, DOI 10.1038/35081073; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; BREWER AA, 2004, SOC NEUR M; Castelo-Branco M, 2002, P NATL ACAD SCI USA, V99, P13914, DOI 10.1073/pnas.202049999; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; CLARKE FJJ, 1962, VISION RES, V2, P53, DOI 10.1016/0042-6989(62)90063-9; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Funk AP, 2003, PERCEPTION, V32, P1325, DOI 10.1068/p5088; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Gawne TJ, 2002, J NEUROPHYSIOL, V88, P2178, DOI 10.1152/jn.00151.200; Goebel R, 1998, EUR J NEUROSCI, V10, P1563, DOI 10.1046/j.1460-9568.1998.00181.x; Graf EW, 2002, VISION RES, V42, P2731, DOI 10.1016/S0042-6989(02)00390-5; Hochstein S, 2002, NEURON, V36, P791, DOI 10.1016/S0896-6273(02)01091-7; Horwitz GD, 2003, J NEUROPHYSIOL, V90, P1333, DOI 10.1152/jn.00146.2003; Hsu LC, 2004, VISION RES, V44, P2857, DOI 10.1016/j.visres.2003.10.029; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; KINGSTONE A, 1995, PERCEPT PSYCHOPHYS, V57, P796, DOI 10.3758/BF03206795; KOTULAK JC, 1986, PERCEPTION, V15, P7, DOI 10.1068/p150007; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Leopold DA, 1998, EXP BRAIN RES, V123, P341, DOI 10.1007/s002210050577; Liu TS, 2004, NEUROIMAGE, V21, P1772, DOI 10.1016/j.neuroimage.2003.12.025; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; Millodot M, 1967, PSYCHOL FR, V12, P190; Mitroff SR, 2004, PERCEPTION, V33, P1267, DOI 10.1068/p5341no; Mitroff SR, 2005, VISION RES, V45, P961, DOI 10.1016/j.visres.2004.09.044; Muckli L, 2005, PLOS BIOL, V3, P1501, DOI 10.1371/journal.pbio.0030265; Muckli L, 2002, J NEUROSCI, V22; Muller NG, 2003, J NEUROSCI, V23, P3561; Pollen DA, 2003, CEREB CORTEX, V13, P807, DOI 10.1093/cercor/13.8.807; RAMACHANDRAN VS, 1992, SCI AM, V266, P86, DOI 10.1038/scientificamerican0592-86; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; Safran AB, 1998, SURV OPHTHALMOL, V42, P449, DOI 10.1016/S0039-6257(97)00134-3; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shulman GL, 2002, CEREB CORTEX, V12, P1124, DOI 10.1093/cercor/12.11.1124; Slotnick SD, 2003, HUM BRAIN MAPP, V18, P22, DOI 10.1002/hbm.10077; Slotnick SD, 2003, NEUROIMAGE, V19, P1602, DOI 10.1016/S1053-8119(03)00187-3; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; Sylvester R, 2005, CURR BIOL, V15, P37, DOI 10.1016/j.cub.2004.12.061; Tong F, 2003, NAT REV NEUROSCI, V4, P219, DOI 10.1038/nrn1055; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Troxler D, 1804, OPHTHALMOLOGISCHES B, P51; Tse PU, 2004, PSYCHOL SCI, V15, P708, DOI 10.1111/j.0956-7976.2004.00745.x; TSE PU, CORTICAL ACTIV UNPUB; Watanabe T, 1998, P NATL ACAD SCI USA, V95, P11489, DOI 10.1073/pnas.95.19.11489; WATANABE T, 1991, PERCEPT PSYCHOPHYS, V50, P459, DOI 10.3758/BF03205062; Zur D, 2003, VISION RES, V43, P971, DOI 10.1016/S0042-6989(03)00038-5	50	35	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5163	10.1371/journal.pone.0005163	http://dx.doi.org/10.1371/journal.pone.0005163			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437RZ	19357789	Green Submitted, Green Published, gold			2022-12-25	WOS:000265505900019
J	Smit-Rigter, LA; Champagne, DL; van Hooft, JA				Smit-Rigter, Laura A.; Champagne, Danielle L.; van Hooft, Johannes A.			Lifelong Impact of Variations in Maternal Care on Dendritic Structure and Function of Cortical Layer 2/3 Pyramidal Neurons in Rat Offspring	PLOS ONE			English	Article							REELIN; HIPPOCAMPUS; MATURATION; PLASTICITY; RESPONSES; INTEGRIN; BEHAVIOR; CORTEX; MODEL; CA1	Maternal licking and grooming (LG) exerts profound influence on hippocampal development and function in the offspring. However, little information is available on the effects of variations in maternal care on other brain regions. Here we examined the effects of variation in the frequency of maternal LG on morphological and electrophysiological properties of layer 2/3 pyramidal neurons in the somatosensory cortex in adult offspring. Compared to low LG offspring, high LG offspring displayed decreased dendritic complexity, reduced spine density and decreased amplitude of spontaneous postsynaptic currents. These changes were accompanied by higher levels of reelin expression in offspring of high LG mothers. Taken together, these findings suggest that differential amount of naturally-occurring variations in maternal LG is associated with enduring changes in dendritic morphology and synaptic function in layer 2/3 pyramidal neurons of the somatosensory cortex.			Smit-Rigter, LA (corresponding author), Univ Amsterdam, Ctr Neurosci, Swammerdam Inst Life Sci, Amsterdam, Netherlands.	j.a.vanhooft@uva.nl						Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; Bock J, 2005, CEREB CORTEX, V15, P802, DOI 10.1093/cercor/bhh181; Bredy TW, 2003, EUR J NEUROSCI, V18, P2903, DOI 10.1111/j.1460-9568.2003.02965.x; BROWNE MAO, 1995, AUST NZ J PSYCHIAT, V29, P437; Cameron NM, 2008, J NEUROENDOCRINOL, V20, P795, DOI 10.1111/j.1365-2826.2008.01725.x; CHAMEAU P, 2009, P NATL ACAD IN PRESS; Champagne DL, 2008, J NEUROSCI, V28, P6037, DOI 10.1523/JNEUROSCI.0526-08.2008; Champagne FA, 2003, PHYSIOL BEHAV, V79, P359, DOI 10.1016/S0031-9384(03)00149-5; CHAMPAGNE FA, 2008, NEUROSCI BIOBEHAV R, V18, P1; Dong E, 2005, P NATL ACAD SCI USA, V102, P12578, DOI 10.1073/pnas.0505394102; Dong E, 2003, P NATL ACAD SCI USA, V100, P5479, DOI 10.1073/pnas.1031602100; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155; Groc L, 2007, J NEUROSCI, V27, P10165, DOI 10.1523/JNEUROSCI.1772-07.2007; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Jossin Y, 2007, J NEUROSCI, V27, P4243, DOI 10.1523/JNEUROSCI.0023-07.2007; Levenson JM, 2008, BBA-GENE REGUL MECH, V1779, P422, DOI 10.1016/j.bbagrm.2008.01.001; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Lom B, 1999, J NEUROSCI, V19, P9928; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Marin-Padilla M, 1998, TRENDS NEUROSCI, V21, P64, DOI 10.1016/S0166-2236(97)01164-8; MCGOWAN PO, 2009, NAT NEUROSCI, P2; Meaney MJ, 2005, TRENDS NEUROSCI, V28, P456, DOI 10.1016/j.tins.2005.07.006; Nakajima K, 1997, P NATL ACAD SCI USA, V94, P8196, DOI 10.1073/pnas.94.15.8196; Niu S, 2004, NEURON, V41, P71, DOI 10.1016/S0896-6273(03)00819-5; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Pinaud R, 2004, INT J NEUROSCI, V114, P321, DOI 10.1080/00207450490264142; Poeggel G, 2003, P NATL ACAD SCI USA, V100, P16137, DOI 10.1073/pnas.2434663100; Qiu SF, 2007, J NEUROPHYSIOL, V97, P2312, DOI 10.1152/jn.00869.2006; Qiu SF, 2006, J NEUROSCI, V26, P12943, DOI 10.1523/JNEUROSCI.2561-06.2006; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Segal M, 2002, PROG BRAIN RES, V138, P53, DOI 10.1016/S0079-6123(02)38070-1; Turner CA, 2003, DEV PSYCHOBIOL, V43, P20, DOI 10.1002/dev.10116; van Hooft JA, 2002, NEUROSCI LETT, V318, P163, DOI 10.1016/S0304-3940(01)02452-1; Weaver ICG, 2006, P NATL ACAD SCI USA, V103, P3480, DOI 10.1073/pnas.0507526103; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Williams SR, 2007, NEURON, V56, P947, DOI 10.1016/j.neuron.2007.12.004	38	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5167	10.1371/journal.pone.0005167	http://dx.doi.org/10.1371/journal.pone.0005167			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357777	gold, Green Published, Green Submitted			2022-12-25	WOS:000265505900020
J	Penteriani, V; Delgado, MD				Penteriani, Vincenzo; Delgado, Maria del Mar			The Dusk Chorus from an Owl Perspective: Eagle Owls Vocalize When Their White Throat Badge Contrasts Most	PLOS ONE			English	Article							AMBIENT LIGHT; DAWN CHORUS; VISUAL CUES; BEHAVIOR; COLOR; SIGNAL; SELECTION; DISPLAYS; BIRDS	Background: An impressive number of studies have investigated bird vocal displays, and many of them have tried to explain the widespread phenomenon of the so-called dawn and dusk chorus, the sunrise and sunset peaks in bird song output. As many as twelve non-exclusive hypotheses have been proposed to explain why twilight peaks in vocal display might be advantageous; but, even after more than two decades of study, the basis underlying the dusk and dawn chorus is still unclear. Moreover, to date, the majority of studies on this topic have focused on songbirds. Methodology/Principal Findings: We investigate here a novel hypothesis on why nocturnal birds with patches of white feathers call at twilight. We propose that white plumage patches and the timing of visual signaling have co-evolved to maximize the effectiveness of social communication such as the dusk chorus. This hypothesis centers on the recent discovery that eagle owls can adopt specific forms of visual signaling and is supported by the observation that adult eagle owls possess a white throat badge that is only visible during vocal displays. By monitoring the calling of eagle owls at dusk, a peak time for bird call output, we found that white throat badges contrasted most with the surrounding background during the owls' twilight chorusing. Conclusions/Significance: Crepuscular and nocturnal species appear to have evolved white patches that, shown in association with vocal displays, allow them to communicate in dark surroundings. The evolution of a white badge that operates jointly with call displays at dawn and dusk may be relevant to the eagle owls' social dynamics. Our explanation for the dusk chorus may possibly represent an overlooked but common pattern of signaling among crepuscular and nocturnal birds that combine patches of white feathers with twilight displays. Furthermore, our findings could be relevant to songbirds that breed in dark forest habitats and have contrasting white badges, as well as birds living in open habitats and showing contrasting bars.			Penteriani, V (corresponding author), Estac Biol Donana, Dept Conservat Biol, E-41013 Seville, Spain.	penteriani@ebd.csic.es		Delgado, Maria del Mar/0000-0002-3009-738X				Aragones J, 1999, WILSON BULL, V111, P340; Bradbury Jack W., 1998, pi; Brown TJ, 2003, IBIS, V145, P120, DOI 10.1046/j.1474-919X.2003.00130.x; Burt John M., 2005, P320, DOI 10.1017/CBO9780511610363.019; Catchpole C., 1995, BIRD SONG BIOL THEME; Dabelsteen Torben, 2002, Acta Ethologica, V4, P65; Delgado MM, 2007, J ZOOL, V271, P3, DOI 10.1111/j.1469-7998.2006.00205.x; Delibes M., 1979, P WORLD LAGOMORPH C, P614, DOI DOI 10.1007/BF00275171; DONAZAR JA, 1987, BIOL CONSERVATION NO, P220; ENDLER JA, 1993, ECOL MONOGR, V63, P1, DOI 10.2307/2937121; Endler JA, 1996, AM NAT, V148, P421, DOI 10.1086/285934; Gomez D, 2004, ECOL LETT, V7, P279, DOI 10.1111/j.1461-0248.2004.00584.x; HENWOOD K, 1979, AM NAT, V114, P260, DOI 10.1086/283473; HOGLUND J, 1990, ANIM BEHAV, V40, P23, DOI 10.1016/S0003-3472(05)80662-1; Hutchinson JMC, 2002, ANIM BEHAV, V64, P527, DOI 10.1006/anbe.2002.3091; Jiguet F, 2001, BEHAV PROCESS, V55, P107, DOI 10.1016/S0376-6357(01)00173-5; McCullagh P, 1989, GEN LINEAR MODELLING; McNaught MK, 2002, J EVOLUTION BIOL, V15, P505, DOI 10.1046/j.1420-9101.2002.00431.x; Penteriani V, 2003, IBIS, V145, pE127, DOI 10.1046/j.1474-919X.2003.00173.x; Penteriani V, 2002, ETHOL ECOL EVOL, V14, P275; Penteriani V, 2006, J AVIAN BIOL, V37, P110, DOI 10.1111/j.0908-8857.2006.03569.x; Penteriani V, 2005, IBIS, V147, P155, DOI 10.1111/j.1474-919x.2004.00381.x; Penteriani V, 2007, ETHOLOGY, V113, P934, DOI 10.1111/j.1439-0310.2007.01414.x; Penteriani V, 2007, BEHAV ECOL, V18, P143, DOI 10.1093/beheco/arl060; Penteriani V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003014; SASInstitute, 2001, SAS STAT SOFTW CHANG, P2001; Staicer Cynthia A., 1996, P426; Villafuerte R, 1994, THESIS U CORDOBA COR	28	25	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e4960	10.1371/journal.pone.0004960	http://dx.doi.org/10.1371/journal.pone.0004960			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19352433	Green Published, Green Submitted, gold			2022-12-25	WOS:000265505700001
J	Alvarez-Iglesias, V; Mosquera-Miguel, A; Cerezo, M; Quintans, B; Zarrabeitia, MT; Cusco, I; Lareu, MV; Garcia, O; Perez-Jurado, L; Carracedo, A; Salas, A				Alvarez-Iglesias, Vanesa; Mosquera-Miguel, Ana; Cerezo, Maria; Quintans, Beatriz; Teresa Zarrabeitia, Maria; Cusco, Ivon; Victoria Lareu, Maria; Garcia, Oscar; Perez-Jurado, Luis; Carracedo, Angel; Salas, Antonio			New Population and Phylogenetic Features of the Internal Variation within Mitochondrial DNA Macro-Haplogroup R0	PLOS ONE			English	Article							MTDNA VARIATION; NEAR-EASTERN; GENE FLOW; ANCESTRY; EVOLUTIONARY; MUTATIONS; ORIGIN; POLYMORPHISMS; DISSECTION; EXPANSION	Background: R0 embraces the most common mitochondrial DNA (mtDNA) lineage in West Eurasia, namely, haplogroup H (similar to 40%). R0 sub-lineages are badly defined in the control region and therefore, the analysis of diagnostic coding region polymorphisms is needed in order to gain resolution in population and medical studies. Methodology/Principal Findings: We sequenced the first hypervariable segment (HVS-I) of 518 individuals from different North Iberian regions. The mtDNAs belonging to R0 (similar to 57%) were further genotyped for a set of 71 coding region SNPs characterizing major and minor branches of R0. We found that the North Iberian Peninsula shows moderate levels of population stratification; for instance, haplogroup V reaches the highest frequency in Cantabria (north-central Iberia), but lower in Galicia (northwest Iberia) and Catalonia (northeast Iberia). When compared to other European and Middle East populations, haplogroups H1, H3 and H5a show frequency peaks in the Franco-Cantabrian region, declining from West towards the East and South Europe. In addition, we have characterized, by way of complete genome sequencing, a new autochthonous clade of haplogroup H in the Basque country, named H2a5. Its coalescence age, 15.668 thousand years ago (kya), dates to the period immediately after the Last Glacial Maximum (LGM). Conclusions/Significance: In contrast to other H lineages that experienced re-expansion outside the Franco-Cantabrian refuge after the LGM (e. g. H1 and H3), H2a5 most likely remained confined to this area till present days.	[Alvarez-Iglesias, Vanesa; Mosquera-Miguel, Ana; Cerezo, Maria; Victoria Lareu, Maria; Carracedo, Angel; Salas, Antonio] Univ Santiago de Compostela, Fac Med, Inst Med Legal, Unidade Xenet, Galicia, Spain; [Alvarez-Iglesias, Vanesa; Mosquera-Miguel, Ana; Cerezo, Maria; Victoria Lareu, Maria; Carracedo, Angel; Salas, Antonio] Univ Santiago de Compostela, Fac Med, Dept Anatom Patol Ciencias Forenses, Galicia, Spain; [Quintans, Beatriz; Carracedo, Angel] Univ Santiago de Compostela, Hosp Clin Univ, FPGMX, Galicia, Spain; [Quintans, Beatriz; Carracedo, Angel] Univ Santiago de Compostela, Hosp Clin Univ, CIBERER, Galicia, Spain; [Teresa Zarrabeitia, Maria] Univ Cantabria, Santander, Spain; [Cusco, Ivon; Perez-Jurado, Luis] Univ Pompeu Fabra, Unidad Genet, Barcelona, Spain; [Cusco, Ivon; Perez-Jurado, Luis] CIBERER, U735, Barcelona, Spain; [Garcia, Oscar] Lab Ertzaintza, Bilbao, Spain; [Perez-Jurado, Luis] Hosp Univ Vall Hebron, Programa Med Mol Genet, Barcelona, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidade de Santiago de Compostela; Universidad de Cantabria; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitari Vall d'Hebron	Alvarez-Iglesias, V (corresponding author), Univ Santiago de Compostela, Fac Med, Inst Med Legal, Unidade Xenet, Galicia, Spain.	antonio.salas@usc.es	Cusco, I/H-2096-2014; Miguel, Ana Mosquera/ABG-9735-2020; Pérez Jurado, Luis Alberto/M-7706-2015; Salas, Antonio/E-3977-2012; Cusco, Ivon/AAF-4662-2021; Salas, Antonio/U-2029-2019; Lareu, Maviky/E-4909-2013; Carracedo, Angel/D-4257-2012	Cusco, I/0000-0003-2104-9332; Miguel, Ana Mosquera/0000-0003-3939-8338; Salas, Antonio/0000-0002-2336-702X; Cusco, Ivon/0000-0003-2104-9332; Salas, Antonio/0000-0002-2336-702X; Lareu, Maviky/0000-0002-6165-9795; Carracedo, Angel/0000-0003-1085-8986; Cerezo Fernandez, Maria/0000-0003-3073-1130; Zarrabeitia, Maria T./0000-0002-2836-7766	Xunta de Galicia (Grupos Emerxentes) [2008/XA122]; Fundacion de Investigacion Medica Mutua Madrilena; Ministerio de Ciencia e Innovacion [SAF2008-02971]	Xunta de Galicia (Grupos Emerxentes)(Xunta de Galicia); Fundacion de Investigacion Medica Mutua Madrilena; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This research received support from Xunta de Galicia (Grupos Emerxentes; 2008/XA122), two grants from the Fundacion de Investigacion Medica Mutua Madrilena, and a grant from the Ministerio de Ciencia e Innovacion (SAF2008-02971) given to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-32; Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073; Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; Achilli A, 2007, AM J HUM GENET, V80, P759, DOI 10.1086/512822; Alvarez-Iglesias V, 2007, FORENSIC SCI INT-GEN, V1, P44, DOI 10.1016/j.fsigen.2006.09.001; Alvarez-Iglesias V, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-26; Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt H.J., 2006, HUMAN MITOCHONDRIAL; Bandelt HJ, 2008, INT J CARDIOL, V126, P439, DOI 10.1016/j.ijcard.2007.02.049; Bandelt HJ, 2006, J HUM GENET, V51, P1073, DOI 10.1007/s10038-006-0066-5; Bandelt HJ, 2004, SCIENCE, V305, P1402; Bandelt HJ, 2004, INT J LEGAL MED, V118, P267, DOI 10.1007/s00414-004-0455-2; Bandelt HJ, 2002, AM J HUM GENET, V71, P1150, DOI 10.1086/344397; Barbujani G, 2000, HUM BIOL, V72, P133; Behar DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002062; Brandstatter A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-191; Brandstatter A, 2006, ELECTROPHORESIS, V27, P2541, DOI 10.1002/elps.200500772; Cerny V, 2007, ANN HUM GENET, V71, P433, DOI 10.1111/j.1469-1809.2006.00339.x; Coble MD, 2004, INT J LEGAL MED, V118, P137, DOI 10.1007/s00414-004-0427-6; Egeland T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003988; FU YX, 1993, GENETICS, V133, P693; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hill C, 2007, AM J HUM GENET, V80, P29, DOI 10.1086/510412; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kivisild T, 2004, AM J HUM GENET, V75, P752, DOI 10.1086/425161; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Loogvali EL, 2004, MOL BIOL EVOL, V21, P2012, DOI 10.1093/molbev/msh209; Maca-Meyer N, 2003, ANN HUM GENET, V67, P329, DOI 10.1046/j.1469-1809.2003.00045.x; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Mendizabal I, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-213; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Mosquera-Miguel A, 2008, CANCER RES, V68, P623, DOI 10.1158/0008-5472.CAN-07-2385; Nei N, 1987, MOL EVOLUTIONARY GEN; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Pereira L, 2004, INT CONGR SER, V1261, P416, DOI 10.1016/S0531-5131(03)01651-0; Pulkes T, 2003, NEUROLOGY, V61, P1144, DOI 10.1212/01.WNL.0000090465.27024.3D; Quintana-Murci L, 2008, P NATL ACAD SCI USA, V105, DOI 10.1073/pnas.0711467105; Quintans B, 2004, FORENSIC SCI INT, V140, P251, DOI 10.1016/j.forsciint.2003.12.005; Richards M, 2002, AM J HUM GENET, V71, P1168, DOI 10.1086/342930; Roostalu U, 2007, MOL BIOL EVOL, V24, P436, DOI 10.1093/molbev/msl173; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Salas A, 2008, AM J HUM BIOL, V20, P584, DOI 10.1002/ajhb.20783; Salas A, 2005, AM J HUM GENET, V77, P676, DOI 10.1086/491675; Salas A, 2005, AM J PHYS ANTHROPOL, V128, P855, DOI 10.1002/ajpa.20117; Salas A, 2005, FORENSIC SCI INT, V148, P191, DOI 10.1016/j.forsciint.2004.06.008; Salas A, 2004, AM J HUM GENET, V74, P454, DOI 10.1086/382194; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Salas A, 2005, BIOCHEM BIOPH RES CO, V335, P891, DOI 10.1016/j.bbrc.2005.07.161; Salas A, 2000, INT CONGR SER, P329; Salas A, 2017, EUR J HUM GENET, V25, pS33, DOI 10.1038/sj.ejhg.5200202; SANTOS M, 1994, HUM BIOL, V66, P963; Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350; TAJIMA F, 1993, MOL BIOL EVOL, V10, P677; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; VANOVEN M, 2008, HUM MUTAT IN PRESS	61	73	73	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5112	10.1371/journal.pone.0005112	http://dx.doi.org/10.1371/journal.pone.0005112			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340307	Green Published, gold, Green Submitted			2022-12-25	WOS:000265500700016
J	Granziera, C; Schmahmann, JD; Hadjikhani, N; Meyer, H; Meuli, R; Wedeen, V; Krueger, G				Granziera, Cristina; Schmahmann, Jeremy Dan; Hadjikhani, Nouchine; Meyer, Heiko; Meuli, Reto; Wedeen, Van; Krueger, Gunnar			Diffusion Spectrum Imaging Shows the Structural Basis of Functional Cerebellar Circuits in the Human Cerebellum In Vivo	PLOS ONE			English	Article								Background: The cerebellum is a complex structure that can be affected by several congenital and acquired diseases leading to alteration of its function and neuronal circuits. Identifying the structural bases of cerebellar neuronal networks in humans in vivo may provide biomarkers for diagnosis and management of cerebellar diseases. Objectives: To define the anatomy of intrinsic and extrinsic cerebellar circuits using high-angular resolution diffusion spectrum imaging (DSI). Methods: We acquired high-resolution structural MRI and DSI of the cerebellum in four healthy female subjects at 3T. DSI tractography based on a streamline algorithm was performed to identify the circuits connecting the cerebellar cortex with the deep cerebellar nuclei, selected brainstem nuclei, and the thalamus. Results: Using in-vivo DSI in humans we were able to demonstrate the structure of the following cerebellar neuronal circuits: (1) connections of the inferior olivary nucleus with the cerebellar cortex, and with the deep cerebellar nuclei (2) connections between the cerebellar cortex and the deep cerebellar nuclei, (3) connections of the deep cerebellar nuclei conveyed in the superior (SCP), middle (MCP) and inferior (ICP) cerebellar peduncles, (4) complex intersections of fibers in the SCP, MCP and ICP, and (5) connections between the deep cerebellar nuclei and the red nucleus and the thalamus. Conclusion: For the first time, we show that DSI tractography in humans in vivo is capable of revealing the structural bases of complex cerebellar networks. DSI thus appears to be a promising imaging method for characterizing anatomical disruptions that occur in cerebellar diseases, and for monitoring response to therapeutic interventions.	[Granziera, Cristina] CHU Vaudois, Dept Neurol, Lausanne, Switzerland; [Schmahmann, Jeremy Dan] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol, Boston, MA USA; [Hadjikhani, Nouchine; Wedeen, Van] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imag, Charlestown, MA USA; [Hadjikhani, Nouchine] Ecole Polytechn Fed, Brain Mind Inst, Lausanne, Switzerland; [Meyer, Heiko] Siemens AG, Erlangen, Germany; [Meuli, Reto] CHU Vaudois, Dept Radiol, Lausanne, Switzerland; [Krueger, Gunnar] Siemens Schweiz AG, Healthcare Sector IM&WS S, Renens, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Siemens AG; Siemens Germany; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Siemens AG	Granziera, C (corresponding author), CHU Vaudois, Dept Neurol, Lausanne, Switzerland.	Cristina.Granziera@chuv.ch	Hadjikhani, Nouchine/C-2018-2008; Schmahmann, Jeremy/ABF-1215-2021; Hoogkamer, Wouter/G-4498-2010	Hadjikhani, Nouchine/0000-0003-4075-3106; Schmahmann, Jeremy/0000-0003-0706-5125; Granziera, Cristina/0000-0002-4917-8761	Center for Biomedical Imaging (CIBM) of Geneva - Lausanne; University of Geneva; University of Lasuanne; Ecole Polytechnique Federale de Lausanne (EPFL); Leenaards foundation; Louis-Jeantet Foundation; Siemens AG (Erlangen) Foundation; NIH [5PO1NS 35611]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS035611] Funding Source: NIH RePORTER	Center for Biomedical Imaging (CIBM) of Geneva - Lausanne; University of Geneva; University of Lasuanne; Ecole Polytechnique Federale de Lausanne (EPFL); Leenaards foundation; Louis-Jeantet Foundation; Siemens AG (Erlangen) Foundation(Siemens AG); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by the Center for Biomedical Imaging (CIBM) of Geneva - Lausanne, the Universities of Geneva and Lasuanne as welll as the Ecole Polytechnique Federale de Lausanne (EPFL), the foundations Leenaards and Louis-Jeantet and Siemens AG (Erlangen). NH was also supported by NIH 5PO1NS 35611.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauman ML, 2005, INT J DEV NEUROSCI, V23, P183, DOI 10.1016/j.ijdevneu.2004.09.006; Bolk L, 1906, CEREBELLUM SAUGETIER; Braitenberg V, 1997, BEHAV BRAIN SCI, V20, P229, DOI 10.1017/S0140525X9700143X; BRODAL P, 1981, J COMP NEUROL, V201, P375, DOI 10.1002/cne.902010306; Catani M, 2008, NEUROIMAGE, V41, P1184, DOI 10.1016/j.neuroimage.2008.03.041; CHAMBERS WW, 1955, J COMP NEUROL, V103, P105, DOI 10.1002/cne.901030107; CHAMBERS WW, 1955, ARCH NEURO PSYCHIATR, V74, P653, DOI 10.1001/archneurpsyc.1955.02330180071008; DeLano MC, 2002, NEUROIMAG CLIN N AM, V12, P21, DOI 10.1016/S1052-5149(03)00068-6; Dimitrova A, 2002, NEUROIMAGE, V17, P240, DOI 10.1006/nimg.2002.1124; Duvernoy H, 1995, HUMAN BRAINSTEM CERE; Habas C, 2007, NEURORADIOLOGY, V49, P849, DOI 10.1007/s00234-007-0267-4; Haines D.E., 2008, NEUROANATOMY ATLAS S; HAINES DE, 1989, J MOTOR BEHAV, V21, P518; Holmes G, 1939, BRAIN, V62, P1, DOI 10.1093/brain/62.1.1; Jansen J, 1940, J COMP NEUROL, V73, P267, DOI 10.1002/cne.900730204; Jansen J., 1942, NORSK AKAD AVH 1 MAT, V3, P1; Larsell O, 1972, COMP ANATOMY HISTOLO; MALACARNE M, 1776, NUOVA ESPOSIZIONE ST; MIDDLETON FA, 1994, SCIENCE, V266, P458, DOI 10.1126/science.7939688; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Nandhini ATA, 2002, AMINO ACIDS, V22, P27; Okugawa G, 2006, PROG NEURO-PSYCHOPH, V30, P1408, DOI 10.1016/j.pnpbp.2006.05.014; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Salamon N, 2007, J NEURORADIOLOGY, V34, P115, DOI 10.1016/j.neurad.2007.03.002; Schmahmann J. D., 2007, SPINOCEREBELLAR DEGE, P1; Schmahmann JD, 2004, J NEUROPSYCH CLIN N, V16, P367, DOI 10.1176/appi.neuropsych.16.3.367; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; SCHMAHMANN JD, 1991, ARCH NEUROL-CHICAGO, V48, P1178, DOI 10.1001/archneur.1991.00530230086029; SCHMAHMANN JD, 1997, INT REV NEUROBIOL, V41; SCHMAHMANN JD, 2000, MRI ADAS HUMAN CEREB; Schmahmann JD, 2007, CEREBELLUM, V6, P254, DOI 10.1080/14734220701490995; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; SNIDER RS, 1952, J NEUROPHYSIOL, V15, P27, DOI 10.1152/jn.1952.15.1.27; Tuch DS, 2005, PHILOS T R SOC B, V360, P869, DOI 10.1098/rstb.2005.1651; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Van Essen DC, 2002, ANN NY ACAD SCI, V978, P468; Voogd J, 2004, J NEUROCYTOL, V33, P5, DOI 10.1023/B:NEUR.0000029645.72074.2b; WANG R, 2007, BERL P INT SOC MAG R; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Wiggins GC, 2006, MAGN RESON MED, V56, P216, DOI 10.1002/mrm.20925	41	96	100	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5101	10.1371/journal.pone.0005101	http://dx.doi.org/10.1371/journal.pone.0005101			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340289	Green Published, Green Submitted, gold			2022-12-25	WOS:000265500700014
J	Klopstock, N; Katzenellenbogen, M; Pappo, O; Sklair-Levy, M; Olam, D; Mizrahi, L; Potikha, T; Galun, E; Goldenberg, D				Klopstock, Naama; Katzenellenbogen, Mark; Pappo, Orit; Sklair-Levy, Miriam; Olam, Devorah; Mizrahi, Lina; Potikha, Tamara; Galun, Eithan; Goldenberg, Daniel			HCV Tumor Promoting Effect Is Dependent on Host Genetic Background	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; AMYOTROPHIC-LATERAL-SCLEROSIS; HEPATOCELLULAR-CARCINOMA; TRANSGENIC MICE; LIVER CARCINOGENESIS; MOLECULAR-MECHANISMS; CORE PROTEIN; MOUSE MODEL; EXPRESSION; CANCER	Background: The hepatitis C virus (HCV) is one of the major risk factors for the development of hepatocellular carcinoma (HCC). Nevertheless, transgenic mice which express the whole HCV polyprotein (HCV-Tg) do not develop HCC. Whereas chronic HCV infection causes inflammation in patients, in HCV-Tg mice, the host immune reaction against viral proteins is lacking. We aimed to test the role of HCV proteins in HCC development on the background of chronic inflammation in vivo. Methodology/Principal Findings: We crossed HCV-Tg mice that do not develop HCC with the Mdr2-knockout (Mdr2-KO) mice which develop inflammation-associated HCC, to generate Mdr2-KO/HCV-Tg mice. We studied the effect of the HCV transgene on tumor incidence, hepatocyte mitosis and apoptosis, and investigated the potential contributing factors for the generated phenotype by gene expression and protein analyses. The Mdr2-KO/HCV-Tg females from the N2 generation of this breeding (having 75% of the FVB/N genome and 25% of the C57BL/6 genome) produced significantly larger tumors in comparison with Mdr2-KO mice. In parallel, the Mdr2-KO/HCV-Tg females had an enhanced inflammatory gene expression signature. However, in the N7 generation (having 99.2% of the FVB/N genome and 0.8% of the C57BL/6 genome) there was no difference in tumor development between Mdr2-KO/HCV-Tg and Mdr2-KO animals of both sexes. The HCV transgene was similarly expressed in the livers of Mdr2-KO/HCV-Tg females of both generations, as revealed by detection of the HCV transcript and the core protein. Conclusion: These findings suggest that the HCV transgene accelerated inflammation-associated hepatocarcinogenesis in a host genetic background-dependent manner.	[Klopstock, Naama; Olam, Devorah; Mizrahi, Lina; Potikha, Tamara; Galun, Eithan; Goldenberg, Daniel] Hadassah Hebrew Univ Med Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel; [Katzenellenbogen, Mark] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Bioinformat & Microarray Unit, IL-52100 Ramat Gan, Israel; [Pappo, Orit] Hadassah Hebrew Univ, Med Ctr, Dept Pathol, Jerusalem, Israel; [Sklair-Levy, Miriam] Sheba Med Ctr, Breast Imag Ctr, Tel Hashomer, Israel	Hebrew University of Jerusalem; Bar Ilan University; Hebrew University of Jerusalem; Hadassah University Medical Center; Chaim Sheba Medical Center	Klopstock, N (corresponding author), Hadassah Hebrew Univ Med Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel.	goldenberg@hadassah.org.il	Galun, Eithan/AAD-9117-2022	Galun, Eithan/0000-0002-6243-6702	EC [LSHB-CT-2004-512034, LSHB-CT-2005-018961]; Barbara Fox Foundation; Harold Grinspoon Foundation; Horowitz Foundation; Wolfson Foundation; Sam and Ellie Fishman Chair in Gene Therapy; Kamea Scientific Foundation of the Israeli Government	EC(European CommissionEuropean Commission Joint Research Centre); Barbara Fox Foundation; Harold Grinspoon Foundation; Horowitz Foundation; Wolfson Foundation; Sam and Ellie Fishman Chair in Gene Therapy; Kamea Scientific Foundation of the Israeli Government	E.G. is supported by the EC grants LSHB-CT-2004-512034 (MOLEDA) and LSHB-CT-2005-018961 (INTHER), and by grants from the Barbara Fox, the Harold Grinspoon, the Horowitz and the Wolfson Foundations. E.G. holds the Sam and Ellie Fishman Chair in Gene Therapy. D.G. is supported by the Kamea Scientific Foundation of the Israeli Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid MR, 2006, MICROVASC RES, V72, P136, DOI 10.1016/j.mvr.2006.05.010; Ahn SG, 2002, EXP MOL MED, V34, P243, DOI 10.1038/emm.2002.34; Alonzi T, 2004, J GEN VIROL, V85, P1509, DOI 10.1099/vir.0.19724-0; Amin J, 2006, J HEPATOL, V45, P197, DOI 10.1016/j.jhep.2006.02.014; Avila MA, 2000, J HEPATOL, V33, P907, DOI 10.1016/S0168-8278(00)80122-1; Berruyer C, 2004, MOL CELL BIOL, V24, P7214, DOI 10.1128/MCB.24.16.7214-7224.2004; Blindenbacher A, 2003, GASTROENTEROLOGY, V124, P1465, DOI 10.1016/S0016-5085(03)00290-7; Bursch W, 2004, TOXICOL LETT, V149, P25, DOI 10.1016/j.toxlet.2003.12.018; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Damdinsuren B, 2005, INT J ONCOL, V26, P319; Davie SA, 2007, TRANSGENIC RES, V16, P193, DOI 10.1007/s11248-006-9056-9; El-Serag H, 2003, ANN INTERN MED, V139, P817, DOI 10.7326/0003-4819-139-10-200311180-00009; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; FREUND R, 1992, VIROLOGY, V191, P724, DOI 10.1016/0042-6822(92)90248-N; Furutani T, 2006, GASTROENTEROLOGY, V130, P2087, DOI 10.1053/j.gastro.2006.02.060; Gale M, 2005, NATURE, V436, P939, DOI 10.1038/nature04078; HAGEN TM, 1994, P NATL ACAD SCI USA, V91, P12808, DOI 10.1073/pnas.91.26.12808; Huang H, 1999, AM J PATHOL, V155, P1795, DOI 10.1016/S0002-9440(10)65496-X; *JACKS LAB, MOUS GEN INF DAT; Kamegaya Y, 2005, HEPATOLOGY, V41, P660, DOI 10.1002/hep.20621; Katzenellenbogen M, 2006, CANCER RES, V66, P4001, DOI 10.1158/0008-5472.CAN-05-2937; Katzenellenbogen M, 2007, MOL CANCER RES, V5, P1159, DOI 10.1158/1541-7786.MCR-07-0172; Katzenellenbogen M, 2007, MOL CANCER THER, V6, P1283, DOI 10.1158/1535-7163.MCT-06-0420; Kim J, 2005, CANCER RES, V65, P6189, DOI 10.1158/0008-5472.CAN-04-4439; Kurt-Jones EA, 2007, INFECT IMMUN, V75, P471, DOI 10.1128/IAI.02039-05; Lee CGL, 2003, ONCOGENE, V22, P2592, DOI 10.1038/sj.onc.1206337; Lerat H, 2002, GASTROENTEROLOGY, V122, P352, DOI 10.1053/gast.2002.31001; Liang TJ, 2004, GASTROENTEROLOGY, V127, pS62, DOI 10.1053/j.gastro.2004.09.017; Lifsted T, 1998, INT J CANCER, V77, P640, DOI 10.1002/(SICI)1097-0215(19980812)77:4<640::AID-IJC26>3.0.CO;2-8; Liu L, 2004, CANCER RES, V64, P3491, DOI 10.1158/0008-5472.CAN-03-2106; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Lu SN, 2006, INT J CANCER, V119, P1946, DOI 10.1002/ijc.22045; Machida K, 2004, P NATL ACAD SCI USA, V101, P4262, DOI 10.1073/pnas.0303971101; Marden JJ, 2007, J CLIN INVEST, V117, P2913, DOI 10.1172/JCI31265; Markiewski MM, 2007, AM J PATHOL, V171, P715, DOI 10.2353/ajpath.2007.070166; Marshall A, 2005, GASTROENTEROLOGY, V128, P33, DOI 10.1053/j.gastro.2004.09.076; MAUAD TH, 1994, AM J PATHOL, V145, P1237; Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053; Naas T, 2005, J GEN VIROL, V86, P2185, DOI 10.1099/vir.0.80969-0; Nakamoto Y, 1998, J EXP MED, V188, P341, DOI 10.1084/jem.188.2.341; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Okamoto M, 2006, ANN SURG ONCOL, V13, P947, DOI 10.1245/ASO.2006.07.018; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Ren JW, 2006, J BIOL CHEM, V281, P11413, DOI 10.1074/jbc.M507218200; Sakurai T, 2006, P NATL ACAD SCI USA, V103, P10544, DOI 10.1073/pnas.0603499103; Shackel NA, 2002, AM J PATHOL, V160, P641, DOI 10.1016/S0002-9440(10)64884-5; Smith MW, 2003, HEPATOLOGY, V38, P1458, DOI [10.1016/jhep.2003.09.024, 10.1053/jhep.2003.09024]; Starr A, 2006, INT J CANCER, V119, P269, DOI 10.1002/ijc.21818; Tang WL, 2007, AM J PATHOL, V171, P1831, DOI 10.2353/ajpath.2007.070413; Tsafrir D, 2005, BIOINFORMATICS, V21, P2301, DOI 10.1093/bioinformatics/bti329; Tsutsumi T, 2003, HEPATOLOGY, V38, P820, DOI 10.1053/jhep.2003.50399; Vietor I, 2007, DIFFERENTIATION, V75, P891, DOI 10.1111/j.1432-0436.2007.00205.x; Wakabayashi Y, 2007, NATURE, V445, P761, DOI 10.1038/nature05489; Wu DC, 2006, P NATL ACAD SCI USA, V103, P12132, DOI 10.1073/pnas.0603670103; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; Yamashita T, 2001, BIOCHEM BIOPH RES CO, V282, P647, DOI 10.1006/bbrc.2001.4610; Yan XR, 2008, CANCER LETT, V262, P133, DOI 10.1016/j.canlet.2007.12.010; Yang F, 2007, CANCER RES, V67, P863, DOI 10.1158/0008-5472.CAN-06-1078; Yu MC, 2004, GASTROENTEROLOGY, V127, pS72, DOI 10.1016/j.gastro.2004.09.018	59	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5025	10.1371/journal.pone.0005025	http://dx.doi.org/10.1371/journal.pone.0005025			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340302	Green Published, Green Submitted, gold			2022-12-25	WOS:000265500700008
J	Liao, HI; Olson, CA; Hwang, SM; Deng, HY; Wong, E; Baric, RS; Roberts, RW; Sun, R				Liao, Hsiang-I.; Olson, C. Anders; Hwang, Seungmin; Deng, Hongyu; Wong, Elaine; Baric, Ralph S.; Roberts, Richard W.; Sun, Ren			mRNA Display Design of Fibronectin-based Intrabodies That Detect and Inhibit Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANKYRIN REPEAT PROTEINS; SARS CORONAVIRUS; SELF-ASSOCIATION; TERMINAL DOMAIN; III DOMAIN; BINDING; SELECTION; ANTIBODIES; THERAPEUTICS; RECOGNITION	The nucleocapsid (N) protein of severe acute respiratory syndrome (SARS) coronavirus plays important roles in both viral replication and modulation of host cell processes. New ligands that target the N protein may thus provide tools to track the protein inside cells, detect interaction hot spots on the protein surface, and discover sites that could be used to develop new anti-SARS therapies. Using mRNA display selection and directed evolution, we designed novel antibody-like protein affinity reagents that target SARS N protein with high affinity and selectivity. Our libraries were based on an 88-residue variant of the 10th fibronectin type III domain from human fibronectin (10Fn3). This selection resulted in eight independent 10Fn3 intrabodies, two that require the N-terminal domain for binding and six that recognize the C terminus, one with K-d = 1.7 nM. 10Fn3 intrabodies are well expressed in mammalian cells and are relocalized by N in SARS-infected cells. Seven of the selected intrabodies tested do not perturb cellular function when expressed singly in vivo and inhibit virus replication from 11- to 5900-fold when expressed in cells prior to infection. Targeting two sites on SARS-N simultaneously using two distinct 10Fn3s results in synergistic inhibition of virus replication.	[Liao, Hsiang-I.; Hwang, Seungmin; Deng, Hongyu; Wong, Elaine; Sun, Ren] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Sun, Ren] Univ Calif Los Angeles, Calif Nano Syst Inst, Los Angeles, CA 90095 USA; [Olson, C. Anders] CALTECH, Pasadena, CA 91125 USA; [Baric, Ralph S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Roberts, Richard W.] Univ So Calif, Dept Chem Chem Engn & Biol, Los Angeles, CA 90089 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; California Institute of Technology; University of North Carolina; University of North Carolina Chapel Hill; University of Southern California	Sun, R (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, 650 Charles E Young Dr S,CHS 23-120, Los Angeles, CA 90095 USA.	rsun@mednet.ucla.edu		Hwang, Seungmin/0000-0003-0846-5462	National Institutes of Health [RO1 GM60416]; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060416] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM60416 (to R. W. R.). This work was also supported by a microbial pathogenesis training grant from Burroughs Wellcome Fund.	Amstutz P, 2005, J BIOL CHEM, V280, P24715, DOI 10.1074/jbc.M501746200; Cardinale A, 2003, EUR J BIOCHEM, V270, P3389, DOI 10.1046/j.1432-1033.2003.03722.x; Cardinale A, 2001, EUR J BIOCHEM, V268, P268, DOI 10.1046/j.1432-1327.2001.01876.x; CARLSON JR, 1988, MOL CELL BIOL, V8, P2638, DOI 10.1128/MCB.8.6.2638; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Chang CK, 2006, J BIOMED SCI, V13, P59, DOI 10.1007/s11373-005-9035-9; Chen CY, 2007, J MOL BIOL, V368, P1075, DOI 10.1016/j.jmb.2007.02.069; Enjuanes L, 2006, ANNU REV MICROBIOL, V60, P211, DOI 10.1146/annurev.micro.60.080805.142157; Hosse RJ, 2006, PROTEIN SCI, V15, P14, DOI 10.1110/ps.051817606; Ja WW, 2005, J BIOL CHEM, V280, P32057, DOI 10.1074/jbc.C500319200; Kawe M, 2006, J BIOL CHEM, V281, P40252, DOI 10.1074/jbc.M602506200; Koide A, 1998, J MOL BIOL, V284, P1141, DOI 10.1006/jmbi.1998.2238; Lipovsek D, 2004, J IMMUNOL METHODS, V290, P51, DOI 10.1016/j.jim.2004.04.008; Liu RH, 2000, METHOD ENZYMOL, V318, P268; Luo HB, 2006, BIOCHEMISTRY-US, V45, P11827, DOI 10.1021/bi0609319; Maynard J, 2000, ANNU REV BIOMED ENG, V2, P339, DOI 10.1146/annurev.bioeng.2.1.339; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; Nizak C, 2003, SCIENCE, V300, P984, DOI 10.1126/science.1083911; Olson CA, 2008, ACS CHEM BIOL, V3, P480, DOI 10.1021/cb800069c; Olson CA, 2007, PROTEIN SCI, V16, P476, DOI 10.1110/ps.062498407; Rajpal A, 2001, J BIOL CHEM, V276, P33139, DOI 10.1074/jbc.M101332200; Roberts RS, 2006, ADV EXP MED BIOL, V581, P597; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Saikatendu KS, 2007, J VIROL, V81, P3913, DOI 10.1128/JVI.02236-06; Satija N, 2007, ANN NY ACAD SCI, V1102, P26, DOI 10.1196/annals.1408.002; Stocks M, 2005, CURR OPIN CHEM BIOL, V9, P359, DOI 10.1016/j.cbpa.2005.06.003; Surjit M, 2004, BIOCHEM BIOPH RES CO, V317, P1030, DOI 10.1016/j.bbrc.2004.03.154; Vascotto F, 2004, J GEN VIROL, V85, P3285, DOI 10.1099/vir.0.80075-0; Visintin M, 1999, P NATL ACAD SCI USA, V96, P11723, DOI 10.1073/pnas.96.21.11723; Yount B, 2003, P NATL ACAD SCI USA, V100, P12995, DOI 10.1073/pnas.1735582100; Yu IM, 2005, J BIOL CHEM, V280, P23280, DOI 10.1074/jbc.M501015200	33	34	36	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17512	17520		10.1074/jbc.M901547200	http://dx.doi.org/10.1074/jbc.M901547200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19364769	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000267202500017
J	Muniyappa, H; Song, SW; Mathews, CK; Das, KC				Muniyappa, Harish; Song, Shiwei; Mathews, Christopher K.; Das, Kumuda C.			Reactive Oxygen Species-independent Oxidation of Thioredoxin in Hypoxia INACTIVATION OF RIBONUCLEOTIDE REDUCTASE AND REDOX-MEDIATED CHECKPOINT CONTROL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; BREAST-CANCER CELLS; GENE-EXPRESSION; TUMOR HYPOXIA; ATAXIA-TELANGIECTASIA; REPLICATION ARREST; DRUG-RESISTANCE; CYTOSOLIC NADPH; NITRIC-OXIDE; SOLID TUMORS	We have investigated the role of cellular redox state on the regulation of cell cycle in hypoxia and shown that whereas cells expressing mutant thioredoxin (Trx) or a normal level of Trx undergo increased apoptosis, cells overexpressing Trx are protected against apoptosis. We show that hypoxia activates p53 and Chk1/Chk2 proteins in cells expressing normal or mutant Trx but not in cells overexpressing Trx. We also show that the activity of ribonucleotide reductase decreases in hypoxia in cells expressing redox-inactive Trx. Although hypoxia has been shown to induce reactive oxygen species (ROS) generation in the mitochondria resulting in enhanced p53 expression, our data demonstrate that hypoxia-induced p53 expression and phosphorylation are independent of ROS. Furthermore, hypoxia induces oxidation of Trx, and this oxidation is potentiated in the presence of 6-aminonicotinamide, an inhibitor of glucose-6-phosphate dehydrogenase. Taken together our study shows that Trx redox state is modulated in hypoxia independent of ROS and is a critical determinant of cell cycle regulation.	[Muniyappa, Harish; Das, Kumuda C.] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA; [Song, Shiwei; Mathews, Christopher K.] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA	University of Arkansas System; University of Arkansas Medical Sciences; Oregon State University	Das, KC (corresponding author), 4301 W Markham,Slot 845, Little Rock, AR 72205 USA.	kdas@uams.edu	Das, Kumuda/A-7662-2012		National Institutes of Health [R01 HL071558]; University of Arkansas for Medical Science Research Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071558] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Arkansas for Medical Science Research Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL071558. This work was also supported by the University of Arkansas for Medical Science Research Council (to K. C. D.).	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Avval FZ, 2009, J BIOL CHEM, V284, P8233, DOI 10.1074/jbc.M809338200; Bilodeau JF, 2000, EXP CELL RES, V256, P347, DOI 10.1006/excr.2000.4844; Blancher C, 1998, CANCER METAST REV, V17, P187, DOI 10.1023/A:1006002419244; Brown JM, 1999, CANCER RES, V59, P5863; Brown JM, 2000, MOL MED TODAY, V6, P157, DOI 10.1016/S1357-4310(00)01677-4; Brown JM, 1998, CANCER RES, V58, P1408; Cash TP, 2007, FREE RADICAL BIO MED, V43, P1219, DOI 10.1016/j.freeradbiomed.2007.07.001; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chandel NS, 2000, ONCOGENE, V19, P3840, DOI 10.1038/sj.onc.1203727; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Danielsen T, 1998, BRIT J CANCER, V78, P1547, DOI 10.1038/bjc.1998.722; Das KC, 1998, J IMMUNOL METHODS, V211, P9, DOI 10.1016/S0022-1759(97)00163-4; Das KC, 1997, AM J RESP CELL MOL, V17, P713, DOI 10.1165/ajrcmb.17.6.2809; Das KC, 1999, AM J PHYSIOL-LUNG C, V276, pL530, DOI 10.1152/ajplung.1999.276.3.L530; Das KC, 2004, AM J PHYSIOL-LUNG C, V286, pL87, DOI 10.1152/ajplung.00203.2002; Das KC, 2001, J BIOL CHEM, V276, P4662, DOI 10.1074/jbc.M006206200; Day BJ, 1995, J PHARMACOL EXP THER, V275, P1227; Doege K, 2005, BLOOD, V106, P2311, DOI 10.1182/blood-2005-03-1138; FAULKNER KM, 1994, J BIOL CHEM, V269, P23471; Gallegos A, 1996, CANCER RES, V56, P5765; Giaccia AJ, 2004, GENE DEV, V18, P2183, DOI 10.1101/gad.1243304; Gibson SL, 2005, CANCER RES, V65, P10734, DOI 10.1158/0008-5472.CAN-05-1160; Green SL, 1998, CANCER J SCI AM, V4, P218; Gupte SA, 2006, AM J PHYSIOL-HEART C, V290, pH2228, DOI 10.1152/ajpheart.00615.2005; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Hammond EM, 2005, BIOCHEM BIOPH RES CO, V331, P718, DOI 10.1016/j.bbrc.2005.03.154; Hammond EM, 2004, DNA REPAIR, V3, P1117, DOI 10.1016/j.dnarep.2004.03.035; Hammond EM, 2003, MUTAT RES-FUND MOL M, V532, P205, DOI 10.1016/j.mrfmmm.2003.08.017; Hammond EM, 2003, J BIOL CHEM, V278, P12207, DOI 10.1074/jbc.M212360200; Hammond EM, 2002, MOL CELL BIOL, V22, P1834, DOI 10.1128/MCB.22.6.1834-1843.2002; Hockel M, 2001, SEMIN ONCOL, V28, P36, DOI 10.1016/S0093-7754(01)90211-8; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007; Krtolica A, 1999, BRIT J CANCER, V80, P1875, DOI 10.1038/sj.bjc.6690615; Lambert AJ, 2008, BBA-BIOENERGETICS, V1777, P397, DOI 10.1016/j.bbabio.2008.03.005; Li JJ, 1998, CARCINOGENESIS, V19, P833, DOI 10.1093/carcin/19.5.833; Metzen E, 2003, MOL BIOL CELL, V14, P3470, DOI 10.1091/mbc.e02-12-0791; OBLONG JE, 1994, J BIOL CHEM, V269, P11714; Park WH, 2007, J CELL BIOCHEM, V102, P98, DOI 10.1002/jcb.21280; Plummer ER, 2006, CURR OPIN PHARMACOL, V6, P364, DOI 10.1016/j.coph.2006.02.004; Ravi D, 2005, J BIOL CHEM, V280, P40084, DOI 10.1074/jbc.M507192200; Rotman G, 1997, BIOESSAYS, V19, P911, DOI 10.1002/bies.950191011; Rundle NT, 2001, J BIOL CHEM, V276, P48231, DOI 10.1074/jbc.M103990200; Saito S, 2002, J BIOL CHEM, V277, P12491, DOI 10.1074/jbc.C200093200; Shieh SY, 1999, EMBO J, V18, P1815, DOI 10.1093/emboj/18.7.1815; SLABAUGH MB, 1984, J VIROL, V52, P507, DOI 10.1128/JVI.52.2.507-514.1984; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Srinivas V, 2001, J BIOL CHEM, V276, P21995, DOI 10.1074/jbc.C100177200; STCLAIR DK, 1991, CANCER RES, V51, P939; TEICHER BA, 1994, CANCER METAST REV, V13, P139, DOI 10.1007/BF00689633; Tomida A, 1999, ANTI-CANCER DRUG DES, V14, P169; VAUPEL P, 1991, CANCER RES, V51, P3316; Webster L, 1998, BRIT J CANCER, V77, P227, DOI 10.1038/bjc.1998.38; White CW, 2006, FREE RADICAL BIO MED, V40, P923, DOI 10.1016/j.freeradbiomed.2005.12.008; Wolin MS, 2005, AM J PHYSIOL-LUNG C, V289, pL159, DOI 10.1152/ajplung.00060.2005; Xue LJ, 2006, CANCER RES, V66, P1900, DOI 10.1158/0008-5472.CAN-05-2656	60	23	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17069	17081		10.1074/jbc.M109.008557	http://dx.doi.org/10.1074/jbc.M109.008557			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19369702	Green Published, hybrid			2022-12-25	WOS:000266962400045
J	Krishnan, N; Jeong, DG; Jung, SK; Ryu, SE; Xiao, A; Allis, CD; Kim, SJ; Tonks, NK				Krishnan, Navasona; Jeong, Dae Gwin; Jung, Suk-Kyeong; Ryu, Seong Eon; Xiao, Andrew; Allis, C. David; Kim, Seung Jun; Tonks, Nicholas K.			Dephosphorylation of the C-terminal Tyrosyl Residue of the DNA Damage-related Histone H2A.X Is Mediated by the Protein Phosphatase Eyes Absent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-H2AX; CANCER; RECOGNITION; MECHANISM; CHROMATIN; DYNAMICS	In mammalian cells, the DNA damage-related histone H2A variant H2A. X is characterized by a C-terminal tyrosyl residue, Tyr-142, which is phosphorylated by an atypical kinase, WSTF. The phosphorylation status of Tyr-142 in H2A. X has been shown to be an important regulator of the DNA damage response by controlling the formation of gamma H2A.X foci, which are platforms for recruiting molecules involved in DNA damage repair and signaling. In this work, we present evidence to support the identification of the Eyes Absent (EYA) phosphatases, protein-tyrosine phosphatases of the haloacid dehalogenase superfamily, as being responsible for dephosphorylating the C-terminal tyrosyl residue of histone H2A. X. We demonstrate that EYA2 and EYA3 displayed specificity for Tyr-142 of H2A. X in assays in vitro. Suppression of eya3 by RNA interference resulted in elevated basal phosphorylation and inhibited DNA damage-induced dephosphorylation of Tyr-142 of H2A. X in vivo. This study provides the first indication of a physiological substrate for the EYA phosphatases and suggests a novel role for these enzymes in regulation of the DNA damage response.	[Jeong, Dae Gwin; Jung, Suk-Kyeong; Ryu, Seong Eon; Kim, Seung Jun] Korea Res Inst Biosci & Biotechnol, Med Prote Res Ctr, Taejon 305333, South Korea; [Krishnan, Navasona; Tonks, Nicholas K.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Xiao, Andrew; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol, New York, NY 10065 USA	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Cold Spring Harbor Laboratory; Rockefeller University	Kim, SJ (corresponding author), Korea Res Inst Biosci & Biotechnol, Med Prote Res Ctr, 52 Eoeun Dong, Taejon 305333, South Korea.	ksj@kribb.re.kr; tonks@cshl.edu	Kim, Seung Jun/N-5248-2019	Kim, Seung Jun/0000-0002-6913-6358	National Institutes of Health [CA53840, GM40922]; Cold Spring Harbor Laboratory Cancer Center [P30-CA45508]; Korea Research Institute of Bioscience & Biotechnology Research Initiative Program; NATIONAL CANCER INSTITUTE [P30CA045508, R01CA053840, R37CA053840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040922] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cold Spring Harbor Laboratory Cancer Center; Korea Research Institute of Bioscience & Biotechnology Research Initiative Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA53840 (to N. K. T.) and GM40922 (to C. D. A.) and Cold Spring Harbor Laboratory Cancer Center Support Grant P30-CA45508. This work was also supported by a grant from the Korea Research Institute of Bioscience & Biotechnology Research Initiative Program (to S. J. K.).	Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; Ghosh A, 2008, MOL CELL, V32, P478, DOI 10.1016/j.molcel.2008.09.021; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Jenic J, 2007, ANNU REV BIOCHEM, V76, P513, DOI 10.1146/annurev.biochem.76.052705.164916; Kim YJ, 2007, P NATL ACAD SCI USA, V104, P6596, DOI 10.1073/pnas.0702099104; Kimura H, 2006, J CELL BIOL, V175, P389, DOI 10.1083/jcb.200608001; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Kriebel M, 2007, DEV DYNAM, V236, P1526, DOI 10.1002/dvdy.21170; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Lukong KE, 2003, BBA-REV CANCER, V1653, P73, DOI 10.1016/j.bbcan.2003.09.001; Nakada S, 2008, EMBO REP, V9, P1019, DOI 10.1038/embor.2008.162; Rayapureddi JP, 2006, FEBS LETT, V580, P3853, DOI 10.1016/j.febslet.2006.06.009; Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093; Reichenberger KJ, 2005, CANCER RES, V65, P2668, DOI 10.1158/0008-5472.CAN-04-4286; Sarmiento M, 2000, BIOCHEMISTRY-US, V39, P8171, DOI 10.1021/bi000319w; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; Xiao A, 2009, NATURE, V457, P57, DOI 10.1038/nature07668; Xu PX, 1999, NAT GENET, V23, P113, DOI 10.1038/12722; Zhang L, 2005, CANCER RES, V65, P925; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	27	104	112	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16066	16070		10.1074/jbc.C900032200	http://dx.doi.org/10.1074/jbc.C900032200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19351884	Green Published, hybrid			2022-12-25	WOS:000266730900002
J	Xing, J; Jayasundar, JJ; Ouyang, YX; Dong, WJ				Xing, Jun; Jayasundar, Jayant J.; Ouyang, Yexin; Dong, Wen-Ji			Forster Resonance Energy Transfer Structural Kinetic Studies of Cardiac Thin Filament Deactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TROPONIN-I; INHIBITORY REGION; CROSS-BRIDGE; CONFORMATIONAL TRANSITIONS; MYOSIN SUBFRAGMENT-1; MUSCLE; CA2+; CALCIUM; COMPLEX; ACTIN	Cardiac thin filament deactivation is initiated by Ca2+ dissociation from troponin C (cTnC), followed by multiple structural changes of thin filament proteins. These structural transitions are the molecular basis underlying the thin filament regulation of cardiac relaxation, but the detailed mechanism remains elusive. In this study Forster resonance energy transfer (FRET) was used to investigate the dynamics and kinetics of the Ca2+-induced conformational changes of the cardiac thin filaments, specifically the closing of the cTnC N-domain, the cTnC-cTnI (troponin I) interaction, and the cTnI-actin interaction. The cTnC N-domain conformational change was examined by monitoring FRET between a donor (AEDANS) attached to one cysteine residue and an acceptor (DDPM) attached the other cysteine of the mutant cTnC(L13C/N51C). The cTnC-cTnI interaction was investigated by monitoring the distance changes from residue 89 of cTnC to residues 151 and 167 of cTnI, respectively. The cTnI-actin interaction was investigated by monitoring the distance changes from residues 151 and 167 of cTnI to residue 374 of actin. FRET Ca2+ titrations and stopped-flow kinetic measurements show that different thin filament structural transitions have different Ca2+ sensitivities and Ca2+ dissociation-induced kinetics. The observed structural transitions involving the regulatory region and the mobile domain of cTnI occurred at fast kinetic rates, whereas the kinetics of the structural transitions involving the cTnI inhibitory region was slow. Our results suggest that the thin filament deactivation upon Ca2+ dissociation is a two-step process. One step involves rapid binding of the mobile domain of cTnI to actin, which is kinetically coupled with the conformational change of the N-domain of cTnC and the dissociation of the regulatory region of cTnI from cTnC. The other step involves switching the inhibitory region of cTnI from interacting with cTnC to interacting with actin. The latter processes may play a key role in regulating cross-bridge kinetics.	[Jayasundar, Jayant J.; Ouyang, Yexin; Dong, Wen-Ji] Washington State Univ, Sch Chem Engn & Bioengn, Pullman, WA 99164 USA; [Dong, Wen-Ji] Washington State Univ, Dept Vet & Comparat Anat, Pullman, WA 99164 USA; [Xing, Jun] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA	Washington State University; Washington State University; University of Alabama System; University of Alabama Birmingham	Dong, WJ (corresponding author), Washington State Univ, Sch Chem Engn & Bioengn, Pullman, WA 99164 USA.	wdong@vetmed.wsu.edu	Dong, Wenji/A-8579-2011	Jayasundar, Jayant James/0000-0001-9963-9629	National Institutes of Health [HL80186]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL80186 (to W.-J.D.).	Bevington PR., 2002, DATA REDUCTION ERROR; CHEUNG HC, 1991, BIOCHEMISTRY-US, V30, P5238, DOI 10.1021/bi00235a018; de Tombe PP, 2007, AM J PHYSIOL-REG I, V292, pR1129, DOI 10.1152/ajpregu.00630.2006; Dong WJ, 2008, J BIOL CHEM, V283, P3424, DOI 10.1074/jbc.M703822200; Dong WJ, 2007, BIOCHEMISTRY-US, V46, P9752, DOI 10.1021/bi700574n; Dong WJ, 2006, ARCH BIOCHEM BIOPHYS, V456, P135, DOI 10.1016/j.abb.2006.08.007; Dong WJ, 2003, J BIOL CHEM, V278, P42394, DOI 10.1074/jbc.M304858200; Dong WJ, 1999, J BIOL CHEM, V274, P31382, DOI 10.1074/jbc.274.44.31382; Dong WJ, 2003, J BIOL CHEM, V278, P8686, DOI 10.1074/jbc.M212886200; Dong WJ, 2001, J MOL BIOL, V314, P51, DOI 10.1006/jmbi.2001.5118; EBASHI S, 1969, Quarterly Reviews of Biophysics, V2, P351; FARAH CS, 1995, FASEB J, V9, P755, DOI 10.1096/fasebj.9.9.7601340; Gomes AV, 2004, ANN NY ACAD SCI, V1015, P214, DOI 10.1196/annals.1302.018; GORDON AM, 1987, J GEN PHYSIOL, V90, P321, DOI 10.1085/jgp.90.3.321; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; GUTH K, 1987, J BIOL CHEM, V262, P13627; HANNON JD, 1992, CIRC RES, V71, P984, DOI 10.1161/01.RES.71.4.984; Hoffman RMB, 2006, J MOL BIOL, V361, P625, DOI 10.1016/j.jmb.2006.06.031; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Kobayashi T, 2000, BIOCHEMISTRY-US, V39, P86, DOI 10.1021/bi991903b; LEHMAN W, 1994, NATURE, V368, P65, DOI 10.1038/368065a0; Li MX, 2004, J MUSCLE RES CELL M, V25, P559, DOI 10.1007/s10974-004-5879-2; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; Murakami K, 2005, J MOL BIOL, V352, P178, DOI 10.1016/j.jmb.2005.06.067; Palmer S, 1998, CIRC RES, V83, P179, DOI 10.1161/01.RES.83.2.179; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Regnier M, 2004, BIOPHYS J, V87, P1815, DOI 10.1529/biophysj.103.039123; Robinson JM, 2004, J MOL BIOL, V340, P295, DOI 10.1016/j.jmb.2004.04.046; SMILLIE LB, 1982, METHOD ENZYMOL, V85, P234; Solzin J, 2007, BIOPHYS J, V93, P3917, DOI 10.1529/biophysj.107.111146; Stehle R, 2002, BIOPHYS J, V83, P2152, DOI 10.1016/S0006-3495(02)73975-1; Stehle R, 2002, BASIC RES CARDIOL S1, V97, pI127, DOI DOI 10.1007/S003950200041; Stehle R, 2007, AM J PHYSIOL-REG I, V292, pR1125, DOI 10.1152/ajpregu.00841.2006; TAO T, 1990, SCIENCE, V247, P1339, DOI 10.1126/science.2138356; Tripet B, 1997, J MOL BIOL, V271, P728, DOI 10.1006/jmbi.1997.1200; WANG CK, 1986, J MOL BIOL, V191, P509, DOI 10.1016/0022-2836(86)90145-2; XING J, 1994, ARCH BIOCHEM BIOPHYS, V313, P229, DOI 10.1006/abbi.1994.1381; Xing J, 2008, BIOCHEMISTRY-US, V47, P13383, DOI 10.1021/bi801492x	39	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16432	16441		10.1074/jbc.M808075200	http://dx.doi.org/10.1074/jbc.M808075200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19369252	Green Published, hybrid			2022-12-25	WOS:000266730900040
J	McKinstry, WJ; Polekhina, G; Diefenbach-Jagger, H; Ho, PWM; Sato, K; Onuma, E; Gillespie, MT; Martin, TJ; Parker, MW				McKinstry, William J.; Polekhina, Galina; Diefenbach-Jagger, Hannelore; Ho, Patricia W. M.; Sato, Koh; Onuma, Etsuro; Gillespie, Matthew T.; Martin, T. John; Parker, Michael W.			Structural Basis for Antibody Discrimination between Two Hormones That Recognize the Parathyroid Hormone Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMANIZED MONOCLONAL-ANTIBODY; HUMORAL HYPERCALCEMIA; BONE METASTASIS; PROTEIN PTHRP; PEPTIDE; BINDING; LOCALIZATION; INVOLVEMENT; SELECTIVITY; FRAGMENT	Parathyroid hormone-related protein (PTHrP) plays a vital role in the embryonic development of the skeleton and other tissues. When it is produced in excess by cancers it can cause hypercalcemia, and its local production by breast cancer cells has been implicated in the pathogenesis of bone metastasis formation in that disease. Antibodies have been developed that neutralize the action of PTHrP through its receptor, parathyroid hormone receptor 1, without influencing parathyroid hormone action through the same receptor. Such neutralizing antibodies against PTHrP are therapeutically effective in animal models of the humoral hypercalcemia of malignancy and of bone metastasis formation. We have determined the crystal structure of the complex between PTHrP (residues 1-108) and a neutralizing monoclonal anti-PTHrP antibody that reveals the only point of contact is an alpha-helical structure extending from residues 14-29. Another striking feature is that the same residues that interact with the antibody also interact with parathyroid hormone receptor 1, showing that the antibody and the receptor binding site on the hormone closely overlap. The structure explains how the antibody discriminates between the two hormones and provides information that could be used in the development of novel agonists and antagonists of their common receptor.	[McKinstry, William J.; Polekhina, Galina; Parker, Michael W.] St Vincents Inst Med Res, Biota Struct Biol Lab, Fitzroy, Vic 3065, Australia; [Diefenbach-Jagger, Hannelore; Ho, Patricia W. M.; Gillespie, Matthew T.; Martin, T. John] St Vincents Inst Med Res, Bone Cell Biol Lab, Fitzroy, Vic 3065, Australia; [Sato, Koh; Onuma, Etsuro] Chugai Pharmaceut Co Ltd, Pharmaceut Res Lab, Shizuoka 4128513, Japan; [McKinstry, William J.; Gillespie, Matthew T.; Martin, T. John] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia; [Parker, Michael W.] Univ Melbourne, Dept Biochem & Mol Biol, Bio21 Mol Sci & Biotechnol Inst, Parkville, Vic 3010, Australia	St. Vincent's Institute of Medical Research; St. Vincent's Institute of Medical Research; Chugai Pharmaceutical Co., Ltd.; Roche Holding; St Vincent's Hospital Melbourne; University of Melbourne; University of Melbourne	Parker, MW (corresponding author), St Vincents Inst Med Res, Biota Struct Biol Lab, 9 Princes St, Fitzroy, Vic 3065, Australia.	mparker@svi.edu.au	Parker, Michael W/F-9069-2013; McKinstry, William J/D-2612-2013	Parker, Michael W/0000-0002-3101-1138; McKinstry, William J/0000-0001-9668-9364; Gillespie, Matthew/0000-0001-6543-8909	Cancer Council of Victoria; National Health and Medical Research Council of Australia; Australian Cancer Research Foundation Rational Drug Discovery Facility; Commonwealth of Australia; United States Department of Energy, Basic Energy Sciences, Office of Energy Research	Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Cancer Research Foundation Rational Drug Discovery Facility; Commonwealth of Australia(Australian Government); United States Department of Energy, Basic Energy Sciences, Office of Energy Research(United States Department of Energy (DOE))	This work was supported in part by grants from the Cancer Council of Victoria and National Health and Medical Research Council of Australia with infrastructural support from the Australian Cancer Research Foundation Rational Drug Discovery Facility. This work, including use of the BioCARS sector, was also supported by the Australian Synchrotron Research Program, which is funded by the Commonwealth of Australia. Use of the Advanced Photon Source was supported by the United States Department of Energy, Basic Energy Sciences, Office of Energy Research.	Bakre MM, 2002, NAT MED, V8, P995, DOI 10.1038/nm753; BARDEN JA, 1989, EUR J BIOCHEM, V184, P379, DOI 10.1111/j.1432-1033.1989.tb15030.x; Barden JA, 1997, J BIOL CHEM, V272, P29572, DOI 10.1074/jbc.272.47.29572; Bergwitz C, 1996, J BIOL CHEM, V271, P26469, DOI 10.1074/jbc.271.43.26469; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen ZG, 2000, BIOCHEMISTRY-US, V39, P12766, DOI 10.1021/bi000882e; Clemens TL, 2001, BRIT J PHARMACOL, V134, P1113, DOI 10.1038/sj.bjp.0704378; Dean T, 2006, MOL ENDOCRINOL, V20, P931, DOI 10.1210/me.2005-0349; Dean T, 2008, MOL ENDOCRINOL, V22, P156, DOI 10.1210/me.2007-0274; Gardella TJ, 2001, TRENDS ENDOCRIN MET, V12, P210, DOI 10.1016/S1043-2760(01)00409-X; Gardella TJ, 1996, J BIOL CHEM, V271, P19888, DOI 10.1074/jbc.271.33.19888; GARDELLA TJ, 1993, ENDOCRINOLOGY, V132, P2024, DOI 10.1210/en.132.5.2024; GARDELLA TJ, 1995, J BIOL CHEM, V270, P6584, DOI 10.1074/jbc.270.12.6584; Gensure RC, 2001, J BIOL CHEM, V276, P28650, DOI 10.1074/jbc.M100717200; Guise T A, 1996, Curr Opin Nephrol Hypertens, V5, P307, DOI 10.1097/00041552-199607000-00004; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; HAMMONDS RG, 1989, J BIOL CHEM, V264, P14806; Henderson MA, 2006, CANCER RES, V66, P2250, DOI 10.1158/0008-5472.CAN-05-2814; Iguchi H, 2001, INT J CANCER, V94, P24, DOI 10.1002/ijc.1425; Jin L, 2000, J BIOL CHEM, V275, P27238; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUKREJA SC, 1990, ENDOCRINOLOGY, V127, P305, DOI 10.1210/endo-127-1-305; KUKREJA SC, 1988, J CLIN INVEST, V82, P1798, DOI 10.1172/JCI113794; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LAWRENCE MC, 2000, J APPL CRYSTALLOGR, V33, P990; Mannstadt M, 1999, AM J PHYSIOL-RENAL, V277, pF665, DOI 10.1152/ajprenal.1999.277.5.F665; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MOSELEY JM, 1995, CRIT REV CL LAB SCI, V32, P299, DOI 10.3109/10408369509084687; MOSELEY JM, 1987, P NATL ACAD SCI USA, V84, P5048, DOI 10.1073/pnas.84.14.5048; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Onuma E, 2005, INT J CANCER, V116, P471, DOI 10.1002/ijc.21038; Onuma E, 2004, ANTICANCER RES, V24, P2665; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pellegrini M, 1998, J BIOL CHEM, V273, P10420, DOI 10.1074/jbc.273.17.10420; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; POWELL GJ, 1991, CANCER RES, V51, P3059; Saito H, 2005, ANTICANCER RES, V25, P3817; SATO K, 1993, J BONE MINER RES, V8, P849; Shimizu M, 2001, ENDOCRINOLOGY, V142, P3068, DOI 10.1210/en.142.7.3068; Suda N, 1996, J CELL PHYSIOL, V166, P94, DOI 10.1002/(SICI)1097-4652(199601)166:1<94::AID-JCP11>3.0.CO;2-P; SUVA LJ, 1987, SCIENCE, V237, P893, DOI 10.1126/science.3616618; Yoneda Toshiyuki, 2000, Cancer, V88, P2979, DOI 10.1002/1097-0142(20000615)88:12+<2979::AID-CNCR13>3.0.CO;2-U	45	11	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15557	15563		10.1074/jbc.M900044200	http://dx.doi.org/10.1074/jbc.M900044200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19346515	hybrid, Green Published			2022-12-25	WOS:000266501000024
J	Hardin, JW; Reyes, FE; Batey, RT				Hardin, John W.; Reyes, Francis E.; Batey, Robert T.			Analysis of a Critical Interaction within the Archaeal Box C/D Small Ribonucleoprotein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL NUCLEOLAR RNA; GUIDED NUCLEOTIDE MODIFICATION; DOMINANT RETINITIS-PIGMENTOSA; RIBOSE METHYLATION; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; SOLUBLE-RNA; PROTEIN; BINDING; L7AE	In archaea and eukarya, box C/D ribonucleoprotein (RNP) complexes are responsible for 2'-O-methylation of tRNAs and rRNAs. The archaeal box C/D small RNP complex requires a small RNA component (sRNA) possessing Watson-Crick complementarity to the target RNA along with three proteins: L7Ae, Nop5p, and fibrillarin. Transfer of a methyl group from S-adenosylmethionine to the target RNA is performed by fibrillarin, which by itself has no affinity for the sRNA-target duplex. Instead, it is targeted to the site of methylation through association with Nop5p, which in turn binds to the L7Ae-sRNA complex. To understand how Nop5p serves as a bridge between the targeting and catalytic functions of the box C/D small RNP complex, we have employed alanine scanning to evaluate the interaction between the Pyrococcus horikoshii Nop5p domain and an L7Ae box C/D RNA complex. From these data, we were able to construct an isolated RNA-binding domain (Nop-RBD) that folds correctly as demonstrated by x-ray crystallography and binds to the L7Ae box C/D RNA complex with near wild type affinity. These data demonstrate that the Nop-RBD is an autonomously folding and functional module important for protein assembly in a number of complexes centered on the L7Ae-kinkturn RNP.	[Hardin, John W.; Reyes, Francis E.; Batey, Robert T.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Batey, RT (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.	robert.batey@colorado.edu	Batey, Robert/A-8265-2009	Batey, Robert/0000-0002-1384-6625	National Institutes of Health [GM08953]; University of Colorado, Boulder	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado, Boulder	This work was supported, in whole or in part, by National Institutes of Health Grant GM08953 (to R.T.B.). This work was also supported by a graduate research training grant (to F.E.R.) through the University of Colorado, Boulder.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aittaleb M, 2004, J BIOL CHEM, V279, P41822, DOI 10.1074/jbc.M406209200; Aittaleb M, 2003, NAT STRUCT BIOL, V10, P256, DOI 10.1038/nsb905; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Clouet-d'Orval B, 2005, BIOCHIMIE, V87, P889, DOI 10.1016/j.biochi.2005.02.004; CUNNINGHAM PR, 1991, BIOCHIMIE, V73, P789, DOI 10.1016/0300-9084(91)90058-9; Decatur WA, 2003, J BIOL CHEM, V278, P695, DOI 10.1074/jbc.R200023200; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; Deng L, 2004, BIOCHEM BIOPH RES CO, V315, P726, DOI 10.1016/j.bbrc.2004.01.114; Dennis PP, 2001, MOL MICROBIOL, V40, P509, DOI 10.1046/j.1365-2958.2001.02381.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gaspin C, 2000, J MOL BIOL, V297, P895, DOI 10.1006/jmbi.2000.3593; Gautier T, 1997, MOL CELL BIOL, V17, P7088, DOI 10.1128/MCB.17.12.7088; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Grosjean H., 1998, MODIFICATION EDITING, DOI [10.1128/9781555818296, DOI 10.1128/9781555818296]; Hamma T, 2004, STRUCTURE, V12, P893, DOI 10.1016/S0969-2126(04)00096-6; Hardin JW, 2006, NUCLEIC ACIDS RES, V34, P5039, DOI 10.1093/nar/gkl644; Helm M, 2006, NUCLEIC ACIDS RES, V34, P721, DOI 10.1093/nar/gkj471; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Holm L, 1996, METHOD ENZYMOL, V266, P653; Kiss T, 2001, EMBO J, V20, P3617, DOI 10.1093/emboj/20.14.3617; KissLaszlo Z, 1996, CELL, V85, P1077, DOI 10.1016/S0092-8674(00)81308-2; Kuhn JF, 2002, NUCLEIC ACIDS RES, V30, P931, DOI 10.1093/nar/30.4.931; Lafontaine DLJ, 1999, RNA, V5, P455, DOI 10.1017/S135583829998192X; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu S, 2007, SCIENCE, V316, P115, DOI 10.1126/science.1137924; MADEJ T, 1995, PROTEINS, V23, P356, DOI 10.1002/prot.340230309; Makarova OV, 2002, EMBO J, V21, P1148, DOI 10.1093/emboj/21.5.1148; Mitchell JR, 1999, MOL CELL BIOL, V19, P567; Moore T, 2004, STRUCTURE, V12, P807, DOI 10.1016/j.str.2004.02.033; Newman DR, 2000, RNA, V6, P861, DOI 10.1017/S1355838200992446; Nolivos S, 2005, NUCLEIC ACIDS RES, V33, P6507, DOI 10.1093/nar/gki962; Nottrott S, 2002, EMBO J, V21, P5527, DOI 10.1093/emboj/cdf544; Omer AD, 2000, SCIENCE, V288, P517, DOI 10.1126/science.288.5465.517; Omer AD, 2003, MOL MICROBIOL, V48, P617, DOI 10.1046/j.1365-2958.2003.03483.x; Omer AD, 2002, P NATL ACAD SCI USA, V99, P5289, DOI 10.1073/pnas.082101999; Oruganti S, 2007, J MOL BIOL, V371, P1141, DOI 10.1016/j.jmb.2007.06.029; Padilla JE, 2003, ACTA CRYSTALLOGR D, V59, P1124, DOI 10.1107/S0907444903007947; Peculis BA, 1997, MOL CELL BIOL, V17, P3702, DOI 10.1128/MCB.17.7.3702; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Reichow SL, 2007, NUCLEIC ACIDS RES, V35, P1452, DOI 10.1093/nar/gkl1172; Rozenski J, 1999, NUCLEIC ACIDS RES, V27, P196, DOI 10.1093/nar/27.1.196; Rozhdestvensky TS, 2003, NUCLEIC ACIDS RES, V31, P869, DOI 10.1093/nar/gkg175; Schultz A, 2006, MOL CELL BIOL, V26, P5146, DOI 10.1128/MCB.02374-05; Sirum-Connolly K, 1995, Nucleic Acids Symp Ser, P73; SIRUMCONNOLLY K, 1993, SCIENCE, V262, P1886, DOI 10.1126/science.8266080; Smith CM, 1997, CELL, V89, P669, DOI 10.1016/S0092-8674(00)80247-0; Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148; Suryadi J, 2005, BIOCHEMISTRY-US, V44, P9657, DOI 10.1021/bi050568q; Szewczak LBW, 2005, RNA, V11, P1407, DOI 10.1261/rna.2830905; Tran E, 2005, RNA, V11, P285, DOI 10.1261/rna.7223405; Tran EJ, 2003, EMBO J, V22, P3930, DOI 10.1093/emboj/cdg368; TYCOWSKI KT, 1994, SCIENCE, V266, P1558, DOI 10.1126/science.7985025; Tycowski KT, 1996, P NATL ACAD SCI USA, V93, P14480, DOI 10.1073/pnas.93.25.14480; Verheggen C, 2001, EMBO J, V20, P5480, DOI 10.1093/emboj/20.19.5480; Vithana EN, 2001, MOL CELL, V8, P375, DOI 10.1016/S1097-2765(01)00305-7; Wang HM, 2000, EMBO J, V19, P317, DOI 10.1093/emboj/19.3.317; Watkins NJ, 2002, MOL CELL BIOL, V22, P8342, DOI 10.1128/MCB.22.23.8342-8352.2002; Zhang XX, 2006, RNA, V12, P1092, DOI 10.1261/rna.2230106; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Ziesche SM, 2004, MOL MICROBIOL, V54, P980, DOI 10.1111/j.1365-2958.2004.04319.x	62	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15317	15324		10.1074/jbc.M901368200	http://dx.doi.org/10.1074/jbc.M901368200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19336398	hybrid, Green Published			2022-12-25	WOS:000266288200066
J	Sato, T; Mihara, K				Sato, Takashi; Mihara, Katsuyoshi			Topogenesis of Mammalian Oxa1, a Component of the Mitochondrial Inner Membrane Protein Export Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINI; INSERTION; IMPORT; YIDC; COMPLEX; MATRIX; TRANSLOCASE; DEPENDENCE; MUTATIONS; INTERACTS	Oxa1 is a mitochondrial inner membrane protein with a predicted five-transmembrane segment (TM1 similar to 5) topology in which the N terminus and a hydrophilic loop, L2, are exposed to the intermembrane space and the C-terminal region and two loops, L1 and L3, are exposed to the matrix. Oxa1 mediates the insertion of mitochondrial DNA-encoded subunits of respiratory complexes and several nuclear DNA-encoded proteins into the inner membrane from the matrix. Compared with yeast Oxa1, little is known about the import and function of mammalian Oxa1. Here, we investigated the topogenesis of Oxa1 in HeLa cells using systematic deletion or mutation constructs and found that (i) the N-terminal 64-residue segment formed a presequence, and its deletion directed the mature protein to the endoplasmic reticulum, indicating that the presequence arrests cotranslational activation of the potential endoplasmic reticulum-targeting signal within mature Oxa1, (ii) systematic deletion of Oxa1 TM segments revealed that the presence of all five TMs is essential for efficient membrane integration, (iii) the species-conserved hexapeptide (GLPWWG) located near the N terminus of TM1 was essential for export of the N-terminal segment and L2 into the intermembrane space from the matrix, i. e. for correct topogenesis of Oxa1, and (iv) GLPWWG placed near the N terminus of TM2 or TM3 in the reporter construct also supported its membrane integration in the Nout-Cin orientation. Together, these results demonstrated that topogenesis of Oxa1 is a cooperative event of all five TMs, and GLPWWG followed immediately by TM1 is essential for correct Oxa1 topogenesis.	[Sato, Takashi; Mihara, Katsuyoshi] Kyushu Univ, Grad Sch Med Sci, Dept Mol Biol, Fukuoka 812, Japan	Kyushu University	Mihara, K (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Mol Biol, Fukuoka 812, Japan.	mihara@cell.med.kyushu-u.ac.jp			Ministry of Education, Science, and Culture of Japan; Human Frontier Science Program; Core Research from Evolutional Science and Technology; Takeda Science Foundation	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Human Frontier Science Program(Human Frontier Science Program); Core Research from Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by grants from the Ministry of Education, Science, and Culture of Japan, Human Frontier Science Program, Core Research from Evolutional Science and Technology, and Takeda Science Foundation.	Beck K, 2001, EMBO REP, V2, P709, DOI 10.1093/embo-reports/kve154; BONNEFOY N, 1994, J MOL BIOL, V239, P201, DOI 10.1006/jmbi.1994.1363; He SC, 1997, MOL BIOL CELL, V8, P1449, DOI 10.1091/mbc.8.8.1449; Hell K, 1998, P NATL ACAD SCI USA, V95, P2250, DOI 10.1073/pnas.95.5.2250; Hell K, 1997, FEBS LETT, V418, P367, DOI 10.1016/S0014-5793(97)01412-9; Hell K, 2001, EMBO J, V20, P1281, DOI 10.1093/emboj/20.6.1281; Herrmann JM, 2003, IUBMB LIFE, V55, P219, DOI 10.1080/1521654031000123349; Herrmann JM, 2004, J BIOL CHEM, V279, P2507, DOI 10.1074/jbc.M310468200; Herrmann JM, 1997, EMBO J, V16, P2217, DOI 10.1093/emboj/16.9.2217; HERRMANN JM, 1995, J BIOL CHEM, V270, P27079, DOI 10.1074/jbc.270.45.27079; Ishihara N, 1998, J BIOCHEM-TOKYO, V123, P722; Jia LX, 2007, MOL BIOL CELL, V18, P1897, DOI 10.1091/mbc.E06-10-0925; Jia LX, 2003, EMBO J, V22, P6438, DOI 10.1093/emboj/cdg624; Kanaji S, 2000, J CELL BIOL, V151, P277, DOI 10.1083/jcb.151.2.277; Lemaire C, 2004, J BIOL CHEM, V279, P47464, DOI 10.1074/jbc.M404861200; Miyazaki E, 2005, MOL BIOL CELL, V16, P1788, DOI 10.1091/mbc.e04-08-0707; Nagamori S, 2004, J CELL BIOL, V165, P53, DOI 10.1083/jcb.200402067; Ott M, 2006, EMBO J, V25, P1603, DOI 10.1038/sj.emboj.7601070; Rehling P, 2004, NAT REV MOL CELL BIO, V5, P519, DOI 10.1038/nrm1426; Reif S, 2005, J MOL BIOL, V354, P520, DOI 10.1016/j.jmb.2005.09.054; Rojo EE, 1999, J BIOL CHEM, V274, P19617, DOI 10.1074/jbc.274.28.19617; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Serek J, 2004, EMBO J, V23, P294, DOI 10.1038/sj.emboj.7600063; Stuart RA, 2002, BBA-MOL CELL RES, V1592, P79, DOI 10.1016/S0167-4889(02)00266-5; Szyrach G, 2003, EMBO J, V22, P6448, DOI 10.1093/emboj/cdg623; VESTWEBER D, 1988, EMBO J, V7, P1147, DOI 10.1002/j.1460-2075.1988.tb02924.x	26	13	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14819	14827		10.1074/jbc.M809520200	http://dx.doi.org/10.1074/jbc.M809520200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19349278	Green Published, hybrid			2022-12-25	WOS:000266288200017
J	Sheikh, IA; Singh, AK; Singh, N; Sinha, M; Singh, SB; Bhushan, A; Kaur, P; Srinivasan, A; Sharma, S; Singh, TP				Sheikh, Ishfaq Ahmed; Singh, Amit Kumar; Singh, Nagendra; Sinha, Mau; Singh, S. Baskar; Bhushan, Asha; Kaur, Punit; Srinivasan, Alagiri; Sharma, Sujata; Singh, Tej P.			Structural Evidence of Substrate Specificity in Mammalian Peroxidases STRUCTURE OF THE THIOCYANATE COMPLEX WITH LACTOPEROXIDASE AND ITS INTERACTIONS AT 2.4 angstrom RESOLUTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN MYELOPEROXIDASE; CRYSTAL-STRUCTURE; BOVINE LACTOPEROXIDASE; EOSINOPHIL PEROXIDASE; MOLECULAR-MECHANISM; ACID IONIZATION; BINDING; HEME; SYSTEM; WATER	The crystal structure of the complex of lactoperoxidase (LPO) with its physiological substrate thiocyanate (SCN-) has been determined at 2.4 angstrom resolution. It revealed that the SCN- ion is bound to LPO in the distal heme cavity. The observed orientation of the SCN- ion shows that the sulfur atom is closer to the heme iron than the nitrogen atom. The nitrogen atom of SCN- forms a hydrogen bond with a water (Wat) molecule at position 6'. This water molecule is stabilized by two hydrogen bonds with Gln(423) N-epsilon 2 and Phe(422) oxygen. In contrast, the placement of the SCN- ion in the structure of myeloperoxidase (MPO) occurs with an opposite orientation, in which the nitrogen atom is closer to the heme iron than the sulfur atom. The site corresponding to the positions of Gln(423), Phe(422) oxygen, and Wat(6') in LPO is occupied primarily by the side chain of Phe(407) in MPO due to an entirely different conformation of the loop corresponding to the segment Arg(418)-Phe(431) of LPO. This arrangement in MPO does not favor a similar orientation of the SCN- ion. The orientation of the catalytic product OSCN- as reported in the structure of LPO center dot OSCN- is similar to the orientation of SCN- in the structure of LPO center dot SCN-. Similarly, in the structure of LPO center dot SCN-center dot CN-, in which CN- binds at Wat(1), the position and orientation of the SCN- ion are also identical to that observed in the structure of LPO center dot SCN.	[Sheikh, Ishfaq Ahmed; Singh, Amit Kumar; Singh, Nagendra; Sinha, Mau; Singh, S. Baskar; Bhushan, Asha; Kaur, Punit; Srinivasan, Alagiri; Sharma, Sujata; Singh, Tej P.] All India Inst Med Sci, Dept Biophys, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Singh, TP (corresponding author), All India Inst Med Sci, Dept Biophys, New Delhi 110029, India.	tpsingh.aiims@gmail.com	Sheikh, Ishfaq A/H-9611-2012	Singh, Nagendra/0000-0003-0419-0684; SINHA, MAU/0000-0003-3011-9160	Department of Science and Technology, New Delhi; University Grants Commission, New Delhi; Council of Scientific and Industrial Research, New Delhi	Department of Science and Technology, New Delhi(Department of Science & Technology (India)); University Grants Commission, New Delhi(University Grants Commission, India); Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by the Department of Science and Technology, New Delhi.; Supported by a fellowship from the University Grants Commission, New Delhi.; Supported by a fellowship from the Council of Scientific and Industrial Research, New Delhi.	Ando K, 1999, J PHYS CHEM A, V103, P10398, DOI 10.1021/jp992481i; Ando K, 1997, J PHYS CHEM B, V101, P10464, DOI 10.1021/jp970173j; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAKKENIST ARJ, 1980, BIOCHIM BIOPHYS ACTA, V613, P337, DOI 10.1016/0005-2744(80)90088-1; Blair-Johnson M, 2001, BIOCHEMISTRY-US, V40, P13990, DOI 10.1021/bi0111808; Ciaccio C, 2004, BIOPHYS J, V86, P448, DOI 10.1016/S0006-3495(04)74121-1; CRULL GB, 1993, J INORG BIOCHEM, V50, P181, DOI 10.1016/0162-0134(93)80024-4; DePillis GD, 1997, J BIOL CHEM, V272, P8857; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FENNA R, 1995, ARCH BIOCHEM BIOPHYS, V316, P653, DOI 10.1006/abbi.1995.1086; Fiedler TJ, 2000, J BIOL CHEM, V275, P11964, DOI 10.1074/jbc.275.16.11964; Furtmuller PG, 2004, JPN J INFECT DIS, V57, pS30; Geissler PL, 2001, SCIENCE, V291, P2121, DOI 10.1126/science.1056991; GOLDSTEIN F, 1950, J BIOL CHEM, V187, P523; HOOGENDOORN H, 1977, CARIES RES, V11, P77, DOI 10.1159/000260252; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Klebanoff SJ, 1999, P ASSOC AM PHYSICIAN, V111, P383, DOI 10.1111/paa.1999.111.5.383; KLEBANOFF SJ, 1970, SCIENCE, V169, P1095, DOI 10.1126/science.169.3950.1095; Kooter IM, 1997, J BIOL INORG CHEM, V2, P191, DOI 10.1007/s007750050124; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MODI S, 1990, INDIAN J CHEM A, V29, P301; MODI S, 1989, BIOCHEMISTRY-US, V28, P4689, DOI 10.1021/bi00437a027; Mohammed OF, 2005, SCIENCE, V310, P83, DOI 10.1126/science.1117756; Mowat CG, 2004, NAT STRUCT MOL BIOL, V11, P1023, DOI 10.1038/nsmb827; MURSHUDOV GN, 1997, PROTEIN CRYSTALLOGR, V33, P31; NICHOL AW, 1987, BIOCHEM J, V247, P147, DOI 10.1042/bj2470147; ORAM JD, 1996, BIOCHEM J, V100, P382; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ruf J, 2006, ARCH BIOCHEM BIOPHYS, V445, P269, DOI 10.1016/j.abb.2005.06.023; SHINDLER JS, 1975, BIOCHEM BIOPH RES CO, V67, P1307, DOI 10.1016/0006-291X(75)90169-2; Singh AK, 2009, BIOPHYS J, V96, P646, DOI 10.1016/j.bpj.2008.09.019; Singh AK, 2008, J MOL BIOL, V376, P1060, DOI 10.1016/j.jmb.2007.12.012; Tahboub YR, 2005, J BIOL CHEM, V280, P26129, DOI 10.1074/jbc.M503027200; Tanaka T, 2003, BIOSCI BIOTECH BIOCH, V67, P2254, DOI 10.1271/bbb.67.2254; TAYLOR KL, 1992, J BIOL CHEM, V267, P25282; Thomsen AR, 2000, ARCH BIOCHEM BIOPHYS, V379, P147, DOI 10.1006/abbi.2000.1866; Wang JG, 2006, ARCH BIOCHEM BIOPHYS, V445, P256, DOI 10.1016/j.abb.2005.10.008; WOLFSON LM, 1993, J FOOD PROTECT, V56, P887, DOI 10.4315/0362-028X-56.10.887; ZGLICZYNSKI JM, 1977, P SOC EXP BIOL MED, V154, P418	39	45	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14849	14856		10.1074/jbc.M807644200	http://dx.doi.org/10.1074/jbc.M807644200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19339248	Green Published, hybrid			2022-12-25	WOS:000266288200020
J	Nakagawa, Y; Nagasawa, M; Yamada, S; Hara, A; Mogami, H; Nikolaev, VO; Lohse, MJ; Shigemura, N; Ninomiya, Y; Kojima, I				Nakagawa, Yuko; Nagasawa, Masahiro; Yamada, Satoko; Hara, Akemi; Mogami, Hideo; Nikolaev, Viacheslav O.; Lohse, Martin J.; Shigemura, Noriatsu; Ninomiya, Yuzo; Kojima, Itaru			Sweet Taste Receptor Expressed in Pancreatic beta-Cells Activates the Calcium and Cyclic AMP Signaling Systems and Stimulates Insulin Secretion	PLOS ONE			English	Article							MAMMALIAN SWEET; SENSITIVITY; SUCRALOSE; BITTER	Background: Sweet taste receptor is expressed in the taste buds and enteroendocrine cells acting as a sugar sensor. We investigated the expression and function of the sweet taste receptor in MIN6 cells and mouse islets. Methodology/Principal Findings: The expression of the sweet taste receptor was determined by RT-PCR and immunohistochemistry. Changes in cytoplasmic Ca2+ ([Ca2+](c)) and cAMP ([cAMP](c)) were monitored in MIN6 cells using fura-2 and Epac1-camps. Activation of protein kinase C was monitored by measuring translocation of MARCKS-GFP. Insulin was measured by radioimmunoassay. mRNA for T1R2, T1R3, and gustducin was expressed in MIN6 cells. In these cells, artificial sweeteners such as sucralose, succharin, and acesulfame-K increased insulin secretion and augmented secretion induced by glucose. Sucralose increased biphasic increase in [Ca2+](c). The second sustained phase was blocked by removal of extracellular calcium and addition of nifedipine. An inhibitor of inositol(1, 4, 5)-trisphophate receptor, 2-aminoethoxydiphenyl borate, blocked both phases of [Ca2+](c) response. The effect of sucralose on [Ca2+](c) was inhibited by gurmarin, an inhibitor of the sweet taste receptor, but not affected by a G(q) inhibitor. Sucralose also induced sustained elevation of [cAMP](c), which was only partially inhibited by removal of extracellular calcium and nifedipine. Finally, mouse islets expressed T1R2 and T1R3, and artificial sweeteners stimulated insulin secretion. Conclusions: Sweet taste receptor is expressed in beta-cells, and activation of this receptor induces insulin secretion by Ca2+ and cAMP-dependent mechanisms.			Nakagawa, Y (corresponding author), Gunma Univ, Inst Mol & Cellular Regulat, Maebashi, Gunma 371, Japan.	ikojima@showa.gunma-u.ac.jp	Alshali, Rasha A/K-8051-2012; Lohse, Martin J/A-7160-2012; Nikolaev, Vyacheslav/AAT-7746-2020	Lohse, Martin J/0000-0002-0599-3510; Shigemura, Noriatsu/0000-0002-3061-6362				Cheng H, 2007, CELL CALCIUM, V41, P51, DOI 10.1016/j.ceca.2006.04.032; Dyer J, 2005, BIOCHEM SOC T, V33, P302, DOI 10.1042/BST0330302; FEIHAN F, 2006, J BIOL CHEM, V281, P21942; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; Grotz VL, 2003, J AM DIET ASSOC, V103, P1607, DOI 10.1016/j.jada.2003.09.021; GRYHKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hara A, 2007, DEV DYNAM, V236, P3451, DOI 10.1002/dvdy.21359; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; LINDERMAN B, 2002, NATURE, V413, P219; Malaisse WJ, 1998, CELL SIGNAL, V10, P727, DOI 10.1016/S0898-6568(98)00017-5; Margolskee RF, 2002, J BIOL CHEM, V277, P1, DOI 10.1074/jbc.R100054200; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Mezitis NHE, 1996, DIABETES CARE, V19, P1004, DOI 10.2337/diacare.19.9.1004; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; MURAYAMA T, 1997, J BIOCH, V122, P498; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Nie Y, 2005, CURR BIOL, V15, P1948, DOI 10.1016/j.cub.2005.09.037; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Reimann F, 2008, CELL METAB, V8, P532, DOI 10.1016/j.cmet.2008.11.002; Schonhoff SE, 2004, ENDOCRINOLOGY, V145, P2639, DOI 10.1210/en.2004-0051; Shigemura N, 2008, BIOCHEM BIOPH RES CO, V367, P356, DOI 10.1016/j.bbrc.2007.12.146; Straub SG, 2003, DIABETES, V52, P356, DOI 10.2337/diabetes.52.2.356; Suzuki Y, 2006, J BIOL CHEM, V281, P28499, DOI 10.1074/jbc.M604291200; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Talavera K, 2005, NATURE, V438, P1022, DOI 10.1038/nature04248; TEITELMAN G, 2001, REC PROG HOR RES, V47, P259; Togashi K, 2006, EMBO J, V25, P1804, DOI 10.1038/sj.emboj.7601083; ZHANG H, 2004, J PHYSL, V61, P133; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	30	223	235	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5106	10.1371/journal.pone.0005106	http://dx.doi.org/10.1371/journal.pone.0005106			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19352508	Green Submitted, gold, Green Published			2022-12-25	WOS:000265505700012
J	Wu, FTH; Stefanini, MO; Gabhann, FM; Popel, AS				Wu, Florence T. H.; Stefanini, Marianne O.; Gabhann, Feilim Mac; Popel, Aleksander S.			A Compartment Model of VEGF Distribution in Humans in the Presence of Soluble VEGF Receptor-1 Acting as a Ligand Trap	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PERIPHERAL-ARTERIAL-DISEASE; HUMAN SKELETAL-MUSCLE; CAPILLARY BASEMENT-MEMBRANE; HEPARAN-SULFATE PROTEOGLYCAN; COLLAGEN-INDUCED ARTHRITIS; FLT-1 GENE-THERAPY; INHIBITS ANGIOGENESIS; ANTIANGIOGENIC GENE; SIGNAL-TRANSDUCTION	Vascular endothelial growth factor (VEGF), through its activation of cell surface receptor tyrosine kinases including VEGFR1 and VEGFR2, is a vital regulator of stimulatory and inhibitory processes that keep angiogenesis - new capillary growth from existing microvasculature - at a dynamic balance in normal physiology. Soluble VEGF receptor-1 (sVEGFR1) - a naturally-occurring truncated version of VEGFR1 lacking the transmembrane and intracellular signaling domains - has been postulated to exert inhibitory effects on angiogenic signaling via two mechanisms: direct sequestration of angiogenic ligands such as VEGF; or dominant-negative heterodimerization with surface VEGFRs. In pre-clinical studies, sVEGFR1 gene and protein therapy have demonstrated efficacy in inhibiting tumor angiogenesis; while in clinical studies, sVEGFR1 has shown utility as a diagnostic or prognostic marker in a widening array of angiogenesis - dependent diseases. Here we developed a novel computational multi-tissue model for recapitulating the dynamic systemic distributions of VEGF and sVEGFR1. Model features included: physiologically-based multi-scale compartmentalization of the human body; intercompartmental macromolecular biotransport processes (vascular permeability, lymphatic drainage); and molecularly-detailed binding interactions between the ligand isoforms VEGF(121) and VEGF(165), signaling receptors VEGFR1 and VEGFR2, non-signaling co-receptor neuropilin-1 (NRP1), as well as sVEGFR1. The model was parameterized to represent a healthy human subject, whereupon we investigated the effects of sVEGFR1 on the distribution and activation of VEGF ligands and receptors. We assessed the healthy baseline stability of circulating VEGF and sVEGFR1 levels in plasma, as well as their reliability in indicating tissue-level angiogenic signaling potential. Unexpectedly, simulated results showed that sVEGFR1 acting as a diffusible VEGF sink alone, i.e., without sVEGFR1-VEGFR heterodimerization - did not significantly lower interstitial VEGF, nor inhibit signaling potential in tissues. Additionally, the sensitivity of plasma VEGF and sVEGFR1 to physiological fluctuations in transport rates may partially account for the heterogeneity in clinical measurements of these circulating angiogenic markers, potentially hindering their diagnostic reliability for diseases.			Wu, FTH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.	florence.wu@jhu.edu	Popel, Aleksander S/A-6724-2009; Mac Gabhann, Feilim/A-3436-2010	Mac Gabhann, Feilim/0000-0003-3481-7740; Popel, Aleksander/0000-0002-6706-9235; Wu, Florence/0000-0002-6439-4606	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079653, R33HL087351, T32HL007284] Funding Source: NIH RePORTER; NHLBI NIH HHS [R33 HL087351, T32 HL7284, R01 HL079653, T32 HL007284] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Afuwape AO, 2003, GENE THER, V10, P1950, DOI 10.1038/sj.gt.3302104; Ahmad S, 2004, CIRC RES, V95, P884, DOI 10.1161/01.RES.0000147365.86159.f5; Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Allen DL, 1999, MUSCLE NERVE, V22, P1350, DOI 10.1002/(SICI)1097-4598(199910)22:10<1350::AID-MUS3>3.0.CO;2-8; Ambati BK, 2007, BRIT J OPHTHALMOL, V91, P505, DOI 10.1136/bjo.2006.107417; Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; ANDERSEN P, 1977, J PHYSIOL-LONDON, V270, P677, DOI 10.1113/jphysiol.1977.sp011975; Anne A., 2007, ESSENTIAL CLIN ANATO, V3rd; Aref S, 2005, HEMATOLOGY, V10, P131, DOI 10.1080/10245330500065797; Arner P, 1999, P NUTR SOC, V58, P913, DOI 10.1017/S0029665199001214; Ashikari-Hada S, 2004, J BIOL CHEM, V279, P12346, DOI 10.1074/jbc.M313523200; AUKLAND K, 1981, PHYSIOL REV, V61, P556, DOI 10.1152/physrev.1981.61.3.556; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Bailey AP, 2006, MED SCI MONITOR, V12, pCR45; Bando H, 2005, BRIT J CANCER, V92, P553, DOI 10.1038/sj.bjc.6602374; Barleon B, 1997, J BIOL CHEM, V272, P10382; BASHKIN P, 1989, BIOCHEMISTRY-US, V28, P1737, DOI 10.1021/bi00430a047; Baum O, 2005, MICROCIRCULATION, V12, P527, DOI 10.1080/10739680591003413; Belgore FM, 2001, CLIN SCI, V100, P567, DOI 10.1042/CS20000234; BIKFALVI A, 1991, J CELL PHYSIOL, V149, P50, DOI 10.1002/jcp.1041490108; Blann AD, 2002, CLIN SCI, V102, P187, DOI 10.1042/CS20010178; Cai J, 2006, J BIOL CHEM, V281, P3604, DOI 10.1074/jbc.M507401200; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cebe-Suarez S, 2006, CELL MOL LIFE SCI, V63, P601, DOI 10.1007/s00018-005-5426-3; Chen RR, 2007, FASEB J, V21, P3896, DOI 10.1096/fj.06-7873com; Chung NA, 2003, HEART, V89, P1411, DOI 10.1136/heart.89.12.1411; Cisek PL, 1997, ANN VASC SURG, V11, P49, DOI 10.1007/s100169900009; Clark M, 2008, J APPL PHYSIOL, V104, P900, DOI 10.1152/japplphysiol.01318.2007; Collinson DJ, 2004, EUR J VASC ENDOVASC, V28, P9, DOI 10.1016/j.ejvs.2004.03.021; Croley AN, 2005, J APPL PHYSIOL, V99, P1872, DOI 10.1152/japplphysiol.00498.2005; Dawson D, 2002, AM J PHYSIOL-ENDOC M, V282, pE714, DOI 10.1152/ajpendo.00373.2001; Diab AE, 2008, INT J GYNECOL OBSTET, V102, P146, DOI 10.1016/j.ijgo.2008.02.016; Dougher M, 1999, ONCOGENE, V18, P1619, DOI 10.1038/sj.onc.1202478; Duval M, 2007, MOL BIOL CELL, V18, P4659, DOI 10.1091/mbc.E07-05-0467; Ebos JML, 2004, MOL CANCER RES, V2, P315; Elliott MA, 1997, MAGN RESON MATER PHY, V5, P93, DOI 10.1007/BF02592238; Eppler SM, 2002, CLIN PHARMACOL THER, V72, P20, DOI 10.1067/mcp.2002.126179; Ewan LC, 2006, TRAFFIC, V7, P1270, DOI 10.1111/j.1600-0854.2006.00462.x; FEINGOLD KR, 1986, J CLIN INVEST, V78, P102, DOI 10.1172/JCI112537; Felmeden DC, 2003, J INTERN MED, V253, P81, DOI 10.1046/j.1365-2796.2003.01087.x; Feng D, 2000, J HISTOCHEM CYTOCHEM, V48, P545, DOI 10.1177/002215540004800412; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Filion RJ, 2004, ANN BIOMED ENG, V32, P645, DOI 10.1023/B:ABME.0000030231.88326.78; Findley CM, 2008, J AM COLL CARDIOL, V52, P387, DOI 10.1016/j.jacc.2008.02.045; Fuh G, 2000, J BIOL CHEM, V275, P26690; Gabhann FM, 2008, MICROCIRCULATION, V15, P715, DOI 10.1080/10739680802095964; GABHANN FM, 2006, PLOS COMPUT BIOL, V2, pE180, DOI DOI 10.1371/JOURNAL.PCBI.0020180; Gagnon ML, 2000, P NATL ACAD SCI USA, V97, P2573, DOI 10.1073/pnas.040337597; Gampel A, 2006, BLOOD, V108, P2624, DOI 10.1182/blood-2005-12-007484; Gao ZN, 2007, ORAL ONCOL, V43, P477, DOI 10.1016/j.oraloncology.2006.05.009; GARLICK DG, 1970, AM J PHYSIOL, V219, P1595, DOI 10.1152/ajplegacy.1970.219.6.1595; Gavin TP, 2007, ACTA PHYSIOL, V191, P139, DOI 10.1111/j.1748-1716.2007.01723.x; Gavin TP, 2007, J PHYSIOL-LONDON, V585, P231, DOI 10.1113/jphysiol.2007.143198; Gehlbach P, 2003, HUM GENE THER, V14, P129, DOI 10.1089/104303403321070829; Green H, 1999, ACTA PHYSIOL SCAND, V165, P177; Gustafsson T, 2005, J APPL PHYSIOL, V98, P2137, DOI 10.1152/japplphysiol.01402.2004; Guyton AC., 2006, TXB MED PHYSL; Havas E, 1997, J PHYSIOL-LONDON, V504, P233, DOI 10.1111/j.1469-7793.1997.233bf.x; Havas E, 2000, EXP PHYSIOL, V85, P863; Hazarika S, 2007, CIRC RES, V101, P948, DOI 10.1161/CIRCRESAHA.107.160630; Hernandez N, 1999, ANAT REC, V256, P425; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Hoffner L, 2003, J PHYSIOL-LONDON, V550, P217, DOI 10.1113/jphysiol.2002.037051; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Hornig C, 2000, LAB INVEST, V80, P443, DOI 10.1038/labinvest.3780050; Huang K, 2001, INT J BIOCHEM CELL B, V33, P315, DOI 10.1016/S1357-2725(01)00019-X; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; ITO T, 2008, BLOOD; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Jaroszewicz J, 2008, CYTOKINE, V44, P14, DOI 10.1016/j.cyto.2008.06.002; Jelkmann W, 2001, CLIN CHEM, V47, P617; Jenniskens GJ, 2006, J CELL PHYSIOL, V206, P283, DOI 10.1002/jcp.20450; Ji JW, 2007, AM J PHYSIOL-HEART C, V293, pH3740, DOI 10.1152/ajpheart.00009.2007; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kappas NC, 2008, J CELL BIOL, V181, P847, DOI 10.1083/jcb.200709114; Karumanchi SA, 2004, ENDOCRINOLOGY, V145, P4835, DOI 10.1210/en.2004-1028; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Kendall RL, 1996, BIOCHEM BIOPH RES CO, V226, P324, DOI 10.1006/bbrc.1996.1355; Kim NH, 2005, KIDNEY INT, V67, P167, DOI 10.1111/j.1523-1755.2005.00067.x; Kim WJ, 2006, J CONTROL RELEASE, V114, P381, DOI 10.1016/j.jconrel.2006.05.029; Kivela R, 2007, AM J PHYSIOL-HEART C, V293, pH2573, DOI 10.1152/ajpheart.00126.2007; KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025; Kommareddy S, 2007, CANCER GENE THER, V14, P488, DOI 10.1038/sj.cgt.7701041; Kraus RM, 2004, J APPL PHYSIOL, V96, P1445, DOI 10.1152/japplphysiol.01031.2003; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Krilleke D, 2007, J BIOL CHEM, V282, P28045, DOI 10.1074/jbc.M700319200; Kumai Y, 2007, J CEREBR BLOOD F MET, V27, P1152, DOI 10.1038/sj.jcbfm.9600420; Ladomery MR, 2007, CANCER LETT, V249, P133, DOI 10.1016/j.canlet.2006.08.015; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lamszus K, 2003, CLIN CANCER RES, V9, P1399; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; LEVESQUE MJ, 1986, ARTERIOSCLEROSIS, V6, P220, DOI 10.1161/01.ATV.6.2.220; LEVICK JR, 1987, Q J EXP PHYSIOL CMS, V72, P409, DOI 10.1113/expphysiol.1987.sp003085; Levitt David G, 2003, BMC Clin Pharmacol, V3, P3, DOI 10.1186/1472-6904-3-3; Li YJ, 2007, DIABETES, V56, P656, DOI 10.2337/db06-0999; Lip PL, 2002, BRIT J OPHTHALMOL, V86, P1299, DOI 10.1136/bjo.86.11.1299; LIU H, 2007, INT J INNOV COMPUT I, V1, P39, DOI [DOI 10.1109/ICHIS.2005.49, DOI 10.1504/IJICA.2007.013400]; Lorquet S, 2008, AM J REPROD IMMUNOL, V60, P85; Luttun A, 2003, J CLIN INVEST, V111, P600, DOI 10.1172/JCI200318015; Mac Gabhann F, 2004, AM J PHYSIOL-HEART C, V286, pH153, DOI 10.1152/ajpheart.00254.2003; Mac Gabhann F, 2007, AM J PHYSIOL-HEART C, V292, pH459, DOI 10.1152/ajpheart.00637.2006; Mac Gabhann F, 2007, ANN BIOMED ENG, V35, P982, DOI 10.1007/s10439-007-9303-0; Mac Gabhann F, 2007, J APPL PHYSIOL, V102, P722, DOI 10.1152/japplphysiol.00800.2006; Mac Gabhann F, 2006, PLOS COMPUT BIOL, V2, P1107, DOI 10.1371/journal.pcbi.0020127; Mac Gabhann F, 2007, BIOPHYS CHEM, V128, P125, DOI 10.1016/j.bpc.2007.03.010; MACGABHANN F, 2005, FASEB J, V19, pA1660; Maharaj ASR, 2007, MICROVASC RES, V74, P100, DOI 10.1016/j.mvr.2007.03.004; Maharaj ASR, 2006, AM J PATHOL, V168, P639, DOI 10.2353/ajpath.2006.050834; Mahasreshti PJ, 2001, CLIN CANCER RES, V7, P2057; Mahendra G, 2005, CANCER GENE THER, V12, P26, DOI 10.1038/sj.cgt.7700754; Makin AJ, 2003, CLIN SCI, V104, P397, DOI 10.1042/CS20020182; McDonald DM, 2005, CHEST, V128, p602S, DOI 10.1378/chest.128.6_suppl.602S-a; McGuigan MRM, 2001, MED SCI SPORT EXER, V33, P2016, DOI 10.1097/00005768-200112000-00007; Miotla J, 2000, LAB INVEST, V80, P1195, DOI 10.1038/labinvest.3780127; Mitsi M, 2006, BIOCHEMISTRY-US, V45, P10319, DOI 10.1021/bi060974p; MOSHER DF, 1984, ANNU REV MED, V35, P561, DOI 10.1146/annurev.me.35.020184.003021; Mukherjee S, 2006, CIRC RES, V98, P743, DOI 10.1161/01.RES.0000214545.99387.e3; Mulay M., 2006, ASCO M, V24, P13061; MYOKEN Y, 1991, P NATL ACAD SCI USA, V88, P5819, DOI 10.1073/pnas.88.13.5819; Neagoe PE, 2005, J BIOL CHEM, V280, P9904, DOI 10.1074/jbc.M412017200; Ng YS, 2001, DEV DYNAM, V220, P112, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1093>3.0.CO;2-D; Nguyen QD, 2006, OPHTHALMOLOGY, V113, P1522, DOI 10.1016/j.ophtha.2006.05.055; Norgren L, 2007, INT ANGIOL, V26, P81; Ohira Y, 1999, J APPL PHYSIOL, V87, P1776, DOI 10.1152/jappl.1999.87.5.1776; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; OLSZEWSKI W, 1977, ACTA PHYSIOL SCAND, V99, P149, DOI 10.1111/j.1748-1716.1977.tb10365.x; OLSZEWSKI WL, 1977, LYMPHOLOGY, V10, P178; Pan Q, 2007, J BIOL CHEM, V282, P24049, DOI 10.1074/jbc.M703554200; QUHONG, 1995, J HISTOCHEM CYTOCHEM, V43, P381, DOI 10.1177/43.4.7534783; Regensteiner JG, 2002, AM J MED, V112, P49, DOI 10.1016/S0002-9343(01)01034-8; Robinson CJ, 2006, J BIOL CHEM, V281, P1731, DOI 10.1074/jbc.M510760200; ROHRBACH DH, 1983, J BIOL CHEM, V258, P1672; Santos SCR, 2007, EXP CELL RES, V313, P1561, DOI 10.1016/j.yexcr.2007.02.020; Rota R, 2004, J GENE MED, V6, P992, DOI 10.1002/jgm.586; Ryan NA, 2006, J APPL PHYSIOL, V100, P178, DOI 10.1152/japplphysiol.00827.2005; Sako A, 2004, CANCER RES, V64, P3624, DOI 10.1158/0008-5472.CAN-04-0304; Schmittmann G, 2000, J PHARM SCI, V89, P115, DOI 10.1002/(SICI)1520-6017(200001)89:1<115::AID-JPS12>3.0.CO;2-7; Shapiro NI, 2008, SHOCK, V29, P452, DOI 10.1097/SHK.0b013e31815072c1; Signorelli SS, 2005, VASC MED, V10, P1, DOI 10.1191/1358863x05vm582oa; SIPERSTEIN MD, 1968, J CLIN INVEST, V47, P1973, DOI 10.1172/JCI105886; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Soker S, 1996, J BIOL CHEM, V271, P5761, DOI 10.1074/jbc.271.10.5761; Stefanini MO, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-77; Takahashi H, 2005, CLIN SCI, V109, P227, DOI 10.1042/CS20040370; Takei T, 2006, BIOTECHNOL BIOENG, V95, P1, DOI 10.1002/bit.20903; Tayebjee MH, 2005, J INTERN MED, V257, P110, DOI 10.1111/j.1365-2796.2004.01431.x; TAYLOR RN, 1991, AM J OBSTET GYNECOL, V165, P895, DOI 10.1016/0002-9378(91)90435-T; TRUSKEY GA, 2004, TRANSPORT PHENOMENA, P389; Tsao PN, 2007, CRIT CARE MED, V35, P1955, DOI 10.1097/01.CCM.0000275273.56547.B8; Venturoli D, 2005, AM J PHYSIOL-RENAL, V288, pF605, DOI 10.1152/ajprenal.00171.2004; Verheu HMW, 2007, CLIN CANCER RES, V13, P5341, DOI 10.1158/1078-0432.CCR-07-0847; Vlodavsky EA, 1999, VIRCHOWS ARCH, V435, P58, DOI 10.1007/s004280050395; VRACKO R, 1970, CIRCULATION, V41, P271, DOI 10.1161/01.CIR.41.2.271; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Wang DF, 2002, AM J PHYSIOL-GASTR L, V282, pG1088, DOI 10.1152/ajpgi.00250.2001; Ward SR, 2005, J BIOMECH, V38, P2317, DOI 10.1016/j.jbiomech.2004.10.001; Widmer M, 2007, OBSTET GYNECOL, V109, P168, DOI 10.1097/01.AOG.0000249609.04831.7c; Wijelath ES, 2006, CIRC RES, V99, P853, DOI 10.1161/01.RES.0000246849.17887.66; Williamson JR, 1996, J APPL PHYSIOL, V80, P747, DOI 10.1152/jappl.1996.80.3.747; Woolcock J, 2008, AUST NZ J OBSTET GYN, V48, P64, DOI 10.1111/j.1479-828X.2007.00804.x; Xiao HY, 1999, HAEMOSTASIS, V29, P237; Xu XG, 2000, HEALTH PHYS, V78, P476, DOI 10.1097/00004032-200005000-00003; Ye CS, 2004, ENDOCRINOLOGY, V145, P817, DOI 10.1210/en.2003-1106; Yla-Herttuala S, 2007, J AM COLL CARDIOL, V49, P1015, DOI 10.1016/j.jacc.2006.09.053; Yuan F, 2001, ANN BIOMED ENG, V29, P1150, DOI 10.1114/1.1424915; Zachary I, 2003, BIOCHEM SOC T, V31, P1171; Zhang ZL, 2005, MOL THER, V11, P553, DOI 10.1016/j.ymthe.2004.12.015	167	47	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5108	10.1371/journal.pone.0005108	http://dx.doi.org/10.1371/journal.pone.0005108			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19352513	Green Submitted, gold, Green Published			2022-12-25	WOS:000265505700013
J	Alvarez, M; Ruiz, MF; Sanchez, L				Alvarez, Mercedes; Fernanda Ruiz, Maria; Sanchez, Lucas			Effect of the Gene doublesex of Anastrepha on the Somatic Sexual Development of Drosophila	PLOS ONE			English	Article							GENITAL DISC; FRUIT-FLY; HOX GENE; MELANOGASTER; EVOLUTION; EXPRESSION; PROTEIN; DIFFERENTIATION; DOMINANT; WINGLESS	Background: The gene doublesex (dsx) is at the bottom of the sex determination genetic cascade and is transcribed in both sexes, but gives rise to two different proteins, DsxF and DsxM, which impose female and male sexual development respectively via the sex-specific regulation of the so-called sexual cyto-differentiation genes. The present manuscript addressed the question about the functional conservation of the tephritid Anastrepha DsxF and DsxM proteins to direct the sexual development in Drosophila (Drosophilidae). Methodology: To express these proteins in Drosophila, the GAL4-UAS system was used. The effect of these proteins was monitored in the sexually dimorphic regions of the fly: the foreleg basitarsus, the 5th, 6th and 7th tergites, and the external terminalia. In addition, we analysed the effect of Anastrepha DsxF and DsxM proteins on the regulation of Drosophila yolk protein genes, which are expressed in the fat body of adult females under the control of dsx. Conclusions: The Anastrepha DsxF and DsxM proteins transformed doublesex intersexual Drosophila flies into females and males respectively, though this transformation was incomplete and the extent of their influence varied in the different sexually dimorphic regions of the adult fly. The Anastrepha DsxF and DsxM proteins also behaved as activators and repressors, respectively, of the Drosophila yolk protein genes, as do the DsxF and DsxM proteins of Drosophila itself. Finally, the Anastrepha DsxF and DsxM proteins were found to counteract the functions of Drosophila DsxM and DsxF respectively, reflecting the normal behaviour of the latter proteins towards one another. Collectively, these results indicate that the Anastrepha DsxF and DsxM proteins show conserved female and male sex-determination function respectively in Drosophila, though it appears that they cannot fully substitute the latter's own Dsx proteins. This incomplete function might be partly due to a reduced capacity of the Anastrepha Dsx proteins to completely control the Drosophila sexual cytodifferentiation genes, a consequence of the accumulation of divergence between these species resulting in the formation of different co-adapted complexes between the Dsx proteins and their target genes.	[Alvarez, Mercedes; Fernanda Ruiz, Maria; Sanchez, Lucas] CSIC, Ctr Invest Biol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Alvarez, M (corresponding author), CSIC, Ctr Invest Biol, Madrid, Spain.	lsanchez@cib.csic.es	Sánchez, Lucas/K-4238-2015; Ruiz, Maria Fernanda/F-3290-2016	Sánchez, Lucas/0000-0002-7725-8961; Ruiz, Maria Fernanda/0000-0002-1649-2105	D.G.I.C.Y.T. (Spanish Government). [BFU2005-03000]	D.G.I.C.Y.T. (Spanish Government).(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was financed by grant BFU2005-03000 awarded to L. Sanchez by the D.G.I.C.Y.T. (Spanish Government). The funding agency did not take part in this work but only provided the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An WQ, 1996, MOL CELL BIOL, V16, P3106; BAKER BS, 1980, GENETICS, V94, P383; BOWNES M, 1994, BIOESSAYS, V16, P745, DOI 10.1002/bies.950161009; BOWNES M, 1990, EMBO J, V9, P3975, DOI 10.1002/j.1460-2075.1990.tb07618.x; BOWNES M, 1981, MOL GEN GENET, V182, P222, DOI 10.1007/BF00269661; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bull J. J., 1983, EVOLUTION SEX DETERM; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; CHASE BA, 1995, GENETICS, V139, P1649; Chen SL, 2008, INSECT BIOCHEM MOLEC, V38, P155, DOI 10.1016/j.ibmb.2007.10.003; Cho S, 1997, J BIOL CHEM, V272, P3185, DOI 10.1074/jbc.272.6.3185; Cho S, 2007, GENETICS, V177, P1733, DOI 10.1534/genetics.107.078980; Christiansen AE, 2002, TRENDS GENET, V18, P510, DOI 10.1016/S0168-9525(02)02769-5; DENELL RE, 1972, DROS INFORM SERV, V48, P45; EPPER F, 1981, DEV BIOL, V88, P104, DOI 10.1016/0012-1606(81)90222-0; Estrada B, 2001, DEVELOPMENT, V128, P331; Ruiz MF, 2007, DEV GENES EVOL, V217, P725, DOI 10.1007/s00427-007-0178-8; Garrett-Engele CM, 2002, DEVELOPMENT, V129, P4661; Gorfinkiel N, 1999, MECH DEVELOP, V86, P113, DOI 10.1016/S0925-4773(99)00122-7; Gowen J. W., 1942, DROSOPH INFORM SERV, V16, P63; Hediger M, 2004, DEV GENES EVOL, V214, P29, DOI 10.1007/s00427-003-0372-2; JURSNICH VA, 1993, DEV BIOL, V155, P235, DOI 10.1006/dbio.1993.1021; Keisman EL, 2001, DEVELOPMENT, V128, P1643; Kopp A, 2000, NATURE, V408, P553, DOI 10.1038/35046017; Kuhn S, 2000, GENOME, V43, P1011, DOI 10.1139/gen-43-6-1011; Lagos D, 2005, GENE, V348, P111, DOI 10.1016/j.gene.2004.12.053; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Marin I, 1998, SCIENCE, V281, P1990, DOI 10.1126/science.281.5385.1990; Moreno E, 1999, NATURE, V400, P873, DOI 10.1038/23709; NOTHIGER R, 1987, GENET RES, V50, P113, DOI 10.1017/S001667230002351X; Ohbayashi F, 2001, COMP BIOCHEM PHYS B, V128, P145, DOI 10.1016/S1096-4959(00)00304-3; Ramos-Onsins S, 1998, MOL PHYLOGENET EVOL, V9, P33, DOI 10.1006/mpev.1997.0438; Ruiz MF, 2005, GENETICS, V171, P849, DOI 10.1534/genetics.105.044925; Saccone G, 2008, INT J DEV BIOL, V52, P1051, DOI 10.1387/ijdb.082657gs; Sanchez L, 2001, BIOESSAYS, V23, P698, DOI 10.1002/bies.1099; Sanchez L, 2001, DEVELOPMENT, V128, P1033; Sanchez L, 1997, GENETICS, V147, P231; SANCHEZ L, 2005, COMPREHENSIVE MOL IN, V1, P1; Sanchez L, 2008, INT J DEV BIOL, V52, P837, DOI 10.1387/ijdb.072396ls; Scali C, 2005, J EXP BIOL, V208, P3701, DOI 10.1242/jeb.01819; Shearman DCA, 1998, INSECT MOL BIOL, V7, P355, DOI 10.1046/j.1365-2583.1998.740355.x; Sievert V, 1997, GENOME, V40, P211, DOI 10.1139/g97-030; Suzuki MG, 2001, INSECT BIOCHEM MOLEC, V31, P1201, DOI 10.1016/S0965-1748(01)00067-4; Waterbury JA, 1999, GENETICS, V152, P1653; Williams TM, 2008, CELL, V134, P610, DOI 10.1016/j.cell.2008.06.052	45	13	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5141	10.1371/journal.pone.0005141	http://dx.doi.org/10.1371/journal.pone.0005141			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340310	Green Published, Green Submitted, gold			2022-12-25	WOS:000265500700023
J	Chen, J; Zheng, RJ; Melman, YF; McDonald, TV				Chen, Jerri; Zheng, Renjian; Melman, Yonathan F.; McDonald, Thomas V.			Functional Interactions between KCNE1 C-Terminus and the KCNQ1 Channel	PLOS ONE			English	Article								The KCNE1 gene product (minK protein) associates with the cardiac KvLQT1 potassium channel (encoded by KCNQ1) to create the cardiac slowly activating delayed rectifier, I-Ks. Mutations throughout both genes are linked to the hereditary cardiac arrhythmias in the Long QT Syndrome (LQTS). KCNE1 exerts its specific regulation of KCNQ1 activation via interactions between membrane-spanning segments of the two proteins. Less detailed attention has been focused on the role of the KCNE1 C-terminus in regulating channel behavior. We analyzed the effects of an LQT5 point mutation (D76N) and the truncation of the entire C-terminus (Delta 70) on channel regulation, assembly and interaction. Both mutations significantly shifted voltage dependence of activation in the depolarizing direction and decreased I-Ks current density. They also accelerated rates of channel deactivation but notably, did not affect activation kinetics. Truncation of the C-terminus reduced the apparent affinity of KCNE1 for KCNQ1, resulting in impaired channel formation and presentation of KCNQ1/KCNE1 complexes to the surface. Complete saturation of KCNQ1 channels with KCNE1-D70 could be achieved by relative over-expression of the KCNE subunit. Rate-dependent facilitation of K+ conductance, a key property of I-Ks that enables action potential shortening at higher heart rates, was defective for both KCNE1 C-terminal mutations, and may contribute to the clinical phenotype of arrhythmias triggered by heart rate elevations during exercise in LQTS mutations. These results support several roles for KCNE1 C-terminus interaction with KCNQ1: regulation of channel assembly, open-state destabilization, and kinetics of channel deactivation.	[Chen, Jerri; McDonald, Thomas V.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA; [Zheng, Renjian; McDonald, Thomas V.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Melman, Yonathan F.] Brigham and Womens Hosp, Dept Med, Boston, MA USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Chen, J (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA.	mcdonald@aecom.yu.edu			NIH/NHLBI [R01 HL075615]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093440, R01HL075615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH/NHLBI: grant R01 HL075615. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Abitbol I, 1999, EMBO J, V18, P4137, DOI 10.1093/emboj/18.15.4137; Angelo K, 2002, BIOPHYS J, V83, P1997, DOI 10.1016/S0006-3495(02)73961-1; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; BASS BG, 1975, AM J PHYSIOL, V228, P1717, DOI 10.1152/ajplegacy.1975.228.6.1717; Bendahhou S, 2005, CARDIOVASC RES, V67, P529, DOI 10.1016/j.cardiores.2005.02.014; BOYETT MR, 1978, J PHYSIOL-LONDON, V285, P359, DOI 10.1113/jphysiol.1978.sp012576; CARMELIET E, 1977, J PHYSIOL-PARIS, V73, P903; Chen H, 2007, BIOPHYS J, V93, P2332, DOI 10.1529/biophysj.107.109702; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; Duggal P, 1998, CIRCULATION, V97, P142, DOI 10.1161/01.CIR.97.2.142; Gage SD, 2004, J GEN PHYSIOL, V124, P759, DOI 10.1085/jgp.200409114; GETTES LS, 1972, CIRC RES, V30, P55, DOI 10.1161/01.RES.30.1.55; GOLDSTEIN SAN, 1991, NEURON, V7, P403, DOI 10.1016/0896-6273(91)90292-8; Grunnet M, 2005, BIOCHEM BIOPH RES CO, V328, P1146, DOI 10.1016/j.bbrc.2005.01.071; HOFFMAN BF, 1959, AM J PHYSIOL, V196, P1297, DOI 10.1152/ajplegacy.1959.196.6.1297; Krumerman A, 2004, AM J PHYSIOL-CELL PH, V286, pC1453, DOI 10.1152/ajpcell.00275.2003; Lundquist Andrew L, 2005, J Mol Cell Cardiol, V38, P277, DOI 10.1016/j.yjmcc.2004.11.012; Melman YF, 2002, J BIOL CHEM, V277, P25187, DOI 10.1074/jbc.M200564200; Melman YF, 2004, NEURON, V42, P927, DOI 10.1016/j.neuron.2004.06.001; Melman YF, 2001, J BIOL CHEM, V276, P6439, DOI 10.1074/jbc.M010713200; Panaghie G, 2006, J PHYSIOL-LONDON, V570, P455, DOI 10.1113/jphysiol.2005.100644; Pusch M, 1998, PFLUG ARCH EUR J PHY, V437, P172, DOI 10.1007/s004240050765; Ravn LS, 2008, HEART RHYTHM, V5, P427, DOI 10.1016/j.hrthm.2007.12.019; Rudy Y, 2006, Q REV BIOPHYS, V39, P57, DOI 10.1017/S0033583506004227; SAENEN JB, 2008, J MOL CELL CARDIOL; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; Schwartz PJ, 2001, CIRCULATION, V103, P89; Seebohm G, 2008, CIRC RES, V103, P1451, DOI 10.1161/CIRCRESAHA.108.177360; Sesti F, 1998, J GEN PHYSIOL, V112, P651, DOI 10.1085/jgp.112.6.651; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Splawski I, 1997, NAT GENET, V17, P338, DOI 10.1038/ng1197-338; TAKUMI T, 1991, J BIOL CHEM, V266, P22192; TAKUMI T, 1988, SCIENCE, V242, P1042, DOI 10.1126/science.3194754; Terrenoire C, 2005, CIRC RES, V96, pE25, DOI 10.1161/01.RES.0000160555.58046.9a; Tester DJ, 2005, HEART RHYTHM, V2, P507, DOI 10.1016/j.hrthm.2005.01.020; Tinel N, 2000, EMBO J, V19, P6326, DOI 10.1093/emboj/19.23.6326; Viswanathan PC, 1999, CIRCULATION, V99, P2466, DOI 10.1161/01.CIR.99.18.2466; Yang YQ, 2004, AM J HUM GENET, V75, P899, DOI 10.1086/425342; ZENG JL, 1995, CIRC RES, V77, P140, DOI 10.1161/01.RES.77.1.140	41	34	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5143	10.1371/journal.pone.0005143	http://dx.doi.org/10.1371/journal.pone.0005143			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340287	Green Published, gold, Green Submitted			2022-12-25	WOS:000265500700024
J	Pandey, M; Batzloff, MR; Good, MF				Pandey, Manisha; Batzloff, Michael R.; Good, Michael F.			Mechanism of Protection Induced by Group A Streptococcus Vaccine Candidate J8-DT: Contribution of B and T-Cells Towards Protection	PLOS ONE			English	Article								Vaccination with J8-DT, a leading GAS vaccine candidate, results in protective immunity in mice. Analysis of immunologic correlates of protection indicated a role of J8-specific antibodies that were induced post-immunization. In the present study, several independent experimental approaches were employed to investigate the protective immunological mechanisms involved in J8-DT-mediated immunity. These approaches included the passive transfer of mouse or rabbit immune serum/antibodies in addition to selective depletion of T-cell subsets prior to bacterial challenge. Passive transfer of J8-DT antiserum/antibodies from mice and rabbits conferred significant resistance against challenge to mice. To exclude the possibility of involvement of other host immune factors, the studies were repeated in SCID mice, which highlighted the need for an ongoing immune response for long-lived protection. Depletion of CD4(+) and CD8(+) T-cell subsets confirmed that an active de novo immune response, involving CD4(+) T-helper cells, is required for continued synthesis of antibodies resulting in protection against GAS infection. Taken together these results indicate an involvement of CD4(+) T-cells in J8-DT-mediated protection possibly via an ability to maintain antibody levels. These results have considerable relevance to the development of a broad spectrum passive immunotherapy for GAS disease.	[Pandey, Manisha; Batzloff, Michael R.; Good, Michael F.] Queensland Inst Med Res, PO Royal Brisbane Hosp, Australian Ctr Vaccine Dev, Brisbane, Qld 4006, Australia	QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital	Pandey, M (corresponding author), Queensland Inst Med Res, PO Royal Brisbane Hosp, Australian Ctr Vaccine Dev, Brisbane, Qld 4006, Australia.	Michael.Good@qimr.edu.au			National Institutes of Health (NIH), USA [5-U01-AI060579]; National Heart Foundation of Australia [G 06B 2523, Fellowship]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI060579] Funding Source: NIH RePORTER	National Institutes of Health (NIH), USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart Foundation of Australia(National Heart Foundation of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by The National Institutes of Health (NIH), USA, (Grant reference #5-U01-AI060579) [http://www.nih.gov]; and The National Heart Foundation of Australia (Grant ID G 06B 2523) [http://www.heartfoundation.org.au]. Michael Batzloff is supported by a Fellowship from the National Heart Foundation of Australia) [http://www.heartfoundation.org.au]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batzloff MR, 2003, J INFECT DIS, V187, P1598, DOI 10.1086/374800; Beedham RJ, 2001, VACCINE, V19, P4409, DOI 10.1016/S0264-410X(01)00197-9; BJORKHOLM B, 1986, SCAND J INFECT DIS, V18, P235, DOI 10.3109/00365548609032332; COLIGAN JE, CURRENT PROTOCOLS IM; Darenberg J, 2004, CLIN INFECT DIS, V38, P836, DOI 10.1086/381979; Gupta M, 2001, J VIROL, V75, P4649, DOI 10.1128/JVI.75.10.4649-4654.2001; Hayman WA, 1997, INT IMMUNOL, V9, P1723, DOI 10.1093/intimm/9.11.1723; Hemachudha T, 1999, CLIN INFECT DIS, V28, P143, DOI 10.1086/517179; Hirunpetcharat C, 1999, J IMMUNOL, V162, P7309; HOUGHTEN RA, 1985, P NATL ACAD SCI USA, V82, P5131, DOI 10.1073/pnas.82.15.5131; Kar S, 2005, INFECT IMMUN, V73, P3823, DOI 10.1128/IAI.73.6.3823-3827.2005; Kennedy BJ, 2000, INFECT IMMUN, V68, P2756, DOI 10.1128/IAI.68.5.2756-2765.2000; Li JSY, 2003, INFECT IMMUN, V71, P4229, DOI 10.1128/IAI.71.8.4229-4237.2003; Liu MY, 2007, INFECT IMMUN, V75, P3651, DOI 10.1128/IAI.00038-07; Ohashi N, 1998, INFECT IMMUN, V66, P132, DOI 10.1128/IAI.66.1.132-139.1998; PANDEY M, 2006, INT C SERIES, V1289, P336; Plotkin SA, 2000, CLIN INFECT DIS, V30, P4, DOI 10.1086/313632; Relf WA, 1996, PEPTIDE RES, V9, P12; RHINEHARTJONES TR, 1994, INFECT IMMUN, V62, P3129, DOI 10.1128/IAI.62.8.3129-3137.1994; Siegert J, 2006, MICROBES INFECT, V8, P347, DOI 10.1016/j.micinf.2005.06.024; Smith DJ, 2001, INFECT IMMUN, V69, P3135, DOI 10.1128/IAI.69.5.3135-3142.2001; Sriskandan S, 2006, J ANTIMICROB CHEMOTH, V58, P117, DOI 10.1093/jac/dkl173; Winslow GM, 2000, INFECT IMMUN, V68, P2187, DOI 10.1128/IAI.68.4.2187-2195.2000	23	38	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5147	10.1371/journal.pone.0005147	http://dx.doi.org/10.1371/journal.pone.0005147			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340309	Green Published, Green Submitted, gold			2022-12-25	WOS:000265500700025
J	Ribeiro, PL; Helene, AF; Xavier, G; Navas, C; Ribeiro, FL				Ribeiro, Pedro Leite; Helene, Andre Frazao; Xavier, Gilberto; Navas, Carlos; Ribeiro, Fernando Leite			Ants Can Learn to Forage on One-Way Trails	PLOS ONE			English	Article							LASIUS-NIGER; FOOD RECRUITMENT; DECISION-MAKING; ATTA-CEPHALOTES; ARGENTINE ANT; CUTTING ANT; DESERT ANTS; ORIENTATION; FORMICIDAE; HYMENOPTERA	The trails formed by many ant species between nest and food source are two-way roads on which outgoing and returning workers meet and touch each other all along. The way to get back home, after grasping a food load, is to take the same route on which they have arrived from the nest. In many species such trails are chemically marked by pheromones providing orientation cues for the ants to find their way. Other species rely on their vision and use landmarks as cues. We have developed a method to stop foraging ants from shuttling on two-way trails. The only way to forage is to take two separate roads, as they cannot go back on their steps after arriving at the food or at the nest. The condition qualifies as a problem because all their orientation cues-chemical, visual or any other - are disrupted, as all of them cannot but lead the ants back to the route on which they arrived. We have found that workers of the leaf-cutting ant Atta sexdens rubropilosa can solve the problem. They could not only find the alternative way, but also used the unidirectional traffic system to forage effectively. We suggest that their ability is an evolutionary consequence of the need to deal with environmental irregularities that cannot be negotiated by means of excessively stereotyped behavior, and that it is but an example of a widespread phenomenon. We also suggest that our method can be adapted to other species, invertebrate and vertebrate, in the study of orientation, memory, perception, learning and communication.	[Ribeiro, Pedro Leite; Helene, Andre Frazao; Xavier, Gilberto; Navas, Carlos] Univ Sao Paulo, Inst Biosci, Dept Physiol, Sao Paulo, Brazil; [Ribeiro, Pedro Leite; Ribeiro, Fernando Leite] Univ Sao Paulo, Inst Psychol, Dept Expt Psychol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Ribeiro, PL (corresponding author), Univ Sao Paulo, Inst Biosci, Dept Physiol, Sao Paulo, Brazil.	pedrorib@ib.usp.br	Helene, Andre/R-9720-2016; Xavier, Gilberto F/B-9464-2013; Navas, Carlos/B-2138-2013	Xavier, Gilberto F/0000-0002-8567-7031; Navas, Carlos/0000-0002-9859-0568	Brazilian National Counsel of Technological and Scientific Development	Brazilian National Counsel of Technological and Scientific Development	Brazilian National Counsel of Technological and Scientific Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKERS R, 1992, INSECT SOC, V39, P59, DOI 10.1007/BF01240531; BECKERS R, 1992, J THEOR BIOL, V159, P397, DOI 10.1016/S0022-5193(05)80686-1; BECKERS R, 1990, INSECT SOC, V37, P258, DOI 10.1007/BF02224053; Bregy P, 2008, J EXP BIOL, V211, P1868, DOI 10.1242/jeb.018036; Burd M, 2003, INSECT SOC, V50, P3, DOI 10.1007/s000400300001; Burd M, 2002, AM NAT, V159, P283, DOI 10.1086/338541; CAMAZINE S, 2003, SELF ORGANIZATION BI; CARTHY JD, 1951, BEHAVIOUR, V3, P304, DOI 10.1163/156853951X00313; CARTHY JD, 1950, NATURE, V166, P154, DOI 10.1038/166154a0; Couzin ID, 2003, P ROY SOC B-BIOL SCI, V270, P139, DOI 10.1098/rspb.2002.2210; Dussutour A, 2005, J EXP BIOL, V208, P2903, DOI 10.1242/jeb.01711; Dussutour A, 2006, BEHAV ECOL SOCIOBIOL, V61, P17, DOI 10.1007/s00265-006-0233-x; Evison SEF, 2008, ANIM BEHAV, V75, P963, DOI 10.1016/j.anbehav.2007.07.013; GOSS S, 1989, NATURWISSENSCHAFTEN, V76, P579, DOI 10.1007/BF00462870; GOTWALD WH, 1982, SOCIAL INSECTS; HOLT SJ, 1955, J ANIM ECOL, V24, P1, DOI 10.2307/1877; Jackson DE, 2004, NATURE, V432, P907, DOI 10.1038/nature03105; Jackson DE, 2006, CURR BIOL, V16, pR570, DOI 10.1016/j.cub.2006.07.015; JANDER R, 1974, INSECT SOC, V21, P45, DOI 10.1007/BF02222979; LAMB AE, 1994, BEHAV PROCESS, V31, P111, DOI 10.1016/0376-6357(94)90040-X; Miura T, 1998, J INSECT BEHAV, V11, P179, DOI 10.1023/A:1021039722402; MOGLICH M, 1975, J COMP PHYSIOL, V101, P275; NONACS P, 1990, DEATH DISTANCE MORTA, P23; Ratnieks F, 2005, NATURE, V436, P465, DOI 10.1038/436465a; Robinson EJH, 2005, NATURE, V438, P442, DOI 10.1038/438442a; Robinson EJH, 2008, J THEOR BIOL, V255, P250, DOI 10.1016/j.jtbi.2008.08.015; Rosengren R., 1971, Acta Zoologica Fennica, V133, P1; Rosengren R., 1977, ACTA ZOOL FENN, V149, P1; Sommer S, 2008, P NATL ACAD SCI USA, V105, P317, DOI 10.1073/pnas.0710157104; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; SUNDSTROM L, 1993, INSECT SOC, V40, P147, DOI 10.1007/BF01240703; TAUTZ J, 1994, ZOOL-ANAL COMPLEX SY, V98, P1; Theraulaz G, 2001, B MATH BIOL, V63, P1079, DOI 10.1006/bulm.2001.0260; TRANIELLO JFA, 1977, BEHAV ECOL SOCIOBIOL, V2, P61, DOI 10.1007/BF00299289; Vandermeer J, 2008, NATURE, V451, P457, DOI 10.1038/nature06477; Vick K, 2004, SOCIOBIOLOGY, V44, P505; VILELA EF, 1987, ANIM BEHAV, V35, P1443, DOI 10.1016/S0003-3472(87)80017-9; Wehner R, 2003, J COMP PHYSIOL A, V189, P579, DOI 10.1007/s00359-003-0431-1; WILSON EO, 1971, INSECT SOC, P560; Zar J. H., 1996, BIOSTATISTICAL ANAL	40	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5024	10.1371/journal.pone.0005024	http://dx.doi.org/10.1371/journal.pone.0005024			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337369	Green Submitted, Green Published, gold			2022-12-25	WOS:000265500600009
J	Vitiello, C; Faraso, S; Sorrentino, NC; Di Salvo, G; Nusco, E; Nigro, G; Cutillo, L; Calabro, R; Auricchio, A; Nigro, V				Vitiello, Carmen; Faraso, Stefania; Sorrentino, Nicolina Cristina; Di Salvo, Giovanni; Nusco, Edoardo; Nigro, Gerardo; Cutillo, Luisa; Calabro, Raffaele; Auricchio, Alberto; Nigro, Vincenzo			Disease Rescue and Increased Lifespan in a Model of Cardiomyopathy and Muscular Dystrophy by Combined AAV Treatments	PLOS ONE			English	Article								Background: The BIO14.6 hamster is an excellent animal model for inherited cardiomyopathy, because of its lethal and well-documented course, due to a spontaneous deletion of delta-sarcoglycan gene promoter and first exon. The muscle disease is progressive and average lifespan is 11 months, because heart slowly dilates towards heart failure. Methodology/Principal Findings: Based on the ability of adeno-associated viral (AAV) vectors to transduce heart together with skeletal muscle following systemic administration, we delivered human delta-sarcoglycan cDNA into male BIO14.6 hamsters by testing different ages of injection, routes of administration and AAV serotypes. Body-wide restoration of delta-SG expression was associated with functional reconstitution of the sarcoglycan complex and with significant lowering of centralized nuclei and fibrosis in skeletal muscle. Motor ability and cardiac functions were completely rescued. However, BIO14.6 hamsters having less than 70% of fibers recovering sarcoglycan developed cardiomyopathy, even if the total rescued protein was normal. When we used serotype 2/8 in combination with serotype 2/1, lifespan was extended up to 22 months with sustained heart function improvement. Conclusions/Significance: Our data support multiple systemic administrations of AAV as a general therapeutic strategy for clinical trials in cardiomyopathies and muscle disorders.	[Vitiello, Carmen; Faraso, Stefania; Sorrentino, Nicolina Cristina; Nusco, Edoardo; Cutillo, Luisa; Auricchio, Alberto; Nigro, Vincenzo] Telethon Inst Genet & Med, Naples, Italy; [Di Salvo, Giovanni; Nigro, Gerardo; Calabro, Raffaele] Seconda Univ Studi Napoli, Dip Sci Cardiotorac Resp, AO Monaldi, Naples, Italy; [Auricchio, Alberto] Univ Federico II, Dip Pediat, Naples, Italy; [Nigro, Vincenzo] Seconda Univ Studi Napoli, Dip Patol Gen, Lab Genet Med, Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Universita della Campania Vanvitelli; University of Naples Federico II; Universita della Campania Vanvitelli	Vitiello, C (corresponding author), Telethon Inst Genet & Med, Naples, Italy.	vincenzo.nigro@unina2.it	AURICCHIO, Alberto/AHE-7979-2022; Sorrentino, Nicolina/AAB-1472-2020; Di Salvo, Giovanni/O-7033-2015; Nigro, Vincenzo/AAB-2274-2022	AURICCHIO, Alberto/0000-0002-0832-2472; Di Salvo, Giovanni/0000-0002-0305-0113; Nigro, Vincenzo/0000-0002-3378-5006; Sorrentino, Nicolina Cristina/0000-0002-3426-5109; Cutillo, Luisa/0000-0002-2205-0338; Calabro, Raffaele/0000-0001-9546-8914	Telethon (TIGEM-TNP42TELC); Ministero dell'Istruzione dell'Universita e della Ricerca (MIUR) [2006061957_003]	Telethon (TIGEM-TNP42TELC)(Fondazione Telethon); Ministero dell'Istruzione dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This study was supported by grants from Telethon (TIGEM-TNP42TELC), Ministero dell'Istruzione dell'Universita e della Ricerca (MIUR: PRIN 2006 Prot.2006061957_003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allocca M, 2008, J CLIN INVEST, V118, P1955, DOI 10.1172/JCI34316; Blankinship MJ, 2004, MOL THER, V10, P671, DOI 10.1016/j.ymthe.2004.07.016; Bostick B, 2008, CIRC RES, V102, P121, DOI 10.1161/CIRCRESAHA.107.162982; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; Chamberlain JS, 2007, FASEB J, V21, P2195, DOI 10.1096/fj.06-7353com; Chao HJ, 2000, MOL THER, V2, P619, DOI 10.1006/mthe.2000.0219; Chao HJ, 2001, MOL THER, V4, P217, DOI 10.1006/mthe.2001.0449; Choi VW, 2005, CURR GENE THER, V5, P299, DOI 10.2174/1566523054064968; Cohen N, 2004, HEART, V90, P835, DOI 10.1136/hrt.2003.023390; Do T, 2002, CURR OPIN PEDIATR, V14, P50, DOI 10.1097/00008480-200202000-00009; Duan DS, 2001, J VIROL, V75, P7662, DOI 10.1128/JVI.75.16.7662-7671.2001; Gao GP, 2000, HUM GENE THER, V11, P2079, DOI 10.1089/104303400750001390; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; Heydemann A, 2007, HUM MOL GENET, V16, P355, DOI 10.1093/hmg/ddl453; Holt KH, 1998, MOL CELL, V1, P841, DOI 10.1016/S1097-2765(00)80083-0; HOMBURGER F, 1962, ARCH INTERN MED, V110, P660, DOI 10.1001/archinte.1962.03620230106015; Homburger F, 1979, Ann N Y Acad Sci, V317, P1, DOI 10.1111/j.1749-6632.1979.tb56503.x; Ikeda Y, 2002, CIRCULATION, V105, P502, DOI 10.1161/hc0402.102953; Inagaki K, 2006, MOL THER, V14, P45, DOI 10.1016/j.ymthe.2006.03.014; Jiang HY, 2006, MOL THER, V14, P452, DOI 10.1016/j.ymthe.2006.05.004; Kobuke K, 2008, HUM MOL GENET, V17, P1201, DOI 10.1093/hmg/ddn009; Li J, 2003, GENE THER, V10, P1807, DOI 10.1038/sj.gt.3302078; Li XY, 1999, NAT BIOTECHNOL, V17, P241, DOI 10.1038/6981; MATSUMURA K, 1992, NATURE, V359, P320, DOI 10.1038/359320a0; Muntoni F, 2003, CURR OPIN NEUROL, V16, P577, DOI 10.1097/00019052-200310000-00003; MUNTONI F, 1993, NEW ENGL J MED, V329, P921, DOI 10.1056/NEJM199309233291304; Neri M, 2007, NEUROMUSCULAR DISORD, V17, P913, DOI 10.1016/j.nmd.2007.07.005; NIGRO G, 1990, INT J CARDIOL, V26, P271, DOI 10.1016/0167-5273(90)90082-G; Nigro V, 1997, HUM MOL GENET, V6, P601, DOI 10.1093/hmg/6.4.601; Nigro V, 1996, NAT GENET, V14, P195, DOI 10.1038/ng1096-195; Ozawa E, 2005, MUSCLE NERVE, V32, P563, DOI 10.1002/mus.20349; Pacak CA, 2006, CIRC RES, V99, pE3, DOI 10.1161/01.RES.0000237661.18885.f6; Politano L, 1996, JAMA-J AM MED ASSOC, V275, P1335, DOI 10.1001/jama.275.17.1335; RAGOT T, 1993, NATURE, V361, P647, DOI 10.1038/361647a0; Scott JM, 2002, NEUROMUSCULAR DISORD, V12, pS23, DOI 10.1016/S0960-8966(02)00078-0; Simonds AK, 2006, CHEST, V130, P1879, DOI 10.1378/chest.130.6.1879; Wang Z, 2005, NAT BIOTECHNOL, V23, P321, DOI 10.1038/nbt1073; Zhu T, 2005, CIRCULATION, V112, P2650, DOI 10.1161/CIRCULATIONAHA.105.565598	39	19	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e5051	10.1371/journal.pone.0005051	http://dx.doi.org/10.1371/journal.pone.0005051			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333401	Green Published, Green Submitted, gold			2022-12-25	WOS:000265499900013
J	Zhou, HF; Chan, HW; Wickline, SA; Lanza, GM; Pham, CTN				Zhou, Hui-fang; Chan, Happy W.; Wickline, Samuel A.; Lanza, Gregory M.; Pham, Christine T. N.			alpha(v)beta(3)-Targeted nanotherapy suppresses inflammatory arthritis in mice	FASEB JOURNAL			English	Article						angiogenesis; K/BxN mouse model; perfluorocarbon nanoparticles; systemic drug delivery	COLLAGEN-INDUCED ARTHRITIS; VX-2 RABBIT TUMORS; RHEUMATOID-ARTHRITIS; MAGNETIC-RESONANCE; INTRAARTICULAR TREATMENT; ANGIOGENESIS; NANOPARTICLES; EFFICACY; BIOLOGICS; INHIBITOR	The purpose of this study was to assess whether an alternative treatment approach that targets angiogenesis, delivered through ligand-targeted nano-therapy, would ameliorate inflammatory arthritis. Arthritis was induced using the K/BxN mouse model of inflammatory arthritis. After arthritis was clearly established, mice received three consecutive daily doses of alpha(v)beta 3-targeted fumagillin nanoparticles. Control groups received no treatment or alpha(v)beta(3)-targeted nanoparticles without drugs. Disease score and paw thickness were measured daily. Mice that received alpha(v)beta(3)-targeted fumagillin nanoparticles showed a significantly lower disease activity score (mean score of 1.4 +/- 0.4; P<0.001) and change in ankle thickness (mean increase of 0.17 +/- 0.05 mm; P<0.001) 7 d after arthritis induction, whereas the group that received alpha(v)beta(3)-targeted nanoparticles without drugs exhibited a mean arthritic score of 9.0 +/- 0.3 and mean change in ankle thickness of 1.01 +/- 0.09 mm. Meanwhile, the group that received no treatment showed a mean arthritic score of 9.8 +/- 0.5 and mean change in ankle thickness of 1.05 +/- 0.10 mm. Synovial tissues from animals treated with targeted fumagillin nanoparticles also showed significant decrease in inflammation and angiogenesis and preserved proteoglycan integrity. Ligand-targeted nanotherapy to deliver antiangiogenic agents may represent an effective way to treat inflammatory arthritis.-Zhou, H.-F., Chan, H. W., Wickline, S. A., Lanza, G. M., Pham, C. T. N. alpha(v)beta(3)-Targeted nanotherapy suppresses inflammatory arthritis in mice. FASEB J. 23, 2978-2985 (2009). www.fasebj.org	[Zhou, Hui-fang; Pham, Christine T. N.] Washington Univ, Sch Med, Div Rheumatol, St Louis, MO USA; [Wickline, Samuel A.; Lanza, Gregory M.] Washington Univ, Sch Med, Div Cardiol, St Louis, MO USA; [Chan, Happy W.] Univ Calif Davis, Div Rheumatol, Sch Med, Davis, CA 95616 USA	Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California Davis	Pham, CTN (corresponding author), 660 S Euclid Ave,Box 8045, St Louis, MO 63110 USA.	cpham@im.wustl.edu			National Institutes of Health [AR-056468, CA-119342, HL-78631]; NATIONAL CANCER INSTITUTE [U54CA119342] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056468] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the National Institutes of Health (AR-056468, CA-119342, and HL-78631). The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. S. A. W. and G. M. L. are scientific cofounders of Kereos, Inc. and minority shareholders (<5%). We extend sincere appreciation to Ralph Fuhrhop for formulation chemistry. We thank Dr. Fei Shih (Washington University) for the generous gift of K/BxN serum.	Adkison AM, 2002, J CLIN INVEST, V109, P363, DOI 10.1172/JCI13462; Badger AM, 2001, ARTHRITIS RHEUM-US, V44, P128, DOI 10.1002/1529-0131(200101)44:1<128::AID-ANR17>3.0.CO;2-M; Bernier SG, 2004, P NATL ACAD SCI USA, V101, P10768, DOI 10.1073/pnas.0404105101; Bhargava P, 1999, CLIN CANCER RES, V5, P1989; Buch MH, 2007, RHEUMATOLOGY, V46, P1153, DOI 10.1093/rheumatology/kem075; Caruthers SD, 2006, INVEST RADIOL, V41, P305, DOI 10.1097/01.rli.0000199281.60135.6a; Ceponis A, 2001, ARTHRITIS RHEUM, V44, P1908; de Bandt M, 2000, ARTHRITIS RHEUM, V43, P2056; Fukumura D, 2007, MICROVASC RES, V74, P72, DOI 10.1016/j.mvr.2007.05.003; Gartlehner G, 2006, J RHEUMATOL, V33, P2398; Gerlag DM, 2001, ARTHRITIS RES, V3, P357, DOI 10.1186/ar327; Hannig G, 2007, ARTHRITIS RHEUM-US, V56, P850, DOI 10.1002/art.22402; Hu G, 2007, INT J CANCER, V120, P1951, DOI 10.1002/ijc.22581; Ji H, 2001, J EXP MED, V194, P321, DOI 10.1084/jem.194.3.321; KAUFMAN R, 1996, EMULSIONS EMULSION S, V132, P343; Koch AE, 2003, ANN RHEUM DIS, V62, P60, DOI 10.1136/ard.62.suppl_2.ii60; Kochansky J, 2004, APIDOLOGIE, V35, P301, DOI 10.1051/apido:2004017; Koning GA, 2006, ARTHRITIS RHEUM-US, V54, P1198, DOI 10.1002/art.21719; Krafft MP, 2001, ADV DRUG DELIVER REV, V47, P209, DOI 10.1016/S0169-409X(01)00107-7; Kudelka AP, 1998, NEW ENGL J MED, V338, P991, DOI 10.1056/NEJM199804023381412; Lainer DT, 2005, EXPERT OPIN INV DRUG, V14, P1, DOI 10.1517/13543784.14.1.1; Lainer-Carr D, 2007, NAT CLIN PRACT RHEUM, V3, P434, DOI 10.1038/ncprheum0559; Lanza GM, 2005, CURR TOP DEV BIOL, V70, P57, DOI 10.1016/S0070-2153(05)70003-X; Liggins RT, 2004, INFLAMM RES, V53, P363, DOI 10.1007/s00011-004-1273-1; Liu SP, 1998, SCIENCE, V282, P1324, DOI 10.1126/science.282.5392.1324; Mandik-Nayak L, 2005, IMMUNOL RES, V32, P5, DOI 10.1385/IR:32:1-3:005; Nahar M, 2006, CRIT REV THER DRUG, V23, P259, DOI 10.1615/CritRevTherDrugCarrierSyst.v23.i4.10; Neubauer AM, 2007, J CARDIOVASC MAGN R, V9, P565, DOI 10.1080/10976640600945481; Offodile R, 1999, TUMORI, V85, P51, DOI 10.1177/030089169908500111; Riess JG, 2001, CHEM REV, V101, P2797, DOI 10.1021/cr970143c; Schmieder AH, 2005, MAGN RESON MED, V53, P621, DOI 10.1002/mrm.20391; Schmieder AH, 2008, FASEB J, V22, P4179, DOI 10.1096/fj.08-112060; Schnell MA, 2002, HUM GENE THER, V13, P155, DOI 10.1089/10430340152712700; Siddiqui MAA, 2007, CURR OPIN RHEUMATOL, V19, P308, DOI 10.1097/01.bor.0000265447.48722.04; Storgard CM, 1999, J CLIN INVEST, V103, P47, DOI 10.1172/JCI3756; Szekanecz Z, 2005, FRONT BIOSCI-LANDMRK, V10, P1739, DOI 10.2741/1657; Tarner IH, 2007, NAT CLIN PRACT RHEUM, V3, P336, DOI 10.1038/ncprheum0506; Tsai CY, 2007, ARTHRITIS RHEUM-US, V56, P544, DOI 10.1002/art.22401; VANLENT PLEM, 1993, RHEUMATOL INT, V13, P21, DOI 10.1007/BF00290330; Winter PM, 2008, FASEB J, V22, P2758, DOI 10.1096/fj.07-103929; Winter PM, 2006, ARTERIOSCL THROM VAS, V26, P2103, DOI 10.1161/01.ATV.0000235724.11299.76; Winter PM, 2003, CANCER RES, V63, P5838; Winter PM, 2003, CIRCULATION, V108, P2270, DOI 10.1161/01.CIR.0000093185.16083.95; YADAV JS, 2008, SYNTHESIS-STUTTGART, V9, P1460; Zink A, 2006, ARTHRITIS RHEUM-US, V54, P3399, DOI 10.1002/art.22193	45	67	68	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2009	23	9					2978	2985		10.1096/fj.09-129874	http://dx.doi.org/10.1096/fj.09-129874			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19376816	Green Published			2022-12-25	WOS:000270241000020
J	Issuree, PDA; Pushparaj, PN; Pervaiz, S; Melendez, AJ				Issuree, Priya D. A.; Pushparaj, Peter N.; Pervaiz, Shazib; Melendez, Alirio J.			Resveratrol attenuates C5a-induced inflammatory responses in vitro and in vivo by inhibiting phospholipase D and sphingosine kinase activities	FASEB JOURNAL			English	Article						infl131ammation; neutrophil migration; oxidative burst; chemotaxis; ERK1/2; anaphylatoxin	ACTIVATED PROTEIN-KINASE; SIGNAL-REGULATED KINASE; C5A DELAYS APOPTOSIS; FC-GAMMA-RI; NF-KAPPA-B; HUMAN-NEUTROPHILS; PHOSPHATIDIC-ACID; TNF-ALPHA; KEY ROLE; OXIDATIVE BURST	The anti-inflammatory activity of the phytoalexin resveratrol (RSV) was evaluated in C5 anaphylatoxin (C5a)-stimulated primary neutrophils and in a mouse model of acute peritonitis. Pretreatment of human and mouse neutrophils with RSV significantly blocked oxidative burst, leukocyte migration, degranulation, and inflammatory cytokine production. The anti-inflammatory activity of RSV was a function of inhibition of sphingosine kinase (SphK) activity (IC50 similar to 20 mu M) within 5 min of exposure, its membrane localization, and SphK1-mediated Ca2+ release. As an experimental control, the SphK1 pharmacological inhibitor N,N-dimethyl sphingosine (DMS) was used to compare the inhibitory effect of RSV. We also provide evidence that the SphK inhibitory effect of RSV was mediated via its ability to block phospholipase D (PLD) activity and membrane recruitment. Furthermore, RSV blocked ERK1/2 phosphorylation, which functioned independently of SphK1 in this study. To provide in vivo relevance to these data, C5a-induced model of acute peritonitis was established, and the effects of prior injection of RSV were investigated. Indeed, prior injection of RSV virtually completely attenuated the effects of C5a on vascular permeability, neutrophil migration, release of interleukin 1 beta, tumor necrosis factor alpha, interleukin 6, and the chemokine MIP-1 alpha. Taken together, these data demonstrate strong anti-inflammatory activity of RSV in vitro and in vivo and highlight SphK1 as a potential target of this remarkable phytoalexin. These data could have tremendous implications for the clinical use of RSV in inflammatory pathologies.-Issuree, P. D. A., Pushparaj, P. N., Pervaiz, S., Melendez, A. J. Resveratrol attenuates C5a-induced inflammatory responses in vitro and in vivo by inhibiting phospholipase D and sphingosine kinase activities. FASEB J. 23, 2412-2424 (2009)	[Issuree, Priya D. A.; Pushparaj, Peter N.; Pervaiz, Shazib; Melendez, Alirio J.] Natl Univ Singapore, Dept Physiol, Yong Loo Lin Sch Med, Singapore 117597, Singapore; [Pervaiz, Shazib; Melendez, Alirio J.] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117597, Singapore; [Pervaiz, Shazib] Natl Univ Singapore, Duke NUS Grad Med Sch, Singapore 117597, Singapore; [Pushparaj, Peter N.; Melendez, Alirio J.] Univ Glasgow, Glasgow Biomed Res Ctr, Glasgow, Lanark, Scotland; [Pervaiz, Shazib] Singapore Massachusetts Inst Technol, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; University of Glasgow; Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Pervaiz, S (corresponding author), Natl Univ Singapore, Dept Physiol, Yong Loo Lin Sch Med, Singapore 117597, Singapore.	phssp@nus.edu.sg; a.melendez-romero@clinmed.gla.ac.uk	Pushparaj, Peter Natesan/H-9871-2012; Pervaiz, Shazib/C-4188-2015	Pushparaj, Peter Natesan/0000-0001-7574-1880; Issuree, Priya/0000-0002-8886-6436	National University of Singapore Academic Research Funds; Medical Research Council-UK [MRC G0700794]; National Medical Research Council and the Biomedical Research Council, Singapore; Medical Research Council [G0700794] Funding Source: researchfish	National University of Singapore Academic Research Funds(National University of Singapore); Medical Research Council-UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Medical Research Council and the Biomedical Research Council, Singapore(National Medical Research Council, Singapore); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	A. J. M. is supported by the National University of Singapore Academic Research Funds and Medical Research Council-UK, grant MRC G0700794. S. P. is supported by grants from the National Medical Research Council and the Biomedical Research Council, Singapore. P. D. A. I. performed most of the experiments and helped in the initial draft of the manuscript; P.N.P. performed Ca<SUP>2+</SUP> measurements and helped with the animal experiments and the initial draft of the manuscript; S. P. is a senior principal investigator and was involved in designing the study, analyzing the data, writing the final version of the manuscript, and funding support for the work; A. J. M. is a senior principal investigator and was involved in designing the study, setting up the in vivo model, analyzing the data, writing the manuscript, and funding support for the work.	Aggarwal BB, 2004, ANTICANCER RES, V24, P2783; AGWU DE, 1991, J CLIN INVEST, V88, P531, DOI 10.1172/JCI115336; Albert D, 2008, J LEUKOCYTE BIOL, V83, P1019, DOI 10.1189/jlb.0807531; Barthomeuf C, 2007, FREE RADICAL BIO MED, V42, P312, DOI 10.1016/j.freeradbiomed.2006.11.002; BAULDRY SA, 1991, J BIOL CHEM, V266, P4173; Baumruker T, 2005, IMMUNOL LETT, V96, P175, DOI 10.1016/j.imlet.2004.09.001; Blaukat A, 2001, BIOL CHEM, V382, P135, DOI 10.1515/BC.2001.020; Bohm M, 2002, DEUT MED WOCHENSCHR, V127, P2748, DOI 10.1055/s-2002-36275; Boncoeur E, 2008, INT J BIOCHEM CELL B, V40, P432, DOI 10.1016/j.biocel.2007.08.013; Brown KM, 2007, NAT CLIN PRACT NEPHR, V3, P277, DOI 10.1038/ncpneph0465; Chen XL, 2004, AM J PHYSIOL-HEART C, V287, pH1452, DOI 10.1152/ajpheart.01101.2003; Chiou WF, 2004, INT IMMUNOPHARMACOL, V4, P1329, DOI 10.1016/j.intimp.2004.05.017; Choi OH, 1996, NATURE, V380, P634; Clement MV, 1998, BLOOD, V92, P996; Crowell JA, 2004, TOXICOL SCI, V82, P614, DOI 10.1093/toxsci/kfh263; DAHINDEN CA, 1983, J CLIN INVEST, V72, P113, DOI 10.1172/JCI110948; Das Samarjit, 2007, Inflammation & Allergy Drug Targets, V6, P168, DOI 10.2174/187152807781696464; Dewas C, 2000, J IMMUNOL, V165, P5238, DOI 10.4049/jimmunol.165.9.5238; Drost EM, 2002, EUR J IMMUNOL, V32, P393, DOI 10.1002/1521-4141(200202)32:2<393::AID-IMMU393>3.0.CO;2-5; English J, 1999, EXP CELL RES, V253, P255, DOI 10.1006/excr.1999.4687; Feng GJ, 1999, J IMMUNOL, V163, P6403; GERARD C, 1981, J IMMUNOL, V127, P1978; GOLDSTEI.IM, 1974, J IMMUNOL, V113, P1583; Gomez-Cambronero J, 2007, J LEUKOCYTE BIOL, V82, P272, DOI 10.1189/jlb.0107033; Goodridge HS, 2003, IMMUNOLOGY, V109, P415, DOI 10.1046/j.1365-2567.2003.01689.x; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hannigan MO, 2001, J IMMUNOL, V167, P3953, DOI 10.4049/jimmunol.167.7.3953; Holme AL, 2007, J BIOENERG BIOMEMBR, V39, P59, DOI 10.1007/s10863-006-9053-y; HUGLI T E, 1981, Critical Reviews in Immunology, V1, P321; Ibrahim FBM, 2004, J BIOL CHEM, V279, P44802, DOI 10.1074/jbc.M403977200; Jolly PS, 2004, J EXP MED, V199, P959, DOI 10.1084/jem.20030680; JONES SA, 1995, FEBS LETT, V364, P211, DOI 10.1016/0014-5793(95)00397-R; KANAHO Y, 1991, FEBS LETT, V279, P249, DOI 10.1016/0014-5793(91)80160-5; Khanduja KL, 2004, J NUTR SCI VITAMINOL, V50, P61, DOI 10.3177/jnsv.50.61; Lai WQ, 2008, J IMMUNOL, V180, P4323, DOI 10.4049/jimmunol.180.6.4323; Lee C, 2004, J TRAUMA, V57, P955, DOI 10.1097/01.ta.0000149495.44582.76; Lee SC, 2006, PROTEOMICS, V6, P2386, DOI 10.1002/pmic.200500366; Lehman JA, 2001, AM J PHYSIOL-CELL PH, V280, pC183, DOI 10.1152/ajpcell.2001.280.1.C183; Liu K, 2008, J BIOL CHEM, V283, P9977, DOI 10.1074/jbc.M710257200; Mansfield PJ, 2002, BLOOD, V99, P1434, DOI 10.1182/blood.V99.4.1434; MARDER SR, 1985, J IMMUNOL, V134, P3325; Maupas-Schwalm F, 2004, FASEB J, V18, P1398, DOI 10.1096/fj.03-1123fje; Melendez A, 1998, CURR BIOL, V8, P210, DOI 10.1016/S0960-9822(98)70085-5; Melendez AJ, 2002, J BIOL CHEM, V277, P17255, DOI 10.1074/jbc.M110944200; Melendez AJ, 2001, BLOOD, V98, P3421, DOI 10.1182/blood.V98.12.3421; Melendez AJ, 2007, NAT MED, V13, P1375, DOI 10.1038/nm1654; MULLMANN TJ, 1990, J IMMUNOL, V144, P1901; N'Guessan PD, 2007, EUR RESPIR J, V30, P443, DOI 10.1183/09031936.00008707; Nagata T, 2001, BRIT J ANAESTH, V86, P853, DOI 10.1093/bja/86.6.853; Nishiuma T, 2008, AM J PHYSIOL-LUNG C, V294, pL1085, DOI 10.1152/ajplung.00445.2007; Perianayagam MC, 2002, KIDNEY INT, V61, P456, DOI 10.1046/j.1523-1755.2002.00139.x; Perianayagam MC, 2004, EUR J CLIN INVEST, V34, P50, DOI 10.1111/j.1365-2362.2004.01273.x; Pervaiz S, 2004, DRUG RESIST UPDATE, V7, P333, DOI 10.1016/j.drup.2004.11.001; Pervaiz S, 2003, FASEB J, V17, P1975, DOI 10.1096/fj.03-0168rev; Pettus BJ, 2003, FASEB J, V17, P1411, DOI 10.1096/fj.02-1038com; Pilette C, 2002, J IMMUNOL, V168, P4103, DOI 10.4049/jimmunol.168.8.4103; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Pushparaj PN, 2008, INT J BIOCHEM CELL B, V40, P1817, DOI 10.1016/j.biocel.2008.01.015; Riedemann NC, 2002, J IMMUNOL, V168, P1919, DOI 10.4049/jimmunol.168.4.1919; SACKS T, 1978, J CLIN INVEST, V61, P1161, DOI 10.1172/JCI109031; Schett G, 2000, ARTHRITIS RHEUM, V43, P2501, DOI 10.1002/1529-0131(200011)43:11<2501::AID-ANR18>3.0.CO;2-K; Sebai H, 2008, FREE RADICAL RES, V42, P913, DOI 10.1080/10715760802555577; Sethu S, 2008, J IMMUNOL, V180, P6027, DOI 10.4049/jimmunol.180.9.6027; Shu XD, 2002, MOL CELL BIOL, V22, P7758, DOI 10.1128/MCB.22.22.7758-7768.2002; Subbaramaiah K, 1998, J BIOL CHEM, V273, P21875, DOI 10.1074/jbc.273.34.21875; Szewczuk LM, 2004, J NAT PROD, V67, P1777, DOI 10.1021/np0498410; Tou JS, 2001, CELL SIGNAL, V13, P191, DOI 10.1016/S0898-6568(01)00137-1; Vlasenko LP, 2005, J IMMUNOL, V174, P6456, DOI 10.4049/jimmunol.174.10.6456; von Knethen A, 1999, J IMMUNOL, V163, P2858; Wu WC, 2004, MOL CELL BIOL, V24, P7359, DOI 10.1128/MCB.24.17.7359-7369.2004; Xythalis D, 2002, INFLAMMATION, V26, P83, DOI 10.1023/A:1014836211643; Zhi L, 2006, J CELL PHYSIOL, V208, P109, DOI 10.1002/jcp.20646	72	48	49	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2412	2424		10.1096/fj.09-130542	http://dx.doi.org/10.1096/fj.09-130542			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19346296	Bronze			2022-12-25	WOS:000268836700010
J	Michel, V; Bakovic, M				Michel, Vera; Bakovic, Marica			The solute carrier 44A1 is a mitochondrial protein and mediates choline transport	FASEB JOURNAL			English	Article							RAT-LIVER MITOCHONDRIA; FUNCTIONAL-CHARACTERIZATION; ESSENTIAL NUTRIENT; EXPRESSION; MEMBRANE; FAMILY; INHIBITORS; APOPTOSIS; NEURONS; HUMANS	Choline oxidation to betaine takes place in the mitochondria; however, a protein regulating mitochondrial choline transport was never identified. The purpose of this study was to analyze subcellular localization of the solute carrier 44A1 (SLC44A1), a plasma membrane choline transporter sensitive to inhibition by hemicholinium-3. We generated N- and C-terminal-SLC44A1- specific antibodies and analyzed localization of endogenous and overexpressed SLC44A1 in C2C12 mouse muscle cells, MCF7 human breast cancer cells, and mouse tissues using confocal microscopy, differential centrifugation, and Western blotting. We further performed choline uptake competition studies on isolated mitochondria using the specific inhibitor hemicholinium-3 and SLC44A1 antibodies, and analyzed mitochondria of FL83B hepatocytes after the targeted knock-down of SLC44A1 using siRNA technology. In addition, we analyzed SLC44A1 expression during choline deficiency. Localization studies revealed plasma membrane, cytosolic, microsomal, and mitochondrial localization of endogenous and His-tagged SLC44A1. Uptake studies in isolated mitochondria show an accumulation of H-3-choline, which is strongly inhibited by hemicholinium- 3 (60%), by an excess of unlabeled choline (97%), and by both SLC44A1 antibodies. SLC44A1 mRNA and protein expression were down-regulated during choline deficiency. These data clearly establish SLC44A1 as an important mediator of choline transport across both the plasma membrane and the mitochondrial membrane.-Michel, V., Bakovic, M. The solute carrier 44A1 is a mitochondrial protein and mediates choline transport. FASEB J. 23, 2749-2758 ( 2009)	[Michel, Vera; Bakovic, Marica] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada	University of Guelph	Michel, V (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, Anim Sci & Nutr Bldg,Rm 309, Guelph, ON N1G 2W1, Canada.	vmichel@uoguelph.ca			Ontario Graduate Scholarship in Science and Technology; Natural Sciences and Engineering Research Council of Canada	Ontario Graduate Scholarship in Science and Technology; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This study was supported by an Ontario Graduate Scholarship in Science and Technology (to V. M.) and by an operating grant from the Natural Sciences and Engineering Research Council of Canada (to M. B.).	Arnold I, 1998, J BIOL CHEM, V273, P1469, DOI 10.1074/jbc.273.3.1469; Birbes H, 2002, ADV ENZYME REGUL, V42, P113, DOI 10.1016/S0065-2571(01)00026-7; Birbes H, 2001, FASEB J, V15, P2669, DOI 10.1096/fj.01-0539com; BLUSZTAJN JK, 1983, SCIENCE, V221, P614, DOI 10.1126/science.6867732; DEVES R, 1979, BIOCHIM BIOPHYS ACTA, V557, P469, DOI 10.1016/0005-2736(79)90344-4; Diekert K, 1999, P NATL ACAD SCI USA, V96, P11752, DOI 10.1073/pnas.96.21.11752; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fisher MC, 2001, TERATOLOGY, V64, P114, DOI 10.1002/tera.1053; Fujita T, 2006, NEUROSCI LETT, V393, P216, DOI 10.1016/j.neulet.2005.09.069; Fullerton MD, 2006, AM J PHYSIOL-CELL PH, V290, pC1230, DOI 10.1152/ajpcell.00255.2005; GRASSL SM, 1994, BBA-BIOMEMBRANES, V1194, P203, DOI 10.1016/0005-2736(94)90221-6; HAUBRICH DR, 1981, BIOCHEM PHARMACOL, V30, P2993, DOI 10.1016/0006-2952(81)90265-3; HOSTETLER KY, 1979, CANCER RES, V39, P2978; HOVIUS R, 1990, BIOCHIM BIOPHYS ACTA, V1021, P217, DOI 10.1016/0005-2736(90)90036-N; Inazu M, 2005, J NEUROCHEM, V94, P1427, DOI 10.1111/j.1471-4159.2005.03299.x; Jin JK, 2006, NEUROSCI LETT, V407, P263, DOI 10.1016/j.neulet.2006.08.062; KAPLAN CP, 1993, FEBS LETT, V321, P24, DOI 10.1016/0014-5793(93)80613-Y; Kharbanda KK, 2007, J HEPATOL, V46, P314, DOI 10.1016/j.jhep.2006.08.024; Madesh M, 1998, BBA-LIPID LIPID MET, V1389, P206, DOI 10.1016/S0005-2760(97)00155-0; MCMURRAY WC, 1986, BIOCHEM CELL BIOL, V64, P1115, DOI 10.1139/o86-147; Mellott TJ, 2007, BRAIN RES, V1151, P1, DOI 10.1016/j.brainres.2007.03.004; Michel V, 2006, EXP BIOL MED, V231, P490; O'Regan S, 2000, P NATL ACAD SCI USA, V97, P1835, DOI 10.1073/pnas.030339697; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; PORTER RK, 1992, J BIOL CHEM, V267, P14637; PORTER RK, 1993, BIOCHIM BIOPHYS ACTA, V1141, P269, DOI 10.1016/0005-2728(93)90052-H; SIMON JR, 1976, J NEUROCHEM, V26, P909, DOI 10.1111/j.1471-4159.1976.tb06472.x; Spector D. L., 1998, CELLS LAB MANUAL; Stone SJ, 2000, J BIOL CHEM, V275, P34534, DOI 10.1074/jbc.M002865200; STREUMERSVOBODOVA Z, 1977, PHYSIOL BOHEMOSLOV, V26, P525; Traiffort E, 2005, J NEUROCHEM, V92, P1116, DOI 10.1111/j.1471-4159.2004.02962.x; Voelker DR, 2004, TOP CURR GENET, V8, P267; Wang T, 2007, ACTA BIOCH BIOPH SIN, V39, P668, DOI 10.1111/j.1745-7270.2007.00323.x; Wille S, 2001, J IMMUNOL, V167, P5795, DOI 10.4049/jimmunol.167.10.5795; Yuan ZF, 2004, GENE, V341, P305, DOI 10.1016/j.gene.2004.07.042; Zeisel S H, 1997, Adv Pediatr, V44, P263; Zeisel SH, 2000, NUTRITION, V16, P669, DOI 10.1016/S0899-9007(00)00349-X; Zeisel SH, 2005, AM J CLIN NUTR, V82, P719, DOI 10.1093/ajcn/82.4.719; ZEISEL SH, 1991, FASEB J, V5, P2093, DOI 10.1096/fasebj.5.7.2010061; Zhu LJ, 2005, ANAL BIOCHEM, V345, P102, DOI 10.1016/j.ab.2005.07.028	40	46	53	8	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2749	2758		10.1096/fj.08-121491	http://dx.doi.org/10.1096/fj.08-121491			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19357133				2022-12-25	WOS:000268836700043
J	Jeon, BN; Choi, WI; Yu, MY; Yoon, AR; Kim, MH; Yun, CO; Hur, MW				Jeon, Bu-Nam; Choi, Won-Il; Yu, Mi-Young; Yoon, A-Rum; Kim, Myung-Hwa; Yun, Chae-Ok; Hur, Man-Wook			ZBTB2, a Novel Master Regulator of the p53 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN INTERACTION MOTIF; ACUTE PROMYELOCYTIC LEUKEMIA; DNA-BINDING DOMAIN; POZ-DOMAIN; HISTONE DEACETYLASE; FINGER PROTEIN; TRANSCRIPTION; GENE; REPRESSION; SP1	We found that ZBTB2, a POK family transcription factor, is a potent repressor of the ARF-HDM2-p53-p21 pathway important in cell cycle regulation. ZBTB2 repressed transcription of the ARF, p53, and p21 genes, but activated the HDM2 gene. In particular, ZBTB2 repressed transcription of the p21 gene by acting on the two distal p53 binding elements and the proximal Sp1 binding GC-box 5/6 elements. ZBTB2 directly interacted with Sp1 via its POZ domain and zinc fingers, which was important in the repression of transcription activation by Sp1. ZBTB2 and Sp1 competed with each other in binding to the GC-box 5/6 elements and the two p53 binding elements. ZBTB2 directly interacted with p53 via its zinc fingers, inhibiting p53 binding and repressing transcription activation by p53. The POZ domain, required for transcription repression, interacted with corepressors such as BCoR, NCoR, and SMRT. The interactions deacetylated histones Ac-H3 and -H4 at the proximal promoter. Although ectopic ZBTB2 stimulated cell proliferation, knockdown of ZBTB2 expression decreased cell proliferation and DNA synthesis. Overall, our data suggest that ZBTB2 is a potential proto-oncogenic master control gene of the p53 pathway and, in particular, is a potent transcription repressor of the cell cycle arrest gene p21 by inhibiting p53 and Sp1.	[Yoon, A-Rum; Yun, Chae-Ok] Yonsei Univ, Sch Med, Inst Canc Res, Seoul 120752, South Korea; [Jeon, Bu-Nam; Choi, Won-Il; Yu, Mi-Young; Kim, Myung-Hwa; Hur, Man-Wook] Inst Genet Sci, Dept Biochem & Mol Biol, Brain Korea Project Med Sci 21, Seoul 120752, South Korea	Yonsei University	Yun, CO (corresponding author), Yonsei Univ, Sch Med, Inst Canc Res, 134 ShinChon Dong, Seoul 120752, South Korea.	chaeok@yuhs.ac; mwhur2@yuhs.ac	Yun, Chae-Ok/P-3698-2015	CHOI, WONIL/0000-0002-4837-0436; Yun, Chae-Ok/0000-0002-9466-4531; Hur, Man-Wook/0000-0002-3416-1334	National Research Laboratory Research [ROA-2003-000-10318-0, M10416130002-04N1613-00210, R15-2004-024-02001-0]; Medical Research Center; Korean Science and Engineering Foundation of the Korean Ministry of Science and Technology [R13-2002-054-05002-0]; Korean Ministry for Health, Welfare and Family Affairs [00001561]	National Research Laboratory Research(Korea Science and Engineering Foundation); Medical Research Center; Korean Science and Engineering Foundation of the Korean Ministry of Science and Technology(Korea Science and Engineering Foundation); Korean Ministry for Health, Welfare and Family Affairs	This work was supported by National Research Laboratory Research Grants ROA-2003-000-10318-0 (to M.-W. H.) and M10416130002-04N1613-00210 and R15-2004-024-02001-0 (to C.-O. Y.), Medical Research Center Grant R13-2002-054-05002-0 (to M.-W. H.) from the Korean Science and Engineering Foundation of the Korean Ministry of Science and Technology, and Grant 00001561 (to M.-W. H.) from the National R& D Program for Cancer Control, Korean Ministry for Health, Welfare and Family Affairs.	ALBAGLI O, 1995, CELL GROWTH DIFFER, V6, P1193; Aravind L, 1999, J MOL BIOL, V285, P1353, DOI 10.1006/jmbi.1998.2394; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Barna M, 2000, NAT GENET, V25, P166, DOI 10.1038/76014; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Chen WY, 2004, CANCER CELL, V6, P387, DOI 10.1016/j.ccr.2004.08.030; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; Choi WI, 2008, J BIOL CHEM, V283, P29341, DOI 10.1074/jbc.M802477200; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Deltour S, 1999, P NATL ACAD SCI USA, V96, P14831, DOI 10.1073/pnas.96.26.14831; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Dong S, 1996, P NATL ACAD SCI USA, V93, P3624, DOI 10.1073/pnas.93.8.3624; EL DW, 1993, CELL, V75, P817; ELDEIRY WS, 1994, CANCER RES, V54, P1169; FARKAS G, 1994, NATURE, V371, P806, DOI 10.1038/371806a0; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Huynh KD, 2000, GENE DEV, V14, P1810; Jeon BN, 2008, J BIOL CHEM, V283, P33199, DOI 10.1074/jbc.M802935200; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; KERCKAERT JP, 1993, NAT GENET, V5, P66, DOI 10.1038/ng0993-66; KOONIN EV, 1992, TRENDS BIOCHEM SCI, V17, P213, DOI 10.1016/0968-0004(92)90379-N; Koutsodontis G, 2001, J BIOL CHEM, V276, P29116, DOI 10.1074/jbc.M104130200; Lee JA, 2005, J BIOL CHEM, V280, P28061, DOI 10.1074/jbc.M414134200; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; Ogryzko VV, 1997, MOL CELL BIOL, V17, P4877, DOI 10.1128/MCB.17.8.4877; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Yamochi T, 1999, ONCOGENE, V18, P487, DOI 10.1038/sj.onc.1202334	34	47	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					17935	17946		10.1074/jbc.M809559200	http://dx.doi.org/10.1074/jbc.M809559200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19380588	Green Published, hybrid			2022-12-25	WOS:000267712400005
J	Hoffman, DL; Brookes, PS				Hoffman, David L.; Brookes, Paul S.			Oxygen Sensitivity of Mitochondrial Reactive Oxygen Species Generation Depends on Metabolic Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-TRANSPORT-CHAIN; CYTOCHROME BC(1) COMPLEX; SUPEROXIDE-PRODUCTION; HYDROGEN-PEROXIDE; HEART-MITOCHONDRIA; HYPOXIA; CELL; GENTAMICIN; GRADIENTS; NEPHROTOXICITY	The mitochondrial generation of reactive oxygen species (ROS) plays a central role in many cell signaling pathways, but debate still surrounds its regulation by factors, such as substrate availability, [O-2] and metabolic state. Previously, we showed that in isolated mitochondria respiring on succinate, ROS generation was a hyperbolic function of [O-2]. In the current study, we used a wide variety of substrates and inhibitors to probe the O-2 sensitivity of mitochondrial ROS generation under different metabolic conditions. From such data, the apparent K-m for O-2 of putative ROS-generating sites within mitochondria was estimated as follows: 0.2, 0.9, 2.0, and 5.0 mu M O-2 for the complex I flavin site, complex I electron backflow, complex IIIQ(O) site, and electron transfer flavoprotein quinone oxidoreductase of beta-oxidation, respectively. Differential effects of respiratory inhibitors on ROS generation were also observed at varying [O-2]. Based on these data, we hypothesize that at physiological [O-2], complex I is a significant source of ROS, whereas the electron transfer flavoprotein quinone oxidoreductase may only contribute to ROS generation at very high [O-2]. Furthermore, we suggest that previous discrepancies in the assignment of effects of inhibitors on ROS may be due to differences in experimental [O-2]. Finally, the data set (see supplemental material) may be useful in the mathematical modeling of mitochondrial metabolism.	[Brookes, Paul S.] Univ Rochester, Med Ctr, Dept Anesthesiol, Rochester, NY 14642 USA; [Hoffman, David L.] Univ Rochester, Med Ctr, Dept Biochem, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Brookes, PS (corresponding author), Univ Rochester, Med Ctr, Dept Anesthesiol, Box 604,601 Elmwood Ave, Rochester, NY 14642 USA.	paul_brookes@urmc.rochester.edu		Hoffman, David/0000-0002-8661-3291; Brookes, Paul/0000-0002-8639-8413				Acker H, 2005, PHILOS T R SOC B, V360, P2201, DOI 10.1098/rstb.2005.1760; Adam-Vizi V, 2006, TRENDS PHARMACOL SCI, V27, P639, DOI 10.1016/j.tips.2006.10.005; AW TY, 1987, AM J PHYSIOL, V253, pF440, DOI 10.1152/ajprenal.1987.253.3.F440; Barja G, 1998, ANN NY ACAD SCI, V854, P224, DOI 10.1111/j.1749-6632.1998.tb09905.x; Bayir H, 2008, CRIT CARE, V12, DOI 10.1186/cc6779; Bell EL, 2007, J CELL BIOL, V177, P1029, DOI 10.1083/jcb.200609074; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; BOVERIS A, 1976, BIOCHEM J, V156, P435, DOI 10.1042/bj1560435; Brookes PS, 2003, J BIOL CHEM, V278, P31603, DOI 10.1074/jbc.M211784200; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Byun HO, 2008, J CELL BIOCHEM, V104, P1747, DOI 10.1002/jcb.21741; Campian JL, 2004, J BIOL CHEM, V279, P46580, DOI 10.1074/jbc.M406685200; Carre JE, 2008, BBA-BIOENERGETICS, V1777, P763, DOI 10.1016/j.bbabio.2008.04.024; CHANCE B, 1965, J GEN PHYSIOL, V49, P163, DOI 10.1085/jgp.49.1.163; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chen Q, 2008, AM J PHYSIOL-CELL PH, V294, pC460, DOI 10.1152/ajpcell.00211.2007; Chen YQ, 2007, J CELL SCI, V120, P4155, DOI 10.1242/jcs.011163; COLE RP, 1982, J APPL PHYSIOL, V53, P1116, DOI 10.1152/jappl.1982.53.5.1116; DULON D, 1988, ACTA OTO-LARYNGOL, V106, P219, DOI 10.3109/00016488809106429; Forquer I, 2006, J BIOL CHEM, V281, P38459, DOI 10.1074/jbc.M605119200; Gnaiger E, 1998, BBA-BIOENERGETICS, V1365, P249, DOI 10.1016/S0005-2728(98)00076-0; Gnaiger E, 2007, MITOCHONDRIAL PATHWA; Goldman D, 2006, AM J PHYSIOL-HEART C, V290, pH2277, DOI 10.1152/ajpheart.00547.2005; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; Hoffman DL, 2007, AM J PHYSIOL-HEART C, V292, pH101, DOI 10.1152/ajpheart.00699.2006; Johnson DT, 2007, AM J PHYSIOL-CELL PH, V292, pC698, DOI 10.1152/ajpcell.00109.2006; JONES DP, 1986, AM J PHYSIOL, V250, pC663, DOI 10.1152/ajpcell.1986.250.5.C663; Klimova T, 2008, CELL DEATH DIFFER, V15, P660, DOI 10.1038/sj.cdd.4402307; KROON AM, 1983, PHARM WEEKBLAD, V5, P81, DOI 10.1007/BF01960982; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; MAIRBAURL H, 2005, MIP 2005 4 MIT PHYS, P26; Matsumoto A, 2005, MAGN RESON MED, V54, P1530, DOI 10.1002/mrm.20714; Michelakis ED, 2002, CIRC RES, V90, P1307, DOI 10.1161/01.RES.0000024689.07590.C2; Muller FL, 2003, BIOCHEMISTRY-US, V42, P6493, DOI 10.1021/bi0342160; Muller FL, 2008, BIOCHEM J, V409, P491, DOI 10.1042/BJ20071162; *NAT RES COUNC, 1996, NIH PUBL, V8623; PARDEE AB, 1949, J BIOL CHEM, V178, P241; Rengasamy A, 1996, J PHARMACOL EXP THER, V276, P30; Schroedl C, 2002, AM J PHYSIOL-LUNG C, V283, pL922, DOI 10.1152/ajplung.00014.2002; Schuerholz T, 2008, MINERVA ANESTESIOL, V74, P183; Sperl W, 1997, MOL CELL BIOCHEM, V174, P71, DOI 10.1023/A:1006880529195; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Sun H, 2003, ARCH BIOCHEM BIOPHYS, V419, P198, DOI 10.1016/j.abb.2003.08.028; Takahashi E, 1998, AM J PHYSIOL-HEART C, V275, pH225, DOI 10.1152/ajpheart.1998.275.1.H225; Tsai AG, 2003, PHYSIOL REV, V83, P933, DOI 10.1152/physrev.00034.2002; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; WALKER PD, 1987, AM J PHYSIOL, V253, pC495, DOI 10.1152/ajpcell.1987.253.4.C495; Walker PD, 1999, RENAL FAILURE, V21, P433, DOI 10.3109/08860229909085109; Wang QS, 2007, FREE RADICAL BIO MED, V42, P642, DOI 10.1016/j.freeradbiomed.2006.12.008; Wojtovich AP, 2008, BBA-BIOENERGETICS, V1777, P882, DOI 10.1016/j.bbabio.2008.03.025	53	131	135	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16236	16245		10.1074/jbc.M809512200	http://dx.doi.org/10.1074/jbc.M809512200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19366681	Green Published, hybrid			2022-12-25	WOS:000266730900021
J	Jiang, M; Xu, XL; Wang, YH; Toyoda, F; Liu, XS; Zhang, M; Robinson, RB; Tseng, GN				Jiang, Min; Xu, Xulin; Wang, Yuhong; Toyoda, Futoshi; Liu, Xian-Sheng; Zhang, Mei; Robinson, Richard B.; Tseng, Gea-Ny			Dynamic Partnership between KCNQ1 and KCNE1 and Influence on Cardiac I-Ks Current Amplitude by KCNE2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-QT SYNDROME; FAMILIAL ATRIAL-FIBRILLATION; K+ CHANNEL COMPLEXES; OF-FUNCTION MUTATION; POTASSIUM CHANNEL; BETA-SUBUNITS; MINK; EXPRESSION; PORE; MODULATION	Cardiac slow delayed rectifier (I-Ks) channel is composed of KCNQ1 (pore-forming) and KCNE1 (auxiliary) subunits. Although KCNE1 is an obligate I-Ks component that confers the uniquely slow gating kinetics, KCNE2 is also expressed in human heart. In vitro experiments suggest that KCNE2 can associate with the KCNQ1-KCNE1 complex to suppress the current amplitude without altering the slow gating kinetics. Our goal here is to test the role of KCNE2 in cardiac I-Ks channel function. Pulse-chase experiments in COS-7 cells show that there is a KCNE1 turnover in the KCNQ1-KCNE1 complex, supporting the possibility that KCNE1 in the I-Ks channel complex can be substituted by KCNE2 when the latter is available. Biotinylation experiments in COS-7 cells show that although KCNE1 relies on KCNQ1 coassembly for more efficient cell surface expression, KCNE2 can independently traffic to the cell surface, thus becoming available for substituting KCNE1 in the I-Ks channel complex. Injecting vesicles carrying KCNE1 or KCNE2 into KCNQ1-expressing oocytes leads to KCNQ1 modulation in the same manner as KCNQ1 + KCNEx (where x = 1 or 2) cRNA coinjection. Thus, free KCNEx peptides delivered to the cell membrane can associate with existing KCNQ1 channels to modulate their function. Finally, adenovirus-mediated KCNE2 expression in adult guinea pig ventricular myocytes exhibited colocalization with native KCNQ1 protein and reduces the native I-Ks current density. We propose that in cardiac myocytes the I-Ks current amplitude is under dynamic control by the availability of KCNE2 subunits in the cell membrane.	[Jiang, Min; Xu, Xulin; Wang, Yuhong; Liu, Xian-Sheng; Zhang, Mei; Tseng, Gea-Ny] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23298 USA; [Toyoda, Futoshi] Shiga Univ Med Sci, Dept Physiol, Shiga 5202192, Japan; [Robinson, Richard B.] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Robinson, Richard B.] Columbia Univ, Ctr Mol Therapeut, New York, NY 10032 USA	Virginia Commonwealth University; Shiga University of Medical Science; Columbia University; Columbia University	Tseng, GN (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, 1101 E Marshall St, Richmond, VA 23298 USA.	gtseng@vcu.edu			National Institutes of Health [HL-46451, HL-28958]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046451, R01HL107294, P01HL028958] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-46451 (to G.-N.T.) and HL-28958.	Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bendahhou S, 2005, CARDIOVASC RES, V67, P529, DOI 10.1016/j.cardiores.2005.02.014; Chandrasekhar KD, 2006, J BIOL CHEM, V281, P40015, DOI 10.1074/jbc.M604398200; Chen HJ, 2003, NEURON, V40, P15, DOI 10.1016/S0896-6273(03)00570-1; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; Delpon E, 2008, CIRC-ARRHYTHMIA ELEC, V1, P209, DOI 10.1161/CIRCEP.107.748103; ELLINGSEN O, 1993, AM J PHYSIOL, V265, pH747, DOI 10.1152/ajpheart.1993.265.2.H747; Gaborit N, 2005, CIRCULATION, V112, P471, DOI 10.1161/CIRCULATIONAHA.104.506857; Ghosh S, 2006, CIRC RES, V98, P1048, DOI 10.1161/01.RES.0000218863.44140.f2; Haitin Y, 2008, J PHYSIOL-LONDON, V586, P1803, DOI 10.1113/jphysiol.2007.149187; Hong K, 2005, CARDIOVASC RES, V68, P433, DOI 10.1016/j.cardiores.2005.06.023; Jiang M, 2000, CARDIOVASC RES, V48, P34, DOI 10.1016/S0008-6363(00)00159-0; Jiang M, 2004, CIRCULATION, V109, P1783, DOI 10.1161/01.CIR.0000124225.43852.50; Jost N, 2005, CIRCULATION, V112, P1392, DOI 10.1161/CIRCULATIONAHA.105.550111; Kang CB, 2008, BIOCHEMISTRY-US, V47, P7999, DOI 10.1021/bi800875q; Kurokawa J, 2001, J GEN PHYSIOL, V117, P43, DOI 10.1085/jgp.117.1.43; Liu XS, 2007, J MEMBRANE BIOL, V216, P117, DOI 10.1007/s00232-007-9047-7; Liu XS, 2007, AM J PHYSIOL-HEART C, V292, pH560, DOI 10.1152/ajpheart.00616.2006; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lundquist AL, 2006, GENOMICS, V87, P119, DOI 10.1016/j.ygeno.2005.09.004; Lundquist Andrew L, 2005, J Mol Cell Cardiol, V38, P277, DOI 10.1016/j.yjmcc.2004.11.012; Manderfield LJ, 2008, FEBS J, V275, P1336, DOI 10.1111/j.1742-4658.2008.06294.x; MARSAL J, 1995, P NATL ACAD SCI USA, V92, P5224, DOI 10.1073/pnas.92.11.5224; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; Melman YF, 2004, NEURON, V42, P927, DOI 10.1016/j.neuron.2004.06.001; Morin TJ, 2008, P NATL ACAD SCI USA, V105, P1478, DOI 10.1073/pnas.0710366105; Morin TJ, 2007, ACS CHEM BIOL, V2, P469, DOI 10.1021/cb700089s; Nakahira K, 1996, J BIOL CHEM, V271, P7084, DOI 10.1074/jbc.271.12.7084; Nakajo K, 2007, J GEN PHYSIOL, V130, P269, DOI 10.1085/jgp.200709805; Panaghie G, 2006, J PHYSIOL-LONDON, V570, P455, DOI 10.1113/jphysiol.2005.100644; Poulsen AN, 2007, BIOCHEM BIOPH RES CO, V363, P133, DOI 10.1016/j.bbrc.2007.08.146; Qu JH, 2004, J BIOL CHEM, V279, P43497, DOI 10.1074/jbc.M405018200; Radicke S, 2006, CARDIOVASC RES, V71, P695, DOI 10.1016/j.cardiores.2006.06.017; Rocheleau JM, 2008, J GEN PHYSIOL, V131, P59, DOI 10.1085/jgp.200709816; Rocheleau JM, 2006, J GEN PHYSIOL, V128, P721, DOI 10.1085/jgp.200609657; Ruan YF, 2008, CIRC-ARRHYTHMIA ELEC, V1, P290, DOI 10.1161/CIRCEP.108.795617; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; SCHREIBMAYER W, 1994, PFLUG ARCH EUR J PHY, V426, P453, DOI 10.1007/BF00388310; Seebohm G, 2006, BIOPHYS J, V90, P2235, DOI 10.1529/biophysj.105.067165; Seebohm G, 2007, CIRC RES, V100, P686, DOI 10.1161/01.RES.0000260250.83824.8f; Sesti F, 1998, J GEN PHYSIOL, V112, P651, DOI 10.1085/jgp.112.6.651; Shamgar L, 2006, CIRC RES, V98, P1055, DOI 10.1161/01.RES.0000218979.40770.69; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Tapper AR, 2000, J GEN PHYSIOL, V116, P379, DOI 10.1085/jgp.116.3.379; Tapper AR, 2001, J BIOL CHEM, V276, P38249; Tian CL, 2007, BIOCHEMISTRY-US, V46, P11459, DOI 10.1021/bi700705j; Tinel N, 2000, EMBO J, V19, P6326, DOI 10.1093/emboj/19.23.6326; Tseng GN, 2007, HEART RHYTHM, V4, P1542, DOI 10.1016/j.hrthm.2007.08.014; Um SY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000933; Wang HY, 2007, NAT NEUROSCI, V10, P32, DOI 10.1038/nn1822; Wang KW, 1996, NEURON, V16, P571, DOI 10.1016/S0896-6273(00)80076-8; Wang Y, 2007, BIOPHYS J, V93, P3083, DOI 10.1529/biophysj.107.110320; Wiener R, 2008, J BIOL CHEM, V283, P5815, DOI 10.1074/jbc.M707541200; Wu DM, 2006, HEART RHYTHM, V3, P1469, DOI 10.1016/j.hrthm.2006.08.019; Xu XL, 2008, J GEN PHYSIOL, V131, P589, DOI 10.1085/jgp.200809976; Yang YQ, 2004, AM J HUM GENET, V75, P899, DOI 10.1086/425342; Yang YS, 1998, J GEN PHYSIOL, V112, P665, DOI 10.1085/jgp.112.6.665; Zhang M, 2001, CIRC RES, V88, P1012, DOI 10.1161/hh1001.090839	61	47	49	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16452	16462		10.1074/jbc.M808262200	http://dx.doi.org/10.1074/jbc.M808262200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19372218	Green Published, hybrid			2022-12-25	WOS:000266730900042
J	Lahiri, S; Park, H; Laviad, EL; Lu, XQ; Bittman, R; Futerman, AH				Lahiri, Sujoy; Park, Hyejung; Laviad, Elad L.; Lu, Xuequan; Bittman, Robert; Futerman, Anthony H.			Ceramide Synthesis Is Modulated by the Sphingosine Analog FTY720 via a Mixture of Uncompetitive and Noncompetitive Inhibition in an Acyl-CoA Chain Length-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOSUPPRESSIVE AGENT FTY720; IMMUNOMODULATORY DRUG FTY720; LONGEVITY ASSURANCE GENE-1; SUBSTRATE-SPECIFICITY; 1-PHOSPHATE; CELLS; GROWTH; PHOSPHORYLATION; FINGOLIMOD; RECEPTORS	FTY720, a sphingosine analog, is in clinical trials as an immunomodulator. The biological effects of FTY720 are believed to occur after its metabolism to FTY720 phosphate. However, very little is known about whether FTY720 can interact with and modulate the activity of other enzymes of sphingolipid metabolism. We examined the ability of FTY720 to modulate de novo ceramide synthesis. In mammals, ceramide is synthesized by a family of six ceramide synthases, each of which utilizes a restricted subset of acyl-CoAs. We show that FTY720 inhibits ceramide synthase activity in vitro by noncompetitive inhibition toward acyl-CoA and uncompetitive inhibition toward sphinganine; surprisingly, the efficacy of inhibition depends on the acyl-CoA chain length. In cultured cells, FTY720 has a more complex effect, with ceramide synthesis inhibited at high (500 nM to 5 mu M) but not low (<200 nM) sphinganine concentrations, consistent with FTY720 acting as an uncompetitive inhibitor toward sphinganine. Finally, electrospray ionization-tandem mass spectrometry demonstrated, unexpectedly, elevated levels of ceramide, sphingomyelin, and hexosylceramides after incubation with FTY720. Our data suggest a novel mechanism by which FTY720 might mediate some of its biological effects, which may be of mechanistic significance for understanding its mode of action.	[Lahiri, Sujoy; Laviad, Elad L.; Futerman, Anthony H.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Park, Hyejung] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Park, Hyejung] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Lu, Xuequan; Bittman, Robert] CUNY Queens Coll, Dept Chem & Biochem, Flushing, NY 11367 USA	Weizmann Institute of Science; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; City University of New York (CUNY) System; Queens College NY (CUNY)	Futerman, AH (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tony.futerman@weizmann.ac.il		Futerman, Anthony/0000-0003-0013-0115	National Institutes of Health [GM076217, HL-083187]; Israel Science Foundation [1404/07]; Minerva Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R24HL083187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); Minerva Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM076217 (to A. M. and A. H. F.), and HL-083187 ( to R. B.). This work was also supported by Israel Science Foundation Grant 1404/07 and by funds from the Minerva Foundation (to A. H. F.).	Alderton F, 2001, BRIT J PHARMACOL, V134, P6, DOI 10.1038/sj.bjp.0704278; Azuma H, 2002, CANCER RES, V62, P1410; Bandhuvula P, 2005, J BIOL CHEM, V280, P33697, DOI 10.1074/jbc.C500294200; Berdyshev EV, 2009, J BIOL CHEM, V284, P5467, DOI 10.1074/jbc.M805186200; Billich A, 2003, J BIOL CHEM, V278, P47408, DOI 10.1074/jbc.M307687200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brown BA, 2007, ANN PHARMACOTHER, V41, P1660, DOI 10.1345/aph.1G424; Chiba K, 2006, CELL MOL IMMUNOL, V3, P11; Cornish-Bowden A., 1995, FUNDAMENTALS ENZYME; FOLCHPI J, 1957, J BIOL CHEM, V226, P496; HIRSCHBERG K, 1993, BIOCHEM J, V290, P751, DOI 10.1042/bj2900751; Horga Alejandro, 2008, Expert Rev Neurother, V8, P699, DOI 10.1586/14737175.8.5.699; Kharel Y, 2005, J BIOL CHEM, V280, P36865, DOI 10.1074/jbc.M506293200; Kihara A, 2008, BBA-MOL CELL BIOL L, V1781, P496, DOI 10.1016/j.bbalip.2008.05.003; Koybasi S, 2004, J BIOL CHEM, V279, P44311, DOI 10.1074/jbc.M406920200; Lahiri S, 2005, J BIOL CHEM, V280, P33735, DOI 10.1074/jbc.M506485200; Lahiri S, 2007, FEBS LETT, V581, P5289, DOI 10.1016/j.febslet.2007.10.018; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Lu XQ, 2009, J ORG CHEM, V74, P3192, DOI 10.1021/jo900023u; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Mansoor M, 2008, REV RECENT CLIN TRIA, V3, P62, DOI 10.2174/157488708783330486; Matsuoka Y, 2003, BRIT J PHARMACOL, V138, P1303, DOI 10.1038/sj.bjp.0705182; Meno-Tetang GML, 2006, DRUG METAB DISPOS, V34, P1480, DOI 10.1124/dmd.105.009001; Merrill AH, 1996, TRENDS CELL BIOL, V6, P218, DOI 10.1016/0962-8924(96)10021-0; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Miron VE, 2008, AM J PATHOL, V173, P1143, DOI 10.2353/ajpath.2008.080478; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; Nagaoka Y, 2008, BIOL PHARM BULL, V31, P1177, DOI 10.1248/bpb.31.1177; Neviani P, 2007, J CLIN INVEST, V117, P2408, DOI 10.1172/JCI31095; Payne SG, 2007, BLOOD, V109, P1077, DOI 10.1182/blood-2006-03-011437; Pettus BJ, 2004, J BIOL CHEM, V279, P11320, DOI 10.1074/jbc.M309262200; Pinschewer DD, 2000, J IMMUNOL, V164, P5761, DOI 10.4049/jimmunol.164.11.5761; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; Sanchez AM, 2008, EUR J PHARMACOL, V584, P237, DOI 10.1016/j.ejphar.2008.02.011; Sanchez T, 2003, J BIOL CHEM, V278, P47281, DOI 10.1074/jbc.M306896200; Segel IH., 1993, ENZYME KINETICS BEHA; SULLARDS MC, 2001, SCIENCESS STKE, V67; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Yagi H, 2000, EUR J IMMUNOL, V30, P1435, DOI 10.1002/(SICI)1521-4141(200005)30:5<1435::AID-IMMU1435>3.0.CO;2-O; Yopp AC, 2006, CLIN TRANSPLANT, V20, P788, DOI 10.1111/j.1399-0012.2006.00570.x; Zemann B, 2006, BLOOD, V107, P1454, DOI 10.1182/blood-2005-07-2628; Zhang Z, 2007, MINI-REV MED CHEM, V7, P845	43	99	104	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16090	16098		10.1074/jbc.M807438200	http://dx.doi.org/10.1074/jbc.M807438200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19357080	hybrid, Green Published			2022-12-25	WOS:000266730900005
J	Tsunekawa, K; Shijuku, T; Hayashimoto, M; Kojima, Y; Onai, K; Morishita, M; Ishiura, M; Kuroda, T; Nakamura, T; Kobayashi, H; Sato, M; Toyooka, K; Matsuoka, K; Omata, T; Uozumi, N				Tsunekawa, Kenta; Shijuku, Toshiaki; Hayashimoto, Mitsuo; Kojima, Yoichi; Onai, Kiyoshi; Morishita, Megumi; Ishiura, Masahiro; Kuroda, Teruo; Nakamura, Tatsunosuke; Kobayashi, Hiroshi; Sato, Mayuko; Toyooka, Kiminori; Matsuoka, Ken; Omata, Tatsuo; Uozumi, Nobuyuki			Identification and Characterization of the Na+/H+ Antiporter Nhas3 from the Thylakoid Membrane of Synechocystis sp PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP STRAIN PCC-6803; ESCHERICHIA-COLI; CIRCADIAN-RHYTHMS; ION HOMEOSTASIS; REAL-TIME; FUNCTIONAL EXPRESSION; ARABIDOPSIS-THALIANA; SYNECHOCOCCUS SP; PHOTOSYSTEM-II; SALT STRESS	Na+/H+ antiporters influence proton or sodium motive force across the membrane. Synechocystis sp. PCC 6803 has six genes encoding Na+/H+ antiporters, nhaS1-5 and sll0556. In this study, the function of NhaS3 was examined. NhaS3 was essential for growth of Synechocystis, and loss of nhaS3 was not complemented by expression of the Escherichia coli Na+/H+ antiporter NhaA. Membrane fractionation followed by immunoblotting as well as immunogold labeling revealed that NhaS3 was localized in the thylakoid membrane of Synechocystis. NhaS3 was shown to be functional over a pH range from pH 6.5 to 9.0 when expressed in E. coli. A reduction in the copy number of nhaS3 in the Synechocystis genome rendered the cells more sensitive to high Na+ concentrations. NhaS3 had no K+/H+ exchange activity itself but enhanced K+ uptake from the medium when expressed in an E. coli potassium uptake mutant. Expression of nhaS3 increased after shifting from low CO2 to high CO2 conditions. Expression of nhaS3 was also found to be controlled by the circadian rhythm. Gene expression peaked at the beginning of subjective night. This coincided with the time of the lowest rate of CO2 consumption caused by the ceasing of O-2-evolving photosynthesis. This is the first report of a Na+/H+ antiporter localized in thylakoid membrane. Our results suggested a role of NhaS3 in the maintenance of ion homeostasis of H+, Na+, and K+ in supporting the conversion of photosynthetic products and in the supply of energy in the dark.	[Shijuku, Toshiaki; Hayashimoto, Mitsuo; Uozumi, Nobuyuki] Tohoku Univ, Dept Biomol Engn, Grad Sch Engn, Sendai, Miyagi 9808579, Japan; [Tsunekawa, Kenta; Omata, Tatsuo] Nagoya Univ, Lab Mol Plant Physiol, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Kojima, Yoichi] Shizuoka Univ, Dept Environm & Forest Resources Sci, Fac Agr, Shizuoka 4228529, Japan; [Onai, Kiyoshi; Morishita, Megumi; Ishiura, Masahiro] Nagoya Univ, Ctr Gene Res, Nagoya, Aichi 4648602, Japan; [Kuroda, Teruo] Okayama Univ, Dept Genome Appl Microbiol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Nakamura, Tatsunosuke] Niigata Univ Pharm & Appl Life Sci, Dept Microbiol, Niigata 9502081, Japan; [Kobayashi, Hiroshi] Chiba Univ, Grad Sch Pharmaceut Sci, Chiba 2608675, Japan; [Sato, Mayuko; Toyooka, Kiminori] RIKEN Plant Sci Ctr, Yokohama, Kanagawa 2300045, Japan; [Matsuoka, Ken] Kyushu Univ, Lab Plant Nutr, Fac Agr, Fukuoka 8128581, Japan	Tohoku University; Nagoya University; Shizuoka University; Nagoya University; Okayama University; Niigata University; Chiba University; RIKEN; Kyushu University	Uozumi, N (corresponding author), Tohoku Univ, Dept Biomol Engn, Grad Sch Engn, Aobayama 6-6-07, Sendai, Miyagi 9808579, Japan.	uozumi@biophy.che.tohoku.ac.jp	Matsuoka, Ken/E-3215-2010; Uozumi, Nobuyuki/AAG-3252-2019; Toyooka, Kiminori/B-5027-2011	Onai, Kiyoshi/0000-0001-9062-2548; Matsuoka, Ken/0000-0001-7229-7294; Uozumi, Nobuyuki/0000-0003-4268-1126	MEXT [17078005, 20-08103]; JSPS	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-aid for Scientific Research 17078005 and 20-08103 (to N. U.) from MEXT and JSPS.	Allakhverdiev SI, 2000, PLANT PHYSIOL, V123, P1047, DOI 10.1104/pp.123.3.1047; Allakhverdiev SI, 1999, P NATL ACAD SCI USA, V96, P5862, DOI 10.1073/pnas.96.10.5862; Apse MP, 2003, PLANT J, V36, P229, DOI 10.1046/j.1365-313X.2003.01871.x; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Berry S, 2003, FEBS LETT, V548, P53, DOI 10.1016/S0014-5793(03)00729-4; BUURMAN ET, 1995, J BIOL CHEM, V270, P6678, DOI 10.1074/jbc.270.12.6678; Elanskaya IV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P432, DOI 10.1023/A:1015281906254; GOLDBERG EB, 1987, P NATL ACAD SCI USA, V84, P2615, DOI 10.1073/pnas.84.9.2615; Golden SS, 1997, ANNU REV PLANT PHYS, V48, P327, DOI 10.1146/annurev.arplant.48.1.327; Hamada A, 2001, PLANT PHYSIOL, V125, P437, DOI 10.1104/pp.125.1.437; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Inaba M, 2001, J BACTERIOL, V183, P1376, DOI 10.1128/JB.183.4.1376-1384.2001; Inoue H, 1999, FEBS LETT, V443, P11, DOI 10.1016/S0014-5793(98)01652-4; JAGENDORF AT, 1966, P NATL ACAD SCI USA, V55, P170, DOI 10.1073/pnas.55.1.170; KAPLAN A, 1989, PLANT PHYSIOL, V89, P1220, DOI 10.1104/pp.89.4.1220; KARPEL R, 1988, J BIOL CHEM, V263, P10408; Katoh H, 2001, J BACTERIOL, V183, P2779, DOI 10.1128/JB.183.9.2779-2784.2001; Kucho K, 2005, GENES GENET SYST, V80, P19, DOI 10.1266/ggs.80.19; Kucho K, 2005, J BACTERIOL, V187, P2190, DOI 10.1128/JB.187.6.2190-2199.2005; KURODA T, 1994, J BIOCHEM-TOKYO, V116, P1030, DOI 10.1093/oxfordjournals.jbchem.a124624; Matsuda N, 2004, J BIOL CHEM, V279, P54952, DOI 10.1074/jbc.M407268200; Mikkat S, 2000, PLANT CELL ENVIRON, V23, P549, DOI 10.1046/j.1365-3040.2000.00565.x; MILLER AG, 1984, J BACTERIOL, V159, P100, DOI 10.1128/JB.159.1.100-106.1984; MITSUI A, 1986, NATURE, V323, P720, DOI 10.1038/323720a0; Norling B, 1998, FEBS LETT, V436, P189, DOI 10.1016/S0014-5793(98)01123-5; Nowaczyk MM, 2006, PLANT CELL, V18, P3121, DOI 10.1105/tpc.106.042671; Ohkawa H, 2000, J BACTERIOL, V182, P2591, DOI 10.1128/JB.182.9.2591-2596.2000; OHYAMA T, 1994, J BACTERIOL, V176, P4311, DOI 10.1128/jb.176.14.4311-4315.1994; Okamoto K, 2005, PLANT CELL ENVIRON, V28, P1305, DOI 10.1111/j.1365-3040.2005.01377.x; Okamoto K, 2005, ANAL BIOCHEM, V340, P193, DOI 10.1016/j.ab.2004.11.007; OMATA T, 1995, PLANT CELL PHYSIOL, V36, P207, DOI 10.1093/oxfordjournals.pcp.a078751; Onai M, 2004, J BACTERIOL, V186, P4972, DOI 10.1128/JB.186.15.4972-4977.2004; PADAN E, 1994, BBA-BIOENERGETICS, V1187, P206, DOI 10.1016/0005-2728(94)90112-0; PADAN E, 1994, BBA-BIOENERGETICS, V1185, P129, DOI 10.1016/0005-2728(94)90204-6; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Schonknecht G, 1995, P NATL ACAD SCI USA, V92, P12185, DOI 10.1073/pnas.92.26.12185; Serrano R, 2001, CURR OPIN CELL BIOL, V13, P399, DOI 10.1016/S0955-0674(00)00227-1; Shi HZ, 2002, PLANT CELL, V14, P465, DOI 10.1105/tpc.010371; Shibata M, 2002, J BIOL CHEM, V277, P18658, DOI 10.1074/jbc.M112468200; Shijuku T, 2002, BBA-BIOENERGETICS, V1556, P142, DOI 10.1016/S0005-2728(02)00345-6; Shijuku T, 2001, BBA-BIOENERGETICS, V1506, P212, DOI 10.1016/S0005-2728(01)00215-8; Song CP, 2004, P NATL ACAD SCI USA, V101, P10211, DOI 10.1073/pnas.0403709101; Stumpe S, 1997, ARCH MICROBIOL, V167, P126, DOI 10.1007/s002030050425; Sze H, 2004, PLANT PHYSIOL, V136, P2532, DOI 10.1104/pp.104.046003; Toyooka K, 2006, AUTOPHAGY, V2, P96, DOI 10.4161/auto.2.2.2366; Uozumi N, 1998, P NATL ACAD SCI USA, V95, P9773, DOI 10.1073/pnas.95.17.9773; Venema K, 2003, J BIOL CHEM, V278, P22453, DOI 10.1074/jbc.M210794200; Yamaguchi T, 2003, P NATL ACAD SCI USA, V100, P12510, DOI 10.1073/pnas.2034966100; Zhang HX, 2001, NAT BIOTECHNOL, V19, P765, DOI 10.1038/90824; Zhang PP, 2004, PLANT CELL, V16, P3326, DOI 10.1105/tpc.104.026526; ZHAO JD, 1988, ARCH BIOCHEM BIOPHYS, V264, P657, DOI 10.1016/0003-9861(88)90332-3	51	47	49	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16513	16521		10.1074/jbc.M109.001875	http://dx.doi.org/10.1074/jbc.M109.001875			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19372598	Green Published, hybrid			2022-12-25	WOS:000266730900048
J	Keogh, MR; Courtney, PD; Kinney, AJ; Dewey, RE				Keogh, Matthew R.; Courtney, Polly D.; Kinney, Anthony J.; Dewey, Ralph E.			Functional Characterization of Phospholipid N-Methyltransferases from Arabidopsis and Soybean	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLETHANOLAMINE METHYLATION PATHWAY; PHOSPHATIDYLCHOLINE SYNTHESIS; SACCHAROMYCES-CEREVISIAE; INOSITOL SYNTHESIS; YEAST; CHOLINE; GENE; BIOSYNTHESIS; LEAVES; DNA	Phospholipid N-methyltransferase (PLMT) enzymes catalyze the S-adenosylmethionine-dependent methylation of ethanolamine-containing phospholipids to produce the abundant membrane lipid phosphatidylcholine (PtdCho). In mammals and yeast, PLMT activities are required for the de novo synthesis of the choline headgroup found in PtdCho. PLMT enzyme activities have also been reported in plants, yet their roles in PtdCho biosynthesis are less clear because most plants can produce the choline headgroup entirely via soluble substrates, initiated by the methylation of free ethanolamine-phosphate. To gain further insights into the function of PLMT enzymes in plants, we isolated PLMT cDNAs from Arabidopsis and soybean (Glycine max) based upon primary amino acid sequence homology to the rat PLMT, phosphatidylethanolamine N-methyltransferase. Using a heterologous yeast expression system, it was shown that plant PLMTs methylate phosphatidylmonomethylethanolamine and phosphatidyldimethylethanolamine but cannot utilize phosphatidylethanolamine as a substrate. Identification of an Arabidopsis line containing a knock-out dissociator transposon insertion within the single copy AtPLMT gene allowed us to investigate the consequences of loss of PLMT function. Although the accumulation of the PLMT substrates phosphatidylmonomethylethanolamine and phosphatidyldimethylethanolamine was considerably elevated in the atplmt knock-out line, PtdCho levels remained normal, and no obvious differences were observed in plant morphology or development under standard growth conditions. However, because the metabolic routes through which PtdCho is synthesized in plants vary greatly among differing species, it is predicted that the degree with which PtdCho synthesis is dependent upon PLMT activities will also vary widely throughout the plant kingdom.	[Courtney, Polly D.; Dewey, Ralph E.] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA; [Keogh, Matthew R.] N Carolina State Univ, Dept Plant Biol, Raleigh, NC 27695 USA; [Kinney, Anthony J.] DuPont Co Inc, Expt Stn, Crop Genet Res, Wilmington, DE 19880 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; DuPont	Keogh, MR (corresponding author), N Carolina State Univ, Dept Crop Sci, Campus Box 8009, Raleigh, NC 27695 USA.	ralph_dewey@ncsu.edu		Dewey, Ralph/0000-0003-1924-3777	National Science Foundation [9513582]; United States Department of Agriculture Cooperative State Research, Education, and Extension Service [2001-52101-11507]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER; Direct For Biological Sciences [0920663] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant IBN-9513582 and the Initiative for Future Agriculture and Food Systems Grant 2001-52101-11507 from the United States Department of Agriculture Cooperative State Research, Education, and Extension Service.	Bates PD, 2007, J BIOL CHEM, V282, P31206, DOI 10.1074/jbc.M705447200; BECKER DM, 1991, P NATL ACAD SCI USA, V88, P1968, DOI 10.1073/pnas.88.5.1968; Bolognese CP, 2000, PLANT PHYSIOL, V124, P1800, DOI 10.1104/pp.124.4.1800; Boumann HA, 2004, J BIOL CHEM, V279, P40314, DOI 10.1074/jbc.M406517200; BROWSE J, 1986, BIOCHEM J, V235, P25, DOI 10.1042/bj2350025; CARMAN GM, 1989, ANNU REV BIOCHEM, V58, P635, DOI 10.1146/annurev.biochem.58.1.635; Cruz-Ramirez A, 2004, PLANT CELL, V16, P2020, DOI 10.1105/tpc.103.018648; DATKO AH, 1988, PLANT PHYSIOL, V88, P854, DOI 10.1104/pp.88.3.854; DATKO AH, 1988, PLANT PHYSIOL, V88, P1338, DOI 10.1104/pp.88.4.1338; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; DEWEY RE, 1994, PLANT CELL, V6, P1495, DOI 10.1105/tpc.6.10.1495; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; GAYNOR PM, 1991, BIOCHIM BIOPHYS ACTA, V1090, P326, DOI 10.1016/0167-4781(91)90197-T; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Goode JH, 1999, PLANT PHYSIOL BIOCH, V37, P445, DOI 10.1016/S0981-9428(99)80049-7; Guthrie C, 1991, GUIDE YEAST GENETICS; HANSON AD, 1982, PLANT PHYSIOL, V70, P1191, DOI 10.1104/pp.70.4.1191; HITZ WD, 1981, PLANT PHYSIOL, V68, P814, DOI 10.1104/pp.68.4.814; Kanipes MI, 1997, BBA-LIPID LIPID MET, V1348, P134, DOI 10.1016/S0005-2760(97)00121-5; Kinney Anthony J., 1993, P259; KODAKI T, 1987, J BIOL CHEM, V262, P15428; MARSHALL MO, 1973, FEBS LETT, V31, P199, DOI 10.1016/0014-5793(73)80102-4; Martienssen RA, 1998, P NATL ACAD SCI USA, V95, P2021, DOI 10.1073/pnas.95.5.2021; MCGRAW P, 1989, GENETICS, V122, P317; McNeil SD, 2000, PLANT PHYSIOL, V123, P371, DOI 10.1104/pp.123.1.371; Meijer HJG, 2003, ANNU REV PLANT BIOL, V54, P265, DOI 10.1146/annurev.arplant.54.031902.134748; Mou ZL, 2002, PLANT CELL, V14, P2031, DOI 10.1105/tpc.001701; MUDD SH, 1986, PLANT PHYSIOL, V82, P126, DOI 10.1104/pp.82.1.126; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nuccio ML, 2000, J BIOL CHEM, V275, P14095, DOI 10.1074/jbc.275.19.14095; RIDGWAY ND, 1987, J BIOL CHEM, V262, P17231; Rontein D, 2002, METAB ENG, V4, P49, DOI 10.1006/mben.2001.0208; Sambrook J, 2001, MOL CLONING LAB MANU; Shields DJ, 2003, J BIOL CHEM, V278, P35826, DOI 10.1074/jbc.M306308200; SIKORSKI RS, 1989, GENETICS, V122, P19; SUMMERS EF, 1988, GENETICS, V120, P909; Tang GQ, 2005, PLANT J, V44, P433, DOI 10.1111/j.1365-313X.2005.02535.x; VANCE DE, 1996, BIOCH LIPIDS LIPOPRO, P153; WANG XM, 1990, PLANT PHYSIOL, V93, P250, DOI 10.1104/pp.93.1.250; Watkins SM, 2003, J NUTR, V133, P3386, DOI 10.1093/jn/133.11.3386; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; WILLIAMS M, 1994, BIOCHEM J, V304, P463, DOI 10.1042/bj3040463; Zeisel SH, 2007, IUBMB LIFE, V59, P380, DOI 10.1080/15216540701468954; Zhu XN, 2003, BIOCHEM J, V370, P987, DOI 10.1042/BJ20021523	44	37	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15439	15447		10.1074/jbc.M109.005991	http://dx.doi.org/10.1074/jbc.M109.005991			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19366698	hybrid, Green Published			2022-12-25	WOS:000266501000012
J	Loane, DJ; Stoica, BA; Pajoohesh-Ganji, A; Byrnes, KR; Faden, AI				Loane, David J.; Stoica, Bogdan A.; Pajoohesh-Ganji, Ahdeah; Byrnes, Kimberly R.; Faden, Alan I.			Activation of Metabotropic Glutamate Receptor 5 Modulates Microglial Reactivity and Neurotoxicity by Inhibiting NADPH Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAUMATIC NEURONAL INJURY; KINASE-C-DELTA; NITRIC-OXIDE; IN-VITRO; DOPAMINERGIC-NEURONS; CELL-DEATH; P47(PHOX) PHOSPHORYLATION; NEUROPROTECTIVE ACTIVITY; SUPEROXIDE-PRODUCTION; INTERFERON-GAMMA	Microglial-related factors have been implicated in the signaling cascades that contribute to neuronal cell death in various neurodegenerative disorders. Thus, strategies that reduce microglial activation and associated neurotoxicity may have therapeutic benefit. Group II and III metabotropic glutamate receptors (mGluRs) are expressed in microglia and can modulate microglial activity in primary cell cultures. We demonstrate that the group I receptor member mGluR5 is highly expressed in primary microglial cultures and the BV2 microglial cell line. Activation of mGluR5 using the selective agonist (RS)-2-chloro-5-hydroxyphenylglycine (CHPG) significantly attenuates microglial activation in response to lipopolysaccharide and interferon-gamma, as indicated by a reduction in the expression of inducible nitric-oxide synthase, production of nitric oxide and tumor necrosis factor-alpha, and intracellular generation of reactive oxygen species. In addition, microglial-induced neurotoxicity is also markedly reduced by CHPG treatment. The anti-inflammatory effects of CHPG are mediated by the mGluR5 receptor, because either a selective mGluR5 antagonist or small interference RNA knockdown attenuated the actions of this drug. CHPG blocked the lipopolysaccharide-induced increase in expression and enzymatic activity of NADPH oxidase. Moreover, the protective effects of CHPG were significantly reduced when the NADPH oxidase subunits p22(phox) or gp91(phox) were knocked down by small interference RNA. These data suggest that mGluR5 represents a novel target for modulating microglial dependent neuroinflammation, and may have therapeutic relevance for neurological disorders that exhibit microglial-mediated neurodegeneration.	[Loane, David J.; Stoica, Bogdan A.; Pajoohesh-Ganji, Ahdeah; Byrnes, Kimberly R.; Faden, Alan I.] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20057 USA	Georgetown University	Loane, DJ (corresponding author), Georgetown Univ, Med Ctr, Dept Neurosci, 3970 Reservoir Rd NW, Washington, DC 20057 USA.	djl42@georgetown.edu	STOICA, BOGDAN/H-9782-2013; Loane, David/ABD-5177-2021	STOICA, BOGDAN/0000-0002-2501-6434; Loane, David/0000-0003-0393-3503; Byrnes, Kimberly/0000-0002-7501-7734	National Institutes of Health [R01 5R01NS037313-08]; NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037313] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 5R01NS037313-08 from NINDS.	Allen JW, 2000, CELL DEATH DIFFER, V7, P470, DOI 10.1038/sj.cdd.4400678; Bal-Price A, 2001, J NEUROSCI, V21, P6480; Bao WL, 2001, BRAIN RES, V922, P173, DOI 10.1016/S0006-8993(01)03062-1; Bey EA, 2004, J IMMUNOL, V173, P5730, DOI 10.4049/jimmunol.173.9.5730; Biber K, 1999, J NEUROCHEM, V72, P1671, DOI 10.1046/j.1471-4159.1999.721671.x; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Block ML, 2004, FASEB J, V18, P1618, DOI 10.1096/fj.04-1945fje; Byrnes KR, 2009, ANN NEUROL, V66, P63, DOI 10.1002/ana.21673; Byrnes KR, 2009, NEUROTHERAPEUTICS, V6, P94, DOI 10.1016/j.nurt.2008.10.038; Byrnes KR, 2006, GLIA, V53, P420, DOI 10.1002/glia.20295; Cheret C, 2008, J NEUROSCI, V28, P12039, DOI 10.1523/JNEUROSCI.3568-08.2008; Choi SH, 2005, J NEUROSCI, V25, P4082, DOI 10.1523/JNEUROSCI.4306-04.2005; Corti C, 2007, J NEUROSCI, V27, P8297, DOI 10.1523/JNEUROSCI.1889-07.2007; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; D'Antoni S, 2008, NEUROCHEM RES, V33, P2436, DOI 10.1007/s11064-008-9694-9; Faden AI, 2001, EXP NEUROL, V167, P435, DOI 10.1006/exnr.2000.7577; Faden AI, 1997, J NEUROTRAUM, V14, P885, DOI 10.1089/neu.1997.14.885; Fei Z, 2006, J CLIN NEUROSCI, V13, P1023, DOI 10.1016/j.jocn.2005.11.042; Fernandes DC, 2007, AM J PHYSIOL-CELL PH, V292, pC413, DOI 10.1152/ajpcell.00188.2006; Gao HM, 2003, FASEB J, V17, DOI 10.1096/fj.03-0109fje; Gao HM, 2003, J NEUROSCI, V23, P6181; Gao HM, 2008, TRENDS IMMUNOL, V29, P357, DOI 10.1016/j.it.2008.05.002; Geurts JJG, 2003, BRAIN, V126, P1755, DOI 10.1093/brain/awg179; Gibbons HM, 2006, BRAIN RES, V1084, P1, DOI 10.1016/j.brainres.2006.02.032; Golde S, 2002, J NEUROCHEM, V82, P269, DOI 10.1046/j.1471-4159.2002.00973.x; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; He Y, 2003, J NEUROCHEM, V86, P1338, DOI 10.1046/j.1471-4159.2003.01938.x; Iravani MM, 2002, NEUROSCIENCE, V110, P49, DOI 10.1016/S0306-4522(01)00562-0; Lea PM, 2006, CNS DRUG REV, V12, P149, DOI 10.1111/j.1527-3458.2006.00149.x; Lea PM, 2005, BRIT J PHARMACOL, V145, P527, DOI 10.1038/sj.bjp.0706219; Li JM, 2005, MOL CELL BIOL, V25, P2320, DOI 10.1128/MCB.25.6.2320-2330.2005; Li JR, 2005, P NATL ACAD SCI USA, V102, P9936, DOI 10.1073/pnas.0502552102; Mander P, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-20; McNaught KSP, 1998, J NEUROCHEM, V70, P1541; Mount MP, 2007, J NEUROSCI, V27, P3328, DOI 10.1523/JNEUROSCI.5321-06.2007; Movsesyan VA, 2006, J NEUROTRAUM, V23, P117, DOI 10.1089/neu.2006.23.117; Movsesyan VA, 2004, J NEUROCHEM, V89, P1528, DOI 10.1111/j.1471-4159.2004.02451.x; Pacheco R, 2004, J BIOL CHEM, V279, P33352, DOI 10.1074/jbc.M401761200; Patel M, 2005, J NEUROCHEM, V92, P123, DOI 10.1111/j.1471-4159.2004.02838.x; Pawate S, 2004, J NEUROSCI RES, V77, P540, DOI 10.1002/jnr.20180; Pinteaux-Jones F, 2008, J NEUROCHEM, V106, P442, DOI 10.1111/j.1471-4159.2008.05426.x; Qian L, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-23; Qin LY, 2004, J BIOL CHEM, V279, P1415, DOI 10.1074/jbc.M307657200; Qin LY, 2002, J NEUROCHEM, V83, P973, DOI 10.1046/j.1471-4159.2002.01210.x; Schools GP, 1999, J NEUROSCI RES, V58, P533, DOI 10.1002/(SICI)1097-4547(19991115)58:4<533::AID-JNR6>3.0.CO;2-G; Szydlowska K, 2007, EUR J PHARMACOL, V554, P18, DOI 10.1016/j.ejphar.2006.09.061; Taylor DL, 2002, J NEUROCHEM, V82, P1179, DOI 10.1046/j.1471-4159.2002.01062.x; Taylor DL, 2005, J NEUROSCI, V25, P2952, DOI 10.1523/JNEUROSCI.4456-04.2005; Taylor DL, 2003, J NEUROSCI, V23, P2150; Wu XF, 2005, ANTIOXID REDOX SIGN, V7, P654, DOI 10.1089/ars.2005.7.654; Zhang D, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-21; Zhang W, 2007, GLIA, V55, P1178, DOI 10.1002/glia.20532; Zhao XR, 2001, J NEUROSCI RES, V64, P121, DOI 10.1002/jnr.1059; Zhao XX, 2005, J LEUKOCYTE BIOL, V77, P414, DOI 10.1189/jlb.0504284; Zou JY, 2005, BRAIN RES, V1034, P11, DOI 10.1016/j.brainres.2004.11.014	55	87	91	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15629	15639		10.1074/jbc.M806139200	http://dx.doi.org/10.1074/jbc.M806139200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19364772	Green Published, hybrid			2022-12-25	WOS:000266501000031
J	Matsuda, S; Matsuda, Y; D'Adamio, L				Matsuda, Shuji; Matsuda, Yukiko; D'Adamio, Luciano			BRI3 Inhibits Amyloid Precursor Protein Processing in a Mechanistically Distinct Manner from Its Homologue Dementia Gene BRI2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED INTRAMEMBRANE PROTEOLYSIS; GAMMA-SECRETASE; INTRACELLULAR DOMAIN; ALZHEIMERS-DISEASE; A-BETA; APP; PRESENILIN; NOTCH; TRANSCRIPTION; EXPRESSION	Alzheimer disease (AD) is characterized by senile plaques, which are mainly composed of beta amyloid (A beta) peptides. A beta is cleaved off from amyloid precursor protein (APP) with consecutive proteolytic processing: beta-secretase, followed by gamma-secretase. Here, we show that BRI3, a member of the BRI gene family that includes the familial British and Danish dementia gene BRI2, interacts with APP and serves as an endogenous negative regulator of A beta production. BRI3 colocalizes with APP along neuritis in differentiated N2a cells; endogenous BRI3-APP complexes are readily detectable in mouse brain extract; reducing endogenous BRI3 levels by RNA interference results in increased A beta secretion. BRI3 resembles BRI2, because BRI3 overexpression reduces both alpha-and beta-APP cleavage. We propose that BRI3 inhibits the various processing of APP by blocking the access of alpha-and beta-secretases to APP. However, unlike BRI2, the binding of BRI3 to the beta-secretase cleaved APP C-terminal fragment is negligible and BRI3 does not cause the massive accumulation of this APP fragment, suggesting that, unlike BRI2, BRI3 is a poor gamma-cleavage inhibitor. Competitive inhibition of APP processing by BRI3 may provide a new approach to AD therapy and prevention.	[Matsuda, Shuji; Matsuda, Yukiko; D'Adamio, Luciano] Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	D'Adamio, L (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	ldadamio@aecom.yu.edu		D'Adamio, Luciano/0000-0002-9820-4882; D'Adamio, Luciano/0000-0002-2204-9441	National Institutes of Health [RO1 AG22024, RO1 AG21588, R21 AG027139]; NIA; Alzheimer's Association [IIRG-05-14511]; NATIONAL INSTITUTE ON AGING [R21AG027139, R01AG022024, R01AG021588] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 AG22024, RO1 AG21588, and R21 AG027139 from the NIA. This work was also supported by Alzheimer's Association Grant IIRG-05-14511 to L. D.).	Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; BRETELER MMB, 1992, EPIDEMIOL REV, V14, P59, DOI 10.1093/oxfordjournals.epirev.a036092; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Checler F, 2007, CURR ALZHEIMER RES, V4, P423, DOI 10.2174/156720507781788945; Chyung JH, 2005, J BIOL CHEM, V280, P4383, DOI 10.1074/jbc.M409272200; Cupers P, 2001, J NEUROCHEM, V78, P1168, DOI 10.1046/j.1471-4159.2001.00516.x; Deleersnijder W, 1996, J BIOL CHEM, V271, P19475, DOI 10.1074/jbc.271.32.19475; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Evin G, 2006, CNS DRUGS, V20, P351, DOI 10.2165/00023210-200620050-00002; Fotinopoulou A, 2005, J BIOL CHEM, V280, P30768, DOI 10.1074/jbc.C500231200; Giliberto L, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-12; Hamid R, 2007, J NEUROCHEM, V102, P1264, DOI 10.1111/j.1471-4159.2007.04627.x; Kaether C, 2006, TRAFFIC, V7, P408, DOI 10.1111/j.1600-0854.2006.00396.x; Kim HS, 2003, FASEB J, V17, P1951, DOI 10.1096/fj.03-0106fje; Kim JS, 2008, J NEUROSCI, V28, P6030, DOI 10.1523/JNEUROSCI.0891-08.2008; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Leissring MA, 2002, P NATL ACAD SCI USA, V99, P4697, DOI 10.1073/pnas.072033799; Li QM, 2004, J BIOL CHEM, V279, P10542, DOI 10.1074/jbc.M310001200; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Madeira A, 2005, FASEB J, V19, P1905, DOI 10.1096/fj.05-3839fje; Martin L, 2008, J BIOL CHEM, V283, P1644, DOI 10.1074/jbc.M706661200; Matsuda S, 2005, J BIOL CHEM, V280, P28912, DOI 10.1074/jbc.C500217200; Matsuda S, 2001, J NEUROSCI, V21, P6597; Matsuda S, 2008, J NEUROSCI, V28, P8668, DOI 10.1523/JNEUROSCI.2094-08.2008; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Passer Brent, 2000, Journal of Alzheimer's Disease, V2, P289; Roncarati R, 2002, P NATL ACAD SCI USA, V99, P7102, DOI 10.1073/pnas.102192599; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P329, DOI 10.1016/S0968-0004(02)02134-5; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Scheinfeld MH, 2002, J BIOL CHEM, V277, P44195, DOI 10.1074/jbc.M208110200; Scheinfeld MH, 2002, J BIOL CHEM, V277, P3767, DOI 10.1074/jbc.M108357200; Scheinfeld MH, 2003, P NATL ACAD SCI USA, V100, P1729, DOI 10.1073/pnas.0437908100; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Selkoe DJ, 2002, ANNU REV GENOM HUM G, V3, P67, DOI 10.1146/annurev.genom.3.022502.103022; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vidal R, 2000, P NATL ACAD SCI USA, V97, P4920, DOI 10.1073/pnas.080076097; Vidal R, 1999, NATURE, V399, P776; Vidal R, 2001, GENE, V266, P95, DOI 10.1016/S0378-1119(01)00374-2; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Wickham L, 2005, J NEUROCHEM, V92, P93, DOI 10.1111/j.1471-4159.2004.02840.x; Zazzeroni F, 2003, BLOOD, V102, P3270, DOI 10.1182/blood-2003-03-0689	44	39	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15815	15825		10.1074/jbc.M109.006403	http://dx.doi.org/10.1074/jbc.M109.006403			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19366692	hybrid, Green Published			2022-12-25	WOS:000266501000050
J	Shiraiwa, Y; Ikushiro, H; Hayashi, H				Shiraiwa, Yuka; Ikushiro, Hiroko; Hayashi, Hideyuki			Multifunctional Role of His(159) in the Catalytic Reaction of Serine Palmitoyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRIDOXAL-5'-PHOSPHATE-DEPENDENT ENZYMES; 8-AMINO-7-OXONONANOATE SYNTHASE; CRYSTAL-STRUCTURE; COA; BIOSYNTHESIS; VITAMIN-B-6; MECHANISMS; EVOLUTION	Serine palmitoyltransferase (SPT) belongs to the fold type I family of the pyridoxal 5'-phosphate (PLP)-dependent enzyme and forms 3-ketodihydrosphingosine (KDS) from L-serine and palmitoyl-CoA. Like other alpha-oxamine synthase subfamily enzymes, SPT is different from most of the fold type I enzymes in that its re face of the PLP-Lys aldimine is occupied by a His residue (His(159)) instead of an aromatic amino acid residue. His(159) was changed into alanine or aromatic amino acid residues to examine its role during catalysis. All mutant SPTs formed the PLP-L-serine aldimine with dissociation constants several 10-fold higher than that of the wild type SPT and catalyzed the abortive transamination of L-serine. These results indicate that His(159) is not only the anchoring site for L-serine but regulates the alpha-deprotonation of L-serine by fixing the conformation of the PLP-L-serine aldimine to prevent unwanted side reactions. Only H159A SPT retained activity and showed a prominent 505-nm absorption band of the quinonoid species during catalysis. Global analysis of the time-resolved spectra suggested the presence of the two quinonoid intermediates, the first formed from the PLP-L-serine aldimine and the second from the PLP-KDS aldimine. Accumulation of these quinonoid intermediates indicated that His(159) promotes both the Claisen-type condensation as an acid catalyst and the protonation at C alpha of the second quinonoid to form the PLP-KDS aldimine. These results, combined with the previous model building study (Ikushiro, H., Fujii, S., Shiraiwa, Y., and Hayashi, H. (2008) J. Biol. Chem. 283, 7542-7553), lead us to propose a novel mechanism, in which His(159) plays multiple roles by exploiting the stereochemistry of Dunathan's conjecture.	[Shiraiwa, Yuka; Ikushiro, Hiroko; Hayashi, Hideyuki] Osaka Med Coll, Dept Biochem, Takatsuki, Osaka 5698686, Japan	Osaka Medical College	Ikushiro, H (corresponding author), 2-7 Daigakumachi, Takatsuki, Osaka 5698686, Japan.	ikushiro@art.osaka-med.ac.jp; hayashi@art.osaka-med.ac.jp			Japan Society for the Promotion of Science [21570120, 21570149]; Osaka Medical Research Foundation for Incurable Diseases	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Osaka Medical Research Foundation for Incurable Diseases	This work was supported in part by Grants-in-Aid for Scientific Research 21570120 (to H. H.) and 21570149 (to H. I.) from the Japan Society for the Promotion of Science and a grant from the Osaka Medical Research Foundation for Incurable Diseases (to H. I.).	Alexeev D, 1998, J MOL BIOL, V284, P401, DOI 10.1006/jmbi.1998.2086; Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; HADENER A, 1990, BIOCHEM J, V271, P487; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; HAYASHI H, 1995, J BIOCHEM-TOKYO, V118, P463, DOI 10.1093/oxfordjournals.jbchem.a124931; HAYASHI H, 1993, BIOCHEMISTRY-US, V32, P812, DOI 10.1021/bi00054a011; Hunter GA, 1999, BIOCHEMISTRY-US, V38, P3711, DOI 10.1021/bi982390w; Hunter GA, 2007, J BIOL CHEM, V282, P23025, DOI 10.1074/jbc.M609330200; Ikushiro H, 2004, BIOCHEMISTRY-US, V43, P1082, DOI 10.1021/bi035706v; Ikushiro H, 2001, J BIOL CHEM, V276, P18249, DOI 10.1074/jbc.M101550200; Ikushiro H, 2008, J BIOL CHEM, V283, P7542, DOI 10.1074/jbc.M706874200; Mehta PK, 2000, ADV ENZYMOL RAMB, V74, P129; ONUFFER JJ, 1994, PROTEIN ENG, V7, P413, DOI 10.1093/protein/7.3.413; Salzmann D, 2000, BIOCHEM BIOPH RES CO, V270, P576, DOI 10.1006/bbrc.2000.2460; Schmidt A, 2001, BIOCHEMISTRY-US, V40, P5151, DOI 10.1021/bi002204y; Schneider G, 2000, STRUCT FOLD DES, V8, pR1, DOI 10.1016/S0969-2126(00)00085-X; Valls F, 2001, J AGR FOOD CHEM, V49, P38, DOI 10.1021/jf0003202; Webster SP, 2000, BIOCHEMISTRY-US, V39, P516, DOI 10.1021/bi991620j; Yard BA, 2007, J MOL BIOL, V370, P870, DOI 10.1016/j.jmb.2007.04.086	20	14	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15487	15495		10.1074/jbc.M808916200	http://dx.doi.org/10.1074/jbc.M808916200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19346561	Green Published, hybrid			2022-12-25	WOS:000266501000017
J	Andersen, KM; Madsen, L; Prag, S; Johnsen, AH; Semple, CA; Hendil, KB; Hartmann-Petersen, R				Andersen, Katrine M.; Madsen, Louise; Prag, Soren; Johnsen, Anders H.; Semple, Colin A.; Hendil, Klavs B.; Hartmann-Petersen, Rasmus			Thioredoxin Txnl1/TRP32 Is a Redox-active Cofactor of the 26 S Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAENORHABDITIS-ELEGANS; MOLECULAR-CLONING; PROTEIN; IDENTIFICATION; PURIFICATION; DEGRADATION; EXPRESSION; SITE; RECOGNITION; PROTEOMICS	The 26 S proteasome is a large proteolytic machine, which degrades most intracellular proteins. We found that thioredoxin, Txnl1/TRP32, binds to Rpn11, a subunit of the regulatory complex of the human 26 S proteasome. Txnl1 is abundant, metabolically stable, and widely expressed and is present in the cytoplasm and nucleus. Txnl1 has thioredoxin activity with a redox potential of about -250 mV. Mutant Txnl1 with one active site cysteine replaced by serine formed disulfide bonds to eEF1A1, a substrate-recruiting factor of the 26 S proteasome. eEF1A1 is therefore a likely physiological substrate. In response to knockdown of Txnl1, ubiquitin-protein conjugates were moderately stabilized. Hence, Txnl1 is the first example of a direct connection between protein reduction and proteolysis, two major intracellular protein quality control mechanisms.	[Hartmann-Petersen, Rasmus] Univ Copenhagen, Dept Biol, DK-2100 Copenhagen, Denmark; [Prag, Soren] Univ Lisbon, Fac Med, Inst Mol Med, P-1649028 Lisbon, Portugal; [Johnsen, Anders H.] Copenhagen Univ Hosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; [Semple, Colin A.] MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of Copenhagen; Universidade de Lisboa; University of Copenhagen; University of Edinburgh	Hartmann-Petersen, R (corresponding author), Univ Copenhagen, Dept Biol, Univ Pk 13, DK-2100 Copenhagen, Denmark.	rhpetersen@bio.ku.dk	Hartmann-Petersen, Rasmus/K-4434-2014; Semple, Colin A M/A-5613-2009	Hartmann-Petersen, Rasmus/0000-0002-4155-7791; Semple, Colin A M/0000-0003-1765-4118	Danish Research Academy, Lundbeck Foundation; Novo Nordisk Foundation, and Carlsberg Foundation	Danish Research Academy, Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation, and Carlsberg Foundation(Novo Nordisk Foundation)	This work was supported by grants from the Danish Research Academy, Lundbeck Foundation, Novo Nordisk Foundation, and Carlsberg Foundation (to R.H.-P.).	Ambroggio XI, 2004, PLOS BIOL, V2, P113, DOI 10.1371/journal.pbio.0020002; Balmer Y, 2003, P NATL ACAD SCI USA, V100, P370, DOI 10.1073/pnas.232703799; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; Brodegger T, 2004, BIOL CHEM, V385, P1185, DOI 10.1515/BC.2004.153; Brooks P, 2000, BIOCHEM J, V346, P155, DOI 10.1042/0264-6021:3460155; Chen L, 2005, CANCER RES, V65, P5599, DOI 10.1158/0008-5472.CAN-05-0201; Chuang SM, 2005, MOL CELL BIOL, V25, P403, DOI 10.1128/MCB.25.1.403-413.2005; Davy A, 2001, EMBO REP, V2, P821, DOI 10.1093/embo-reports/kve184; Dawson S, 2002, J BIOL CHEM, V277, P10893, DOI 10.1074/jbc.M107313200; Demasi M, 2003, J BIOL CHEM, V278, P679, DOI 10.1074/jbc.M209282200; Felberbaum-Corti M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001144; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; GONEN H, 1994, P NATL ACAD SCI USA, V91, P7648, DOI 10.1073/pnas.91.16.7648; Grune T, 2004, INT J BIOCHEM CELL B, V36, P2519, DOI 10.1016/j.biocel.2004.04.020; Guerrero C, 2008, P NATL ACAD SCI USA, V105, P13333, DOI 10.1073/pnas.0801870105; Hartmann-Petersen R, 2003, TRENDS BIOCHEM SCI, V28, P26, DOI 10.1016/S0968-0004(02)00002-6; Haugstetter J, 2005, J BIOL CHEM, V280, P8371, DOI 10.1074/jbc.M413924200; Hendil KB, 2005, METHOD ENZYMOL, V398, P439, DOI 10.1016/S0076-6879(05)98036-1; Hendil KB, 2004, CURR PROTEIN PEPT SC, V5, P135, DOI 10.2174/1389203043379747; Hirota K, 1997, P NATL ACAD SCI USA, V94, P3633, DOI 10.1073/pnas.94.8.3633; HOFFMAN L, 1992, J BIOL CHEM, V267, P22362; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; HOUGH R, 1987, J BIOL CHEM, V262, P8303; Ishii T, 2005, BIOCHEMISTRY-US, V44, P13893, DOI 10.1021/bi051336u; Jimenez A, 2006, FEBS LETT, V580, P960, DOI 10.1016/j.febslet.2006.01.025; Jimenez A, 2007, YEAST, V24, P481, DOI 10.1002/yea.1483; Jorgensen JP, 2006, J MOL BIOL, V360, P1043, DOI 10.1016/j.jmb.2006.06.011; KE B, 1957, BIOCHIM BIOPHYS ACTA, V25, P650, DOI 10.1016/0006-3002(57)90544-9; Kouwen TRHM, 2008, J MOL BIOL, V379, P520, DOI 10.1016/j.jmb.2008.03.077; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Landino LM, 2004, FREE RADICAL BIO MED, V36, P497, DOI 10.1016/j.freeradbiomed.2003.11.026; Lee KK, 1998, J BIOL CHEM, V273, P19160, DOI 10.1074/jbc.273.30.19160; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Liu CW, 2002, J BIOL CHEM, V277, P26815, DOI 10.1074/jbc.M201782200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lukash TO, 2004, INT J BIOCHEM CELL B, V36, P1341, DOI 10.1016/j.biocel.2003.11.009; Lundgren J, 2005, MOL CELL BIOL, V25, P4662, DOI 10.1128/MCB.25.11.4662-4675.2005; Lyngholm JM, 2001, ALLERGY, V56, P21; MA CP, 1992, J BIOL CHEM, V267, P10515; Madsen L, 2008, INT J BIOCHEM CELL B, V40, P2927, DOI 10.1016/j.biocel.2008.06.008; Malki A, 2002, BIOCHEM BIOPH RES CO, V296, P749, DOI 10.1016/S0006-291X(02)00935-X; Meiners S, 2003, J BIOL CHEM, V278, P21517, DOI 10.1074/jbc.M301032200; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Miranda-Vizuete A, 1998, BIOCHEM BIOPH RES CO, V243, P284, DOI 10.1006/bbrc.1997.8003; Motohashi K, 2001, P NATL ACAD SCI USA, V98, P11224, DOI 10.1073/pnas.191282098; ROST J, 1964, NATURE, V201, P185, DOI 10.1038/201185a0; RUBARTELLI A, 1992, J BIOL CHEM, V267, P24161; SLOT LA, 1987, SCAND J CLIN LAB INV, V47, P393; Sone T, 2004, J BIOL CHEM, V279, P28807, DOI 10.1074/jbc.M403165200; Strickland E, 2000, J BIOL CHEM, V275, P5565, DOI 10.1074/jbc.275.8.5565; Tanahashi N, 2000, J BIOL CHEM, V275, P14336, DOI 10.1074/jbc.275.19.14336; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Vignols F, 2003, J BIOL CHEM, V278, P4516, DOI 10.1074/jbc.M210080200; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wang XR, 2008, MOL CELL PROTEOMICS, V7, P46, DOI 10.1074/mcp.M700261-MCP200; Wiseman RL, 2009, J BIOL CHEM, V284, P15233, DOI 10.1074/jbc.M109.002121; Wong JH, 2003, FEBS LETT, V547, P151, DOI 10.1016/S0014-5793(03)00696-3; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Yamazaki D, 2004, PLANT CELL PHYSIOL, V45, P18, DOI 10.1093/pcp/pch019; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071	62	60	64	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15246	15254		10.1074/jbc.M900016200	http://dx.doi.org/10.1074/jbc.M900016200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19349277	Green Published, hybrid			2022-12-25	WOS:000266288200059
J	Deffieu, M; Bhatia-Kissova, I; Salin, B; Galinier, A; Manon, S; Camougrand, N				Deffieu, Maika; Bhatia-Kissova, Ingrid; Salin, Benedicte; Galinier, Anne; Manon, Stephen; Camougrand, Nadine			Glutathione Participates in the Regulation of Mitophagy in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-GLUTAMYL-TRANSPEPTIDASE; PROGRAMMED CELL-DEATH; SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; MITOCHONDRIAL AUTOPHAGY; AMINO-ACID; NITROGEN-SOURCE; DEGRADATION; STARVATION; GROWTH	Theantioxidant N-acetyl-L-cysteine prevented the autophagy-dependent delivery of mitochondria to the vacuoles, as examined by fluorescence microscopy of mitochondria-targeted green fluorescent protein, transmission electron microscopy, and Western blot analysis of mitochondrial proteins. The effect of N-acetyl-L-cysteine was specific to mitochondrial autophagy (mitophagy). Indeed, autophagy-dependent activation of alkaline phosphatase and the presence of hallmarks of non-selective microautophagy were not altered by N-acetyl-L-cysteine. The effect of N-acetyl-L-cysteine was not related to its scavenging properties, but rather to its fueling effect of the glutathione pool. As a matter of fact, the decrease of the glutathione pool induced by chemical or genetical manipulation did stimulate mitophagy but not general autophagy. Conversely, the addition of a cell-permeable form of glutathione inhibited mitophagy. Inhibition of glutathione synthesis had no effect in the strain Delta uth1, which is deficient in selective mitochondrial degradation. These data show that mitophagy can be regulated independently of general autophagy, and that its implementation may depend on the cellular redox status.	[Camougrand, Nadine] Univ Bordeaux 2, CNRS, Inst Biochim & Genet Cellulaires, UMR 5095, F-33077 Bordeaux, France; [Bhatia-Kissova, Ingrid] Comenius Univ, Dept Biochem, Bratislava 84215, Slovakia; [Salin, Benedicte] Univ Bordeaux 2, Serv Commun Microscopie, F-33076 Bordeaux, France; [Galinier, Anne] Univ Toulouse 3, CNRS, UMR 5018, CHU Rangueil,TSA 50032,IFR 31, F-31059 Toulouse 9, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Comenius University Bratislava; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Camougrand, N (corresponding author), Univ Bordeaux 2, CNRS, Inst Biochim & Genet Cellulaires, UMR 5095, 1 Rue Camille St Saens, F-33077 Bordeaux, France.	n.camougrand@ibgc.cnrs.fr	Manon, Stéphen/C-7088-2017; Bhatia, Ingrid/H-7016-2016	Manon, Stephen/0000-0002-5792-1084; Galinier, Anne/0000-0003-2454-5681	CNRS; Universite de Bordeaux 2; Conseil Regional d'Aquitaine [UMR 5095]; Association pour la Recherche contre le Cancer [3812]; Slovak Ministry of Education [VEGA1/0264/08]; Science and Technology Assistance Agency [APVV-0024-07]; Egide ECO-NET [10187VF]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Bordeaux 2; Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Slovak Ministry of Education; Science and Technology Assistance Agency; Egide ECO-NET	This work was supported in part by grants from the CNRS, the Universite de Bordeaux 2, the Conseil Regional d'Aquitaine (to UMR 5095), and Association pour la Recherche contre le Cancer Grant 3812 (to S. M.), Slovak Ministry of Education Contract VEGA1/0264/08 and Science and Technology Assistance Agency Contract APVV-0024-07 (to I. B.-K.). The France/Slovakia collaboration was supported by Egide ECO-NET 10187VF (to S. M.).	AMY PS, 1983, APPL ENVIRON MICROB, V45, P1041, DOI 10.1128/AEM.45.3.1041-1048.1983; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Camougrand N, 2003, MOL MICROBIOL, V47, P495, DOI 10.1046/j.1365-2958.2003.03311.x; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; Gomes DS, 2002, BBA-GEN SUBJECTS, V1573, P21, DOI 10.1016/S0304-4165(02)00324-0; Grant CM, 2001, MOL MICROBIOL, V39, P533, DOI 10.1046/j.1365-2958.2001.02283.x; Grant CM, 1997, MOL BIOL CELL, V8, P1699, DOI 10.1091/mbc.8.9.1699; Grant CM, 1996, CURR GENET, V29, P511, DOI 10.1007/BF02426954; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; Hamasaki M, 2005, TRAFFIC, V6, P56, DOI 10.1111/j.1600-0854.2004.00245.x; Hammarqvist F, 2005, CLIN NUTR, V24, P236, DOI 10.1016/j.clnu.2004.10.004; Huang WP, 2002, CELL STRUCT FUNCT, V27, P409, DOI 10.1247/csf.27.409; Jazwinski SM, 2005, MECH AGEING DEV, V126, P243, DOI 10.1016/j.mad.2004.08.016; Kanki T, 2008, J BIOL CHEM, V283, P32386, DOI 10.1074/jbc.M802403200; Kiel JAKW, 2003, FEBS LETT, V549, P1, DOI 10.1016/S0014-5793(03)00794-4; Kiffin R, 2006, ANTIOXID REDOX SIGN, V8, P152, DOI 10.1089/ars.2006.8.152; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kissova I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200; Kissova I, 2007, AUTOPHAGY, V3, P329, DOI 10.4161/auto.4034; Kissova I, 2006, FREE RADICAL BIO MED, V41, P1655, DOI 10.1016/j.freeradbiomed.2006.08.012; KLINGENBERG M, 1985, METHOD ENZYMAT AN, V7, P251; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Kundu M, 2005, CELL DEATH DIFFER, V12, P1484, DOI 10.1038/sj.cdd.4401780; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Lenaz G, 2002, ANN NY ACAD SCI, V959, P199, DOI 10.1111/j.1749-6632.2002.tb02094.x; Mehdi K, 1997, MICROBIOL-UK, V143, P1885, DOI 10.1099/00221287-143-6-1885; Melnyk S, 1999, J NUTR BIOCHEM, V10, P490, DOI 10.1016/S0955-2863(99)00033-9; MOAT AG, 1969, J BACTERIOL, V98, P573, DOI 10.1128/JB.98.2.573-578.1969; Nair U, 2005, J BIOL CHEM, V280, P41785, DOI 10.1074/jbc.R500016200; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Nowikovsky K, 2007, CELL DEATH DIFFER, V14, P1647, DOI 10.1038/sj.cdd.4402167; OHTAKE Y, 1990, AGR BIOL CHEM TOKYO, V54, P3145, DOI 10.1080/00021369.1990.10870487; Okamoto K, 1998, J CELL BIOL, V142, P613, DOI 10.1083/jcb.142.3.613; Pan XZ, 2000, MOL BIOL CELL, V11, P2445, DOI 10.1091/mbc.11.7.2445; Penninckx MJ, 2002, FEMS YEAST RES, V2, P295, DOI 10.1111/j.1567-1364.2002.tb00098.x; Priault M, 2005, CELL DEATH DIFFER, V12, P1613, DOI 10.1038/sj.cdd.4401697; Reggiori F, 2005, CURR OPIN CELL BIOL, V17, P415, DOI 10.1016/j.ceb.2005.06.007; Richie JP, 2004, NUTRITION, V20, P800, DOI 10.1016/j.nut.2004.05.009; Roberts P, 2003, MOL BIOL CELL, V14, P129, DOI 10.1091/mbc.E02-08-0483; Rodriguez-Enriquez S, 2004, INT J BIOCHEM CELL B, V36, P2463, DOI 10.1016/j.biocel.2004.04.009; Rodriguez-Enriquez S, 2006, AUTOPHAGY, V2, P39, DOI 10.4161/auto.2229; Rosado CJ, 2008, AUTOPHAGY, V4, P205, DOI 10.4161/auto.5331; Sakai Y, 1998, J CELL BIOL, V141, P625, DOI 10.1083/jcb.141.3.625; Sanz A, 2006, ANTIOXID REDOX SIGN, V8, P582, DOI 10.1089/ars.2006.8.582; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; SJODIN K, 1989, BIOCHEM PHARMACOL, V38, P3981, DOI 10.1016/0006-2952(89)90677-1; Springael JY, 2003, BIOCHEM J, V371, P589, DOI 10.1042/BJ20021893; Tal R, 2007, J BIOL CHEM, V282, P5617, DOI 10.1074/jbc.M605940200; TATEISHI N, 1977, J NUTR, V107, P51, DOI 10.1093/jn/107.1.51; Terman Alexei, 2006, Molecular Aspects of Medicine, V27, P471, DOI 10.1016/j.mam.2006.08.006; Tolkovsky AM, 2002, BIOCHIMIE, V84, P233, DOI 10.1016/S0300-9084(02)01371-8; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Ullmann P, 1996, EUR J BIOCHEM, V236, P662, DOI 10.1111/j.1432-1033.1996.00662.x; VOGT BL, 1993, BIOCHEM PHARMACOL, V46, P257, DOI 10.1016/0006-2952(93)90412-P; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; WATSON TG, 1976, J GEN MICROBIOL, V96, P263, DOI 10.1099/00221287-96-2-263; WELLNER VP, 1984, P NATL ACAD SCI-BIOL, V81, P4732, DOI 10.1073/pnas.81.15.4732; Xue L, 2001, CURR BIOL, V11, P361, DOI 10.1016/S0960-9822(01)00100-2; Xue LZ, 1999, MOL CELL NEUROSCI, V14, P180, DOI 10.1006/mcne.1999.0780; Yu BP, 2006, MECH AGEING DEV, V127, P436, DOI 10.1016/j.mad.2006.01.023; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103	62	85	91	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14828	14837		10.1074/jbc.M109.005181	http://dx.doi.org/10.1074/jbc.M109.005181			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19366696	Green Published, hybrid			2022-12-25	WOS:000266288200018
J	Nishimichi, N; Higashikawa, F; Kinoh, HH; Tateishi, Y; Matsuda, H; Yokosaki, Y				Nishimichi, Norihisa; Higashikawa, Fumiko; Kinoh, Hiromi H.; Tateishi, Yoshiko; Matsuda, Haruo; Yokosaki, Yasuyuki			Polymeric Osteopontin Employs Integrin alpha 9 beta 1 as a Receptor and Attracts Neutrophils by Presenting a de Novo Binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE TRANSGLUTAMINASE; FACTOR-XIII; III REPEAT; CELL; ALPHA(9)BETA(1); TENASCIN; INFILTRATION; INFLAMMATION; SUBSTRATE; MIGRATION	Osteopontin (OPN) is a cytokine and ligand for multiple members of the integrin family. OPN undergoes the in vivo polymerization catalyzed by cross-linking enzyme transglutaminase 2, which consequently increases the bioactivity through enhanced interaction with integrins. The integrin alpha 9 beta 1, highly expressed on neutrophils, binds to the sequence SVVYGLR only after intact OPN is cleaved by thrombin. The SVVYGLR sequence appears to be cryptic in intact OPN because alpha 9 beta 1 does not recognize intact OPN. Because transglutaminase 2-catalyzed polymers change their physical and chemical properties, we hypothesized that the SVVYGLR site might also be exposed on polymeric OPN. As expected, alpha 9 beta 1 turned into a receptor for polymeric OPN, a result obtained by cell adhesion and migration assays with alpha 9-transfected cells and by detection of direct binding of recombinant soluble alpha 9 beta 1 with colorimetry and surface plasmon resonance analysis. Because the N-terminal fragment of thrombincleaved OPN, a ligand for alpha 9 beta 1, has been reported to attract neutrophils, we next examined migration of neutrophils to polymeric OPN using time-lapse microscopy. Polymeric OPN showed potent neutrophil chemotactic activity, which was clearly inhibited by anti-alpha 9 beta 1 antibody. Unexpectedly, mutagenesis studies showed that alpha 9 beta 1 bound to polymeric OPN independently of the SVVYGLR sequence, and further, SVVYGLR sequence of polymeric OPN was cryptic because SVVYGLR-specific antibody did not recognize polymeric OPN. These results demonstrate that polymerization of OPN generates a novel alpha 9 beta 1-binding site and that the interaction of this site with the alpha 9 beta 1 integrin is critical to the neutrophil chemotaxis induced by polymeric OPN.	[Higashikawa, Fumiko; Kinoh, Hiromi H.; Yokosaki, Yasuyuki] Hiroshima Univ, Biomed Res Unit, Cell Matrix Frontier Lab, Minami Ku, Hiroshima 7348551, Japan; Hiroshima Univ, Grad Sch Biosphere Sci, Dept Biochem & Appl Mol Biosci, Immunobiol Lab, Higashihiroshima 7398528, Japan; [Yokosaki, Yasuyuki] Hiroshima Univ, Hlth Adm Ctr, Higashihiroshima 7398521, Japan	Hiroshima University; Hiroshima University; Immuno-Biological Laboratories Co. Ltd.; Hiroshima University	Yokosaki, Y (corresponding author), Hiroshima Univ, Biomed Res Unit, Cell Matrix Frontier Lab, Minami Ku, Biomed Res Bldg 216,1-2-3 Kasumi, Hiroshima 7348551, Japan.	yokosaki@hiroshima-u.ac.jp			Japan New Energy and Industrial Technology Development Organization; Tsuchiya Memorial Medical Foundation	Japan New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Tsuchiya Memorial Medical Foundation	This work was supported by a grant from the Japan New Energy and Industrial Technology Development Organization (to N. N., Y. T., H. M., and Y. Y., new functional antibody technologies) and by a grant from the Tsuchiya Memorial Medical Foundation (to Y. Y.).	Agnihotri R, 2001, J BIOL CHEM, V276, P28261, DOI 10.1074/jbc.M103608200; Apte UM, 2005, TOXICOL APPL PHARM, V207, P25, DOI 10.1016/j.taap.2004.12.018; Banerjee A, 2006, J PATHOL, V208, P473, DOI 10.1002/path.1917; Carrigan SO, 2007, J LEUKOCYTE BIOL, V82, P1575, DOI 10.1189/jlb.0806528; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Diao HY, 2004, IMMUNITY, V21, P539, DOI 10.1016/j.immuni.2004.08.012; Higashikawa F, 2007, FEBS LETT, V581, P2697, DOI 10.1016/j.febslet.2007.05.018; Kaartinen MT, 2007, J HISTOCHEM CYTOCHEM, V55, P375, DOI 10.1369/jhc.6A7087.2006; Kaartinen MT, 2002, J BONE MINER RES, V17, P2161, DOI 10.1359/jbmr.2002.17.12.2161; Koh A, 2007, IMMUNOLOGY, V122, P466, DOI 10.1111/j.1365-2567.2007.02682.x; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; Nitta N, 2007, J IMMUNOL METHODS, V320, P155, DOI 10.1016/j.jim.2006.12.010; PRINCE CW, 1991, BIOCHEM BIOPH RES CO, V177, P1205, DOI 10.1016/0006-291X(91)90669-X; Sato Y, 2008, ATHEROSCLEROSIS, V200, P303, DOI 10.1016/j.atherosclerosis.2008.02.001; Scatena M, 2007, ARTERIOSCL THROM VAS, V27, P2302, DOI 10.1161/ATVBAHA.107.144824; SENGER DR, 1994, MOL BIOL CELL, V5, P565, DOI 10.1091/mbc.5.5.565; Smith LL, 1996, J BIOL CHEM, V271, P28485, DOI 10.1074/jbc.271.45.28485; Takahashi H, 2000, J BIOL CHEM, V275, P23589, DOI 10.1074/jbc.M003526200; Taooka Y, 1999, J CELL BIOL, V145, P413, DOI 10.1083/jcb.145.2.413; Wang A, 1996, AM J RESP CELL MOL, V15, P664, DOI 10.1165/ajrcmb.15.5.8918373; Yokosaki Y, 2005, MATRIX BIOL, V24, P418, DOI 10.1016/j.matbio.2005.05.005; YOKOSAKI Y, 1994, J BIOL CHEM, V269, P26691; Yokosaki Y, 1996, J BIOL CHEM, V271, P24144, DOI 10.1074/jbc.271.39.24144; Yokosaki Y, 1998, J BIOL CHEM, V273, P11423, DOI 10.1074/jbc.273.19.11423; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328; Zemskov EA, 2006, FRONT BIOSCI-LANDMRK, V11, P1057, DOI 10.2741/1863	27	40	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14769	14776		10.1074/jbc.M901515200	http://dx.doi.org/10.1074/jbc.M901515200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19346516	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000266288200012
J	Ciechomska, IA; Goemans, GC; Skepper, JN; Tolkovsky, AM				Ciechomska, I. A.; Goemans, G. C.; Skepper, J. N.; Tolkovsky, A. M.			Bcl-2 complexed with Beclin-1 maintains full anti-apoptotic function	ONCOGENE			English	Article						apoptosis; autophagy; Bcl-2; Beclin-1; endoplasmic reticulum; mitochondria	CELL-DEATH; REGULATES AUTOPHAGY; MOLECULAR-BASIS; INHIBITION; PROTEINS; CANCER; MITOCHONDRIA; DOMAIN; TUMORIGENESIS; DEGRADATION	The binding of Bcl-2 to Beclin-1 reduces Beclin-1's capacity to induce autophagy. Here, we have tested whether the interaction is reciprocated by loss of Bcl-2's anti-apoptotic function. We targeted Bcl-2 to mitochondria or endoplasmic reticulum (ER) and induced apoptosis using several apoptotic stimuli that initiate ER and/or mitochondrial signaling pathways (UV radiation, TNF and cycloheximide, staurosporine, thapsigargin and tunicamycin). When Beclin-1 and Bcl-2 were expressed together in HeLa cells, Beclin-1 ( but not Beclin-1 lacking the Bcl-2-binding domain) followed Bcl-2 to the appropriate organelle with complete or near-complete overlap ( comprising 60 and 30% of cells, respectively). The interaction between Beclin-1 and Bcl-2 was verified by immunoprecipitation, and a membrane-proximate localization of Beclin-1 was shown by immunoelectron microscopy. Apoptosis was followed by measuring changes in nuclear morphology, caspase-3 activity, poly-ADP-ribose polymerase cleavage or punctation of mRFP-Bax on mitochondria. Binding of Beclin-1 to Bcl-2 did not modify apoptosis irrespective of Bcl-2 concentration, location or apoptotic stimulus. A similar result was obtained in Atg5-/- cells that are autophagy-deficient, arguing against compensation for the loss of protection by Bcl-2 by autophagy-mediated survival induced by Beclin-1. Hence, although Beclin-1 contains a BH3-only motif typical of pro-apoptotic proteins, it is a negligible modulator of Bcl-2's anti-apoptotic function. Oncogene (2009) 28, 2128-2141; doi: 10.1038/onc.2009.60; published online 6 April 2009	[Ciechomska, I. A.; Goemans, G. C.; Tolkovsky, A. M.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Ciechomska, I. A.] M Nencki Inst Expt Biol, Dept Cell Biol, PL-02093 Warsaw, Poland; [Skepper, J. N.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 1QW, England	University of Cambridge; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; University of Cambridge	Tolkovsky, AM (corresponding author), Univ Cambridge, Dept Biochem, Bldg 0,Downing Site, Cambridge CB2 1QW, England.	amt@mole.bio.cam.ac.uk	Ciechomksa, Iwona/R-4706-2016	Ciechomksa, Iwona/0000-0002-8068-0020	Wellcome Trust [064232]	Wellcome Trust(Wellcome TrustEuropean Commission)	We thank our colleagues Beth Levine, Zenyu Yue, Noboru Mizushima, Said Aoufouchi, Christoph Borner, Goeff Butcher and Eiki Kominami for their generous gifts of reagents. This work was funded by program Grant no. 064232 from the Wellcome Trust.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Akar U, 2008, AUTOPHAGY, V4, P669, DOI 10.4161/auto.6083; Annis MG, 2004, BBA-MOL CELL RES, V1644, P115, DOI 10.1016/j.bbamcr.2003.07.001; Arsov I, 2008, CELL DEATH DIFFER, V15, P1385, DOI 10.1038/cdd.2008.59; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chu CT, 2007, AUTOPHAGY, V3, P663, DOI 10.4161/auto.4625; Ciechomska Iwona A., 2008, V445, P175, DOI 10.1007/978-1-59745-157-4_12; Erlich S, 2007, AUTOPHAGY, V3, P561, DOI 10.4161/auto.4713; Feng W, 2007, J MOL BIOL, V372, P223, DOI 10.1016/j.jmb.2007.06.069; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Goemans CG, 2008, CELL DEATH DIFFER, V15, P545, DOI 10.1038/sj.cdd.4402290; Hacki J, 2000, ONCOGENE, V19, P2286, DOI 10.1038/sj.onc.1203592; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Jin SK, 2008, AUTOPHAGY, V4, P563, DOI 10.4161/auto.5830; Jin SK, 2007, AUTOPHAGY, V3, P28, DOI 10.4161/auto.3269; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Ku B, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040025; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Maiuri MC, 2007, AUTOPHAGY, V3, P374, DOI 10.4161/auto.4237; Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002; Michaelidis TM, 1996, NEURON, V17, P75, DOI 10.1016/S0896-6273(00)80282-2; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Noble CG, 2008, J BIOL CHEM, V283, P26274, DOI 10.1074/jbc.M804723200; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ravikumar B, 2006, HUM MOL GENET, V15, P1209, DOI 10.1093/hmg/ddl036; Samara C, 2008, CELL DEATH DIFFER, V15, P105, DOI 10.1038/sj.cdd.4402231; Scarlatti F, 2008, CELL DEATH DIFFER, V15, P1318, DOI 10.1038/cdd.2008.51; Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Sinha S, 2008, AUTOPHAGY, V4, P989, DOI 10.4161/auto.6803; Skepper JN, 2000, J MICROSC-OXFORD, V199, P1, DOI 10.1046/j.1365-2818.2000.00704.x; Swerdlow S, 2008, AUTOPHAGY, V4, P612, DOI 10.4161/auto.5920; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Ullman E, 2008, CELL DEATH DIFFER, V15, P422, DOI 10.1038/sj.cdd.4402234; Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	53	128	134	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 28	2009	28	21					2128	2141		10.1038/onc.2009.60	http://dx.doi.org/10.1038/onc.2009.60			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	451DQ	19347031				2022-12-25	WOS:000266451300002
J	Jones, RA; Campbell, CI; Wood, GA; Petrik, JJ; Moorehead, RA				Jones, R. A.; Campbell, C. I.; Wood, G. A.; Petrik, J. J.; Moorehead, R. A.			Reversibility and recurrence of IGF-IR-induced mammary tumors	ONCOGENE			English	Article						insulin-like growth factor; mammary tumorigenesis; tumor recurrence; epithelial to mesenchymal transition; tumor dormancy	GROWTH-FACTOR-I; HUMAN-BREAST-CANCER; MONOCLONAL-ANTIBODY; TRANSCRIPTIONAL REPRESSOR; TRANSGENIC MICE; FACTOR RECEPTOR; MESSENGER-RNA; GENE-EXPRESSION; KINASE-ACTIVITY; SOLID TUMORS	The type-I insulin-like growth factor receptor (IGF-IR) is frequently overexpressed in breast cancer and therapeutic agents targeting IGF-IR are currently in development. The ultimate success of anti-IGF-IR therapies will depend on the extent to which established tumors remain dependent upon IGF-IR signaling for sustained growth. To investigate the potential benefits and pitfalls of targeting IGF-IR, we used a doxycycline inducible mouse model of IGF-IR initiated breast cancer. We found that downregulation of IGF-IR results in tumor-size-dependent regression to an undetectable state. Partially regressed tumors almost always resumed growth in the absence of doxycycline and a proportion of tumors that regressed to an undetectable state ultimately recurred. This reemergence of tumor growth in the absence of doxycycline was facilitated by IGF-IR-dependent and IGF-IR-independent mechanisms. Tumor escape from IGF-IR dependence was associated with an epithelial to mesenchymal transition and upregulation of transcriptional repressors of E-cadherin. These results suggest that tumors initiated by IGF-IR have the ability to become independent of this initiating oncogene, and IGF-IR independence is associated with characteristics consistent with an epithelial to mesenchymal transition. Oncogene (2009) 28, 2152-2162; doi: 10.1038/onc.2009.79; published online 20 April 2009	[Jones, R. A.; Campbell, C. I.; Petrik, J. J.; Moorehead, R. A.] Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada; [Wood, G. A.] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON N1G 2W1, Canada	University of Guelph; University of Guelph	Moorehead, RA (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada.	rmoorehe@uoguelph.ca	Wood, Geoffrey/ABB-2052-2021	Wood, Geoffrey/0000-0003-1756-8607; , Roger/0000-0001-9539-6295; Jones, Robert/0000-0001-7665-9301	Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance; Ontario Graduate Scholarships	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Research Alliance; Ontario Graduate Scholarships(Ontario Graduate Scholarship)	We thank Katrina Watson, Helen Coates and Michelle Ross for excellent technical assistance. This work was supported by operating grants from the Canadian Institutes of Health Research, the Canadian Breast Cancer Research Alliance, the Cancer Research Society as well as a New Investigator Salary Award from the Canadian Institutes of Health Research (RA Moorehead) and Ontario Graduate Scholarships (RA Jones and CI Campbell).	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; ARTEAGA CL, 1989, J CLIN INVEST, V84, P1418, DOI 10.1172/JCI114315; BATES P, 1995, BRIT J CANCER, V72, P1189, DOI 10.1038/bjc.1995.484; Boxer RB, 2004, CANCER CELL, V6, P577, DOI 10.1016/j.ccr.2004.10.013; Burtrum D, 2003, CANCER RES, V63, P8912; Carboni JM, 2005, CANCER RES, V65, P3781, DOI 10.1158/0008-5472.CAN-04-4602; Chaffer CL, 2006, CANCER RES, V66, P11271, DOI 10.1158/0008-5472.CAN-06-2044; Chernicky CL, 2000, CANCER GENE THER, V7, P384, DOI 10.1038/sj.cgt.7700126; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; Debies MT, 2008, J CLIN INVEST, V118, P51, DOI 10.1172/JCI33320; Divisova J, 2006, BREAST CANCER RES TR, V98, P315, DOI 10.1007/s10549-006-9168-1; Dunn SE, 1998, CANCER RES, V58, P3353; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Feng Y, 2006, MOL CANCER THER, V5, P114, DOI 10.1158/1535-7163.MCT-05-0252; Giani C, 1996, BREAST CANCER RES TR, V41, P43, DOI 10.1007/BF01807035; Goetsch L, 2005, INT J CANCER, V113, P316, DOI 10.1002/ijc.20543; Gunther EJ, 2003, GENE DEV, V17, P488, DOI 10.1101/gad.1051603; Hadsell DL, 2000, ONCOGENE, V19, P889, DOI 10.1038/sj.onc.1203386; Haluska P, 2007, CLIN CANCER RES, V13, P5834, DOI 10.1158/1078-0432.CCR-07-1118; Hankinson SE, 1998, LANCET, V351, P1393, DOI 10.1016/S0140-6736(97)10384-1; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Jones RA, 2007, ONCOGENE, V26, P1636, DOI 10.1038/sj.onc.1209955; Jones RA, 2008, MOL CANCER RES, V6, P819, DOI 10.1158/1541-7786.MCR-07-2157; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kurebayashi Junichi, 2007, Breast Cancer, V14, P200, DOI 10.2325/jbcs.954; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; Linnerth NM, 2005, INT J CANCER, V114, P977, DOI 10.1002/ijc.20814; Lu YH, 2001, JNCI-J NATL CANCER I, V93, P1852, DOI 10.1093/jnci/93.24.1852; Mitsiades CS, 2004, CANCER CELL, V5, P221, DOI 10.1016/S1535-6108(04)00050-9; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Moody SE, 2002, CANCER CELL, V2, P451, DOI 10.1016/S1535-6108(02)00212-X; Nahta R, 2007, ONCOGENE, V26, P3637, DOI 10.1038/sj.onc.1210379; Nichols KD, 2008, BIOCHEM PHARMACOL, V75, P1230, DOI 10.1016/j.bcp.2007.10.032; PAIK S, 1992, BREAST CANCER RES TR, V22, P31, DOI 10.1007/BF01833331; Parisot JP, 1999, BRIT J CANCER, V79, P693, DOI 10.1038/sj.bjc.6690112; Pattyn F, 2006, NUCLEIC ACIDS RES, V34, pD684, DOI 10.1093/nar/gkj155; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Podsypanina K, 2008, P NATL ACAD SCI USA, V105, P5242, DOI 10.1073/pnas.0801197105; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Pravtcheva DD, 1998, J EXP ZOOL, V281, P43, DOI 10.1002/(SICI)1097-010X(19980501)281:1<43::AID-JEZ7>3.3.CO;2-3; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Resnik JL, 1998, CANCER RES, V58, P1159; Rowinsky EK, 2007, CLIN CANCER RES, V13, p5549S, DOI 10.1158/1078-0432.CCR-07-1109; SINGER C, 1995, CANCER RES, V55, P2448; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Surmacz E, 2000, J MAMMARY GLAND BIOL, V5, P95, DOI 10.1023/A:1009523501499; Vesuna F, 2008, BIOCHEM BIOPH RES CO, V367, P235, DOI 10.1016/j.bbrc.2007.11.151; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; YEE D, 1988, CANCER RES, V48, P6691; YEE D, 1989, MOL ENDOCRINOL, V3, P509, DOI 10.1210/mend-3-3-509	52	31	35	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 28	2009	28	21					2152	2162		10.1038/onc.2009.79	http://dx.doi.org/10.1038/onc.2009.79			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	451DQ	19377512				2022-12-25	WOS:000266451300004
J	Bourbon-Freie, A; Dub, RE; Xiao, XJ; Lowe, ME				Bourbon-Freie, Angela; Dub, Rachel E.; Xiao, Xunjun; Lowe, Mark E.			Trp-107 and Trp-253 Account for the Increased Steady State Fluorescence That Accompanies the Conformational Change in Human Pancreatic Triglyceride Lipase Induced by Tetrahydrolipstatin and Bile Salt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID SUBSTITUTION MATRICES; MIXED MICELLES; INTERFACIAL ACTIVATION; ENERGY-TRANSFER; YEAST-CELLS; COMPLEX; PROCOLIPASE; DOMAIN; PURIFICATION; TRANSITION	The conformation of a surface loop, the lid, controls activity of pancreatic triglyceride lipase (PTL) by moving from a position that sterically hinders substrate access to the active site into a new conformation that opens and configures the active site. Movement of the lid is accompanied by a large change in steady state tryptophan fluorescence. Although a change in the microenvironment of Trp-253, a lid residue, could account for the increased fluorescence, the mechanism and tryptophan residues have not been identified. To identify the tryptophan residues responsible for the increased fluorescence and to gain insight into the mechanism of lid opening and the structure of PTL in aqueous solution, we examined the effects of mutating individual tryptophan residues to tyrosine, alanine, or phenylalanine on lipase activity and steady state fluorescence. Substitution of tryptophans 86, 107, 253, and 403 reduced activity against tributyrin with the largest effects caused by substituting Trp-86 and Trp-107. Trp-107 and Trp-253 fluorescence accounts for the increased fluorescence emissions of PTL that is stimulated by tetrahydrolipstatin and sodium taurodeoxycholate. The largest contribution is from Trp-107. Contrary to the prediction from the crystal structure of PTL, Trp-107 is likely exposed to solvent. Both tetrahydrolipstatin and sodium taurodeoxycholate are required to produce the increased fluorescence in PTL. Alone, neither is sufficient. Colipase does not significantly influence the conformational changes leading to increased emission fluorescence. Thus, Trp-107 and Trp-253 contribute to the change in steady state fluorescence that is triggered by mixed micelles of inhibitor and bile salt. Furthermore, the results suggest that the conformation of PTL in solution differs significantly from the conformation in crystals.	[Dub, Rachel E.; Xiao, Xunjun; Lowe, Mark E.] UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15213 USA; [Bourbon-Freie, Angela] Washington Univ, Sch Med, Dept Neurosurg, St Louis, MO 63110 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL)	Lowe, ME (corresponding author), UPMC, Childrens Hosp Pittsburgh, Dept Pediat, 3705 5th Ave, Pittsburgh, PA 15213 USA.	mark.lowe@chp.edu		Xiao, Xunjun/0000-0001-5930-4664	National Institutes of Health [HD33060]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD033060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant HD33060.	Ayvazian L, 1998, J BIOL CHEM, V273, P33604, DOI 10.1074/jbc.273.50.33604; Belle V, 2007, BIOCHEMISTRY-US, V46, P2205, DOI 10.1021/bi0616089; Bezzine S, 1998, BIOCHEMISTRY-US, V37, P11846, DOI 10.1021/bi973136r; BORDO D, 1991, J MOL BIOL, V217, P721, DOI 10.1016/0022-2836(91)90528-E; BRUSTEIN EA, 1973, PHOTOCHEM PHOTOBIOL, V18, P263, DOI DOI 10.1016/S1567-5394(01)00170-0; Chahinian H, 2002, BIOCHEMISTRY-US, V41, P13725, DOI 10.1021/bi0257944; Cordle RA, 1998, PROTEIN EXPRES PURIF, V13, P30, DOI 10.1006/prep.1998.0873; Crandall WV, 2001, J BIOL CHEM, V276, P12505, DOI 10.1074/jbc.M009986200; CUDREY C, 1993, BIOCHEMISTRY-US, V32, P13800, DOI 10.1021/bi00213a008; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P547, DOI 10.1021/bi00854a024; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; EGLOFF MP, 1995, BIOCHEMISTRY-US, V34, P2751, DOI 10.1021/bi00009a003; Freie AB, 2006, J BIOL CHEM, V281, P7793, DOI 10.1074/jbc.M512984200; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Henikoff S, 2000, ADV PROTEIN CHEM, V54, P73, DOI 10.1016/S0065-3233(00)54003-0; Hermoso J, 1997, EMBO J, V16, P5531, DOI 10.1093/emboj/16.18.5531; Hermoso J, 1996, J BIOL CHEM, V271, P18007, DOI 10.1074/jbc.271.30.18007; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; JULTILA A, 2000, BIOPHYS J, V78, P1634; Lakowicz J. R, 1999, PRINCIPLES FLUORESCE, P446; Lowe ME, 2002, J LIPID RES, V43, P2007, DOI 10.1194/jlr.R200012-JLR200; Lowe ME, 1997, J BIOL CHEM, V272, P9; LUTHIPENG Q, 1992, EUR J BIOCHEM, V205, P383, DOI 10.1111/j.1432-1033.1992.tb16791.x; Miled N, 2000, BBA-PROTEIN STRUCT M, V1476, P165, DOI 10.1016/S0167-4838(99)00288-5; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Pignol D, 2000, J BIOL CHEM, V275, P4220, DOI 10.1074/jbc.275.6.4220; Ramos P, 2003, BIOCHEMISTRY-US, V42, P12488, DOI 10.1021/bi034900e; ROUARD M, 1978, BIOCHIM BIOPHYS ACTA, V530, P227, DOI 10.1016/0005-2760(78)90008-5; Roussel A, 1998, J BIOL CHEM, V273, P32121, DOI 10.1074/jbc.273.48.32121; Roussel A, 1998, PROTEINS, V32, P523; Sambrook J, 2001, MOL CLONING LAB MANU; VANTILBEURGH H, 1993, NATURE, V362, P814, DOI 10.1038/362814a0; VANTILBEURGH H, 1993, J MOL BIOL, V229, P552, DOI 10.1006/jmbi.1993.1054; Verger R, 1997, TRENDS BIOTECHNOL, V15, P32, DOI 10.1016/S0167-7799(96)10064-0; WEBER G, 1960, BIOCHEM J, V75, P335, DOI 10.1042/bj0750335; WINKLER FK, 1990, NATURE, V343, P771, DOI 10.1038/343771a0; Yang YQ, 2000, J LIPID RES, V41, P48; Yang YQ, 1998, PROTEIN EXPRES PURIF, V13, P36, DOI 10.1006/prep.1998.0874; Yapoudjian S, 2002, EUR J BIOCHEM, V269, P1613, DOI 10.1046/j.1432-1327.2002.02786.x	40	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14157	14164		10.1074/jbc.M901154200	http://dx.doi.org/10.1074/jbc.M901154200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19346257	Green Published, hybrid			2022-12-25	WOS:000266286100022
J	Venkatachalam, K; Venkatesan, B; Valente, AJ; Melby, PC; Nandish, S; Reusch, JEB; Clark, RA; Chandrasekar, B				Venkatachalam, Kaliyamurthi; Venkatesan, Balachandar; Valente, Anthony J.; Melby, Peter C.; Nandish, Sailesh; Reusch, Jane E. B.; Clark, Robert A.; Chandrasekar, Bysani			WISP1, a Pro-mitogenic, Pro-survival Factor, Mediates Tumor Necrosis Factor-alpha (TNF-alpha)-stimulated Cardiac Fibroblast Proliferation but Inhibits TNF-alpha-induced Cardiomyocyte Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; NF-KAPPA-B; TISSUE GROWTH-FACTOR; MYOCARDIAL-INFARCTION; INFLAMMATORY CYTOKINES; CREB PHOSPHORYLATION; SIGNAL-TRANSDUCTION; ACTIVATED PROTEIN; FACTOR-BETA; EXPRESSION	WNT1-inducible signaling pathway protein-1 (WISP1), a member of the CYR61/CTGF/Nov family of growth factors, can mediate cell growth, transformation, and survival. Previously we demonstrated that WISP1 is up-regulated in post-infarct heart, stimulates cardiac fibroblast proliferation, and is induced by the proinflammatory cytokine tumor necrosis factor-alpha (TNF-alpha). Here we investigated (i) the localization of TNF-alpha and WISP1 in post-infarct heart, (ii) the mechanism of TNF-alpha-mediated WISP1 induction in primary human cardiac fibroblasts (CF), (iii) the role of WISP1 in TNF-alpha-mediated CF proliferation and collagen production, and (iv) the effects of WISP1 on TNF-alpha-mediated cardiomyocyte death. TNF-alpha and WISP1 expressions were increased in the border zones and non-ischemic remote regions of the post-ischemic heart. In CF, TNF-alpha potently induced WISP1 expression in cyclic AMP response element-binding protein (CREB)-dependent manner. TNF-alpha induced CREB phosphorylation in vitro and DNA binding and reporter gene activities in vivo. TNF-alpha induced CREB activation via ERK1/2, and inhibition of ERK1/2 and CREB blunted TNF-alpha-mediated WISP1 induction. Most importantly, WISP1 knockdown attenuated TNF-alpha stimulated collagen production and CF proliferation. Furthermore, WISP1 attenuated TNF-alpha-mediated cardiomyocyte death, thus demonstrating pro-mitogenic and pro-survival effects for WISP1 in myocardial constituent cells. Our results suggest that a TNF-alpha/WISP1 signaling pathway may contribute to post-infarct cardiac remodeling, a condition characterized by fibrosis and progressive cardiomyocyte loss.	[Valente, Anthony J.; Melby, Peter C.; Nandish, Sailesh; Clark, Robert A.; Chandrasekar, Bysani] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Venkatachalam, Kaliyamurthi; Venkatesan, Balachandar; Melby, Peter C.; Clark, Robert A.; Chandrasekar, Bysani] S Texas Vet Hlth Care Syst, Dept Vet Affairs, San Antonio, TX 78229 USA; [Reusch, Jane E. B.] Univ Colorado, Hlth Sci Ctr, Dept Med, Div Endocrinol Metab & Diabet, Aurora, CO 80110 USA; [Reusch, Jane E. B.] Denver Vet Affairs Med Ctr, Vet Affairs Res Serv, Denver, CO 80220 USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver	Chandrasekar, B (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	chandraseka@uthscsa.edu	Clark, Robert/Q-6764-2019	Clark, Robert/0000-0002-4892-3619; Reusch, Jane/0000-0001-8620-1003	Research Service of the Department of Veterans Affairs	Research Service of the Department of Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by the Research Service of the Department of Veterans Affairs.	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Anker SD, 2004, HEART, V90, P464, DOI 10.1136/hrt.2002.007005; Banerjee I, 2006, ANN NY ACAD SCI, V1080, P76, DOI 10.1196/annals.1380.007; Baudino TA, 2006, AM J PHYSIOL-HEART C, V291, pH1015, DOI 10.1152/ajpheart.00023.2006; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Chandrasekar B, 2005, J BIOL CHEM, V280, P4553, DOI 10.1074/jbc.M411787200; Chandrasekar B, 1998, BBA-MOL BASIS DIS, V1406, P91, DOI 10.1016/S0925-4439(97)00062-8; Chandrasekar B, 1999, CIRCULATION, V99, P427, DOI 10.1161/01.CIR.99.3.427; Chandrasekar B, 2008, J BIOL CHEM, V283, P4200, DOI 10.1074/jbc.M708142200; Chandrasekar B, 2006, J BIOL CHEM, V281, P15099, DOI 10.1074/jbc.M600200200; Chen CC, 2007, EMBO J, V26, P1257, DOI 10.1038/sj.emboj.7601596; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Clerk A, 1999, J MOL CELL CARDIOL, V31, P2087, DOI 10.1006/jmcc.1999.1040; Colston JT, 2007, AM J PHYSIOL-HEART C, V293, pH1839, DOI 10.1152/ajpheart.00428.2007; Colston JT, 2004, BIOCHEM BIOPH RES CO, V316, P256, DOI 10.1016/j.bbrc.2004.02.042; Colston JT, 2002, J BIOL CHEM, V277, P23477, DOI 10.1074/jbc.M108676200; Cortez DM, 2007, AM J PHYSIOL-HEART C, V293, pH3356, DOI 10.1152/ajpheart.00928.2007; Council NR, 1996, GUIDE CARE USE LAB A; Dhingra S, 2007, AM J PHYSIOL-HEART C, V293, pH3524, DOI 10.1152/ajpheart.00919.2007; Diwan A, 2004, CIRCULATION, V109, P262, DOI 10.1161/01.CIR.0000109642.27985.FA; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Funakoshi Y, 2002, J BIOL CHEM, V277, P18710, DOI 10.1074/jbc.M110430200; GONZALEZ GA, 1991, MOL CELL BIOL, V11, P1306, DOI 10.1128/MCB.11.3.1306; Gustin JA, 2004, AM J PHYSIOL-CELL PH, V286, pC547, DOI 10.1152/ajpcell.00332.2002; Haudek SB, 2007, J CLIN INVEST, V117, P2692, DOI 10.1172/JCI29134; Hirschl MM, 1996, EUR HEART J, V17, P1852; Inkson CA, 2008, J CELL BIOCHEM, V104, P1865, DOI 10.1002/jcb.21754; Irwin MW, 1999, CIRCULATION, V99, P1492, DOI 10.1161/01.CIR.99.11.1492; Jacobs M, 1999, J MOL CELL CARDIOL, V31, P1949, DOI 10.1006/jmcc.1999.1007; Jiang LP, 2008, CHEM-BIOL INTERACT, V171, P348, DOI 10.1016/j.cbi.2007.11.013; JUNQUEIRA LCU, 1979, ANAL BIOCHEM, V94, P96, DOI 10.1016/0003-2697(79)90795-4; Kurrelmeyer K, 1998, CLIN CARDIOL, V21, P14, DOI 10.1002/clc.4960211304; Kurrelmeyer KM, 2000, P NATL ACAD SCI USA, V97, P5456, DOI 10.1073/pnas.070036297; Lee EO, 2004, J NEUROIMMUNOL, V155, P21, DOI 10.1016/j.jneuroim.2004.05.012; Leicht M, 2000, CARDIOVASC RES, V48, P274, DOI 10.1016/S0008-6363(00)00170-X; Liu FC, 1996, NEURON, V17, P1133, DOI 10.1016/S0896-6273(00)80245-7; Liu XQ, 2006, MOL PHARMACOL, V70, P1992, DOI 10.1124/mol.106.028951; Martinez-Velazquez M, 2007, CELL SIGNAL, V19, P1212, DOI 10.1016/j.cellsig.2007.01.001; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Mehrhof FB, 2001, CIRCULATION, V104, P2088, DOI 10.1161/hc4201.097133; Mori T, 1999, J CELL PHYSIOL, V181, P153, DOI 10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K; Munoz V, 2008, J PHYSIOL-LONDON, V586, P2423, DOI 10.1113/jphysiol.2008.153387; Nakano M, 1998, CIRCULATION, V97, P1392, DOI 10.1161/01.CIR.97.14.1392; Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa; Ono H, 2004, ARTERIOSCL THROM VAS, V24, P1634, DOI 10.1161/01.ATV.0000138052.86051.0d; Patel DN, 2007, J BIOL CHEM, V282, P27229, DOI 10.1074/jbc.M703250200; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Porter KE, 2004, CARDIOVASC RES, V64, P507, DOI 10.1016/j.cardiores.2004.07.020; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Reddy VS, 2008, J CELL PHYSIOL, V215, P697, DOI 10.1002/jcp.21348; Sarkar SA, 2007, DIABETOLOGIA, V50, P1649, DOI 10.1007/s00125-007-0707-z; SassoneCorsi P, 1995, ANNU REV CELL DEV BI, V11, P355, DOI 10.1146/annurev.cellbio.11.1.355; Seternes OM, 1999, MOL ENDOCRINOL, V13, P1071, DOI 10.1210/me.13.7.1071; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; Su F, 2002, GENE DEV, V16, P46, DOI 10.1101/gad.942902; Sun Y, 2009, CARDIOVASC RES, V81, P482, DOI 10.1093/cvr/cvn333; Tiyyagura SR, 2006, MT SINAI J MED, V73, P840; VADDI K, 1994, CIRCULATION, V90, P694, DOI 10.1161/01.CIR.90.2.694; Venkatachalam K, 2008, AM J PHYSIOL-HEART C, V294, pH2078, DOI 10.1152/ajpheart.01363.2007; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xu LF, 2000, GENE DEV, V14, P585; Yeger H, 2007, J CELL COMMUN SIGNAL, V1, P159, DOI 10.1007/s12079-008-0022-6; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	66	90	94	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14414	14427		10.1074/jbc.M809757200	http://dx.doi.org/10.1074/jbc.M809757200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19339243	hybrid, Green Published			2022-12-25	WOS:000266286100048
J	Giannoni, E; Fiaschi, T; Ramponi, G; Chiarugi, P				Giannoni, E.; Fiaschi, T.; Ramponi, G.; Chiarugi, P.			Redox regulation of anoikis resistance of metastatic prostate cancer cells: key role for Src and EGFR-mediated pro-survival signals	ONCOGENE			English	Article						anoikis; prostate cancer cell; EGFR; reactive oxygen species; Src	REACTIVE-OXYGEN; TUMOR PROGRESSION; OXIDATIVE STRESS; GROWTH; ACTIVATION; ADHESION; MECHANISMS; KINASE; CARCINOGENESIS; ANCHORAGE	Resistance to detachment-induced apoptosis, a process commonly referred as anoikis, is emerging as a hallmark of metastatic malignancies, mainly because it can ensure anchorage-independent growth and survival during organ colonization. Besides, a sustained oxidative stress has been associated with several steps of carcinogenesis, including transformation and achievement of a motile mesenchymal phenotype. Here, we demonstrate that metastatic prostate carcinoma cells, undergoing a constitutive deregulated production of reactive oxygen species due to sustained activation of 5-lipoxygenase, lack suicidal pathways in response to lack of matrix contact. These amplified and persistent redox signals in PC3 cells leads to maintenance of Src oxidation and activation in the absence of adhesion, thereby sustaining a ligand-independent phosphorylation of epidermal growth factor receptor. This leads to chronic activation of pro-survival signals, culminating in degradation of the pro-apoptotic protein Bim, thereby promoting cell survival even in the absence of proper adhesion. Anoikis sensitivity of metastatic cells is restored with antioxidant intervention or genetic manipulation of the redox-mediated pro-survival pathway, as well as exposure to a pro-oxidant environment strongly increases anoikis resistance in nontransformed prostate epithelial cells. Hence, our results allow new insight into the aetiology of the molecular mechanisms granting anoikis resistance of metastatic cancers, opening new avenues to pharmacological intervention for antioxidant-sensitive invasive tumours. Oncogene (2009) 28, 2074-2086; doi:10.1038/onc.2009.77; published online 20 April 2009	[Giannoni, E.; Fiaschi, T.] Univ Florence, Dept Biochem Sci, Florence, Italy; [Ramponi, G.; Chiarugi, P.] Univ Florence, Ctr Res Transfer & High Educ, Florence, Italy	University of Florence; University of Florence	Chiarugi, P (corresponding author), Dipartimento Sci Biochim, Viale Morgagni 50, I-50134 Florence, Italy.	paola.chiarugi@unifi.it	Giannoni, Elisa/AAE-2092-2020; Chiarugi, Paola/CDD-7988-2022	Chiarugi, Paola/0000-0001-7655-2969; Giannoni, Elisa/0000-0001-7136-1098	Italian Association for Cancer Research (AIRC); Ministero della Universitae Ricerca Scientifica e Tecnologica (MIUR-PRIN 2004); Progetto TRESOR (Regione Toscana); Cassa di Risparmio di Firenze; Consorzio Interuniversitario Biotecnologie (CIB)	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero della Universitae Ricerca Scientifica e Tecnologica (MIUR-PRIN 2004)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Progetto TRESOR (Regione Toscana)(Regione Toscana); Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); Consorzio Interuniversitario Biotecnologie (CIB)	This work was supported by the Italian Association for Cancer Research (AIRC), by the Ministero della Universitae Ricerca Scientifica e Tecnologica (MIUR-PRIN 2004), by the Progetto TRESOR (Regione Toscana), by the Cassa di Risparmio di Firenze and by the Consorzio Interuniversitario Biotecnologie (CIB).	Bouillet P, 2002, J CELL SCI, V115, P1567; Cabodi S, 2004, BIOCHEM SOC T, V32, P438, DOI 10.1042/BST0320438; Cannito S, 2008, CARCINOGENESIS, V29, P2267, DOI 10.1093/carcin/bgn216; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chang YM, 2008, ONCOGENE, V27, P6365, DOI 10.1038/onc.2008.250; Chiarugi P, 2003, J CELL BIOL, V161, P933, DOI 10.1083/jcb.200211118; Chiarugi P, 2007, CELL SIGNAL, V19, P672, DOI 10.1016/j.cellsig.2006.11.009; Clerkin JS, 2008, CANCER LETT, V266, P30, DOI 10.1016/j.canlet.2008.02.029; Coll MAL, 2005, ONCOGENE, V24, P1727, DOI 10.1038/sj.onc.1208379; Comoglio PM, 2003, CURR OPIN CELL BIOL, V15, P565, DOI 10.1016/S0955-0674(03)00096-6; Diaz-Montero CM, 2006, EUR J CANCER, V42, P1491, DOI 10.1016/j.ejca.2006.03.007; Federico A, 2007, INT J CANCER, V121, P2381, DOI 10.1002/ijc.23192; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Giannoni E, 2008, CELL DEATH DIFFER, V15, P867, DOI 10.1038/cdd.2008.3; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; Goldenberg-Furmanov M, 2004, CANCER RES, V64, P1058, DOI 10.1158/0008-5472.CAN-03-2420; Haklar G, 2001, CANCER LETT, V165, P219, DOI 10.1016/S0304-3835(01)00421-9; Irani K, 1998, BIOCHEM PHARMACOL, V55, P1339; Kairouz-Wahbe R, 2008, P NATL ACAD SCI USA, V105, P1528, DOI 10.1073/pnas.0711357105; Kopfstein L, 2006, CELL MOL LIFE SCI, V63, P449, DOI 10.1007/s00018-005-5296-8; Le Gall M, 2000, MOL BIOL CELL, V11, P1103, DOI 10.1091/mbc.11.3.1103; Ley R, 2005, CELL DEATH DIFFER, V12, P1008, DOI 10.1038/sj.cdd.4401688; Mallozzi C, 2001, FREE RADICAL BIO MED, V30, P1108, DOI 10.1016/S0891-5849(01)00509-3; Martinez-Sanchez G, 2007, J EXP CLIN CANC RES, V26, P39; Moldovan L, 2006, CARDIOVASC RES, V71, P236, DOI 10.1016/j.cardiores.2006.05.003; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; Nelson KK, 2004, FREE RADICAL BIO MED, V37, P768, DOI 10.1016/j.freeradbiomed.2004.06.008; Park SI, 2008, CANCER RES, V68, P3323, DOI 10.1158/0008-5472.CAN-07-2997; Pidgeon GP, 2007, CANCER METAST REV, V26, P503, DOI 10.1007/s10555-007-9098-3; Pulukuri SM, 2005, J BIOL CHEM, V280, P36529, DOI 10.1074/jbc.M503111200; Qi XJ, 2006, J BIOL CHEM, V281, P813, DOI 10.1074/jbc.M505546200; Quadros MRD, 2004, CANCER RES, V64, P3934, DOI 10.1158/0008-5472.CAN-04-0214; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Sundaresan M, 1996, BIOCHEM J, V318, P379, DOI 10.1042/bj3180379; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Taddei ML, 2007, ANTIOXID REDOX SIGN, V9, P469, DOI 10.1089/ars.2006.1392; Toyokuni S, 2006, ANTIOXID REDOX SIGN, V8, P1373, DOI 10.1089/ars.2006.8.1373; Valentijn AJ, 2004, BIOCHEM SOC T, V32, P421, DOI 10.1042/BST0320421; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wei L, 2004, ONCOGENE, V23, P9052, DOI 10.1038/sj.onc.1208091; Wu WS, 2008, CANCER METAST REV, V27, P303, DOI 10.1007/s10555-008-9112-4; Wu WS, 2006, CANCER METAST REV, V25, P695, DOI 10.1007/s10555-006-9037-8; Zeng QH, 2002, J BIOL CHEM, V277, P25203, DOI 10.1074/jbc.M201598200; Zhu ZY, 2001, CANCER RES, V61, P1707	46	92	95	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 21	2009	28	20					2074	2086		10.1038/onc.2009.77	http://dx.doi.org/10.1038/onc.2009.77			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	448BI	19377510				2022-12-25	WOS:000266235800002
J	Nguyen, A; Chang, ACM; Reddel, RR				Nguyen, A.; Chang, A. C. M.; Reddel, R. R.			Stanniocalcin-1 acts in a negative feedback loop in the prosurvival ERK1/2 signaling pathway during oxidative stress	ONCOGENE			English	Article						stanniocalcin-1; STC1; ERK1/2; oxidative stress; PD98059; apoptosis	DIFFERENTIAL GENE-EXPRESSION; ELEVATED EXPRESSION; PROTEIN; GROWTH; CELLS; RECEPTOR; OXYGEN; IDENTIFICATION; SENSITIVITY; ACTIVATION	Mammalian Stanniocalcin-1 (STC1) is a glycoprotein that has been implicated in various biological processes including angiogenesis. Aberrant STC1 expression has been reported in breast, ovarian and prostate cancers, but the significance of this is not well understood. Here, we report that oxidative stress caused a 40-fold increase in STC1 levels in mouse embryo. broblasts (MEFs). STC1(-/-) MEFs were resistant to growth inhibition and cell death induced by H2O2 or by 20% O-2 ( which is hyperoxic for most mammalian cells); this is the first phenotype reported for STC1-null cells. STC1(-/-) cells had higher levels of activated MEK and ERK1/2 than their wild-type (WT) counterparts, and these levels were all reduced by stable expression of exogenous STC1 in STC1(-/-) cells. Furthermore, pharmacological inhibition by PD98059 or UO126 of MEK and therefore of ERK1/2 activation restored sensitivity of STC1(-/-) cells to oxidative stress. We also found that H2O2- induced STC1 expression in WT cells was abolished by inhibition of ERK1/2 activation. Thus, the ERK1/2 signaling pathway upregulates STC1 expression, which in turn downregulates the level of activated MEK and consequently ERK1/2 in a novel negative feedback loop. Therefore, STC1 expression downregulates prosurvival ERK1/2 signaling and reduces survival under conditions of oxidative stress. Oncogene (2009) 28, 1982-1992; doi:10.1038/onc.2009.65; published online 6 April 2009	[Nguyen, A.; Chang, A. C. M.; Reddel, R. R.] Childrens Med Res Inst, Canc Res Unit, Westmead, NSW 2145, Australia; [Nguyen, A.; Chang, A. C. M.; Reddel, R. R.] Univ Sydney, Fac Med, Sydney, NSW 2006, Australia	Children's Medical Research Institute - Australia; University of Sydney	Reddel, RR (corresponding author), Childrens Med Res Inst, Canc Res Unit, 214 Hawkesbury Rd, Westmead, NSW 2145, Australia.	rreddel@cmri.usyd.edu.au	Reddel, Roger R/A-6635-2014	Reddel, Roger R/0000-0002-6302-6107	Australian Postgraduate Award; Carcinogenesis Fellowship of the Cancer Council NSW; National Health and Medical Research Council of Australia Senior Principal Research Fellowship	Australian Postgraduate Award(Australian Government); Carcinogenesis Fellowship of the Cancer Council NSW(Cancer Council New South Wales); National Health and Medical Research Council of Australia Senior Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by an Australian Postgraduate Award, the Carcinogenesis Fellowship of the Cancer Council NSW and a National Health and Medical Research Council of Australia Senior Principal Research Fellowship.	Adayev T, 2003, BBA-MOL CELL RES, V1640, P85, DOI 10.1016/S0167-4889(03)00023-5; Arrington ED, 2000, FREE RADICAL BIO MED, V29, P1166, DOI 10.1016/S0891-5849(00)00439-1; Bai XC, 2002, BIOCHEM J, V363, P395, DOI 10.1042/0264-6021:3630395; Bell SE, 2001, J CELL SCI, V114, P2755; Benn SC, 2004, NAT REV NEUROSCI, V5, P686, DOI 10.1038/nrn1477; BESSER D, 1995, CELL GROWTH DIFFER, V6, P1009; Bouras T, 2002, CANCER RES, V62, P1289; Chang ACM, 2005, MOL CELL BIOL, V25, P10604, DOI 10.1128/MCB.25.23.10604-10610.2005; Chang ACM, 2003, ENDOCR-RELAT CANCER, V10, P359, DOI 10.1677/erc.0.0100359; CHANG ACM, 1995, MOL CELL ENDOCRINOL, V112, P241, DOI 10.1016/0303-7207(95)03601-3; Chang ACM, 1996, MOL CELL ENDOCRINOL, V124, P185, DOI 10.1016/S0303-7207(96)03929-9; Di Micco R, 2008, CELL CYCLE, V7, P3601, DOI 10.4161/cc.7.22.7152; Ellard JP, 2007, MOL CELL ENDOCRINOL, V264, P90, DOI 10.1016/j.mce.2006.10.008; Filvaroff EH, 2002, ENDOCRINOLOGY, V143, P3681, DOI 10.1210/en.2001-211424; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; Fujiwara Y, 2000, INT J ONCOL, V16, P799; Ismail RS, 2000, CANCER RES, V60, P6744; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Jellinek DA, 2000, BIOCHEM J, V350, P453, DOI 10.1042/0264-6021:3500453; Jiang WQ, 2000, J ENDOCRINOL, V165, P457, DOI 10.1677/joe.0.1650457; Joensuu K, 2008, CANCER LETT, V265, P76, DOI 10.1016/j.canlet.2008.02.022; Kahn J, 2000, AM J PATHOL, V156, P1887, DOI 10.1016/S0002-9440(10)65062-6; Kanellis J, 2004, AM J PHYSIOL-RENAL, V286, pF356, DOI 10.1152/ajprenal.00138.2003; Koizumi K, 2007, CIRC J, V71, P796, DOI 10.1253/circj.71.796; Lai KP, 2007, BIOCHEM BIOPH RES CO, V356, P968, DOI 10.1016/j.bbrc.2007.03.074; Lal A, 2001, JNCI-J NATL CANCER I, V93, P1337, DOI 10.1093/jnci/93.17.1337; Lee IH, 2008, J BIOL CHEM, V283, P6312, DOI 10.1074/jbc.M706878200; Long H, 2003, CELL PHYSIOL BIOCHEM, V13, P401, DOI 10.1159/000075128; Madsen KL, 1998, AM J PHYSIOL-GASTR L, V274, pG96, DOI 10.1152/ajpgi.1998.274.1.G96; McCudden CR, 2002, J BIOL CHEM, V277, P45249, DOI 10.1074/jbc.M205954200; Okabe H, 2001, CANCER RES, V61, P2129; Olsen HS, 1996, P NATL ACAD SCI USA, V93, P1792, DOI 10.1073/pnas.93.5.1792; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Sheikh-Hamad D, 2000, AM J PHYSIOL-RENAL, V278, pF417, DOI 10.1152/ajprenal.2000.278.3.F417; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; SUNDELL K, 1992, J COMP PHYSIOL B, V162, P489; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; VANDERKOOI JM, 1991, AM J PHYSIOL, V260, pC1131, DOI 10.1152/ajpcell.1991.260.6.C1131; Varghese R, 2002, ENDOCRINOLOGY, V143, P868, DOI 10.1210/en.143.3.868; Wagner GF, 1997, J BONE MINER RES, V12, P165, DOI 10.1359/jbmr.1997.12.2.165; WAGNER GF, 1988, GEN COMP ENDOCR, V72, P237, DOI 10.1016/0016-6480(88)90206-7; Wang XT, 1998, BIOCHEM J, V333, P291, DOI 10.1042/bj3330291; Welcsh PL, 2002, P NATL ACAD SCI USA, V99, P7560, DOI 10.1073/pnas.062181799; Westberg JA, 2007, AM J PHYSIOL-HEART C, V293, pH1766, DOI 10.1152/ajpheart.00017.2007; Westberg JA, 2007, STROKE, V38, P1025, DOI 10.1161/01.STR.0000258113.67252.fa; Wu SF, 2006, J BIOL CHEM, V281, P5120, DOI 10.1074/jbc.M506667200; Xu Jianming, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2801s70; Yeung HY, 2005, ENDOCRINOLOGY, V146, P4951, DOI 10.1210/en.2005-0365; Yeung HY, 2003, ENDOCRINOLOGY, V144, P4446, DOI 10.1210/en.2003-0504; Yoshiko Y, 2003, ENDOCRINOLOGY, V144, P4134, DOI 10.1210/en.2003-0130; Zhang KZ, 2000, P NATL ACAD SCI USA, V97, P3637, DOI 10.1073/pnas.070045897	51	48	50	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 7	2009	28	18					1982	1992		10.1038/onc.2009.65	http://dx.doi.org/10.1038/onc.2009.65			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	442DT	19347030				2022-12-25	WOS:000265820900005
J	Dzirasa, K; Santos, LM; Ribeiro, S; Stapleton, J; Gainetdinov, RR; Caron, MG; Nicolelis, MAL				Dzirasa, Kafui; Santos, Lucas M.; Ribeiro, Sidarta; Stapleton, Jennifer; Gainetdinov, Raul R.; Caron, Marc G.; Nicolelis, Miguel A. L.			Persistent Hyperdopaminergia Decreases the Peak Frequency of Hippocampal Theta Oscillations during Quiet Waking and REM Sleep	PLOS ONE			English	Article								Long-term changes in dopaminergic signaling are thought to underlie the pathophysiology of a number of psychiatric disorders. Several conditions are associated with cognitive deficits such as disturbances in attention processes and learning and memory, suggesting that persistent changes in dopaminergic signaling may alter neural mechanisms underlying these processes. Dopamine transporter knockout (DAT-KO) mice exhibit a persistent five-fold increase in extracellular dopamine levels. Here, we demonstrate that DAT-KO mice display lower hippocampal theta oscillation frequencies during baseline periods of waking and rapid-eye movement sleep. These altered theta oscillations are not reversed via treatment with the antidopaminergic agent haloperidol. Thus, we propose that persistent hyperdopaminergia, together with secondary alterations in other neuromodulatory systems, results in lower frequency activity in neural systems responsible for various cognitive processes.			Dzirasa, K (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	nicoleli@neuro.duke.edu	Gainetdinov, Raul R/G-5875-2011; Dzirasa, Kafui/GQB-1424-2022; Ribeiro, Sidarta/C-5794-2016	Gainetdinov, Raul R/0000-0003-2951-6038; Ribeiro, Sidarta/0000-0001-9325-9545	NINDS NIH HHS [R33 NS049534] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R33NS049534] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BRAGIN A, 1995, J NEUROSCI, V15, P47; Breitenstein C, 2006, NEUROPSYCHOPHARMACOL, V31, P2552, DOI 10.1038/sj.npp.1301167; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; CARLSSON A, 1987, ANNU REV NEUROSCI, V10, P19; Dzirasa K, 2006, J NEUROSCI, V26, P10577, DOI 10.1523/JNEUROSCI.1767-06.2006; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Gainetdinov RR, 2003, ANNU REV PHARMACOL, V43, P261, DOI 10.1146/annurev.pharmtox.43.050802.112309; Gainetdinov RR, 2001, P NATL ACAD SCI USA, V98, P11047, DOI 10.1073/pnas.191353298; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Gordon JA, 2005, J NEUROSCI, V25, P6509, DOI 10.1523/JNEUROSCI.1211-05.2005; Horschitz S, 2005, MOL PSYCHIATR, V10, P1104, DOI 10.1038/sj.mp.4001730; Jones SR, 1998, J NEUROSCI, V18, P1979; JOUVET M, 1969, SCIENCE, V163, P32, DOI 10.1126/science.163.3862.32; Jucaite A, 2005, BIOL PSYCHIAT, V57, P229, DOI 10.1016/j.biopsych.2004.11.009; Kellendonk C, 2006, NEURON, V49, P603, DOI 10.1016/j.neuron.2006.01.023; Kichigina V F, 2004, Zh Vyssh Nerv Deiat Im I P Pavlova, V54, P210; Kudina T A, 2004, Neurosci Behav Physiol, V34, P929, DOI 10.1023/B:NEAB.0000042576.39132.f5; Laruelle M, 1999, J PSYCHOPHARMACOL, V13, P358, DOI 10.1177/026988119901300405; Lu J, 2006, J NEUROSCI, V26, P193, DOI 10.1523/JNEUROSCI.2244-05.2006; Nakagawa T, 2000, Nihon Shinkei Seishin Yakurigaku Zasshi, V20, P71; Neumeister A, 2004, J NEUROSCI, V24, P589, DOI 10.1523/JNEUROSCI.4921-03.2004; Pogorelov VM, 2005, NEUROPSYCHOPHARMACOL, V30, P1818, DOI 10.1038/sj.npp.1300724; SANTOS LM, 2008, BEHAV BRAIN IN PRESS; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; SHIN J, 2005, P NATL ACAD SCI US, V102; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Staub DR, 2006, BRAIN RES, V1070, P77, DOI 10.1016/j.brainres.2005.10.096; Svenningsson P, 2006, SCIENCE, V311, P77, DOI 10.1126/science.1117571; TEITELBAUM H, 1975, Science (Washington D C), V188, P1114, DOI 10.1126/science.175440; TIMOIARIA C, 1970, PHYSIOL BEHAV, V5, P1057, DOI 10.1016/0031-9384(70)90162-9; VANDERWOLF CH, 1986, BRAIN RES, V374, P342, DOI 10.1016/0006-8993(86)90428-2; Vanderwolf CH, 1977, CIBA F SYMP, P199; Wespatat V, 2004, J NEUROSCI, V24, P9067, DOI 10.1523/JNEUROSCI.2221-04.2004; Wu NP, 2007, J NEUROPHYSIOL, V98, P423, DOI 10.1152/jn.00971.2006; Yamamoto J, 1997, PSYCHOPHARMACOLOGY, V131, P379, DOI 10.1007/s002130050306; ZETLER G, 1985, PHARMACOLOGY, V31, P318, DOI 10.1159/000138140	37	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2009	4	4							e5238	10.1371/journal.pone.0005238	http://dx.doi.org/10.1371/journal.pone.0005238			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VA	19381303	Green Published, gold, Green Submitted			2022-12-25	WOS:000265513800011
J	He, Y; Wang, JH; Wang, L; Chen, ZJ; Yan, CG; Yang, H; Tang, HH; Zhu, CZ; Gong, QY; Zang, YF; Evans, AC				He, Yong; Wang, Jinhui; Wang, Liang; Chen, Zhang J.; Yan, Chaogan; Yang, Hong; Tang, Hehan; Zhu, Chaozhe; Gong, Qiyong; Zang, Yufeng; Evans, Alan C.			Uncovering Intrinsic Modular Organization of Spontaneous Brain Activity in Humans	PLOS ONE			English	Article							RESTING-STATE NETWORKS; FUNCTIONAL CONNECTIVITY; DEFAULT MODE; COMMUNITY STRUCTURE; COMPONENT ANALYSIS; CEREBRAL-CORTEX; LOW-FREQUENCY; FLUCTUATIONS; ARCHITECTURE; ATTENTION	The characterization of topological architecture of complex brain networks is one of the most challenging issues in neuroscience. Slow (< 0.1 Hz), spontaneous fluctuations of the blood oxygen level dependent (BOLD) signal in functional magnetic resonance imaging are thought to be potentially important for the reflection of spontaneous neuronal activity. Many studies have shown that these fluctuations are highly coherent within anatomically or functionally linked areas of the brain. However, the underlying topological mechanisms responsible for these coherent intrinsic or spontaneous fluctuations are still poorly understood. Here, we apply modern network analysis techniques to investigate how spontaneous neuronal activities in the human brain derived from the resting-state BOLD signals are topologically organized at both the temporal and spatial scales. We first show that the spontaneous brain functional networks have an intrinsically cohesive modular structure in which the connections between regions are much denser within modules than between them. These identified modules are found to be closely associated with several well known functionally interconnected subsystems such as the somatosensory/motor, auditory, attention, visual, subcortical, and the "default'' system. Specifically, we demonstrate that the module-specific topological features can not be captured by means of computing the corresponding global network parameters, suggesting a unique organization within each module. Finally, we identify several pivotal network connectors and paths (predominantly associated with the association and limbic/paralimbic cortex regions) that are vital for the global coordination of information flow over the whole network, and we find that their lesions (deletions) critically affect the stability and robustness of the brain functional system. Together, our results demonstrate the highly organized modular architecture and associated topological properties in the temporal and spatial brain functional networks of the human brain that underlie spontaneous neuronal dynamics, which provides important implications for our understanding of how intrinsically coherent spontaneous brain activity has evolved into an optimal neuronal architecture to support global computation and information integration in the absence of specific stimuli or behaviors.	[He, Yong; Wang, Jinhui; Wang, Liang; Yan, Chaogan; Zhu, Chaozhe; Zang, Yufeng] Beijing Normal Univ, State Key Lab Cognit Neurosci, Beijing 100875, Peoples R China; [Chen, Zhang J.; Evans, Alan C.] McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ, Canada; [Yang, Hong] Zhejiang Univ, Affiliated Hosp 1, Coll Med Sci, Dept Radiol, Hangzhou, Peoples R China; [Yang, Hong; Tang, Hehan; Gong, Qiyong] Sichuan Univ, West China Hosp, Huaxi MR Res Ctr, Dept Radiol, Chengdu, Peoples R China	Beijing Normal University; McGill University; Zhejiang University; Sichuan University	He, Y (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci, Beijing 100875, Peoples R China.	yong.he@bnu.edu.cn	He, Yong/Q-5756-2018; ZANG, Yu-Feng/J-1558-2012; He, Yong/C-2161-2009; Yan, Chao-Gan/D-1713-2015; Gong, Qiyong/W-3052-2019; Evans, Alan C/B-2373-2013; Wang, jinhui/AAF-8668-2019	ZANG, Yu-Feng/0000-0003-1833-8010; Yan, Chao-Gan/0000-0003-3413-5977; Gong, Qiyong/0000-0002-5912-4871; Evans, Alan C/0000-0003-3841-6098; 				Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; BOCCALETTI S, 2006, COMPLEX NETWORKS STR, P175; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bullinaria JA, 2007, COGNITIVE SCI, V31, P673, DOI 10.1080/15326900701399939; CHEN ZJ, 2008, CEREB CORTEX; Cohen AL, 2008, NEUROIMAGE, V41, P45, DOI 10.1016/j.neuroimage.2008.01.066; Cohen J, 2003, APPL MULTIPLE REGRES, V3rd, DOI DOI 10.4324/9780203774441; Cohen MX, 2008, EUR J NEUROSCI, V27, P1534, DOI 10.1111/j.1460-9568.2008.06117.x; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Ferrarini L., 2008, HUM BRAIN MAPP; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Fraser HB, 2005, NAT GENET, V37, P351, DOI 10.1038/ng1530; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; GONG G, 2008, CEREB CORTEX; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Guimera R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.025101; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Guimera R, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/02/P02001; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Guimera R, 2007, NAT PHYS, V3, P63, DOI 10.1038/nphys489; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Hintze A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040023; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Jiang TZ, 2004, HUM BRAIN MAPP, V22, P63, DOI 10.1002/hbm.20012; Kaiser M, 2004, BIOL CYBERN, V90, P311, DOI 10.1007/s00422-004-0479-1; Kaiser M, 2007, EUR J NEUROSCI, V25, P3185, DOI 10.1111/j.1460-9568.2007.05574.x; Kiviniemi V, 2003, NEUROIMAGE, V19, P253, DOI 10.1016/S1053-8119(03)00097-1; Kotter R, 2003, NEURAL NETWORKS, V16, P1261, DOI 10.1016/j.neunet.2003.06.002; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Popuri K, 2020, HUM BRAIN MAPP, V41, P4127, DOI 10.1002/hbm.25115; Raichle ME, 2006, SCIENCE, V314, P1249, DOI 10.1126/science.1134405; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Salvador R, 2005, PHILOS T R SOC B, V360, P937, DOI 10.1098/rstb.2005.1645; Scannell JW, 1999, CEREB CORTEX, V9, P277, DOI 10.1093/cercor/9.3.277; Schwarz AJ, 2008, MAGN RESON IMAGING, V26, P914, DOI 10.1016/j.mri.2008.01.048; Spirin V, 2006, P NATL ACAD SCI USA, V103, P8774, DOI 10.1073/pnas.0510258103; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stephan KE, 2003, SCIENCE, V301, P384, DOI 10.1126/science.1086025; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Thirion B, 2007, NEUROIMAGE, V35, P105, DOI 10.1016/j.neuroimage.2006.11.054; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; WANG J, 2008, HUM BRAIN MAPP; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wink AM, 2006, NEUROBIOL AGING, V27, P1395, DOI 10.1016/j.neurobiolaging.2005.08.011; Wolf DM, 2003, CURR OPIN MICROBIOL, V6, P125, DOI 10.1016/S1369-5274(03)00033-X; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhou CS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.238103	84	472	495	3	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2009	4	4							e5226	10.1371/journal.pone.0005226	http://dx.doi.org/10.1371/journal.pone.0005226			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VA	19381298	Green Published, gold, Green Submitted			2022-12-25	WOS:000265513800007
J	Koziel, J; Maciag-Gudowska, A; Mikolajczyk, T; Bzowska, M; Sturdevant, DE; Whitney, AR; Shaw, LN; Deleo, FR; Potempa, J				Koziel, Joanna; Maciag-Gudowska, Agnieszka; Mikolajczyk, Tomasz; Bzowska, Malgorzata; Sturdevant, Daniel E.; Whitney, Adeline R.; Shaw, Lindsey N.; DeLeo, Frank R.; Potempa, Jan			Phagocytosis of Staphylococcus aureus by Macrophages Exerts Cytoprotective Effects Manifested by the Upregulation of Antiapoptotic Factors	PLOS ONE			English	Article							NF-KAPPA-B; PROGRAMMED CELL-DEATH; BCL-2 FAMILY-MEMBER; INTRACELLULAR REPLICATION; CHLAMYDIA-PNEUMONIAE; HEMATOPOIETIC-CELLS; HUMAN NEUTROPHILS; APOPTOSIS; SURVIVAL; EXPRESSION	It is becoming increasingly apparent that Staphylococcus aureus are able to survive engulfment by macrophages, and that the intracellular environment of these host cells, which is essential to innate host defenses against invading microorganisms, may in fact provide a refuge for staphylococcal survival and dissemination. Based on this, we postulated that S. aureus might induce cytoprotective mechanisms by changing gene expression profiles inside macrophages similar to obligate intracellular pathogens, such as Mycobacterium tuberculosis. To validate our hypothesis we first ascertained whether S. aureus infection could affect programmed cell death in human (hMDMs) and mouse (RAW 264.7) macrophages and, specifically, protect these cells against apoptosis. Our findings indicate that S. aureus-infected macrophages are more resistant to staurosporine-induced cell death than control cells, an effect partly mediated via the inhibition of cytochrome c release from mitochondria. Furthermore, transcriptome analysis of human monocyte-derived macrophages during S. aureus infection revealed a significant increase in the expression of antiapoptotic genes. This was confirmed by quantitative RT-PCR analysis of selected genes involved in mitochondria-dependent cell death, clearly showing overexpression of BCL2 and MCL1. Cumulatively, the results of our experiments argue that S. aureus is able to induce a cytoprotective effect in macrophages derived from different mammal species, which can prevent host cell elimination, and thus allow intracellular bacterial survival. Ultimately, it is our contention that this process may contribute to the systemic dissemination of S. aureus infection.			Koziel, J (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, Krakow, Poland.	kaniajoanna@gmail.com	Potempa, Jan/AAA-6850-2021; Mikolajczyk, Tomasz/AFQ-2278-2022; Bzowska, Małgorzata/A-6947-2019; Shaw, Lindsey/AAI-1741-2020	Mikolajczyk, Tomasz/0000-0002-7990-2896; Shaw, Lindsey/0000-0002-0629-8990; Potempa, Jan/0000-0002-3600-7461; DeLeo, Frank/0000-0003-3150-2516	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI001079, ZIAAI001079, Z01AI000900, ZIAAI000900] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abu-Zant A, 2005, INFECT IMMUN, V73, P5339, DOI 10.1128/IAI.73.9.5339-5349.2005; Akarid K, 2004, J LEUKOCYTE BIOL, V76, P95, DOI 10.1189/jlb.1001877; AMEISEN JC, 1994, IMMUNOL REV, V142, P9, DOI 10.1111/j.1600-065X.1994.tb00882.x; Archer GL, 1998, CLIN INFECT DIS, V26, P1179, DOI 10.1086/520289; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Banga S, 2007, P NATL ACAD SCI USA, V104, P5121, DOI 10.1073/pnas.0611030104; Baran J, 1996, INFECT IMMUN, V64, P4242, DOI 10.1128/IAI.64.10.4242-4248.1996; Battle T. E., 2002, Current Molecular Medicine (Hilversum), V2, P381, DOI 10.2174/1566524023362456; Bayles KW, 1998, INFECT IMMUN, V66, P336, DOI 10.1128/IAI.66.1.336-342.1998; Bender LM, 2005, CELL DEATH DIFFER, V12, P473, DOI 10.1038/sj.cdd.4401578; Bernal-Mizrachi L, 2006, P NATL ACAD SCI USA, V103, P9220, DOI 10.1073/pnas.0507809103; Binnicker MJ, 2004, INFECT IMMUN, V72, P6408, DOI 10.1128/IAI.72.11.6408-6417.2004; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; Conte D, 2006, MOL CELL BIOL, V26, P699, DOI 10.1128/MCB.26.2.699-708.2006; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Droin N, 1998, ONCOGENE, V16, P2885, DOI 10.1038/sj.onc.1201821; Dzhagalov I, 2007, BLOOD, V109, P1620, DOI 10.1182/blood-2006-03-013771; Fischer SF, 2001, INFECT IMMUN, V69, P7121, DOI 10.1128/IAI.69.11.7121-7129.2001; Freeman SN, 2008, J BIOL CHEM, V283, P2353, DOI 10.1074/jbc.M705986200; Fujisawa A, 2007, BLOOD, V109, P2903, DOI 10.1182/blood-2006-07-033597; Goepel F, 2004, J LEUKOCYTE BIOL, V75, P836, DOI 10.1189/jlb.0703317; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hacker G, 2006, MED MICROBIOL IMMUN, V195, P11, DOI 10.1007/s00430-005-0239-4; Hiramatsu K, 2001, Lancet Infect Dis, V1, P147, DOI 10.1016/S1473-3099(01)00091-3; Hiroi M, 1998, ANTICANCER RES, V18, P3475; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Hu XL, 1998, BLOOD, V92, P2759, DOI 10.1182/blood.V92.8.2759.420k29_2759_2765; Hudson MC, 1995, MICROB PATHOGENESIS, V19, P409, DOI 10.1006/mpat.1995.0075; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Joshi SG, 2004, FEMS MICROBIOL LETT, V234, P333, DOI 10.1016/j.femsle.2004.03.046; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; KATOH O, 1995, CANCER RES, V55, P5687; Keita M, 2007, BIOCHEM BIOPH RES CO, V361, P481, DOI 10.1016/j.bbrc.2007.07.048; Kobayashi SD, 2003, P NATL ACAD SCI USA, V100, P10948, DOI 10.1073/pnas.1833375100; Kubica M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001409; Leber JH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040006; Lee NK, 2002, J BIOCHEM MOL BIOL, V35, P61; Lee SY, 2007, INFECT IMMUN, V75, P1291, DOI 10.1128/IAI.01700-06; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Linares J, 2001, CLIN MICROBIOL INFEC, V7, P8, DOI 10.1046/j.1469-0691.2001.00054.x; Liu HT, 2001, J EXP MED, V194, P113, DOI 10.1084/jem.194.2.113; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lotz S, 2004, J LEUKOCYTE BIOL, V75, P467, DOI 10.1189/jlb.0803360; Lowy FD, 2000, TRENDS MICROBIOL, V8, P341, DOI 10.1016/S0966-842X(00)01803-5; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Lundqvist-Gustafsson H, 2001, J LEUKOCYTE BIOL, V70, P642; MANGAN DF, 1991, J IMMUNOL, V146, P1541; Menzies BE, 1998, INFECT IMMUN, V66, P5994, DOI 10.1128/IAI.66.12.5994-5998.1998; Monack DM, 2001, MICROBES INFECT, V3, P1201, DOI 10.1016/S1286-4579(01)01480-0; Nakhjiri SF, 2001, FEMS MICROBIOL LETT, V200, P145, DOI 10.1111/j.1574-6968.2001.tb10706.x; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Okuda J, 2006, MICROB PATHOGENESIS, V41, P226, DOI 10.1016/j.micpath.2006.08.002; Potempa J, 2009, J INNATE IMMUN, V1, P70, DOI 10.1159/000181144; Rebollo A, 2000, MOL CELL BIOL, V20, P3407, DOI 10.1128/MCB.20.10.3407-3416.2000; ROGERS DE, 1952, J EXP MED, V95, P209, DOI 10.1084/jem.95.2.209; Shikama Y, 2003, EUR J IMMUNOL, V33, P1998, DOI 10.1002/eji.200324013; Shirin H, 2000, INFECT IMMUN, V68, P5321, DOI 10.1128/IAI.68.9.5321-5328.2000; Sly LM, 2003, J IMMUNOL, V170, P430, DOI 10.4049/jimmunol.170.1.430; Smagur J, 2009, J INNATE IMMUN, V1, P98, DOI 10.1159/000181014; TSUBATA T, 1993, NATURE, V364, P645, DOI 10.1038/364645a0; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Wahl C, 2001, INFECT IMMUN, V69, P7039, DOI 10.1128/IAI.69.11.7039-7045.2001; Wajant H, 2003, ESSAYS BIOCHEM, V39, P53, DOI 10.1042/bse0390053; Weil M, 1996, J CELL BIOL, V133, P1053, DOI 10.1083/jcb.133.5.1053; Williams G T, 1994, Trends Microbiol, V2, P463, DOI 10.1016/0966-842X(94)90648-3; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yang T, 1996, J CELL PHYSIOL, V166, P523, DOI 10.1002/(SICI)1097-4652(199603)166:3<523::AID-JCP7>3.0.CO;2-R; Ying SM, 2005, INFECT IMMUN, V73, P1399, DOI 10.1128/IAI.73.3.1399-1403.2005; Zetola N, 2005, LANCET INFECT DIS, V5, P275, DOI 10.1016/S1473-3099(05)70112-2; Zhou P, 1997, BLOOD, V89, P630, DOI 10.1182/blood.V89.2.630; ZYCHLINSKY A, 1992, NATURE, V358, P167, DOI 10.1038/358167a0	72	116	121	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2009	4	4							e5210	10.1371/journal.pone.0005210	http://dx.doi.org/10.1371/journal.pone.0005210			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VA	19381294	Green Submitted, Green Published, gold			2022-12-25	WOS:000265513800004
J	Kucharz, K; Krogh, M; Ng, AN; Toresson, H				Kucharz, Krzysztof; Krogh, Morten; Ng, Ai Na; Toresson, Hakan			NMDA Receptor Stimulation Induces Reversible Fission of the Neuronal Endoplasmic Reticulum	PLOS ONE			English	Article								With few exceptions the endoplasmic reticulum (ER) is considered a continuous system of endomembranes within which proteins and ions can move. We have studied dynamic structural changes of the ER in hippocampal neurons in primary culture and organotypic slices. Fluorescence recovery after photobleaching (FRAP) was used to quantify and model ER structural dynamics. Ultrastructure was assessed by electron microscopy. In live cell imaging experiments we found that, under basal conditions, the ER of neuronal soma and dendrites was continuous. The smooth and uninterrupted appearance of the ER changed dramatically after glutamate stimulation. The ER fragmented into isolated vesicles in a rapid fission reaction that occurred prior to overt signs of neuronal damage. ER fission was found to be independent of ER calcium levels. Apart from glutamate, the calcium ionophore ionomycin was able to induce ER fission. The N-methyl, D-aspartate (NMDA) receptor antagonist MK-801 inhibited ER fission induced by glutamate as well as by ionomycin. Fission was not blocked by either ifenprodil or kinase inhibitors. Interestingly, sub-lethal NMDA receptor stimulation caused rapid ER fission followed by fusion. Hence, ER fission is not strictly associated with cellular damage or death. Our results thus demonstrate that neuronal ER structure is dynamically regulated with important consequences for protein mobility and ER luminal calcium tunneling.			Kucharz, K (corresponding author), Lund Univ, Dept Clin Sci Lund, Wallenberg Neurosci Ctr, Expt Brain Res Lab, Lund, Sweden.	hakan.toresson@med.lu.se		Kucharz, Krzysztof/0000-0002-6852-5300; Ng, Ai Na/0000-0002-6219-5523				Antonny B, 2001, CURR OPIN CELL BIOL, V13, P438, DOI 10.1016/S0955-0674(00)00234-9; Bardo S, 2006, TRENDS PHARMACOL SCI, V27, P78, DOI 10.1016/j.tips.2005.12.008; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Cheung ECC, 2007, APOPTOSIS, V12, P979, DOI 10.1007/s10495-007-0745-5; Choi YM, 2006, J NEUROSCI, V26, P12127, DOI 10.1523/JNEUROSCI.3158-06.2006; Dayel MJ, 1999, BIOPHYS J, V76, P2843, DOI 10.1016/S0006-3495(99)77438-2; DeGracia DJ, 2004, J NEUROCHEM, V91, P1, DOI 10.1111/j.1471-4159.2004.02703.x; Fam NP, 1997, MOL CELL BIOL, V17, P1396, DOI 10.1128/MCB.17.3.1396; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; Harmer AR, 2002, BIOCHEM J, V367, P137, DOI 10.1042/BJ20020305; Horton AC, 2003, J NEUROSCI, V23, P6188; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Jones VC, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-10; KOCH GLE, 1988, J CELL SCI, V91, P511; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; MARTONE ME, 1993, J NEUROSCI, V13, P4636; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; Mattson MP, 2000, J NEUROSCI, V20, P1358; Meldolesi J, 2001, PROG NEUROBIOL, V65, P309, DOI 10.1016/S0301-0082(01)00004-1; Ng AN, 2008, FASEB J, V22, P2832, DOI 10.1096/fj.07-103903; Park MK, 2000, EMBO J, V19, P5729, DOI 10.1093/emboj/19.21.5729; Paschen W, 2005, CELL CALCIUM, V38, P409, DOI 10.1016/j.ceca.2005.06.019; PELHAM HRB, 1988, EMBO J, V7, P913, DOI 10.1002/j.1460-2075.1988.tb02896.x; Petersen OH, 2007, CELL CALCIUM, V42, P373, DOI 10.1016/j.ceca.2007.05.012; PETITO CK, 1984, J CEREBR BLOOD F MET, V4, P194, DOI 10.1038/jcbfm.1984.28; PETITO CK, 1984, J NEUROPATH EXP NEUR, V43, P141, DOI 10.1097/00005072-198403000-00004; Pfeffer S, 2003, CELL, V112, P507, DOI 10.1016/S0092-8674(03)00118-1; Ribeiro CMP, 2000, CELL CALCIUM, V27, P175, DOI 10.1054/ceca.2000.0108; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; Rytter A, 2003, J CEREBR BLOOD F MET, V23, P23, DOI 10.1097/01.WCB.0000034361.37277.1B; Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019; Sokka AL, 2007, J NEUROSCI, V27, P901, DOI 10.1523/JNEUROSCI.4289-06.2007; Solovyova N, 2003, PFLUG ARCH EUR J PHY, V446, P447, DOI 10.1007/s00424-003-1094-z; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Subramanian K, 1997, CELL, V89, P963, DOI 10.1016/S0092-8674(00)80281-0; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; Terasaki M, 1996, DEV BIOL, V179, P320, DOI 10.1006/dbio.1996.0263; TERASAKI M, 1991, J CELL BIOL, V114, P929, DOI 10.1083/jcb.114.5.929; TERASAKI M, 1994, P NATL ACAD SCI USA, V91, P7510, DOI 10.1073/pnas.91.16.7510; Toresson H, 2005, EUR J NEUROSCI, V22, P1793, DOI 10.1111/j.1460-9568.2005.04342.x; Verkhratsky A, 2005, PHYSIOL REV, V85, P201, DOI 10.1152/physrev.00004.2004; Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202; Wang C, 2002, J CEREBR BLOOD F MET, V22, P206, DOI 10.1097/00004647-200202000-00008; Wei HF, 1996, J NEUROCHEM, V67, P2390; WILLIAMS K, 1993, NEURON, V10, P267, DOI 10.1016/0896-6273(93)90317-K; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec	48	34	37	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2009	4	4							e5250	10.1371/journal.pone.0005250	http://dx.doi.org/10.1371/journal.pone.0005250			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VA	19381304	Green Published, gold, Green Submitted			2022-12-25	WOS:000265513800015
J	Barnabe, GF; Schwindt, TT; Calcagnotto, ME; Motta, FL; Martinez, GJ; Oliveira, AC; Keim, LMN; D'Almeida, V; Mendez-Otero, R; Mello, LE				Barnabe, Gabriela F.; Schwindt, Telma T.; Calcagnotto, Maria E.; Motta, Fabiana L.; Martinez, Gilberto Jr.; de Oliveira, Allan C.; Keim, Leda M. N.; D'Almeida, Vania; Mendez-Otero, Rosalia; Mello, Luiz E.			Chemically-Induced RAT Mesenchymal Stem Cells Adopt Molecular Properties of Neuronal-Like Cells but Do Not Have Basic Neuronal Functional Properties	PLOS ONE			English	Article								Induction of adult rat bone marrow mesenchymal stem cells (MSC) by means of chemical compounds (beta-mercaptoethanol, dimethyl sulfoxide and butylated hydroxyanizole) has been proposed to lead to neuronal transdifferentiation, and this protocol has been broadly used by several laboratories worldwide. Only a few hours of MSC chemical induction using this protocol is sufficient for the acquisition of neuronal-like morphology and neuronal protein expression. However, given that cell death is abundant, we hypothesize that, rather than true neuronal differentiation, this particular protocol leads to cellular toxic effects. We confirm that the induced cells with neuronal-like morphology positively stained for NF-200, S100, beta-tubulin III, NSE and MAP-2 proteins. However, the morphological and molecular changes after chemical induction are also associated with an increase in the apoptosis of over 50% of the plated cells after 24 h. Moreover, increased intracellular cysteine after treatment indicates an impairment of redox circuitry during chemical induction, and in vitro electrophysiological recordings (patch-clamp) of the chemically induced MSC did not indicate neuronal properties as these cells do not exhibit Na+ or K+ currents and do not fire action potentials. Our findings suggest that a disruption of redox circuitry plays an important role in this specific chemical induction protocol, which might result in cytoskeletal alterations and loss of functional ion-gated channels followed by cell death. Despite the neuronal-like morphology and neural protein expression, induced rat bone marrow MSC do not have basic functional neuronal properties, although it is still plausible that other methods of induction and/or sources of MSC can achieve a successful neuronal differentiation in vitro.			Barnabe, GF (corresponding author), Univ Fed Sao Paulo, Dept Fisiol, Sao Paulo, Brazil.	lemello@unifesp.br	D'Almeida, Vânia/B-5092-2011; calcagnotto, maria elisa/B-1645-2013; Mendez-Otero, Rosalia/AAL-7551-2020; Mello, Luiz E/B-4177-2009; CALCAGNOTTO, MARIA ELISA/AAU-7718-2020; D'Almeida, Vânia/AAV-3955-2020; D'Almeida, Vania/AAB-7115-2020; Barnabe, Gabriela/E-9033-2013; de Oliveira, Allan/B-1871-2013	D'Almeida, Vânia/0000-0003-0947-5312; calcagnotto, maria elisa/0000-0001-8196-0596; Mendez-Otero, Rosalia/0000-0002-1798-9930; Mello, Luiz E/0000-0002-6969-1108; CALCAGNOTTO, MARIA ELISA/0000-0001-8196-0596; D'Almeida, Vânia/0000-0003-0947-5312; Barnabe, Gabriela/0000-0001-8790-4480; Motta, Fabiana/0000-0003-2230-995X; Neumann Keim, Leda Maria/0000-0002-5483-8808				Abouelfetouh A, 2004, BRAIN RES, V1029, P114, DOI 10.1016/j.brainres.2004.07.092; ALEXANIAN AR, 2008, STEM CELLS DEV; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Bae JS, 2007, STEM CELLS, V25, P1307, DOI 10.1634/stemcells.2006-0561; Beyer Nardi N, 2006, HANDB EXP PHARM, V174, P249; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Bonilla S, 2005, NEUROSCIENCE, V133, P85, DOI 10.1016/j.neuroscience.2005.02.019; Bortner CD, 2007, ARCH BIOCHEM BIOPHYS, V462, P176, DOI 10.1016/j.abb.2007.01.020; Bossolasco P, 2005, EXP NEUROL, V193, P312, DOI 10.1016/j.expneurol.2004.12.013; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; Corti S, 2002, EXP NEUROL, V177, P443, DOI 10.1006/exnr.2002.8004; Croft AP, 2006, STEM CELLS, V24, P1841, DOI 10.1634/stemcells.2005-0609; Deng WW, 2001, BIOCHEM BIOPH RES CO, V282, P148, DOI 10.1006/bbrc.2001.4570; Goodwin PA, 1998, J PHARMACOL TOXICOL, V39, P229, DOI 10.1016/S1056-8719(98)00029-X; Goolsby J, 2003, P NATL ACAD SCI USA, V100, P14926, DOI 10.1073/pnas.2434383100; Gurok U, 2004, J NEUROSCI, V24, P5982, DOI 10.1523/JNEUROSCI.0809-04.2004; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hool LC, 2007, ANTIOXID REDOX SIGN, V9, P409, DOI 10.1089/ars.2006.1446; Hsieh J, 2004, CURR OPIN GENET DEV, V14, P461, DOI 10.1016/j.gde.2004.07.006; Jin KL, 2003, EXP NEUROL, V184, P78, DOI 10.1016/S0014-4886(03)00133-X; Jones DP, 2004, FASEB J, V18, P1246, DOI 10.1096/fj.03-0971fje; Kabos P, 2002, EXP NEUROL, V178, P288, DOI 10.1006/exnr.2002.8039; Kelly CM, 2005, BRAIN RES BULL, V68, P83, DOI 10.1016/j.brainresbull.2005.08.020; Kohyama J, 2001, DIFFERENTIATION, V68, P235, DOI 10.1046/j.1432-0436.2001.680411.x; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Krampera M, 2007, BONE, V40, P382, DOI 10.1016/j.bone.2006.09.006; Kuwabara T, 2004, CELL, V116, P779, DOI 10.1016/S0092-8674(04)00248-X; Lang F, 2007, ARCH BIOCHEM BIOPHYS, V462, P189, DOI 10.1016/j.abb.2006.12.028; Laterza OF, 2006, CLIN CHEM, V52, P1713, DOI 10.1373/clinchem.2006.070912; Li GR, 2006, STEM CELLS, V24, P1519, DOI 10.1634/stemcells.2005-0307; Liu YP, 2002, CLIN EXP PHARMACOL P, V29, P305, DOI 10.1046/j.1440-1681.2002.03649.x; Lu P, 2005, EXP NEUROL, V193, P273, DOI 10.1016/j.expneurol.2005.01.031; Lu P, 2004, J NEUROSCI RES, V77, P174, DOI 10.1002/jnr.20148; Martin D, 2003, J BIOL CHEM, V278, P53082, DOI 10.1074/jbc.M306861200; Mezey E, 2003, P NATL ACAD SCI USA, V100, P1364, DOI 10.1073/pnas.0336479100; Miller BA, 2006, J MEMBRANE BIOL, V209, P31, DOI 10.1007/s00232-005-0839-3; Munoz-Elias G, 2003, STEM CELLS, V21, P437, DOI 10.1634/stemcells.21-4-437; Munoz-Elias G, 2004, J NEUROSCI, V24, P4585, DOI 10.1523/JNEUROSCI.5060-03.2004; Neuhuber B, 2004, J NEUROSCI RES, V77, P192, DOI 10.1002/jnr.20147; Pfeiffer CM, 1999, CLIN CHEM, V45, P290; Ratajczak MZ, 2004, LEUKEMIA, V18, P29, DOI 10.1038/sj.leu.2403184; Rismanchi N, 2003, BRAIN RES, V991, P46, DOI 10.1016/j.brainres.2003.07.004; SAGARA JI, 2007, NEUROCHEM RES; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Scintu F, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-14; Suzuki H, 2004, BIOCHEM BIOPH RES CO, V322, P918, DOI 10.1016/j.bbrc.2004.07.201; Svendsen CN, 1999, BRAIN PATHOL, V9, P499, DOI 10.1111/j.1750-3639.1999.tb00538.x; Taschenberger H, 2005, J PHYSIOL-LONDON, V568, P513, DOI 10.1113/jphysiol.2005.093468; Tondreau T, 2004, DIFFERENTIATION, V72, P319, DOI 10.1111/j.1432-0436.2004.07207003.x; WATANABE M, 1990, DEV BRAIN RES, V53, P89, DOI 10.1016/0165-3806(90)90127-K; Wenisch S, 2006, BONE, V38, P911, DOI 10.1016/j.bone.2005.10.021; Woodbury D, 2002, J NEUROSCI RES, V69, P908, DOI 10.1002/jnr.10365; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Zhao L, 2007, CELL BIOL INT, V31, P916, DOI 10.1016/j.cellbi.2007.02.006	58	61	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2009	4	4							e5222	10.1371/journal.pone.0005222	http://dx.doi.org/10.1371/journal.pone.0005222			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TU	19370156	Green Submitted, Green Published, gold			2022-12-25	WOS:000265510600005
J	Majumdar, I; Kinch, LN; Grishin, NV				Majumdar, Indraneel; Kinch, Lisa N.; Grishin, Nick V.			A Database of Domain Definitions for Proteins with Complex Interdomain Geometry	PLOS ONE			English	Article								Protein structural domains are necessary for understanding evolution and protein folding, and may vary widely from functional and sequence based domains. Although, various structural domain databases exist, defining domains for some proteins is non-trivial, and definitions of their domain boundaries are not available. Here, we present a novel database of manually defined structural domains for a representative set of proteins from the SCOP "multi-domain proteins'' class. (http://prodata.swmed.edu/multidom/). We consider our domains as mobile evolutionary units, which may rearrange during protein evolution. Additionally, they may be visualized as structurally compact and possibly independently folding units. We also found that representing domains as evolutionary and folding units do not always lead to a unique domain definition. However, unlike existing databases, we retain and refine these "alternate'' domain definitions after careful inspection of structural similarity, functional sites and automated domain definition methods. We provide domain definitions, including actual residue boundaries, for proteins that well known databases like SCOP and CATH do not attempt to split. Our alternate domain definitions are suitable for sequence and structure searches by automated methods. Additionally, the database can be used for training and testing domain delineation algorithms. Since our domains represent structurally compact evolutionary units, the database may be useful for studying domain properties and evolution.			Majumdar, I (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	indraneel@chop.swmed.edu; grishin@chop.swmed.edu		Kinch, Lisa/0000-0003-3041-2615	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067165] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM67165, R01 GM067165] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexandrov N, 2003, BIOINFORMATICS, V19, P429, DOI 10.1093/bioinformatics/btg006; ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Augustin MA, 2001, NAT STRUCT BIOL, V8, P57, DOI 10.1038/83060; BARON M, 1991, TRENDS BIOCHEM SCI, V16, P13, DOI 10.1016/0968-0004(91)90009-K; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chandonia JM, 2004, NUCLEIC ACIDS RES, V32, pD189, DOI 10.1093/nar/gkh034; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Greene LH, 2007, NUCLEIC ACIDS RES, V35, pD291, DOI 10.1093/nar/gkl959; Hegyi H, 1997, J PROTEIN CHEM, V16, P545, DOI 10.1023/A:1026382032119; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; JANIN J, 1985, METHOD ENZYMOL, V115, P420; Kamada K, 1996, NATURE, V383, P598, DOI 10.1038/383598a0; Kinch LN, 2003, PROTEINS, V53, P395, DOI 10.1002/prot.10557; LEVITT M, 1976, NATURE, V261, P552, DOI 10.1038/261552a0; Majumdar I, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-202; Murzin AG, 1998, CURR OPIN STRUC BIOL, V8, P380, DOI 10.1016/S0959-440X(98)80073-0; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; ORENGO CA, 1994, NATURE, V372, P631, DOI 10.1038/372631a0; PHILLIPS DC, 1966, SCI AM, V215, P78, DOI 10.1038/scientificamerican1166-78; ROSE GD, 1979, J MOL BIOL, V134, P447, DOI 10.1016/0022-2836(79)90363-2; RUSSELL RB, 1994, PROTEIN ENG, V7, P1407, DOI 10.1093/protein/7.12.1407; SIDDIQUI AS, 1995, PROTEIN SCI, V4, P872; SWINDELLS MB, 1995, PROTEIN SCI, V4, P103; Veretnik S, 2004, J MOL BIOL, V339, P647, DOI 10.1016/j.jmb.2004.03.053; WETLAUFE.DB, 1973, P NATL ACAD SCI USA, V70, P697, DOI 10.1073/pnas.70.3.697; WETLAUFER DB, 1973, ANNU REV BIOCHEM, V42, P135, DOI 10.1146/annurev.bi.42.070173.001031; ZEHFUS MH, 1986, BIOCHEMISTRY-US, V25, P5759, DOI 10.1021/bi00367a062	28	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5084	10.1371/journal.pone.0005084	http://dx.doi.org/10.1371/journal.pone.0005084			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19352501	Green Submitted, Green Published, gold			2022-12-25	WOS:000265505700007
J	Amleh, A; Nair, SJ; Sun, J; Sutherland, A; Hasty, P; Li, R				Amleh, Asma; Nair, Sreejith J.; Sun, Jianlong; Sutherland, Ann; Hasty, Paul; Li, Rong			Mouse Cofactor of BRCA1 (Cobra1) Is Required for Early Embryogenesis	PLOS ONE			English	Article								Background: Negative elongation factor (NELF) is a four-subunit protein complex conserved from Drosophila to humans. In vitro biochemical and tissue culture-based studies have demonstrated an important role of NELF in controlling RNA polymerase II (Pol II) pausing in transcription. However, the physiological significance of NELF function is not clear due to the lack of any genetic systems for studying NELF. Principal Findings: Here we show that disruption of the mouse B subunit of NELF (NELF-B), also known as cofactor of BRCA1 (Cobra1), causes inner cell mass (ICM) deficiency and embryonic lethality at the time of implantation. Consistent with the phenotype of the Cobra1 knockout (KO) embryos, knockdown of Cobra1 in mouse embryonic stem cells (ESCs) reduces the efficiency of colony formation and increases spontaneous differentiation. Cobra1-depleted ESCs maintain normal levels of Oct4, Nanog, and Sox2, master regulators of pluripotency in ESCs. However, knockdown of Cobra1 leads to precocious expression of developmental regulators including lymphoid enhancer-binding factor 1 (Lef1). Chromatin immunoprecipitation (ChIP) indicates that Cobra1 binds to the Lef1 promoter and modulates the abundance of promoter-bound RNA polymerase. Conclusions: Cobra1 is essential for early embryogenesis. Our findings also indicate that Cobra1 helps maintain the undifferentiated state of mESCs by preventing unscheduled expression of developmental genes.	[Amleh, Asma; Nair, Sreejith J.; Sun, Jianlong; Hasty, Paul; Li, Rong] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78229 USA; [Sutherland, Ann] Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22903 USA	University of Texas System; University of Texas Health San Antonio; University of Virginia	Amleh, A (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78229 USA.	lir3@uthscsa.edu		Hasty, Paul/0000-0003-3046-0131; Sutherland, Ann/0000-0003-1925-2825; Amleh, Asma/0000-0003-3613-3182; Nair, Sreejith Janardhanan/0000-0001-6295-1133	National Institutes of Health [DK064604]; Department of Defense Breast Cancer Research Program [predoctoral fellowships]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064604] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program(United States Department of Defense); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by a grant to R.L. from the National Institutes of Health (DK064604), and predoctoral fellowships to J.S. and S.J.N. from the Department of Defense Breast Cancer Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida M, 2006, MOL CELL BIOL, V26, P6094, DOI 10.1128/MCB.02366-05; Aiyar SE, 2007, INT J BIOL SCI, V3, P486; Aiyar SE, 2004, GENE DEV, V18, P2134, DOI 10.1101/gad.1214104; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Dejosez M, 2008, CELL, V133, P1162, DOI 10.1016/j.cell.2008.05.047; Ding N, 2008, MOL CELL, V31, P347, DOI 10.1016/j.molcel.2008.05.023; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; He SY, 2008, STEM CELLS, V26, P842, DOI 10.1634/stemcells.2007-0356; Hoppler S, 2007, J CELL SCI, V120, P385, DOI 10.1242/jcs.03363; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Moynahan ME, 2002, ONCOGENE, V21, P8994, DOI 10.1038/sj.onc.1206177; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Narita T, 2003, MOL CELL BIOL, V23, P1863, DOI 10.1128/MCB.23.6.1863-1873.2003; Narita T, 2007, MOL CELL, V26, P349, DOI 10.1016/j.molcel.2007.04.011; O'Rourke JR, 2007, DEV BIOL, V311, P359, DOI 10.1016/j.ydbio.2007.08.032; Pereira L, 2006, MOL CELL BIOL, V26, P7479, DOI 10.1128/MCB.00368-06; Radonjic M, 2005, MOL CELL, V18, P171, DOI 10.1016/j.molcel.2005.03.010; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rotureau B, 2005, EXP PARASITOL, V111, P207, DOI 10.1016/j.exppara.2005.07.003; STEPHENS LE, 1995, GENE DEV, V9, P1883, DOI 10.1101/gad.9.15.1883; Sun J, 2007, J STEROID BIOCHEM, V107, P131, DOI 10.1016/j.jsbmb.2007.05.031; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Ye QN, 2001, J CELL BIOL, V155, P911, DOI 10.1083/jcb.200108049; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	39	42	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5034	10.1371/journal.pone.0005034	http://dx.doi.org/10.1371/journal.pone.0005034			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340312	Green Submitted, gold, Green Published			2022-12-25	WOS:000265500700009
J	Irelan, JT; del Arroyo, AG; Gutierrez, A; Peters, G; Quon, KC; Miraglia, L; Chanda, SK				Irelan, Jeffrey T.; del Arroyo, Ana Gutierrez; Gutierrez, Abel; Peters, Gordon; Quon, Kim C.; Miraglia, Loren; Chanda, Sumit K.			A Functional Screen for Regulators of CKDN2A Reveals MEOX2 as a Transcriptional Activator of INK4a	PLOS ONE			English	Article								The CDKN2A locus encodes two important tumor suppressors, INK4a and ARF, which respond to oncogenic stresses by inducing cellular senescence. We conducted a genome-scale cDNA overexpression screen using a reporter containing INK4a regulatory sequences to identify novel transcriptional activators of this locus. This screen revealed 285 cDNAs that putatively regulate the transcriptional activation of INK4a. Of these, 56 are annotated as transcription factors, including two previously reported activators of the locus, ETS2 and JUNB. Fourteen genes were further validated for activity and specificity, including several homeodomain proteins. We found that the transcription of one of these, the homeodomain protein MEOX2 ( GAX) is enhanced in primary cells during the induction of senescence, and forced expression of this protein results in the induction of premature senescence. We further demonstrate that MEOX2-induced senescence is dependent upon INK4a activity, and chromatin immunoprecipitation studies indicate that MEOX2 directly binds the INK4a promoter. These results support a role for this homeodomain protein as a direct regulator of INK4a transcription and senescence in human cells.	[Irelan, Jeffrey T.; Gutierrez, Abel; Quon, Kim C.; Miraglia, Loren; Chanda, Sumit K.] Novo Res Fdn, Genom Inst, San Diego, CA USA; [del Arroyo, Ana Gutierrez; Peters, Gordon] CRUK London Res Inst, London, England	Cancer Research UK	Irelan, JT (corresponding author), Novo Res Fdn, Genom Inst, San Diego, CA USA.	jirelan@gmail.com; schanda@burnham.org			Genomics Institute of the Novartis Research Foundation	Genomics Institute of the Novartis Research Foundation	This work was supported by the Genomics Institute of the Novartis Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Brookes S, 2002, EMBO J, V21, P2936, DOI 10.1093/emboj/cdf289; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chen Y, 2007, J BIOL CHEM, V282, P507, DOI 10.1074/jbc.M606604200; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Cortese R, 2008, INT J BIOCHEM CELL B, V40, P1494, DOI 10.1016/j.biocel.2007.11.018; GORSKI DH, 1993, MOL CELL BIOL, V13, P3722, DOI 10.1128/MCB.13.6.3722; Mankoo BS, 2003, DEVELOPMENT, V130, P4655, DOI 10.1242/dev.00687; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Owens BM, 2002, STEM CELLS, V20, P364, DOI 10.1634/stemcells.20-5-364; Pardal R, 2005, COLD SH Q B, V70, P177, DOI 10.1101/sqb.2005.70.057; Park YB, 2002, CANCER GENET CYTOGEN, V133, P105, DOI 10.1016/S0165-4608(01)00575-1; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Sherr CJ, 2001, CELL, V106, P531, DOI 10.1016/S0092-8674(01)00486-X; Smith RC, 1997, GENE DEV, V11, P1674, DOI 10.1101/gad.11.13.1674; Wang W, 2001, J BIOL CHEM, V276, P48655, DOI 10.1074/jbc.M108278200; Wu ZH, 2005, NAT MED, V11, P959, DOI 10.1038/nm1287	22	24	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5067	10.1371/journal.pone.0005067	http://dx.doi.org/10.1371/journal.pone.0005067			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340300	gold, Green Published, Green Submitted			2022-12-25	WOS:000265500700011
J	Shen, HCJ; Adem, A; Ylaya, K; Wilson, A; He, M; Lorang, D; Hewitt, SM; Pechhold, K; Harlan, DM; Lubensky, IA; Schmidt, LS; Linehan, WM; Libutti, SK				Shen, H. -C. Jennifer; Adem, Asha; Ylaya, Kris; Wilson, Arianne; He, Mei; Lorang, Dominique; Hewitt, Stephen M.; Pechhold, Klaus; Harlan, David M.; Lubensky, Irina A.; Schmidt, Laura S.; Linehan, W. Marston; Libutti, Steven K.			Deciphering von Hippel-Lindau (VHL/Vhl)-Associated Pancreatic Manifestations by Inactivating Vhl in Specific Pancreatic Cell Populations	PLOS ONE			English	Article								The von Hippel-Lindau (VHL) syndrome is a pleomorphic familial disease characterized by the development of highly vascularized tumors, such as hemangioblastomas of the central nervous system, pheochromocytomas, renal cell carcinomas, cysts and neuroendocrine tumors of the pancreas. Up to 75% of VHL patients are affected by VHL-associated pancreatic lesions; however, very few reports in the published literature have described the cellular origins and biological roles of VHL in the pancreas. Since homozygous loss of Vhl in mice resulted in embryonic lethality, this study aimed to characterize the functional significance of VHL in the pancreas by conditionally inactivating Vhl utilizing the Cre/LoxP system. Specifically, Vhl was inactivated in different pancreatic cell populations distinguished by their roles during embryonic organ development and their endocrine lineage commitment. With Cre recombinase expression directed by a glucagon promoter in a-cells or an insulin promoter in beta-cells, we showed that deletion of Vhl is dispensable for normal functions of the endocrine pancreas. In addition, deficiency of VHL protein (pVHL) in terminally differentiated alpha-cells or beta-cells is insufficient to induce pancreatic neuroendocrine tumorigenesis. Most significantly, we presented the first mouse model of VHL-associated pancreatic disease in mice lacking pVHL utilizing Pdx1-Cre transgenic mice to inactivate Vhl in pancreatic progenitor cells. The highly vascularized microcystic adenomas and hyperplastic islets that developed in Pdx1-Cre; Vhl f/f homozygous mice exhibited clinical features similar to VHL patients. Establishment of three different, cell-specific Vhl knockouts in the pancreas have allowed us to provide evidence suggesting that VHL is functionally important for postnatal ductal and exocrine pancreas, and that VHL-associated pancreatic lesions are likely to originate from progenitor cells, not mature endocrine cells. The novel model systems reported here will provide the basis for further functional and genetic studies to define molecular mechanisms involved in VHL-associated pancreatic diseases.	[Shen, H. -C. Jennifer; Adem, Asha; Wilson, Arianne; He, Mei; Lorang, Dominique; Libutti, Steven K.] NCI, Surg Branch, Tumor Angiogenesis Sect, Bethesda, MD 20892 USA; [Ylaya, Kris; Hewitt, Stephen M.] NCI, Lab Pathol, Tissue Array Res Program, Bethesda, MD USA; [Pechhold, Klaus; Harlan, David M.] NIDDKD, Diabetes Branch, Bethesda, MD USA; [Lubensky, Irina A.] NCI, Div Canc Treatment & Diagnosis, Rockville, MD USA; [Schmidt, Laura S.; Linehan, W. Marston] NCI, Urol Oncol Branch, Bethesda, MD USA; [Schmidt, Laura S.] NCI, Sci Applicat Int Corp SAIC Frederick Inc, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Shen, HCJ (corresponding author), NCI, Surg Branch, Tumor Angiogenesis Sect, Bldg 10, Bethesda, MD 20892 USA.	Steven_Libutti@nih.gov		Hewitt, Stephen/0000-0001-8283-1788	Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute (NCI), [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [ZIABC011038, ZIABC011028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK055113] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute (NCI),(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported in part by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute (NCI), and with federal funds from the NIH-NCI, under contract HHSN261200800001E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPERT LC, 1988, AM J SURG PATHOL, V12, P251, DOI 10.1097/00000478-198804000-00001; Biju MP, 2004, MOL CELL BIOL, V24, P9038, DOI 10.1128/MCB.24.20.9038-9047.2004; BINKOVITZ LA, 1990, AM J ROENTGENOL, V155, P501, DOI 10.2214/ajr.155.3.1974734; Blansfield JA, 2007, SURGERY, V142, P814, DOI 10.1016/j.surg.2007.09.012; CHEN F, 1995, HUM MUTAT, V5, P66, DOI 10.1002/humu.1380050109; Clifford SC, 2001, HUM MOL GENET, V10, P1029, DOI 10.1093/hmg/10.10.1029; Cohen HT, 1999, BIOCHEM BIOPH RES CO, V266, P43, DOI 10.1006/bbrc.1999.1767; Couch V, 2000, MAYO CLIN PROC, V75, P265; Esteban-Barragan MA, 2002, CANCER RES, V62, P2929; Flamme I, 1998, AM J PATHOL, V153, P25, DOI 10.1016/S0002-9440(10)65541-1; Friedrich CA, 2001, HUM MOL GENET, V10, P763, DOI 10.1093/hmg/10.7.763; Gannon M, 2000, GENESIS, V26, P139, DOI 10.1002/(SICI)1526-968X(200002)26:2<139::AID-GENE12>3.0.CO;2-7; Glavac D, 1996, HUM GENET, V98, P271, DOI 10.1007/s004390050206; Gnarra JR, 1997, P NATL ACAD SCI USA, V94, P9102, DOI 10.1073/pnas.94.17.9102; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Herrera PL, 2002, ENDOCRINE, V19, P267, DOI 10.1385/ENDO:19:3:267; Hoffman MA, 2001, HUM MOL GENET, V10, P1019, DOI 10.1093/hmg/10.10.1019; Hong SB, 2006, LAB INVEST, V86, P664, DOI 10.1038/labinvest.3700431; HOUGH DM, 1994, AM J ROENTGENOL, V162, P1091, DOI 10.2214/ajr.162.5.8165988; Iliopoulos O, 1996, P NATL ACAD SCI USA, V93, P10595, DOI 10.1073/pnas.93.20.10595; Ivanov S, 2001, AM J PATHOL, V158, P905, DOI 10.1016/S0002-9440(10)64038-2; KESSLER PM, 1995, MOL MED, V1, P457, DOI 10.1007/BF03401583; Kurban G, 2006, CANCER RES, V66, P1313, DOI 10.1158/0008-5472.CAN-05-2560; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Libutti SK, 1998, SURGERY, V124, P1153, DOI 10.1067/msy.1998.91823; LINEHAN WM, 1995, JAMA-J AM MED ASSOC, V273, P564; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Lubensky IA, 1998, AM J PATHOL, V153, P223, DOI 10.1016/S0002-9440(10)65563-0; Ma WB, 2003, CANCER RES, V63, P5320; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mohr VH, 2000, AM J PATHOL, V157, P1615, DOI 10.1016/S0002-9440(10)64799-2; MOROHOSHI T, 1983, HISTOPATHOLOGY, V7, P645, DOI 10.1111/j.1365-2559.1983.tb02277.x; Mukhopadhyay D, 1997, MOL CELL BIOL, V17, P5629, DOI 10.1128/MCB.17.9.5629; NEUMANN HPH, 1991, GASTROENTEROLOGY, V101, P465, DOI 10.1016/0016-5085(91)90026-H; NYONGO A, 1985, AM J CLIN PATHOL, V84, P114, DOI 10.1093/ajcp/84.1.114; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; Pal S, 1997, J BIOL CHEM, V272, P27509, DOI 10.1074/jbc.272.44.27509; Park DM, 2007, PLOS MED, V4, P333, DOI 10.1371/journal.pmed.0040060; Park SK, 2007, INT J ONCOL, V30, P341; Pfander D, 2004, DEVELOPMENT, V131, P2497, DOI 10.1242/dev.01138; Pioli PA, 2001, J BIOL CHEM, V276, P40346, DOI 10.1074/jbc.M105391200; Rankin EB, 2006, CANCER RES, V66, P2576, DOI 10.1158/0008-5472.CAN-05-3241; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Richards FM, 1996, HUM MOL GENET, V5, P639, DOI 10.1093/hmg/5.5.639; Shen HCJ, 2008, ENDOCR-RELAT CANCER, V15, P267, DOI 10.1677/ERC-07-0191; SHORTEN SD, 1986, AM J SURG PATHOL, V10, P365, DOI 10.1097/00000478-198606000-00001; Tang N, 2006, MOL CELL BIOL, V26, P2519, DOI 10.1128/MCB.26.7.2519-2530.2006; Thurston G, 1996, AM J PHYSIOL-HEART C, V271, pH2547, DOI 10.1152/ajpheart.1996.271.6.H2547	50	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e4897	10.1371/journal.pone.0004897	http://dx.doi.org/10.1371/journal.pone.0004897			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340311	Green Published, Green Submitted, gold			2022-12-25	WOS:000265500700001
J	Anish, R; Hossain, MB; Jacobson, RH; Takada, S				Anish, Ramakrishnan; Hossain, Mohammad B.; Jacobson, Raymond H.; Takada, Shinako			Characterization of Transcription from TATA-Less Promoters: Identification of a New Core Promoter Element XCPE2 and Analysis of Factor Requirements	PLOS ONE			English	Article							RNA-POLYMERASE-II; PREINITIATION COMPLEX; GENE-EXPRESSION; DNA-SEQUENCES; GENOME-WIDE; BINDING; PROTEIN; TBP; RECOGNITION; RECRUITMENT	Background: More than 80% of mammalian protein-coding genes are driven by TATA-less promoters which often show multiple transcriptional start sites (TSSs). However, little is known about the core promoter DNA sequences or mechanisms of transcriptional initiation for this class of promoters. Methodology/Principal Findings: Here we identify a new core promoter element XCPE2 (X core promoter element 2) (consensus sequence: A/C/G-C-C/T-C-G/A-T-T-G/A-C-C/A(+1)-C/T) that can direct specific transcription from the second TSS of hepatitis B virus X gene mRNA. XCPE2 sequences can also be found in human promoter regions and typically appear to drive one of the start sites within multiple TSS-containing TATA-less promoters. To gain insight into mechanisms of transcriptional initiation from this class of promoters, we examined requirements of several general transcription factors by in vitro transcription experiments using immunodepleted nuclear extracts and purified factors. Our results show that XCPE2-driven transcription uses at least TFIIB, either TFIID or free TBP, RNA polymerase II (RNA pol II) and the MED26-containing mediator complex but not Gcn5. Therefore, XCPE2-driven transcription can be carried out by a mechanism which differs from previously described TAF-dependent mechanisms for initiator (Inr)- or downstream promoter element (DPE)containing promoters, the TBP- and SAGA (Spt-Ada-Gcn5-acetyltransferase)-dependent mechanism for yeast TATA-containing promoters, or the TFTC (TBP-free-TAF-containing complex)-dependent mechanism for certain Inr-containing TATA-less promoters. EMSA assays using XCPE2 promoter and purified factors further suggest that XCPE2 promoter recognition requires a set of factors different from those for TATA box, Inr, or DPE promoter recognition. Conclusions/Significance: We identified a new core promoter element XCPE2 that are found in multiple TSS-containing TATA-less promoters. Mechanisms of promoter recognition and transcriptional initiation for XCPE2-driven promoters appear different from previously shown mechanisms for classical promoters that show single "focused'' TSSs. Our studies provide insight into novel mechanisms of RNA Pol II transcription from multiple TSS-containing TATA-less promoters.	[Anish, Ramakrishnan; Hossain, Mohammad B.; Jacobson, Raymond H.; Takada, Shinako] Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Dept Biochem & Mol Biol, Genes & Dev Program, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Anish, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Dept Biochem & Mol Biol, Genes & Dev Program, Houston, TX 77030 USA.	stakada@mdanderson.org		Thachangattuthodi, Anish/0000-0002-8029-5421	M.D. Anderson Cancer Center; American Gastroenterological Association (AGA)/Elsevier Research Initiative Award; NIH [AI057504, GM069769]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069769] Funding Source: NIH RePORTER	M.D. Anderson Cancer Center; American Gastroenterological Association (AGA)/Elsevier Research Initiative Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by an institutional research grant from M.D. Anderson Cancer Center, an American Gastroenterological Association (AGA)/Elsevier Research Initiative Award, and a grant (AI057504) from the NIH to S.T., and a grant (GM069769) from the NIH to R.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKI E, 1988, NUCLEIC ACIDS RES, V16, P1627, DOI 10.1093/nar/16.4.1627; ASO T, 1994, J BIOL CHEM, V269, P26575; Bajic VB, 2006, PLOS GENET, V2, P614, DOI 10.1371/journal.pgen.0020054; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Burke TW, 1996, GENE DEV, V10, P711, DOI 10.1101/gad.10.6.711; Butler JEF, 2001, GENE DEV, V15, P2515, DOI 10.1101/gad.924301; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Cavusoglu N, 2003, PROTEOMICS, V3, P217, DOI 10.1002/pmic.200390030; Cheng JX, 2002, CURR BIOL, V12, P1828, DOI 10.1016/S0960-9822(02)01257-5; FitzGerald PC, 2004, GENOME RES, V14, P1562, DOI 10.1101/gr.1953904; Frith MC, 2008, GENOME RES, V18, P1, DOI 10.1101/gr.6831208; Hasegawa J, 2003, J BIOCHEM, V133, P133, DOI 10.1093/jb/mvg013; HAYASHIDA T, 1994, GENE, V141, P267; Hilton TL, 2005, MOL CELL BIOL, V25, P4321, DOI 10.1128/MCB.25.10.4321-4332.2005; Hube F, 2005, MOL BIOTECHNOL, V31, P81, DOI 10.1385/MB:31:1:081; Izawa M, 2006, JPN J VET RES, V53, P159; KOBAYASHI M, 1984, GENE, V30, P227; Lee DH, 2005, MOL CELL BIOL, V25, P9674, DOI 10.1128/MCB.25.21.9674-9686.2005; Li XY, 2002, CURR BIOL, V12, P1240, DOI 10.1016/S0960-9822(02)00932-6; Lim CY, 2004, GENE DEV, V18, P1606, DOI 10.1101/gad.1193404; Martinez E, 1998, J BIOL CHEM, V273, P23781, DOI 10.1074/jbc.273.37.23781; Mittler G, 2001, EMBO REP, V2, P808, DOI 10.1093/embo-reports/kve186; Muller F, 2007, J BIOL CHEM, V282, P14685, DOI 10.1074/jbc.R700012200; Oelgeschlager T, 1998, MOL CELL, V1, P925, DOI 10.1016/S1097-2765(00)80092-1; Ohler U, 2002, GENOME BIOL, V3, DOI [10.1186/gb-2002-3-12-research0087, DOI 10.1186/GB-2002-3-12-RESEARCH0087]; Ohtsuki S, 1998, GENE DEV, V12, P547, DOI 10.1101/gad.12.4.547; Ren DL, 2005, ARCH BIOCHEM BIOPHYS, V435, P347, DOI 10.1016/j.abb.2004.12.028; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; Sermwittayawong D, 2006, EMBO J, V25, P3791, DOI 10.1038/sj.emboj.7601265; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Suzuki Y, 2001, GENOME RES, V11, P677, DOI 10.1101/gr.GR-1640R; Takada S, 1996, VIROLOGY, V216, P80, DOI 10.1006/viro.1996.0036; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Tokusumi Y, 2004, J VIROL, V78, P10856, DOI 10.1128/JVI.78.20.10856-10864.2004; Tokusumi Y, 2007, MOL CELL BIOL, V27, P1844, DOI 10.1128/MCB.01363-06; VERRIJZER CP, 1995, CELL, V81, P1115, DOI 10.1016/S0092-8674(05)80016-9; WANG BQ, 1994, PROTEIN EXPRES PURIF, V5, P476, DOI 10.1006/prep.1994.1067; WANG EH, 1994, SCIENCE, V263, P811, DOI 10.1126/science.8303298; Weis L, 1997, MOL CELL BIOL, V17, P2973, DOI 10.1128/MCB.17.6.2973; Wieczorek E, 1998, NATURE, V393, P187, DOI 10.1038/30283; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Wu PYJ, 2004, MOL CELL, V15, P199, DOI 10.1016/j.molcel.2004.06.005; Wu SY, 2003, MOL CELL BIOL, V23, P6229, DOI 10.1128/MCB.23.17.6229-6242.2003; Wu SY, 1998, EMBO J, V17, P4478, DOI 10.1093/emboj/17.15.4478	47	56	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5103	10.1371/journal.pone.0005103	http://dx.doi.org/10.1371/journal.pone.0005103			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337366	Green Submitted, Green Published, gold			2022-12-25	WOS:000265500600023
J	Mennerat, A; Perret, P; Lambrechts, MM				Mennerat, Adele; Perret, Philippe; Lambrechts, Marcel M.			Local Individual Preferences for Nest Materials in a Passerine Bird	PLOS ONE			English	Article							BLUE TIT; AROMATIC PLANTS; COMMON RAVENS; GREEN PLANTS; CORVUS-CORAX; INFORMATION; NESTLINGS; POPULATION; HYPOTHESIS; OLFACTION	Background: Variation in the behavioural repertoire of animals is acquired by learning in a range of animal species. In nest-building birds, the assemblage of nest materials in an appropriate structure is often typical of a bird genus or species. Yet plasticity in the selection of nest materials may be beneficial because the nature and abundance of nest materials vary across habitats. Such plasticity can be learned, either individually or socially. In Corsican populations of blue tits Cyanistes caeruleus, females regularly add in their nests fragments of several species of aromatic plants during the whole breeding period. The selected plants represent a small fraction of the species present in the environment and have positive effects on nestlings. Methodology/Principal Findings: We investigated spatiotemporal variations of this behaviour to test whether the aromatic plant species composition in nests depends on 1) plant availability in territories, 2) female experience or 3) female identity. Our results indicate that territory plays a very marginal role in the aromatic plant species composition of nests. Female experience is not related to a change in nest plant composition. Actually, this composition clearly depends on female identity, i.e. results from individual preferences which, furthermore, are repeatable both within and across years. A puzzling fact is the strong difference in plant species composition of nests across distinct study plots. Conclusions/Significance: This study demonstrates that plant species composition of nests results from individual preferences that are homogeneous within study plots. We propose several hypotheses to interpret this pattern of spatial variation before discussing them in the light of preliminary results. As a conclusion, we cannot exclude the possibility of social transmission of individual preferences for aromatic plants. This is an exciting perspective for further work in birds, where nest construction behaviour has classically been considered as a stereotypic behaviour.	[Mennerat, Adele; Perret, Philippe; Lambrechts, Marcel M.] CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, F-34033 Montpellier, France; [Mennerat, Adele] Lab Evolut & Divers Biol, UMR 5174, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA)	Mennerat, A (corresponding author), CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, F-34033 Montpellier, France.	adele.mennerat@bio.uib.no	Mennerat, Adele/K-4133-2019	Mennerat, Adele/0000-0003-0368-7197	ANR [ANR-05 NT05-3_42075]	ANR(French National Research Agency (ANR))	This study was partly funded by an ANR research grant to M.M. Lambrechts and P. Heeb (ANR-05 NT05-3_42075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beecher MD, 2005, TRENDS ECOL EVOL, V20, P143, DOI 10.1016/j.tree.2005.01.004; Benskin CMWH, 2002, ANIM BEHAV, V64, P823, DOI 10.1006/anbe.2002.2005; BLONDEL J, 1985, J ANIM ECOL, V54, P531, DOI 10.2307/4497; CLARK L, 1988, OECOLOGIA, V77, P174, DOI 10.1007/BF00379183; CLARK L, 1985, OECOLOGIA, V67, P169, DOI 10.1007/BF00384280; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Collias NE, 1997, CONDOR, V99, P253, DOI 10.2307/1369932; Fritz J, 1999, ANIM BEHAV, V57, P785, DOI 10.1006/anbe.1998.1035; Gajdon GK, 2004, LEARN BEHAV, V32, P62; GALEF BG, 1983, ANIM BEHAV, V31, P748, DOI 10.1016/S0003-3472(83)80232-2; Galef BG, 2005, BIOSCIENCE, V55, P489, DOI 10.1641/0006-3568(2005)055[0489:SLIAES]2.0.CO;2; Giraldeau LA, 2008, ADV STUD BEHAV, V38, P59, DOI 10.1016/S0065-3454(08)00002-8; Gwinner H, 2000, ANIM BEHAV, V59, P301, DOI 10.1006/anbe.1999.1306; Gwinner H, 1997, BEHAVIOUR, V134, P337, DOI 10.1163/156853997X00575; Gwinner H, 2008, ANIM BEHAV, V75, P971, DOI 10.1016/j.anbehav.2007.08.008; Hansell M.H., 2000, BIRD NESTS CONSTRUCT, DOI [10.1017/CBO9781139106788, DOI 10.1017/CBO9781139106788]; Healy S, 2008, CURR BIOL, V18, pR271, DOI 10.1016/j.cub.2008.01.020; Lafuma L, 2001, BEHAV PROCESS, V56, P113, DOI 10.1016/S0376-6357(01)00191-7; Laland KN, 2006, TRENDS ECOL EVOL, V21, P542, DOI 10.1016/j.tree.2006.06.005; Laland KN, 1998, BEHAV ECOL, V9, P493, DOI 10.1093/beheco/9.5.493; Laland KN, 1997, ANIM BEHAV, V53, P1161, DOI 10.1006/anbe.1996.0318; Lambrechts MM, 2000, ACTA OECOL, V21, P175, DOI 10.1016/S1146-609X(00)00122-3; Lambrechts MM, 1997, EVOL ECOL, V11, P599, DOI 10.1007/s10682-997-1515-0; Lambrechts MM, 2004, OECOLOGIA, V141, P555, DOI 10.1007/s00442-004-1681-5; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Liu WC, 2007, P NATL ACAD SCI USA, V104, P20398, DOI 10.1073/pnas.0710067104; Mennerat A, 2008, BEHAV PROCESS, V79, P189, DOI 10.1016/j.beproc.2008.07.003; Mennerat A, 2008, J AVIAN BIOL, V39, P127, DOI 10.1111/j.0908-8857.2008.04400.x; Mennerat A, 2009, ANIM BEHAV, V77, P569, DOI 10.1016/j.anbehav.2008.11.008; Nicol CJ, 2004, LEARN BEHAV, V32, P72; Petit C, 2002, ECOL LETT, V5, P585, DOI 10.1046/j.1461-0248.2002.00361.x; Rossi PG, 2007, J ESSENT OIL RES, V19, P176, DOI 10.1080/10412905.2007.9699254; Schwab C, 2008, ANIM BEHAV, V75, P501, DOI 10.1016/j.anbehav.2007.06.006; Wheelwright NT, 2008, ANIM BEHAV, V75, P1479, DOI 10.1016/j.anbehav.2007.08.030; WIMBERGER PH, 1984, AUK, V101, P615, DOI 10.1093/auk/101.3.615; Zohar O, 1995, MAMMALIA, V59, P481, DOI 10.1515/mamm.1995.59.4.481	36	45	48	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5104	10.1371/journal.pone.0005104	http://dx.doi.org/10.1371/journal.pone.0005104			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337365	Green Published, gold, Green Submitted			2022-12-25	WOS:000265500600024
J	Tan, M; Xia, M; Chen, YT; Bu, WM; Hegde, RS; Meller, J; Li, XM; Jiang, X				Tan, Ming; Xia, Ming; Chen, Yutao; Bu, Weiming; Hegde, Rashmi S.; Meller, Jarek; Li, Xuemei; Jiang, Xi			Conservation of Carbohydrate Binding Interfaces - Evidence of Human HBGA Selection in Norovirus Evolution	PLOS ONE			English	Article							BLOOD GROUP ANTIGENS; NORWALK VIRUS-INFECTION; CAPSID PROTEIN FORMS; RECEPTOR-BINDING; STRUCTURAL BASIS; P-DOMAIN; PARTICLE; FAMILY; ABO; CLASSIFICATION	Background: Human noroviruses are the major viral pathogens of epidemic acute gastroenteritis. These genetically diverse viruses comprise two major genogroups (GI and GII) and approximately 30 genotypes. Noroviruses recognize human histo-blood group antigens (HBGAs) in a diverse, strain-specific manner. Recently the crystal structures of the HBGA-binding interfaces of the GI Norwalk virus and the GII VA387 have been determined, which allows us to examine the genetic and structural relationships of the HBGA-binding interfaces of noroviruses with variable HBGA-binding patterns. Our hypothesis is that, if HBGAs are the viral receptors necessary for norovirus infection and spread, their binding interfaces should be under a selection pressure in the evolution of noroviruses. Methods and Findings: Structural comparison of the HBGA-binding interfaces of the two noroviruses has revealed shared features but significant differences in the location, sequence composition, and HBGA-binding modes. On the other hand, the primary sequences of the HBGA-binding interfaces are highly conserved among strains within each genogroup. The roles of critical residues within the binding sites have been verified by site-directed mutagenesis followed by functional analysis of strains with variable HBGA-binding patterns. Conclusions and Significance: Our data indicate that the human HBGAs are an important factor in norovirus evolution. Each of the two major genogroups represents an evolutionary lineage characterized by distinct genetic traits. Functional convergence of strains with the same HBGA targets subsequently resulted in acquisition of analogous HBGA binding interfaces in the two genogroups that share an overall structural similarity, despite their distinct locations and amino acid compositions. On the other hand, divergent evolution may have contributed to the observed overall differences between and within the two lineages. Thus, both divergent and convergent evolution, as well as the polymorphic human HBGAs, likely contribute to the diversity of noroviruses. The finding of genogroup-specific conservation of HBGA binding interfaces will facilitate the development of rational strategies to control and prevent norovirus-associated gastroenteritis.	[Tan, Ming; Xia, Ming; Jiang, Xi] Cincinnati Childrens Hosp, Med Ctr, Div Infect Dis, Cincinnati, OH USA; [Tan, Ming; Hegde, Rashmi S.; Meller, Jarek; Jiang, Xi] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA; [Bu, Weiming; Hegde, Rashmi S.] Cincinnati Childrens Hosp, Med Ctr, Div Dev Biol, Cincinnati, OH USA; [Meller, Jarek] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45221 USA; [Chen, Yutao; Li, Xuemei] Chinese Acad Sci, Inst Biophys, Natl Lab Bio Macromol, Beijing 100864, Peoples R China	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Chinese Academy of Sciences; Institute of Biophysics, CAS	Tan, M (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div Infect Dis, Cincinnati, OH USA.	jason.jiang@cchmc.org	Xia, Ming/AAY-7154-2021; Meller, Jaroslaw/A-1971-2011	Meller, Jaroslaw/0000-0002-1162-8253	National Institute of Health, the National Institute of Allergy and Infectious diseases [R01 AI37093, R01 AI55649]; National Institute of Child Health [PO1 HD13021]; Department of Defense [PR033018]; Translational Research Initiative of Cincinnati Children's Hospital Medical Center [SPR102032]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD013021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055649, R01AI037093] Funding Source: NIH RePORTER	National Institute of Health, the National Institute of Allergy and Infectious diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Child Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Department of Defense(United States Department of Defense); Translational Research Initiative of Cincinnati Children's Hospital Medical Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research described in this article was supported by the National Institute of Health, the National Institute of Allergy and Infectious diseases (R01 AI37093 and R01 AI55649) and National Institute of Child Health (PO1 HD13021), and the Department of Defense (PR033018) to X.J. This work was also supported by a grant from the Translational Research Initiative of Cincinnati Children's Hospital Medical Center (SPR102032) to M.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briscoe AD, 2000, J MOL EVOL, V51, P110, DOI 10.1007/s002390010071; Bu WM, 2008, J VIROL, V82, P5340, DOI 10.1128/JVI.00135-08; Cao S, 2007, J VIROL, V81, P5949, DOI 10.1128/JVI.00219-07; Choi JM, 2008, P NATL ACAD SCI USA, V105, P9175, DOI 10.1073/pnas.0803275105; da Silva AK, 2007, APPL ENVIRON MICROB, V73, P7891, DOI 10.1128/AEM.01428-07; Estes MK, 2006, CURR OPIN INFECT DIS, V19, P467, DOI 10.1097/01.qco.0000244053.69253.3d; FARKAS T, 2008, 27 ANN M AM SOC VIR; Farkas T, 2008, J VIROL, V82, P5408, DOI 10.1128/JVI.00070-08; Fukami-Kobayashi K, 2003, MOL BIOL EVOL, V20, P267, DOI 10.1093/molbev/msg038; GREEN KY, 2001, FIELDS VIROLOGY, P841; GREENBERG HB, 1981, J VIROL, V37, P994, DOI 10.1128/JVI.37.3.994-999.1981; HARDY ME, 1995, J VIROL, V69, P1693, DOI 10.1128/JVI.69.3.1693-1698.1995; Harrington PR, 2004, J VIROL, V78, P3035, DOI 10.1128/JVI.78.6.3035-3045.2004; Harrington PR, 2002, J VIROL, V76, P12335, DOI 10.1128/JVI.76.23.12335-12343.2002; HEDLUND K, 2007, 3 INT CAL C, P38; Huang PW, 2005, J VIROL, V79, P6714, DOI 10.1128/JVI.79.11.6714-6722.2005; Huang PW, 2003, J INFECT DIS, V188, P19, DOI 10.1086/375742; Hutson AM, 2005, J MED VIROL, V77, P116, DOI 10.1002/jmv.20423; Hutson AM, 2003, J VIROL, V77, P405, DOI 10.1128/JVI.77.1.405-415.2003; Hutson AM, 2002, J INFECT DIS, V185, P1335, DOI 10.1086/339883; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Marionneau S, 2002, GASTROENTEROLOGY, V122, P1967, DOI 10.1053/gast.2002.33661; Ming Tan, 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000348; MOE C, 2007, 3 INT CAL C; Oliver SL, 2006, VIROLOGY, V350, P240, DOI 10.1016/j.virol.2006.02.027; Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; Ruvoen-Clouet N, 2000, J VIROL, V74, P11950, DOI 10.1128/JVI.74.24.11950-11954.2000; Scipioni A, 2008, VET J, V178, P32, DOI 10.1016/j.tvjl.2007.11.012; Shirato H, 2008, J VIROL, V82, P10756, DOI 10.1128/JVI.00802-08; Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07; STEWART CB, 1987, NATURE, V330, P401, DOI 10.1038/330401a0; Stuart AD, 2007, J GEN VIROL, V88, P177, DOI 10.1099/vir.0.82158-0; Sumiyama K, 2000, GENE, V259, P75, DOI 10.1016/S0378-1119(00)00440-6; Tan M, 2005, J VIROL, V79, P14017, DOI 10.1128/JVI.79.22.14017-14030.2005; Tan M, 2005, TRENDS MICROBIOL, V13, P285, DOI 10.1016/j.tim.2005.04.004; Tan M, 2004, J VIROL, V78, P6233, DOI 10.1128/JVI.78.12.6233-6242.2004; Tan M, 2004, J MED VIROL, V74, P641, DOI 10.1002/jmv.20228; Tan M, 2003, J VIROL, V77, P12562, DOI 10.1128/JVI.77.23.12562-12571.2003; Tan M, 2008, VIROLOGY, V382, P115, DOI 10.1016/j.virol.2008.08.047; Tan M, 2008, VIROLOGY, V379, P324, DOI 10.1016/j.virol.2008.06.041; Tan M, 2008, CURR OPIN INVEST DR, V9, P146; Tan M, 2006, J VIROL, V80, P7322, DOI 10.1128/JVI.00233-06; Wobus CE, 2006, J VIROL, V80, P5104, DOI 10.1128/JVI.02346-05; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	45	98	106	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5058	10.1371/journal.pone.0005058	http://dx.doi.org/10.1371/journal.pone.0005058			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337380	Green Published, gold, Green Submitted			2022-12-25	WOS:000265500600017
J	Py, B; Basmaciogullari, S; Bouchet, J; Zarka, M; Moura, IC; Benhamou, M; Monteiro, RC; Hocini, H; Madrid, R; Benichou, S				Py, Benedicte; Basmaciogullari, Stephane; Bouchet, Jerome; Zarka, Marion; Moura, Ivan C.; Benhamou, Marc; Monteiro, Renato C.; Hocini, Hakim; Madrid, Ricardo; Benichou, Serge			The Phospholipid Scramblases 1 and 4 Are Cellular Receptors for the Secretory Leukocyte Protease Inhibitor and Interact with CD4 at the Plasma Membrane	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROTEINASE-INHIBITOR; EPITHELIAL-CELLS; DENDRITIC CELLS; HUMAN SALIVA; BINDS; EXPRESSION; INFECTION; IDENTIFICATION; TRANSMISSION	Secretory leukocyte protease inhibitor (SLPI) is secreted by epithelial cells in all the mucosal fluids such as saliva, cervical mucus, as well in the seminal liquid. At the physiological concentrations found in saliva, SLPI has a specific antiviral activity against HIV-1 that is related to the perturbation of the virus entry process at a stage posterior to the interaction of the viral surface glycoprotein with the CD4 receptor. Here, we confirm that recombinant SLPI is able to inhibit HIV-1 infection of primary T lymphocytes, and show that SLPI can also inhibit the transfer of HIV-1 virions from primary monocyte-derived dendritic cells to autologous T lymphocytes. At the molecular level, we show that SLPI is a ligand for the phospholipid scramblase 1 (PLSCR1) and PLSCR4, membrane proteins that are involved in the regulation of the movements of phospholipids between the inner and outer leaflets of the plasma membrane. Interestingly, we reveal that PLSCR1 and PLSCR4 also interact directly with the CD4 receptor at the cell surface of T lymphocytes. We find that the same region of the cytoplasmic domain of PLSCR1 is involved in the binding to CD4 and SLPI. Since SLPI was able to disrupt the association between PLSCR1 and CD4, our data suggest that SLPI inhibits HIV-1 infection by modulating the interaction of the CD4 receptor with PLSCRs. These interactions may constitute new targets for antiviral intervention.	[Py, Benedicte; Basmaciogullari, Stephane; Bouchet, Jerome; Zarka, Marion; Madrid, Ricardo; Benichou, Serge] Univ Paris 05, CNRS, UMR 8104, Inst Cochin, Paris, France; [Py, Benedicte; Basmaciogullari, Stephane; Bouchet, Jerome; Zarka, Marion; Madrid, Ricardo; Benichou, Serge] INSERM, U567, Paris, France; [Moura, Ivan C.; Benhamou, Marc; Monteiro, Renato C.] INSERM, U699, Paris, France; [Moura, Ivan C.; Benhamou, Marc; Monteiro, Renato C.] Univ Paris 07 Denis Diderot, F-75221 Paris, France; [Hocini, Hakim] INSERM, U743, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Benichou, S (corresponding author), Univ Paris 05, CNRS, UMR 8104, Inst Cochin, Paris, France.	serge.benichou@inserm.fr	Moura, Ivan C/A-9510-2013; bouchet, jerome/I-7716-2019; Py, Benedicte/M-6129-2014; Monteiro, Renato C/U-8633-2017; Cruz Moura, Ivan/A-9510-2013	Moura, Ivan C/0000-0002-2977-0354; bouchet, jerome/0000-0002-6611-4380; Monteiro, Renato C/0000-0001-5202-5646; Madrid Gonzalez, Ricardo/0000-0002-1350-9864; Cruz Moura, Ivan/0000-0002-8418-2803; py, benedicte/0000-0001-6716-7807; Benhamou, Marc/0000-0001-7763-3795; Benichou, Serge/0000-0003-3602-3530	INSERM; CNRS; Universite Paris-Descartes; French National Agency for AIDS Research (ANRS); Sidaction	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paris-Descartes; French National Agency for AIDS Research (ANRS)(ANRSFrench National Research Agency (ANR)); Sidaction	This work was supported in part by INSERM, CNRS, Universite Paris-Descartes, the French National Agency for AIDS Research (ANRS), and Sidaction. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baqui AAMA, 1999, CLIN DIAGN LAB IMMUN, V6, P808, DOI 10.1128/CDLI.6.6.808-811.1999; BENICHOU S, 1994, J BIOL CHEM, V269, P30073; Bevers EM, 1999, BBA-MOL CELL BIOL L, V1439, P317, DOI 10.1016/S1388-1981(99)00110-9; Bouchard D, 2006, LANCET ONCOL, V7, P167, DOI 10.1016/S1470-2045(06)70579-4; Bouhlal H, 2005, J IMMUNOL, V174, P7202, DOI 10.4049/jimmunol.174.11.7202; Chen MH, 2005, J BIOL CHEM, V280, P10599, DOI 10.1074/jbc.M413194200; DEVAUX PF, 1992, ANNU REV BIOPH BIOM, V21, P417, DOI 10.1146/annurev.bb.21.060192.002221; Farquhar C, 2002, J INFECT DIS, V186, P1173, DOI 10.1086/343805; Hocini H, 2000, CLIN DIAGN LAB IMMUN, V7, P515, DOI 10.1128/CDLI.7.3.515-518.2000; Jana NK, 2005, J VIROL, V79, P6432, DOI 10.1128/JVI.79.10.6432-6440.2005; Jin FY, 1997, CELL, V88, P417, DOI 10.1016/S0092-8674(00)81880-2; Kazmi SH, 2006, CLIN VACCINE IMMUNOL, V13, P1111, DOI 10.1128/CDLI.00426-05; KEARNEY JF, 1979, J IMMUNOL, V123, P1548; Li J, 2001, J BIOL CHEM, V276, P18579, DOI 10.1074/jbc.M100846200; Ma G, 2004, J EXP MED, V200, P1337, DOI 10.1084/jem.20041115; MCNEELY TB, 1995, J CLIN INVEST, V96, P456, DOI 10.1172/JCI118056; McNeely TB, 1997, BLOOD, V90, P1141, DOI 10.1182/blood.V90.3.1141.1141_1141_1149; Pastorelli C, 2001, J BIOL CHEM, V276, P20407, DOI 10.1074/jbc.M100790200; Peytavi R, 1999, J BIOL CHEM, V274, P1635, DOI 10.1074/jbc.274.3.1635; Pillay K, 2001, J INFECT DIS, V183, P653, DOI 10.1086/318535; Py B, 2007, APOPTOSIS, V12, P1879, DOI 10.1007/s10495-007-0106-4; RICE WG, 1990, SCIENCE, V249, P178, DOI 10.1126/science.2371565; Ryzhova EV, 2006, J VIROL, V80, P2694, DOI 10.1128/JVI.80.6.2694-2704.2006; Sahu SK, 2007, ARCH BIOCHEM BIOPHYS, V462, P103, DOI 10.1016/j.abb.2007.04.002; Sallenave JM, 1997, J LEUKOCYTE BIOL, V61, P695, DOI 10.1002/jlb.61.6.695; Samsom JN, 2007, J IMMUNOL, V179, P6588, DOI 10.4049/jimmunol.179.10.6588; Selig L, 1999, J VIROL, V73, P592, DOI 10.1128/JVI.73.1.592-600.1999; Shine NR, 2002, BIOORG CHEM, V30, P249, DOI 10.1016/S0045-2068(02)00008-1; Shugars D C, 1997, Oral Dis, V3 Suppl 1, pS70; Skott P, 2002, ORAL DIS, V8, P160, DOI 10.1034/j.1601-0825.2002.01807.x; Sun J, 2001, J BIOL CHEM, V276, P28984, DOI 10.1074/jbc.M102505200; Taggart CC, 2005, J EXP MED, V202, P1659, DOI 10.1084/jem.20050768; THOMPSON RC, 1986, P NATL ACAD SCI USA, V83, P6692, DOI 10.1073/pnas.83.18.6692; Tseng CC, 2000, FEBS LETT, V475, P232, DOI 10.1016/S0014-5793(00)01700-2; Wahl S M, 1997, Oral Dis, V3 Suppl 1, pS64; Wiedmer T, 2000, BBA-BIOMEMBRANES, V1467, P244, DOI 10.1016/S0005-2736(00)00236-4; Wiedmer T, 2003, BIOCHEMISTRY-US, V42, P1227, DOI 10.1021/bi026679w; Wilflingseder D, 2005, MOL IMMUNOL, V42, P229, DOI 10.1016/j.molimm.2004.06.019; Xu WF, 2007, NAT IMMUNOL, V8, P294, DOI 10.1038/ni1434; Zamoyska R, 1998, CURR OPIN IMMUNOL, V10, P82, DOI 10.1016/S0952-7915(98)80036-8; Zhao J, 1998, J BIOL CHEM, V273, P6603, DOI 10.1074/jbc.273.12.6603; Zhou QS, 1997, J BIOL CHEM, V272, P18240, DOI 10.1074/jbc.272.29.18240	42	56	57	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e5006	10.1371/journal.pone.0005006	http://dx.doi.org/10.1371/journal.pone.0005006			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333378	Green Submitted, Green Published, gold			2022-12-25	WOS:000265499900010
J	Raaijmakers, HCA; Versteegh, JE; Uitdehaag, JCM				Raaijmakers, Hans C. A.; Versteegh, Judith E.; Uitdehaag, Joost C. M.			The X-ray Structure of RU486 Bound to the Progesterone Receptor in a Destabilized Agonistic Conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; IN-VITRO; CRYSTAL-STRUCTURES; ESTROGEN-RECEPTOR; B ISOFORMS; CHO-CELLS; MIFEPRISTONE; ANTAGONISM; MECHANISM; (ANTI)PROGESTAGENS	Here we describe the 1.95 angstrom structure of the clinically used antiprogestin RU486 (mifepristone) in complex with the progesterone receptor (PR). The structure was obtained by taking a crystal of the PR ligand binding domain containing the agonist norethindrone and soaking it in a solution containing the antagonist RU486 for extended times. Clear ligand exchange could be observed in one copy of the PR ligand binding domain dimer in the crystal. RU486 binds while PR is in an agonistic conformation without displacing helix 12. Although this is probably because of the constraints of the crystal lattice, it demonstrates that helix 12 displacement is not a prerequisite for RU486 binding. Interestingly, B-factor analysis clearly shows that helix 12 becomes more flexible after RU486 binding, suggesting that RU486, being a model antagonist, does not induce one fixed conformation of helix 12 but changes its positional equilibrium. This conclusion is confirmed by comparing the structures of RU486 bound to PR and RU486 bound to the glucocorticoid receptor.	[Versteegh, Judith E.; Uitdehaag, Joost C. M.] Schering Plough Res Inst, Dept Mol Pharmacol & DMPK, NL-5340 BH Oss, Netherlands; [Raaijmakers, Hans C. A.] Schering Plough Res Inst, Dept Mol Design & Informat, NL-5340 BH Oss, Netherlands	Merck & Company; Merck & Company	Uitdehaag, JCM (corresponding author), Schering Plough Res Inst, Dept Mol Pharmacol & DMPK, Rm RH2121,POB 20, NL-5340 BH Oss, Netherlands.	joost.uitdehaag@spcorp.com		raaijmakers, hans/0000-0002-2567-7363				ALLAN GF, 1992, J BIOL CHEM, V267, P19513; Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Attardi BJ, 2004, J STEROID BIOCHEM, V88, P277, DOI 10.1016/j.jsbmb.2003.12.004; BENHAMOU B, 1992, SCIENCE, V255, P206, DOI 10.1126/science.1372753; BRANDEN C, 1991, INTRO PROTEIN STRUCT, P13; Cadepond F, 1997, ANNU REV MED, V48, P129; COPELAND RA, 2000, ENZYMES, P285; Dijkema R, 1998, J STEROID BIOCHEM, V64, P147, DOI 10.1016/S0960-0760(97)00160-X; Greschik I, 2003, CURR TOP MED CHEM, V3, P1573, DOI 10.2174/1568026033451736; Hassell AM, 2007, ACTA CRYSTALLOGR D, V63, P72, DOI 10.1107/S0907444906047020; Honer C, 2003, MOL PHARMACOL, V63, P1012, DOI 10.1124/mol.63.5.1012; Jones DG, 2005, BIOORG MED CHEM LETT, V15, P3203, DOI 10.1016/j.bmcl.2005.05.001; Kauppi B, 2003, J BIOL CHEM, V278, P22748, DOI 10.1074/jbc.M212711200; KLOOSTERBOER HJ, 1995, ANN NY ACAD SCI, V761, P192, DOI 10.1111/j.1749-6632.1995.tb31379.x; Kong EH, 2003, BIOCHEM SOC T, V31, P56, DOI 10.1042/BST0310056; Leonhardt SA, 2002, EXP BIOL MED, V227, P969, DOI 10.1177/153537020222701104; Letz M, 1999, BBA-PROTEIN STRUCT M, V1429, P391, DOI 10.1016/S0167-4838(98)00249-0; Madauss KP, 2007, MOL ENDOCRINOL, V21, P1066, DOI 10.1210/me.2006-0524; Madauss KP, 2004, J MED CHEM, V47, P3381, DOI 10.1021/jm030640n; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakabayashi M, 2008, J MED CHEM, V51, P5320, DOI 10.1021/jm8004477; Nettles KW, 2008, NAT CHEM BIOL, V4, P241, DOI 10.1038/nchembio.76; Palmer S, 2000, J STEROID BIOCHEM, V75, P33, DOI 10.1016/S0960-0760(00)00134-5; Poole AJ, 2006, SCIENCE, V314, P1467, DOI 10.1126/science.1130471; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; PRECIGOUX G, 1975, ACTA CRYSTALLOGR B, V31, P1527, DOI 10.1107/S0567740875005638; Pullen MA, 2006, STEROIDS, V71, P792, DOI 10.1016/j.steroids.2006.05.009; REISCH J, 1994, ARCH PHARM, V327, P809; SADOWSKI J, 1993, CHEM REV, V93, P2567, DOI 10.1021/cr00023a012; Schoonen WGEJ, 1998, J STEROID BIOCHEM, V64, P157, DOI 10.1016/S0960-0760(97)00161-1; Schoonen WGEJ, 2000, J STEROID BIOCHEM, V74, P109, DOI 10.1016/S0960-0760(00)00094-7; VANGEERESTEIN VJ, 1987, ACTA CRYSTALLOGR C, V43, P2398, DOI 10.1107/S0108270187087626; VEGETO E, 1992, CELL, V69, P703, DOI 10.1016/0092-8674(92)90234-4; Vellieux FMD, 1997, J APPL CRYSTALLOGR, V30, P396, DOI 10.1107/S0021889896012551; WEHLE H, 1995, STEROIDS, V60, P368, DOI 10.1016/0039-128X(94)00067-M; Williams SP, 1998, NATURE, V393, P392, DOI 10.1038/30775; Winneker RC, 2008, STEROIDS, V73, P689, DOI 10.1016/j.steroids.2008.03.005	37	53	54	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19572	19579		10.1074/jbc.M109.007872	http://dx.doi.org/10.1074/jbc.M109.007872			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19372222	Green Published, hybrid			2022-12-25	WOS:000267908300049
J	Ohana, E; Hoch, E; Keasar, C; Kambe, T; Yifrach, O; Hershfinkel, M; Sekler, I				Ohana, Ehud; Hoch, Eitan; Keasar, Chen; Kambe, Taiho; Yifrach, Ofer; Hershfinkel, Michal; Sekler, Israel			Identification of the Zn2+ Binding Site and Mode of Operation of a Mammalian Zn2+ Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ZINC TRANSPORTER; SECRETORY PATHWAY; ALKALINE-PHOSPHATASES; SENSING RECEPTOR; VERTEBRATE CELLS; METAL-BINDING; MOUSE-BRAIN; PH; MECHANISM; MEMBRANE	Vesicular zinc transporters (ZnTs) play a critical role in regulating Zn2+ homeostasis in various cellular compartments and are linked to major diseases ranging from Alzheimer disease to diabetes. Despite their importance, the intracellular localization of ZnTs poses a major challenge for establishing the mechanisms by which they function and the identity of their ion binding sites. Here, we combine fluorescence-based functional analysis and structural modeling aimed at elucidating these functional aspects. Expression of ZnT5 was followed by both accelerated removal of Zn2+ from the cytoplasm and its increased vesicular sequestration. Further, activity of this zinc transport was coupled to alkalinization of the trans-Golgi network. Finally, structural modeling of ZnT5, based on the x-ray structure of the bacterial metal transporter YiiP, identified four residues that can potentially form the zinc binding site on ZnT5. Consistent with this model, replacement of these residues, Asp(599) and His(451), with alanine was sufficient to block Zn2+ transport. These findings indicate, for the first time, that Zn2+ transport mediated by a mammalian ZnT is catalyzed by H+/Zn2+ exchange and identify the zinc binding site of ZnT proteins essential for zinc transport.	[Sekler, Israel] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol, IL-84105 Beer Sheva, Israel; [Keasar, Chen] Ben Gurion Univ Negev, Dept Comp Sci, IL-84105 Beer Sheva, Israel; [Yifrach, Ofer] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Hershfinkel, Michal] Ben Gurion Univ Negev, Dept Morphol, IL-84105 Beer Sheva, Israel; [Kambe, Taiho] Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto 6068502, Japan	Ben Gurion University; Ben Gurion University; Ben Gurion University; Ben Gurion University; Kyoto University	Sekler, I (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol, POB 653, IL-84105 Beer Sheva, Israel.	sekler@bgu.ac.il	YIFRACH, Ofer/F-1480-2012; Keasar, Chen/J-8413-2012; Hershfinkel, Michal/F-1548-2012; Ohana, Ehud/ABB-3060-2020; ohana, ehud/C-3077-2014; KEASAR, CHEN/HGB-9794-2022	Hershfinkel, Michal/0000-0003-1652-1989; Ohana, Ehud/0000-0001-8598-4042; Keasar, Chen/0000-0003-0994-1520	Israel Science Foundation (ISF) [985/05]; German-Israel Foundation [917-119.1/2006]; ISF [450/03]	Israel Science Foundation (ISF)(Israel Science Foundation); German-Israel Foundation(German-Israeli Foundation for Scientific Research and Development); ISF(Israel Science Foundation)	This work was supported in part by Israel Science Foundation (ISF) Grant 985/05 (to I.S.), German-Israel Foundation Grant 917-119.1/2006 (to I.S.), and ISF Grant 450/03 (to M.H.).	ATAR D, 1995, J BIOL CHEM, V270, P2473, DOI 10.1074/jbc.270.6.2473; Azriel-Tamir H, 2004, J BIOL CHEM, V279, P51804, DOI 10.1074/jbc.M406581200; Burdette SC, 2001, J AM CHEM SOC, V123, P7831, DOI 10.1021/ja010059l; Canzoniero LMT, 1997, NEUROBIOL DIS, V4, P275, DOI 10.1006/nbdi.1997.0160; Chao Y, 2004, J BIOL CHEM, V279, P12043, DOI 10.1074/jbc.M313510200; Chao Y, 2004, J BIOL CHEM, V279, P17173, DOI 10.1074/jbc.M400208200; Dunn MF, 2005, BIOMETALS, V18, P295, DOI 10.1007/s10534-005-3685-y; Ellis CD, 2005, J BIOL CHEM, V280, P28811, DOI 10.1074/jbc.M505500200; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Hershfinkel M, 2001, P NATL ACAD SCI USA, V98, P11749, DOI 10.1073/pnas.201193398; Huang LP, 2002, J BIOL CHEM, V277, P26389, DOI 10.1074/jbc.M200462200; Huang LP, 1997, NAT GENET, V17, P292, DOI 10.1038/ng1197-292; Inoue K, 2002, HUM MOL GENET, V11, P1775, DOI 10.1093/hmg/11.15.1775; Ishihara K, 2006, J BIOL CHEM, V281, P17743, DOI 10.1074/jbc.M602470200; Jackson KA, 2007, J BIOL CHEM, V282, P10423, DOI 10.1074/jbc.M610535200; Jordan BA, 2001, P NATL ACAD SCI USA, V98, P343, DOI 10.1073/pnas.011384898; Kalisman N, 2005, BIOINFORMATICS, V21, P3931, DOI 10.1093/bioinformatics/bti630; Kambe T, 2002, J BIOL CHEM, V277, P19049, DOI 10.1074/jbc.M200910200; Kawachi M, 2008, J BIOL CHEM, V283, P8374, DOI 10.1074/jbc.M707646200; Lee JY, 2002, P NATL ACAD SCI USA, V99, P7705, DOI 10.1073/pnas.092034699; Levi V, 2002, BIOPHYS J, V82, P437, DOI 10.1016/S0006-3495(02)75408-8; Love R, 2005, BRAIN RES, V1061, P1, DOI 10.1016/j.brainres.2005.08.018; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; MacDiarmid CW, 2002, J BIOL CHEM, V277, P39187, DOI 10.1074/jbc.M205052200; Machen TE, 2003, AM J PHYSIOL-CELL PH, V285, pC205, DOI 10.1152/ajpcell.00008.2003; Mao XQ, 2007, J BIOL CHEM, V282, P6992, DOI 10.1074/jbc.M610552200; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Montanini B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-107; Nitzan YB, 2002, DEV BRAIN RES, V137, P149, DOI 10.1016/S0165-3806(02)00437-6; Obara K, 2005, P NATL ACAD SCI USA, V102, P14489, DOI 10.1073/pnas.0506222102; Ohana E, 2004, J BIOL CHEM, V279, P4278, DOI 10.1074/jbc.M309229200; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Schapiro FB, 2000, J BIOL CHEM, V275, P21025, DOI 10.1074/jbc.M002386200; Sekler I, 2002, J COMP NEUROL, V447, P201, DOI 10.1002/cne.10224; SEKLER I, 1995, J BIOL CHEM, V270, P28751, DOI 10.1074/jbc.270.48.28751; Sekler I, 2007, MOL MED, V13, P337, DOI 10.2119/2007-00037.Sekler; Sensi SL, 2006, BIOGERONTOLOGY, V7, P367, DOI 10.1007/s10522-006-9051-9; Seve M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-32; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Stiernet P, 2006, J BIOL CHEM, V281, P22142, DOI 10.1074/jbc.M513224200; Suzuki T, 2005, J BIOL CHEM, V280, P637, DOI 10.1074/jbc.M411247200; Suzuki T, 2005, J BIOL CHEM, V280, P30956, DOI 10.1074/jbc.M506902200; Valentine RA, 2007, J BIOL CHEM, V282, P14389, DOI 10.1074/jbc.M701752200; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Wei YN, 2006, J BIOL CHEM, V281, P23492, DOI 10.1074/jbc.M602254200; Wei YN, 2005, J BIOL CHEM, V280, P33716, DOI 10.1074/jbc.M506107200	47	135	137	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17677	17686		10.1074/jbc.M109.007203	http://dx.doi.org/10.1074/jbc.M109.007203			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19366695	Green Published, hybrid			2022-12-25	WOS:000267202500034
J	Li, XJ; Serwanski, DR; Miralles, CP; Nagata, K; De Blas, AL				Li, Xuejing; Serwanski, David R.; Miralles, Celia P.; Nagata, Koh-ichi; De Blas, Angel L.			Septin 11 Is Present in GABAergic Synapses and Plays a Functional Role in the Cytoarchitecture of Neurons and GABAergic Synaptic Connectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOBUTYRIC ACID(A) RECEPTOR; GABA-A RECEPTOR; MAMMALIAN SEPTIN; IMMUNOCYTOCHEMICAL LOCALIZATION; POSTSYNAPTIC DENSITIES; STRUCTURAL INSIGHTS; SPLICE VARIANT; SUBUNIT; PROTEIN; BRAIN	Mass spectrometry and immunoblot analysis of a rat brain fraction enriched in type-II postsynaptic densities and postsynaptic GABAergic markers showed enrichment in the protein septin 11. Septin 11 is expressed throughout the brain, being particularly high in the spiny branchlets of the Purkinje cells in the molecular layer of cerebellum and in the olfactory bulb. Immunofluorescence of cultured hippocampal neurons showed that 54 +/- 4% of the GABAergic synapses and 25 +/- 2% of the glutamatergic synapses had colocalizing septin 11 clusters. Similar colocalization numbers were found in the molecular layer of cerebellar sections. In cultured hippocampal neurons, septin 11 clusters were frequently present at the base of dendritic protrusions and at the bifurcation points of the dendritic branches. Electron microscopy immunocytochemistry of the rat brain cerebellum revealed the accumulation of septin 11 at the neck of dendritic spines, at the bifurcation of dendritic branches, and at some GABAergic synapses. Knocking down septin 11 in cultured hippocampal neurons with septin 11 small hairpin RNAs showed (i) reduced dendritic arborization; (ii) decreased density and increased length of dendritic protrusions; and (iii) decreased GABAergic synaptic contacts that these neurons receive. The results indicate that septin 11 plays important roles in the cytoarchitecture of neurons, including dendritic arborization and dendritic spines, and that septin 11 also plays a role in GABAergic synaptic connectivity.	[Li, Xuejing; Serwanski, David R.; Miralles, Celia P.; De Blas, Angel L.] Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA; [Nagata, Koh-ichi] Aichi Human Serv Ctr, Inst Dev Res, Dept Mol Neurobiol, Aichi 4800392, Japan	University of Connecticut	De Blas, AL (corresponding author), Univ Connecticut, Dept Physiol & Neurobiol, 75 N Eagleville Rd,U-3156, Storrs, CT 06269 USA.	angel.deblas@uconn.edu			National Institutes of Health; NINDS [NS38752, NS39287]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038752, R01NS039287] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health, NINDS, Grants NS38752 and NS39287.	Amin ND, 2008, J NEUROSCI, V28, P3631, DOI 10.1523/JNEUROSCI.0453-08.2008; Barral Y, 2000, MOL CELL, V5, P841, DOI 10.1016/S1097-2765(00)80324-X; Barral Y, 2008, CURR OPIN CELL BIOL, V20, P12, DOI 10.1016/j.ceb.2007.12.001; Beites CL, 2005, BIOCHEM J, V385, P347, DOI 10.1042/BJ20041090; Beites CL, 1999, NAT NEUROSCI, V2, P434, DOI 10.1038/8100; Blaser S, 2006, J PATHOL, V210, P103, DOI 10.1002/path.2013; Caltagarone J, 1998, NEUROREPORT, V9, P2907, DOI 10.1097/00001756-199808240-00042; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Chandra D, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-30; Charych EI, 2004, J BIOL CHEM, V279, P38978, DOI 10.1074/jbc.M405786200; Charych EI, 2004, J NEUROCHEM, V90, P173, DOI 10.1111/j.1471-4159.2004.02481.x; Christie SB, 2006, MOL CELL NEUROSCI, V31, P1, DOI 10.1016/j.mcn.2005.08.014; Christie SB, 2003, J COMP NEUROL, V456, P361, DOI 10.1002/cne.10535; Christie SB, 2002, NEUROREPORT, V13, P2355, DOI 10.1097/00001756-200212030-00037; Christie SB, 2002, PROG BRAIN RES, V136, P157; Christie SB, 2002, J NEUROSCI, V22, P684, DOI 10.1523/JNEUROSCI.22-03-00684.2002; COTMAN CW, 1974, J CELL BIOL, V63, P441, DOI 10.1083/jcb.63.2.441; DEBLAS AL, 1983, ANAL BIOCHEM, V133, P214, DOI 10.1016/0003-2697(83)90245-2; DEBLAS AL, 1984, J NEUROSCI, V4, P265; DEBLAS AL, 1988, J NEUROSCI, V8, P602; Dent J, 2002, P NATL ACAD SCI USA, V99, P3064, DOI 10.1073/pnas.052715199; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Fritschy JM, 2006, J NEUROSCI, V26, P3245, DOI 10.1523/JNEUROSCI.5118-05.2006; Fujishima K, 2007, J NEUROCHEM, V102, P77, DOI 10.1111/j.1471-4159.2007.04478.x; GOSLIN K, 1998, CULTURING NERVE CELL; Hanai N, 2004, FEBS LETT, V568, P83, DOI 10.1016/j.febslet.2004.05.030; Homanics GE, 1999, NEUROPHARMACOLOGY, V38, P253, DOI 10.1016/S0028-3908(98)00177-4; Hsu SC, 1998, NEURON, V20, P1111, DOI 10.1016/S0896-6273(00)80493-6; Ihara M, 2007, NEURON, V53, P519, DOI 10.1016/j.neuron.2007.01.019; Ito H, 2005, ONCOGENE, V24, P7064, DOI 10.1038/sj.onc.1208862; Joo E, 2005, TRAFFIC, V6, P626, DOI 10.1111/j.1600-0854.2005.00305.x; Kartmann B, 2001, J CELL SCI, V114, P839; Kawasaki BT, 1997, J NEUROSCI RES, V49, P381, DOI 10.1002/(SICI)1097-4547(19970801)49:3<381::AID-JNR13>3.0.CO;2-2; Kinoshita A, 2000, J COMP NEUROL, V428, P223, DOI 10.1002/1096-9861(20001211)428:2<223::AID-CNE3>3.0.CO;2-M; Kinoshita A, 1998, AM J PATHOL, V153, P1551, DOI 10.1016/S0002-9440(10)65743-4; Kinoshita M, 2006, CURR OPIN CELL BIOL, V18, P54, DOI 10.1016/j.ceb.2005.12.005; Kinoshita M, 2003, J BIOCHEM, V134, P491, DOI 10.1093/jb/mvg182; Kremer BE, 2005, MOL BIOL CELL, V16, P4648, DOI 10.1091/mbc.E05-03-0267; Kremer BE, 2007, CELL, V130, P837, DOI 10.1016/j.cell.2007.06.053; Kuhlenbaumer G, 2005, NAT GENET, V37, P1044, DOI 10.1038/ng1649; Li RW, 2005, J COMP NEUROL, V488, P11, DOI 10.1002/cne.20566; Li RW, 2005, J NEUROCHEM, V95, P756, DOI 10.1111/j.1471-4159.2005.03426.x; Li X, 2007, J NEUROCHEM, V102, P1329, DOI 10.1111/j.1471-4159.2007.04635.x; Longtine MS, 2003, TRENDS CELL BIOL, V13, P403, DOI 10.1016/S0962-8924(03)00151-X; Lukoyanova N, 2008, J MOL BIOL, V376, P1, DOI 10.1016/j.jmb.2007.11.029; Miralles CP, 1999, J COMP NEUROL, V413, P535; MORENO JI, 1994, J COMP NEUROL, V350, P260, DOI 10.1002/cne.903500209; Nagata K, 2004, J BIOL CHEM, V279, P55895, DOI 10.1074/jbc.M406153200; Nusser Z, 1998, J NEUROSCI, V18, P1693; Ono R, 2005, MOL CELL BIOL, V25, P10965, DOI 10.1128/MCB.25.24.10965-10978.2005; Peng XR, 2002, MOL CELL BIOL, V22, P378, DOI 10.1128/MCB.22.1.378-387.2002; Riquelme R, 2002, J NEUROSCI, V22, P10720; Rodal AA, 2005, MOL BIOL CELL, V16, P372, DOI 10.1091/mbc.e04-08-0734; Serwanski DR, 2006, J COMP NEUROL, V499, P458, DOI 10.1002/cne.21115; SHOLL DA, 1953, J ANAT, V87, P387; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Son JH, 2005, J NEUROCHEM, V94, P1040, DOI 10.1111/j.1471-4159.2005.03257.x; Sudo K, 2007, HUM MUTAT, V28, P1005, DOI 10.1002/humu.20554; Tada T, 2007, CURR BIOL, V17, P1752, DOI 10.1016/j.cub.2007.09.039; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Vrabioiu AM, 2006, NATURE, V443, P466, DOI 10.1038/nature05109; Walikonis RS, 2000, J NEUROSCI, V20, P4069; Xie YL, 2007, CURR BIOL, V17, P1746, DOI 10.1016/j.cub.2007.08.042; Xue J, 2004, J NEUROCHEM, V91, P579, DOI 10.1111/j.1471-4159.2004.02755.x; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Yu W, 2007, MOL CELL NEUROSCI, V36, P484, DOI 10.1016/j.mcn.2007.08.008	66	42	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17253	17265		10.1074/jbc.M109.008870	http://dx.doi.org/10.1074/jbc.M109.008870			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19380581	Green Published, hybrid			2022-12-25	WOS:000266962400062
J	Bunda, S; Wang, YT; Mitts, TF; Liu, P; Arab, S; Arabkhari, M; Hinek, A				Bunda, Severa; Wang, Yanting; Mitts, Thomas F.; Liu, Peter; Arab, Sara; Arabkhari, Majid; Hinek, Aleksander			Aldosterone Stimulates Elastogenesis in Cardiac Fibroblasts via Mineralocorticoid Receptor-independent Action Involving the Consecutive Activation of G alpha(13), c-Src, the Insulin-like Growth Factor-I Receptor, and Phosphatidylinositol 3-Kinase/Akt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; CONGESTIVE-HEART-FAILURE; COLLAGEN GENE-EXPRESSION; ANGIOTENSIN-II; AUTOPHOSPHORYLATION SITES; REGULATES TRANSCRIPTION; ESTROGEN-RECEPTOR; BINDING PROTEIN; KINASE-ACTIVITY; ELASTIN GENE	We previously demonstrated that aldosterone, which stimulates collagen production through the mineralocorticoid receptor (MR)-dependent pathway, also induces elastogenesis via a parallel MR-independent mechanism involving insulin-like growth factor-I receptor (IGF-IR) signaling. The present study provides a more detailed explanation of this signaling pathway. Our data demonstrate that small interfering RNA-driven elimination of MR in cardiac fibroblasts does not inhibit aldosterone-induced IGF-IR phosphorylation and subsequent increase in elastin production. These results exclude the involvement of the MR in aldosterone-induced increases in elastin production. Results of further experiments aimed at identifying the upstream signaling component(s) that might be activated by aldosterone also eliminate the putative involvement of pertussis toxin-sensitive G alpha(i) proteins, which have previously been shown to be responsible for some MR-independent effects of aldosterone. Instead, we found that small interfering RNA-dependent elimination of another heterotrimeric G protein, G alpha(13), eliminates aldosterone-induced elastogenesis. We further demonstrate that aldosterone first engages G alpha(13) and then promotes its transient interaction with c-Src, which constitutes a prerequisite step for aldosterone-dependent activation of the IGF-IR and propagation of consecutive downstream elastogenic signaling involving phosphatidylinositol 3-kinase/Akt. In summary, the data we present reveal new details of an MR-independent cellular signaling pathway through which aldosterone stimulates elastogenesis in human cardiac fibroblasts.	[Bunda, Severa; Wang, Yanting; Mitts, Thomas F.; Arabkhari, Majid; Hinek, Aleksander] Univ Toronto, Hosp Sick Children, Dept Lab Med & Pathobiol, Physiol & Expt Med Program, Toronto, ON M5G 1X8, Canada; [Liu, Peter; Hinek, Aleksander] Univ Toronto, Heart & Stroke Richard Lewar Ctr Excellence, Toronto, ON M5G 1X8, Canada; [Liu, Peter; Arab, Sara] Univ Hlth Network, Toronto Gen Hosp, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Hinek, A (corresponding author), Univ Toronto, Hosp Sick Children, Dept Lab Med & Pathobiol, Physiol & Expt Med Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	alek.hinek@sickkids.ca	Hinek, Aleksander/V-8790-2019		Canadian Institute of Health Research [PG 13920]; Heart and Stroke Foundation of Ontario [NA 5435, NA 4381]; Career Investigator Award [CI 4198]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Career Investigator Award	This work was supported by the Canadian Institute of Health Research through Grant PG 13920, by the Heart and Stroke Foundation of Ontario through Grants NA 5435 and NA 4381, and by Career Investigator Award CI 4198 (to A.H.).	Adarichev VA, 2003, AM J PHYSIOL-CELL PH, V285, pC922, DOI 10.1152/ajpcell.00115.2003; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; ANDO A, 1992, J BIOL CHEM, V267, P12788; Arima S, 2006, STEROIDS, V71, P281, DOI 10.1016/j.steroids.2005.09.013; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bohmer S, 2006, BIOL CHEM, V387, P917, DOI 10.1515/BC.2006.116; BRILLA CG, 1993, AM J CARDIOL, V71, pA12, DOI 10.1016/0002-9149(93)90239-9; Bunda S, 2007, AM J PATHOL, V171, P809, DOI 10.2353/ajpath.2007.070101; Chai WX, 2005, HYPERTENSION, V46, P701, DOI 10.1161/01.HYP.0000182661.98259.4f; CHRIST M, 1994, MOL CELL ENDOCRINOL, V99, pR31, DOI 10.1016/0303-7207(94)90027-2; Coles JG, 2005, J THORAC CARDIOV SUR, V129, P1128, DOI 10.1016/j.jtcvs.2004.11.055; Conn KJ, 1996, J BIOL CHEM, V271, P28853, DOI 10.1074/jbc.271.46.28853; Connell JMC, 2005, J ENDOCRINOL, V186, P1, DOI 10.1677/joe.1.06017; Dib K, 2001, J IMMUNOL, V166, P6311, DOI 10.4049/jimmunol.166.10.6311; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; EISEN C, 1994, CELL MOL BIOL, V40, P351; ERLANGER BF, 1957, J BIOL CHEM, V228, P713; Filardo EJ, 2008, STEROIDS, V73, P870, DOI 10.1016/j.steroids.2007.12.025; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Gekle M, 1998, J PHYSIOL-LONDON, V511, P255, DOI 10.1111/j.1469-7793.1998.255bi.x; Gustafsson AB, 2000, MOL PHARMACOL, V58, P1470, DOI 10.1124/mol.58.6.1470; Hafizi S, 1998, CIRCULATION, V98, P2553, DOI 10.1161/01.CIR.98.23.2553; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Haseroth K, 1999, BIOCHEM BIOPH RES CO, V266, P257, DOI 10.1006/bbrc.1999.1771; HINEK A, 1993, J BIOL CHEM, V268, P1405; HINEK A, 1994, J CELL BIOL, V126, P563, DOI 10.1083/jcb.126.2.563; HINEK A, 1993, J CLIN INVEST, V91, P1198, DOI 10.1172/JCI116280; Jennings DL, 2005, PHARMACOTHERAPY, V25, P1126, DOI 10.1592/phco.2005.25.8.1126; JENSEN DE, 1995, J BIOL CHEM, V270, P6555, DOI 10.1074/jbc.270.12.6555; JI H, 1994, J BIOL CHEM, V269, P16533; Jiang XY, 2007, ACTA CARDIOL, V62, P429, DOI 10.2143/AC.62.5.2023404; Jiang YX, 1996, J BIOL CHEM, V271, P160, DOI 10.1074/jbc.271.1.160; Karni R, 2003, FEBS LETT, V537, P47, DOI 10.1016/S0014-5793(03)00069-3; Kim M, 2006, BIOCHEM BIOPH RES CO, V339, P271, DOI 10.1016/j.bbrc.2005.11.014; Kim S, 2006, BLOOD, V107, P947, DOI 10.1182/blood-2005-07-3040; Klages B, 1999, J CELL BIOL, V144, P745, DOI 10.1083/jcb.144.4.745; Krumins AM, 2006, J BIOL CHEM, V281, P10250, DOI 10.1074/jbc.M511551200; Kuang PP, 2007, AM J PHYSIOL-LUNG C, V292, pL944, DOI 10.1152/ajplung.00184.2006; Kurose H, 2003, LIFE SCI, V74, P155, DOI 10.1016/j.lfs.2003.09.003; Le Moellic C, 2004, J AM SOC NEPHROL, V15, P1145; LEROITH D, 1995, ENDOCR REV, V16, P143, DOI 10.1210/er.16.2.143; Li JZ, 1996, BLOOD, V88, P417, DOI 10.1182/blood.V88.2.417.bloodjournal882417; Li L, 2003, CRIT REV ORAL BIOL M, V14, P100, DOI 10.1177/154411130301400204; LIU DL, 1993, J VIROL, V67, P6835, DOI 10.1128/JVI.67.11.6835-6840.1993; Losel RM, 2008, FRONT NEUROENDOCRIN, V29, P258, DOI 10.1016/j.yfrne.2007.09.002; Mazak I, 2004, CIRCULATION, V109, P2792, DOI 10.1161/01.CIR.0000131860.80444.AB; MEYER C, 1995, EUR J BIOCHEM, V229, P736, DOI 10.1111/j.1432-1033.1995.tb20521.x; Mihailidou AS, 2006, STEROIDS, V71, P277, DOI 10.1016/j.steroids.2005.09.017; Minuz P, 2006, BIOCHEM J, V400, P127, DOI 10.1042/BJ20061015; Mita MM, 2003, CANCER BIOL THER, V2, pS169; Nagai Y, 2005, HYPERTENSION, V46, P1039, DOI 10.1161/01.HYP.0000174593.88899.68; NAKAMURA I, 1995, FEBS LETT, V361, P79, DOI 10.1016/0014-5793(95)00153-Z; Nishida M, 2007, J BIOL CHEM, V282, P23117, DOI 10.1074/jbc.M611780200; Peterson JE, 1996, J BIOL CHEM, V271, P31562, DOI 10.1074/jbc.271.49.31562; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Rodems SM, 1998, J VIROL, V72, P9173, DOI 10.1128/JVI.72.11.9173-9180.1998; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Shi CS, 2000, J BIOL CHEM, V275, P24470, DOI 10.1074/jbc.M908449199; Simoncini T, 2006, MOL ENDOCRINOL, V20, P1756, DOI 10.1210/me.2005-0259; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Urbach V, 2001, J PHYSIOL-LONDON, V537, P267, DOI 10.1111/j.1469-7793.2001.0267k.x; WEBER KT, 1991, CIRCULATION, V83, P1849, DOI 10.1161/01.CIR.83.6.1849; WEHLING M, 1992, MOL CELL ENDOCRINOL, V90, pC5, DOI 10.1016/0303-7207(92)90092-K; WIDDOP RE, 1993, AM J PHYSIOL, V265, pH226, DOI 10.1152/ajpheart.1993.265.1.H226; WILDLING L, 2009, PFLUGERS AR IN PRESS; WOLFE BL, 1993, J BIOL CHEM, V268, P12418; Xiao F, 2004, HYPERTENSION, V44, P340, DOI 10.1161/01.HYP.0000140771.21243.ed; Yamaguchi Y, 2003, J BIOL CHEM, V278, P14936, DOI 10.1074/jbc.M301409200; Yanazume T, 2002, J BIOL CHEM, V277, P8618, DOI 10.1074/jbc.M107924200; YANO H, 1993, J BIOL CHEM, V268, P25846; YOUNG M, 1994, J CLIN INVEST, V93, P2578, DOI 10.1172/JCI117269; Zannad F, 2000, CIRCULATION, V102, P2700, DOI 10.1161/01.CIR.102.22.2700; Zannad F, 2001, HYPERTENSION, V38, P1227, DOI 10.1161/hy1101.099484; Zhou GP, 1996, MOL CELL BIOCHEM, V154, P171, DOI 10.1007/BF00226785; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2231, DOI 10.1073/pnas.0336132100; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2237, DOI 10.1073/pnas.0436133100	78	43	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16633	16647		10.1074/jbc.M109.008748	http://dx.doi.org/10.1074/jbc.M109.008748			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19372600	Green Published, hybrid			2022-12-25	WOS:000266730900059
J	Olsson, M; Tang, KW; Persson, C; Wilhelmsson, LM; Billeter, M; Elias, P				Olsson, Monica; Tang, Ka-Wei; Persson, Cecilia; Wilhelmsson, L. Marcus; Billeter, Martin; Elias, Per			Stepwise Evolution of the Herpes Simplex Virus Origin Binding Protein and Origin of Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CERCOPITHECINE HERPESVIRUS-1 GENOME; TYPE-1 DNA-REPLICATION; SEQUENCE REQUIREMENTS; PRIMATE HERPESVIRUSES; GENETIC ARRANGEMENT; VIRAL ORIGIN; UL9; DOMAIN; ICP8; ORIS	The herpes simplex virus replicon consists of cis-acting sequences, oriS and oriL, and the origin binding protein (OBP) encoded by the UL9 gene. Here we identify essential structural features in the initiator protein OBP and the replicator sequence oriS, and we relate the appearance of these motifs to the evolutionary history of the alphaherpesvirus replicon. Our results reveal two conserved sequence elements in herpes simplex virus type 1, OBP; the RVKNL motif, common to and specific for all alphaherpesviruses, is required for DNA binding, and the WPXXXGAXXFXXL motif, found in a subset of alphaherpesviruses, is required for specific binding to the single strand DNA-binding protein ICP8. A 121-amino acid minimal DNA binding domain containing conserved residues is not soluble and does not bind DNA. Additional sequences present 220 amino acids upstream from the RVKNL motif are needed for solubility and function. We also examine the binding sites for OBP in origins of DNA replication and how they are arranged. NMR and DNA melting experiments demonstrate that origin sequences derived from many, but not all, alphaherpesviruses can adopt stable boxI/boxIII hairpin conformations. Our results reveal a stepwise evolutionary history of the herpes simplex virus replicon and suggest that replicon divergence contributed to the formation of major branches of the herpesvirus family.	[Olsson, Monica; Tang, Ka-Wei; Elias, Per] Univ Gothenburg, Inst Biomed, Dept Med Biochem & Cell Biol, Sahlgrenska Acad, S-40530 Gothenburg, Sweden; [Persson, Cecilia] Univ Gothenburg, Swedish NMR Ctr, S-40530 Gothenburg, Sweden; [Wilhelmsson, L. Marcus] Chalmers, Dept Chem & Biol Engn Phys Chem, S-41296 Gothenburg, Sweden; [Billeter, Martin] Univ Gothenburg, Dept Chem, Biophys Grp, S-40530 Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; Chalmers University of Technology; University of Gothenburg	Elias, P (corresponding author), Univ Gothenburg, Inst Biomed, Dept Med Biochem & Cell Biol, Sahlgrenska Acad, Box 440, S-40530 Gothenburg, Sweden.	per.elias@medkem.gu.es	Wilhelmsson, Marcus/A-9165-2008; Billeter, Martin/A-8293-2010	Wilhelmsson, Marcus/0000-0002-2193-6639; Tang, Ka-Wei/0000-0003-1189-5092	Swedish Cancer Foundation; The Swedish Research Council; Sahlgrenska University Hospital Lakarutbildningsavtal	Swedish Cancer Foundation; The Swedish Research Council(Swedish Research Council); Sahlgrenska University Hospital Lakarutbildningsavtal	This work was supported by grants from the Swedish Cancer Foundation, The Swedish Research Council, and the Sahlgrenska University Hospital Lakarutbildningsavtal.	ARBUCKLE MI, 1993, J GEN VIROL, V74, P1349, DOI 10.1099/0022-1317-74-7-1349; Aslani A, 2000, J BIOL CHEM, V275, P5880, DOI 10.1074/jbc.275.8.5880; Aslani A, 2002, J BIOL CHEM, V277, P41204, DOI 10.1074/jbc.M208270200; Aslani A, 2001, P NATL ACAD SCI USA, V98, P7194, DOI 10.1073/pnas.121177198; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; BLUMEL J, 1995, J GEN VIROL, V76, P3119, DOI 10.1099/0022-1317-76-12-3119; BOEHMER PE, 1994, J BIOL CHEM, V269, P29329; BOEHMER PE, 1993, P NATL ACAD SCI USA, V90, P8444, DOI 10.1073/pnas.90.18.8444; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; CHEN D, 1995, J VIROL, V69, P4515, DOI 10.1128/JVI.69.7.4515-4518.1995; Davison AJ, 2009, ARCH VIROL, V154, P171, DOI 10.1007/s00705-008-0278-4; DEB S, 1991, J VIROL, V65, P2829, DOI 10.1128/JVI.65.6.2829-2838.1991; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dykes C, 1997, J GEN VIROL, V78, P1125, DOI 10.1099/0022-1317-78-5-1125; ELIAS P, 1986, P NATL ACAD SCI USA, V83, P6322, DOI 10.1073/pnas.83.17.6322; ELIAS P, 1990, J BIOL CHEM, V265, P17167; Falkenberg M, 2000, P NATL ACAD SCI USA, V97, P3896, DOI 10.1073/pnas.97.8.3896; Guntert Peter, 2004, Methods Mol Biol, V278, P353; GUSTAFSSON CM, 1995, J BIOL CHEM, V270, P19028, DOI 10.1074/jbc.270.32.19028; Hammarsten O, 1997, NUCLEIC ACIDS RES, V25, P1753, DOI 10.1093/nar/25.9.1753; HAZUDA DJ, 1991, J BIOL CHEM, V266, P24621; Herbst L, 2004, CURR BIOL, V14, pR697, DOI 10.1016/j.cub.2004.08.040; HERNANDEZ TR, 1991, J VIROL, V65, P1649, DOI 10.1128/JVI.65.3.1649-1652.1991; KNIPE DM, 2007, FIELDS VIROLOGY, P2479; Krug LT, 2001, VIROLOGY, V288, P145, DOI 10.1006/viro.2001.1066; Krug LT, 2001, J VIROL, V75, P3925, DOI 10.1128/JVI.75.8.3925-3936.2001; Lehman IR, 1999, J BIOL CHEM, V274, P28059, DOI 10.1074/jbc.274.40.28059; Macao B, 2004, J BIOL CHEM, V279, P29211, DOI 10.1074/jbc.M400371200; Makhov AM, 2003, P NATL ACAD SCI USA, V100, P898, DOI 10.1073/pnas.0237171100; MARKY LA, 1987, BIOPOLYMERS, V26, P1601, DOI 10.1002/bip.360260911; MARTIN DW, 1991, J VIROL, V65, P4359, DOI 10.1128/JVI.65.8.4359-4369.1991; MARTIN DW, 1994, VIROLOGY, V198, P71, DOI 10.1006/viro.1994.1009; Muylaert I, 2007, J BIOL CHEM, V282, P10865, DOI 10.1074/jbc.M611834200; Ohsawa K, 2003, ARCH VIROL, V148, P989, DOI 10.1007/s00705-003-0011-2; Ohsawa K, 2002, J VIROL, V76, P1516, DOI 10.1128/JVI.76.3.1516-1520.2002; Perelygina L, 2003, J VIROL, V77, P6167, DOI 10.1128/JVI.77.11.6167-6177.2003; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; SCHEFFLE.IE, 1968, J MOL BIOL, V36, P291, DOI 10.1016/0022-2836(68)90156-3; Schildgen O, 2005, J VIROL, V79, P7273, DOI 10.1128/JVI.79.11.7273-7278.2005; Simonsson S, 1998, J BIOL CHEM, V273, P24633, DOI 10.1074/jbc.273.38.24633; Stacy BA, 2008, VET MICROBIOL, V126, P63, DOI 10.1016/j.vetmic.2007.07.002; STOW ND, 1986, J GEN VIROL, V67, P1613, DOI 10.1099/0022-1317-67-8-1613; STOW ND, 1990, VIROLOGY, V177, P570, DOI 10.1016/0042-6822(90)90522-S; Stow ND, 1998, VIROLOGY, V240, P183, DOI 10.1006/viro.1997.8910; Strang BL, 2005, J VIROL, V79, P12487, DOI 10.1128/JVI.79.19.12487-12494.2005; Thureen DR, 2006, J VIROL, V80, P7863, DOI 10.1128/JVI.00134-06; WEIR HM, 1989, NUCLEIC ACIDS RES, V17, P1409, DOI 10.1093/nar/17.4.1409; WEIR HM, 1990, J GEN VIROL, V71, P1379, DOI 10.1099/0022-1317-71-6-1379; XODO LE, 1988, BIOCHEMISTRY-US, V27, P6321, DOI 10.1021/bi00417a018	49	16	16	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16246	16255		10.1074/jbc.M807551200	http://dx.doi.org/10.1074/jbc.M807551200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19351883	hybrid, Green Published			2022-12-25	WOS:000266730900022
J	Jerga, A; Rock, CO				Jerga, Agoston; Rock, Charles O.			Acyl-Acyl Carrier Protein Regulates Transcription of Fatty Acid Biosynthetic Genes via the FabT Repressor in Streptococcus pneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; FACTOR FADR; LIPID BIOSYNTHESIS; STRUCTURAL BASIS; BINDING; COENZYME; METABOLISM; INHIBITION; MECHANISM; BACTERIA	Long-chain acyl-acyl carrier proteins (acyl-ACP) are established biochemical regulators of bacterial type II fatty acid synthases due to their ability to feedback-inhibit the early steps in the biosynthetic pathway. In Streptococcus pneumoniae, the expression of the fatty acid synthase (fab) genes is controlled by a helix-turn-helix transcriptional repressor called FabT. A screen of pathway intermediates identified acyl-ACP as a ligand that increased the affinity of FabT for DNA. FabT bound to a wide range of acyl-ACP chain lengths in the absence of DNA, but only the long-chain acyl-ACPs increase the affinity of FabT for DNA. FabT affinity for DNA increased with increasing acyl-ACP chain length with cis-vaccenoyl-ACP being the most effective ligand. Thus, FabT is a new ACP-interacting partner that acts as a transcriptional rheostat to fine tune the expression of the fab genes based on the demand for fatty acids.	[Jerga, Agoston; Rock, Charles O.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Rock, CO (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	charles.rock@stjude.org			National Institutes of Health [GM34496]; Cancer Center (CORE) Support Grant [CA21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034496, R37GM034496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center (CORE) Support Grant; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM34496, Cancer Center (CORE) Support Grant CA21765, and the American Lebanese Syrian Associated Charities.	ALBERTS AW, 1972, J BIOL CHEM, V247, P3190; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Campbell JW, 2001, J BACTERIOL, V183, P5982, DOI 10.1128/JB.183.20.5982-5990.2001; Cronan JE, 1997, J BACTERIOL, V179, P1819, DOI 10.1128/jb.179.5.1819-1823.1997; CRONAN JE, 2008, ESCHERICHIA COLI SAL; Davis MS, 2001, J BACTERIOL, V183, P1499, DOI 10.1128/JB.183.4.1499-1503.2001; DiRusso CC, 1998, J BIOL CHEM, V273, P33652, DOI 10.1074/jbc.273.50.33652; DIRUSSO CC, 1992, J BIOL CHEM, V267, P8685; DIRUSSO CC, 1985, J BACTERIOL, V161, P583, DOI 10.1128/JB.161.2.583-588.1985; Heath RJ, 2000, NATURE, V406, P145, DOI 10.1038/35018162; Heath RJ, 1996, J BIOL CHEM, V271, P10996, DOI 10.1074/jbc.271.18.10996; Heath RJ, 1999, J BIOL CHEM, V274, P11110, DOI 10.1074/jbc.274.16.11110; HELMKAMP GM, 1968, J BIOL CHEM, V243, P3229; HENRY MF, 1992, CELL, V70, P671, DOI 10.1016/0092-8674(92)90435-F; HENRY MF, 1991, J MOL BIOL, V222, P843, DOI 10.1016/0022-2836(91)90574-P; JACKOWSKI S, 1983, J BIOL CHEM, V258, P5186; Jerga A, 2009, J BIOL CHEM, V284, P7246, DOI 10.1074/jbc.M805962200; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Lishanski A, 2000, Nucleic Acids Res, V28, pE42, DOI 10.1093/nar/28.9.e42; Lu YJ, 2006, MOL CELL, V23, P765, DOI 10.1016/j.molcel.2006.06.030; Lu YJ, 2006, MOL MICROBIOL, V59, P551, DOI 10.1111/j.1365-2958.2005.04951.x; Marrakchi H, 2002, J BIOL CHEM, V277, P44809, DOI 10.1074/jbc.M208920200; McCue LA, 2001, NUCLEIC ACIDS RES, V29, P774, DOI 10.1093/nar/29.3.774; OVERATH P, 1969, EUR J BIOCHEM, V7, P559; RAMAN N, 1995, J BIOL CHEM, V270, P1092, DOI 10.1074/jbc.270.3.1092; ROCK CO, 1979, J BIOL CHEM, V254, P7123; Rock CO, 2002, BIOCHEM BIOPH RES CO, V292, P1155, DOI 10.1006/bbrc.2001.2022; Schujman GE, 2005, CURR OPIN MICROBIOL, V8, P149, DOI 10.1016/j.mib.2005.02.003; Schujman GE, 2003, DEV CELL, V4, P663, DOI 10.1016/S1534-5807(03)00123-0; Schujman GE, 2008, MOL MICROBIOL, V68, P987, DOI 10.1111/j.1365-2958.2008.06202.x; Schujman GE, 2006, EMBO J, V25, P4074, DOI 10.1038/sj.emboj.7601284; ULLMAN EF, 1994, P NATL ACAD SCI USA, V91, P5426, DOI 10.1073/pnas.91.12.5426; van Aalten DMF, 2000, EMBO J, V19, P5167, DOI 10.1093/emboj/19.19.5167; van Aalten DMF, 2001, EMBO J, V20, P2041, DOI 10.1093/emboj/20.8.2041; Xu YB, 2001, J BIOL CHEM, V276, P17373, DOI 10.1074/jbc.M100195200; Zhang YM, 2002, J BIOL CHEM, V277, P15558, DOI 10.1074/jbc.M201399200; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839; Zhang YM, 2007, MOL MICROBIOL, V66, P622, DOI 10.1111/j.1365-2958.2007.05934.x; Zhang YM, 2009, J LIPID RES, V50, pS115, DOI 10.1194/jlr.R800046-JLR200	39	46	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15364	15368		10.1074/jbc.C109.002410	http://dx.doi.org/10.1074/jbc.C109.002410			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19376778	hybrid, Green Published			2022-12-25	WOS:000266501000004
J	Lehtinen, MJ; Rops, AL; Isenman, DE; van der Vlag, J; Jokiranta, TS				Lehtinen, Markus J.; Rops, Angelique L.; Isenman, David E.; van der Vlag, Johan; Jokiranta, T. Sakari			Mutations of Factor H Impair Regulation of Surface-bound C3b by Three Mechanisms in Atypical Hemolytic Uremic Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEMENT FACTOR-H; HEPARIN-BINDING DOMAIN; SHORT CONSENSUS REPEAT; ENDOTHELIAL-CELLS; PROTEIN BETA-1H; 3RD COMPONENT; FACTOR H-1; FACTOR-B; RECOGNITION; SITE	Atypical hemolytic uremic syndrome (aHUS) is a thrombotic microangiopathy associated with mutations in complement proteins, most frequently in the main plasma alternative pathway regulator factorH(FH). The hotspot for the FH mutations is in domains 19-20 (FH19-20) that are indispensable for FH activity on C3b bound covalently to host cells. In aHUS, down-regulation of cell-bound C3b by FH is impaired, but it is not clear whether this is due to an altered FH binding to surface-bound C3b or to cell surface structures. To explore the molecular pathogenesis of aHUS we tested binding of 14 FH19-20 point mutants to C3b and its C3d fragment, mouse glomerular endothelial cells (mGEnC-1), and heparin. The cell binding correlated well, but not fully, with heparin binding and the cell binding site was overlapping but distinct from the C3b/C3d binding site that was shown to extend to domain 19. Our results show that aHUS-associated FH19-20 mutants have different combinations of three primary defects: impaired binding to C3b/C3d, impaired binding to the mGEnC-1 cells/heparin, and, as a novel observation, an enhanced mGEnC-1 cell or heparin binding. We propose a model of the molecular pathogenesis of aHUS where all three mechanisms lead eventually to impaired control of C3b on the endothelial cell surfaces. Based on the results with the aHUS patient mutants and the overlap in FH19-20 binding sites for mGEnC-1/heparin and C3b/C3d we conclude that binding of FH19-20 to C3b/C3d is essential for target discrimination by the alternative pathway.	[Lehtinen, Markus J.; Jokiranta, T. Sakari] Univ Helsinki, Dept Bacteriol & Immunol, Haartman Inst, FIN-00290 Helsinki, Finland; [Rops, Angelique L.; van der Vlag, Johan] Radboud Univ Nijmegen, Med Ctr, Div Nephrol, Nijmegen Ctr Mol Life Sci,Nephrol Res Lab, NL-6500 HB Nijmegen, Netherlands; [Isenman, David E.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Helsinki; Radboud University Nijmegen; University of Toronto	Lehtinen, MJ (corresponding author), Univ Helsinki, POB 21,Haartmaninkatu 3, FIN-00014 Helsinki, Finland.	markus.j.lehtinen@helsinki.fi	Van der Vlag, Johan/E-4636-2010; Jokiranta, T. Sakari/F-1906-2011	Van der Vlag, Johan/0000-0001-7843-5918; 	Academy of Finland Projects [201506, 202529]; Sigrid Juselius Foundation; Dutch Kidney Foundation [C05.2152]; Helsinki University Central Hospital Funds	Academy of Finland Projects(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Dutch Kidney Foundation; Helsinki University Central Hospital Funds	This work was supported in part by the Academy of Finland Projects 201506 and 202529, The Sigrid Juselius Foundation, Dutch Kidney Foundation Grant C05.2152, and The Helsinki University Central Hospital Funds.	Blackmore TK, 1996, J IMMUNOL, V157, P5422; Blackmore TK, 1998, J IMMUNOL, V160, P3342; Cheng ZZ, 2006, MOL IMMUNOL, V43, P972, DOI 10.1016/j.molimm.2005.05.011; de Jorge EG, 2007, P NATL ACAD SCI USA, V104, P240, DOI 10.1073/pnas.0603420103; Ferreira VP, 2006, J IMMUNOL, V177, P6308, DOI 10.4049/jimmunol.177.9.6308; Fremeaux-Bacchi V, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.019083; Fremeaux-Bacchi V, 2008, BLOOD, V112, P4948, DOI 10.1182/blood-2008-01-133702; GORDON DL, 1995, J IMMUNOL, V155, P348; HARRISON RA, 1980, MOL IMMUNOL, V17, P219, DOI 10.1016/0161-5890(80)90074-7; HARRISON RA, 1980, MOL IMMUNOL, V17, P9, DOI 10.1016/0161-5890(80)90119-4; Hellwage J, 2002, J IMMUNOL, V169, P6935, DOI 10.4049/jimmunol.169.12.6935; Herbert AP, 2006, J BIOL CHEM, V281, P16512, DOI 10.1074/jbc.M513611200; Jarva H, 1999, J IMMUNOL, V163, P3957; Jokiranta TS, 2006, EMBO J, V25, P1784, DOI 10.1038/sj.emboj.7601052; Jokiranta TS, 2000, J BIOL CHEM, V275, P27657; Jokiranta TS, 2005, AM J PATHOL, V167, P1173, DOI 10.1016/S0002-9440(10)61205-9; Jozsi M, 2006, J AM SOC NEPHROL, V17, P170, DOI 10.1681/ASN.2005080868; KAVANAGH D, 2006, BR MED B, V5, P5; KOISTINEN V, 1989, COMPLEMENT INFLAMMAT, V6, P270, DOI 10.1159/000463102; LAW SK, 1977, P NATL ACAD SCI USA, V74, P2701, DOI 10.1073/pnas.74.7.2701; LESAVRE PH, 1978, J EXP MED, V148, P1498, DOI 10.1084/jem.148.6.1498; Manuelian T, 2003, J CLIN INVEST, V111, P1181, DOI 10.1172/JCI200316651; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; Nagar B, 1998, SCIENCE, V280, P1277, DOI 10.1126/science.280.5367.1277; Noris M, 2003, LANCET, V362, P1542, DOI 10.1016/S0140-6736(03)14742-3; Ormsby RJ, 2006, MOL IMMUNOL, V43, P1624, DOI 10.1016/j.molimm.2005.09.012; PANGBURN MK, 1991, J BIOL CHEM, V266, P16847; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; PANGBURN MK, 1978, P NATL ACAD SCI USA, V75, P2416, DOI 10.1073/pnas.75.5.2416; PANGBURN MK, 1981, J EXP MED, V154, P856, DOI 10.1084/jem.154.3.856; Perez-Caballero D, 2001, AM J HUM GENET, V68, P478, DOI 10.1086/318201; Pickering MC, 2007, J EXP MED, V204, P1249, DOI 10.1084/jem.20070301; Richards A, 2003, P NATL ACAD SCI USA, V100, P12966, DOI 10.1073/pnas.2135497100; Richards A, 2001, AM J HUM GENET, V68, P485, DOI 10.1086/318203; Rops AL, 2008, KIDNEY INT, V73, P52, DOI 10.1038/sj.ki.5002573; Rops AL, 2004, KIDNEY INT, V66, P2193, DOI 10.1111/j.1523-1755.2004.66009.x; RUDDY S, 1969, J IMMUNOL, V102, P533; Ruggenenti P, 2001, KIDNEY INT, V60, P831, DOI 10.1046/j.1523-1755.2001.060003831.x; Sanchez-Corral P, 2002, AM J HUM GENET, V71, P1285, DOI 10.1086/344515; Schmidt CQ, 2008, J IMMUNOL, V181, P2610, DOI 10.4049/jimmunol.181.4.2610; SEYA T, 1986, J EXP MED, V163, P837, DOI 10.1084/jem.163.4.837; Vaziri-Sani F, 2006, KIDNEY INT, V69, P981, DOI 10.1038/sj.ki.5000155; Warwicker P, 1998, KIDNEY INT, V53, P836, DOI 10.1111/j.1523-1755.1998.00824.x; WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268; WHALEY K, 1976, J EXP MED, V144, P1147, DOI 10.1084/jem.144.5.1147	45	83	83	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15650	15658		10.1074/jbc.M900814200	http://dx.doi.org/10.1074/jbc.M900814200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19351878	Green Published, hybrid			2022-12-25	WOS:000266501000033
J	Suel, KE; Chook, YM				Sueel, Katherine E.; Chook, Yuh Min			Kap104p Imports the PY-NLS-containing Transcription Factor Tfg2p into the Nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TATA-BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; NUCLEOCYTOPLASMIC TRANSPORT; LOCALIZATION SIGNALS; CRYSTALLOGRAPHIC ANALYSIS; PREINITIATION COMPLEX; INITIATION COMPLEX; KARYOPHERIN ALPHA; STRUCTURAL BASIS	A previous bioinformatics study identified a putative PY-NLS in the yeast transcription factor Tfg2p (Suel, K. E., Gu, H., and Chook, Y. M. (2008) PLoS Biol. 6, e137). In this study, we validate Tfg2p as a Kap104p substrate and examine the energetic organization of its PY-NLS. The Tfg2p PY-NLS can target a heterologous protein into the cell nucleus through interactions with Kap104p. Surprisingly, full-length Tfg2p is still localized to the nucleus of Kap104p temperature-sensitive cells and, similarly, Tfg2p with a mutated PY-NLS is nuclear in wild-type cells. Other Karyopherin beta s (Kap beta s) such as Kap108p and Kap120p also bind Tfg2p and may import it into the nucleus. More importantly, we demonstrate that Tfg2p is retained in the nucleus through DNA binding. Mutations of DNA binding residues relieve nuclear retention and unmask the role of Kap104p in Tfg2p nuclear import. More generally, steady-state localization of a nuclear protein is dictated by its nuclear import and export activities as well as its interactions in the nucleus and the cytoplasm.	[Sueel, Katherine E.; Chook, Yuh Min] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Chook, YM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk, Dallas, TX 75390 USA.	yuhmin.chook@utsouthwestern.edu	Chook, Yuh Min/AAA-9549-2019		National Institutes of Health [R01-GM069909, 5-T32-GM008297]; Welch Foundation [1-1532]; University of Texas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069909, T32GM008297] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); University of Texas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM069909 and 5-T32-GM008297. This work was also supported by Welch Foundation Grant 1-1532 and the University of Texas Southwestern Endowed Scholars Program.	Aitchison JD, 1996, SCIENCE, V274, P624, DOI 10.1126/science.274.5287.624; Albertini M, 1998, J CELL BIOL, V143, P1447, DOI 10.1083/jcb.143.6.1447; Bertolotti A, 1998, MOL CELL BIOL, V18, P1489, DOI 10.1128/MCB.18.3.1489; Brachmann CB, 1998, YEAST, V14, P115; Cardoso MC, 1999, J CELL BIOL, V147, P25, DOI 10.1083/jcb.147.1.25; Catimel B, 2001, J BIOL CHEM, V276, P34189, DOI 10.1074/jbc.M103531200; Chen HT, 2007, NAT STRUCT MOL BIOL, V14, P696, DOI 10.1038/nsmb1272; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Chung WH, 2003, MOL CELL, V12, P1003, DOI 10.1016/S1097-2765(03)00387-3; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Conti E, 2001, CURR OPIN CELL BIOL, V13, P310, DOI 10.1016/S0955-0674(00)00213-1; Damelin M, 2002, METHOD ENZYMOL, V351, P587; Fontes MRM, 2003, J BIOL CHEM, V278, P27981, DOI 10.1074/jbc.M303275200; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Freire-Picos MA, 2005, NUCLEIC ACIDS RES, V33, P5045, DOI 10.1093/nar/gki825; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Gaiser F, 2000, J MOL BIOL, V302, P1119, DOI 10.1006/jmbi.2000.4110; Ghazy MA, 2004, MOL CELL BIOL, V24, P10975, DOI 10.1128/MCB.24.24.10975-10985.2004; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Groft CM, 1998, P NATL ACAD SCI USA, V95, P9117, DOI 10.1073/pnas.95.16.9117; HENRY NL, 1994, GENE DEV, V8, P2868, DOI 10.1101/gad.8.23.2868; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hodel MR, 2001, J BIOL CHEM, V276, P1317, DOI 10.1074/jbc.M008522200; Hodges JL, 2005, MOL BIOL CELL, V16, P3200, DOI 10.1091/mbc.E04-11-0990; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Khaperskyy DA, 2008, MOL CELL BIOL, V28, P3757, DOI 10.1128/MCB.02272-07; Lange A, 2008, J BIOL CHEM, V283, P12926, DOI 10.1074/jbc.M800898200; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Lee DCY, 1999, J BIOL CHEM, V274, P29031, DOI 10.1074/jbc.274.41.29031; Leslie DM, 2004, MOL CELL BIOL, V24, P8487, DOI 10.1128/MCB.24.19.8487-8503.2004; Makhnevych T, 2003, CELL, V115, P813, DOI 10.1016/S0092-8674(03)00986-3; Morehouse H, 1999, P NATL ACAD SCI USA, V96, P12542, DOI 10.1073/pnas.96.22.12542; Mosammaparast N, 2002, J BIOL CHEM, V277, P862, DOI 10.1074/jbc.M106845200; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Mosammaparast N, 2002, EMBO J, V21, P6527, DOI 10.1093/emboj/cdf647; Mosammaparast N, 2001, J CELL BIOL, V153, P251, DOI 10.1083/jcb.153.2.251; Pemberton LF, 1999, J CELL BIOL, V145, P1407, DOI 10.1083/jcb.145.7.1407; Rout MP, 1997, CELL, V89, P715, DOI 10.1016/S0092-8674(00)80254-8; SIKORSKI RS, 1989, GENETICS, V122, P19; Siomi MC, 1998, MOL CELL BIOL, V18, P4141, DOI 10.1128/MCB.18.7.4141; Suel KE, 2008, PLOS BIOL, V6, P1253, DOI 10.1371/journal.pbio.0060137; TAN SY, 1995, P NATL ACAD SCI USA, V92, P6042, DOI 10.1073/pnas.92.13.6042; Titov AA, 1999, J CELL BIOL, V147, P235, DOI 10.1083/jcb.147.2.235; Truant R, 1998, MOL CELL BIOL, V18, P1449, DOI 10.1128/MCB.18.3.1449; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Yoshida K, 2001, J CELL BIOL, V152, P729, DOI 10.1083/jcb.152.4.729; Ziegler E. C., 2005, SCI STKE, pre6, DOI DOI 10.1126/STKE.2842005RE6	49	22	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15416	15424		10.1074/jbc.M809384200	http://dx.doi.org/10.1074/jbc.M809384200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19366694	Green Published, hybrid			2022-12-25	WOS:000266501000009
J	Hristova, VA; Beasley, SA; Rylett, RJ; Shaw, GS				Hristova, Ventzislava A.; Beasley, Steven A.; Rylett, R. Jane; Shaw, Gary S.			Identification of a Novel Zn2+-binding Domain in the Autosomal Recessive Juvenile Parkinson-related E3 Ligase Parkin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEIN LIGASE; EARLY-ONSET PARKINSONISM; DISEASE GENE-PRODUCT; POINT MUTATIONS; COMPARATIVE GENOMICS; S-NITROSYLATION; RBR FAMILY; RING; FINGER; DEGRADATION	Missense mutations in park2, encoding the parkin protein, account for similar to 50% of autosomal recessive juvenile Parkinson disease (ARJP) cases. Parkin belongs to the family of RBR (RING-between-RING) E3 ligases involved in the ubiquitin-mediated degradation and trafficking of proteins such as Pael-R and synphillin-1. The proposed architecture of parkin, based largely on sequence similarity studies, consists of N-terminal ubiquitin-like and C-terminal RBR domains. These domains are separated by a similar to 160-residue unique parkin sequence having no recognizable domain structure. We used limited proteolysis experiments on bacterially expressed and purified parkin to identify a new domain (RING0) within the unique parkin domain sequence. RING0 comprises two distinct, conserved cysteine-rich clusters between Cys(150)-Cys(169) and Cys(196)-His(215) consisting of CX2-3CX11CX2C and CX4-6CX10-16-CX2(H/C) motifs. The positions of the cysteine/histidine residues in this region bear similarity to parkin RING1 and RING2 domains, as well as other E3 ligase RING domains. However, in parkin a 26-residue linker region separates the motifs, which is not typical of other RING domain structures. Further, the RING0 domain includes all but one of the known ARJP mutation sites between the ubiquitin-like and RBR regions of parkin. Using electrospray ionization mass spectrometry and inductively coupled plasma-atomic emission spectrometry analysis, we determined that the RING0, RING1, IBR, and RING2 domains each bind two Zn2+ ions, the first observation of an E3 ligase with the ability to bind eight metal ions. Removal of the zinc from parkin causes near complete unfolding of the protein, an observation that rationalizes cysteine-based ARJP mutations found throughout parkin, including RING0 (C212Y) that form cellular inclusions and/or are defective for ubiquitination likely because of poor zinc binding and misfolding. The identification of the RING0 domain in parkin provides a new overall domain structure for the protein that will be important in assessing the roles of ARJP mutations and designing experiments aimed at understanding the disease.	[Hristova, Ventzislava A.; Beasley, Steven A.; Shaw, Gary S.] Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada; [Rylett, R. Jane] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada; [Hristova, Ventzislava A.; Rylett, R. Jane] Robarts Res Lab, Mol Brain Res Grp, London, ON N6A 5K8, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Shaw, GS (corresponding author), Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada.	gshaw1@uwo.ca	Rylett, Rebecca Jane/K-3597-2013; Shaw, Gary S./C-7656-2009; Beasley, Steven/B-8106-2019	Rylett, Rebecca Jane/0000-0002-9158-9599; Shaw, Gary S./0000-0002-4685-9625; Beasley, Steven/0000-0002-8702-5651	Canadian Institutes of Health Research; Canada Research Chairs Program; Ontario Graduate and Parkinson's Society of Canada Graduate Scholarships	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); Ontario Graduate and Parkinson's Society of Canada Graduate Scholarships	This work was supported by research grants from the Canadian Institutes of Health Research (to G. S. S. and R.J.R.) and the Canada Research Chairs Program (to G. S. S.) and by Ontario Graduate and Parkinson's Society of Canada Graduate Scholarships (to V. A. H.).	Abbas N, 1999, HUM MOL GENET, V8, P567, DOI 10.1093/hmg/8.4.567; Ardley HC, 2001, J BIOL CHEM, V276, P19640, DOI 10.1074/jbc.M011028200; Beasley SA, 2007, P NATL ACAD SCI USA, V104, P3095, DOI 10.1073/pnas.0610548104; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Capili AD, 2004, J MOL BIOL, V340, P1117, DOI 10.1016/j.jmb.2004.05.035; Choi P, 2003, MOL BRAIN RES, V117, P179, DOI 10.1016/S0169-328X(03)00318-8; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Doss-Pepe EW, 2005, J BIOL CHEM, V280, P16619, DOI 10.1074/jbc.M413591200; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Foroud T, 2003, NEUROLOGY, V60, P796, DOI 10.1212/01.WNL.0000049470.00180.07; Gu WJ, 2003, NEUROBIOL DIS, V14, P357, DOI 10.1016/j.nbd.2003.08.011; Hampe C, 2006, HUM MOL GENET, V15, P2059, DOI 10.1093/hmg/ddl131; Hattori N, 1998, BIOCHEM BIOPH RES CO, V249, P754, DOI 10.1006/bbrc.1998.9134; Hedrich K, 2002, NEUROLOGY, V58, P1239, DOI 10.1212/WNL.58.8.1239; Henn IH, 2005, J NEUROCHEM, V92, P114, DOI 10.1111/j.1471-4159.2004.02854.x; Hennig J, 2008, J MOL BIOL, V377, P431, DOI 10.1016/j.jmb.2008.01.005; Huynh DP, 2003, HUM MOL GENET, V12, P2587, DOI 10.1093/hmg/ddg269; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Jiang HB, 2004, J BIOL CHEM, V279, P54380, DOI 10.1074/jbc.M409282200; Joch M, 2007, MOL BIOL CELL, V18, P3105, DOI 10.1091/mbc.E05-11-1027; Kalia SK, 2004, NEURON, V44, P931, DOI 10.1016/j.neuron.2004.11.026; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lohmann E, 2003, ANN NEUROL, V54, P176, DOI 10.1002/ana.10613; Lucas JI, 2006, J MOL BIOL, V357, P9, DOI 10.1016/j.jmb.2005.12.068; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Marin I, 2004, PHYSIOL GENOMICS, V17, P253, DOI 10.1152/physiolgenomics.00226.2003; Marin I, 2002, MOL BIOL EVOL, V19, P2039, DOI 10.1093/oxfordjournals.molbev.a004029; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; Morett E, 1999, TRENDS BIOCHEM SCI, V24, P229, DOI 10.1016/S0968-0004(99)01381-X; Moynihan TP, 1999, J BIOL CHEM, V274, P30963, DOI 10.1074/jbc.274.43.30963; Niwa J, 2001, BIOCHEM BIOPH RES CO, V281, P706, DOI 10.1006/bbrc.2001.4414; Periquet M, 2003, BRAIN, V126, P1271, DOI 10.1093/brain/awg136; Periquet M, 2001, AM J HUM GENET, V68, P617, DOI 10.1086/318791; Pineda-Trujillo NL, 2001, NEUROSCI LETT, V298, P87, DOI 10.1016/S0304-3940(00)01733-X; Rankin CA, 2001, J BIOMED SCI, V8, P421; Ren Y, 2003, J NEUROSCI, V23, P3316; Roehm PC, 1997, BIOCHEMISTRY-US, V36, P10240, DOI 10.1021/bi970863d; Safadi SS, 2007, BIOCHEMISTRY-US, V46, P14162, DOI 10.1021/bi7016969; Sakata E, 2003, EMBO REP, V4, P301, DOI 10.1038/sj.embor.embor764; Sato S, 2006, EMBO J, V25, P211, DOI 10.1038/sj.emboj.7600774; Satoh J, 1999, NEUROREPORT, V10, P2735, DOI 10.1097/00001756-199909090-00008; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shyu WC, 2005, PARKINSONISM RELAT D, V11, P173, DOI 10.1016/j.parkreldis.2004.12.004; Sriram SR, 2005, HUM MOL GENET, V14, P2571, DOI 10.1093/hmg/ddi292; Tashiro M, 2003, J BIOMOL NMR, V25, P153, DOI 10.1023/A:1022254432039; Tsai YC, 2003, J BIOL CHEM, V278, P22044, DOI 10.1074/jbc.M212235200; Um JW, 2006, J NEUROSCI RES, V84, P1543, DOI 10.1002/jnr.21041; Um JW, 2006, J BIOL CHEM, V281, P3595, DOI 10.1074/jbc.M504994200; Upadhya SC, 2003, TRENDS BIOCHEM SCI, V28, P280, DOI 10.1016/S0968-0004(03)00092-6; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; von Coelln R, 2004, CELL TISSUE RES, V318, P175, DOI 10.1007/s00441-004-0924-4; Wang C, 2005, J NEUROCHEM, V93, P422, DOI 10.1111/j.1471-4159.2005.03023.x; West A, 2002, AM J MED GENET, V114, P584, DOI 10.1002/ajmg.10525; Wong ESP, 2007, J BIOL CHEM, V282, P12310, DOI 10.1074/jbc.M609466200; Yamanaka K, 2003, NAT CELL BIOL, V5, P336, DOI 10.1038/ncb952; Yao DD, 2004, P NATL ACAD SCI USA, V101, P10810, DOI 10.1073/pnas.0404161101; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	61	97	102	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14978	14986		10.1074/jbc.M808700200	http://dx.doi.org/10.1074/jbc.M808700200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19339245	hybrid, Green Published			2022-12-25	WOS:000266288200034
J	Rock, JR; O'Neal, WK; Gabriel, SE; Randell, SH; Harfe, BD; Boucher, RC; Grubb, BR				Rock, Jason R.; O'Neal, Wanda K.; Gabriel, Sherif E.; Randell, Scott H.; Harfe, Brian D.; Boucher, Richard C.; Grubb, Barbara R.			Transmembrane Protein 16A (TMEM16A) Is a Ca2+-regulated Cl- Secretory Channel in Mouse Airways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE LIQUID VOLUME; SMOOTH-MUSCLE-CELLS; CYSTIC-FIBROSIS; CHLORIDE CONDUCTANCE; EXTRACELLULAR ATP; ION-TRANSPORT; CALCIUM; CFTR; MICE; REGULATOR	For almost two decades, it has been postulated that calcium-activated Cl- channels (CaCCs) play a role in airway epithelial Cl- secretion, but until recently, the molecular identity of the airway CaCC(s) was unknown. Recent studies have unequivocally identified TMEM16A as a glandular epithelial CaCC. We have studied the airway bioelectrics of neonatal mice homozygous for a null allele of Tmem16a (Tmem16a(-/-)) to investigate the role of this channel in Cl- secretion in airway surface epithelium. When compared with wild-type tracheas, the Tmem16a(-/-) tracheas exhibited a >60% reduction in purinoceptor (UTP)-regulated CaCC activity. Other members of the Tmem16 gene family, including Tmem16f and Tmem16k, were also detected by reverse transcription-PCR in neonatal tracheal epithelium, suggesting that other family members could be considered as contributing to the small residual UTP response. TMEM16A, however, appeared to contribute little to unstimulated Cl- secretion, whereas studies with cystic fibrosis transmembrane conductance regulator (CFTR)-deficient mice and wild-type littermates revealed that unstimulated Cl- secretion reflected similar to 50% CFTR activity and similar to 50% non-Tmem16a activity. Interestingly, the tracheas of both the Tmem16a(-/-) and the CFTR-/- mice exhibited similar congenital cartilaginous defects that may reflect acommon Cl- secretory defect mediated by the molecularly distinct Cl- channels. Importantly, the residual CaCC activity in Tmem16a(-/-) mice appeared inadequate for normal airway hydration because Tmem16a(-/-) tracheas exhibited significant, neonatal, lumenal mucusaccumulation. Our data suggest that TMEM16A CaCC-mediated Cl- secretion appears to be necessary for normal airway surface liquid homeostasis.	[O'Neal, Wanda K.; Gabriel, Sherif E.; Randell, Scott H.; Boucher, Richard C.; Grubb, Barbara R.] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27708 USA; [Harfe, Brian D.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA	University of North Carolina; University of North Carolina Chapel Hill; Duke University; State University System of Florida; University of Florida	Grubb, BR (corresponding author), Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, 7011 Thurston Bowles Bldg,CB 7248, Chapel Hill, NC 27599 USA.	bgrubb@med.unc.edu			National Institutes of Health [P30 Dk065988, P01-HL034322]; SCCOR NIH [5 P50 HL084934]; Cystic Fibrosis Foundation [CFF R0 26-CR037]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034322, P50HL084934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK065988] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SCCOR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P30 Dk065988, P01-HL034322, and SCCOR NIH 5 P50 HL084934. This work was also supported by RDP Grant CFF R0 26-CR037 from the Cystic Fibrosis Foundation.	Angermann JE, 2006, J GEN PHYSIOL, V128, P73, DOI 10.1085/jgp.200609507; Barro-Soria R, 2008, BBA-MOL CELL RES, V1783, P1993, DOI 10.1016/j.bbamcr.2008.06.016; Bonvin E, 2008, J PHYSIOL-LONDON, V586, P3231, DOI 10.1113/jphysiol.2008.150763; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; CLARKE LL, 1994, P NATL ACAD SCI USA, V91, P479, DOI 10.1073/pnas.91.2.479; Grubb Barbara R, 2002, Methods Mol Med, V70, P525; GRUBB BR, 1994, AM J PHYSIOL, V267, pC293, DOI 10.1152/ajpcell.1994.267.1.C293; GRUBB BR, 2007, PEDIATR PULM, V30, P280; KNOWLES MR, 1991, NEW ENGL J MED, V325, P533, DOI 10.1056/NEJM199108223250802; Kunzelmann K, 2007, PFLUG ARCH EUR J PHY, V454, P879, DOI 10.1007/s00424-007-0245-z; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; MASON SJ, 1991, BRIT J PHARMACOL, V103, P1649, DOI 10.1111/j.1476-5381.1991.tb09842.x; Matthews HR, 2003, CURR OPIN NEUROBIOL, V13, P469, DOI 10.1016/S0959-4388(03)00097-7; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; STUTTS MJ, 1992, P NATL ACAD SCI USA, V89, P1621, DOI 10.1073/pnas.89.5.1621; Tarran R, 2006, ANNU REV PHYSIOL, V68, P543, DOI 10.1146/annurev.physiol.68.072304.112754; Tarran R, 2002, J GEN PHYSIOL, V120, P407, DOI 10.1085/jgp.20028599; Vandebrouck C, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-113; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313	21	199	204	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14875	14880		10.1074/jbc.C109.000869	http://dx.doi.org/10.1074/jbc.C109.000869			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19363029	Green Published, hybrid			2022-12-25	WOS:000266288200023
J	Kang, J; Perry, JK; Pandey, V; Fielder, GC; Mei, B; Qian, PX; Wu, ZS; Zhu, T; Liu, DX; Lobie, PE				Kang, J.; Perry, J. K.; Pandey, V.; Fielder, G. C.; Mei, B.; Qian, P. X.; Wu, Z. S.; Zhu, T.; Liu, D. X.; Lobie, P. E.			Artemin is oncogenic for human mammary carcinoma cells	ONCOGENE			English	Article						artemin; GDNF; mammary; carcinoma; oncogenicity	NEUROTROPHIC FACTOR GDNF; PANCREATIC-CANCER CELLS; HUMAN GROWTH-HORMONE; BREAST-CANCER; STROMAL FIBROBLASTS; NEURONAL CELLS; NUDE-MICE; FAMILY; EXPRESSION; RECEPTOR	We report that artemin, a member of the glial cell line-derived neurotrophic factor family of ligands, is oncogenic for human mammary carcinoma. Artemin is expressed in numerous human mammary carcinoma cell lines. Forced expression of artemin in mammary carcinoma cells results in increased anchorage-independent growth, increased colony formation in soft agar and in three-dimensional Matrigel, and also promotes a scattered cell phenotype with enhanced migration and invasion. Moreover, forced expression of artemin increases tumor size in xenograft models and leads to highly proliferative, poorly differentiated and invasive tumors. Expression data in Oncomine indicate that high artemin expression is significantly associated with residual disease after chemotherapy, metastasis, relapse and death. Artemin protein is detectable in 65% of mammary carcinoma and its expression correlates to decreased overall survival in the cohort of patients. Depletion of endogenous artemin with small interfering RNA, or antibody inhibition of artemin, decreases the oncogenicity and invasiveness of mammary carcinoma cells. Artemin is therefore oncogenic for human mammary carcinoma, and targeted therapeutic approaches to inhibit artemin function in mammary carcinoma warrant consideration. Oncogene (2009) 28, 2034-2045; doi:10.1038/onc.2009.66; published online 13 April 2009	[Kang, J.; Perry, J. K.; Pandey, V.; Fielder, G. C.; Liu, D. X.; Lobie, P. E.] Univ Auckland, Liggins Inst, Auckland 1010, North Island, New Zealand; [Mei, B.; Qian, P. X.; Zhu, T.] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Mei, B.; Qian, P. X.; Zhu, T.] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Mei, B.] Anhui Med Univ, Inst Basic Med, Hefei, Anhui, Peoples R China; [Wu, Z. S.] Anhui Med Univ, Dept Pathol, Hefei, Anhui, Peoples R China; [Lobie, P. E.] Univ Auckland, Fac Med & Hlth Sci, Dept Mol Med & Pathol, Auckland 1010, North Island, New Zealand	University of Auckland; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui Medical University; Anhui Medical University; University of Auckland	Lobie, PE (corresponding author), Univ Auckland, Liggins Inst, 2-6 Pk Ave,Private Bag 92019, Auckland 1010, North Island, New Zealand.	p.lobie@auckland.ac.nz	Pandey, Vijay/P-2767-2016; Qian, Pengxu/B-9376-2016	Perry, Jo/0000-0002-4418-947X; Qian, Pengxu/0000-0001-5636-6704; Kang, Jian/0000-0001-9998-4975	Breast Cancer Research Trust (NZ); Foundation for Research, Science and Technology of New Zealand; Hundred-Talent Scheme of Chinese Academy of Sciences; National Natural Science Foundation of China [2007CB914801, 2007CB914503]; National Basic Research Program of China [30571030]	Breast Cancer Research Trust (NZ); Foundation for Research, Science and Technology of New Zealand(New Zealand Foundation for Research, Science and Technology); Hundred-Talent Scheme of Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	We thank Alan Beedle for critical reading of the manuscript. This work was funded by the Breast Cancer Research Trust (NZ), the Foundation for Research, Science and Technology of New Zealand, the Hundred-Talent Scheme of Chinese Academy of Sciences, the National Natural Science Foundation of China (2007CB914801 & 2007CB914503) and the National Basic Research Program of China (30571030).	Airaksinen MS, 1999, MOL CELL NEUROSCI, V13, P313, DOI 10.1006/mcne.1999.0754; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Anderson J, 2001, AM J PATHOL, V159, P1089, DOI 10.1016/S0002-9440(10)61784-1; Bespalov MM, 2007, TRENDS PHARMACOL SCI, V28, P68, DOI 10.1016/j.tips.2006.12.005; BROUTYBOYE D, 1993, ANTICANCER RES, V13, P1087; Ceyhan GO, 2007, GUT, V56, P534, DOI 10.1136/gut.2006.105528; Ceyhan GO, 2006, ANN SURG, V244, P274, DOI 10.1097/01.sla.0000217642.68697.55; CHUNG LWK, 1993, SEMIN CANCER BIOL, V4, P183; Duxbury MS, 2004, ANN SURG, V240, P667, DOI 10.1097/01.sla.0000140755.97224.9a; Enomoto H, 2004, NEURON, V44, P623, DOI 10.1016/j.neuron.2004.10.032; Esseghir S, 2007, CANCER RES, V67, P11732, DOI 10.1158/0008-5472.CAN-07-2343; Hutcheson IR, 2006, ENDOCR-RELAT CANCER, V13, pS89, DOI 10.1677/erc.1.01279; Ichihara M, 2004, CANCER LETT, V204, P197, DOI 10.1016/S0304-3835(03)00456-7; Ito Y, 2005, SURGERY, V138, P788, DOI 10.1016/j.surg.2005.07.007; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Liu DX, 2007, CELL DEATH DIFFER, V14, P1893, DOI 10.1038/sj.cdd.4402209; Lubaroff D M, 1980, Prog Clin Biol Res, V37, P243; Masure S, 1999, EUR J BIOCHEM, V266, P892, DOI 10.1046/j.1432-1327.1999.00925.x; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Meng XJ, 2001, MOL CELL ENDOCRINOL, V184, P33, DOI 10.1016/S0303-7207(01)00649-9; Meng XJ, 2001, CANCER RES, V61, P3267; Okada Y, 1999, INT J CANCER, V81, P67, DOI 10.1002/(SICI)1097-0215(19990331)81:1<67::AID-IJC13>3.0.CO;2-V; Pandey V, 2008, ENDOCRINOLOGY, V149, P3909, DOI 10.1210/en.2008-0286; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Pasini B, 1996, TRENDS GENET, V12, P138, DOI 10.1016/0168-9525(96)10012-3; Pettaway CA, 1996, CLIN CANCER RES, V2, P1627; Popsueva A, 2003, J CELL BIOL, V161, P119, DOI 10.1083/jcb.200212174; Poteryaev D, 1999, FEBS LETT, V463, P63, DOI 10.1016/S0014-5793(99)01590-2; Saarma M, 1999, MICROSC RES TECHNIQ, V45, P292, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<292::AID-JEMT13>3.0.CO;2-8; Sadlonova A, 2005, BREAST CANCER RES, V7, pR46, DOI 10.1186/bcr949; Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786; Schueler-Furman O, 2006, TRENDS PHARMACOL SCI, V27, P72, DOI 10.1016/j.tips.2005.12.004; Singh S, 2007, CANCER METAST REV, V26, P453, DOI 10.1007/s10555-007-9068-9; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Su G, 2007, J BIOL CHEM, V282, P14906, DOI 10.1074/jbc.M611739200; Takahashi M, 2001, CYTOKINE GROWTH F R, V12, P361, DOI 10.1016/S1359-6101(01)00012-0; Trupp M, 1999, J BIOL CHEM, V274, P20885, DOI 10.1074/jbc.274.30.20885; Veit C, 2004, CANCER RES, V64, P5291, DOI 10.1158/0008-5472.CAN-04-1112; Wu KJ, 2003, CANCER EPIDEM BIOMAR, V12, P920; Zhang PS, 2003, FASEB J, V17, P767, DOI 10.1096/fj.02-0603fje; Zhu T, 2005, CANCER RES, V65, P317; Zhu ZW, 2001, CLIN CANCER RES, V7, P105; Zinkel S, 2006, CELL DEATH DIFFER, V13, P1351, DOI 10.1038/sj.cdd.4401987	43	61	71	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 14	2009	28	19					2034	2045		10.1038/onc.2009.66	http://dx.doi.org/10.1038/onc.2009.66			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	445BF	19363524				2022-12-25	WOS:000266023900004
J	Orengo, JM; Leliwa-Sytek, A; Evans, JE; Evans, B; van de Hoef, D; Nyako, M; Day, K; Rodriguez, A				Orengo, Jamie Marie; Leliwa-Sytek, Aleksandra; Evans, James E.; Evans, Barbara; van de Hoef, Diana; Nyako, Marian; Day, Karen; Rodriguez, Ana			Uric Acid Is a Mediator of the Plasmodium falciparum-Induced Inflammatory Response	PLOS ONE			English	Article								Background: Malaria triggers a high inflammatory response in the host that mediates most of the associated pathologies and contributes to death. The identification of pro-inflammatory molecules derived from Plasmodium is essential to understand the mechanisms of pathogenesis and to develop targeted interventions. Uric acid derived from hypoxanthine accumulated in infected erythrocytes has been recently proposed as a mediator of inflammation in rodent malaria. Methods and Findings: We found that human erythrocytes infected with Plasmodium falciparum gradually accumulate hypoxanthine in their late stages of development. To analyze the role of hypoxanthine-derived uric acid induced by P. falciparum on the inflammatory cytokine response from human blood mononuclear cells, cultures were treated with allopurinol, to inhibit uric acid formation from hypoxanthine, or with uricase, to degrade uric acid. Both treatments significantly reduce the secretion of TNF, IL-6, IL-1 beta and IL-10 from human cells. Conclusions and Significance: Uric acid is a major contributor of the inflammatory response triggered by P. falciparum in human peripheral blood mononuclear cells. Since the inflammatory reaction induced by P. falciparum is considered a major cause of malaria pathogenesis, identifying the mechanisms used by the parasite to induce the host inflammatory response is essential to develop urgently needed therapies against this disease.			Orengo, JM (corresponding author), Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA.	ana.rodriguez@nyu.edu	Day, Karen/F-3697-2015	Day, Karen/0000-0002-6115-6135; Rodriguez, Ana/0000-0002-0060-3405; Orengo, Jamie/0000-0002-2695-6508	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007180] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI007180, 5 T32 AI 07180] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 2000, T R SOC TROP MED S1, V94, pS1; Clark IA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-85; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Cronstein BN, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1908; DAS BS, 1993, AM J TROP MED HYG, V49, P720, DOI 10.4269/ajtmh.1993.49.720; El-Nashar Thanaa M., 2002, Journal of the Egyptian Society of Parasitology, V32, P525; FEIGELSON P, 1957, J BIOL CHEM, V226, P993; Franke-Fayard B, 2005, P NATL ACAD SCI USA, V102, P11468, DOI 10.1073/pnas.0503386102; Gillman BM, 2004, INFECT IMMUN, V72, P6359, DOI 10.1128/IAI.72.11.6359-6366.2004; GRAU GE, 1989, NEW ENGL J MED, V320, P1586, DOI 10.1056/NEJM198906153202404; Kanellis J, 2005, SEMIN NEPHROL, V25, P39, DOI 10.1016/j.semnephrol.2004.09.007; Karunaweera ND, 2003, TRENDS PARASITOL, V19, P188, DOI 10.1016/S1471-4922(03)00036-9; KIPPEN I, 1974, ANN RHEUM DIS, V33, P313, DOI 10.1136/ard.33.4.313; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; KWIATKOWSKI D, 1990, LANCET, V336, P1201, DOI 10.1016/0140-6736(90)92827-5; Mackintosh CL, 2004, TRENDS PARASITOL, V20, P597, DOI 10.1016/j.pt.2004.09.006; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Oda M, 2002, MOL BIOL EVOL, V19, P640, DOI 10.1093/oxfordjournals.molbev.a004123; Orengo JM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000013; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Pascual E, 2004, CURR OPIN RHEUMATOL, V16, P282, DOI 10.1097/00002281-200405000-00020; PASVOL G, 1978, ANN TROP MED PARASIT, V72, P87, DOI 10.1080/00034983.1978.11719283; Sarma PSA, 1998, AM J TROP MED HYG, V58, P454, DOI 10.4269/ajtmh.1998.58.454; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; VANDERPOLL T, 1994, J EXP MED, V180, P1985, DOI 10.1084/jem.180.5.1985; Vorbach C, 2003, TRENDS IMMUNOL, V24, P512, DOI 10.1016/S1471-4906(03)00237-0; Walther M, 2006, J IMMUNOL, V177, P5736, DOI 10.4049/jimmunol.177.8.5736	30	34	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2009	4	4							e5194	10.1371/journal.pone.0005194	http://dx.doi.org/10.1371/journal.pone.0005194			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TW	19381275	Green Published, gold			2022-12-25	WOS:000265510800004
J	Yang, XJ; Karuturi, RKM; Sun, F; Aau, MY; Yu, K; Shao, RG; Miller, LD; Tan, PBO; Yu, Q				Yang, Xiaojing; Karuturi, R. K. Murthy; Sun, Feng; Aau, Meiyee; Yu, Kun; Shao, Rongguang; Miller, Lance D.; Tan, Patrick Boon Ooi; Yu, Qiang			CDKN1C (p57(KIP2)) Is a Direct Target of EZH2 and Suppressed by Multiple Epigenetic Mechanisms in Breast Cancer Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; PROMOTER DNA METHYLATION; GROUP PROTEIN EZH2; PROSTATE-CANCER; HISTONE H3; LYSINE-27 METHYLATION; CHROMATIN PATTERN; COLORECTAL-CANCER; GENE-EXPRESSION; HUMAN GENOME	CDKN1C (encoding tumor suppressor p57(KIP2)) is a cyclin-dependent kinase (CDK) inhibitor whose family members are often transcriptionally downregulated in human cancer via promoter DNA methylation. In this study, we show that CDKN1C is repressed in breast cancer cells mainly through histone modifications. In particular, we show that CDKN1C is targeted by histone methyltransferase EZH2-mediated histone H3 lysine 27 trimethylation (H3K27me3), and can be strongly activated by inhibition of EZH2 in synergy with histone deacetylase inhibitor. Consistent with the overexpression of EZH2 in a variety of human cancers including breast cancer, CDKN1C in these cancers is downregulated, and breast tumors expressing low levels of CDKN1C are associated with a poor prognosis. We further show that assessing both EZH2 and CDKN1C expression levels as a measurement of EZH2 pathway activity provides a more predictive power of disease outcome than that achieved with EZH2 or CDKN1C alone. Taken together, our study reveals a novel epigenetic mechanism governing CDKN1C repression in breast cancer. Importantly, as a newly identified EZH2 target with prognostic value, it has implications in patient stratification for cancer therapeutic targeting EZH2-mediated gene repression.	[Yang, Xiaojing; Karuturi, R. K. Murthy; Sun, Feng; Aau, Meiyee; Miller, Lance D.; Tan, Patrick Boon Ooi; Yu, Qiang] ASTAR, Genome Inst Singapore, Singapore, Singapore; [Yang, Xiaojing; Shao, Rongguang] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing, Peoples R China; [Sun, Feng] Natl Univ Singapore, Dept Pharm, Singapore, Singapore; [Yu, Kun; Tan, Patrick Boon Ooi] Duke NUS, Grad Med Sch, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; National University of Singapore; National University of Singapore	Yang, XJ (corresponding author), ASTAR, Genome Inst Singapore, Singapore, Singapore.	yuq@gis.a-star.edu.sg	Yang, Xiaojing/G-9201-2012	Miller, Lance/0000-0003-3799-2528; Yu, Qiang/0000-0003-2132-8278	Agency for Science, Technology & Research (A* Star) of Singapore	Agency for Science, Technology & Research (A* Star) of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by Agency for Science, Technology & Research (A* Star) of Singapore.(http://www.a-star.edu.sg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bachman KE, 2003, CANCER CELL, V3, P89, DOI 10.1016/S1535-6108(02)00234-9; Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Egger G, 2007, CANCER RES, V67, P346, DOI 10.1158/0008-5472.CAN-06-2845; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Hall P, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-16; Jiang X, 2008, CANCER CELL, V13, P529, DOI 10.1016/j.ccr.2008.04.019; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Karnik SK, 2005, P NATL ACAD SCI USA, V102, P14659, DOI 10.1073/pnas.0503484102; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kondo Y, 2003, MOL CELL BIOL, V23, P206, DOI 10.1128/MCB.23.1.206-215.2003; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Li YH, 2002, BLOOD, V100, P2572, DOI 10.1182/blood-2001-11-0026; Marks PA, 2004, ADV CANCER RES, V91, P137, DOI 10.1016/S0065-230X(04)91004-4; McGarvey KM, 2008, CANCER RES, V68, P5753, DOI 10.1158/0008-5472.CAN-08-0700; McGarvey KM, 2007, CANCER RES, V67, P5097, DOI 10.1158/0008-5472.CAN-06-2029; McGarvey KM, 2006, CANCER RES, V66, P3541, DOI 10.1158/0008-5472.CAN-05-2481; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Nguyen CT, 2002, CANCER RES, V62, P6456; Ohm JE, 2007, CELL CYCLE, V6, P1040, DOI 10.4161/cc.6.9.4210; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pateras IS, 2006, INT J CANCER, V119, P2546, DOI 10.1002/ijc.22214; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Soejima H, 2004, ONCOGENE, V23, P4380, DOI 10.1038/sj.onc.1207576; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wozniak RJ, 2007, ONCOGENE, V26, P77, DOI 10.1038/sj.onc.1209763; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	43	138	150	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5011	10.1371/journal.pone.0005011	http://dx.doi.org/10.1371/journal.pone.0005011			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340297	Green Published, Green Submitted, gold			2022-12-25	WOS:000265500700006
J	Geissbuhler, Y; Kannady, K; Chaki, PP; Emidi, B; Govella, NJ; Mayagaya, V; Kiama, M; Mtasiwa, D; Mshinda, H; Lindsay, SW; Tanner, M; Fillinger, U; de Castro, MC; Killeen, GF				Geissbuehler, Yvonne; Kannady, Khadija; Chaki, Prosper Pius; Emidi, Basiliana; Govella, Nicodem James; Mayagaya, Valeliana; Kiama, Michael; Mtasiwa, Deo; Mshinda, Hassan; Lindsay, Steven William; Tanner, Marcel; Fillinger, Ulrike; de Castro, Marcia Caldas; Killeen, Gerry Francis			Microbial Larvicide Application by a Large-Scale, Community-Based Program Reduces Malaria Infection Prevalence in Urban Dar Es Salaam, Tanzania	PLOS ONE			English	Article							BACILLUS-SPHAERICUS; ANOPHELES-GAMBIAE; CULEX-QUINQUEFASCIATUS; ENVIRONMENTAL-MANAGEMENT; MOSQUITO-CONTROL; BREEDING SITES; TRANSMISSION; POPULATIONS; EFFICACY; URBANIZATION	Background: Malaria control in Africa is most tractable in urban settlements yet most research has focused on rural settings. Elimination of malaria transmission from urban areas may require larval control strategies that complement adult mosquito control using insecticide-treated nets or houses, particularly where vectors feed outdoors. Methods and Findings: Microbial larvicide (Bacillus thuringiensis var. israelensis (Bti)) was applied weekly through programmatic, non-randomized community-based, but vertically managed, delivery systems in urban Dar es Salaam, Tanzania. Continuous, randomized cluster sampling of malaria infection prevalence and non-random programmatic surveillance of entomological inoculation rate (EIR) respectively constituted the primary and secondary outcomes surveyed within a population of approximately 612,000 residents in 15 fully urban wards covering 55 km(2). Bti application for one year in 3 of those wards (17 km 2 with 128,000 residents) reduced crude annual transmission estimates (Relative EIR [95% Confidence Interval] = 0.683 [0.491-0.952], P = 0.024) but program effectiveness peaked between July and September (Relative EIR [CI] = 0.354 [0.193 to 0.650], P = 0.001) when 45% (9/20) of directly observed transmission events occurred. Larviciding reduced malaria infection risk among children <= 5 years of age (OR [CI] = 0.284 [0.101 to 0.801], P = 0.017) and provided protection at least as good as personal use of an insecticide treated net (OR [CI] = 0.764 [0.614-0.951], P = 0.016). Conclusions: In this context, larviciding reduced malaria prevalence and complemented existing protection provided by insecticide-treated nets. Larviciding may represent a useful option for integrated vector management in Africa, particularly in its rapidly growing urban centres.	[Geissbuehler, Yvonne; Tanner, Marcel] Swiss Trop Inst, Dept Epidemiol & Publ Hlth, CH-4002 Basel, Switzerland; [Geissbuehler, Yvonne; Kannady, Khadija; Chaki, Prosper Pius; Emidi, Basiliana; Govella, Nicodem James; Kiama, Michael] Minist of Region Adm Local Gov, Dar es Salaam City Council, Dar Es Salaam, Tanzania; [Geissbuehler, Yvonne; Chaki, Prosper Pius; Govella, Nicodem James; Mayagaya, Valeliana; Mshinda, Hassan; Killeen, Gerry Francis] Ifakara Hlth Inst, Coordinat Office, Dar Es Salaam, Tanzania; [Chaki, Prosper Pius; Govella, Nicodem James; Lindsay, Steven William; Fillinger, Ulrike; Killeen, Gerry Francis] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Emidi, Basiliana; Mayagaya, Valeliana] Univ Dar Es Salaam, Dept Zool & Marine Biol, Dar Es Salaam, Tanzania; [Mtasiwa, Deo] Minist Hlth & Social Welfare, Dar Es Salaam, Tanzania; [de Castro, Marcia Caldas] Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, Boston, MA USA; [Killeen, Gerry Francis] Univ Liverpool Liverpool Sch Trop Med, Vector Grp, Liverpool, Merseyside, England	University of Basel; Swiss Tropical & Public Health Institute; Ifakara Health Institute; Durham University; University of Dar es Salaam; Harvard University; Harvard T.H. Chan School of Public Health; Liverpool School of Tropical Medicine	Geissbuhler, Y (corresponding author), Swiss Trop Inst, Dept Epidemiol & Publ Hlth, CH-4002 Basel, Switzerland.	gkilleen@ihi.or.tz	Emidi, Basiliana/AAL-2962-2021	Emidi, Basiliana/0000-0001-6856-541X; Lindsay, Steve/0000-0002-3461-9050; Fillinger, Ulrike/0000-0002-4037-431X	Bill & Melinda Gates Foundation [23750]; Valent Biosciences Corporation; US Centers for Disease Control and Prevention; US Agency for International Development; Wellcome Trust [076806]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Valent Biosciences Corporation; US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); US Agency for International Development(United States Agency for International Development (USAID)); Wellcome Trust(Wellcome TrustEuropean Commission)	This study was supported financially by the Bill & Melinda Gates Foundation (Award number 23750), Valent Biosciences Corporation, US Centers for Disease Control and Prevention and US Agency for International Development (Environmental Health Program, Dar es Salaam Mission and the President's Malaria Initiative, all administered through Research Triangle International) and a Wellcome Trust Research Career Development Fellowship (Award number 076806) to GFK. These funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, OPERATIONS COSTS COS; [Anonymous], 1968, ANOPHELINAE AFR S SA; BANG YH, 1977, E AFR MED J, V54, P403; BANG YH, 1975, E AFR MED J, V52, P578; Barbazan P, 1998, J AM MOSQUITO CONTR, V14, P33; Beier JC, 1999, AM J TROP MED HYG, V61, P109, DOI 10.4269/ajtmh.1999.61.109; BURKOT TR, 1984, AM J TROP MED HYG, V33, P783, DOI 10.4269/ajtmh.1984.33.783; CHAVASSE DC, 1995, MED VET ENTOMOL, V9, P147, DOI 10.1111/j.1365-2915.1995.tb00171.x; Chavasse DC, 1996, T ROY SOC TROP MED H, V90, P493, DOI 10.1016/S0035-9203(96)90291-6; CHAVASSE DC, 1995, MED VET ENTOMOL, V9, P141, DOI 10.1111/j.1365-2915.1995.tb00170.x; Clyde David F, 1967, MALARIA TANZANIA; De Castro MC, 2004, AM J TROP MED HYG, V71, P103, DOI 10.4269/ajtmh.2004.71.103; Dongus S, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-37; Drakeley C, 2003, TROP MED INT HEALTH, V8, P767, DOI 10.1046/j.1365-3156.2003.01100.x; FILLINGER U, 2008, B WHO IN PRESS; Fillinger U, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-20; Fillinger Ulrike, 2006, Trop Med Int Health, V11, P1629, DOI 10.1111/j.1365-3156.2006.01733.x; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; GARRETTJONES C, 1964, NATURE, V204, P1173, DOI 10.1038/2041173a0; Geissbuhler Y, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-126; Gillies M, 1987, ANOPHELINAE AFRICA S; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; KARCH S, 1992, J AM MOSQUITO CONTR, V8, P376; Keiser J, 2004, AM J TROP MED HYG, V71, P118, DOI 10.4269/ajtmh.2004.71.118; Keiser J, 2005, LANCET INFECT DIS, V5, P695, DOI 10.1016/S1473-3099(05)70268-1; Kilama WL, 1994, P 11 ANN JOINT SCI C; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Killeen GF, 2006, AM J TROP MED HYG, V74, P517, DOI 10.4269/ajtmh.2006.74.517; Killeen GF, 2003, LANCET INFECT DIS, V3, P663, DOI 10.1016/S1473-3099(03)00776-X; Killeen GF, 2002, LANCET INFECT DIS, V2, P618, DOI 10.1016/S1473-3099(02)00397-3; Kiszewski A, 2007, B WORLD HEALTH ORGAN, V85, P623, DOI 10.2471/BLT.06.039529; KUMAR A, 1994, J AM MOSQUITO CONTR, V10, P534; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Macpherson CNL, 1991, HLTH DIS TANZANIA, P117; Majambere S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-76; MTASIWA D, 2003, DAR SALAAM CITY REGI; Mukabana WR, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-9; National Bureau of Statistics, 2003, 2002 POP HOUS CENS G; Robert V, 2003, AM J TROP MED HYG, V68, P169, DOI 10.4269/ajtmh.2003.68.169; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; SERVICE MW, 1977, B ENTOMOL RES, V67, P343, DOI 10.1017/S0007485300011184; Shililu JI, 2003, J AM MOSQUITO CONTR, V19, P251; Shililu J, 2007, AM J TROP MED HYG, V76, P103, DOI 10.4269/ajtmh.2007.76.103; SHOUSHA A. T., 1948, BULL WORLD HEALTH ORGAN, V1, P309; Skovmand O, 1997, J VECTOR ECOL, V22, P43; Smith TA, 2001, TRENDS PARASITOL, V17, P145, DOI 10.1016/S1471-4922(00)01814-6; Snow RW, 2008, PLOS MED, V5, P1068, DOI 10.1371/journal.pmed.0050142; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Soper FL, 1943, ANOPHELES GAMBIAE BR; STEPHENS C, 1995, B WORLD HEALTH ORGAN, V73, P97; United Nations, 2004, WORLD URB PROSP 2003; Utzinger J, 2002, TROP MED INT HEALTH, V7, P657, DOI 10.1046/j.1365-3156.2002.00916.x; Utzinger J, 2001, TROP MED INT HEALTH, V6, P677, DOI 10.1046/j.1365-3156.2001.00769.x; Wang SJ, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-29; Watson, 2001, BATTLE BANNOCKBURN; WORRALL E, 2007, INTEGRATED VECTOR MA; 2002, NATL MALARIA MEDIUM	58	148	151	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e5107	10.1371/journal.pone.0005107	http://dx.doi.org/10.1371/journal.pone.0005107			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333402	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000265499900028
J	Pearson, MS; Bethony, JM; Pickering, DA; de Oliveira, LM; Jariwala, A; Santiago, H; Miles, AP; Zhan, B; Jiang, DS; Ranjit, N; Mulvenna, J; Tribolet, L; Plieskatt, J; Smith, T; Bottazzi, ME; Jones, K; Keegan, B; Hotez, PJ; Loukas, A				Pearson, Mark S.; Bethony, Jeffrey M.; Pickering, Darren A.; de Oliveira, Luciana M.; Jariwala, Amar; Santiago, Helton; Miles, Aaron P.; Zhan, Bin; Jiang, Desheng; Ranjit, Najju; Mulvenna, Jason; Tribolet, Leon; Plieskatt, Jordan; Smith, Tracey; Bottazzi, Maria Elena; Jones, Kathryn; Keegan, Brian; Hotez, Peter J.; Loukas, Alex			An enzymatically inactivated hemoglobinase from Necator americanus induces neutralizing antibodies against multiple hookworm species and protects dogs against heterologous hookworm infection	FASEB JOURNAL			English	Article						vaccine; protease; hemoglobin; neglected tropical disease	TRANSMITTED HELMINTH INFECTIONS; D ASPARTIC PROTEASES; CATHEPSIN-D; HAEMONCHUS-CONTORTUS; ANCYLOSTOMA-CANINUM; FASCIOLA-HEPATICA; VACCINATION; VACCINES; PROTEINASES; LARVAE	Hookworms digest hemoglobin from erythrocytes via a proteolytic cascade that begins with the aspartic protease, APR-1. Ac-APR-1 from the dog hookworm, Ancylostoma caninum, protects dogs against hookworm infection via antibodies that neutralize enzymatic activity and interrupt blood-feeding. Toward developing a human hookworm vaccine, we expressed both wild-type (Na-APR-1(wt)) and mutant (Na-APR-1(mut)-mutagenesis of the catalytic aspartic acids) forms of Na-APR-1 from the human hookworm, Necator americanus. Refolded Na-APR-1(wt) was catalytically active, and Na-APR-1(mut) was catalytically inactive but still bound substrates. Vaccination of canines with Na-APR-1(mut) and heterologous challenge with A. caninum resulted in significantly reduced parasite egg burdens (P=0.034) and weight loss (P=0.022). Vaccinated dogs also had less gut pathology, fewer adult worms, and reduced blood loss compared to controls but these did not reach statistical significance. Vaccination with Na-APR-1mut induced antibodies that bound the native enzyme in the parasite gut and neutralized enzymatic activity of Na-APR-1(wt) and APR-1 orthologues from three other hookworm species that infect humans. IgG1 against Na-APR-1(mut) was the most prominently detected antibody in sera from people resident in high-transmission areas for N. americanus, indicating that natural boosting may occur in exposed humans. Na-APR-1(mut) is now a lead antigen for the development of an antihematophagy vaccine for human hookworm disease.-Pearson, M. S., Bethony, J. M., Pickering, D. A., de Oliveira, L. M., Jariwala, A., Santiago, H., Miles, A. P., Zhan, B., Jiang, D., Ranjit, N., Mulvenna, J., Tribolet, L., Plieskatt, J., Smith, T., Bottazzi, M. E., Jones, K., Keegan, B., Hotez, P. J., Loukas, A. An enzymatically inactivated hemoglobinase from Necator americanus induces neutralizing antibodies against multiple hookworm species and protects dogs against heterologous hookworm infection. FASEB J. 23, 3007-3019 (2009). www.fasebj.org	[Pearson, Mark S.; Pickering, Darren A.; Ranjit, Najju; Mulvenna, Jason; Tribolet, Leon; Loukas, Alex] Queensland Inst Med Res, Div Infect Dis, Brisbane, Qld 4006, Australia; [Pearson, Mark S.; Pickering, Darren A.; Ranjit, Najju; Mulvenna, Jason; Tribolet, Leon; Loukas, Alex] Australian Ctr Vaccine Dev, Brisbane, Qld 4006, Australia; [Bethony, Jeffrey M.; de Oliveira, Luciana M.; Jariwala, Amar; Santiago, Helton; Miles, Aaron P.; Zhan, Bin; Jiang, Desheng; Plieskatt, Jordan; Smith, Tracey; Bottazzi, Maria Elena; Jones, Kathryn; Keegan, Brian; Hotez, Peter J.] George Washington Univ, Med Ctr, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA	QIMR Berghofer Medical Research Institute; George Washington University	Loukas, A (corresponding author), Queensland Inst Med Res, Div Infect Dis, 300 Herston Rd, Brisbane, Qld 4006, Australia.	alex.loukas@qimr.edu.au	de Oliveira, Luciana/AAE-7182-2022; Pearson, Mark S/O-5636-2014; de Oliveira, Luciana M/I-8842-2012; Santiago, Helton/AAA-8558-2021; Loukas, Alex/B-7355-2014; Mulvenna, Jason/H-7110-2014; Santiago, Helton/F-8704-2012	de Oliveira, Luciana/0000-0002-3080-8604; Loukas, Alex/0000-0002-0896-8441; Mulvenna, Jason/0000-0003-3521-8061; Santiago, Helton/0000-0002-5695-8256; Hotez, Peter/0000-0001-8770-1042; Plieskatt, Jordan/0000-0002-2333-7234; Tribolet, Leon/0000-0002-2093-9678; Pearson, Mark/0000-0002-0002-1544; Wolf, Nathaniel/0000-0001-6567-2447; Bottazzi, Maria Elena/0000-0002-8429-0476	Bill and Melinda Gates Foundation; Albert B. Sabin Vaccine Institute; National Health and Medical Research Council of Australia (NHMRC); ARC/NHMRC Research Network for Parasitology; Australian Centre for Vaccine Development	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Albert B. Sabin Vaccine Institute; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); ARC/NHMRC Research Network for Parasitology(Australian Research CouncilNational Health and Medical Research Council (NHMRC) of Australia); Australian Centre for Vaccine Development	We thank Drs. Jane Halpern, Philip Russell, and Ami Shah-Brown for helpful discussions and Mark J. Hoenerhoff for conducting the canine clinical pathology. This work was funded by a grant awarded from the Bill and Melinda Gates Foundation to the Albert B. Sabin Vaccine Institute and a grant from the National Health and Medical Research Council of Australia (NHMRC). A. L. is the recipient of an NHMRC senior research fellowship. J. B. is the recipient of travel awards from the ARC/NHMRC Research Network for Parasitology and the Australian Centre for Vaccine Development.	Albonico M, 2004, INT J PARASITOL, V34, P1205, DOI 10.1016/j.ijpara.2004.08.001; ALBONICO M, 1995, T ROY SOC TROP MED H, V89, P538, DOI 10.1016/0035-9203(95)90101-9; BALDWIN ET, 1993, P NATL ACAD SCI USA, V90, P6796, DOI 10.1073/pnas.90.14.6796; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Bethony J, 2005, FASEB J, V19, P1743, DOI 10.1096/fj.05-3936fje; Brooker S, 2007, T ROY SOC TROP MED H, V101, P146, DOI 10.1016/j.trstmh.2006.05.012; Brooker S, 2006, INT J PARASITOL, V36, P1143, DOI 10.1016/j.ijpara.2006.05.009; Dalton JP, 2003, INT J PARASITOL, V33, P1173, DOI 10.1016/S0020-7519(03)00171-1; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; Don TA, 2004, INT J PARASITOL, V34, P1029, DOI 10.1016/j.ijpara.2004.04.013; Don TA, 2008, INT J INFECT DIS, V12, pE39, DOI 10.1016/j.ijid.2007.10.007; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Fleming FM, 2006, TROP MED INT HEALTH, V11, P56, DOI 10.1111/j.1365-3156.2005.01541.x; Fujiwara RT, 2006, VACCINE, V24, P501, DOI 10.1016/j.vaccine.2005.07.091; Geldhof P, 2002, PARASITE IMMUNOL, V24, P263, DOI 10.1046/j.1365-3024.2002.00461.x; Hotez P.J., 2007, ANN NY ACAD SCI, V1136, P38; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Hotez PJ, 2003, J PARASITOL, V89, P853, DOI 10.1645/GE-46R; HUMPHREY W, 1996, J MOL GRAPHICS, V14, P27, DOI DOI 10.1016/0263-7855(96)00018-5; Jacobson RH, 1998, REV SCI TECH OIE, V17, P469, DOI 10.20506/rst.17.2.1119; Knox DP, 2003, INT J PARASITOL, V33, P1129, DOI 10.1016/S0020-7519(03)00167-X; Krauer K, 2004, J GEN VIROL, V85, P165, DOI 10.1099/vir.0.19549-0; KREMER M, 2004, 112W10324 HARV U CTR; Leal AT, 2006, VET IMMUNOL IMMUNOP, V114, P341, DOI 10.1016/j.vetimm.2006.08.011; Loukas A, 2005, PLOS MED, V2, P1008, DOI 10.1371/journal.pmed.0020295; Loukas A, 2004, J INFECT DIS, V189, P1952, DOI 10.1086/386346; Loukas A, 2006, LANCET INFECT DIS, V6, P733, DOI 10.1016/S1473-3099(06)70630-2; McManus DP, 2008, CLIN MICROBIOL REV, V21, P225, DOI 10.1128/CMR.00046-07; Morales ME, 2008, MOL BIOCHEM PARASIT, V157, P160, DOI 10.1016/j.molbiopara.2007.10.009; Munn EA, 1997, INT J PARASITOL, V27, P359, DOI 10.1016/S0020-7519(97)00003-9; Piacenza L, 1997, J HELMINTHOL, V71, P333, DOI 10.1017/S0022149X00016151; Piacenza L, 1999, INFECT IMMUN, V67, P1954; Quinn CP, 2002, EMERG INFECT DIS, V8, P1103, DOI 10.3201/eid0810.020380; RANJIT N, 2009, J INFECT DIS; Redmond DL, 2004, VACCINE, V22, P4252, DOI 10.1016/j.vaccine.2004.04.028; Tarcha EJ, 2006, INFECT IMMUN, V74, P516, DOI 10.1128/IAI.74.1.516-527.2006; Verity CK, 2001, PARASITE IMMUNOL, V23, P153, DOI 10.1046/j.1365-3024.2001.00369.x; Vilanova M, 2004, IMMUNOLOGY, V111, P334, DOI 10.1111/j.1365-2567.2004.01819.x; Williamson AL, 2004, J BIOL CHEM, V279, P35950, DOI 10.1074/jbc.M405842200; Williamson AL, 2003, PARASITOLOGY, V126, P179, DOI 10.1017/S0031182002002706; Williamson AL, 2002, FASEB J, V16, P1458, DOI 10.1096/fj.02-0181fje; Xiao S, 2008, EXP PARASITOL, V118, P32, DOI 10.1016/j.exppara.2007.05.010; Yoshida Y., 1960, Japanese Journal of Parasitology, V9, P735	43	70	70	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2009	23	9					3007	3019		10.1096/fj.09-131433	http://dx.doi.org/10.1096/fj.09-131433			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19380510	Green Published			2022-12-25	WOS:000270241000023
J	Schnitger, AKD; Yassine, H; Kafatos, FC; Osta, MA				Schnitger, Anna K. D.; Yassine, Hassan; Kafatos, Fotis C.; Osta, Mike A.			Two C-type Lectins Cooperate to Defend Anopheles gambiae against Gram-negative Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOPOLYSACCHARIDE-BINDING PROTEIN; MANDUCA-SEXTA; TOBACCO HORNWORM; BOMBYX-MORI; RECOGNITION; HEMOLYMPH; INSECT; MELANIZATION; IMMULECTIN-2; GENES	C-type lectins (CTLs) are a family of proteins that share a common structural motif, the carbohydrate recognition domain, and may act as receptors in pathogen recognition. Indeed, some vertebrate CTLs, particularly the collectins, are unequivocally implicated in the innate immune response to certain microbes. Although studies in insects and other invertebrates have described CTL activation of effector immune responses in vitro, the contribution of these CTLs to immune defenses in vivo is still poorly understood. Here we report that two CTLs, CTL4 and CTLMA2, which were shown previously to inhibit Plasmodium berghei ookinete melanization in the malaria vector Anopheles gambiae, are transcriptionally induced by bacterial challenge. Using in vivo reverse genetic analysis, we show that both CTLs are required for the clearance of Escherichia coli, but not Staphylococcus aureus, from adult female mosquitoes. Silencing either CTL dramatically reduces mosquito survival to Gram-negative but not to Gram-positive bacterial infections, suggesting a role in defense against Gram-negative bacteria. Furthermore, molecular characterization reveals that both CTLs are secreted into the mosquito hemolymph mainly in the form of a disulfide-linked heterodimer. This association explains the similar roles of these CTLs in bacterial defense as well as in the melanization response to P. berghei ookinetes. Apparently, CTL4 and CTLMA2 serve pleiotropic functions in the innate immune response of A. gambiae.	[Kafatos, Fotis C.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London SW7 2AZ, England; [Yassine, Hassan; Osta, Mike A.] Amer Univ Beirut, Fac Arts & Sci, Dept Biol, Beirut 11072020, Lebanon	Imperial College London; American University of Beirut	Kafatos, FC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Exhibit Rd, London SW7 2AZ, England.	f.kafatos@imperial.ac.uk; mo07@aub.edu.lb			National Institutes of Health [2PO1AI044220-06A1]; Wellcome Trust Programme [GR077229/Z/05/Z]; American University of Beirut Research Board [DDF111030988140]; Lebanese National Center for Scientific Research [111030522369]; European Commission [LSHP-CT-2004-503578]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044220] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust Programme(Wellcome Trust); American University of Beirut Research Board; Lebanese National Center for Scientific Research; European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Project Grant 2PO1AI044220-06A1 from NIAID. This work was also supported by The Wellcome Trust Programme Grant GR077229/Z/05/Z, the American University of Beirut Research Board Grant DDF111030988140, Lebanese National Center for Scientific Research Grant 111030522369, and is part of the activities of the BioMalPar Network of Excellence supported by European Commission Grant LSHP-CT-2004-503578 under "Life Sciences, Genomics and Biotechnology for Health" in the European Commission 6th Framework Programme.	Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Blandin S, 2002, EMBO REP, V3, P852, DOI 10.1093/embo-reports/kvf180; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Danielli A, 2000, P NATL ACAD SCI USA, V97, P7136, DOI 10.1073/pnas.97.13.7136; De Masi F, 2005, PROTEOMICS, V5, P4070, DOI 10.1002/pmic.200401279; Dimopoulos G, 2002, P NATL ACAD SCI USA, V99, P8814, DOI 10.1073/pnas.092274999; Drickamer K, 2002, BIOCHEM SOC SYMP, V69, P59; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; Eleftherianos I, 2006, DEV COMP IMMUNOL, V30, P1099, DOI 10.1016/j.dci.2006.02.008; Holmskov U, 2003, ANNU REV IMMUNOL, V21, P547, DOI 10.1146/annurev.immunol.21.120601.140954; JOMORI T, 1992, FEBS LETT, V296, P283, DOI 10.1016/0014-5793(92)80305-Z; Koizumi N, 1999, FEBS LETT, V443, P139, DOI 10.1016/S0014-5793(98)01701-3; Koizumi N, 1997, EUR J BIOCHEM, V248, P217, DOI 10.1111/j.1432-1033.1997.t01-1-00217.x; Koizumi N, 1999, J INSECT PHYSIOL, V45, P853, DOI 10.1016/S0022-1910(99)00069-4; KUHLMAN M, 1989, J EXP MED, V169, P1733, DOI 10.1084/jem.169.5.1733; LeVine AM, 2000, J IMMUNOL, V165, P3934, DOI 10.4049/jimmunol.165.7.3934; Lindh JM, 2005, APPL ENVIRON MICROB, V71, P7217, DOI 10.1128/AEM.71.11.7217-7223.2005; Matsushita M, 1996, RES IMMUNOL, V147, P115, DOI 10.1016/0923-2494(96)87185-9; Michel K, 2006, P NATL ACAD SCI USA, V103, P16858, DOI 10.1073/pnas.0608033103; Muller HM, 1999, J BIOL CHEM, V274, P11727, DOI 10.1074/jbc.274.17.11727; Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789; SALAZAR CE, 1993, NUCLEIC ACIDS RES, V21, P4147, DOI 10.1093/nar/21.17.4147; Schnitger AKD, 2007, J BIOL CHEM, V282, P21884, DOI 10.1074/jbc.M701635200; Schulenburg H, 2008, IMMUNOBIOLOGY, V213, P237, DOI 10.1016/j.imbio.2007.12.004; SCHWEINLE JE, 1989, J CLIN INVEST, V84, P1821, DOI 10.1172/JCI114367; Shi L, 2004, J EXP MED, V199, P1379, DOI 10.1084/jem.20032207; Shin SW, 2000, FEBS LETT, V467, P70, DOI 10.1016/S0014-5793(00)01127-3; Tanji T, 2006, BIOCHEM J, V396, P127, DOI 10.1042/BJ20051921; Volz J, 2006, CELL MICROBIOL, V8, P1392, DOI 10.1111/j.1462-5822.2006.00718.x; Watanabe A, 2006, J IMMUNOL, V177, P4594, DOI 10.4049/jimmunol.177.7.4594; Waterhouse RM, 2007, SCIENCE, V316, P1738, DOI 10.1126/science.1139862; WEIS WI, 1991, SCIENCE, V254, P1608, DOI 10.1126/science.1721241; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; Wilson R, 1999, J IMMUNOL, V162, P1590; Yu XQ, 2006, INSECT MOL BIOL, V15, P119, DOI 10.1111/j.1365-2583.2006.00618.x; Yu XQ, 2005, INSECT BIOCHEM MOLEC, V35, P285, DOI 10.1016/j.ibmb.2005.01.004; Yu XQ, 2004, DEV COMP IMMUNOL, V28, P891, DOI 10.1016/j.dci.2004.02.005; Yu XQ, 2003, DEV COMP IMMUNOL, V27, P189, DOI 10.1016/S0145-305X(02)00099-X; Yu XQ, 1999, INSECT BIOCHEM MOLEC, V29, P585, DOI 10.1016/S0965-1748(99)00036-3; Yu XQ, 2000, J BIOL CHEM, V275, P37373, DOI 10.1074/jbc.M003021200; Zirwes RF, 1997, P NATL ACAD SCI USA, V94, P11387, DOI 10.1073/pnas.94.21.11387	41	80	87	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17616	17624		10.1074/jbc.M808298200	http://dx.doi.org/10.1074/jbc.M808298200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19380589	Green Published, hybrid			2022-12-25	WOS:000267202500027
J	Anwar, A; Leong, KM; Ng, ML; Chu, JJH; Garcia-Blanco, MA				Anwar, Azlinda; Leong, K. M.; Ng, Mary L.; Chu, Justin J. H.; Garcia-Blanco, Mariano A.			The Polypyrimidine Tract-binding Protein Is Required for Efficient Dengue Virus Propagation and Associates with the Viral Replication Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C VIRUS; TRANS-ACTING FACTORS; NUCLEAR-LOCALIZATION; INTERNAL INITIATION; GENE-EXPRESSION; RNA-SYNTHESIS; 3'-UNTRANSLATED REGION; HCV REPLICATION; HOST FACTORS; STRAND RNA	The polypyrimidine tract-binding protein (PTB) functions primarily as an IRES trans-acting factor in the propagation of hepatitis C virus and picornaviruses. PTB interacts with secondary structures within the 3'- and 5'-untranslated regions of these viral genomes to mediate efficient IRES-mediated viral translation. PTB has also been reported to bind to the untranslated region of the single-stranded RNA dengue virus (DENV), suggesting a similar function for PTB in flaviviruses. Indeed small interfering RNA-mediated PTB knockdown inhibited the production of infectious DENV, and this inhibition was specific to PTB knockdown and not due to a nonspecific anti-viral state. In fact, PTB depletion did not inhibit the production infectious yellow fever virus, another flavivirus. Nevertheless, whereas PTB knockdown led to a significant decrease in the accumulation of DENV viral RNAs, it did not impair translation. Moreover, PTB was shown to interact with the DENV nonstructural 4A protein, a known component of the viral replication complex, and with the DENV genome during infection. These data suggest that PTB interacts with the replication complex of DENV and is acting at the level of viral RNA replication.	[Ng, Mary L.; Chu, Justin J. H.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117597, Singapore; [Anwar, Azlinda; Leong, K. M.; Garcia-Blanco, Mariano A.] Duke Natl Univ Singapore, Grad Sch Med, Program Emerging Infect Dis, Singapore 169547, Singapore; [Garcia-Blanco, Mariano A.] Duke Univ, Med Ctr, Durham, NC 27710 USA	National University of Singapore; National University of Singapore; Duke University	Chu, JJH (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, 8 Med Dr, Singapore 117597, Singapore.	miccjh@nus.edu.sg; garci001@mc.duke.edu	Chu, Justin Jang Hann/ABA-8297-2021; Kim, Seongman/N-6910-2014	Chu, Justin Jang Hann/0000-0002-1673-6819	Agency for Science, Technology and Research of Singapore; Singapore Ministry of Health [R-913-200-002-304]; National University of Singapore [R-182-000-117-112]; National Medical Research Council (Singapore) [NMRC/NIG/0012/2007]	Agency for Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR)); Singapore Ministry of Health(Ministry of Health-Singapore); National University of Singapore(National University of Singapore); National Medical Research Council (Singapore)(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Agency for Science, Technology and Research of Singapore and Singapore Ministry of Health Award R-913-200-002-304 (to M. A. G.-B.) and National University of Singapore Grant R-182-000-117-112 and National Medical Research Council (Singapore) Grant NMRC/NIG/0012/2007 (to J.J.H.C.).	Ahlquist P, 2003, J VIROL, V77, P8181, DOI 10.1128/JVI.77.15.8181-8186.2003; Aizaki H, 2006, J BIOMED SCI, V13, P469, DOI 10.1007/s11373-006-9088-4; Alvarez DE, 2005, VIROLOGY, V339, P200, DOI 10.1016/j.virol.2005.06.009; Anwar A, 2006, ANAL BIOCHEM, V352, P120, DOI 10.1016/j.ab.2006.01.046; Anwar A, 2005, VIROLOGY, V332, P66, DOI 10.1016/j.virol.2004.11.022; Auweter SD, 2008, CELL MOL LIFE SCI, V65, P516, DOI 10.1007/s00018-007-7378-2; Back SH, 2002, J VIROL, V76, P2529, DOI 10.1128/JVI.76.5.2529-2542.2002; BEHRENS SE, 2006, MOL BIOL FLAVIVIRUS, P101; Brinton MA, 2001, ANN NY ACAD SCI, V951, P207; Chang KS, 2006, VIRUS RES, V115, P1, DOI 10.1016/j.virusres.2005.06.012; Choi KS, 2002, VIROLOGY, V303, P58, DOI 10.1006/viro.2002.1675; Clyde K, 2006, J VIROL, V80, P11418, DOI 10.1128/JVI.01257-06; De Nova-Ocampo M, 2002, VIROLOGY, V295, P337, DOI 10.1006/viro.2002.1407; Domitrovich AM, 2005, VIROLOGY, V335, P72, DOI 10.1016/j.virol.2005.02.009; Edgil D, 2006, J VIROL, V80, P2976, DOI 10.1128/JVI.80.6.2976-2986.2006; Florez PM, 2005, J VIROL, V79, P6172, DOI 10.1128/JVI.79.10.6172-6179.2005; Gama-Carvalho M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r113; GARCIABLANCO MA, 1989, GENE DEV, V3, P1874, DOI 10.1101/gad.3.12a.1874; Gould E., 1985, VIROLOGY PRACTICAL A, P43; Gritsun TS, 2007, VIROLOGY, V366, P8, DOI 10.1016/j.virol.2007.04.011; Gritsun TS, 2007, VIROLOGY, V358, P258, DOI 10.1016/j.virol.2006.09.033; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Hiscox JA, 2007, NAT REV MICROBIOL, V5, P119, DOI 10.1038/nrmicro1597; Huang PY, 1999, J VIROL, V73, P9110, DOI 10.1128/JVI.73.11.9110-9116.1999; Hunt SL, 1999, RNA, V5, P344, DOI 10.1017/S1355838299981414; Jang SK, 2006, VIRUS RES, V119, P2, DOI 10.1016/j.virusres.2005.11.003; Kamath RV, 2001, MOL BIOL CELL, V12, P3808, DOI 10.1091/mbc.12.12.3808; Kaminski A, 1998, RNA, V4, P626, DOI 10.1017/S1355838298971898; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; Karakasiliotis I, 2006, J GEN VIROL, V87, P3339, DOI 10.1099/vir.0.82153-0; Kim SM, 2006, VIRUS RES, V115, P131, DOI 10.1016/j.virusres.2005.07.013; Li HP, 1999, J VIROL, V73, P772, DOI 10.1128/JVI.73.1.772-777.1999; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Lindenbach BD, 2007, J VIROL, V81, P8905, DOI 10.1128/JVI.00937-07; Marianneau P, 1998, J INFECT DIS, V178, P1270, DOI 10.1086/314466; Martinez-Salas E, 2008, J GEN VIROL, V89, P611, DOI 10.1099/vir.0.83426-0; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Pryor MJ, 2007, TRAFFIC, V8, P795, DOI 10.1111/j.1600-0854.2007.00579.x; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; Pulido MR, 2007, VIROLOGY, V364, P466, DOI 10.1016/j.virol.2007.03.013; Sangiambut S, 2008, J GEN VIROL, V89, P1254, DOI 10.1099/vir.0.83264-0; Song YT, 2005, RNA, V11, P1809, DOI 10.1261/rna.7430405; Spellman R, 2006, TRENDS BIOCHEM SCI, V31, P73, DOI 10.1016/j.tibs.2005.12.003; Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016; Spriggs KA, 2005, CELL DEATH DIFFER, V12, P585, DOI 10.1038/sj.cdd.4401642; Stoneley M, 2004, ONCOGENE, V23, P3200, DOI 10.1038/sj.onc.1207551; Thurner C, 2004, J GEN VIROL, V85, P1113, DOI 10.1099/vir.0.19462-0; Tischendorf JJW, 2004, ARCH VIROL, V149, P1955, DOI 10.1007/s00705-004-0341-8; TOLLERVEY D, 1993, CELL, V72, P443, DOI 10.1016/0092-8674(93)90120-F; Uchil PD, 2006, J VIROL, V80, P5451, DOI 10.1128/JVI.01982-05; Wagner EJ, 2002, MOL CELL, V10, P943, DOI 10.1016/S1097-2765(02)00645-7; Westaway EG, 2003, ADV VIRUS RES, V59, P99, DOI 10.1016/S0065-3527(03)59004-2; Westaway EG, 1997, VIROLOGY, V234, P31, DOI 10.1006/viro.1997.8629; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Wollerton MC, 2004, MOL CELL, V13, P91, DOI 10.1016/S1097-2765(03)00502-1; WU BF, 1996, J BIOL CHEM, V271, P4201; Yi MY, 2000, J VIROL, V74, P6459, DOI 10.1128/JVI.74.14.6459-6468.2000	58	45	46	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17021	17029		10.1074/jbc.M109.006239	http://dx.doi.org/10.1074/jbc.M109.006239			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19380576	hybrid, Green Published			2022-12-25	WOS:000266962400040
J	Nigro, J; Wang, AM; Mukhopadhyay, D; Lauer, M; Midura, RJ; Sackstein, R; Hascall, VC				Nigro, Julie; Wang, Aimin; Mukhopadhyay, Durba; Lauer, Mark; Midura, Ronald J.; Sackstein, Robert; Hascall, Vincent C.			Regulation of Heparan Sulfate and Chondroitin Sulfate Glycosaminoglycan Biosynthesis by 4-Fluoro-glucosamine in Murine Airway Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-D-XYLOSIDE; PROTEOGLYCANS; INHIBITION	The importance of the pathological changes in proteoglycans has driven the need to study and design novel chemical tools to control proteoglycan synthesis. Accordingly, we tested the fluorinated analogue of glucosamine (4-fluoro-N-acetyl-glucosamine (4-F-GlcNAc)) on the synthesis of heparan sulfate (HS) and chondroitin sulfate (CS) by murine airway smooth muscle (ASM) cells in the presence of radiolabeled metabolic precursors. Secreted and cell-associated CS and HS were assessed for changes in size by Superose 6 chromatography. Treatment of ASM cells with 4-F-GlcNAc (100 mu M) reduced the quantity (by 64.1-76.6%) and decreased the size of HS/CS glycosaminoglycans associated with the cell layer (K-av shifted from 0.30 to 0.45). The quantity of CS secreted into the medium decreased by 65.7-73.0%, and the size showed a K-av shift from 0.30 to 0.50. Treatment of ASM cells with 45 mu M and 179 mu M 4-F-GlcNAc in the presence of a stimulator of CS synthesis, 4-methylumbelliferyl-beta-D-xyloside, reduced the amount of the xyloside-CS chains by 65.4 and 87.0%, respectively. The size of xyloside-CS chains synthesized in the presence of 4-F-GlcNAc were only slightly larger than those with xyloside treatment alone (K-av of 0.55 compared with that of 0.6). The effects of 4-F-GlcNAc to inhibit CS synthesis were not observed with equimolar concentrations of glucosamine. We propose that 4-F-GlcNAc inhibits CS synthesis by inhibiting 4-epimerization of UDP-GlcNAc to UDP-GalNAc, thereby depleting one of the substrates required, whereas HS elongation is inhibited by truncation when the nonreducing terminus of the growing chain is capped with 4-F-GlcNAc.	[Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn, Cleveland Clin Fdn, Lerner Res Inst, Cleveland, OH 44195 USA; [Sackstein, Robert] Harvard Univ, Sch Med, Brigham Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Sackstein, Robert] Harvard Univ, Sch Med, Brigham Womens Hosp, Dept Med, Boston, MA 02115 USA; [Nigro, Julie] Commonwealth Sci & Ind Res Org Mol & Hlth Technol, Clayton, Vic 3168, Australia	Cleveland Clinic Foundation; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Hascall, VC (corresponding author), Cleveland Clin, Dept Biomed Engn, Cleveland Clin Fdn, Lerner Res Inst, ND20, Cleveland, OH 44195 USA.	hascalv@ccf.org			National Institutes of Health [P11 HL081064, HL073714, CA121335]; NATIONAL CANCER INSTITUTE [R01CA121335] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073714, P01HL081064] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P11 HL081064, HL073714 (to R. S.), and CA121335 (to R. S.).	Berkin A, 2000, CARBOHYD RES, V326, P250, DOI 10.1016/S0008-6215(00)00049-5; BERNACKI RJ, 1977, J SUPRAMOL STR CELL, V7, P235, DOI 10.1002/jss.400070208; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; CONTRERAS A, 1978, J ANTIBIOT, V31, P598, DOI 10.7164/antibiotics.31.598; Dimitroff CJ, 2003, J CLIN INVEST, V112, P1008, DOI 10.1172/JCI200319220; Feng F, 2004, ORG BIOMOL CHEM, V2, P1617, DOI 10.1039/b402860k; Johnson PRA, 2000, AM J RESP CRIT CARE, V162, P2145, DOI 10.1164/ajrccm.162.6.9909111; Kisilevsky R, 2002, J MOL NEUROSCI, V19, P45, DOI 10.1007/s12031-002-0009-3; LOHMANDER S, 1979, ARCH BIOCHEM BIOPHYS, V192, P148, DOI 10.1016/0003-9861(79)90080-8; Morgenstern DA, 2002, PROG BRAIN RES, V137, P313; Nakashima Y, 2008, CARDIOVASC RES, V79, P14, DOI 10.1093/cvr/cvn099; POTTERPERIGO S, 1992, ARCH BIOCHEM BIOPHYS, V297, P101, DOI 10.1016/0003-9861(92)90646-E; Roberts C R, 1998, Can Respir J, V5, P48; SHARMA M, 1990, CARBOHYD RES, V198, P205, DOI 10.1016/0008-6215(90)84293-4; TSUCHIYA T, 1990, CHEM DEV FLUORINATED, P91; Uldry M, 2002, FEBS LETT, V524, P199, DOI 10.1016/S0014-5793(02)03058-2; Whitelock JM, 2008, BIOCHEMISTRY-US, V47, P11174, DOI 10.1021/bi8013938	17	26	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16832	16839		10.1074/jbc.M109.002956	http://dx.doi.org/10.1074/jbc.M109.002956			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19346253	Green Published, hybrid			2022-12-25	WOS:000266962400019
J	Williams, JR; Khandoga, AL; Goyal, P; Fells, JI; Perygin, DH; Siess, W; Parrill, AL; Tigyi, G; Fujiwara, Y				Williams, Jesica R.; Khandoga, Anna L.; Goyal, Pankaj; Fells, James I.; Perygin, Donna H.; Siess, Wolfgang; Parrill, Abby L.; Tigyi, Gabor; Fujiwara, Yuko			Unique Ligand Selectivity of the GPR92/LPA(5) Lysophosphatidate Receptor Indicates Role in Human Platelet Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; DIFFERENTIATION GENE FAMILY; CYCLIC PHOSPHATIDIC-ACID; LOW-DENSITY-LIPOPROTEIN; SPHINGOSINE 1-PHOSPHATE; N-ARACHIDONYLGLYCINE; ENDOGENOUS LIGANDS; ORPHAN GPCR; IDENTIFICATION; AGGREGATION	Lysophosphatidic acid (LPA) is a ligand for LPA(1-3) of the endothelial differentiation gene family G-protein-coupled receptors, and LPA(4-8) is related to the purinergic family G-protein-coupled receptor. Because the structure-activity relationship (SAR) of GPR92/LPA(5) is limited and whether LPA is its preferred endogenous ligand has been questioned in the literature, in this study we applied a combination of computational and experimental site-directed mutagenesis of LPA(5) residues predicted to interact with the headgroup of LPA. Four residues involved in ligand recognition in LPA(5) were identified as follows: R2.60N mutant abolished receptor activation, whereas H4.64E, R6.62A, and R7.32A greatly reduced receptor activation. We also investigated the SAR of LPA5 using LPA analogs and other non-lysophospholipid ligands. SAR revealed that the rank order of agonists is alkyl glycerol phosphate > LPA > farnesyl phosphates >> N-arachidonoylglycine. These results confirm LPA(5) to be a bona fide lysophospholipid receptor. We also evaluated several compounds with previously established selectivity for the endothelial differentiation gene receptors and found several that are LPA(5) agonists. A pharmacophore model of LPA(5) binding requirements was developed for in silico screening, which identified two non-lipid LPA(5) antagonists. Because LPA(5) transcripts are abundant in human platelets, we tested its antagonists on platelet activation and found that these non-lipid LPA(5) antagonists inhibit platelet activation. The present results suggest that selective inhibition of LPA(5) may provide a basis for future anti-thrombotic therapies.	[Tigyi, Gabor; Fujiwara, Yuko] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; [Williams, Jesica R.; Fells, James I.; Perygin, Donna H.; Parrill, Abby L.] Univ Memphis, Dept Chem, Memphis, TN 38152 USA; [Williams, Jesica R.; Fells, James I.; Perygin, Donna H.; Parrill, Abby L.] Univ Memphis, Computat Res Mat Inst, Memphis, TN 38152 USA; [Khandoga, Anna L.; Goyal, Pankaj; Siess, Wolfgang] Univ Munich, Fac Med, Inst Prevent Cardiovasc Dis, D-80336 Munich, Germany	University of Tennessee System; University of Tennessee Health Science Center; University of Memphis; University of Memphis; University of Munich	Fujiwara, Y (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Physiol, 894 Union Ave, Memphis, TN 38163 USA.	yuko@physio1.utmem.edu	Goyal, Pankaj/C-3567-2012; Siess, Wolfgang/A-6430-2009	Siess, Wolfgang/0000-0003-0698-6416; Parrill, Abby/0000-0003-1658-8497	National Institutes of Health [CA92160, HL79004, HL084007]; NCI; American Heart Association [0625325B, 0715125B]; Graduate Program of the Bavarian Eliteforderungsgesetz Deutsche Forschungsgemeinschaft [Si 274/9-3]; NATIONAL CANCER INSTITUTE [R01CA092160] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079004, R01HL084007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080405] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Heart Association(American Heart Association); Graduate Program of the Bavarian Eliteforderungsgesetz Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant CA92160 from NCI and National Institutes of Health Grants HL79004 ( to G. T.) and HL084007 ( to A. L. P.). This work was also supported by American Heart Association Grants 0625325B ( to Y. F.) and 0715125B ( to J. F.) and Graduate Program of the Bavarian Eliteforderungsgesetz Deutsche Forschungsgemeinschaft Grant Si 274/9-3 ( to A. L. K.).	Amisten S, 2008, THROMB RES, V122, P47, DOI 10.1016/j.thromres.2007.08.014; Baker DL, 2006, J BIOL CHEM, V281, P22786, DOI 10.1074/jbc.M512486200; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bandoh K, 1999, J BIOL CHEM, V274, P27776, DOI 10.1074/jbc.274.39.27776; Bond SD, 1999, J COMPUT PHYS, V151, P114, DOI 10.1006/jcph.1998.6171; Burstein SH, 2002, BIOCHEM PHARMACOL, V64, P1147, DOI 10.1016/S0006-2952(02)01301-1; Durgam GG, 2006, BIOORG MED CHEM LETT, V16, P633, DOI 10.1016/j.bmcl.2005.10.031; Fang XJ, 2002, BBA-MOL CELL BIOL L, V1582, P257, DOI 10.1016/S1388-1981(02)00179-8; Fells JI, 2008, BIOORGAN MED CHEM, V16, P6207, DOI 10.1016/j.bmc.2008.04.035; Fischer DJ, 1998, MOL PHARMACOL, V54, P979, DOI 10.1124/mol.54.6.979; Fujiwara Y, 2005, J BIOL CHEM, V280, P35038, DOI 10.1074/jbc.M504351200; GERLACH E, 1963, BIOCHEM Z, V337, P477; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Haseruck N, 2004, BLOOD, V103, P2585, DOI 10.1182/blood-2003-04-1127; Holdsworth G, 2005, GENE, V350, P59, DOI 10.1016/j.gene.2005.01.016; Inagaki Y, 2005, BIOCHEM J, V389, P187, DOI 10.1042/BJ20050046; Jin JG, 1998, P NATL ACAD SCI USA, V95, P8070, DOI 10.1073/pnas.95.14.8070; Keularts IMLW, 2000, J BIOL CHEM, V275, P1763, DOI 10.1074/jbc.275.3.1763; Khandoga AL, 2008, PLATELETS, V19, P415, DOI 10.1080/09537100802220468; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; Kotarsky K, 2006, J PHARMACOL EXP THER, V318, P619, DOI 10.1124/jpet.105.098848; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Liliom K, 2006, BBA-MOL CELL BIOL L, V1761, P1506, DOI 10.1016/j.bbalip.2006.09.012; Maschberger P, 2000, J BIOL CHEM, V275, P19159, DOI 10.1074/jbc.M910257199; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Murakami M, 2008, BIOCHEM BIOPH RES CO, V371, P707, DOI 10.1016/j.bbrc.2008.04.145; Naor MM, 2007, J MOL GRAPH MODEL, V26, P519, DOI 10.1016/j.jmgm.2007.03.004; NEGRESCU EV, 1995, J BIOL CHEM, V270, P1057, DOI 10.1074/jbc.270.3.1057; Oh DY, 2008, J BIOL CHEM, V283, P21054, DOI 10.1074/jbc.M708908200; Pamuklar Z, 2008, ARTERIOSCL THROM VAS, V28, P555, DOI 10.1161/ATVBAHA.107.151837; Panetti TS, 2001, PROSTAG OTH LIPID M, V64, P93, DOI 10.1016/S0090-6980(01)00102-2; Parrill AL, 2008, BBA-MOL CELL BIOL L, V1781, P540, DOI 10.1016/j.bbalip.2008.04.011; Parrill AL, 2005, BIOCHEM SOC T, V33, P1366, DOI 10.1042/BST0331366; Parrill AL, 2000, J BIOL CHEM, V275, P39379, DOI 10.1074/jbc.M007680200; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Pulcinelli FM, 1999, FEBS LETT, V460, P37, DOI 10.1016/S0014-5793(99)01313-7; Retzer M, 2000, CELL SIGNAL, V12, P645, DOI 10.1016/S0898-6568(00)00108-X; Rother E, 2003, CIRCULATION, V108, P741, DOI 10.1161/01.CIR.0000083715.37658.C4; Sardar VM, 2002, BBA-MOL CELL BIOL L, V1582, P309, DOI 10.1016/S1388-1981(02)00185-3; Siess W, 1999, P NATL ACAD SCI USA, V96, P6931, DOI 10.1073/pnas.96.12.6931; Siess W, 2004, J CELL BIOCHEM, V92, P1086, DOI 10.1002/jcb.20108; SIMON MF, 1982, BIOCHEM BIOPH RES CO, V108, P1743, DOI 10.1016/S0006-291X(82)80113-7; Szkopinska A, 2005, ACTA BIOCHIM POL, V52, P45; Tabata KI, 2007, BIOCHEM BIOPH RES CO, V363, P861, DOI 10.1016/j.bbrc.2007.09.063; Tigyi G, 2001, PROSTAG OTH LIPID M, V64, P47, DOI 10.1016/S0090-6980(01)00107-1; Uchiyama A, 2007, BBA-MOL CELL BIOL L, V1771, P103, DOI 10.1016/j.bbalip.2006.10.001; Valentine WJ, 2008, J BIOL CHEM, V283, P12175, DOI 10.1074/jbc.M708847200; Wang DA, 2001, J BIOL CHEM, V276, P49213, DOI 10.1074/jbc.M107301200; Weiner JA, 1999, P NATL ACAD SCI USA, V96, P5233, DOI 10.1073/pnas.96.9.5233	49	109	114	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17304	17319		10.1074/jbc.M109.003194	http://dx.doi.org/10.1074/jbc.M109.003194			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19366702	Green Published, hybrid			2022-12-25	WOS:000266962400066
J	Howlett, AC; Gray, AJ; Hunter, JM; Willardson, BM				Howlett, Alyson C.; Gray, Amy J.; Hunter, Jesse M.; Willardson, Barry M.			Role of Molecular Chaperones in G Protein beta 5/Regulator of G Protein Signaling Dimer Assembly and G Protein beta gamma Dimer Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSDUCIN-LIKE PROTEIN; GTPASE-ACCELERATING PROTEIN; CRYSTAL-STRUCTURE; RGS PROTEINS; SUBUNIT; COMPLEX; RHODOPSIN; TRAFFICKING; ACTIVATION; REGULATORS	The G protein beta gamma subunit dimer (G beta gamma) and the G beta 5/regulator of G protein signaling (RGS) dimer play fundamental roles in propagating and regulating G protein pathways, respectively. How these complexes form dimers when the individual subunits are unstable is a question that has remained unaddressed for many years. In the case of G beta gamma, recent studies have shown that phosducin-like protein 1 (PhLP1) works as a co-chaperone with the cytosolic chaperonin complex (CCT) to fold G beta and mediate its interaction with G gamma. However, it is not known what fraction of the many G beta gamma combinations is assembled this way or whether chaperones influence the specificity of G beta gamma dimer formation. Moreover, the mechanism of G beta 5-RGS assembly has yet to be assessed experimentally. The current study was undertaken to directly address these issues. The data show that PhLP1 plays a vital role in the assembly of G gamma 2 with all four G beta 1-4 subunits and in the assembly of G gamma 2 with all twelve G gamma subunits, without affecting the specificity of the G beta gamma interactions. The results also show that G beta 5-RGS7 assembly is dependent on CCT and PhLP1, but the apparent mechanism is different from that of G beta gamma. PhLP1 seems to stabilize the interaction of G beta 5 with CCT until G beta 5 is folded, after which it is released to allow G beta 5 to interact with RGS7. These findings point to a general role for PhLP1 in the assembly of all G beta gamma combinations and suggest a CCT-dependent mechanism for G beta 5-RGS7 assembly that utilizes the co-chaperone activity of PhLP1 in a unique way.	[Howlett, Alyson C.; Gray, Amy J.; Hunter, Jesse M.; Willardson, Barry M.] Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA	Brigham Young University	Willardson, BM (corresponding author), Brigham Young Univ, Dept Chem & Biochem, C-100 BNSN, Provo, UT 84602 USA.	barry_willardson@byu.edu		Willardson, Barry/0000-0002-8503-2268	National Institutes of Health [GM078550, EY012287]; NATIONAL EYE INSTITUTE [R01EY012287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM078550 and EY012287 (to B. M. W.).	Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Carter Michael D, 2004, J Biomol Tech, V15, P257; Cheever ML, 2008, NAT STRUCT MOL BIOL, V15, P155, DOI 10.1038/nsmb.1377; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; Dingus J, 2005, BIOCHEMISTRY-US, V44, P11882, DOI 10.1021/bi0504254; Downes GB, 1999, GENOMICS, V62, P544, DOI 10.1006/geno.1999.5992; Dupre DJ, 2007, J BIOL CHEM, V282, P13703, DOI 10.1074/jbc.M608846200; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Fletcher JE, 1998, J BIOL CHEM, V273, P636, DOI 10.1074/jbc.273.1.636; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; Gautam N, 1998, CELL SIGNAL, V10, P447, DOI 10.1016/S0898-6568(98)00006-0; Grantham J, 2006, EXP CELL RES, V312, P2309, DOI 10.1016/j.yexcr.2006.03.028; He W, 2000, J BIOL CHEM, V275, P37093, DOI 10.1074/jbc.M006982200; Hu G, 2002, P NATL ACAD SCI USA, V99, P9755, DOI 10.1073/pnas.152094799; Humrich J, 2005, J BIOL CHEM, V280, P20042, DOI 10.1074/jbc.M409233200; Jones MB, 2004, MOL INTERV, V4, P200, DOI 10.1124/mi.4.4.4; Jones MB, 1999, ANAL BIOCHEM, V268, P126, DOI 10.1006/abio.1998.3064; KISSELEV O, 1993, J BIOL CHEM, V268, P24519; Knol JC, 2005, MOL CELL BIOL, V25, P8393, DOI 10.1128/MCB.25.18.8393-8400.2005; Kubota S, 2006, P NATL ACAD SCI USA, V103, P8360, DOI 10.1073/pnas.0600195103; Kunisawa J, 2003, MOL CELL, V12, P565, DOI 10.1016/j.molcel.2003.08.009; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Lukov GL, 2006, J BIOL CHEM, V281, P22261, DOI 10.1074/jbc.M601590200; Lukov GL, 2005, EMBO J, V24, P1965, DOI 10.1038/sj.emboj.7600673; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; Martemyanov KA, 2005, J BIOL CHEM, V280, P5133, DOI 10.1074/jbc.C400596200; Martin-Benito J, 2004, P NATL ACAD SCI USA, V101, P17410, DOI 10.1073/pnas.0405070101; McLaughlin JN, 2002, P NATL ACAD SCI USA, V99, P7962, DOI 10.1073/pnas.112075699; McLaughlin JN, 2002, J BIOL CHEM, V277, P34885, DOI 10.1074/jbc.M205583200; Myung CS, 2006, MOL PHARMACOL, V69, P877, DOI 10.1124/mol.105.018994; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Ray K, 1996, TRENDS CARDIOVAS MED, V6, P115, DOI 10.1016/1050-1738(96)00021-7; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Robishaw JD, 2004, CURR OPIN CELL BIOL, V16, P206, DOI 10.1016/j.ceb.2004.02.007; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Savage JR, 2000, J BIOL CHEM, V275, P30399, DOI 10.1074/jbc.M005120200; Thulin CD, 1999, MOL VIS, V5, pU13; Valpuesta JM, 2002, FEBS LETT, V529, P11, DOI 10.1016/S0014-5793(02)03180-0; WATSON AJ, 1994, J BIOL CHEM, V269, P22150; Wells CA, 2006, J BIOL CHEM, V281, P20221, DOI 10.1074/jbc.M602409200; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Willars GB, 2006, SEMIN CELL DEV BIOL, V17, P363, DOI 10.1016/j.semcdb.2006.03.005; Witherow DS, 2003, RECEPTOR CHANNEL, V9, P205, DOI 10.1080/10606820390203848	43	21	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16386	16399		10.1074/jbc.M900800200	http://dx.doi.org/10.1074/jbc.M900800200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19376773	Green Published, hybrid			2022-12-25	WOS:000266730900036
J	Kim, JR; Kee, HJ; Kim, JY; Joung, H; Nam, KI; Eom, GH; Choe, N; Kim, HS; Kim, JC; Kook, H; Seo, SB; Kook, H				Kim, Ju-Ryoung; Kee, Hae Jin; Kim, Ji-Young; Joung, Hosouk; Nam, Kwang-Il; Eom, Gwang Hyeon; Choe, Nakwon; Kim, Hyung-Suk; Kim, Jeong Chul; Kook, Hoon; Seo, Sang Beom; Kook, Hyun			Enhancer of Polycomb1 Acts on Serum Response Factor to Regulate Skeletal Muscle Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; TRANSCRIPTION FACTOR; PROTEIN; TIP60; COMPLEX; CELLS; MYOD; ACTIVATION; CHROMATIN; PROMOTER	Skeletal muscle differentiation is well regulated by a series of transcription factors. We reported previously that enhancer of polycomb1 (Epc1), a chromatin protein, can modulate skeletal muscle differentiation, although the mechanisms of this action have yet to be defined. Here we report that Epc1 recruits both serum response factor (SRF) and p300 to induce skeletal muscle differentiation. Epc1 interacted physically with SRF. Transfection of Epc1 to myoblast cells potentiated the SRF-induced expression of skeletal muscle-specific genes as well as multinucleation. Proximal CArG box in the skeletal alpha-actin promoter was responsible for the synergistic activation of the promoter-luciferase. Epc1 knockdown caused a decrease in the acetylation of histones associated with serum response element (SRE) of the skeletal alpha-actin promoter. The Epc1.SRF complex bound to the SRE, and the knockdown of Epc1 resulted in a decrease in SRF binding to the skeletal alpha-actin promoter. Epc1 recruited histone acetyltransferase activity, which was potentiated by cotransfection with p300 but abolished by si-p300. Epc1 directly bound to p300 in myoblast cells. Epc1(+/-) mice showed distortion of skeletal alpha-actin, and the isolated myoblasts from the mice had impaired muscle differentiation. These results suggest that Epc1 is required for skeletal muscle differentiation by recruiting both SRF and p300 to the SRE of muscle-specific gene promoters.	[Kim, Ju-Ryoung; Kee, Hae Jin; Eom, Gwang Hyeon; Choe, Nakwon; Kook, Hyun] Chonnam Natl Univ, Dept Pharmacol, Sch Med, Kwangju 501746, South Korea; [Kim, Ju-Ryoung; Kee, Hae Jin; Joung, Hosouk; Eom, Gwang Hyeon; Choe, Nakwon; Kook, Hyun] Chonnam Natl Univ, Med Res Ctr Gene Regulat, Sch Med, Kwangju 501746, South Korea; [Nam, Kwang-Il] Chonnam Natl Univ, Dept Anat, Sch Med, Kwangju 501746, South Korea; [Kim, Hyung-Suk] Chonnam Natl Univ, Dept Forens Med, Sch Med, Kwangju 501746, South Korea; [Kee, Hae Jin; Joung, Hosouk; Nam, Kwang-Il; Kim, Hyung-Suk; Kook, Hoon; Kook, Hyun] Chonnam Natl Univ, Ctr Biomed Human Resources BK 21, Sch Med, Kwangju 501746, South Korea; [Kim, Jeong Chul] Chonnam Natl Univ Hosp, Dept Surg, Kwangju 501746, South Korea; [Kook, Hoon] Chonnam Natl Univ Hosp, Dept Pediat, Kwangju 501746, South Korea; [Kim, Ji-Young; Seo, Sang Beom] Chung Ang Univ, Coll Nat Sci, Dept Life Sci, Seoul 156745, South Korea	Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University Hospital; Chonnam National University; Chonnam National University Hospital; Chung Ang University	Kook, H (corresponding author), Chonnam Natl Univ, Dept Pharmacol, Sch Med, Kwangju 501746, South Korea.	kookhyun@chonnam.ac.kr	Kee, Hae Jin/ABC-9979-2021; Kook, Hyun/AAR-5405-2021; Nam, Kwang Il/C-4580-2019	Kook, Hyun/0000-0002-0740-1806; Nam, Kwang Il/0000-0001-5380-6815; Kee, Hae Jin/0000-0002-9774-4828	Korea Research Foundation [KRF-2007-313-E00126]; Ministry of Education, Science, and Technology [M10648000081-08N4800-08110]; Korean Government [KRF-2008-532-E00003]; Heart Research Center of Chonnam National University Hospital [A084869]	Korea Research Foundation(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korean Government(Korean Government); Heart Research Center of Chonnam National University Hospital	This work was supported in part by Korea Research Foundation Grant KRF-2007-313-E00126.; Supported by Research Program for New Drug Target Discovery Grant M10648000081-08N4800-08110 from the Ministry of Education, Science, and Technology and by Korea Research Foundation Grant KRF-2008-532-E00003 funded by the Korean Government.; Supported by Grant A084869 from the Heart Research Center of Chonnam National University Hospital.	Arnold HH, 1998, CURR OPIN GENET DEV, V8, P539, DOI 10.1016/S0959-437X(98)80008-7; Attwooll C, 2005, J BIOL CHEM, V280, P1199, DOI 10.1074/jbc.M412509200; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Boudreault AA, 2003, GENE DEV, V17, P1415, DOI 10.1101/gad.1056603; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Carnac G, 1998, MOL BIOL CELL, V9, P1891, DOI 10.1091/mbc.9.7.1891; Carson JA, 1998, AM J PHYSIOL-CELL PH, V275, pC1438, DOI 10.1152/ajpcell.1998.275.6.C1438; Chan HM, 2001, J CELL SCI, V114, P2363; Chang PS, 2001, J BIOL CHEM, V276, P17206, DOI 10.1074/jbc.M010983200; Croissant JD, 1996, DEV BIOL, V177, P250, DOI 10.1006/dbio.1996.0160; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Eckner R, 1996, GENE DEV, V10, P2478, DOI 10.1101/gad.10.19.2478; EDMONDSON DG, 1993, J BIOL CHEM, V268, P755; Fluck M, 2000, BIOCHEM BIOPH RES CO, V270, P488, DOI 10.1006/bbrc.2000.2457; Fu J, 2007, J BIOL CHEM, V282, P12410, DOI 10.1074/jbc.M608748200; Gupta M, 2007, CAN J PHYSIOL PHARM, V85, P349, DOI 10.1139/Y07-009; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Kee HJ, 2007, J BIOL CHEM, V282, P7700, DOI 10.1074/jbc.M611198200; Kim MS, 2006, J BIOL CHEM, V281, P15082, DOI 10.1074/jbc.M513593200; L'honore A, 2003, MOL BIOL CELL, V14, P2151, DOI 10.1091/mbc.e02-07-0451; Legube G, 2003, EMBO REP, V4, P944, DOI 10.1038/sj.embor.embor941; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Lim W, 2004, PHYSIOL GENOMICS, V18, P79, DOI 10.1152/physiolgenomics.00148.2003; Lough JW, 2002, DEV DYNAM, V223, P419, DOI 10.1002/dvdy.10058; Marsh DR, 1998, J MUSCLE RES CELL M, V19, P897, DOI 10.1023/A:1005485400448; McAllister D, 2002, GENE, V289, P169, DOI 10.1016/S0378-1119(02)00546-2; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Niu Z, 2005, J BIOL CHEM, V280, P32531, DOI 10.1074/jbc.M501372200; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; Roth JF, 2003, EMBO J, V22, P5186, DOI 10.1093/emboj/cdg473; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Shimono Y, 2000, J BIOL CHEM, V275, P39411, DOI 10.1074/jbc.M006585200; Stankunas K, 1998, DEVELOPMENT, V125, P4055; Stewart AFR, 1998, CIRC RES, V83, P43, DOI 10.1161/01.RES.83.1.43; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang SX, 2005, J BIOL CHEM, V280, P6204, DOI 10.1074/jbc.M409506200; Weinhold B, 2000, EMBO J, V19, P5835, DOI 10.1093/emboj/19.21.5835	42	28	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16308	16316		10.1074/jbc.M807725200	http://dx.doi.org/10.1074/jbc.M807725200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19359245	Green Published, hybrid			2022-12-25	WOS:000266730900028
J	Hui, XY; Zhu, WD; Wang, Y; Lam, KSL; Zhang, JL; Wu, DH; Kraegen, EW; Li, YX; Xu, AM				Hui, Xiaoyan; Zhu, Weidong; Wang, Yu; Lam, Karen S. L.; Zhang, Jialiang; Wu, Donghai; Kraegen, Edward W.; Li, Yixue; Xu, Aimin			Major Urinary Protein-1 Increases Energy Expenditure and Improves Glucose Intolerance through Enhancing Mitochondrial Function in Skeletal Muscle of Diabetic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSERVED LYSINE RESIDUES; INSULIN-RESISTANCE; COLLAGENOUS DOMAIN; METABOLIC SYNDROME; GENE-EXPRESSION; POTENTIAL ROLE; FEMALE MICE; LIVER; ADIPONECTIN; DYSFUNCTION	Major urinary protein-1 (MUP-1) is a low molecular weight secreted protein produced predominantly from the liver. Structurally it belongs to the lipocalin family, which carries small hydrophobic ligands such as pheromones. However, the physiological functions of MUP-1 remain poorly understood. Here we provide evidence demonstrating that MUP-1 is an important player in regulating energy expenditure and metabolism in mice. Both microarray and real-time PCR analysis demonstrated that the MUP-1 mRNA abundance in the liver of db/db obese mice was reduced by similar to 30-fold compared with their lean littermates, whereas this change was partially reversed by treatment with the insulin-sensitizing drug rosiglitazone. In both dietary and genetic obese mice, the circulating concentrations of MUP-1 were markedly decreased compared with the lean controls. Chronic elevation of circulating MUP-1 in db/db mice, using an osmotic pump-based protein delivery system, increased energy expenditure and locomotor activity, raised core body temperature, and decreased glucose intolerance as well as insulin resistance. At the molecular level, MUP-1-mediated improvement in metabolic profiles was accompanied by increased expression of genes involved in mitochondrial biogenesis, elevated mitochondrial oxidative capacity, decreased triglyceride accumulation, and enhanced insulin-evoked Akt signaling in skeletal muscle but not in liver. Altogether, these findings raise the possibility that MUP-1 deficiency might contribute to the metabolic dysregulation in obese/diabetic mice, and suggest that the beneficial metabolic effects of MUP-1 are attributed in part to its ability in increasing mitochondrial function in skeletal muscle.	[Zhu, Weidong; Lam, Karen S. L.; Zhang, Jialiang; Xu, Aimin] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Zhu, Weidong; Wang, Yu; Lam, Karen S. L.; Zhang, Jialiang; Xu, Aimin] Univ Hong Kong, Res Ctr Heart Brain Hormone & Healthy Aging, Hong Kong, Hong Kong, Peoples R China; [Wang, Yu; Xu, Aimin] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Hui, Xiaoyan; Li, Yixue] Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai 200031, Peoples R China; [Wu, Donghai] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou 510663, Guangdong, Peoples R China; [Kraegen, Edward W.] Univ New S Wales, Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Kraegen, Edward W.] Univ New S Wales, Sch Med Sci, Sydney, NSW 2010, Australia	University of Hong Kong; University of Hong Kong; University of Hong Kong; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Garvan Institute of Medical Research; University of New South Wales Sydney; University of New South Wales Sydney	Xu, AM (corresponding author), Univ Hong Kong, Dept Med, L8-40,New Lab Block,21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.	amxu@hkucc.hku.hk	HUI, Xiaoyan Hannah/M-5175-2019; Xu, Aimin/D-3291-2013	HUI, Xiaoyan Hannah/0000-0002-7525-5812; Xu, Aimin/0000-0002-0668-033X; wang, yu/0000-0001-8697-2940	Hong Kong Research Council General Research scheme [HKU778007M]; University of Hong Kong; Major State Basic Research Development Program [2006CB910700]	Hong Kong Research Council General Research scheme; University of Hong Kong(University of Hong Kong); Major State Basic Research Development Program(National Basic Research Program of China)	This work was funded by Grant HKU778007M from the Hong Kong Research Council General Research scheme (to Y.W.), a seeding fund for basic research and an Outstanding Young Researcher Award from the University of Hong Kong (to A.X.), and Major State Basic Research Development Program Grant 2006CB910700 (to Y.L.).	Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bhattacharjee A, 1998, TOXICOL APPL PHARM, V150, P186, DOI 10.1006/taap.1998.8392; Bradbury MW, 2006, AM J PHYSIOL-GASTR L, V290, pG194, DOI 10.1152/ajpgi.00413.2005; Brennan PA, 1999, NEUROSCIENCE, V90, P1463, DOI 10.1016/S0306-4522(98)00556-9; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Chen C, 2003, NAT BIOTECHNOL, V21, P294, DOI 10.1038/nbt795; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Fritsche L, 2008, CURR MED CHEM, V15, P1316, DOI 10.2174/092986708784534956; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Gervois P, 2004, J BIOL CHEM, V279, P16154, DOI 10.1074/jbc.M400346200; Holland WL, 2007, NUTR REV, V65, pS39, DOI 10.1301/nr.2007.jun.S39-S46; Hoo Ruby Lc, 2008, Expert Rev Endocrinol Metab, V3, P29, DOI 10.1586/17446651.3.1.29; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472; Kraegen EW, 2008, P NATL ACAD SCI USA, V105, P7627, DOI 10.1073/pnas.0803901105; Kumar KG, 2008, CELL METAB, V8, P468, DOI 10.1016/j.cmet.2008.10.011; Lara-Castro C, 2008, ENDOCRIN METAB CLIN, V37, P841, DOI 10.1016/j.ecl.2008.09.002; Lautt WW, 1999, CAN J PHYSIOL PHARM, V77, P553, DOI 10.1139/cjpp-77-8-553; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; MARCHLEWSKAKOJ A, 1981, J REPROD FERTIL, V61, P221, DOI 10.1530/jrf.0.0610221; MCINTOSH I, 1989, MOL CELL BIOL, V9, P2202, DOI 10.1128/MCB.9.5.2202; MUCIGNATCARETTA C, 1995, J PHYSIOL-LONDON, V486, P517, DOI 10.1113/jphysiol.1995.sp020830; Nisoli E, 2007, CIRC RES, V100, P795, DOI 10.1161/01.RES.0000259591.97107.6c; Oike Y, 2005, NAT MED, V11, P400, DOI 10.1038/nm1214; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Polonsky KS, 2006, NEW ENGL J MED, V354, P2596, DOI 10.1056/NEJMe068091; Reitman ML, 2007, CELL METAB, V5, P405, DOI 10.1016/j.cmet.2007.05.010; Sreekumar R, 2002, DIABETES, V51, P1913, DOI 10.2337/diabetes.51.6.1913; Wang W, 2007, ASAIO J, V53, P41, DOI 10.1097/01.mat.0000247960.90841.80; Wang Y, 2002, J BIOL CHEM, V277, P19521, DOI 10.1074/jbc.M200601200; Wang Y, 2007, MOL ENDOCRINOL, V21, P972, DOI 10.1210/me.2006-0249; Wang Y, 2006, J BIOL CHEM, V281, P16391, DOI 10.1074/jbc.M513907200; Xie HS, 1996, AM J PHYSIOL-ENDOC M, V270, pE858, DOI 10.1152/ajpendo.1996.270.5.E858; Xu A, 2007, CIRCULATION, V115, P1537, DOI 10.1161/CIRCULATIONAHA.106.647503; Xu AM, 2009, ENDOCRINOLOGY, V150, P625, DOI 10.1210/en.2008-0999; Xu AM, 2005, P NATL ACAD SCI USA, V102, P6086, DOI 10.1073/pnas.0408452102; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476; Zhou MY, 2008, HEPATOLOGY, V48, P1087, DOI 10.1002/hep.22444	42	91	94	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14050	14057		10.1074/jbc.M109.001107	http://dx.doi.org/10.1074/jbc.M109.001107			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19336396	Green Published, hybrid			2022-12-25	WOS:000266286100011
J	Lee, SH; Lee, SJ; Chung, JY; Jung, YS; Choi, SY; Hwang, SH; Choi, D; Ha, NC; Park, BJ				Lee, S-H; Lee, S-J; Chung, J-Y; Jung, Y-S; Choi, S-Y; Hwang, S. H.; Choi, D.; Ha, N-C; Park, B-J			p53, secreted by K-Ras-Snail pathway, is endocytosed by K-Ras-mutated cells; implication of target-specific drug delivery and early diagnostic marker	ONCOGENE			English	Article						p53; Snail; secretion; endocytosis; diagnostic marker	COLON-CANCER CELLS; ANTI-P53 ANTIBODIES; NUCLEAR EXPORT; EXPRESSION; MUTATIONS; ACTIVATION; CHOLANGIOCARCINOMAS; RESTORATION; CLEARANCE; ONCOGENE	p53 is eliminated from K-Ras-mutated cancer cells through direct interaction with Snail. However, it is not achieved through proteasome-mediated degradation or transcriptional repression. Here we provide evidence that p53, binding with Snail, is exported from a K-Ras-mutated cell through a vesicle transport-like mechanism, independently using a p53-nuclear-exporting mechanism. Although we can detect p53 in culture media, a majority of p53 might be degraded by extracellular proteases. Thus, we can recover the secreted p53 in culture media by the inhibition of protease and endocytosis. In addition, a considerable amount of p53 is endocytosed by neighboring cells. As p53 resorption occurs in a K-Ras-dependent manner, treatment of recombinant p53 is detected in the whole-cell lysate of K-Ras-mutated cells, but not in that of wild-type cells. Using the property of p53, we can deliver the chemical (propidium iodine) into K-Ras mutated cells selectively. In contrast, Snail, a co-secreted protein with p53 in response to oncogenic K-Ras, shows resistance to endocytosis and protease, and results in remaining in the media. Thus, we can detect an autoantibody against Snail in the serum of a human cancer patient. Our finding can be used for a mutant K-Ras-specific anticancer drug delivery system and for the diagnosis of pancreatic, colon and lung cancers. Oncogene (2009) 28, 2005-2014; doi:10.1038/onc.2009.67; published online 6 April 2009	[Lee, S-H; Lee, S-J; Chung, J-Y; Jung, Y-S; Choi, S-Y; Park, B-J] Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, Pusan 609735, South Korea; [Hwang, S. H.] Pusan Natl Univ Hosp, Dept Lab Med, Pusan, South Korea; [Choi, D.] Shunchoonhyang Med Ctr, Seoul, South Korea; [Ha, N-C] Pusan Natl Univ, Coll Pharm, Dept Mfg Pharm, Pusan 609735, South Korea	Pusan National University; Pusan National University; Pusan National University Hospital; Pusan National University	Park, BJ (corresponding author), Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, Pusan 609735, South Korea.	bjpark1219@pusan.ac.kr	Lee, Sang Joon/AAG-2448-2019; Hwang, Sang-Hyun/C-3571-2008; Hwang, Sanghyun/L-5314-2019	Hwang, Sang-Hyun/0000-0003-3201-5728; Hwang, Sanghyun/0000-0003-3201-5728	Research Team for Longevity Life Sciences in Pusan National University; Pusan National University (PNU) [PNU-2008-101-2008-596-000]	Research Team for Longevity Life Sciences in Pusan National University; Pusan National University (PNU)	This work was supported by a research grant from the Research Team for Longevity Life Sciences in Pusan National University and by the Bio-Scientific Research Grant funded by the Pusan National University (PNU, Bio-Scientific Research Grant)(PNU-2008-101-2008-596-000).	Bergqvist M, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-66; Bres V, 2003, NAT CELL BIOL, V5, P754, DOI 10.1038/ncb1023; Collins NL, 2005, MOL CELL BIOL, V25, P5282, DOI 10.1128/MCB.25.12.5282-5291.2005; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Genschel J, 2000, HUM MUTAT, V16, P451, DOI 10.1002/1098-1004(200012)16:6<451::AID-HUMU1>3.0.CO;2-9; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Halaschek-Wiener J, 2004, CELL SIGNAL, V16, P1319, DOI 10.1016/j.cellsig.2004.04.003; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004; Koivusalo R, 2006, CANCER RES, V66, P11817, DOI 10.1158/0008-5472.CAN-06-2185; Le PU, 2003, J CELL SCI, V116, P1059, DOI 10.1242/jcs.00327; Lee SH, 2009, NEOPLASIA, V11, P22, DOI 10.1593/neo.81006; LEON M, 1995, ANTICANCER RES, V15, P859; LEVI S, 1991, CANCER RES, V51, P3497; Limpaiboon T, 2004, HEPATO-GASTROENTEROL, V51, P25; Nie LH, 2007, J BIOL CHEM, V282, P14616, DOI 10.1074/jbc.M610515200; Park BJ, 2006, CANCER RES, V66, P6913, DOI 10.1158/0008-5472.CAN-05-3740; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Roy UKB, 2008, MOL CARCINOGEN, V47, P538, DOI 10.1002/mc.20414; Shin J, 2006, CELL PHYSIOL BIOCHEM, V17, P211, DOI 10.1159/000094126; Soussi T, 2000, CANCER RES, V60, P1777; Sun YB, 2000, J BIOL CHEM, V275, P11327, DOI 10.1074/jbc.275.15.11327; TSUDA H, 1992, MOL CARCINOGEN, V6, P266, DOI 10.1002/mc.2940060408; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yang GY, 2005, CA-CANCER J CLIN, V55, P352, DOI 10.3322/canjclin.55.6.352	30	28	31	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 14	2009	28	19					2005	2014		10.1038/onc.2009.67	http://dx.doi.org/10.1038/onc.2009.67			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	445BF	19347028				2022-12-25	WOS:000266023900001
J	Vepachedu, R; Karim, Z; Patel, O; Goplen, N; Alam, R				Vepachedu, Ramarao; Karim, Zunayet; Patel, Ojas; Goplen, Nicholas; Alam, Rafeul			Unc119 Protects from Shigella Infection by Inhibiting the Abl Family Kinases	PLOS ONE			English	Article							ACTIN-BINDING DOMAINS; TYROSINE KINASE; F-ACTIN; EPITHELIAL-CELLS; FLEXNERI; INVASION; ENTRY; PHOSPHORYLATION; CORTACTIN; INNATE	Background: Bacteria engage cell surface receptors and intracellular signaling molecules to enter the cell. Unc119 is an adaptor protein, which interacts with receptors and tyrosine kinases. Its role in bacterial invasion of cells is unknown. Methodology/Principal Findings: We used biochemical, molecular and cell biology approaches to identify the binding partners of Unc119, and to study the effect of Unc119 on Abl family kinases and Shigella infection. We employed loss-of-function and gain-in-function approaches to study the effect of Unc119 in a mouse model of pulmonary shigellosis. Unc119 interacts with Abl family kinases and inhibits their kinase activity. As a consequence, it inhibits Crk phosphorylation, which is essential for Shigella infection. Unc119 co-localizes with Crk and Shigella in infected cells. Shigella infectivity increases in Unc119-deficient epithelial and macrophage cells. In a mouse model of shigellosis cell-permeable TAT-Unc119 inhibits Shigella infection. Conversely, Unc119 knockdown in vivo results in enhanced bacterial invasion and increased lethality. Unc119 is an inducible protein. Its expression is upregulated by probacteria and bacterial products such as lipopolysacharide and sodium butyrate. The latter inhibits Shigella infection in mouse lungs but is ineffective in Unc119 deficiency. Conclusions: Unc119 inhibits signaling pathways that are used by Shigella to enter the cell. As a consequence it provides partial but significant protection from Shigella infections. Unc119 induction in vivo boosts host defense against infections.			Vepachedu, R (corresponding author), Natl Jewish Hlth, Denver, CO USA.	alamr@njc.org			NHLBI NIH HHS [HL 36577, P01 HL036577] Funding Source: Medline; NIAID NIH HHS [AI68088, HHSN272200700048C, R01 AI059719, R01 AI068088] Funding Source: Medline; PHS HHS [N01 HHSN 272200700048C] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059719, R01AI068088] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bougneres L, 2004, J CELL BIOL, V166, P225, DOI 10.1083/jcb.200402073; Bourdet-Sicard R, 1999, EMBO J, V18, P5853, DOI 10.1093/emboj/18.21.5853; Bourguignon LYW, 2001, J BIOL CHEM, V276, P7327, DOI 10.1074/jbc.M006498200; Burton EA, 2003, EMBO J, V22, P5471, DOI 10.1093/emboj/cdg512; Cen O, 2003, J BIOL CHEM, V278, P8837, DOI 10.1074/jbc.M208261200; Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035; DAI ZH, 1995, GENE DEV, V9, P2569, DOI 10.1101/gad.9.21.2569; DEHIO C, 1995, EMBO J, V14, P2471, DOI 10.1002/j.1460-2075.1995.tb07244.x; Dumenil G, 1998, J CELL BIOL, V143, P1003, DOI 10.1083/jcb.143.4.1003; Dumenil G, 2000, J CELL SCI, V113, P71; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; ELSINGHORST EA, 1994, METHOD ENZYMOL, V236, P405; Elwell CA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000021; Gorska MM, 2004, J EXP MED, V199, P369, DOI 10.1084/jem.20030589; Handa Y, 2007, NAT CELL BIOL, V9, P121, DOI 10.1038/ncb1526; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; Ingersoll MA, 2006, INFECT IMMUN, V74, P2317, DOI 10.1128/IAI.74.4.2317-2327.2006; Kain KH, 2001, J BIOL CHEM, V276, P16185, DOI 10.1074/jbc.M100095200; Lafont F, 2002, EMBO J, V21, P4449, DOI 10.1093/emboj/cdf457; Leng Y, 2005, P NATL ACAD SCI USA, V102, P1098, DOI 10.1073/pnas.0409120102; Miller AL, 2004, J CELL BIOL, V165, P407, DOI 10.1083/jcb.200308055; NORIEGA FR, 1994, INFECT IMMUN, V62, P5168, DOI 10.1128/IAI.62.11.5168-5172.1994; Ogawa M, 2008, NAT REV MICROBIOL, V6, P11, DOI 10.1038/nrmicro1814; PHALIPON A, 1995, J EXP MED, V182, P769, DOI 10.1084/jem.182.3.769; Phalipon A, 2007, IMMUNOL CELL BIOL, V85, P119, DOI 10.1038/sj.icb7100025; Phillips C, 2000, CANCER PRACT, V8, P165, DOI 10.1046/j.1523-5394.2000.84009.x; Plattner R, 2003, NAT CELL BIOL, V5, P309, DOI 10.1038/ncb949; Raqib R, 2006, P NATL ACAD SCI USA, V103, P9178, DOI 10.1073/pnas.0602888103; Reeves PM, 2005, NAT MED, V11, P731, DOI 10.1038/nm1265; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; SHI YG, 1995, GENE DEV, V9, P2583, DOI 10.1101/gad.9.21.2583; Skoudy A, 2000, CELL MICROBIOL, V2, P19, DOI 10.1046/j.1462-5822.2000.00028.x; TENHOEVE J, 1994, BLOOD, V84, P1731; Van Nhieu GT, 1999, CURR OPIN MICROBIOL, V2, P51; VANDEVERG LL, 1995, INFECT IMMUN, V63, P1947, DOI 10.1128/IAI.63.5.1947-1954.1995; VANETTEN RA, 1994, J CELL BIOL, V124, P325, DOI 10.1083/jcb.124.3.325; VANNHIEU GT, 2000, CELL MICROBIOL, V2, P187, DOI DOI 10.1046/J.1462-5822.2000.00046.X; Vepachedu R, 2007, J IMMUNOL, V179, P682, DOI 10.4049/jimmunol.179.1.682; Wang YX, 2001, P NATL ACAD SCI USA, V98, P14865, DOI 10.1073/pnas.251249298; Watarai M, 1996, J EXP MED, V183, P991, DOI 10.1084/jem.183.3.991; Way SS, 1998, INFECT IMMUN, V66, P1342, DOI 10.1128/IAI.66.4.1342-1348.1998; WELCH PJ, 1993, CELL, V75, P779, DOI 10.1016/0092-8674(93)90497-E; Wen ST, 1997, GENE DEV, V11, P2456, DOI 10.1101/gad.11.19.2456; Woodring PJ, 2003, J CELL SCI, V116, P2613, DOI 10.1242/jcs.00622; Woodring PJ, 2002, J CELL BIOL, V156, P879, DOI 10.1083/jcb.200110014; Woodring PJ, 2001, J BIOL CHEM, V276, P27104, DOI 10.1074/jbc.M100559200; Yoshida S, 2003, TRENDS MICROBIOL, V11, P139, DOI 10.1016/S0966-842X(03)00023-4; Zhu JY, 1996, MOL CELL BIOL, V16, P7054	50	12	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2009	4	4							e5211	10.1371/journal.pone.0005211	http://dx.doi.org/10.1371/journal.pone.0005211			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TW	19381274	gold, Green Published, Green Submitted			2022-12-25	WOS:000265510800006
J	Villaescusa, JC; Buratti, C; Penkov, D; Mathiasen, L; Planaguma, J; Ferretti, E; Blasi, F				Villaescusa, J. Carlos; Buratti, Claudia; Penkov, Dmitry; Mathiasen, Lisa; Planaguma, Jesus; Ferretti, Elisabetta; Blasi, Francesco			Cytoplasmic Prep1 Interacts with 4EHP Inhibiting Hoxb4 Translation	PLOS ONE			English	Article							HOMEOBOX-CONTAINING GENES; MESSENGER-RNA; MEIOTIC MATURATION; OOCYTE MATURATION; MOUSE OOCYTES; PROTEIN; EXPRESSION; DROSOPHILA; PBX; POLYADENYLATION	Background: Homeobox genes are essential for embryonic patterning and cell fate determination. They are regulated mostly at the transcriptional level. In particular, Prep1 regulates Hox transcription in association with Pbx proteins. Despite its nuclear role as a transcription factor, Prep1 is located in the cytosol of mouse oocytes from primary to antral follicles. The homeodomain factor Bicoid (Bcd) has been shown to interact with 4EHP (eukaryotic translation initiation factor 4E homolog protein) to repress translation of Caudal mRNA and to drive Drosophila embryo development. Interestingly, Prep1 contains a putative binding motif for 4EHP, which may reflect a novel unknown function. Methodology/Principal Findings: In this paper we show by confocal microscopy and deconvolution analysis that Prep1 and 4EHP co-localize in the cytosol of growing mouse oocytes, demonstrating their interaction by co-immunoprecipitation and pull-down experiments. A functional 4EHP-binding motif present in Prep1 has been also identified by mutagenesis analysis. Moreover, Prep1 inhibits (>95%) the in vitro translation of a luciferase reporter mRNA fused to the Hoxb4 3'UTR, in the presence of 4EHP. RNA electrophoretic mobility shift assay was used to demonstrate that Prep1 binds the Hoxb4 3'UTR. Furthermore, conventional histology and immunohistochemistry has shown a dramatic oocyte growth failure in hypomorphic mouse Prep1(i/i) females, accompanied by an increased production of Hoxb4. Finally, Hoxb4 overexpression in mouse zygotes showed a slow in vitro development effect. Conclusions: Prep1 has a novel cytoplasmic, 4EHP-dependent, function in the regulation of translation. Mechanistically, the Prep1-4EHP interaction might bridge the 3'UTR of Hoxb4 mRNA to the 59 cap structure. This is the first demonstration that a mammalian homeodomain transcription factor regulates translation, and that this function can be possibly essential for the development of female germ cells and involved in mammalian zygote development.			Villaescusa, JC (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Lab, Stockholm, Sweden.	blasi.Francesco@hsr.it	Ferretti, Elisabetta/ABD-7257-2021	Villaescusa, J. Carlos/0000-0001-9456-9828; Blasi, Francesco/0000-0001-9406-1784	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; Telethon [GGP06028] Funding Source: Medline	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Telethon(Fondazione Telethon)		Angenstein F, 2005, J BIOL CHEM, V280, P6496, DOI 10.1074/jbc.M412742200; BACHVAROVA R, 1989, DEVELOPMENT, V106, P561; BACHVAROVA R, 1985, DEV BIOL, V108, P325, DOI 10.1016/0012-1606(85)90036-3; BACHVAROVA R, 1981, DEV BIOL, V86, P384, DOI 10.1016/0012-1606(81)90196-2; Berthelsen J, 1999, GENE DEV, V13, P946, DOI 10.1101/gad.13.8.946; Brend T, 2003, DEVELOPMENT, V130, P2717, DOI 10.1242/dev.00471; Brun ACM, 2004, BLOOD, V103, P4126, DOI 10.1182/blood-2003-10-3557; CHATOT CL, 1989, J REPROD FERTIL, V86, P679, DOI 10.1530/jrf.0.0860679; Chawengsaksophak K, 1996, GENOMICS, V34, P270, DOI 10.1006/geno.1996.0286; Cho PF, 2005, CELL, V121, P411, DOI 10.1016/j.cell.2005.02.024; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Deflorian G, 2004, DEVELOPMENT, V131, P613, DOI 10.1242/dev.00948; Diaz VM, 2007, MOL CELL BIOL, V27, P7981, DOI 10.1128/MCB.01290-07; DIROSA P, 2007, DEV BIOL; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; Ferretti E, 2000, DEVELOPMENT, V127, P155; Ferretti E, 2005, MOL CELL BIOL, V25, P8541, DOI 10.1128/MCB.25.19.8541-8552.2005; Ferretti E, 2006, MOL CELL BIOL, V26, P5650, DOI 10.1128/MCB.00313-06; GEBAUER F, 1994, EMBO J, V13, P5712, DOI 10.1002/j.1460-2075.1994.tb06909.x; HUARTE J, 1987, GENE DEV, V1, P1201, DOI 10.1101/gad.1.10.1201; Kuersten S, 2003, NAT REV GENET, V4, P626, DOI 10.1038/nrg1125; Kuliev A, 1996, J ASSIST REPROD GEN, V13, P177, DOI 10.1007/BF02072541; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; MURTHA MT, 1991, P NATL ACAD SCI USA, V88, P10711, DOI 10.1073/pnas.88.23.10711; Niessing D, 2002, GENE DEV, V16, P2576, DOI 10.1101/gad.240002; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Oh B, 2000, DEVELOPMENT, V127, P3795; Penkov D, 2005, MOL CELL BIOL, V25, P10768, DOI 10.1128/MCB.25.24.10768-10781.2005; Ponsuksili S, 2001, MOL REPROD DEV, V60, P297, DOI 10.1002/mrd.1091; Rom E, 1998, J BIOL CHEM, V273, P13104, DOI 10.1074/jbc.273.21.13104; SCHULTZ RM, 1983, DEV BIOL, V97, P264, DOI 10.1016/0012-1606(83)90085-4; SCHULTZ RM, 1983, DEV BIOL, V95, P294, DOI 10.1016/0012-1606(83)90030-1; Sedarat F, 2004, J APPL PHYSIOL, V97, P1098, DOI 10.1152/japplphysiol.00089.2004; Semotok JL, 2007, DIFFERENTIATION, V75, P482, DOI 10.1111/j.1432-0436.2007.00178.x; SMALL S, 1991, GENE DEV, V5, P827, DOI 10.1101/gad.5.5.827; Small S, 1991, CURR OPIN GENET DEV, V1, P255, DOI 10.1016/S0959-437X(05)80079-6; Stauber M, 1999, P NATL ACAD SCI USA, V96, P3786, DOI 10.1073/pnas.96.7.3786; Tee AR, 2004, FEBS LETT, V564, P58, DOI 10.1016/S0014-5793(04)00313-8; Thomson AM, 1999, BIOTECHNIQUES, V27, P1032, DOI 10.2144/99275rr03; Topisirovic I, 2005, HISTOL HISTOPATHOL, V20, P1275, DOI 10.14670/HH-20.1275; Villaescusa JC, 2004, GENE, V330, P1, DOI 10.1016/j.gene.2004.01.024; Waskiewicz AJ, 2002, DEV CELL, V3, P723, DOI 10.1016/S1534-5807(02)00319-2; Zuberek J, 2007, RNA, V13, P691, DOI 10.1261/rna.453107	43	38	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5213	10.1371/journal.pone.0005213	http://dx.doi.org/10.1371/journal.pone.0005213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TN	19365557	Green Published, Green Submitted, gold			2022-12-25	WOS:000265509900018
J	Calvo-Pinilla, E; Rodriguez-Calvo, T; Anguita, J; Sevilla, N; Ortego, J				Calvo-Pinilla, Eva; Rodriguez-Calvo, Teresa; Anguita, Juan; Sevilla, Noemi; Ortego, Javier			Establishment of a Bluetongue Virus Infection Model in Mice that Are Deficient in the Alpha/Beta Interferon Receptor	PLOS ONE			English	Article								Bluetongue (BT) is a noncontagious, insect-transmitted disease of ruminants caused by the bluetongue virus (BTV). A laboratory animal model would greatly facilitate the studies of pathogenesis, immune response and vaccination against BTV. Herein, we show that adult mice deficient in type I IFN receptor (IFNAR((-/-))) are highly susceptible to BTV-4 and BTV-8 infection when the virus is administered intravenously. Disease was characterized by ocular discharges and apathy, starting at 48 hours post-infection and quickly leading to animal death within 60 hours of inoculation. Infectious virus was recovered from the spleen, lung, thymus, and lymph nodes indicating a systemic infection. In addition, a lymphoid depletion in spleen, and severe pneumonia were observed in the infected mice. Furthermore, IFNAR((-/-)) adult mice immunized with a BTV-4 inactivated vaccine showed the induction of neutralizing antibodies against BTV-4 and complete protection against challenge with a lethal dose of this virus. The data indicate that this mouse model may facilitate the study of BTV pathogenesis, and the development of new effective vaccines for BTV.			Calvo-Pinilla, E (corresponding author), CISA INIA, Ctr Invest Sanidad Anim, Madrid, Spain.	ortego@inia.es	Rodriguez-Calvo, Teresa/A-6831-2010; Ortego, Javier/M-6810-2019; Rodriguez-Calvo, Teresa/AAH-2365-2019; ortego, javier/K-6020-2014; Sevilla, Noemi/K-8648-2014; Anguita, Juan/D-5432-2011; CALVO-PINILLA, EVA/L-5348-2014	Ortego, Javier/0000-0002-4275-7277; ortego, javier/0000-0002-4275-7277; Sevilla, Noemi/0000-0003-0118-0376; Anguita, Juan/0000-0003-2061-7182; CALVO-PINILLA, EVA/0000-0002-4667-4081				BARRATTBOYES SM, 1994, VET MICROBIOL, V40, P361, DOI 10.1016/0378-1135(94)90123-6; Barros SC, 2007, VET MICROBIOL, V124, P25, DOI 10.1016/j.vetmic.2007.04.014; Bouloy M, 2001, J VIROL, V75, P1371, DOI 10.1128/JVI.75.3.1371-1377.2001; Breard E, 2007, VIRUS RES, V125, P191, DOI 10.1016/j.virusres.2007.01.002; Brewer AW, 1998, ARCH VIROL, V143, P145, DOI 10.1007/s007050050274; CARR MA, 1995, ARCH VIROL, V140, P915, DOI 10.1007/BF01314967; DeMaula CD, 2000, VIRUS RES, V67, P59, DOI 10.1016/S0168-1702(00)00130-1; FIETTE L, 1995, J EXP MED, V181, P2069, DOI 10.1084/jem.181.6.2069; FOSTER NM, 1991, AM J VET RES, V52, P192; Franchi P, 2008, J VIROL METHODS, V153, P263, DOI 10.1016/j.jviromet.2008.07.007; FULTON RW, 1982, CAN J COMP MED, V46, P100; Ida-Hosonuma M, 2005, J VIROL, V79, P4460, DOI 10.1128/JVI.79.7.4460-4469.2005; Jameson P, 1981, Methods Enzymol, V78, P254; JAMESON P, 1978, INFECT IMMUN, V20, P321, DOI 10.1128/IAI.20.1.321-323.1978; Jones LD, 1997, CLIN DIAGN LAB IMMUN, V4, P297, DOI 10.1128/CDLI.4.3.297-301.1997; LETCHWORTH GJ, 1983, INFECT IMMUN, V39, P208, DOI 10.1128/IAI.39.1.208-212.1983; MACLACHLAN NJ, 1985, AM J VET RES, V46, P1238; MACLACHLAN NJ, 1990, VET PATHOL, V27, P223, DOI 10.1177/030098589002700402; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Mellor PS, 2002, VET J, V164, P20, DOI 10.1053/tvjl.2002.0713; Mertens PPC, 2004, VIRUS RES, V101, P29, DOI 10.1016/j.virusres.2003.12.004; Mrkic B, 1998, J VIROL, V72, P7420, DOI 10.1128/JVI.72.9.7420-7427.1998; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; NARAYAN O, 1972, AM J PATHOL, V68, P1; Ohka S, 2007, J VIROL, V81, P7902, DOI 10.1128/JVI.02675-06; Ohno S, 2007, J VIROL, V81, P1650, DOI 10.1128/JVI.02134-06; PARADELL HMM, 2008, BLUET MIN BRESC; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; REED L. J., 1938, AMER JOUR HYG, V27, P493; Saegerman C, 2008, EMERG INFECT DIS, V14, P539, DOI 10.3201/eid1404.071441; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Schwartz-Cornil I, 2008, VET RES, V39, DOI 10.1051/vetres:2008023; SEN GC, 1993, ADV VIRUS RES, V42, P57, DOI 10.1016/S0065-3527(08)60083-4; Staeheli P, 1990, Adv Virus Res, V38, P147, DOI 10.1016/S0065-3527(08)60862-3; Toussaint JF, 2007, J VIROL METHODS, V140, P115, DOI 10.1016/j.jviromet.2006.11.007; VERWOERD DW, 1970, J VIROL, V5, P1; VERWOERD DW, 1972, J VIROL, V10, P783, DOI 10.1128/JVI.10.4.783-794.1972; Waibler Z, 2007, J VIROL, V81, P12102, DOI 10.1128/JVI.01190-07	38	70	70	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5171	10.1371/journal.pone.0005171	http://dx.doi.org/10.1371/journal.pone.0005171			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357779	Green Published, gold, Green Submitted			2022-12-25	WOS:000265505900022
J	Adeney, JM; Christensen, NL; Pimm, SL				Adeney, J. Marion; Christensen, Norman L., Jr.; Pimm, Stuart L.			Reserves Protect against Deforestation Fires in the Amazon	PLOS ONE			English	Article							LAND-USE; CONSERVATION; CLIMATE; HIGHWAY; FEEDBACKS; PATTERNS; DROUGHT; IMPACT; POLICY; FUTURE	Background: Reserves are the principal means to conserve forests and biodiversity, but the question of whether reserves work is still debated. In the Amazon, fires are closely linked to deforestation, and thus can be used as a proxy for reserve effectiveness in protecting forest cover. We ask whether reserves in the Brazilian Amazon provide effective protection against deforestation and consequently fires, whether that protection is because of their location or their legal status, and whether some reserve types are more effective than others. Methodology/Principal Findings: Previous work has shown that most Amazonian fires occur close to roads and are more frequent in El Nino years. We quantified these relationships for reserves and unprotected areas by examining satellite-detected hot pixels regressed against road distance across the entire Brazilian Amazon and for a decade with 2 El Nino-related droughts. Deforestation fires, as measured by hot pixels, declined exponentially with increasing distance from roads in all areas. Fewer deforestation fires occurred within protected areas than outside and the difference between protected and unprotected areas was greatest near roads. Thus, reserves were especially effective at preventing these fires where they are known to be most likely to burn; but they did not provide absolute protection. Even within reserves, at a given distance from roads, there were more deforestation fires in regions with high human impact than in those with low impact. The effect of El Nino on deforestation fires was greatest outside of reserves and near roads. Indigenous reserves, limited-use reserves, and fully protected reserves all had fewer fires than outside areas and did not appear to differ in their effectiveness. Conclusions/Significance: Taking time, regional factors, and climate into account, our results show that reserves are an effective tool for curbing destructive burning in the Amazon.			Adeney, JM (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	stuartpimm@aol.com	pimm, stuart/ABF-1082-2020					Alencar A, 2006, EARTH INTERACT, V10; Aragao LEOC, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2006GL028946., 10.1029/2006GL028946]; Arima EY, 2007, J REGIONAL SCI, V47, P541, DOI 10.1111/j.1467-9787.2007.00519.x; Asner GP, 2005, SCIENCE, V310, P480, DOI 10.1126/science.1118051; Bell GD, 1999, B AM METEOROL SOC, V80, pS1, DOI 10.1175/1520-0477-80.5s.S1; BOWMAN MS, 2008, ECOLOGICAL EC; Campos MT, 2006, CONSERV BIOL, V20, P1553, DOI 10.1111/j.1523-1739.2006.00546.x; Carvalho GO, 2002, ENVIRONMENT, V44, P34, DOI 10.1080/00139150209605606; Chomitz KM, 2003, AM J AGR ECON, V85, P1016, DOI 10.1111/1467-8276.00504; Cochrane MA, 2003, NATURE, V421, P913, DOI 10.1038/nature01437; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; Curtis S, 2007, J HYDROMETEOROL, V8, P678, DOI 10.1175/JHM601.1; de Mendonca MJC, 2004, ECOL ECON, V49, P89, DOI 10.1016/j.ecolecon.2003.11.011; *ESA ESRIN, 2004, ION ATSR WORLD FIR A; Fearnside PM, 2007, ENVIRON MANAGE, V39, P601, DOI 10.1007/s00267-006-0149-2; Fearnside PM, 2006, ENVIRON MANAGE, V38, P705, DOI 10.1007/s00267-005-0295-y; Fearnside PM, 2003, WORLD DEV, V31, P757, DOI 10.1016/S0305-750X(03)00011-1; Ferreira LV, 2005, ESTUD AV-SAO PAULO, V19, P157, DOI DOI 10.1590/S0103-40142005000100010; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; GOODLAND RJ, 1975, AMAZON JUNGLE GREEN; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; Kerr RA, 2000, SCIENCE, V288, P1984, DOI 10.1126/science.288.5473.1984; Kirby KR, 2006, FUTURES, V38, P432, DOI 10.1016/j.futures.2005.07.011; Malhi Y, 2004, PHILOS T R SOC B, V359, P311, DOI 10.1098/rstb.2003.1433; Marengo JA, 2008, J CLIMATE, V21, P495, DOI 10.1175/2007JCLI1600.1; MESQUITA RCG, 2007, BIODIVERSIDADE MEDIO, P239; *MIN MEIO AMB, 2000, SNUC SIST NAC UN CON; Moran EF, 2006, CLIMATIC CHANGE, V77, P343, DOI 10.1007/s10584-005-9035-9; Mota BW, 2006, ATMOS CHEM PHYS, V6, P1409, DOI 10.5194/acp-6-1409-2006; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; Nepstad D, 2004, GLOBAL CHANGE BIOL, V10, P704, DOI 10.1111/j.1529-8817.2003.00772.x; Nepstad D, 2001, FOREST ECOL MANAG, V154, P395, DOI 10.1016/S0378-1127(01)00511-4; Nepstad DC, 2006, CONSERV BIOL, V20, P1595, DOI 10.1111/j.1523-1739.2006.00510.x; Oliveira PJC, 2007, SCIENCE, V317, P1233, DOI 10.1126/science.1146324; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Peres CA, 2001, CONSERV BIOL, V15, P793, DOI 10.1046/j.1523-1739.2001.015003793.x; Pfaff A, 2007, J REGIONAL SCI, V47, P109, DOI 10.1111/j.1467-9787.2007.00502.x; Pimm SL, 2001, SCIENCE, V293, P2207, DOI 10.1126/science.1061626; Pimm SL, 2001, WORLD ACCORDING PIMM; RIBEIRO B, 2005, SERIE ESTADO AMAZONI, V6; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Roman-Cuesta RM, 2006, CONSERV BIOL, V20, P1074, DOI 10.1111/j.1523-1739.2006.00478.x; Ruiz-Perez M, 2005, AMBIO, V34, P218, DOI 10.1639/0044-7447(2005)034[0218:CADIAE]2.0.CO;2; SCHROEDER W, 2007, LBAECO LC 23 CHARACT; Schroeder W, 2005, EARTH INTERACT, V9; Schwartzman S, 2005, CONSERV BIOL, V19, P721, DOI 10.1111/j.1523-1739.2005.00695.x; SERRA MA, 2004, I PESQUISA EC APLICA, V27, P193; Setzer A.W., 1996, BIOMASS BURNING GLOB, P25; SKOLE D, 1993, SCIENCE, V260, P1905, DOI 10.1126/science.260.5116.1905; Soares B, 2004, GLOBAL CHANGE BIOL, V10, P745, DOI 10.1111/j.1529-8817.2003.00769.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sombroek W, 2001, AMBIO, V30, P388, DOI 10.1639/0044-7447(2001)030[0388:SATPOA]2.0.CO;2; Souza C., 2006, DINAMICA DESMATAMENT; Stolle F, 2004, INT J REMOTE SENS, V25, P471, DOI 10.1080/01431160310001618022; TEIXEIRA G, 2008, PRESIDENTE LULA CARL; Vale MM, 2007, BIRD CONSERV INT, V17, P245, DOI 10.1017/S0959270907000743; Vanclay JK, 2001, SCIENCE, V293, P1007, DOI 10.1126/science.293.5532.1007a; WOLTER K, 2007, MULTIVARIATE ENSO IN; [No title captured], DOI DOI 10.1029/2006E0260001	61	102	104	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5014	10.1371/journal.pone.0005014	http://dx.doi.org/10.1371/journal.pone.0005014			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437RX	19352423	gold, Green Published, Green Submitted			2022-12-25	WOS:000265505700002
J	Miller, TL; McNabb, SJN; Hilsenrath, P; Pasipanodya, J; Weis, SE				Miller, Thaddeus L.; McNabb, Scott J. N.; Hilsenrath, Peter; Pasipanodya, Jotam; Weis, Stephen E.			Personal and Societal Health Quality Lost to Tuberculosis	PLOS ONE			English	Article							NEW-YORK-CITY; PULMONARY IMPAIRMENT; COST-EFFECTIVENESS; UNITED-STATES; FOLLOW-UP; MORTALITY; SURVIVORS; LESSONS; LIFE	Background: In developed countries, tuberculosis is considered a disease with little loss of Quality-Adjusted Life Years (QALYs). Tuberculosis treatment is predominantly ambulatory and death from tuberculosis is rare. Research has shown that there are chronic pulmonary sequelae in a majority of patients who have completed treatment for pulmonary tuberculosis (PTB). This and other health effects of tuberculosis have not been considered in QALY calculations. Consequently both the burden of tuberculosis on the individual and the value of tuberculosis prevention to society are underestimated. We estimated QALYs lost to pulmonary TB patients from all known sources, and estimated health loss to prevalent TB disease. Methodology/Principal Findings: We calculated values for health during illness and treatment, pulmonary impairment after tuberculosis (PIAT), death rates, years-of-life-lost to death, and normal population health. We then compared the lifetime expected QALYs for a cohort of tuberculosis patients with that expected for comparison populations with latent tuberculosis infection and without tuberculosis infection. Persons with culture-confirmed tuberculosis accrued fewer lifetime QALYs than those without tuberculosis. Acute tuberculosis morbidity cost 0.046 QALYs (4% of total) per individual. Chronic morbidity accounted for an average of 0.96 QALYs (78% of total). Mortality accounted for 0.22 QALYs lost (18% of total). The net benefit to society of averting one case of PTB was about 1.4 QALYs. Conclusions/Significance: Tuberculosis, a preventable disease, results in QALYs lost owing to illness, impairment, and death. The majority of QALYs lost from tuberculosis resulted from impairment after microbiologic cure. Successful TB prevention efforts yield more health quality than previously thought and should be given high priority by health policy makers. (Refer to Abstracto S1 for Spanish language abstract)			Miller, TL (corresponding author), Univ N Texas, Hlth Sci Ctr, Sch Publ Hlth, Ft Worth, TX USA.	sweis@hsc.unt.edu		Hilsenrath, Peter/0000-0002-0866-8043				*AM THOR SOC, 1999, AM J RESP CRIT CARE, V161, P5221; Angus DC, 2002, AM J RESP CRIT CARE, V165, P540; [Anonymous], 2003, MMWR RECOMM REP; [Anonymous], GLOB TUB CONTR SURV; BASS JB, 1994, AM J RESP CRIT CARE, V149, P1359, DOI 10.1164/ajrccm.149.5.8173779; *CDC DIV TUB EL NA, VIR HEP STD TB PREV; *CDCP, 2005, REP TUB US 2004; *CDCP, US LIF TABL 2002; COCCHIARELLA L, 2000, GUIDES EVALUATION PE; Coker R, 1998, BRIT MED J, V317, P616, DOI 10.1136/bmj.317.7159.616; Comstock GW, 1999, INT J TUBERC LUNG D, V3, P847; Cooper AB, 1999, CRIT CARE MED, V27, P2616, DOI 10.1097/00003246-199912000-00002; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Garcia-Garcia MD, 2002, EMERG INFECT DIS, V8, P1327; GRAHAM JD, 2003, VALUING HLTH OMB PER; GROSS CR, 2001, ETIOLOGY TREATMENT A, P50; GROSS CR, 2001, ETIOLOGY TREATMENT A, P52; Hansel NN, 2004, CHEST, V126, P1079, DOI 10.1378/chest.126.4.1079; *HARV CTR RISK AN, COST UT AN PUBL 1976; Jamison D.T., 1993, DIS CONTROL PRIORITI; KEELER EB, 1983, MANAGE SCI, V29, P300, DOI 10.1287/mnsc.29.3.300; LANDESMAN SH, 1993, AM J PUBLIC HEALTH, V83, P766, DOI 10.2105/AJPH.83.5.766; Mannino DM, 2003, THORAX, V58, P388, DOI 10.1136/thorax.58.5.388; MAUCHAND R, 1999, INT J EPIDEMIOL, V28, P563; MCHUGH LG, 1994, AM J RESP CRIT CARE, V150, P90, DOI 10.1164/ajrccm.150.1.8025779; Miller TL, 2006, ANN EPIDEMIOL, V16, P777, DOI 10.1016/j.annepidem.2006.04.007; Miller TL, 2006, ANN EPIDEMIOL, V16, P305, DOI 10.1016/j.annepidem.2005.07.053; MILLER WF, 1981, CLIN CHEST MED, V2, P327; Niskanen M, 1999, CRIT CARE MED, V27, P1132, DOI 10.1097/00003246-199906000-00035; Pasipanodya JG, 2007, CHEST, V132, P1591, DOI 10.1378/chest.07-0755; Pasipanodya JG, 2007, CHEST, V131, P1817, DOI 10.1378/chest.06-2949; REICHMAN LB, 1991, AM REV RESPIR DIS, V144, P741, DOI 10.1164/ajrccm/144.4.741; Russell LB, 1996, JAMA-J AM MED ASSOC, V276, P1172, DOI 10.1001/jama.276.14.1172; Schwartzman K, 2005, NEW ENGL J MED, V353, P1008, DOI 10.1056/NEJMsa043194; Sterling TR, 2006, INT J TUBERC LUNG D, V10, P542; Taylor Z, 2000, INT J TUBERC LUNG D, V4, pS127; TENGS TO, 1995, RISK ANAL, V15, P369, DOI 10.1111/j.1539-6924.1995.tb00330.x; Tocque K, 2005, INT J TUBERC LUNG D, V9, P797; van Praag B.M.S., 2008, HAPPINESS QUANTIFIED; VECINO M, 2009, STABILITY PULM UNPUB; Weis SE, 2005, INT J TUBERC LUNG D, V9, P467; *WHO, HLTH STAT VAL SUSC P	43	47	47	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5080	10.1371/journal.pone.0005080	http://dx.doi.org/10.1371/journal.pone.0005080			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437RX	19352424	Green Published, gold, Green Submitted			2022-12-25	WOS:000265505700006
J	Yang, XR; Zhou, XB; Huang, WT; Wu, LY; Monzon, FA; Chang, CC; Wong, STC				Yang, Xiaorong; Zhou, Xiaobo; Huang, Wan-Ting; Wu, Lingyun; Monzon, Federico A.; Chang, Chung-Che; Wong, Stephen T. C.			Pattern-Selection Based Power Analysis and Discrimination of Low- and High-Grade Myelodysplastic Syndromes Study Using SNP Arrays	PLOS ONE			English	Article							COPY NUMBER; PROGNOSTIC-SIGNIFICANCE; CANCER	Copy Number Aberration (CNA) in myelodysplastic syndromes (MDS) study using single nucleotide polymorphism (SNP) arrays have been received increasingly attentions in the recent years. In the current study, a new Constraint Moving Average (CMA) algorithm is adopted to determine the regions of CNA regions first. In addition to large regions of CNA, using the proposed CMA algorithm, small regions of CNA can also be detected. Real-time Polymerase Chain Reaction (qPCR) results prove that the CMA algorithm presents an insightful discovery of both large and subtle regions. Based on the results of CMA, two independent applications are studied. The first one is power analysis for sample estimation. An accurate estimation of sample size needed for the desired purpose of an experiment will be important for effort-efficiency and cost-effectiveness. The power analysis is performed to determine the minimum sample size required for ensuring at least 100 lambda% (0<lambda <= 1) detected regions statistically different from normal references. As expected, power increase with increasing sample size for a fixed significance level. The second application is the distinguishment of high-grade MDS patients from low-grade ones. We propose to calculate the General Variant Level (GVL) score to integrate the general information of each patient at genotype level, and use it as the unified measurement for the classification. Traditional MDS classifications usually refer to cell morphology and The International Prognostic Scoring System (IPSS), which belongs to the classification at the phenotype level. The proposed GVL score integrates the information of CNA region, the number of abnormal chromosomes and the total number of the altered SNPs at the genotype level. Statistical tests indicate that the high and low grade MDS patients can be well separated by GVL score, which appears to correlate better with clinical outcome than the traditional classification approaches using morphology and IPSS sore at the phenotype level.			Yang, XR (corresponding author), Cornell Univ, Weill Med Coll, Methodist Hosp Res Inst, Ctr Biotechnol & Informat, Houston, TX USA.	xzhou@tmhs.org	Wu, Ling-Yun/C-4222-2008	Wu, Ling-Yun/0000-0001-9487-0215	NATIONAL LIBRARY OF MEDICINE [R01LM010185] Funding Source: NIH RePORTER	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Delforge Michel, 2003, Hematol J, V4, P303, DOI 10.1038/sj.thj.6200315; Fridlyand J, 2004, J MULTIVARIATE ANAL, V90, P132, DOI 10.1016/j.jmva.2004.02.008; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gondek LP, 2007, EXP HEMATOL, V35, P1728, DOI 10.1016/j.exphem.2007.08.009; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Gumus G, 2002, CANCER GENET CYTOGEN, V133, P168, DOI 10.1016/S0165-4608(01)00569-6; HAASE D, 1995, ANN HEMATOL, V70, P171, DOI 10.1007/BF01700373; Haase D, 2007, BLOOD, V110, P4385, DOI 10.1182/blood-2007-03-082404; Hofmann WK, 2004, HEMATOL J, V5, P1, DOI 10.1038/sj.thj.6200335; Huang T, 2005, BIOINFORMATICS, V21, P3811, DOI 10.1093/bioinformatics/bti646; HUANG WT, 2009, LEUKEMIA RE IN PRESS; Johnson R. A., 2007, APPL MULTIVARIATE ST, V6th; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li C, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-8-RESEARCH0032; Mohamedali A, 2007, BLOOD, V110, P3365, DOI 10.1182/blood-2007-03-079673; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; OLSHEN AB, 2004, BIOINFORMATICS, V5, P577; Sole F, 2005, HAEMATOLOGICA, V90, P1168; Thomas JG, 2001, GENOME RES, V11, P1227, DOI 10.1101/gr.165101; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308	23	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5054	10.1371/journal.pone.0005054	http://dx.doi.org/10.1371/journal.pone.0005054			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19352488	Green Published, Green Submitted, gold			2022-12-25	WOS:000265505700005
J	Laakkonen, JP; Makela, AR; Kakkonen, E; Turkki, P; Kukkonen, S; Peranen, J; Yla-Herttuala, S; Airenne, KJ; Oker-Blom, C; Vihinen-Ranta, M; Marjomaki, V				Laakkonen, Johanna P.; Makela, Anna R.; Kakkonen, Elina; Turkki, Paula; Kukkonen, Sari; Peranen, Johan; Yla-Herttuala, Seppo; Airenne, Kari J.; Oker-Blom, Christian; Vihinen-Ranta, Maija; Marjomaki, Varpu			Clathrin-Independent Entry of Baculovirus Triggers Uptake of E. coli in Non-Phagocytic Human Cells	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; EFFICIENT GENE-TRANSFER; RECOMBINANT BACULOVIRUS; MAMMALIAN-CELLS; MACROPINOCYTOSIS; EXPRESSION; MACROPINOSOMES; TRANSDUCTION; ENDOCYTOSIS; MECHANISMS	The prototype baculovirus, Autographa californica multiple nucleopolyhedrovirus, an insect pathogen, holds great potential as a gene therapy vector. To develop transductional targeting and gene delivery by baculovirus, we focused on characterizing the nature and regulation of its uptake in human cancer cells. Baculovirus entered the cells along fluid-phase markers from the raft areas into smooth-surfaced vesicles devoid of clathrin. Notably, regulators associated with macropinocytosis, namely EIPA, Pak1, Rab34, and Rac1, had no significant effect on viral transduction, and the virus did not induce fluid-phase uptake. The internalization and nuclear uptake was, however, affected by mutants of RhoA, and of Arf6, a regulator of clathrin-independent entry. Furthermore, the entry of baculovirus induced ruffle formation and triggered the uptake of fluorescent E. coli bioparticles. To conclude, baculovirus enters human cells via a clathrin-independent pathway, which is able to trigger bacterial uptake. This study increases our understanding of virus entry strategies and gives new insight into baculovirus-mediated gene delivery in human cells.			Laakkonen, JP (corresponding author), Univ Jyvaskyla, Nanosci Ctr, Dept Biol & Environm Sci, Jyvaskyla, Finland.	vmarjoma@cc.jyu.fi		Turkki, Paula/0000-0002-5969-4807; Vihinen-Ranta, Maija/0000-0003-0959-1153; Laakkonen, Johanna/0000-0002-8556-9727; Marjomaki, Varpu/0000-0002-4592-5926; Siljamaki, Elina/0000-0003-1709-8633; Yla-Herttuala, Seppo/0000-0001-7593-2708				Airenne KJ, 2000, GENE THER, V7, P1499, DOI 10.1038/sj.gt.3301269; Amstutz B, 2008, EMBO J, V27, P956, DOI 10.1038/emboj.2008.38; BALANA ME, 2005, J CELL SCI; Bishop NE, 2003, INT REV CYTOL, V232, P1, DOI 10.1016/S0074-7696(03)32001-7; BLISSARD GW, 1992, J VIROL, V66, P6829, DOI 10.1128/JVI.66.11.6829-6835.1992; Boshans RL, 2000, MOL CELL BIOL, V20, P3685, DOI 10.1128/MCB.20.10.3685-3694.2000; BRAUNAGEL SC, 1994, VIROLOGY, V202, P315, DOI 10.1006/viro.1994.1348; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004; Clement C, 2006, J CELL BIOL, V174, P1009, DOI 10.1083/jcb.200509155; Day PM, 2003, VIROLOGY, V307, P1, DOI 10.1016/S0042-6822(02)00143-5; Dharmawardhane S, 2000, MOL BIOL CELL, V11, P3341, DOI 10.1091/mbc.11.10.3341; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Duisit G, 1999, J GENE MED, V1, P93; Ghigo E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000087; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; GRUENBERG J, 1989, J CELL BIOL, V108, P1301, DOI 10.1083/jcb.108.4.1301; Haeseleer F, 2001, INVEST OPHTH VIS SCI, V42, P3294; HOFMANN C, 1995, P NATL ACAD SCI USA, V92, P10099, DOI 10.1073/pnas.92.22.10099; Hu YC, 2006, ADV VIRUS RES, V68, P287, DOI 10.1016/S0065-3527(06)68008-1; Jones AT, 2007, J CELL MOL MED, V11, P670, DOI 10.1111/j.1582-4934.2007.00062.x; Kalia M, 2006, MOL BIOL CELL, V17, P3689, DOI 10.1091/mbc.E05-10-0980; KANKAANPAA P, 2006, BIOIMAGEXD WORLD WID; Kansau I, 2004, INFECT IMMUN, V72, P3733, DOI 10.1128/IAI.72.7.3733-3742.2004; KARJALAINEN M, 2008, MOL BIOL CELL; KIRKHAM M, 2005, BIOCH BIOPHYS ACTA; Kitajima M, 2008, CLIN VACCINE IMMUNOL, V15, P376, DOI 10.1128/CVI.00285-07; Kukkonen SP, 2003, MOL THER, V8, P853, DOI 10.1016/j.ymthe.2003.07.009; Laakkonen JP, 2008, CELL MICROBIOL, V10, P667, DOI 10.1111/j.1462-5822.2007.01074.x; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; Lee CJ, 2008, J VIROL, V82, P6470, DOI 10.1128/JVI.00117-08; Lehtolainen P, 2002, GENE THER, V9, P1693, DOI 10.1038/sj.gt.3301854; Liberali P, 2008, EMBO J, V27, P970, DOI 10.1038/emboj.2008.59; Liu NQ, 2002, J VIROL, V76, P6689, DOI 10.1128/JVI.76.13.6689-6700.2002; Long G, 2006, J VIROL, V80, P8830, DOI 10.1128/JVI.00880-06; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mahonen AJ, 2007, J BIOTECHNOL, V131, P1, DOI 10.1016/j.jbiotec.2007.05.022; Makela AR, 2008, J BIOTECHNOL, V134, P20, DOI 10.1016/j.jbiotec.2007.12.010; Makela AR, 2008, COMB CHEM HIGH T SCR, V11, P86, DOI 10.2174/138620708783744525; Makela AR, 2006, J VIROL, V80, P6603, DOI 10.1128/JVI.00528-06; Matilainen H, 2005, J VIROL, V79, P15452, DOI 10.1128/JVI.79.24.15452-15459.2005; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Niedergang F, 2005, CURR TOP MICROBIOL, V291, P43; Nishibe Y, 2008, GENE THER, V15, P990, DOI 10.1038/gt.2008.29; Nunes-Correia I, 2004, CELL MOL BIOL LETT, V9, P47; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; RABINOVITCH M, 1995, TRENDS CELL BIOL, V5, P85, DOI 10.1016/S0962-8924(00)88955-2; Sansonetti PJ, 2001, AM J PHYSIOL-GASTR L, V280, pG319, DOI 10.1152/ajpgi.2001.280.3.G319; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Slack J, 2007, ADV VIRUS RES, V69, P99, DOI 10.1016/S0065-3527(06)69003-9; Summers MD, 2006, ADV VIRUS RES, V68, P3, DOI 10.1016/S0065-3527(06)68001-9; SUMMERS MD, 1976, J VIROL, V17, P962, DOI 10.1128/JVI.17.3.962-972.1976; Sun P, 2003, J BIOL CHEM, V278, P4063, DOI 10.1074/jbc.M208699200; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Tani H, 2001, VIROLOGY, V279, P343, DOI 10.1006/viro.2000.0699; THEILMANN DA, 2005, FAMILY BACULOVIRIDAE; van Loo ND, 2001, J VIROL, V75, P961, DOI 10.1128/JVI.75.2.961-970.2001; Van Nhieu GT, 1999, CURR OPIN MICROBIOL, V2, P51; Veiga E, 2005, NAT CELL BIOL, V7, P894, DOI 10.1038/ncb1292; Veiga E, 2007, CELL HOST MICROBE, V2, P340, DOI 10.1016/j.chom.2007.10.001; VOLKMAN LE, 1983, APPL ENVIRON MICROB, V45, P1085, DOI 10.1128/AEM.45.3.1085-1093.1983; Wang CY, 2006, CANCER RES, V66, P5798, DOI 10.1158/0008-5472.CAN-05-4514	64	38	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2009	4	4							e5093	10.1371/journal.pone.0005093	http://dx.doi.org/10.1371/journal.pone.0005093			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RT	19352496	Green Submitted, Green Published, gold			2022-12-25	WOS:000265505300014
J	Avnit-Sagi, T; Kantorovich, L; Kredo-Russo, S; Hornstein, E; Walker, MD				Avnit-Sagi, Tali; Kantorovich, Lia; Kredo-Russo, Sharon; Hornstein, Eran; Walker, Michael D.			The Promoter of the pri-miR-375 Gene Directs Expression Selectively to the Endocrine Pancreas	PLOS ONE			English	Article								microRNAs ( miRNAs) are known to play an essential role in controlling a broad range of biological processes including animal development. Accordingly, many miRNAs are expressed preferentially in one or a small number of cell types. Yet the mechanisms responsible for this selectivity are not well understood. The aim of this study was to elucidate the molecular basis of cell-specific expression of the pri-miR-375 gene, which is selectively expressed in pancreatic islets, and has been implicated both in the development of islets, and the function of mature pancreatic beta cells. An evolutionarily conserved 768 bp region of DNA upstream of the pri-miR-375 gene was linked to GFP and luciferase reporter genes, and expression monitored in transgenic mice and transfected cultured cells. Deletion and targeted mutagenesis analysis was used to evaluate the functional significance of sequence blocks within the upstream fragment. 5'-RACE analysis was used for mapping the pri-miR-375 gene transcription start site. The conserved 768 bp region was able to direct preferential expression of a GFP reporter gene to pancreatic islets in transgenic mice. Deletion analysis using a luciferase reporter gene in transfected cultured cell lines confirmed the cell specificity of the putative promoter region, and identified several key cis-elements essential for optimal activity, including E-boxes and a TATA sequence. Consistent with this, 5'-RACE analysis identified a transcription start site within this DNA region, 24 bp downstream of the TATA sequence. These studies define the promoter of the pri-miR-375 gene, and show that islet-specific expression of the pri-miR-375 gene is controlled at the transcriptional level. Detailed analysis of the transcriptional mechanisms controlling expression of miRNA genes will be essential to permit a comprehensive understanding of the complex role of miRNAs such as miR-375 in developmental processes.	[Avnit-Sagi, Tali; Kantorovich, Lia; Walker, Michael D.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Kredo-Russo, Sharon; Hornstein, Eran] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Avnit-Sagi, T (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	m.walker@weizmann.ac.il	HORNSTEIN, ERAN/K-1340-2012	HORNSTEIN, ERAN/0000-0002-5534-1924	Juvenile Diabetes Research Foundation, New York; D-CURE Diabetes Care in Israel	Juvenile Diabetes Research Foundation, New York(Juvenile Diabetes Research Foundation); D-CURE Diabetes Care in Israel	Supported by research grants from the Juvenile Diabetes Research Foundation, New York (to MDW and EH), from D-CURE Diabetes Care in Israel (to MDW) and from Mrs. Judith Bennatar (to MDW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Baroukh N, 2007, J BIOL CHEM, V282, P19575, DOI 10.1074/jbc.M611841200; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; BOSHART M, 1992, GENE, V110, P129, DOI 10.1016/0378-1119(92)90456-Y; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chakrabarti SK, 2003, TRENDS ENDOCRIN MET, V14, P78, DOI 10.1016/S1043-2760(02)00039-5; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; EDLUND T, 1985, SCIENCE, V230, P912, DOI 10.1126/science.3904002; EFRAT S, 1988, P NATL ACAD SCI USA, V85, P9037, DOI 10.1073/pnas.85.23.9037; El Ouaamari A, 2008, DIABETES, V57, P2708, DOI 10.2337/db07-1614; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gleason CE, 2007, P NATL ACAD SCI USA, V104, P8681, DOI 10.1073/pnas.0702844104; Glick E, 2000, J BIOL CHEM, V275, P2199, DOI 10.1074/jbc.275.3.2199; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Huang HP, 2002, MOL ENDOCRINOL, V16, P541, DOI 10.1210/me.16.3.541; Joglekar MV, 2007, TRENDS ENDOCRIN MET, V18, P393, DOI 10.1016/j.tem.2007.10.001; Joglekar MV, 2007, DEV BIOL, V311, P603, DOI 10.1016/j.ydbio.2007.09.008; Joglekar MV, 2009, GENE EXPR PATTERNS, V9, P109, DOI 10.1016/j.gep.2008.10.001; Keller DM, 2007, J BIOL CHEM, V282, P32084, DOI 10.1074/jbc.M700899200; Kloosterman WP, 2007, PLOS BIOL, V5, P1738, DOI 10.1371/journal.pbio.0050203; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175; Pennacchio LA, 2001, NAT REV GENET, V2, P100, DOI 10.1038/35052548; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; SANTERRE RF, 1981, P NATL ACAD SCI-BIOL, V78, P4339, DOI 10.1073/pnas.78.7.4339; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; WALKER MD, 1983, NATURE, V306, P557, DOI 10.1038/306557a0; WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373; Wilson ME, 2003, MECH DEVELOP, V120, P65, DOI 10.1016/S0925-4773(02)00333-7; Zhao L, 2005, J BIOL CHEM, V280, P11887, DOI 10.1074/jbc.M409475200	42	98	100	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2009	4	4							e5033	10.1371/journal.pone.0005033	http://dx.doi.org/10.1371/journal.pone.0005033			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437QA	19343226	gold, Green Submitted, Green Published			2022-12-25	WOS:000265500800004
J	Chen, CH; Lai, JM; Chou, TY; Chen, CY; Su, LJ; Lee, YC; Cheng, TS; Hong, YR; Chou, CK; Whang-Peng, J; Wu, YC; Huang, CYF				Chen, Chang-Han; Lai, Jin-Mei; Chou, Teh-Ying; Chen, Cheng-Yu; Su, Li-Jen; Lee, Yuan-Chii; Cheng, Tai-Shan; Hong, Yi-Ren; Chou, Chen-Kung; Whang-Peng, Jacqueline; Wu, Yu-Chung; Huang, Chi-Ying F.			VEGFA Upregulates FLJ10540 and Modulates Migration and Invasion of Lung Cancer via PI3K/AKT Pathway	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOINOSITIDE 3-KINASE; MESENCHYMAL TRANSITION; AKT ACTIVATION; CELL INVASION; EXPRESSION; PROTEIN; TUMOR; ADENOCARCINOMA	Background: Lung adenocarcinoma is the leading cause of cancer-related deaths among both men and women in the world. Despite recent advances in diagnosis and treatment, the mortality rates with an overall 5-year survival of only 15%. This high mortality is probably attributable to early metastasis. Although several well-known markers correlated with poor/metastasis prognosis in lung adenocarcinoma patients by immunohistochemistry was reported, the molecular mechanisms of lung adenocarcinoma development are still not clear. To explore novel molecular markers and their signaling pathways will be crucial for aiding in treatment of lung adenocarcinoma patients. Methodology/Principal Findings: To identify novel lung adenocarcinoma-associated/metastasis genes and to clarify the underlying molecular mechanisms of these targets in lung cancer progression, we created a bioinformatics scheme consisting of integrating three gene expression profile datasets, including pairwise lung adenocarcinoma, secondary metastatic tumors vs. benign tumors, and a series of invasive cell lines. Among the novel targets identified, FLJ10540 was overexpressed in lung cancer tissues and is associated with cell migration and invasion. Furthermore, we employed two co-expression strategies to identify in which pathway FLJ10540 was involved. Lung adenocarcinoma array profiles and tissue microarray IHC staining data showed that FLJ10540 and VEGF-A, as well as FLJ10540 and phospho-AKT exhibit positive correlations, respectively. Stimulation of lung cancer cells with VEGF-A results in an increase in FLJ10540 protein expression and enhances complex formation with PI3K. Treatment with VEGFR2 and PI3K inhibitors affects cell migration and invasion by activating the PI3K/AKT pathway. Moreover, knockdown of FLJ10540 destabilizes formation of the P110-alpha/P85-alpha-(PI3K) complex, further supporting the participation of FLJ10540 in the VEGF-A/PI3K/AKT pathway. Conclusions/Significance: This finding set the stage for further testing of FLJ10540 as a new therapeutic target for treating lung cancer and may contribute to the development of new therapeutic strategies that are able to block the PI3K/AKT pathway in lung cancer cells.	[Chen, Chang-Han] Chang Gung Univ, Coll Med, Chang Gung Mem Hospital, Kaohsiung Med Ctr,Dept Otolaryngol, Kaohsiung, Taiwan; [Lai, Jin-Mei] Fu Jen Catholic Univ, Dept Life Sci, Taipei, Hsien, Taiwan; [Chou, Teh-Ying; Chen, Cheng-Yu; Huang, Chi-Ying F.] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Su, Li-Jen; Wu, Yu-Chung] Taipei Vet Gen Hosp, Dept Surg, Div Thorac Surg, Taipei, Taiwan; [Lee, Yuan-Chii] Taipei Med Univ, Grad Inst Med Informat, Taipei, Taiwan; [Cheng, Tai-Shan; Hong, Yi-Ren] Kaohsiung Med Univ, Grad Inst Biochem, Kaohsiung, Taiwan; [Chou, Chen-Kung] Chang Gung Univ, Dept Life Sci, Tao Yuan, Taiwan; [Whang-Peng, Jacqueline] Wan Fang Hosp, Div Canc Ctr, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Fu Jen Catholic University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Medical University; Kaohsiung Medical University; Chang Gung University; Taipei Municipal WanFang Hospital	Chen, CH (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hospital, Kaohsiung Med Ctr,Dept Otolaryngol, Kaohsiung, Taiwan.	jqwpeng@tmu.edu.tw; wuyc@vghtpe.gov.tw; cyhuang5@ym.edu.tw	Huang, Chi-Ying/AAG-7672-2022; Huang, Chi-Ying/AFL-7729-2022	Huang, Chi-Ying/0000-0003-4898-4937; Huang, Chi-Ying/0000-0003-4898-4937; Su, Li-Jen/0000-0002-8342-9800; Hong, Yi-Ren/0000-0001-5470-6090	NRPGM; National Yang Ming University [Program for Promoting Academic Excellence of Universities]; Taichung Veteran General Hospital [TCVGH-957326D]; NSC [96-3112-B-075-001, 95-3112-B-075-002, NSC97-3112-B-010-025-CC1, NSC97-2627-B-030-001, NSC97-2627-B-010-011, 94-2752-B-010-002-PAE]; Chang Gung Hosp [CMRPD140211]	NRPGM; National Yang Ming University; Taichung Veteran General Hospital; NSC(Ministry of Science and Technology, Taiwan); Chang Gung Hosp	This study was supported in part by grants from the Chang Gung Hospital (CMRPD140211) and NSC (94-2752-B-010-002-PAE) to Chen-Kung Chou, NSC (Program for Interdisciplinary Research Project: NSC97-2627-B-010-011 to Chi-Ying Huang, NSC97-2627-B-030-001 to J.-M. Lai), and NSC97-3112-B-010-025-CC1, Taichung Veteran General Hospital (TCVGH-957326D), and the Program for Promoting Academic Excellence of Universities (National Yang Ming University) to Chi- Ying Huang, and NSC (95-3112-B-075-002 and 96-3112-B-075-001) to Yu-Chung Wu. The Gene Expression Analysis Core Facility is supported by the National Research Program for Genomic Medicine (NRPGM), National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abid R, 2004, ARTERIOSCL THROM VAS, V24, P294, DOI 10.1161/01.ATV.0000110502.10593.06; Alitalo K, 2002, CANCER CELL, V1, P219, DOI 10.1016/S1535-6108(02)00051-X; Bouwknecht J. Adriaan, 2002, Behavioural Brain Research, V136, P489, DOI 10.1016/S0166-4328(02)00200-0; Brognard J, 2001, CANCER RES, V61, P3986; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chen CH, 2007, ONCOGENE, V26, P4272, DOI 10.1038/sj.onc.1210207; Chen JJW, 2001, CANCER RES, V61, P5223; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Dance M, 2006, J BIOL CHEM, V281, P23285, DOI 10.1074/jbc.M600987200; David O, 2004, CLIN CANCER RES, V10, P6865, DOI 10.1158/1078-0432.CCR-04-0174; Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003; Fontanini G, 2002, BRIT J CANCER, V86, P558, DOI 10.1038/sj.bjc.6600130; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Fu SL, 2005, BIOCHEM BIOPH RES CO, V338, P830, DOI 10.1016/j.bbrc.2005.10.045; *GA KBAP, 2008, SURG MAN NONSM CELL, P765; Gupta AK, 2004, LUNG, V182, P151, DOI 10.1007/S00408/004/0310-8; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hendrix MJC, 1996, CANCER METAST REV, V15, P507, DOI 10.1007/BF00054016; Hendrix ND, 2006, CANCER RES, V66, P1354, DOI 10.1158/0008-5472.CAN-05-3694; Hsu JM, 2004, J BIOL CHEM, V279, P32592, DOI 10.1074/jbc.M404950200; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kerbel RS, 2004, NAT REV CANCER, V4, P423, DOI 10.1038/nrc1369; Kim D, 2001, FASEB J, V15, P1953, DOI 10.1096/fj.01-0198com; Kim SA, 2006, CANCER LETT, V235, P53, DOI 10.1016/j.canlet.2005.04.003; Kroll J, 1997, J BIOL CHEM, V272, P32521, DOI 10.1074/jbc.272.51.32521; Lantuejoul S, 2003, J PATHOL, V200, P336, DOI 10.1002/path.1367; Laramee M, 2007, J BIOL CHEM, V282, P7758, DOI 10.1074/jbc.M611327200; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Li X, 2006, ONCOGENE, V25, P609, DOI 10.1038/sj.onc.1209077; Lin XB, 2001, LANGENBECK ARCH SURG, V386, P293, DOI 10.1007/s004230100203; Marinov M, 2007, CRIT REV ONCOL HEMAT, V63, P172, DOI 10.1016/j.critrevonc.2007.04.002; Martinez-Garay I, 2006, GENOMICS, V87, P243, DOI 10.1016/j.ygeno.2005.11.006; Massion PP, 2004, AM J RESP CRIT CARE, V170, P1088, DOI 10.1164/rccm.200404-487OC; Niehrs C, 1999, NATURE, V402, P483, DOI 10.1038/990025; Ohta Y, 1997, BRIT J CANCER, V76, P1041, DOI 10.1038/bjc.1997.505; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Ramesh R, 2004, MOL THER, V9, P510, DOI 10.1016/j.ymthe.2004.01.019; Sakai M, 2006, ONCOGENE, V25, P480, DOI 10.1038/sj.onc.1209051; Shibusa T, 1998, CLIN CANCER RES, V4, P1483; Shih JY, 2001, JNCI-J NATL CANCER I, V93, P1392, DOI 10.1093/jnci/93.18.1392; Shijubo N, 1999, AM J RESP CRIT CARE, V160, P1269, DOI 10.1164/ajrccm.160.4.9807094; Su ZD, 2007, CURR OPIN INVEST DR, V8, P140; Tanaka F, 2001, CLIN CANCER RES, V7, P3410; Tanno S, 2001, CANCER RES, V61, P589; Thakker GD, 1999, J BIOL CHEM, V274, P10002, DOI 10.1074/jbc.274.15.10002; Tsao AS, 2003, CANCER EPIDEM BIOMAR, V12, P660; Tsurutani J, 2006, J CLIN ONCOL, V24, P306, DOI 10.1200/JCO.2005.02.4133; Volm M, 1997, INT J CANCER, V74, P64, DOI 10.1002/(SICI)1097-0215(19970220)74:1<64::AID-IJC11>3.0.CO;2-I; Yang AD, 2006, CANCER RES, V66, P46, DOI 10.1158/0008-5472.CAN-05-3086; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033; Yoeli-Lerner M, 2006, CELL CYCLE, V5, P603, DOI 10.4161/cc.5.6.2561; Zachary I, 2003, BIOCHEM SOC T, V31, P1171; Zhao WM, 2006, MOL BIOL CELL, V17, P3881, DOI 10.1091/mbc.E06-01-0015	54	103	108	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5052	10.1371/journal.pone.0005052	http://dx.doi.org/10.1371/journal.pone.0005052			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337377	gold, Green Published, Green Submitted			2022-12-25	WOS:000265500600015
J	Freitas, JM; Andrade, LO; Pires, SF; Lima, R; Chiari, E; Santos, RR; Soares, M; Machado, CR; Franco, GR; Pena, SDJ; Macedo, AM				Freitas, Jorge M.; Andrade, Luciana O.; Pires, Simone F.; Lima, Ricardo; Chiari, Egler; Santos, Ricardo R.; Soares, Milena; Machado, Carlos R.; Franco, Gloria R.; Pena, Sergio D. J.; Macedo, Andrea M.			The MHC Gene Region of Murine Hosts Influences the Differential Tissue Tropism of Infecting Trypanosoma cruzi Strains	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-II DRB1; CHAGAS-DISEASE; DENDRITIC CELLS; H2 COMPLEX; MICE; POLYMORPHISM; HLA; CARDIOMYOPATHY; SUSCEPTIBILITY	We have previously demonstrated that both parasite genetic variability and host genetic background were important in determining the differential tissue distribution of the Col1.7G2 and JG T. cruzi monoclonal strains after artificial infections in mice. We observed that the JG strain was most prevalent in hearts of mouse lineages with the MHC haplotype H-2(d) (BALB/c and DBA2), while Col1.7G2 was predominant in hearts from C57BL/6 mice, which have the H-2(b) haplotype. To assess whether the MHC gene region indeed influenced tissue tropism of T. cruzi, we used the same two parasite strains to infect C57BL/6 (H-2(b)) and C57BLKS/J (H-2(d)) mice; the latter strain results from the introgression of DBA2 MHC region into the C57BL/6 background. We also performed ex vivo infections of cardiac explants from four congenic mice lineages with the H-2(b) and H-2(d) haplotypes arranged in two different genetic backgrounds: C57BLKS/J (H-2(d)) versus C57BL/6 (H-2(b)) and BALB/c (H-2(d)) versus BALB/B10-H2(b) (H-2(b)). In agreement with our former observations, Col1.7G2 was predominant in hearts from C57BL/6 mice (H-2(b)), but we observed a clear predominance of the JG strain in hearts from C57BLKS/J animals (H-2(d)). In the ex vivo experiments Col1.7G2 also prevailed in explants from H-2(b) animals while no predominance of any of the strains was observed in H-2(d) mice explants, regardless of the genetic background. These observations clearly demonstrate that the MHC region influences the differential tissue distribution pattern of infecting T. cruzi strains, which by its turn may be in a human infection the determinant for the clinical forms of the Chagas disease.	[Freitas, Jorge M.; Pires, Simone F.; Machado, Carlos R.; Franco, Gloria R.; Pena, Sergio D. J.; Macedo, Andrea M.] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Andrade, Luciana O.] Univ Fed Minas Gerais, Dept Morfol, Belo Horizonte, MG, Brazil; [Chiari, Egler] Univ Fed Minas Gerais, Dept Parasitol, Belo Horizonte, MG, Brazil; [Lima, Ricardo; Santos, Ricardo R.; Soares, Milena] Ctr Pesquisas Goncalo Moniz CPqGM, Salvador, BA, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Freitas, JM (corresponding author), Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.	landrade@icb.ufmg.br	Macedo, Andréa M/C-1506-2013; MACHADO, CARLOS/AAW-1492-2020; Machado, Carlos Renato/H-1043-2015; Soares, Milena B. P./O-3771-2018; Andrade, Luciana Oliveira/F-8912-2012; Franco, Glória/I-3654-2013	Machado, Carlos Renato/0000-0002-8724-3165; Andrade, Luciana Oliveira/0000-0002-0536-8790; Franco, Glória/0000-0001-5245-2365; Soares, Milena/0000-0001-7549-2992; Santana de Lima, Ricardo/0000-0002-1279-3445	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); WHO Special Program for Research and Training in Tropical Diseases	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); WHO Special Program for Research and Training in Tropical Diseases	This work has received funding from the following agnecies: Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and WHO Special Program for Research and Training in Tropical Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguillon JC, 2000, INT J PARASITOL, V30, P981, DOI 10.1016/S0020-7519(00)00078-3; Amadou C, 1999, IMMUNOL REV, V167, P211, DOI 10.1111/j.1600-065X.1999.tb01394.x; Andrade LO, 1999, MOL BIOCHEM PARASIT, V100, P163, DOI 10.1016/S0166-6851(99)90035-X; Andrade LO, 2002, EXP PARASITOL, V100, P269, DOI 10.1016/S0014-4894(02)00024-3; Borras SG, 2006, ANN CLIN BIOCHEM, V43, P214, DOI 10.1258/000456306776865205; Colorado IA, 2000, HUM IMMUNOL, V61, P320, DOI 10.1016/S0198-8859(99)00177-9; Cruz-Robles D, 2004, HUM IMMUNOL, V65, P60, DOI 10.1016/j.humimm.2003.10.008; Fae KC, 2000, MICROBES INFECT, V2, P745, DOI 10.1016/S1286-4579(00)00501-3; FEDERICI EE, 1964, AM J TROP MED HYG, V13, P272, DOI 10.4269/ajtmh.1964.13.272; Freitas JM, 2005, INT J PARASITOL, V35, P411, DOI 10.1016/j.ijpara.2004.10.023; Fux B, 2003, INFECT IMMUN, V71, P6392, DOI 10.1128/IAI.71.11.6392-6401.2003; Graefe SEB, 2003, GENES IMMUN, V4, P321, DOI 10.1038/sj.gene.6363972; Macedo AM, 2004, MEM I OSWALDO CRUZ, V99, P1, DOI 10.1590/S0074-02762004000100001; Macedo AM, 1998, PARASITOL TODAY, V14, P119, DOI 10.1016/S0169-4758(97)01179-4; Oliveira RP, 1998, P NATL ACAD SCI USA, V95, P3776, DOI 10.1073/pnas.95.7.3776; SANTOS FR, 1993, HUM GENET, V90, P655; Soto CDA, 2003, INFECT IMMUN, V71, P1194, DOI 10.1128/IAI.71.3.1194-1199.2003; Terabe M, 2004, PARASITOL INT, V53, P217, DOI 10.1016/j.parint.2003.12.002; TRISCHMANN TM, 1982, INFECT IMMUN, V35, P546, DOI 10.1128/IAI.35.2.546-551.1982; Vago AR, 1996, LANCET, V348, P891, DOI 10.1016/S0140-6736(05)64761-7; Van Overtvelt L, 2002, INT IMMUNOL, V14, P1135, DOI 10.1093/intimm/dxf077; WRIGHTSMAN RA, 1984, INFECT IMMUN, V44, P351, DOI 10.1128/IAI.44.2.351-354.1984	22	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5113	10.1371/journal.pone.0005113	http://dx.doi.org/10.1371/journal.pone.0005113			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337367	gold, Green Submitted, Green Published			2022-12-25	WOS:000265500600026
J	McPartland, JM				McPartland, John M.			Obesity, the Endocannabinoid System, and Bias Arising from Pharmaceutical Sponsorship	PLOS ONE			English	Article							CARDIOMETABOLIC RISK-FACTORS; CONFLICTS-OF-INTEREST; CANNABINOID RECEPTORS; METABOLIC SYNDROME; WEIGHT-LOSS; RIMONABANT; OVERWEIGHT; INDUSTRY; DISEASE; ATHEROSCLEROSIS	Background: Previous research has shown that academic physicians conflicted by funding from the pharmaceutical industry have corrupted evidence based medicine and helped enlarge the market for drugs. Physicians made pharmaceutical-friendly statements, engaged in disease mongering, and signed biased review articles ghost-authored by corporate employees. This paper tested the hypothesis that bias affects review articles regarding rimonabant, an anti-obesity drug that blocks the central cannabinoid receptor. Methods/Principal Findings: A MEDLINE search was performed for rimonabant review articles, limited to articles authored by USA physicians who served as consultants for the company that manufactures rimonabant. Extracted articles were examined for industry-friendly bias, identified by three methods: analysis with a validated instrument for monitoring bias in continuing medical education (CME); analysis for bias defined as statements that ran contrary to external evidence; and a tally of misrepresentations about the endocannabinoid system. Eight review articles were identified, but only three disclosed authors' financial conflicts of interest, despite easily accessible information to the contrary. The Takhar CME bias instrument demonstrated statistically significant bias in all the review articles. Biased statements that were nearly identical reappeared in the articles, including disease mongering, exaggerating rimonabant's efficacy and safety, lack of criticisms regarding rimonabant clinical trials, and speculations about surrogate markers stated as facts. Distinctive and identical misrepresentations regarding the endocannabinoid system also reappeared in articles by different authors. Conclusions: The findings are characteristic of bias that arises from financial conflicts of interest, and suggestive of ghostwriting by a common author. Resolutions for this scenario are proposed.	[McPartland, John M.] Michigan State Univ, Dept Osteopath Manipulat Med, E Lansing, MI 48824 USA	Michigan State University	McPartland, JM (corresponding author), Michigan State Univ, Dept Osteopath Manipulat Med, E Lansing, MI 48824 USA.	mcpruitt@verizon.net						Addy C, 2008, CELL METAB, V7, P68, DOI 10.1016/j.cmet.2007.11.012; Angeli M, 1996, NEW ENGL J MED, V335, P1055, DOI 10.1056/NEJM199610033351410; [Anonymous], 2006, Prescrire Int, V15, P123; Aronne LJ, 2007, AM J MED, V120, pS26, DOI 10.1016/j.amjmed.2007.01.005; Banzi R, 2008, INTERN EMERG MED, V3, P53, DOI 10.1007/s11739-008-0139-x; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Bensaid M, 2003, MOL PHARMACOL, V63, P908, DOI 10.1124/mol.63.4.908; Birmingham K, 1999, NAT MED, V5, P717, DOI 10.1038/10421; Bosman A, 2007, AM J TROP MED HYG, V77, P193, DOI 10.4269/ajtmh.2007.77.193; Cannon Christopher P, 2005, Clin Cornerstone, V7, P17, DOI 10.1016/S1098-3597(05)80064-X; Choudhry NK, 2002, JAMA-J AM MED ASSOC, V287, P612, DOI 10.1001/jama.287.5.612; Christensen R, 2007, LANCET, V370, P1706, DOI 10.1016/S0140-6736(07)61721-8; Cleland SJ, 2006, LANCET, V368, P1632, DOI 10.1016/S0140-6736(06)69572-X; Curioni C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006162.pub2; Davis SN, 2006, J MANAGE CARE PHARM, V12, pS4, DOI 10.18553/jmcp.2006.12.s1-A.S4; Dora JM, 2008, JAMA-J AM MED ASSOC, V300, P280, DOI 10.1001/jama.2008.24; *EMA, 2007, SUMM PROD CHAR ACOMP; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; Errami M, 2008, NATURE, V451, P397, DOI 10.1038/451397a; *FDA, 2007, 21888 FDA; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Fugh-Berman A, 2005, J GEN INTERN MED, V20, P546, DOI 10.1111/j.1525-1497.2005.05857.x; Gadde KM, 2006, JAMA-J AM MED ASSOC, V296, P649, DOI 10.1001/jama.296.6.649; Gagnon MA, 2008, PLOS MED, V5, P29, DOI 10.1371/journal.pmed.0050001; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Gotzsche PC, 2007, PLOS MED, V4, P47, DOI 10.1371/journal.pmed.0040019; Healy D, 2003, BRIT J PSYCHIAT, V183, P22, DOI 10.1192/bjp.183.1.22; HENRY RR, 2006, J AM ACAD PHYS S NOV, P8; Hollander P, 2007, AM J MED, V120, pS18, DOI 10.1016/j.amjmed.2006.11.014; Jensen MD, 2006, OBESITY, V14, p143S, DOI 10.1038/oby.2006.294; Jorgensen AW, 2006, BMJ-BRIT MED J, V333, P782, DOI 10.1136/bmj.38973.444699.0B; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; Kastelein JJP, 2008, NEW ENGL J MED, V358, P1431, DOI 10.1056/NEJMoa0800742; Lambert ML, 2007, LANCET, V369, P553, DOI 10.1016/S0140-6736(07)60262-1; Ledford H, 2008, NATURE, V452, P510, DOI 10.1038/452510a; Lillo JL, 2007, J AM OSTEOPATH ASSOC, V107, pS12; Lurie P, 2006, JAMA-J AM MED ASSOC, V295, P1921, DOI 10.1001/jama.295.16.1921; LYNN AB, 1994, J PHARMACOL EXP THER, V268, P1612; MACPHERSON K, 1997, NEWARK STAR LED 0217; Matias I, 2007, TRENDS ENDOCRIN MET, V18, P27, DOI 10.1016/j.tem.2006.11.006; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; McPartland JM, 2007, BRIT J PHARMACOL, V152, P583, DOI 10.1038/sj.bjp.0707399; McPartland JM, 2008, J AM OSTEOPATH ASSOC, V108, P586, DOI 10.7556/jaoa.2008.108.10.586; McPartland JM, 2008, J AM OSTEOPATH ASSOC, V108, P190; Moffatt B, 2007, PERSPECT BIOL MED, V50, P18, DOI 10.1353/pbm.2007.0009; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Moynihan R, 2006, BRIT MED J, V332, P745, DOI 10.1136/bmj.332.7544.745-a; Moynihan R, 2006, PLOS MED, V3, P425, DOI 10.1371/journal.pmed.0030191; Mukherjee D, 2001, JAMA-J AM MED ASSOC, V286, P954, DOI 10.1001/jama.286.8.954; *NAASO, 2004, UND TREAT PN; *NAASO, 2008, UND TREAT OB; National Institutes of Health, 1998, OBES RES S2, V6, p51S, DOI DOI 10.1002/J.1550-8528.1998.TB00690.X; Nieri P, 2003, N-S ARCH PHARMACOL, V368, P352, DOI 10.1007/s00210-003-0831-3; *NIH, 2007, NAT I HLTH CLIN TRIA; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1547, DOI 10.1001/jama.299.13.1547; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Padwal R, 2006, NEW ENGL J MED, V354, P974; Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761; PLUTZKY J, 2006, DOC NEWS S       SEP, P1; Prentice A M, 2001, Obes Rev, V2, P141, DOI 10.1046/j.1467-789x.2001.00031.x; Roberfroid D, 2007, LANCET, V369, P553, DOI 10.1016/S0140-6736(07)60261-X; Ross JS, 2008, JAMA-J AM MED ASSOC, V299, P1800, DOI 10.1001/jama.299.15.1800; Rucker D, 2007, BMJ-BRIT MED J, V335, P1194, DOI 10.1136/bmj.39385.413113.25; Rumsfeld JS, 2008, JAMA-J AM MED ASSOC, V299, P1601, DOI 10.1001/jama.299.13.1601; Ryberg E, 2005, FEBS LETT, V579, P259, DOI 10.1016/j.febslet.2004.11.085; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Saguy AC, 2008, SOCIOL FORUM, V23, P53, DOI 10.1111/j.1600-0838.2004.00399.x-i1; *SAN AV, 2006, PACK INS ACOMPLIA 20; Simons-Morton DG, 2006, JAMA-J AM MED ASSOC, V295, P826, DOI 10.1001/jama.295.7.826; Smith R, 2005, PLOS MED, V2, P364, DOI 10.1371/journal.pmed.0020138.g001; *STAT VERM, 2008, PHARM MARK DISCL; Steinbrook R, 2005, NEW ENGL J MED, V353, P116, DOI 10.1056/NEJMp058108; Steinman MA, 2006, ANN INTERN MED, V145, P284, DOI 10.7326/0003-4819-145-4-200608150-00008; Stelfox HT, 1998, NEW ENGL J MED, V338, P101, DOI 10.1056/NEJM199801083380206; Strawbridge WJ, 2000, AM J PUBLIC HEALTH, V90, P340, DOI 10.2105/AJPH.90.3.340; Takhar J, 2007, J CONTIN EDUC HEALTH, V27, P118, DOI 10.1002/chp.110; Taylor R, 2005, NATURE, V437, P1070, DOI 10.1038/4371070a; Teixeira-Clerc F, 2006, NAT MED, V12, P671, DOI 10.1038/nm1421; Tierney WM, 2005, J GEN INTERN MED, V20, P550, DOI 10.1111/j.1525-1497.2005.41008.x; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; Van Gaal L, 2008, DIABETES CARE, V31, pS229, DOI 10.2337/dc08-s258; Watson KE, 2007, REV CARDIOVASC MED, V8, pS37; WAXMAN HA, 2004, COMMITTEE OVERSIGHT; Yanovski SZ, 2005, NEW ENGL J MED, V353, P2187, DOI 10.1056/NEJMe058243; 2006, JAMA, V295, P1252	88	9	8	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e5092	10.1371/journal.pone.0005092	http://dx.doi.org/10.1371/journal.pone.0005092			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333392	Green Submitted, gold, Green Published			2022-12-25	WOS:000265499900025
J	Nakamaru, Y; Vuppusetty, C; Wada, H; Milne, JC; Ito, M; Rossios, C; Elliot, M; Hogg, J; Kharitonov, S; Goto, H; Bemis, JE; Elliott, P; Barnes, PJ; Ito, K				Nakamaru, Yuji; Vuppusetty, Chaitanya; Wada, Hiroo; Milne, Jill C.; Ito, Misako; Rossios, Christos; Elliot, Mark; Hogg, James; Kharitonov, Sergei; Goto, Hajime; Bemis, Jean E.; Elliott, Peter; Barnes, Peter J.; Ito, Kazuhiro			A protein deacetylase SIRT1 is a negative regulator of metalloproteinase-9	FASEB JOURNAL			English	Article						cigarette smoke; chronic obstructive pulmonary disease; COPD; oxidative stress; U937 cells	NF-KAPPA-B; OBSTRUCTIVE PULMONARY-DISEASE; SMALL-MOLECULE ACTIVATORS; OXIDATIVE STRESS; CIGARETTE-SMOKE; MATRIX-METALLOPROTEINASE-9 EXPRESSION; ALVEOLAR MACROPHAGES; LUNG-DISEASES; IN-VITRO; EMPHYSEMA	Inappropriate elevation of matrix metalloproteinase-9 (MMP9) is reported to be involved in the pathogenesis of chronic obstructive pulmonary disease (COPD). The object of this study was to identify the molecular mechanism underlying this increase of MMP9 expression, and here we show that oxidative stress-dependent reduction of a protein deacetylase, SIRT1, known as a putative antiaging enzyme, causes elevation of MMP9 expression. A sirtuin inhibitor, splitomycin, and SIRT1 knockdown by RNA interference led an increase in MMP9 expression in human monocytic U937 cells and in primary sputum macrophages, which was detected by RT-PCR, Western blot, activity assay, and zymography. In fact, the SIRT1 level was significantly decreased in peripheral lungs of patients with COPD, and this increase was inversely correlated with MMP9 expression and MMP9 promoter activation detected by a chromatin immunoprecipitation assay. H2O2 reduced SIRT1 expression and activity in U937 cells; furthermore, cigarette smoke exposure also caused reduction of SIRT1 expression in lung tissue of A/J mice, with concomitant elevation of MMP9. Intranasal treatment of a selective and novel SIRT1 small molecule activator, SRT2172, blocked the increase of MMP9 expression in the lung as well as pulmonary neutrophilia and the reduction in exercise tolerance. Thus, SIRT1 is a negative regulator of MMP9 expression, and SIRT1 activation is implicated as a novel therapeutic approach to treating chronic inflammatory diseases, in which MMP9 is abundant.-Nakamaru, Y., Vuppusetty, C., Wada, H., Milne, J. C., Ito, M., Rossios, C., Elliot, M., Hogg, J., Kharitonov, S., Goto, H., Bemis, J. E., Elliott, P., Barnes, P. J., Ito, K. A protein deacetylase SIRT1 is a negative regulator of metalloproteinase-9. FASEB J. 23, 2810-2819 (2009). www.fasebj.org	[Nakamaru, Yuji; Vuppusetty, Chaitanya; Ito, Misako; Rossios, Christos; Kharitonov, Sergei; Barnes, Peter J.; Ito, Kazuhiro] Univ London Imperial Coll Sci Technol & Med, Airway Dis Sect, Natl Heart & Lung Inst, London SW3 6LY, England; [Wada, Hiroo; Goto, Hajime] Kyorin Univ, Dept Resp Med, Sch Med, Tokyo, Japan; [Milne, Jill C.; Bemis, Jean E.; Elliott, Peter] GSK Co, Sirtris, Cambridge, MA USA; [Elliot, Mark; Hogg, James] Univ British Columbia, James Hogg iCAPTURE Ctr Cardiovasc & Pulm Res, St Pauls Hosp, Vancouver, BC V5Z 1M9, Canada	Imperial College London; Kyorin University; GlaxoSmithKline; St. Paul's Hospital; University of British Columbia; University of Saskatchewan	Ito, K (corresponding author), Univ London Imperial Coll Sci Technol & Med, Airway Dis Sect, Natl Heart & Lung Inst, London SW3 6LY, England.	k.ito@imperial.ac.uk	Nakamaru, Yuji/G-5441-2012; Wada, Hiroo/ABF-2531-2020; Ito, Kazuhiro/AAF-5994-2019	Rossios, Christos/0000-0003-3470-3233; Barnes, Peter/0000-0002-5122-4018	Clinical Research Committee (Royal Brompton Hospital); GlaxoSmithKline (GSK); Teijin Ltd.; Sirtris; GSK company; Canadian Institutes of Health Research [7246]	Clinical Research Committee (Royal Brompton Hospital); GlaxoSmithKline (GSK)(GlaxoSmithKline); Teijin Ltd.; Sirtris; GSK company; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants to K.I. and P.J.B. from the Clinical Research Committee (Royal Brompton Hospital), nonrestrictive funding from GlaxoSmithKline (GSK) and Teijin Ltd., and a project grant from Sirtris, a GSK company. W.M.E and J.C.H. were supported by Canadian Institutes of Health Research grant 7246. The authors declare that they have no competing interests. We are indebted to Sally Meah (National Heart and Lung Institute, London, UK) for assistance in collecting clinical samples and to Dr. Yuichi Kunori for assistance in preparation of the SIRT1 plasmid.	Antonicelli F, 2007, CURR TOP DEV BIOL, V79, P99, DOI 10.1016/S0070-2153(06)79005-6; Barnes Peter J, 2004, Proc Am Thorac Soc, V1, P264, DOI 10.1513/pats.200402-014MS; Barnes PJ, 2005, EUR RESPIR J, V25, P552, DOI 10.1183/09031936.05.00117504; Bernhard D, 2007, EXP GERONTOL, V42, P160, DOI 10.1016/j.exger.2006.09.016; Boschetto P, 2006, THORAX, V61, P1037, DOI 10.1136/thx.2006.058321; Brindicci C, 2005, EUR RESPIR J, V26, P52, DOI 10.1183/09031936.04.00125304; Chang YH, 2008, CLIN BIOCHEM, V41, P955, DOI 10.1016/j.clinbiochem.2008.04.012; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2003, J MOL MED, V81, P549, DOI 10.1007/s00109-003-0469-0; Deshmukh HS, 2008, AM J RESP CELL MOL, V38, P446, DOI 10.1165/rcmb.2006-0339OC; Eberhardt W, 2000, J IMMUNOL, V165, P5788, DOI 10.4049/jimmunol.165.10.5788; Foronjy R, 2008, AM J PHYSIOL-LUNG C, V294, pL1149, DOI 10.1152/ajplung.00481.2007; Fortino V, 2007, TOXICOL LETT, V173, P73, DOI 10.1016/j.toxlet.2007.06.004; Furukawa A, 2007, CELL PHYSIOL BIOCHEM, V20, P45, DOI 10.1159/000104152; *GOLD, 2007, EX SUMM GLOB STRAT D; Habedank D, 1998, EUR J APPL PHYSIOL O, V77, P421, DOI 10.1007/s004210050354; Harman D, 2006, ANN NY ACAD SCI, V1067, P10, DOI 10.1196/annals.1354.003; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Ito I, 2005, AM J RESP CRIT CARE, V172, P1378, DOI 10.1164/rccm.200506-953OC; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Ito K, 2004, BIOCHEM BIOPH RES CO, V315, P240, DOI 10.1016/j.bbrc.2004.01.046; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Kolev K, 2003, THROMB HAEMOSTASIS, V90, P528, DOI 10.1160/TH03-02-0070; Kruszewski M, 2005, DNA REPAIR, V4, P1306, DOI 10.1016/j.dnarep.2005.06.013; Lelongt B, 2001, J EXP MED, V193, P793, DOI 10.1084/jem.193.7.793; Lombard DB, 2008, J INTERN MED, V263, P128, DOI 10.1111/j.1365-2796.2007.01902.x; Meyer KC, 1998, MECH AGEING DEV, V104, P169, DOI 10.1016/S0047-6374(98)00065-7; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Minematsu N, 2001, BIOCHEM BIOPH RES CO, V289, P116, DOI 10.1006/bbrc.2001.5936; Montuschi P, 2000, AM J RESP CRIT CARE, V162, P1175, DOI 10.1164/ajrccm.162.3.2001063; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; NEWBY AC, 1994, BASIC RES CARDIOL, V89, P59; Nikula KJ, 2000, CHEST, V117, p246S, DOI 10.1378/chest.117.5_suppl_1.246S-a; Ohbayashi H, 2002, CURR PROTEIN PEPT SC, V3, P409, DOI 10.2174/1389203023380549; OhIshi S, 1997, AM J RESP CRIT CARE, V156, P1579, DOI 10.1164/ajrccm.156.5.96-11035; Pageon H, 2007, EUR J DERMATOL, V17, P12; Patel BD, 2006, THORAX, V61, P568, DOI 10.1136/thx.2005.053827; Rajendrasozhan S, 2008, AM J RESP CRIT CARE, V177, P861, DOI 10.1164/rccm.200708-1269OC; Ram M, 2006, J CLIN IMMUNOL, V26, P299, DOI 10.1007/s10875-006-9022-6; Russell REK, 2002, AM J RESP CELL MOL, V26, P602, DOI 10.1165/ajrcmb.26.5.4685; Salvioli S, 2006, CURR PHARM DESIGN, V12, P3161, DOI 10.2174/138161206777947470; van Kempen LCL, 2002, CANCER CELL, V2, P251, DOI 10.1016/S1535-6108(02)00157-5; Wallace AM, 2008, COPD, V5, P13, DOI 10.1080/15412550701817789; Yang SR, 2007, AM J PHYSIOL-LUNG C, V292, pL567, DOI 10.1152/ajplung.00308.2006; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yoon HK, 2007, ENVIRON HEALTH PERSP, V115, P1557, DOI 10.1289/ehp.10289	49	178	193	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2009	23	9					2810	2819		10.1096/fj.08-125468	http://dx.doi.org/10.1096/fj.08-125468			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19376817				2022-12-25	WOS:000270241000004
J	Dunstan, MS; Hang, PC; Zelinskaya, NV; Honek, JF; Conn, GL				Dunstan, Mark S.; Hang, Pei C.; Zelinskaya, Natalia V.; Honek, John F.; Conn, Graeme L.			Structure of the Thiostrepton Resistance Methyltransferase center dot S-Adenosyl-L-methionine Complex and Its Interaction with Ribosomal RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; X-RAY; PROTEIN; SITE; ANTIBIOTICS; METHYLATION; MECHANISM; MUTANTS; REVEALS; FOLD	The x-ray crystal structure of the thiostrepton resistance RNA methyltransferase (Tsr)center dot S-adenosyl-L-methionine (AdoMet) complex was determined at 2.45-angstrom resolution. Tsr is definitively confirmed as a Class IV methyltransferase of the SpoU family with an N-terminal "L30-like" putative target recognition domain. The structure and our in vitro analysis of the interaction of Tsr with its target domain from 23 S ribosomal RNA (rRNA) demonstrate that the active biological unit is a Tsr homodimer. In vitro methylation assays show that Tsr activity is optimal against a 29-nucleotide hairpin rRNA though the full 58-nucleotide L11-binding domain and intact 23 S rRNA are also effective substrates. Molecular docking experiments predict that Tsr center dot rRNA binding is dictated entirely by the sequence and structure of the rRNA hairpin containing the A1067 target nucleotide and is most likely driven primarily by large complementary electrostatic surfaces. One L30-like domain is predicted to bind the target loop and the other is near an internal loop more distant from the target site where a nucleotide change (U1061 to A) also decreases methylation by Tsr. Furthermore, a predicted interaction with this internal loop by Tsr amino acid Phe-88 was confirmed by mutagenesis and RNA binding experiments. We therefore propose that Tsr achieves its absolute target specificity using the N-terminal domains of each monomer in combination to recognize the two distinct structural elements of the target rRNA hairpin such that both Tsr subunits contribute directly to the positioning of the target nucleotide on the enzyme.	[Zelinskaya, Natalia V.; Conn, Graeme L.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Dunstan, Mark S.] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England; [Hang, Pei C.; Honek, John F.] Univ Waterloo, Dept Chem, Waterloo, ON N2L 3G1, Canada	Emory University; University of Manchester; University of Waterloo	Conn, GL (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd NE, Atlanta, GA 30322 USA.	gconn@emory.edu	Dunstan, Mark/B-8934-2013	Conn, Graeme/0000-0002-2419-380X; Honek, John/0000-0002-4035-4538; Dunstan, Mark/0000-0002-9416-5505	The Wellcome Trust [79242]; National Sciences and Engineering Council (Canada)	The Wellcome Trust(Wellcome TrustEuropean Commission); National Sciences and Engineering Council (Canada)	This work was supported by The Wellcome Trust (Grant 79242 to G. L. C.) and National Sciences and Engineering Council (Canada) (to J. F. H.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ahn HJ, 2003, EMBO J, V22, P2593, DOI 10.1093/emboj/cdg269; Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BECHTHOLD A, 1994, EUR J BIOCHEM, V224, P431, DOI 10.1111/j.1432-1033.1994.00431.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cameron DM, 2004, NUCLEIC ACIDS RES, V32, P3220, DOI 10.1093/nar/gkh644; Chao JA, 2004, STRUCTURE, V12, P1165, DOI 10.1016/j.str.2004.04.023; Clouet-d'Orval B, 2005, BIOCHIMIE, V87, P889, DOI 10.1016/j.biochi.2005.02.004; Conn GL, 1998, BIOCHEMISTRY-US, V37, P11980, DOI 10.1021/bi980825+; Conn GL, 1999, SCIENCE, V284, P1171, DOI 10.1126/science.284.5417.1171; Conn GL, 2009, DNA RNA MODIFICATION; COWLAN K, 1994, JOINT CCP4 ESF EACBM, V31, P34; CUNDLIFFE E, 1989, ANNU REV MICROBIOL, V43, P207, DOI 10.1146/annurev.micro.43.1.207; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; Doi Y, 2007, CLIN INFECT DIS, V45, P88, DOI 10.1086/518605; Dunstan MS, 2005, CHEM BIOL, V12, P201, DOI 10.1016/j.chembiol.2004.11.019; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferre-D'Amare AR, 2003, CURR OPIN STRUC BIOL, V13, P49, DOI 10.1016/S0959-440X(02)00002-7; Gaynor M, 2003, CURR TOP MED CHEM, V3, P949, DOI 10.2174/1568026033452159; Goodman CD, 2007, MOL BIOCHEM PARASIT, V152, P181, DOI 10.1016/j.molbiopara.2007.01.005; Gustafsson C, 1996, NUCLEIC ACIDS RES, V24, P3756, DOI 10.1093/nar/24.19.3756; Gustilo EM, 2008, CURR OPIN MICROBIOL, V11, P134, DOI 10.1016/j.mib.2008.02.003; Harms JM, 2008, MOL CELL, V30, P26, DOI 10.1016/j.molcel.2008.01.009; He Y, 2007, ACTA CRYSTALLOGR D, V63, P793, DOI 10.1107/S0907444907023451; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Liao ZY, 2006, MOL PHARMACOL, V70, P366, DOI 10.1124/mol.105.021865; LONG KS, 2009, DNA RNA MODIFICATION; Mao HY, 1999, NAT STRUCT BIOL, V6, P1139; Michel G, 2002, STRUCTURE, V10, P1303, DOI 10.1016/S0969-2126(02)00852-3; Mosbacher TG, 2005, J MOL BIOL, V345, P535, DOI 10.1016/j.jmb.2004.10.051; Poehlsgaard J, 2005, NAT REV MICROBIOL, V3, P870, DOI 10.1038/nrmicro1265; Rozenski J, 1999, NUCLEIC ACIDS RES, V27, P196, DOI 10.1093/nar/27.1.196; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Taylor AB, 2008, NUCLEIC ACIDS RES, V36, P1542, DOI 10.1093/nar/gkm1172; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; THOMPSON J, 1982, J BIOL CHEM, V257, P7915; Tkaczuk KL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-73; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Walker SC, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng082; Watanabe K, 2005, J BIOL CHEM, V280, P10368, DOI 10.1074/jbc.M411209200; WIENEN B, 1979, J BIOL CHEM, V254, P8031; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; Xu Z, 2008, NAT STRUCT MOL BIOL, V15, P534, DOI 10.1038/nsmb.1408	45	24	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17013	17020		10.1074/jbc.M901618200	http://dx.doi.org/10.1074/jbc.M901618200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19369248	hybrid, Green Published			2022-12-25	WOS:000266962400039
J	Slugoski, MD; Smith, KM; Ng, AML; Yao, SYM; Karpinski, E; Cass, CE; Baldwin, SA; Young, JD				Slugoski, Melissa D.; Smith, Kyla M.; Ng, Amy M. L.; Yao, Sylvia Y. M.; Karpinski, Edward; Cass, Carol E.; Baldwin, Stephen A.; Young, James D.			Conserved Glutamate Residues Glu-343 and Glu-519 Provide Mechanistic Insights into Cation/Nucleoside Cotransport by Human Concentrative Nucleoside Transporter hCNT3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; FUNCTIONAL-CHARACTERIZATION; NA+/PROLINE TRANSPORTER; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; LACTOSE PERMEASE; ACIDIC RESIDUES; CNT FAMILY; NA+; BINDING	Human concentrative nucleoside transporter 3 (hCNT3) utilizes electrochemical gradients of both Na+ and H+ to accumulate pyrimidine and purine nucleosides within cells. We have employed radioisotope flux and electrophysiological techniques in combination with site-directed mutagenesis and heterologous expression in Xenopus oocytes to identify two conserved pore-lining glutamate residues (Glu-343 and Glu-519) with essential roles in hCNT3 Na+/nucleoside and H+/nucleoside cotransport. Mutation of Glu-343 and Glu-519 to aspartate, glutamine, and cysteine severely compromised hCNT3 transport function, and changes included altered nucleoside and cation activation kinetics (all mutants), loss or impairment of H+ dependence (all mutants), shift in Na+ : nucleoside stoichiometry from 2:1 to 1:1 (E519C), complete loss of catalytic activity (E519Q) and, similar to the corresponding mutant in Na+-specific hCNT1, uncoupled Na+ currents (E343Q). Consistent with close-proximity integration of cation/solute-binding sites within a common cation/permeant translocation pore, mutation of Glu-343 and Glu-519 also altered hCNT3 nucleoside transport selectivity. Both residues were accessible to the external medium and inhibited by p-chloromercuribenzene sulfonate when converted to cysteine.	[Slugoski, Melissa D.; Smith, Kyla M.; Ng, Amy M. L.; Yao, Sylvia Y. M.; Karpinski, Edward; Young, James D.] Univ Alberta, Dept Physiol, Membrane Prot Res Grp, Edmonton, AB T6G 2H7, Canada; [Cass, Carol E.] Univ Alberta, Dept Oncol, Membrane Prot Res Grp, Edmonton, AB T6G 2H7, Canada; [Cass, Carol E.] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Baldwin, Stephen A.] Univ Leeds, Inst Membrane & Syst Biol, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England	University of Alberta; University of Alberta; University of Alberta; University of Leeds	Young, JD (corresponding author), Univ Alberta, Dept Physiol, Membrane Prot Res Grp, 7-55 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	james.young@ualberta.ca			National Cancer Institute of Canada; Canadian Cancer Society; Alberta Cancer Board	National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Alberta Cancer Board	This work was supported in part by the National Cancer Institute of Canada with funds from the Canadian Cancer Society and the Alberta Cancer Board.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; CASS CE, 1995, DRUG TRANSPORT ANTIM, P403; Chen NH, 2004, J BIOL CHEM, V279, P5508, DOI 10.1074/jbc.M306294200; Damaraju VL, 2007, AM J PHYSIOL-RENAL, V293, pF200, DOI 10.1152/ajprenal.00007.2007; Damaraju VL, 2003, ONCOGENE, V22, P7524, DOI 10.1038/sj.onc.1206952; DASCAL N, 1987, CRIT REV BIOCHEM MOL, V22, P317, DOI 10.3109/10409238709086960; Errasti-Murugarren E, 2008, MOL PHARMACOL, V73, P379, DOI 10.1124/mol.107.041848; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; FRANCO PJ, 1994, J BIOL CHEM, V269, P7379; Gray JH, 2004, PFLUG ARCH EUR J PHY, V447, P728, DOI 10.1007/s00424-003-1107-y; Grewer C, 2003, J BIOL CHEM, V278, P2585, DOI 10.1074/jbc.M207956200; Griffith DA, 1999, BIOCHEMISTRY-US, V38, P7524, DOI 10.1021/bi990076b; Griffith DA, 1996, BBA-REV BIOMEMBRANES, V1286, P153, DOI 10.1016/S0304-4157(96)00008-1; Hamilton SR, 2001, J BIOL CHEM, V276, P27981, DOI 10.1074/jbc.M100518200; Hilgemann DW, 1999, J GEN PHYSIOL, V114, P459, DOI 10.1085/jgp.114.3.459; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Kaback HR, 2005, CR BIOL, V328, P557, DOI 10.1016/j.crvi.2005.03.008; Karlin A, 1997, P NATL ACAD SCI USA, V94, P5508, DOI 10.1073/pnas.94.11.5508; King AE, 2006, TRENDS PHARMACOL SCI, V27, P416, DOI 10.1016/j.tips.2006.06.004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Latini S, 2001, J NEUROCHEM, V79, P463, DOI 10.1046/j.1471-4159.2001.00607.x; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Lin F, 1996, BIOPHYS J, V71, P3126, DOI 10.1016/S0006-3495(96)79506-1; Loewen SK, 1999, J BIOL CHEM, V274, P24475, DOI 10.1074/jbc.274.35.24475; Loewen SK, 2004, MOL MEMBR BIOL, V21, P1, DOI 10.1080/0968768031000140836; Loewen SK, 2003, YEAST, V20, P661, DOI 10.1002/yea.1000; Lu CC, 1999, J GEN PHYSIOL, V114, P445, DOI 10.1085/jgp.114.3.445; Noel J, 2003, BIOCHEMISTRY-US, V42, P15361, DOI 10.1021/bi035296a; Pastor-Anglada M, 2007, J PHYSIOL BIOCHEM, V63, P97, DOI 10.1007/BF03174089; Pirch T, 2002, J BIOL CHEM, V277, P8790, DOI 10.1074/jbc.M111008200; POURCHER T, 1993, J BIOL CHEM, V268, P3209; Quick M, 1998, BIOCHEMISTRY-US, V37, P13800, DOI 10.1021/bi980562j; Quick M, 1997, BIOCHEMISTRY-US, V36, P4631, DOI 10.1021/bi963063w; Quick M, 2001, J BIOL CHEM, V276, P1728, DOI 10.1074/jbc.M005521200; Ritzel MWL, 1998, MOL MEMBR BIOL, V15, P203; Ritzel MWL, 1997, AM J PHYSIOL-CELL PH, V272, pC707, DOI 10.1152/ajpcell.1997.272.2.C707; Ritzel MWL, 2001, J BIOL CHEM, V276, P2914, DOI 10.1074/jbc.M007746200; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Slugoski MD, 2008, J BIOL CHEM, V283, P24922, DOI 10.1074/jbc.M801793200; Slugoski MD, 2008, J BIOL CHEM, V283, P8496, DOI 10.1074/jbc.M710433200; Slugoski MD, 2007, BIOCHEMISTRY-US, V46, P1684, DOI 10.1021/bi061692s; Slugoski MD, 2009, J BIOL CHEM, V284, P17281, DOI 10.1074/jbc.M109.009704; Smith FM, 2007, MOL MEMBR BIOL, V24, P53, DOI 10.1080/09687860600942534; Smith KM, 2005, J BIOL CHEM, V280, P25436, DOI 10.1074/jbc.M409454200; Smith KM, 2004, J PHYSIOL-LONDON, V558, P807, DOI 10.1113/jphysiol.2004.068189; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Xiao GQ, 2001, MOL PHARMACOL, V59, P339, DOI 10.1124/mol.59.2.339; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yao SY, 2002, AM J PHYSIOL-CELL PH, V283, pC155, DOI 10.1152/ajpcell.00587.2001; Yao SYM, 2007, J BIOL CHEM, V282, P30607, DOI 10.1074/jbc.M703285200; Yao SYM, 2000, PRACT APPROACH SER, P47; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Young JD, 2008, XENOBIOTICA, V38, P995, DOI [10.1080/00498250801927427, 10.1080/00498250801927427 ]; Young JD, 2001, CURR TOP MEMBR, V50, P329; Zhang J, 2006, BIOCHEM J, V394, P389, DOI 10.1042/BJ20051476	56	15	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17266	17280		10.1074/jbc.M109.009613	http://dx.doi.org/10.1074/jbc.M109.009613			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19380587	Green Published, hybrid			2022-12-25	WOS:000266962400063
J	Kotorashvili, A; Russo, SJ; Mulugeta, S; Guttentag, S; Beers, MF				Kotorashvili, Adam; Russo, Scott J.; Mulugeta, Surafel; Guttentag, Susan; Beers, Michael F.			Anterograde Transport of Surfactant Protein C Proprotein to Distal Processing Compartments Requires PPDY-mediated Association with Nedd4 Ubiquitin Ligases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL NA+ CHANNEL; INTERSTITIAL LUNG-DISEASE; RAT TYPE-II; PULMONARY SURFACTANT; TERMINAL PROPEPTIDE; AGGRESOME FORMATION; RNA INTERFERENCE; WW DOMAINS; CELLS; GENE	Biosynthesis of surfactant protein C (SP-C) by alveolar type 2 cells requires proteolytic processing of a 21-kDa propeptide (proSP-C-21) in post-Golgi compartments to yield a 3.7-kDa mature form. Scanning alanine mutagenesis, binding assays, and co-immunoprecipitation were used to characterize the proSP-C targeting domain. Delivery of proSP-C-21 to distal processing organelles is dependent upon the NH2-terminal cytoplasmic SP-C propeptide, which contains a conserved PPDY motif. In A549 cells, transfection of EGFP/proSP-C-21 constructs containing polyalanine substitution for Glu(11)-Thr(18), (PPDY16)-P-13, or P-14, Y-16 produced endoplasmic reticulum retention of the fusion proteins. Protein-protein interactions of proSP-C with known WW domains were screened using a solid-phase array that revealed binding of the proSP-C NH2 terminus to several WW domains found in the Nedd4 family of E3 ligases. Specificity of the interaction was confirmed by co-immunoprecipitation of proSP-C and Nedd4 or Nedd4-2 in epithelial cell lines. By Western blotting and reverse transcription-PCR, both forms were detected in primary human type 2 cells. Knockdown of Nedd4-2 by small interference RNA transfection of cultured human type 2 cells blocked processing of S-35-labeled proSP-C-21. Mutagenesis of potential acceptor sites for ubiquitination in the cytosolic domain of proSP-C (Lys(6), Lys(34), or both) failed to inhibit trafficking of EGFP/proSP-C-21. These results indicate that PPDY-mediated interaction with Nedd4 E3-ligases is required for trafficking of proSP-C. We speculate that the Nedd4/proSP-C tandem is part of a larger protein complex containing a ubiquitinated component that further directs its transport.	[Beers, Michael F.] Univ Penn, Sch Med, Div Pulm & Crit Care, Surfactant Biol Labs,Dept Med, Philadelphia, PA 19104 USA; [Guttentag, Susan] Childrens Hosp Philadelphia, Dept Pediat, Div Neonatol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Beers, MF (corresponding author), Univ Penn, Sch Med, Div Pulm & Crit Care, Surfactant Biol Labs,Dept Med, H410F Hill Pavil,380 S Univ Ave, Philadelphia, PA 19104 USA.	mfbeers@mail.med.upenn.edu	Russo, Scott/R-7107-2019; Guttentag, Susan/ABE-7405-2020; Guttentag, Susan H/D-8705-2013	Russo, Scott/0000-0002-6470-1805; Guttentag, Susan/0000-0003-4420-5879; Guttentag, Susan H/0000-0003-4420-5879	National Institutes of Health [HL-19737, HL-059959, HL090732]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090732, R01HL059959, P01HL019737, R56HL059959] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-19737 (to M.F.B.), HL-059959 (to S.G.), and HL090732 (to S.M.).	Akinbi HT, 1997, J BIOL CHEM, V272, P9640; Beers MF, 1995, AM J PHYSIOL-LUNG C, V269, pL744, DOI 10.1152/ajplung.1995.269.6.L744; Beers MF, 2005, ANNU REV PHYSIOL, V67, P663, DOI 10.1146/annurev.physiol.67.040403.101937; Beers MF, 1998, J BIOL CHEM, V273, P15287, DOI 10.1074/jbc.273.24.15287; Beers MF, 1996, J BIOL CHEM, V271, P14361, DOI 10.1074/jbc.271.24.14361; BEERS MF, 1994, J BIOL CHEM, V269, P20318; Bortnick AE, 2003, AM J PHYSIOL-LUNG C, V285, pL869, DOI 10.1152/ajplung.00077.2003; Brasch F, 2004, EUR RESPIR J, V24, P30, DOI 10.1183/09031936.04.00000104; Brasch F, 2002, AM J RESP CELL MOL, V26, P659, DOI 10.1165/ajrcmb.26.6.4744; Cao XR, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160940; Conkright JJ, 2001, J BIOL CHEM, V276, P14658, DOI 10.1074/jbc.M011770200; FISHER JH, 1989, BIOCHIM BIOPHYS ACTA, V995, P225, DOI 10.1016/0167-4838(89)90040-X; Fotia AB, 2006, INT J BIOCHEM CELL B, V38, P472, DOI 10.1016/j.biocel.2005.11.006; Gerson KD, 2008, J BIOL CHEM, V283, P10330, DOI 10.1074/jbc.M707516200; GLASSER SW, 1990, J BIOL CHEM, V265, P21986; GLASSER SW, 1988, J BIOL CHEM, V263, P10326; Glasser SW, 2003, J BIOL CHEM, V278, P14291, DOI 10.1074/jbc.M210909200; Glasser SW, 2001, P NATL ACAD SCI USA, V98, P6366, DOI 10.1073/pnas.101500298; GLASSER SW, 1988, J BIOL CHEM, V263, P9; Gonzales LW, 2002, AM J PHYSIOL-LUNG C, V283, pL940, DOI 10.1152/ajplung.00127.2002; Guttentag SH, 2005, AM J RESP CELL MOL, V33, P14, DOI 10.1165/rcmb.2004-0293OC; Henry PC, 2003, J BIOL CHEM, V278, P20019, DOI 10.1074/jbc.M211153200; Huang X, 2000, NAT STRUCT BIOL, V7, P634, DOI 10.1038/77923; Ing B, 2007, MOL CELL BIOL, V27, P481, DOI 10.1128/MCB.00463-06; Johnson AL, 2001, AM J RESP CELL MOL, V24, P253, DOI 10.1165/ajrcmb.24.3.4312; Kabore AF, 2001, J CELL SCI, V114, P293; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; KUMAR S, 2008, P AUSTR PHYSL SOC, V39; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li TB, 2007, AM J PHYSIOL-LUNG C, V293, pL1069, DOI 10.1152/ajplung.00151.2007; Malbert-Colas L, 2003, PFLUG ARCH EUR J PHY, V447, P35, DOI 10.1007/s00424-003-1152-6; MOORE KJ, 1992, GENOMICS, V12, P388, DOI 10.1016/0888-7543(92)90389-A; Mulugeta S, 2005, AM J RESP CELL MOL, V32, P521, DOI 10.1165/rcmb.2005-0009OC; Mulugeta S, 2003, J BIOL CHEM, V278, P47979, DOI 10.1074/jbc.M308210200; Myat A, 2002, NEURON, V35, P447, DOI 10.1016/S0896-6273(02)00795-X; Nogee LM, 2002, CHEST, V121, p20S, DOI 10.1378/chest.121.3_suppl.20S; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Russo SJ, 1999, AM J PHYSIOL-LUNG C, V277, pL1034, DOI 10.1152/ajplung.1999.277.5.L1034; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Shi PP, 2008, AM J PHYSIOL-RENAL, V295, pF462, DOI 10.1152/ajprenal.90300.2008; Shi W, 2004, AM J PHYSIOL-LUNG C, V286, pL293, DOI 10.1152/ajplung.00228.2003; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; Snyder PM, 2001, J BIOL CHEM, V276, P28321, DOI 10.1074/jbc.M011487200; Solarin KO, 1997, PEDIATR RES, V42, P356, DOI 10.1203/00006450-199709000-00017; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 2006, PHYSIOL REV, V86, P669, DOI 10.1152/physrev.00020.2005; Stevens PA, 2005, PEDIATR RES, V57, P89, DOI 10.1203/01.PDR.0000147567.02473.5A; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; VOORHOUT WF, 1993, MICROSC RES TECHNIQ, V26, P366, DOI 10.1002/jemt.1070260504; Vorbroker DK, 1995, AM J PHYSIOL-LUNG C, V269, pL727, DOI 10.1152/ajplung.1995.269.6.L727; Wang WJ, 2003, J CELL SCI, V116, P683, DOI 10.1242/jcs.00267; Wang WJ, 2002, J BIOL CHEM, V277, P19929, DOI 10.1074/jbc.M201537200; WARR RG, 1987, P NATL ACAD SCI USA, V84, P7915, DOI 10.1073/pnas.84.22.7915; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	56	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16667	16678		10.1074/jbc.M109.002816	http://dx.doi.org/10.1074/jbc.M109.002816			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19366705	hybrid, Green Published			2022-12-25	WOS:000266730900062
J	Kim, YS; Kim, NH; Yeom, SJ; Kim, SW; Oh, DK				Kim, Yeong-Su; Kim, Nam-Hee; Yeom, Soo-Jin; Kim, Seon-Won; Oh, Deok-Kun			In Vitro Characterization of a Recombinant Blh Protein from an Uncultured Marine Bacterium as a beta-Carotene 15,15 '-Dioxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-A; ENZYMATIC CONVERSION; DIPHOSPHATE SYNTHASE; MOLECULAR-CLONING; GENOME SEQUENCE; EXPRESSION; GENE; IDENTIFICATION; PATTERN; BACTERIORHODOPSIN	Codon optimization was used to synthesize the blh gene from the uncultured marine bacterium 66A03 for expression in Escherichia coli. The expressed enzyme cleaved beta-carotene at its central double bond (15,15') to yield two molecules of all-trans-retinal. The molecular mass of the native purified enzyme was similar to 64 kDa as a dimer of 32-kDa subunits. The K-m, k(cat), and k(cat)/K-m values for beta-carotene as substrate were 37 mu M, 3.6 min(-1), and 97 mM(-1) min(-1), respectively. The enzyme exhibited the highest activity for beta-carotene, followed by beta-cryptoxanthin, beta-apo-4'-carotenal, alpha-carotene, and gamma-carotene in decreasing order, but not for beta-apo-8'-carotenal, beta-apo-12'-carotenal, lutein, zeaxanthin, or lycopene, suggesting that the presence of one unsubstituted beta-ionone ring in a substrate with a molecular weight greater than C-35 seems to be essential for enzyme activity. The oxygen atom of retinal originated not from water but from molecular oxygen, suggesting that the enzyme was beta-carotene 15,15'-dioxygenase. Although the Blh protein and beta-carotene 15,15'-monooxygenases catalyzed the same biochemical reaction, the Blh protein was unrelated to the mammalian beta-carotene 15,15'-monooxygenases as assessed by their different properties, including DNA and amino acid sequences, molecular weight, form of association, reaction mechanism, kinetic properties, and substrate specificity. This is the first report of in vitro characterization of a bacterial beta-carotene-cleaving enzyme.	[Kim, Yeong-Su; Kim, Nam-Hee; Yeom, Soo-Jin; Oh, Deok-Kun] Konkuk Univ, Dept Biosci & Biotechnol, Seoul 143701, South Korea; [Kim, Seon-Won] Gyeongsang Natl Univ, Environm Biotechnol Natl Care Res Ctr, Div Appl Life Sci BK21, Jinju 660701, South Korea; [Kim, Seon-Won] Gyeongsang Natl Univ, Plant Mol Biol & Biotechnol Res Ctr, Jinju 660701, South Korea	Konkuk University; Gyeongsang National University; Gyeongsang National University	Oh, DK (corresponding author), Konkuk Univ, Dept Biosci & Biotechnol, 1 Hwayang Dong, Seoul 143701, South Korea.	deokkun@konkuk.ac.kr	Yeom, Soojin/AAE-3558-2022	Kim, Yeong-Su/0000-0002-9831-2883; Yeom, Soo-Jin/0000-0001-7307-237X				Baliga NS, 2004, GENOME RES, V14, P2221, DOI 10.1101/gr.2700304; Borowski T, 2008, CHEM-EUR J, V14, P2264, DOI 10.1002/chem.200701344; Boulanger A, 2003, FASEB J, V17, P1304, DOI 10.1096/fj.02-0690fje; Bower MJ, 1997, J MOL BIOL, V267, P1268, DOI 10.1006/jmbi.1997.0926; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Burgess-Brown NA, 2008, PROTEIN EXPRES PURIF, V59, P94, DOI 10.1016/j.pep.2008.01.008; Ding YX, 2008, BIOSCI BIOTECH BIOCH, V72, P1571, DOI 10.1271/bbb.80067; During A, 1996, ANAL BIOCHEM, V241, P199, DOI 10.1006/abio.1996.0400; During A, 2004, ARCH BIOCHEM BIOPHYS, V430, P77, DOI 10.1016/j.abb.2004.03.024; EHRENSHAFT M, 1994, APPL ENVIRON MICROB, V60, P2766, DOI 10.1128/AEM.60.8.2766-2771.1994; FIDGE NH, 1969, BIOCHEM J, V114, P689, DOI 10.1042/bj1140689; Galperin MY, 1998, GENOME RES, V8, P779, DOI 10.1101/gr.8.8.779; GLOVER J, 1960, VITAM HORM, V18, P371; GOODMAN DS, 1967, J BIOL CHEM, V242, P3543; GOODMAN DS, 1966, J BIOL CHEM, V241, P1929; Grolier P, 1997, ARCH BIOCHEM BIOPHYS, V348, P233, DOI 10.1006/abbi.1997.0388; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Iwata-Reuyl D, 2003, BIOCHEMISTRY-US, V42, P3359, DOI 10.1021/bi0206614; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kim YS, 2007, APPL MICROBIOL BIOT, V76, P1339, DOI 10.1007/s00253-007-1118-2; Kloer DP, 2005, SCIENCE, V308, P267, DOI 10.1126/science.1108965; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LAKSHMAN.MR, 1972, J LIPID RES, V13, P477; Lampert JM, 2003, DEVELOPMENT, V130, P2173, DOI 10.1242/dev.00437; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leuenberger M. G., 2001, ANGEW CHEM, V113, P2683; Leuenberger MG, 2001, ANGEW CHEM INT EDIT, V40, P2614, DOI 10.1002/1521-3773(20010716)40:14<2613::AID-ANIE2613>3.0.CO;2-Z; Lindqvist A, 2002, J BIOL CHEM, V277, P23942, DOI 10.1074/jbc.M202756200; Martinez A, 2007, P NATL ACAD SCI USA, V104, P5590, DOI 10.1073/pnas.0611470104; McCarren J, 2007, ENVIRON MICROBIOL, V9, P846, DOI 10.1111/j.1462-2920.2006.01203.x; Mongodin EF, 2005, P NATL ACAD SCI USA, V102, P18147, DOI 10.1073/pnas.0509073102; Nagao A, 1996, ARCH BIOCHEM BIOPHYS, V328, P57, DOI 10.1006/abbi.1996.0142; Ng WV, 2000, P NATL ACAD SCI USA, V97, P12176, DOI 10.1073/pnas.190337797; Paik J, 2001, J BIOL CHEM, V276, P32160, DOI 10.1074/jbc.M010086200; Pan XC, 2008, DNA SEQUENCE, V19, P98, DOI 10.1080/10425170701446509; Peck RF, 2001, J BIOL CHEM, V276, P5739, DOI 10.1074/jbc.M009492200; Pfeiffer F, 2008, GENOMICS, V91, P335, DOI 10.1016/j.ygeno.2008.01.001; Poliakov E, 2005, J BIOL CHEM, V280, P29217, DOI 10.1074/jbc.M500409200; Ramos A, 2008, APPL MICROBIOL BIOT, V79, P819, DOI 10.1007/s00253-008-1492-4; Redmond TM, 2001, J BIOL CHEM, V276, P6560, DOI 10.1074/jbc.M009030200; Sabehi G, 2005, PLOS BIOL, V3, P1409, DOI 10.1371/journal.pbio.0030273; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scherzinger D, 2008, MOL MICROBIOL, V69, P231, DOI 10.1111/j.1365-2958.2008.06282.x; SHAND RF, 1994, J BACTERIOL, V176, P1655, DOI 10.1128/jb.176.6.1655-1660.1994; Takaya A, 2003, BBA-GENE STRUCT EXPR, V1625, P214, DOI 10.1016/S0167-4781(02)00602-4; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; von Lintig J, 2001, ARCH BIOCHEM BIOPHYS, V385, P47, DOI 10.1006/abbi.2000.2096; WOLF G, 1995, NUTR REV, V53, P134, DOI 10.1111/j.1753-4887.1995.tb01537.x; Wyss A, 2000, BIOCHEM BIOPH RES CO, V271, P334, DOI 10.1006/bbrc.2000.2619; Wyss A, 2001, BIOCHEM J, V354, P521, DOI 10.1042/0264-6021:3540521; Yan WM, 2001, GENOMICS, V72, P193, DOI 10.1006/geno.2000.6476; Yang CF, 1996, J BACTERIOL, V178, P840, DOI 10.1128/jb.178.3.840-845.1996	52	28	31	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15781	15793		10.1074/jbc.M109.002618	http://dx.doi.org/10.1074/jbc.M109.002618			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19366683	hybrid, Green Published			2022-12-25	WOS:000266501000047
J	Chaptal, V; Ottolia, M; Mercado-Besserer, G; Nicoll, DA; Philipson, KD; Abramson, J				Chaptal, Vincent; Ottolia, Michela; Mercado-Besserer, Gabriel; Nicoll, Debora A.; Philipson, Kenneth D.; Abramson, Jeff			Structure and Functional Analysis of a Ca2+ Sensor Mutant of the Na+/Ca2+ Exchanger	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-CA2+ EXCHANGER; NCX1; MODEL	The mammalian Na+/Ca2+ exchanger, NCX1.1, serves as the main mechanism for Ca2+ efflux across the sarcolemma following cardiac contraction. In addition to transporting Ca2+, NCX1.1 activity is also strongly regulated by Ca2+ binding to two intracellular regulatory domains, CBD1 and CBD2. The structures of both of these domains have been solved by NMR spectroscopy and x-ray crystallography, greatly enhancing our understanding of Ca2+ regulation. Nevertheless, the mechanisms by which Ca2+ regulates the exchanger remain incompletely understood. The initial NMR study showed that the first regulatory domain, CBD1, unfolds in the absence of regulatory Ca2+. It was further demonstrated that a mutation of an acidic residue involved in Ca2+ binding, E454K, prevents this structural unfolding. A contradictory result was recently obtained in a second NMR study in which Ca2+ removal merely triggered local rearrangements of CBD1. To address this issue, we solved the crystal structure of the E454K-CBD1 mutant and performed electrophysiological analyses of the full-length exchanger with mutations at position 454. We show that the lysine substitution replaces the Ca2+ ion at position 1 of the CBD1 Ca2+ binding site and participates in a charge compensation mechanism. Electrophysiological analyses show that mutations of residue Glu-454 have no impact on Ca2+ regulation of NCX1.1. Together, structural and mutational analyses indicate that only two of the four Ca2+ ions that bind to CBD1 are important for regulating exchanger activity.	[Chaptal, Vincent; Ottolia, Michela; Mercado-Besserer, Gabriel; Nicoll, Debora A.; Philipson, Kenneth D.; Abramson, Jeff] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Ottolia, Michela; Nicoll, Debora A.; Philipson, Kenneth D.] Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Philipson, KD (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA.	kphilipson@mednet.ucla.edu; jabramson@mednet.ucla.edu		chaptal, vincent/0000-0003-2603-0294	National Institutes of Health [GM07844, HL49101]; American Heart Association [0630258N]; Human Frontier Science Program (HFSP) [RGY0069]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078844] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Human Frontier Science Program (HFSP)(Human Frontier Science Program); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM07844 (to J.A.) and Grant HL49101 (to K. D. P.). This work was also supported by American Heart Association Grant 0630258N and Human Frontier Science Program (HFSP) Grant RGY0069 (to J.A.).	Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Boyman L, 2009, J BIOL CHEM, V284, P6185, DOI 10.1074/jbc.M809012200; del Monte F, 2008, HEART FAIL REV, V13, P151, DOI 10.1007/s10741-007-9071-9; Dyck C, 1999, J GEN PHYSIOL, V114, P701, DOI 10.1085/jgp.114.5.701; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Hilgemann DW, 1998, METHOD ENZYMOL, V293, P267; Johnson E, 2008, J MOL BIOL, V377, P945, DOI 10.1016/j.jmb.2008.01.046; MATSUOKA S, 1995, J GEN PHYSIOL, V105, P403, DOI 10.1085/jgp.105.3.403; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MERCADOBESSERER G, 2007, P NATL ACAD SCI USA, V104, P18467; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicoll DA, 1999, J BIOL CHEM, V274, P910, DOI 10.1074/jbc.274.2.910; Nicoll DA, 2007, ANN NY ACAD SCI, V1099, P1, DOI 10.1196/annals.1387.014; Nicoll DA, 2006, J BIOL CHEM, V281, P21577, DOI 10.1074/jbc.C600117200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Schwarz EM, 1997, P NATL ACAD SCI USA, V94, P10249, DOI 10.1073/pnas.94.19.10249	18	24	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14688	14692		10.1074/jbc.C900037200	http://dx.doi.org/10.1074/jbc.C900037200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19332552	Green Published, hybrid			2022-12-25	WOS:000266288200004
J	Liu, CC; Pearson, C; Bu, GJ				Liu, Chia-Chen; Pearson, Chelsea; Bu, Guojun			Cooperative Folding and Ligand-binding Properties of LRP6 beta-Propeller Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN-6; LDL-RECEPTOR; MOLECULAR CHAPERONE; TUMOR-GROWTH; BONE-MASS; FAMILY; MESD; DENSITY; DICKKOPF-1; MUTATION	Wnt/beta-catenin signaling controls cell growth during development, and its misregulation in adults can cause human diseases. LRP6, the essential co-receptor for the Wnt pathway, consists of four beta-propeller domains flanked by epidermal growth factor repeats in its extracellular region. To understand the maturation and ligand-binding properties of individual BP domains, we generated soluble receptor consisting of individual BPs, as well as combinations of these domains. We show that BP1, BP2, and BP4 each can be folded and secreted, and their secretion was enhanced by co-expression of Mesd, a molecular chaperone essential for LRP6 folding and maturation. BP3 is not secreted when expressed on its own or in combination with BP2 or BP1 and 2 (BP12); however, folding and secretion of BP3 is vastly enhanced when expressed together with BP4. Similar cooperative folding and maturation was observed between BP1 and BP2. These results suggest that BP1 forms a functional folding unit with BP2, whereas BP3 folds together with BP4. Using these BP constructs, we also found that BP12 and BP34 constitute independent ligand-binding domains capable of binding Wnt3a, Dkk1, and Mesd. The ability of Mesd to block the binding of both Wnt3a and Dkk1 to LRP6 enables this specialized chaperone to function as a Wnt signaling modulator. Together, our studies reveal unique properties of the LRP6 BP domains and provide novel tools to understand LRP6 function in ligand binding and Wnt signaling. Our results also support the development of soluble LRP6 receptors and Mesd as potential therapeutic molecules that target Wnt signaling.	[Bu, Guojun] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Bu, GJ (corresponding author), Washington Univ, Sch Med, Dept Pediat, Campus Box 8208,660 S Euclid Ave, St Louis, MO 63110 USA.	bu@wustl.edu			National Institutes of Health [CA100520]; Midwest Regional Center for Excellence in Emerging infections Diseases; NATIONAL CANCER INSTITUTE [R01CA100520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Midwest Regional Center for Excellence in Emerging infections Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA100520. This work was also supported by a grant from the Midwest Regional Center for Excellence in Emerging infections Diseases (to G. B.).	Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Bafico A, 1998, ONCOGENE, V16, P2819, DOI 10.1038/sj.onc.1201797; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Beglova N, 2004, MOL CELL, V16, P281, DOI 10.1016/j.molcel.2004.09.038; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brown SD, 1998, BIOCHEM BIOPH RES CO, V248, P879, DOI 10.1006/bbrc.1998.9061; Bu GJ, 1996, J BIOL CHEM, V271, P22218, DOI 10.1074/jbc.271.36.22218; Bu GJ, 2001, INT REV CYTOL, V209, P79; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Culi J, 2004, EMBO J, V23, P1372, DOI 10.1038/sj.emboj.7600132; DeAlmeida VI, 2007, CANCER RES, V67, P5371, DOI 10.1158/0008-5472.CAN-07-0266; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Jeon H, 2001, NAT STRUCT BIOL, V8, P499, DOI 10.1038/88556; Koduri V, 2007, BIOCHEMISTRY-US, V46, P6570, DOI 10.1021/bi700049g; Koehler Christian, 2006, Journal of Structural and Functional Genomics, V7, P131, DOI 10.1007/s10969-007-9016-5; Kubota T, 2008, J BONE MINER RES, V23, P1661, DOI 10.1359/JBMR.080512; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Lal A, 2005, MOL CELL PROBE, V19, P385, DOI 10.1016/j.mcp.2005.06.007; Li YH, 2005, J CELL SCI, V118, P5305, DOI 10.1242/jcs.02651; Li Yonghe, 2005, Future Oncol, V1, P673, DOI 10.2217/14796694.1.5.673; Li YH, 2006, FEBS LETT, V580, P5423, DOI 10.1016/j.febslet.2006.09.011; Li YS, 2000, J BIOL CHEM, V275, P37187, DOI 10.1074/jbc.M000490200; Lustig B, 2003, J CANCER RES CLIN, V129, P199, DOI 10.1007/s00432-003-0431-0; MacDonald BT, 2004, DEVELOPMENT, V131, P2543, DOI 10.1242/dev.01126; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Semenov MV, 2008, J BIOL CHEM, V283, P21427, DOI 10.1074/jbc.M800014200; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; SINGH I, 1990, EMBO J, V9, P631, DOI 10.1002/j.1460-2075.1990.tb08155.x; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; You L, 2004, CANCER RES, V64, P5385, DOI 10.1158/0008-5472.CAN-04-1227; Zhang YH, 2004, MOL CELL BIOL, V24, P4677, DOI 10.1128/MCB.24.11.4677-4684.2004; Zi XL, 2005, CANCER RES, V65, P9762, DOI 10.1158/0008-5472.CAN-05-0103	41	25	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15299	15307		10.1074/jbc.M807285200	http://dx.doi.org/10.1074/jbc.M807285200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19339249	hybrid, Green Published			2022-12-25	WOS:000266288200064
J	Akiri, G; Cherian, MM; Vijayakumar, S; Liu, G; Bafico, A; Aaronson, SA				Akiri, G.; Cherian, M. M.; Vijayakumar, S.; Liu, G.; Bafico, A.; Aaronson, S. A.			Wnt pathway aberrations including autocrine Wnt activation occur at high frequency in human non-small-cell lung carcinoma	ONCOGENE			English	Article						autocrine; lung cancer; wnt	HUMAN CANCER-CELLS; BETA-CATENIN; SIGNALING PATHWAY; STEM-CELLS; EPITHELIAL-CELLS; MUTATIONS; ADENOCARCINOMA; IDENTIFICATION; APC; DIFFERENTIATION	Lung cancer is the most common cause of cancer mortality worldwide. Non-small-cell lung carcinomas (NSCLCs), which represent around 80% of lung tumors, exhibit poor prognosis and are usually refractory to conventional chemotherapy. Elucidating the molecular and cellular mechanisms that are dysregulated in NSCLCs may lead to new possibilities for targeted therapy or enhanced efficacy of current therapies. Here we demonstrate Wnt pathway activation in around 50% of human NSCLC cell lines and primary tumors, through different mechanisms, including autocrine Wnt pathway activation involving upregulation of specific Wnt ligands. Downregulation of activated Wnt signaling inhibited NSCLC proliferation and induced a more differentiated phenotype. Together, our findings establish importance of activated Wnt signaling in human NSCLCs and offer the possibility of targeting upregulated Wnt signaling as a new therapeutic modality for this disease. Oncogene (2009) 28, 2163-2172; doi: 10.1038/onc.2009.82; published online 20 April 2009	[Akiri, G.; Cherian, M. M.; Vijayakumar, S.; Liu, G.; Bafico, A.; Aaronson, S. A.] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Aaronson, SA (corresponding author), Mt Sinai Sch Med, Dept Oncol Sci, 1 Gustave L Levy Pl,Box 1130, New York, NY 10029 USA.	stuart.aaronson@mssm.edu			National Cancer Institute [5R01CA071672]; New York State Department of Health and American Urological Association; NATIONAL CANCER INSTITUTE [R01CA071672] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); New York State Department of Health and American Urological Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant number 5R01CA071672 from the National Cancer Institute. SV is supported by consecutive post-doctoral fellowships from New York State Department of Health and American Urological Association. We are grateful to Dr J Minna and Dr A Gazdar (University of Texas Southwestern Medical Center, Dallas, TX, USA) for providing us with some NSCLC cell lines. We thank Dr Stefano Rivella (Weill Medical College of Cornell University, New York, NY, USA) for the generous gift of the lentiviral vector, pRRL-SIN-cPPT-PGK-GFP. We also thank Dr Robert Hannigan (Mount Sinai School of Medicine, New York, NY, USA) and Professor Roger Tsien (Howard Hughes Medical Institute, University of California, San Diego, CA, USA) for kindly providing us with the cDNA encoding mOrange. We especially thank Randy Arroyave for excellent technical assistance and Martina Kracikova and Ioana Rus for critical reading of this paper.	Bafico A, 1998, ONCOGENE, V16, P2819, DOI 10.1038/sj.onc.1201797; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Bernasconi NL, 2000, AM J RESP CELL MOL, V23, P560, DOI 10.1165/ajrcmb.23.4.4233; BRAGA VMM, 1992, DEVELOPMENT, V115, P427; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; GUZMAN J, 1994, EUR RESPIR J, V7, P736, DOI 10.1183/09031936.94.07040736; He B, 2004, NEOPLASIA, V6, P7, DOI 10.1016/S1476-5586(04)80048-4; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Minna JD, 2002, CANCER CELL, V1, P49, DOI 10.1016/S1535-6108(02)00027-2; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Mucenski ML, 2005, AM J PHYSIOL-LUNG C, V289, pL971, DOI 10.1152/ajplung.00172.2005; Nakamura N, 2006, ONCOGENE, V25, P4245, DOI 10.1038/sj.onc.1209442; Ohgaki H, 2004, CANCER LETT, V207, P197, DOI 10.1016/j.canlet.2003.10.020; Okubo Tadashi, 2004, J Biol, V3, P11, DOI 10.1186/jbiol3; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Reynolds SD, 2008, STEM CELLS, V26, P1337, DOI 10.1634/stemcells.2008-0053; RICHARDSON GE, 1993, SEMIN ONCOL, V20, P105; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; SCHILLER JH, 1992, IN VITRO CELL DEV-AN, V28A, P461; Shigemitsu K, 2001, ONCOGENE, V20, P4249, DOI 10.1038/sj.onc.1204557; Sunaga N, 2001, GENE CHROMOSOME CANC, V30, P316, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1097>3.0.CO;2-9; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; VENEMBRE P, 1994, FEBS LETT, V346, P171, DOI 10.1016/0014-5793(94)80695-0; You L, 2004, ONCOGENE, V23, P6170, DOI 10.1038/sj.onc.1207844; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157	33	112	133	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 28	2009	28	21					2163	2172		10.1038/onc.2009.82	http://dx.doi.org/10.1038/onc.2009.82			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	451DQ	19377513	Green Accepted			2022-12-25	WOS:000266451300005
J	Sato, Y; Uemura, T; Morimitsu, K; Sato-Nishiuchi, R; Manabe, R; Takagi, J; Yamada, M; Sekiguchi, K				Sato, Yuya; Uemura, Toshihiko; Morimitsu, Keisuke; Sato-Nishiuchi, Ryoko; Manabe, Ri-ichiroh; Takagi, Junichi; Yamada, Masashi; Sekiguchi, Kiyotoshi			Molecular Basis of the Recognition of Nephronectin by Integrin alpha 8 beta 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; LIGAND-BINDING SPECIFICITIES; STRUCTURAL BASIS; KIDNEY MORPHOGENESIS; PROTEIN NEPHRONECTIN; BASEMENT-MEMBRANE; HUMAN FIBRONECTIN; ADHESIVE FUNCTION; EMBRYONIC KIDNEY; LAMININ ISOFORMS	Integrin alpha 8 beta 1 interacts with a variety of Arg-Gly-Asp (RGD)-containing ligands in the extracellular matrix. Here, we examined the binding activities of alpha 8 beta 1 integrin toward a panel of RGD-containing ligands. Integrin alpha 8 beta 1 bound specifically to nephronectin with an apparent dissociation constant of 0.28 +/- 0.01 nM, but showed only marginal affinities for fibronectin and other RGD-containing ligands. The high-affinity binding to alpha 8 beta 1 integrin was fully reproduced with a recombinant nephronectin fragment derived from the RGD-containing central "linker" segment. A series of deletion mutants of the recombinant fragment identified the LFEIFEIER sequence on the C-terminal side of the RGD motif as an auxiliary site required for high-affinity binding to alpha 8 beta 1 integrin. Alanine scanning mutagenesis within the LFEIFEIER sequence defined the EIE sequence as a critical motif ensuring the high-affinity integrin-ligand interaction. Although a synthetic LFEIFEIER peptide failed to inhibit the binding of alpha 8 beta 1 integrin to nephronectin, a longer peptide containing both the RGD motif and the LFEIFEIER sequence was strongly inhibitory, and was similar to 2,000-fold more potent than a peptide containing only the RGD motif. Furthermore, trans-complementation assays using recombinant fragments containing either the RGD motif or LFEIFEIER sequence revealed a clear synergism in the binding to alpha 8 beta 1 integrin. Taken together, these results indicate that the specific high-affinity binding of nephronectin to alpha 8 beta 1 integrin is achieved by bipartite interaction of the integrin with the RGD motif and LFEIFEIER sequence, with the latter serving as a synergy site that greatly potentiates the RGD-driven integrin-ligand interaction but has only marginal activity to secure the interaction by itself.	[Sato, Yuya; Uemura, Toshihiko; Morimitsu, Keisuke; Sato-Nishiuchi, Ryoko; Manabe, Ri-ichiroh; Takagi, Junichi; Yamada, Masashi; Sekiguchi, Kiyotoshi] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Osaka University	Sekiguchi, K (corresponding author), Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	sekiguch@protein.osaka-u.ac.jp			New Energy and Industrial Technology Development Organization of Japan [17082005, 20370046, 06001294-0]	New Energy and Industrial Technology Development Organization of Japan(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported in part by Grants-in-aid for Scientific Research 17082005 and 20370046 (to K. S.) and Research Contract 06001294-0 with the New Energy and Industrial Technology Development Organization of Japan.	AKIYAMA SK, 1985, J BIOL CHEM, V260, P402; AKIYAMA Y, 1998, GEN INF SER WORKSH G, V9, P131; AOTA S, 1994, J BIOL CHEM, V269, P24756; BOSSY B, 1991, EMBO J, V10, P2375, DOI 10.1002/j.1460-2075.1991.tb07776.x; Brandenberger R, 2001, J CELL BIOL, V154, P447, DOI 10.1083/jcb.200103069; Denda S, 1998, MOL BIOL CELL, V9, P1425, DOI 10.1091/mbc.9.6.1425; DiCara D, 2007, J BIOL CHEM, V282, P9657, DOI 10.1074/jbc.M610461200; EKBLOM P, 1981, J CELL BIOL, V91, P1, DOI 10.1083/jcb.91.1.1; Evans AL, 2000, NAT GENET, V24, P424, DOI 10.1038/74286; Gu JG, 2001, J BIOL CHEM, V276, P27090, DOI 10.1074/jbc.M102284200; Hansen JE, 1998, GLYCOCONJUGATE J, V15, P115, DOI 10.1023/A:1006960004440; Humphries JD, 2000, J BIOL CHEM, V275, P20337, DOI 10.1074/jbc.M000568200; Humphries MJ, 2003, CURR OPIN STRUC BIOL, V13, P236, DOI 10.1016/S0959-440X(03)00035-6; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ido H, 2007, J BIOL CHEM, V282, P11144, DOI 10.1074/jbc.M609402200; Kamata T, 2001, J BIOL CHEM, V276, P44275, DOI 10.1074/jbc.M107021200; Kiyozumi D, 2005, EXP CELL RES, V306, P9, DOI 10.1016/j.yexcr.2005.01.020; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Linton JM, 2007, DEVELOPMENT, V134, P2501, DOI 10.1242/dev.005033; Lu M, 2002, J CELL SCI, V115, P4641, DOI 10.1242/jcs.00145; Manabe R, 1997, J CELL BIOL, V139, P295, DOI 10.1083/jcb.139.1.295; Manabe RI, 2008, P NATL ACAD SCI USA, V105, P12849, DOI 10.1073/pnas.0803640105; Morimura N, 2001, J BIOL CHEM, V276, P42172, DOI 10.1074/jbc.M103216200; Mould AP, 2000, J BIOL CHEM, V275, P20324, DOI 10.1074/jbc.M000572200; Mould AP, 2003, J BIOL CHEM, V278, P39993, DOI 10.1074/jbc.M304627200; Muller U, 1997, CELL, V88, P603, DOI 10.1016/S0092-8674(00)81903-0; MULLER U, 1995, MOL BIOL CELL, V6, P433; Nishiuchi R, 2006, MATRIX BIOL, V25, P189, DOI 10.1016/j.matbio.2005.12.001; Nishiuchi R, 2003, J BIOCHEM, V134, P497, DOI 10.1093/jb/mvg185; OBARA M, 1988, CELL, V53, P649, DOI 10.1016/0092-8674(88)90580-6; Osada A, 2005, EXP CELL RES, V303, P148, DOI 10.1016/j.yexcr.2004.04.053; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Redick SD, 2000, J CELL BIOL, V149, P521, DOI 10.1083/jcb.149.2.521; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Scherberich A, 2005, ONCOGENE, V24, P1525, DOI 10.1038/sj.onc.1208342; Scherberich A, 2004, J CELL SCI, V117, P571, DOI 10.1242/jcs.00867; SCHNAPP LM, 1995, J BIOL CHEM, V270, P23196, DOI 10.1074/jbc.270.39.23196; SEKIGUCHI K, 1983, J BIOL CHEM, V258, P4359; Takagi J, 2004, BIOCHEM SOC T, V32, P403, DOI 10.1042/BST0320403; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Takagi J, 2007, CURR OPIN CELL BIOL, V19, P557, DOI 10.1016/j.ceb.2007.09.002; von der Mark H, 2007, J MOL BIOL, V371, P1188, DOI 10.1016/j.jmb.2007.05.074; Wagner TE, 2003, J HISTOCHEM CYTOCHEM, V51, P1307, DOI 10.1177/002215540305101008; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; YATOHGO T, 1988, CELL STRUCT FUNCT, V13, P281, DOI 10.1247/csf1975.13.281	48	51	54	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14524	14536		10.1074/jbc.M900200200	http://dx.doi.org/10.1074/jbc.M900200200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19342381	hybrid, Green Published			2022-12-25	WOS:000266286100059
J	Natan, D; Nagler, A; Arav, A				Natan, Dity; Nagler, Arnon; Arav, Amir			Freeze-Drying of Mononuclear Cells Derived from Umbilical Cord Blood Followed by Colony Formation	PLOS ONE			English	Article							GREEN TEA; EPIGALLOCATECHIN GALLATE; DESICCATION TOLERANCE; LARGE-VOLUME; SUCCESSFUL PREGNANCIES; CHILLING SENSITIVITY; SALT CONCENTRATION; PHASE-TRANSITIONS; STEM-CELLS; CRYOPRESERVATION	Background: We recently showed that freeze-dried cells stored for 3 years at room temperature can direct embryonic development following cloning. However, viability, as evaluated by membrane integrity of the cells after freeze-drying, was very low; and it was mainly the DNA integrity that was preserved. In the present study, we improved the cells' viability and functionality after freeze-drying. Methodology/Principal Findings: We optimized the conditions of directional freezing, i.e. interface velocity and cell concentration, and we added the antioxidant EGCG to the freezing solution. The study was performed on mononuclear cells (MNCs) derived from human umbilical cord blood. After freeze-drying, we tested the viability, number of CD34(+)-presenting cells and ability of the rehydrated hematopoietic stem cells to differentiate into different blood cells in culture. The viability of the MNCs after freeze-drying and rehydration with pure water was 88%-91%. The total number of CD34(+)-presenting cells and the number of colonies did not change significantly when evaluated before freezing, after freeze-thawing, and after freeze-drying (5.4x10 (4)+/- 4.7, 3.49x10(4)+/- 6 and 6.31x10(4 +/-)12.27 cells, respectively, and 31 +/- 25.15, 47 +/- 45.8 and 23.44 +/- 13.3 colonies, respectively). Conclusions: This is the first report of nucleated cells which have been dried and then rehydrated with double-distilled water remaining viable, and of hematopoietic stem cells retaining their ability to differentiate into different blood cells.			Natan, D (corresponding author), Core Dynam Ltd, Ness Ziona, Israel.	dity@coredynamics.com						Abdelwahed W, 2006, INT J PHARM, V324, P74, DOI 10.1016/j.ijpharm.2006.06.047; Allison SD, 1998, ARCH BIOCHEM BIOPHYS, V358, P171, DOI 10.1006/abbi.1998.0832; Arav A, 1996, CRYOBIOLOGY, V33, P589, DOI 10.1006/cryo.1996.0062; Arav A., 1992, Embryonic development and manipulation in animal production: trends in research and applications., P255; Arav A, 2005, HUM REPROD, V20, P3554, DOI 10.1093/humrep/dei278; Arav A, 2002, REPROD NUTR DEV, V42, P583, DOI 10.1051/rnd:2002044; Arav A, 2002, MOL CELL ENDOCRINOL, V187, P77, DOI 10.1016/S0303-7207(01)00700-6; Aversa F, 1998, NEW ENGL J MED, V339, P1186, DOI 10.1056/NEJM199810223391702; Bielanski A, 2003, CRYOBIOLOGY, V46, P146, DOI 10.1016/S0011-2240(03)00020-8; Choi CW, 2001, INT J HEMATOL, V73, P245, DOI 10.1007/BF02981945; Crowe JH, 2005, INTEGR COMP BIOL, V45, P810, DOI 10.1093/icb/45.5.810; Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73; Crowe JH, 1997, CRYOBIOLOGY, V35, P20, DOI 10.1006/cryo.1997.2020; CROWE JH, 1994, CRYOBIOLOGY, V31, P355, DOI 10.1006/cryo.1994.1043; CROWE LM, 1991, BIOCHIM BIOPHYS ACTA, V1064, P267, DOI 10.1016/0005-2736(91)90311-U; Crowe LM, 1996, BIOPHYS J, V71, P2087, DOI 10.1016/S0006-3495(96)79407-9; CROWE LM, 1985, ARCH BIOCHEM BIOPHYS, V242, P240, DOI 10.1016/0003-9861(85)90498-9; CROWE LM, 1988, BIOCHIM BIOPHYS ACTA, V946, P193, DOI 10.1016/0005-2736(88)90392-6; De Loecker W, 1998, CRYOBIOLOGY, V37, P103, DOI 10.1006/cryo.1998.2106; DROBNIS EZ, 1993, J EXP ZOOL, V265, P432, DOI 10.1002/jez.1402650413; FAHY GM, 1987, CRYOBIOLOGY, V24, P196, DOI 10.1016/0011-2240(87)90023-X; Fujiki H, 1999, P SOC EXP BIOL MED, V220, P225, DOI 10.1046/j.1525-1373.1999.d01-38.x; Gacitua H, 2005, THERIOGENOLOGY, V63, P931, DOI 10.1016/j.theriogenology.2004.05.012; Gavish Z, 2008, REJUV RES, V11, P765, DOI 10.1089/rej.2008.0706; Halle P, 2001, TRANSFUSION, V41, P667, DOI 10.1046/j.1537-2995.2001.41050667.x; Hamza A, 2006, J PHYS CHEM B, V110, P2910, DOI 10.1021/jp0550762; Han DW, 2008, BIOORGAN MED CHEM, V16, P9652, DOI 10.1016/j.bmc.2008.10.009; Hassan HT, 1996, STEM CELLS, V14, P419, DOI 10.1002/stem.140419; Hosu BG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002787; HUBEL A, 1992, CRYOBIOLOGY, V29, P183, DOI 10.1016/0011-2240(92)90019-X; JENNINGS TA, 2002, LYOPHILIZATION; Kawai K, 2004, J ALLERGY CLIN IMMUN, V113, P1211, DOI 10.1016/j.jaci.2004.02.044; Kumazawa S, 2004, BIOSCI BIOTECH BIOCH, V68, P1743, DOI 10.1271/bbb.68.1743; Kusadasi N, 2000, LEUKEMIA, V14, P1944, DOI 10.1038/sj.leu.2401917; Laroche V, 2005, TRANSFUSION, V45, P1909, DOI 10.1111/j.1537-2995.2005.00638.x; Leidy C, 2004, CELL BIOCHEM BIOPHYS, V40, P123, DOI 10.1385/CBB:40:2:123; Loi P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002978; Ma LP, 2000, CHINESE SCI BULL, V45, P2052, DOI 10.1007/BF03183525; Ma XC, 2005, CRYOBIOLOGY, V51, P15, DOI 10.1016/j.cryobiol.2005.04.007; MAZUR P, 1981, BIOPHYS J, V36, P653, DOI 10.1016/S0006-3495(81)84757-1; MAZUR P, 1985, CRYOBIOLOGY, V22, P509, DOI 10.1016/0011-2240(85)90029-X; MAZUR P, 1963, J GEN PHYSIOL, V47, P347, DOI 10.1085/jgp.47.2.347; MCGANN LE, 1988, CRYOBIOLOGY, V25, P178, DOI 10.1016/0011-2240(88)90024-7; Morris GJ, 2005, CRYOBIOLOGY, V50, P231, DOI 10.1016/j.cryobiol.2005.01.005; Mounier Nicolas, 2005, Bull Cancer, V92, pE31; O'Brien JK, 2006, REPROD FERT DEVELOP, V18, P319, DOI 10.1071/RD05108; POTTS M, 1994, MICROBIOL REV, V58, P755, DOI 10.1128/MMBR.58.4.755-805.1994; Potts M, 2005, INTEGR COMP BIOL, V45, P800, DOI 10.1093/icb/45.5.800; Rindler V, 1999, CRYOBIOLOGY, V38, P2, DOI 10.1006/cryo.1998.2143; Rindler V, 1999, CRYOBIOLOGY, V39, P228, DOI 10.1006/cryo.1999.2204; Rogers I, 2001, CYTOTHERAPY, V3, P269, DOI 10.1080/146532401317070907; Roth Z, 2008, THERIOGENOLOGY, V70, P887, DOI 10.1016/j.theriogenology.2008.05.053; Salvucci O, 2002, BLOOD, V99, P2703, DOI 10.1182/blood.V99.8.2703; Saragusty J, 2006, THERIOGENOLOGY, V66, P775, DOI 10.1016/j.theriogenology.2006.01.055; Searles JA, 2001, J PHARM SCI, V90, P872, DOI 10.1002/jps.1040; Si W, 2006, THERIOGENOLOGY, V65, P788, DOI 10.1016/j.theriogenology.2005.06.010; Sun WQ, 1996, BIOPHYS J, V70, P1769, DOI 10.1016/S0006-3495(96)79740-0; Thephinlap C, 2007, MED CHEM, V3, P289, DOI 10.2174/157340607780620608; Tipoe George L., 2007, Cardiovascular & Hematological Disorders - Drug Targets, V7, P135; Wang W, 2000, INT J PHARMACEUT, V203, P1, DOI 10.1016/S0378-5173(00)00423-3; WEISS L, 1959, BIOPHYSIC BIOCH CYTO, V7, P673; Wolkers WF, 2002, COMP BIOCHEM PHYS A, V131, P535, DOI 10.1016/S1095-6433(01)00505-0; WU D, 2007, FASEB J, V21; Yamakov V, 2002, NAT MATER, V1, P45, DOI 10.1038/nmat700; Yanagawa Y, 2003, CURR MICROBIOL, V47, P244, DOI 10.1007/s00284-002-3956-6; Zeron Y, 2002, CRYOBIOLOGY, V45, P143, DOI 10.1016/S0011-2240(02)00123-2; Zeron Y, 2002, MOL REPROD DEV, V61, P271, DOI 10.1002/mrd.1156	67	50	51	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2009	4	4							e5240	10.1371/journal.pone.0005240	http://dx.doi.org/10.1371/journal.pone.0005240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VA	19381290	Green Submitted, Green Published, gold			2022-12-25	WOS:000265513800012
J	Hanson, S; Thorson, A; Rosling, H; Ortendahl, C; Hanson, C; Killewo, J; Ekstrom, AM				Hanson, Stefan; Thorson, Anna; Rosling, Hans; Ortendahl, Claes; Hanson, Claudia; Killewo, Japhet; Ekstrom, Anna Mia			Estimating the Capacity for ART Provision in Tanzania with the Use of Data on Staff Productivity and Patient Losses	PLOS ONE			English	Article								Background: International targets for access to antiretroviral therapy (ART) have over-estimated the capacity of health systems in low-income countries in Sub-Saharan Africa. The WHO target for number on treatment by end 2005 for Tanzania was 10 times higher than actually achieved. The target of the national Care and Treatment Plan (CTP) was also not reached. We aimed at estimating the capacity for ART provision and created five scenarios for ART production given existing resource limitations. Methods: A situation analysis including scrutiny of staff factors, such as available data on staff and patient factors including access to ART and patient losses, made us conclude that the lack of clinical staff is the main limiting factor for ART scale-up, assuming that sufficient drugs and supplies are provided by donors. We created a simple formula to estimate the number of patients on ART based on availability and productivity of clinical staff, time needed to initiate vs maintain a patient on ART and patient losses using five different scenarios with varying levels of these parameters. Findings: Our scenario assuming medium productivity (40% higher than that observed in 2002) and medium loss of patients (20% in addition to 15% first-year mortality) coincides with the actual reported number of patients initiated on ART up to 2008, but is considerably below the national CTP target of 90% coverage for 2009, corresponding to 420,000 on ART and 710,000 life-years saved (LY's). Our analysis suggests that a coverage of 40% or 175,000 on treatment and 350,000 LY's saved is more achievable. Conclusion: A comparison of our scenario estimations and actual output 2006-2008 indicates that a simple user-friendly dynamic model can estimate the capacity for ART scale-up in resource-poor settings based on identification of a limiting staff factor and information on availability of this staff and patient losses. Thus, it is possible to set more achievable targets.			Hanson, S (corresponding author), Karolinska Inst, Div Int Hlth IHCAR, Stockholm, Sweden.	Stefan.Hanson@ki.se	Visan, Delia/GXW-3349-2022	Thorson, Anna/0000-0002-8703-6561				[Anonymous], 2001, MACR HLTH INV HLTH E; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Binswanger HP, 2000, SCIENCE, V288, P2173, DOI 10.1126/science.288.5474.2173; BISSON G, 2007, C RETR OPP INF LOS A; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; FERRADINI L, 2004, 15 INT C AIDS BANGK; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; *GLOB FUND FIGHT A, 2002, FRAM DOC GLOB FUND F; High Level Forum, 2005, PAR DECL AID EFF OWN; Jaffar S, 2004, B WORLD HEALTH ORGAN, V82, P462; Kabugo C, 2005, JAIDS-J ACQ IMM DEF, V38, P578, DOI 10.1097/01.qai.0000134742.26338.2f; KILLEWO J, 2004, NAT HIV AIDS CAR TRE; Kurowski C, 2004, HUMAN RESOURCES HLTH; Lowrance DW, 2008, JAIDS-J ACQ IMM DEF, V49, P287, DOI 10.1097/QAI.0b013e3181893ef0; Marston M, 2007, AIDS, V21, pS65, DOI 10.1097/01.aids.0000299412.82893.62; *MIN HLTH, 2003, BURD DIS PROF COAST; *MIN HLTH, 2003, POL IMPL TANZ MORT B, V2; *MIN HLTH, 2001, CENS HUM RE IN PRESS; *MIN HLTH NAT AIDS, 2006, SURV HIV SYPH INF AN; *MOHSW CAP PROJ NA, 2006, LAB MARK STUD TANZ H; *OECD DAC, 2007, EXT EV TANZ HLTH SEC; Piot P, 2006, LANCET, V368, P526, DOI 10.1016/S0140-6736(06)69161-7; *POP DIV DEP EC SO, 2006 REV WORLD URB P; Ramiah I, 2005, HEALTH AFFAIR, V24, P545, DOI 10.1377/hlthaff.24.2.545; Rosen S, 2005, LANCET, V365, P354, DOI 10.1016/S0140-6736(05)70202-6; Spacek LA, 2006, INT J STD AIDS, V17, P116, DOI 10.1258/095646206775455766; *TANZ COMM AIDS SA, 2005, HIV AIDS IND SURV; Tassie JM, 2003, AIDS, V17, P1995, DOI 10.1097/00002030-200309050-00023; *UN GEN ASS, 2000, UNS MILL DEV GOALS; *UN REP TANZ, HIV AIDS CAR TREATM; *UNAIDS, 2006, UNAIDS WHO AIDS EP U; *UNAIDS, 2005, SPECTR MOD VERS 2005; *UNAIDS, 2007, AIDS EP UPD; *UNAIDS, 2005, EP PROJ PACK EPP VER; Van Damme W, 2006, AIDS, V20, P653, DOI 10.1097/01.aids.0000216364.44409.b1; van Oosterhout JJ, 2005, TROP MED INT HEALTH, V10, P464, DOI 10.1111/j.1365-3156.2005.01409.x; Weidle PJ, 2002, LANCET, V360, P34, DOI 10.1016/S0140-6736(02)09330-3; *WHO, 2006, 3 5 IN PROGR GLOB AC; *WHO UNAIDS UNICEF, 2008, UN ACC SCAL UP HIV A; *WHO UNFPA UNICEF, 2006, STAT KEN UG TRIAL FI; *WJ CLINT FDN, HIV AIDS IN; Wools-Kaloustian K, 2006, AIDS, V20, P41, DOI 10.1097/01.aids.0000196177.65551.ea	42	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2009	4	4							e5294	10.1371/journal.pone.0005294	http://dx.doi.org/10.1371/journal.pone.0005294			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TW	19381270	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000265510800015
J	Gnocchi, VF; White, RB; Ono, Y; Ellis, JA; Zammit, PS				Gnocchi, Viola F.; White, Robert B.; Ono, Yusuke; Ellis, Juliet A.; Zammit, Peter S.			Further Characterisation of the Molecular Signature of Quiescent and Activated Mouse Muscle Satellite Cells	PLOS ONE			English	Article							DREIFUSS MUSCULAR-DYSTROPHY; MYOGENIC STEM-CELLS; SKELETAL-MUSCLE; SELF-RENEWAL; M-CADHERIN; EXPRESSION; MUTATIONS; MARKER; PROGRESSION; CONTRIBUTE	Satellite cells are the resident stem cells of adult skeletal muscle. To date though, there is a paucity of native markers that can be used to easily identify quiescent satellite cells, with Pax7 probably being the best that is currently available. Here we have further characterized a number of recently described satellite cell markers, and also describe novel ones. Caveolin-1, integrin alpha 7 and the calcitonin receptor proved reliable markers for quiescent satellite cells, being expressed by all satellite cells identified with Pax7. These three markers remained expressed as satellite cells were activated and underwent proliferation. The nuclear envelope proteins lamin A/C and emerin, mutations in which underlie Emery-Dreifuss muscular dystrophy, were also expressed in both quiescent and proliferating satellite cells. Conversely, Jagged-1, a Notch ligand, was not expressed in quiescent satellite cells but was induced upon activation. These findings further contribute to defining the molecular signature of muscle satellite cells.			Gnocchi, VF (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, Guys Campus, London WC2R 2LS, England.	peter.zammit@kcl.ac.uk	Zammit, peter/GXV-7746-2022; White, Robert/H-6080-2014	Ono, Yusuke/0000-0002-4802-7507; White, Robert/0000-0002-2854-0936; zammit, peter/0000-0001-9562-3072	MRC [G0700307] Funding Source: UKRI; Medical Research Council [G0700307] Funding Source: Medline; Wellcome Trust [085137/Z/08/Z] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; BISCHOFF R, 2004, SATELLITE STEM CELLS; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Collins CA, 2007, STEM CELLS, V25, P885, DOI 10.1634/stemcells.2006-0372; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Cornelison DDW, 2001, DEV BIOL, V239, P79, DOI 10.1006/dbio.2001.0416; Day K, 2007, DEV BIOL, V304, P246, DOI 10.1016/j.ydbio.2006.12.026; Ellis JA, 2006, CELL MOL LIFE SCI, V63, P2702, DOI 10.1007/s00018-006-6247-8; Ellis JA, 1998, J CELL SCI, V111, P781; FIDZIANSKA A, 1995, FOLIA NEUROPATHOL, V33, P125; Fukada S, 2004, EXP CELL RES, V296, P245, DOI 10.1016/j.yexcr.2004.02.018; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Garry DJ, 1997, DEV BIOL, V188, P280, DOI 10.1006/dbio.1997.8657; Gnocchi VF, 2008, BIOCHEM SOC T, V36, P1344, DOI 10.1042/BST0361344; Hayashi YK, 1998, NAT GENET, V19, P94, DOI 10.1038/ng0598-94; ILLA I, 1992, ANN NEUROL, V31, P46, DOI 10.1002/ana.410310109; IRINTCHEV A, 1994, DEV DYNAM, V199, P326, DOI 10.1002/aja.1001990407; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Lee HJ, 2004, MOL CELL BIOL, V24, P8428, DOI 10.1128/MCB.24.19.8428-8436.2004; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Minetti C, 1998, NAT GENET, V18, P365, DOI 10.1038/ng0498-365; Nagata Y, 2006, J HISTOCHEM CYTOCHEM, V54, P375, DOI 10.1369/jhc.5A6675.2006; Nawrotzki R, 2003, HUM MOL GENET, V12, P483, DOI 10.1093/hmg/ddg047; Noden DM, 2006, DEV DYNAM, V235, P1194, DOI 10.1002/dvdy.20697; PARK YE, 2008, NEUROMUSCUL DISORD; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; ROSENBLATT JD, 1992, J APPL PHYSIOL, V73, P2538, DOI 10.1152/jappl.1992.73.6.2538; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sajko S, 2004, J HISTOCHEM CYTOCHEM, V52, P179, DOI 10.1177/002215540405200205; Schmidt K, 2003, J BIOL CHEM, V278, P29769, DOI 10.1074/jbc.M301539200; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Sinha-Hikim I, 2004, J CLIN ENDOCR METAB, V89, P5245, DOI 10.1210/jc.2004-0084; Volonte D, 2004, FASEB J, V18, P237, DOI 10.1096/fj.04-2215fje; WHALEN RG, 1990, DEV BIOL, V141, P24, DOI 10.1016/0012-1606(90)90099-5; YABLONKAREUVENI Z, 1994, DEV BIOL, V164, P588, DOI 10.1006/dbio.1994.1226; Zammit PS, 2008, J CELL SCI, V121, P2975, DOI 10.1242/jcs.019661; Zammit PS, 2001, DIFFERENTIATION, V68, P193, DOI 10.1046/j.1432-0436.2001.680407.x; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007; Zammit PS, 2002, EXP CELL RES, V281, P39, DOI 10.1006/excr.2002.5653	45	105	110	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2009	4	4							e5205	10.1371/journal.pone.0005205	http://dx.doi.org/10.1371/journal.pone.0005205			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TU	19370151	Green Published, Green Submitted, gold			2022-12-25	WOS:000265510600002
J	Schweitzer, JK; Pietrini, SD; D'Souza-Schorey, C				Schweitzer, Jill Kuglin; Pietrini, Sean D.; D'Souza-Schorey, Crislyn			ARF6-Mediated Endosome Recycling Reverses Lipid Accumulation Defects in Niemann-Pick Type C Disease	PLOS ONE			English	Article								In human Niemann-Pick Type C (NPC) disease, endosomal trafficking defects lead to an accumulation of free cholesterol and other lipids in late endosome/lysosome (LE/LY) compartments, a subsequent block in cholesterol esterification and significantly reduced cholesterol efflux out of the cell. Here we report that nucleotide cycling or cellular knockdown of the small GTP-binding protein, ARF6, markedly impacts cholesterol homeostasis. Unregulated ARF6 activation attenuates the NPC phenotype at least in part by decreasing cholesterol accumulation and restoring normal sphingolipid trafficking. These effects depend on ARF6-stimulated cholesterol efflux out of the endosomal recycling compartment, a major cell repository for free cholesterol. We also show that fibroblasts derived from different NPC patients displayed varying levels of ARF6 that is GTP-bound, which correlate with their response to sustained ARF6 activation. These studies support emerging evidence that early endocytic defects impact NPC disease and suggest that such heterogeneity in NPC disease could result in diverse responses to therapeutic interventions aimed at modulating the trafficking of lipids.			Schweitzer, JK (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	D'Souza-Schorey.1@nd.edu						Boshans RL, 2000, MOL CELL BIOL, V20, P3685, DOI 10.1128/MCB.20.10.3685-3694.2000; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Chen W, 2001, J BIOL CHEM, V276, P43564, DOI 10.1074/jbc.M107938200; Choi HY, 2003, J BIOL CHEM, V278, P32569, DOI 10.1074/jbc.M304553200; Choudhury A, 2004, MOL BIOL CELL, V15, P4500, DOI 10.1091/mbc.E04-05-0432; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Cruz JC, 2000, J BIOL CHEM, V275, P41309, DOI 10.1074/jbc.M008272200; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Ganley IG, 2006, J BIOL CHEM, V281, P17890, DOI 10.1074/jbc.M601679200; Holtta-Vuori M, 2002, MOL BIOL CELL, V13, P3107, DOI 10.1091/mbc.E02-01-0025; Ikonen E, 2004, SEMIN CELL DEV BIOL, V15, P445, DOI 10.1016/j.semcdb.2004.03.001; Kaptzan T, 2009, AM J PATHOL, V174, P14, DOI 10.2353/ajpath.2009.080660; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289; Linder MD, 2007, MOL BIOL CELL, V18, P47, DOI 10.1091/mbc.E06-07-0575; Liscum L, 2004, BBA-MOL CELL BIOL L, V1685, P22, DOI 10.1016/j.bbalip.2004.08.008; LISCUM L, 1989, J BIOL CHEM, V264, P11796; Mukhejee S, 2004, BBA-MOL CELL BIOL L, V1685, P28, DOI 10.1016/j.bbalip.2004.08.009; Narita K, 2005, FASEB J, V19, P1558, DOI 10.1096/fj.04-2714fje; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Pagano RE, 2003, PHILOS T R SOC B, V358, P885, DOI 10.1098/rstb.2003.1275; Palacios F, 2001, EMBO J, V20, P4973, DOI 10.1093/emboj/20.17.4973; Pipalia NH, 2007, TRAFFIC, V8, P130, DOI 10.1111/j.1600-0854.2006.00513.x; Schweitzer JK, 2005, EXP CELL RES, V311, P74, DOI 10.1016/j.yexcr.2005.07.033; Schweitzer JK, 2002, J BIOL CHEM, V277, P27210, DOI 10.1074/jbc.M201569200; Sugii S, 2003, J LIPID RES, V44, P1033, DOI 10.1194/jlr.D200036-JLR200; Walter M, 2003, J LIPID RES, V44, P243, DOI 10.1194/jlr.M200230-JLR200; Wang MD, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M700326200; Wastney ME, 2003, ADV EXP MED BIOL, V537, P63	29	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2009	4	4							e5193	10.1371/journal.pone.0005193	http://dx.doi.org/10.1371/journal.pone.0005193			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TO	19365558	Green Published, Green Submitted, gold			2022-12-25	WOS:000265510000002
J	Le, TT; Cheng, JX				Le, Thuc T.; Cheng, Ji-Xin			Single-Cell Profiling Reveals the Origin of Phenotypic Variability in Adipogenesis	PLOS ONE			English	Article							RAMAN SCATTERING MICROSCOPY; ADIPOCYTE DIFFERENTIATION; LIPID DROPLETS; GLUCOSE; GENE; METABOLISM; PATHWAYS; PROTEIN; PREF-1	Phenotypic heterogeneity in a clonal cell population is a well-observed but poorly understood phenomenon. Here, a single-cell approach is employed to investigate non-mutative causes of phenotypic heterogeneity during the differentiation of 3T3-L1 cells into fat cells. Using coherent anti-Stokes Raman scattering microscopy and flow cytometry, adipogenic gene expression, insulin signaling, and glucose import are visualized simultaneously with lipid droplet accumulation in single cells. Expression of adipogenic genes PPAR gamma, C/EBP alpha, aP2, LP2 suggests a commitment to fat cell differentiation in all cells. However, the lack of lipid droplet in many differentiating cells suggests adipogenic gene expression is insufficient for lipid droplet formation. Instead, cell-to-cell variability in lipid droplet formation is dependent on the cascade responses of an insulin signaling pathway which includes insulin sensitivity, kinase activity, glucose import, expression of an insulin degradation enzyme, and insulin degradation rate. Increased and prolonged insulin stimulation promotes lipid droplet accumulation in all differentiating cells. Single-cell profiling reveals the kinetics of an insulin signaling cascade as the origin of phenotypic variability in drug-inducible adipogenesis.			Le, TT (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.	jcheng@purdue.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL089074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB004966] Funding Source: NIH RePORTER; NHLBI NIH HHS [F32 HL089074, F32HL089074] Funding Source: Medline; NIBIB NIH HHS [R21 EB004966] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Avery SV, 2006, NAT REV MICROBIOL, V4, P577, DOI 10.1038/nrmicro1460; Chen SB, 2007, P NATL ACAD SCI USA, V104, P10482, DOI 10.1073/pnas.0704360104; Cheng JX, 2004, J PHYS CHEM B, V108, P827, DOI 10.1021/jp035693v; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Duckworth WC, 1997, BBA-MOL CELL RES, V1358, P163, DOI 10.1016/S0167-4889(97)00066-9; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Evans CL, 2008, ANNU REV ANAL CHEM, V1, P883, DOI 10.1146/annurev.anchem.1.031207.112754; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Fukumura D, 2003, CIRC RES, V93, pE88, DOI 10.1161/01.RES.0000099243.20096.FA; Gordon A, 2007, NAT METHODS, V4, P175, DOI 10.1038/nmeth1008; GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3; Hellerer T, 2007, P NATL ACAD SCI USA, V104, P14658, DOI 10.1073/pnas.0703594104; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kepler TB, 1998, P NATL ACAD SCI USA, V95, P11514, DOI 10.1073/pnas.95.20.11514; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; Le TT, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2795437; Le TT, 2007, MOL IMAGING, V6, P205, DOI 10.2310/7290.2007.00018; Le TT, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-42; Le TT, 2005, P NATL ACAD SCI USA, V102, P9160, DOI 10.1073/pnas.0503311102; Lee YH, 2004, J LIPID RES, V45, P1162, DOI 10.1194/jlr.D300028-JLR200; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Mandrup S, 1997, P NATL ACAD SCI USA, V94, P4300, DOI 10.1073/pnas.94.9.4300; Mattick JS, 2007, J EXP BIOL, V210, P1526, DOI 10.1242/jeb.005017; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; MURPHY RF, 1982, CYTOMETRY, V2, P402; Nan XL, 2006, BIOPHYS J, V91, P728, DOI 10.1529/biophysj.105.074534; Nan XL, 2003, J LIPID RES, V44, P2202, DOI 10.1194/jlr.D300022-JLR200; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Potma EO, 2005, CHEMPHYSCHEM, V6, P77, DOI 10.1002/cphc.200400390; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; ROSEN OM, 1987, SCIENCE, V237, P1452, DOI 10.1126/science.2442814; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shigematsu S, 2001, J BIOL CHEM, V276, P15292, DOI 10.1074/jbc.M009684200; Smas CM, 1998, J BIOL CHEM, V273, P31751, DOI 10.1074/jbc.273.48.31751; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Temple KA, 2007, FEBS LETT, V581, P469, DOI 10.1016/j.febslet.2007.01.007; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; Wang HW, 2008, OPT EXPRESS, V16, P5782, DOI 10.1364/OE.16.005782; Wang HF, 2005, BIOPHYS J, V89, P581, DOI 10.1529/biophysj.105.061911; Wilkinson GR, 2005, NEW ENGL J MED, V352, P2211, DOI 10.1056/NEJMra032424; Yamada K, 2000, J BIOL CHEM, V275, P22278, DOI 10.1074/jbc.M908048199; Yamaguchi T, 2007, J LIPID RES, V48, P1078, DOI 10.1194/jlr.M600493-JLR200; Zhang HB, 2003, J BIOL CHEM, V278, P20906, DOI 10.1074/jbc.M300022200; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976; Zhao LX, 2004, J NEUROSCI, V24, P11120, DOI 10.1523/JNEUROSCI.2860-04.2004	52	48	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5189	10.1371/journal.pone.0005189	http://dx.doi.org/10.1371/journal.pone.0005189			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357775	Green Published, gold, Green Submitted			2022-12-25	WOS:000265505900023
J	Berg, S; Firdessa, R; Habtamu, M; Gadisa, E; Mengistu, A; Yamuah, L; Ameni, G; Vordermeier, M; Robertson, BD; Smith, NH; Engers, H; Young, D; Hewinson, RG; Aseffa, A; Gordon, SV				Berg, Stefan; Firdessa, Rebuma; Habtamu, Meseret; Gadisa, Endalamaw; Mengistu, Araya; Yamuah, Lawrence; Ameni, Gobena; Vordermeier, Martin; Robertson, Brian D.; Smith, Noel H.; Engers, Howard; Young, Douglas; Hewinson, R. Glyn; Aseffa, Abraham; Gordon, Stephen V.			The Burden of Mycobacterial Disease in Ethiopian Cattle: Implications for Public Health	PLOS ONE			English	Article								Background: Bovine tuberculosis (bTB), caused by Mycobacterium bovis, is a debilitating disease of cattle. Ethiopia has one of the largest cattle populations in the world, with an economy highly dependent on its livestock. Furthermore, Ethiopia has one of the highest incidence rates of human extrapulmonary TB in the world, a clinical presentation that is often associated with transmission of M. bovis from cattle to humans. Methodology/Principal Findings: Here we present a comprehensive investigation of the prevalence of bTB in Ethiopia based on cases identified at slaughterhouses. Out of approximately 32,800 inspected cattle, similar to 4.7% showed suspect tuberculous lesions. Culture of suspect lesions yielded acid-fast bacilli in similar to 11% of cases, with M. bovis accounting for 58 of 171 acid-fast cultures, while 53 isolates were non-tuberculous mycobacteria. Strikingly, M. tuberculosis was isolated from eight cattle, an unusual finding that suggests human to animal transmission. Conclusions/Significance: Our analysis has revealed that bTB is widely spread throughout Ethiopia, albeit at a low prevalence, and provides underpinning evidence for public health policy formulation.			Berg, S (corresponding author), Vet Labs Agcy, TB Res Grp, Addlestone, Surrey, England.	stephen.gordon@ucd.ie	Hewinson, Glyn/F-7077-2010; Hewinson, Glyn/AAA-2364-2019; Aseffa, Abraham/J-3248-2016; Smith, Noel H/C-6708-2011; Berg, Stefan/AAU-6463-2020; Vordermeier, H Martin/C-6936-2011; Berg, Stefan O/D-3847-2011; Firdessa, Rebuma/P-6238-2019; Hewinson, Glyn/J-1902-2014; Ameni, Gobena/AAR-4201-2020	Aseffa, Abraham/0000-0002-8028-1150; Berg, Stefan/0000-0002-3470-7579; Firdessa, Rebuma/0000-0003-2523-165X; Ameni, Gobena/0000-0003-3987-0671; Robertson, Brian D./0000-0001-5785-5307; Hewinson, Glyn/0000-0002-5517-4281; Gordon, Stephen/0000-0002-4833-5542	MRC [MC_U117581288] Funding Source: UKRI; Medical Research Council [MC_U117581288] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Allix C, 2006, J CLIN MICROBIOL, V44, P1951, DOI 10.1128/JCM.01775-05; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ameni G, 2007, VET REC, V161, P782; Ameni G., 2003, Bulletin of Animal Health and Production in Africa, V51, P125; Ameni G, 2007, CLIN VACCINE IMMUNOL, V14, P1356, DOI 10.1128/CVI.00205-07; Aranaz A, 1996, J CLIN MICROBIOL, V34, P2734, DOI 10.1128/JCM.34.11.2734-2740.1996; Asseged B, 2004, TROP ANIM HEALTH PRO, V36, P537, DOI 10.1023/B:TROP.0000040934.32330.44; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Diguimbaye-Djaibe C, 2006, SCHWEIZ ARCH TIERH, V148, P251, DOI 10.1024/0036-7281.148.5.251; Esparcia O, 2008, J CLIN MICROBIOL, V46, P1885, DOI 10.1128/JCM.01441-07; GALLAGHER J, 1977, J HYG-CAMBRIDGE, V79, P155, DOI 10.1017/S0022172400052943; Halderman MN, 2004, POLITICAL EC PROPOOR; Han XY, 2002, AM J CLIN PATHOL, V118, P796, DOI 10.1309/HN44-XQYM-JMAQ-2EDL; Harmsen D, 2002, NUCLEIC ACIDS RES, V30, P416, DOI 10.1093/nar/30.1.416; Hogardt M, 2008, JPN J INFECT DIS, V61, P77; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kazwala RR, 2006, VET MICROBIOL, V112, P201, DOI 10.1016/j.vetmic.2005.11.026; Kidane D, 2002, J CLIN MICROBIOL, V40, P4230, DOI 10.1128/JCM.40.11.4230-4234.2002; KIRSCHNER P, 1993, J CLIN MICROBIOL, V31, P2882, DOI 10.1128/JCM.31.11.2882-2889.1993; Liebana E, 2008, VET J, V176, P354, DOI 10.1016/j.tvjl.2007.07.001; Lyashchenko KP, 2006, CLIN VACCINE IMMUNOL, V13, P722, DOI 10.1128/CVI.00133-06; Mayo J, 1998, EMERG INFECT DIS, V4, P124, DOI 10.3201/eid0401.980119; McCorry TP, 2004, VET MICROBIOL, V99, P281, DOI 10.1016/j.vetmic.2003.12.006; Michel AL, 2007, BMC VET RES, V3, P23, DOI DOI 10.1186/1746-6148-3-23; Muller B, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-26; Ocepek M, 2005, J CLIN MICROBIOL, V43, P3555, DOI 10.1128/JCM.43.7.3555-3557.2005; Oloya J, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-95; Prasad HK, 2005, TUBERCULOSIS, V85, P421, DOI 10.1016/j.tube.2005.08.005; Reischl U, 2006, INT J SYST EVOL MICR, V56, P2575, DOI 10.1099/ijs.0.64527-0; Roberts GD, 1991, MANUAL CLIN MICROBIO, P304; SHITAYE JE, 2007, VET MED, P317; Smith NH, 2006, NAT REV MICROBIOL, V4, P670, DOI 10.1038/nrmicro1472; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; Tsolaki AG, 2004, P NATL ACAD SCI USA, V101, P4865, DOI 10.1073/pnas.0305634101; Vordermeier HM, 2007, CLIN VACCINE IMMUNOL, V14, P1203, DOI 10.1128/CVI.00116-07; Wilton S, 1992, PCR Methods Appl, V1, P269; World Health Organisation, 2008, GLOB TUB CONTR SURV, P1	38	95	100	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2009	4	4							e5068	10.1371/journal.pone.0005068	http://dx.doi.org/10.1371/journal.pone.0005068			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RT	19352493	Green Published, gold, Green Submitted			2022-12-25	WOS:000265505300009
J	Barco, R; Garcia, CB; Eid, JE				Barco, Roy; Garcia, Christina B.; Eid, Josiane E.			The Synovial Sarcoma-Associated SYT-SSX2 Oncogene Antagonizes the Polycomb Complex Protein Bmi1	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; GENE-EXPRESSION; METHYLTRANSFERASE ACTIVITY; DEVELOPMENTAL REGULATORS; TUMOR-SUPPRESSOR; ONCOPROTEIN SYT; BREAST-CANCER; SSX; MICROARRAY; IDENTIFICATION	This study demonstrates deregulation of polycomb activity by the synovial sarcoma-associated SYT-SSX2 oncogene, also known as SS18-SSX2. Synovial sarcoma is a soft tissue cancer associated with a recurrent t(X: 18) translocation event that generates one of two fusion proteins, SYT-SSX1 or SYT-SSX2. The role of the translocation products in this disease is poorly understood. We present evidence that the SYT-SSX2 fusion protein interacts with the polycomb repressive complex and modulates its gene silencing activity. SYT-SSX2 causes destabilization of the polycomb subunit Bmi1, resulting in impairment of polycomb-associated histone H2A ubiquitination and reactivation of polycomb target genes. Silencing by polycomb complexes plays a vital role in numerous physiological processes. In recent years, numerous reports have implicated gain of polycomb silencing function in several cancers. This study provides evidence that, in the appropriate context, expression of the SYT-SSX2 oncogene leads to loss of polycomb function. It challenges the notion that cancer is solely associated with an increase in polycomb function and suggests that any imbalance in polycomb activity could drive the cell toward oncogenesis. These findings provide a mechanism by which the SYT-SSX2 chimera may contribute to synovial sarcoma pathogenesis.	[Barco, Roy; Garcia, Christina B.; Eid, Josiane E.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37235 USA	Vanderbilt University	Barco, R (corresponding author), Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37235 USA.	josiane.eid@vanderbilt.edu		Garcia, Christina/0000-0001-7892-0120	Public Health Service award [T32 GM07347]; National Institute of General Medical Studies; Vanderbilt Ingram Cancer Center [P30 CA068485];  [RO1CA106481]; NATIONAL CANCER INSTITUTE [T32CA009592, R01CA106481, P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER	Public Health Service award(United States Department of Health & Human ServicesUnited States Public Health Service); National Institute of General Medical Studies(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Vanderbilt Ingram Cancer Center; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant RO1CA106481, by the Public Health Service award T32 GM07347 from the National Institute of General Medical Studies for the Vanderbilt Medical-Scientist Training Program, and by the Vanderbilt Ingram Cancer Center Core Grant P30 CA068485. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovich C, 2005, ANN NY ACAD SCI, V1044, P109, DOI 10.1196/annals.1349.014; Barco R, 2007, MOL BIOL CELL, V18, P4003, DOI 10.1091/mbc.E07-05-0496; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; CLARK J, 1994, NAT GENET, V7, P502, DOI 10.1038/ng0894-502; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; de Bruijn DRH, 2006, CANCER RES, V66, P9474, DOI 10.1158/0008-5472.CAN-05-3726; Eid JE, 2000, CELL, V102, P839, DOI 10.1016/S0092-8674(00)00072-6; Guo WJ, 2007, CANCER RES, V67, P5083, DOI 10.1158/0008-5472.CAN-06-4368; Haldar M, 2007, CANCER CELL, V11, P375, DOI 10.1016/j.ccr.2007.01.016; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kato H, 2002, J BIOL CHEM, V277, P5498, DOI 10.1074/jbc.M108702200; Kirmizis A, 2003, MOL CANCER THER, V2, P113; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lee YF, 2003, BRIT J CANCER, V88, P510, DOI 10.1038/sj.bjc.6600766; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Lubieniecka JM, 2008, CANCER RES, V68, P4303, DOI 10.1158/0008-5472.CAN-08-0092; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nagai M, 2001, P NATL ACAD SCI USA, V98, P3843, DOI 10.1073/pnas.061036798; Nagayama S, 2002, CANCER RES, V62, P5859; Nielsen TO, 2003, AM J PATHOL, V163, P1449, DOI 10.1016/S0002-9440(10)63502-X; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Perani M, 2003, ONCOGENE, V22, P8156, DOI 10.1038/sj.onc.1207031; Pretto D, 2006, ONCOGENE, V25, P3661, DOI 10.1038/sj.onc.1209413; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Sanchez-Beato M, 2006, MODERN PATHOL, V19, P684, DOI 10.1038/modpathol.3800577; Satijn DPE, 1997, MOL CELL BIOL, V17, P4105, DOI 10.1128/MCB.17.7.4105; Soulez M, 1999, ONCOGENE, V18, P2739, DOI 10.1038/sj.onc.1202613; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Subramaniam MM, 2006, VIRCHOWS ARCH, V449, P435, DOI 10.1007/s00428-006-0271-9; Thaete C, 1999, HUM MOL GENET, V8, P585, DOI 10.1093/hmg/8.4.585; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vider BZ, 2000, BIOCHEM BIOPH RES CO, V272, P513, DOI 10.1006/bbrc.2000.2804; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wu FT, 2007, FRONT BIOSCI-LANDMRK, V12, P4370, DOI 10.2741/2394; Zhu P, 2007, MOL CELL, V27, P609, DOI 10.1016/j.molcel.2007.07.024	40	26	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5060	10.1371/journal.pone.0005060	http://dx.doi.org/10.1371/journal.pone.0005060			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337376	Green Submitted, Green Published, gold			2022-12-25	WOS:000265500600018
J	Brouwer, GJ; Tong, F; Hagoort, P; van Ee, R				Brouwer, Gijs Joost; Tong, Frank; Hagoort, Peter; van Ee, Raymond			Perceptual Incongruence Influences Bistability and Cortical Activation	PLOS ONE			English	Article								We employed a parametric psychophysical design in combination with functional imaging to examine the influence of metric changes in perceptual incongruence on perceptual alternation rates and cortical responses. Subjects viewed a bistable stimulus defined by incongruent depth cues; bistability resulted from incongruence between binocular disparity and monocular perspective cues that specify different slants (slant rivalry). Psychophysical results revealed that perceptual alternation rates were positively correlated with the degree of perceived incongruence. Functional imaging revealed systematic increases in activity that paralleled the psychophysical results within anterior intraparietal sulcus, prior to the onset of perceptual alternations. We suggest that this cortical activity predicts the frequency of subsequent alternations, implying a putative causal role for these areas in initiating bistable perception. In contrast, areas implicated in form and depth processing (LOC and V3A) were sensitive to the degree of slant, but failed to show increases in activity when these cues were in conflict.	[Brouwer, Gijs Joost; van Ee, Raymond] Univ Utrecht, Helmholtz Inst, Dept Phys, NL-3508 TC Utrecht, Netherlands; [Tong, Frank] Vanderbilt Univ, Dept Psychol, Nashville, TN USA; [Hagoort, Peter] FC Donders Ctr Cognit Neuroimaging, Nijmegen, Netherlands	Utrecht University; Vanderbilt University	Brouwer, GJ (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	gbrouwer@cns.nyu.edu	Hagoort, Peter/B-7417-2012; van Ee, Raymond/C-4881-2013	van Ee, Raymond/0000-0002-1134-8665	Utrecht University	Utrecht University	GB and RvE were supported by a High Potential grant from Utrecht University to RvE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WJ, 2001, NAT NEUROSCI, V4, P1063, DOI 10.1038/nn729; Backus BT, 2001, J NEUROPHYSIOL, V86, P2054, DOI 10.1152/jn.2001.86.4.2054; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brouwer GJ, 2007, J NEUROSCI, V27, P1015, DOI 10.1523/JNEUROSCI.4593-06.2007; Brouwer GJ, 2005, J NEUROSCI, V25, P10403, DOI 10.1523/JNEUROSCI.2408-05.2005; Chandrasekaran C, 2007, J NEUROPHYSIOL, V97, P1553, DOI 10.1152/jn.01074.2006; Cusack R, 2005, J COGNITIVE NEUROSCI, V17, P641, DOI 10.1162/0898929053467541; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Georgieva S, 2009, J NEUROSCI, V29, P727, DOI 10.1523/JNEUROSCI.4753-08.2009; Grill-Spector K, 1998, HUM BRAIN MAPP, V6, P316, DOI 10.1002/(SICI)1097-0193(1998)6:4<316::AID-HBM9>3.0.CO;2-6; Haynes JD, 2005, CURR BIOL, V15, P1301, DOI 10.1016/j.cub.2005.06.026; Hinkle DA, 2002, NAT NEUROSCI, V5, P665, DOI 10.1038/nn875; Hol K, 2003, J VISION, V3, P486, DOI 10.1167/3.7.3; Janssen P, 2000, NEURON, V27, P385, DOI 10.1016/S0896-6273(00)00045-3; Janssen P, 2000, SCIENCE, V288, P2054, DOI 10.1126/science.288.5473.2054; Janssen P, 2001, J NEUROSCI, V21, P9419, DOI 10.1523/JNEUROSCI.21-23-09419.2001; Janssen P, 1999, P NATL ACAD SCI USA, V96, P8217, DOI 10.1073/pnas.96.14.8217; Kamphuisen A, 2008, J VISION, V8, DOI 10.1167/8.5.4; Kleinschmidt A, 1998, P ROY SOC B-BIOL SCI, V265, P2427, DOI 10.1098/rspb.1998.0594; Knapen T, 2006, VISION RES, V46, P3381, DOI 10.1016/j.visres.2006.03.027; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; Kourtzi Z, 2003, CEREB CORTEX, V13, P911, DOI 10.1093/cercor/13.9.911; Kriegeskorte N, 2001, NEUROIMAGE, V14, P329, DOI 10.1006/nimg.2001.0831; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; LUI Y, 2004, J NEUROSCI, V24, P3795; Lumer ED, 1999, P NATL ACAD SCI USA, V96, P1669, DOI 10.1073/pnas.96.4.1669; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Muckli L, 2002, J NEUROSCI, V22; Neri P, 2004, J NEUROPHYSIOL, V92, P1880, DOI 10.1152/jn.01042.2003; Nguyenkim JD, 2003, J NEUROSCI, V23, P7117, DOI 10.1523/JNEUROSCI.23-18-07117.2003; Pettigrew JD, 1998, P ROY SOC B-BIOL SCI, V265, P2141, DOI 10.1098/rspb.1998.0551; Preston TJ, 2008, J NEUROSCI, V28, P11315, DOI 10.1523/JNEUROSCI.2728-08.2008; Raemaekers M, 2009, BRAIN RES, V1252, P161, DOI 10.1016/j.brainres.2008.11.078; Shikata E, 1996, NEUROREPORT, V7, P2389, DOI 10.1097/00001756-199610020-00022; Shikata E, 2003, EUR J NEUROSCI, V17, P1105, DOI 10.1046/j.1460-9568.2003.02540.x; Shikata E, 2001, J NEUROPHYSIOL, V85, P1309, DOI 10.1152/jn.2001.85.3.1309; Slotnick SD, 2003, HUM BRAIN MAPP, V18, P22, DOI 10.1002/hbm.10077; Slotnick SD, 2005, COGNITIVE BRAIN RES, V24, P97, DOI 10.1016/j.cogbrainres.2004.12.008; Sterzer P, 2007, P NATL ACAD SCI USA, V104, P323, DOI 10.1073/pnas.0609006104; Suzuki S, 2000, PSYCHOL SCI, V11, P202, DOI 10.1111/1467-9280.00242; Taira M, 2000, J NEUROPHYSIOL, V83, P3140, DOI 10.1152/jn.2000.83.5.3140; Talairach J., 1988, COPLANAR STEREOTAXIC; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Tononi G, 2000, BRAIN RES REV, V31, P391, DOI 10.1016/S0165-0173(99)00056-9; Tononi G, 1998, P NATL ACAD SCI USA, V95, P3198, DOI 10.1073/pnas.95.6.3198; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P811, DOI 10.1073/pnas.95.3.811; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Tsao DY, 2003, NEURON, V39, P555, DOI 10.1016/S0896-6273(03)00459-8; Tsutsui KI, 2002, SCIENCE, V298, P409, DOI 10.1126/science.1074128; Tsutsui KI, 2001, J NEUROPHYSIOL, V86, P2856, DOI 10.1152/jn.2001.86.6.2856; van Dam LCJ, 2005, VISION RES, V45, P2417, DOI 10.1016/j.visres.2005.03.013; van Ee R, 2005, VISION RES, V45, P29, DOI 10.1016/j.visres.2004.07.039; van Ee R, 2003, J OPT SOC AM A, V20, P1398, DOI 10.1364/JOSAA.20.001398; van Ee R, 2002, PERCEPTION, V31, P51, DOI 10.1068/p3303; van Ee R, 2001, NATURE, V410, P690, DOI 10.1038/35070569; van Ee R, 2002, J VISION, V2, P597, DOI 10.1167/2.9.2; Wandell BA, 1999, ANNU REV NEUROSCI, V22, P145, DOI 10.1146/annurev.neuro.22.1.145; Welchman AE, 2005, NAT NEUROSCI, V8, P820, DOI 10.1038/nn1461	63	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e5056	10.1371/journal.pone.0005056	http://dx.doi.org/10.1371/journal.pone.0005056			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333385	Green Published, gold, Green Submitted			2022-12-25	WOS:000265499900014
J	Cork, AJ; Jergic, S; Hammerschmidt, S; Kobe, B; Pancholi, V; Benesch, JLP; Robinson, CV; Dixon, NE; Aquilina, JA; Walker, MJ				Cork, Amanda J.; Jergic, Slobodan; Hammerschmidt, Sven; Kobe, Bostjan; Pancholi, Vijay; Benesch, Justin L. P.; Robinson, Carol V.; Dixon, Nicholas E.; Aquilina, J. Andrew; Walker, Mark J.			Defining the Structural Basis of Human Plasminogen Binding by Streptococcal Surface Enolase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCI; PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; MASS-SPECTROMETRY; ALPHA-ENOLASE; ANGSTROM RESOLUTION; MACROMOLECULAR ASSEMBLIES; HISTIDINE-RESIDUES; CRYSTAL-STRUCTURE; ACTIVATION	The flesh-eating bacterium group A Streptococcus ( GAS) binds and activates human plasminogen, promoting invasive disease. Streptococcal surface enolase (SEN), a glycolytic pathway enzyme, is an identified plasminogen receptor of GAS. Here we used mass spectrometry ( MS) to confirm that GAS SEN is octameric, thereby validating in silico modeling based on the crystal structure of Streptococcus pneumoniae alpha-enolase. Site-directed mutagenesis of surface-located lysine residues (SENK252+255A, SENK304A, SENK334A, SENK344E, SENK435L, and SEN Delta 434- 435) was used to examine their roles in maintaining structural integrity, enzymatic function, and plasminogen binding. Structural integrity of the GAS SEN octamer was retained for all mutants except SENK344E, as determined by circular dichroism spectroscopy and MS. However, ion mobility MS revealed distinct differences in the stability of several mutant octamers in comparison with wild type. Enzymatic analysis indicated that SENK344E had lost alpha-enolase activity, which was also reduced in SENK334A and SEN Delta 434-435. Surface plasmon resonance demonstrated that the capacity to bind human plasminogen was abolished in SENK252+255A, SENK435L, and SEN Delta 434-435. The lysine residues at positions 252, 255, 434, and 435 therefore play a concerted role in plasminogen acquisition. This study demonstrates the ability of combining in silico structural modeling with ion mobility-MS validation for undertaking functional studies on complex protein structures.	[Aquilina, J. Andrew; Walker, Mark J.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia; [Jergic, Slobodan; Dixon, Nicholas E.] Univ Wollongong, Sch Chem, Wollongong, NSW 2522, Australia; [Hammerschmidt, Sven] Ernst Moritz Arndt Univ Greifswald, Inst Genet & Funct Genom, Dept Genet Microorganisms, D-17487 Greifswald, Germany; [Kobe, Bostjan] Univ Queensland, Sch Mol & Microbial Sci, Brisbane, Qld 4072, Australia; [Kobe, Bostjan] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Pancholi, Vijay] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Benesch, Justin L. P.; Robinson, Carol V.] Univ Cambridge, Dept Chem, Cambridge CB2 1TN, England	University of Wollongong; University of Wollongong; Ernst Moritz Arndt Universitat Greifswald; University of Queensland; University of Queensland; University System of Ohio; Ohio State University; University of Cambridge	Walker, MJ (corresponding author), Univ Wollongong, Sch Biol Sci, Northfields Ave, Wollongong, NSW 2522, Australia.	mwalker@uow.edu.au	Pancholi, Vijay/E-3810-2011; Dixon, Nicholas E/A-1226-2008; Aquilina, John Andrew/AGF-4013-2022; Kobe, Bostjan/D-1292-2009; Cork, Amanda/C-3830-2012; Walker, Mark J./F-6940-2011; Hammerschmidt, Sven/G-2598-2010; Aquilina, J. Andrew/A-5366-2013	Dixon, Nicholas E/0000-0002-5958-6945; Kobe, Bostjan/0000-0001-9413-9166; Cork, Amanda/0000-0003-2207-6877; Hammerschmidt, Sven/0000-0002-6382-6681; Benesch, Justin/0000-0002-1507-3742; robinson, carol/0000-0001-7829-5505; Walker, Mark/0000-0001-7423-2769				Abad MC, 2002, J MOL BIOL, V318, P1009, DOI 10.1016/S0022-2836(02)00211-5; Benesch JL, 2006, CURR OPIN STRUC BIOL, V16, P245, DOI 10.1016/j.sbi.2006.03.009; Benesch JLP, 2003, ANAL CHEM, V75, P2208, DOI 10.1021/ac034132x; Benesch JLP, 2007, CHEM REV, V107, P3544, DOI 10.1021/cr068289b; Benesch JLP, 2006, CHEM BIOL, V13, P597, DOI 10.1016/j.chembiol.2006.04.006; Benesch JLP, 2009, ANAL CHEM, V81, P1270, DOI 10.1021/ac801950u; Benesch JLP, 2009, J AM SOC MASS SPECTR, V20, P341, DOI 10.1016/j.jasms.2008.11.014; BERGE A, 1993, J BIOL CHEM, V268, P25417; Bergmann S, 2003, MOL MICROBIOL, V49, P411, DOI 10.1046/j.1365-2958.2003.03557.x; Bergmann S, 2007, THROMB HAEMOSTASIS, V98, P512, DOI 10.1160/TH07-02-0117; Boel G, 2004, J MOL BIOL, V337, P485, DOI 10.1016/j.jmb.2003.12.082; Byrne B, 2002, CURR OPIN STRUC BIOL, V12, P239, DOI 10.1016/S0959-440X(02)00316-0; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carapetis JR, 1999, EPIDEMIOL INFECT, V122, P59, DOI 10.1017/S0950268898001952; Cole J. N., 2006, MOL BIOL STREPTOCOCC, P359; Cole JN, 2005, INFECT IMMUN, V73, P3137, DOI 10.1128/IAI.73.5.3137-3146.2005; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; D'Costa SS, 1998, MICROB PATHOGENESIS, V24, P341, DOI 10.1006/mpat.1998.0207; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; Derbise A, 2004, INFECT IMMUN, V72, P94, DOI 10.1128/IAI.72.1.94-105.2004; Ehinger S, 2004, J MOL BIOL, V343, P997, DOI 10.1016/j.jmb.2004.08.088; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Geiger JH, 2004, J THROMB HAEMOST, V2, P23, DOI 10.1111/j.1538-7836.2004.00544.x; GILES K, 2008, 56 ASMS C MASS SPECT; Hernandez H, 2006, EMBO REP, V7, P605, DOI 10.1038/sj.embor.7400702; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; KAPUR V, 1995, MOL MICROBIOL, V16, P509, DOI 10.1111/j.1365-2958.1995.tb02415.x; KUUSELA P, 1992, INFECT IMMUN, V60, P196, DOI 10.1128/IAI.60.1.196-201.1992; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; LOTTENBERG R, 1992, J BACTERIOL, V174, P5204, DOI 10.1128/JB.174.16.5204-5210.1992; Madhusudhan M.S., 2007, CURR PROTOC PROTEIN, V2; McArthur JD, 2008, FASEB J, V22, P3146, DOI 10.1096/fj.08-109348; McKay FC, 2004, INFECT IMMUN, V72, P364, DOI 10.1128/IAI.72.1.364-370.2004; Mesleh MF, 1996, J PHYS CHEM-US, V100, P16082, DOI 10.1021/jp961623v; Morris AM, 2008, FEBS J, V275, P5885, DOI 10.1111/j.1742-4658.2008.06719.x; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Pancholi V, 2003, INT J MED MICROBIOL, V293, P391, DOI 10.1078/1438-4221-00283; PANCHOLI V, 1992, J EXP MED, V176, P415, DOI 10.1084/jem.176.2.415; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; Parry MAA, 2000, TRENDS BIOCHEM SCI, V25, P53, DOI 10.1016/S0968-0004(99)01521-2; PONTING CP, 1992, BLOOD COAGUL FIBRIN, V3, P605, DOI 10.1097/00001721-199210000-00012; Pringle SD, 2007, INT J MASS SPECTROM, V261, P1, DOI 10.1016/j.ijms.2006.07.021; REDDY KNN, 1972, J BIOL CHEM, V247, P1683; Riekel C, 2005, CURR OPIN STRUC BIOL, V15, P556, DOI 10.1016/j.sbi.2005.08.013; Ruotolo BT, 2008, NAT PROTOC, V3, P1139, DOI 10.1038/nprot.2008.78; Ruotolo BT, 2005, SCIENCE, V310, P1658, DOI 10.1126/science.1120177; SAKSELA O, 1988, ANNU REV CELL BIOL, V4, P93, DOI 10.1146/annurev.cb.04.110188.000521; Sanderson-Smith M, 2006, J BIOL CHEM, V281, P3217, DOI 10.1074/jbc.M508758200; Sanderson-Smith ML, 2008, FASEB J, V22, P2715, DOI 10.1096/fj.07-105643; Sanderson-Smith ML, 2007, J BACTERIOL, V189, P1435, DOI 10.1128/JB.01218-06; Sanderson-Smith ML, 2006, J BIOL CHEM, V281, P25965, DOI 10.1074/jbc.M603846200; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Tart AH, 2007, TRENDS MICROBIOL, V15, P318, DOI 10.1016/j.tim.2007.05.001; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; Walker MJ, 2005, TRENDS MICROBIOL, V13, P308, DOI 10.1016/j.tim.2005.05.006; WANG H, 1995, J INFECT DIS, V171, P85, DOI 10.1093/infdis/171.1.85; Winram SB, 1998, MICROBIOL-SGM, V144, P2025, DOI 10.1099/00221287-144-8-2025; Wold F., 1971, ENZYMES, P499; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	62	54	56	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17129	17137		10.1074/jbc.M109.004317	http://dx.doi.org/10.1074/jbc.M109.004317			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19363026	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000266962400051
J	Dhar, SK; St Clair, DK				Dhar, Sanjit Kumar; St Clair, Daret K.			Nucleophosmin Blocks Mitochondrial Localization of p53 and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; MANGANESE SUPEROXIDE-DISMUTASE; P53-DEPENDENT APOPTOSIS; P53-INDUCED APOPTOSIS; BCL-2 FAMILY; DNA-DAMAGE; CELL-DEATH; GENE; ACTIVATION; EXPRESSION	Activation of p53 is an important mechanism in apoptosis. However, whether the presence of p53 in mitochondria plays an important role in p53-mediated apoptosis is unclear. Here, we demonstrate that overexpression of NPM (nucleophosmin) significantly suppresses 12-O-tetradecanoylphorbol 13-acetate (TPA)-mediated apoptosis, in part, by blocking the mitochondrial localization of p53. Within 1 h following TPA treatment of skin epithelial (JB6) cells, p53 accumulated in mitochondria. Expression of NPM enhances p53 levels in the nucleus but reduces p53 levels in mitochondria, as detected by immunocytochemistry and Western blot analysis. The suppressive effect of NPM on p53 mitochondrial localization is also observed in TPA-treated primary epithelial cells and in JB6 cells treated with doxorubicin. NPM enhances the expression of p53 target gene p21 and bax. However, the increase in Bax level in the absence of p53 in mitochondria did not lead to an increase in TPA-induced apoptosis, suggesting that the presence of p53 in mitochondria is important. Suppression of NPM by NPM small interfering RNA leads to an increase of p53 levels in mitochondria and apoptosis. Furthermore, suppression of NPM in tumor cells with a high constitutive level of NPM results in p53 translocation to mitochondria and enhances TPA-mediated apoptosis. The results demonstrate the effect of NPM on p53 localization in mitochondria and apoptosis. Together, the data indicate that the presence of p53 in mitochondria plays an important role in stress-induced apoptosis and suggest that NPM may protect cells from apoptosis by reducing the mitochondrial level of p53.	[Dhar, Sanjit Kumar; St Clair, Daret K.] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA	University of Kentucky	St Clair, DK (corresponding author), Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA.	DSTCL00@uky.edu			National Institutes of Health [CA 49797, CA 73599]; NATIONAL CANCER INSTITUTE [R29CA049797, R01CA073599, R01CA049797] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA 49797 and CA 73599 (to D. K. S. C.).	BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; Baptiste N, 2004, CELL, V116, P487, DOI 10.1016/S0092-8674(04)00164-3; Bates S, 1999, CELL MOL LIFE SCI, V55, P28, DOI 10.1007/s000180050267; Bernardi R, 2004, NAT CELL BIOL, V6, P665, DOI 10.1038/ncb1147; Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; Brugarolas J, 1999, P NATL ACAD SCI USA, V96, P1002, DOI 10.1073/pnas.96.3.1002; CAELLES C, 1994, NATURE, V370, P220, DOI 10.1038/370220a0; Chen JJ, 2008, J IMMUNOL, V180, P8030, DOI 10.4049/jimmunol.180.12.8030; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; COLBURN NH, 1979, NATURE, V281, P589, DOI 10.1038/281589a0; Colombo E, 2005, MOL CELL BIOL, V25, P8874, DOI 10.1128/MCB.25.20.8874-8886.2005; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; Dhar SK, 2006, J BIOL CHEM, V281, P21698, DOI 10.1074/jbc.M601083200; Dhar SK, 2004, J BIOL CHEM, V279, P28209, DOI 10.1074/jbc.M403553200; Erster S, 2004, MOL CELL BIOL, V24, P6728, DOI 10.1128/MCB.24.15.6728-6741.2004; HAUPT Y, 1995, GENE DEV, V9, P2170, DOI 10.1101/gad.9.17.2170; Higuchi Y, 1998, BIOCHEM BIOPH RES CO, V248, P597, DOI 10.1006/bbrc.1998.8978; Hsu CY, 1998, ONCOGENE, V16, P915, DOI 10.1038/sj.onc.1201615; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Kondo T, 1997, ONCOGENE, V15, P1275, DOI 10.1038/sj.onc.1201286; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li J, 2005, LEUKEMIA RES, V29, P1415, DOI 10.1016/j.leukres.2005.05.005; Li J, 2004, J BIOL CHEM, V279, P41275, DOI 10.1074/jbc.C400297200; Li PF, 1999, EMBO J, V18, P6027, DOI 10.1093/emboj/18.21.6027; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Lohrum MAE, 1999, CELL DEATH DIFFER, V6, P1162, DOI 10.1038/sj.cdd.4400625; Louria-Hayon I, 2003, J BIOL CHEM, V278, P33134, DOI 10.1074/jbc.M301264200; Marchenko ND, 2007, EMBO J, V26, P923, DOI 10.1038/sj.emboj.7601560; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; MIYASHITA T, 1995, CELL, V80, P293; Nozawa Y, 1996, J PATHOL, V178, P48; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Ohtsuka T, 2004, NAT CELL BIOL, V6, P121, DOI 10.1038/ncb1087; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Prives C, 1999, J PATHOL, V187, P112; Reed JC, 1998, BBA-BIOENERGETICS, V1366, P127, DOI 10.1016/S0005-2728(98)00108-X; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Sakaguchi K, 1997, BIOCHEMISTRY-US, V36, P10117, DOI 10.1021/bi970759w; Schuler M, 2001, BIOCHEM SOC T, V29, P684, DOI 10.1042/0300-5127:0290684; Shields LBE, 1997, J SOC GYNECOL INVEST, V4, P298, DOI 10.1016/S1071-5576(97)00068-3; Subong ENP, 1999, PROSTATE, V39, P298; TANAKA M, 1992, CANCER RES, V52, P3372; TSUJIMOTO Y, 1986, P NATL ACAD SCI USA, V83, P5214, DOI 10.1073/pnas.83.14.5214; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wu MH, 2002, J BIOL CHEM, V277, P48234, DOI 10.1074/jbc.M206550200; Zhao YF, 2005, CANCER RES, V65, P3745, DOI 10.1158/0008-5472.CAN-04-3835	50	49	51	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16409	16418		10.1074/jbc.M109.005736	http://dx.doi.org/10.1074/jbc.M109.005736			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19366707	Green Published, hybrid			2022-12-25	WOS:000266730900038
J	Hinton, A; Sennoune, SR; Bond, S; Fang, M; Reuveni, M; Sahagian, GG; Jay, D; Martinez-Zaguilan, R; Forgac, M				Hinton, Ayana; Sennoune, Souad R.; Bond, Sarah; Fang, Min; Reuveni, Moshe; Sahagian, G. Gary; Jay, Daniel; Martinez-Zaguilan, Raul; Forgac, Michael			Function of a Subunit Isoforms of the V-ATPase in pH Homeostasis and in Vitro Invasion of MDA-MB231 Human Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; PROTON-TRANSLOCATING ATPASE; PLASMA-MEMBRANE; A3 ISOFORM; OSTEOCLAST DIFFERENTIATION; CYSTEINE CATHEPSINS; MOLECULAR-CLONING; VIVO DISSOCIATION; INTRACELLULAR PH; DRUG-RESISTANCE	It has previously been shown that highly invasive MDA-MB231 human breast cancer cells express vacuolar proton-translocating ATPase (V-ATPases) at the cell surface, whereas the poorly invasive MCF7 cell line does not. Bafilomycin, a specific V-ATPase inhibitor, reduces the in vitro invasion of MB231 cells but not MCF7 cells. Targeting of V-ATPases to different cellular membranes is controlled by isoforms of subunit a. mRNA levels for a subunit isoforms were measured in MB231 and MCF7 cells using quantitative reverse transcription-PCR. The results show that although all four isoforms are detectable in both cell types, levels of a3 and a4 are much higher in MB231 than in MCF7 cells. Isoform-specific small interfering RNAs (siRNA) were employed to selectively reduce mRNA levels for each isoform in MB231 cells. V-ATPase function was assessed using the fluorescent indicators SNARF-1 and pyranine to monitor the pH of the cytosol and endosomal/lysosomal compartments, respectively. Cytosolic pH was decreased only on knockdown of a3, whereas endosome/lysosome pH was increased on knockdown of a1, a2, and a3. Treatment of cells with siRNA to a4 did not affect either cytosolic or endosome/lysosome pH. Measurement of invasion using an in vitro transwell assay revealed that siRNAs to both a3 and a4 significantly inhibited invasion of MB231 cells. Immunofluorescence staining of MB231 cells for V-ATPase distribution revealed extensive intracellular staining, with plasma membrane staining observed in similar to 18% of cells. Knockdown of a4 had the greatest effect on plasma membrane staining, leading to a 32% reduction. These results suggest that the a4 isoform may be responsible for targeting V-ATPases to the plasma membrane of MB231 cells and that cell surface V-ATPases play a significant role in invasion. However, other V-ATPases affecting the pH of the cytosol and intracellular compartments, particularly those containing a3, are also involved in invasion.	[Hinton, Ayana; Bond, Sarah; Fang, Min; Sahagian, G. Gary; Jay, Daniel; Forgac, Michael] Tufts Univ, Dept Physiol, Sch Med, Boston, MA 02111 USA; [Sennoune, Souad R.; Martinez-Zaguilan, Raul] Texas Tech Univ, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA; [Reuveni, Moshe] ARO Volcani Ctr, Dept Ornamental Hort, IL-50250 Bet Dagan, Israel	Tufts University; Texas Tech University System; Texas Tech University; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Forgac, M (corresponding author), Tufts Univ, Dept Physiol, Sch Med, 136 Harrison Ave, Boston, MA 02111 USA.	michael.forgac@tufts.edu			National Institutes of Health [GM34478]; National Institutes of Health Ruth L. Kirschstein Institutional Research Training Grant [T32DK007542]; National Institutes of Health Training in Education and Critical Research Skills Grant [K12GM074869]; American Heart Association [SD 0435197N, GIA 0855168]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034478, R37GM034478, K12GM074869] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Ruth L. Kirschstein Institutional Research Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training in Education and Critical Research Skills Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM34478 (to M. F.), post-doctoral support (to A. H.) and pre-doctoral support (to S. B.) from National Institutes of Health Ruth L. Kirschstein Institutional Research Training Grant T32DK007542, and post-doctoral support (to A. H.) from National Institutes of Health Training in Education and Critical Research Skills Grant K12GM074869. This work was also supported by American Heart Association Grants SD 0435197N (to S. R. S.) and GIA 0855168 (to R. M. Z.).	Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; GILLIES RJ, 1991, J BIOL CHEM, V266, P1551; Gocheva V, 2007, CELL CYCLE, V6, P60, DOI 10.4161/cc.6.1.3669; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hu YW, 2005, FEBS LETT, V579, P4937, DOI 10.1016/j.febslet.2005.07.078; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Joyce JA, 2004, CELL CYCLE, V3, P1516, DOI 10.4161/cc.3.12.1289; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Kubota S, 2000, BIOCHEM BIOPH RES CO, V278, P390, DOI 10.1006/bbrc.2000.3802; Lu YD, 2005, CANCER RES, V65, P6843, DOI 10.1158/0008-5472.CAN-04-3822; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; Martinez-Zaguilan R, 1999, BIOCHEM PHARMACOL, V57, P1037, DOI 10.1016/S0006-2952(99)00022-2; MARTINEZZAGUILAN R, 1991, AM J PHYSIOL, V260, pC297, DOI 10.1152/ajpcell.1991.260.2.C297; Morel N, 2003, J CELL SCI, V116, P4751, DOI 10.1242/jcs.00791; Murakami T, 2001, INT J CANCER, V93, P869, DOI 10.1002/ijc.1418; Nishi T, 2000, J BIOL CHEM, V275, P6824, DOI 10.1074/jbc.275.10.6824; Ohta T, 1996, BRIT J CANCER, V73, P1511, DOI 10.1038/bjc.1996.285; Oka T, 2001, J BIOL CHEM, V276, P40050, DOI 10.1074/jbc.M106488200; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Philippe JM, 2002, GLIA, V37, P365, DOI 10.1002/glia.10041; Pietrement C, 2006, BIOL REPROD, V74, P185, DOI 10.1095/biolreprod.105.043752; Raghunand N, 1999, BIOCHEM PHARMACOL, V57, P1047, DOI 10.1016/S0006-2952(99)00021-0; Rojas JD, 2006, AM J PHYSIOL-HEART C, V291, pH1147, DOI 10.1152/ajpheart.00166.2006; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Sennoune SR, 2004, CELL BIOCHEM BIOPHYS, V40, P185, DOI 10.1385/CBB:40:2:185; Smith AN, 2001, J BIOL CHEM, V276, P42382, DOI 10.1074/jbc.M107267200; Smith AN, 2000, NAT GENET, V26, P71, DOI 10.1038/79208; Sun-Wada GH, 2006, J CELL SCI, V119, P4531, DOI 10.1242/jcs.03234; Torigoe T, 2002, J BIOL CHEM, V277, P36534, DOI 10.1074/jbc.M202605200; Toyomura T, 2000, J BIOL CHEM, V275, P8760, DOI 10.1074/jbc.275.12.8760; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Wang Y, 2008, J BIOL CHEM, V283, P20696, DOI 10.1074/jbc.M803258200	34	153	157	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16400	16408		10.1074/jbc.M901201200	http://dx.doi.org/10.1074/jbc.M901201200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19366680	hybrid, Green Published			2022-12-25	WOS:000266730900037
J	Ma, TH; Wang, Z; Guo, YQ; Pei, DQ				Ma, Tianhua; Wang, Zhe; Guo, Yunqian; Pei, Duanqing			The C-terminal Pentapeptide of Nanog Tryptophan Repeat Domain Interacts with Nac1 and Regulates Stem Cell Proliferation but Not Pluripotency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUSTAINING FACTOR; SELF-RENEWAL; MOUSE; TRANSCRIPTION; EXPRESSION; NETWORK; PROTEIN; IDENTIFICATION; GENERATION; CLONING	Overexpression of Nanog in mouse embryonic stem (ES) cells has been shown to abrogate the requirement of leukemia inhibitory factor for self-renewal in culture. Little is known about the molecular mechanism of Nanog function. Here we describe the role of the tryptophan repeat (WR) domain, one of the two transactivators at its C terminus, in regulating stem cell proliferation as well as pluripotency. We first created a supertransactivator, W2W3x10, by duplicating repeats W2W3 10 times and discovered that it can functionally substitute for wild type WR at sustaining pluripotency, albeit with a significantly slower cell cycle, phenocopying Nanog(9W) with the C-terminal pentapeptide (WNAAP) of WR deleted. ES cells carrying both W2W3x10 and Nanog(9W) have a longer G(1) phase, a shorter S phase in cell cycle distribution and progression analysis, and a lower level of pAkt(Ser(473)) compared with wild type Nanog, suggesting that both mutants impact the cell cycle machinery via the phosphatidylinositol 3-kinase/Akt pathway. Both mutants remain competent in dimerizing with Nanog but cannot form a complex with Nac1 efficiently, suggesting that WNAAP may be involved in Nac1 binding. By tagging Gal4DBD with WNAAP, we demonstrated that this pentapeptide is sufficient to confer Nac1 binding. Furthermore, we can rescue W2W3x10 by placing WNAAP at the corresponding locations. Finally, we found that Nanog and Nac1 synergistically up-regulate ERas expression and promote the proliferation of ES cells. These results suggest that Nanog interacts with Nac1 through WNAAP to regulate the cell cycle of ES cells via the ERas/phosphatidylinositol 3-kinase/Akt pathway, but not pluripotency, thus decoupling cell cycle control from pluripotency.	[Ma, Tianhua; Wang, Zhe; Guo, Yunqian; Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, S China Inst Stem Cell Biol & Regenerat Med, Stem Cell & Canc Biol Grp,Key Lab Regenerat Biol, Guangzhou 510663, Guangdong, Peoples R China; [Ma, Tianhua; Wang, Zhe; Guo, Yunqian] Tsinghua Univ, Lab Stem Cell Biol, Sch Med, Dept Biol Sci & Biotechnol,Inst Biomed, Beijing 100084, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Tsinghua University	Pei, DQ (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, S China Inst Stem Cell Biol & Regenerat Med, Stem Cell & Canc Biol Grp,Key Lab Regenerat Biol, Guangzhou 510663, Guangdong, Peoples R China.	pei_duanqing@gibh.ac.cn	Guo, Yunqian/L-4716-2013; zhou, xingru/G-4442-2012		National Natural Science Foundation of China [30725012, 30630039]; Chinese Academy of Sciences [KSCX2-YW-R-48]; Guangzhou Science and Technology [2006A50104002]; Ministry of Science and Technology 973 Grants [2006CB701504, 2006CB943600, 2007CB948002, 2007CB947804, 2009CB941000]; National High Technology Project 863 Grant [2005AA210930]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Guangzhou Science and Technology; Ministry of Science and Technology 973 Grants(National Basic Research Program of China); National High Technology Project 863 Grant(National High Technology Research and Development Program of China)	This work was supported by National Natural Science Foundation of China Grants 30725012 and 30630039; Chinese Academy of Sciences Grant KSCX2-YW-R-48; Guangzhou Science and Technology Grant 2006A50104002; Ministry of Science and Technology 973 Grants 2006CB701504, 2006CB943600, 2007CB948002, 2007CB947804, and 2009CB941000; and National High Technology Project 863 Grant 2005AA210930.	Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; Jirmanova L, 2002, ONCOGENE, V21, P5515, DOI 10.1038/sj.onc.1205728; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mackler SA, 2003, NEUROSCIENCE, V121, P355, DOI 10.1016/S0306-4522(03)00376-2; Mackler SA, 2000, J NEUROSCI, V20, P6210, DOI 10.1523/JNEUROSCI.20-16-06210.2000; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mullin NP, 2008, BIOCHEM J, V411, P227, DOI 10.1042/BJ20080134; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pan GJ, 2005, J BIOL CHEM, V280, P1401, DOI 10.1074/jbc.M407847200; Pan GJ, 2003, CELL RES, V13, P499, DOI 10.1038/sj.cr.7290193; Pan GJ, 2006, FASEB J, V20, P1730, DOI 10.1096/fj.05-5543fje; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang J, 2008, P NATL ACAD SCI USA, V105, P6326, DOI 10.1073/pnas.0802288105; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang Z, 2008, J BIOL CHEM, V283, P4480, DOI 10.1074/jbc.M706009200; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	25	20	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16071	16081		10.1074/jbc.M109.005041	http://dx.doi.org/10.1074/jbc.M109.005041			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19366700	Green Published, hybrid			2022-12-25	WOS:000266730900003
J	Pardossi-Piquard, R; Yang, SP; Kanemoto, S; Gu, Y; Chen, FS; Bohm, C; Sevalle, J; Li, T; Wong, PC; Checler, F; Schmitt-Ulms, G; St George-Hyslop, P; Fraser, PE				Pardossi-Piquard, Raphaelle; Yang, Seung-Pil; Kanemoto, Soshi; Gu, Yongjun; Chen, Fusheng; Boehm, Christopher; Sevalle, Jean; Li, Tong; Wong, Philip C.; Checler, Frederic; Schmitt-Ulms, Gerold; St. George-Hyslop, Peter; Fraser, Paul E.			APH1 Polar Transmembrane Residues Regulate the Assembly and Activity of Presenilin Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE COMPLEXES; ALZHEIMERS-DISEASE; MISSENSE MUTATIONS; BETA-APP; INTRAMEMBRANE PROTEOLYSIS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; NICASTRIN; MEMBRANE; PROTEIN	Complexes involved in the gamma/epsilon-secretase-regulated intramembranous proteolysis of substrates such as the amyloid-beta precursor protein are composed primarily of presenilin (PS1 or PS2), nicastrin, anterior pharynx defective-1 (APH1), and PEN2. The presenilin aspartyl residues form the catalytic site, and similar potentially functional polar transmembrane residues in APH1 have been identified. Substitution of charged (E84A, R87A) or polar (Q83A) residues in TM3 had no effect on complex assembly or activity. In contrast, changes to either of two highly conserved histidines (H171A, H197A) located in TM5 and TM6 negatively affected PS1 cleavage and altered binding to other secretase components, resulting in decreased amyloid generating activity. Charge replacement with His-to-Lys substitutions rescued nicastrin maturation and PS1 endoproteolysis leading to assembly of the formation of structurally normal but proteolytically inactive gamma-secretase complexes. Substitution with a negatively charged side chain (His-to-Asp) or altering the structural location of the histidines also disrupted gamma-secretase binding and abolished functionality of APH1. These results suggest that the conserved transmembrane histidine residues contribute to APH1 function and can affect presenilin catalytic activity.	[Fraser, Paul E.] Univ Toronto, Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada; [Sevalle, Jean; Checler, Frederic] CNRS, Inst Pharmacol Mol & Cellulaire, Equipe Labellisee Fdn Rech Med, F-06560 Valbonne, France; [Sevalle, Jean; Checler, Frederic] CNRS, Inst NeuroMed Mol, Equipe Labellisee Fdn Rech Med, F-06560 Valbonne, France; [Li, Tong; Wong, Philip C.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Li, Tong; Wong, Philip C.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Schmitt-Ulms, Gerold] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1L5, Canada; [St. George-Hyslop, Peter] Univ Hlth Network, Toronto Western Hosp Res Inst, Dept Med, Div Neurol, Toronto, ON M5T 2S8, Canada; [St. George-Hyslop, Peter] Univ Cambridge, Dept Clin Neurosci, Cambridge CB2 OXY, England; [Fraser, Paul E.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada	University of Toronto; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); Johns Hopkins University; Johns Hopkins University; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Cambridge; University of Toronto	Fraser, PE (corresponding author), Univ Toronto, Ctr Res Neurodegenerat Dis, 6 Queens Pk Crescent W, Toronto, ON M5S 3H2, Canada.	paul.fraser@utoronto.ca	Checler, Frederic/C-1241-2009; Pardossi-Piquard, Raphaëlle/D-6263-2012; Pardossi-Piquard, Raphaëlle/ABA-4472-2021	Checler, Frederic/0000-0003-2098-1750; Pardossi-Piquard, Raphaëlle/0000-0001-5292-4414; Yang, Seung-Pil/0000-0003-3980-7103; St George-Hyslop, Peter/0000-0003-0796-7209	Canadian Institutes of Health Research; Howard Hughes Medical Institute; Alzheimer Society of Ontario; Ontario Research and Development Challenge Fund; Canada Foundation for Innovation; Weston and Garfield Foundation; Fondation pour la Recherche Medicale; Conseil General des Alpes Maritimes; France Alzheimer Association; Wellcome Trust; National Institutes of Health [R01 NS45150, P01 NS047308]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS047308, R01NS045150] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Alzheimer Society of Ontario; Ontario Research and Development Challenge Fund(General Electric); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Weston and Garfield Foundation; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Conseil General des Alpes Maritimes(Region Provence-Alpes-Cote d'Azur); France Alzheimer Association; Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the Canadian Institutes of Health Research, Howard Hughes Medical Institute, Alzheimer Society of Ontario, The Ontario Research and Development Challenge Fund and the Canada Foundation for Innovation, the Weston and Garfield Foundation, and Fondation pour la Recherche Medicale and the Conseil General des Alpes Maritimes.; Funded by France Alzheimer Association.; Supported by the Wellcome Trust.; Development of the knockout mice was supported by National Institutes of Health Grants R01 NS45150 and P01 NS047308 (NINDS).	Ben-Shem A, 2007, P NATL ACAD SCI USA, V104, P462, DOI 10.1073/pnas.0609773104; Brokx SJ, 2005, BIOCHEMISTRY-US, V44, P10339, DOI 10.1021/bi050621a; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Capell A, 1998, J BIOL CHEM, V273, P3205, DOI 10.1074/jbc.273.6.3205; Checler F, 2001, J NEUROCHEM, V76, P1621, DOI 10.1046/j.1471-4159.2001.00244.x; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Chen FS, 2001, NAT CELL BIOL, V3, P751, DOI 10.1038/35087069; Choma C, 2000, NAT STRUCT BIOL, V7, P161; Cotten JF, 1999, J BIOL CHEM, V274, P5429, DOI 10.1074/jbc.274.9.5429; Courville P, 2008, J BIOL CHEM, V283, P9651, DOI 10.1074/jbc.M709906200; da Costa CA, 2006, J NEUROSCI, V26, P6377, DOI 10.1523/JNEUROSCI.0651-06.2006; DE SB, 1999, NATURE, V398, P518; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Dolcini V, 2008, BIOCHEM BIOPH RES CO, V371, P69, DOI 10.1016/j.bbrc.2008.03.151; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Evin G, 2006, CNS DRUGS, V20, P351, DOI 10.2165/00023210-200620050-00002; Fortna RR, 2004, J BIOL CHEM, V279, P3685, DOI 10.1074/jbc.M310505200; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Franco PJ, 2001, BBA-BIOMEMBRANES, V1510, P231, DOI 10.1016/S0005-2736(00)00353-9; Freeman M, 2004, NAT REV MOL CELL BIO, V5, P188, DOI 10.1038/nrm1334; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Gu YJ, 2004, J BIOL CHEM, V279, P31329, DOI 10.1074/jbc.M401548200; Gu YJ, 2003, J BIOL CHEM, V278, P7374, DOI 10.1074/jbc.M209499200; Guo ZY, 2005, J BIOL CHEM, V280, P37814, DOI 10.1074/jbc.M508384200; Gupta SK, 1998, J BIOL CHEM, V273, P4282, DOI 10.1074/jbc.273.7.4282; Hu J, 2006, P NATL ACAD SCI USA, V103, P6865, DOI 10.1073/pnas.0601944103; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; Kaether C, 2007, EMBO REP, V8, P743, DOI 10.1038/sj.embor.7401027; Kim SH, 2005, J BIOL CHEM, V280, P41953, DOI 10.1074/jbc.M509070200; Kim SH, 2001, J BIOL CHEM, V276, P43343, DOI 10.1074/jbc.M108245200; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kulkarni AA, 2007, PHARM RES-DORDR, V24, P66, DOI 10.1007/s11095-006-9119-x; Lee SF, 2002, J BIOL CHEM, V277, P45013, DOI 10.1074/jbc.M208164200; Lee SF, 2004, J BIOL CHEM, V279, P4144, DOI 10.1074/jbc.M309745200; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Ma GJ, 2005, J NEUROSCI, V25, P192, DOI 10.1523/JNEUROSCI.3814-04.2005; Ma ZM, 2006, J GEN PHYSIOL, V127, P309, DOI 10.1085/jgp.200509421; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Partridge AW, 2004, PROTEINS, V54, P648, DOI 10.1002/prot.10611; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Rogaeva E, 2006, J ALZHEIMERS DIS, V9, P381; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Serneels L, 2005, P NATL ACAD SCI USA, V102, P1719, DOI 10.1073/pnas.0408901102; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Shirotani K, 2004, J BIOL CHEM, V279, P41340, DOI 10.1074/jbc.M405768200; Shirotani K, 2004, J NEUROCHEM, V89, P1520, DOI 10.1111/j.1471-4159.2004.02447.x; Spasic D, 2008, J CELL SCI, V121, P413, DOI 10.1242/jcs.015255; Spasic D, 2007, J CELL BIOL, V176, P629, DOI 10.1083/jcb.200609180; Stojanovic A, 2004, J BIOL CHEM, V279, P35932, DOI 10.1074/jbc.M403821200; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Wang YC, 2007, P NATL ACAD SCI USA, V104, P2098, DOI 10.1073/pnas.0611080104; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wolfe MS, 1998, J MED CHEM, V41, P6, DOI 10.1021/jm970621b; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Yu G, 1998, J BIOL CHEM, V273, P16470, DOI 10.1074/jbc.273.26.16470; Zhang ML, 2005, J BIOL CHEM, V280, P26169, DOI 10.1074/jbc.M502102200; Zhou FX, 2000, NAT STRUCT BIOL, V7, P154	64	29	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16298	16307		10.1074/jbc.M109.000067	http://dx.doi.org/10.1074/jbc.M109.000067			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19369254	hybrid, Green Published			2022-12-25	WOS:000266730900027
J	Suarez, J; Ranguelova, K; Schelvis, JPM; Magliozzo, RS				Suarez, Javier; Ranguelova, Kalina; Schelvis, Johannes P. M.; Magliozzo, Richard S.			Antibiotic Resistance in Mycobacterium tuberculosis PEROXIDASE INTERMEDIATE BYPASS CAUSES POOR ISONIAZID ACTIVATION BY THE S315G MUTANT OF M-TUBERCULOSIS CATALASE-PEROXIDASE (KatG)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALASE-PEROXIDASE KATG; SITE-DIRECTED MUTAGENESIS; ISONIAZID ACTIVATION; HYDROGEN-PEROXIDE; S315T MUTANT; NUCLEOTIDE-SEQUENCE; CRYSTAL-STRUCTURE; ACTIVE-SITE; INHA; OVEREXPRESSION	KatG (catalase-peroxidase) in Mycobacterium tuberculosis is responsible for activation of isoniazid (INH), a pro-drug used to treat tuberculosis infections. Resistance to INH is a global health problem most often associated with mutations in the katG gene. The origin of INH resistance caused by the KatG[S315G] mutant enzyme is examined here. Overexpressed KatG[ S315G] was characterized by optical, EPR, and resonance Raman spectroscopy and by studies of the INH activation mechanism in vitro. Catalase activity and peroxidase activity with artificial substrates were moderately reduced (50 and 35%, respectively), whereas the rates of formation of oxyferryl heme:po rphyrin pi-cation radical and the decay of heme intermediates were similar to 2- fold faster in KatG[S315G] compared with WT enzyme. The INH binding affinity for the resting enzyme was unchanged, whereas INH activation, measured by the rate of formation of an acyl-nicotinamide adenine dinucleotide adduct considered to be a bactericidal molecule, was reduced by 30% compared with WT KatG. INH resistance is suggested to arise from a redirection of catalytic intermediates into nonproductive reactions that interfere with oxidation of INH. In the resting mutant enzyme, a rapid evolution of 5-c heme to 6-c species occurred in contrast with the behavior of WT KatG and KatG[S315T] and consistent with greater flexibility at the heme edge in the absence of the hydroxyl of residue 315. Insights into the effects of mutations at residue 315 on enzyme structure, peroxidation kinetics, and specific interactions with INH are presented.	[Suarez, Javier; Ranguelova, Kalina; Magliozzo, Richard S.] CUNY Brooklyn Coll, Dept Chem, Brooklyn, NY 11210 USA; [Suarez, Javier; Ranguelova, Kalina; Magliozzo, Richard S.] CUNY, Grad Ctr, Dept Biochem, New York, NY 11216 USA; [Schelvis, Johannes P. M.] NYU, Dept Chem, New York, NY 10003 USA	City University of New York (CUNY) System; Brooklyn College (CUNY); City University of New York (CUNY) System; New York University	Magliozzo, RS (corresponding author), CUNY Brooklyn Coll, Dept Chem, 2900 Bedford Ave, Brooklyn, NY 11210 USA.	rmagliozzo@brooklyn.cuny.edu			National Institutes of Health [AI060014]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI060014, R01AI060014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI060014 ( to R. S. M.) from NIAID.	Argyrou A, 2006, NAT STRUCT MOL BIOL, V13, P408, DOI 10.1038/nsmb1089; Argyrou A, 2006, BIOCHEMISTRY-US, V45, P13947, DOI 10.1021/bi061874m; Bertrand T, 2004, J BIOL CHEM, V279, P38991, DOI 10.1074/jbc.M402382200; Broussy S, 2005, ORG BIOMOL CHEM, V3, P670, DOI 10.1039/b417698g; Cardoso RF, 2004, ANTIMICROB AGENTS CH, V48, P3373, DOI 10.1128/AAC.48.9.3373-3381.2004; Chouchane S, 2003, J BIOL CHEM, V278, P8154, DOI 10.1074/jbc.M208256200; Chouchane S, 2000, BIOCHEMISTRY-US, V39, P9975, DOI 10.1021/bi0005815; Chouchane S, 2002, J BIOL CHEM, V277, P42633, DOI 10.1074/jbc.M207916200; Dalla Costa ER, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-39; Engleder M, 2000, BIOCHIMIE, V82, P211, DOI 10.1016/S0300-9084(00)00204-2; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gegia M, 2008, ANTIMICROB AGENTS CH, V52, P725, DOI 10.1128/AAC.01124-07; Ghiladi RA, 2005, J AM CHEM SOC, V127, P13428, DOI 10.1021/ja054366t; GIROTTO S, 2004, THESIS GRADUATE CTR; Hazbon MH, 2006, ANTIMICROB AGENTS CH, V50, P2640, DOI 10.1128/AAC.00112-06; Hutchison DCS, 2003, RESP MED, V97, P65, DOI 10.1053/rmed.2002.1412; Ivancich A, 2003, J AM CHEM SOC, V125, P14093, DOI 10.1021/ja035582+; Jakopitsch C, 2007, BIOCHEMISTRY-US, V46, P1183, DOI 10.1021/bi062266+; Johnsson K, 1997, J BIOL CHEM, V272, P2834, DOI 10.1074/jbc.272.5.2834; JOHNSSON K, 1995, J AM CHEM SOC, V117, P5009, DOI 10.1021/ja00122a038; Kapetanaki S, 2003, BIOCHEMISTRY-US, V42, P3835, DOI 10.1021/bi026992y; Kapetanaki SM, 2007, J INORG BIOCHEM, V101, P422, DOI 10.1016/j.jinorgbio.2006.11.004; KELMAN DJ, 1992, FREE RADICAL RES COM, V16, P27, DOI 10.3109/10715769209049156; KELMAN DJ, 1994, J BIOL CHEM, V269, P7458; KOCHI A, 1991, TUBERCLE, V72, P1, DOI 10.1016/0041-3879(91)90017-M; Larsen MH, 2002, MOL MICROBIOL, V46, P453, DOI 10.1046/j.1365-2958.2002.03162.x; Lei BF, 2000, J BIOL CHEM, V275, P2520, DOI 10.1074/jbc.275.4.2520; LOEWEN PC, 1990, MOL GEN GENET, V224, P147, DOI 10.1007/BF00259461; MARCINKEVICIENE JA, 1995, J BIOL CHEM, V270, P22290, DOI 10.1074/jbc.270.38.22290; Marttila HJ, 2008, INT J TUBERC LUNG D, V12, P338; Metcalfe C, 2008, J BIOL CHEM, V283, P6193, DOI 10.1074/jbc.M707412200; Morlock GP, 2003, ANTIMICROB AGENTS CH, V47, P3799, DOI 10.1128/AAC.47.12.3799-3805.2003; Nagy JM, 1997, J BIOL CHEM, V272, P31265, DOI 10.1074/jbc.272.50.31265; Ng VH, 2004, MOL MICROBIOL, V52, P1291, DOI 10.1111/j.1365-2958.2004.04078.x; Parsons LA, 2005, ANTIMICROB AGENTS CH, V49, P2218, DOI 10.1128/AAC.49.6.2218-2225.2005; Phyu S, 2003, EMERG INFECT DIS, V9, P274; QUEMARD A, 1995, BIOCHEMISTRY-US, V34, P8235, DOI 10.1021/bi00026a004; Ranguelova K, 2008, BIOCHEMISTRY-US, V47, P12583, DOI 10.1021/bi801511u; Ranguelova K, 2007, J BIOL CHEM, V282, P6255, DOI 10.1074/jbc.M607309200; ROBITZEK EH, 1952, AM REV TUBERC PULM, V65, P402; Rouse DA, 1996, MOL MICROBIOL, V22, P583, DOI 10.1046/j.1365-2958.1996.00133.x; Rozwarski DA, 1998, SCIENCE, V279, P98, DOI 10.1126/science.279.5347.98; Saint-Joanis B, 1999, BIOCHEM J, V338, P753, DOI 10.1042/0264-6021:3380753; SEPKOWITZ KA, 1995, CLIN INFECT DIS, V20, P232, DOI 10.1093/clinids/20.2.232; Sepkowitz KA, 2001, EMERG INFECT DIS, V7, P259, DOI 10.3201/eid0702.010222; SINHA BK, 1983, J BIOL CHEM, V258, P796; Svistunenko DA, 2001, BBA-PROTEIN STRUCT M, V1546, P365, DOI 10.1016/S0167-4838(01)00157-1; Timmins GS, 2006, MOL MICROBIOL, V62, P1220, DOI 10.1111/j.1365-2958.2006.05467.x; WELINDER KG, 1991, BIOCHIM BIOPHYS ACTA, V1080, P215; Wengenack NL, 1997, J INFECT DIS, V176, P722, DOI 10.1086/514096; Wengenack NL, 1998, BIOCHEMISTRY-US, V37, P15825, DOI 10.1021/bi982023k; Wengenack NL, 2001, BIOCHEMISTRY-US, V40, P8990, DOI 10.1021/bi002614m; Yu SW, 2003, J BIOL CHEM, V278, P14769, DOI 10.1074/jbc.M300326200; Yu SW, 2002, PROTEIN SCI, V11, P58, DOI 10.1110/ps.ps.09902; Zhao XB, 2006, BIOCHEMISTRY-US, V45, P4131, DOI 10.1021/bi051967o; Zhao XB, 2007, BIOCHEMISTRY-US, V46, P3161, DOI 10.1021/bi062218p; 2007, MORTAL WKLY REP, V56, P250	57	18	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16146	16155		10.1074/jbc.M109.005546	http://dx.doi.org/10.1074/jbc.M109.005546			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19363028	Green Published, hybrid			2022-12-25	WOS:000266730900011
J	Fila, T; Trazzi, S; Crochemore, C; Bartesaghi, R; Ciani, E				Fila, Tatiana; Trazzi, Stefania; Crochemore, Christophe; Bartesaghi, Renata; Ciani, Elisabetta			Lot1 Is a Key Element of the Pituitary Adenylate Cyclase-activating Polypeptide (PACAP)/Cyclic AMP Pathway That Negatively Regulates Neuronal Precursor Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; ZINC-FINGER PROTEIN; CEREBELLAR GRANULE CELLS; TUMOR-SUPPRESSOR GENE; ADRENAL PHEOCHROMOCYTOMA CELLS; RECEPTOR MESSENGER-RNAS; POSITIVE FEEDBACK LOOP; PACAP BINDING-SITES; PC12 CELLS; NEURITE OUTGROWTH	The tumor suppressor gene Lot1 is highly expressed during brain development. During cerebellar development, Lot1 is expressed by proliferating granule cells with a time course matching the expression of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor, a neuropeptide receptor that plays an important role in the regulation of granule cell proliferation/survival. Although it has become clear that Lot1 is a negative regulator of cell division in tumor cells, its role in neuronal proliferation is not understood. We previously demonstrated that in cerebellar granule cells Lot1 expression is regulated by the PACAP/cAMP system. The aim of this study was to investigate the role played by Lot1 in neuron proliferation/survival and to identify the molecular mechanisms underlying its actions. Using a Lot1-inducible expression system, we found that in PC12 cells Lot1 negatively regulates proliferation and favors differentiation by up-regulating the expression of the PACAP receptor. In cerebellar granule cells in culture, an increase in Lot1 expression was paralleled by inhibition of proliferation and up-regulation of the PACAP receptor, which in turn positively regulated Lot1 expression. Silencing of Lot1 leads to an increase in granule cell proliferation and a reduction in survival. Confirming the in vitro results, in vivo experiments showed that PACAP induced an increase in Lot1 expression that was paralleled by inhibition of cerebellar granule cell proliferation. These data show that Lot1 is a key element of the PACAP/cAMP pathway that negatively regulates neuronal precursor proliferation. The existence of a PACAP receptor/Lot1-positive feedback loop may powerfully regulate neural proliferation during critical phases of cerebellar development.	[Fila, Tatiana; Trazzi, Stefania; Bartesaghi, Renata; Ciani, Elisabetta] Univ Bologna, Dept Human & Gen Physiol, I-40126 Bologna, Italy; [Crochemore, Christophe] Univ Bologna, Dept Biol, I-40126 Bologna, Italy	University of Bologna; University of Bologna	Ciani, E (corresponding author), Univ Bologna, Dept Human & Gen Physiol, Piazza Porta San Donato 2, I-40126 Bologna, Italy.	elisabetta.ciani@unibo.it	Ciani, Elisabetta/AAL-6462-2020	ciani, elisabetta/0000-0003-3130-5168; Trazzi, Stefania/0000-0003-2623-2769	University of Bologna	University of Bologna	This work was supported by the University of Bologna through funding for basic research (to E.C.).	Abdollahi A, 1997, CANCER RES, V57, P2029; Abdollahi A, 1999, ONCOGENE, V18, P6477, DOI 10.1038/sj.onc.1203067; Abdollahi A, 1997, ONCOGENE, V14, P1973, DOI 10.1038/sj.onc.1201034; Alam S, 2005, DEV DYNAM, V234, P772, DOI 10.1002/dvdy.20577; Allais A, 2007, EUR J NEUROSCI, V25, P2604, DOI 10.1111/j.1460-9568.2007.05535.x; Altman J., 1982, CEREBELLUM NEW VISTA, V47, P8; Arima T, 2005, NUCLEIC ACIDS RES, V33, P2650, DOI 10.1093/nar/gki555; Arimura A, 1998, JPN J PHYSIOL, V48, P301, DOI 10.2170/jjphysiol.48.301; Barrett AL, 2008, DEV BIOL, V317, P234, DOI 10.1016/j.ydbio.2008.02.025; BASILLE M, 1993, NEUROSCIENCE, V57, P329, DOI 10.1016/0306-4522(93)90066-O; Basille M, 2000, J COMP NEUROL, V425, P495; Basille M, 2000, ANN NY ACAD SCI, V921, P304; Basille M, 2006, REGUL PEPTIDES, V137, P27, DOI 10.1016/j.regpep.2006.03.010; Bilanges B, 1999, ONCOGENE, V18, P3979, DOI 10.1038/sj.onc.1202933; Bilanges B, 2001, ONCOGENE, V20, P1246, DOI 10.1038/sj.onc.1204237; Botia B, 2007, PEPTIDES, V28, P1746, DOI 10.1016/j.peptides.2007.04.013; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Carey RG, 2002, J NEUROSCI, V22, P1583, DOI 10.1523/JNEUROSCI.22-05-01583.2002; Cavallaro S, 1996, MOL PHARMACOL, V50, P60; Cheng AW, 2003, DEV BIOL, V258, P319, DOI 10.1016/S0012-1606(03)00120-9; Ciani E, 1999, MOL BRAIN RES, V69, P290, DOI 10.1016/S0169-328X(99)00116-3; Ciani E, 2003, DEV BRAIN RES, V142, P193, DOI 10.1016/S0165-3806(03)00092-0; Ciani E, 2002, J BIOL CHEM, V277, P49896, DOI 10.1074/jbc.M206177200; Ciani E, 1995, J MOL NEUROSCI, V6, P131, DOI 10.1007/BF02736772; Colitti CV, 1998, ONCOGENE, V16, P555, DOI 10.1038/sj.onc.1201523; Conconi MT, 2006, INT REV CYTOL, V249, P1, DOI 10.1016/S0074-7696(06)49001-X; Contestabile A, 2005, J BIOL CHEM, V280, P33541, DOI 10.1074/jbc.M413323200; Contestabile A, 2009, BRAIN PATHOL, V19, P224, DOI 10.1111/j.1750-3639.2008.00168.x; DEUTSCH PJ, 1992, J BIOL CHEM, V267, P5108; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; Dicicco-Bloom E, 1998, ANN NY ACAD SCI, V865, P274, DOI 10.1111/j.1749-6632.1998.tb11188.x; Falluel-Morel A, 2008, J MOL NEUROSCI, V36, P8, DOI 10.1007/s12031-008-9111-5; Foehr ED, 2000, J NEUROSCI, V20, P7556; Godard T, 1999, CYTOMETRY, V36, P117, DOI 10.1002/(SICI)1097-0320(19990601)36:2<117::AID-CYTO5>3.0.CO;2-#; Gonzalez BJ, 1997, NEUROSCIENCE, V78, P419, DOI 10.1016/S0306-4522(96)00617-3; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GUNNING PW, 1981, J CELL BIOL, V89, P240, DOI 10.1083/jcb.89.2.240; Hansen TVO, 2000, J NEUROCHEM, V75, P1870, DOI 10.1046/j.1471-4159.2000.0751870.x; Hashimoto H, 2000, J NEUROCHEM, V74, P501, DOI 10.1046/j.1471-4159.2000.740501.x; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; HERNANDEZ A, 1995, PEPTIDES, V16, P927, DOI 10.1016/0196-9781(95)00059-S; Hoffmann A, 1998, ANN NY ACAD SCI, V865, P49, DOI 10.1111/j.1749-6632.1998.tb11162.x; JANKNECHT R, 1995, CARCINOGENESIS, V16, P443, DOI 10.1093/carcin/16.3.443; Kas K, 1998, J BIOL CHEM, V273, P23026, DOI 10.1074/jbc.273.36.23026; Kiermayer S, 2005, MOL BIOL CELL, V16, P5639, DOI 10.1091/mbc.E05-05-0432; Lazarovici P, 1998, MOL PHARMACOL, V54, P547, DOI 10.1124/mol.54.3.547; Lelievre V, 2008, DEV BIOL, V313, P359, DOI 10.1016/j.ydbio.2007.10.031; Lemeta S, 2006, HUM PATHOL, V37, P749, DOI 10.1016/j.humpath.2006.02.002; Li Y, 2006, GENE DEV, V20, P2793, DOI 10.1101/gad.1466306; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu NR, 1997, P NATL ACAD SCI USA, V94, P3357, DOI 10.1073/pnas.94.7.3357; Ma L, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-11; McCulloch DA, 2002, BIOCHEM SOC T, V30, P441, DOI 10.1042/bst0300441; Ng YP, 2003, J BIOL CHEM, V278, P38731, DOI 10.1074/jbc.M304623200; Nicot A, 2002, J NEUROSCI, V22, P9244; Nielsen HS, 1998, NEUROREPORT, V9, P2639, DOI 10.1097/00001756-199808030-00039; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; Pagotto U, 2000, CANCER RES, V60, P6794; Pennuto M, 2002, MOL BIOL CELL, V13, P2706, DOI 10.1091/mbc.E02-01-0036; Piras G, 2000, MOL CELL BIOL, V20, P3308, DOI 10.1128/MCB.20.9.3308-3315.2000; Ravni A, 2008, MOL PHARMACOL, V73, P1688, DOI 10.1124/mol.107.044792; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Shi GX, 2006, MOL CELL BIOL, V26, P9136, DOI 10.1128/MCB.00332-06; Singhal S, 2003, CANCER BIOL THER, V2, P291, DOI 10.4161/cbt.2.3.399; Skoglosa Y, 1999, NEUROSCI LETT, V265, P207, DOI 10.1016/S0304-3940(99)00250-5; Smith RJ, 2002, GENE, V292, P101, DOI 10.1016/S0378-1119(02)00666-2; Somogyvari-Vigh A, 2004, CURR PHARM DESIGN, V10, P2861, DOI 10.2174/1381612043383548; Spengler D, 1997, EMBO J, V16, P2814, DOI 10.1093/emboj/16.10.2814; Stork PJS, 2003, TRENDS BIOCHEM SCI, V28, P267, DOI 10.1016/S0968-0004(03)00087-2; Suh JH, 2001, NAT NEUROSCI, V4, P123, DOI 10.1038/83936; TISCHLER AS, 1978, LAB INVEST, V39, P77; Tsuda T, 2004, DEV DYNAM, V229, P340, DOI 10.1002/dvdy.10439; Valente T, 2005, DEV DYNAM, V233, P667, DOI 10.1002/dvdy.20373; Valente T, 2001, MECH DEVELOP, V108, P207, DOI 10.1016/S0925-4773(01)00492-0; Varrault A, 1998, P NATL ACAD SCI USA, V95, P8835, DOI 10.1073/pnas.95.15.8835; Vaudry D, 2000, P NATL ACAD SCI USA, V97, P13390, DOI 10.1073/pnas.97.24.13390; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Vaudry D, 1999, P NATL ACAD SCI USA, V96, P9415, DOI 10.1073/pnas.96.16.9415; Vaudry D, 2002, ANN NY ACAD SCI, V971, P491, DOI 10.1111/j.1749-6632.2002.tb04513.x; Vaudry D, 2000, ANN NY ACAD SCI, V921, P293; Vaudry D, 1998, ANN NY ACAD SCI, V865, P92, DOI 10.1111/j.1749-6632.1998.tb11167.x; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; Ye WZ, 2009, DEV NEUROBIOL, V69, P1, DOI 10.1002/dneu.20680	83	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15325	15338		10.1074/jbc.M109.002329	http://dx.doi.org/10.1074/jbc.M109.002329			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19346254	Green Published, hybrid			2022-12-25	WOS:000266288200067
J	Jones, DTW; Kocialkowski, S; Liu, L; Pearson, DM; Ichimura, K; Collins, VP				Jones, D. T. W.; Kocialkowski, S.; Liu, L.; Pearson, D. M.; Ichimura, K.; Collins, V. P.			Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma	ONCOGENE			English	Article						RAF1; BRAF; SRGAP3; fusion gene; pilocytic astrocytoma; MAPK	HUMAN CANCER; GENE; REGION; TUMORS	Pilocytic astrocytomas (PAs), WHO malignancy grade I, are the most frequently occurring central nervous system tumour in 5- to 19-year-olds. Recent reports have highlighted the importance of MAPK pathway activation in PAs, particularly through a tandem duplication leading to an oncogenic BRAF fusion gene. Here, we report two alternative mechanisms resulting in MAPK activation in PAs. Firstly, in striking similarity to the common BRAF fusion, tandem duplication at 3p25 was observed, which produces an in-frame oncogenic fusion between SRGAP3 and RAF1. This fusion includes the Raf1 kinase domain, and shows elevated kinase activity when compared with wild-type Raf1. Secondly, a novel 3 bp insertion at codon 598 in BRAF mimics the hotspot V600E mutation to produce a transforming, constitutively active BRaf kinase. Although these two alterations are not common, they bring the number of cases with an identified 'hit' on the Ras/Raf-signalling pathway to 36 from our series of 44 (82%), confirming its central importance to the development of pilocytic astrocytomas. Oncogene (2009) 28, 2119-2123; doi:10.1038/onc.2009.73; published online 13 April 2009	[Jones, D. T. W.; Kocialkowski, S.; Liu, L.; Pearson, D. M.; Ichimura, K.; Collins, V. P.] Univ Cambridge, Dept Pathol, Div Mol Histopathol, Cambridge CB2 0QQ, Cambs, England	University of Cambridge	Jones, DTW (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Mol Histopathol, Dept Pathol, Box 231,Level 3 Lab Block,Hills Rd, Cambridge CB2 0QQ, Cambs, England.	davidjones@cantab.net	Jones, David TW/G-9588-2013; Jones, David T. W./Z-1963-2019	Jones, David TW/0000-0002-2036-5141; 	Cancer Research UK; Samantha Dickson Brain Tumour Trust; CAMPOD	Cancer Research UK(Cancer Research UK); Samantha Dickson Brain Tumour Trust; CAMPOD	We thank Dr MG McCabe, Dr M Dimitriadi, Miss S Rigby, Miss F McDuff, Dr S Turner and Professor Y Yuasa for their help and for reagents. We also thank the Mapping and Microarray Facility groups of the Wellcome Trust Sanger Institute, UK and the Centre for Microarray resources in the Department of Pathology, University of Cambridge for technical assistance. This work was supported by grants from Cancer Research UK, the Samantha Dickson Brain Tumour Trust and CAMPOD.	BONNER T, 1984, SCIENCE, V223, P71, DOI 10.1126/science.6691137; *CENTR BRAIN TUM R, 2005, STAT REP PRIM BRAIN; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dirven CMF, 1997, CHILD NERV SYST, V13, P17, DOI 10.1007/s003810050033; Emuss V, 2005, CANCER RES, V65, P9719, DOI 10.1158/0008-5472.CAN-05-1683; Endris V, 2002, P NATL ACAD SCI USA, V99, P11754, DOI 10.1073/pnas.162241099; Giannini C, 1997, BRAIN PATHOL, V7, P785, DOI 10.1111/j.1750-3639.1997.tb01064.x; Icking A, 2006, FEBS LETT, V580, P223, DOI 10.1016/j.febslet.2005.11.078; Janzarik WG, 2007, NEUROPEDIATRICS, V38, P61, DOI 10.1055/s-2007-984451; Jones DTW, 2008, CANCER RES, V68, P8673, DOI 10.1158/0008-5472.CAN-08-2097; Jones DTW, 2006, J NEUROPATH EXP NEUR, V65, P1049, DOI 10.1097/01.jnen.0000240465.33628.87; Le LQ, 2007, ONCOGENE, V26, P4609, DOI 10.1038/sj.onc.1210261; Listernick R, 1999, AM J MED GENET, V89, P38, DOI 10.1002/(SICI)1096-8628(19990326)89:1<38::AID-AJMG8>3.0.CO;2-M; Maltzman TH, 1997, CANCER EPIDEM BIOMAR, V6, P239; Moretti S, 2006, ONCOGENE, V25, P4235, DOI 10.1038/sj.onc.1209448; RAPP UR, 1983, P NATL ACAD SCI-BIOL, V80, P4218, DOI 10.1073/pnas.80.14.4218; Sharma MK, 2005, NEUROLOGY, V65, P1335, DOI 10.1212/01.wnl.0000180409.78098.d7; Shimizu K, 1986, Princess Takamatsu Symp, V17, P85; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; STANTON VP, 1989, MOL CELL BIOL, V9, P639, DOI 10.1128/MCB.9.2.639; TAHIRA T, 1987, NUCLEIC ACIDS RES, V15, P4809, DOI 10.1093/nar/15.12.4809; The KIDSREEN Group, 2004, KIDSCREEN 52 HLTH QU, P1; The WHO, 2020, CLASSIFICATION TUMOU; TOMLINSON FH, 1994, J CHILD NEUROL, V9, P301, DOI 10.1177/088307389400900317; Yang Y, 2006, EXP CELL RES, V312, P2379, DOI 10.1016/j.yexcr.2006.04.001; Zebisch A, 2006, CELL MOL LIFE SCI, V63, P1314, DOI 10.1007/s00018-006-6005-y	26	228	236	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 21	2009	28	20					2119	2123		10.1038/onc.2009.73	http://dx.doi.org/10.1038/onc.2009.73			5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	448BI	19363522	Green Accepted			2022-12-25	WOS:000266235800006
J	Macdonald-Obermann, JL; Pike, LJ				Macdonald-Obermann, Jennifer L.; Pike, Linda J.			The Intracellular Juxtamembrane Domain of the Epidermal Growth Factor (EGF) Receptor Is Responsible for the Allosteric Regulation of EGF Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE DOMAIN; EXTRACELLULAR DOMAIN; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; AFFINITY; DIMERIZATION; ACTIVATION; SURFACE; PHOSPHORYLATION; REGION	We have previously shown that the binding of epidermal growth factor (EGF) to its receptor can best be described by a model that involves negative cooperativity in an aggregating system (Macdonald, J. L., and Pike, L. J. (2008) Proc. Natl. Acad. Sci. U. S. A. 105, 112-117). However, despite the fact that biochemical analyses indicate that EGF induces dimerization of its receptor, the binding data provided no evidence for positive linkage between EGF binding and dimer assembly. By analyzing the binding of EGF to a number of receptor mutants, we now report that in naive, unphosphorylated EGF receptors, ligand binding is positively linked to receptor dimerization but the linkage is abolished upon autophosphorylation of the receptor. Both phosphorylated and unphosphorylated EGF receptors exhibit negative cooperativity, indicating that mechanistically, cooperativity is distinct from the phenomenon of linkage. Nonetheless, both the positive linkage and the negative cooperativity observed in EGF binding require the presence of the intracellular juxtamembrane domain. This indicates the existence of inside-out signaling in the EGF receptor system. The intracellular juxtamembrane domain has previously been shown to be required for the activation of the EGF receptor tyrosine kinase (Thiel, K. W., and Carpenter, G. (2007) Proc. Natl. Acad. Sci. U. S. A. 104, 19238-19243). Our experiments expand the role of this domain to include the allosteric control of ligand binding by the extracellular domain.	[Macdonald-Obermann, Jennifer L.; Pike, Linda J.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Pike, LJ (corresponding author), 660 So Euclid Ave,Box 8231, St Louis, MO 63110 USA.	pike@biochem.wustl.edu			National Institutes of Health [R01GM064491, R01GM082824]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082824, R01GM064491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM064491 and R01GM082824 (to L. J. P.).	Aifa S, 2006, PROTEINS, V62, P1036, DOI 10.1002/prot.20780; Aifa S, 2005, EXP CELL RES, V302, P108, DOI 10.1016/j.yexcr.2004.08.032; CADENA DL, 1994, J BIOL CHEM, V269, P260; CHEN WS, 1989, CELL, V59, P33, DOI 10.1016/0092-8674(89)90867-2; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; COCHET C, 1988, J BIOL CHEM, V263, P3290; DORAN DM, 1980, J IMMUNOL METHODS, V39, P155, DOI 10.1016/0022-1759(80)90304-X; DOWNWARD J, 1984, NATURE, V311, P483, DOI 10.1038/311483a0; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HSUAN JJ, 1989, BIOCHEM J, V262, P659, DOI 10.1042/bj2620659; KING AC, 1982, J BIOL CHEM, V257, P3053; Lee NY, 2006, PROTEIN SCI, V15, P1142, DOI 10.1110/ps.052045306; Lee NY, 2005, PROTEIN SCI, V14, P2793, DOI 10.1110/ps.051630305; Liu P, 2007, BIOPHYS J, V93, P684, DOI 10.1529/biophysj.106.102087; Macdonald J, 2006, BBA-MOL CELL RES, V1763, P870, DOI 10.1016/j.bbamcr.2006.05.002; Macdonald JL, 2008, P NATL ACAD SCI USA, V105, P112, DOI 10.1073/pnas.0707080105; Macdonald-Obermann JL, 2009, BIOCHEMISTRY-US, V48, P2505, DOI 10.1021/bi802249x; MAGUN BE, 1980, J BIOL CHEM, V255, P6373; MARGOLIS B, 1990, EMBO J, V9, P4375, DOI 10.1002/j.1460-2075.1990.tb07887.x; Mattoon D, 2004, P NATL ACAD SCI USA, V101, P923, DOI 10.1073/pnas.0307286101; McLaughlin S, 2005, J GEN PHYSIOL, V126, P41, DOI 10.1085/jgp.200509274; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; REES AR, 1984, EMBO J, V3, P1843, DOI 10.1002/j.1460-2075.1984.tb02057.x; Saffarian S, 2007, BIOPHYS J, V93, P1021, DOI 10.1529/biophysj.107.105494; SHOYAB M, 1979, NATURE, V279, P387, DOI 10.1038/279387a0; Thiel KW, 2007, P NATL ACAD SCI USA, V104, P19238, DOI 10.1073/pnas.0703854104; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; Walker F, 2004, J BIOL CHEM, V279, P22387, DOI 10.1074/jbc.M401244200; WELLS A, 1990, SCIENCE, V247, P962, DOI 10.1126/science.2305263; Wong I, 1995, METHOD ENZYMOL, V259, P95; Wyman J., 1990, BINDING LINKAGE FUNC, P203; Yang KS, 2009, J BIOL CHEM, V284, P7474, DOI 10.1074/jbc.M808041200; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	36	66	67	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13570	13576		10.1074/jbc.M109.001487	http://dx.doi.org/10.1074/jbc.M109.001487			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19336395	hybrid, Green Published			2022-12-25	WOS:000265877300034
J	Zhu, TF; Szostak, JW				Zhu, Ting F.; Szostak, Jack W.			Preparation of Large Monodisperse Vesicles	PLOS ONE			English	Article								Preparation of monodisperse vesicles is important both for research purposes and for practical applications. While the extrusion of vesicles through small pores (similar to 100 nm in diameter) results in relatively uniform populations of vesicles, extrusion to larger sizes results in very heterogeneous populations of vesicles. Here we report a simple method for preparing large monodisperse multilamellar vesicles through a combination of extrusion and large-pore dialysis. For example, extrusion of polydisperse vesicles through 5-mu m-diameter pores eliminates vesicles larger than 5 mu m in diameter. Dialysis of extruded vesicles against 3-mu m-pore-size polycarbonate membranes eliminates vesicles smaller than 3 mu m in diameter, leaving behind a population of monodisperse vesicles with a mean diameter of 4 mu m. The simplicity of this method makes it an effective tool for laboratory vesicle preparation with potential applications in preparing large monodisperse liposomes for drug delivery.	[Zhu, Ting F.; Szostak, Jack W.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; [Zhu, Ting F.; Szostak, Jack W.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Zhu, Ting F.] Harvard Univ, Massachusetts Inst Technol, Div Hlth Sci & Technol, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT)	Zhu, TF (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA.	szostak@molbio.mgh.harvard.edu			NASA Exobiology Program [EXB02-0031-0018]; Howard Hughes Medical Institute	NASA Exobiology Program(National Aeronautics & Space Administration (NASA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported in part by grant EXB02-0031-0018 from the NASA Exobiology Program. JWS is an Investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; Chen IA, 2004, BIOPHYS J, V87, P988, DOI 10.1529/biophysj.104.039875; Chen IA, 2004, SCIENCE, V305, P1474, DOI 10.1126/science.1100757; Chen IA, 2004, P NATL ACAD SCI USA, V101, P7965, DOI 10.1073/pnas.0308045101; Dhand Rajiv, 2004, Respir Care, V49, P666; Edwards DA, 1998, J APPL PHYSIOL, V85, P379, DOI 10.1152/jappl.1998.85.2.379; ENOCH HG, 1979, P NATL ACAD SCI USA, V76, P145, DOI 10.1073/pnas.76.1.145; Grabielle-Madelmont C, 2003, J BIOCHEM BIOPH METH, V56, P189, DOI 10.1016/S0165-022X(03)00059-9; Hanczyc MM, 2003, SCIENCE, V302, P618, DOI 10.1126/science.1089904; HARGREAVES WR, 1978, BIOCHEMISTRY-US, V17, P3759, DOI 10.1021/bi00611a014; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; Knight V, 1999, CANCER CHEMOTH PHARM, V44, P177, DOI 10.1007/s002800050965; Korgel BA, 1998, BIOPHYS J, V74, P3264, DOI 10.1016/S0006-3495(98)78033-6; LIU DX, 1992, BIOCHIM BIOPHYS ACTA, V1104, P95, DOI 10.1016/0005-2736(92)90136-A; Lorenceau E, 2005, LANGMUIR, V21, P9183, DOI 10.1021/la050797d; Nagayasu A, 1999, ADV DRUG DELIVER REV, V40, P75, DOI 10.1016/S0169-409X(99)00041-1; NAGAYASU A, 1995, BIOL PHARM BULL, V18, P1020; OLSON F, 1979, BIOCHIM BIOPHYS ACTA, V557, P9, DOI 10.1016/0005-2736(79)90085-3; Patty PJ, 2003, BIOPHYS J, V85, P996, DOI 10.1016/S0006-3495(03)74538-X; Sugiura S, 2008, LANGMUIR, V24, P4581, DOI 10.1021/la703509r; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; Utada AS, 2005, SCIENCE, V308, P537, DOI 10.1126/science.1109164; Verschraegen CF, 2004, CLIN CANCER RES, V10, P2319, DOI 10.1158/1078-0432.CCR-0929-3	23	61	61	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2009	4	4							e5009	10.1371/journal.pone.0005009	http://dx.doi.org/10.1371/journal.pone.0005009			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RS	19347043	Green Published, Green Submitted, gold			2022-12-25	WOS:000265505200001
J	Liu, Y; Sanoff, HK; Cho, H; Burd, CE; Torrice, C; Mohlke, KL; Ibrahim, JG; Thomas, NE; Sharpless, NE				Liu, Yan; Sanoff, Hanna K.; Cho, Hyunsoon; Burd, Christin E.; Torrice, Chad; Mohlke, Karen L.; Ibrahim, Joseph G.; Thomas, Nancy E.; Sharpless, Norman E.			INK4/ARF Transcript Expression Is Associated with Chromosome 9p21 Variants Linked to Atherosclerosis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; SMOOTH-MUSCLE-CELLS; GENETIC-VARIATION; P16(INK4A); LOCUS; SENESCENCE; SUSCEPTIBILITY; PROLIFERATION; REPLICATION	Background: Genome-wide association studies (GWAS) have linked common single nucleotide polymorphisms (SNPs) on chromosome 9p21 near the INK4/ARF (CDKN2A/B) tumor suppressor locus with risk of atherosclerotic diseases and type 2 diabetes mellitus. To explore the mechanism of this association, we investigated whether expression of proximate transcripts (p16(INK4a), p15(INK4b), ARF, ANRIL and MTAP) correlate with genotype of representative 9p21 SNPs. Methodology/Principal Findings: We analyzed expression of 9p21 transcripts in purified peripheral blood T-cells (PBTL) from 170 healthy donors. Samples were genotyped for six selected disease-related SNPs spanning the INK4/ARF locus. Correlations among these variables were determined by univariate and multivariate analysis. Significantly reduced expression of all INK4/ARF transcripts (p15(INK4b), p16(INK4a), ARF and ANRIL) was found in PBTL of individuals harboring a common SNP (rs10757278) associated with increased risk of coronary artery disease, stroke and aortic aneurysm. Expression of MTAP was not influenced by rs10757278 genotype. No association of any these transcripts was noted with five other tested 9p21 SNPs. Conclusions/Significance: Genotypes of rs10757278 linked to increased risk of atherosclerotic diseases are also associated with decreased expression in PBTL of the INK4/ARF locus, which encodes three related anti-proliferative transcripts of known importance in tumor suppression and aging.	[Liu, Yan; Burd, Christin E.; Torrice, Chad; Mohlke, Karen L.; Sharpless, Norman E.] Univ N Carolina, Sch Med, Dept Genet, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Liu, Yan; Sanoff, Hanna K.; Burd, Christin E.; Torrice, Chad; Sharpless, Norman E.] Univ N Carolina, Sch Med, Dept Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Cho, Hyunsoon; Ibrahim, Joseph G.] Univ N Carolina, Sch Med, Dept Biostat, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Thomas, Nancy E.] Univ N Carolina, Sch Med, Dept Dermatol, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Liu, Y (corresponding author), Univ N Carolina, Sch Med, Dept Genet, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA.	nes@med.unc.edu	Core, Mammalian Genotyping/AFU-1631-2022	Sharpless, Norman/0000-0001-7078-9455	NIH [RR023248, AG024379, DK072193, CA009156-34]; Ellison Medical Foundation; Burroughs Wellcome Fund; NATIONAL CANCER INSTITUTE [T32CA009156, R01CA112243] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR023248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024379] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the NIH (RR023248, AG024379, DK072193), the Ellison Medical Foundation and the Burroughs Wellcome Fund. Y.L. is supported by NIH training grant CA009156-34. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Anderson JL, 2008, AM HEART J, V156, P1155, DOI 10.1016/j.ahj.2008.07.006; Baker DJ, 2008, NAT CELL BIOL, V10, P825, DOI 10.1038/ncb1744; Boehm Manfred, 2003, Prog Cell Cycle Res, V5, P19; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Broadbent HM, 2008, HUM MOL GENET, V17, P806, DOI 10.1093/hmg/ddm352; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Gizard F, 2005, J CLIN INVEST, V115, P3228, DOI 10.1172/JCI22756; Grainger DJ, 2004, ARTERIOSCL THROM VAS, V24, P399, DOI 10.1161/01.ATV.0000114567.76772.33; He J, 2008, NAT STRUCT MOL BIOL, V15, P1169, DOI 10.1038/nsmb.1499; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Kalinina N, 2004, ARTERIOSCL THROM VAS, V24, P1391, DOI 10.1161/01.ATV.0000133605.89421.79; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Kumar R, 2001, INT J CANCER, V95, P388, DOI 10.1002/1097-0215(20011120)95:6<388::AID-IJC1069>3.0.CO;2-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matarin M, 2008, STROKE, V39, P1586, DOI 10.1161/STROKEAHA.107.502963; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; Matthews C, 2006, CIRC RES, V99, P156, DOI 10.1161/01.RES.0000233315.38086.bc; McKeller RN, 2002, P NATL ACAD SCI USA, V99, P3848, DOI 10.1073/pnas.052484199; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Melzer D, 2007, MECH AGEING DEV, V128, P370, DOI 10.1016/j.mad.2007.03.005; MUENDLEIN A, 2008, ATHEROSCLER IN PRESS; Ng K, 2007, EMBO REP, V8, P34, DOI 10.1038/sj.embor.7400871; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; Paynter NP, 2009, ANN INTERN MED, V150, P65, DOI 10.7326/0003-4819-150-2-200901200-00003; Rauscher FM, 2003, CIRCULATION, V108, P457, DOI 10.1161/01.CIR.0000082924.75945.48; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schunkert H, 2008, CIRCULATION, V117, P1675, DOI 10.1161/CIRCULATIONAHA.107.730614; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Shields JM, 2007, CANCER RES, V67, P1502, DOI 10.1158/0008-5472.CAN-06-3311; Signer RAJ, 2008, GENE DEV, V22, P3115, DOI 10.1101/gad.1715808; Wutz A, 2007, TRENDS GENET, V23, P457, DOI 10.1016/j.tig.2007.07.004; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	41	185	194	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2009	4	4							e5027	10.1371/journal.pone.0005027	http://dx.doi.org/10.1371/journal.pone.0005027			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437QA	19343170	Green Published, Green Submitted, gold			2022-12-25	WOS:000265500800002
J	Maidhof, C; Rieger, M; Prinz, W; Koelsch, S				Maidhof, Clemens; Rieger, Martina; Prinz, Wolfgang; Koelsch, Stefan			Nobody Is Perfect: ERP Effects Prior to Performance Errors in Musicians Indicate Fast Monitoring Processes	PLOS ONE			English	Article							AUDITORY-FEEDBACK; BRAIN POTENTIALS; FUNCTIONAL-SIGNIFICANCE; MISMATCH NEGATIVITY; CINGULATE CORTEX; MOVEMENT; COMPONENTS; NOVELTY; ATTENTION; DYNAMICS	Background One central question in the context of motor control and action monitoring is at what point in time errors can be detected. Previous electrophysiological studies investigating this issue focused on brain potentials elicited after erroneous responses, mainly in simple speeded response tasks. In the present study, we investigated brain potentials before the commission of errors in a natural and complex situation. Methodology/Principal Findings: Expert pianists bimanually played scales and patterns while the electroencephalogram (EEG) was recorded. Event-related potentials (ERPs) were computed for correct and incorrect performances. Results revealed differences already 100 ms prior to the onset of a note (i.e., prior to auditory feedback). We further observed that erroneous keystrokes were delayed in time and pressed more slowly. Conclusions: Our data reveal neural mechanisms in musicians that are able to detect errors prior to the execution of erroneous movements. The underlying mechanism probably relies on predictive control processes that compare the predicted outcome of an action with the action goal.	[Maidhof, Clemens; Rieger, Martina; Prinz, Wolfgang; Koelsch, Stefan] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Koelsch, Stefan] Univ Sussex, Dept Psychol, Brighton BN1 9RH, E Sussex, England	Max Planck Society; University of Sussex	Maidhof, C (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	maidhof@cbs.mpg.de	Koelsch, Stefan/AAV-1556-2020	Rieger, Martina/0000-0002-2421-296X; Maidhof, Clemens/0000-0002-9562-9551	German Research Foundation (Deutsche Forschungsgemeinschaft) [KO 2266/4-1]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This study was supported in part by a grant from the German Research Foundation (Deutsche Forschungsgemeinschaft) awarded to S.K. (KO 2266/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Colebatch JG, 2007, MOVEMENT DISORD, V22, P601, DOI 10.1002/mds.21323; COURCHESNE E, 1975, ELECTROEN CLIN NEURO, V39, P131, DOI 10.1016/0013-4694(75)90003-6; Crapse TB, 2008, CURR OPIN NEUROBIOL, V18, P552, DOI 10.1016/j.conb.2008.09.017; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Endrass T, 2007, EUR J NEUROSCI, V26, P1714, DOI 10.1111/j.1460-9568.2007.05785.x; Escera C, 1998, J COGNITIVE NEUROSCI, V10, P590, DOI 10.1162/089892998562997; Escera C, 2007, J PSYCHOPHYSIOL, V21, P251, DOI 10.1027/0269-8803.21.34.251; EVARTS EV, 1974, J NEUROPHYSIOL, V37, P373, DOI 10.1152/jn.1974.37.2.373; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Falkenstein M., 1990, PSYCHOPHYSIOLOGICAL, P192; Finney SA, 2003, MEM COGNITION, V31, P51, DOI 10.3758/BF03196082; Finney SA, 2001, BEHAV RES METH INS C, V33, P167, DOI 10.3758/BF03195362; Finney SA, 1997, MUSIC PERCEPT, V15, P153; Finney SA, 2001, BEHAV RES METH INS C, V33, P65, DOI 10.3758/BF03195348; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gehring WJ, 1995, EEG CL N SU, P261; Hajcak G, 2005, BIOL PSYCHOL, V70, P67, DOI 10.1016/j.biopsycho.2004.12.001; Hajcak G, 2003, PSYCHOPHYSIOLOGY, V40, P895, DOI 10.1111/1469-8986.00107; Hatsopoulos NG, 2007, J NEUROSCI, V27, P5105, DOI 10.1523/JNEUROSCI.3570-06.2007; Holdefer RN, 2002, EXP BRAIN RES, V146, P233, DOI 10.1007/s00221-002-1166-x; Kaiser J, 1997, INT J PSYCHOPHYSIOL, V27, P215, DOI 10.1016/S0167-8760(97)00055-X; Kawagoe A, 1999, IEEE T APPL SUPERCON, V9, P727, DOI 10.1109/77.783398; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; MARTENIUK RG, 1984, Q J EXP PSYCHOL-A, V36, P335, DOI 10.1080/14640748408402163; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Moller J, 2007, CEREB CORTEX, V17, P1173, DOI 10.1093/cercor/bhl028; Munte TF, 2002, NAT REV NEUROSCI, V3, P473, DOI 10.1038/nrn843; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Overbeek TJM, 2005, J PSYCHOPHYSIOL, V19, P319, DOI 10.1027/0269-8803.19.4.319; Padilla ML, 2006, J COGNITIVE NEUROSCI, V18, P1477, DOI 10.1162/jocn.2006.18.9.1477; Palmer C, 2005, CURR DIR PSYCHOL SCI, V14, P247, DOI 10.1111/j.0963-7214.2005.00374.x; PALMER C, 1993, J EXP PSYCHOL LEARN, V19, P457, DOI 10.1037/0278-7393.19.2.457; Palmer C, 2003, PSYCHOL REV, V110, P683, DOI 10.1037/0033-295X.110.4.683; Pfordresher P. Q., 2006, ADV COGN PSYCHOL, V2, P183, DOI [10.2478/v10053-008-0054-8, DOI 10.2478/V10053-008-0054-8]; Pfordresher PQ, 2005, J EXP PSYCHOL HUMAN, V31, P1331, DOI 10.1037/0096-1523.31.6.1331; Pfordresher PQ, 2003, J EXP PSYCHOL HUMAN, V29, P949, DOI 10.1037/0096-1523.29.5.949; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; PORTER R, 1975, BRAIN RES, V98, P21, DOI 10.1016/0006-8993(75)90507-7; Poulet JFA, 2007, TRENDS NEUROSCI, V30, P14, DOI 10.1016/j.tins.2006.11.005; RABBITT P, 1978, ERGONOMICS, V21, P945, DOI 10.1080/00140137808931800; Ridderinkhof KR, 2003, NEUROSCI LETT, V348, P1, DOI 10.1016/S0304-3940(03)00566-4; SHIBASAKI H, 1980, ELECTROEN CLIN NEURO, V49, P213, DOI 10.1016/0013-4694(80)90216-3; Spijkers W, 1997, ACTA PSYCHOL, V96, P207, DOI 10.1016/S0001-6918(97)00017-6; Swinnen SP, 2004, TRENDS COGN SCI, V8, P18, DOI 10.1016/j.tics.2003.10.017; THACH WT, 1978, J NEUROPHYSIOL, V41, P654, DOI 10.1152/jn.1978.41.3.654; van Boxtel GJM, 2005, J PSYCHOPHYSIOL, V19, P1, DOI 10.1027/0269-8803.19.1.1; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837; van Veen V, 2006, CLIN EEG NEUROSCI, V37, P330, DOI 10.1177/155005940603700411; Verleger R, 2008, CLIN NEUROPHYSIOL, V119, P968, DOI 10.1016/j.clinph.2007.11.175; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI [10.1037/0033-295X.111.4.931, 10.1037/0033-295x.111.4.931]; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152	58	58	59	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5032	10.1371/journal.pone.0005032	http://dx.doi.org/10.1371/journal.pone.0005032			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437PY	19337379	Green Submitted, Green Published, gold			2022-12-25	WOS:000265500600010
J	Dumont, M; Wille, E; Stack, C; Calingasan, NY; Beal, MF; Lin, MT				Dumont, Magali; Wille, Elizabeth; Stack, Cliona; Calingasan, Noel Y.; Beal, M. Flint; Lin, Michael T.			Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease	FASEB JOURNAL			English	Article						Tg19959 mice; antioxidant; behavior; amyloid; synaptophysin	BETA-PEPTIDE; MITOCHONDRIAL DYSFUNCTION; COGNITIVE IMPAIRMENT; HYDROGEN-PEROXIDE; TGCRND8 MICE; IN-VIVO; DAMAGE; MECHANISM; AMYLOIDOGENESIS; EXPRESSION	In Alzheimer's disease (AD), oxidative stress is present early and contributes to disease pathogenesis. We previously reported that in Tg19959 transgenic AD mice, partial deficiency of the mitochondrial antioxidant enzyme manganese superoxide dismutase (MnSOD) exacerbated amyloid pathology. We therefore asked whether MnSOD overexpression would prove beneficial against AD pathogenesis, by studying the offspring of Tg19959 mice crossed with MnSOD-overexpressing mice. At 4 mo of age, there was a 2- to 3-fold increase in MnSOD protein levels in Tg19959-MnSOD mice compared to Tg19959 littermates. Tg19959-MnSOD mice also had a 50% increase in catalase protein levels, a 50% decrease in levels of oxidized protein, and a 33% reduction in cortical plaque burden compared to Tg19959 littermates. Spatial memory was impaired and synaptophysin levels were decreased in Tg19959 mice compared to wild-type littermates, but memory and synaptophysin levels were restored to wild-type levels in Tg19959-MnSOD littermates. These benefits occurred without changes in sodium dodecyl sulfate-soluble or formic acid-soluble A beta pools or A beta oligomers in Tg19959-MnSOD mice compared to Tg19959 littermates. These data demonstrate that facilitation of the mitochondrial antioxidant response improves resistance to A beta, slows plaque formation or increases plaque degradation, and markedly attenuates the phenotype in a transgenic AD mouse model.-Dumont, M., Wille, E., Stack, C., Calingasan, N. Y., Beal, M. F., Lin, M. T. Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease. FASEB J. 23, 2459-2466 (2009)	[Dumont, Magali; Wille, Elizabeth; Stack, Cliona; Calingasan, Noel Y.; Beal, M. Flint; Lin, Michael T.] Weill Cornell Med Coll, Dept Neurol & Neurosci, New York, NY 10065 USA	Cornell University	Lin, MT (corresponding author), Weill Cornell Med Coll, Dept Neurol & Neurosci, 525 E 68th St,A501, New York, NY 10065 USA.	mtl2002@med.cornell.edu		DUMONT, MAGALI/0000-0001-9990-6512	U.S. National Institutes of Health [AG20729]; NATIONAL INSTITUTE ON AGING [R01AG020729] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Charles Epstein (University of California, San Francisco, CA, USA) for providing MnSOD-overexpressing mice, and Anatoly Starkov, Davide Tampelini, Gunnar Gouras, and Yoon Kim for providing important scientific inputs to the manuscript. This research project was supported by U.S. National Institutes of Health grant AG20729.	BEHL C, 1992, BIOCHEM BIOPH RES CO, V186, P944, DOI 10.1016/0006-291X(92)90837-B; Bellucci A, 2006, NEUROBIOL DIS, V23, P260, DOI 10.1016/j.nbd.2006.03.012; Bieschke J, 2005, BIOCHEMISTRY-US, V44, P4977, DOI 10.1021/bi0501030; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Daumas S, 2008, LEARN MEMORY, V15, P625, DOI 10.1101/lm.990208; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; Dudal S, 2004, NEUROBIOL AGING, V25, P861, DOI 10.1016/j.neurobiolaging.2003.08.008; Dumont M, 2009, J NEUROCHEM, V109, P502, DOI 10.1111/j.1471-4159.2009.05970.x; Esposito L, 2006, J NEUROSCI, V26, P5167, DOI 10.1523/JNEUROSCI.0482-06.2006; Hartman RE, 2006, NEUROBIOL DIS, V24, P506, DOI 10.1016/j.nbd.2006.08.006; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; Hyde LA, 2005, BEHAV BRAIN RES, V160, P344, DOI 10.1016/j.bbr.2004.12.017; Joseph JA, 2003, NUTR NEUROSCI, V6, P153, DOI 10.1080/1028415031000111282; Jucker M, 2008, NEURON, V59, P8, DOI 10.1016/j.neuron.2008.06.014; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Keller JN, 2005, NEUROLOGY, V64, P1152, DOI 10.1212/01.WNL.0000156156.13641.BA; Keller JN, 1998, J NEUROSCI, V18, P687; Li F, 2004, J NEUROCHEM, V89, P1308, DOI 10.1111/j.1471-4159.2004.02455.x; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu L, 2008, J MOL BIOL, V377, P1236, DOI 10.1016/j.jmb.2008.01.057; Lovasic L, 2005, GENES BRAIN BEHAV, V4, P197, DOI 10.1111/j.1601-183X.2004.00104.x; Melov S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000536; Morelra PI, 2008, FREE RADICAL BIO MED, V44, P1493, DOI 10.1016/j.freeradbiomed.2008.01.002; Murray IVJ, 2007, J BIOL CHEM, V282, P9335, DOI 10.1074/jbc.M608589200; Nunomura A, 2007, CURR MED CHEM, V14, P2968, DOI 10.2174/092986707782794078; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Pappolla MA, 1998, AM J PATHOL, V152, P871; Raineri I, 2001, FREE RADICAL BIO MED, V31, P1018, DOI 10.1016/S0891-5849(01)00686-4; Ringman JM, 2008, NEUROLOGY, V71, P85, DOI 10.1212/01.wnl.0000303973.71803.81; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Siedlak SL, 2009, FREE RADICAL RES, V43, P156, DOI 10.1080/10715760802644694; Smith MA, 1998, J NEUROCHEM, V70, P2212, DOI 10.1046/j.1471-4159.1998.70052212.x; Sung S, 2003, FASEB J, V17, P323, DOI 10.1096/fj.03-0961fje; Tabner BJ, 2005, J BIOL CHEM, V280, P35789, DOI 10.1074/jbc.C500238200; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; Tamagno E, 2005, J NEUROCHEM, V92, P628, DOI 10.1111/j.1471-4159.2004.02895.x; Tamagno E, 2002, NEUROBIOL DIS, V10, P279, DOI 10.1006/nbdi.2002.0515; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Varadarajan S, 1999, BRAIN RES BULL, V50, P133, DOI 10.1016/S0361-9230(99)00093-3; Yatin SM, 1999, NEUROCHEM RES, V24, P427, DOI 10.1023/A:1020997903147; Yoshiike Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003235	44	173	175	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2459	2466		10.1096/fj.09-132928	http://dx.doi.org/10.1096/fj.09-132928			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19346295	Green Published			2022-12-25	WOS:000268836700014
J	Fu, Q; Yu, X; Callaway, CW; Lane, RH; McKnight, RA				Fu, Qi; Yu, Xing; Callaway, Christopher W.; Lane, Robert H.; McKnight, Robert A.			Epigenetics: intrauterine growth retardation (IUGR) modifies the histone code along the rat hepatic IGF-1 gene	FASEB JOURNAL			English	Article						chromatin; DNA methylation; Barker hypothesis; chromatin immunoprecipitation; insulin resistance	FACTOR-I GENE; RNA-POLYMERASE-II; MESSENGER RIBONUCLEIC-ACIDS; TRANSCRIPTION START SITES; BIRTH-WEIGHT; UTEROPLACENTAL INSUFFICIENCY; LYSINE-4 METHYLATION; INSULIN-RESISTANCE; GESTATIONAL-AGE; EXTRAHEPATIC TISSUES	Intrauterine growth restriction ( IUGR) decreases serum insulin growth factor-1 (IGF-1) levels. IGF-1 is an epigenetically regulated gene that has two promoters, alternative exon 5 splicing, and multiple termination sites. The regulation of gene expression involves the whole gene, as evidenced by the aforementioned IGF-1 paradigm. We hypothesized that IUGR in the rat would affect hepatic IGF-1 expression and alter the epigenetic characteristics of the IGF-1 gene along its length. IUGR was induced through a bilateral uterine artery ligation of the pregnant rat, a well-characterized model of IUGR. Pups from anesthesia and sham-operated dams were used as controls. Real-time RTPCR and ELISA was used to measure expression at day of life (DOL) 0 and 21. Bisulfite sequencing and chromatin immunoprecipitation (ChIP) quantified IGF-1 epigenetic characteristics. A nontranscribed intergenic control was used for ChIP studies. IUGR decreased hepatic and serum IGF-1. Concurrently, IUGR modified epigenetic characteristics, particularly the histone code, along the length of the hepatic IGF-1 gene. Many changes persisted postnatally, and the postnatal effect of IUGR on the histone code was gender-specific. We conclude that IUGR modifies epigenetic characteristics of the rat hepatic IGF-1 gene along the length of the whole gene.-Fu, Q., Yu, X., Callaway, C. W., Lane, R. H., McKnight, R. A. Epigenetics: intrauterine growth retardation (IUGR) modifies the histone code along the rat hepatic IGF-1 gene. FASEB J. 23, 2438-2449 (2009)	[Fu, Qi; Yu, Xing; Callaway, Christopher W.; Lane, Robert H.; McKnight, Robert A.] Univ Utah, Sch Med, Dept Pediat, Div Neonatol, Salt Lake City, UT 84158 USA	Utah System of Higher Education; University of Utah	Lane, RH (corresponding author), Univ Utah, Sch Med, Dept Pediat, Div Neonatol, POB 581289, Salt Lake City, UT 84158 USA.	robert.lane@hsc.utah.edu		Callaway, Christopher/0000-0003-2072-0972	U.S. National Institutes of Health [HD41075]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD041075] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The project was funded by the U.S. National Institutes of Health, grant HD41075. We thank the Division of Neonatology and the Developmental Origins of Health Laboratories at the University of Utah for their support and guidance.	ADAMO M, 1989, ENDOCRINOLOGY, V124, P2737, DOI 10.1210/endo-124-6-2737; Adamo ML, 2006, ENDOCRINOLOGY, V147, P2944, DOI 10.1210/en.2005-0742; ADAMO ML, 1991, MOL ENDOCRINOL, V5, P1677, DOI 10.1210/mend-5-11-1677; Ahmad K, 2002, CELL, V111, P281, DOI 10.1016/S0092-8674(02)01081-4; Alisi A, 2003, LIVER INT, V23, P179, DOI 10.1034/j.1600-0676.2003.00829.x; ASHTON IK, 1985, ACTA ENDOCRINOL-COP, V110, P558, DOI 10.1530/acta.0.1100558; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; BASCRGA M, 2005, AM J PHYSIOL, V289, pR1348; BELL GI, 1986, NUCLEIC ACIDS RES, V14, P7873, DOI 10.1093/nar/14.20.7873; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; BUTLER AA, 1994, MOL CELL ENDOCRINOL, V101, P321, DOI 10.1016/0303-7207(94)90249-6; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; CHEW SL, 1995, ENDOCRINOLOGY, V136, P1939, DOI 10.1210/en.136.5.1939; Dehe PM, 2006, J BIOL CHEM, V281, P35404, DOI 10.1074/jbc.M603099200; Demeny MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000316; El Khattabi I, 2003, AM J PHYSIOL-ENDOC M, V285, pE991, DOI 10.1152/ajpendo.00037.2003; Fatemi M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni180; Fattal-Valevski A, 2005, J PEDIATR ENDOCR MET, V18, P671; Flanagan DE, 2000, AM J PHYSIOL-ENDOC M, V278, pE700, DOI 10.1152/ajpendo.2000.278.4.E700; FOYT HL, 1992, MOL ENDOCRINOL, V6, P1881, DOI 10.1210/me.6.11.1881; Frusca T, 1997, EARLY HUM DEV, V48, P177, DOI 10.1016/S0378-3782(96)01854-3; Fu Q, 2004, PHYSIOL GENOMICS, V20, P108, DOI 10.1152/physiolgenomics.00175.2004; Fu Q, 2006, FASEB J, V20, P2127, DOI 10.1096/fj.06-6179fje; Gerber M, 2003, J BIOL CHEM, V278, P26303, DOI 10.1074/jbc.R300014200; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; GULER HP, 1987, NEW ENGL J MED, V317, P137, DOI 10.1056/NEJM198707163170303; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Hardy S, 2002, J BIOL CHEM, V277, P32875, DOI 10.1074/jbc.M205860200; Howe L, 2001, GENE DEV, V15, P3144, DOI 10.1101/gad.931401; Huang HS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000809; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Isaksson OGP, 2001, HORM RES, V55, P18, DOI 10.1159/000063468; Jones PA, 1999, TRENDS GENET, V15, P34, DOI 10.1016/S0168-9525(98)01636-9; Ke X, 2006, PHYSIOL GENOMICS, V25, P16, DOI 10.1152/physiolgenomics.00093.2005; Ke XR, 2005, AM J PHYSIOL-REG I, V288, pR1038, DOI 10.1152/ajpregu.00701.2004; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; LASSARRE C, 1991, PEDIATR RES, V29, P219, DOI 10.1203/00006450-199103000-00001; LEROITH D, 1989, J MOL NEUROSCI, V1, P3, DOI 10.1007/BF02896850; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; LOWE WL, 1988, MOL ENDOCRINOL, V2, P528, DOI 10.1210/mend-2-6-528; Martin DGE, 2006, MOL CELL BIOL, V26, P7871, DOI 10.1128/MCB.00573-06; McNairn AJ, 2003, BIOESSAYS, V25, P647, DOI 10.1002/bies.10305; Mi J, 2000, ANN INTERN MED, V132, P253, DOI 10.7326/0003-4819-132-4-200002150-00002; Ng HH, 1999, CURR OPIN GENET DEV, V9, P158, DOI 10.1016/S0959-437X(99)80024-0; Ozkan H, 1999, BIOL NEONATE, V76, P274, DOI 10.1159/000014169; PHILLIPS DIW, 1994, DIABETOLOGIA, V37, P150, DOI 10.1007/s001250050086; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Radunovic N, 2000, J CLIN ENDOCR METAB, V85, P85, DOI 10.1210/jc.85.1.85; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Richards EJ, 2002, CURR BIOL, V12, pR694, DOI 10.1016/S0960-9822(02)01208-3; ROBERTS CT, 1987, MOL ENDOCRINOL, V1, P243, DOI 10.1210/mend-1-3-243; ROBERTS CT, 1987, BIOCHEM BIOPH RES CO, V146, P1154, DOI 10.1016/0006-291X(87)90768-6; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; SHIMATSU A, 1987, NUCLEIC ACIDS RES, V15, P7196, DOI 10.1093/nar/15.17.7196; SHIMATSU A, 1987, J BIOL CHEM, V262, P7894; SIEGFRIED JM, 1992, P NATL ACAD SCI USA, V89, P8107, DOI 10.1073/pnas.89.17.8107; SIMMONS JG, 1993, GROWTH FACTORS, V9, P205, DOI 10.3109/08977199309010833; Simmons RA, 2001, DIABETES, V50, P2279, DOI 10.2337/diabetes.50.10.2279; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Syddall HE, 2005, AM J EPIDEMIOL, V161, P1074, DOI 10.1093/aje/kwi137; Tenhola S, 2005, EUR J ENDOCRINOL, V152, P335, DOI 10.1530/eje.1.01869; TOBIN G, 1990, MOL ENDOCRINOL, V4, P1914, DOI 10.1210/mend-4-12-1914; Tresaugues L, 2006, J MOL BIOL, V359, P1170, DOI 10.1016/j.jmb.2006.04.050; Tsirka AE, 2001, J ENDOCRINOL, V169, P373, DOI 10.1677/joe.0.1690373; VALDEZ R, 1994, DIABETOLOGIA, V37, P624, DOI 10.1007/s001250050157; Verkauskiene R, 2005, J CLIN ENDOCR METAB, V90, P5672, DOI 10.1210/jc.2005-0423; VILEISIS RA, 1986, PEDIATR RES, V20, P126, DOI 10.1203/00006450-198602000-00006; Witlin AG, 1997, ANNU REV MED, V48, P115; Woelfle J, 2003, J BIOL CHEM, V278, P22696, DOI 10.1074/jbc.M301362200; Woods KA, 1996, NEW ENGL J MED, V335, P1363, DOI 10.1056/NEJM199610313351805; Woods KA, 2000, J CLIN ENDOCR METAB, V85, P1407, DOI 10.1210/jc.85.4.1407; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Yarbrough DE, 1998, DIABETES CARE, V21, P1652, DOI 10.2337/diacare.21.10.1652; Zhang JH, 1997, ENDOCRINOLOGY, V138, P3112, DOI 10.1210/en.138.8.3112; Zimmermann P, 1997, ULTRASOUND OBST GYN, V9, P330, DOI 10.1046/j.1469-0705.1997.09050330.x; 2002, AM J PHYSL, V283, pR281	81	139	149	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2438	2449		10.1096/fj.08-124768	http://dx.doi.org/10.1096/fj.08-124768			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19364764	Green Published			2022-12-25	WOS:000268836700012
J	Yende, S; Angus, DC; Kong, L; Kellum, JA; Weissfeld, L; Ferrell, R; Finegold, D; Carter, M; Leng, L; Peng, ZY; Bucala, R				Yende, Sachin; Angus, Derek C.; Kong, Lan; Kellum, John A.; Weissfeld, Lisa; Ferrell, Robert; Finegold, David; Carter, Melinda; Leng, Lin; Peng, Zhi-Yong; Bucala, Richard			The influence of macrophage migration inhibitory factor gene polymorphisms on outcome from community-acquired pneumonia	FASEB JOURNAL			English	Article						cytokines; innate immunity; sepsis; TNF	FACTOR MIF GENE; SEPTIC SHOCK; RHEUMATOID-ARTHRITIS; CRITICAL MEDIATOR; SEPSIS; SEVERITY; ASSOCIATION; INFECTIONS; PREDICTION; CYTOKINE	The cytokine, macrophage migration inhibitory factor (MIF), is encoded in a functionally polymorphic locus and subjects with high-expression MIF alleles are at an increased risk of inflammatory disease. Severe sepsis is the leading cause of death in intensive care units, and the prevailing hypothesis is that an excessive innate response contributes to its pathogenesis. To assess if MIF alleles influence the clinical course of infection, we conducted a case-control study to assess susceptibility and a parallel inception cohort study of community-acquired pneumonia (CAP) to assess risk of severe sepsis and 90-d mortality. Two distinct polymorphisms in the MIF promoter were analyzed: a G/C transition at -173 and a CATT repeat at -794. The frequency of both polymorphisms was similar in the CAP cohort (n = 1739) and controls (n = 639); however, the 90-d mortality was lower for the high-expression C allele (P=0.003). This association remained significant after adjusting for demographics, comorbid conditions, and disease severity score [hazard ratio=0.64 (0.44-0.91), P=0.01]. The hazard ratio was similar in different geographic subcohorts, and the association remained significant after adjusting for false discovery. These data indicate that polymorphisms associated with higher MIF expression may have a beneficial effect in community-acquired pneumonia.-Yende, S., Angus, D. C., Kong, L., Kellum, J. A., Weissfeld, L., Ferrell, R., Finegold, D., Carter, M., Leng, L., Peng, Z.-Y., Bucala, R. The influence of macrophage migration inhibitory factor gene polymorphisms on outcome from community-acquired pneumonia. FASEB J. 23, 2403-2411 (2009)	[Yende, Sachin; Angus, Derek C.; Kong, Lan; Kellum, John A.; Weissfeld, Lisa; Carter, Melinda; Peng, Zhi-Yong] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Clin Res Invest & Syst Modeling Acute Illness Lab, Pittsburgh, PA 15261 USA; [Kong, Lan; Weissfeld, Lisa] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Ferrell, Robert; Finegold, David] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Leng, Lin; Bucala, Richard] Yale Univ, Sch Med, Dept Pathol & Med, New Haven, CT USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yale University	Angus, DC (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Clin Res Invest & Syst Modeling Acute Illness Lab, 614 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	angusdc@upmc.edu	Kellum, John/AAP-3072-2020; Angus, Derek C/E-9671-2012; Kellum, John A/HCH-2944-2022	Kellum, John/0000-0003-1995-2653; Kellum, John A/0000-0003-1995-2653; Finegold, David/0000-0001-9901-2578; Leng, Lin/0000-0002-0605-358X	NIH [NIGMS R01 GM61992, NIAID R01 AI042310, NO1 AI50031]; GlaxoSmithKline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042310, N01AI050031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061992] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlaxoSmithKline(GlaxoSmithKline); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are indebted to the nurses, respiratory therapists, phlebotomists, physicians, and other health care professionals who participated in GenIMS, as well as the patients and their families who supported this trial. A complete list of GenIMS investigators is available online (http://www.ccm.upmc.edu/genims_investigators). GenIMS was funded by NIH grants NIGMS R01 GM61992, NIAID R01 AI042310, and NO1 AI50031, with additional support from GlaxoSmithKline for enrollment and clinical data collection, Diagnostic Products Corporation for the cytokine assays, and an internal seed grant from the Department of Critical Care Medicine at the University of Pittsburgh. Yale University (R.B.) has applied for a patent describing the diagnostic value of MIF genotype. No other potential conflicts of interest were identified on behalf of the GenIMS investigators.	Baugh JA, 2002, GENES IMMUN, V3, P170, DOI 10.1038/sj.gene.6363867; Beishuizen A, 2001, J CLIN ENDOCR METAB, V86, P2811, DOI 10.1210/jc.86.6.2811; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; Bozza FA, 2004, SHOCK, V22, P309, DOI 10.1097/01.shk.0000140305.01641.c8; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Calandra T, 1998, P NATL ACAD SCI USA, V95, P11383, DOI 10.1073/pnas.95.19.11383; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Christ-Crain M, 2004, LANCET, V363, P600, DOI 10.1016/S0140-6736(04)15591-8; Cohen J, 2001, CRIT CARE MED, V29, P880, DOI 10.1097/00003246-200104000-00039; Donn R, 2004, ARTHRITIS RHEUM-US, V50, P1604, DOI 10.1002/art.20178; Donn R, 2002, ARTHRITIS RHEUM-US, V46, P2402, DOI 10.1002/art.10492; Donn RP, 2001, ARTHRITIS RHEUM-US, V44, P1782, DOI 10.1002/1529-0131(200108)44:8<1782::AID-ART314>3.0.CO;2-#; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Gallagher PM, 2003, THORAX, V58, P154, DOI 10.1136/thorax.58.2.154; Gando S, 2001, INTENS CARE MED, V27, P1187, DOI 10.1007/s001340000818; GUYATT GH, 1995, JAMA-J AM MED ASSOC, V274, P1800, DOI 10.1001/jama.274.22.1800; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Holmes CL, 2003, CHEST, V124, P1103, DOI 10.1378/chest.124.3.1103; Honma N, 2000, IMMUNOLOGY, V100, P84, DOI 10.1046/j.1365-2567.2000.00011.x; Joshi N, 1999, NEW ENGL J MED, V341, P1906, DOI 10.1056/NEJM199912163412507; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Koebernick H, 2002, P NATL ACAD SCI USA, V99, P13681, DOI 10.1073/pnas.212488699; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lehmann LE, 2001, INTENS CARE MED, V27, P1412, DOI 10.1007/s001340101022; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Metersky ML, 2004, AM J RESP CRIT CARE, V169, P342, DOI 10.1164/rccm.200309-1248OC; Meyer-Siegler KL, 2007, GENES IMMUN, V8, P646, DOI 10.1038/sj.gene.6364427; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Morand EF, 2002, RHEUMATOLOGY, V41, P558, DOI 10.1093/rheumatology/41.5.558; Pollak N, 2005, INFECT IMMUN, V73, P6488, DOI 10.1128/IAI.73.10.6488-6492.2005; Radstake TRDJ, 2005, ARTHRITIS RHEUM, V52, P3020, DOI 10.1002/art.21285; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Satoskar AR, 2001, INFECT IMMUN, V69, P906, DOI 10.1128/IAI.69.2.906-911.2001; Waterer GW, 2001, AM J RESP CRIT CARE, V163, P1599, DOI 10.1164/ajrccm.163.7.2011088; Zhong XB, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni123	41	72	75	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2403	2411		10.1096/fj.09-129445	http://dx.doi.org/10.1096/fj.09-129445			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19346297	Green Published			2022-12-25	WOS:000268836700009
J	Ono, RN; Sengle, G; Charbonneau, NL; Carlberg, V; Bachinger, HP; Sasaki, T; Lee-Arteaga, S; Zilberberg, L; Rifkin, DB; Ramirez, F; Chu, ML; Sakai, LY				Ono, Robert N.; Sengle, Gerhard; Charbonneau, Noe L.; Carlberg, Valerie; Bachinger, Hans Peter; Sasaki, Takako; Lee-Arteaga, Sui; Zilberberg, Lior; Rifkin, Daniel B.; Ramirez, Francesco; Chu, Mon-Li; Sakai, Lynn Y.			Latent Transforming Growth Factor beta-binding Proteins and Fibulins Compete for Fibrillin-1 and Exhibit Exquisite Specificities in Binding Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROFIBRIL-ASSOCIATED GLYCOPROTEIN-1; TGF-BETA; EXTRACELLULAR-MATRIX; IN-VIVO; DEVELOPMENTAL EXPRESSION; TISSUE LOCALIZATION; TERNARY COMPLEX; MARFAN-SYNDROME; INTERACTS; LTBP-1	Latent transforming growth factor (TGF) beta-binding proteins (LTBPs) interact with fibrillin-1. This interaction is important for proper sequestration and extracellular control of TGF beta. Surface plasmon resonance interaction studies show that residues within the first hybrid domain (Hyb1) of fibrillin-1 contribute to interactions with LTBP-1 and LTBP-4. Modulation of binding affinities by fibrillin-1 polypeptides in which residues in the third epidermal growth factor-like domain (EGF3) are mutated demonstrates that the binding sites for LTBP-1 and LTBP-4 are different and suggests that EGF3 may also contribute residues to the binding site for LTBP-4. In addition, fibulin-2, fibulin-4, and fibulin-5 bind to residues contained within EGF3/Hyb1, but mutated polypeptides again indicate differences in their binding sites in fibrillin-1. Results demonstrate that these protein-protein interactions exhibit "exquisite specificities," a phrase commonly used to describe monoclonal antibody interactions. Despite these differences, interactions between LTBP-1 and fibrillin-1 compete for interactions between fibrillin-1 and these fibulins. All of these proteins have been immunolocalized to microfibrils. However, in fibrillin-1 (Fbn1) null fibroblast cultures, LTBP-1 and LTBP-4 are not incorporated into microfibrils. In contrast, in fibulin-2 (Fbln2) null or fibulin-4 (Fbln4) null cultures, fibrillin-1, LTBP-1, and LTBP-4 are incorporated into microfibrils. These data show for the first time that fibrillin-1, but not fibulin-2 or fibulin-4, is required for appropriate matrix assembly of LTBPs. These studies also suggest that the fibulins may affect matrix sequestration of LTBPs, because in vitro interactions between these proteins are competitive.	[Sengle, Gerhard; Carlberg, Valerie; Bachinger, Hans Peter; Sasaki, Takako; Sakai, Lynn Y.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Ono, Robert N.; Charbonneau, Noe L.; Bachinger, Hans Peter; Sakai, Lynn Y.] Oregon Hlth & Sci Univ, Shriners Hosp Children, Portland, OR 97239 USA; [Lee-Arteaga, Sui; Ramirez, Francesco] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Zilberberg, Lior; Rifkin, Daniel B.] NYU, Langone Med Ctr, Dept Cell Biol, New York, NY 10016 USA; [Chu, Mon-Li] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA	Oregon Health & Science University; Oregon Health & Science University; Icahn School of Medicine at Mount Sinai; New York University; NYU Langone Medical Center; Jefferson University	Sakai, LY (corresponding author), 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	lys@shcc.org			National Institutes of Health [P01 AR049698]; Shriners Hospitals for Children; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR049698] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospitals for Children; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 AR049698 (to F. R., D. B. R., and L. Y. S.). This work was also supported a grant from the Shriners Hospitals for Children (to H. P. B. and L. Y. S.).	Arteaga-Solis E, 2001, J CELL BIOL, V154, P275, DOI 10.1083/jcb.200105046; Carta L, 2006, J BIOL CHEM, V281, P8016, DOI 10.1074/jbc.M511599200; Charbonneau NL, 2003, J BIOL CHEM, V278, P2740, DOI 10.1074/jbc.M209201200; Charbonneau Noe L, 2004, Birth Defects Res C Embryo Today, V72, P37, DOI 10.1002/bdrc.20000; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Comeglio P, 2002, BRIT J OPHTHALMOL, V86, P1359, DOI 10.1136/bjo.86.12.1359; CORSON GM, 1993, GENOMICS, V17, P476, DOI 10.1006/geno.1993.1350; Dallas SL, 2000, J BONE MINER RES, V15, P68, DOI 10.1359/jbmr.2000.15.1.68; DALLAS SL, 1995, J CELL BIOL, V131, P539, DOI 10.1083/jcb.131.2.539; El-Hallous E, 2007, J BIOL CHEM, V282, P8935, DOI 10.1074/jbc.M608204200; Fontana L, 2005, FASEB J, V19, P1798, DOI 10.1096/fj.05-4134com; GIBSON MA, 1986, J BIOL CHEM, V261, P1429; Giltay R, 1999, MATRIX BIOL, V18, P469, DOI 10.1016/S0945-053X(99)00038-4; Gregory KE, 2005, J BIOL CHEM, V280, P27970, DOI 10.1074/jbc.M504270200; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Hanssen E, 2004, J BIOL CHEM, V279, P29185, DOI 10.1074/jbc.M313672200; Hirai M, 2007, EMBO J, V26, P3283, DOI 10.1038/sj.emboj.7601768; Hirani R, 2007, MATRIX BIOL, V26, P213, DOI 10.1016/j.matbio.2006.12.006; Isogai Z, 2002, J BIOL CHEM, V277, P4565, DOI 10.1074/jbc.M110583200; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Keene DR, 1997, J HISTOCHEM CYTOCHEM, V45, P1069, DOI 10.1177/002215549704500805; Kobayashi N, 2007, J BIOL CHEM, V282, P11805, DOI 10.1074/jbc.M611029200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McLaughlin PJ, 2006, MOL CELL BIOL, V26, P1700, DOI 10.1128/MCB.26.5.1700-1709.2006; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Reinboth B, 2002, J BIOL CHEM, V277, P3950, DOI 10.1074/jbc.M109540200; Reinhardt DP, 1996, J BIOL CHEM, V271, P19489, DOI 10.1074/jbc.271.32.19489; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; SASAKI T, 1995, J MOL BIOL, V254, P892, DOI 10.1006/jmbi.1995.0664; SENGLE G, 2008, PRIMER METABOLIC BON, P27; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; Sicot FX, 2008, MOL CELL BIOL, V28, P1061, DOI 10.1128/MCB.01876-07; Taipale J, 1996, J HISTOCHEM CYTOCHEM, V44, P875, DOI 10.1177/44.8.8756760; Tiedemann K, 2005, J BIOL CHEM, V280, P11404, DOI 10.1074/jbc.M409882200; Trask BC, 2000, MOL BIOL CELL, V11, P1499, DOI 10.1091/mbc.11.5.1499; Unsold C, 2001, J CELL SCI, V114, P187; Weinbaum JS, 2008, J BIOL CHEM, V283, P25533, DOI 10.1074/jbc.M709962200; Wuttke M, 2001, J BIOL CHEM, V276, P36839, DOI 10.1074/jbc.M105689200; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; ZHANG H, 1995, J CELL BIOL, V129, P1165, DOI 10.1083/jcb.129.4.1165	42	125	127	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16872	16881		10.1074/jbc.M809348200	http://dx.doi.org/10.1074/jbc.M809348200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19349279	hybrid, Green Published			2022-12-25	WOS:000266962400023
J	Hatipoglu, OF; Hirohata, S; Cilek, MZ; Ogawa, H; Miyoshi, T; Obika, M; Demircan, K; Shinohata, R; Kusachi, S; Ninomiya, Y				Hatipoglu, Omer F.; Hirohata, Satoshi; Cilek, M. Zeynel; Ogawa, Hiroko; Miyoshi, Toru; Obika, Masanari; Demircan, Kadir; Shinohata, Ryoko; Kusachi, Shozo; Ninomiya, Yoshifumi			ADAMTS1 Is a Unique Hypoxic Early Response Gene Expressed by Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUMS-27 CHONDROSARCOMA CELLS; MYOCARDIAL-INFARCTION; INDUCIBLE FACTOR-1; HUMAN CHONDROCYTES; IN-VITRO; MATRIX; METALLOPROTEINASES; INTERLEUKIN-1-BETA; ACTIVATION; INDUCTION	ADAMTS1 (a disintegrin and metalloproteinase with thrombospondin motifs 1) is a member of the matrix metalloproteinase family. We have previously reported that ADAMTS1 was strongly expressed in myocardial infarction. In this study, we investigated whether hypoxia induced ADAMTS1 and investigated its regulatory mechanism. In hypoxia, the expression level of ADAMTS1 mRNA and protein rapidly increased in endothelial cells, but not in other cell types. Interestingly, the induction of ADAMTS1 by hypoxia was transient, whereas vascular endothelial growth factor induction by hypoxia in human umbilical vein endothelial cells (HUVEC) increased in a time-dependent manner. CoCl2, a transition metal that mimics hypoxia, induced ADAMTS1 in HUVEC. The phosphatidylinositol 3-kinase inhibitor LY294002 dose-dependently inhibited the increase of ADAMTS1 mRNA expression in hypoxia. We characterized the promoter region of ADAMTS1, and the secreted luciferase assay system demonstrated that hypoxia induced luciferase secretion in the culture medium 4.6-fold in HUVEC. In the promoter region of ADAMTS1, we found at least three putative hypoxia-inducible factor (HIF) binding sites, and the chromatin immunoprecipitation assay revealed HIF-1 binding to HIF binding sites in the promoter region of ADAMTS1 under hypoxia. Recombinant ADAMTS1 protein promoted the migration of HUVEC under hypoxic conditions. In summary, we found that ADAMTS1 is transiently induced by hypoxia in endothelial cells, and its transcription is mediated by HIF-1 binding. Our data indicate that ADAMTS1 is a novel acute hypoxia-inducible gene.	[Hatipoglu, Omer F.; Hirohata, Satoshi; Cilek, M. Zeynel; Ogawa, Hiroko; Miyoshi, Toru; Obika, Masanari; Demircan, Kadir; Ninomiya, Yoshifumi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Mol Biol & Biochem, Okayama 7008558, Japan; [Shinohata, Ryoko; Kusachi, Shozo] Okayama Univ, Dept Med Technol, Grad Sch Hlth Sci, Okayama 7008558, Japan	Okayama University; Okayama University	Hirohata, S (corresponding author), 2-5-1 Shikata Cho, Okayama 7008558, Japan.	hirohas@cc.okayama-u.ac.jp	Kusachi, Shozo/B-1779-2011; Cilek, Mehmet Zeynel/F-1143-2016; SHINOHATA, Ryoko/B-1793-2011; Hatipoglu, Omer Faruk/J-6706-2019	Cilek, Mehmet Zeynel/0000-0002-0808-2691; SHINOHATA, Ryoko/0000-0003-1144-083X; Hatipoglu, Omer Faruk/0000-0002-1012-001X	Japan Society for the Promotion of Science [19659142, 20390399]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a grant-in-aid for scientific research from the Japan Society for the Promotion of Science (Grants 19659142 and 20390399 (to S. H.)).	Bevitt DJ, 2003, BBA-GENE STRUCT EXPR, V1626, P83, DOI 10.1016/S0167-4781(03)00047-2; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Cross AK, 2006, BRAIN RES, V1088, P19, DOI 10.1016/j.brainres.2006.02.136; Demircan K, 2005, ARTHRITIS RHEUM-US, V52, P1451, DOI 10.1002/art.21010; Demircan K, 2009, HEAD NECK-J SCI SPEC, V31, P793, DOI 10.1002/hed.21045; Faller DV, 1999, CLIN EXP PHARMACOL P, V26, P74, DOI 10.1046/j.1440-1681.1999.02992.x; Fischer S, 2004, J CELL PHYSIOL, V198, P359, DOI 10.1002/jcp.10417; Flannery CR, 1999, MATRIX BIOL, V18, P225, DOI 10.1016/S0945-053X(99)00024-4; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Hatipoglu OF, 2009, ACTA MED OKAYAMA, V63, P79; Hirohata S, 2002, J BIOL CHEM, V277, P12182, DOI 10.1074/jbc.M109665200; Jonnsson-Rylander AC, 2005, ARTERIOSCL THROM VAS, V25, P180, DOI 10.1161/01.ATV.0000150045.27127.37; Kalinski T, 2007, HUM PATHOL, V38, P86, DOI 10.1016/j.humpath.2006.06.012; Kapitsinou PP, 2008, CELL DEATH DIFFER, V15, P650, DOI 10.1038/sj.cdd.4402313; Krampert M, 2005, J BIOL CHEM, V280, P23844, DOI 10.1074/jbc.M412212200; Kuno K, 1997, J BIOL CHEM, V272, P556, DOI 10.1074/jbc.272.1.556; Miyoshi T, 2006, FASEB J, V20, P1904, DOI 10.1096/fj.05-5565fje; Nakamura K, 2004, J BIOCHEM, V136, P439, DOI 10.1093/jb/mvh138; Ng YH, 2006, HUM REPROD, V21, P1990, DOI 10.1093/humrep/del108; Petersen EJ, 2008, ATHEROSCLEROSIS, V198, P301, DOI 10.1016/j.atherosclerosis.2007.10.015; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Russell DL, 2003, J BIOL CHEM, V278, P42330, DOI 10.1074/jbc.M300519200; Sabatine MS, 2008, ARTERIOSCL THROM VAS, V28, P562, DOI 10.1161/ATVBAHA.107.156653; Secchiero P, 2008, BLOOD, V111, P1287, DOI 10.1182/blood-2007-05-092031; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Sezaki S, 2005, EXP BIOL MED, V230, P621; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Toeda K, 2005, MOL CELL BIOCHEM, V280, P47, DOI 10.1007/s11010-005-8051-4; Torres-Collado AX, 2006, J BIOL CHEM, V281, P17827, DOI 10.1074/jbc.M513465200; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664; Vazquez F, 1999, J BIOL CHEM, V274, P23349, DOI 10.1074/jbc.274.33.23349; Wang G L, 1996, Curr Opin Hematol, V3, P156; Wiesener MS, 2003, ANN MED, V35, P183, DOI 10.1080/0785389031000458233; Yamawaki H, 2009, GLYCOBIOLOGY, V19, P83, DOI 10.1093/glycob/cwn109; Yaykasli KO, 2009, MOL CELL BIOCHEM, V323, P69, DOI 10.1007/s11010-008-9965-4	36	53	53	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16325	16333		10.1074/jbc.M109.001313	http://dx.doi.org/10.1074/jbc.M109.001313			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19349275	Green Published, hybrid			2022-12-25	WOS:000266730900030
J	Hu, XB; Kang, S; Chen, XY; Shoemaker, CB; Jin, MM				Hu, Xuebo; Kang, Sungkwon; Chen, Xiaoyue; Shoemaker, Charles B.; Jin, Moonsoo M.			Yeast Surface Two-hybrid for Quantitative in Vivo Detection of Protein-Protein Interactions via the Secretory Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN FLUORESCENT PROTEIN; SACCHAROMYCES-CEREVISIAE; LIVING CELLS; ANTIBODY; AFFINITY; DISPLAY; COMPLEMENTATION; EXPRESSION; EVOLUTION; SEQUENCES	A quantitative in vivo method for detecting protein-protein interactions will enhance our understanding of protein interaction networks and facilitate affinity maturation as well as designing new interaction pairs. We have developed a novel platform, dubbed "yeast surface two-hybrid (YS2H)," to enable a quantitative measurement of pairwise protein interactions via the secretory pathway by expressing one protein (bait) anchored to the cell wall and the other (prey) in soluble form. In YS2H, the prey is released either outside of the cells or remains on the cell surface by virtue of its binding to the bait. The strength of their interaction is measured by antibody binding to the epitope tag appended to the prey or direct readout of split green fluorescence protein (GFP) complementation. When two alpha-helices forming coiled coils were expressed as a pair of prey and bait, the amount of the prey in complex with the bait progressively decreased as the affinity changes from 100 pM to 10 mu M. With GFP complementation assay, we were able to discriminate a 6-log difference in binding affinities in the range of 100 pM to 100 mu M. The affinity estimated from the level of antibody binding to fusion tags was in good agreement with that measured in solution using a surface plasmon resonance technique. In contrast, the level of GFP complementation linearly increased with the on-rate of coiled coil interactions, likely because of the irreversible nature of GFP reconstitution. Furthermore, we demonstrate the use of YS2H in exploring the nature of antigen recognition by antibodies and activation allostery in integrins and in isolating heavy chain-only antibodies against botulinum neurotoxin.	[Hu, Xuebo; Kang, Sungkwon; Chen, Xiaoyue; Jin, Moonsoo M.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA; [Shoemaker, Charles B.] Tufts Cummings Sch Vet Med, Dept Biomed Sci, North Grafton, MA 01536 USA	Cornell University	Jin, MM (corresponding author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA.	mj227@cornell.edu	Jin, Moonsoo/D-6128-2011		National Institutes of Health [NO1-AI30050]; American Heart Association; Northeast Biodefense Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI030050] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Northeast Biodefense Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant NO1-AI30050 (to C. B. S.). This work was also supported by an American Heart Association Scientist Development grant (to M. M. J.) and a Northeast Biodefense Center grant (to M. M. J.).	Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Boder ET, 2005, BIOTECHNOL BIOENG, V92, P485, DOI 10.1002/bit.20616; Colby DW, 2004, METHOD ENZYMOL, V388, P348; De Crescenzo G, 2003, BIOCHEMISTRY-US, V42, P1754, DOI 10.1021/bi0268450; Dranginis AM, 2007, MICROBIOL MOL BIOL R, V71, P282, DOI 10.1128/MMBR.00037-06; EGELMITANI M, 1988, GENE, V73, P113, DOI 10.1016/0378-1119(88)90317-4; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Ghosh I, 2000, J AM CHEM SOC, V122, P5658, DOI 10.1021/ja994421w; Gietz RD, 2007, NAT PROTOC, V2, P38, DOI 10.1038/nprot.2007.15; Hagihara Y, 2002, P NATL ACAD SCI USA, V99, P6619, DOI 10.1073/pnas.102172099; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Huang LL, 2006, J LEUKOCYTE BIOL, V80, P905, DOI 10.1189/jlb.1105649; Jeong KJ, 2007, P NATL ACAD SCI USA, V104, P8247, DOI 10.1073/pnas.0702650104; Jin M, 2006, P NATL ACAD SCI USA, V103, P5758, DOI 10.1073/pnas.0601164103; Jin M, 2004, STRUCTURE, V12, P2137, DOI 10.1016/j.str.2004.10.005; JOHNSTON M, 1984, MOL CELL BIOL, V4, P1440, DOI 10.1128/MCB.4.8.1440; Krebber C, 1997, J MOL BIOL, V268, P607, DOI 10.1006/jmbi.1997.0981; Maass DR, 2007, J IMMUNOL METHODS, V324, P13, DOI 10.1016/j.jim.2007.04.008; Magliery TJ, 2005, J AM CHEM SOC, V127, P146, DOI 10.1021/ja046699g; Nyfeler B, 2005, P NATL ACAD SCI USA, V102, P6350, DOI 10.1073/pnas.0501976102; Remy Ingrid, 2004, Methods Mol Biol, V261, P411; SANCHEZMADRID F, 1982, P NATL ACAD SCI-BIOL, V79, P7489, DOI 10.1073/pnas.79.23.7489; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Shimaoka M, 2006, P NATL ACAD SCI USA, V103, P13991, DOI 10.1073/pnas.0605716103; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Stagljar I, 2002, TRENDS BIOCHEM SCI, V27, P559, DOI 10.1016/S0968-0004(02)02197-7; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; van den Beucken T, 2003, FEBS LETT, V546, P288, DOI 10.1016/S0014-5793(03)00602-1	31	22	23	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16369	16376		10.1074/jbc.M109.001743	http://dx.doi.org/10.1074/jbc.M109.001743			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19369257	hybrid, Green Published			2022-12-25	WOS:000266730900034
J	Liu, JX; Hu, B; Wang, Y; Gui, JF; Xiao, WH				Liu, Jing-Xia; Hu, Bo; Wang, Yang; Gui, Jian-Fang; Xiao, Wuhan			Zebrafish eaf1 and eaf2/u19 Mediate Effective Convergence and Extension Movements through the Maintenance of wnt11 and wnt5 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL MOVEMENTS; EMBRYONIC-DEVELOPMENT; AXIS FORMATION; FACTOR-2 EAF2; GASTRULATION; ELL; PROTEIN; ROLES; GENE; MLL	Studies have attributed several functions to the Eaf family, including tumor suppression and eye development. Given the potential association between cancer and development, we set forth to explore Eaf1 and Eaf2/U19 activity in vertebrate embryogenesis, using zebrafish. In situ hybridization revealed similar eaf1 and eaf2/u19 expression patterns. Morpholino-mediated knockdown of either eaf1 or eaf2/u19 expression produced similar morphological changes that could be reversed by ectopic expression of target or reciprocal-target mRNA. However, combination of Eaf1 and Eaf2/U19 (Eafs)-morpholinos increased the severity of defects, suggesting that Eaf1 and Eaf2/U19 only share some functional redundancy. The Eafs knockdown phenotype resembled that of embryos with defects in convergence and extension movements. Indeed, knockdown caused expression pattern changes for convergence and extension movement markers, whereas cell tracing experiments using kaeda mRNA showed a correlation between Eafs knockdown and cell migration defects. Cardiac and pancreatic differentiation markers revealed that Eafs knockdown also disrupted midline convergence of heart and pancreatic organ precursors. Noncanonical Wnt signaling plays a key role in both convergence and extension movements and midline convergence of organ precursors. We found that Eaf1 and Eaf2/U19 maintained expression levels of wnt11 and wnt5. Moreover, wnt11 or wnt5 mRNA partially rescued the convergence and extension movement defects occurring in eafs morphants. Wnt11 and Wnt5 converge on rhoA, so not surprisingly, rhoA mRNA more effectively rescued defects than either wnt11 or wnt5 mRNA alone. However, the ectopic expression of wnt11 and wnt5 did not affect eaf1 and eaf2/u19 expression. These data indicate that eaf1 and eaf2/u19 act upstream of noncanonical Wnt signaling to mediate convergence and extension movements.	[Liu, Jing-Xia; Hu, Bo; Xiao, Wuhan] Chinese Acad Sci, Key Lab Biodivers & Conservat Aquat Organisms, Wuhan 430072, Peoples R China; [Wang, Yang; Gui, Jian-Fang] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Fresh Water Ecol & Biotechnol, Wuhan 430072, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Xiao, WH (corresponding author), Chinese Acad Sci, Key Lab Biodivers & Conservat Aquat Organisms, Wuhan 430072, Peoples R China.	w-xiao@ihb.ac.cn	Xiao, Wuhan/GLU-7352-2022; hu, bo/ABC-3810-2021	hu, bo/0000-0001-5656-9632	National Natural Science Foundation of China (NSFC) [30700440, 20890113]; Chinese Academy of Sciences [KSCX2-YW-N-020];  [2004CB117404];  [2007CB815705];  [2006CB504100]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); ; ; 	Supported by National Natural Science Foundation of China (NSFC) (Youth Foundation) Grant 30700440 and Grant 20890113.; Supported by "973" Grants 2004CB117404, 2007CB815705, and 2006CB504100; NSFC Grant 30671037; and Chinese Academy of Sciences Grant KSCX2-YW-N-020. To whom correspondence should be addressed.	Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Correa RG, 2005, CURR BIOL, V15, P1291, DOI 10.1016/j.cub.2005.06.023; Hammond KL, 2003, DEVELOPMENT, V130, P1403, DOI 10.1242/dev.00360; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Jopling C, 2005, EMBO REP, V6, P426, DOI 10.1038/sj.embor.7400386; Jopling C, 2007, PLOS GENET, V3, P2468, DOI 10.1371/journal.pgen.0030225; Jopling C, 2007, MECH DEVELOP, V124, P129, DOI 10.1016/j.mod.2006.10.003; KELLER R, 1992, DEVELOPMENT, P81; Kilian B, 2003, MECH DEVELOP, V120, P467, DOI 10.1016/S0925-4773(03)00004-2; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kong SE, 2005, P NATL ACAD SCI USA, V102, P10094, DOI 10.1073/pnas.0503017102; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Lee H, 2002, DEV CELL, V2, P607, DOI 10.1016/S1534-5807(02)00166-1; Li M, 2003, DEV DYNAM, V228, P273, DOI 10.1002/dvdy.10367; Luo RT, 2001, MOL CELL BIOL, V21, P5678, DOI 10.1128/MCB.21.16.5678-5687.2001; Matsui T, 2005, GENE DEV, V19, P164, DOI 10.1101/gad.1253605; Maurus D, 2005, EMBO J, V24, P1181, DOI 10.1038/sj.emboj.7600603; Mitani K, 2000, BIOCHEM BIOPH RES CO, V279, P563, DOI 10.1006/bbrc.2000.3970; Miyasaka KY, 2007, P NATL ACAD SCI USA, V104, P11274, DOI 10.1073/pnas.0702000104; Myers DC, 2002, TRENDS GENET, V18, P447, DOI 10.1016/S0168-9525(02)02725-7; Ober EA, 2004, EMBO REP, V5, P78, DOI 10.1038/sj.embor.7400047; Reiter JF, 2001, DEVELOPMENT, V128, P125; Shilatifard A, 1996, SCIENCE, V271, P1873, DOI 10.1126/science.271.5257.1873; Simone F, 2003, BLOOD, V101, P2355, DOI 10.1182/blood-2002-06-1664; Simone F, 2001, BLOOD, V98, P201, DOI 10.1182/blood.V98.1.201; Stainier DYR, 2001, NAT REV GENET, V2, P39, DOI 10.1038/35047564; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; THIRMAN MJ, 1994, P NATL ACAD SCI USA, V91, P12110, DOI 10.1073/pnas.91.25.12110; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Wang Z, 1997, P NATL ACAD SCI USA, V94, P12999, DOI 10.1073/pnas.94.24.12999; Westerfield M, 1999, TRENDS GENET, V15, P248, DOI 10.1016/S0168-9525(99)01741-2; Westfall TA, 2003, J CELL BIOL, V162, P889, DOI 10.1083/jcb.200303107; Wunnenberg-Stapleton K, 1999, DEVELOPMENT, V126, P5339; Xiao W, 2008, ONCOGENE, V27, P1536, DOI 10.1038/sj.onc.1210786; Xiao WH, 2003, CANCER RES, V63, P4698; Xiao WH, 2009, CANCER RES, V69, P2599, DOI 10.1158/0008-5472.CAN-08-2595; Yamashita S, 2002, DEV CELL, V2, P363, DOI 10.1016/S1534-5807(02)00126-0; Yang ZG, 2001, DEV BIOL, V231, P138, DOI 10.1006/dbio.2000.0139; Zhu SZ, 2006, CELL SIGNAL, V18, P359, DOI 10.1016/j.cellsig.2005.05.019	41	38	40	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16679	16692		10.1074/jbc.M109.009654	http://dx.doi.org/10.1074/jbc.M109.009654			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19380582	hybrid, Green Published			2022-12-25	WOS:000266730900063
J	Prats, C; Helge, JW; Nordby, P; Qvortrup, K; Ploug, T; Dela, F; Wojtaszewski, JFP				Prats, Clara; Helge, Jorn W.; Nordby, Pernille; Qvortrup, Klaus; Ploug, Thorkil; Dela, Flemming; Wojtaszewski, Jorgen F. P.			Dual Regulation of Muscle Glycogen Synthase during Exercise by Activation and Compartmentalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT SKELETAL-MUSCLE; NUCLEAR-MAGNETIC-RESONANCE; POLYCYSTIC-OVARY-SYNDROME; CASEIN KINASE-II; PROTEIN-KINASE; SARCOPLASMIC-RETICULUM; INSULIN ACTIVATION; INCREASED RISK; PHOSPHORYLATION; GLUCOSE	Glycogen synthase (GS) is considered the rate-limiting enzyme in glycogenesis but still today there is a lack of understanding on its regulation. We have previously shown phosphorylation-dependent GS intracellular redistribution at the start of glycogen re-synthesis in rabbit skeletal muscle (Prats, C., Cadefau, J. A., Cusso, R., Qvortrup, K., Nielsen, J. N., Wojtaszewki, J. F., Wojtaszewki, J. F., Hardie, D. G., Stewart, G., Hansen, B. F., and Ploug, T. (2005) J. Biol. Chem. 280, 23165-23172). In the present study we investigate the regulation of human muscle GS activity by glycogen, exercise, and insulin. Using immunocytochemistry we investigate the existence and relevance of GS intracellular compartmentalization during exercise and during glycogen re-synthesis. The results show that GS intrinsic activity is strongly dependent on glycogen levels and that such regulation involves associated dephosphorylation at sites 2 + 2a, 3a, and 3a + 3b. Furthermore, we report the existence of several glycogen metabolism regulatory mechanisms based on GS intracellular compartmentalization. After exhausting exercise, epinephrine-induced protein kinase A activation leads to GS site 1b phosphorylation targeting the enzyme to intramyofibrillar glycogen particles, which are preferentially used during muscle contraction. On the other hand, when phosphorylated at sites 2 + 2a, GS is preferentially associated with subsarcolemmal and intermyofibrillar glycogen particles. Finally, we verify the existence in human vastus lateralis muscle of the previously reported mechanism of glycogen metabolism regulation in rabbit tibialis anterior muscle. After overnight low muscle glycogen level and/or in response to exhausting exercise-induced glycogenolysis, GS is associated with spherical structures at the I-band of sarcomeres.	[Prats, Clara; Helge, Jorn W.; Nordby, Pernille; Qvortrup, Klaus; Ploug, Thorkil; Dela, Flemming] Univ Copenhagen, Dept Biomed Sci, Ctr Healthy Ageing, Copenhagen Muscle Res Ctr, DK-2200 Copenhagen N, Denmark; [Wojtaszewski, Jorgen F. P.] Univ Copenhagen, Inst Exercise & Sport Sci, Mol Physiol Grp, DK-2200 Copenhagen N, Denmark	University of Copenhagen; University of Copenhagen	Prats, C (corresponding author), Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	cprats@mfi.ku.dk	Prats, Clara/F-5993-2014; Wojtaszewski, Jørgen FP/P-6583-2014; Dela, Flemming/B-3239-2008; Helge, Jørn Wulff/I-7096-2012; Dela, Flemming/AAU-1691-2021	Prats, Clara/0000-0001-6465-3068; Wojtaszewski, Jørgen FP/0000-0001-9785-6830; Dela, Flemming/0000-0001-9970-9535; Helge, Jørn Wulff/0000-0001-9724-5423; Dela, Flemming/0000-0001-9970-9535; Ploug, Thorkil/0000-0002-5375-6595; Qvortrup, Klaus/0000-0001-8811-0260; Nordby, Pernille/0000-0002-3934-6952; wojtaszewski, jorgen/0000-0001-8185-3408	Copenhagen Muscle Research Centre; Novo Nordisk Research Foundation; Danish Diabetes Association; Lundbeck Foundation; Velux Foundation; Foundation of 1870; Direktor Jacob and Olga Madsens Foundation; Aase and Ejnar Danielsens foundation; European Commission [LSHM-CT-2004-005272]; Danish Medical Research Council	Copenhagen Muscle Research Centre; Novo Nordisk Research Foundation(Novo Nordisk Foundation); Danish Diabetes Association; Lundbeck Foundation(Lundbeckfonden); Velux Foundation(Velux Fonden); Foundation of 1870; Direktor Jacob and Olga Madsens Foundation; Aase and Ejnar Danielsens foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by The Copenhagen Muscle Research Centre, the Novo Nordisk Research Foundation, The Danish Diabetes Association, the Lundbeck Foundation, the Velux Foundation, the Foundation of 1870, Direktor Jacob and Olga Madsens Foundation, Aase and Ejnar Danielsens foundation, and an Integrated Project (Grant LSHM-CT-2004-005272) funded by the European Commission and The Danish Medical Research Council.	ANDERSEN P, 1985, J APPL PHYSIOL, V59, P1647, DOI 10.1152/jappl.1985.59.5.1647; Aschenbach WG, 2001, J BIOL CHEM, V276, P39959, DOI 10.1074/jbc.M105518200; BERGSTROM J, 1962, SCAND J CLIN LAB INV, V14, P1; BOGARDUS C, 1984, J CLIN INVEST, V73, P1185, DOI 10.1172/JCI111304; CARLING D, 1989, BIOCHIM BIOPHYS ACTA, V1012, P81, DOI 10.1016/0167-4889(89)90014-1; Cohen P, 1997, FEBS LETT, V410, P3, DOI 10.1016/S0014-5793(97)00490-0; DAMSBO P, 1991, DIABETOLOGIA, V34, P239, DOI 10.1007/BF00405082; DANFORTH WH, 1965, J BIOL CHEM, V240, P588; DAWSON DJ, 1969, AUST J BIOL SCI, V22, P247, DOI 10.1071/BI9690247; DEPAOLIROACH AA, 1983, J BIOL CHEM, V258, P702; ERIKSSON J, 1989, NEW ENGL J MED, V321, P337, DOI 10.1056/NEJM198908103210601; FernandezNovell JM, 1997, BIOCHEM J, V321, P227, DOI 10.1042/bj3210227; Ferrer JC, 1997, FEBS LETT, V415, P249, DOI 10.1016/S0014-5793(97)01136-8; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; FLOTOW H, 1989, J BIOL CHEM, V264, P9126; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; FRIDEN J, 1989, ACTA PHYSIOL SCAND, V135, P381, DOI 10.1111/j.1748-1716.1989.tb08591.x; Glintborg D, 2008, J CLIN ENDOCR METAB, V93, P3618, DOI 10.1210/jc.2008-0760; GOLDSTEIN MA, 1985, J MUSCLE RES CELL M, V6, P177, DOI 10.1007/BF00713059; Hojlund K, 2003, DIABETES, V52, P1393, DOI 10.2337/diabetes.52.6.1393; Hojlund K, 2008, DIABETES, V57, P357, DOI 10.2337/db07-0706; Hojlund K, 2006, CURR DIABETES REV, V2, P375, DOI 10.2174/1573399810602040375; HUANG TS, 1977, BIOCHEM BIOPH RES CO, V75, P643, DOI 10.1016/0006-291X(77)91521-2; Jorgensen SB, 2004, DIABETES, V53, P3074, DOI 10.2337/diabetes.53.12.3074; Lai YC, 2007, AM J PHYSIOL-ENDOC M, V293, pE1622, DOI 10.1152/ajpendo.00113.2007; Marchand I, 2002, J APPL PHYSIOL, V93, P1598, DOI 10.1152/japplphysiol.00585.2001; McBride A, 2009, CELL METAB, V9, P23, DOI 10.1016/j.cmet.2008.11.008; MEYER F, 1970, J BIOL CHEM, V245, P6642; Nielsen JN, 2001, J PHYSIOL-LONDON, V531, P757, DOI 10.1111/j.1469-7793.2001.0757h.x; Parker GJ, 2003, J BIOL CHEM, V278, P10022, DOI 10.1074/jbc.M207787200; PICTON C, 1982, FEBS LETT, V150, P191, DOI 10.1016/0014-5793(82)81332-X; Ploug T, 1998, J CELL BIOL, V142, P1429, DOI 10.1083/jcb.142.6.1429; Prats C, 2005, J BIOL CHEM, V280, P23165, DOI 10.1074/jbc.M502713200; Prats C, 2002, BBA-GEN SUBJECTS, V1573, P68, DOI 10.1016/S0304-4165(02)00332-X; Roach Peter J., 1998, Journal of Basic and Clinical Physiology and Pharmacology, V9, P139; ROACH PJ, 1978, J CYCLIC NUCL PROT, V4, P245; ROACH PJ, 1990, FASEB J, V4, P2961, DOI 10.1096/fasebj.4.12.2168324; ROACH PJ, 1991, J BIOL CHEM, V266, P14139; Roden M, 2001, RECENT PROG HORM RES, V56, P219, DOI 10.1210/rp.56.1.219; Rybicka KK, 1996, TISSUE CELL, V28, P253, DOI 10.1016/S0040-8166(96)80013-9; SCHALINJANTTI C, 1992, DIABETES, V41, P598, DOI 10.2337/diabetes.41.5.598; SHULMAN GI, 1990, NEW ENGL J MED, V322, P223, DOI 10.1056/NEJM199001253220403; SJOSTROM M, 1982, HISTOCHEMISTRY, V76, P425, DOI 10.1007/BF00489899; SKURAT AV, 1994, J BIOL CHEM, V269, P25534; STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0; VAAG A, 1992, J CLIN INVEST, V89, P782, DOI 10.1172/JCI115656; VILLARPALASI C, 1991, BIOCHIM BIOPHYS ACTA, V1095, P261, DOI 10.1016/0167-4889(91)90109-B; VILLARPALASI C, 1995, BBA-GEN SUBJECTS, V1244, P203, DOI 10.1016/0304-4165(95)00006-W; WANSON JC, 1968, J CELL BIOL, V38, P130, DOI 10.1083/jcb.38.1.130; WANSON JC, 1972, J CELL BIOL, V54, P206, DOI 10.1083/jcb.54.2.206; Wojtaszewski JFP, 2002, DIABETES, V51, P284, DOI 10.2337/diabetes.51.2.284	51	63	66	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15692	15700		10.1074/jbc.M900845200	http://dx.doi.org/10.1074/jbc.M900845200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19339242	hybrid, Green Published			2022-12-25	WOS:000266501000038
J	Chin, M; Herscovitch, M; Zhang, N; Waxman, DJ; Gilmore, TD				Chin, M.; Herscovitch, M.; Zhang, N.; Waxman, D. J.; Gilmore, T. D.			Overexpression of an activated REL mutant enhances the transformed state of the human B-lymphoma BJAB cell line and alters its gene expression profile	ONCOGENE			English	Article						c-rel; NF-kappa B; malignant transformation; BJAB; lymphoma; microarray	NF-KAPPA-B; EPSTEIN-BARR-VIRUS; TRANSCRIPTION FACTOR REL; TRANSACTIVATION DOMAIN; MOUSE; INDUCTION; CD40; IKK; CHEMOTHERAPY; RESISTANCE	The human REL proto-oncogene encodes a transcription factor in the nuclear factor (NF)-kappa B family. Overexpression of REL is acutely transforming in chicken lymphoid cells, but has not been shown to transform any mammalian lymphoid cell type. In this report, we show that overexpression of a highly transforming mutant of REL (REL Delta TAD1) increases the oncogenic properties of the human B-cell lymphoma BJAB cell line, as shown by increased colony formation in soft agar, tumor formation in SCID (severe combined immunodeficient) mice, and adhesion. BJAB-RELDTAD1 cells also show decreased activation of caspase in response to doxorubicin. BJAB-REL Delta TAD1 cells have increased levels of active nuclear REL protein as determined by immunofluorescence, subcellular fractionation and electrophoretic mobility shift assay. Overexpression of RELDTAD1 in BJAB cells has transformed the gene expression pro. le of BJAB cells from that of a germinal center B-cell subtype of diffuse large B-cell lymphoma (DLBCL) (GCB-DLBCL) to that of an activated B-cell subtype (ABC-DLBCL), as evidenced by increased expression of many ABC-defining mRNAs. Upregulated genes in BJAB-RELDTAD1 cells include several NF-kappa B targets that encode proteins previously implicated in B-cell development or oncogenesis, including BCL2, IRF4, CD40 and VCAM1. The cell system we describe here may be valuable for further characterizing the molecular details of REL-induced lymphoma in humans. Oncogene (2009) 28, 2100-2111; doi:10.1038/onc.2009.74; published online 20 April 2009	[Chin, M.; Herscovitch, M.; Zhang, N.; Waxman, D. J.; Gilmore, T. D.] Boston Univ, Dept Biol, Boston, MA 02215 USA	Boston University	Gilmore, TD (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	gilmore@bu.edu		Waxman, David/0000-0001-7982-9206	Saarland Ministry of Education, Culture and Science; NATIONAL CANCER INSTITUTE [R29CA047763, R01CA047763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007381] Funding Source: NIH RePORTER	Saarland Ministry of Education, Culture and Science; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Anna-Maria Bohrer for technical assistance and Martina Sester for support in flow cytometry experiments. This work was supported by a grant of the Saarland Ministry of Education, Culture and Science to HU-S.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Barth TFE, 2003, BLOOD, V101, P3681, DOI 10.1182/blood-2002-08-2577; Clodfelter KH, 2007, PHYSIOL GENOMICS, V31, P63, DOI 10.1152/physiolgenomics.00055.2007; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Dierlamm J, 2008, HAEMATOLOGICA, V93, P688, DOI 10.3324/haematol.12057; Enberg I, 1983, INT J CANCER, V31, P163; Feuerhake F, 2005, BLOOD, V106, P1392, DOI 10.1182/blood-2004-12-4901; FINKE J, 1992, BLOOD, V80, P459; Gapuzan MER, 2002, ONCOGENE, V21, P2484, DOI 10.1038/sj.onc.1205333; Gilmore TD, 1999, ONCOGENE, V18, P6925, DOI 10.1038/sj.onc.1203222; Gilmore TD, 2004, ONCOGENE, V23, P2275, DOI 10.1038/sj.onc.1207410; Gilmore TD, 2003, VIROLOGY, V316, P9, DOI 10.1016/S0042-6822(03)00562-2; Gupta N, 2008, CANCER RES, V68, P808, DOI 10.1158/0008-5472.CAN-07-3169; HAMMARSKJOLD ML, 1992, J VIROL, V66, P6496; HENDERSON S, 1991, CELL, V65, P1107, DOI 10.1016/0092-8674(91)90007-L; Ho L, 2005, BLOOD, V105, P2891, DOI 10.1182/blood-2004-06-2297; Holloway MG, 2008, MOL ENDOCRINOL, V22, P1274, DOI 10.1210/me.2007-0564; Houldsworth J, 2004, BLOOD, V103, P1862, DOI 10.1182/blood-2003-04-1359; Hrdlickova R, 2001, MOL CELL BIOL, V21, P6369; Iqbal J, 2006, J CLIN ONCOL, V24, P961, DOI 10.1200/JCO.2005.03.4264; Kalaitzidis D, 2002, ONCOGENE, V21, P8759, DOI 10.1038/sj.onc.1206033; Kalaitzidis D, 2002, GENE CHROMOSOME CANC, V34, P129, DOI 10.1002/gcc.10051; Lam LT, 2008, P NATL ACAD SCI USA, V105, P20798, DOI 10.1073/pnas.0806491106; Lee HH, 1999, P NATL ACAD SCI USA, V96, P1421, DOI 10.1073/pnas.96.4.1421; Leeman JR, 2008, ONCOGENE, V27, P6770, DOI 10.1038/onc.2008.284; Liang MC, 2003, MOL PHARMACOL, V64, P123, DOI 10.1124/mol.64.1.123; Lucas PC, 2007, ONCOGENE, V26, P5643, DOI 10.1038/sj.onc.1210342; Mainou BA, 2006, J VIROL, V80, P6458, DOI 10.1128/JVI.00135-06; Martin AG, 2001, J BIOL CHEM, V276, P15840, DOI 10.1074/jbc.M011313200; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; PEREZ JR, 1994, MOL CELL BIOL, V14, P5326, DOI 10.1128/MCB.14.8.5326; Rhodes DR, 2005, NAT GENET, V37, P579, DOI 10.1038/ng1578; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Shaffer AL, 2002, NAT REV IMMUNOL, V2, P920, DOI 10.1038/nri953; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Snow AL, 2006, J IMMUNOL, V177, P3283, DOI 10.4049/jimmunol.177.5.3283; Starczynowski DT, 2007, ONCOGENE, V26, P2685, DOI 10.1038/sj.onc.1210089; Starczynowski DT, 2005, ONCOGENE, V24, P7355, DOI 10.1038/sj.onc.1208902; Starczynowski DT, 2003, ONCOGENE, V22, P6928, DOI 10.1038/sj.onc.1206801; Stoffel A, 2004, P NATL ACAD SCI USA, V101, P9079, DOI 10.1073/pnas.0402415101; van Imhoff GW, 2006, J CLIN ONCOL, V24, P4135, DOI 10.1200/JCO.2006.05.5897; VONDERHEIDE RH, 1992, J EXP MED, V175, P1433, DOI 10.1084/jem.175.6.1433; Voorzanger-Rousselot N, 1998, BLOOD, V92, P3381, DOI 10.1182/blood.V92.9.3381.421k02_3381_3387; WENNBORG A, 1987, INT J CANCER, V40, P202, DOI 10.1002/ijc.2910400213; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100; Yamamoto N, 2000, FEBS LETT, V484, P153, DOI 10.1016/S0014-5793(00)02145-1; Zarnegar B, 2004, P NATL ACAD SCI USA, V101, P8108, DOI 10.1073/pnas.0402629101	49	24	24	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 21	2009	28	20					2100	2111		10.1038/onc.2009.74	http://dx.doi.org/10.1038/onc.2009.74			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	448BI	19377508	Green Accepted			2022-12-25	WOS:000266235800004
J	Laitem, C; Leprivier, G; Choul-Li, S; Begue, A; Monte, D; Larsimont, D; Dumont, P; Duterque-Coquillaud, M; Aumercier, M				Laitem, C.; Leprivier, G.; Choul-Li, S.; Begue, A.; Monte, D.; Larsimont, D.; Dumont, P.; Duterque-Coquillaud, M.; Aumercier, M.			Ets-1 p27: a novel Ets-1 isoform with dominant-negative effects on the transcriptional properties and the subcellular localization of Ets-1 p51	ONCOGENE			English	Article						Ets-1; transcriptional regulation; subcellular localization; dominant-negative isoform; alternative splicing	ALTERNATIVELY SPLICED ISOFORMS; MESSENGER-RNA; DNA-BINDING; STROMELYSIN PROMOTER; ENDOTHELIAL-CELLS; EXPRESSION; PROTEIN; GENE; PROTOONCOGENE; CARCINOMA	The transcription factor Ets-1 is implicated in various physiological processes and invasive pathologies. We identified a novel variant of ets-1, ets-1 Delta(III-VI), resulting from the alternative splicing of exons III to VI. This variant encodes a 27 kDa isoform, named Ets-1 p27. Ets-1 p27 lacks the threonine-38 residue, the Pointed domain and the transactivation domain, all of which are required for the transactivation of Ets-1 target genes. Both inhibitory domains surrounding the DNA-binding domain are conserved, suggesting that Ets-1 p27, like the full-length Ets-1 p51 isoform, is autoinhibited for DNA binding. We showed that Ets-1 p27 binds DNA in the same way as Ets-1 p51 does and that it acts both at a transcriptional and a subcellular localization level, thereby constituting a dual-acting dominant negative of Ets-1 p51. Ets-1 p27 blocks Ets-1 p51-mediated transactivation of target genes and induces the translocation of Ets-1 p51 from the nucleus to the cytoplasm. Furthermore, Ets-1 p27 overexpression represses the tumor properties of MDA-MB-231 mammary carcinoma cells in correlation with the known implication of Ets-1 in various cellular mechanisms. Thus the dual-acting dominant-negative function of Ets-1 p27 gives to the Ets-1 p27/Ets-1 p51 ratio a determining effect on cell fate. Oncogene (2009) 28, 2087-2099; doi:10.1038/onc.2009.72; published online 20 April 2009	[Laitem, C.; Leprivier, G.; Choul-Li, S.; Begue, A.; Monte, D.; Dumont, P.; Duterque-Coquillaud, M.; Aumercier, M.] Univ Lille 1, Inst Pasteur Lille, Inst Biol Lille, CNRS,UMR 8161, F-59021 Lille, France; [Laitem, C.; Leprivier, G.; Choul-Li, S.; Begue, A.; Monte, D.; Dumont, P.; Duterque-Coquillaud, M.; Aumercier, M.] Univ Lille 2, IFR 142, Lille, France; [Larsimont, D.] Inst Jules Bordet, Dept Pathol, B-1000 Brussels, Belgium	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Institut Jules Bordet; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Aumercier, M (corresponding author), Univ Lille 1, Inst Pasteur Lille, Inst Biol Lille, CNRS,UMR 8161, 1 Rue Prof Calmette,BP 447, F-59021 Lille, France.	marc.aumercier@ibl.fr	CHOUL-LI, Souhaila/ABA-2431-2020	CHOUL-LI, Souhaila/0000-0003-0682-4214; Duterque-Coquillaud, Martine/0000-0003-3943-5629; monte, didier/0000-0002-0613-6203	Centre National de la Recherche Scientifique (CNRS); la Ligue contre le Cancer- Comite du Pas-de-Calais; Fondation pour la Recherche Medicale-Comite Nord-Pas-de-Calais (FRM)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); la Ligue contre le Cancer- Comite du Pas-de-Calais; Fondation pour la Recherche Medicale-Comite Nord-Pas-de-Calais (FRM)(Fondation pour la Recherche Medicale)	We thank Isabelle Roland, Anne-Claire Flourens, Nathalie Tomavo and Arnaud Legrand for technical assistance, and Dr Yvan de Launoit for stimulating discussions. We thank the Microscopy Facility of the Institut Pasteur de Lille Campus. This work was supported by the Centre National de la Recherche Scientifique (CNRS) and by grants from la Ligue contre le Cancer- Comite du Pas-de-Calais and from the Fondation pour la Recherche Medicale-Comite Nord-Pas-de-Calais (FRM). The Ministere de la Recherche et de l'Enseignement Superieur provided a student fellowship to Clelia Laitem. La Ligue contre le Cancer provided a student fellowship to Gabriel Leprivier. The CNRS and the Conseil Regional du Nord-Pas-de-Calais provided a PhD fellowship (BDI) to Souhaila Choul-li.	Alipov G, 2005, HISTOPATHOLOGY, V46, P202, DOI 10.1111/j.1365-2559.2005.02059.x; Araud T, 2007, NUCLEIC ACIDS RES, V35, P4649, DOI 10.1093/nar/gkm482; Baillat D, 2006, ONCOGENE, V25, P5764, DOI 10.1038/sj.onc.1209583; Baillat D, 2002, J BIOL CHEM, V277, P29386, DOI 10.1074/jbc.M200088200; Baillat D, 2009, BIOCHEM BIOPH RES CO, V378, P213, DOI 10.1016/j.bbrc.2008.11.035; BUTTICE G, 1993, J BIOL CHEM, V268, P7196; Cho JY, 2004, J BIOL CHEM, V279, P19512, DOI 10.1074/jbc.M309074200; Coutte L, 1999, ONCOGENE, V18, P6278, DOI 10.1038/sj.onc.1203020; Cowley DO, 2000, GENE DEV, V14, P366; De Haro L, 2005, GENOMICS, V85, P493, DOI 10.1016/j.ygeno.2004.12.003; de Nigris F, 2001, CANCER RES, V61, P2267; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; FISHER RJ, 1994, PROTEIN SCI, V3, P257; Foulds CE, 2004, MOL CELL BIOL, V24, P10954, DOI 10.1128/MCB.24.24.10954-10964.2004; Hewett PW, 2001, INT J BIOCHEM CELL B, V33, P347, DOI 10.1016/S1357-2725(01)00022-X; HIGASHINO F, 1995, ONCOGENE, V10, P1461; Higuchi T, 2007, MOL CELL BIOL, V27, P3353, DOI 10.1128/MCB.01871-06; Jayaraman G, 1999, J BIOL CHEM, V274, P17342, DOI 10.1074/jbc.274.24.17342; John SA, 2008, J BIOL CHEM, V283, P951, DOI 10.1074/jbc.M705262200; JORCYK CL, 1991, ONCOGENE, V6, P523; Katayama S, 2005, HISTOL HISTOPATHOL, V20, P119, DOI 10.14670/HH-20.119; Kherrouche Z, 2006, BIOCHEM J, V396, P547, DOI 10.1042/BJ20051981; Kita D, 2001, CANCER RES, V61, P7985; Kitange G, 1999, MODERN PATHOL, V12, P618; KOIZUMI S, 1990, ONCOGENE, V5, P675; Laitem C, 2008, PROTEIN EXPRES PURIF, V62, P53, DOI 10.1016/j.pep.2008.06.010; Lee GM, 2005, J BIOL CHEM, V280, P7088, DOI 10.1074/jbc.M410722200; Lei WL, 2007, AM J PHYSIOL-LUNG C, V293, pL1359, DOI 10.1152/ajplung.00130.2007; Li B, 2007, FRONT BIOSCI-LANDMRK, V12, P2269, DOI 10.2741/2229; Li RH, 1999, P NATL ACAD SCI USA, V96, P3876, DOI 10.1073/pnas.96.7.3876; Lulli V, 2006, CELL DEATH DIFFER, V13, P1064, DOI 10.1038/sj.cdd.4401811; Maroulakou IG, 2000, ONCOGENE, V19, P6432, DOI 10.1038/sj.onc.1204039; Mylona EE, 2006, CANCER DETECT PREV, V30, P111, DOI 10.1016/j.cdp.2006.03.006; Nakayama T, 2001, MODERN PATHOL, V14, P415, DOI 10.1038/modpathol.3880328; O'Leary DA, 2005, GENE, V344, P79, DOI 10.1016/j.gene.2004.09.031; POGNONEC P, 1990, ONCOGENE, V5, P603; Pufall MA, 2002, ANNU REV CELL DEV BI, V18, P421, DOI 10.1146/annurev.cellbio.18.031502.133614; Raffetseder U, 2004, KIDNEY INT, V66, P622, DOI 10.1111/j.1523-1755.2004.00782.x; RayGallet D, 1996, BIOCHEM BIOPH RES CO, V223, P257, DOI 10.1006/bbrc.1996.0881; Redlich K, 2001, ARTHRITIS RHEUM, V44, P266, DOI 10.1002/1529-0131(200102)44:2<266::AID-ANR43>3.3.CO;2-7; ROWE A, 1992, EXP CELL RES, V202, P199, DOI 10.1016/0014-4827(92)90420-D; Sarrazin S, 2000, MOL CELL BIOL, V20, P2959, DOI 10.1128/MCB.20.9.2959-2969.2000; Sasaki A, 2004, BIOCHEM BIOPH RES CO, V317, P1128, DOI 10.1016/j.bbrc.2004.03.172; Seidel JJ, 2002, GENE DEV, V16, P127, DOI 10.1101/gad.950902; Shin C, 2004, NAT REV MOL CELL BIO, V5, P727, DOI 10.1038/nrm1467; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Takai N, 2000, CANCER, V89, P2059, DOI 10.1002/1097-0142(20001115)89:10<2059::AID-CNCR5>3.0.CO;2-3; Takai N, 2006, GYNECOL OBSTET INVES, V61, P15, DOI 10.1159/000087855; Takai N, 2002, INT J MOL MED, V9, P287; Taniguchi H, 2007, INT J CANCER, V121, P1609, DOI 10.1002/ijc.22870; Teruyama K, 2001, J CELL PHYSIOL, V188, P243, DOI 10.1002/jcp.1112; Valter MM, 1999, CANCER RES, V59, P5608; WASYLYK C, 1991, EMBO J, V10, P1127, DOI 10.1002/j.1460-2075.1991.tb08053.x	54	31	33	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 21	2009	28	20					2087	2099		10.1038/onc.2009.72	http://dx.doi.org/10.1038/onc.2009.72			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	448BI	19377509				2022-12-25	WOS:000266235800003
J	Uhlmann-Schiffler, H; Kiermayer, S; Stahl, H				Uhlmann-Schiffler, H.; Kiermayer, S.; Stahl, H.			The DEAD box protein Ddx42p modulates the function of ASPP2, a stimulator of apoptosis	ONCOGENE			English	Article						apoptosis; ASPP2; Ddx42p; p53; ubiquitination	MESSENGER-RNA; KAPPA-B; TUMOR-SUPPRESSOR; P53; HELICASE; 53BP2; EXPRESSION; P68; PROLIFERATION; INHIBITION	Ddx42p is a recently characterized mammalian DEAD box protein with unknown cellular function. We found that in human cells Ddx42p physically interacts with ASPP2, a major apoptosis inducer known to enhance p53 transactivation of proapoptotic genes. The proteins interact via a domain within the carboxy-terminal part of Ddx42p and a mid-amino-terminal sequence as well as the ankyrin-SH3 region of ASPP2. Overexpression of Ddx42p interferes with apoptosis induction by ASPP2, whereas Ddx42p knockdown reduces the survival rate of cultured human cells. In addition, ASPP2 is found in cytoplasm and nucleus at low Ddx42p level, and predominantly in cytoplasm at high concentration of Ddx42p, respectively. Our results show that Ddx42p is capable of modulating ASPP2 function. Oncogene (2009) 28, 2065-2073; doi:10.1038/onc.2009.75; published online 20 April 2009	[Uhlmann-Schiffler, H.; Kiermayer, S.; Stahl, H.] Univ Saarland, Dept Med Biochem & Mol Biol, D-6642 Homburg, Germany	Saarland University	Uhlmann-Schiffler, H (corresponding author), Univ Saarland, Dept Med Biochem & Mol Biol, Kirrberger St Geb 45, D-6642 Homburg, Germany.	heike.uhlmann.schiffler@uniklinikum-saarland.de			Saarland Ministry of Education, Culture and Science	Saarland Ministry of Education, Culture and Science	We thank Anna-Maria Bohrer for technical assistance and Martina Sester for support in flow cytometry experiments. This work was supported by a grant of the Saarland Ministry of Education, Culture and Science to HU-S.	Bagnasco L, 2007, FASEB J, V21, P1256, DOI 10.1096/fj.06-7082com; Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; Bergamaschi D, 2004, MOL CELL BIOL, V24, P1341, DOI 10.1128/MCB.24.3.1341-1350.2004; Chao CH, 2006, CANCER RES, V66, P6579, DOI 10.1158/0008-5472.CAN-05-2415; Chen YZ, 2003, J NEUROCHEM, V85, P801, DOI 10.1046/j.1471-4159.2003.01727.x; EARNSHAW WC, 1995, CURR OPIN CELL BIOL, V7, P337, DOI 10.1016/0955-0674(95)80088-3; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; Goh PY, 2004, J VIROL, V78, P5288, DOI 10.1128/JVI.78.10.5288-5298.2004; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Gutti RK, 2008, J BIOL CHEM, V283, P17055, DOI 10.1074/jbc.M708449200; Hock J, 2007, EMBO REP, V8, P1052, DOI 10.1038/sj.embor.7401088; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Jalal C, 2007, NUCLEIC ACIDS RES, V35, P3590, DOI 10.1093/nar/gkm058; Katz C, 2008, P NATL ACAD SCI USA, V105, P12277, DOI 10.1073/pnas.0711269105; Kobayashi S, 2005, GENES CELLS, V10, P253, DOI 10.1111/j.1365-2443.2005.00835.x; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lin CW, 2008, VIRUS RES, V137, P49, DOI 10.1016/j.virusres.2008.05.015; Lin F, 2008, CANCER BIOL THER, V7, P1669, DOI 10.4161/cbt.7.10.6660; Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468; Liu ZJ, 2005, FEBS LETT, V579, P1587, DOI 10.1016/j.febslet.2005.01.069; Lopez CD, 2000, MOL CELL BIOL, V20, P8018, DOI 10.1128/MCB.20.21.8018-8025.2000; Naumovski L, 1996, MOL CELL BIOL, V16, P3884; Rotem S, 2008, J BIOL CHEM, V283, P18990, DOI 10.1074/jbc.M708717200; Sachdev S, 1998, MOL CELL BIOL, V18, P2524, DOI 10.1128/MCB.18.5.2524; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Stanelle J, 2002, NUCLEIC ACIDS RES, V30, P1859, DOI 10.1093/nar/30.8.1859; Takahashi N, 2005, GENES CELLS, V10, P803, DOI 10.1111/j.1365-2443.2005.00878.x; Tidow H, 2007, J MOL BIOL, V371, P948, DOI 10.1016/j.jmb.2007.05.024; Trigiante G, 2006, NAT REV CANCER, V6, P217, DOI 10.1038/nrc1818; Uhlmann-Schiffler H, 2006, NUCLEIC ACIDS RES, V34, P10, DOI 10.1093/nar/gkj403; Uhlmann-Schiffler H, 2002, J BIOL CHEM, V277, P1066, DOI 10.1074/jbc.M107535200; Vives V, 2006, GENE DEV, V20, P1262, DOI 10.1101/gad.374006; Will CL, 2002, EMBO J, V21, P4978, DOI 10.1093/emboj/cdf480; Yang JP, 1999, ONCOGENE, V18, P5177, DOI 10.1038/sj.onc.1202904; Zhu ZY, 2005, J BIOL CHEM, V280, P34473, DOI 10.1074/jbc.M503736200	35	21	21	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 21	2009	28	20					2065	2073		10.1038/onc.2009.75	http://dx.doi.org/10.1038/onc.2009.75			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	448BI	19377511				2022-12-25	WOS:000266235800001
J	Chatterjee, S; Szustakowski, JD; Nanguneri, NR; Mickanin, C; Labow, MA; Nohturfft, A; Dev, KK; Sivasankaran, R				Chatterjee, Sandipan; Szustakowski, Joseph D.; Nanguneri, Nirmala R.; Mickanin, Craig; Labow, Mark A.; Nohturfft, Axel; Dev, Kumlesh K.; Sivasankaran, Rajeev			Identification of Novel Genes and Pathways Regulating SREBP Transcriptional Activity	PLOS ONE			English	Article								Background: Lipid metabolism in mammals is orchestrated by a family of transcription factors called sterol regulatory element-binding proteins (SREBPs) that control the expression of genes required for the uptake and synthesis of cholesterol, fatty acids, and triglycerides. SREBPs are thus essential for insulin-induced lipogenesis and for cellular membrane homeostasis and biogenesis. Although multiple players have been identified that control the expression and activation of SREBPs, gaps remain in our understanding of how SREBPs are coordinated with other physiological pathways. Methodology: To identify novel regulators of SREBPs, we performed a genome-wide cDNA over-expression screen to identify proteins that might modulate the transcription of a luciferase gene driven from an SREBP-specific promoter. The results were verified through secondary biological assays and expression data were analyzed by a novel application of the Gene Set Enrichment Analysis (GSEA) method. Conclusions/Significance: We screened 10,000 different cDNAs and identified a number of genes and pathways that have previously not been implicated in SREBP control and cellular cholesterol homeostasis. These findings further our understanding of lipid biology and should lead to new insights into lipid associated disorders.			Chatterjee, S (corresponding author), 3V Biosci, Schlieren, Switzerland.	devk@tcd.ie; rajeev.sivasankaran@novartis.com	Szustakowski, Joseph/HGB-2712-2022	Dev, Kumlesh/0000-0003-4274-9119; Nohturfft, Axel/0000-0001-9484-3209; Szustakowski, Joseph/0000-0001-7900-3973; Nirmala, Nanguneri/0000-0003-0267-9793				Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Adams CM, 2003, P NATL ACAD SCI USA, V100, P10647, DOI 10.1073/pnas.1534833100; Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; BRIGGS MR, 1993, J BIOL CHEM, V268, P14490; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Butler MH, 1997, J CELL BIOL, V137, P1355, DOI 10.1083/jcb.137.6.1355; Cao S, 2005, J BIOL CHEM, V280, P1901, DOI 10.1074/jbc.M407941200; Carlton J, 2005, TRAFFIC, V6, P75, DOI 10.1111/j.1600-0854.2005.00260.x; CONOVER WJ, 1981, TECHNOMETRICS, V23, P351, DOI 10.2307/1268225; Cooper CD, 2002, J BIOL CHEM, V277, P44962, DOI 10.1074/jbc.M209427200; Cruciani V, 2002, BIOL CELL, V94, P433, DOI 10.1016/S0248-4900(02)00014-X; de Preux AS, 2007, MOL CELL NEUROSCI, V35, P525, DOI 10.1016/j.mcn.2007.04.010; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Espenshade PJ, 2002, P NATL ACAD SCI USA, V99, P11694, DOI 10.1073/pnas.182412799; Felder TK, 2005, BBA-GENE STRUCT EXPR, V1731, P41, DOI 10.1016/j.bbaexp.2005.08.004; Ferre P, 2007, HORM RES, V68, P72, DOI 10.1159/000100426; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Harada N, 2008, BIOCHEM BIOPH RES CO, V368, P820, DOI 10.1016/j.bbrc.2008.02.004; Hattula K, 2006, J CELL SCI, V119, P4866, DOI 10.1242/jcs.03275; Hermey G, 2001, NEUROSCI LETT, V313, P83, DOI 10.1016/S0304-3940(01)02252-2; Hermey G, 2003, J BIOL CHEM, V278, P7390, DOI 10.1074/jbc.M210851200; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; HUA XX, 1995, GENOMICS, V25, P667, DOI 10.1016/0888-7543(95)80009-B; Hua XX, 1996, J BIOL CHEM, V271, P10379, DOI 10.1074/jbc.271.17.10379; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; INOUE A, 1999, J METASTABLE NANOCRY, V1, P1; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Janowski BA, 2002, P NATL ACAD SCI USA, V99, P12675, DOI 10.1073/pnas.202471599; Kemp DM, 2007, BIOINFORMATICS, V23, P1356, DOI 10.1093/bioinformatics/btm116; Kotzka J, 2000, J LIPID RES, V41, P99; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; Lampe PD, 2004, INT J BIOCHEM CELL B, V36, P1171, DOI 10.1016/S1357-2725(03)00264-4; Lampe PD, 2000, ARCH BIOCHEM BIOPHYS, V384, P205, DOI 10.1006/abbi.2000.2131; Leithe E, 2004, J CELL SCI, V117, P1211, DOI 10.1242/jcs.00951; Lo JC, 2007, SCIENCE, V316, P285, DOI 10.1126/science.1137221; Matsuda M, 2001, GENE DEV, V15, P1206, DOI 10.1101/gad.891301; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mukhopadhyay A, 2007, EMBO REP, V8, P931, DOI 10.1038/sj.embor.7401055; Najima Y, 2005, J BIOL CHEM, V280, P27523, DOI 10.1074/jbc.M414549200; Natesampillai S, 2006, J BIOL CHEM, V281, P3040, DOI 10.1074/jbc.M509417200; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; Nohturfft A, 1998, P NATL ACAD SCI USA, V95, P12848, DOI 10.1073/pnas.95.22.12848; Nohturfft A, 1999, P NATL ACAD SCI USA, V96, P11235, DOI 10.1073/pnas.96.20.11235; Nohturfft A, 1996, P NATL ACAD SCI USA, V93, P13709, DOI 10.1073/pnas.93.24.13709; Ou JF, 2001, P NATL ACAD SCI USA, V98, P6027, DOI 10.1073/pnas.111138698; Pai JT, 1998, J BIOL CHEM, V273, P26138, DOI 10.1074/jbc.273.40.26138; Parraga A, 1998, STRUCT FOLD DES, V6, P661, DOI 10.1016/S0969-2126(98)00067-7; Pucadyil TJ, 2006, PROG LIPID RES, V45, P295, DOI 10.1016/j.plipres.2006.02.002; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; Reddy JV, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000019; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Sakai J, 1998, J BIOL CHEM, V273, P5785, DOI 10.1074/jbc.273.10.5785; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Sakai J, 1997, J BIOL CHEM, V272, P20213, DOI 10.1074/jbc.272.32.20213; SATO R, 1994, J BIOL CHEM, V269, P17267; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Siegal, 1956, NONPARAMETRIC STAT B; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Sun LP, 2005, J BIOL CHEM, V280, P26483, DOI 10.1074/jbc.M504041200; Szustakowski JD, 2006, GENOMICS, V87, P129, DOI 10.1016/j.ygeno.2005.08.009; Thewke DP, 1998, J BIOL CHEM, V273, P21402, DOI 10.1074/jbc.273.33.21402; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; Verges M, 2007, FRONT BIOSCI-LANDMRK, V12, P3825, DOI 10.2741/2355; Vihanto MM, 2006, J CELL SCI, V119, P2299, DOI 10.1242/jcs.02946; Wang H, 2002, MOL CELL BIOL, V22, P8478, DOI 10.1128/MCB.22.24.8478-8490.2002; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; Wang XH, 2006, CHINESE EDUC SOC, V39, P75, DOI 10.2753/CED1061-1932390506; Weber B, 1996, HUM MOL GENET, V5, P771, DOI 10.1093/hmg/5.6.771; Worgall TS, 1998, J BIOL CHEM, V273, P25537, DOI 10.1074/jbc.273.40.25537; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Yoshikawa T, 2002, J BIOL CHEM, V277, P1705, DOI 10.1074/jbc.M105711200; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao HG, 1996, P NATL ACAD SCI USA, V93, P6101, DOI 10.1073/pnas.93.12.6101	84	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2009	4	4							e5197	10.1371/journal.pone.0005197	http://dx.doi.org/10.1371/journal.pone.0005197			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VA	19381295	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000265513800001
J	Mouri, K; Nacher, JC; Akutsu, T				Mouri, Kazunari; Nacher, Jose C.; Akutsu, Tatsuya			A Mathematical Model for the Detection Mechanism of DNA Double-Strand Breaks Depending on Autophosphorylation of ATM	PLOS ONE			English	Article							P53-MDM2 FEEDBACK LOOP; HYDROGEN-PEROXIDE; POSITIVE-FEEDBACK; DAMAGE; MULTISTABILITY; BIFURCATION; ACTIVATION; SIMULATION; GENERATION; SWITCH	Background: After IR stress, DNA double-strand breaks (DSBs) occur and repair proteins (RPs) bind to them, generating DSB-RP complexes (DSBCs), which results in repaired DSBs (RDSBs). In recent experimental studies, it is suggested that the ATM proteins detect these DNA lesions depending on the autophosphorylation of ATM which exists as a dimer before phosphorylation. Interestingly, the ATM proteins can work as a sensor for a small number of DSBs (approximately 18 DSBs in a cell after exposure to IR). Thus the ATM proteins amplify the small input signals based on the phosphorylation of the ATM dimer proteins. The true DSB-detection mechanism depending on ATM autophosphorylation has yet to be clarified. Methodology/Principal Findings: We propose a mathematical model for the detection mechanism of DSBs by ATM. Our model includes both a DSB-repair mechanism and an ATM-phosphorylation mechanism. We model the former mechanism as a stochastic process, and obtain theoretical mean values of DSBs and DSBCs. In the latter mechanism, it is known that ATM autophosphorylates itself, and we find that the autophosphorylation induces bifurcation of the phosphorylated ATM (ATM*). The bifurcation diagram depends on the total concentration of ATM, which makes three types of steady state diagrams of ATM*: monostable, reversible bistable, and irreversible bistable. Bistability exists depending on the Hill coefficient in the equation of ATM autophosphorylation, and it emerges as the total concentration of ATM increases. Combining these two mechanisms, we find that ATM* exhibits switch-like behaviour in the presence of bistability, and the detection time after DNA damage decreases when the total concentration of ATM increases. Conclusions/Significance: This work provides a mathematical model that explains the DSB-detection mechanism depending on ATM autophosphorylation. These results indicate that positive auto-regulation works both as a sensor and amplifier of small input signals.			Mouri, K (corresponding author), Kyoto Univ, Inst Chem Res, Bioinformat Ctr, Kyoto 606, Japan.	kmouri@kuicr.kyoto-u.ac.jp		Akutsu, Tatsuya/0000-0001-9763-797X				Alon U., 2006, INTRO SYSTEMS BIOL D; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Arkin A, 1998, GENETICS, V149, P1633; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Cantoni O, 1997, GEN PHARMACOL-VASC S, V29, P513, DOI 10.1016/S0306-3623(96)00363-1; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kiehl TR, 2004, BIOINFORMATICS, V20, P316, DOI 10.1093/bioinformatics/btg409; Kurz EU, 2004, DNA REPAIR, V3, P889, DOI 10.1016/j.dnarep.2004.03.029; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Ma L, 2005, P NATL ACAD SCI USA, V102, P14266, DOI 10.1073/pnas.0501352102; MELLO AC, 1984, BIOCHIM BIOPHYS ACTA, V781, P56, DOI 10.1016/0167-4781(84)90123-4; Nair VD, 2004, J BIOL CHEM, V279, P27494, DOI 10.1074/jbc.M312135200; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Samuni AM, 2001, BBA-GEN SUBJECTS, V1525, P70, DOI 10.1016/S0304-4165(00)00172-0; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Wilkinson DJ, 2006, MATH COMPUTATIONAL B, V2nd; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; You ZS, 2007, NAT CELL BIOL, V9, P311, DOI 10.1038/ncb1651	32	21	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5131	10.1371/journal.pone.0005131	http://dx.doi.org/10.1371/journal.pone.0005131			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TN	19365581	Green Published, gold, Green Submitted			2022-12-25	WOS:000265509900002
J	Henry, S; Richard-Yris, MA; Tordjman, S; Hausberger, M				Henry, Severine; Richard-Yris, Marie-Annick; Tordjman, Sylvie; Hausberger, Martine			Neonatal Handling Affects Durably Bonding and Social Development	PLOS ONE			English	Article							SKIN-TO-SKIN; INFANT-MOTHER ATTACHMENT; NEWBORN-INFANTS; MATERNAL SENSITIVITY; REARING CONDITIONS; EQUUS-CABALLUS; RHESUS-MONKEY; ANIMAL-MODELS; WARD ROUTINES; BEHAVIOR	The neonatal period in humans and in most mammals is characterized by intense mother-young interactions favoring pair bonding and the adaptation of neonates to their new environment. However, in many post-delivery procedures, human babies commonly experience combined maternal separation and intense handling for about one hour post-birth. Currently, the effects of such disturbances on later attachment and on the development of newborns are still debated: clearly, further investigations are required. As animals present good models for controlled experimentation, we chose domestic horses to investigate this issue. Horses, like humans, are characterized by single births, long lactating periods and selective mother-infant bonds. Routine postnatal procedures for foals, as for human babies, also involve intense handling and maternal separation. In the present study, we monitored the behavior of foals from early stages of development to "adolescence'', in a normal ecological context (social groups with adults and peers). Experimental foals, separated from their mothers and handled for only 1 hour post-birth, were compared to control foals, left undisturbed after birth. Our results revealed short- and long-term effects of this unique neonatal experience on attachment and subsequent social competences. Thus, experimental foals presented patterns of insecure attachment to their mothers (strong dependence on their mothers, little play) and impaired social competences (social withdrawal, aggressiveness) at all ages. We discuss these results in terms of mother-young interactions, timing of interactions and relationships between bonding and subsequent social competences. Our results indicate that this ungulate species could become an interesting animal model. To our knowledge, this is the first clear demonstration that intervention just after birth affects bonding and subsequent social competences (at least until "adolescence''). It opens new research directions for studies on both humans and other animals.			Henry, S (corresponding author), Univ Rennes 1, CNRS, UMR Ethos Ethol Anim & Humaine 6552, Rennes, France.	severine.henry@univ-rennes1.fr						ACOLET D, 1989, ACTA PAEDIATR SCAND, V78, P189, DOI 10.1111/j.1651-2227.1989.tb11055.x; Ainsworth M., 1978, PATTERNS ATTACHMENT; ALI Z, 1981, DEV MED CHILD NEUROL, V23, P337; Als H., 1995, ZERO 3, V16, P1; Anand KJS, 2000, BIOL NEONATE, V77, P69, DOI 10.1159/000014197; Arnold JL, 2002, DEV PSYCHOBIOL, V41, P205, DOI 10.1002/dev.10069; Bertin A, 2007, DEV PSYCHOBIOL, V49, P362, DOI 10.1002/dev.20223; BLASS EM, 1995, BEHAV NEUROSCI, V109, P342, DOI 10.1037/0735-7044.109.2.342; BLASS EM, 1980, SCIENCE, V210, P15, DOI 10.1126/science.6997992; Blass EM, 1999, PAIN, V83, P611, DOI 10.1016/S0304-3959(99)00166-9; Bowlby J, 1969, ATTACHMENT LOSS SEPA; BRAKE SC, 1982, DEV PSYCHOBIOL, V15, P529, DOI 10.1002/dev.420150605; Buranasin B, 1991, Asia Pac J Public Health, V5, P217; Bystrova K, 2003, ACTA PAEDIATR, V92, P320; Caldji C, 2000, NEUROPSYCHOPHARMACOL, V22, P219, DOI 10.1016/S0893-133X(99)00110-4; CARSON K, 1983, APPL ANIM ETHOL, V10, P165, DOI 10.1016/0304-3762(83)90138-4; Castellan NJ, 1988, NONPARAMETRIC STAT B; CHAMPOUX M, 1989, AM J PRIMATOL, V19, P111, DOI 10.1002/ajp.1350190204; CHRISTENSSON K, 1995, ACTA PAEDIATR, V84, P468, DOI 10.1111/j.1651-2227.1995.tb13676.x; CHRISTENSSON K, 1992, ACTA PAEDIATR, V81, P488, DOI 10.1111/j.1651-2227.1992.tb12280.x; Crowell-Davis SL, 2005, Domestic Horse: The Origins, Development and Management of Its Behaviour, P126; CROWELLDAVIS SL, 1986, ANIM BEHAV, V34, P1007, DOI 10.1016/S0003-3472(86)80159-2; DECHATEAU P, 1977, ACTA PAEDIATR SCAND, V66, P145, DOI 10.1111/j.1651-2227.1977.tb07826.x; EGELAND B, 1984, CHILD DEV, V55, P753, DOI 10.1111/j.1467-8624.1984.tb03813.x; EGELAND B, 1987, PSYCHOL MALTREATMENT, P110; Fairbanks LA., 1996, ADV STUDY BEHAV VOL, V25, P579, DOI [10.1016/S0065-3454(08)60343-5, DOI 10.1016/S0065-3454(08)60343-5]; Feldman R, 2007, J CHILD PSYCHOL PSYC, V48, P329, DOI 10.1111/j.1469-7610.2006.01701.x; Ferber SG, 2004, PEDIATRICS, V113, P858, DOI 10.1542/peds.113.4.858; Fleming AS, 1999, NEUROSCI BIOBEHAV R, V23, P673, DOI 10.1016/S0149-7634(99)00011-1; FLEMING AS, 2002, HDB PARENTING BIOL E, P00061; GOLDBERG S, 1986, CHILD DEV, V57, P37, DOI 10.2307/1130635; Gottlieb G, 2004, SOC DEV, V13, P311, DOI 10.1111/j.1467-9507.2004.000269.x; Goursaud AP, 1999, PHYSIOL BEHAV, V67, P49, DOI 10.1016/S0031-9384(99)00037-2; Gray L, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.1.e14; HALES DJ, 1977, DEV MED CHILD NEUROL, V19, P454; HARLOW HF, 1965, P NATL ACAD SCI USA, V54, P90, DOI 10.1073/pnas.54.1.90; Hausberger M, 2007, J COMP PSYCHOL, V121, P109, DOI 10.1037/0735-7036.121.1.109; Henry S, 2006, DEV PSYCHOBIOL, V48, P712, DOI 10.1002/dev.20189; HINDE RA, 1971, ANIM BEHAV, V19, P165, DOI 10.1016/S0003-3472(71)80152-5; HINDE RA, 1966, NATURE, V210, P1021, DOI 10.1038/2101021a0; HOFER MA, 1987, CHILD DEV, V58, P633, DOI 10.2307/1130203; HWANG CP, 1981, EARLY HUM DEV, V5, P279, DOI 10.1016/0378-3782(81)90035-9; Jaffe J, 2001, MONOGR SOC RES CHILD, V66, P1, DOI 10.1111/1540-5834.00137; Jansson UM, 1995, J TROP PEDIATRICS, V41, P360, DOI 10.1093/tropej/41.6.360; Klaus M, 1998, Pediatrics, V102, P1244; Klaus M, 2001, BIRTH-ISS PERINAT C, V28, P274, DOI 10.1046/j.1523-536X.2001.00274.x; KLAUS MH, 1970, PEDIATRICS, V46, P187; KLAUS MH, 1972, NEW ENGL J MED, V286, P460, DOI 10.1056/NEJM197203022860904; Koepke JE, 1997, INFANT BEHAV DEV, V20, P93, DOI 10.1016/S0163-6383(97)90064-3; LAMB ME, 1977, CHILD DEV, V48, P167, DOI 10.1111/j.1467-8624.1977.tb04257.x; LEVY F, 1983, PHYSIOL BEHAV, V31, P687, DOI 10.1016/S0031-9384(83)80004-3; Liu D, 2000, J NEUROENDOCRINOL, V12, P5; LONG JG, 1980, PEDIATRICS, V65, P203, DOI 10.1542/peds.65.2.203; Lvoff NM, 2000, ARCH PEDIAT ADOL MED, V154, P474, DOI 10.1001/archpedi.154.5.474; Lyons DM, 1998, DEV PSYCHOBIOL, V32, P285, DOI 10.1002/(SICI)1098-2302(199805)32:4<285::AID-DEV3>3.3.CO;2-N; Matthiesen AS, 2001, BIRTH-ISS PERINAT C, V28, P13, DOI 10.1046/j.1523-536x.2001.00013.x; McElwain NL, 2006, J FAM PSYCHOL, V20, P247, DOI 10.1037/0893-3200.20.2.247; Meaney MJ, 1996, DEV NEUROSCI-BASEL, V18, P49, DOI 10.1159/000111395; Michelsson K, 1996, ACTA PAEDIATR, V85, P471, DOI 10.1111/j.1651-2227.1996.tb14064.x; MILLER RM, 1991, IMPRINT TRAINING NEW; Mooncey S, 1997, INFANT BEHAV DEV, V20, P553, DOI 10.1016/S0163-6383(97)90045-X; Moons CPH, 2005, APPL ANIM BEHAV SCI, V91, P321, DOI 10.1016/j.applanim.2004.10.007; Morelius E, 2006, EARLY HUM DEV, V82, P669, DOI 10.1016/j.earlhumdev.2005.12.013; Nievar MA, 2008, SOC DEV, V17, P102, DOI 10.1111/j.1467-9507.2007.00417.x; NOIROT E, 1983, BEHAV PROCESS, V8, P65, DOI 10.1016/0376-6357(83)90044-X; Nowak R, 1997, PHYSIOL BEHAV, V62, P681, DOI 10.1016/S0031-9384(97)00079-6; Nyqvist KH, 1997, MIDWIFERY, V13, P24, DOI 10.1016/S0266-6138(97)90029-2; OSWALT GL, 1975, DEV PSYCHOBIOL, V8, P129, DOI 10.1002/dev.420080205; PASTOR DL, 1981, DEV PSYCHOL, V17, P326, DOI 10.1037/0012-1649.17.3.326; PEDERSON DR, 1990, CHILD DEV, V61, P1974, DOI 10.1111/j.1467-8624.1990.tb03579.x; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; Poindron P, 1993, Oxf Rev Reprod Biol, V15, P311; POINDRON P, 1993, REPROD MAMMALS MAN, P553; Polan HJ, 1999, DEV PSYCHOBIOL, V34, P269, DOI 10.1002/(SICI)1098-2302(199905)34:2<269::AID-DEV3>3.0.CO;2-L; Pryce Christopher R., 1996, Advances in the Study of Behavior, V25, P423; Pryce CR, 2005, NEUROSCI BIOBEHAV R, V29, P649, DOI 10.1016/j.neubiorev.2005.03.011; Pryce CR, 2001, BEHAV NEUROSCI, V115, P71, DOI 10.1037//0735-7044.115.1.71; RIGHARD L, 1990, LANCET, V336, P1105, DOI 10.1016/0140-6736(90)92579-7; Rosenblatt J. S., 1979, Advances in the Study of Behavior, V10, P225, DOI 10.1016/S0065-3454(08)60096-0; ROSENBLUM LA, 1984, CHILD DEV, V55, P305, DOI 10.1111/j.1467-8624.1984.tb00293.x; SCHAAL B, 1995, BEHAVIOUR, V132, P351, DOI 10.1163/156853995X00603; Schaal B, 1998, BIOL NEONATE, V74, P266, DOI 10.1159/000014033; SCHAPIRO S, 1970, PHYSIOL BEHAV, V5, P815, DOI 10.1016/0031-9384(70)90285-4; SELIGMAN ME, 1968, J ABNORM PSYCHOL, V73, P256, DOI 10.1037/h0025831; Sevi A, 2003, APPL ANIM BEHAV SCI, V83, P41, DOI 10.1016/S0168-1591(03)00088-1; Simpson BS, 2002, APPL ANIM BEHAV SCI, V78, P303, DOI 10.1016/S0168-1591(02)00107-7; SMOTHERMAN WP, 1990, PHYSIOL BEHAV, V47, P863, DOI 10.1016/0031-9384(90)90010-2; Sroufe LA, 2005, ATTACH HUM DEV, V7, P349, DOI 10.1080/14616730500365928; SROUFE LA, 1983, CHILD DEV, V54, P1615, DOI 10.2307/1129825; Stern J.M., 1996, ADV STUD BEHAV, V25, P243; VARENDI H, 1994, LANCET, V344, P989, DOI 10.1016/S0140-6736(94)91645-4; Veissier I, 1998, APPL ANIM BEHAV SCI, V57, P233, DOI 10.1016/S0168-1591(98)00099-9; Waring G.H., 2003, HORSE BEHAV BEHAV TR; WATERS E, 1979, CHILD DEV, V50, P821, DOI 10.2307/1128949; WIDSTROM AM, 1993, ACTA PAEDIATR, V82, P281, DOI 10.1111/j.1651-2227.1993.tb12660.x; Winberg J, 2005, DEV PSYCHOBIOL, V47, P217, DOI 10.1002/dev.20094; WOLFF A, 1994, ETHOLOGY, V96, P1, DOI 10.1111/j.1439-0310.1994.tb00876.x; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	109	35	36	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5216	10.1371/journal.pone.0005216	http://dx.doi.org/10.1371/journal.pone.0005216			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437RX	19352503	gold, Green Published, Green Submitted			2022-12-25	WOS:000265505700027
J	Abel, J; Eskeland, R; Raffa, GD; Kremmer, E; Imhof, A				Abel, Jochen; Eskeland, Ragnhild; Raffa, Grazia D.; Kremmer, Elisabeth; Imhof, Axel			Drosophila HP1c Is Regulated by an Auto-Regulatory Feedback Loop through Its Binding Partner Woc	PLOS ONE			English	Article								HP1 is a major component of chromatin and regulates gene expression through its binding to methylated histone H3. Most eukaryotes express at least three isoforms of HP1 with similar domain architecture. However, despite the common specificity for methylated histone H3, the three HP1 isoforms bind to different regions of the genome. Most of the studies so far focused on the HP1a isoform and its role in transcriptional regulation. As HP1a requires additional factors to bind methylated chromatin in vitro, we wondered whether another isoform might also require additional targeting factors. Indeed, we found that HP1c interacts with the DNA binding factors Woc and Row and requires Woc to become targeted to chromatin in vivo. Moreover, we show that the interaction between HP1c and Woc constitutes a transcriptional feedback loop that operates to balance the concentration of HP1c within the cell. This regulation may prevent HP1c from binding to methylated heterochromatin.			Abel, J (corresponding author), Univ Munich, Munich Ctr Integrated Prot Sci, Munich, Germany.	lmhof@lmu.de	Imhof, Axel/AAU-5313-2021; Eskeland, Ragnhild/K-7018-2014; Eskeland, Ragnhild/GSN-9383-2022; Eskeland, Ragnhild/AFM-2892-2022	Imhof, Axel/0000-0003-2993-8249; Eskeland, Ragnhild/0000-0003-2789-3171; Eskeland, Ragnhild/0000-0003-2789-3171; raffa, grazia daniela/0000-0002-5072-5240				Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bonaldi T, 2008, MOL CELL, V31, P762, DOI 10.1016/j.molcel.2008.07.018; Clegg NJ, 1998, GENOME, V41, P495, DOI 10.1139/gen-41-4-495; Danzer JR, 2004, DEVELOPMENT, V131, P3571, DOI 10.1242/dev.01223; De Lucia F, 2005, NUCLEIC ACIDS RES, V33, P2852, DOI 10.1093/nar/gki584; du Chene I, 2007, EMBO J, V26, P424, DOI 10.1038/sj.emboj.7601517; Eskeland R, 2007, MOL CELL BIOL, V27, P453, DOI 10.1128/MCB.01576-06; Fanti L, 2008, CURR OPIN GENET DEV, V18, P169, DOI 10.1016/j.gde.2008.01.009; Font-Burgada J, 2008, GENE DEV, V22, P3007, DOI 10.1101/gad.481408; Gocke CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003255; Greil F, 2003, GENE DEV, V17, P2825, DOI 10.1101/gad.281503; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hiragami K, 2005, CELL MOL LIFE SCI, V62, P2711, DOI 10.1007/s00018-005-5287-9; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Kato M, 2007, CELL STRUCT FUNCT, V32, P57, DOI 10.1247/csf.06032; Koike N, 2000, FEBS LETT, V467, P17, DOI 10.1016/S0014-5793(00)01105-4; Kulkarni S, 1999, GENOMICS, V55, P118, DOI 10.1006/geno.1998.5634; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Lu BY, 2000, GENETICS, V155, P699; Mateescu B, 2008, EMBO REP, V9, P267, DOI 10.1038/embor.2008.1; Meehan RR, 2003, EMBO J, V22, P3164, DOI 10.1093/emboj/cdg306; Muchardt C, 2002, EMBO REP, V3, P975, DOI 10.1093/embo-reports/kvf194; MURAWSKA M, MOL CELL BIOL; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Raffa GD, 2005, MOL CELL, V20, P821, DOI 10.1016/j.molcel.2005.12.003; Reiter A, 1998, BLOOD, V92, P1735, DOI 10.1182/blood.V92.5.1735.417k11_1735_1742; SADAIE M, 2008, MOL CELL BIOL; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Smedley D, 1999, GENOMICS, V60, P244, DOI 10.1006/geno.1999.5918; Smothers JF, 2001, MOL CELL BIOL, V21, P2555, DOI 10.1128/MCB.21.7.2555-2569.2001; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; Vermaak D, 2005, PLOS GENET, V1, P96, DOI 10.1371/journal.pgen.0010009; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Warren JT, 2001, MOL CELL ENDOCRINOL, V181, P1, DOI 10.1016/S0303-7207(01)00404-X; Wismar J, 2000, DEV BIOL, V226, P1, DOI 10.1006/dbio.2000.9811; Yahi H, 2008, J BIOL CHEM, V283, P23692, DOI 10.1074/jbc.M802647200	39	20	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2009	4	4							e5089	10.1371/journal.pone.0005089	http://dx.doi.org/10.1371/journal.pone.0005089			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RT	19352434	Green Published, Green Submitted, gold			2022-12-25	WOS:000265505300012
J	Wernimont, A; Edwards, A				Wernimont, Amy; Edwards, Aled			In Situ Proteolysis to Generate Crystals for Structure Determination: An Update	PLOS ONE			English	Article								For every 100 purified proteins that enter crystallization trials, an average of 30 form crystals, and among these only 13-15 crystallize in a form that enables structure determination. In 2007, Dong et al reported that the addition of trace amounts of protease to crystallization trials-in situ proteolysis-significantly increased the number of proteins in a given set that produce diffraction quality crystals. 69 proteins that had previously resisted structure determination were subjected to crystallization with in situ proteolysis and ten crystallized in a form that led to structure determination (14.5% success rate). Here we apply in situ proteolysis to over 270 new soluble proteins that had failed in the past to produce crystals suitable for structure determination. These proteins had produced no crystals, crystals that diffracted poorly, or produced twinned and/or unmanageable diffraction data. The new set includes yeast and prokaryotic proteins, enzymes essential to protozoan parasites, and human proteins such as GTPases, chromatin remodeling proteins, and tyrosine kinases. 34 proteins yielded deposited crystal structures of 2.8 A resolution or better, for an overall 12.6% success rate, and at least ten more yielded well-diffracting crystals presently in refinement. The success rate among proteins that had previously crystallized was double that of those that had never before yielded crystals. The overall success rate is similar to that observed in the smaller study, and appears to be higher than any other method reported to rescue stalled protein crystallography projects.			Wernimont, A (corresponding author), Univ Toronto, Midwest Ctr Struct Genom & Struct Genom Consortiu, Toronto, ON, Canada.	awernimont@gmail.com	Min, Jinrong/G-3449-2011	Min, Jinrong/0000-0001-5210-3130; Edwards, Aled/0000-0002-4782-6016	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BOCHKAREV A, 1995, CELL, V83, P39, DOI 10.1016/0092-8674(95)90232-5; COHEN SL, 1995, PROTEIN SCI, V4, P1088, DOI 10.1002/pro.5560040607; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Dale GE, 2003, J STRUCT BIOL, V142, P88, DOI 10.1016/S1047-8477(03)00041-8; Derewenda ZS, 2004, METHODS, V34, P354, DOI 10.1016/j.ymeth.2004.03.024; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; Gao Xia, 2005, Journal of Structural and Functional Genomics, V6, P129, DOI 10.1007/s10969-005-1918-5; Grabowski M, 2007, CURR OPIN STRUC BIOL, V17, P347, DOI 10.1016/j.sbi.2007.06.003; Graslund S, 2008, PROTEIN EXPRES PURIF, V58, P210, DOI 10.1016/j.pep.2007.11.008; Kim YC, 2008, NAT METHODS, V5, P853, DOI 10.1038/nmeth1008-853; Leulliot N, 2005, ACTA CRYSTALLOGR D, V61, P664, DOI 10.1107/S0907444905000028; Malawski GA, 2006, PROTEIN SCI, V15, P2718, DOI 10.1110/ps.062491906; O'Toole N, 2004, PROTEINS, V56, P201, DOI 10.1002/prot.20060; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Reinking J, 2005, CELL, V122, P195, DOI 10.1016/j.cell.2005.07.005; Vedadi M, 2007, MOL BIOCHEM PARASIT, V151, P100, DOI 10.1016/j.molbiopara.2006.10.011; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005	18	68	72	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2009	4	4							e5094	10.1371/journal.pone.0005094	http://dx.doi.org/10.1371/journal.pone.0005094			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RT	19352432	Green Published, Green Submitted, gold			2022-12-25	WOS:000265505300015
J	Zhang, G; Ignatova, Z				Zhang, Gong; Ignatova, Zoya			Generic Algorithm to Predict the Speed of Translational Elongation: Implications for Protein Biogenesis	PLOS ONE			English	Article							TRANSFER-RNA GENES; CODON USAGE; ESCHERICHIA-COLI; COMPLETE GENOME; RARE CODONS; EXPRESSION; SELECTION; RATES; PREFERENCES; FREQUENCIES	Synonymous codon usage and variations in the level of isoaccepting tRNAs exert a powerful selective force on translation fidelity. We have developed an algorithm to evaluate the relative rate of translation which allows large-scale comparisons of the non-uniform translation rate on the protein biogenesis. Using the complete genomes of Escherichia coli and Bacillus subtilis we show that stretches of codons pairing to minor tRNAs form putative sites to locally attenuate translation; thereby the tendency is to cluster in near proximity whereas long contiguous stretches of slow-translating triplets are avoided. The presence of slow-translating segments positively correlates with the protein length irrespective of the protein abundance. The slow-translating clusters are predominantly located down-stream of the domain boundaries presumably to fine-tune translational accuracy with the folding fidelity of multidomain proteins. Translation attenuation patterns at highly structurally and functionally conserved domains are preserved across the species suggesting a concerted selective pressure on the codon selection and species-specific tRNA abundance in these regions.	[Zhang, Gong; Ignatova, Zoya] Univ Potsdam, Dept Biochem, Inst Biochem & Biol, Potsdam, Germany	University of Potsdam	Zhang, G (corresponding author), Univ Potsdam, Dept Biochem, Inst Biochem & Biol, Potsdam, Germany.	ignatova@uni-potsdam.de	Zhang, Gong/Q-7419-2017	Zhang, Gong/0000-0003-0418-3433; Ignatova, Zoya/0000-0002-9478-8825	SysMO; KAAD [fellowship]	SysMO; KAAD	This work was supported by SysMO (Kosmobac project) to ZI and KAAD-fellowship to GZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKASHI H, 1994, GENETICS, V136, P927; ANDERSSON SGE, 1990, MICROBIOL REV, V54, P198, DOI 10.1128/MMBR.54.2.198-210.1990; Angov E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002189; Apic Gordana, 2003, Journal of Structural and Functional Genomics, V4, P67, DOI 10.1023/A:1026113408773; Barak Z, 1996, J MOL BIOL, V256, P676, DOI 10.1006/jmbi.1996.0117; BONEKAMP F, 1989, J BACTERIOL, V171, P5812, DOI 10.1128/jb.171.11.5812-5816.1989; Buchan JR, 2006, NUCLEIC ACIDS RES, V34, P1015, DOI 10.1093/nar/gkj488; BULMER M, 1987, NATURE, V325, P728, DOI 10.1038/325728a0; CHEN GFT, 1990, NUCLEIC ACIDS RES, V18, P1465, DOI 10.1093/nar/18.6.1465; Clarke TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003412; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; CURRAN JF, 1989, J MOL BIOL, V209, P65, DOI 10.1016/0022-2836(89)90170-8; Dittmar KA, 2005, EMBO REP, V6, P151, DOI 10.1038/sj.embor.7400341; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Fedorov AN, 1997, J BIOL CHEM, V272, P32715, DOI 10.1074/jbc.272.52.32715; Frank J, 1995, BIOCHEM CELL BIOL, V73, P757, DOI 10.1139/o95-084; Gerstein M, 1998, FOLD DES, V3, P497, DOI 10.1016/S1359-0278(98)00066-2; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Hubbard SJ, 1996, J MOL BIOL, V261, P289, DOI 10.1006/jmbi.1996.0460; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; IRWIN B, 1995, J BIOL CHEM, V270, P22801, DOI 10.1074/jbc.270.39.22801; JANSSEN GMC, 1988, J BIOL CHEM, V263, P1773; Kanaya S, 2001, J MOL EVOL, V53, P290, DOI 10.1007/s002390010219; Kanaya S, 1999, GENE, V238, P143, DOI 10.1016/S0378-1119(99)00225-5; Kelley WL, 1998, TRENDS BIOCHEM SCI, V23, P222, DOI 10.1016/S0968-0004(98)01215-8; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Knight R. D., 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-4-RESEARCH0010; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Komar AA, 2009, TRENDS BIOCHEM SCI, V34, P16, DOI 10.1016/j.tibs.2008.10.002; KRASHENINNIKOV I A, 1989, Biokhimiya, V54, P187; Kruger MK, 1998, J MOL BIOL, V284, P621, DOI 10.1006/jmbi.1998.2196; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lavner Y, 2005, GENE, V345, P127, DOI 10.1016/j.gene.2004.11.035; Maity H, 2005, P NATL ACAD SCI USA, V102, P4741, DOI 10.1073/pnas.0501043102; Makhoul CH, 2002, J BIOMOL STRUCT DYN, V20, P413, DOI 10.1080/07391102.2002.10506859; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Phoenix DA, 1997, FEMS MICROBIOL LETT, V155, P63, DOI 10.1016/S0378-1097(97)00367-4; PURVIS IJ, 1987, J MOL BIOL, V193, P413, DOI 10.1016/0022-2836(87)90230-0; Rocha EPC, 2004, GENOME RES, V14, P2279, DOI 10.1101/gr.2896904; Roche ED, 1999, EMBO J, V18, P4579, DOI 10.1093/emboj/18.16.4579; Rodnina MV, 2001, TRENDS BIOCHEM SCI, V26, P124, DOI 10.1016/S0968-0004(00)01737-0; SORENSEN MA, 1989, J MOL BIOL, V207, P365, DOI 10.1016/0022-2836(89)90260-X; Sorensen MA, 1998, METH MOL B, V77, P129; Teichmann SA, 1998, P NATL ACAD SCI USA, V95, P14658, DOI 10.1073/pnas.95.25.14658; Thanaraj TA, 1996, PROTEIN SCI, V5, P1594, DOI 10.1002/pro.5560050814; Tsai CJ, 2008, J MOL BIOL, V383, P281, DOI 10.1016/j.jmb.2008.08.012; TU CL, 1992, P NATL ACAD SCI USA, V89, P8636, DOI 10.1073/pnas.89.18.8636; VARENNE S, 1984, J MOL BIOL, V180, P549, DOI 10.1016/0022-2836(84)90027-5; WALL D, 1994, J BIOL CHEM, V269, P5446; Withey JH, 2003, ANNU REV MICROBIOL, V57, P101, DOI 10.1146/annurev.micro.57.030502.090945; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554	52	64	70	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2009	4	4							e5036	10.1371/journal.pone.0005036	http://dx.doi.org/10.1371/journal.pone.0005036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437QA	19343177	Green Published, Green Submitted, gold			2022-12-25	WOS:000265500800005
J	Cobb, JE; White, SJ; Harrap, SB; Ellis, JA				Cobb, Joanna E.; White, Stefan J.; Harrap, Stephen B.; Ellis, Justine A.			Androgen Receptor Copy Number Variation and Androgenetic Alopecia: A Case-Control Study	PLOS ONE			English	Article								Background: The functional polymorphism that explains the established association of the androgen receptor (AR) with androgenetic alopecia (AGA) remains unidentified, but Copy Number Variation (CNV) might be relevant. CNV involves changes in copy number of large segments of DNA, leading to the altered dosage of gene regulators or genes themselves. Two recent reports indicate regions of CNV in and around AR, and these have not been studied in relation to AGA. The aim of this preliminary case-control study was to determine if AR CNV is associated with AGA, with the hypothesis that CNV is the functional AR variant contributing to this condition. Methodology/Principal Findings: Multiplex Ligation-dependent Probe Amplification was used to screen for CNV in five AR exons and a conserved, non-coding region upstream of AR in 85 men carefully selected as cases and controls for maximal phenotypic contrast. There was no evidence of CNV in AR in any of the cases or controls, and thus no evidence of significant association between AGA and AR CNV. Conclusions/Significance: The results suggest this form of genomic variation at the AR locus is unlikely to predispose to AGA.	[Cobb, Joanna E.; Harrap, Stephen B.; Ellis, Justine A.] Univ Melbourne, Dept Physiol, Melbourne, Vic, Australia; [White, Stefan J.; Ellis, Justine A.] Murdoch Childrens Res Inst, Parkville, Vic, Australia	University of Melbourne; Murdoch Children's Research Institute	Cobb, JE (corresponding author), Univ Melbourne, Dept Physiol, Melbourne, Vic, Australia.	justine.ellis@mcri.edu.au	Ellis, Justine A/G-5006-2011	Harrap, Stephen/0000-0003-2907-6714; Ellis, Justine/0000-0003-4103-4445; Cobb, Joanna/0000-0002-2760-3114	NHMRC [Fellowship]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	JE: NHMRC Australia Capacity Building Grant in Population Health. SW: NHMRC Fellowship (Australia). www.nhmrc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruder CEG, 2008, AM J HUM GENET, V82, P763, DOI 10.1016/j.ajhg.2007.12.011; Ellis JA, 2001, J INVEST DERMATOL, V116, P452, DOI 10.1046/j.1523-1747.2001.01261.x; Ellis JA, 2007, HUM GENET, V121, P451, DOI 10.1007/s00439-006-0317-8; Harrap SB, 2000, AM J EPIDEMIOL, V152, P704, DOI 10.1093/aje/152.8.704; Hayes VM, 2005, CANCER EPIDEM BIOMAR, V14, P993, DOI 10.1158/1055-9965.EPI-04-0778; Hillmer AM, 2005, AM J HUM GENET, V77, P140, DOI 10.1086/431425; Lalic T, 2005, EUR J HUM GENET, V13, P1231, DOI 10.1038/sj.ejhg.5201465; Levy-Nissenbaum E, 2005, EUR J DERMATOL, V15, P339; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Taylor R, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-60; White SJ, 2004, HUM MUTAT, V24, P86, DOI 10.1002/humu.20054	15	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5081	10.1371/journal.pone.0005081	http://dx.doi.org/10.1371/journal.pone.0005081			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340294	Green Published, gold			2022-12-25	WOS:000265500700012
J	Debellis, L; Diana, A; Arcidiacono, D; Fiorotto, R; Portincasa, P; Altomare, DF; Spirli, C; de Bernard, M				Debellis, Lucantonio; Diana, Anna; Arcidiacono, Diletta; Fiorotto, Romina; Portincasa, Piero; Altomare, Donato Francesco; Spirli, Carlo; de Bernard, Marina			The Vibrio cholerae Cytolysin Promotes Chloride Secretion from Intact Human Intestinal Mucosa	PLOS ONE			English	Article								Background: The pathogenicity of the Vibrio cholerae strains belonging to serogroup O1 and O139 is due to the production of virulence factors such as cholera toxin (CT) and the toxin-coregulated pilus (TCP). The remaining serogroups, which mostly lack CT and TCP, are more frequently isolated from aquatic environmental sources than from clinical samples; nevertheless, these strains have been reported to cause human disease, such as sporadic outbreaks of watery diarrhoea and inflammatory enterocolitis. This evidence suggested the possibility that other virulence factor(s) than cholera toxin might be crucial in the pathogenesis of Vibrio cholerae-induced diarrhoea, but their nature remains unknown. VCC, the hemolysin produced by virtually all Vibrio cholerae strains, has been proposed as a possible candidate, though a clear-cut demonstration attesting VCC as crucial in the pathogenesis of Vibrio cholerae-induced diarrhoea is still lacking. Methodology/Principal Findings: Electrophysiological parameters and paracellular permeability of stripped human healthy colon tissues, obtained at subtotal colectomy, mounted in Ussing chamber were studied in the presence or absence of VCC purified from culture supernatants of V. cholerae O1 El Tor strain. Short circuit current (I-SC) and transepithelial resistance (R-T) were measured by a computerized voltage clamp system. The exposure of sigmoid colon specimens to 1 nM VCC resulted in an increase of I-SC by 20.7%, with respect to the basal values, while R-T was reduced by 12.3%. Moreover, increase in I-SC was abolished by bilateral Cl- reduction. Conclusion/Significance: Our results demonstrate that VCC, by forming anion channels on the apical membrane of enterocytes, triggers an outward transcellular flux of chloride. Such an ion movement, associated with the outward movement of Na+ and water, might be responsible for the diarrhoea caused by the non-toxigenic strains of Vibrio cholerae.	[Debellis, Lucantonio; Diana, Anna] Univ Bari, Dept Gen & Environm Physiol, Bari, Italy; [Arcidiacono, Diletta; de Bernard, Marina] Venetian Inst Mol Med, Padua, Italy; [Fiorotto, Romina; Spirli, Carlo] Yale Univ, Dept Internal Med, Sect Digest Dis, New Haven, CT 06520 USA; [Portincasa, Piero] Univ Med Sch, Dept Internal & Publ Med, Bari, Italy; [Altomare, Donato Francesco] Univ Bari, Policlin, Dept Emergency, Organ Transplant Gen Surg & Liver Transplant Units, I-70121 Bari, Italy; [de Bernard, Marina] Univ Padua, Dept Biol, I-35100 Padua, Italy	Universita degli Studi di Bari Aldo Moro; Veneto Institute Molecular Medicine; Yale University; Universita degli Studi di Bari Aldo Moro; University of Padua	Debellis, L (corresponding author), Univ Bari, Dept Gen & Environm Physiol, Bari, Italy.	marina.debernard@unipd.it	Arcidiacono, Diletta/AAZ-8127-2021; Fiorotto, Romina/K-4088-2012; Arcidiacono, Diletta/B-2557-2017	Arcidiacono, Diletta/0000-0002-4417-6513; Arcidiacono, Diletta/0000-0002-4417-6513; Altomare, Donato Francesco/0000-0001-8980-2752; Debellis, Lucantonio/0000-0002-7571-0969; de Bernard, Marina/0000-0002-0091-4502; portincasa, piero/0000-0001-5359-1471	Italian Ministry of University and Research [2006064313]; Progetti di Ricerca di Ateneo [CPDA074121/07]; Fondazione Guido Berlucchi; University of Bari [2007]; ALF/AASLD liver scholar award	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Progetti di Ricerca di Ateneo; Fondazione Guido Berlucchi; University of Bari; ALF/AASLD liver scholar award	This work was supported by the following grants: Italian Ministry of University and Research, Prin projects (grant 2006064313), Progetti di Ricerca di Ateneo (grant CPDA074121/07) and Fondazione Guido Berlucchi to M.d.B.; University of Bari grant 2007 to L.D. C.S. is a recipient of an ALF/AASLD liver scholar award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Saka HA, 2008, MICROB PATHOGENESIS, V44, P118, DOI 10.1016/j.micpath.2007.08.013; ALM RA, 1988, MOL MICROBIOL, V2, P481; Alrefai WA, 2001, DIGEST DIS SCI, V46, P2209, DOI 10.1023/A:1011971117097; [Anonymous], 2001, Wkly Epidemiol Rec, V76, P117; Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; Bhakdi S, 1996, ARCH MICROBIOL, V165, P73, DOI 10.1007/s002030050300; BIWERSI J, 1991, BIOCHEMISTRY-US, V30, P7879, DOI 10.1021/bi00246a001; BLAKE PA, 1980, ANNU REV MICROBIOL, V34, P341, DOI 10.1146/annurev.mi.34.100180.002013; Coelho A, 2000, INFECT IMMUN, V68, P1700, DOI 10.1128/IAI.68.3.1700-1705.2000; COELHO A, 1995, J CLIN MICROBIOL, V33, P114, DOI 10.1128/JCM.33.1.114-118.1995; Debellis L, 2001, AM J PHYSIOL-GASTR L, V281, pG1440, DOI 10.1152/ajpgi.2001.281.6.G1440; Eichstaedt S, 2009, CELL CALCIUM, V45, P165, DOI 10.1016/j.ceca.2008.09.001; Faruque SM, 2004, P NATL ACAD SCI USA, V101, P2123, DOI 10.1073/pnas.0308485100; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Figueroa-Arredondo P, 2001, INFECT IMMUN, V69, P1613, DOI 10.1128/IAI.69.3.1613-1624.2001; FINCH MJ, 1987, AM J TROP MED HYG, V36, P393, DOI 10.4269/ajtmh.1987.36.393; Flemstrom G, 1999, AM J PHYSIOL-GASTR L, V277, pG375, DOI 10.1152/ajpgi.1999.277.2.G375; Gitter AH, 2000, PFLUG ARCH EUR J PHY, V439, P477, DOI 10.1007/s004240050966; Greger R, 1997, NEWS PHYSIOL SCI, V12, P62; HALL RH, 1990, INFECT IMMUN, V58, P3375, DOI 10.1128/IAI.58.10.3375-3379.1990; HICHINOSE Y, 1987, INFECT IMMUN, V55, P1090; Karaolis DKR, 1998, P NATL ACAD SCI USA, V95, P3134, DOI 10.1073/pnas.95.6.3134; Krasilnikov OV, 2007, BIOCHIMIE, V89, P271, DOI 10.1016/j.biochi.2006.12.003; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; Laohachai KN, 2003, TOXICON, V42, P687, DOI 10.1016/j.toxicon.2003.08.010; Mall M, 1999, AM J PHYSIOL-GASTR L, V277, pG709, DOI 10.1152/ajpgi.1999.277.3.G709; Mayol JM, 2006, WORLD J GASTROENTERO, V12, P5523, DOI 10.3748/wjg.v12.i34.5523; Moschetta A, 2003, BIOL CELL, V95, P115, DOI 10.1016/S0248-4900(03)00011-X; Moschioni M, 2002, CELL MICROBIOL, V4, P397, DOI 10.1046/j.1462-5822.2002.00199.x; Nagamune K, 1997, J BIOL CHEM, V272, P1338, DOI 10.1074/jbc.272.2.1338; Ninin E, 2000, EUR J CLIN MICROBIOL, V19, P489, DOI 10.1007/s100960000296; Pantano S, 2006, TOXICON, V47, P35, DOI 10.1016/j.toxicon.2005.09.007; Peixoto EBMI, 2005, CELL STRUCT FUNCT, V29, P165, DOI 10.1247/csf.29.165; Prasad M, 1997, SURGERY, V121, P430, DOI 10.1016/S0039-6060(97)90314-7; Saha D. R., 2006, Indian Journal of Experimental Biology, V44, P221; Saha PK, 1996, J CLIN MICROBIOL, V34, P1114, DOI 10.1128/JCM.34.5.1114-1117.1996; Saka HA, 2007, AUTOPHAGY, V3, P363, DOI 10.4161/auto.4159; SANDLE GI, 1986, GUT, V27, P999, DOI 10.1136/gut.27.9.999; SANYAL SC, 1984, AUST J EXP BIOL MED, V62, P515, DOI 10.1038/icb.1984.48; Singh DV, 2001, APPL ENVIRON MICROB, V67, P910, DOI 10.1128/AEM.67.2.910-921.2001; Spirli C, 2001, GASTROENTEROLOGY, V121, P156, DOI 10.1053/gast.2001.25516; Strugala V, 2003, P NUTR SOC, V62, P237, DOI 10.1079/PNS2002205; Yamada Shozo, 1990, Endocr Pathol, V1, P58, DOI 10.1007/BF02915156; Zitzer A, 1999, J BIOL CHEM, V274, P1375, DOI 10.1074/jbc.274.3.1375; Zitzer A, 1997, EUR J BIOCHEM, V247, P209, DOI 10.1111/j.1432-1033.1997.00209.x; ZITZER AO, 1993, ZBL BAKT-INT J MED M, V279, P494, DOI 10.1016/S0934-8840(11)80421-4	46	24	26	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e5074	10.1371/journal.pone.0005074	http://dx.doi.org/10.1371/journal.pone.0005074			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333391	gold, Green Published, Green Submitted			2022-12-25	WOS:000265499900020
J	Potier, M; Gonzalez, JC; Motiani, RK; Abdullaev, IF; Bisaillon, JM; Singer, HA; Trebak, M				Potier, Marie; Gonzalez, Jose C.; Motiani, Rajender K.; Abdullaev, Iskandar F.; Bisaillon, Jonathan M.; Singer, Harold A.; Trebak, Mohamed			Evidence for STIM1-and Orai1-dependent store-operated calcium influx through I-CRAC in vascular smooth muscle cells: role in proliferation and migration	FASEB JOURNAL			English	Article						Ca2+ release-activated Ca2+ channels; store-operated Ca2+ entry channels; TRPC channels; phenotypic modulation	CAPACITATIVE CA2+ ENTRY; CHANNELS; ACTIVATION; DEPLETION; ORAI1; INHIBITION; CURRENTS; TRPC1; TRANSCRIPTION; POTENTIATION	The identity of store-operated calcium (Ca2+) entry (SOCE) channels in vascular smooth muscle cells (VSMCs) remains a highly contentious issue. Whereas previous studies have suggested that SOCE in VSMCs is mediated by the nonselective transient receptor potential canonical (TRPC) 1 protein, the identification of STIM1 and Orai1 as essential components of I-CRAC, a highly Ca2+-selective SOCE current in leukocytes, has challenged that view. Here we show that cultured proliferative migratory VSMCs isolated from rat aorta (called "synthetic") display SOCE with classic features, namely inhibition by 2-aminoethoxydiphenyl borate, ML-9, and low concentrations of lanthanides. On store depletion, synthetic VSMCs and A7r5 cells display currents with characteristics of I-CRAC. Protein knockdown of either STIM1 or Orai1 in synthetic VSMCs greatly reduced SOCE, whereas Orai2, Orai3, TRPC1, TRPC4, and TRPC6 knockdown had no effect. Orai1 knockdown reduced I-CRAC in synthetic VSMCs and A7r5 cells. Synthetic VSMCs showed up-regulated STIM1/Orai1 proteins and SOCE compared with quiescent freshly isolated VSMC. Knockdown of STIM1 and Orai1 inhibited synthetic VSMC proliferation and migration, whereas STIM2, Orai2, and Orai3 knockdown had no effect. To our knowledge, these results are the first to show I-CRAC in VSMCs and resolve a long-standing controversy by identifying CRAC as the elusive VSMC SOCE channel important for proliferation and migration.-Potier, M., Gonzalez, J. C., Motiani, R. K., Abdullaev, I. F., Bisaillon, J. M., Singer, H. A., and Trebak, M. Evidence for STIM1- and Orai1-dependent store-operated calcium influx through I-CRAC in vascular smooth muscle cells: role in proliferation and migration. FASEB J. 23, 2425-2437 (2009)	[Potier, Marie; Gonzalez, Jose C.; Motiani, Rajender K.; Abdullaev, Iskandar F.; Bisaillon, Jonathan M.; Singer, Harold A.; Trebak, Mohamed] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA	Albany Medical College	Trebak, M (corresponding author), Albany Med Coll, Ctr Cardiovasc Sci, MC8,47 New Scotland Ave, Albany, NY 12208 USA.	trebakm@mail.amc.edu	Abdullaev, Iskandar/AAH-2478-2021; Potier-Cartereau, marie/AAC-4510-2022; Trebak, Mohamed/E-7405-2014	Potier-Cartereau, marie/0000-0002-1361-3397; Potier, Marie-Claude/0000-0003-2462-7150	NIH [K22ES014729]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092510, R01HL049426, R01HL097111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K22ES014729] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by an NIH early career grant (K22ES014729) to M. T. We gratefully acknowledge Dr. Wayne DeHaven (National Institute of Environmental Health Sciences, NIH) for helpful advice on the patch-clamp recordings and Wendy Hobb for administrative assistance.	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Albert AP, 2007, J PHYSIOL-LONDON, V583, P25, DOI 10.1113/jphysiol.2007.137802; Albert AP, 2002, J PHYSIOL-LONDON, V538, P717, DOI 10.1113/jphysiol.2001.013101; Aubart FC, 2009, MOL THER, V17, P455, DOI 10.1038/mt.2008.291; Bakowski D, 2002, CELL CALCIUM, V32, P379, DOI 10.1016/S0143416002001914; Bergdahl A, 2005, AM J PHYSIOL-CELL PH, V288, pC872, DOI 10.1152/ajpcell.00334.2004; Berra-Romani R, 2008, AM J PHYSIOL-CELL PH, V295, pC779, DOI 10.1152/ajpcell.00173.2008; Broad LM, 1999, J PHYSIOL-LONDON, V517, P121, DOI 10.1111/j.1469-7793.1999.0121z.x; Brueggemann LI, 2006, J PHARMACOL EXP THER, V317, P488, DOI 10.1124/jpet.105.095067; Brueggemann LI, 2005, BIOCHEM J, V388, P237, DOI 10.1042/BJ20041360; CASTEELS R, 1981, J PHYSIOL-LONDON, V317, P263, DOI 10.1113/jphysiol.1981.sp013824; Csutora P, 2008, J BIOL CHEM, V283, P14524, DOI 10.1074/jbc.M709575200; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Dietrich A, 2007, PFLUG ARCH EUR J PHY, V455, P465, DOI 10.1007/s00424-007-0314-3; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Flemming R, 2003, BRIT J PHARMACOL, V139, P955, DOI 10.1038/sj.bjp.0705327; Giachini FRC, 2009, HYPERTENSION, V53, P409, DOI 10.1161/HYPERTENSIONAHA.108.124404; Golovina VA, 2001, AM J PHYSIOL-HEART C, V280, pH746, DOI 10.1152/ajpheart.2001.280.2.H746; Guo RW, 2009, CARDIOVASC RES, V81, P660, DOI 10.1093/cvr/cvn338; Gwack Y, 2007, CELL CALCIUM, V42, P145, DOI 10.1016/j.ceca.2007.03.007; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; House SJ, 2008, PFLUG ARCH EUR J PHY, V456, P769, DOI 10.1007/s00424-008-0491-8; House SJ, 2007, AM J PHYSIOL-CELL PH, V292, pC2276, DOI 10.1152/ajpcell.00606.2006; Kunichika N, 2004, AM J PHYSIOL-LUNG C, V287, pL962, DOI 10.1152/ajplung.00452.2003; Li J, 2008, CIRC RES, V103, pE97, DOI 10.1161/CIRCRESAHA.108.182931; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; McDaniel SS, 2001, AM J PHYSIOL-LUNG C, V280, pL870, DOI 10.1152/ajplung.2001.280.5.L870; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Ng LC, 2001, CIRC RES, V89, P923, DOI 10.1161/hh2201.100315; NILIUS B, 2004, SCI STKE, pPE36; Owens Gary K, 2007, Novartis Found Symp, V283, P174; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Peel SE, 2008, AM J RESP CELL MOL, V38, P744, DOI 10.1165/rcmb.2007-0395OC; Peel SE, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-119; Peinelt C, 2008, J PHYSIOL-LONDON, V586, P3061, DOI 10.1113/jphysiol.2008.151365; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Potier M, 2008, PFLUG ARCH EUR J PHY, V457, P405, DOI 10.1007/s00424-008-0533-2; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Smyth JT, 2008, J CELL SCI, V121, P762, DOI 10.1242/jcs.023903; Sweeney M, 2002, AM J PHYSIOL-LUNG C, V283, pL144, DOI 10.1152/ajplung.00412.2001; Trebak M, 2003, J BIOL CHEM, V278, P16244, DOI 10.1074/jbc.M300544200; Trebak M, 2002, J BIOL CHEM, V277, P21617, DOI 10.1074/jbc.M202549200; Trepakova ES, 2001, J BIOL CHEM, V276, P7782, DOI 10.1074/jbc.M010104200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wamhoff BR, 2006, CIRC RES, V98, P868, DOI 10.1161/01.RES.0000216596.73005.3c; Xu SZ, 2001, CIRC RES, V88, P84, DOI 10.1161/01.RES.88.1.84; Zarayskiy V, 2007, CHANNELS, V1, P246, DOI 10.4161/chan.4835; ZARAYSKIY VV, 2008, BIOPHYS J S, V94; ZWEIFACH A, 1995, J GEN PHYSIOL, V105, P209, DOI 10.1085/jgp.105.2.209	52	216	228	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2425	2437		10.1096/fj.09-131128	http://dx.doi.org/10.1096/fj.09-131128			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19364762	Green Published			2022-12-25	WOS:000268836700011
J	Chatterji, U; Bobardt, M; Selvarajah, S; Yang, F; Tang, HL; Sakamoto, N; Vuagniaux, G; Parkinson, T; Gallay, P				Chatterji, Udayan; Bobardt, Michael; Selvarajah, Suganya; Yang, Feng; Tang, Hengli; Sakamoto, Noayo; Vuagniaux, Gregoire; Parkinson, Tanya; Gallay, Philippe			The Isomerase Active Site of Cyclophilin A Is Critical for Hepatitis C Virus Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIS-TRANS ISOMERASE; CYCLOSPORINE-A; HOMOLOG NINAA; TYPE-1; INFECTION; PROTEIN; BINDING; RESISTANCE; INHIBITORS; THERAPY	Cyclosporine A and nonimmunosuppressive cyclophilin (Cyp) inhibitors such as Debio 025, NIM811, and SCY-635 block hepatitis C virus (HCV) replication in vitro. This effect was recently confirmed in HCV-infected patients where Debio 025 treatment dramatically decreased HCV viral load, suggesting that Cyps inhibitors represent a novel class of anti-HCV agents. However, it remains unclear how these compounds control HCV replication. Recent studies suggest that Cyps are important for HCV replication. However, a profound disagreement currently exists as to the respective roles of Cyp members in HCV replication. In this study, we analyzed the respective contribution of Cyp members to HCV replication by specifically knocking down their expression by both transient and stable small RNA interference. Only the CypA knockdown drastically decreased HCV replication. The re-expression of an exogenous CypA escape protein, which contains escape mutations at the small RNA interference recognition site, restored HCV replication, demonstrating the specificity for the CypA requirement. We then mutated residues that reside in the hydrophobic pocket of CypA where proline-containing peptide substrates and cyclosporine A bind and that are vital for the enzymatic or the hydrophobic pocket binding activity of CypA. Remarkably, these CypA mutants fail to restore HCV replication, suggesting for the first time that HCV exploits either the isomerase or the chaperone activity of CypA to replicate in hepatocytes and that CypA is the principal mediator of the Cyp inhibitor anti-HCV activity. Moreover, we demonstrated that the HCV NS5B polymerase associates with CypA via its enzymatic pocket. The study of the roles of Cyps in HCV replication should lead to the identification of new targets for the development of alternate anti-HCV therapies.	[Gallay, Philippe] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Yang, Feng; Tang, Hengli] Florida State Univ, Tallahassee, FL 32306 USA; [Sakamoto, Noayo] Tokyo Med & Dent Univ, Tokyo 1138519, Japan; [Parkinson, Tanya] Pfizer Ltd, Sandwich CT13 9NJ, Kent, England; [Vuagniaux, Gregoire] Debiopharm, CH-1002 Lausanne, Switzerland	Scripps Research Institute; State University System of Florida; Florida State University; Tokyo Medical & Dental University (TMDU); Pfizer; Debiopharm	Gallay, P (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, IMM 9,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gallay@scripps.edu	Tang, Hengli/F-2085-2014; Sakamoto, Naoya/G-2734-2012	Sakamoto, Naoya/0000-0003-0061-059X				Akiyama H, 1997, BONE MARROW TRANSPL, V20, P993, DOI 10.1038/sj.bmt.1700996; BANG H, 1991, BIOMED BIOCHIM ACTA, V50, pS137; Bieniasz PD, 2004, NAT IMMUNOL, V5, P1109, DOI 10.1038/ni1125; Braaten D, 2001, EMBO J, V20, P1300, DOI 10.1093/emboj/20.6.1300; Braaten D, 1996, J VIROL, V70, P3551, DOI 10.1128/JVI.70.6.3551-3560.1996; Braaten D, 1997, J VIROL, V71, P2107, DOI 10.1128/JVI.71.3.2107-2113.1997; Coelmont L, 2009, ANTIMICROB AGENTS CH, V53, P967, DOI 10.1128/AAC.00939-08; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; Cullen BR, 2003, NAT MED, V9, P1112, DOI 10.1038/nm0903-1112; Eckert B, 2005, NAT STRUCT MOL BIOL, V12, P619, DOI 10.1038/nsmb946; Fernandes F, 2007, HEPATOLOGY, V46, P1026, DOI 10.1002/hep.21809; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; Fischer G, 2006, MOL MICROBIOL, V61, P1388, DOI 10.1111/j.1365-2958.2006.05349.x; Flisiak R, 2008, HEPATOLOGY, V47, P817, DOI 10.1002/hep.22131; Flisiak R, 2007, EXPERT OPIN INV DRUG, V16, P1345, DOI 10.1517/13543784.16.9.1345; FRANKE EK, 1994, NATURE, V372, P359, DOI 10.1038/372359a0; Goto K, 2006, BIOCHEM BIOPH RES CO, V343, P879, DOI 10.1016/j.bbrc.2006.03.059; GOTO K, 2008, 14 INT S HEP C VIR G, pP235; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Hayashi N, 2006, J GASTROENTEROL, V41, P17, DOI 10.1007/s00535-005-1740-7; HOPKINS S, 2008, 59 ANN M AM ASS STUD; HUBNER D, 1991, FEBS LETT, V284, P79, DOI 10.1016/0014-5793(91)80766-V; Inoue K, 2005, TRANSPLANT P, V37, P1233, DOI 10.1016/j.transproceed.2004.11.041; Inoue K, 2003, J GASTROENTEROL, V38, P567, DOI 10.1007/s00535-002-1104-5; Ishii N, 2006, J VIROL, V80, P4510, DOI 10.1128/JVI.80.9.4510-4520.2006; Kao CL, 2001, J CLIN MICROBIOL, V39, P3672, DOI 10.1128/JCM.39.10.3672-3677.2001; Kapadia SB, 2003, P NATL ACAD SCI USA, V100, P2014, DOI 10.1073/pnas.252783999; KAUL A, 2008, 15 INT S HEP C VIR R; LANG K, 1987, NATURE, V329, P268, DOI 10.1038/329268a0; Liu SK, 2004, NUCLEIC ACIDS RES, V32, P3752, DOI 10.1093/nar/gkh715; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; Luban J, 2007, J VIROL, V81, P1054, DOI 10.1128/JVI.01519-06; Ma S, 2006, ANTIMICROB AGENTS CH, V50, P2976, DOI 10.1128/AAC.00310-06; Martin NC, 2006, J VIROL METHODS, V134, P74, DOI 10.1016/j.jviromet.2005.12.002; Mathy JE, 2008, ANTIMICROB AGENTS CH, V52, P3267, DOI 10.1128/AAC.00498-08; Nakagawa M, 2004, BIOCHEM BIOPH RES CO, V313, P42, DOI 10.1016/j.bbrc.2003.11.080; Paeshuyse J, 2006, HEPATOLOGY, V43, P761, DOI 10.1002/hep.21102; Pawlotsky JM, 2006, HEPATOLOGY, V43, pS207, DOI 10.1002/hep.21064; Robida JM, 2007, J VIROL, V81, P5829, DOI 10.1128/JVI.02524-06; Saphire ACS, 1999, EMBO J, V18, P6771, DOI 10.1093/emboj/18.23.6771; Schiene C, 2000, CURR OPIN STRUC BIOL, V10, P40, DOI 10.1016/S0959-440X(99)00046-9; Shin EC, 2005, HEPATOLOGY, V42, p245A; Sokolskaja E, 2004, J VIROL, V78, P12800, DOI 10.1128/JVI.78.23.12800-12808.2004; STAMNES MA, 1991, CELL, V65, P219, DOI 10.1016/0092-8674(91)90156-S; THALI M, 1994, NATURE, V372, P363, DOI 10.1038/372363a0; Towers GJ, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-40; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; Watashi K, 2003, HEPATOLOGY, V38, P1282, DOI 10.1053/jhep.2003.50449; Watashi K, 2005, MOL CELL, V19, P111, DOI 10.1016/j.molcel.2005.05.014; WEIDMANN B, 2008, 15 INT S HEP C VIR R; Yang F, 2008, J VIROL, V82, P5269, DOI 10.1128/JVI.02614-07; ZYDOWSKY LD, 1992, PROTEIN SCI, V1, P1092, DOI 10.1002/pro.5560010903	52	155	171	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16998	17005		10.1074/jbc.M109.007625	http://dx.doi.org/10.1074/jbc.M109.007625			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19380579	Green Published			2022-12-25	WOS:000266962400037
J	Kaur, H; Kumar, C; Junot, C; Toledano, MB; Bachhawat, AK				Kaur, Hardeep; Kumar, Chitranshu; Junot, Christophe; Toledano, Michel B.; Bachhawat, Anand K.			Dug1p Is a Cys-Gly Peptidase of the gamma-Glutamyl Cycle of Saccharomyces cerevisiae and Represents a Novel Family of Cys-Gly Peptidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; SCHIZOSACCHAROMYCES-POMBE; GLUTATHIONE TRANSPORTER; LEUCYL AMINOPEPTIDASE; RENAL DIPEPTIDASE; PURIFICATION; CYSTEINYLGLYCINE; IDENTIFICATION; TRANSPEPTIDASE; DEGRADATION	GSH metabolism in yeast is carried out by the gamma-glutamyl cycle as well as by the DUG complex. One of the last steps in the gamma-glutamyl cycle is the cleavage of Cys-Gly by a peptidase to the constitutent amino acids. Saccharomyces cerevisiae extracts carry Cys-Gly dipeptidase activity, but the corresponding gene has not yet been identified. We describe the isolation and characterization of a novel Cys-Gly dipeptidase, encoded by the DUG1 gene. Dug1p had previously been identified as part of the Dug1p-Dug2p-Dug3p complex that operates as an alternate GSH degradation pathway and has also been suggested to function as a possible di- or tripeptidase based on genetic studies. We show here that Dug1p is a homodimer that can also function in a Dug2-Dug3-independent manner as a dipeptidase with high specificity for Cys-Gly and no activity toward tri- or tetrapeptides in vitro. This activity requires zinc or manganese ions. Yeast cells lacking Dug1p (dug1 Delta) accumulate Cys-Gly. Unlike all other Cys-Gly peptidases, which are members of the metallopeptidase M17, M19, or M1 families, Dug1p is the first to belong to the M20A family. We also show that the Dug1p Schizosaccharomyces pombe orthologue functions as the exclusive Cys-Gly peptidase in this organism. The human orthologue CNDP2 also displays Cys-Gly peptidase activity, as seen by complementation of the dug1 Delta mutant and by biochemical characterization, which revealed a high substrate specificity and affinity for Cys-Gly. The results indicate that the Dug1p family represents a novel class of Cys-Gly dipeptidases.	[Kaur, Hardeep; Bachhawat, Anand K.] Inst Microbial Technol, Chandigarh 160036, India; [Kumar, Chitranshu; Toledano, Michel B.] CEA Saclay, Lab Stress Oxydants & Cancers, F-91191 Gif Sur Yvette, France; [Junot, Christophe] CEA, Serv Pharmacol & Immunoanal, DSV, iBiTec S,SPI, F-91191 Gif Sur Yvette, France	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Bachhawat, AK (corresponding author), Inst Microbial Technol, Sector 39-A, Chandigarh 160036, India.	anand@imtech.res.in	Junot, Christophe/AAG-2251-2020		Department of Science and Technology, Government of India; Department of Biotechnology, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	Supported by grant-in-aid projects from the Department of Science and Technology, Government of India, and the Department of Biotechnology, Government of India. To whom correspondence should be addressed.	ADACHI H, 1989, J BIOCHEM-TOKYO, V105, P957, DOI 10.1093/oxfordjournals.jbchem.a122787; Alfa C, 1993, EXPT FISSION YEAST L; Bourbouloux A, 2000, J BIOL CHEM, V275, P13259, DOI 10.1074/jbc.275.18.13259; CAMPBELL BJ, 1984, J BIOL CHEM, V259, P4586; Cappiello M, 2004, BIOCHEM J, V378, P35, DOI 10.1042/BJ20031336; Chaudhuri B, 1997, GENETICS, V145, P75; Chu LR, 2008, J BIOL CHEM, V283, P19351, DOI 10.1074/jbc.M801034200; Del Bello B, 1999, FASEB J, V13, P69; Dominici S, 1999, FREE RADICAL BIO MED, V27, P623, DOI 10.1016/S0891-5849(99)00111-2; Dringen R, 2001, J NEUROSCI RES, V66, P1003, DOI 10.1002/jnr.10042; Enoiu M, 2000, FREE RADICAL BIO MED, V29, P825, DOI 10.1016/S0891-5849(00)00370-1; FAHEY RC, 1987, J MOL EVOL, V25, P81, DOI 10.1007/BF02100044; FERGUSON KA, 1964, METABOLISM, V13, P985, DOI 10.1016/S0026-0495(64)80018-4; Fujita Y, 2004, BIOSCI BIOTECH BIOCH, V68, P306, DOI 10.1271/bbb.68.306; GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627; Ganguli D, 2007, GENETICS, V175, P1137, DOI 10.1534/genetics.106.066944; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JASPERS CJ, 1985, PHYTOCHEMISTRY, V24, P703; Josch C, 2003, BIOL CHEM, V384, P213, DOI 10.1515/BC.2003.023; KOZAK EM, 1982, J BIOL CHEM, V257, P6322; Kumada HO, 2007, BIOSCI BIOTECH BIOCH, V71, P3102, DOI 10.1271/bbb.70443; Kumar C, 2003, FEMS MICROBIOL LETT, V219, P187, DOI 10.1016/S0378-1097(03)00059-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lafaye A, 2005, J BIOL CHEM, V280, P24723, DOI 10.1074/JBC.M502285200; Madalinski G, 2008, ANAL CHEM, V80, P3291, DOI 10.1021/ac7024915; MCINTYRE T, 1982, J BIOL CHEM, V257, P1915; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; OLSON CK, 1950, J BIOL CHEM, V186, P731; Otani H, 2005, J BIOCHEM, V137, P167, DOI 10.1093/jb/mvi016; Paolicchi A, 2002, BIOCHEM PHARMACOL, V64, P1027, DOI 10.1016/S0006-2952(02)01173-5; Penninckx MJ, 2002, FEMS YEAST RES, V2, P295, DOI 10.1111/j.1567-1364.2002.tb00098.x; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; SHERWOOD RF, 1985, EUR J BIOCHEM, V148, P447, DOI 10.1111/j.1432-1033.1985.tb08860.x; Srikanth CV, 2005, CURR GENET, V47, P345, DOI 10.1007/s00294-005-0571-7; Suzuki H, 2001, J BACTERIOL, V183, P1489, DOI 10.1128/JB.183.4.1489-1490.2001; Suzuki H, 2001, BIOSCI BIOTECH BIOCH, V65, P1549, DOI 10.1271/bbb.65.1549; Teufel M, 2003, J BIOL CHEM, V278, P6521, DOI 10.1074/jbc.M209764200; Thakur A, 2008, FEMS YEAST RES, V8, P916, DOI 10.1111/j.1567-1364.2008.00423.x	38	58	64	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14493	14502		10.1074/jbc.M808952200	http://dx.doi.org/10.1074/jbc.M808952200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19346245	Green Published, hybrid			2022-12-25	WOS:000266286100056
J	Ngan, S; Stronach, EA; Photiou, A; Waxman, J; Ali, S; Buluwela, L				Ngan, S.; Stronach, E. A.; Photiou, A.; Waxman, J.; Ali, S.; Buluwela, L.			Microarray coupled to quantitative RT-PCR analysis of androgen-regulated genes in human LNCaP prostate cancer cells	ONCOGENE			English	Article						prostate cancer; LNCaP cells; androgens; anti-androgens; real-time RT-PCR; microarrays	LIGAND-BINDING DOMAIN; 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE; RECEPTOR ACTIVATION; RESPONSIVE GENES; TUMOR-SUPPRESSOR; NUCLEAR RECEPTOR; HORMONE-RECEPTOR; GROWTH; EXPRESSION; BETA	The androgen receptor (AR) mediates the growth-stimulatory effects of androgens in prostate cancer cells. Identification of androgen-regulated genes in prostate cancer cells is therefore of considerable importance for de. ning the mechanisms of prostate-cancer development and progression. Although several studies have used microarrays to identify AR-regulated genes in prostate cancer cell lines and in prostate tumours, we present here the results of gene expression microarray profiling of the androgen-responsive LNCaP prostate-cancer cell line treated with R1881 for the identification of androgen-regulated genes. We show that the expression of 319 genes is stimulated by 24h after R1881 addition, with a similar number (300) of genes being significantly repressed. Expression of the upregulated genes, as well as of 60 of the most robustly downregulated genes, was carried out using quantitative RT-PCR (Q-RT-PCR) over a time-course of R1881 treatment from 0 to 72 h. Q-RT-PCR was also carried out following treatment with other AR agonists (dihydrotestosterone, estradiol and medroxyprogesterone) and antagonists (cyproterone acetate, hydroxyflutamide and bicalutamide). This study provides a comprehensive analysis of androgen-regulated gene expression in the LNCaP prostate cancer cell line, and identifies a number of androgen-regulated genes, not described previously, as candidates for mediating androgen responses in prostate cancer cells. Oncogene (2009) 28, 2051-2063; doi:10.1038/onc.2009.68; published online 13 April 2009	[Ngan, S.; Stronach, E. A.; Photiou, A.; Waxman, J.; Ali, S.; Buluwela, L.] Univ London Imperial Coll Sci Technol & Med, Dept Oncol, London W1 0NN, England	Imperial College London	Ali, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Oncol, Du Cane Rd, London W1 0NN, England.	simak.ali@imperial.ac.uk; l.buluwela@imperial.ac.uk	Ali, Simak/M-6912-2018	Ali, Simak/0000-0002-1320-0816; Coombes, Raoul Charles/0000-0002-4811-1100	Joron trust; Hammersmith Hospital trustees; Prostate Cancer Charity; Cancer Research UK	Joron trust; Hammersmith Hospital trustees; Prostate Cancer Charity; Cancer Research UK(Cancer Research UK)	We are grateful to the members of the group for advice and support. Our particular thanks go to Drs Greg Brooke and Charlotte Bevan for discussions, and to Dr Lev Soinov for aiding the analysis of the microarray data. This work was carried out through the support of the Joron trust, Hammersmith Hospital trustees, Prostate Cancer Charity and Cancer Research UK.	Abdulkadir SA, 2002, MOL CELL BIOL, V22, P1495, DOI 10.1128/MCB.22.5.1495-1503.2002; Agoulnik IU, 2006, J CELL BIOCHEM, V99, P362, DOI 10.1002/jcb.20811; Akashi T, 2006, ONCOL REP, V16, P831; Arnold JT, 2007, PROSTATE, V67, P1152, DOI 10.1002/pros.20585; Brinkmann AO, 1999, J STEROID BIOCHEM, V69, P307, DOI 10.1016/S0960-0760(99)00049-7; Brooke GN, 2008, ONCOGENE, V27, P2941, DOI 10.1038/sj.onc.1210955; Burmester JK, 2004, HUM HERED, V57, P172, DOI 10.1159/000081443; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; CARTER HB, 1990, PROSTATE, V16, P39; Chen H, 2002, CANCER RES, V62, P338; Cheng I, 2006, JNCI-J NATL CANCER I, V98, P123, DOI 10.1093/jnci/djj013; Chintharlapalli S, 2005, J BIOL CHEM, V280, P24903, DOI 10.1074/jbc.M500107200; Chipuk JE, 2002, J BIOL CHEM, V277, P1240, DOI 10.1074/jbc.M108855200; CUNHA GR, 1987, ENDOCR REV, V8, P338, DOI 10.1210/edrv-8-3-338; DAVIES P, 1991, J ENDOCRINOL, V131, P5, DOI 10.1677/joe.0.1310005; Dehm SM, 2006, J CELL BIOCHEM, V99, P333, DOI 10.1002/jcb.20794; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Doesburg P, 1997, BIOCHEMISTRY-US, V36, P1052, DOI 10.1021/bi961775g; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Furr BJA, 1996, UROLOGY, V47, P13, DOI 10.1016/S0090-4295(96)80003-3; Gottlieb B, 2004, HUM MUTAT, V23, P527, DOI 10.1002/humu.20044; Guo YP, 1999, CANCER RES, V59, P1366; Guo YP, 1997, INT J CANCER, V71, P573, DOI 10.1002/(SICI)1097-0215(19970516)71:4<573::AID-IJC11>3.3.CO;2-1; Guo YP, 1998, CELL GROWTH DIFFER, V9, P185; Heemers HV, 2006, MOL ENDOCRINOL, V20, P2265, DOI 10.1210/me.2005-0479; Hodgson MC, 2007, CANCER RES, V67, P8388, DOI 10.1158/0008-5472.CAN-07-0617; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Ke N, 2004, CANCER RES, V64, P8208, DOI 10.1158/0008-5472.CAN-04-2134; Kim MJ, 2002, CANCER RES, V62, P2999; Kwok WK, 2005, CANCER RES, V65, P5153, DOI 10.1158/0008-5472.CAN-04-3785; Lau KM, 2000, CANCER RES, V60, P3175; Lee MY, 2009, BIOCHEM J, V417, P313, DOI 10.1042/BJ20080762; Lu NZ, 2006, PHARMACOL REV, V58, P782, DOI 10.1124/pr.58.4.9; Malkowicz SB, 1996, UROLOGY, V47, P29, DOI 10.1016/S0090-4295(96)80005-7; Masiello D, 2002, J BIOL CHEM, V277, P26321, DOI 10.1074/jbc.M203310200; MCCONNELL JD, 1991, UROL CLIN N AM, V18, P1; Myung SJ, 2006, P NATL ACAD SCI USA, V103, P12098, DOI 10.1073/pnas.0603235103; Nelson PS, 2002, P NATL ACAD SCI USA, V99, P11890, DOI 10.1073/pnas.182376299; Oettgen P, 2000, J BIOL CHEM, V275, P1216, DOI 10.1074/jbc.275.2.1216; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Qi W, 2008, BIOCHEM J, V416, P453, DOI 10.1042/BJ20080651; Rae JM, 2006, PROSTATE, V66, P886, DOI 10.1002/pros.20403; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Shanmugam I, 2007, CELL DEATH DIFFER, V14, P2085, DOI 10.1038/sj.cdd.4402227; Shilatifard A, 1997, P NATL ACAD SCI USA, V94, P3639, DOI 10.1073/pnas.94.8.3639; Simone F, 2003, BLOOD, V101, P2355, DOI 10.1182/blood-2002-06-1664; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sobel RE, 2005, J UROLOGY, V173, P342, DOI 10.1097/01.ju.0000141580.30910.57; Steketee K, 2002, INT J CANCER, V100, P309, DOI 10.1002/ijc.10495; Storlazzi CT, 2003, HUM MOL GENET, V12, P2349, DOI 10.1093/hmg/ddg237; Takahashi Y, 2007, MOL CARCINOGEN, V46, P117, DOI 10.1002/mc.20254; Tamura K, 2007, CANCER RES, V67, P5117, DOI 10.1158/0008-5472.CAN-06-4040; Taplin ME, 2004, J CELL BIOCHEM, V91, P483, DOI 10.1002/jcb.10653; VELDSCHOLTE J, 1992, BIOCHEMISTRY-US, V31, P2393, DOI 10.1021/bi00123a026; VELDSCHOLTE J, 1992, J STEROID BIOCHEM, V41, P665, DOI 10.1016/0960-0760(92)90401-4; Wolf I, 2006, CANCER RES, V66, P7818, DOI 10.1158/0008-5472.CAN-05-4368; Xiao WH, 2003, CANCER RES, V63, P4698; Ying JM, 2005, CLIN CANCER RES, V11, P6442, DOI 10.1158/1078-0432.CCR-05-0267; Yoon HG, 2006, MOL ENDOCRINOL, V20, P1048, DOI 10.1210/me.2005-0324; Yuen HF, 2006, MODERN PATHOL, V19, P931, DOI 10.1038/modpathol.3800602; Zha S, 2005, PROSTATE, V63, P316, DOI 10.1002/pros.20177; Zha S, 2003, CANCER RES, V63, P7365	63	52	52	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 14	2009	28	19					2051	2063		10.1038/onc.2009.68	http://dx.doi.org/10.1038/onc.2009.68			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	445BF	19363526				2022-12-25	WOS:000266023900006
J	Nam, J; Aguda, BD; Rath, B; Agarwal, S				Nam, Jin; Aguda, Baltazar D.; Rath, Bjoern; Agarwal, Sudha			Biomechanical Thresholds Regulate Inflammation through the NF-kappa B Pathway: Experiments and Modeling	PLOS ONE			English	Article								Background: During normal physical activities cartilage experiences dynamic compressive forces that are essential to maintain cartilage integrity. However, at non-physiologic levels these signals can induce inflammation and initiate cartilage destruction. Here, by examining the pro-inflammatory signaling networks, we developed a mathematical model to show the magnitude-dependent regulation of chondrocytic responses by compressive forces. Methodology/Principal Findings: Chondrocytic cells grown in 3-D scaffolds were subjected to various magnitudes of dynamic compressive strain (DCS), and the regulation of pro-inflammatory gene expression via activation of nuclear factor-kappa B (NF-kappa B) signaling cascade examined. Experimental evidences provide the existence of a threshold in the magnitude of DCS that regulates the mRNA expression of nitric oxide synthase (NOS2), an inducible pro-inflammatory enzyme. Interestingly, below this threshold, DCS inhibits the interleukin-1 beta (IL-1 beta)-induced pro-inflammatory gene expression, with the degree of suppression depending on the magnitude of DCS. This suppression of NOS2 by DCS correlates with the attenuation of the NF-kappa B signaling pathway as measured by IL-1 beta-induced phosphorylation of the inhibitor of kappa B (I kappa B)-alpha, degradation of I alpha B-alpha and I kappa B-beta, and subsequent nuclear translocation of NF-kappa B p65. A mathematical model developed to understand the complex dynamics of the system predicts two thresholds in the magnitudes of DCS, one for the inhibition of IL-1 beta-induced expression of NOS2 by DCS at low magnitudes, and second for the DCS-induced expression of NOS2 at higher magnitudes. Conclusions/Significance: Experimental and computational results indicate that biomechanical signals suppress and induce inflammation at critical thresholds through activation/suppression of the NF-kappa B signaling pathway. These thresholds arise due to the bistable behavior of the networks originating from the positive feedback loop between NF-kappa B and its target genes. These findings lay initial groundwork for the identification of the thresholds in physical activities that can differentiate its favorable actions from its unfavorable consequences on joints.			Agarwal, S (corresponding author), Ohio State Univ, Coll Dent, Biomech & Tissue Engn Lab, Columbus, OH 43210 USA.	agarwal.61@osu.edu	Rath, Björn/AAF-3938-2022; Rath, Björn/AFI-8239-2022	Nam, Jin/0000-0001-5117-8958	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT000646] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048781] Funding Source: NIH RePORTER; NCCIH NIH HHS [R01 AT000646, AT000646] Funding Source: Medline; NCRR NIH HHS [UL1 RR025755] Funding Source: Medline; NIAMS NIH HHS [R01 AR048781, AR048781] Funding Source: Medline	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Agarwal S, 2004, ARTHRITIS RHEUM-US, V50, P3541, DOI 10.1002/art.20601; Buckwalter JA, 2003, J ORTHOP SPORT PHYS, V33, P578, DOI 10.2519/jospt.2003.33.10.578; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Delarue FL, 2001, ONCOGENE, V20, P6531, DOI 10.1038/sj.onc.1204801; Dossumbekova A, 2007, ARTHRITIS RHEUM, V56, P3284, DOI 10.1002/art.22933; Ferretti M, 2005, J ORTHOP RES, V23, P1165, DOI 10.1016/j.orthres.2005.01.025; Fransen M, 2002, J RHEUMATOL, V29, P1737; Gabay O, 2008, OSTEOARTHR CARTILAGE, V16, P373, DOI 10.1016/j.joca.2007.06.016; Goldmann WH, 2002, CELL BIOL INT, V26, P313, DOI 10.1006/cbir.2002.0857; Hernandez-Molina G, 2008, ARTHRIT RHEUM-ARTHR, V59, P1221, DOI 10.1002/art.24010; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575; KUNZ D, 1994, P NATL ACAD SCI USA, V91, P5387, DOI 10.1073/pnas.91.12.5387; Madhavan S, 2007, J IMMUNOL, V179, P6246, DOI 10.4049/jimmunol.179.9.6246; Nam J, 2009, TISSUE ENG PT A, V15, P513, DOI 10.1089/ten.tea.2007.0353; Rath B, 2008, J BIOMECH, V41, P1095, DOI 10.1016/j.jbiomech.2007.11.024; Simkin PA, 1999, J RHEUMATOL, V26, P1987; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319	18	83	84	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2009	4	4							e5262	10.1371/journal.pone.0005262	http://dx.doi.org/10.1371/journal.pone.0005262			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TU	19370157	Green Published, Green Submitted, gold			2022-12-25	WOS:000265510600011
J	Santana, MS; de Lacerda, MVG; Barbosa, MDV; Alecrim, WD; Alecrim, MDC				Santana, Marli Stela; Guimaraes de Lacerda, Marcus Vinicius; Vale Barbosa, Maria das Gracas; Alecrim, Wilson Duarte; Costa Alecrim, Maria das Gracas			Glucose-6-Phosphate Dehydrogenase Deficiency in an Endemic Area for Malaria in Manaus: A Cross-Sectional Survey in the Brazilian Amazon	PLOS ONE			English	Article							G6PD DEFICIENCY; MOLECULAR CHARACTERIZATION; MUTATIONS	Background: There is a paucity of information regarding glucose-6-phosphate dehydrogenase (G6PD) deficiency in endemic areas for malaria in Latin America. Methodology/Principal Findings: This study determined the prevalence of the G6PD deficiency in 200 male non-consanguineous individuals residing in the Ismail Aziz Community, on the outskirts of Manaus (Brazilian Amazon). Six individuals (3%) were deficient using the qualitative Brewer's test. Gel electrophoresis showed that five of these patients were G6PD A(-). The deficiency was not associated with the ethnic origin (P = 0.571). In a multivariate logistic regression analysis, G6PD deficiency protected against three or more episodes of malaria (P = 0.049), independently of the age, and was associated with a history of jaundice (P = 0.020) and need of blood transfusion (P = 0.045) during previous treatment for malarial infection, independently of the age and the previous malarial exposure. Conclusions/Significance: The frequency of G6PD deficiency was similar to other studies performed in Brazil and the finding of a predominant G6PD A 2 variant will help the clinical management of patients with drug-induced haemolysis. The history of jaundice and blood transfusion during previous malarial infection may trigger the screening of patients for G6PD deficiency. The apparent protection against multiple malarial infections in an area primarily endemic for Plasmodium vivax needs further investigation.			Santana, MS (corresponding author), Univ State Amazonas, Manaus, Amazonas, Brazil.	marli.maciel@uol.com.br; marcuslacerda@uol.com.br	Santana, Marli/ABB-1259-2021; Barbosa Guerra, Maria das Graças/AGZ-7397-2022	Santana, Marli/0000-0001-8170-5181; 				Al-Riyami A, 2003, J TROP PEDIATRICS, V49, P1; Alecrim M das G, 1999, Rev Soc Bras Med Trop, V32, P67, DOI 10.1590/S0037-86821999000100013; Badens C, 2000, Hematol J, V1, P264, DOI 10.1038/sj.thj.6200042; Beutler E, 2002, BLOOD CELL MOL DIS, V28, P93, DOI 10.1006/bcmd.2002.0490; Beutler E, 2007, AM J TROP MED HYG, V77, P779, DOI 10.4269/ajtmh.2007.77.779; *BRAZ MIN HLTH, 2006, EP B MAL SIVEP; BREWER GJ, 1962, JAMA-J AM MED ASSOC, V180, P386, DOI 10.1001/jama.1962.03050180032008; Castro S, 2006, J MED SCREEN, V13, P85, DOI 10.1258/096914106777589641; Compri M B, 2000, Cad Saude Publica, V16, P335, DOI 10.1590/S0102-311X2000000200004; De Araujo C, 2006, HAEMATOL-HEMATOL J, V91, P262; de Lacerda MVG, 2007, REV SOC BRAS MED TRO, V40, P489, DOI 10.1590/S0037-86822007000400026; FORBES J, 1991, CLIN CHIM ACTA, V199, P279, DOI 10.1016/0009-8981(91)90121-R; *FUNASA, 2001, MAL THER GUID; GONCALVES MJF, 2004, BRAZIL REV SALUD PUB, V6, P156; GREENE LS, 1993, ANN HUM BIOL, V20, P497, DOI 10.1080/03014469300002892; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; Hamel AR, 2002, BLOOD CELL MOL DIS, V28, P399, DOI 10.1006/bcmd.2002.0524; Iwai K, 2001, HUM GENET, V108, P445, DOI 10.1007/s004390100527; Louicharoen C, 2005, J HUM GENET, V50, P448, DOI 10.1007/s10038-005-0276-2; LUZZATTO L, 1995, BRIT J HAEMATOL, V91, P511, DOI 10.1111/j.1365-2141.1995.tb05331.x; ROTH EF, 1983, P NATL ACAD SCI-BIOL, V80, P298, DOI 10.1073/pnas.80.1.298; Saad STO, 1997, HUM HERED, V47, P17, DOI 10.1159/000154383; Santana MS, 2007, REV SOC BRAS MED TRO, V40, P533, DOI 10.1590/S0037-86822007000500008; Silva Mônica C.M., 2004, Rev. Soc. Bras. Med. Trop., V37, P215, DOI 10.1590/S0037-86822004000300004; Sukumar S, 2004, BLOOD CELL MOL DIS, V33, P141, DOI 10.1016/j.bcmd.2004.06.003; Usanga EA, 2000, HUM HERED, V50, P158, DOI 10.1159/000022906; WEIMER TA, 1993, HUM BIOL, V65, P41; WHO, 2008, WHO REP; *WHO, 1975, J MED SCREEN, V13, P85; YOSHIDA A, 1971, B WORLD HEALTH ORGAN, V45, P243	30	27	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2009	4	4							e5259	10.1371/journal.pone.0005259	http://dx.doi.org/10.1371/journal.pone.0005259			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TU	19370159	gold, Green Submitted, Green Published			2022-12-25	WOS:000265510600010
J	Shachaf, CM; Elchuri, SV; Koh, AL; Zhu, J; Nguyen, LN; Mitchell, DJ; Zhang, JW; Swartz, KB; Sun, L; Chan, S; Sinclair, R; Nolan, GP				Shachaf, Catherine M.; Elchuri, Sailaja V.; Koh, Ai Leen; Zhu, Jing; Nguyen, Lienchi N.; Mitchell, Dennis J.; Zhang, Jingwu; Swartz, Kenneth B.; Sun, Lei; Chan, Selena; Sinclair, Robert; Nolan, Garry P.			A Novel Method for Detection of Phosphorylation in Single Cells by Surface Enhanced Raman Scattering (SERS) using Composite Organic-Inorganic Nanoparticles (COINs)	PLOS ONE			English	Article								Background: Detection of single cell epitopes has been a mainstay of immunophenotyping for over three decades, primarily using fluorescence techniques for quantitation. Fluorescence has broad overlapping spectra, limiting multiplexing abilities. Methodology/Principal Findings: To expand upon current detection systems, we developed a novel method for multi-color immuno-detection in single cells using "Composite Organic-Inorganic Nanoparticles'' (COINs) Raman nanoparticles. COINs are Surface-Enhanced Raman Scattering (SERS) nanoparticles, with unique Raman spectra. To measure Raman spectra in single cells, we constructed an automated, compact, low noise and sensitive Raman microscopy device (Integrated Raman BioAnalyzer). Using this technology, we detected proteins expressed on the surface in single cells that distinguish T-cells among human blood cells. Finally, we measured intracellular phosphorylation of Stat1 (Y701) and Stat6 (Y641), with results comparable to flow cytometry. Conclusions/Significance: Thus, we have demonstrated the practicality of applying COIN nanoparticles for measuring intracellular phosphorylation, offering new possibilities to expand on the current fluorescent technology used for immunoassays in single cells.			Shachaf, CM (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	gnolan@stanford.edu	Sinclair, Rodney/AAI-8355-2020; Nolan, Garry/AAE-7903-2019	Sinclair, Rodney/0000-0001-6751-1428; Nolan, Garry/0000-0002-8862-9043	NCI NIH HHS [U54 RFA-CA-05-024] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chattopadhyay PK, 2006, NAT MED, V12, P972, DOI 10.1038/nm1371; Doering WE, 2003, ANAL CHEM, V75, P6171, DOI 10.1021/ac034672u; FLEISCHMANN M, 1974, CHEM PHYS LETT, V26, P163, DOI 10.1016/0009-2614(74)85388-1; Goddard G, 2006, CYTOM PART A, V69A, P842, DOI 10.1002/cyto.a.20320; Grubisha DS, 2003, ANAL CHEM, V75, P5936, DOI 10.1021/ac034356f; Irish JM, 2006, NAT REV CANCER, V6, P146, DOI 10.1038/nrc1804; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Irish JM, 2007, BLOOD, V109, P2589, DOI 10.1182/blood-2006-02-004234; Irish JM, 2006, BLOOD, V108, P3135, DOI 10.1182/blood-2006-02-003921; Irish JM, 2006, J IMMUNOL, V177, P1581, DOI 10.4049/jimmunol.177.3.1581; Kneipp J, 2005, ANAL CHEM, V77, P2381, DOI 10.1021/ac050109v; Kneipp K, 1999, CHEM REV, V99, P2957, DOI 10.1021/cr980133r; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Lee AW, 2008, J VIROL, V82, P3702, DOI 10.1128/JVI.01582-07; Mulvaney SP, 2003, LANGMUIR, V19, P4784, DOI 10.1021/la026706j; Ni J, 1999, ANAL CHEM, V71, P4903, DOI 10.1021/ac990616a; Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102; Qian XM, 2008, NAT BIOTECHNOL, V26, P83, DOI 10.1038/nbt1377; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Shachaf CM, 2007, BLOOD, V110, P2674, DOI 10.1182/blood-2006-09-048033; Su X, 2005, NANO LETT, V5, P49, DOI 10.1021/nl0484088; Sun L, 2007, NANO LETT, V7, P351, DOI 10.1021/nl062453t; Van Meter MEM, 2007, BLOOD, V109, P3945, DOI 10.1182/blood-2006-09-047530; VO-DINH T, 1994, ANAL CHEM, V66, P3379, DOI 10.1021/ac00092a014; Watson DA, 2008, CYTOM PART A, V73A, P119, DOI 10.1002/cyto.a.20520	25	33	35	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2009	4	4							e5206	10.1371/journal.pone.0005206	http://dx.doi.org/10.1371/journal.pone.0005206			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TS	19367337	gold, Green Published, Green Submitted			2022-12-25	WOS:000265510400006
J	Noyes, HA; Alimohammadian, MH; Agaba, M; Brass, A; Fuchs, H; Gailus-Durner, V; Hulme, H; Iraqi, F; Kemp, S; Rathkolb, B; Wolf, E; de Angelis, MH; Roshandel, D; Naessens, J				Noyes, Harry A.; Alimohammadian, Mohammad H.; Agaba, Morris; Brass, Andy; Fuchs, Helmut; Gailus-Durner, Valerie; Hulme, Helen; Iraqi, Fuad; Kemp, Stephen; Rathkolb, Birgit; Wolf, Eckard; de Angelis, Martin Hrabe; Roshandel, Delnaz; Naessens, Jan			Mechanisms Controlling Anaemia in Trypanosoma congolense Infected Mice	PLOS ONE			English	Article								Background: Trypanosoma congolense are extracellular protozoan parasites of the blood stream of artiodactyls and are one of the main constraints on cattle production in Africa. In cattle, anaemia is the key feature of disease and persists after parasitaemia has declined to low or undetectable levels, but treatment to clear the parasites usually resolves the anaemia. Methodology/Principal Findings: The progress of anaemia after Trypanosoma congolense infection was followed in three mouse strains. Anaemia developed rapidly in all three strains until the peak of the first wave of parasitaemia. This was followed by a second phase, characterized by slower progress to severe anaemia in C57BL/6, by slow recovery in surviving A/J and a rapid recovery in BALB/c. There was no association between parasitaemia and severity of anaemia. Furthermore, functional T lymphocytes are not required for the induction of anaemia, since suppression of T cell activity with Cyclosporin A had neither an effect on the course of infection nor on anaemia. Expression of genes involved in erythropoiesis and iron metabolism was followed in spleen, liver and kidney tissues in the three strains of mice using microarrays. There was no evidence for a response to erythropoietin, consistent with anaemia of chronic disease, which is erythropoietin insensitive. However, the expression of transcription factors and genes involved in erythropoiesis and haemolysis did correlate with the expression of the inflammatory cytokines I/6 and Ifng. Conclusions/Significance: The innate immune response appears to be the major contributor to the inflammation associated with anaemia since suppression of T cells with CsA had no observable effect. Several transcription factors regulating haematopoiesis, Tal1, Gata1, Zfpm1 and Klf1 were expressed at consistently lower levels in C57BL/6 mice suggesting that these mice have a lower haematopoietic capacity and therefore less ability to recover from haemolysis induced anaemia after infection.			Noyes, HA (corresponding author), Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England.	j.naessens@cgiar.org	Noyes, Harry A/B-1151-2010; Rathkolb, Birgit/F-7041-2013; Zeef, Leo/D-6922-2011; Fuchs, Helmut/M-7347-2014; de Angelis, Martin Hrabe/F-5531-2012; Gailus-Durner, Valerie/M-7337-2014	Noyes, Harry A/0000-0002-0656-200X; Fuchs, Helmut/0000-0002-5143-2677; de Angelis, Martin Hrabe/0000-0002-7898-2353; Roshandel, Delnaz/0000-0002-4902-8587; Wolf, Eckhard/0000-0002-0430-9510; Brass, Andrew/0000-0002-0389-7058; Alimohammadian, Mohammad Hossein/0000-0003-3077-6638	Wellcome Trust [GR066764MA] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Anosa VO, 1997, COMP HAEMATOL INT, V7, P14, DOI 10.1007/BF01320994; ASSOKU RKG, 1989, VET PARASITOL, V31, P199, DOI 10.1016/0304-4017(89)90070-8; Beaumont C, 2004, M S-MED SCI, V20, P68, DOI 10.1051/medsci/200420168; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; CHENG TC, 1976, P NATL ACAD SCI USA, V73, P1811, DOI 10.1073/pnas.73.6.1811; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; ESIEVO KAN, 1990, J COMP PATHOL, V102, P357, DOI 10.1016/S0021-9975(08)80157-0; FACER CA, 1982, J COMP PATHOL, V92, P393, DOI 10.1016/0021-9975(82)90025-1; Ferreira R, 2005, MOL CELL BIOL, V25, P1215, DOI 10.1128/MCB.25.4.1215-1227.2005; Goh SH, 2007, PHYSIOL GENOMICS, V30, P172, DOI 10.1152/physiolgenomics.00247.2006; GREENBLATT HC, 1984, INFECT IMMUN, V43, P337, DOI 10.1128/IAI.43.1.337-340.1984; Gregory RC, 2000, CYTOKINE, V12, P845, DOI 10.1006/cyto.2000.0686; HAAN G, 1997, INTRINSIC EXTRINSIC, P529; KAZAZIAN HH, 1974, ANN NY ACAD SCI, V241, P170, DOI 10.1111/j.1749-6632.1974.tb21876.x; Kemp SJ, 1996, VET IMMUNOL IMMUNOP, V54, P239, DOI 10.1016/S0165-2427(96)05692-9; Kemp SJ, 1997, NAT GENET, V16, P194, DOI 10.1038/ng0697-194; Kierstein S, 2006, GENES IMMUN, V7, P667, DOI 10.1038/sj.gene.6364345; KOBAYASHI A, 1976, TROPENMED PARASITOL, V27, P411; Kristjanson PM, 1999, AGR SYST, V59, P79, DOI 10.1016/S0308-521X(98)00086-9; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Liang Y, 2007, NAT GENET, V39, P178, DOI 10.1038/ng1938; MABBOTT N, 1995, INFECT IMMUN, V63, P1563, DOI 10.1128/IAI.63.4.1563-1566.1995; Magez S, 2004, J INFECT DIS, V189, P527, DOI 10.1086/381151; Magez S, 1998, J IMMUNOL, V160, P1949; Mertens B, 1999, J INTERF CYTOK RES, V19, P59, DOI 10.1089/107999099314423; Moestrup SK, 2004, ANN MED, V36, P347, DOI 10.1080/07853890410033171; MORRISON WI, 1979, EXP PARASITOL, V48, P364, DOI 10.1016/0014-4894(79)90121-8; MORRISON WI, 1978, CLIN EXP IMMUNOL, V32, P25; MURRAY M, 1988, ACTA TROP, V45, P389; MURRAY M, 1982, ADV PARASIT, V21, P1, DOI 10.1016/S0065-308X(08)60274-2; Naessens J, 2006, INT J PARASITOL, V36, P521, DOI 10.1016/j.ijpara.2006.02.012; Naessens J, 2005, CLIN EXP IMMUNOL, V139, P405, DOI 10.1111/j.1365-2249.2004.02717.x; Naessens J, 2003, VET PARASITOL, V111, P125, DOI 10.1016/S0304-4017(02)00360-6; Naessens J, 2002, VET IMMUNOL IMMUNOP, V87, P187, DOI 10.1016/S0165-2427(02)00070-3; Nakamura Y, 2003, PARASITOL RES, V90, P171, DOI 10.1007/s00436-003-0844-3; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Ngure RM, 2008, VET PARASITOL, V151, P14, DOI 10.1016/j.vetpar.2007.10.007; Nok AJ, 2003, J BIOCHEM, V134, P173; Nok AJ, 2003, J BIOCHEM, V133, P725, DOI 10.1093/jb/mvg093; RIFKIN MR, 1990, P NATL ACAD SCI USA, V87, P801, DOI 10.1073/pnas.87.2.801; Sato T, 1999, BLOOD, V94, P2548, DOI 10.1182/blood.V94.8.2548.420k38_2548_2554; Schaer CA, 2007, J LEUKOCYTE BIOL, V82, P106, DOI 10.1189/jlb.0706453; Shamseddine A, 1998, EUR J GYNAECOL ONCOL, V19, P591; Shi MQ, 2005, INFECT IMMUN, V73, P8393, DOI 10.1128/IAI.73.12.8393-8396.2005; Shi MQ, 2004, J LEUKOCYTE BIOL, V76, P399, DOI 10.1189/jlb.1003500; Shih LY, 1999, J AM SOC NEPHROL, V10, P315; SILEGHEM M, 1995, EUR J IMMUNOL, V25, P1965, DOI 10.1002/eji.1830250725; Sileghem M, 2001, VET IMMUNOL IMMUNOP, V78, P325, DOI 10.1016/S0165-2427(01)00241-0; Stijemans B, 2007, VET PARASITOL, V148, P3, DOI 10.1016/j.vetpar.2007.05.005; Stijlemans B, 2008, IMMUNOBIOLOGY, V213, P823, DOI 10.1016/j.imbio.2008.07.023; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Taniguchi S, 1997, BLOOD, V90, P2244, DOI 10.1182/blood.V90.6.2244.2244_2244_2252; TRAIL JCM, 1992, VET PARASITOL, V42, P213, DOI 10.1016/0304-4017(92)90063-F; VANASSENDAELFT O, 1970, SPECTROPHOTOMETRY HA; Vanhollebeke B, 2007, P NATL ACAD SCI USA, V104, P4118, DOI 10.1073/pnas.0609902104; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Weiss G, 2002, BLOOD REV, V16, P87, DOI 10.1054/blre.2002.0193; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631; Zumkeller W, 2002, LEUKEMIA LYMPHOMA, V43, P487, DOI 10.1080/10428190290011958	60	35	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5170	10.1371/journal.pone.0005170	http://dx.doi.org/10.1371/journal.pone.0005170			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TN	19365556	Green Published, Green Submitted, gold			2022-12-25	WOS:000265509900005
J	Zinser, ER; Lindell, D; Johnson, ZI; Futschik, ME; Steglich, C; Coleman, ML; Wright, MA; Rector, T; Steen, R; McNulty, N; Thompson, LR; Chisholm, SW				Zinser, Erik R.; Lindell, Debbie; Johnson, Zackary I.; Futschik, Matthias E.; Steglich, Claudia; Coleman, Maureen L.; Wright, Matthew A.; Rector, Trent; Steen, Robert; McNulty, Nathan; Thompson, Luke R.; Chisholm, Sallie W.			Choreography of the Transcriptome, Photophysiology, and Cell Cycle of a Minimal Photoautotroph, Prochlorococcus	PLOS ONE			English	Article							LIGHT-INDUCIBLE POLYPEPTIDES; CYANOBACTERIUM SYNECHOCOCCUS-ELONGATUS; CIRCADIAN GENE-EXPRESSION; SYNECHOCYSTIS SP PCC-6803; GROUP-2 SIGMA-FACTORS; NORTH PACIFIC-OCEAN; SP STRAIN PCC-6803; PROBE LEVEL DATA; EQUATORIAL PACIFIC; PHOTOSYSTEM-II	The marine cyanobacterium Prochlorococcus MED4 has the smallest genome and cell size of all known photosynthetic organisms. Like all phototrophs at temperate latitudes, it experiences predictable daily variation in available light energy which leads to temporal regulation and partitioning of key cellular processes. To better understand the tempo and choreography of this minimal phototroph, we studied the entire transcriptome of the cell over a simulated daily light-dark cycle, and placed it in the context of diagnostic physiological and cell cycle parameters. All cells in the culture progressed through their cell cycles in synchrony, thus ensuring that our measurements reflected the behavior of individual cells. Ninety percent of the annotated genes were expressed, and 80% had cyclic expression over the diel cycle. For most genes, expression peaked near sunrise or sunset, although more subtle phasing of gene expression was also evident. Periodicities of the transcripts of genes involved in physiological processes such as in cell cycle progression, photosynthesis, and phosphorus metabolism tracked the timing of these activities relative to the light-dark cycle. Furthermore, the transitions between photosynthesis during the day and catabolic consumption of energy reserves at night-metabolic processes that share some of the same enzymes - appear to be tightly choreographed at the level of RNA expression. In-depth investigation of these patterns identified potential regulatory proteins involved in balancing these opposing pathways. Finally, while this analysis has not helped resolve how a cell with so little regulatory capacity, and a 'deficient' circadian mechanism, aligns its cell cycle and metabolism so tightly to a light- dark cycle, it does provide us with a valuable framework upon which to build when the Prochlorococcus proteome and metabolome become available.			Zinser, ER (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	chisholm@mit.edu	Futschik, Matthias/AAK-8837-2020; Johnson, Zackary I/E-4601-2011; Thompson, Luke R./Z-3344-2019	Futschik, Matthias/0000-0002-6245-8071; Johnson, Zackary I/0000-0003-0793-8512; Thompson, Luke R./0000-0002-3911-1280; Chisholm, Sallie/0000-0003-1480-2445; Coleman, Maureen/0000-0001-5065-0106; Lindell, Debbie/0000-0003-0612-4517				ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Badger MR, 2006, J EXP BOT, V57, P249, DOI 10.1093/jxb/eri286; Barber RT, 1996, DEEP-SEA RES PT II, V43, P933, DOI 10.1016/0967-0645(96)00035-5; Baroli I, 1998, PLANTA, V205, P288, DOI 10.1007/s004250050323; Battchikova N, 2007, PHYSIOL PLANTARUM, V131, P22, DOI 10.1111/j.1399-3054.2007.00929.x; Behrenfeld MJ, 1998, PHOTOSYNTH RES, V58, P259, DOI 10.1023/A:1006138630573; Behrenfeld MJ, 2004, J PHYCOL, V40, P4, DOI 10.1046/j.1529-8817.2004.03083.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertilsson S, 2003, LIMNOL OCEANOGR, V48, P1721, DOI 10.4319/lo.2003.48.5.1721; Bhaya D, 2002, FEMS MICROBIOL LETT, V215, P209, DOI 10.1111/j.1574-6968.2002.tb11393.x; Binder BJ, 1996, DEEP-SEA RES PT II, V43, P907, DOI 10.1016/0967-0645(96)00023-9; Bruyant F, 2005, LIMNOL OCEANOGR, V50, P850, DOI 10.4319/lo.2005.50.3.0850; Bukhov N, 2004, PHOTOSYNTH RES, V82, P17, DOI 10.1023/B:PRES.0000040442.59311.72; Burbage CD, 2007, J PHYCOL, V43, P266, DOI 10.1111/j.1529-8817.2007.00315.x; BUSTOS SA, 1990, J BACTERIOL, V172, P1998, DOI 10.1128/jb.172.4.1998-2004.1990; CAMPBELL L, 1994, LIMNOL OCEANOGR, V39, P954, DOI 10.4319/lo.1994.39.4.0954; CARPENTER EJ, 1988, MAR ECOL PROG SER, V43, P105, DOI 10.3354/meps043105; Cavender-Bares KK, 1999, LIMNOL OCEANOGR, V44, P237, DOI 10.4319/lo.1999.44.2.0237; Chen YB, 1998, J BACTERIOL, V180, P3598, DOI 10.1128/JB.180.14.3598-3605.1998; Choe SE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r16; Claustre H, 2002, LIMNOL OCEANOGR, V47, P1637, DOI 10.4319/lo.2002.47.6.1637; Coleman ML, 2006, SCIENCE, V311, P1768, DOI 10.1126/science.1122050; de Lichtenberg U, 2005, BIOINFORMATICS, V21, P1164, DOI 10.1093/bioinformatics/bti093; Diner BA, 2002, ANNU REV PLANT BIOL, V53, P551, DOI 10.1146/annurev.arplant.53.100301.135238; Dufresne A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r14; Espinosa J, 2006, MOL MICROBIOL, V61, P457, DOI 10.1111/j.1365-2958.2006.05231.x; Figge RM, 2000, MOL MICROBIOL, V36, P44, DOI 10.1046/j.1365-2958.2000.01806.x; Follows MJ, 2007, SCIENCE, V315, P1843, DOI 10.1126/science.1138544; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Futschik ME, 2008, BIOINFORMATICS, V24, P1063, DOI 10.1093/bioinformatics/btn072; Futschik Matthias E., 2005, Journal of Bioinformatics and Computational Biology, V3, P965, DOI 10.1142/S0219720005001375; Garczarek L, 2001, ENVIRON MICROBIOL, V3, P168, DOI 10.1046/j.1462-2920.2001.00173.x; Garczarek L, 2001, PLANT MOL BIOL, V46, P683, DOI 10.1023/A:1011681726654; Goldberg RN, 2004, BIOINFORMATICS, V20, P2874, DOI 10.1093/bioinformatics/bth314; Golden SS, 2003, NAT REV MICROBIOL, V1, P191, DOI 10.1038/nrmicro774; Golden SS, 2003, CURR OPIN MICROBIOL, V6, P535, DOI 10.1016/j.mib.2003.10.012; Hagen KD, 2001, J BIOL CHEM, V276, P11477, DOI 10.1074/jbc.M010472200; Havaux M, 2003, BBA-BIOENERGETICS, V1557, P21, DOI 10.1016/S0005-2728(02)00391-2; He QF, 2001, J BIOL CHEM, V276, P306, DOI 10.1074/jbc.M008686200; Holtzendorff J, 2001, J BACTERIOL, V183, P915, DOI 10.1128/JB.183.3.915-920.2001; Holtzendorff J, 2008, J BIOL RHYTHM, V23, P187, DOI 10.1177/0748730408316040; Howitt CA, 1999, J BACTERIOL, V181, P3994, DOI 10.1128/JB.181.13.3994-4003.1999; Imamura S, 2003, FEBS LETT, V554, P357, DOI 10.1016/S0014-5793(03)01188-8; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ivleva NB, 2006, P NATL ACAD SCI USA, V103, P17468, DOI 10.1073/pnas.0606639103; Iwasaki H, 2000, CELL, V101, P223, DOI 10.1016/S0092-8674(00)80832-6; Jacquet S, 2001, J PHYCOL, V37, P357, DOI 10.1046/j.1529-8817.2001.037003357.x; Johnson Z, 1999, DEEP-SEA RES PT II, V46, P1719, DOI 10.1016/S0967-0645(99)00041-7; Johnson Z, 2003, PHOTOSYNTH RES, V75, P85, DOI 10.1023/A:1022440305765; Johnson ZI, 2007, LIMNOL OCEANOGR-METH, V5, P417, DOI 10.4319/lom.2007.5.417; Johnson ZI, 2004, MAR ECOL PROG SER, V283, P73, DOI 10.3354/meps283073; Katayama M, 1999, J BACTERIOL, V181, P3516, DOI 10.1128/JB.181.11.3516-3524.1999; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; Kornberg A., 1992, DNA REPLICATION; Kucho K, 2005, J BACTERIOL, V187, P2190, DOI 10.1128/JB.187.6.2190-2199.2005; Kumar L, 2007, BIOINFORMATION, V2, P5, DOI 10.6026/97320630002005; Labiosa RG, 2006, J PHYCOL, V42, P622, DOI 10.1111/j.1529-8817.2006.00217.x; LEWIS MR, 1983, MAR ECOL PROG SER, V13, P99, DOI 10.3354/meps013099; Li H, 2000, J BACTERIOL, V182, P4268, DOI 10.1128/JB.182.15.4268-4277.2000; Lindell D, 2005, NATURE, V438, P86, DOI 10.1038/nature04111; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; Lindell D, 2007, NATURE, V449, P83, DOI 10.1038/nature06130; Liu HB, 1997, AQUAT MICROB ECOL, V12, P39, DOI 10.3354/ame012039; LIU Y, 1995, J BACTERIOL, V177, P2080, DOI 10.1128/jb.177.8.2080-2086.1995; LIU Y, 1995, GENE DEV, V9, P1469, DOI 10.1101/gad.9.12.1469; Martiny AC, 2006, P NATL ACAD SCI USA, V103, P12552, DOI 10.1073/pnas.0601301103; Mary I, 2008, ENVIRON MICROBIOL, V10, P2124, DOI 10.1111/j.1462-2920.2008.01633.x; MONGER BC, 1993, APPL ENVIRON MICROB, V59, P905, DOI 10.1128/AEM.59.3.905-911.1993; Moore LR, 2007, LIMNOL OCEANOGR-METH, V5, P353, DOI 10.4319/lom.2007.5.353; Moore LR, 2005, AQUAT MICROB ECOL, V39, P257, DOI 10.3354/ame039257; Moore LR, 2002, LIMNOL OCEANOGR, V47, P989, DOI 10.4319/lo.2002.47.4.0989; Muro-Pastor MI, 2005, PHOTOSYNTH RES, V83, P135, DOI 10.1007/s11120-004-2082-7; Nair U, 2002, J BACTERIOL, V184, P3530, DOI 10.1128/JB.184.13.3530-3538.2002; Nakamura Y, 1998, NUCLEIC ACIDS RES, V26, P63, DOI 10.1093/nar/26.1.63; OLSON RJ, 1985, DEEP-SEA RES, V32, P1273, DOI 10.1016/0198-0149(85)90009-3; Osmond CB, 1994, PHOTOINHIBITION PHOT, P1; Partensky F, 1996, DEEP-SEA RES PT I, V43, P1191, DOI 10.1016/0967-0637(96)00056-8; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Pichard SL, 1996, MAR ECOL PROG SER, V139, P257, DOI 10.3354/meps139257; Promnares K, 2006, J BIOL CHEM, V281, P32705, DOI 10.1074/jbc.M606360200; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Rothfield L, 2005, NAT REV MICROBIOL, V3, P959, DOI 10.1038/nrmicro1290; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sakshaug E, 1997, J PLANKTON RES, V19, P1637, DOI 10.1093/plankt/19.11.1637; Salem K, 2004, J BACTERIOL, V186, P1729, DOI 10.1128/JB.186.6.1729-1736.2004; SCHAEFER MR, 1989, J BIOL CHEM, V264, P7412; Shalapyonok A, 1998, APPL ENVIRON MICROB, V64, P1066; Smith RM, 2006, P NATL ACAD SCI USA, V103, P8564, DOI 10.1073/pnas.0508696103; So AKC, 2004, J BACTERIOL, V186, P623, DOI 10.1128/JB.186.3.623-630.2004; Steglich C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000173; Steglich C, 2006, J BACTERIOL, V188, P7796, DOI 10.1128/JB.01097-06; Stoeckel J, 2008, P NATL ACAD SCI USA, V105, P6156, DOI 10.1073/pnas.0711068105; Summerfield TC, 2007, J BACTERIOL, V189, P7829, DOI 10.1128/JB.01036-07; SWEENEY BM, 1989, J PHYCOL, V25, P183, DOI 10.1111/j.0022-3646.1989.00183.x; Takai N, 2006, P NATL ACAD SCI USA, V103, P12109, DOI 10.1073/pnas.0602955103; TALLING JF, 1966, J ECOL, V54, P99, DOI 10.2307/2257661; Tamoi M, 2005, PLANT J, V42, P504, DOI 10.1111/j.1365-313X.2005.02391.x; Toepel J, 2008, J BACTERIOL, V190, P3904, DOI 10.1128/JB.00206-08; Tolonen AC, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100087; Tsinoremas NF, 1996, EMBO J, V15, P2488, DOI 10.1002/j.1460-2075.1996.tb00606.x; Van Mooy BAS, 2006, P NATL ACAD SCI USA, V103, P8607, DOI 10.1073/pnas.0600540103; VAULOT D, 1995, SCIENCE, V268, P1480, DOI 10.1126/science.268.5216.1480; VAULOT D, 1989, CYTOMETRY, V10, P629, DOI 10.1002/cyto.990100519; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vicente M, 2006, J BACTERIOL, V188, P19, DOI 10.1128/JB.188.1.19-27.2006; Wang Q, 2008, PLANT PHYSIOL, V147, P1239, DOI 10.1104/pp.108.121087; WEBB WL, 1974, OECOLOGIA, V17, P281, DOI 10.1007/BF00345747; Wedel N, 1997, P NATL ACAD SCI USA, V94, P10479, DOI 10.1073/pnas.94.19.10479; West NJ, 1999, APPL ENVIRON MICROB, V65, P2585; Woelfle MA, 2006, J BIOL RHYTHM, V21, P419, DOI 10.1177/0748730406294418; Xu H, 2004, J BIOL CHEM, V279, P27971, DOI 10.1074/jbc.M403307200; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660; Yoshimura T, 2007, FEBS LETT, V581, P1495, DOI 10.1016/j.febslet.2007.03.010	115	142	142	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5135	10.1371/journal.pone.0005135	http://dx.doi.org/10.1371/journal.pone.0005135			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19352512	Green Published, Green Submitted, gold			2022-12-25	WOS:000265505700022
J	Di Filippo, M; Bernardi, G				Di Filippo, Miriam; Bernardi, Giorgio			The Early Apoptotic DNA Fragmentation Targets a Small Number of Specific Open Chromatin Regions	PLOS ONE			English	Article								We report here that early apoptotic DNA fragmentation, as obtained by using an entirely new approach, is the result of an attack at a small number of specific open chromatin regions of interphase nuclei. This was demonstrated as follows: (i) chicken liver was excised and kept in sterile tubes for 1 to 3 hours at 37 degrees C; (ii) this induced apoptosis (possibly because of oxygen deprivation), as shown by the electrophoretic nucleosomal ladder produced by DNA preparations; (iii) low molecular-weight DNA fragments (similar to 200 bp) were cloned, sequenced, and shown to derive predominantly from genes and surrounding 100 kb regions; (iv) a few hundred cuts were produced, very often involving the same chromosomal sites; (v) at comparable DNA degradation levels, micrococcal nuclease (MNase) also showed a general preference for genes and surrounding regions, but MNase cuts were located at sites that were quite distinct from, and less specific than, those cut by apoptosis. In conclusion, the approach presented here, which is the mildest and least intrusive approach, identifies a preferred accessibility landscape in interphase chromatin.	[Di Filippo, Miriam; Bernardi, Giorgio] Stn Zool Anton Dohrn, Lab Mol Evolut, Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli	Di Filippo, M (corresponding author), Stn Zool Anton Dohrn, Lab Mol Evolut, Naples, Italy.	bernardi@szn.it	Bernardi, Giorgio/G-1639-2011		Stazione Zoologica Anton Dohrn	Stazione Zoologica Anton Dohrn	The financing of the experiments was covered by Stazione Zoologica Anton Dohrn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardi G., 2005, STRUCTURAL EVOLUTION; Bernardi G, 2007, P NATL ACAD SCI USA, V104, P8385, DOI 10.1073/pnas.0701652104; COCKELL M, 1983, J MOL BIOL, V170, P423, DOI 10.1016/S0022-2836(83)80156-9; COMPTON MM, 1992, CANCER METAST REV, V11, P105, DOI 10.1007/BF00048058; Costantini M, 2007, GENE, V400, P9, DOI 10.1016/j.gene.2007.05.025; Coullin P, 2005, CHROMOSOME RES, V13, P665, DOI 10.1007/s10577-005-1004-7; Counis MF, 2006, BIOCHIMIE, V88, P1851, DOI 10.1016/j.biochi.2006.07.008; Counis MF, 2000, BIOCHEM CELL BIOL, V78, P405, DOI 10.1139/bcb-78-4-405; Di Filippo M, 2008, GENE, V419, P62, DOI 10.1016/j.gene.2008.02.012; DINGWALL C, 1981, NUCLEIC ACIDS RES, V9, P2659, DOI 10.1093/nar/9.12.2659; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; FILIPSKI J, 1990, EMBO J, V9, P1319, DOI 10.1002/j.1460-2075.1990.tb08241.x; FLICK JT, 1986, J MOL BIOL, V190, P619, DOI 10.1016/0022-2836(86)90247-0; FOX KR, 1992, NUCLEIC ACIDS RES, V20, P1235, DOI 10.1093/nar/20.6.1235; Hale AJ, 1996, EUR J BIOCHEM, V236, P1, DOI 10.1111/j.1432-1033.1996.00001.x; HEWISH DR, 1973, BIOCHEM BIOPH RES CO, V52, P504, DOI 10.1016/0006-291X(73)90740-7; HORZ W, 1981, NUCLEIC ACIDS RES, V9, P2643, DOI 10.1093/nar/9.12.2643; Hughes FM, 1998, CELL DEATH DIFFER, V5, P1017; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KORNBERG RD, 1989, METHOD ENZYMOL, V170, P3; Kornberg RD, 2007, NAT STRUCT MOL BIOL, V14, P986, DOI 10.1038/nsmb1107-986; OLOFSSON B, 1983, BIOCHIM BIOPHYS ACTA, V740, P339, DOI 10.1016/0167-4781(83)90143-4; Saccone S, 2002, GENE, V300, P169, DOI 10.1016/S0378-1119(02)01038-7; Scovassi AI, 2003, EUR J HISTOCHEM, V47, P185; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; Varriale A, 2006, GENE, V385, P111, DOI 10.1016/j.gene.2006.05.031; Walker PR, 1997, BIOCHEM CELL BIOL, V75, P287, DOI 10.1139/bcb-75-4-287; Widlak P, 2006, BIOCHEM CELL BIOL, V84, P405, DOI 10.1139/O06-063; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0	29	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2009	4	4							e5010	10.1371/journal.pone.0005010	http://dx.doi.org/10.1371/journal.pone.0005010			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RS	19347039	Green Submitted, Green Published, gold			2022-12-25	WOS:000265505200002
J	Nemolato, S; Messana, I; Cabras, T; Manconi, B; Inzitari, R; Fanali, C; Vento, G; Tirone, C; Romagnoli, C; Riva, A; Fanni, D; Di Felice, E; Faa, G; Castagnola, M				Nemolato, Sonia; Messana, Irene; Cabras, Tiziana; Manconi, Barbara; Inzitari, Rosanna; Fanali, Chiara; Vento, Giovanni; Tirone, Chiara; Romagnoli, Costantino; Riva, Alessandro; Fanni, Daniela; Di Felice, Eliana; Faa, Gavino; Castagnola, Massimo			Thymosin beta(4) and beta(10) Levels in Pre-Term Newborn Oral Cavity and Foetal Salivary Glands Evidence a Switch of Secretion during Foetal Development	PLOS ONE			English	Article							PARALLEL RELATION; BETA-4; EXPRESSION; MIGRATION; HPLC	Background: Thymosin beta(4), its sulfoxide, and thymosin beta(10) were detected in whole saliva of human pre-term newborns by reversed-phase high performance chromatography coupled to electrospray ion-trap mass spectrometry. Methodology/Principal Findings: Despite high inter-individual variability, concentration of beta-thymosins increases with an inversely proportional trend to postmenstrual age (PMA: gestational age plus chronological age after birth) reaching a value more than twenty times higher than in adult whole saliva at 190 days (27 weeks) of PMA (thymosin beta(4) concentration: more than 2.0 mu mol/L versus 0.1 mu mol/L). On the other hand, the ratio between thymosin beta(4) and thymosin beta(10) exhibits a constant value of about 4 along all the range of PMA (190-550 days of PMA) examined. In order to investigate thymosin beta(4) origin and to better establish the trend of its production as a function of gestational age (GA), immunohistochemical analysis of major and minor salivary glands of different pre-term fetuses were carried out, starting from 84 days (12 weeks) of gestational age. Reactive granules were seen in all glands with a maximum of expression around 140-150 days of GA, even though with high inter-and intra-individual variability. In infants and adults reactive granules in acinar cells were not observed, but just a diffuse cytoplasmatic staining in ductal cells. Significance: This study outlines for the first time that salivary glands during foetal life express and secrete peptides such as b-thymosins probably involved in the development of the oral cavity and its annexes. The secretion increases from about 12 weeks till to about 21 weeks of GA, subsequently it decreases, almost disappearing in the period of expected date of delivery, when the gland switches towards the secretion of adult specific salivary peptides. The switch observed may be an example of further secretion switches involving other exocrine and endocrine glands during foetal development.	[Nemolato, Sonia; Riva, Alessandro; Fanni, Daniela; Di Felice, Eliana; Faa, Gavino] Univ Cagliari, Dipartimento Citomorfol, Cagliari, Italy; [Messana, Irene; Cabras, Tiziana; Manconi, Barbara] Univ Cagliari, Dipartimento Sci Appl Biosist, Cagliari, Italy; [Inzitari, Rosanna; Fanali, Chiara; Castagnola, Massimo] Univ Cattolica, Ist Biochim Biochim Clin, Rome, Italy; [Inzitari, Rosanna; Fanali, Chiara; Castagnola, Massimo] Ist Sci Int ISI Paolo VI, Ist Chim Riconoscimento Mol, CNR, Rome, Italy; [Vento, Giovanni; Tirone, Chiara; Romagnoli, Costantino] Univ Cattolica, Ist Clin Pediat, Div Neonatol, Rome, Italy	University of Cagliari; University of Cagliari; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Nemolato, S (corresponding author), Univ Cagliari, Dipartimento Citomorfol, Cagliari, Italy.	massimo.castagnola@icrm.cnr.it	Tirone, Chiara/K-5579-2018; Castagnola, Massimo/AAM-6355-2021; Castagnola, Massimo/AAB-2825-2019; Cabras, Tiziana/AAF-6231-2020; Fanni, Daniela/ABD-9643-2020; Messana, Irene/L-2478-2019; Fanni, Daniela/N-5669-2016	Castagnola, Massimo/0000-0002-0959-7259; Fanni, Daniela/0000-0003-2797-8343; Messana, Irene/0000-0002-1436-6105; Fanni, Daniela/0000-0003-2797-8343; Vento, Giovanni/0000-0003-3121-9569; Faa, Gavino/0000-0002-6129-0975	Universita di Cagliari; Universita Cattolica in Rome; MIUR; Italian National Research Council (CNR); Regione Sardegna; Fondazione Banco di Sardegna; International Scientific Institute Paolo VI (ISI); Telethon [GGP06170]	Universita di Cagliari; Universita Cattolica in Rome; MIUR(Ministry of Education, Universities and Research (MIUR)); Italian National Research Council (CNR)(Consiglio Nazionale delle Ricerche (CNR)); Regione Sardegna(Regione Sardegna); Fondazione Banco di Sardegna(Fondazione Banco di Sardegna); International Scientific Institute Paolo VI (ISI); Telethon(Fondazione Telethon)	We acknowledge the financial support of Universita di Cagliari, Universita Cattolica in Rome, MIUR, Italian National Research Council (CNR), Regione Sardegna and Fondazione Banco di Sardegna, International Scientific Institute Paolo VI (ISI), and Telethon Grant N. GGP06170 thanks to their programs of scientific research promotion and diffusion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badamchian M, 2007, ANN NY ACAD SCI, V1112, P458, DOI 10.1196/annals.1415.046; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; GRANT DS, 1995, J CELL SCI, V108, P3685; Hannappel E, 2007, ANN NY ACAD SCI, V1112, P21, DOI 10.1196/annals.1415.018; Huff T, 2001, INT J BIOCHEM CELL B, V33, P205, DOI 10.1016/S1357-2725(00)00087-X; Huff T, 1997, ANAL CHIM ACTA, V352, P249, DOI 10.1016/S0003-2670(97)00132-3; Inzitari R, 2007, J PROTEOME RES, V6, P1371, DOI 10.1021/pr060520e; Inzitari R, 2009, J SEP SCI, V32, P57, DOI 10.1002/jssc.200800496; Lourenco SV, 2007, HISTOCHEM CELL BIOL, V128, P361, DOI 10.1007/s00418-007-0322-6; Lourenco SV, 2008, VIRCHOWS ARCH, V452, P427, DOI 10.1007/s00428-007-0552-y; LOW TLK, 1981, P NATL ACAD SCI-BIOL, V78, P1162, DOI 10.1073/pnas.78.2.1162; Malinda KM, 1997, FASEB J, V11, P474, DOI 10.1096/fasebj.11.6.9194528; Philp D, 2003, FASEB J, V17, P385, DOI 10.1096/fj.03-0244fje; Reti R, 2008, EUR J ORAL SCI, V116, P424, DOI 10.1111/j.1600-0722.2008.00569.x; Smart Nicola, 2007, Angiogenesis, V10, P229, DOI 10.1007/s10456-007-9077-x; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Sosne G, 2001, EXP EYE RES, V72, P605, DOI 10.1006/exer.2000.0985; WELLER FE, 1987, J IMMUNOASSAY, V8, P203, DOI 10.1080/15321818708057022; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5	19	37	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5109	10.1371/journal.pone.0005109	http://dx.doi.org/10.1371/journal.pone.0005109			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337364	gold, Green Published, Green Submitted			2022-12-25	WOS:000265500600025
J	Corney, D; Haynes, JD; Rees, G; Lotto, RB				Corney, David; Haynes, John-Dylan; Rees, Geraint; Lotto, R. Beau			The Brightness of Colour	PLOS ONE			English	Article							SPECTRALLY OPPONENT INPUTS; HUMAN LUMINANCE PATHWAY; CONE INPUTS; VISUAL-CORTEX; WAVELENGTH; SENSITIVITIES; STATISTICS; LIGHTNESS; SLOW; PHOTORECEPTOR	Background: The perception of brightness depends on spatial context: the same stimulus can appear light or dark depending on what surrounds it. A less well-known but equally important contextual phenomenon is that the colour of a stimulus can also alter its brightness. Specifically, stimuli that are more saturated (i.e. purer in colour) appear brighter than stimuli that are less saturated at the same luminance. Similarly, stimuli that are red or blue appear brighter than equiluminant yellow and green stimuli. This non-linear relationship between stimulus intensity and brightness, called the Helmholtz-Kohlrausch (HK) effect, was first described in the nineteenth century but has never been explained. Here, we take advantage of the relative simplicity of this 'illusion' to explain it and contextual effects more generally, by using a simple Bayesian ideal observer model of the human visual ecology. We also use fMRI brain scans to identify the neural correlates of brightness without changing the spatial context of the stimulus, which has complicated the interpretation of related fMRI studies. Results: Rather than modelling human vision directly, we use a Bayesian ideal observer to model human visual ecology. We show that the HK effect is a result of encoding the non-linear statistical relationship between retinal images and natural scenes that would have been experienced by the human visual system in the past. We further show that the complexity of this relationship is due to the response functions of the cone photoreceptors, which themselves are thought to represent an efficient solution to encoding the statistics of images. Finally, we show that the locus of the response to the relationship between images and scenes lies in the primary visual cortex (V1), if not earlier in the visual system, since the brightness of colours (as opposed to their luminance) accords with activity in V1 as measured with fMRI. Conclusions: The data suggest that perceptions of brightness represent a robust visual response to the likely sources of stimuli, as determined, in this instance, by the known statistical relationship between scenes and their retinal responses. While the responses of the early visual system (receptors in this case) may represent specifically the statistics of images, post receptor responses are more likely represent the statistical relationship between images and scenes. A corollary of this suggestion is that the visual cortex is adapted to relate the retinal image to behaviour given the statistics of its past interactions with the sources of retinal images: the visual cortex is adapted to the signals it receives from the eyes, and not directly to the world beyond.	[Corney, David; Lotto, R. Beau] UCL, Inst Ophthalmol, London, England; [Haynes, John-Dylan] Bernstein Ctr Computat Neurosci Berlin, Berlin, Germany; [Rees, Geraint] UCL, Inst Cognit Neurosci, London, England; [Rees, Geraint] UCL, Wellcome Trust Ctr Neuroimag, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London	Corney, D (corresponding author), UCL, Inst Ophthalmol, London, England.	lotto@ucl.ac.uk	Haynes, John-Dylan/Q-1148-2016; Rees, Geraint/C-1493-2008; Corney, David/P-6941-2019; Corney, David/C-1601-2008	Haynes, John-Dylan/0000-0003-1786-6954; Rees, Geraint/0000-0002-9623-7007; Corney, David/0000-0002-0651-9028	European Union [27731]	European Union(European Commission)	Work partially supported by European Union grant 27731. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews TJ, 2004, CURR BIOL, V14, P418, DOI 10.1016/j.cub.2004.02.030; Ayama M, 1998, COLOR RES APPL, V23, P274, DOI 10.1002/(SICI)1520-6378(199810)23:5<274::AID-COL4>3.0.CO;2-T; Boots B, 2007, NETWORK-COMP NEURAL, V18, P11, DOI 10.1080/09548980601113254; Bowmaker JK, 1997, VISION RES, V37, P2183, DOI 10.1016/S0042-6989(97)00026-6; Boyaci H, 2007, CURR BIOL, V17, P989, DOI 10.1016/j.cub.2007.05.005; Brainard DH, 2008, J VISION, V8, DOI 10.1167/8.5.15; Brainard DH, 1997, J OPT SOC AM A, V14, P1393, DOI 10.1364/JOSAA.14.001393; Conway BR, 2001, J NEUROSCI, V21, P2768, DOI 10.1523/JNEUROSCI.21-08-02768.2001; Cornelissen FW, 2006, J NEUROSCI, V26, P3634, DOI 10.1523/JNEUROSCI.4382-05.2006; Corney D, 2007, PLOS COMPUT BIOL, V3, P1790, DOI 10.1371/journal.pcbi.0030180; FAIRCHILD MD, 1998, COLOR APPEARANCE MOD; Foster DH, 2006, J OPT SOC AM A, V23, P2359, DOI 10.1364/JOSAA.23.002359; Foster DH, 2004, VISUAL NEUROSCI, V21, P331, DOI 10.1017/S0952523804213335; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Geisler W.S., 2003, VISUAL NEUROSCIENCES, P825; Gurney K, 2007, PHILOS T R SOC B, V362, P339, DOI 10.1098/rstb.2006.1962; Haynes JD, 2004, P NATL ACAD SCI USA, V101, P4286, DOI 10.1073/pnas.0307948101; Howe CQ, 2005, P NATL ACAD SCI USA, V102, P1228, DOI 10.1073/pnas.0409311102; Hung CP, 2001, VISION RES, V41, P1389, DOI 10.1016/S0042-6989(01)00075-X; Johnson EN, 2004, J NEUROPHYSIOL, V91, P2501, DOI 10.1152/jn.01043.2003; Kaiser P.K, 1996, HUMAN COLOR VISION; Knill DC, 1996, PERCEPTION BAYESIAN; LENNIE P, 1993, J OPT SOC AM A, V10, P1283, DOI 10.1364/JOSAA.10.001283; LENNIE P, 1990, J NEUROSCI, V10, P649; Lewis A, 2006, J VISION, V6, P285, DOI 10.1167/6.3.8; Long F, 2003, P NATL ACAD SCI USA, V100, P15190, DOI 10.1073/pnas.2036361100; Lotto RB, 2005, P NATL ACAD SCI USA, V102, P3852, DOI 10.1073/pnas.0500681102; Lotto RB, 2005, P NATL ACAD SCI USA, V102, P16870, DOI 10.1073/pnas.0503773102; MacEvoy SP, 2001, P NATL ACAD SCI USA, V98, P8827, DOI 10.1073/pnas.161280398; MALONEY LT, 1986, J OPT SOC AM A, V3, P1673, DOI 10.1364/JOSAA.3.001673; Mullen KT, 2007, EUR J NEUROSCI, V25, P491, DOI 10.1111/j.1460-9568.2007.05302.x; Murray SO, 2006, NAT NEUROSCI, V9, P429, DOI 10.1038/nn1641; Nayatani Y, 1998, COLOR RES APPL, V23, P374, DOI 10.1002/(SICI)1520-6378(199812)23:6<374::AID-COL5>3.0.CO;2-W; Osorio D, 2005, P ROY SOC B-BIOL SCI, V272, P1745, DOI 10.1098/rspb.2005.3156; Oxtoby EK, 2005, PERCEPTION, V34, P961, DOI 10.1068/p5186; Pridmore RW, 2007, COLOR RES APPL, V32, P208, DOI 10.1002/col.20312; Purves D., 2003, WHY WE SEE WHAT WE D; Regan BC, 2001, PHILOS T R SOC B, V356, P229, DOI 10.1098/rstb.2000.0773; Roe AW, 2005, P NATL ACAD SCI USA, V102, P3869, DOI 10.1073/pnas.0500097102; Schlessinger E, 2005, GECCO 2005: Genetic and Evolutionary Computation Conference, Vols 1 and 2, P115; Sharpe LT, 2005, J VISION, V5, P948, DOI 10.1167/5.11.3; Stockman A, 2005, J VISION, V5, P702, DOI 10.1167/5.9.5; Stockman A, 2005, J PHYSIOL-LONDON, V566, P77, DOI 10.1113/jphysiol.2005.084095; Stockman A, 2005, J PHYSIOL-LONDON, V566, P61, DOI 10.1113/jphysiol.2005.084046; Stockman A, 2000, VISION RES, V40, P1711, DOI 10.1016/S0042-6989(00)00021-3; Thomson EE, 2005, NEURAL COMPUT, V17, P741, DOI 10.1162/0899766053429435; von der Twer T, 2001, NETWORK-COMP NEURAL, V12, P395, DOI 10.1088/0954-898X/12/3/309; von Helmholtz H., 1867, TREATISE PHYSL OPTIC; Wachtler T, 2001, J OPT SOC AM A, V18, P65, DOI 10.1364/JOSAA.18.000065; Wandell BA, 2000, J COGNITIVE NEUROSCI, V12, P739, DOI 10.1162/089892900562561; Webster MA, 1997, VISION RES, V37, P3283, DOI 10.1016/S0042-6989(97)00125-9; WYSZECKI G, 1967, J OPT SOC AM, V57, P254, DOI 10.1364/JOSA.57.000254	53	28	29	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e5091	10.1371/journal.pone.0005091	http://dx.doi.org/10.1371/journal.pone.0005091			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333398	Green Published, Green Submitted, gold			2022-12-25	WOS:000265499900024
J	Percherancier, Y; Germain-Desprez, D; Galisson, F; Mascle, XH; Dianoux, L; Estephan, P; Chelbi-Alix, MK; Aubry, M				Percherancier, Yann; Germain-Desprez, Delphine; Galisson, Frederic; Mascle, Xavier H.; Dianoux, Laurent; Estephan, Patricia; Chelbi-Alix, Mounira K.; Aubry, Muriel			Role of SUMO in RNF4-mediated Promyelocytic Leukemia Protein (PML) Degradation SUMOYLATION OF PML AND PHOSPHO-SWITCH CONTROL OF ITS SUMO BINDING DOMAIN DISSECTED IN LIVING CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; NUCLEAR-BODY FORMATION; LIVING CELLS; UBIQUITIN LIGASE; TRANSFER BRET; RNF4; DYNAMICS; BODIES; ALPHA; RECRUITMENT	Promyelocytic leukemia protein (PML) is a tumor suppressor acting as the organizer of subnuclear structures called PML nuclear bodies (NBs). Both covalent modification of PML by the small ubiquitin-like modifier (SUMO) and non-covalent binding of SUMO to the PML SUMO binding domain (SBD) are necessary for PML NB formation and maturation. PML sumoylation and proteasome-dependent degradation induced by the E3 ubiquitin ligase, RNF4, are enhanced by the acute promyelocytic leukemia therapeutic agent, arsenic trioxide (As2O3). Here, we established a novel bioluminescence resonance energy transfer (BRET) assay to dissect and monitor PML/SUMO interactions dynamically in living cells upon addition of therapeutic agents. Using this sensitive and quantitative SUMO BRET assay that distinguishes PML sumoylation from SBD-mediated PML/SUMO non-covalent interactions, we probed the respective roles of covalent and non-covalent PML/SUMO interactions in PML degradation and interaction with RNF4. We found that, although dispensable for As2O3-enhanced PML sumoylation and RNF4 interaction, PML SBD core sequence was required for As2O3- and RNF4-induced PML degradation. As confirmed with a phosphomimetic mutant, phosphorylation of a stretch of serine residues, contained within PML SBD was needed for PML interaction with SUMO-modified protein partners and thus for NB maturation. However, mutation of these serine residues did not impair As2O3- and RNF4-induced PML degradation, contrasting with the known role of these phosphoserine residues for casein kinase 2-promoted PML degradation. Altogether, these data suggest a model whereby sumoylation- and SBD-dependent PML oligomerization within NBs is sufficient for RNF4-mediated PML degradation and does not require the phosphorylation-dependent association of PML with other sumoylated partners.	[Percherancier, Yann; Galisson, Frederic; Dianoux, Laurent; Chelbi-Alix, Mounira K.] Inst Andre Lwoff, CNRS, FRE2937, F-94801 Villejuif, France; [Germain-Desprez, Delphine; Mascle, Xavier H.; Estephan, Patricia; Aubry, Muriel] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada	Centre National de la Recherche Scientifique (CNRS); Universite de Montreal	Chelbi-Alix, MK (corresponding author), 7 Rue Guy Moquet, F-94801 Villejuif, France.	mchelbi@vjf.cnrs.fr; muriel.aubry@umontreal.ca		percherancier, yann/0000-0002-2410-5806	Natural Sciences and Engineering Research Council of Canada; Association pour la Recherche sur le Cancer; Ligue Nationale Contre le Cancer	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	This work was supported in part by a grant from Natural Sciences and Engineering Research Council of Canada (to M.A.), the Association pour la Recherche sur le Cancer, and the Ligue Nationale Contre le Cancer (to M.K. C.-A.).	Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Ayaydin F, 2004, MOL BIOL CELL, V15, P5208, DOI 10.1091/mbc.E04-07-0589; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; DETHE H, 1990, NATURE, V347, P558, DOI 10.1038/347558a0; Duprez E, 1999, J CELL SCI, V112, P381; Germain-Desprez D, 2003, J BIOL CHEM, V278, P22367, DOI 10.1074/jbc.M302234200; Hamdan FF, 2005, J BIOMOL SCREEN, V10, P463, DOI 10.1177/1087057105275344; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Kaiser FJ, 2003, J BIOL CHEM, V278, P38780, DOI 10.1074/jbc.M306259200; Kamitani T, 1998, J BIOL CHEM, V273, P26675, DOI 10.1074/jbc.273.41.26675; Lafarga M, 2002, MOL BIOL CELL, V13, P2771, DOI 10.1091/mbc.E02-03-0122; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Mascle XH, 2007, J BIOL CHEM, V282, P10190, DOI 10.1074/jbc.M611429200; Mukhopadhyay D, 2006, J CELL BIOL, V174, P939, DOI 10.1083/jcb.200510103; Negorev D, 2001, ONCOGENE, V20, P7234, DOI 10.1038/sj.onc.1204764; Percherancier Y, 2005, J BIOL CHEM, V280, P9895, DOI 10.1074/jbc.M411151200; Perroy J, 2004, NAT METHODS, V1, P203, DOI 10.1038/NMETH722; Petrie K, 2008, NAT CELL BIOL, V10, P507, DOI 10.1038/ncb0508-507; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Scaglioni PP, 2006, CELL, V126, P269, DOI 10.1016/j.cell.2006.05.041; Seeler JS, 2001, ONCOGENE, V20, P7243, DOI 10.1038/sj.onc.1204758; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Stehmeier P, 2009, MOL CELL, V33, P400, DOI 10.1016/j.molcel.2009.01.013; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Weidtkamp-Peters S, 2008, J CELL SCI, V121, P2731, DOI 10.1242/jcs.031922; Xu Y, 1999, P NATL ACAD SCI USA, V96, P151, DOI 10.1073/pnas.96.1.151; Yang XJ, 2006, MOL CELL, V23, P779, DOI 10.1016/j.molcel.2006.08.009; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zhu J, 1997, P NATL ACAD SCI USA, V94, P3978, DOI 10.1073/pnas.94.8.3978	32	47	51	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16595	16608		10.1074/jbc.M109.006387	http://dx.doi.org/10.1074/jbc.M109.006387			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19380586	Green Published, hybrid			2022-12-25	WOS:000266730900056
J	Qu, ZQ; Cheng, W; Cui, YY; Cui, YY; Zheng, J				Qu, Zhiqiang; Cheng, Wei; Cui, Yuanyuan; Cui, Yuanyuan; Zheng, Jie			Human Disease-causing Mutations Disrupt an N-C-terminal Interaction and Channel Function of Bestrophin 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-GATED CHANNELS; CHLORIDE CHANNEL; RETINAL DEGENERATION; MOUSE BESTROPHIN-2; CA2+ CHANNELS; CELLS; MEMBRANE; FAMILY; ELECTRORETINOGRAM; PRODUCT	Mutations in the human bestrophin 1 (hBest1) chloride channel cause Best vitelliform macular dystrophy. Although mutations in its transmembrane domains were found to alter biophysical properties of the channel, the mechanism for disease-causing mutations in its N and C termini remains elusive. We hypothesized that these mutations lead to channel dysfunction through disruption of an N-C-terminal interaction. Here, we present data demonstrating that hBest1 N and C termini indeed interact both in vivo and in vitro. In addition, using a spectrum-based fluorescence resonance energy transfer method, we showed that functional hBest1 channels in the plasma membrane were multimers. Disease-causing mutations in the N terminus (R19C, R25C, and K30C) and the C terminus (G299E, D301N, and D312N) caused channel dysfunction and disruption of the N-C interaction. Consistent with the functional and biochemical results, mutants D301N and D312N clearly reduced fluorescence resonance energy transfer signal, indicating that the N-C interaction was indeed perturbed. These results suggest that hBest1 functions as a multimer in the plasma membrane, and disruption of the N-C interaction by mutations leads to hBest1 channel dysfunction.	[Qu, Zhiqiang; Cui, Yuanyuan] Emory Univ, Dept Cell Biol, Sch Med, Atlanta, GA 30322 USA; [Cheng, Wei; Cui, Yuanyuan; Zheng, Jie] Univ Calif Davis, Dept Physiol & Membrane Biol, Sch Med, Davis, CA 95616 USA; [Qu, Zhiqiang] Qingdao Univ, Dept Physiol, Sch Med, Qingdao 266071, Shandong, Peoples R China	Emory University; University of California System; University of California Davis; Qingdao University	Qu, ZQ (corresponding author), Emory Univ, Dept Cell Biol, Sch Med, 615 Michael St,535 Whitehead Bldg, Atlanta, GA 30322 USA.	zqu@emory.edu	cheng, wei/F-2135-2011; Cui, Yuanyuan/G-1899-2015; Cui, Yuanyuan/G-1787-2017	Cui, Yuanyuan/0000-0002-1455-5643	National Institutes of Health [REY016754A, GM60448, EY014852]; American Federation of Aging; Qingdao University; American Heart Association [0665201Y]; National Center for Research Resources [C06-RR-12088-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012088] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY016754, R01EY014852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Federation of Aging; Qingdao University; American Heart Association(American Heart Association); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant REY016754A (to J. Z.), GM60448, and EY014852. This work was also supported by an American Federation of Aging Research Award and a Qingdao University Faculty Grant (to Z. Q.), American Heart Association Grant 0665201Y (to J. Z.), and Research Facilities Improvement Program Grant C06-RR-12088-01 from the National Center for Research Resources.	Brady JD, 2006, P NATL ACAD SCI USA, V103, P15635, DOI 10.1073/pnas.0603344103; Bykova EA, 2006, NAT STRUCT MOL BIOL, V13, P1115, DOI 10.1038/nsmb1176; Cheng W, 2007, J GEN PHYSIOL, V129, P191, DOI 10.1085/jgp.200709731; Chien LT, 2006, J GEN PHYSIOL, V128, P247, DOI 10.1085/jgp.200609581; Gallemore RP, 1997, PROG RETIN EYE RES, V16, P509, DOI 10.1016/S1350-9462(96)00037-7; Hartzell C, 2005, PHYSIOLOGY, V20, P292, DOI 10.1152/physiol.00021.2005; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; Marmorstein AD, 2000, P NATL ACAD SCI USA, V97, P12758, DOI 10.1073/pnas.220402097; Marmorstein AD, 2007, EXP EYE RES, V85, P423, DOI 10.1016/j.exer.2006.03.021; Marmorstein LY, 2006, J GEN PHYSIOL, V127, P577, DOI 10.1085/jgp.200509473; NEHER E, 1992, SCIENCE, V256, P498, DOI 10.1126/science.1373906; Pifferi S, 2006, P NATL ACAD SCI USA, V103, P12929, DOI 10.1073/pnas.0604505103; Qiang Z, 2007, J BIOL CHEM, V282, P17460, DOI 10.1074/jbc.M701043200; Qu ZQ, 2008, AM J PHYSIOL-CELL PH, V294, pC1371, DOI 10.1152/ajpcell.00398.2007; Qu ZQ, 2006, J NEUROSCI, V26, P5411, DOI 10.1523/JNEUROSCI.5500-05.2006; Qu ZQ, 2004, J GEN PHYSIOL, V124, P371, DOI 10.1085/jgp.200409108; Qu ZQ, 2004, J GEN PHYSIOL, V123, P327, DOI 10.1085/jgp.200409031; Qu ZQ, 2003, J BIOL CHEM, V278, P49563, DOI 10.1074/jbc.M308414200; Qu ZQ, 2000, J BIOL CHEM, V275, P31573, DOI 10.1074/jbc.M003473200; Rosenthal R, 2005, FASEB J, V19, P178, DOI 10.1096/fj.05-4495fje; SORIA RB, 2006, J BIOL CHEM, V281, P17460; Stanton JB, 2006, BBA-BIOMEMBRANES, V1758, P241, DOI 10.1016/j.bbamem.2006.01.024; Sun H, 2002, P NATL ACAD SCI USA, V99, P4008, DOI 10.1073/pnas.052692999; Takanishi CL, 2006, BRAIN RES, V1091, P132, DOI 10.1016/j.brainres.2006.01.119; Tsunenari T, 2003, J BIOL CHEM, V278, P41114, DOI 10.1074/jbc.M306150200; Tsunenari T, 2006, J GEN PHYSIOL, V127, P749, DOI 10.1085/jgp.200609527; Varnum MD, 1997, SCIENCE, V278, P110, DOI 10.1126/science.278.5335.110; WAJIMA R, 1993, OPHTHALMOLOGICA, V207, P174, DOI 10.1159/000310429; Xiao Q, 2008, J GEN PHYSIOL, V132, P681, DOI 10.1085/jgp.200810056; Yu K, 2008, J NEUROSCI, V28, P5660, DOI 10.1523/JNEUROSCI.0065-08.2008; Yu K, 2007, INVEST OPHTH VIS SCI, V48, P4694, DOI 10.1167/iovs.07-0301; Zheng J, 2000, NEURON, V28, P369, DOI 10.1016/S0896-6273(00)00117-3; Zheng J, 2003, J NEUROSCI, V23, P8167	33	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16473	16481		10.1074/jbc.M109.002246	http://dx.doi.org/10.1074/jbc.M109.002246			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19372599	Green Published, hybrid			2022-12-25	WOS:000266730900044
J	Kim, T; Kim, K; Lee, SH; So, HS; Lee, J; Kim, N; Choi, Y				Kim, Taesoo; Kim, Kabsun; Lee, Seoung Hoon; So, Hong-Seob; Lee, Junwon; Kim, Nacksung; Choi, Yongwon			Identification of LRRc17 as a Negative Regulator of Receptor Activator of NF-kappa B Ligand (RANKL)-induced Osteoclast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR RECEPTOR; NUCLEAR-FACTOR; T-CELLS; OSTEOPROTEGERIN; PROTEIN; RANKL; CYTOKINE; TRANCE; NFATC1; KINASE	Osteoblasts are the primary cells responsible for bone formation. They also support osteoclast formation from bone marrow precursors in response to osteotropic factors by inducing receptor activator of NF-kappa B ligand (RANKL) expression and down-regulating osteoprotegerin (OPG) production. In addition to the RANKL-RANK-OPG signaling axis, other factors produced by osteoblasts/stromal cells are involved in osteoclastogenesis. Here, we describe the identification and characterization of leucine-rich repeat-containing 17 (LRRc17), a member of the LRR superfamily that acts as a negative regulator of RANKL-induced osteoclast differentiation. Osteoblasts showed high levels of LRRc17 expression, which was down-regulated in response to the pro-osteoclastogenic factor 1,25-dihydroxyvitamin D-3. Recombinant LRRc17 protein inhibited RANKL-induced osteoclast differentiation from bone marrow precursors, whereas it did not affect the differentiation or activation of macrophages and dendritic cells. These results suggest that among the cell types derived from common myeloid precursors, LRRc17 specifically regulates osteoclasts. Further analysis revealed that LRRc17 attenuated RANKL-induced expression of NFATc1 by blocking phospholipase C-gamma signaling, which, in turn, inhibited RANKL-mediated osteoclast differentiation. Taken together, our results demonstrated a novel inhibitory activity of LRRc17 in RANKL-induced osteoclastogenesis.	[Kim, Kabsun; Kim, Nacksung] Chonnam Natl Univ, Sch Med, Med Res Ctr Gene Regulat, Natl Res Lab Regulat Bone Metab & Dis, Kwangju 501746, South Korea; [Kim, Taesoo; Lee, Seoung Hoon; Choi, Yongwon] Univ Penn, Sch Med, Dept Pathol, Philadelphia, PA 19104 USA; [Kim, Taesoo; Lee, Seoung Hoon; Choi, Yongwon] Univ Penn, Sch Med, Dept Lab Med, Philadelphia, PA 19104 USA; [Lee, Seoung Hoon] Wonkwang Univ, Sch Dent, Dept Oral Microbiol & Immunol, Iksan 570749, South Korea; [So, Hong-Seob] Wonkwang Univ, Sch Med, Vestibulocochlear Syst Res Ctr, Iksan 570749, Jeonbuk, South Korea; [So, Hong-Seob] Wonkwang Univ, Sch Med, Dept Microbiol, Iksan 570749, Jeonbuk, South Korea; [Lee, Junwon] Pai Chai Univ, Dept Life Sci & Genet Engn, Taejon 302725, South Korea	Chonnam National University; University of Pennsylvania; University of Pennsylvania; Wonkwang University; Wonkwang University; Wonkwang University; Pai Chai University	Kim, N (corresponding author), Chonnam Natl Univ, Sch Med, Med Res Ctr Gene Regulat, Natl Res Lab Regulat Bone Metab & Dis, Hak Dong 5, Kwangju 501746, South Korea.	nacksung@chonnam.ac.kr; ychoi3@mail.med.upenn.edu			National Institutes of Health [AR053843]; Korean government (MEST) [R0A-2007-000-20025-0]; Medical Research Center for Gene Regulation at Chonnam National University [R13-2002013-03001-0]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053843] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Medical Research Center for Gene Regulation at Chonnam National University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR053843 (to Y.C.) through the NIAMS. This work was also supported in part by the Korea Science and Engineering Foundation National Research Laboratory Program grant funded by the Korean government (MEST) (Grant R0A-2007-000-20025-0) (to N.K.) and Grant R13-2002013-03001-0 from the Korea Science and Engineering foundation through the Medical Research Center for Gene Regulation at Chonnam National University.	Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003; Curtiss NP, 2005, GENOMICS, V85, P600, DOI 10.1016/j.ygeno.2005.01.013; Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200; Kearns AE, 2008, ENDOCR REV, V29, P155, DOI 10.1210/er.2007-0014; Kim D, 1996, BBA-GENE STRUCT EXPR, V1309, P183, DOI 10.1016/S0167-4781(96)00158-3; Kim K, 2005, J BIOL CHEM, V280, P35209, DOI 10.1074/jbc.M505815200; Kim K, 2007, J IMMUNOL, V178, P5588, DOI 10.4049/jimmunol.178.9.5588; Kim K, 2007, BLOOD, V109, P3253, DOI 10.1182/blood-2006-09-048249; Kim N, 2002, J EXP MED, V195, P201, DOI 10.1084/jem.20011681; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lee J, 2006, BLOOD, V107, P2686, DOI 10.1182/blood-2005-07-2798; Lee ZH, 2003, BIOCHEM BIOPH RES CO, V305, P211, DOI 10.1016/S0006-291X(03)00695-8; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Suda T, 1997, METHOD ENZYMOL, V282, P223; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takami M, 2002, J IMMUNOL, V169, P1516, DOI 10.4049/jimmunol.169.3.1516; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2005, J MOL MED, V83, P170, DOI 10.1007/s00109-004-0612-6; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Theoleyre S, 2004, CYTOKINE GROWTH F R, V15, P457, DOI 10.1016/j.cytogfr.2004.06.004; Waddington R. J., 2003, European Cells & Materials, V6, P12; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597	29	29	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15308	15316		10.1074/jbc.M807722200	http://dx.doi.org/10.1074/jbc.M807722200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19336404	Green Published, hybrid			2022-12-25	WOS:000266288200065
J	Kumar, S; Kostin, S; Flacke, JP; Reusch, HP; Ladilov, Y				Kumar, Sanjeev; Kostin, Sawa; Flacke, Jan-Paul; Reusch, H. Peter; Ladilov, Yury			Soluble Adenylyl Cyclase Controls Mitochondria-dependent Apoptosis in Coronary Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; PERMEABILITY TRANSITION; CARDIAC MYOCYTES; CYCLIC-AMP; PH; ACTIVATION; BAX; HOMEOSTASIS; INHIBITION; ISCHEMIA	The cAMP signaling pathway plays an essential role in modulating the apoptotic response to various stress stimuli. Until now, it was attributed exclusively to the activity of the G-protein-responsive transmembrane adenylyl cyclase. In addition to transmembrane AC, mammalian cells possess a second source of cAMP, the ubiquitously expressed soluble adenylyl cyclase (sAC). However, the role of this cyclase in apoptosis was unknown. A mitochondrial localization of this cyclase has recently been demonstrated, which led us to the hypothesis that sAC may play a role in apoptosis through modulation of mitochondria-dependent apoptosis. To prove this hypothesis, apoptosis was induced by simulated in vitro ischemia or by acidosis, which is an important component of ischemia. Suppression of sAC activity with the selective inhibitor KH7 or sAC knockdown by small interfering RNA transfection abolished endothelial apoptosis. Furthermore, pharmacological inhibition or knockdown of protein kinase A, an important cAMP target, demonstrated a significant anti-apoptotic effect. Analysis of the underlying mechanisms revealed (i) the translocation of sAC to mitochondria under acidic stress and (ii) activation of the mitochondrial pathway of apoptosis, i. e. cytochrome c release and caspase-9 cleavage. sAC inhibition or knockdown abolished the activation of the mitochondrial pathway of apoptosis. Analysis of mitochondrial co-localization of Bcl-2 family proteins demonstrated sAC- and protein kinase A-dependent translocation of Bax to mitochondria. Taken together, these results suggest the important role of sAC in modulating the mitochondria-dependent pathway of apoptosis in endothelial cells.	[Ladilov, Yury] Ruhr Univ Bochum, Klin Pharmakol Abt, D-44801 Bochum, Germany; [Kostin, Sawa] Max Planck Inst Heart & Lung Res, D-61231 Bad Nauheim, Germany	Ruhr University Bochum; Max Planck Society	Ladilov, Y (corresponding author), Ruhr Univ Bochum, Klin Pharmakol Abt, Univ Str 150, D-44801 Bochum, Germany.	yury.ladilov@ruhr-uni-bochum.de	Ladilov, Yury/AAD-3547-2021; Kumar, Sanjeev/P-8547-2014; Ladilov, Yury/AAN-2603-2020	Kumar, Sanjeev/0000-0003-0562-2645; 	Deutsche Forschungsgemeinschaft [LA 1159/6-1]; Ruhr-Universitat Bochum [F620-08]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruhr-Universitat Bochum	This work was supported by Grant LA 1159/6-1 from the Deutsche Forschungsgemeinschaft and by Forum Grant F620-08 from the Ruhr-Universitat Bochum.	Ando H, 1999, AM J PHYSIOL-HEART C, V276, pH1755, DOI 10.1152/ajpheart.1999.276.5.H1755; Aoyama K, 2005, J CEREBR BLOOD F MET, V25, P358, DOI 10.1038/sj.jcbfm.9600043; Arokium H, 2007, J BIOL CHEM, V282, P35104, DOI 10.1074/jbc.M704891200; Bombeli T, 1997, BLOOD, V89, P2429, DOI 10.1182/blood.V89.7.2429; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Chen JW, 2004, CIRC RES, V94, P370, DOI 10.1161/01.RES.0000113782.07824.BE; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; D'Arcangelo D, 2000, CIRC RES, V86, P312, DOI 10.1161/01.RES.86.3.312; Desaubry L, 1996, J BIOL CHEM, V271, P2380, DOI 10.1074/jbc.271.5.2380; Er E, 2006, BBA-BIOENERGETICS, V1757, P1301, DOI 10.1016/j.bbabio.2006.05.032; Geng WD, 2005, AM J PHYSIOL-CELL PH, V288, pC1305, DOI 10.1152/ajpcell.00584.2004; GOTTLIEB RA, 1995, P NATL ACAD SCI USA, V92, P5965, DOI 10.1073/pnas.92.13.5965; Han H, 2005, J EXP MED, V202, P353, DOI 10.1084/jem.20050778; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Khabbaz KR, 2008, J THORAC CARDIOV SUR, V135, P139, DOI 10.1016/j.jtcvs.2007.07.035; Kumar S, 2007, J CELL MOL MED, V11, P798, DOI 10.1111/j.1582-4934.2007.00053.x; Kumar S, 2007, CARDIOVASC RES, V73, P172, DOI 10.1016/j.cardiores.2006.09.018; Kwak HJ, 2008, CELL SIGNAL, V20, P803, DOI 10.1016/j.cellsig.2007.12.011; Ladilov Y, 2000, CARDIOVASC RES, V47, P394, DOI 10.1016/S0008-6363(00)00108-5; Lagadic-Gossmann D, 2004, CELL DEATH DIFFER, V11, P953, DOI 10.1038/sj.cdd.4401466; Leone V, 2007, AM J PHYSIOL-GASTR L, V293, pG673, DOI 10.1152/ajpgi.00584.2006; Lou LG, 2002, J BIOL CHEM, V277, P32799, DOI 10.1074/jbc.M201491200; Moon EY, 2003, BLOOD, V101, P4122, DOI 10.1182/blood-2002-10-3208; Piper HM, 1990, CELL CULTURE TECHNIQ, P158; RUBIN CS, 1994, BBA-MOL CELL RES, V1224, P467; Rudolph JA, 2004, J BIOL CHEM, V279, P14828, DOI 10.1074/jbc.M310289200; Sayner SL, 2006, CIRC RES, V98, P675, DOI 10.1161/01.RES.0000209516.84815.3e; Scarabelli TM, 2002, CIRC RES, V90, P745, DOI 10.1161/01.RES.0000015224.07870.9A; SCOTT JD, 1990, J BIOL CHEM, V265, P21561; SIMMEN HP, 1993, AM J SURG, V166, P24, DOI 10.1016/S0002-9610(05)80576-8; Smith PG, 2005, BLOOD, V105, P308, DOI 10.1182/blood-2004-01-0240; Tafani M, 2002, J BIOL CHEM, V277, P49569, DOI 10.1074/jbc.M208915200; TANNOCK IF, 1989, CANCER RES, V49, P4373; Terminella C, 2002, AM J PHYSIOL-LUNG C, V283, pL1291, DOI 10.1152/ajplung.00246.2001; Thatte HS, 2004, ANN THORAC SURG, V77, P1376, DOI 10.1016/j.athoracsur.2003.07.047; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; Webster KA, 1999, J CLIN INVEST, V104, P239; Weiss JN, 2003, CIRC RES, V93, P292, DOI 10.1161/01.RES.0000087542.26971.D4; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P112, DOI 10.1161/01.ATV.0000191634.13057.15; Xin MG, 2006, J BIOL CHEM, V281, P18859, DOI 10.1074/jbc.M512543200; Young JJ, 2008, J NEUROSCI RES, V86, P118, DOI 10.1002/jnr.21458; YU HJ, 1995, FEBS LETT, V374, P89; Zhang LZ, 2004, J BIOL CHEM, V279, P20858, DOI 10.1074/jbc.M310643200; Zippin JH, 2002, FASEB J, V16, P82, DOI 10.1096/fj.02-0598fje	46	70	74	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14760	14768		10.1074/jbc.M900925200	http://dx.doi.org/10.1074/jbc.M900925200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19336406	Green Published, hybrid			2022-12-25	WOS:000266288200011
J	Nabilsi, NH; Broaddus, RR; Loose, DS				Nabilsi, N. H.; Broaddus, R. R.; Loose, D. S.			DNA methylation inhibits p53-mediated survivin repression	ONCOGENE			English	Article						DNA methylation; endometrium; cancer	WILD-TYPE P53; ENDOMETRIAL CARCINOMA; EXPRESSION; GENE; CANCER; CARCINOGENESIS; APOPTOSIS; DIAGNOSIS; REGION; HTERT	The molecular progression of endometrial cancer is poorly understood, and both genetic and epigenetic factors play a role. Survivin is a member of the inhibitor of apoptosis (IAP) gene family and contains a canonical CpG island that has been described as epigenetically regulated. As survivin is overexpressed in endometrial tumors, we hypothesized that hypomethylation could explain this expression pattern. Surprisingly, methylation-specific PCR and pyrosequencing showed that survivin was hypermethylated in endometrial tumors and correlated with increased survivin expression. We speculated that methylation could inhibit the binding of p53, a repressor of survivin expression. Our data indicates that demethylation of the survivin promoter by decitabine results in p53-dependent survivin repression and that p53 binding can be inhibited by DNA methylation. We are the first to report survivin de-repression by DNA methylation. We also present microarray data, which suggest that de-repression by methylation is a general mechanism of p53 regulation. Demethylation induced by decitabine is traditionally thought to be active in tumors by allowing the re-expression of tumor suppressor genes. However, our results indicate that an additional important mechanism is to decrease the expression of oncogenes. Oncogene (2009) 28, 2046-2050; doi:10.1038/onc.2009.62; published online 13 April 2009	[Nabilsi, N. H.; Loose, D. S.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Broaddus, R. R.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center	Loose, DS (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, 6431 Fannin St,MSB 5-132A, Houston, TX 77030 USA.	david.s.loose@uth.tmc.edu			NIH [1P50CA098258-01]; Rosalie B Hite Graduate Student Fellowship; NATIONAL CANCER INSTITUTE [P50CA098258] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rosalie B Hite Graduate Student Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by Grant NIH 1P50CA098258-01 (SPORE in Endometrial Cancer), and a Rosalie B Hite Graduate Student Fellowship.	Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Ambrosini G, 1998, J BIOL CHEM, V273, P11177, DOI 10.1074/jbc.273.18.11177; Campanero MR, 2000, P NATL ACAD SCI USA, V97, P6481, DOI 10.1073/pnas.100340697; Erkanli S, 2006, INT J GYNECOL CANCER, V16, P1412, DOI 10.1111/j.1525-1438.2006.00541.x; Erkanli S, 2007, GYNECOL ONCOL, V104, P320, DOI 10.1016/j.ygyno.2006.08.044; Esteve PO, 2005, P NATL ACAD SCI USA, V102, P1000, DOI 10.1073/pnas.0407729102; Fukuda S, 2006, MOL CANCER THER, V5, P1087, DOI 10.1158/1535-7163.MCT-05-0375; Furlan D, 2006, CLIN CANCER RES, V12, P3329, DOI 10.1158/1078-0432.CCR-05-2679; Hattori M, 2001, CANCER LETT, V169, P155, DOI 10.1016/S0304-3835(01)00499-2; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Hopfer O, 2007, EXP HEMATOL, V35, P712, DOI 10.1016/j.exphem.2007.01.054; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Konno R, 2000, MOL HUM REPROD, V6, P529, DOI 10.1093/molehr/6.6.529; Lehner R, 2002, ACTA OBSTET GYN SCAN, V81, P162, DOI 10.1034/j.1600-0412.2002.810213.x; Li FZ, 1999, BIOCHEM J, V344, P305, DOI 10.1042/0264-6021:3440305; Meng RD, 1999, INT J ONCOL, V14, P5; Mirza A, 2002, ONCOGENE, V21, P2613, DOI 10.1038/sj.onc.1205353; Prat J, 2007, PATHOLOGY, V39, P72, DOI 10.1080/00313020601136153; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P1245, DOI 10.1093/nar/gkl1125; Renaud S, 2005, NUCLEIC ACIDS RES, V33, P6850, DOI 10.1093/nar/gki989; Shang YF, 2006, NAT REV CANCER, V6, P360, DOI 10.1038/nrc1879; Takai N, 2002, CANCER LETT, V184, P105, DOI 10.1016/S0304-3835(02)00190-8; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Xie R, 2007, MODERN PATHOL, V20, P1045, DOI 10.1038/modpathol.3800940; Yoshida HY, 2006, CANCER RES, V66, P889, DOI 10.1158/0008-5472.CAN-05-2828; Zhou XC, 2007, GYNECOL ONCOL, V107, P143, DOI 10.1016/j.ygyno.2007.06.019	26	80	83	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 14	2009	28	19					2046	2050		10.1038/onc.2009.62	http://dx.doi.org/10.1038/onc.2009.62			5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	445BF	19363521				2022-12-25	WOS:000266023900005
J	Beltrand, J; Nicolescu, R; Kaguelidou, F; Verkauskiene, R; Sibony, O; Chevenne, D; Claris, O; Levy-Marchal, C				Beltrand, Jacques; Nicolescu, Ramona; Kaguelidou, Florentia; Verkauskiene, Rasa; Sibony, Oliver; Chevenne, Didier; Claris, Olivier; Levy-Marchal, Claire			Catch-Up Growth Following Fetal Growth Restriction Promotes Rapid Restoration of Fat Mass but Without Metabolic Consequences at One Year of Age	PLOS ONE			English	Article								Background: Fetal growth restriction (FGR) followed by rapid weight gain during early life has been suggested to be the initial sequence promoting central adiposity and insulin resistance. However, the link between fetal and early postnatal growth and the associated anthropometric and metabolic changes have been poorly studied. Methodology/Principal Findings: Over the first year of post-natal life, changes in body mass index, skinfold thickness and hormonal concentrations were prospectively monitored in 94 infants in whom the fetal growth velocity had previously been measured using a repeated standardized procedure of ultrasound fetal measurements. 45 infants, thinner at birth, had experienced previous FGR (FGR+) regardless of birth weight. Growth pattern in the first four months of life was characterized by greater change in BMI z-score in FGR+ (+1.26+/21.2 vs +0.58+/21.17 SD in FGR-) resulting in the restoration of BMI and of fat mass to values similar to FGR-, independently of caloric intakes. Growth velocity after 4 months was similar and BMI z-score and fat mass remained similar at 12 months of age. At both time-points, fetal growth velocity was an independent predictor of fat mass in FGR+. At one year, fasting insulin levels were not different but leptin was significantly higher in the FGR+ (4.43+/-1.41 vs 2.63+/-1 ng/ml in FGR-). Conclusion: Early catch-up growth is related to the fetal growth pattern itself, irrespective of birth weight, and is associated with higher insulin sensitivity and lower leptin levels after birth. Catch-up growth promotes the restoration of body size and fat stores without detrimental consequences at one year of age on body composition or metabolic profile. The higher leptin concentration at one year may reflect a positive energy balance in children who previously faced fetal growth restriction.			Beltrand, J (corresponding author), INSERM, U690, Paris, France.	claire.levy-marchal@inserm.fr	beltrand, jacques/AAV-6455-2021	beltrand, jacques/0000-0002-3759-3490				Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Bazaes RA, 2003, PEDIATRICS, V111, P804, DOI 10.1542/peds.111.4.804; Beltrand J, 2008, J CLIN ENDOCR METAB, V93, P4027, DOI 10.1210/jc.2008-0562; Beltrand J, 2008, PEDIATR RES, V64, P86, DOI 10.1203/PDR.0b013e318174e6d8; Botton J, 2008, AM J CLIN NUTR, V87, P1760, DOI 10.1093/ajcn/87.6.1760; Bouret SG, 2007, J NEUROENDOCRINOL, V19, P575, DOI 10.1111/j.1365-2826.2007.01563.x; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Brennan AM, 2006, NAT CLIN PRACT ENDOC, V2, P318, DOI 10.1038/ncpendmet0196; BROOK CGD, 1971, ARCH DIS CHILD, V46, P182, DOI 10.1136/adc.46.246.182; Chan JL, 2003, J CLIN INVEST, V111, P1409, DOI 10.1172/JCI200317490; Chomtho S, 2008, AM J CLIN NUTR, V87, P1776, DOI 10.1093/ajcn/87.6.1776; COLLE E, 1976, PEDIATRICS, V57, P363; Ekelund U, 2006, AM J CLIN NUTR, V83, P324; Ekelund U, 2007, J CLIN ENDOCR METAB, V92, P98, DOI 10.1210/jc.2006-1071; Ezzahir N, 2005, PEDIATR RES, V58, P243, DOI 10.1203/01.PDR.0000169980.35179.89; GARDOSI J, 1995, ULTRASOUND OBST GYN, V6, P168, DOI 10.1046/j.1469-0705.1995.06030168.x; GARDOSI J, 1992, LANCET, V339, P283, DOI 10.1016/0140-6736(92)91342-6; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; HADLOCK FP, 1985, AM J OBSTET GYNECOL, V151, P333, DOI 10.1016/0002-9378(85)90298-4; HOKKENKOELEGA ACS, 1995, PEDIATR RES, V38, P267, DOI 10.1203/00006450-199508000-00022; Ibanez L, 2008, J CLIN ENDOCR METAB, V93, P925, DOI 10.1210/jc.2007-1618; Ibanez L, 2006, J CLIN ENDOCR METAB, V91, P2153, DOI 10.1210/jc.2005-2778; Ikenasio-Thorpe BA, 2007, J ENDOCRINOL, V193, P31, DOI 10.1677/joe.1.07017; Jaquet D, 2005, DIABETOLOGIA, V48, P849, DOI 10.1007/s00125-005-1724-4; Jaquet D, 1999, J CLIN ENDOCR METAB, V84, P1949, DOI 10.1210/jc.84.6.1949; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Larsen T, 1997, EARLY HUM DEV, V47, P157, DOI 10.1016/S0378-3782(96)01780-X; Law CM, 2002, CIRCULATION, V105, P1088, DOI 10.1161/hc0902.104677; Leroy B, 1971, Rev Fr Gynecol Obstet, V66, P391; Leunissen RWJ, 2008, J CLIN ENDOCR METAB, V93, P445, DOI 10.1210/jc.2007-1543; Mantzoros CS, 2009, PEDIATRICS, V123, P682, DOI 10.1542/peds.2008-0343; Martinez-Aguayo A, 2007, CLIN ENDOCRINOL, V67, P526, DOI 10.1111/j.1365-2265.2007.02919.x; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; Rodriguez G, 2005, ARCH DIS CHILD-FETAL, V90, P273, DOI 10.1136/adc.2004.060723; RollandCachera MF, 1997, AM J CLIN NUTR, V65, P1709, DOI 10.1093/ajcn/65.6.1709; ROLLANDCACHERA MF, 1991, EUR J CLIN NUTR, V45, P13; Roseboom T, 2006, EARLY HUM DEV, V82, P485, DOI 10.1016/j.earlhumdev.2006.07.001; Schubring C, 1999, CLIN ENDOCRINOL, V51, P199, DOI 10.1046/j.1365-2265.1999.00761.x; SEMPE M, 1977, ARCH FR PEDIATR, V34, P687; Singhal A, 2004, CIRCULATION, V109, P1108, DOI 10.1161/01.CIR.0000118500.23649.DF; Singhal A, 2003, LANCET, V361, P1089, DOI 10.1016/S0140-6736(03)12895-4; Singhal A, 2007, CIRCULATION, V115, P213, DOI 10.1161/CIRCULATIONAHA.106.617811; Siri WE., 1956, ADV BIOL MED PHYS, V4, P239, DOI DOI 10.1016/B978-1-4832-3110-5.50011-X; Soto N, 2003, J CLIN ENDOCR METAB, V88, P3645, DOI 10.1210/jc.2002-030031; Stettler N, 2003, AM J CLIN NUTR, V77, P1374, DOI 10.1093/ajcn/77.6.1374; Stettler N, 2002, PEDIATRICS, V109, P194, DOI 10.1542/peds.109.2.194; Veening MA, 2002, J CLIN ENDOCR METAB, V87, P4657, DOI 10.1210/jc.2001-011940; Vickers MH, 2005, ENDOCRINOLOGY, V146, P4211, DOI 10.1210/en.2005-0581; Yliharsila H, 2008, AM J CLIN NUTR, V87, P1769, DOI 10.1093/ajcn/87.6.1769	50	53	55	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e5343	10.1371/journal.pone.0005343	http://dx.doi.org/10.1371/journal.pone.0005343			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19381307	Green Submitted, Green Published, gold			2022-12-25	WOS:000265514900008
J	Lim, S; Ahn, SY; Song, IC; Chung, MH; Jang, HC; Park, KS; Lee, KU; Pak, YK; Lee, HK				Lim, Soo; Ahn, Sun Young; Song, In Chan; Chung, Myung Hee; Jang, Hak Chul; Park, Kyong Soo; Lee, Ki-Up; Pak, Youngmi Kim; Lee, Hong Kyu			Chronic Exposure to the Herbicide, Atrazine, Causes Mitochondrial Dysfunction and Insulin Resistance	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; FAST-FOOD RESTAURANTS; DNA-DAMAGE; SERUM CONCENTRATIONS; NATIONAL-HEALTH; RISK-ASSESSMENT; US ADULTS; OBESITY; FAT; LYMPHOCYTES	There is an apparent overlap between areas in the USA where the herbicide, atrazine (ATZ), is heavily used and obesity-prevalence maps of people with a BMI over 30. Given that herbicides act on photosystem II of the thylakoid membrane of chloroplasts, which have a functional structure similar to mitochondria, we investigated whether chronic exposure to low concentrations of ATZ might cause obesity or insulin resistance by damaging mitochondrial function. Sprague-Dawley rats (n = 48) were treated for 5 months with low concentrations (30 or 300 mu g kg(-1) day(-1)) of ATZ provided in drinking water. One group of animals was fed a regular diet for the entire period, and another group of animals was fed a high-fat diet (40% fat) for 2 months after 3 months of regular diet. Various parameters of insulin resistance were measured. Morphology and functional activities of mitochondria were evaluated in tissues of ATZ-exposed animals and in isolated mitochondria. Chronic administration of ATZ decreased basal metabolic rate, and increased body weight, intra-abdominal fat and insulin resistance without changing food intake or physical activity level. A high-fat diet further exacerbated insulin resistance and obesity. Mitochondria in skeletal muscle and liver of ATZ-treated rats were swollen with disrupted cristae. ATZ blocked the activities of oxidative phosphorylation complexes I and III, resulting in decreased oxygen consumption. It also suppressed the insulin-mediated phosphorylation of Akt. These results suggest that long-term exposure to the herbicide ATZ might contribute to the development of insulin resistance and obesity, particularly where a high-fat diet is prevalent.			Lim, S (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	ykpak@khu.ac.kr; hkleemd@snu.ac.kr	Pak, Youngmi Kim/AAI-1091-2020; Jang, Hak Chul/D-9637-2012; Park, Kyong Soo/C-2265-2008; Lim, Soo/AAU-8107-2020	Pak, Youngmi Kim/0000-0001-7424-3484; Jang, Hak Chul/0000-0002-4188-6536; Park, Kyong Soo/0000-0003-3597-342X; Lim, Soo/0000-0002-4137-1671; Song, In-Chan/0000-0002-5357-5751				ATTARDI G, 1996, MITOCHONDRIAL BIOG B; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Cantemir C, 1997, TOXICOL LETT, V93, P87, DOI 10.1016/S0378-4274(97)00050-7; Cheney MA, 1997, COMP BIOCHEM PHYS C, V118, P159, DOI 10.1016/S0742-8413(97)00102-3; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Clements C, 1997, ENVIRON MOL MUTAGEN, V29, P277, DOI 10.1002/(SICI)1098-2280(1997)29:3&lt;277::AID-EM8&gt;3.0.CO;2-9; De Roos AJ, 2003, OCCUP ENVIRON MED, V60, DOI 10.1136/oem.60.9.e11; Della Croce C, 1996, J Environ Pathol Toxicol Oncol, V15, P21; *EPA, 2006, TRIAZ CUM RISK ASS A; Fisher MT, 2005, TOXICOL LETT, V157, P99, DOI 10.1016/j.toxlet.2005.01.008; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Fukamachi K, 2004, CANCER SCI, V95, P404, DOI 10.1111/j.1349-7006.2004.tb03223.x; Gammon DW, 2005, PEST MANAG SCI, V61, P331, DOI 10.1002/ps.1000; Hayes T, 2002, NATURE, V419, P895, DOI 10.1038/419895a; Hessel PA, 2004, J OCCUP ENVIRON MED, V46, P379, DOI 10.1097/01.jom.0000121128.73921.a1; Jahren AH, 2008, P NATL ACAD SCI USA, V105, P17855, DOI 10.1073/pnas.0809870105; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; Jin CJ, 2007, J NUTR, V137, P339, DOI 10.1093/jn/137.2.339; Kandori H, 2005, CANCER SCI, V96, P221, DOI 10.1111/j.1349-7006.2005.00041.x; Kim MS, 2006, NAT NEUROSCI, V9, P901, DOI 10.1038/nn1731; Kolpin DW, 1997, J ENVIRON QUAL, V26, P1007, DOI 10.2134/jeq1997.00472425002600040012x; KUCZMARSKI RJ, 1994, JAMA-J AM MED ASSOC, V272, P205, DOI 10.1001/jama.272.3.205; Lee DH, 2007, DIABETES CARE, V30, P622, DOI 10.2337/dc06-2190; Lee DH, 2006, J EPIDEMIOL COMMUN H, V60, P1006, DOI 10.1136/jech.2006.053389; Lee DH, 2006, DIABETES CARE, V29, P1638, DOI 10.2337/dc06-0543; Lim S, 2009, OBESITY, V17, P188, DOI 10.1038/oby.2008.486; Lind PM, 2004, TOXICOL LETT, V150, P293, DOI 10.1016/j.toxlet.2004.02.008; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Machann J, 2004, DIABETES OBES METAB, V6, P239, DOI 10.1111/j.1462-8902.2004.00339.x; Maddock J, 2004, AM J HEALTH PROMOT, V19, P137, DOI 10.4278/0890-1171-19.2.137; MAY JB, 1987, CORN CHEM TECHNOLOGY; MCELROY JA, 2006, J EXPO SCI ENV EPIDE; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Nelson BA, 2002, AM J PHYSIOL-ENDOC M, V282, pE497, DOI 10.1152/ajpendo.00438.2001; Noland RC, 2007, AM J PHYSIOL-ENDOC M, V293, pE31, DOI 10.1152/ajpendo.00500.2006; OULMI Y, 1995, ECOTOX ENVIRON SAFE, V32, P39, DOI 10.1006/eesa.1995.1083; Park KS, 2001, AM J PHYSIOL-ENDOC M, V280, pE1007, DOI 10.1152/ajpendo.2001.280.6.E1007; Park SY, 2005, J BIOL CHEM, V280, P9855, DOI 10.1074/jbc.M409399200; PCHELINTSEVA O, 1995, ARCH BIOCHEM BIOPHYS, V323, P54, DOI 10.1006/abbi.1995.0009; Pelletier C, 2003, Obes Rev, V4, P17, DOI 10.1046/j.1467-789X.2003.00085.x; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; PINO A, 1988, MUTAT RES, V209, P145, DOI 10.1016/0165-7992(88)90032-2; Poulton J, 1998, DIABETOLOGIA, V41, P54, DOI 10.1007/s001250050866; RIBAS G, 1995, MUTAT RES-GENET TOX, V344, P41, DOI 10.1016/0165-1218(95)90037-3; ROBERT J, 2002, 1291 USGS; Saldana TM, 2007, DIABETES CARE, V30, P529, DOI 10.2337/dc06-1832; Satia JA, 2004, PUBLIC HEALTH NUTR, V7, P1089, DOI 10.1079/PHN2004662; SCHOTTLER SP, 1994, ENVIRON SCI TECHNOL, V28, P2228, DOI 10.1021/es00061a036; Shertzer HG, 2006, TOXICOL APPL PHARM, V217, P363, DOI 10.1016/j.taap.2006.09.014; Sinha R, 2002, DIABETES, V51, P1022, DOI 10.2337/diabetes.51.4.1022; Solomon KR, 1996, ENVIRON TOXICOL CHEM, V15, P31, DOI [10.1002/etc.5620150105, 10.1897/1551-5028(1996)015&lt;0031:ERAOAI&gt;2.3.CO;2]; Takahashi N, 2007, CELL METAB, V6, P506, DOI 10.1016/j.cmet.2007.10.011; Yoon YS, 2003, J BIOL CHEM, V278, P51577, DOI 10.1074/jbc.M308489200; Young HA, 2005, J OCCUP ENVIRON MED, V47, P1148, DOI 10.1097/01.jom.0000177044.43959.e8; Zeljezic D, 2006, TOXICOL IN VITRO, V20, P923, DOI 10.1016/j.tiv.2006.01.017	55	136	139	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5186	10.1371/journal.pone.0005186	http://dx.doi.org/10.1371/journal.pone.0005186			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TN	19365547	Green Submitted, gold, Green Published			2022-12-25	WOS:000265509900014
J	Ararat, E; Brozovich, FV				Ararat, Erhan; Brozovich, Frank V.			Losartan Decreases p42/44 MAPK Signaling and Preserves LZ+MYPT1 Expression	PLOS ONE			English	Article								Heart failure is associated with impairment in nitric oxide (NO) mediated vasodilatation, which has been demonstrated to result from a reduction in the relative expression of the leucine zipper positive (LZ+) isoform of the myosin targeting subunit (MYPT1) of myosin light chain phosphatase. Further, captopril preserves normal LZ+ MYPT1 expression, the sensitivity to cGMP-mediated vasodilatation and modulates the expression of genes in the p42/44 MAPK and p38 MAPK signaling cascades. This study tests whether angiotensin receptor blockade (ARB) with losartan decreases p42/44 MAPK or p38 MAPK signaling and preserves LZ+ MYPT1 expression in a rat infarct model of heart failure. In aortic smooth muscle, p42/44 MAPK activation increases and LZ+ MYPT1 expression falls after LAD ligation. Losartan treatment decreases the activation of p42/44 MAPK to the uninfarcted control level and preserves normal LZ+ MYPT1 expression. The expression and activation of p38 MAPK, however, is low and does not change following LAD ligation or with losartan therapy. These data suggest that either reducing or blocking the effects of circulating angiotensin II, both decreases the activation of the p42/44 MAPK signaling cascade and preserves LZ+ MYPT1 expression. Thus, the ability of ACE-inhibitors and ARBs to modulate the vascular phenotype, to preserve normal flow mediated vasodilatation may explain the beneficial effects of these drugs compared to other forms of afterload reduction in the treatment of heart failure.			Ararat, E (corresponding author), Mayo Clin & Mayo Fdn, Mayo Med Sch, Div Cardiovasc Dis, Rochester, MN 55905 USA.	brozovich.frank@mayo.edu			NHLBI NIH HHS [R01 HL069894, HL69894] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069894] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abassi ZA, 1997, CIRCULATION, V96, P3655; Alioua A, 1998, J BIOL CHEM, V273, P32950, DOI 10.1074/jbc.273.49.32950; Chen FC, 2008, J VASC RES, V45, P445, DOI 10.1159/000126735; Chen FC, 2006, J MOL CELL CARDIOL, V41, P488, DOI 10.1016/j.yjmcc.2006.05.018; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Dirksen WP, 2000, AM J PHYSIOL-CELL PH, V278, pC589, DOI 10.1152/ajpcell.2000.278.3.C589; El-Toukhy A, 2006, FEBS LETT, V580, P5779, DOI 10.1016/j.febslet.2006.09.035; Fukao M, 1999, J BIOL CHEM, V274, P10927, DOI 10.1074/jbc.274.16.10927; Furchgott RF, 1999, BIOSCIENCE REP, V19, P235, DOI 10.1023/A:1020537506008; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Given AM, 2007, AM J PHYSIOL-CELL PH, V292, pC432, DOI 10.1152/ajpcell.00175.2006; GONG MC, 1992, J BIOL CHEM, V267, P14662; Hartshorne DJ, 1998, J MUSCLE RES CELL M, V19, P325, DOI 10.1023/A:1005385302064; HARTSHORNE DJ, 1987, BIOCH CONTRACTILE PR, P432; Hoit BD, 1999, J CARD FAIL, V5, P324, DOI 10.1016/S1071-9164(99)91337-4; Huang QQ, 2004, J BIOL CHEM, V279, P597, DOI 10.1074/jbc.M308496200; Karim SM, 2004, CIRC RES, V95, P612, DOI 10.1161/01.RES.0000142736.39359.58; Khatri JJ, 2001, J BIOL CHEM, V276, P37250, DOI 10.1074/jbc.M105275200; Khromov AS, 2006, P NATL ACAD SCI USA, V103, P2440, DOI 10.1073/pnas.0508566103; Liang QR, 2006, J CARD FAIL, V12, P479, DOI 10.1016/j.cardfail.2006.04.006; Liu YH, 1997, J CLIN INVEST, V99, P1926, DOI 10.1172/JCI119360; Lu Y, 2008, AM J PHYSIOL-CELL PH, V294, pC564, DOI 10.1152/ajpcell.00285.2007; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Michael SK, 2008, P NATL ACAD SCI USA, V105, P6702, DOI 10.1073/pnas.0802128105; Nakamura K, 2007, CIRC RES, V101, P712, DOI 10.1161/CIRCRESAHA.107.153981; Niiro N, 2001, J BIOL CHEM, V276, P29567, DOI 10.1074/jbc.M102753200; Ogut O, 2000, AM J PHYSIOL-CELL PH, V279, pC1722, DOI 10.1152/ajpcell.2000.279.6.C1722; Payne MC, 2006, J MOL CELL CARDIOL, V40, P274, DOI 10.1016/j.yjmcc.2005.07.009; Payne MC, 2004, AM J PHYSIOL-HEART C, V286, pH1801, DOI 10.1152/ajpheart.00696.2003; Pfeffer J M, 1987, Circulation, V75, pI149; PFEFFER JM, 1985, CIRC RES, V57, P84, DOI 10.1161/01.RES.57.1.84; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Pourdjabbar A, 2005, AM J PHYSIOL-HEART C, V288, pH1997, DOI 10.1152/ajpheart.00671.2004; Pourdjabbar A, 2005, CAN J PHYSIOL PHARM, V83, P989, DOI 10.1139/Y05-072; Rembold CM, 2000, J PHYSIOL-LONDON, V524, P865, DOI 10.1111/j.1469-7793.2000.00865.x; Richer C, 1999, CARDIOVASC RES, V41, P100, DOI 10.1016/S0008-6363(98)00227-2; SCHMIDT HHHW, 1993, BIOCHIM BIOPHYS ACTA, V1178, P153, DOI 10.1016/0167-4889(93)90006-B; See F, 2004, J AM COLL CARDIOL, V44, P1679, DOI 10.1016/j.jacc.2004.07.038; SHIMIZU H, 1994, J BIOL CHEM, V269, P30407; Shukla S, 2008, CIRC RES, V103, P485, DOI 10.1161/CIRCRESAHA.108.178384; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Somlyo AV, 2007, CIRC RES, V101, P645, DOI 10.1161/CIRCRESAHA.107.161893; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Walker LA, 2001, J BIOL CHEM, V276, P24519, DOI 10.1074/jbc.M103560200; Weg-Remers S, 2001, EMBO J, V20, P4194, DOI 10.1093/emboj/20.15.4194; Wooldridge AA, 2004, J BIOL CHEM, V279, P34496, DOI 10.1074/jbc.M405957200; Wu XQ, 1998, J BIOL CHEM, V273, P11362, DOI 10.1074/jbc.273.18.11362; Zhang HY, 2007, CIRC RES, V100, P730, DOI 10.1161/01.RES.0000260189.38975.35	48	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5144	10.1371/journal.pone.0005144	http://dx.doi.org/10.1371/journal.pone.0005144			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357768	gold, Green Published, Green Submitted			2022-12-25	WOS:000265505900012
J	Schmidt, JV; Schmidt, CL; Ozer, F; Ernst, RE; Feldheim, KA; Ashley, MV; Levine, M				Schmidt, Jennifer V.; Schmidt, Claudia L.; Ozer, Fusun; Ernst, Robin E.; Feldheim, Kevin A.; Ashley, Mary V.; Levine, Marie			Low Genetic Differentiation across Three Major Ocean Populations of the Whale Shark, Rhincodon typus	PLOS ONE			English	Article								Background: Whale sharks are a declining species for which little biological data is available. While these animals are protected in many parts of their range, they are fished legally and illegally in some countries. Baseline biological and ecological data are needed to allow the formulation of an effective conservation plan for whale sharks. It is not known, for example, whether the whale shark is represented by a single worldwide panmictic population or by numerous, reproductively isolated populations. Genetic analysis of population structure is one essential component of the baseline data required for whale shark conservation. Methodology/Principal Findings: We have identified 8 polymorphic microsatellites in the whale shark and used these markers to assess genetic variation and population structure in a panel of whale sharks covering a broad geographic region. This is the first record of microsatellite loci in the whale shark, which displayed an average of 9 alleles per locus and mean H-o = 0.66 and H-e = 0.69. All but one of the eight loci meet the expectations of Hardy-Weinberg equilibrium. Analysis of these loci in whale sharks representing three major portions of their range, the Pacific (P), Caribbean (C), and Indian (I) Oceans, determined that there is little population differentiation between animals sampled in different geographic regions, indicating historical gene flow between populations. F-ST values for inter-ocean comparisons were low (PxC = 0.0387, CxI = 0.0296 and PxI = -0.0022), and only CxI approached statistical significance (p = 0.0495). Conclusions/Significance: We have shown only low levels of genetic differentiation between geographically distinct whale shark populations. Existing satellite tracking data have revealed both regional and long-range migration of whale sharks throughout their range, which supports the finding of gene flow between populations. Whale sharks traverse geographic and political boundaries during their life history and interbreed with animals from distant populations; conservation efforts must therefore target international protection for this species.	[Schmidt, Jennifer V.; Schmidt, Claudia L.; Ozer, Fusun; Ashley, Mary V.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Schmidt, Jennifer V.; Ernst, Robin E.; Levine, Marie] Shark Res Inst, Princeton, NJ USA; [Feldheim, Kevin A.] Field Museum, Pritzker Lab Mol Systemat & Evolut, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Field Museum of Natural History (Chicago)	Schmidt, JV (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.	jvs@uic.edu	Ozer, Fusun/ABH-2640-2021	Ozer, Fusun/0000-0003-0443-5805	University of Illinois at Chicago; The Shark Research Institute	University of Illinois at Chicago; The Shark Research Institute	This work was supported by start-up funds from the University of Illinois at Chicago (to JVS) and by The Shark Research Institute. Fragment data were collected in the Field Museum's Pritzker Laboratory for Molecular Systematics and Evolution operated with support from the Pritzker Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arzoumanian Z, 2005, J APPL ECOL, V42, P999, DOI 10.1111/j.1365-2664.2005.01117.x; Bradshaw CJA, 2008, BIOL CONSERV, V141, P1894, DOI 10.1016/j.biocon.2008.05.007; Bradshaw CJA, 2007, J ANIM ECOL, V76, P480, DOI 10.1111/j.1365-2656.2006.01201.x; Bremer JRA, 1996, J EXP MAR BIOL ECOL, V197, P295, DOI 10.1016/0022-0981(95)00164-6; Broughton RE, 1997, MOL MAR BIOL BIOTECH, V6, P308; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Carlsson J, 2007, J HERED, V98, P23, DOI 10.1093/jhered/esl046; Castro ALF, 2007, MOL ECOL, V16, P5183, DOI 10.1111/j.1365-294X.2007.03597.x; Chapman DD, 2004, MOL ECOL, V13, P1965, DOI 10.1111/j.1365-294X.2004.02178.x; Chevolot M, 2007, J HERED, V98, P712, DOI 10.1093/jhered/esm077; Colman JG, 1997, J FISH BIOL, V51, P1219, DOI 10.1111/j.1095-8649.1997.tb01138.x; Compagno LJV, 2001, SHARKS WORLD ANNOTAT; Coombs JA, 2008, MOL ECOL RESOUR, V8, P578, DOI 10.1111/j.1471-8286.2007.02036.x; Daly-Engel TS, 2006, ENVIRON BIOL FISH, V76, P419, DOI 10.1007/s10641-006-9008-5; DeSalle R, 2004, NAT REV GENET, V5, P702, DOI 10.1038/nrg1425; DeWoody JA, 2000, J FISH BIOL, V56, P461, DOI 10.1111/j.1095-8649.2000.tb00748.x; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Dudgeon CL, 2006, MOL ECOL NOTES, V6, P1086, DOI 10.1111/j.1471-8286.2006.01442.x; Eckert SA, 2002, J ZOOL, V257, P111, DOI 10.1017/S0952836902000705; Eckert SA, 2001, ENVIRON BIOL FISH, V60, P299, DOI 10.1023/A:1007674716437; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Ely B, 2002, MAR BIOTECHNOL, V4, P583, DOI 10.1007/s10126-002-0040-y; Feldheim KA, 2001, MOL ECOL, V10, P295, DOI 10.1046/j.1365-294x.2001.01182.x; Feldheim KA, 2002, J FISH BIOL, V61, P1309, DOI 10.1006/jfbi.2002.2139; Feldheim KA, 2001, COPEIA, P781, DOI 10.1643/0045-8511(2001)001[0781:MPOALS]2.0.CO;2; Feldheim KA, 2007, MOL ECOL NOTES, V7, P1366, DOI 10.1111/j.1471-8286.2007.01888.x; Fontaine MC, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-30; Gifford A, 2007, FISH RES, V84, P17, DOI 10.1016/j.fishres.2006.11.011; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Graham RT, 2007, FISH RES, V84, P71, DOI 10.1016/j.fishres.2006.11.026; Haberl M, 1999, MOL ECOL, V8, P1347, DOI 10.1046/j.1365-294X.1999.00692.x; Hamilton MB, 1999, BIOTECHNIQUES, V27, P500, DOI 10.2144/99273st03; Heist EJ, 1999, AM FISH S S, V23, P161; Heist EJ, 2003, MOL ECOL NOTES, V3, P59, DOI 10.1046/j.1471-8286.2003.00348.x; HEIST EJ, 1999, MICROSATELLITE DNA V, P182; Heyman WD, 2001, MAR ECOL PROG SER, V215, P275, DOI 10.3354/meps215275; Hoffman JI, 2006, MOL ECOL, V15, P3841, DOI 10.1111/j.1365-294X.2006.03053.x; Holmberg J, 2008, ECOL APPL, V18, P222, DOI 10.1890/07-0315.1; Hsu HH, 2007, FISH RES, V84, P25, DOI 10.1016/j.fishres.2006.11.030; Jarman SN, 2004, J FISH BIOL, V65, P586, DOI 10.1111/j.0022-1112.2004.00466.x; Joung SJ, 1996, ENVIRON BIOL FISH, V46, P219, DOI 10.1007/BF00004997; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kanda N, 2007, CONSERV GENET, V8, P853, DOI 10.1007/s10592-006-9232-8; Keeney DB, 2003, MOL ECOL NOTES, V3, P501, DOI 10.1046/j.1471-8286.2003.00492.x; Keeney DB, 2005, MOL ECOL, V14, P1911, DOI 10.1111/j.1365-294X.2005.02549.x; Langella O, 1999, POPULATIONS 1 2 30; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Martin AP, 2002, MOL PHYLOGENET EVOL, V23, P205, DOI 10.1016/S1055-7903(02)00001-5; McCauley L, 2004, MOL ECOL NOTES, V4, P494, DOI 10.1111/j.1471-8286.2004.00724.x; Meekan MG, 2006, MAR ECOL PROG SER, V319, P275, DOI 10.3354/meps319275; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nelson JD, 2007, FISH RES, V84, P47, DOI 10.1016/j.fishres.2006.11.013; Norman BM, 2007, FISH RES, V84, P81, DOI 10.1016/j.fishres.2006.11.015; Ovenden JR, 2006, MOL ECOL NOTES, V6, P415, DOI 10.1111/j.1471-8286.2005.01254.x; Palsboll PJ, 1999, BIOL J LINN SOC, V68, P3, DOI 10.1111/j.1095-8312.1999.tb01155.x; Pardini AT, 2000, MOL ECOL, V9, P1176, DOI 10.1046/j.1365-294x.2000.00954-4.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Portnoy DS, 2006, MOL ECOL NOTES, V6, P431, DOI 10.1111/j.1471-8286.2006.01261.x; Portnoy DS, 2007, MOL ECOL, V16, P187, DOI 10.1111/j.1365-294X.2006.03138.x; Primmer CR, 1996, NAT GENET, V13, P391, DOI 10.1038/ng0896-391; Pritchard JK, 2000, GENETICS, V155, P945; Quattro JM, 2006, MAR BIOL, V148, P1143, DOI 10.1007/s00227-005-0151-x; Ramirez-Macias D, 2007, FISH RES, V84, P87, DOI 10.1016/j.fishres.2006.11.038; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rowat D, 2007, FISH RES, V84, P32, DOI 10.1016/j.fishres.2006.11.009; Rowat D, 2007, ENVIRON BIOL FISH, V80, P465, DOI 10.1007/s10641-006-9148-7; Schneider S., 2000, ARLEQUIN SOFTWARE PO, V2, P2496; Schrey AW, 2002, CONSERV GENET, V3, P459, DOI 10.1023/A:1020583609967; Schug MD, 1997, NAT GENET, V15, P99, DOI 10.1038/ng0197-99; Stevens JD, 2007, FISH RES, V84, P4, DOI 10.1016/j.fishres.2006.11.008; Stewart BS, 2005, ENVIRON BIOL FISH, V74, P184, DOI 10.1007/s10641-005-2229-1; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Wilmer JW, 1999, MOL ECOL, V8, P1417, DOI 10.1046/j.1365-294x.1999.00705.x; Wilson SG, 2006, MAR BIOL, V148, P1157, DOI 10.1007/s00227-005-0153-8; Wilson SG, 2001, ENVIRON BIOL FISH, V61, P1, DOI 10.1023/A:1011069914753; Wintner SP, 2000, ENVIRON BIOL FISH, V59, P441, DOI 10.1023/A:1026564707027	77	78	81	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2009	4	4							e4988	10.1371/journal.pone.0004988	http://dx.doi.org/10.1371/journal.pone.0004988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RT	19352489	Green Published, gold			2022-12-25	WOS:000265505300001
J	Spaeth, EL; Dembinski, JL; Sasser, AK; Watson, K; Klopp, A; Hall, B; Andreeff, M; Marini, F				Spaeth, Erika L.; Dembinski, Jennifer L.; Sasser, A. Kate; Watson, Keri; Klopp, Ann; Hall, Brett; Andreeff, Michael; Marini, Frank			Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression	PLOS ONE			English	Article								Background: Tumor associated fibroblasts (TAF), are essential for tumor progression providing both a functional and structural supportive environment. TAF, known as activated fibroblasts, have an established biological impact on tumorigenesis as matrix synthesizing or matrix degrading cells, contractile cells, and even blood vessel associated cells. The production of growth factors, cytokines, chemokines, matrix-degrading enzymes, and immunomodulatory mechanisms by these cells augment tumor progression by providing a suitable environment. There are several suggested origins of the TAF including tissue-resident, circulating, and epithelial-to-mesenchymal-transitioned cells. Methodology/Principal Findings: We provide evidence that TAF are derived from mesenchymal stem cells (MSC) that acquire a TAF phenotype following exposure to or systemic recruitment into adenocarcinoma xenograft models including breast, pancreatic, and ovarian. We define the MSC derived TAF in a xenograft ovarian carcinoma model by the immunohistochemical presence of 1) fibroblast specific protein and fibroblast activated protein; 2) markers phenotypically associated with aggressiveness, including tenascin-c, thrombospondin-1, and stromelysin-1; 3) production of protumorigenic growth factors including hepatocyte growth factor, epidermal growth factor, and interleukin-6; and 4) factors indicative of vascularization, including alpha-smooth muscle actin, desmin, and vascular endothelial growth factor. We demonstrate that under long-term tumor conditioning in vitro, MSC express TAF-like proteins. Additionally, human MSC but not murine MSC stimulated tumor growth primarily through the paracrine production of secreted IL6. Conclusions/Significance: Our results suggest the dependence of in vitro Skov-3 tumor cell proliferation is due to the presence of tumor-stimulated MSC secreted IL6. The subsequent TAF phenotype arises from the MSC which ultimately promotes tumor growth through the contribution of microvascularization, stromal networks, and the production of tumor-stimulating paracrine factors.	[Spaeth, Erika L.; Dembinski, Jennifer L.; Watson, Keri; Klopp, Ann; Andreeff, Michael; Marini, Frank] Univ Texas MD Anderson Canc Ctr, Sect Mol Hematol & Therapy, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA; [Sasser, A. Kate; Hall, Brett] Ohio State Univ, Ctr Childhood Canc, Columbus Childrens Res Inst, Dept Pediat, Columbus, OH USA	University of Texas System; UTMD Anderson Cancer Center; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Spaeth, EL (corresponding author), Univ Texas MD Anderson Canc Ctr, Sect Mol Hematol & Therapy, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA.	fmarini@mdanderson.org		Spaeth, Erika/0000-0002-5397-3493; Dembinski, Jennifer/0000-0001-9259-9572	National Cancer Institute [CA-109451, Ca-116199, CA-55164, CA-16672, CA-49639]; Paul and Mary Haas Chair in Genetics; Susan G. Komen Breast Cancer Foundation [BCTR0504372]; Army Department of Defense [BC083397]; NATIONAL CANCER INSTITUTE [P50CA116199, R01CA109451, RC1CA146381, P01CA049639, P01CA055164, P30CA016672] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Paul and Mary Haas Chair in Genetics; Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Army Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the National Cancer Institute (CA-109451 and Ca-116199 for FCM and CA-55164, CA-16672, and CA-49639 for MA) and by the Paul and Mary Haas Chair in Genetics (MA). JLD and FCM are also supported in part by grants from the Susan G. Komen Breast Cancer Foundation (BCTR0504372). ELS is also supported by the Army Department of Defense (BC083397). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abounader R, 2005, NEURO-ONCOLOGY, V7, P436, DOI 10.1215/S1152851705000050; Annabi B, 2004, J CELL BIOCHEM, V91, P1146, DOI 10.1002/jcb.10763; Bae S, 2008, BRIT J HAEMATOL, V142, P827, DOI 10.1111/j.1365-2141.2008.07241.x; Ball SG, 2004, INT J BIOCHEM CELL B, V36, P714, DOI 10.1016/j.biocel.2003.10.015; BEXELL D, 2008, MOL THER; Corso S, 2008, ONCOGENE, V27, P684, DOI 10.1038/sj.onc.1210697; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dong JY, 2004, EMBO J, V23, P2800, DOI 10.1038/sj.emboj.7600289; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Emura M, 2000, IN VITRO CELL DEV-AN, V36, P77; Haddow A, 1972, Adv Cancer Res, V16, P181; Hall B., 2007, V180, P263; Hall B, 2007, INT J HEMATOL, V86, P8, DOI 10.1532/IJH97.06230; Harrison P, 2000, BIOCHEM BIOPH RES CO, V271, P203, DOI 10.1006/bbrc.2000.2612; Hung SC, 2005, CLIN CANCER RES, V11, P7749, DOI 10.1158/1078-0432.CCR-05-0876; Ilan N, 2003, CURR OPIN CELL BIOL, V15, P515, DOI 10.1016/S0955-0674(03)00100-5; Javazon EH, 2004, EXP HEMATOL, V32, P414, DOI 10.1016/j.exphem.2004.02.004; Jeon ES, 2008, STEM CELLS, V26, P789, DOI 10.1634/stemcells.2007-0742; Jiang Han fang, 2008, Beijing Da Xue Xue Bao Yi Xue Ban, V40, P453; Jodele S, 2005, CANCER RES, V65, P3200, DOI 10.1158/0008-5472.CAN-04-3770; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kanehira M, 2007, CANCER GENE THER, V14, P894, DOI 10.1038/sj.cgt.7701079; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Khakoo AY, 2006, J EXP MED, V203, P1235, DOI 10.1084/jem.20051921; Kinner B, 2002, EXP CELL RES, V278, P72, DOI 10.1006/excr.2002.5561; Klopp AH, 2007, CANCER RES, V67, P11687, DOI 10.1158/0008-5472.CAN-07-1406; Koyama H, 2008, AM J PATHOL, V172, P179, DOI 10.2353/ajpath.2008.070360; Kunz-Schughart LA, 2002, HISTOL HISTOPATHOL, V17, P599, DOI 10.14670/HH-17.599; Labelle M, 2008, CANCER RES, V68, P1388, DOI 10.1158/0008-5472.CAN-07-2706; LAZARIDES E, 1981, COLD SPRING HARB SYM, V46, P351; Littlepage LE, 2005, CANCER CELL, V7, P499, DOI 10.1016/j.ccr.2005.05.019; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Matsumoto Y, 2008, BIOCHEM BIOPH RES CO, V366, P110, DOI 10.1016/j.bbrc.2007.11.089; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Nakamura K, 2004, GENE THER, V11, P1155, DOI 10.1038/sj.gt.3302276; Ogawa M, 2006, BLOOD, V108, P2893, DOI 10.1182/blood-2006-04-016600; Ohlsson LB, 2003, EXP MOL PATHOL, V75, P248, DOI 10.1016/j.yexmp.2003.06.001; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Ruiter D, 2002, LANCET ONCOL, V3, P35, DOI 10.1016/S1470-2045(01)00620-9; Sasser AK, 2007, FASEB J, V21, P3763, DOI 10.1096/fj.07-8832com; Sasser AK, 2007, CANCER LETT, V254, P255, DOI 10.1016/j.canlet.2007.03.012; Silzle T, 2004, INT J CANCER, V108, P173, DOI 10.1002/ijc.11542; Sonabend AM, 2008, STEM CELLS; SPAETH E, 2008, GENE THER; Spix JK, 2007, EXP CELL RES, V313, P3319, DOI 10.1016/j.yexcr.2007.06.006; Studeny M, 2004, JNCI-J NATL CANCER I, V96, P1593, DOI 10.1093/jnci/djh299; Studeny M, 2002, CANCER RES, V62, P3603; Studeny M, 2001, BLOOD, V98, p696A; Tsujino T, 2007, CLIN CANCER RES, V13, P2082, DOI 10.1158/1078-0432.CCR-06-2191; Udagawa T, 2006, FASEB J, V20, P95, DOI 10.1096/fj.04-3669com; Untergasser G, 2005, MECH AGEING DEV, V126, P59, DOI 10.1016/j.mad.2004.09.023; Wels J, 2008, GENE DEV, V22, P559, DOI 10.1101/gad.1636908; XIN H, 2007, STEM CELLS; Yang F, 2008, ONCOGENE, V27, P450, DOI 10.1038/sj.onc.1210663; Yazhou C, 2004, TUMOR BIOL, V25, P290, DOI 10.1159/000081394	57	616	639	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2009	4	4							e4992	10.1371/journal.pone.0004992	http://dx.doi.org/10.1371/journal.pone.0004992			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RT	19352430	Green Submitted, Green Published, gold			2022-12-25	WOS:000265505300002
J	Boon, K; Bailey, NW; Yang, J; Steel, MP; Groshong, S; Kervitsky, D; Brown, KK; Schwarz, MI; Schwartz, DA				Boon, Kathy; Bailey, Nathaniel W.; Yang, Jun; Steel, Mark P.; Groshong, Steve; Kervitsky, Dolly; Brown, Kevin K.; Schwarz, Marvin I.; Schwartz, David A.			Molecular Phenotypes Distinguish Patients with Relatively Stable from Progressive Idiopathic Pulmonary Fibrosis (IPF)	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; EPITHELIAL EXPRESSION; NATURAL-HISTORY; SERIAL ANALYSIS; POTENTIAL ROLE; PATHOGENESIS; SURVIVAL; ADENOCARCINOMA; ADRENOMEDULLIN; MICROARRAY	Background: Idiopathic pulmonary fibrosis (IPF) is a progressive, chronic interstitial lung disease that is unresponsive to current therapy and often leads to death. However, the rate of disease progression differs among patients. We hypothesized that comparing the gene expression profiles between patients with stable disease and those in which the disease progressed rapidly will lead to biomarker discovery and contribute to the understanding of disease pathogenesis. Methodology and Principal Findings: To begin to address this hypothesis, we applied Serial Analysis of Gene Expression (SAGE) to generate lung expression profiles from diagnostic surgical lung biopsies in 6 individuals with relatively stable (or slowly progressive) IPF and 6 individuals with progressive IPF (based on changes in DLCO and FVC over 12 months). Our results indicate that this comprehensive lung IPF SAGE transcriptome is distinct from normal lung tissue and other chronic lung diseases. To identify candidate markers of disease progression, we compared the IPF SAGE profiles in stable and progressive disease, and identified a set of 102 transcripts that were at least 5-fold up regulated and a set of 89 transcripts that were at least 5-fold down regulated in the progressive group (P-value <= 0.05). The over expressed genes included surfactant protein A1, two members of the MAPK-EGR-1-HSP70 pathway that regulate cigarette-smoke induced inflammation, and Plunc (palate, lung and nasal epithelium associated), a gene not previously implicated in IPF. Interestingly, 26 of the up regulated genes are also increased in lung adenocarcinomas and have low or no expression in normal lung tissue. More importantly, we defined a SAGE molecular expression signature of 134 transcripts that sufficiently distinguished relatively stable from progressive IPF. Conclusions: These findings indicate that molecular signatures from lung parenchyma at the time of diagnosis could prove helpful in predicting the likelihood of disease progression or possibly understanding the biological activity of IPF.	NHLBI, Natl Inst Environm Hlth Sci, Res Triangle Pk, NC USA; Duke Univ, Med Ctr, Durham, NC 27706 USA; Natl Jewish Hlth, Denver, CO USA; Univ Colorado, Hlth Sci Ctr, Denver, CO USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); NIH National Institute of Environmental Health Sciences (NIEHS); Duke University; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Boon, K (corresponding author), NHLBI, Natl Inst Environm Hlth Sci, Res Triangle Pk, NC USA.	Kathy.Boon@gmail.com	Brown, Kevin/ABF-2544-2020		National Heart, Lung, and Blood Institute; National Institute of Environmental Health Sciences	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the intramural research programs at the National Heart, Lung, and Blood Institute, and the National Institute of Environmental Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	American Thoracic Society/European Respiratory Society. International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), 2001, AM J RESP CRIT CARE, V165, P277, DOI DOI 10.1164/AJRCCM.165.2.ATS01; Baran CP, 2007, AM J RESP CRIT CARE, V176, P78, DOI 10.1164/rccm.200609-1279OC; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bingle CD, 2002, HUM MOL GENET, V11, P937, DOI 10.1093/hmg/11.8.937; Bingle L, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-79; Boon K, 2002, P NATL ACAD SCI USA, V99, P11287, DOI 10.1073/pnas.152324199; Capelli A, 2005, EUR RESPIR J, V25, P701, DOI 10.1183/09031936.05.00082604; Chen JJ, 2002, P NATL ACAD SCI USA, V99, P12257, DOI 10.1073/pnas.192436499; DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1; Di YP, 2003, J BIOL CHEM, V278, P1165, DOI 10.1074/jbc.M210523200; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fattman CL, 2008, AM J PHYSIOL-LUNG C, V294, pL572, DOI 10.1152/ajplung.00291.2007; Gharaee-Kermani M, 2003, CYTOKINE, V24, P266, DOI 10.1016/j.cyto.2003.08.003; Gharaee-Kermani M, 2007, PHARM RES-DORDR, V24, P819, DOI 10.1007/s11095-006-9216-x; Glas AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-278; Gouyer V, 2005, CANCER-AM CANCER SOC, V103, P1676, DOI 10.1002/cncr.20965; Hetzel M, 2005, LUNG, V183, P225, DOI 10.1007/s00408-004-2534-z; IYONAGA K, 1994, HUM PATHOL, V25, P455, DOI 10.1016/0046-8177(94)90117-1; Kadota J, 2005, RESP MED, V99, P111, DOI 10.1016/j.rmed.2004.04.018; Kaminski N, 2003, AM J RESP CELL MOL, V29, pS32; Kaminski Naftali, 2006, Proc Am Thorac Soc, V3, P339, DOI 10.1513/pats.200601-011TK; Kang HR, 2007, J EXP MED, V204, P1083, DOI 10.1084/jem.20061273; Kim Dong Soon, 2006, Proc Am Thorac Soc, V3, P285, DOI 10.1513/pats.200601-005TK; King TE, 2001, AM J RESP CRIT CARE, V164, P1171, DOI 10.1164/ajrccm.164.7.2003140; Lee KS, 2008, EUR RESPIR J, V31, P523, DOI 10.1183/09031936.00125007; Li CJ, 2007, AM J PHYSIOL-LUNG C, V292, pL1297, DOI 10.1152/ajplung.00194.2006; Maher TM, 2007, EUR RESPIR J, V30, P835, DOI 10.1183/09031936.00069307; Martinez FJ, 2005, ANN INTERN MED, V142, P963, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00005; Meek PM, 1999, AM J RESP CRIT CARE, V159, P321; Nevins JR, 2007, NAT REV GENET, V8, P601, DOI 10.1038/nrg2137; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Pardo Annie, 2006, Proc Am Thorac Soc, V3, P383, DOI 10.1513/pats.200601-012TK; Pio R, 2002, MICROSC RES TECHNIQ, V57, P23, DOI 10.1002/jemt.10047; Robertson N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r6; Rosas IO, 2008, PLOS MED, V5, P623, DOI 10.1371/journal.pmed.0050093; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; SCHWARTZ DA, 1994, AM J RESP CRIT CARE, V149, P444, DOI 10.1164/ajrccm.149.2.8306043; Selman M, 2000, AM J PHYSIOL-LUNG C, V279, pL562, DOI 10.1152/ajplung.2000.279.3.L562; Selman M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000482; Selman Moises, 2006, Proc Am Thorac Soc, V3, P364, DOI 10.1513/pats.200601-003TK; Sentani K, 2008, MODERN PATHOL, V21, P464, DOI 10.1038/modpathol.3801050; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; St Croix B, 2000, SCIENCE, V289, P1197; Steele MP, 2005, AM J RESP CRIT CARE, V172, P1146, DOI 10.1164/rccm.200408-1104OC; Strieter RM, 2005, CHEST, V128, p526S, DOI 10.1378/chest.128.5_suppl_1.526S; Swiderski RE, 1998, AM J PATHOL, V152, P821; Thannickal Victor J, 2006, Proc Am Thorac Soc, V3, P350, DOI 10.1513/pats.200601-001TK; van 't Veer LJ, 2003, BREAST CANCER RES, V5, P57, DOI 10.1186/bcr562; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Vizza CD, 2005, REGUL PEPTIDES, V124, P187, DOI 10.1016/j.regpep.2004.07.021; Walters DM, 2008, ANTIOXID REDOX SIGN, V10, P321, DOI 10.1089/ars.2007.1901; Wang HY, 2007, IEEE ACM T COMPUT BI, V4, P163, DOI 10.1109/TCBB.2007.070204; Williams RE, 2005, MOL BIOSYST, V1, P166, DOI 10.1039/b500852b; Wittke A, 2004, J IMMUNOL, V173, P3432, DOI 10.4049/jimmunol.173.5.3432; Yang IV, 2007, AM J RESP CRIT CARE, V175, P45, DOI 10.1164/rccm.200601-062OC	55	138	143	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2009	4	4							e5134	10.1371/journal.pone.0005134	http://dx.doi.org/10.1371/journal.pone.0005134			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RS	19347046	Green Published, gold			2022-12-25	WOS:000265505200007
J	Chamberlain, J; Francis, S; Brookes, Z; Shaw, G; Graham, D; Alp, NJ; Dower, S; Crossman, DC				Chamberlain, Janet; Francis, Sheila; Brookes, Zoe; Shaw, Gary; Graham, Delyth; Alp, Nicholas J.; Dower, Steven; Crossman, David C.			Interleukin-1 Regulates Multiple Atherogenic Mechanisms in Response to Fat Feeding	PLOS ONE			English	Article								Background: Atherosclerosis is an inflammatory process that develops in individuals with known risk factors that include hypertension and hyperlipidaemia, influenced by diet. However, the interplay between diet, inflammatory mechanisms and vascular risk factors requires further research. We hypothesised that interleukin-1 (IL-1) signaling in the vessel wall would raise arterial blood pressure and promote atheroma. Methodology/Principal Findings: Apoe(-/-) and Apoe(-/-)/IL-1R1(-/-) mice were fed high fat diets for 8 weeks, and their blood pressure and atherosclerosis development measured. Apoe(-/-)/IL-R1(-/-) mice had a reduced blood pressure and significantly less atheroma than Apoe(-/-) mice. Selective loss of IL-1 signaling in the vessel wall by bone marrow transplantation also reduced plaque burden (p<0.05). This was associated with an IL-1 mediated loss of endothelium-dependent relaxation and an increase in vessel wall Nox 4. Inhibition of IL-1 restored endothelium-dependent vasodilatation and reduced levels of arterial oxidative stress. Conclusions/Significance: The IL-1 cytokine system links atherogenic environmental stimuli with arterial inflammation, oxidative stress, increased blood pressure and atherosclerosis. This is the first demonstration that inhibition of a single cytokine can block the rise in blood pressure in response to an environmental stimulus. IL-1 inhibition may have profound beneficial effects on atherogenesis in man.	[Chamberlain, Janet; Francis, Sheila; Brookes, Zoe; Shaw, Gary; Crossman, David C.] Univ Sheffield, Cardiovasc Res Unit, Sch Med & Biomed Sci, Sheffield, S Yorkshire, England; [Graham, Delyth] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow G12 8QQ, Lanark, Scotland; [Alp, Nicholas J.] Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX1 2JD, England; [Dower, Steven] Univ Sheffield, Sch Med & Biomed Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield; University of Glasgow; University of Oxford; University of Sheffield	Chamberlain, J (corresponding author), Univ Sheffield, Cardiovasc Res Unit, Sch Med & Biomed Sci, Sheffield, S Yorkshire, England.	j.chamberlain@sheffield.ac.uk		Brookes, Zoe/0000-0002-8096-6256; dower, steve/0000-0002-4675-4225	British Heart Foundation [RG 2001/008]; MRC [G0502131] Funding Source: UKRI; Medical Research Council [G0502131] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by British Heart Foundation Programme Grant RG 2001/008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate A, 2008, CIRCULATION, V117, P2670, DOI 10.1161/CIRCULATIONAHA.107.740233; Alp NJ, 2004, ARTERIOSCL THROM VAS, V24, P445, DOI 10.1161/01.ATV.0000115637.48689.77; Alp NJ, 2003, J CLIN INVEST, V112, P725, DOI 10.1172/JCI200317786; Andrew PS, 2003, AM J PHYSIOL-REG I, V284, pR1567, DOI 10.1152/ajpregu.00417.2002; Appel LJ, 2005, JAMA-J AM MED ASSOC, V294, P2455, DOI 10.1001/jama.294.19.2455; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; BEVILACQUA MP, 1984, J EXP MED, V160, P618, DOI 10.1084/jem.160.2.618; Brookes ZLS, 2003, AM J PHYSIOL-REG I, V284, pR1604, DOI 10.1152/ajpregu.00411.2002; Chamberlain J, 2006, AM J PATHOL, V168, P1396, DOI 10.2353/ajpath.2006.051054; Chen JQ, 2001, CIRCULATION, V104, P2391, DOI 10.1161/hc4501.099729; Chi HH, 2004, CIRCULATION, V110, P1678, DOI 10.1161/01.CIR.0000142085.39015.31; COLOTTA F, 1994, IMMUNOL TODAY, V15, P562, DOI 10.1016/0167-5699(94)90217-8; Devlin CM, 2002, P NATL ACAD SCI USA, V99, P6280, DOI 10.1073/pnas.092324399; Dewberry R, 2000, ARTERIOSCL THROM VAS, V20, P2394, DOI 10.1161/01.ATV.20.11.2394; Dickinson HO, 2006, J HYPERTENS, V24, P215, DOI 10.1097/01.hjh.0000199800.72563.26; Elhage R, 1998, CIRCULATION, V97, P242, DOI 10.1161/01.CIR.97.3.242; Ellmark SHM, 2005, CARDIOVASC RES, V65, P495, DOI 10.1016/j.cardiores.2004.10.026; Galea J, 1996, ARTERIOSCL THROM VAS, V16, P1000, DOI 10.1161/01.ATV.16.8.1000; Getz GS, 2006, ARTERIOSCL THROM VAS, V26, P242, DOI 10.1161/01.ATV.0000201071.49029.17; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Guzik TJ, 2006, ARTERIOSCL THROM VAS, V26, P333, DOI 10.1161/01.ATV.0000196651.64776.51; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Ikonomidis I, 2008, CIRCULATION, V117, P2662, DOI 10.1161/CIRCULATIONAHA.107.731877; Isoda K, 2004, ARTERIOSCL THROM VAS, V24, P1068, DOI 10.1161/01.ATV.0000127025.48140.a3; Kamari Y, 2007, ATHEROSCLEROSIS, V195, P31, DOI 10.1016/j.atherosclerosis.2006.11.026; Kaur J, 2004, MED PRIN PRACT, V13, P26, DOI 10.1159/000074047; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Laursen JB, 2001, CIRCULATION, V103, P1282; LIBBY P, 1986, J CLIN INVEST, V78, P1432, DOI 10.1172/JCI112732; Massaro M, 2006, P NATL ACAD SCI USA, V103, P15184, DOI 10.1073/pnas.0510086103; MORRIS MC, 1993, CIRCULATION, V88, P523, DOI 10.1161/01.CIR.88.2.523; Morton AC, 2005, CARDIOVASC RES, V68, P493, DOI 10.1016/j.cardiores.2005.06.026; Ray KK, 2002, CLIN SCI, V103, P303, DOI 10.1042/cs1030303; SYMONS JA, 1995, P NATL ACAD SCI USA, V92, P1714, DOI 10.1073/pnas.92.5.1714; Takeuchi Hiroyuki, 2007, J Oleo Sci, V56, P347; Tamaru M, 1998, ARTERIOSCL THROM VAS, V18, P1292, DOI 10.1161/01.ATV.18.8.1292; Vergnes L, 2003, J BIOL CHEM, V278, P42774, DOI 10.1074/jbc.M306022200; Wilde DW, 2000, HYPERTENSION, V35, P832, DOI 10.1161/01.HYP.35.3.832; Yang Hagen, 2007, Conn Med, V71, P533	40	97	100	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2009	4	4							e5073	10.1371/journal.pone.0005073	http://dx.doi.org/10.1371/journal.pone.0005073			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RS	19347044	Green Published, Green Accepted, gold			2022-12-25	WOS:000265505200005
J	Lucas, J; Bilzer, A; Moll, L; Zundorf, I; Dingermann, T; Eichinger, L; Siol, O; Winckler, T				Lucas, Joerg; Bilzer, Annika; Moll, Lorna; Zuendorf, Ilse; Dingermann, Theodor; Eichinger, Ludwig; Siol, Oliver; Winckler, Thomas			The Carboxy-Terminal Domain of Dictyostelium C-Module-Binding Factor Is an Independent Gene Regulatory Entity	PLOS ONE			English	Article							NUCLEAR-PROTEIN; EXPRESSION; VECTORS; DATABASE; CLONING; GENOME; GROWTH; MODEL	The C-module-binding factor (CbfA) is a multidomain protein that belongs to the family of jumonji-type (JmjC) transcription regulators. In the social amoeba Dictyostelium discoideum, CbfA regulates gene expression during the unicellular growth phase and multicellular development. CbfA and a related D. discoideum CbfA-like protein, CbfB, share a paralogous domain arrangement that includes the JmjC domain, presumably a chromatin-remodeling activity, and two zinc finger-like (ZF) motifs. On the other hand, the CbfA and CbfB proteins have completely different carboxy-terminal domains, suggesting that the plasticity of such domains may have contributed to the adaptation of the CbfA-like transcription factors to the rapid genome evolution in the dictyostelid clade. To support this hypothesis we performed DNA microarray and real-time RT-PCR measurements and found that CbfA regulates at least 160 genes during the vegetative growth of D. discoideum cells. Functional annotation of these genes revealed that CbfA predominantly controls the expression of gene products involved in housekeeping functions, such as carbohydrate, purine nucleoside/nucleotide, and amino acid metabolism. The CbfA protein displays two different mechanisms of gene regulation. The expression of one set of CbfA-dependent genes requires at least the JmjC/ZF domain of the CbfA protein and thus may depend on chromatin modulation. Regulation of the larger group of genes, however, does not depend on the entire CbfA protein and requires only the carboxy-terminal domain of CbfA (CbfA-CTD). An AT-hook motif located in CbfA-CTD, which is known to mediate DNA binding to A+T-rich sequences in vitro, contributed to CbfA-CTD-dependent gene regulatory functions in vivo.	[Lucas, Joerg; Bilzer, Annika; Siol, Oliver; Winckler, Thomas] Univ Jena, Inst Pharm, Sch Biol & Pharm, Dept Pharmaceut Biol, Jena, Germany; [Moll, Lorna; Eichinger, Ludwig] Univ Cologne, Med Fac, Inst Biochem I, D-5000 Cologne, Germany; [Zuendorf, Ilse; Dingermann, Theodor] Goethe Univ Frankfurt, Inst Pharmaceut Biol, D-6000 Frankfurt, Germany	Friedrich Schiller University of Jena; University of Cologne; Goethe University Frankfurt	Lucas, J (corresponding author), Univ Jena, Inst Pharm, Sch Biol & Pharm, Dept Pharmaceut Biol, Jena, Germany.	t.winckler@uni-jena.de	Eichinger, Ludwig/AAJ-8895-2021; Dingermann, Theodor/M-6970-2014	Eichinger, Ludwig/0000-0003-1594-6117; Dingermann, Theodor/0000-0002-2788-1085; Moll, Lorna/0000-0003-1194-7323	Deutsche Forschungsgemeinschaft DFG [SFB 604]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft DFG (SFB 604). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4413, DOI 10.1093/nar/26.19.4413; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Chisholm RL, 2006, NUCLEIC ACIDS RES, V34, pD423, DOI 10.1093/nar/gkj090; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Farbrother P, 2006, CELL MICROBIOL, V8, P438, DOI 10.1111/j.1462-5822.2005.00633.x; Geier A, 1996, EUR J BIOCHEM, V241, P70, DOI 10.1111/j.1432-1033.1996.0070t.x; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hentschel U, 2001, ANAL BIOCHEM, V296, P83, DOI 10.1006/abio.2001.5207; Horn J, 1999, EUR J BIOCHEM, V265, P441, DOI 10.1046/j.1432-1327.1999.00768.x; JOHNSON KR, 1988, J BIOL CHEM, V263, P18338; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Maeda M, 2004, SCIENCE, V304, P875, DOI 10.1126/science.1094647; MANFIOLETTI G, 1991, NUCLEIC ACIDS RES, V19, P6793, DOI 10.1093/nar/19.24.6793; MANSTEIN DJ, 1995, GENE, V162, P129, DOI 10.1016/0378-1119(95)00351-6; Meima ME, 2007, PROTEIN EXPRES PURIF, V53, P283, DOI 10.1016/j.pep.2007.01.001; Na JB, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-123; Otsuka H, 1998, GENE DEV, V12, P1738, DOI 10.1101/gad.12.11.1738; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PITT GS, 1993, GENE DEV, V7, P2172, DOI 10.1101/gad.7.11.2172; Reeves R, 2001, BBA-GENE STRUCT EXPR, V1519, P13, DOI 10.1016/S0167-4781(01)00215-9; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; Sillo A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-291; Siol O, 2006, EUKARYOT CELL, V5, P658, DOI 10.1128/EC.5.4.658-664.2006; TAKEUCHI T, 1995, GENE DEV, V9, P1211, DOI 10.1101/gad.9.10.1211; Thomason PA, 2006, PLASMID, V56, P145, DOI 10.1016/j.plasmid.2006.04.001; Wemmer DE, 1999, BIOPOLYMERS, V52, P197, DOI 10.1002/1097-0282(1999)52:4<197::AID-BIP1004>3.0.CO;2-U; Winckler T, 2004, EUKARYOT CELL, V3, P1349, DOI 10.1128/EC.3.5.1349-1358.2004; Winckler T, 2001, J MOL BIOL, V305, P703, DOI 10.1006/jmbi.2000.4341; Xu Qikai, 2005, Appl Bioinformatics, V4, P281, DOI 10.2165/00822942-200504040-00008	30	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2009	4	4							e5012	10.1371/journal.pone.0005012	http://dx.doi.org/10.1371/journal.pone.0005012			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437QA	19343174	Green Submitted, Green Published, gold			2022-12-25	WOS:000265500800001
J	Bollyky, PL; Bice, JB; Sweet, IR; Falk, BA; Gebe, JA; Clark, AE; Gersuk, VH; Aderem, A; Hawn, TR; Nepom, GT				Bollyky, Paul L.; Bice, Jeffrey B.; Sweet, Ian R.; Falk, Ben A.; Gebe, John A.; Clark, April E.; Gersuk, Vivian H.; Aderem, Alan; Hawn, Thomas R.; Nepom, Gerald T.			The Toll-Like Receptor Signaling Molecule Myd88 Contributes to Pancreatic Beta-Cell Homeostasis in Response to Injury	PLOS ONE			English	Article							HUMAN GINGIVAL FIBROBLASTS; GLUCAGON-LIKE PEPTIDE-1; GENE-EXPRESSION; INNATE IMMUNITY; ISLET TRANSPLANTATION; MYD88-DEFICIENT MICE; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; GUT FLORA; LIPOPOLYSACCHARIDE	Commensal flora and pathogenic microbes influence the incidence of diabetes in animal models yet little is known about the mechanistic basis of these interactions. We hypothesized that Myd88, an adaptor molecule in the Toll-like-receptor (TLR) pathway, regulates pancreatic beta-cell function and homeostasis. We first examined beta-cells histologically and found that Myd88(-/-) mice have smaller islets in comparison to C57Bl/6 controls. Myd88(-/-) mice were nonetheless normoglycemic both at rest and after an intra-peritoneal glucose tolerance test (IPGTT). In contrast, after low-dose streptozotocin (STZ) challenge, Myd88(-/-) mice had an abnormal IPGTT relative to WT controls. Furthermore, Myd88(-/-) mice suffer enhanced beta-cell apoptosis and have enhanced hepatic damage with delayed recovery upon low-dose STZ treatment. Finally, we treated WT mice with broad-spectrum oral antibiotics to deplete their commensal flora. In WT mice, low dose oral lipopolysaccharide, but not lipotichoic acid or antibiotics alone, strongly promoted enhanced glycemic control. These data suggest that Myd88 signaling and certain TLR ligands mediate a homeostatic effect on b-cells primarily in the setting of injury.	Benaroya Res Inst, Seattle, WA USA; Inst Syst Biol, Seattle, WA USA; Univ Washington, Sch Med, Seattle, WA 98195 USA	Benaroya Research Institute; Institute for Systems Biology (ISB); University of Washington; University of Washington Seattle	Bollyky, PL (corresponding author), Benaroya Res Inst, Seattle, WA USA.	pbollyky@benaroyaresearch.org		Nepom, Gerald/0000-0002-8063-1464	NIH [DK46635, HL18645, DK53004, DK080178-01]; JDRF (The Center for Translational Research at BRI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK080178, R01DK046635] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF (The Center for Translational Research at BRI)(Juvenile Diabetes Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the NIH (DK46635, HL18645, and DK53004) and the JDRF (The Center for Translational Research at BRI). PLB is supported by NIH K-08 grant DK080178-01 and an NIH LRP grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; Alyanakian MA, 2006, DIABETES, V55, P179, DOI 10.2337/diabetes.55.1.179; Arnush M, 1998, J CLIN INVEST, V102, P516, DOI 10.1172/JCI844; Balasa B, 2000, CLIN IMMUNOL, V95, P93, DOI 10.1006/clim.2000.4855; Brugman S, 2006, DIABETOLOGIA, V49, P2105, DOI 10.1007/s00125-006-0334-0; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Clevers H, 2004, CELL, V118, P671, DOI 10.1016/j.cell.2004.09.005; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; CORNELL RP, 1985, DIABETES, V34, P1253, DOI 10.2337/diabetes.34.12.1253; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; Drucker DJ, 2003, ENDOCRINOLOGY, V144, P5145, DOI 10.1210/en.2003-1147; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Franchimont D, 2004, GUT, V53, P987, DOI 10.1136/gut.2003.030205; Francois S, 2005, J IMMUNOL, V174, P3633, DOI 10.4049/jimmunol.174.6.3633; Gelman AE, 2004, J IMMUNOL, V172, P6065, DOI 10.4049/jimmunol.172.10.6065; Heald KA, 1996, TRANSPLANT P, V28, P824; JACOB AI, 1977, GASTROENTEROLOGY, V72, P1268; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; LEY R, 2006, NATURE, V444, P1023; Li M, 2001, J IMMUNOL, V166, P7128, DOI 10.4049/jimmunol.166.12.7128; Lombardo E, 2007, J IMMUNOL, V178, P3731, DOI 10.4049/jimmunol.178.6.3731; Macedo L, 2007, AM J PATHOL, V171, P1774, DOI 10.2353/ajpath.2007.061048; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; MONTANA E, 1993, J CLIN INVEST, V91, P780, DOI 10.1172/JCI116297; OBrien BA, 1996, J PATHOL, V178, P176; Oguri S, 2002, CLIN DIAGN LAB IMMUN, V9, P1307, DOI 10.1128/CDLI.9.6.1307-1312.2002; Pick A, 1998, DIABETES, V47, P358, DOI 10.2337/diabetes.47.3.358; Putnins EE, 2002, INFECT IMMUN, V70, P6541, DOI 10.1128/IAI.70.12.6541-6548.2002; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; RICORDI C, 1990, ACTA DIABETOL LAT, V27, P185, DOI 10.1007/BF02581331; Rivera CA, 2007, J HEPATOL, V47, P571, DOI 10.1016/j.jhep.2007.04.019; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Sai P, 1996, DIABETES METAB, V22, P341; Saini KS, 1996, BIOCHEM MOL BIOL INT, V39, P1229; Saitoh N, 2004, MICROBIOL IMMUNOL, V48, P629, DOI 10.1111/j.1348-0421.2004.tb03471.x; Salaun B, 2007, EUR J IMMUNOL, V37, P3311, DOI 10.1002/eji.200737744; Sanaie AR, 2002, J PERIODONTAL RES, V37, P66, DOI 10.1034/j.1600-0765.2002.t01-1-90770.x; Sawa H, 2007, SURG TODAY, V37, P867, DOI 10.1007/s00595-007-3520-x; Seki E, 2005, HEPATOLOGY, V41, P443, DOI 10.1002/hep.20603; SERREZE DV, 1989, J AUTOIMMUN, V2, P759, DOI 10.1016/0896-8411(89)90003-6; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; SOBEL DO, 1994, DIABETES, V43, P518, DOI 10.2337/diabetes.43.4.518; Sugiyama A, 1996, INFECT IMMUN, V64, P1426, DOI 10.1128/IAI.64.4.1426-1431.1996; TAKAHASHI K, 1993, CLIN IMMUNOL IMMUNOP, V69, P318, DOI 10.1006/clin.1993.1187; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Thomas KE, 2006, J IMMUNOL, V176, P2512, DOI 10.4049/jimmunol.176.4.2512; Uematsu S, 2002, J IMMUNOL, V168, P5811, DOI 10.4049/jimmunol.168.11.5811; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; van der Werf N, 2007, DIABETES-METAB RES, V23, P169, DOI 10.1002/dmrr.695; van Tol EAF, 1999, AM J PHYSIOL-GASTR L, V277, pG245, DOI 10.1152/ajpgi.1999.277.1.G245; Vives-Pi M, 2003, CLIN EXP IMMUNOL, V133, P208, DOI 10.1046/j.1365-2249.2003.02211.x; WEIBEL ER, 1969, J CELL BIOL, V42, P68, DOI 10.1083/jcb.42.1.68; Wen L, 2004, J IMMUNOL, V172, P3173, DOI 10.4049/jimmunol.172.5.3173; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wideman RD, 2006, P NATL ACAD SCI USA, V103, P13468, DOI 10.1073/pnas.0600655103; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270	59	34	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5063	10.1371/journal.pone.0005063	http://dx.doi.org/10.1371/journal.pone.0005063			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19357791	Green Submitted, Green Published, gold			2022-12-25	WOS:000265500600019
J	Branney, PA; Faas, L; Steane, SE; Pownall, ME; Isaacs, HV				Branney, Peter A.; Faas, Laura; Steane, Sarah E.; Pownall, Mary Elizabeth; Isaacs, Harry V.			Characterisation of the Fibroblast Growth Factor Dependent Transcriptome in Early Development	PLOS ONE			English	Article							MAP KINASE PHOSPHATASE; EARLY XENOPUS-EMBRYOS; MESODERM INDUCTION; SPEMANN ORGANIZER; NEURAL INDUCTION; GENE-EXPRESSION; SELF-RENEWAL; FGF; GASTRULATION; CELLS	Background: FGF signaling has multiple roles in regulating processes in animal development, including the specification and patterning of the mesoderm. In addition, FGF signaling supports self renewal of human embryonic stem cells and is required for differentiation of murine embryonic stem cells into a number of lineages. Methodology/Principal Findings: Given the importance of FGF signaling in regulating development and stem cell behaviour, we aimed to identify the transcriptional targets of FGF signalling during early development in the vertebrate model Xenopus laevis. We analysed the effects on gene expression in embryos in which FGF signaling was inhibited by dominant negative FGF receptors. 67 genes positively regulated by FGF signaling and 16 genes negatively regulated by FGF signaling were identified. FGF target genes are expressed in distinct waves during the late blastula to early gastrula phase. Many of these genes are expressed in the early mesoderm and dorsal ectoderm. A widespread requirement for FGF in regulating genes expressed in the Spemann organizer is revealed. The FGF targets MKP1 and DUSP5 are shown to be negative regulators of FGF signaling in early Xenopus tissues. FoxD3 and Lin28, which are involved in regulating pluripotency in ES cells are shown to be down regulated when FGF signaling is blocked. Conclusions: We have undertaken a detailed analysis of FGF target genes which has generated a robust, well validated data set. We have found a widespread role for FGF signaling in regulating the expression of genes mediating the function of the Spemann organizer. In addition, we have found that the FGF targets MKP1 and DUSP5 are likely to contribute to the complex feedback loops involved in modulating responses to FGF signaling. We also find a link between FGF signaling and the expression of known regulators of pluripotency.	[Branney, Peter A.; Faas, Laura; Steane, Sarah E.; Pownall, Mary Elizabeth; Isaacs, Harry V.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England	University of York - UK	Branney, PA (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	hvi1@york.ac.uk		Pownall, Mary Elizabeth/0000-0003-2329-5844; steane, sarah/0000-0001-8594-3486	BBSRC [BB/D010039/1]; Biotechnology and Biological Sciences Research Council [BB/D010039/1, BB/C505408/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Work funded by BBSRC grant BB/D010039/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMAYA E, 1993, DEVELOPMENT, V118, P477; AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Bottcher RT, 2004, NAT CELL BIOL, V6, P38, DOI 10.1038/ncb1082; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; BURKS PJ, 2008, BIOL CELL; Christen B, 1999, DEVELOPMENT, V126, P119; Christensen MM, 1997, CLIN ORAL IMPLAN RES, V8, P455, DOI 10.1034/j.1600-0501.1997.080603.x; CHRISTIAN JL, 1992, EMBO J, V11, P33, DOI 10.1002/j.1460-2075.1992.tb05024.x; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; CORNELL RA, 1994, DEVELOPMENT, V120, P453; CORNELL RA, 1995, DEVELOPMENT, V121, P2429; Delaune E, 2005, DEVELOPMENT, V132, P299, DOI 10.1242/dev.01582; Fisher ME, 2002, DEVELOPMENT, V129, P1307; Fletcher RB, 2006, DEVELOPMENT, V133, P1703, DOI 10.1242/dev.02342; Fletcher RB, 2008, DEV DYNAM, V237, P1243, DOI 10.1002/dvdy.21517; Frazzetto G, 2002, MECH DEVELOP, V113, P3, DOI 10.1016/S0925-4773(01)00664-5; Gomez AR, 2005, DEV DYNAM, V232, P695, DOI 10.1002/dvdy.20227; GRIFFIN K, 1995, DEVELOPMENT, V121, P2983; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Hongo I, 1999, DEV BIOL, V216, P561, DOI 10.1006/dbio.1999.9515; Isaacs HV, 1998, EMBO J, V17, P3413, DOI 10.1093/emboj/17.12.3413; Isaacs HV, 1997, CELL MOL LIFE SCI, V53, P350, DOI 10.1007/PL00000611; ISAACS HV, 1994, EMBO J, V13, P4469, DOI 10.1002/j.1460-2075.1994.tb06769.x; ISAACS HV, 1992, DEVELOPMENT, V114, P711; Keenan ID, 2006, DEV BIOL, V299, P478, DOI 10.1016/j.ydbio.2006.08.040; KIMELMAN D, 1987, CELL, V51, P869, DOI 10.1016/0092-8674(87)90110-3; Klingbeil P, 2001, INT J DEV BIOL, V45, P379; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; LABONNE C, 1994, DEVELOPMENT, V120, P463; LABONNE C, 1995, DEVELOPMENT, V121, P1475; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Levine B, 2007, DEV BIOL, V305, P217, DOI 10.1016/j.ydbio.2007.02.013; LEWIS T, 1995, J CELL SCI, V108, P2885; Liu Y, 2008, STEM CELLS, V26, P2475, DOI 10.1634/stemcells.2008-0269; Lombardo A, 1998, INT J DEV BIOL, V42, P1101; Mason C, 1996, MECH DEVELOP, V55, P133, DOI 10.1016/0925-4773(96)00495-9; Mathieu J, 2004, DEVELOPMENT, V131, P629, DOI 10.1242/dev.00964; Mitchell TS, 2001, DEV BIOL, V237, P295, DOI 10.1006/dbio.2001.0385; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Nutt SL, 2001, GENE DEV, V15, P1152, DOI 10.1101/gad.191301; Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125; Pera EM, 2003, GENE DEV, V17, P3023, DOI 10.1101/gad.1153603; Pownall ME, 1996, DEVELOPMENT, V122, P3881; Ribisi S, 2000, DEV BIOL, V227, P183, DOI 10.1006/dbio.2000.9889; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; SCHULTEMERKER S, 1995, CURR BIOL, V5, P62, DOI 10.1016/S0960-9822(95)00017-0; Sheng GJ, 2003, CELL, V115, P603, DOI 10.1016/S0092-8674(03)00927-9; Shinga J, 2001, MECH DEVELOP, V109, P225, DOI 10.1016/S0925-4773(01)00528-7; Sivak JM, 2005, DEV CELL, V8, P689, DOI 10.1016/j.devcel.2005.02.011; SLACK JMW, 1987, NATURE, V326, P197, DOI 10.1038/326197a0; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Steiner AB, 2006, DEVELOPMENT, V133, P4827, DOI 10.1242/dev.02663; Takeuchi M, 2003, CURR BIOL, V13, P674, DOI 10.1016/S0960-9822(03)00245-8; UMBHAUER M, 1995, NATURE, V376, P58, DOI 10.1038/376058a0; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Winning RS, 1996, DEV BIOL, V179, P309, DOI 10.1006/dbio.1996.0262; Yang XS, 2002, DEV CELL, V3, P425, DOI 10.1016/S1534-5807(02)00256-3; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; ZARAISKY AG, 1995, DEVELOPMENT, V121, P3839	64	37	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e4951	10.1371/journal.pone.0004951	http://dx.doi.org/10.1371/journal.pone.0004951			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333377	Green Submitted, Green Published, gold			2022-12-25	WOS:000265499900006
J	Cooper, HM; Huang, JY; Verdin, E; Spelbrink, JN				Cooper, Helen M.; Huang, Jing-Yi; Verdin, Eric; Spelbrink, Johannes N.			A New Splice Variant of the Mouse SIRT3 Gene Encodes the Mitochondrial Precursor Protein	PLOS ONE			English	Article							DEACETYLASE	Background: Mammals have seven NAD-dependent protein deacetylases. These proteins, called sirtuins, are homologous to yeast Sir2, and are emerging as important regulators of lifespan and intermediary metabolism. Three mammalian sirtuins, SIRT3-5 are mitochondrial. Sirtuins are highly conserved between species, yet mouse SIRT3 was reported to be markedly shorter than its human counterpart and to lack the N-terminal mitochondrial targeting signal present in the human protein. Results: We have isolated a novel mouse SIRT3 splice variant. This cDNA contains two translation initiation codons upstream of the originally reported start site. We show, using immunofluorescence and protein expression analysis that these longer variants are expressed and efficiently targeted to mitochondria, and that the processed forms of these longer variants are identical in size to the endogenous mouse SIRT3. We also show that the previously described form of SIRT3 is not mitochondrial. Conclusions: Our observations point to a high level of conservation of SIRT3 as a mitochondrial protein in mice and human and indicate that several previous studies, which addressed mouse Sirt3 function, need to be re-evaluated.	[Cooper, Helen M.; Spelbrink, Johannes N.] Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland; [Cooper, Helen M.; Spelbrink, Johannes N.] Tampere Univ Hosp, Tampere, Finland; [Huang, Jing-Yi; Verdin, Eric] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA	Tampere University; Tampere University; Tampere University Hospital; University of California System; University of California San Francisco; The J David Gladstone Institutes	Cooper, HM (corresponding author), Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland.	hans.spelbrink@uta.fi	Spelbrink, Johannes N/L-4661-2015; Verdin, Eric/AAB-7999-2019	Spelbrink, Johannes N/0000-0002-9756-2602; Verdin, Eric/0000-0003-3703-3183	Academy of Finland [110689, 103213]; Sigrid Juselius Foundation; Tampere University Hospital Medical Research Fund [9J119, 9H102]; Larry L. Hillblom Foundation [postdoctoral fellowship]; J. David Gladstone Institutes	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Tampere University Hospital Medical Research Fund; Larry L. Hillblom Foundation; J. David Gladstone Institutes(University of California System)	This work was supported by the Academy of Finland [110689, 103213 and CoE funding to JNS]; Sigrid Juselius Foundation [to J.N.S.]; and the Tampere University Hospital Medical Research Fund [9J119 to J.N.S., 9H102 to H.M.C.]. J-Y.H is supported by a postdoctoral fellowship from the Larry L. Hillblom Foundation and E.V. is supported by the J. David Gladstone Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cooper HM, 2008, BIOCHEM J, V411, P279, DOI 10.1042/BJ20071624; Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Lecluyse E, 1999, DRUG METAB DISPOS, V27, P909; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Malka Florence, 2007, V372, P3, DOI 10.1007/978-1-59745-365-3_1; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Nakamura Y, 2008, BIOCHEM BIOPH RES CO, V366, P174, DOI 10.1016/j.bbrc.2007.11.122; Scher MB, 2007, GENE DEV, V21, P920, DOI 10.1101/gad.1527307; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200; Yang YH, 2000, GENOMICS, V69, P355, DOI 10.1006/geno.2000.6360	17	56	59	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e4986	10.1371/journal.pone.0004986	http://dx.doi.org/10.1371/journal.pone.0004986			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333382	Green Published, Green Submitted, gold			2022-12-25	WOS:000265499900009
J	Graham, AI; Hunt, S; Stokes, SL; Bramall, N; Bunch, J; Cox, AG; McLeod, CW; Poole, RK				Graham, Alison I.; Hunt, Stuart; Stokes, Sarah L.; Bramall, Neil; Bunch, Josephine; Cox, Alan G.; McLeod, Cameron W.; Poole, Robert K.			Severe Zinc Depletion of Escherichia coli ROLES FOR HIGH AFFINITY ZINC BINDING BY ZinT, ZINC TRANSPORT AND ZINC-INDEPENDENT PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONSIVE REGULATOR ZUR; TRANSCRIPTIONAL RESPONSE; UPTAKE SYSTEM; BACILLUS-SUBTILIS; SACCHAROMYCES-CEREVISIAE; STREPTOMYCES-COELICOLOR; RIBOSOMAL-PROTEINS; ARRAY TECHNOLOGY; GENE-EXPRESSION; METAL-BINDING	Zinc ions play indispensable roles in biological chemistry. However, bacteria have an impressive ability to acquire Zn2+ from the environment, making it exceptionally difficult to achieve Zn2+ deficiency, and so a comprehensive understanding of the importance of Zn2+ has not been attained. Reduction of the Zn2+ content of Escherichia coli growth medium to 60 nM or less is reported here for the first time, without recourse to chelators of poor specificity. Cells grown in Zn2+-deficient medium had a reduced growth rate and contained up to five times less cellular Zn2+. To understand global responses to Zn2+ deficiency, microarray analysis was conducted of cells grown under Zn2+-replete and Zn2+-depleted conditions in chemostat cultures. Nine genes were up-regulated more than 2-fold (p<0.05) in cells from Zn2+-deficient chemostats, including zinT (yodA). zinT is shown to be regulated by Zur ( zinc uptake regulator). A mutant lacking zinT displayed a growth defect and a 3-fold lowered cellular Zn2+ level under Zn2+ limitation. The purified ZinT protein possessed a single, high affinity metal-binding site that can accommodate Zn2+ or Cd2+. A further up-regulated gene, ykgM, is believed to encode a non-Zn2+ finger-containing paralogue of the Zn2+ finger ribosomal protein L31. The gene encoding the periplasmic Zn2+- binding protein znuA showed increased expression. During both batch and chemostat growth, cells "found" more Zn2+ than was originally added to the culture, presumably because of leaching from the culture vessel. Zn2+ elimination is shown to be a more precise method of depleting Zn2+ than by using the chelator N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine.	[Graham, Alison I.; Hunt, Stuart; Poole, Robert K.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Stokes, Sarah L.; Bramall, Neil; Bunch, Josephine; Cox, Alan G.; McLeod, Cameron W.] Univ Sheffield, Ctr Analyt Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield; University of Sheffield	Poole, RK (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Western Bank, Sheffield S10 2TN, S Yorkshire, England.	r.poole@sheffield.ac.uk		Bunch, Josephine/0000-0002-4257-1296	Biotechnology and Biological Sciences Research Council, UK; Biotechnology and Biological Sciences Research Council [BB/C509831/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council, UK.	Akanuma G, 2006, J BACTERIOL, V188, P2715, DOI 10.1128/JB.188.7.2715-2720.2006; Ammendola S, 2007, INFECT IMMUN, V75, P5867, DOI 10.1128/IAI.00559-07; Andreini C, 2006, J PROTEOME RES, V5, P3173, DOI 10.1021/pr0603699; [Anonymous], 1975, PRINCIPLES MICROBIAL; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Beard SJ, 1997, MOL MICROBIOL, V25, P883, DOI 10.1111/j.1365-2958.1997.mmi518.x; Berducci G, 2004, FEBS LETT, V569, P289, DOI 10.1016/j.febslet.2004.06.008; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Birch RM, 2003, PROTEOMICS, V3, P764, DOI 10.1002/pmic.200300397; Blencowe DK, 2003, FEMS MICROBIOL REV, V27, P291, DOI 10.1016/S0168-6445(03)00041-X; Brocklehurst KR, 2000, MICROBIOL-UK, V146, P2277, DOI 10.1099/00221287-146-9-2277; Cai F, 2006, INFECT IMMUN, V74, P5617, DOI 10.1128/IAI.00552-06; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; CICCOGNANI DT, 1992, FEMS MICROBIOL LETT, V94, P1; Da Silva J. F., 2001, BIOL CHEM ELEMENTS I; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; David G, 2003, J BIOL CHEM, V278, P43728, DOI 10.1074/jbc.M304484200; David G, 2002, ACTA CRYSTALLOGR D, V58, P1243, DOI 10.1107/S0907444902008326; Davis LM, 2009, J BACTERIOL, V191, P1631, DOI 10.1128/JB.01394-08; de Seny D, 2001, J BIOL CHEM, V276, P45065, DOI 10.1074/jbc.M106447200; Fekkes P, 1999, BIOCHEMISTRY-US, V38, P5111, DOI 10.1021/bi982818r; Ferenci T, 2008, ADV MICROB PHYSIOL, V53, P169, DOI 10.1016/S0065-2911(07)53003-1; Ferianc P, 1998, MICROBIOL-UK, V144, P1045, DOI 10.1099/00221287-144-4-1045; GARLAND PB, 1962, NATURE, V196, P987, DOI 10.1038/196987a0; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hantke K, 2005, CURR OPIN MICROBIOL, V8, P196, DOI 10.1016/j.mib.2005.02.001; Hayes A, 2002, METHODS, V26, P281, DOI 10.1016/S1046-2023(02)00032-4; Hoskisson PA, 2005, MICROBIOL-SGM, V151, P3153, DOI 10.1099/mic.0.27924-0; HUGHES MN, 1991, J GEN MICROBIOL, V137, P725, DOI 10.1099/00221287-137-4-725; Jackson KA, 2007, J BIOL CHEM, V282, P10423, DOI 10.1074/jbc.M610535200; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Kannan G, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-37; Kay Alan R, 2004, BMC Physiol, V4, P4, DOI 10.1186/1472-6793-4-4; Kershaw CJ, 2007, BIOCHEM BIOPH RES CO, V364, P66, DOI 10.1016/j.bbrc.2007.09.094; Kershaw CJ, 2005, MICROBIOL-SGM, V151, P1187, DOI 10.1099/mic.0.27650-0; KOCH AL, 1961, BIOCHIM BIOPHYS ACTA, V51, P429, DOI 10.1016/0006-3002(61)90599-6; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LaurentWinter C, 1997, EUR J BIOCHEM, V244, P767, DOI 10.1111/j.1432-1033.1997.00767.x; Lee LJ, 2005, J BACTERIOL, V187, P1124, DOI 10.1128/JB.187.3.1124-1134.2005; LIN PS, 1983, CANCER RES, V43, P1049; Makarova K. S., 2001, GENOME BIOL, V2, P14; Moore CM, 2005, MOL MICROBIOL, V57, P27, DOI 10.1111/j.1365-2958.2005.04642.x; MUKHERJEE G, 1995, J INORG BIOCHEM, V59, P827, DOI 10.1016/0162-0134(94)00082-L; Nanamiya H, 2004, MOL MICROBIOL, V52, P273, DOI 10.1111/j.1365-2958.2003.03972.x; Neidhardt FC, 1990, PHYSL BACTERIAL CELL, P418; Notley-McRobb L, 1999, ENVIRON MICROBIOL, V1, P45, DOI 10.1046/j.1462-2920.1999.00003.x; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Owen GA, 2007, J BACTERIOL, V189, P4078, DOI 10.1128/JB.01901-06; Panina EM, 2003, P NATL ACAD SCI USA, V100, P9912, DOI 10.1073/pnas.1733691100; Patzer SI, 2000, J BIOL CHEM, V275, P24321, DOI 10.1074/jbc.M001775200; Patzer SI, 1998, MOL MICROBIOL, V28, P1199, DOI 10.1046/j.1365-2958.1998.00883.x; Piper MDW, 2002, J BIOL CHEM, V277, P37001, DOI 10.1074/jbc.M204490200; Puskarova A, 2002, MICROBIOL-SGM, V148, P3801, DOI 10.1099/00221287-148-12-3801; Scott C, 2000, FEMS MICROBIOL LETT, V192, P85, DOI 10.1111/j.1574-6968.2000.tb09363.x; Sebat JL, 2001, APPL ENVIRON MICROB, V67, P3934, DOI 10.1128/AEM.67.9.3934-3942.2001; Shin JH, 2007, J BACTERIOL, V189, P4070, DOI 10.1128/JB.01851-06; Sigdel TK, 2006, J BACTERIOL, V188, P6709, DOI 10.1128/JB.00680-06; SIMONS TJB, 1993, J BIOCHEM BIOPH METH, V27, P25, DOI 10.1016/0165-022X(93)90065-V; Stojnev T, 2007, CURR MICROBIOL, V55, P99, DOI 10.1007/s00284-006-0516-5; Wang AY, 2005, J BACTERIOL, V187, P3259, DOI 10.1128/JB.187.9.3259-3266.2005; Yamamoto K, 2005, J BACTERIOL, V187, P6333, DOI 10.1128/JB.187.18.6333-6340.2005; Yamamoto K, 2005, MOL MICROBIOL, V56, P215, DOI 10.1111/j.1365-2958.2005.04532.x; Yatsunyk LA, 2008, J BIOL INORG CHEM, V13, P271, DOI 10.1007/s00775-007-0320-0	63	107	113	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18377	18389		10.1074/jbc.M109.001503	http://dx.doi.org/10.1074/jbc.M109.001503			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19377097	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000267712400050
J	Takahasi, K; Kumeta, H; Tsuduki, N; Narita, R; Shigemoto, T; Hirai, R; Yoneyama, M; Horiuchi, M; Ogura, K; Fujita, T; Inagaki, F				Takahasi, Kiyohiro; Kumeta, Hiroyuki; Tsuduki, Natsuko; Narita, Ryo; Shigemoto, Taeko; Hirai, Reiko; Yoneyama, Mitsutoshi; Horiuchi, Masataka; Ogura, Kenji; Fujita, Takashi; Inagaki, Fuyuhiko			Solution Structures of Cytosolic RNA Sensor MDA5 and LGP2 C-terminal Domains IDENTIFICATION OF THE RNA RECOGNITION LOOP IN RIG-I-LIKE RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TORSION ANGLE DYNAMICS; DOUBLE-STRANDED-RNA; ANTIVIRAL RESPONSES; INNATE IMMUNITY; REGULATORY DOMAIN; ADAPTER PROTEIN; HELICASE; MECHANISM; VIRUSES; DYANA	The RIG-I like receptor (RLR) comprises three homologues: RIG-I (retinoic acid-inducible gene I), MDA5(melanoma differentiation-associated gene 5), and LGP2 (laboratory of genetics and physiology 2). Each RLR senses different viral infections by recognizing replicating viral RNA in the cytoplasm. The RLR contains a conserved C-terminal domain (CTD), which is responsible for the binding specificity to the viral RNAs, including double-stranded RNA (dsRNA) and 5'-triphosphated single-stranded RNA (5'ppp-ssRNA). Here, the solution structures of the MDA5 and LGP2 CTD domains were solved by NMR and compared with those of RIG-I CTD. The CTD domains each have a similar fold and a similar basic surface but there is the distinct structural feature of a RNA binding loop; The LGP2 and RIG-I CTD domains have a large basic surface, one bank of which is formed by the RNA binding loop. MDA5 also has a large basic surface that is extensively flat due to open conformation of the RNA binding loop. The NMR chemical shift perturbation study showed that dsRNA and 5'ppp-ssRNA are bound to the basic surface of LGP2 CTD, whereas dsRNA is bound to the basic surface of MDA5 CTD but much more weakly, indicating that the conformation of the RNA binding loop is responsible for the sensitivity to dsRNA and 5'ppp-ssRNA. Mutation study of the basic surface and the RNA binding loop supports the conclusion from the structure studies. Thus, the CTD is responsible for the binding affinity to the viral RNAs.	[Takahasi, Kiyohiro; Kumeta, Hiroyuki; Tsuduki, Natsuko; Horiuchi, Masataka; Ogura, Kenji; Inagaki, Fuyuhiko] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Biol Struct, Kita Ku, Sapporo, Hokkaido 0010021, Japan; [Narita, Ryo; Shigemoto, Taeko; Hirai, Reiko; Yoneyama, Mitsutoshi; Fujita, Takashi] Kyoto Univ, Inst Virus Res, Mol Genet Lab, Kyoto 6068507, Japan; [Narita, Ryo; Shigemoto, Taeko; Hirai, Reiko; Yoneyama, Mitsutoshi; Fujita, Takashi] Kyoto Univ, Grad Sch Biostudies, Mol Cell Biol Lab, Kyoto 6068507, Japan; [Yoneyama, Mitsutoshi] Japan Sci & Technol Agcy, PRESTO, Saitama 3320012, Japan	Hokkaido University; Kyoto University; Kyoto University; Japan Science & Technology Agency (JST)	Inagaki, F (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Biol Struct, Kita Ku, N-21,W-11, Sapporo, Hokkaido 0010021, Japan.	finagaki@pharm.hokudai.ac.jp	Yoneyama, Mitsutoshi/D-8244-2017; Horiuchi, Masataka/D-5491-2012	Yoneyama, Mitsutoshi/0000-0001-9512-0408; Kumeta, Hiroyuki/0000-0003-3713-2122	Japanese Ministry of Education, Culture, Sports, Science, and Technology; Uehara Memorial Foundation; Nippon Boehringer Ingelheim Co., Ltd	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Nippon Boehringer Ingelheim Co., Ltd(Boehringer Ingelheim)	This work was supported by grants-in-aid (Tokutei-ryoiki (Matrix of Infection Phenomena), Kiban (S)) and National Projects on Targeted Proteins Research Program from the Japanese Ministry of Education, Culture, Sports, Science, and Technology, by a Research Grant of the Uehara Memorial Foundation, and by Nippon Boehringer Ingelheim Co., Ltd.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; LI X, 2009, J BIOL CHEM; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pippig DA, 2009, NUCLEIC ACIDS RES, V37, P2014, DOI 10.1093/nar/gkp059; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Venkataraman T, 2007, J IMMUNOL, V178, P6444, DOI 10.4049/jimmunol.178.10.6444; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2008, IMMUNITY, V29, P178, DOI 10.1016/j.immuni.2008.07.009	24	157	168	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17465	17474		10.1074/jbc.M109.007179	http://dx.doi.org/10.1074/jbc.M109.007179			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19380577	Green Published, hybrid			2022-12-25	WOS:000267202500013
J	Tralau, T; Lafite, P; Levy, C; Combe, JP; Scrutton, NS; Leys, D				Tralau, Tewes; Lafite, Pierre; Levy, Colin; Combe, John P.; Scrutton, Nigel S.; Leys, David			An Internal Reaction Chamber in Dimethylglycine Oxidase Provides Efficient Protection from Exposure to Toxic Formaldehyde	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-METHYLTRYPTOPHAN OXIDASE; SARCOSINE DEHYDROGENASE; ENZYMATIC-PROPERTIES; SUBSTRATE; TETRAHYDROFOLATE; DETOXIFICATION; DISSIMILATION; MITOCHONDRIA; PROTEINS; ENZYMES	We report a synthetic biology approach to demonstrate substrate channeling in an unusual bifunctional flavoprotein dimethylglycine oxidase. The catabolism of dimethylglycine through methyl group oxidation can potentially liberate toxic formaldehyde, a problem common to many amine oxidases and dehydrogenases. Using a novel synthetic in vivo reporter system for cellular formaldehyde, we found that the oxidation of dimethylglycine is coupled to the synthesis of 5,10-methylenetetrahydrofolate through an unusual substrate channeling mechanism. We also showed that uncoupling of the active sites could be achieved by mutagenesis or deletion of the 5,10-methylenetetrahydrofolate synthase site and that this leads to accumulation of intracellular formaldehyde. Channeling occurs by non-biased diffusion of the labile intermediate through a large solvent cavity connecting both active sites. This central "reaction chamber" is created by a modular protein architecture that appears primitive when compared with the sophisticated design of other paradigm substrate-channeling enzymes. The evolutionary origins of the latter were likely similar to dimethylglycine oxidase. This work demonstrates the utility of synthetic biology approaches to the study of enzyme mechanisms in vivo and points to novel channeling mechanisms that protect the cell milieu from potentially toxic reaction products.	[Tralau, Tewes; Lafite, Pierre; Levy, Colin; Combe, John P.; Scrutton, Nigel S.; Leys, David] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England	University of Manchester	Leys, D (corresponding author), Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, 131 Princess St, Manchester M1 7DN, Lancs, England.	david.leys@manchester.ac.uk	Lafite, Pierre/F-6806-2011	Lafite, Pierre/0000-0003-1637-4966; Tralau, Tewes/0000-0002-7857-4237; Levy, Colin/0000-0002-9724-310X	Biotechnology and Biological Sciences Research Council (BBSRC) [BBE0170101]; Biotechnology and Biological Sciences Research Council [BB/D01963X/1, BB/E017010/1] Funding Source: researchfish; BBSRC [BB/D01963X/1, BB/E017010/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council (BBSRC) Grant BBE0170101.	An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BARAK AJ, 1983, LIFE SCI, V32, P771, DOI 10.1016/0024-3205(83)90311-9; Basran J, 2002, BIOCHEMISTRY-US, V41, P4733, DOI 10.1021/bi025519h; Basran J, 2006, BIOCHEMISTRY-US, V45, P11151, DOI 10.1021/bi061094d; Bosetti C, 2008, ANN ONCOL, V19, P29, DOI 10.1093/annonc/mdm202; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Douce R, 2001, TRENDS PLANT SCI, V6, P167, DOI 10.1016/S1360-1385(01)01892-1; Duine JA, 1999, BIOFACTORS, V10, P201, DOI 10.1002/biof.5520100217; Dunn MF, 2008, TRENDS BIOCHEM SCI, V33, P254, DOI 10.1016/j.tibs.2008.04.008; ELDIN S, 1995, J AM CHEM SOC, V117, P6631, DOI 10.1021/ja00129a043; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gabdoulline RR, 1997, BIOPHYS J, V72, P1917, DOI 10.1016/S0006-3495(97)78838-6; Gonzalez CF, 2006, J BIOL CHEM, V281, P14514, DOI 10.1074/jbc.M600996200; Graham JWA, 2007, PLANT CELL, V19, P3723, DOI 10.1105/tpc.107.053371; Hall NE, 1998, J PHYS CHEM A, V102, P4930, DOI 10.1021/jp9810825; Herring CD, 2004, J BACTERIOL, V186, P6714, DOI 10.1128/JB.186.20.6714-6720.2004; Holden HM, 1999, CELL MOL LIFE SCI, V56, P507, DOI 10.1007/s000180050448; Huang XY, 2001, ANNU REV BIOCHEM, V70, P149, DOI 10.1146/annurev.biochem.70.1.149; Ilari A, 2008, PROTEINS, V71, P2065, DOI 10.1002/prot.21898; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Khanna P, 2001, BIOCHEMISTRY-US, V40, P1441, DOI 10.1021/bi0024411; Levovich I, 2008, CANCER CHEMOTH PHARM, V62, P471, DOI 10.1007/s00280-007-0627-0; Leys D, 2003, EMBO J, V22, P4038, DOI 10.1093/emboj/cdg395; MACKENZIE CG, 1958, J BIOL CHEM, V232, P417; Maden BEH, 2000, BIOCHEM J, V350, P609, DOI 10.1042/0264-6021:3500609; Manjasetty BA, 2003, P NATL ACAD SCI USA, V100, P6992, DOI 10.1073/pnas.1236794100; Meskys R, 2001, EUR J BIOCHEM, V268, P3390, DOI 10.1046/j.1432-1327.2001.02239.x; Mouilleron S, 2007, CURR OPIN STRUC BIOL, V17, P653, DOI 10.1016/j.sbi.2007.09.003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myers RS, 2003, BIOCHEMISTRY-US, V42, P7013, DOI 10.1021/bi034314l; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PORTER DH, 1985, ARCH BIOCHEM BIOPHYS, V243, P396, DOI 10.1016/0003-9861(85)90516-8; Raushel FM, 2003, ACCOUNTS CHEM RES, V36, P539, DOI 10.1021/ar020047k; Sambrook J, 1989, MOL CLONING LAB MANU, V3; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schirch V, 2005, CURR OPIN CHEM BIOL, V9, P482, DOI 10.1016/j.cbpa.2005.08.017; Scrutton NS, 2004, NAT PROD REP, V21, P722, DOI 10.1039/b306788m; Scrutton NS, 2005, BIOCHEM SOC T, V33, P776, DOI 10.1042/BST0330776; THURNHEER T, 1986, J GEN MICROBIOL, V132, P1215; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Weeks A, 2006, CURR OPIN CHEM BIOL, V10, P465, DOI 10.1016/j.cbpa.2006.08.008; WITTWER AJ, 1981, J BIOL CHEM, V256, P4109; Yurimoto H, 2005, CHEM REC, V5, P367, DOI 10.1002/tcr.20056	48	20	22	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17826	17834		10.1074/jbc.M109.006262	http://dx.doi.org/10.1074/jbc.M109.006262			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19369258	hybrid, Green Published			2022-12-25	WOS:000267202500048
J	Porte, S; Valencia, E; Yakovtseva, EA; Borras, E; Shafqat, N; Debreczeny, JE; Pike, ACW; Oppermann, U; Farres, J; Fita, I; Pares, X				Porte, Sergio; Valencia, Eva; Yakovtseva, Evgenia A.; Borras, Emma; Shafqat, Naeem; Debreczeny, Judit E.; Pike, Ashley C. W.; Oppermann, Udo; Farres, Jaume; Fita, Ignacio; Pares, Xavier			Three-dimensional Structure and Enzymatic Function of Proapoptotic Human p53-inducible Quinone Oxidoreductase PIG3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZETA-CRYSTALLIN; ALCOHOL-DEHYDROGENASE; THIOESTER REDUCTASE; TUMOR-SUPPRESSOR; GUINEA-PIG; BINDING; PROTEIN; NADPH; IDENTIFICATION; SEQUENCE	Tumor suppressor p53 regulates the expression of p53-induced genes ( PIG) that trigger apoptosis. PIG3 or TP53I3 is the only known member of the medium chain dehydrogenase/reductase superfamily induced by p53 and is used as a proapoptotic marker. Although the participation of PIG3 in the apoptotic pathway is proven, the protein and its mechanism of action were never characterized. We analyzed human PIG3 enzymatic function and found NADPH-dependent reductase activity with ortho-quinones, which is consistent with the classification of PIG3 in the quinone oxidoreductase family. However, the activity is much lower than that of zeta-crystallin, a better known quinone oxidoreductase. In addition, we report the crystallographic structure of PIG3, which allowed the identification of substrate- and cofactor-binding sites, with residues fully conserved from bacteria to human. Tyr-59 in zeta-crystallin (Tyr-51 in PIG3) was suggested to participate in the catalysis of quinone reduction. However, kinetics of Tyr/Phe and Tyr/Ala mutants of both enzymes demonstrated that the active site Tyr is not catalytic but may participate in substrate binding, consistent with a mechanism based on propinquity effects. It has been proposed that PIG3 contribution to apoptosis would be through oxidative stress generation. We found that in vitro activity and in vivo overexpression of PIG3 accumulate reactive oxygen species. Accordingly, an inactive PIG3 mutant (S151V) did not produce reactive oxygen species in cells, indicating that enzymatically active protein is necessary for this function. This supports that PIG3 action is through oxidative stress produced by its enzymatic activity and provides essential knowledge for eventual control of apoptosis.	[Porte, Sergio; Yakovtseva, Evgenia A.; Borras, Emma; Farres, Jaume; Pares, Xavier] Univ Autonoma Barcelona, Fac Biosci, Dept Biochem & Mol Biol, E-08193 Barcelona, Spain; [Valencia, Eva; Fita, Ignacio] CSIC, IBMB, Inst Mol Biol, E-08028 Barcelona, Spain; [Valencia, Eva; Fita, Ignacio] IRB Barcelona, Barcelona 08028, Spain; [Shafqat, Naeem; Debreczeny, Judit E.; Pike, Ashley C. W.; Oppermann, Udo] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Oppermann, Udo] Botnar Res Ctr, Oxford Biomed Res Unit, Oxford OX3 7LD, England	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Oxford; University of Oxford	Pares, X (corresponding author), Univ Autonoma Barcelona, Fac Biosci, Dept Biochem & Mol Biol, E-08193 Barcelona, Spain.	xavier.pares@uab.es	Fita, Ignasi/R-4515-2019; Farrés, Jaume/F-8648-2016; Pares, Xavier/K-8228-2017	Fita, Ignasi/0000-0002-7521-2679; Farrés, Jaume/0000-0001-9069-3987; Pares, Xavier/0000-0002-5071-9465; Shafqat, Sheikh Naeem/0000-0002-1468-4082	Spanish Direccion General de Investigacion [BFU2005-02621, BFU2008-02945/BMC, BFU2005-08686C02-01]; Generalitat de Catalunya [2005 SGR 00112]; Canadian Institutes for Health Research [1097737]; Canadian Foundation for Innovation, Genome Canada; Ontario Genomics Institute,	Spanish Direccion General de Investigacion(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation, Genome Canada(Genome CanadaCanada Foundation for Innovation); Ontario Genomics Institute,	This work was supported by Spanish Direccion General de Investigacion Grants BFU2005-02621, BFU2008-02945/BMC, and BFU2005-08686C02-01 and the Generalitat de Catalunya Grant 2005 SGR 00112. The Structural Genomics Consortium is a registered charity ( number 1097737) and receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada, through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck, the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust.	Airenne TT, 2003, J MOL BIOL, V327, P47, DOI 10.1016/S0022-2836(03)00038-X; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAKER PJ, 1992, J MOL BIOL, V228, P662, DOI 10.1016/0022-2836(92)90848-E; Bergamaschi D, 2004, MOL CELL BIOL, V24, P1341, DOI 10.1128/MCB.24.3.1341-1350.2004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campomenosi P, 2001, ONCOGENE, V20, P3573, DOI 10.1038/sj.onc.1204468; Carugo O, 1997, PROTEINS, V28, P10, DOI 10.1002/(SICI)1097-0134(199705)28:1<10::AID-PROT2>3.3.CO;2-R; Chen ZJ, 2008, J MOL BIOL, V379, P830, DOI 10.1016/j.jmb.2008.04.041; Contente A, 2003, CANCER RES, V63, P1756; Contente A, 2002, NAT GENET, V30, P315, DOI 10.1038/ng836; Delia D, 1997, CARCINOGENESIS, V18, P943, DOI 10.1093/carcin/18.5.943; Edwards KJ, 1996, ARCH BIOCHEM BIOPHYS, V328, P173, DOI 10.1006/abbi.1996.0158; Fernandez MR, 2007, CELL MOL LIFE SCI, V64, P1419, DOI 10.1007/s00018-007-7091-1; Flatt PM, 2000, CANCER LETT, V156, P63, DOI 10.1016/S0304-3835(00)00441-9; FUJII Y, 1990, J BIOL CHEM, V265, P9914; Gallego O, 2006, BIOCHEM J, V399, P101, DOI 10.1042/BJ20051988; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HIROMI K, 1980, ANAL BIOCHEM, V101, P421, DOI 10.1016/0003-2697(80)90208-0; Hori T, 2004, J BIOL CHEM, V279, P22615, DOI 10.1074/jbc.M312655200; HUANG QL, 1987, CURR EYE RES, V6, P725, DOI 10.3109/02713688709034836; Ibrahim H, 2008, KIDNEY INT, V73, P11, DOI 10.1038/sj.ki.5002581; Ito M, 2006, JPN J CLIN ONCOL, V36, P116, DOI 10.1093/jjco/hyi225; Johnson TM, 1996, P NATL ACAD SCI USA, V93, P11848, DOI 10.1073/pnas.93.21.11848; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jornvall H, 2008, CELL MOL LIFE SCI, V65, P3875, DOI 10.1007/s00018-008-8586-0; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Kim IK, 2008, J MOL BIOL, V379, P372, DOI 10.1016/j.jmb.2008.04.003; Kranthi BV, 2006, NUCLEIC ACIDS RES, V34, P4060, DOI 10.1093/nar/gkl577; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Liang XQ, 2004, FEBS LETT, V569, P94, DOI 10.1016/j.febslet.2004.05.057; MA Q, 1992, J BIOL CHEM, V267, P22298; MacFarlane M, 2004, EMBO REP, V5, P674, DOI 10.1038/sj.embor.7400191; Mano J, 2002, PLANT CELL PHYSIOL, V43, P1445, DOI 10.1093/pcp/pcf187; Mano J, 2000, EUR J BIOCHEM, V267, P3661, DOI 10.1046/j.1432-1327.2000.01398.x; Maruyama A, 2003, MICROBIOL-SGM, V149, P389, DOI 10.1099/mic.0.25796-0; Moll UM, 2004, MOL CANCER RES, V2, P371; Naumann U, 2006, CANCER GENE THER, V13, P469, DOI 10.1038/sj.cgt.7700917; Nomdedeu JF, 2008, LEUKEMIA RES, V32, P186, DOI 10.1016/j.leukres.2007.01.023; Oppermann U, 2007, ANNU REV PHARMACOL, V47, P293, DOI 10.1146/annurev.pharmtox.47.120505.105316; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; RAO PV, 1992, J BIOL CHEM, V267, P96; Rao PV, 1997, BIOCHEMISTRY-US, V36, P5353, DOI 10.1021/bi9622985; Riveros-Rosas H, 2003, EUR J BIOCHEM, V270, P3309, DOI 10.1046/j.1432-1033.2003.03704.x; Rosell A, 2003, J MOL BIOL, V330, P75, DOI 10.1016/S0022-2836(03)00431-5; Rossman M.G., 1975, ENZYMES, V11, P61, DOI 10.1016/S1874-6047(08)60210-3; ROYALL JA, 1993, ARCH BIOCHEM BIOPHYS, V302, P348, DOI 10.1006/abbi.1993.1222; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Schlegel BP, 1998, BIOCHEMISTRY-US, V37, P11003, DOI 10.1021/bi980475r; STINSON RA, 1973, BIOCHEM J, V131, P719, DOI 10.1042/bj1310719; Tanaka T, 2007, CELL, V130, P638, DOI 10.1016/j.cell.2007.08.001; Tang A, 2001, J BIOL CHEM, V276, P21375, DOI 10.1074/jbc.M101941200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Valencia E, 2004, J MOL BIOL, V341, P1049, DOI 10.1016/j.jmb.2004.06.037; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; YOKOMIZO T, 1993, J BIOL CHEM, V268, P18128; Yokomizo T, 1996, J BIOL CHEM, V271, P2844, DOI 10.1074/jbc.271.5.2844; Youn B, 2006, J BIOL CHEM, V281, P40076, DOI 10.1074/jbc.M605900200; Zhang Q, 2008, FOOD CHEM TOXICOL, V46, P2042, DOI 10.1016/j.fct.2008.01.049	61	42	48	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17194	17205		10.1074/jbc.M109.001800	http://dx.doi.org/10.1074/jbc.M109.001800			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19349281	hybrid, Green Published			2022-12-25	WOS:000266962400057
J	Dittmer, PJ; Miranda, JG; Gorski, JA; Palmer, AE				Dittmer, Philip J.; Miranda, Jose G.; Gorski, Jessica A.; Palmer, Amy E.			Genetically Encoded Sensors to Elucidate Spatial Distribution of Cellular Zinc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; FLUORESCENT PROTEIN; MITOCHONDRIAL DYSFUNCTION; DYNAMIC-RANGE; NITRIC-OXIDE; METALLOTHIONEIN; INDICATORS; CA2+; ZN2+; NEUROBIOLOGY	Transition metals are essential enzyme cofactors that are required for a wide range of cellular processes. Paradoxically, whereas metal ions are essential for numerous cellular processes, they are also toxic. Therefore cells must tightly regulate metal accumulation, transport, distribution, and export. Improved tools to interrogate metal ion availability and spatial distribution within living cells would greatly advance our understanding of cellular metal homeostasis. In this work, we present genetically encoded sensors for Zn2+ based on the principle of fluorescence resonance energy transfer. We also develop methodology to calibrate the probes within the cellular environment. To identify both sources of and sinks for Zn2+, these sensors are genetically targeted to specific locations within the cell, including cytosol, plasma membrane, and mitochondria. Localized probes reveal that mitochondria contain an elevated pool of Zn2+ under resting conditions that can be released into the cytosol upon glutamate stimulation of hippocampal neurons. We also observed that Zn2+ is taken up into mitochondria following glutamate/Zn2+ treatment and that there is heterogeneity in both the magnitude and kinetics of the response. Our results suggest that mitochondria serve as a source of and a sink for Zn2+ signals under different cellular conditions.	[Dittmer, Philip J.; Miranda, Jose G.; Palmer, Amy E.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Gorski, Jessica A.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Palmer, AE (corresponding author), Univ Colorado, Dept Chem & Biochem, UCB 215, Boulder, CO 80309 USA.	Amy.Palmer@Colorado.edu	Miranda, Jose/HCI-6099-2022	Dittmer, Philip/0000-0002-5681-1502	National Institutes of Health [T32 GM-065103, GM084027]; University of Colorado; Whitehall Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065103, R01GM084027] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado; Whitehall Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 GM-065103 (to P. J. D.) and GM084027 (to A. E. P.). This work was also supported by the University of Colorado and a Whitehall Foundation beginning grant-in-aid.	BANKER G, 1998, CULTURING NERVE CELL; Bossy-Wetzel E, 2004, NEURON, V41, P351, DOI 10.1016/S0896-6273(04)00015-7; Bozym RA, 2006, ACS CHEM BIOL, V1, P103, DOI 10.1021/cb500043a; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; ElrodErickson M, 1996, STRUCTURE, V4, P1171, DOI 10.1016/S0969-2126(96)00125-6; Evers TH, 2007, J MOL BIOL, V374, P411, DOI 10.1016/j.jmb.2007.09.021; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hires SA, 2008, P NATL ACAD SCI USA, V105, P4411, DOI 10.1073/pnas.0712008105; Hong SH, 2003, P NATL ACAD SCI USA, V100, P2255, DOI 10.1073/pnas.0438005100; KAO JPY, 1994, METHOD CELL BIOL, V40, P155; KRONCKE KD, 1994, BIOCHEM BIOPH RES CO, V200, P1105, DOI 10.1006/bbrc.1994.1564; Malaiyandi LM, 2005, J NEUROCHEM, V93, P1242, DOI 10.1111/j.1471-4159.2005.03116.x; MARET W, 1995, NEUROCHEM INT, V27, P111, DOI 10.1016/0197-0186(94)00173-R; MARET W, 1994, P NATL ACAD SCI USA, V91, P237, DOI 10.1073/pnas.91.1.237; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nolan EM, 2006, J AM CHEM SOC, V128, P15517, DOI 10.1021/ja065759a; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Qiao W, 2006, P NATL ACAD SCI USA, V103, P8674, DOI 10.1073/pnas.0600928103; Que EL, 2008, CHEM REV, V108, P1517, DOI 10.1021/cr078203u; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Sensi SL, 2000, EUR J NEUROSCI, V12, P3813, DOI 10.1046/j.1460-9568.2000.00277.x; Sensi SL, 2003, P NATL ACAD SCI USA, V100, P6157, DOI 10.1073/pnas.1031598100; Suhy DA, 1999, J BIOL CHEM, V274, P9183, DOI 10.1074/jbc.274.14.9183; van Dongen EMWM, 2007, J AM CHEM SOC, V129, P3494, DOI 10.1021/ja069105d; Walkup GK, 2000, J AM CHEM SOC, V122, P5644, DOI 10.1021/ja000868p; Walkup GK, 1996, J AM CHEM SOC, V118, P3053, DOI 10.1021/ja9538501; Wilkinson Keith D, 2004, Methods Mol Biol, V261, P15; Zhang J, 2007, MOL BIOSYST, V3, P759, DOI 10.1039/b706628g	34	170	172	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16289	16297		10.1074/jbc.M900501200	http://dx.doi.org/10.1074/jbc.M900501200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19363034	Green Published, hybrid			2022-12-25	WOS:000266730900026
J	Shi, XM; Shao, CH; Zhang, X; Zambonelli, C; Redfield, AG; Head, JF; Seaton, BA; Roberts, MF				Shi, Xiaomeng; Shao, Chenghua; Zhang, Xin; Zambonelli, Carlo; Redfield, Alfred G.; Head, James F.; Seaton, Barbara A.; Roberts, Mary F.			Modulation of Bacillus thuringiensis Phosphatidylinositol-specific Phospholipase C Activity by Mutations in the Putative Dimerization Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIELD-CYCLING NMR; CIRCULAR-DICHROISM SPECTRA; ANGLE NEUTRON-SCATTERING; MEMBRANE-PROTEINS; PHOSPHODIESTERASE ACTIVITY; TRYPTOPHAN RESIDUES; ACTIVATION; BINDING; PHOSPHATIDYLCHOLINE; DYNAMICS	Cleavage of phosphatidylinositol (PI) to inositol 1,2-(cyclic)phosphate (cIP) and cIP hydrolysis to inositol 1-phosphate by Bacillus thuringiensis phosphatidylinositol-specific phospholipase C are activated by the enzyme binding to phosphatidylcholine (PC) surfaces. Part of this reflects improved binding of the protein to interfaces. However, crystallographic analysis of an interfacially impaired phosphatidylinositol-specific phospholipase (W47A/W242A) suggested protein dimerization might occur on the membrane. In the W47A/W242A dimer, four tyrosine residues from one monomer interact with the same tyrosine cluster of the other, forming a tight dimer interface close to the membrane binding regions. We have constructed mutant proteins in which two or more of these tyrosine residues have been replaced with serine. Phospholipid binding and enzymatic activity of these mutants have been examined to assess the importance of these residues to enzyme function. Replacing two tyrosines had small effects on enzyme activity. However, removal of three or four tyrosine residues weakened PC binding and reduced PI cleavage by the enzyme as well as PC activation of cIP hydrolysis. Crystal structures of Y247S/Y251S in the absence and presence of myo-inositol as well as Y246S/Y247S/Y248S/Y251S indicate that both mutant proteins crystallized as monomers, were very similar to one another, and had no change in the active site region. Kinetic assays, lipid binding, and structural results indicate that either (i) a specific PC binding site, critical for vesicle activities and cIP activation, has been impaired, or (ii) the reduced dimerization potential for Y246S/Y247S/ Y248S and Y246S/Y247S/Y248S/Y251S is responsible for their reduced catalytic activity in all assay systems.	[Shi, Xiaomeng; Zhang, Xin; Zambonelli, Carlo; Roberts, Mary F.] Boston Coll, Dept Chem, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA; [Shao, Chenghua; Head, James F.; Seaton, Barbara A.] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA; [Redfield, Alfred G.] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA	Boston College; Boston University; Brandeis University	Roberts, MF (corresponding author), Boston Coll, Dept Chem, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA.	mary.roberts@bc.edu		Head, James/0000-0002-6226-4146; Seaton, Barbara/0000-0003-4654-7709; Zhang, Xin/0000-0003-3023-664X	National Institutes of Health [GM60418]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060418] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM60418 (to M.F.R.).	ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Barrall GA, 1996, J CHEM PHYS, V104, P509, DOI 10.1063/1.470847; Berg OG, 2004, BIOCHEMISTRY-US, V43, P2080, DOI 10.1021/bi035063j; BIAN JR, 1992, J COLLOID INTERF SCI, V153, P420, DOI 10.1016/0021-9797(92)90333-H; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Feng JW, 2003, J BIOL CHEM, V278, P24651, DOI 10.1074/jbc.M301207200; Feng JW, 2002, J BIOL CHEM, V277, P19867, DOI 10.1074/jbc.M200938200; Gelb MH, 2000, BBA-MOL CELL BIOL L, V1488, P20, DOI 10.1016/S1388-1981(00)00106-2; Ghosh AK, 1997, BIOCHEMISTRY-US, V36, P14291, DOI 10.1021/bi971933j; Han SK, 1999, J BIOL CHEM, V274, P11881, DOI 10.1074/jbc.274.17.11881; Heinz DW, 1998, J MOL BIOL, V275, P635, DOI 10.1006/jmbi.1997.1490; HEINZ DW, 1995, EMBO J, V14, P3855, DOI 10.1002/j.1460-2075.1995.tb00057.x; HERZFELD J, 1978, BIOCHEMISTRY-US, V17, P2711, DOI 10.1021/bi00607a003; Hong HD, 2007, J AM CHEM SOC, V129, P8320, DOI 10.1021/ja068849o; JAIN MK, 1989, BIOCHIM BIOPHYS ACTA, V1002, P127, DOI 10.1016/0005-2760(89)90281-6; Jones T. A., 1992, MANUAL; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Klauda JB, 2008, BIOPHYS J, V94, P3074, DOI 10.1529/biophysj.107.121806; LIN TL, 1986, J AM CHEM SOC, V108, P3499, DOI 10.1021/ja00272a055; LIN TL, 1987, J PHYS CHEM-US, V91, P406, DOI 10.1021/j100286a031; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qian XQ, 1998, BIOCHEMISTRY-US, V37, P6513, DOI 10.1021/bi972650u; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Roberts MF, 2004, P NATL ACAD SCI USA, V101, P17066, DOI 10.1073/pnas.0407565101; Roberts MF, 2004, J AM CHEM SOC, V126, P13765, DOI 10.1021/ja046658k; Roberts MF, 2004, BIOCHEMISTRY-US, V43, P3637, DOI 10.1021/bi035979q; Safferling M, 2003, BIOCHEMISTRY-US, V42, P13969, DOI 10.1021/bi035173q; Santos JSD, 2000, BIOCHEMISTRY-US, V39, P14065, DOI 10.1021/bi000659h; SCHIFFER M, 1992, PROTEIN ENG, V5, P213, DOI 10.1093/protein/5.3.213; Shao CH, 2007, J BIOL CHEM, V282, P9228, DOI 10.1074/jbc.M610918200; Toker A, 2002, CELL MOL LIFE SCI, V59, P761, DOI 10.1007/s00018-002-8465-z; Tsou LK, 2002, J AM CHEM SOC, V124, P14917, DOI 10.1021/ja026721a; VOLWERK JJ, 1990, BIOCHEMISTRY-US, V29, P8056, DOI 10.1021/bi00487a010; Wallace BA, 1999, ADV EXP MED BIOL, V467, P789; Wehbi H, 2003, BIOCHEMISTRY-US, V42, P9374, DOI 10.1021/bi034195+; Wehbi H, 2003, BBA-BIOMEMBRANES, V1613, P15, DOI 10.1016/S0005-2736(03)00134-2; Wu YQ, 1997, BIOCHEMISTRY-US, V36, P8514, DOI 10.1021/bi970560j; Zhang X, 2004, J BIOL CHEM, V279, P20490, DOI 10.1074/jbc.M401016200; Zhou C, 1997, BIOCHEMISTRY-US, V36, P347, DOI 10.1021/bi960601w; Zhou C, 1997, BIOCHEMISTRY-US, V36, P10089, DOI 10.1021/bi970846o; Zhou C, 1998, BIOCHEMISTRY-US, V37, P16430, DOI 10.1021/bi980601r; [No title captured]	45	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15607	15618		10.1074/jbc.M901601200	http://dx.doi.org/10.1074/jbc.M901601200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19369255	Green Published, hybrid			2022-12-25	WOS:000266501000029
J	Gill, MB; Vivithanaporn, P; Swanson, GT				Gill, Martin B.; Vivithanaporn, Pornpun; Swanson, Geoffrey T.			Glutamate Binding and Conformational Flexibility of Ligand-binding Domains Are Critical Early Determinants of Efficient Kainate Receptor Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM QUALITY-CONTROL; D-ASPARTATE RECEPTOR; ENDOPLASMIC-RETICULUM; PHARMACOLOGICAL CHAPERONES; SYNAPTIC-TRANSMISSION; AMPA; TRAFFICKING; EXPRESSION; DESENSITIZATION; CHECKPOINT	Intracellular glutamate binding within the endoplasmic reticulum (ER) is thought to be necessary for plasma membrane expression of ionotropic glutamate receptors. Here we determined the importance of glutamate binding to folding and assembly of soluble ligand-binding domains (LBDs), as well as full-length receptors, by comparing the secretion of a soluble GluR6-S1S2 protein versus the plasma membrane localization of GluR6 kainate receptors following mutagenesis of the LBD. The mutations were designed to either eliminate glutamate binding, thereby trapping the bilobate LBD in an "open" conformation, or "lock" the LBD in a closed conformation with an engineered interdomain disulfide bridge. Analysis of plasma membrane localization, medium secretion of soluble LBD proteins, and measures of folding efficiency suggested that loss of glutamate binding affinity significantly impacted subunit protein folding and assembly. In contrast, receptors with conformationally restricted LBDs also exhibited decreased PM expression and altered oligomeric receptor assembly but did not exhibit any deficits in subunit folding. Secretion of the closed LBD protein was enhanced compared with wild-type GluR6-S1S2. Our results suggest that glutamate acts as a chaperone molecule for appropriate folding of nascent receptors and that relaxation of LBDs from fully closed states during oligomerization represents a critical transition that necessarily engages other determinants within receptor dimers. Glutamate receptor LBDs therefore must access multiple conformations for efficient biogenesis.	[Gill, Martin B.; Swanson, Geoffrey T.] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Vivithanaporn, Pornpun] Mahidol Univ, Fac Sci, Dept Pharmacol, Bangkok 10400, Thailand; [Vivithanaporn, Pornpun] Univ Alberta, Dept Neurol, Edmonton, AB T6G 2S2, Canada	Northwestern University; Feinberg School of Medicine; Mahidol University; University of Alberta	Swanson, GT (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Searle 7-443,303 E Chicago Ave, Chicago, IL 60611 USA.	gtswanson@northwestern.edu						Atlason PT, 2007, J BIOL CHEM, V282, P25299, DOI 10.1074/jbc.M702778200; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Blanke ML, 2008, J BIOL CHEM, V283, P21519, DOI 10.1074/jbc.M709190200; Coleman SK, 2009, J NEUROSCI, V29, P303, DOI 10.1523/JNEUROSCI.3953-08.2009; Fleck MW, 2006, NEUROSCIENTIST, V12, P232, DOI 10.1177/1073858405283828; Fleck MW, 2003, J NEUROSCI, V23, P1219; Greger IH, 2007, TRENDS NEUROSCI, V30, P407, DOI 10.1016/j.tins.2007.06.005; Greger IH, 2007, CURR OPIN NEUROBIOL, V17, P289, DOI 10.1016/j.conb.2007.04.007; Greger IH, 2006, NEURON, V51, P85, DOI 10.1016/j.neuron.2006.05.020; Grunwald ME, 2003, NEUROPHARMACOLOGY, V45, P768, DOI 10.1016/S0028-3908(03)00274-0; Hirbec H, 2003, NEURON, V37, P625, DOI 10.1016/S0896-6273(02)01191-1; Kenny AV, 2009, J BIOL CHEM, V284, P324, DOI 10.1074/jbc.M804023200; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Madden DR, 2000, EUR J BIOCHEM, V267, P4281; Mah SJ, 2005, J NEUROSCI, V25, P2215, DOI 10.1523/JNEUROSCI.4573-04.2005; Matsuda S, 2004, EUR J NEUROSCI, V19, P1683, DOI 10.1111/j.1460-9568.2004.03307.x; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; Morello JP, 2000, TRENDS PHARMACOL SCI, V21, P466, DOI 10.1016/S0165-6147(00)01575-3; Park YY, 2006, NEURON, V49, P95, DOI 10.1016/j.neuron.2005.11.035; Penn AC, 2008, EMBO J, V27, P3056, DOI 10.1038/emboj.2008.222; Petaja-Repo UE, 2002, EMBO J, V21, P1628, DOI 10.1093/emboj/21.7.1628; Pinheiro P, 2006, CELL TISSUE RES, V326, P457, DOI 10.1007/s00441-006-0265-6; Priel A, 2006, NEURON, V52, P1037, DOI 10.1016/j.neuron.2006.12.006; Schiffer HH, 1997, NEURON, V19, P1141, DOI 10.1016/S0896-6273(00)80404-3; Selkirk JV, 2002, J NEUROCHEM, V80, P346, DOI 10.1046/j.0022-3042.2001.00704.x; Snapp E.L., 2003, CURRENT PROTOCOLS CE; Valluru L, 2005, J BIOL CHEM, V280, P6085, DOI 10.1074/jbc.M411549200; Vazhappilly R, 2002, NEUROSCI LETT, V318, P153, DOI 10.1016/S0304-3940(01)02482-X; Vivithanaporn P, 2007, J NEUROSCI, V27, P10423, DOI 10.1523/JNEUROSCI.2674-07.2007; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62	31	24	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14503	14512		10.1074/jbc.M900510200	http://dx.doi.org/10.1074/jbc.M900510200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19342380	Green Published, hybrid			2022-12-25	WOS:000266286100057
J	Gartner, T; Steinfath, M; Andorf, S; Lisec, J; Meyer, RC; Altmann, T; Willmitzer, L; Selbig, J				Gaertner, Tanja; Steinfath, Matthias; Andorf, Sandra; Lisec, Jan; Meyer, Rhonda C.; Altmann, Thomas; Willmitzer, Lothar; Selbig, Joachim			Improved Heterosis Prediction by Combining Information on DNA- and Metabolic Markers	PLOS ONE			English	Article								Background: Hybrids represent a cornerstone in the success story of breeding programs. The fundamental principle underlying this success is the phenomenon of hybrid vigour, or heterosis. It describes an advantage of the offspring as compared to the two parental lines with respect to parameters such as growth and resistance against abiotic or biotic stress. Dominance, overdominance or epistasis based models are commonly used explanations. Conclusion/Significance: The heterosis level is clearly a function of the combination of the parents used for offspring production. This results in a major challenge for plant breeders, as usually several thousand combinations of parents have to be tested for identifying the best combinations. Thus, any approach to reliably predict heterosis levels based on properties of the parental lines would be highly beneficial for plant breeding. Methodology/Principal Findings: Recently, genetic data have been used to predict heterosis. Here we show that a combination of parental genetic and metabolic markers, identified via feature selection and minimum-description-length based regression methods, significantly improves the prediction of biomass heterosis in resulting offspring. These findings will help furthering our understanding of the molecular basis of heterosis, revealing, for instance, the presence of nonlinear genotype-phenotype relationships. In addition, we describe a possible approach for accelerated selection in plant breeding.			Gartner, T (corresponding author), Univ Potsdam, Dept Bioinformat, Inst Biochem & Biol, Potsdam, Germany.	selbig@mpimp-golm.mpg.de	Meyer, Rhonda/X-7393-2019; Willmitzer, Lothar/F-7377-2011	Andorf, Sandra/0000-0002-3093-2568; Lisec, Jan/0000-0003-1220-2286; Meyer, Rhonda C./0000-0002-6210-4900; Altmann, Thomas/0000-0002-3759-360X				Barone A, 2004, AM J POTATO RES, V81, P111, DOI 10.1007/BF02853608; CHARLESWORTH B, 1992, AM NAT, V140, P126, DOI 10.1086/285406; Chong IG, 2005, CHEMOMETR INTELL LAB, V78, P103, DOI 10.1016/j.chemolab.2004.12.011; Crow J. F., 1952, Heterosis., P282; Dirlewanger E, 2004, P NATL ACAD SCI USA, V101, P9891, DOI 10.1073/pnas.0307937101; Dubcovsky J, 2004, CROP SCI, V44, P1895, DOI 10.2135/cropsci2004.1895; Duvick DN, 2001, NAT REV GENET, V2, P69, DOI 10.1038/35047587; Eriksson L., 2001, MULTI MEGAVARIATE DA; Gehringer A, 2007, BREEDING SCI, V57, P315, DOI 10.1270/jsbbs.57.315; Hageman R. H., 1988, Corn and corn improvement. Third edition., P431; KACSER H, 1981, GENETICS, V97, P639; Kopka J, 2005, BIOINFORMATICS, V21, P1635, DOI 10.1093/bioinformatics/bti236; Kusterer B, 2007, GENETICS, V175, P2009, DOI 10.1534/genetics.106.069005; Lippman ZB, 2007, TRENDS GENET, V23, P60, DOI 10.1016/j.tig.2006.12.006; Lisec J, 2008, PLANT J, V53, P960, DOI 10.1111/j.1365-313X.2007.03383.x; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; MANGELSDORF AJ, 1952, HETEROSIS, P321; Melchinger AE, 2007, GENETICS, V177, P1815, DOI 10.1534/genetics.107.077537; Melchinger AE, 2007, GENETICS, V177, P1827, DOI [10.1534/genetics.107.080564, 10.1534/genetics.107.084871]; Mevik BH, 2007, J STAT SOFTW, V18, P1, DOI 10.18637/jss.v018.i02; Meyer RC, 2007, P NATL ACAD SCI USA, V104, P4759, DOI 10.1073/pnas.0609709104; Miedaner T, 2002, PLANT BREEDING, V121, P475, DOI 10.1046/j.1439-0523.2002.00765.x; Ofori A, 2008, BIOENERG RES, V1, P98, DOI 10.1007/s12155-008-9001-2; Panella L, 2007, EUPHYTICA, V154, P383, DOI 10.1007/s10681-006-9209-1; Perez-Enciso M, 2003, HUM GENET, V112, P581, DOI 10.1007/s00439-003-0921-9; R Development Core Team, 2007, R LANG ENV STAT COMP; RISSANEN J, 1978, AUTOMATICA, V14, P465, DOI 10.1016/0005-1098(78)90005-5; Schrader L., 1985, EXPLOITATION PHYSL G, P79; Schrag TA, 2006, THEOR APPL GENET, V113, P1037, DOI 10.1007/s00122-006-0363-6; Schrag TA, 2007, THEOR APPL GENET, V114, P1345, DOI 10.1007/s00122-007-0521-5; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SHULL GH, 1948, GENETICS, V33, P439; THORBURN WM, 1915, MIND, V24, P287, DOI DOI 10.1093/MIND/XXIV.2.287; Torjek O, 2003, PLANT J, V36, P122, DOI 10.1046/j.1365-313X.2003.01861.x; Torjek O, 2006, THEOR APPL GENET, V113, P1551, DOI 10.1007/s00122-006-0402-3; VIRMANI SS, 1994, MONOGRAPHS THEORETIC, V22, P142; Vuylsteke M, 2000, HEREDITY, V85, P208, DOI 10.1046/j.1365-2540.2000.00747.x; Waaijenborg S, 2008, STAT APPL GENET MOL, V7; Wold H., 1975, PERSPECTIVES PROBABI, P520; Yang J, 2005, THEOR APPL GENET, V110, P1268, DOI 10.1007/s00122-005-1963-2; Young ND, 1999, MOL BREEDING, V5, P505	41	39	42	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2009	4	4							e5220	10.1371/journal.pone.0005220	http://dx.doi.org/10.1371/journal.pone.0005220			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TU	19370148	Green Published, gold, Green Submitted			2022-12-25	WOS:000265510600004
J	Kok, K; Nock, GE; Verrall, EAG; Mitchell, MP; Hommes, DW; Peppelenbosch, MP; Vanhaesebroeck, B				Kok, Klaartje; Nock, Gemma E.; Verrall, Elizabeth A. G.; Mitchell, Michael P.; Hommes, Daan W.; Peppelenbosch, Maikel P.; Vanhaesebroeck, Bart			Regulation of p110 delta PI 3-Kinase Gene Expression	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; TRANSCRIPTION FACTOR; BREAST-CANCER; MICE LACKING; SKELETAL-MUSCLE; ADIPOSE-TISSUE; B-CELL; EMBRYONIC LETHALITY; CATALYTIC SUBUNIT	Background: Despite an intense interest in the biological functions of the phosphoinositide 3-kinase (PI3K) signalling enzymes, little is known about the regulation of PI3K gene expression. This also applies to the leukocyte-enriched p110 delta catalytic subunit of PI3K, an enzyme that has attracted widespread interest because of its role in immunity and allergy. Principal Findings: We show that p110 delta expression is mainly regulated at the transcriptional level. In fibroblasts, lymphocytes and myeloid cells, p110 delta gene transcription appears to be constitutive and not subject to acute stimulation. 5'RACE experiments revealed that p110 delta mRNA transcripts contain distinct upstream untranslated exons (named exon -1, -2a, -2b, -2c and -2d), which are located up to 81 kb upstream of the translational start codon in exon 1. The levels of all the different p110 delta transcripts are higher in leukocytes compared to non-leukocytes, with the p110 delta transcript containing exon -2a most abundantly expressed. We have identified a highly conserved transcription factor (TF) binding cluster in the p110 delta gene which has enhanced promoter activity in leukocytes compared to non-leukocytes. In human, this TF cluster is located immediately upstream of exon -2a whilst in mouse, it is located within exon -2a. Conclusion: This study identifies a conserved PIK3CD promoter region that may account for the predominant leukocyte expression of delta.			Kok, K (corresponding author), Queen Mary Univ London, Inst Canc, Ctr Cell Signalling, Charterhouse Sq, London, England.	bart.vanh@qmul.ac.uk		Peppelenbosch, Maikel/0000-0001-9112-6028	MRC [G0800914, G0700755] Funding Source: UKRI; Medical Research Council [G0700755, G0800914] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abell K, 2005, NAT CELL BIOL, V7, P392, DOI 10.1038/ncb1242; Alloatti G, 2005, FEBS LETT, V579, P133, DOI 10.1016/j.febslet.2004.11.059; Andreelli F, 1999, DIABETOLOGIA, V42, P358, DOI 10.1007/s001250051163; Astanehe A, 2008, J CELL SCI, V121, P664, DOI 10.1242/jcs.013029; Ayyanan A, 2006, P NATL ACAD SCI USA, V103, P3799, DOI 10.1073/pnas.0600065103; Baier R, 1999, CELL GROWTH DIFFER, V10, P447; Barbier M, 2001, NATURE, V413, P796, DOI 10.1038/35101660; Barbour LA, 2004, ENDOCRINOLOGY, V145, P1144, DOI 10.1210/en.2003-1297; Bi L, 1999, J BIOL CHEM, V274, P10963, DOI 10.1074/jbc.274.16.10963; Bi L, 2002, MAMM GENOME, V13, P169, DOI 10.1007/s00335-001-2123-x; Billottet C, 2009, CANCER RES, V69, P1027, DOI 10.1158/0008-5472.CAN-08-2608; Birney E., 2007, NATURE, V447, P799, DOI [10.1038/nature05874, DOI 10.1038/NATURE05874]; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; BORIES JC, 1995, NATURE, V377, P635, DOI 10.1038/377635a0; Brickner AG, 1995, GENE, V167, P261, DOI 10.1016/0378-1119(95)00673-7; Buggy Y, 2006, EUR J CANCER, V42, P485, DOI 10.1016/j.ejca.2005.10.018; Buratowski S, 2008, SCIENCE, V322, P1804, DOI 10.1126/science.1168805; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chantry D, 1997, J BIOL CHEM, V272, P19236, DOI 10.1074/jbc.272.31.19236; Ciraolo E, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1161577; Clayton E, 2001, BIOCHEM BIOPH RES CO, V280, P1328, DOI 10.1006/bbrc.2001.4281; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; De Boer ML, 1999, INT J BIOCHEM CELL B, V31, P1221, DOI 10.1016/S1357-2725(99)00069-2; Down TA, 2002, GENOME RES, V12, P458, DOI 10.1101/gr.216102; Ducluzeau PH, 2001, DIABETES, V50, P1134, DOI 10.2337/diabetes.50.5.1134; Eickholt BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000869; Furlan A, 2008, J CELL PHYSIOL, V215, P782, DOI 10.1002/jcp.21360; Gebeshuber CA, 2007, CELLS TISSUES ORGANS, V185, P51, DOI 10.1159/000101303; Geering B, 2007, P NATL ACAD SCI USA, V104, P7809, DOI 10.1073/pnas.0700373104; Geiman TM, 2002, J CELL BIOCHEM, V87, P117, DOI 10.1002/jcb.10286; Guillermet-Guibert J, 2008, P NATL ACAD SCI USA, V105, P8292, DOI 10.1073/pnas.0707761105; GUO C, 2008, GENES CHROMOSOMES CA; Hart A, 2000, IMMUNITY, V13, P167, DOI 10.1016/S1074-7613(00)00017-0; Hatsell S, 2003, J MAMMARY GLAND BIOL, V8, P145, DOI 10.1023/A:1025944723047; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Hirsch E, 2000, GENE, V256, P69, DOI 10.1016/S0378-1119(00)00328-0; HU P, 1993, MOL CELL BIOL, V13, P7677, DOI 10.1128/MCB.13.12.7677; HUI RC, 2008, MOL CELL BIOL; Ito Y, 1996, MOL BRAIN RES, V37, P329; Iwama A, 1998, NUCLEIC ACIDS RES, V26, P3034, DOI 10.1093/nar/26.12.3034; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; Jin ZX, 2002, J IMMUNOL, V169, P3783, DOI 10.4049/jimmunol.169.7.3783; Kallin A, 2007, J LIPID RES, V48, P1628, DOI 10.1194/jlr.M700136-JLR200; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; KOK K, 2008, TRENDS BIOC IN PRESS; Krugmann S, 1999, J BIOL CHEM, V274, P17152, DOI 10.1074/jbc.274.24.17152; Laville M, 1996, J CLIN INVEST, V98, P43, DOI 10.1172/JCI118775; Lefai E, 2001, BIOCHEM J, V360, P117, DOI 10.1042/0264-6021:3600117; LEIDEN JM, 1994, CURR OPIN IMMUNOL, V6, P231, DOI 10.1016/0952-7915(94)90096-5; Li LX, 2006, ENDOCRINOLOGY, V147, P3318, DOI 10.1210/en.2006-0155; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; MacDonald PE, 2004, ENDOCRINOLOGY, V145, P4078, DOI 10.1210/en.2004-0028; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MUTHUSAMY N, 1995, NATURE, V377, P639, DOI 10.1038/377639a0; Northcott CA, 2005, CLIN EXP PHARMACOL P, V32, P851, DOI 10.1111/j.1440-1681.2010.04276.x; Northcott CA, 2004, HYPERTENSION, V43, P885, DOI 10.1161/01.HYP.0000118518.20331.e8; Northcott CA, 2002, CIRC RES, V91, P360, DOI 10.1161/01.RES.0000030861.13850.F1; Ogilvy S, 1998, BLOOD, V91, P419, DOI 10.1182/blood.V91.2.419.419_419_430; Okamotoa T, 2004, MOL BRAIN RES, V131, P119, DOI 10.1016/j.molbrainres.2004.08.015; Okkenhaug K, 2002, SCIENCE, V297, P1031; Ozato K, 2007, J BIOL CHEM, V282, P20065, DOI 10.1074/jbc.R700003200; Pankow S, 2006, J CELL SCI, V119, P4033, DOI 10.1242/jcs.03175; PARK SY, 2008, NAT STRUCT MOL BIOL; Patrucco E, 2004, CELL, V118, P375, DOI 10.1016/j.cell.2004.07.017; Paun A, 2007, BIOCHIMIE, V89, P744, DOI 10.1016/j.biochi.2007.01.014; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Puri KD, 2005, BLOOD, V106, P150, DOI 10.1182/blood-2005-01-0023; RAO A, 1994, IMMUNOL TODAY, V15, P274, DOI 10.1016/0167-5699(94)90007-8; Ravindranath A, 2008, CURR MOL MED, V8, P38; SAWADA S, 1991, MOL CELL BIOL, V11, P5506, DOI 10.1128/MCB.11.11.5506; Sawyer C, 2003, CANCER RES, V63, P1667; Scott EW, 1997, IMMUNITY, V6, P437, DOI 10.1016/S1074-7613(00)80287-3; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Shestakova E, 2001, J VIROL, V75, P3444, DOI 10.1128/JVI.75.7.3444-3452.2001; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Span PN, 2002, ONCOGENE, V21, P8506, DOI 10.1038/sj.onc.1206040; Spender LC, 2006, J GEN VIROL, V87, P2859, DOI 10.1099/vir.0.82128-0; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Su GH, 1997, EMBO J, V16, P7118, DOI 10.1093/emboj/16.23.7118; Suire S, 2005, CURR BIOL, V15, P566, DOI 10.1016/j.cub.2005.02.020; Teschendorff AE, 2007, PLOS COMPUT BIOL, V3, P1539, DOI 10.1371/journal.pcbi.0030161; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; Vanden Berghe W, 1999, J BIOL CHEM, V274, P32091, DOI 10.1074/jbc.274.45.32091; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Vecchione C, 2005, J EXP MED, V201, P1217, DOI 10.1084/jem.20040995; Voigt P, 2006, J BIOL CHEM, V281, P9977, DOI 10.1074/jbc.M512502200; Wang LC, 1997, EMBO J, V16, P4374, DOI 10.1093/emboj/16.14.4374; Yang N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001758; Zhang H, 2005, J BIOL CHEM, V280, P43188, DOI 10.1074/jbc.M506598200	94	42	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5145	10.1371/journal.pone.0005145	http://dx.doi.org/10.1371/journal.pone.0005145			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357769	Green Submitted, Green Published, gold			2022-12-25	WOS:000265505900013
J	Beider, K; Abraham, M; Begin, M; Wald, H; Weiss, ID; Wald, O; Pikarsky, E; Abramovitch, R; Zeira, E; Galun, E; Nagler, A; Peled, A				Beider, Katia; Abraham, Michal; Begin, Michal; Wald, Hanna; Weiss, Ido D.; Wald, Ori; Pikarsky, Eli; Abramovitch, Rinat; Zeira, Evelyne; Galun, Eithan; Nagler, Arnon; Peled, Amnon			Interaction between CXCR4 and CCL20 Pathways Regulates Tumor Growth	PLOS ONE			English	Article								The chemokine receptor CXCR4 and its ligand CXCL12 is overexpressed in the majority of tumors and is critically involved in the development and metastasis of these tumors. CXCR4 is expressed in malignant tumor cells whereas its ligand SDF-1 (CXCL12) is expressed mainly by cancer associated fibroblasts (CAF). Similarly to CXCR4, the chemokine CCL20 is overexpressed in variety of tumors; however its role and regulation in tumors is not fully clear. Here, we show that the chemokine receptor CXCR4 stimulates the production of the chemokine CCL20 and that CCL20 stimulates the proliferation and adhesion to collagen of various tumor cells. Furthermore, overexpression of CCL20 in tumor cells promotes growth and adhesion in vitro and increased tumor growth and invasiveness in vivo. Moreover, neutralizing antibodies to CCL20 inhibit the in vivo growth of tumors that either overexpress CXCR4 or CCL20 or naturally express CCL20. These results reveal a role for CCL20 in CXCR4-dependent and -independent tumor growth and suggest a therapeutic potential for CCL20 and CCR6 antagonists in the treatment of CXCR4- and CCL20-dependent malignancies.	[Beider, Katia; Abraham, Michal; Begin, Michal; Wald, Hanna; Weiss, Ido D.; Wald, Ori; Abramovitch, Rinat; Zeira, Evelyne; Galun, Eithan; Peled, Amnon] Hadassah Hebrew Univ Hosp, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel; [Pikarsky, Eli] Hadassah Hebrew Univ Hosp, Dept Pathol, Jerusalem, Israel; [Abramovitch, Rinat] Hadassah Hebrew Univ Hosp, HBRC, MRI Lab, Jerusalem, Israel; [Nagler, Arnon] Chaim Sheba Med Ctr, Bone Marrow Transplant Dept, Tel Hashomer, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Chaim Sheba Medical Center	Beider, K (corresponding author), Hadassah Hebrew Univ Hosp, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel.	arnon.nagler@sheba.health.gov.il; peled@hadassah.org.il	pikarsky, eli/GXV-7099-2022; Galun, Eithan/AAD-9117-2022	Galun, Eithan/0000-0002-6243-6702; pikarsky, eli/0000-0003-4186-7105	Prostate Cancer Fund (PCF), USA; Israeli Science Foundation (ISF)	Prostate Cancer Fund (PCF), USA; Israeli Science Foundation (ISF)(Israel Science Foundation)	This work was supported by the Prostate Cancer Fund (PCF), USA, and the Israeli Science Foundation (ISF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachelder RE, 2002, CANCER RES, V62, P7203; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Balkwill F, 2003, SEMIN IMMUNOL, V15, P49, DOI 10.1016/S1044-5323(02)00127-6; Barash H, 2007, RADIOLOGY, V243, P727, DOI 10.1148/radiol.2433060433; Barbero S, 2003, CANCER RES, V63, P1969; Bell D, 1999, J EXP MED, V190, P1417, DOI 10.1084/jem.190.10.1417; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bonnotte B, 2004, J IMMUNOL, V173, P4929, DOI 10.4049/jimmunol.173.8.4929; Burger JA, 1999, BLOOD, V94, P3658, DOI 10.1182/blood.V94.11.3658.423k11_3658_3667; Charbonnier AS, 1999, J EXP MED, V190, P1755, DOI 10.1084/jem.190.12.1755; Dagan-Berger M, 2006, BLOOD, V107, P3821, DOI 10.1182/blood-2004-01-0214; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Fushimi T, 2000, J CLIN INVEST, V105, P1383, DOI 10.1172/JCI7548; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; Geminder H, 2001, J IMMUNOL, V167, P4747, DOI 10.4049/jimmunol.167.8.4747; Ghadjar P, 2008, J CANCER RES CLIN, V134, P1181, DOI 10.1007/s00432-008-0403-5; Harder J, 2000, AM J RESP CELL MOL, V22, P714, DOI 10.1165/ajrcmb.22.6.4023; Hieshima K, 1997, J BIOL CHEM, V272, P5846, DOI 10.1074/jbc.272.9.5846; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Kleeff J, 1999, INT J CANCER, V81, P650, DOI 10.1002/(SICI)1097-0215(19990517)81:4<650::AID-IJC23>3.0.CO;2-#; Koshiba T, 2000, CLIN CANCER RES, V6, P3530; Liang ZX, 2004, CANCER RES, V64, P4302, DOI 10.1158/0008-5472.CAN-03-3958; Liang ZX, 2005, CANCER RES, V65, P967; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murphy PM, 2001, NEW ENGL J MED, V345, P833, DOI 10.1056/NEJM200109133451113; Peng SB, 2005, MOL CANCER RES, V3, P227; Rubie C, 2006, SCAND J IMMUNOL, V63, P468, DOI 10.1111/j.1365-3083.2006.001766.x; Rubie C, 2006, TUMOR BIOL, V27, P166, DOI 10.1159/000092777; Soriano SF, 2003, EUR J IMMUNOL, V33, P1328, DOI 10.1002/eji.200323897; Spiegel A, 2004, BLOOD, V103, P2900, DOI 10.1182/blood-2003-06-1891; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Sugita S, 2002, J IMMUNOL, V168, P5621, DOI 10.4049/jimmunol.168.11.5621; Sun YX, 2005, J BONE MINER RES, V20, P318, DOI 10.1359/JBMR.041109; Taichman RS, 2002, CANCER RES, V62, P1832; Tanaka Y, 1999, EUR J IMMUNOL, V29, P633, DOI 10.1002/(SICI)1521-4141(199902)29:02<633::AID-IMMU633>3.0.CO;2-I; Zhang XF, 2001, BLOOD, V97, P3342, DOI 10.1182/blood.V97.11.3342; Zhou Y, 2002, J BIOL CHEM, V277, P49481, DOI 10.1074/jbc.M206222200; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	40	59	62	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5125	10.1371/journal.pone.0005125	http://dx.doi.org/10.1371/journal.pone.0005125			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340288	Green Published, Green Submitted, gold			2022-12-25	WOS:000265500700020
J	Guengerich, FP				Guengerich, F. Peter			Thematic Minireview Series: Metals in Biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Metals have important roles in biochemistry ranging from essential to toxic. This prologue introduces the second of the Thematic Minireview Series on Metals in Biology, which includes minireviews on five metals: iron, zinc, nickel, vanadium, and arsenic. Three of the minireviews are focused on the roles of the metals in enzymes ( iron, nickel, and vanadium). Zinc deficiency is discussed in another, and the arsenic minireview deals with the toxic and some potentially useful applications of the biological effects.	[Guengerich, F. Peter] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Guengerich, F. Peter] Vanderbilt Univ, Ctr Mol Toxicol, Sch Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu							0	15	15	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18557	18557		10.1074/jbc.M109.003863	http://dx.doi.org/10.1074/jbc.M109.003863			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19363036	Green Published, hybrid			2022-12-25	WOS:000267711500001
J	Hurd, PJ; Bannister, AJ; Halls, K; Dawson, MA; Vermeulen, M; Olsen, JV; Ismail, H; Somers, J; Mann, M; Owen-Hughes, T; Gout, I; Kouzarides, T				Hurd, Paul J.; Bannister, Andrew J.; Halls, Karen; Dawson, Mark A.; Vermeulen, Michiel; Olsen, Jesper V.; Ismail, Heba; Somers, Joanna; Mann, Matthias; Owen-Hughes, Tom; Gout, Ivan; Kouzarides, Tony			Phosphorylation of Histone H3 Thr-45 Is Linked to Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE C-DELTA; NEUTROPHIL APOPTOSIS; LEUKEMIA-CELLS; LYSINE 9; ACTIVATION; RECOGNITION; METHYLATION; TRAP; SITE; HL60	Numerous post-translational modifications have been identified in histones. Most of these occur within the histone tails, but a few have been identified within the histone core sequences. Histone core post-translational modifications have the potential to directly modulate nucleosome structure and consequently DNA accessibility. Here, we identify threonine 45 of histone H3 (H3T45) as a site of phosphorylation in vivo. We find that phosphorylation of H3T45 (H3T45ph) increases dramatically in apoptotic cells, around the time of DNA nicking. To further explore this connection, we analyzed human neutrophil cells because they are short-lived cells that undergo apoptosis in vivo. Freshly isolated neutrophils contain very little H3T45ph, whereas cells cultured for 20 h possess significant amounts; the kinetics of H3T45ph induction closely parallel those of caspase-3 activation. Cytokine inhibition of neutrophil apoptosis leads to reduced levels of H3T45ph. We identify protein kinase C-delta as the kinase responsible for H3T45ph in vitro and in vivo. Given the nucleosomal position of H3T45, we postulate that H3T45ph induces structural change within the nucleosome to facilitate DNA nicking and/or fragmentation.	[Hurd, Paul J.; Bannister, Andrew J.; Halls, Karen; Dawson, Mark A.; Kouzarides, Tony] Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Hurd, Paul J.; Bannister, Andrew J.; Halls, Karen; Dawson, Mark A.; Kouzarides, Tony] Univ Cambridge, Dept Pathol, Cambridge CB2 1QN, England; [Dawson, Mark A.] Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 OXY, England; [Vermeulen, Michiel; Olsen, Jesper V.; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany; [Ismail, Heba; Gout, Ivan] UCL, Dept Struct & Mol Biol, London WC1E 6BT, England; [Somers, Joanna; Owen-Hughes, Tom] Univ Dundee, Dept Biochem, Wellcome Trust Bioctr, Div Gene Regulat & Express, Dundee DD1 5EH, Scotland	University of Cambridge; University of Cambridge; University of Cambridge; Max Planck Society; University of London; University College London; University of Dundee	Kouzarides, T (corresponding author), Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	tk106@mole.bio.cam.ac.uk	Olsen, Jesper/ABH-4638-2020; Dawson, Mark A/B-9317-2017; Vermeulen, Michiel/C-8883-2013; Mann, Matthias/A-3454-2013	Olsen, Jesper/0000-0002-4747-4938; Dawson, Mark A/0000-0002-5464-5029; Vermeulen, Michiel/0000-0003-0836-6894; Mann, Matthias/0000-0003-1292-4799; Hurd, Paul/0000-0003-1112-9347; Kouzarides, Tony/0000-0002-8918-4162; Bannister, Andrew/0000-0002-6312-4436; Owen-Hughes, Tom/0000-0002-0618-8185	Cancer Research UK; European Union	Cancer Research UK(Cancer Research UK); European Union(European Commission)	This work was supported by grants from Cancer Research UK and the 6th Research Framework Programme of the European Union (EPIgenetic TReatment Of Neoplastic disease (Epitron) and Small Modulators of Gene Activation and Repression by Targeting Epigenetic Regulators (SMARTER)) (to T. K.). We declare competing financial interests; T. K. is a director of Abcam Ltd.	Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bannister AJ, 2004, METHOD ENZYMOL, V376, P269; Choi MR, 2007, APOPTOSIS, V12, P2025, DOI 10.1007/s10495-007-0121-5; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Ferreira H, 2007, MOL CELL BIOL, V27, P4037, DOI 10.1128/MCB.02229-06; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hughes PJ, 2001, BIOCHEM J, V355, P361, DOI 10.1042/0264-6021:3550361; Khwaja A, 1999, BLOOD, V94, P291, DOI 10.1182/blood.V94.1.291.413k10_291_301; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luo HBR, 2008, AM J HEMATOL, V83, P288, DOI 10.1002/ajh.21078; MacDonald N, 2005, MOL CELL, V20, P199, DOI 10.1016/j.molcel.2005.08.032; Olins AL, 2001, EXP CELL RES, V268, P115, DOI 10.1006/excr.2001.5269; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Pongracz J, 1999, J BIOL CHEM, V274, P37329, DOI 10.1074/jbc.274.52.37329; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Reyland ME, 2007, BIOCHEM SOC T, V35, P1001, DOI 10.1042/BST0351001; Schroeder MJ, 2004, ANAL CHEM, V76, P3590, DOI 10.1021/ac0497104; Simon HU, 2003, IMMUNOL REV, V193, P101, DOI 10.1034/j.1600-065X.2003.00038.x; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Thomson S, 2001, MOL CELL, V8, P1231, DOI 10.1016/S1097-2765(01)00404-X; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005	27	81	83	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16575	16583		10.1074/jbc.M109.005421	http://dx.doi.org/10.1074/jbc.M109.005421			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19363025	hybrid, Green Published			2022-12-25	WOS:000266730900054
J	Masuyama, N; Kuronita, T; Tanaka, R; Muto, T; Hirota, Y; Takigawa, A; Fujita, H; Aso, Y; Amano, J; Tanaka, Y				Masuyama, Naoko; Kuronita, Toshio; Tanaka, Rika; Muto, Tomonori; Hirota, Yuko; Takigawa, Azusa; Fujita, Hideaki; Aso, Yoshinori; Amano, Jun; Tanaka, Yoshitaka			HM1.24 Is Internalized from Lipid Rafts by Clathrin-mediated Endocytosis through Interaction with alpha-Adaptin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE-MYELOMA CELLS; GPI-ANCHORED PROTEINS; FACTOR-II RECEPTOR; MOLECULAR-CLONING; MEMBRANE-PROTEIN; SORTING SIGNALS; BINDING SITE; COATED PITS; HIV-1 VPU; DISTINCT	HM1.24/Bst2/CD317 is a protein highly expressed in multiple myeloma cells and has unique topology with two membrane anchor domains, an NH2-terminal transmembrane domain and a glycosylphosphatidylinositol attached to the COOH terminus. We show here that human HM1.24 is localized not only on the cell surface but also in the trans-Golgi network and/or recycling endosomes, where it resides in detergent-resistant microdomains, lipid rafts. In contrast to other glycosylphosphatidylinositol-anchored proteins, HM1.24 was internalized from lipid rafts on the cell surface by clathrin-mediated endocytosis. Interestingly, a non-canonical tyrosine-based motif, which contains two tyrosine residues, Tyr-6 and Tyr-8, present in the NH2-terminal cytoplasmic tail, was essential for endocytosis through interaction with an alpha-adaptin, but not mu 2-subunit, of the AP-2 complex. Indeed, an appendage domain of alpha-adaptin was identified as a protein interacting with the cytoplasmic tail of HM1.24. Furthermore, overexpression of the appendage domain of alpha-adaptin in cells depleted of alpha-adaptin could rescue the clathrin-mediated endocytosis of HM1.24 but not of the transferrin receptor. Taken together, our findings suggest that clathrin-dependent endocytosis of human HM1.24 from the cell surface lipid rafts is mediated by direct interaction with alpha-adaptin.	[Masuyama, Naoko; Kuronita, Toshio; Tanaka, Rika; Muto, Tomonori; Hirota, Yuko; Takigawa, Azusa; Fujita, Hideaki; Tanaka, Yoshitaka] Kyushu Univ, Grad Sch Pharmaceut Sci, Div Pharmaceut Cell Biol, Fukuoka 8128582, Japan; [Aso, Yoshinori; Amano, Jun] Chugai Pharmaceut Co Ltd, Fuji Gotemba Res Labs, Gotemba, Shizuoka 4128513, Japan	Kyushu University; Chugai Pharmaceutical Co., Ltd.; Roche Holding	Tanaka, Y (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Div Pharmaceut Cell Biol, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	tanakay@bioc.phar.kyushu-u.ac.jp		Fujita, Hideaki/0000-0002-4105-4430	Ministry of Education, Culture, Sports, Sciences and Technology of Japan	Ministry of Education, Culture, Sports, Sciences and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid from the Ministry of Education, Culture, Sports, Sciences and Technology of Japan.	Abrami L, 2006, J CELL BIOL, V172, P309, DOI 10.1083/jcb.200507067; Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Benmerah A, 1996, J BIOL CHEM, V271, P12111, DOI 10.1074/jbc.271.20.12111; Benmerah A, 1998, J CELL BIOL, V140, P1055, DOI 10.1083/jcb.140.5.1055; Benmerah A, 2000, J BIOL CHEM, V275, P3288, DOI 10.1074/jbc.275.5.3288; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; CANFIELD WM, 1991, J BIOL CHEM, V266, P5682; Capurso G, 2006, ENDOCR-RELAT CANCER, V13, P541, DOI 10.1677/erc.1.01153; Dell'Angelica EC, 1998, SCIENCE, V280, P431, DOI 10.1126/science.280.5362.431; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Fessart D, 2007, J CELL SCI, V120, P1723, DOI 10.1242/jcs.03444; GOTO T, 1994, BLOOD, V84, P1922; Grutzmann R, 2005, ONCOGENE, V24, P5079, DOI 10.1038/sj.onc.1208696; Guha A, 2003, J CELL SCI, V116, P3373, DOI 10.1242/jcs.00637; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Hirosako K, 2004, BIOCHEM BIOPH RES CO, V316, P845, DOI 10.1016/j.bbrc.2004.02.119; Hirota Y, 2007, BIOCHEM BIOPH RES CO, V364, P40, DOI 10.1016/j.bbrc.2007.09.089; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; ISHIKAWA J, 1995, GENOMICS, V26, P527, DOI 10.1016/0888-7543(95)80171-H; Janvier K, 2005, MOL BIOL CELL, V16, P4231, DOI 10.1091/mbc.E05-03-0213; Johannessen LE, 2006, MOL CELL BIOL, V26, P389, DOI 10.1128/MCB.26.2.389-401.2006; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Kuronita T, 2005, TRAFFIC, V6, P895, DOI 10.1111/j.1600-0854.2005.00325.x; Kuronita T, 2002, J CELL SCI, V115, P4117, DOI 10.1242/jcs.00075; LARKIN JM, 1983, CELL, V33, P273, DOI 10.1016/0092-8674(83)90356-2; Li XY, 2007, MOL BIOL CELL, V18, P1261, DOI 10.1091/mbc.E06-03-0236; Mayor S, 2004, NAT REV MOL CELL BIO, V5, P110, DOI 10.1038/nrm1309; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Nichols B, 2003, J CELL SCI, V116, P4707, DOI 10.1242/jcs.00840; Nichols BJ, 2002, NAT CELL BIOL, V4, P374, DOI 10.1038/ncb787; Ohno H, 1998, J BIOL CHEM, V273, P25915, DOI 10.1074/jbc.273.40.25915; Ohtomo T, 1999, BIOCHEM BIOPH RES CO, V258, P583, DOI 10.1006/bbrc.1999.0683; Ono K, 1999, MOL IMMUNOL, V36, P387, DOI 10.1016/S0161-5890(99)00029-2; Owen DJ, 1999, CELL, V97, P805, DOI 10.1016/S0092-8674(00)80791-6; Ozaki S, 1997, BLOOD, V90, P3179, DOI 10.1182/blood.V90.8.3179; Peden AA, 2002, J CELL BIOL, V156, P327, DOI 10.1083/jcb.200107140; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Praefcke GJK, 2004, EMBO J, V23, P4371, DOI 10.1038/sj.emboj.7600445; Rapoport I, 1998, EMBO J, V17, P2148, DOI 10.1093/emboj/17.8.2148; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Shih W, 1995, J BIOL CHEM, V270, P31083, DOI 10.1074/jbc.270.52.31083; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Stoddart A, 2005, MOL BIOL CELL, V16, P2339, DOI 10.1091/mbc.e05-01-0025; Stoddart A, 2002, IMMUNITY, V17, P451, DOI 10.1016/S1074-7613(02)00416-8; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Sunaga N, 2004, CANCER RES, V64, P4277, DOI 10.1158/0008-5472.CAN-03-3941; Taylor DR, 2005, J CELL SCI, V118, P5141, DOI 10.1242/jcs.02627; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Van Damme N, 2008, CELL MICROBIOL, V10, P1040, DOI 10.1111/j.1462-5822.2007.01101.x; van Deurs B, 2003, TRENDS CELL BIOL, V13, P92, DOI 10.1016/S0962-8924(02)00039-9; Vidal-Laliena M, 2005, CELL IMMUNOL, V236, P6, DOI 10.1016/j.cellimm.2005.08.002; Volonte D, 1999, J BIOL CHEM, V274, P12702, DOI 10.1074/jbc.274.18.12702; Walter-Yohrling J, 2003, CANCER RES, V63, P8939; Yao DY, 2002, MOL BIOL CELL, V13, P4001, DOI 10.1091/mbc.02-07-0104	65	117	118	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15927	15941		10.1074/jbc.M109.005124	http://dx.doi.org/10.1074/jbc.M109.005124			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19359243	hybrid, Green Published			2022-12-25	WOS:000266501000060
J	Cimmino, F; Schulte, JH; Zollo, M; Koster, J; Versteeg, R; Iolascon, A; Eggert, A; Schramm, A				Cimmino, F.; Schulte, J. H.; Zollo, M.; Koster, J.; Versteeg, R.; Iolascon, A.; Eggert, A.; Schramm, A.			Galectin-1 is a major effector of TrkB-mediated neuroblastoma aggressiveness	ONCOGENE			English	Article						neuroblastoma; Galectin-1; TrkB; neurotrophin receptors	NEUROTROPHIC FACTOR; CLASSICAL HODGKIN; TUMOR PROGRESSION; IMMUNE PRIVILEGE; GENE-EXPRESSION; H-RAS; CELLS; CANCER; TARGET; INVASIVENESS	Expression of Trk receptors is an important prognostic factor in neuroblastoma (NB) and other cancers. TrkB and its ligand brain-derived neurotrophic factor (BDNF) are preferentially expressed in NB with poor prognosis, conferring invasive and metastatic potential to the tumor cells as well as enhancing therapy resistance. Galectin-1 (Gal-1) has emerged as an interesting cancer target, as it is involved in modulating cell proliferation, cell death and cell migration, all of which are linked to cancer initiation and progression. We previously identified Gal-1 mRNA to be upregulated in patients with aggressive, relapsing NB and found that Gal-1 protein was upregulated in human SY5Y NB cells on activation of ectopically expressed TrkB (SY5Y-TrkB), but not TrkA (SY5Y-TrkA). Here, we report that Gal-1 mRNA levels positively correlated with TrkB expression and anticorrelated with TrkA expression in a cohort of 102 primary NB. Immunohistochemical analyses of 92 primary NB specimens revealed high Gal-1 expression in stromal septae and in neuroblasts. BDNF-mediated activation of TrkB enhanced invasiveness and migration in vitro, which could be impaired by transient transfection using Gal-1-specific siRNA or a neutralizing antibody directed against Gal-1. The addition of recombinant Gal-1 (rGal-1) in the absence of BDNF partially restored migration and invasive capacity. Using the Trk inhibitor K252a, we could show that the upregulation of Gal-1 protein strictly depended on activated TrkB. Our data suggest that targeting Gal-1 might be a promising strategy for the treatment of aggressive NB. Oncogene (2009) 28, 2015-2023; doi:10.1038/onc.2009.70; published online 13 April 2009	[Cimmino, F.; Zollo, M.; Iolascon, A.] Univ Naples Federico 2, Dipartimento Biochim & Biotecnol Med, Ctr Ingn Genet CEINGE Biotecnol Avanzate, Naples, Italy; [Koster, J.; Versteeg, R.] AMC Amsterdam, Dept Human Genet, Amsterdam, Netherlands; [Cimmino, F.; Schulte, J. H.; Eggert, A.; Schramm, A.] Univ Childrens Hosp Essen, Div Hematol Oncol, Essen, Germany	CEINGE Biotecnologie Avanzate; University of Naples Federico II; University of Amsterdam; Academic Medical Center Amsterdam; University of Duisburg Essen	Schramm, A (corresponding author), Univ Childrens Hosp Essen, Div Hematol Oncol, Hufelandstr 55, D-45122 Essen Nrw, Germany.	alexander.schramm@uni-due.de	Schulte, Johannes H./V-2474-2018; Schulte, Johannes H/G-3981-2010; Schramm, Alexander/G-5688-2010; Versteeg, Rogier/AAQ-1765-2020; Eggert, Angelika/AAE-6907-2022; Koster, Jan/C-5934-2008; Iolascon, Achille/A-4461-2014; Cimmino, Flora/AAA-2378-2020; Cimmino, FLORA/K-6205-2016	Schramm, Alexander/0000-0001-7670-7529; Eggert, Angelika/0000-0003-3476-8184; Koster, Jan/0000-0002-0890-7585; Cimmino, Flora/0000-0003-1538-9285; Cimmino, FLORA/0000-0003-1538-9285; Versteeg, Rogier/0000-0001-7172-0388; iolascon, achille/0000-0002-9558-0356; Schulte, Johannes Hubertus/0000-0003-0671-1201	European Union [037260]	European Union(European Commission)	This study was supported by the 6th framework program of the European Union, Grant no. 037260 (EET-Pipeline).	Belanis L, 2008, MOL BIOL CELL, V19, P1404, DOI 10.1091/mbc.E07-10-1053; Chiang WF, 2008, ORAL ONCOL, V44, P325, DOI 10.1016/j.oraloncology.2007.03.004; Cimmino F, 2007, J PROTEOME RES, V6, P2550, DOI 10.1021/pr060701g; Eggert A, 2001, CANCER RES, V61, P1314; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; He JL, 2004, J BIOL CHEM, V279, P4705, DOI 10.1074/jbc.M311183200; Hecht M, 2005, CARCINOGENESIS, V26, P2105, DOI 10.1093/carcin/bgi192; Hecht M, 2004, CANCER RES, V64, P6109, DOI 10.1158/0008-5472.CAN-04-1014; Ho R, 2002, CANCER RES, V62, P6462; Hughes RC, 2001, BIOCHIMIE, V83, P667; Jaboin J, 2002, CANCER RES, V62, P6756; Jung EJ, 2007, INT J CANCER, V120, P2331, DOI 10.1002/ijc.22434; Juszczynski P, 2007, P NATL ACAD SCI USA, V104, P13134, DOI 10.1073/pnas.0706017104; Le Mercier M, 2008, J NEUROPATH EXP NEUR, V67, P456, DOI 10.1097/NEN.0b013e318170f892; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Lucarelli E, 1997, EUR J CANCER, V33, P2068, DOI 10.1016/S0959-8049(97)00266-9; Mathieu V, 2007, J INVEST DERMATOL, V127, P2399, DOI 10.1038/sj.jid.5700869; MATSUMOTO K, 1995, CANCER RES, V55, P1798; NAKAGAWARA A, 1994, MOL CELL BIOL, V14, P759, DOI 10.1128/MCB.14.1.759; NAKAGAWARA A, 1993, NEW ENGL J MED, V328, P847, DOI 10.1056/NEJM199303253281205; Paz A, 2001, ONCOGENE, V20, P7486, DOI 10.1038/sj.onc.1204950; Rabinovich GA, 2005, BRIT J CANCER, V92, P1188, DOI 10.1038/sj.bjc.6602493; Rodig SJ, 2008, CLIN CANCER RES, V14, P3338, DOI 10.1158/1078-0432.CCR-07-4709; Rubinstein N, 2004, CANCER CELL, V5, P241, DOI 10.1016/S1535-6108(04)00024-8; Salatino M, 2008, EXPERT OPIN BIOL TH, V8, P45, DOI 10.1517/14712598.8.1.45; Schramm A, 2005, ONCOGENE, V24, P7902, DOI 10.1038/sj.onc.1208936; Schramm A, 2005, CANCER LETT, V228, P143, DOI 10.1016/j.canlet.2005.02.051; Schulte JH, 2005, ONCOGENE, V24, P165, DOI 10.1038/sj.onc.1208000; Schulte JH, 2008, CANCER LETT, V271, P56, DOI 10.1016/j.canlet.2008.05.039; Schulte JH, 2009, CANCER RES, V69, P2065, DOI 10.1158/0008-5472.CAN-08-1735; Sitek B, 2005, MOL CELL PROTEOMICS, V4, P291, DOI 10.1074/mcp.M400188-MCP200; Stephan H, 2008, PEDIATR BLOOD CANCER, V50, P218, DOI 10.1002/pbc.21369; TAPLEY P, 1992, ONCOGENE, V7, P371; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Thijssen VLJL, 2007, BLOOD, V110, P2819, DOI 10.1182/blood-2007-03-077792; Thijssen VLJL, 2006, P NATL ACAD SCI USA, V103, P15975, DOI 10.1073/pnas.0603883103; Yamashiro DJ, 1997, EUR J CANCER, V33, P2054, DOI 10.1016/S0959-8049(97)00309-2	37	53	55	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 14	2009	28	19					2015	2023		10.1038/onc.2009.70	http://dx.doi.org/10.1038/onc.2009.70			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	445BF	19363525				2022-12-25	WOS:000266023900002
J	Xiridou, M; Borkent-Raven, B; Hulshof, J; Wallinga, J				Xiridou, Maria; Borkent-Raven, Barbara; Hulshof, Joost; Wallinga, Jacco			How Hepatitis D Virus Can Hinder the Control of Hepatitis B Virus	PLOS ONE			English	Article							TRANSMISSION DYNAMICS; MATHEMATICAL-MODEL; INFECTION; TUBERCULOSIS; IMPACT; HIV; COINFECTION; COEXISTENCE; PERSISTENCE; PREVALENCE	Background: Hepatitis D (or hepatitis delta) virus is a defective virus that relies on hepatitis B virus (HBV) for transmission; infection with hepatitis D can occur only as coinfection with HBV or superinfection of an existing HBV infection. Because of the bond between the two viruses, control measures for HBV may have also affected the spread of hepatitis D, as evidenced by the decline of hepatitis D in recent years. Since the presence of hepatitis D is associated with suppressed HBV replication and possibly infectivity, it is reasonable to speculate that hepatitis D may facilitate the control of HBV. Methodology and Principal Findings: We introduced a mathematical model for the transmission of HBV and hepatitis D, where individuals with dual HBV and hepatitis D infection transmit both viruses. We calculated the reproduction numbers of single HBV infections and dual HBV and hepatitis D infections and examined the endemic prevalences of the two viruses. The results show that hepatitis D virus modulates not only the severity of the HBV epidemic, but also the impact of interventions for HBV. Surprisingly we find that the presence of hepatitis D virus may hamper the eradication of HBV. Interventions that aim to reduce the basic reproduction number of HBV below one may not be sufficient to eradicate the virus, as control of HBV depends also on the reproduction numbers of dual infections. Conclusions and Significance: For populations where hepatitis D is endemic, plans for control programs ignoring the presence of hepatitis D may underestimate the HBV epidemic and produce overoptimistic results. The current HBV surveillance should be augmented with monitoring of hepatitis D, in order to improve accuracy of the monitoring and the efficacy of control measures.			Xiridou, M (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands.	maria.xiridou@rivm.nl	Wallinga, Jacco/C-4382-2018	Wallinga, Jacco/0000-0003-1725-5627				Abu-Raddad LJ, 2006, SCIENCE, V314, P1603, DOI 10.1126/science.1132338; Boots M, 2007, SCIENCE, V315, P1284, DOI 10.1126/science.1137126; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Currie CSM, 2003, AIDS, V17, P2501, DOI 10.1097/00002030-200311210-00013; Davidovich U, 2000, AIDS, V14, P701, DOI 10.1097/00002030-200004140-00009; EDMUNDS WJ, 1993, P ROY SOC B-BIOL SCI, V253, P197, DOI 10.1098/rspb.1993.0102; Edmunds WJ, 1996, STAT MED, V15, P2215, DOI 10.1002/(SICI)1097-0258(19961030)15:20&lt;2215::AID-SIM369&gt;3.0.CO;2-2; Ferguson N, 1999, P NATL ACAD SCI USA, V96, P790, DOI 10.1073/pnas.96.2.790; GAETA G, 2002, HEPATOLOGY, V32, P824; HADLER SC, 1984, ANN INTERN MED, V100, P339, DOI 10.7326/0003-4819-100-3-339; Inoue J, 2005, J MED VIROL, V76, P333, DOI 10.1002/jmv.20363; Jardi R, 2001, HEPATOLOGY, V34, P404, DOI 10.1053/jhep.2001.26511; Kao JH, 2002, J CLIN MICROBIOL, V40, P4068, DOI 10.1128/JCM.40.11.4068-4071.2002; Keeling MJ, 1997, SCIENCE, V275, P65, DOI 10.1126/science.275.5296.65; Kirupaharan N, 2004, B MATH BIOL, V66, P841, DOI 10.1016/j.bulm.2003.11.007; Lloyd-Smith JO, 2008, PARASITOLOGY, V135, P795, DOI 10.1017/S0031182008000292; Martcheva M, 2007, MATH BIOSCI, V207, P58, DOI 10.1016/j.mbs.2006.09.010; Mast E., 2004, VACCINES, P299; MAY RM, 1995, P ROY SOC B-BIOL SCI, V261, P209, DOI 10.1098/rspb.1995.0138; MAY RM, 1994, J THEOR BIOL, V170, P95, DOI 10.1006/jtbi.1994.1171; MYERS MW, 1980, J VIROL, V35, P65, DOI 10.1128/JVI.35.1.65-75.1980; Nasell I, 2002, MATH BIOSCI, V179, P1, DOI 10.1016/S0025-5564(02)00098-6; Niro GA, 2005, J VIRAL HEPATITIS, V12, P2, DOI 10.1111/j.1365-2893.2005.00601.x; POLISH LB, 1993, CLIN MICROBIOL REV, V6, P211, DOI 10.1128/CMR.6.3.211-229.1993; Restif O, 2006, P ROY SOC B-BIOL SCI, V273, P409, DOI 10.1098/rspb.2005.3335; SUREAU C, 1993, J VIROL, V67, P366, DOI 10.1128/JVI.67.1.366-372.1993; van Houdt R, 2007, VACCINE, V25, P2698, DOI 10.1016/j.vaccine.2006.06.058; Webb SD, 2007, J THEOR BIOL, V249, P140, DOI 10.1016/j.jtbi.2007.06.013; *WHO, 2001, HEP DELT; WHO, 2002, HEP B; Williams BG, 2005, P NATL ACAD SCI USA, V102, P9619, DOI 10.1073/pnas.0501615102; Williams JR, 1996, EPIDEMIOL INFECT, V116, P71, DOI 10.1017/S0950268800058970; Xridou M, 2009, EPIDEMIOL INFECT, V137, P504, DOI 10.1017/S0950268808000976; Zhao SJ, 2000, INT J EPIDEMIOL, V29, P744, DOI 10.1093/ije/29.4.744	34	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2009	4	4							e5247	10.1371/journal.pone.0005247	http://dx.doi.org/10.1371/journal.pone.0005247			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VA	19381302	gold, Green Published, Green Submitted			2022-12-25	WOS:000265513800014
J	Alejo, A; Saraiva, M; Ruiz-Arguello, MB; Viejo-Borbolla, A; de Marco, MF; Salguero, FJ; Alcami, A				Alejo, Ali; Saraiva, Margarida; Begona Ruiz-Arguello, Maria; Viejo-Borbolla, Abel; Fernandez de Marco, Mar; Javier Salguero, Francisco; Alcami, Antonio			A Method for the Generation of Ectromelia Virus (ECTV) Recombinants: In Vivo Analysis of ECTV vCD30 Deletion Mutants	PLOS ONE			English	Article							NECROSIS-FACTOR RECEPTOR; BACTERIAL ARTIFICIAL CHROMOSOME; INTERFERON-BINDING PROTEIN; VACCINIA VIRUS; POXVIRUS PROTEIN; COWPOX VIRUSES; CD30 LIGAND; GENE; RESISTANCE; TNF	Background: Ectromelia virus (ECTV) is the causative agent of mousepox, a lethal disease of mice with similarities to human smallpox. Mousepox progression involves replication at the initial site of infection, usually the skin, followed by a rapid spread to the secondary replicative organs, spleen and liver, and finally a dissemination to the skin, where the typical rash associated with this and other orthopoxviral induced diseases appears. Case fatality rate is genetically determined and reaches up to 100% in susceptible mice strains. Like other poxviruses, ECTV encodes a number of proteins with immunomodulatory potential, whose role in mousepox progression remains largely undescribed. Amongst these is a secreted homologue of the cellular tumour necrosis factor receptor superfamily member CD30 which has been proposed to modulate a Th1 immune response in vivo. Methodology/Principal Findings: To evaluate the contribution of viral CD30 (vCD30) to virus pathogenesis in the infected host, we have adapted a novel transient dominant method for the selection of recombinant ECTVs. Using this method, we have generated an ECTV vCD30 deletion mutant, its corresponding revertant control virus as well as a virus encoding the extracellular domain of murine CD30. These viruses contain no exogenous marker DNA sequences in their genomes, as opposed to other ECTVs reported up to date. Conclusions/Significance: We show that the vCD30 is expressed as a secreted disulfide linked trimer and that the absence of vCD30 does not impair mousepox induced fatality in vivo. Replacement of vCD30 by a secreted version of mouse CD30 caused limited attenuation of ECTV. The recombinant viruses generated may be of use in the study of the role of the cellular CD30-CD30L interaction in the development of the immune response. The method developed might be useful for the construction of ECTV mutants for the study of additional genes.	[Alejo, Ali; Begona Ruiz-Arguello, Maria; Javier Salguero, Francisco] Inst Nacl Invest & Tecnol Agr & Alimentaria, Ctr Invest Sanidad Anim, Madrid, Spain; [Saraiva, Margarida; Alcami, Antonio] Univ Cambridge, Dept Med, Addenbrookes Hosp, Cambridge, England; [Viejo-Borbolla, Abel; Fernandez de Marco, Mar; Alcami, Antonio] CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Viejo-Borbolla, Abel; Fernandez de Marco, Mar; Alcami, Antonio] Univ Autonoma Madrid, Madrid, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid	Alejo, A (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria, Ctr Invest Sanidad Anim, Madrid, Spain.	aalcami@cbm.uam.es	Alcami, Antonio/F-8512-2015; Viejo-Borbolla, Abel/AAO-1585-2020; Salguero, Francisco J/A-7336-2010; Saraiva, Margarida/E-8781-2011; Alejo, Ali/AAF-1477-2020	Alcami, Antonio/0000-0002-3333-6016; Viejo-Borbolla, Abel/0000-0001-6395-4010; Saraiva, Margarida/0000-0002-8180-1293; Alejo, Ali/0000-0002-1613-6063; Salguero, Francisco Javier/0000-0002-5315-3882	Medical Research Council [G9800943] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G9800943] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Afonso CL, 2005, J VIROL, V79, P966, DOI 10.1128/JVI.79.2.966-977.2005; Alcami A, 1999, J GEN VIROL, V80, P949, DOI 10.1099/0022-1317-80-4-949; Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Alcami A, 1996, TRENDS MICROBIOL, V4, P321, DOI 10.1016/0966-842X(96)10051-2; ALCAMI A, 1992, CELL, V71, P153, DOI 10.1016/0092-8674(92)90274-G; Alejo A, 2006, P NATL ACAD SCI USA, V103, P5995, DOI 10.1073/pnas.0510462103; Bartlett NW, 2004, J GEN VIROL, V85, P1401, DOI 10.1099/vir.0.79980-0; Born TL, 2000, J IMMUNOL, V164, P3246, DOI 10.4049/jimmunol.164.6.3246; Brunetti CR, 2003, P NATL ACAD SCI USA, V100, P4831, DOI 10.1073/pnas.0737244100; Cerutti A, 2000, J IMMUNOL, V165, P786, DOI 10.4049/jimmunol.165.2.786; Chan FKM, 2007, CYTOKINE, V37, P101, DOI 10.1016/j.cyto.2007.03.005; Chaudhri G, 2004, P NATL ACAD SCI USA, V101, P9057, DOI 10.1073/pnas.0402949101; Chaudhri G, 2006, J VIROL, V80, P6339, DOI 10.1128/JVI.00116-06; CHEN W, 1993, VIROLOGY, V196, P682, DOI 10.1006/viro.1993.1525; COLAMONICI OR, 1995, J BIOL CHEM, V270, P15974, DOI 10.1074/jbc.270.27.15974; Comeau MR, 1998, IMMUNITY, V8, P473, DOI 10.1016/S1074-7613(00)80552-X; Cottingham MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001638; Cunnion KM, 1999, MOL GENET METAB, V67, P278, DOI 10.1006/mgme.1999.2878; DAVISON AJ, 1989, J MOL BIOL, V210, P771, DOI 10.1016/0022-2836(89)90108-3; DELANO ML, 1995, J VIROL, V69, P5875, DOI 10.1128/JVI.69.9.5875-5877.1995; Demmin GL, 2001, J VIROL, V75, P10856, DOI 10.1128/JVI.75.22.10856-10869.2001; Di Giulio DB, 2004, LANCET INFECT DIS, V4, P15, DOI 10.1016/S1473-3099(03)00856-9; Domi A, 2002, P NATL ACAD SCI USA, V99, P12415, DOI 10.1073/pnas.192420599; Esteban DJ, 2005, J GEN VIROL, V86, P2645, DOI 10.1099/vir.0.81090-0; FALKNER FG, 1990, J VIROL, V64, P3108, DOI 10.1128/JVI.64.6.3108-3111.1990; Fang M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040030; Fenner Frank, 1997, P535; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Fleming SB, 1997, J VIROL, V71, P4857, DOI 10.1128/JVI.71.6.4857-4861.1997; Gileva IP, 2006, BBA-PROTEINS PROTEOM, V1764, P1710, DOI 10.1016/j.bbapap.2006.09.006; HU FQ, 1994, VIROLOGY, V204, P343, DOI 10.1006/viro.1994.1539; Huang JN, 2004, J BIOL CHEM, V279, P54110, DOI 10.1074/jbc.M410583200; Johnston JB, 2004, CELL MICROBIOL, V6, P695, DOI 10.1111/j.1462-5822.2004.00423.x; Kennedy MK, 2006, IMMUNOLOGY, V118, P143, DOI 10.1111/j.1365-2567.2006.02354.x; KOCHNEVA GV, 1994, VIRUS RES, V34, P49, DOI 10.1016/0168-1702(94)90118-X; Loparev VN, 1998, P NATL ACAD SCI USA, V95, P3786, DOI 10.1073/pnas.95.7.3786; MACKETT M, 1985, CONSTRUCTION CHARACT, P191; Moss B, 2007, FIELDS VIROLOGY; Nishimura H, 2005, J IMMUNOL, V175, P4627, DOI 10.4049/jimmunol.175.7.4627; Nuara AA, 2008, P NATL ACAD SCI USA, V105, P1861, DOI 10.1073/pnas.0705753105; Panchanathan V, 2006, J VIROL, V80, P6333, DOI 10.1128/JVI.00115-06; Panus JF, 2002, P NATL ACAD SCI USA, V99, P8348, DOI 10.1073/pnas.122238599; Rahman MM, 2006, J BIOL CHEM, V281, P22517, DOI 10.1074/jbc.M604645200; Rahman Masmudur M, 2006, PLoS Pathog, V2, pe4; Ruiz-Arguello MB, 2005, SYMP SOC GEN MICROBI, V64, P269; Sakala IG, 2007, J VIROL, V81, P3346, DOI 10.1128/JVI.01927-06; Sanchez-Puig JM, 2000, GENE, V257, P57, DOI 10.1016/S0378-1119(00)00398-X; Saraiva M, 2002, J EXP MED, V196, P829, DOI 10.1084/jem.20020319; Saraiva M, 2001, J VIROL, V75, P226, DOI 10.1128/JVI.75.1.226-233.2001; Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049; SENKEVICH TG, 1994, VIROLOGY, V198, P118, DOI 10.1006/viro.1994.1014; SENKEVICH TG, 1995, J VIROL, V69, P4103, DOI 10.1128/JVI.69.7.4103-4111.1995; SPRIGGS MK, 1992, CELL, V71, P145, DOI 10.1016/0092-8674(92)90273-F; SYMONS JA, 1995, CELL, V81, P551, DOI 10.1016/0092-8674(95)90076-4; Tang C, 2008, J IMMUNOL, V181, P6316, DOI 10.4049/jimmunol.181.9.6316; Tulman ER, 2006, J VIROL, V80, P9244, DOI 10.1128/JVI.00945-06; Vanderplasschen A, 1997, J GEN VIROL, V78, P2041, DOI 10.1099/0022-1317-78-8-2041; Wassenaar TA, 2008, PROTEINS, V70, P333, DOI 10.1002/prot.21541; Xu RH, 2008, J EXP MED, V205, P981, DOI 10.1084/jem.20071854	59	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5175	10.1371/journal.pone.0005175	http://dx.doi.org/10.1371/journal.pone.0005175			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TN	19365546	Green Published, Green Submitted, gold			2022-12-25	WOS:000265509900006
J	Steiling, K; Kadar, AY; Bergerat, A; Flanigon, J; Sridhar, S; Shah, V; Ahmad, QR; Brody, JS; Lenburg, ME; Steffen, M; Spira, A				Steiling, Katrina; Kadar, Aran Y.; Bergerat, Agnes; Flanigon, James; Sridhar, Sriram; Shah, Vishal; Ahmad, Q. Rushdy; Brody, Jerome S.; Lenburg, Marc E.; Steffen, Martin; Spira, Avrum			Comparison of Proteomic and Transcriptomic Profiles in the Bronchial Airway Epithelium of Current and Never Smokers	PLOS ONE			English	Article								Background: Although prior studies have demonstrated a smoking-induced field of molecular injury throughout the lung and airway, the impact of smoking on the airway epithelial proteome and its relationship to smoking-related changes in the airway transcriptome are unclear. Methodology/Principal Findings: Airway epithelial cells were obtained from never (n = 5) and current (n = 5) smokers by brushing the mainstem bronchus. Proteins were separated by one dimensional polyacrylamide gel electrophoresis (1D-PAGE). After in-gel digestion, tryptic peptides were processed via liquid chromatography/tandem mass spectrometry (LC-MS/MS) and proteins identified. RNA from the same samples was hybridized to HG-U133A microarrays. Protein detection was compared to RNA expression in the current study and a previously published airway dataset. The functional properties of many of the 197 proteins detected in a majority of never smokers were similar to those observed in the never smoker airway transcriptome. LC-MS/MS identified 23 proteins that differed between never and current smokers. Western blotting confirmed the smoking-related changes of PLUNC, P4HB1, and uteroglobin protein levels. Many of the proteins differentially detected between never and current smokers were also altered at the level of gene expression in this cohort and the prior airway transcriptome study. There was a strong association between protein detection and expression of its corresponding transcript within the same sample, with 86% of the proteins detected by LC-MS/MS having a detectable corresponding probeset by microarray in the same sample. Forty-one proteins identified by LC-MS/MS lacked detectable expression of a corresponding transcript and were detected in <= 5% of airway samples from a previously published dataset. Conclusions/Significance: 1D-PAGE coupled with LC-MS/MS effectively profiled the airway epithelium proteome and identified proteins expressed at different levels as a result of cigarette smoke exposure. While there was a strong correlation between protein and transcript detection within the same sample, we also identified proteins whose corresponding transcripts were not detected by microarray. This noninvasive approach to proteomic profiling of airway epithelium may provide additional insights into the field of injury induced by tobacco exposure.			Steiling, K (corresponding author), Boston Univ, Med Ctr, Ctr Pulm, Boston, MA 02215 USA.	steiling@bu.edu	Lenburg, Marc/B-8027-2008	Lenburg, Marc/0000-0002-5760-4708; Brody, Jerome/0000-0002-2824-802X; Steiling, Katrina/0000-0001-9663-2093; Steffen, Martin/0000-0002-7853-7364; Spira, Avrum/0000-0003-1467-0489	NCI NIH HHS [R01CA124640, R01 CA124640] Funding Source: Medline; NIEHS NIH HHS [U01ES016035, U01 ES016035] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA124640] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES016035] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Adachi J, 2007, MOL CELL PROTEOMICS, V6, P1257, DOI 10.1074/mcp.M600476-MCP200; Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333; Beane J, 2008, CANCER PREV RES, V1, P56, DOI 10.1158/1940-6207.CAPR-08-0011; Beane J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r201; Brockmann R, 2007, PLOS COMPUT BIOL, V3, P531, DOI 10.1371/journal.pcbi.0030057; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P300; Chelius D, 2002, J PROTEOME RES, V1, P317, DOI 10.1021/pr025517j; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Chen GA, 2002, CLIN CANCER RES, V8, P2298; Chen YR, 2006, J PROTEOME RES, V5, P2727, DOI 10.1021/pr060212g; Crawford EL, 2000, CANCER RES, V60, P1609; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Duan XB, 2008, J PROTEOME RES, V7, P4955, DOI 10.1021/pr800295j; Franklin WA, 1997, J CLIN INVEST, V100, P2133, DOI 10.1172/JCI119748; Futcher B, 1999, MOL CELL BIOL, V19, P7357; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Ghafouri B, 2002, PROTEOMICS, V2, P112, DOI 10.1002/1615-9861(200201)2:1<112::AID-PROT112>3.0.CO;2-N; Gianazza E, 2004, AM J MED, V117, P51, DOI 10.1016/j.amjmed.2004.01.022; Greenbaum D, 2002, BIOINFORMATICS, V18, P585, DOI 10.1093/bioinformatics/18.4.585; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Guo MZ, 2004, CLIN CANCER RES, V10, P5131, DOI 10.1158/1078-0432.CCR-03-0763; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Habermann JK, 2007, GENE CHROMOSOME CANC, V46, P10, DOI 10.1002/gcc.20382; Hackett NR, 2003, AM J RESP CELL MOL, V29, P331, DOI 10.1165/rcmb.2002-0321OC; Harvey BG, 2007, J MOL MED, V85, P39, DOI 10.1007/s00109-006-0103-z; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Kakhniashvili DG, 2004, MOL CELL PROTEOMICS, V3, P501, DOI 10.1074/mcp.M300132-MCP200; Kelsen SG, 2008, AM J RESP CELL MOL, V38, P541, DOI 10.1165/rcmb.2007-0221OC; Lee EJ, 2009, CHEST, V135, P344, DOI 10.1378/chest.08-1583; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lorenz P, 2003, PROTEOMICS, V3, P991, DOI 10.1002/pmic.200300412; Mullins DN, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-141; National Center for Health Statistics, 2005, HLTH US 2005 CHARTB; Nissom PM, 2006, MOL BIOTECHNOL, V34, P125, DOI 10.1385/MB:34:2:125; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Pilette C, 2001, AM J RESP CRIT CARE, V163, P185, DOI 10.1164/ajrccm.163.1.9912137; Powell CA, 2003, LUNG CANCER-J IASLC, V39, P23, DOI 10.1016/S0169-5002(02)00384-7; Powell CA, 1999, CLIN CANCER RES, V5, P2025; Rahman SMJ, 2005, AM J RESP CRIT CARE, V172, P1556, DOI 10.1164/rccm.200502-274OC; Robin M, 2002, EUR RESPIR J, V20, P1152, DOI 10.1183/09031936.02.02042001; Ruse CI, 2004, PROTEOMICS, V4, P1505, DOI 10.1002/pmic.200300682; Schembri F, 2009, P NATL ACAD SCI USA, V106, P2319, DOI 10.1073/pnas.0806383106; Schmidt MW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100117; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shijubo N, 1997, EUR RESPIR J, V10, P1108, DOI 10.1183/09031936.97.10051108; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Siu FM, 2008, PROTEOMICS, V8, P3105, DOI 10.1002/pmic.200700829; Spira A, 2004, P NATL ACAD SCI USA, V101, P10143, DOI 10.1073/pnas.0401422101; Spira A, 2007, NAT MED, V13, P361, DOI 10.1038/nm1556; Unwin RD, 2006, CELL CYCLE, V5, P1587, DOI 10.4161/cc.5.15.3101; White SL, 2004, BRIT J CANCER, V90, P173, DOI 10.1038/sj.bjc.6601458; Willey JC, 1997, CHEST, V111, pS83, DOI 10.1378/chest.111.6_Supplement.83S; Wistuba II, 1997, JNCI-J NATL CANCER I, V89, P1366, DOI 10.1093/jnci/89.18.1366; Xia D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r116; Xie LF, 2009, BIOGERONTOLOGY, V10, P125, DOI 10.1007/s10522-008-9157-3; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Yi ZP, 2008, J PROTEOME RES, V7, P3230, DOI 10.1021/pr800064s; Yoshida A, 1998, EUR J BIOCHEM, V251, P549, DOI 10.1046/j.1432-1327.1998.2510549.x; Zhang SP, 2008, TOXICOL LETT, V178, P191, DOI 10.1016/j.toxlet.2008.03.014	61	55	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5043	10.1371/journal.pone.0005043	http://dx.doi.org/10.1371/journal.pone.0005043			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357784	Green Submitted, Green Published, gold			2022-12-25	WOS:000265505900002
J	Walkiewicz, MA; Stern, M				Walkiewicz, Magdalena A.; Stern, Michael			Increased Insulin/Insulin Growth Factor Signaling Advances the Onset of Metamorphosis in Drosophila	PLOS ONE			English	Article								Mechanisms by which attainment of specific body sizes trigger developmental transitions to adulthood (e. g. puberty or metamorphosis) are incompletely understood. In Drosophila, metamorphosis is triggered by ecdysone synthesis from the prothoracic gland (PG), whereas growth rate is increased by insulin/insulin growth factor signalling (IIS). Transgene-induced activation of PI3K, the major effector of IIS, within the PG advances the onset of metamorphosis via precocious ecdysone synthesis, raising the possibility that IIS triggers metamorphosis via PI3K activation in the PG. Here we show that blocking the protein kinase A (PKA) pathway in the insulin producing cells (IPCs) increases IIS. This increased IIS increases larval growth rate and also advances the onset of metamorphosis, which is accompanied by precocious ecdysone synthesis and increased transcription of at least one ecdysone biosynthetic gene. Our observations suggest that IIS is regulated by PKA pathway activity in the IPCs. In addition, taken together with previous findings, our observations are consistent with the possibility that, in Drosophila, attainment of a specific body size triggers metamorphosis via the IIS-mediated activation of PI3K and hence ecdysone synthesis in the PG.			Walkiewicz, MA (corresponding author), Rice Univ, Dept Biochem & Cell Biol, POB 1892, Houston, TX 77251 USA.	walkiewi@rice.edu			Division Of Integrative Organismal Systems [0820660] Funding Source: National Science Foundation	Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Arquier N, 2008, CELL METAB, V7, P333, DOI 10.1016/j.cmet.2008.02.003; Bartke A, 2004, CURR TOP DEV BIOL, V63, P189, DOI 10.1016/S0070-2153(04)63006-7; Belvin MP, 1999, NEURON, V22, P777, DOI 10.1016/S0896-6273(00)80736-9; BRAND AH, 1993, DEVELOPMENT, V118, P401; Broughton S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003721; Caldwell PE, 2005, CURR BIOL, V15, P1785, DOI 10.1016/j.cub.2005.09.011; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Eggers A, 1998, J BIOL CHEM, V273, P18499, DOI 10.1074/jbc.273.29.18499; Eresh S, 1997, EMBO J, V16, P2014, DOI 10.1093/emboj/16.8.2014; Gronke S, 2007, PLOS BIOL, V5, P1248, DOI 10.1371/journal.pbio.0050137; Hussain MA, 2000, DIABETES, V49, P1681, DOI 10.2337/diabetes.49.10.1681; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Kao G, 2007, CELL, V128, P577, DOI 10.1016/j.cell.2006.12.031; Kaplan DD, 2008, GENE DEV, V22, P1877, DOI 10.1101/gad.1670508; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Lee KS, 2008, NAT CELL BIOL, V10, P468, DOI 10.1038/ncb1710; LI W, 1995, CELL, V80, P553, DOI 10.1016/0092-8674(95)90509-X; McBrayer Z, 2007, DEV CELL, V13, P857, DOI 10.1016/j.devcel.2007.11.003; Mirth C, 2005, CURR BIOL, V15, P1796, DOI 10.1016/j.cub.2005.09.017; Noda M, 2004, MOL NEUROBIOL, V29, P31, DOI 10.1385/MN:29:1:31; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; RIDDIFORD LM, 1993, RECEPTOR, V3, P203; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Rybczynski R, 2001, MOL CELL ENDOCRINOL, V184, P1, DOI 10.1016/S0303-7207(01)00664-5; Shingleton AW, 2005, PLOS BIOL, V3, P1607, DOI 10.1371/journal.pbio.0030289; Simon D, 2002, HORM RES, V57, P53, DOI 10.1159/000058102; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567	29	80	82	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2009	4	4							e5072	10.1371/journal.pone.0005072	http://dx.doi.org/10.1371/journal.pone.0005072			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RT	19352497	Green Submitted, Green Published, gold			2022-12-25	WOS:000265505300010
J	Wagner, KM; Rueegg, M; Niemann, A; Suter, U				Wagner, Konstanze M.; Rueegg, Marcel; Niemann, Axel; Suter, Ueli			Targeting and Function of the Mitochondrial Fission Factor GDAP1 Are Dependent on Its Tail-Anchor	PLOS ONE			English	Article							MARIE-TOOTH-DISEASE; DIFFERENTIATION-ASSOCIATED PROTEIN-1; OUTER-MEMBRANE PROTEINS; GLUTATHIONE TRANSFERASE; PEROXISOMAL FISSION	Proteins controlling mitochondrial dynamics are often targeted to and anchored into the mitochondrial outer membrane (MOM) by their carboxyl-terminal tail-anchor domain (TA). However, it is not known whether the TA modulates protein function. GDAP1 is a mitochondrial fission factor with two neighboring hydrophobic domains each flanked by basic amino acids (aa). Here we define GDAP1 as TA MOM protein. GDAP1 carries a single transmembrane domain (TMD) that is, together with the adjacent basic aa, critical for MOM targeting. The flanking N-terminal region containing the other hydrophobic domain is located in the cytoplasm. TMD sequence, length, and high hydrophobicity do not influence GDAP1 fission function if MOM targeting is maintained. The basic aa bordering the TMD in the cytoplasm, however, are required for both targeting of GDAP1 as part of the TA and GDAP1-mediated fission. Thus, this GDAP1 region contains critical overlapping motifs defining intracellular targeting by the TA concomitant with functional aspects.	[Wagner, Konstanze M.; Rueegg, Marcel; Niemann, Axel; Suter, Ueli] ETH, Inst Cell Biol, Dept Biol, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Wagner, KM (corresponding author), ETH, Inst Cell Biol, Dept Biol, CH-8093 Zurich, Switzerland.	axel.niemann@cell.biol.ethz.ch; usuter@cell.biol.ethz.ch	Niemann, Axel/J-5245-2013; Suter, Ueli/A-1624-2010; Niemann, Axel/A-6245-2012	Niemann, Axel/0000-0002-2930-0950; 	Swiss National Science Foundation; ETH Zurich; NCCR Neural Plasticity and Repair	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich(ETH Zurich); NCCR Neural Plasticity and Repair(Swiss National Science Foundation (SNSF))	This study is supported by the Swiss National Science Foundation, the ETH Zurich, and the NCCR Neural Plasticity and Repair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell BM, 2007, J CELL SCI, V120, P1743, DOI 10.1242/jcs.002410; Borgese N, 2001, MOL BIOL CELL, V12, P2482, DOI 10.1091/mbc.12.8.2482; Borgese N, 2003, J CELL BIOL, V161, P1013, DOI 10.1083/jcb.200303069; BORGESE N, 2007, CURR OPIN CELL BIOL; Brambillasca S, 2006, J CELL BIOL, V175, P767, DOI 10.1083/jcb.200608101; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; De Brito OM, 2008, ANTIOXID REDOX SIGN, V10, P621, DOI 10.1089/ars.2007.1934; Egan B, 1999, FEBS LETT, V451, P243, DOI 10.1016/S0014-5793(99)00581-5; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Habib SJ, 2003, FEBS LETT, V555, P511, DOI 10.1016/S0014-5793(03)01325-5; Henderson MPA, 2007, METHODS, V41, P427, DOI 10.1016/j.ymeth.2006.07.004; Isenmann S, 1998, MOL BIOL CELL, V9, P1649, DOI 10.1091/mbc.9.7.1649; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Kuroda R, 1998, J BIOL CHEM, V273, P31097, DOI 10.1074/jbc.273.47.31097; Marco A, 2004, MOL BIOL EVOL, V21, P176, DOI 10.1093/molbev/msh013; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087; Niemann A, 2006, NEUROMOL MED, V8, P217, DOI 10.1385/NMM:8:1:217; Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X; Pedrola L, 2005, HUM MOL GENET, V14, P1087, DOI 10.1093/hmg/ddi121; Rojo M, 2002, J CELL SCI, V115, P1663; Setoguchi K, 2006, EMBO J, V25, P5635, DOI 10.1038/sj.emboj.7601438; Shield AJ, 2006, BIOCHEM BIOPH RES CO, V347, P859, DOI 10.1016/j.bbrc.2006.06.189; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Wattenberg B, 2001, TRAFFIC, V2, P66, DOI 10.1034/j.1600-0854.2001.20108.x; Wattenberg BW, 2007, BIOSCIENCE REP, V27, P385, DOI 10.1007/s10540-007-9061-0	28	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5160	10.1371/journal.pone.0005160	http://dx.doi.org/10.1371/journal.pone.0005160			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340293	Green Submitted, gold, Green Published			2022-12-25	WOS:000265500700029
J	Chi, MN; Chalmel, F; Agius, E; Vanzo, N; Khabar, KSA; Jegou, B; Morello, D				Chi, Mai Nguyen; Chalmel, Frederic; Agius, Eric; Vanzo, Nathalie; Khabar, Khalid S. A.; Jegou, Bernard; Morello, Dominique			Temporally Regulated Traffic of HuR and Its Associated ARE-Containing mRNAs from the Chromatoid Body to Polysomes during Mouse Spermatogenesis	PLOS ONE			English	Article							CELL NUCLEAR FACTOR; CHROMOSOME SYNAPSIS; TRANSLATIONAL REGULATION; BINDING PROTEIN; GENE-EXPRESSION; MICE DEFICIENT; P-BODIES; IDENTIFICATION; PHOSPHORYLATION; DIFFERENTIATION	Background: In mammals, a temporal disconnection between mRNA transcription and protein synthesis occurs during late steps of germ cell differentiation, in contrast to most somatic tissues where transcription and translation are closely linked. Indeed, during late stages of spermatogenesis, protein synthesis relies on the appropriate storage of translationally inactive mRNAs in transcriptionally silent spermatids. The factors and cellular compartments regulating mRNA storage and the timing of their translation are still poorly understood. The chromatoid body (CB), that shares components with the P. bodies found in somatic cells, has recently been proposed to be a site of mRNA processing. Here, we describe a new component of the CB, the RNA binding protein HuR, known in somatic cells to control the stability/translation of AU-rich containing mRNAs (ARE-mRNAs). Methodology/Principal Findings: Using a combination of cell imagery and sucrose gradient fractionation, we show that HuR localization is highly dynamic during spermatid differentiation. First, in early round spermatids, HuR colocalizes with the Mouse Vasa Homolog, MVH, a marker of the CB. As spermatids differentiate, HuR exits the CB and concomitantly associates with polysomes. Using computational analyses, we identified two testis ARE-containing mRNAs, Brd2 and GCNF that are bound by HuR and MVH. We show that these target ARE-mRNAs follow HuR trafficking, accumulating successively in the CB, where they are translationally silent, and in polysomes during spermatid differentiation. Conclusions/Significance: Our results reveal a temporal regulation of HuR trafficking together with its target mRNAs from the CB to polysomes as spermatids differentiate. They strongly suggest that through the transport of ARE-mRNAs from the CB to polysomes, HuR controls the appropriate timing of ARE-mRNA translation. HuR might represent a major post-transcriptional regulator, by promoting mRNA storage and then translation, during male germ cell differentiation.	[Chi, Mai Nguyen; Agius, Eric; Vanzo, Nathalie; Morello, Dominique] Univ Toulouse 3, CNRS, UMR5547, CBD,IFR 109, F-31062 Toulouse, France; [Chalmel, Frederic; Jegou, Bernard] Inserm, U625, Rennes, France; [Chalmel, Frederic; Jegou, Bernard] Univ Rennes 1, GERHM, IFR 140, Campus Beaulieu, F-35014 Rennes, France; [Khabar, Khalid S. A.] King Faisal Specialist Hosp & Res Ctr, Program Biomol Res, Riyadh, Saudi Arabia	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; King Faisal Specialist Hospital & Research Center	Chi, MN (corresponding author), Univ Toulouse 3, CNRS, UMR5547, CBD,IFR 109, F-31062 Toulouse, France.	morello@cict.fr	Chalmel, Frédéric/AAM-1079-2021; Jégou, Bernard/I-4742-2015; Chalmel, Frédéric/L-5360-2018; agius, Eric/AHC-9705-2022; Khabar, Khalid/AAG-3487-2019; Khabar, Khalid/A-4772-2011; Chalmel, Frederic/M-1297-2016	Chalmel, Frédéric/0000-0002-0535-3628; Chalmel, Frédéric/0000-0002-0535-3628; Khabar, Khalid/0000-0003-1003-9788; Khabar, Khalid/0000-0003-1003-9788; Agius, Eric/0000-0003-2123-9283; JEGOU, Bernard/0000-0003-0623-3609; Nguyen-Chi, Mai/0000-0003-2672-2426	ARC [3823]; ARECA network Pole proteomique et Cancer; INSERM; MRT; FRM; Universite Paul Sabatier; Universite Franco-Italienne (Leonardo da Vinci)	ARC(Australian Research Council); ARECA network Pole proteomique et Cancer; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); MRT; FRM(Fondation pour la Recherche Medicale); Universite Paul Sabatier; Universite Franco-Italienne (Leonardo da Vinci)	This work was supported by the ARC contract n 3823, ARECA network Pole proteomique et Cancer, INSERM and MRT. Mai Nguyen Chi is supported by FRM, Universite Paul Sabatier (ATUPS grant) and Universite Franco-Italienne (Leonardo da Vinci). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; BELLVE AR, 1977, J HISTOCHEM CYTOCHEM, V25, P480, DOI 10.1177/25.7.893996; Bevilacqua A, 2003, J CELL PHYSIOL, V195, P356, DOI 10.1002/jcp.10272; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Cataldo L, 1999, MOL HUM REPROD, V5, P206, DOI 10.1093/molehr/5.3.206; Chalmel F, 2007, P NATL ACAD SCI USA, V104, P8346, DOI 10.1073/pnas.0701883104; Chung ACK, 2001, MOL CELL BIOL, V21, P663, DOI 10.1128/MCB.21.2.663-677.2001; Cooney AJ, 1998, BIOCHEM BIOPH RES CO, V245, P94, DOI 10.1006/bbrc.1998.8391; Davies B, 2004, MOL CELL BIOL, V24, P8642, DOI 10.1128/MCB.24.19.8642-8648.2004; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; DOLLER A, 2008, CELL SIGNAL; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Eystathioy T, 2002, MOL BIOL CELL, V13, P1338, DOI 10.1091/mbc.01-11-0544; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Franks TM, 2007, GENE DEV, V21, P719, DOI 10.1101/gad.1494707; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Gallouzi IE, 2001, SCIENCE, V294, P1895, DOI 10.1126/science.1064693; Ganguly A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1241, DOI 10.1152/ajpendo.00344.2006; Gouble A, 2002, CANCER RES, V62, P1489; Grivna ST, 2006, P NATL ACAD SCI USA, V103, P13415, DOI 10.1073/pnas.0605506103; Halees AS, 2008, NUCLEIC ACIDS RES, V36, pD137, DOI 10.1093/nar/gkm959; Hecht NB, 1998, BIOESSAYS, V20, P555, DOI 10.1002/(SICI)1521-1878(199807)20:7<555::AID-BIES6>3.3.CO;2-J; Iguchi N, 2006, P NATL ACAD SCI USA, V103, P7712, DOI 10.1073/pnas.0510999103; Johnstone O, 2001, ANNU REV GENET, V35, P365, DOI 10.1146/annurev.genet.35.102401.090756; Khabar KSA, 2005, J INTERF CYTOK RES, V25, P1, DOI 10.1089/jir.2005.25.1; Kim HH, 2008, GENE DEV, V22, P1804, DOI 10.1101/gad.1645808; Kimura T, 2003, MOL CELL BIOL, V23, P1304, DOI 10.1128/MCB.23.4.1304-1315.2003; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Kotaja N, 2004, NAT METHODS, V1, P249, DOI 10.1038/nmeth1204-249; Kotaja N, 2007, NAT REV MOL CELL BIO, V8, P85, DOI 10.1038/nrm2081; Kotaja N, 2006, J CELL SCI, V119, P2819, DOI 10.1242/jcs.03022; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; Levadoux-Martin M, 2003, EMBO REP, V4, P394, DOI 10.1038/sj.embor.embor803; Li HW, 2002, J BIOL CHEM, V277, P44623, DOI 10.1074/jbc.M206187200; Li ZH, 2003, DEV GROWTH DIFFER, V45, P449; Lindsay EA, 1999, NATURE, V401, P379, DOI 10.1038/43900; Lykke-Andersen J, 2002, MOL CELL BIOL, V22, P8114, DOI 10.1128/MCB.22.23.8114-8121.2002; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Matsumoto K, 1999, HETEROCYCL COMMUN, V5, P19; MEISTRICH ML, 1978, FED PROC, V37, P2522; MONESI V, 1964, Arch Ital Anat Embriol, V69, P89; Oliveira-dos-Santos AJ, 2000, P NATL ACAD SCI USA, V97, P12272, DOI 10.1073/pnas.220414397; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Parvinen M, 2005, INT J ANDROL, V28, P189, DOI 10.1111/j.1365-2605.2005.00542.x; PARVINEN M, 1972, ANAT REC, V174, P435, DOI 10.1002/ar.1091740404; Pitteloud N, 2007, P NATL ACAD SCI USA, V104, P17447, DOI 10.1073/pnas.0707173104; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Salmon NA, 2006, GENESIS, V44, P515, DOI 10.1002/dvg.20241; Schmidt EE, 1999, MOL CELL BIOL, V19, P3904; Shang EY, 2004, GENE EXPR PATTERNS, V4, P513, DOI 10.1016/j.modgep.2004.03.002; Soller M, 2004, CURR BIOL, V14, pR53, DOI 10.1016/j.cub.2003.12.041; Steger K, 1999, ANAT EMBRYOL, V199, P471, DOI 10.1007/s004290050245; Styhler S, 1998, DEVELOPMENT, V125, P1569; Tanaka SS, 2000, GENE DEV, V14, P841; Wang GH, 2003, GENESIS, V36, P48, DOI 10.1002/gene.10200; Yang GY, 2003, BIOL REPROD, V68, P1620, DOI 10.1095/biolreprod.102.012013; Yoshida K, 1998, MOL CELL, V1, P707, DOI 10.1016/S1097-2765(00)80070-2; Zechel C, 2005, MOL REPROD DEV, V72, P550, DOI 10.1002/mrd.20377; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652	63	33	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e4900	10.1371/journal.pone.0004900	http://dx.doi.org/10.1371/journal.pone.0004900			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333380	Green Published, gold, Green Submitted			2022-12-25	WOS:000265499900003
J	Cho, HJ; Son, SM; Jin, SM; Hong, HS; Shin, DH; Kim, SJ; Huh, K; Mook-Jung, I				Cho, H. J.; Son, S. M.; Jin, S. M.; Hong, H. S.; Shin, D. H.; Kim, S. J.; Huh, K.; Mook-Jung, I.			RAGE regulates BACE1 and A beta generation via NFAT1 activation in Alzheimer's disease animal model	FASEB JOURNAL			English	Article						Tg2576; plaques; intracellular calcium; secretase; AGE; SH-SY5Y	GLYCATION END-PRODUCTS; AMYLOID PRECURSOR PROTEIN; CELL-SURFACE RECEPTOR; SECRETASE ACTIVITY; SOLUBLE RECEPTOR; GAMMA-SECRETASE; OXIDATIVE STRESS; NUCLEAR-FACTOR; MOUSE-BRAIN; EXPRESSION	The receptor for advanced glycation end products (RAGE) is a multiligand cell surface receptor, and amyloid beta peptide (A beta) is one of the ligands for RAGE. Because RAGE is a transporter of A beta from the blood to the brain, RAGE is believed to play an important role in Alzheimer's disease (AD) pathogenesis. In the present study, the role of RAGE in A beta production was examined in the brain tissue of an AD animal model, Tg2576 mice, as well as cultured cells. Because beta-site APP-cleaving enzyme 1 (BACE1), an essential protease for A beta production, is up-regulated in cells overexpressing RAGE and in RAGE-injected brains of Tg2576 mice, the molecular mechanisms underlying RAGE, BACE1 expression, and A beta production were examined. Because RAGE stimulates intracellular calcium, nuclear factor of activated T-cells 1 (NFAT1) was examined. NFAT1 was activated following RAGE-induced BACE1 expression followed by A beta generation. Injection of soluble RAGE (sRAGE), which acts as a competitor with full-length RAGE (fRAGE), into aged Tg2576 mouse brains reduced the levels of plaques, A beta, BACE1, and the active form of NFAT1 compared with fRAGE-injected Tg2576 mice. Taken together, RAGE stimulates functional BACE1 expression through NFAT1 activation, resulting in more A beta production and deposition in the brain.-Cho, H. J., Son, S. M., Jin, S. M., Hong, H. S., Shin, D. H., Kim, S. J., Huh, K., Mook-Jung, I. RAGE regulates BACE1 and A beta generation via NFAT1 activation in Alzheimer's disease animal model. FASEB J. 23, 2639-2649 ( 2009)	[Cho, H. J.; Son, S. M.; Jin, S. M.; Hong, H. S.; Mook-Jung, I.] Seoul Natl Univ, Coll Med, Dept Biochem & Biomed Sci, Seoul 110799, South Korea; [Shin, D. H.; Kim, S. J.] Seoul Natl Univ, Coll Med, Dept Physiol, Seoul 110799, South Korea; [Huh, K.; Mook-Jung, I.] Seoul Natl Univ, Coll Med, Hypoxia Dis Inst, Seoul 110799, South Korea; [Huh, K.] Ajou Univ, Sch Med, Grad Program Neurosci, Suwon 441749, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Ajou University	Mook-Jung, I (corresponding author), Seoul Natl Univ, Coll Med, Dept Biochem & Biomed Sci, 28 Yungun Dong, Seoul 110799, South Korea.	inhee@snu.ac.kr	Kim, Sung Joon/H-1825-2012; Mook, Inhee/J-2754-2012	Kim, Sung-Joon/0000-0002-0289-121X	21C Frontier Functional Proteomics Project [FPR08K1301-02210]; New Drug Target Discovery Project [08N4800-09610]; Aging and Apoptosis Research Center Program Project [R112002-097-08001]; Korean Research Foundation [KRF-2007-355-C00040]	21C Frontier Functional Proteomics Project(Ministry of Education, Science & Technology (MEST), Republic of Korea); New Drug Target Discovery Project; Aging and Apoptosis Research Center Program Project; Korean Research Foundation(National Research Foundation of Korea)	This work was supported by grants from the 21C Frontier Functional Proteomics Project (FPR08K1301-02210), the New Drug Target Discovery Project (08N4800-09610), the Aging and Apoptosis Research Center Program Project (R112002-097-08001), and the World Class University-Neurocytomics Program project to I. M.-J. and the Korean Research Foundation (MOEHRD; KRF-2007-355-C00040) to H.J.C.	BACHMAN DL, 1993, NEUROLOGY, V43, P515, DOI 10.1212/WNL.43.3_Part_1.515; Boo JH, 2008, BIOCHEM BIOPH RES CO, V372, P913, DOI 10.1016/j.bbrc.2008.05.153; Bourne KZ, 2007, J NEUROSCI RES, V85, P1194, DOI 10.1002/jnr.21252; Cho HJ, 2008, AGING CELL, V7, P137, DOI 10.1111/j.1474-9726.2007.00360.x; Cho HJ, 2007, GLIA, V55, P253, DOI 10.1002/glia.20451; Collison KS, 2002, J LEUKOCYTE BIOL, V71, P433; Costantini C, 2006, EMBO J, V25, P1997, DOI 10.1038/sj.emboj.7601062; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Du YS, 1997, P NATL ACAD SCI USA, V94, P11657, DOI 10.1073/pnas.94.21.11657; Emanuele E, 2005, ARCH NEUROL-CHICAGO, V62, P1734, DOI 10.1001/archneur.62.11.1734; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Fukumoto H, 2004, AM J PATHOL, V164, P719, DOI 10.1016/S0002-9440(10)63159-8; Gibson GE, 1999, ANN NY ACAD SCI, V893, P79, DOI 10.1111/j.1749-6632.1999.tb07819.x; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Goova MT, 2001, AM J PATHOL, V159, P513, DOI 10.1016/S0002-9440(10)61723-3; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Hanford LE, 2004, J BIOL CHEM, V279, P50019, DOI 10.1074/jbc.M409782200; Heine RJ, 2002, DIABETOLOGIA, V45, P461, DOI 10.1007/s00125-001-0726-0; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Jin SM, 2008, CELL DEATH DIFFER, V15, P1375, DOI 10.1038/cdd.2008.49; Jin SM, 2007, CELL DEATH DIFFER, V14, P189, DOI 10.1038/sj.cdd.4402003; JOHNSTON JA, 1994, FEBS LETT, V354, P274, DOI 10.1016/0014-5793(94)01137-0; Kume S, 2005, J BONE MINER RES, V20, P1647, DOI 10.1359/JBMR.050514; Lander HM, 1997, J BIOL CHEM, V272, P17810, DOI 10.1074/jbc.272.28.17810; Lee M, 2006, MOL CELLS, V22, P1; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Malherbe P, 1999, MOL BRAIN RES, V71, P159, DOI 10.1016/S0169-328X(99)00174-6; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; Petrova R, 2002, J MOL CELL CARDIOL, V34, P1425, DOI 10.1006/jmcc.2002.2084; Plyte S, 2001, J BIOL CHEM, V276, P14350, DOI 10.1074/jbc.M007854200; Puglielli L, 2003, NAT NEUROSCI, V6, P345, DOI 10.1038/nn0403-345; Sato Takashi, 2006, Am J Alzheimers Dis Other Demen, V21, P197; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; Selkoe DJ, 2004, NAT CELL BIOL, V6, P1054, DOI 10.1038/ncb1104-1054; Simm A, 2004, EXP GERONTOL, V39, P407, DOI 10.1016/j.exger.2003.12.006; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Takeuchi M, 2003, J NEUROPATH EXP NEUR, V62, P486, DOI 10.1093/jnen/62.5.486; Takeuchi M, 2008, CURR PHARM DESIGN, V14, P973, DOI 10.2174/138161208784139693; Takeuchi M, 2004, CURR ALZHEIMER RES, V1, P39, DOI 10.2174/1567205043480582; Thornalley PJ, 1998, CELL MOL BIOL, V44, P1013; Tyler SJ, 2002, BIOCHEM BIOPH RES CO, V299, P373, DOI 10.1016/S0006-291X(02)02635-9; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yan SD, 2000, BBA-MOL BASIS DIS, V1502, P145, DOI 10.1016/S0925-4439(00)00041-7; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Zlokovic BV, 2008, NEUROTHERAPEUTICS, V5, P409, DOI 10.1016/j.nurt.2008.05.011	52	94	99	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2639	2649		10.1096/fj.08-126383	http://dx.doi.org/10.1096/fj.08-126383			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19332646				2022-12-25	WOS:000268836700032
J	Venkatakrishnan, P; Nakayasu, ES; Almeida, IC; Miller, RT				Venkatakrishnan, Priya; Nakayasu, Ernesto S.; Almeida, Igor C.; Miller, R. Timothy			Absence of Nitric-oxide Synthase in Sequentially Purified Rat Liver Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AORTIC ENDOTHELIAL-CELLS; RELAXING FACTOR; HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; SKELETAL-MUSCLE; SMOOTH-MUSCLE; L-ARGININE; NO; PEROXYNITRITE; RESPIRATION	Data, both for and against the presence of a mitochondrial nitric-oxide synthase (NOS) isoform, is in the refereed literature. However, irrefutable evidence has not been forthcoming. In light of this controversy, we designed studies to investigate the existence of the putative mitochondrial NOS. Using repeated differential centrifugation followed by Percoll gradient fractionation, ultrapure, never frozen rat liver mitochondria and submitochondrial particles were obtained. Following trypsin digestion and desalting, the mitochondrial samples were analyzed by nano-HPLC-coupled linear ion trap-mass spectrometry. Linear ion trap-mass spectrometry analyses of rat liver mitochondria as well as submitochondrial particles were negative for any peptide from any NOS isoform. However, recombinant neuronal NOS-derived peptides from spiked mitochondrial samples were easily detected, down to 50 fmol on column. The protein calmodulin (CaM), absolutely required for NOS activity, was absent, whereas peptides from CaM-spiked samples were detected. Also, L-[C-14] arginine to L-[C-14] citrulline conversion assays were negative for NOS activity. Finally, Western blot analyses of rat liver mitochondria, using NOS(neuronal or endothelial) and CaM antibodies, were negative for any NOS isoform or CaM. In conclusion, and in light of our present limits of detection, data from carefully conducted, properly controlled experiments for NOS detection, utilizing three independent yet complementary methodologies, independently as well as collectively, refute the claim that a NOS isoform exists within rat liver mitochondria.	[Venkatakrishnan, Priya; Nakayasu, Ernesto S.; Almeida, Igor C.; Miller, R. Timothy] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA	University of Texas System; University of Texas El Paso	Miller, RT (corresponding author), 500 W Univ Ave, El Paso, TX 79968 USA.	tmiller2@utep.edu	Nakayasu, Ernesto S./AAJ-8374-2020; Almeida, Igor C./AAF-9409-2019	Nakayasu, Ernesto S./0000-0002-4056-2695; Almeida, Igor C./0000-0002-2443-8213	NIEHS [ES 011982]; NCRR [5G12RR008124]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR008124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011982] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES 011982 (to R. T. M.) from NIEHS and by Grant 5G12RR008124 from NCRR to the Border Biomedical Research Center, University of Texas, El Paso.	Bates TE, 1996, BIOCHEM BIOPH RES CO, V218, P40, DOI 10.1006/bbrc.1996.0008; BATES TE, 1995, BIOCHEM BIOPH RES CO, V213, P896, DOI 10.1006/bbrc.1995.2213; BOVERIS A, 1975, FEBS LETT, V54, P311, DOI 10.1016/0014-5793(75)80928-8; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brookes PS, 2004, MITOCHONDRION, V3, P187, DOI 10.1016/j.mito.2003.10.001; BROWN GC, 1995, NEUROSCI LETT, V193, P201, DOI 10.1016/0304-3940(95)11703-Y; Brown MR, 2006, J BIOL CHEM, V281, P11658, DOI 10.1074/jbc.M510303200; Cadenas E, 2000, FREE RADICAL RES, V33, P747, DOI 10.1080/10715760000301271; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; DIONISI O, 1975, BIOCHIM BIOPHYS ACTA, V403, P292, DOI 10.1016/0005-2744(75)90059-5; EBEL RE, 1975, FEBS LETT, V55, P198, DOI 10.1016/0014-5793(75)80991-4; Elfering SL, 2002, J BIOL CHEM, V277, P38079, DOI 10.1074/jbc.M205256200; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; FORSTERMANN U, 1991, P NATL ACAD SCI USA, V88, P1788, DOI 10.1073/pnas.88.5.1788; Frandsen U, 1996, BIOCHEM BIOPH RES CO, V227, P88, DOI 10.1006/bbrc.1996.1472; FURCHGOTT RF, 1989, FASEB J, V3, P2007, DOI 10.1096/fasebj.3.9.2545495; Ghafourifar P, 2005, METHOD ENZYMOL, V396, P424, DOI 10.1016/S0076-6879(05)96036-9; Ghafourifar P, 2002, METHOD ENZYMOL, V359, P339; Ghafourifar P, 1997, FEBS LETT, V418, P291, DOI 10.1016/S0014-5793(97)01397-5; Giulivi C, 2003, FREE RADICAL BIO MED, V34, P397, DOI 10.1016/S0891-5849(02)01298-4; Giulivi C, 1998, J BIOL CHEM, V273, P11038, DOI 10.1074/jbc.273.18.11038; HIBBS JB, 1988, BIOCHEM BIOPH RES CO, V157, P87, DOI 10.1016/S0006-291X(88)80015-9; Hotta Y, 1999, EUR J PHARMACOL, V380, P37, DOI 10.1016/S0014-2999(99)00531-2; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; IGNARRO LJ, 1988, J PHARMACOL EXP THER, V246, P218; IGNARRO LJ, 1989, FASEB J, V3, P31, DOI 10.1096/fasebj.3.1.2642868; Jachymova M, 2005, P NATL ACAD SCI USA, V102, P15833, DOI 10.1073/pnas.0506522102; Jurado JD, 2007, TOXICON, V49, P339, DOI 10.1016/j.toxicon.2006.10.004; Kanai A, 2004, AM J PHYSIOL-HEART C, V286, pH13, DOI 10.1152/ajpheart.00737.2003; Kanai AJ, 2001, P NATL ACAD SCI USA, V98, P14126, DOI 10.1073/pnas.241380298; Kennedy MC, 1997, J BIOL CHEM, V272, P20340, DOI 10.1074/jbc.272.33.20340; KNOWLES RG, 1989, P NATL ACAD SCI USA, V86, P5159, DOI 10.1073/pnas.86.13.5159; KOBZIK L, 1995, BIOCHEM BIOPH RES CO, V211, P375, DOI 10.1006/bbrc.1995.1824; Lacza Z, 2006, NITRIC OXIDE-BIOL CH, V14, P162, DOI 10.1016/j.niox.2005.05.011; Lacza Z, 2004, J NEUROCHEM, V90, P942, DOI 10.1111/j.1471-4159.2004.02553.x; Lacza Z, 2003, FREE RADICAL BIO MED, V35, P1217, DOI 10.1016/S0891-5849(03)00510-0; Lacza Z, 2001, FREE RADICAL BIO MED, V31, P1609, DOI 10.1016/S0891-5849(01)00754-7; Lopez-Figueroa MO, 2000, BIOCHEM BIOPH RES CO, V272, P129, DOI 10.1006/bbrc.2000.2748; Lopez-Figueroa MO, 2002, METHOD ENZYMOL, V352, P296; MALINSKI T, 1993, BIOCHEM BIOPH RES CO, V193, P1076, DOI 10.1006/bbrc.1993.1735; Martasek P, 1996, BIOCHEM BIOPH RES CO, V219, P359, DOI 10.1006/bbrc.1996.0238; Miller RT, 2002, CHEM RES TOXICOL, V15, P927, DOI 10.1021/tx020016y; Moncada S, 2000, Verh K Acad Geneeskd Belg, V62, P171; MURAD F, 1992, JPN J PHARM S2, V58, P150; NARAYANAN K, 1994, J MED CHEM, V37, P885, DOI 10.1021/jm00033a004; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Nishimura JS, 1999, J BIOL CHEM, V274, P5399, DOI 10.1074/jbc.274.9.5399; PERTOFT H, 1978, ANAL BIOCHEM, V88, P271, DOI 10.1016/0003-2697(78)90419-0; POLLOCK JS, 1991, P NATL ACAD SCI USA, V88, P10480, DOI 10.1073/pnas.88.23.10480; Radi R, 2002, BIOL CHEM, V383, P401, DOI 10.1515/BC.2002.044; RADI R, 1994, ARCH BIOCHEM BIOPHYS, V308, P89, DOI 10.1006/abbi.1994.1013; REINHART PH, 1982, BIOCHEM J, V204, P731, DOI 10.1042/bj2040731; Rodrigues ML, 2008, EUKARYOT CELL, V7, P58, DOI 10.1128/EC.00370-07; ROMAN LJ, 1995, P NATL ACAD SCI USA, V92, P8428, DOI 10.1073/pnas.92.18.8428; Schild L, 2003, FASEB J, V17, P2194, DOI 10.1096/fj.02-1170com; SCHMIDT K, 1994, BIOCHEM J, V301, P645, DOI 10.1042/bj3010645; SHETA EA, 1994, J BIOL CHEM, V269, P15147; SHIN WS, 1992, J BIOL CHEM, V267, P20377; Stone Kathryn L., 1996, P415, DOI 10.1007/978-1-60327-259-9_71; STUEHR DJ, 1992, ADV ENZYMOL RELAT AR, V65, P287; Tatoyan A, 1998, J BIOL CHEM, V273, P11044, DOI 10.1074/jbc.273.18.11044; Tay YMS, 2004, FREE RADICAL RES, V38, P591, DOI 10.1080/10715760410001694008; Thomas DD, 2003, ANTIOXID REDOX SIGN, V5, P307, DOI 10.1089/152308603322110887; Thomas DD, 2001, P NATL ACAD SCI USA, V98, P355, DOI 10.1073/pnas.98.1.355; Zanella B, 2002, BIOCHEM BIOPH RES CO, V290, P1010, DOI 10.1006/bbrc.2001.6284	66	47	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					19843	19855		10.1074/jbc.M109.003301	http://dx.doi.org/10.1074/jbc.M109.003301			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19372221	Green Published, hybrid			2022-12-25	WOS:000268097400011
J	Gutman, BL; Niyogi, KK				Gutman, Benjamin L.; Niyogi, Krishna K.			Evidence for Base Excision Repair of Oxidative DNA Damage in Chloroplasts of Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI ENDONUCLEASE-VIII; SUBCELLULAR-LOCALIZATION; COMPACTING PROTEIN; SULFITE REDUCTASE; SORTING SIGNALS; GLYCOSYLASE; MUTANTS; HOMOLOG; GENOME; PURIFICATION	Chloroplasts are the sites of photosynthesis in plants, and they contain their own multicopy, requisite genome. Chloroplasts are also major sites for production of reactive oxygen species, which can damage essential components of the chloroplast, including the chloroplast genome. Compared with mitochondria in animals, relatively little is known about the potential to repair oxidative DNA damage in chloroplasts. Here we provide evidence of DNA glycosylase-lyase/endonuclease activity involved in base excision repair of oxidized pyrimidines in chloroplast protein extracts of Arabidopsis thaliana. Three base excision repair components (two endonuclease III homologs and an apurinic/apyrimidinic endonuclease) that might account for this activity were identified by bioinformatics. Transient expression of protein-green fluorescent protein fusions showed that all three are targeted to the chloroplast and co-localized with chloroplast DNA in nucleoids. The glycosylase-lyase/endonuclease activity of one of the endonuclease III homologs, AtNTH2, which had not previously been characterized, was confirmed in vitro. T-DNA insertions in each of these genes were identified, and the physiological and biochemical phenotypes of the single, double, and triple mutants were analyzed. This mutant analysis revealed the presence of a third glycosylase activity and potentially another pathway for repair of oxidative DNA damage in chloroplasts.	[Gutman, Benjamin L.; Niyogi, Krishna K.] Univ Calif Berkeley, Dept Plant & Microbial Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Niyogi, KK (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Sci, 111 Koshland Hall, Berkeley, CA 94720 USA.	niyogi@nature.berkeley.edu			National Institutes of Health [R01GM071908]; United States Department of Agriculture; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071908] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM071908 from NIGMS. This work was also supported by the United States Department of Agriculture.	Abdel-Ghany SE, 2005, PLANT CELL, V17, P1233, DOI 10.1105/tpc.104.030452; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; BABIYCHUK E, 1994, P NATL ACAD SCI USA, V91, P3299, DOI 10.1073/pnas.91.8.3299; Bandaru V, 2002, DNA REPAIR, V1, P517, DOI 10.1016/S1568-7864(02)00036-8; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; BENSEN RJ, 1987, PLANT PHYSIOL, V84, P1102, DOI 10.1104/pp.84.4.1102; Cadet J, 2000, MUTAT RES-REV MUTAT, V462, P121, DOI 10.1016/S1383-5742(00)00022-3; CERUTTI H, 1992, P NATL ACAD SCI USA, V89, P8068, DOI 10.1073/pnas.89.17.8068; Chi-Ham CL, 2002, PLANT MOL BIOL, V49, P621, DOI 10.1023/A:1015500431421; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Cho HS, 2004, PLANT CELL, V16, P2665, DOI 10.1105/tpc.104.024281; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; Dizdaroglu M, 2005, MUTAT RES-FUND MOL M, V591, P45, DOI 10.1016/j.mrfmmm.2005.01.033; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Girard PM, 1997, BIOCHIMIE, V79, P559, DOI 10.1016/S0300-9084(97)82004-4; Hays JB, 2002, DNA REPAIR, V1, P579, DOI 10.1016/S1568-7864(02)00093-9; Hoffman PD, 2004, GENE DEV, V18, P2676, DOI 10.1101/gad.1217204; Huffman JL, 2005, MUTAT RES-FUND MOL M, V577, P55, DOI 10.1016/j.mrfmmm.2005.03.012; Ikeda S, 1998, J BIOL CHEM, V273, P21585, DOI 10.1074/jbc.273.34.21585; Jiang DY, 1997, J BACTERIOL, V179, P3773, DOI 10.1128/jb.179.11.3773-3782.1997; Khakhlova O, 2006, PLANT J, V46, P85, DOI 10.1111/j.1365-313X.2006.02673.x; Kliebenstein DJ, 1998, PLANT PHYSIOL, V118, P637, DOI 10.1104/pp.118.2.637; KLIMYUK VI, 1993, PLANT J, V3, P493, DOI 10.1046/j.1365-313X.1993.t01-26-00999.x; Krokan HE, 1997, BIOCHEM J, V325, P1; Li A, 2002, PLANT CELL, V14, P263, DOI 10.1105/tpc.010258; Murphy TM, 2005, PHYSIOL PLANTARUM, V123, P227, DOI 10.1111/j.1399-3054.2005.00453.x; Murphy TM, 2001, J PHOTOCH PHOTOBIO B, V61, P87, DOI 10.1016/S1011-1344(01)00172-5; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; NETRAWALI MS, 1984, ENVIRON EXP BOT, V24, P63, DOI 10.1016/0098-8472(84)90061-3; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Roldan-Arjona T, 2000, PLANT MOL BIOL, V44, P43, DOI 10.1023/A:1006429114451; Saito Y, 1997, J BACTERIOL, V179, P3783, DOI 10.1128/jb.179.11.3783-3785.1997; Sato N, 2001, FEBS LETT, V487, P347, DOI 10.1016/S0014-5793(00)02342-5; Schein AI, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.16.e82; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Stivers JT, 2003, CHEM REV, V103, P2729, DOI 10.1021/cr010219b; Sunderland PA, 2006, PLANT J, V47, P356, DOI 10.1111/j.1365-313X.2006.02791.x; Sung JS, 2006, FEBS J, V273, P1620, DOI 10.1111/j.1742-4658.2006.05192.x; TAIZ L, 1991, PLANT PHYSIOL, P111; Tell G, 2005, ANTIOXID REDOX SIGN, V7, P367, DOI 10.1089/ars.2005.7.367; Weigel D, 2002, ARABIDOPSIS LAB MANU, P217; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305	45	42	45	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17006	17012		10.1074/jbc.M109.008342	http://dx.doi.org/10.1074/jbc.M109.008342			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19372224	hybrid, Green Published			2022-12-25	WOS:000266962400038
J	Arakane, Y; Lomakin, J; Beeman, RW; Muthukrishnan, S; Gehrke, SH; Kanost, MR; Kramer, KJ				Arakane, Yasuyuki; Lomakin, Joseph; Beeman, Richard W.; Muthukrishnan, Subbaratnam; Gehrke, Stevin H.; Kanost, Michael R.; Kramer, Karl J.			Molecular and Functional Analyses of Amino Acid Decarboxylases Involved in Cuticle Tanning in Tribolium castaneum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHITIN-SYNTHASE GENES; RED FLOUR BEETLE; DOPA DECARBOXYLASE; MANDUCA-SEXTA; BETA-ALANINE; INSECT CUTICLE; ADULT DEVELOPMENT; TOBACCO HORNWORM; SCLEROTIZATION; CATECHOLAMINE	Aspartate 1-decarboxylase (ADC) and 3,4-dihydroxyphenylalanine decarboxylase (DDC) provide beta-alanine and dopamine used in insect cuticle tanning. beta-Alanine is conjugated with dopamine to yield N-beta-alanyldopamine (NBAD), a substrate for the phenol oxidase laccase that catalyzes the synthesis of cuticle protein cross-linking agents and pigment precursors. We identified ADC and DDC genes in the red flour beetle, Tribolium castaneum (Tc), and investigated their functions. TcADC mRNA was most abundant prior to the pupal-adult molt. Injection of TcADC double-stranded (ds) RNA (dsTcADC) into mature larvae resulted in depletion of NBAD in pharate adults, accumulation of dopamine, and abnormally dark pigmentation of the adult cuticle. Injection of beta-alanine, the expected product of ADC, into dsTcADC-treated pupae rescued the pigmentation phenotype, resulting in normal rust-red color. A similar pattern of catechol content consisting of elevated dopamine and depressed NBAD was observed in the genetic black mutants of Tribolium, in which levels of TcADC mRNA were drastically reduced. Furthermore, from the Tribolium black mutant and dsTcADC-injected insects both exhibited similar changes in material properties. Dynamic mechanical analysis of elytral cuticle from beetles with depleted TcADC transcripts revealed diminished cross-linking of cuticular components, further confirming the important role of oxidation products of NBAD as cross-linking agents during cuticle tanning. Injection of dsTcDDC into larvae produced a lethal pupal phenotype, and the resulting grayish pupal cuticle exhibited many small patches of black pigmentation. When dsTcDDC was injected into young pupae, the resulting adults had abnormally dark brown body color, but there was little mortality. Injection of dsTcDDC resulted in more than a 5-fold increase in levels of DOPA, indicating that lack of TcDDC led to accumulation of its substrate, DOPA.	[Arakane, Yasuyuki; Muthukrishnan, Subbaratnam; Kanost, Michael R.; Kramer, Karl J.] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA; [Lomakin, Joseph; Gehrke, Stevin H.] Univ Kansas, Dept Chem & Petr Engn, Lawrence, KS 66045 USA; [Beeman, Richard W.; Kramer, Karl J.] USDA ARS, Grain Mkt & Prod Res Ctr, Manhattan, KS 66502 USA	Kansas State University; University of Kansas; United States Department of Agriculture (USDA)	Kanost, MR (corresponding author), Kansas State Univ, Dept Biochem, 141 Chalmers Hall, Manhattan, KS 66506 USA.	kanost@ksu.edu	mo, qin/O-7877-2014; Gehrke, Stevin H/A-5265-2014	Kanost, Michael/0000-0002-6827-0061	National Science Foundation [IOS 0726425]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant IOS 0726425. This is Contribution 08-298-J from the Kansas Agricultural Experiment Station.	ANDERSEN SO, 2005, COMPREHENSIVE MOL IN, V4, P145; Andersen SO, 2007, INSECT BIOCHEM MOLEC, V37, P969, DOI 10.1016/j.ibmb.2007.05.002; Arakane Y, 2005, INSECT MOL BIOL, V14, P453, DOI 10.1111/j.1365-2583.2005.00576.x; Arakane Y, 2005, P NATL ACAD SCI USA, V102, P11337, DOI 10.1073/pnas.0504982102; Arakane Y, 2004, INSECT BIOCHEM MOLEC, V34, P291, DOI 10.1016/j.ibmb.2003.11.004; BEEMAN RW, 1990, J ECON ENTOMOL, V83, P1745, DOI 10.1093/jee/83.5.1745; BLACK BC, 1987, MOL GEN GENET, V209, P306, DOI 10.1007/BF00329658; Ferdig MT, 1996, INSECT MOL BIOL, V5, P119, DOI 10.1111/j.1365-2583.1996.tb00046.x; Ferry J.D, 1980, VISCOELASTIC PROPERT, P33; Gardel ML, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.188102; HALISCAK JP, 1983, J ECON ENTOMOL, V76, P717, DOI 10.1093/jee/76.4.717; HIRUMA K, 1995, DEV BIOL, V169, P195, DOI 10.1006/dbio.1995.1137; Hodgetts RB, 2006, ANNU REV ENTOMOL, V51, P259, DOI 10.1146/annurev.ento.51.110104.151143; HOFFMAN BD, 2005, ARXIVPHYSICS0504051V; HOPKINS TL, 1992, ANNU REV ENTOMOL, V37, P273, DOI 10.1146/annurev.en.37.010192.001421; HOPKINS TL, 1984, INSECT BIOCHEM, V14, P533, DOI 10.1016/0020-1790(84)90008-8; HOPKINS TL, 1982, SCIENCE, V217, P364, DOI 10.1126/science.217.4557.364; Huang CY, 2005, INSECT MOL BIOL, V14, P237, DOI 10.1111/j.1365-2583.2004.00552.x; Koenderink GH, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysLettRev.96.138307; Kong HJ, 2003, MACROMOLECULES, V36, P4582, DOI 10.1021/ma034137w; Kramer KJ, 2001, TETRAHEDRON, V57, P385, DOI 10.1016/S0040-4020(00)00949-2; KRAMER KJ, 1984, INSECT BIOCHEM, V14, P293, DOI 10.1016/0020-1790(84)90063-5; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lorenzen MD, 2002, GENETICS, V160, P225; MARSH JL, 1986, GENETICS, V112, P249; MENARD KP, 1999, DYNAMIC MECH ANAL PR, P84; MORGAN TD, 1987, INSECT BIOCHEM, V17, P255, DOI 10.1016/0020-1790(87)90066-7; Phillips AM, 2005, GENE, V351, P131, DOI 10.1016/j.gene.2005.03.013; ROSELAND CR, 1987, INSECT BIOCHEM, V17, P21, DOI 10.1016/0020-1790(87)90139-9; SOKOLOFF A, 1977, BIOL TRIBOLIUM, V3, P96; SOKOLOFF ALEXANDER, 1960, JOUR HEREDITY, V51, P131; THOMAS BR, 1989, INSECT BIOCHEM, V19, P611, DOI 10.1016/0020-1790(89)90095-4; Tomoyasu Y, 2004, DEV GENES EVOL, V214, P575, DOI 10.1007/s00427-004-0434-0; UJVARY I, 1987, INSECT BIOCHEM, V17, P389, DOI 10.1016/0020-1790(87)90001-1	34	143	154	6	53	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16584	16594		10.1074/jbc.M901629200	http://dx.doi.org/10.1074/jbc.M901629200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19366687	Green Published, hybrid			2022-12-25	WOS:000266730900055
J	du Plessis, DJF; Berrelkamp, G; Nouwen, N; Driessen, AJM				du Plessis, David J. F.; Berrelkamp, Greetje; Nouwen, Nico; Driessen, Arnold J. M.			The Lateral Gate of SecYEG Opens during Protein Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL CYTOPLASMIC MEMBRANE; ESCHERICHIA-COLI; CONDUCTING CHANNEL; PREPROTEIN TRANSLOCATION; CROSS-LINKING; CATALYTIC CYCLE; SECA PROTEIN; ATPASE; COMPLEX; OMPT	The SecYEG translocon of Escherichia coli mediates the translocation of preproteins across the cytoplasmic membrane. Here, we have examined the role of the proposed lateral gate of the translocon in translocation. A dual cysteine cross-linking approach allowed the introduction of cross-linker arms of various lengths between adjoining aminoacyl positions of transmembrane segments 2b and 7 of the lateral gate. Oxidation and short spacer linkers that fix the gate in the closed state abolished preprotein translocation, whereas long spacer linkers support translocation. The cross-linking data further suggests that SecYEG lateral gate opening and activation of the SecA ATPase are coupled processes. It is concluded that lateral gate opening is a critical step during SecA-dependent protein translocation.	[du Plessis, David J. F.; Berrelkamp, Greetje; Nouwen, Nico; Driessen, Arnold J. M.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Microbiol, NL-9751 NN Haren, Netherlands	University of Groningen	Driessen, AJM (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Microbiol, NL-9751 NN Haren, Netherlands.	a.j.m.driessen@rug.nl	Driessen, Arnold J.M./D-1876-2012	Driessen, Arnold J.M./0000-0001-9258-9104	Netherlands Royal Academy of Sciences (KNAW); NanoNed; Dutch Ministry of Economic Affairs; Netherlands Foundation for Scientific Research, Chemical Sciences	Netherlands Royal Academy of Sciences (KNAW); NanoNed; Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Netherlands Foundation for Scientific Research, Chemical Sciences(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Royal Academy of Sciences (KNAW), NanoNed, a national nanotechnology program coordinated by the Dutch Ministry of Economic Affairs, and the Netherlands Foundation for Scientific Research, Chemical Sciences.	AKIYAMA Y, 1990, BIOCHEM BIOPH RES CO, V167, P711, DOI 10.1016/0006-291X(90)92083-C; ARKOWITZ RA, 1993, EMBO J, V12, P243, DOI 10.1002/j.1460-2075.1993.tb05650.x; BANEYX F, 1990, J BACTERIOL, V172, P491, DOI 10.1128/JB.172.1.491-494.1990; Bol R, 2007, J BIOL CHEM, V282, P29785, DOI 10.1074/jbc.M702140200; BRUNDAGE L, 1990, CELL, V62, P649, DOI 10.1016/0092-8674(90)90111-Q; CABELLI RJ, 1988, CELL, V55, P683, DOI 10.1016/0092-8674(88)90227-9; CHEN LL, 1991, J BIOL CHEM, V266, P18237; de Keyzer J, 2002, J BIOL CHEM, V277, P46059, DOI 10.1074/jbc.M208449200; DRIESSEN AJM, 1992, EMBO J, V11, P847, DOI 10.1002/j.1460-2075.1992.tb05122.x; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Economou A, 1995, CELL, V83, P1171, DOI 10.1016/0092-8674(95)90143-4; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Erlandson KJ, 2008, NATURE, V455, P984, DOI 10.1038/nature07439; Fekkes P, 1999, MICROBIOL MOL BIOL R, V63, P161, DOI 10.1128/MMBR.63.1.161-173.1999; Gumbart J, 2007, BIOCHEMISTRY-US, V46, P11147, DOI 10.1021/bi700835d; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; JOLY JC, 1993, EMBO J, V12, P255, DOI 10.1002/j.1460-2075.1993.tb05651.x; KIM JS, 1995, ANAL BIOCHEM, V225, P174, DOI 10.1006/abio.1995.1131; KORADI R, 1996, J MOL GRAPHICS, V14, P32; KOSOWER NS, 1987, METHOD ENZYMOL, V143, P76; KOSOWER NS, 1980, BIOCHIM BIOPHYS ACTA, V622, P201, DOI 10.1016/0005-2795(80)90031-8; Kramer RA, 2000, FEBS LETT, V468, P220, DOI 10.1016/S0014-5793(00)01231-X; LILL R, 1989, EMBO J, V8, P961, DOI 10.1002/j.1460-2075.1989.tb03458.x; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Mitra K, 2006, FEBS LETT, V580, P3353, DOI 10.1016/j.febslet.2006.05.019; Mitra K, 2006, NAT STRUCT MOL BIOL, V13, P957, DOI 10.1038/nsmb1166; Nomen N, 2007, J MOL BIOL, V372, P422, DOI 10.1016/j.jmb.2007.07.003; Nouwen N, 2001, FEBS LETT, V508, P103, DOI 10.1016/S0014-5793(01)03033-2; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Plath K, 2004, MOL BIOL CELL, V15, P1, DOI 10.1091/mbc.E03-06-0390; Pohlschroder M, 1997, CELL, V91, P563, DOI 10.1016/S0092-8674(00)80443-2; RANDALL LL, 1983, CELL, V33, P231, DOI 10.1016/0092-8674(83)90352-5; Scheuring J, 2005, J MOL BIOL, V354, P258, DOI 10.1016/j.jmb.2005.09.058; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; Tomkiewicz D, 2006, J BIOL CHEM, V281, P15709, DOI 10.1074/jbc.M600205200; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van der Does C, 2003, METHOD ENZYMOL, V372, P86; van der Sluis EO, 2002, FEBS LETT, V527, P159, DOI 10.1016/S0014-5793(02)03202-7; van der Wolk JPW, 1997, EMBO J, V16, P7297, DOI 10.1093/emboj/16.24.7297; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	42	72	74	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15805	15814		10.1074/jbc.M901855200	http://dx.doi.org/10.1074/jbc.M901855200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19366685	hybrid, Green Published			2022-12-25	WOS:000266501000049
J	Pouget, P; Wattiez, N; Rivaud-Pechoux, S; Gaymard, B				Pouget, Pierre; Wattiez, Nicolas; Rivaud-Pechoux, Sophie; Gaymard, Bertrand			A Fragile Balance: Perturbation of GABA Mediated Circuit in Prefrontal Cortex Generates High Intraindividual Performance Variability	PLOS ONE			English	Article							NEURONAL-ACTIVITY; EYE-MOVEMENTS; MONKEYS; INVOLVEMENT; INHIBITION; DEFICIT	High intraindividual performance variability is one of the most robust findings to emerge in cognitive-experimental research of attention deficit hyperactivity disorder (ADHD). Evidences from studies incorporating structural or functional human brain mapping methods indicate that this increased intraindividual variability is not simply a sequel of general brain dysfunction, but is likely related to the functioning of neural circuits that engage the prefrontal cortex, particularly the dorsolateral areas (dlPFC). In order to examine further the anatomical and pharmacological substrate responsible for this high intraindividual variability disorder, we injected GABA(A) antagonist (bicuculline) or GABA(A) agonist (muscimol) in the dlPFC of monkeys performing a reflexive oculomotor task. Here we show that, whereas GABA(A) agonist injection induced no or minimal impairments, injection of GABA(A) antagonist dramatically increased the intraindividual variability of saccade response time and of saccade spatial accuracy (amplitude and direction). Overall, this study demonstrates that the balance between excitatory/inhibitory activities in the dlPFC is fragile but crucial, since local micro-injection of GABA(A) antagonist can induce marked behavioural effects. It also reveals that higher cognitive areas such as the dlPFC are markedly capable to influence the productions and metrics of reflexive movements. Altogether, this study provides promising perspectives for the development of new therapeutic strategies for the treatment of diseases in which high intravariability disorders are a prominent feature.			Pouget, P (corresponding author), Hop La Pitie Salpetriere, INSERM, U975, Paris, France.	pierre.pouget@upmc.fr	Pouget, Pierre/N-8031-2019	Pouget, Pierre/0000-0002-4721-7376				Bellgrove MA, 2004, NEUROPSYCHOLOGIA, V42, P1910, DOI 10.1016/j.neuropsychologia.2004.05.007; BOCH RA, 1989, J NEUROPHYSIOL, V61, P1064, DOI 10.1152/jn.1989.61.5.1064; Castellanos FX, 2006, TRENDS COGN SCI, V10, P117, DOI 10.1016/j.tics.2006.01.011; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; Condy C, 2007, CEREB CORTEX, V17, P221, DOI 10.1093/cercor/bhj140; Constantinidis C, 2002, NAT NEUROSCI, V5, P175, DOI 10.1038/nn799; Di Martino A, 2008, BIOL PSYCHIAT, V64, P607, DOI 10.1016/j.biopsych.2008.03.008; FUNAHASHI S, 1991, J NEUROPHYSIOL, V65, P1464, DOI 10.1152/jn.1991.65.6.1464; Iba M, 2003, J NEUROPHYSIOL, V89, P587, DOI 10.1152/jn.00148.2002; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Leventhal AG, 2003, SCIENCE, V300, P812, DOI 10.1126/science.1082874; Mansouri FA, 2007, SCIENCE, V318, P987, DOI 10.1126/science.1146384; SAWAGUCHI T, 1988, BEHAV BRAIN RES, V31, P193, DOI 10.1016/0166-4328(88)90023-X; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; Sawaguchi T, 2001, NEUROSCI RES, V39, P123, DOI 10.1016/S0168-0102(00)00204-2; SCHILLER PH, 2003, PROG BRAIN RES, V149, P157; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Stuss DT, 2003, BRAIN, V126, P2363, DOI 10.1093/brain/awg237; Wardak C, 2006, J NEUROSCI, V26, P4228, DOI 10.1523/JNEUROSCI.3336-05.2006; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727	20	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2009	4	4							e5208	10.1371/journal.pone.0005208	http://dx.doi.org/10.1371/journal.pone.0005208			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VA	19381296	Green Published, Green Submitted, gold			2022-12-25	WOS:000265513800003
J	Sakamoto, K; Onimaru, K; Munakata, K; Suda, N; Tamura, M; Ochi, H; Tanaka, M				Sakamoto, Koji; Onimaru, Koh; Munakata, Keijiro; Suda, Natsuno; Tamura, Mika; Ochi, Haruki; Tanaka, Mikiko			Heterochronic Shift in Hox-Mediated Activation of Sonic hedgehog Leads to Morphological Changes during Fin Development	PLOS ONE			English	Article								We explored the molecular mechanisms of morphological transformations of vertebrate paired fin/limb evolution by comparative gene expression profiling and functional analyses. In this study, we focused on the temporal differences of the onset of Sonic hedgehog (Shh) expression in paired appendages among different vertebrates. In limb buds of chick and mouse, Shh expression is activated as soon as there is a morphological bud, concomitant with Hoxd10 expression. In dogfish (Scyliorhinus canicula), however, we found that Shh was transcribed late in fin development, concomitant with Hoxd13 expression. We utilized zebrafish as a model to determine whether quantitative changes in hox expression alter the timing of shh expression in pectoral fins of zebrafish embryos. We found that the temporal shift of Shh activity altered the size of endoskeletal elements in paired fins of zebrafish and dogfish. Thus, a threshold level of hox expression determines the onset of shh expression, and the subsequent heterochronic shift of Shh activity can affect the size of the fin endoskeleton. This process may have facilitated major morphological changes in paired appendages during vertebrate limb evolution.			Sakamoto, K (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Nagatsuta Cho, Yokohama, Kanagawa, Japan.	mitanaka@bio.titech.ac.jp	Onimaru, Koh/K-5289-2014; Tanaka, Mikiko/B-9329-2015; Ochi, Haruki/AAR-7235-2020; Onimaru, Koh/AAB-4923-2019; Tanaka, Mikiko/X-1904-2019	Onimaru, Koh/0000-0002-2428-9510; Tanaka, Mikiko/0000-0001-8092-8594; Ochi, Haruki/0000-0002-0088-581X; Tanaka, Mikiko/0000-0001-8092-8594				Burglin TR, 1997, NUCLEIC ACIDS RES, V25, P4173, DOI 10.1093/nar/25.21.4173; Buscher D, 1997, MECH DEVELOP, V62, P175, DOI 10.1016/S0925-4773(97)00656-4; Capellini TD, 2006, DEVELOPMENT, V133, P2263, DOI 10.1242/dev.02395; Charite J, 2000, DEVELOPMENT, V127, P2461; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen YT, 2004, DEVELOPMENT, V131, P2339, DOI 10.1242/dev.01115; COATES M, 1993, NATURE, V364, P195, DOI 10.1038/364195b0; Covassin L, 2006, DEV BIOL, V299, P551, DOI 10.1016/j.ydbio.2006.08.020; Crossley PH, 1996, CELL, V84, P127, DOI 10.1016/S0092-8674(00)80999-X; Dahn RD, 2007, NATURE, V445, P311, DOI 10.1038/nature05436; Davis MC, 2007, NATURE, V447, P473, DOI 10.1038/nature05838; DOLLE P, 1989, NATURE, V342, P767, DOI 10.1038/342767a0; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Freitas R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000754; Gibert Y, 2006, DEVELOPMENT, V133, P2649, DOI 10.1242/dev.02438; Gould A, 1998, NEURON, V21, P39, DOI 10.1016/S0896-6273(00)80513-9; Grandel H, 1998, MECH DEVELOP, V79, P99, DOI 10.1016/S0925-4773(98)00176-2; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Horigome N, 1999, DEV BIOL, V207, P287, DOI 10.1006/dbio.1998.9175; Huang D, 1998, DEVELOPMENT, V125, P3235; Kimmel CB, 1998, DEV BIOL, V203, P245, DOI 10.1006/dbio.1998.9016; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kmita M, 2005, NATURE, V435, P1113, DOI 10.1038/nature03648; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; Maruoka Y, 1998, MECH DEVELOP, V74, P175, DOI 10.1016/S0925-4773(98)00061-6; Neumann CJ, 1999, DEVELOPMENT, V126, P4817; Niederreither K, 2002, DEVELOPMENT, V129, P3563; NISWANDER L, 1993, CELL, V75, P579, DOI 10.1016/0092-8674(93)90391-3; NISWANDER L, 1992, DEVELOPMENT, V114, P755; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Saunders J. W., 1968, EPITHELIAL MESENCHYM, P78; Scherz PJ, 2007, DEV BIOL, V308, P343, DOI 10.1016/j.ydbio.2007.05.030; Serpente P, 2005, DEVELOPMENT, V132, P503, DOI 10.1242/dev.01593; SIMEONE A, 1990, NATURE, V346, P763, DOI 10.1038/346763a0; SORDINO P, 1995, NATURE, V375, P678, DOI 10.1038/375678a0; Summerbell D., 1991, DEV PATTERNING VERTE; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; Tanaka M, 2002, NATURE, V416, P527, DOI 10.1038/416527a; Tarchini B, 2006, NATURE, V443, P985, DOI 10.1038/nature05247; Thisse B, 2004, METHOD CELL BIOL, V77, P505; THOROGOOD P, 1993, NATURE, V364, P196, DOI 10.1038/364196a0; TICKLE C, 1981, NATURE, V289, P295, DOI 10.1038/289295a0; TICKLE C, 1975, NATURE, V254, P199, DOI 10.1038/254199a0; Towers M, 2008, NATURE, V452, P882, DOI 10.1038/nature06718; Waskiewicz AJ, 2002, DEV CELL, V3, P723, DOI 10.1016/S1534-5807(02)00319-2; Welscher PT, 2002, GENE DEV, V16, P421, DOI 10.1101/gad.219202; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; Yang Y, 1997, DEVELOPMENT, V124, P4393; Zakany J, 2004, SCIENCE, V304, P1669, DOI 10.1126/science.1096049; Zhu JJ, 2008, DEV CELL, V14, P624, DOI 10.1016/j.devcel.2008.01.008; Zuniga A, 1999, DEVELOPMENT, V126, P13	53	50	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5121	10.1371/journal.pone.0005121	http://dx.doi.org/10.1371/journal.pone.0005121			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TN	19365553	Green Published, gold, Green Submitted			2022-12-25	WOS:000265509900001
J	di Tomaso, E; London, N; Fuja, D; Logie, J; Tyrrell, JA; Kamoun, W; Munn, LL; Jain, RK				di Tomaso, Emmanuelle; London, Nyall; Fuja, Daniel; Logie, James; Tyrrell, James A.; Kamoun, Walid; Munn, Lance L.; Jain, Rakesh K.			PDGF-C Induces Maturation of Blood Vessels in a Model of Glioblastoma and Attenuates the Response to Anti-VEGF Treatment	PLOS ONE			English	Article							PROTEASE-ACTIVATED LIGAND; GROWTH-FACTOR; KINASE INHIBITOR; RECEPTOR; EXPRESSION; BETA; CELL; CANCER; ANGIOGENESIS; VASCULATURE	Background: Recent clinical trials of VEGF inhibitors have shown promise in the treatment of recurrent glioblastomas (GBM). However, the survival benefit is usually short-lived as tumors escape anti-VEGF therapies. Here we tested the hypothesis that Platelet Derived Growth Factor-C (PDGF-C), an isoform of the PDGF family, affects GBM progression independent of VEGF pathway and hinders anti-VEGF therapy. Principal Findings: We first showed that PDGF-C is present in human GBMs. Then, we overexpressed or downregulated PDGF-C in a human GBM cell line, U87MG, and grew them in cranial windows in nude mice to assess vessel structure and function using intravital microscopy. PDGF-C overexpressing tumors had smaller vessel diameters and lower vascular permeability compared to the parental or siRNA-transfected tumors. Furthermore, vessels in PDGF-C overexpressing tumors had more extensive coverage with NG2 positive perivascular cells and a thicker collagen IV basement membrane than the controls. Treatment with DC101, an anti-VEGFR-2 antibody, induced decreases in vessel density in the parental tumors, but had no effect on the PDGF-C overexpressing tumors. Conclusion: These results suggest that PDGF-C plays an important role in glioma vessel maturation and stabilization, and that it can attenuate the response to anti-VEGF therapy, potentially contributing to escape from vascular normalization.			di Tomaso, E (corresponding author), Massachusetts Gen Hosp, Dept Radiat Oncol, EL Steele Lab Tumor Biol, Boston, MA 02114 USA.	munn@steele.mgh.harvard.edu; jain@steele.mgh.harvard.edu	Jain, Rakesh K/I-1384-2017; Tyrrell, James/A-6359-2010; Munn, Lance L/L-3950-2016	Jain, Rakesh K/0000-0001-7571-3548; Munn, Lance L/0000-0003-0698-7232; Fuja, Daniel/0000-0002-9351-7580	NCI NIH HHS [P01 CA080124, P01-CA80124] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA080124] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderberg C, 2009, CANCER RES, V69, P369, DOI 10.1158/0008-5472.CAN-08-2724; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bergsten E, 2001, NAT CELL BIOL, V3, P512, DOI 10.1038/35074588; Bhardwaj B, 1996, CLIN CANCER RES, V2, P773; Black P, 1996, PEDIATR NEUROSURG, V24, P74, DOI 10.1159/000121020; Campbell JS, 2007, DIFFERENTIATION, V75, P843, DOI 10.1111/j.1432-0436.2007.00235.x; Cao RH, 2002, FASEB J, V16, P1575, DOI 10.1096/fj.02-0319com; Cloughesy TF, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.2010b; Crawford Y, 2009, CANCER CELL, V15, P21, DOI 10.1016/j.ccr.2008.12.004; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; di Tomaso E, 2005, CANCER RES, V65, P5740, DOI 10.1158/0008-5472.CAN-04-4552; Eitner F, 2008, J AM SOC NEPHROL, V19, P281, DOI 10.1681/ASN.2007030290; FRAIZER GE, 1987, J CELL PHYSIOL, V133, P169, DOI 10.1002/jcp.1041330122; FUNA K, 1990, CANCER RES, V50, P748; George D, 2003, ADV EXP MED BIOL, V532, P141; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Gerstner ER, 2007, EXPERT OPIN INV DRUG, V16, P1895, DOI 10.1517/13543784.16.12.1895; Gordon GJ, 2005, AM J PATHOL, V166, P1827, DOI 10.1016/S0002-9440(10)62492-3; Hagendoorn J, 2006, CANCER RES, V66, P3360, DOI 10.1158/0008-5472.CAN-05-2655; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; HERMANSSON M, 1988, P NATL ACAD SCI USA, V85, P7748, DOI 10.1073/pnas.85.20.7748; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jain RK, 2008, PLOS MED, V5, P20, DOI 10.1371/journal.pmed.0050024; Jain RK, 2002, NAT REV CANCER, V2, P266, DOI 10.1038/nrc778; Jayson GC, 2005, J CLIN ONCOL, V23, P973, DOI 10.1200/JCO.2005.01.032; KAMOUN W, JCO IN PRESS; KAPLAN DR, 1979, BLOOD, V53, P1043; Kawai T, 1997, LAB INVEST, V77, P431; Kilic T, 2000, CANCER RES, V60, P5143; LaRochelle WJ, 2001, NAT CELL BIOL, V3, P517, DOI 10.1038/35074593; Li J, 2001, NEUROLOGY, V56, P885, DOI 10.1212/WNL.56.7.885; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; Li XR, 2003, CYTOKINE GROWTH F R, V14, P91, DOI 10.1016/S1359-6101(02)00090-4; Lokker NA, 2002, CANCER RES, V62, P3729; Shimizu F, 2008, J CELL PHYSIOL, V217, P388, DOI 10.1002/jcp.21508; Su EJ, 2008, NAT MED, V14, P731, DOI 10.1038/nm1787; Sundberg C, 1997, AM J PATHOL, V151, P479; Tejada ML, 2006, CLIN CANCER RES, V12, P2676, DOI 10.1158/1078-0432.CCR-05-1770; Tyrrell JA, 2007, IEEE T MED IMAGING, V26, P223, DOI 10.1109/TMI.2006.889722; Vredenburgh JJ, 2007, J CLIN ONCOL, V25, P4722, DOI 10.1200/JCO.2007.12.2440; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; YUAN F, 1994, CANCER RES, V54, P4564	43	91	92	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5123	10.1371/journal.pone.0005123	http://dx.doi.org/10.1371/journal.pone.0005123			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19352490	gold, Green Published, Green Submitted			2022-12-25	WOS:000265505700019
J	Newhouse, S; Farrall, M; Wallace, C; Hoti, M; Burke, B; Howard, P; Onipinla, A; Lee, K; Shaw-Hawkins, S; Dobson, R; Brown, M; Samani, NJ; Dominiczak, AF; Connell, JM; Lathrop, GM; Kooner, J; Chambers, J; Elliott, P; Clarke, R; Collins, R; Laan, M; Org, E; Juhanson, P; Veldre, G; Viigimaa, M; Eyheramendy, S; Cappuccio, FP; Ji, C; Iacone, R; Strazzullo, P; Kumari, M; Marmot, M; Brunner, E; Caulfield, M; Munroe, PB				Newhouse, Stephen; Farrall, Martin; Wallace, Chris; Hoti, Mimoza; Burke, Beverley; Howard, Philip; Onipinla, Abiodun; Lee, Kate; Shaw-Hawkins, Sue; Dobson, Richard; Brown, Morris; Samani, Nilesh J.; Dominiczak, Anna F.; Connell, John M.; Lathrop, G. Mark; Kooner, Jaspal; Chambers, John; Elliott, Paul; Clarke, Robert; Collins, Rory; Laan, Maris; Org, Elin; Juhanson, Peeter; Veldre, Gudrun; Viigimaa, Margus; Eyheramendy, Susana; Cappuccio, Francesco P.; Ji, Chen; Iacone, Roberto; Strazzullo, Pasquale; Kumari, Meena; Marmot, Michael; Brunner, Eric; Caulfield, Mark; Munroe, Patricia B.			Polymorphisms in the WNK1 Gene Are Associated with Blood Pressure Variation and Urinary Potassium Excretion	PLOS ONE			English	Article								WNK1-a serine/threonine kinase involved in electrolyte homeostasis and blood pressure (BP) control-is an excellent candidate gene for essential hypertension (EH). We and others have previously reported association between WNK1 and BP variation. Using tag SNPs (tSNPs) that capture 100% of common WNK1 variation in HapMap, we aimed to replicate our findings with BP and to test for association with phenotypes relating to WNK1 function in the British Genetics of Hypertension (BRIGHT) study case-control resource (1700 hypertensive cases and 1700 normotensive controls). We found multiple variants to be associated with systolic blood pressure, SBP (7/28 tSNPs min-p = 0.0005), diastolic blood pressure, DBP (7/28 tSNPs min-p = 0.002) and 24 hour urinary potassium excretion (10/28 tSNPs min-p = 0.0004). Associations with SBP and urine potassium remained significant after correction for multiple testing (p = 0.02 and p = 0.01 respectively). The major allele (A) of rs765250, located in intron 1, demonstrated the strongest evidence for association with SBP, effect size 3.14 mmHg (95% CI: 1.23-4.9), DBP 1.9 mmHg (95% CI: 0.7-3.2) and hypertension, odds ratio (OR: 1.3 [95% CI: 1.0-1.7]). We genotyped this variant in six independent populations (n = 14,451) and replicated the association between rs765250 and SBP in a meta-analysis (p = 7 x 10(-3), combined with BRIGHT data-set p = 2 x 10(-4), n = 17,851). The associations of WNK1 with DBP and EH were not confirmed. Haplotype analysis revealed striking associations with hypertension and BP variation (global permutation p<10(-7)). We identified several common haplotypes to be associated with increased BP and multiple low frequency haplotypes significantly associated with lower BP (>10 mmHg reduction) and risk for hypertension (OR<0.60). Our data indicates that multiple rare and common WNK1 variants contribute to BP variation and hypertension, and provide compelling evidence to initiate further genetic and functional studies to explore the role of WNK1 in BP regulation and EH.	[Newhouse, Stephen; Wallace, Chris; Hoti, Mimoza; Burke, Beverley; Howard, Philip; Onipinla, Abiodun; Lee, Kate; Shaw-Hawkins, Sue; Dobson, Richard; Caulfield, Mark; Munroe, Patricia B.] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, Clin Pharmacol & Barts & London Genome Ctr, London, England; [Farrall, Martin] Univ Oxford, Wellcome Trust Ctr Human Genet, Dept Cardiovasc Med, Oxford OX1 2JD, England; [Brown, Morris] Univ Cambridge, Addenbrooke Hosp, Cambridge Inst Med Res, Cambridge CB2 1TN, England; [Samani, Nilesh J.] Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester LE1 7RH, Leics, England; [Dominiczak, Anna F.; Connell, John M.] Univ Glasgow, Western Infirmary, BHF Glasgow Cardiovasc Res Ctr, Div Cardiovas & Med Sci, Glasgow G12 8QQ, Lanark, Scotland; [Lathrop, G. Mark] Ctr Natl Genotypage, Evry, France; [Kooner, Jaspal; Chambers, John; Elliott, Paul] Imperial Coll London, Natl Heart & Lung Inst, Fac Med, London, England; [Clarke, Robert; Collins, Rory] Univ Oxford, Clin Trial Serv Unit, Epidemiol Studies Unit, Oxford OX1 2JD, England; [Laan, Maris; Org, Elin; Juhanson, Peeter] Univ Tartu, Inst Mol & Cell Biol, Tartu, Estonia; [Veldre, Gudrun] Univ Tartu, Inst Mol & Cell Biol, Dept Cardiol, Tartu, Estonia; [Veldre, Gudrun; Viigimaa, Margus] N Estonia Med Ctr, Ctr Cardiol, Tallinn, Estonia; [Eyheramendy, Susana] Pontificia Univ Catolica Chile, Dept Stat, Santiago, Chile; [Cappuccio, Francesco P.; Ji, Chen] Clin Sci Res Inst, Warwick Med Sch, Coventry, W Midlands, England; [Iacone, Roberto; Strazzullo, Pasquale] Federico II Univ Naples, Sch Med, Dept Clin & Expt Med, Naples, Italy; [Kumari, Meena; Marmot, Michael; Brunner, Eric] UCL, Dept Epidemiol & Publ Hlth, London, England	University of London; Queen Mary University London; University of Oxford; Wellcome Centre for Human Genetics; University of Cambridge; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Glasgow; CEA; UDICE-French Research Universities; Universite Paris Saclay; Imperial College London; University of Oxford; University of Tartu; University of Tartu; Pontificia Universidad Catolica de Chile; University of Warwick; University of Naples Federico II; University of London; University College London	Newhouse, S (corresponding author), Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, Clin Pharmacol & Barts & London Genome Ctr, London, England.	p.b.munroe@qmul.ac.uk	Viigimaa, Margus/AAX-3864-2020; Brunner, Eric/H-2114-2011; Org, Elin/AAJ-9631-2021; Marmot, M G/Y-3920-2019; Newhouse, Stephen J/C-9330-2011; Iacone, Roberto/M-2867-2016; Dominiczak, Anna F/D-2262-2009; Dominiczak, Anna F/P-9390-2017; Laan, Maris/A-4100-2011; Dobson, Richard j/C-9269-2011	Brunner, Eric/0000-0002-0595-4474; Marmot, M G/0000-0002-2431-6419; Newhouse, Stephen J/0000-0002-1843-9842; Iacone, Roberto/0000-0003-3360-3855; Dominiczak, Anna F/0000-0003-4913-3608; Laan, Maris/0000-0002-8519-243X; Dobson, Richard j/0000-0003-4224-9245; Eyheramendy, Susana/0000-0003-4723-9660; Munroe, Patricia/0000-0002-4176-2947; Kumari, Meena/0000-0001-9716-1035; Caulfield, Mark/0000-0001-9295-3594; Org, Elin/0000-0001-8688-9717; Org, Elin/0000-0003-1451-9375; Lee, Kathryn/0000-0001-6848-4767; Elliott, Paul/0000-0002-7511-5684; Burke, Beverley/0000-0002-4164-297X; Ji, Chen/0000-0003-4919-3299; Wallace, Chris/0000-0001-9755-1703; Viigimaa, Margus/0000-0001-5575-5978	Wellcome Trust International Senior Research Fellowship [070191/Z/03/Z]; Estonian Ministry of Education and Science [0182721s06]; Medical Research Council of Great Britain [G9521010D]; British Heart Foundation [PG02/128, FS/05/061/19501]; The William Harvey Research Foundation; Economic and Social Research Council; Health and Safety Executive; National Heart Lung and Blood Institute, US, NIH [HL36310]; National Institute on Aging, US, NIH [AG13196, AG1764406S1]; Agency for Health Care Policy Research [HS06516]; John D and Catherine T MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health; Department of Health; MRC [G0400874, G9521010, MC_U137686857] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Medical Research Council [G0100222, G9817803B, G8802774, G9521010, G0400874, MC_U137686857, G19/35] Funding Source: researchfish; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS006516] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017644, R37AG013196, R01AG013196] Funding Source: NIH RePORTER	Wellcome Trust International Senior Research Fellowship(Wellcome Trust); Estonian Ministry of Education and Science(Ministry of Education and Research, Estonia); Medical Research Council of Great Britain(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); The William Harvey Research Foundation; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Health and Safety Executive; National Heart Lung and Blood Institute, US, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging, US, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Agency for Health Care Policy Research(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); John D and Catherine T MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health; Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The HYPEST sample collection was financed by Wellcome Trust International Senior Research Fellowship to Maris Laan (grant no. 070191/Z/03/Z) in Biomedical Science in Central Europe and by Estonian Ministry of Education and Science core grant no. 0182721s06. The BRIGHT study and current work are supported by the Medical Research Council of Great Britain (grant number; G9521010D) and the British Heart Foundation (grant number PG02/128). CW is funded by the British Heart Foundation (grant number: FS/05/061/19501). SJN is funded by the Medical Research Council and The William Harvey Research Foundation. Profs Dominiczak and Samani are British Heart Foundation Chairholders. The LOLIPOP Study was funded by the British Heart Foundation. The Whitehall II study has been supported by grants from the Medical Research Council; Economic and Social Research Council; British Heart Foundation; Health and Safety Executive; Department of Health; National Heart Lung and Blood Institute (HL36310), US, NIH: National Institute on Aging (AG13196), US, NIH; Agency for Health Care Policy Research (HS06516); and the John D and Catherine T MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health. Samples from the English Longitudinal Study of Ageing (ELSA) DNA Repository (EDNAR), received support under a grant (AG1764406S1) awarded by the National Institute on Aging (NIA). ELSA was developed by a team of researchers based at the National Centre for Social Research, University College London and the Institute of Fiscal Studies. The data were collected by the National Centre for Social Research. The developers and funders of ELSA and the Archive do not bear any responsibility for the analyses or interpretations presented here. Michael Marmot is supported by a MRC Research Professorship. The Whitehall-1 study was supported by the British Heart Foundation and Medical Research Council. The funders of this work did not take part in study design, data collection, or analysis of these data. In addition, none of the funders took part in the decision to publish, or in preparation of this manuscript.	Achard JM, 2003, AM J MED, V114, P495, DOI 10.1016/S0002-9343(03)00054-8; Ahituv N, 2007, AM J HUM GENET, V80, P779, DOI 10.1086/513471; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Caulfield M, 2003, LANCET, V361, P2118, DOI 10.1016/S0140-6736(03)13722-1; Clarke R, 2007, ARCH INTERN MED, V167, P1373, DOI 10.1001/archinte.167.13.1373; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Cope G, 2006, J AM SOC NEPHROL, V17, P1867, DOI 10.1681/ASN.2005111224; Cui JSS, 2003, HYPERTENSION, V41, P207, DOI 10.1161/01.HYP.0000044938.94050.E3; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Delaloy C, 2003, MOL CELL BIOL, V23, P9208, DOI 10.1128/MCB.23.24.9208-9221.2003; Delaloy C, 2006, AM J PATHOL, V169, P105, DOI 10.2353/ajpath.2006.051290; FU Y, 2006, AM J PHYSL RENAL PHY; Galletti F, 2007, J HYPERTENS, V25, P1671, DOI 10.1097/HJH.0b013e3281afa09e; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; GOLBANG AP, 2006, AM J PHYSL RENAL PHY; GORDON RD, 1986, HYPERTENSION, V8, P93, DOI 10.1161/01.HYP.8.2.93; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P219; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; KANNEL WB, 1969, DIS CHEST, V56, P43, DOI 10.1378/chest.56.1.43; Lazrak A, 2006, P NATL ACAD SCI USA, V103, P1615, DOI 10.1073/pnas.0510609103; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Luna A, 2007, BIOINFORMATICS, V23, P774, DOI 10.1093/bioinformatics/btl657; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Modiano G, 2005, EUR J HUM GENET, V13, P184, DOI 10.1038/sj.ejhg.5201306; Naray-Fejes-Toth A, 2004, P NATL ACAD SCI USA, V101, P17434, DOI 10.1073/pnas.0408146101; Newhouse SJ, 2005, HUM MOL GENET, V14, P1805, DOI 10.1093/hmg/ddi187; O'Reilly M, 2003, J AM SOC NEPHROL, V14, P2447, DOI 10.1097/01.ASN.0000089830.97681.3B; Petersen S, 2005, EUROPEAN CARDIOVASCU; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Shekarabi M, 2008, J CLIN INVEST, V118, P2496, DOI 10.1172/JCI34088; Stevens VJ, 2001, ANN INTERN MED, V134, P1, DOI 10.7326/0003-4819-134-1-200101020-00007; Strazzullo P, 2006, J HYPERTENS, V24, P1633, DOI 10.1097/01.hjh.0000239300.48130.07; Subramanya AR, 2006, AM J PHYSIOL-RENAL, V290, pF619, DOI 10.1152/ajprenal.00280.2005; Tobin MD, 2008, HYPERTENSION, V51, P1658, DOI 10.1161/HYPERTENSIONAHA.108.112664; Tobin MD, 2005, CIRCULATION, V112, P3423, DOI 10.1161/CIRCULATIONAHA.105.555474; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; TOBIN MD, 2008, HYPERTENSION; Turner ST, 2005, HYPERTENSION, V46, P758, DOI 10.1161/01.HYP.0000186240.81996.57; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; WARD R, 1995, HYPERTENSION PATHOPH; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100; Zhu XF, 2005, HUM MOL GENET, V14, P639, DOI 10.1093/hmg/ddi060	49	38	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2009	4	4							e5003	10.1371/journal.pone.0005003	http://dx.doi.org/10.1371/journal.pone.0005003			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437QB	19347040	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000265500900001
J	Cordeiro, MT; Braga-Neto, U; Nogueira, RMR; Marques, ETA				Cordeiro, Marli Tenorio; Braga-Neto, Ulisses; Ribeiro Nogueira, Rita Maria; Marques, Ernesto T. A., Jr.			Reliable Classifier to Differentiate Primary and Secondary Acute Dengue Infection Based on IgG ELISA	PLOS ONE			English	Article								Background: Dengue virus infection causes a wide spectrum of illness, ranging from sub-clinical to severe disease. Severe dengue is associated with sequential viral infections. A strict definition of primary versus secondary dengue infections requires a combination of several tests performed at different stages of the disease, which is not practical. Methods and Findings: We developed a simple method to classify dengue infections as primary or secondary based on the levels of dengue-specific IgG. A group of 109 dengue infection patients were classified as having primary or secondary dengue infection on the basis of a strict combination of results from assays of antigen-specific IgM and IgG, isolation of virus and detection of the viral genome by PCR tests performed on multiple samples, collected from each patient over a period of 30 days. The dengue-specific IgG levels of all samples from 59 of the patients were analyzed by linear discriminant analysis (LDA), and one-and two-dimensional classifiers were designed. The one-dimensional classifier was estimated by bolstered resubstitution error estimation to have 75.1% sensitivity and 92.5% specificity. The two-dimensional classifier was designed by taking also into consideration the number of days after the onset of symptoms, with an estimated sensitivity and specificity of 91.64% and 92.46%. The performance of the two-dimensional classifier was validated using an independent test set of standard samples from the remaining 50 patients. The classifications of the independent set of samples determined by the two-dimensional classifiers were further validated by comparing with two other dengue classification methods: hemagglutination inhibition (HI) assay and an in-house anti-dengue IgG-capture ELISA method. The decisions made with the two-dimensional classifier were in 100% accordance with the HI assay and 96% with the in-house ELISA. Conclusions: Once acute dengue infection has been determined, a 2-D classifier based on common dengue virus IgG kits can reliably distinguish primary and secondary dengue infections. Software for calculation and validation of the 2-D classifier is made available for download.	[Cordeiro, Marli Tenorio; Braga-Neto, Ulisses; Marques, Ernesto T. A., Jr.] Fiocruz MS, Aggeu Magalhaes Res Ctr, Virol & Expt Therapy Lab, Recife, PE, Brazil; [Cordeiro, Marli Tenorio] Cent Lab Publ Hlth, Secretar Saude Estado Pernambuco, Recife, PE, Brazil; [Ribeiro Nogueira, Rita Maria] Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil; [Braga-Neto, Ulisses] Texas A&M Univ, Dept Electr & Comp Engn, College Stn, TX USA; [Marques, Ernesto T. A., Jr.] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD USA; [Marques, Ernesto T. A., Jr.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21218 USA	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Texas A&M University System; Texas A&M University College Station; Johns Hopkins University; Johns Hopkins University	Cordeiro, MT (corresponding author), Fiocruz MS, Aggeu Magalhaes Res Ctr, Virol & Expt Therapy Lab, Recife, PE, Brazil.	emarques@jhmi.edu	Publica, Inct Saude/J-9544-2013; Marques, Ernesto/L-4514-2013; Marques, Ernesto T. A/L-4967-2013; Braga-Neto, Ulisses/ABI-2677-2020	Marques, Ernesto/0000-0003-3826-9358; Marques, Ernesto T. A/0000-0003-3826-9358; 	National Institute of Allergy and Infectious Diseases (NIAID/NIH) [U19 AI56541, N01 AI 40085]; Brazilian National Research Council (CNPq) [DCR 35.0382/2004.2]; Direct For Computer & Info Scie & Enginr [0845407] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI040085, U19AI056541, R01AI040085] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to acknowledge the support of the National Institute of Allergy and Infectious Diseases (NIAID/NIH), under Grants U19 AI56541 and N01 AI 40085. Dr. Braga-Neto would like to acknowledge the support of the Brazilian National Research Council (CNPq), under Grant DCR 35.0382/2004.2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRAGA UM, 2005, GENOMIC SIGNAL PROCE; Braga-Neto U, 2004, PATTERN RECOGN, V37, P1267, DOI 10.1016/j.patcog.2003.08.017; BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172; CHUNGUE E, 1989, T ROY SOC TROP MED H, V83, P708, DOI 10.1016/0035-9203(89)90404-5; CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561; Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128; GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Guzman MG, 2004, INT J INFECT DIS, V8, P69, DOI 10.1016/j.ijid.2003.03.003; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Halstead Scott B., 1997, P23; IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531; KUNO G, 1987, AM J TROP MED HYG, V36, P153, DOI 10.4269/ajtmh.1987.36.153; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Matheus S, 2005, J CLIN MICROBIOL, V43, P2793, DOI 10.1128/JCM.43.6.2793-2797.2005; Miagostovich MP, 1999, J CLIN VIROL, V14, P183, DOI 10.1016/S1386-6532(99)00059-1; MORENS DM, 1985, J CLIN MICROBIOL, V22, P250, DOI 10.1128/JCM.22.2.250-254.1985; RDevelopmentCoreTeam, 2005, R LANG ENV STAT COMP; Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7; Schilling S, 2004, J CLIN VIROL, V31, P179, DOI 10.1016/j.jcv.2004.03.020; Vaughn DW, 1999, AM J TROP MED HYG, V60, P693, DOI 10.4269/ajtmh.1999.60.693; Vorndam AV, 1997, DENGUE DENGUE HEMORR; *WORLD ORG VOLC OB, 1997, DIR VOLC OBS 1996 19, P1	23	33	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e4945	10.1371/journal.pone.0004945	http://dx.doi.org/10.1371/journal.pone.0004945			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340301	Green Published, gold, Green Submitted			2022-12-25	WOS:000265500700003
J	Dambacher, M; Rolfs, M; Gollner, K; Kliegl, R; Jacobs, AM				Dambacher, Michael; Rolfs, Martin; Goellner, Kristin; Kliegl, Reinhold; Jacobs, Arthur M.			Event-Related Potentials Reveal Rapid Verification of Predicted Visual Input	PLOS ONE			English	Article							INTERACTIVE ACTIVATION MODEL; TOP-DOWN INFLUENCES; WORD FORM AREA; SELECTIVE ATTENTION; SPATIAL ATTENTION; BRAIN POTENTIALS; VISUOSPATIAL ATTENTION; LETTER PERCEPTION; VENTRAL STREAM; CORTEX	Human information processing depends critically on continuous predictions about upcoming events, but the temporal convergence of expectancy-based top-down and input-driven bottom-up streams is poorly understood. We show that, during reading, event-related potentials differ between exposure to highly predictable and unpredictable words no later than 90 ms after visual input. This result suggests an extremely rapid comparison of expected and incoming visual information and gives an upper temporal bound for theories of top-down and bottom-up interactions in object recognition.	[Dambacher, Michael; Rolfs, Martin; Goellner, Kristin; Kliegl, Reinhold] Univ Potsdam, Dept Psychol, Potsdam, Germany; [Dambacher, Michael; Jacobs, Arthur M.] Free Univ Berlin, Dept Ed & Psychol, Berlin, Germany; [Rolfs, Martin] Univ Paris 05, CNRS, Lab Psychol Percept, Paris, France	University of Potsdam; Free University of Berlin; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Dambacher, M (corresponding author), Univ Potsdam, Dept Psychol, Potsdam, Germany.	michael.dambacher@uni-potsdam.de	Kliegl, Reinhold/AAD-3463-2019; Kliegl, Reinhold/A-1276-2009; Rolfs, Martin/A-7214-2008	Kliegl, Reinhold/0000-0002-0180-8488; Kliegl, Reinhold/0000-0002-0180-8488; Jacobs, Arthur/0000-0002-7910-3955; Rolfs, Martin/0000-0002-8214-8556; Dambacher, Michael/0000-0003-3712-0594	Deutsche Forschungsgemeinschaft [FOR868/1, KL655/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was supported by Deutsche Forschungsgemeinschaft, grants FOR868/1 and KL655/6-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AnlloVento L, 1996, PERCEPT PSYCHOPHYS, V58, P191, DOI 10.3758/BF03211875; Bar M, 2007, TRENDS COGN SCI, V11, P280, DOI 10.1016/j.tics.2007.05.005; Carlsson K, 2000, J COGNITIVE NEUROSCI, V12, P691, DOI 10.1162/089892900562318; Chaumon M, 2008, J VISION, V8, DOI 10.1167/8.3.10; Churchland P., 1994, LARGE SCALE NEURONAL, P23; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Dambacher M, 2006, BRAIN RES, V1084, P89, DOI 10.1016/j.brainres.2006.02.010; Davidson PR, 2003, CURR OPIN NEUROBIOL, V13, P232, DOI 10.1016/S0959-4388(03)00038-2; DeLong KA, 2005, NAT NEUROSCI, V8, P1117, DOI 10.1038/nn1504; Di Lollo V, 2000, J EXP PSYCHOL GEN, V129, P481, DOI 10.1037/0096-3445.129.4.481; Di Lollo V, 2001, J EXP PSYCHOL GEN, V130, P479, DOI 10.1037/0096-3445.130.3.479; Di Russo F, 2003, CEREB CORTEX, V13, P486, DOI 10.1093/cercor/13.5.486; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Enns JT, 2000, TRENDS COGN SCI, V4, P345, DOI 10.1016/S1364-6613(00)01520-5; Foxe JJ, 2002, EXP BRAIN RES, V142, P139, DOI 10.1007/s00221-001-0906-7; Geyken A., 2007, IDIOMS COLLOCATIONS, P23; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Grossberg S, 1999, CONSCIOUS COGN, V8, P1, DOI 10.1006/ccog.1998.0372; Guyonneau R, 2004, J PHYSIOL-PARIS, V98, P487, DOI 10.1016/j.jphysparis.2005.09.004; Hayhoe M, 2000, VIS COGN, V7, P43, DOI 10.1080/135062800394676; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Hopf JM, 2004, J NEUROSCI, V24, P1822, DOI 10.1523/JNEUROSCI.3564-03.2004; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Kelly SP, 2008, CEREB CORTEX, V18, P2629, DOI 10.1093/cercor/bhn022; Kliegl R, 2006, J EXP PSYCHOL GEN, V135, P12, DOI 10.1037/0096-3445.135.1.12; KUTAS M, 1984, NATURE, V307, P161, DOI 10.1038/307161a0; Kutas M., 2006, HDB PSYCHOLINGUISTIC, P659, DOI [10.1016/B978-012369374-7/50018-3, DOI 10.1016/B978-012369374-7/50018-3]; Kveraga K, 2007, BRAIN COGNITION, V65, P145, DOI 10.1016/j.bandc.2007.06.007; LAVIE N, 1994, PERCEPT PSYCHOPHYS, V56, P183, DOI 10.3758/BF03213897; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; Lleras A, 2005, PSYCHOL SCI, V16, P684, DOI 10.1111/j.1467-9280.2005.01596.x; Lleras A, 2007, PERCEPT PSYCHOPHYS, V69, P980, DOI 10.3758/BF03193936; Luck SJ, 2000, TRENDS COGN SCI, V4, P432, DOI 10.1016/S1364-6613(00)01545-X; MANGUN GR, 1993, ATTENTION PERFORM, V14, P219; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; Martinez A, 2001, VISION RES, V41, P1437, DOI 10.1016/S0042-6989(00)00267-4; McCandliss BD, 2003, TRENDS COGN SCI, V7, P293, DOI 10.1016/S1364-6613(03)00134-7; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P375, DOI 10.1037/0033-295X.88.5.375; MUMFORD D, 1992, BIOL CYBERN, V66, P241, DOI 10.1007/BF00198477; O'Connor DH, 2002, NAT NEUROSCI, V5, P1203, DOI 10.1038/nn957; O'Regan JK, 2000, VIS COGN, V7, P191, DOI 10.1080/135062800394766; OREGAN JK, 1992, CAN J PSYCHOL, V46, P461, DOI 10.1037/h0084327; Penolazzi B, 2007, BIOL PSYCHOL, V74, P374, DOI 10.1016/j.biopsycho.2006.09.008; Pitts MA, 2008, BRAIN COGNITION, V67, P11, DOI 10.1016/j.bandc.2007.10.004; Poghosyan V, 2007, NEUROIMAGE, V35, P759, DOI 10.1016/j.neuroimage.2006.11.052; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; RUMELHART DE, 1982, PSYCHOL REV, V89, P60, DOI 10.1037/0033-295X.89.1.60; Sauseng P, 2005, EUR J NEUROSCI, V22, P2917, DOI 10.1111/j.1460-9568.2005.04482.x; Schoenfeld MA, 2007, CEREB CORTEX, V17, P2468, DOI 10.1093/cercor/bhl154; Sereno SC, 2003, PSYCHOL SCI, V14, P328, DOI 10.1111/1467-9280.14471; Sigman M, 2005, NEURON, V46, P823, DOI 10.1016/j.neuron.2005.05.014; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; ULLMAN S, 1995, CEREB CORTEX, V5, P1, DOI 10.1093/cercor/5.1.1; Valdes-Sosa M, 1998, J COGNITIVE NEUROSCI, V10, P137, DOI 10.1162/089892998563743; Van Berkum JJA, 2005, J EXP PSYCHOL LEARN, V31, P443, DOI 10.1037/0278-7393.31.3.443; VanRullen R, 2002, VISION RES, V42, P2593, DOI 10.1016/S0042-6989(02)00298-5; Vinckier F, 2007, NEURON, V55, P143, DOI 10.1016/j.neuron.2007.05.031; Williams MA, 2008, NAT NEUROSCI, V11, P1439, DOI 10.1038/nn.2218; Worden MS, 2000, J NEUROSCI, V20; Ziegler JC, 1998, MEM COGNITION, V26, P490, DOI 10.3758/BF03201158	61	60	62	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e5047	10.1371/journal.pone.0005047	http://dx.doi.org/10.1371/journal.pone.0005047			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437PR	19333386	Green Published, gold, Green Submitted			2022-12-25	WOS:000265499900012
J	Ogonuki, N; Inoue, K; Hirose, M; Miura, I; Mochida, K; Sato, T; Mise, N; Mekada, K; Yoshiki, A; Abe, K; Kurihara, H; Wakana, S; Ogura, A				Ogonuki, Narumi; Inoue, Kimiko; Hirose, Michiko; Miura, Ikuo; Mochida, Keiji; Sato, Takahiro; Mise, Nathan; Mekada, Kazuyuki; Yoshiki, Atsushi; Abe, Kuniya; Kurihara, Hiroki; Wakana, Shigeharu; Ogura, Atsuo			A High-Speed Congenic Strategy Using First-Wave Male Germ Cells	PLOS ONE			English	Article								Background: In laboratory mice and rats, congenic breeding is essential for analyzing the genes of interest on specific genetic backgrounds and for analyzing quantitative trait loci. However, in theory it takes about 3-4 years to achieve a strain carrying about 99% of the recipient genome at the tenth backcrossing (N10). Even with marker-assisted selection, the so-called 'speed congenic strategy', it takes more than a year at N4 or N5. Methodology/Principal Findings: Here we describe a new high-speed congenic system using round spermatids retrieved from immature males (22-25 days of age). We applied the technique to three genetically modified strains of mice: transgenic (TG), knockin (KI) and N-ethyl-N-nitrosourea (ENU)-induced mutants. The donor mice had mixed genetic backgrounds of C57BL/6 (B6):DBA/2 or B6:129 strains. At each generation, males used for backcrossing were selected based on polymorphic marker analysis and their round spermatids were injected into B6 strain oocytes. Backcrossing was repeated until N4 or N5. For the TG and ENU-mutant strains, the N5 generation was achieved on days 188 and 190 and the proportion of B6-homozygous loci was 100% (74 markers) and 97.7% (172/176 markers), respectively. For the KI strain, N4 was achieved on day 151, all the 86 markers being B6-homozygous as early as on day 106 at N3. The carrier males at the final generation were all fertile and propagated the modified genes. Thus, three congenic strains were established through rapid generation turnover between 41 and 44 days. Conclusions/Significance: This new high-speed breeding strategy enables us to produce congenic strains within about half a year. It should provide the fastest protocol for precise definition of the phenotypic effects of genes of interest on desired genetic backgrounds.	[Ogonuki, Narumi; Inoue, Kimiko; Hirose, Michiko; Miura, Ikuo; Mochida, Keiji; Mise, Nathan; Mekada, Kazuyuki; Yoshiki, Atsushi; Abe, Kuniya; Wakana, Shigeharu; Ogura, Atsuo] RIKEN, BioResource Ctr, Tsukuba, Ibaraki, Japan; [Inoue, Kimiko; Ogura, Atsuo] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Sato, Takahiro; Kurihara, Hiroki] Univ Tokyo, Grad Sch Med, Dept Physiol Chem & Metabolism, Tokyo, Japan; Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrative Med, Tokyo, Japan; [Sato, Takahiro; Ogura, Atsuo] Banyu Pharm Co Ltd, Tsukuba Safety Assessment Lab, Tsukuba, Ibaraki, Japan	RIKEN; University of Tsukuba; University of Tokyo; University of Tokyo	Ogonuki, N (corresponding author), RIKEN, BioResource Ctr, Tsukuba, Ibaraki, Japan.	ogura@rtc.riken.go.jp	Ogura, Atsuo/J-3916-2014; Yoshiki, Atsushi/O-6162-2019; 名丹, 三瀬/AAD-1036-2021	Ogura, Atsuo/0000-0003-0447-1988; Yoshiki, Atsushi/0000-0002-9450-5151; Kurihara, Hiroki/0000-0002-6476-5593	KAKENHI [20062012, 19300151]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI (20062012 [A.O.] and 19300151 [A.O.]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2008, NAT GENET, V40, P516, DOI 10.1038/ng.147; Armstrong NJ, 2006, MAMM GENOME, V17, P273, DOI 10.1007/s00335-005-0123-y; Behringer R, 1998, NAT GENET, V18, P108, DOI 10.1038/ng0298-108; CHATOT CL, 1989, J REPROD FERTIL, V86, P679, DOI 10.1530/jrf.0.0860679; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; DORMAN AFE, 2008, BRAIN BEHAV IN PRESS; Flaherty L, 1981, MOUSE BIOMEDICAL RES, P215; FUJIWARA Y, 1994, P NATL ACAD SCI USA, V91, P12258, DOI 10.1073/pnas.91.25.12258; George SHL, 2007, P NATL ACAD SCI USA, V104, P4455, DOI 10.1073/pnas.0609277104; Glaser S, 2005, NAT GENET, V37, P1187, DOI 10.1038/ng1668; Hayashi S, 2003, BIOL REPROD, V69, P1170, DOI 10.1095/biolreprod.103.016832; Hirabayashi M, 2002, MOL REPROD DEV, V62, P295, DOI 10.1002/mrd.10127; Jahnukainen K, 2004, BIOL REPROD, V70, P290, DOI 10.1095/biolreprod.103.018390; KIMURA Y, 1995, DEVELOPMENT, V121, P2397; Kishigami S, 2006, DEV BIOL, V289, P195, DOI 10.1016/j.ydbio.2005.10.026; LIVY DJ, 1991, J HERED, V82, P459, DOI 10.1093/oxfordjournals.jhered.a111128; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; Masuya H, 2007, HUM MOL GENET, V16, P2366, DOI 10.1093/hmg/ddm195; MEKADA K, 2009, EXP ANIM IN PRESS; Miki H, 2006, J REPROD DEVELOP, V52, P239, DOI 10.1262/jrd.17078; Miki H, 2004, J REPROD DEVELOP, V50, P131, DOI 10.1262/jrd.50.131; MIKI H, GENESIS IN PRESS; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagy A., 2003, MANIPULATING MOUSE E; Ogonuki N, 2006, P NATL ACAD SCI USA, V103, P13098, DOI 10.1073/pnas.0605755103; Ogura A, 1998, P NATL ACAD SCI USA, V95, P5611, DOI 10.1073/pnas.95.10.5611; OGURA A, 1993, BIOL REPROD, V48, P219, DOI 10.1095/biolreprod48.2.219; Pacholczyk G, 2008, BIOTECHNIQUES, V44, P413, DOI 10.2144/000112706; Pravenec M, 2007, GENOME RES, V17, P1319, DOI 10.1101/gr.6548207; Saar K, 2008, NAT GENET, V40, P560, DOI 10.1038/ng.124; Sato T, 2008, DEVELOPMENT, V135, P755, DOI 10.1242/dev.012708; Seong E, 2004, TRENDS GENET, V20, P59, DOI 10.1016/j.tig.2003.12.006; Shimozawa N, 2002, GENESIS, V34, P203, DOI 10.1002/gene.10143; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; Tamashiro KLK, 2002, NAT MED, V8, P262, DOI 10.1038/nm0302-262; Yoshida N, 2007, NAT PROTOC, V2, P296, DOI 10.1038/nprot.2007.7; Yoshiki A, 2006, ILAR J, V47, P94, DOI 10.1093/ilar.47.2.94; Ziyyat A, 2001, HUM REPROD, V16, P1449, DOI 10.1093/humrep/16.7.1449	38	30	32	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e4943	10.1371/journal.pone.0004943	http://dx.doi.org/10.1371/journal.pone.0004943			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333383	Green Submitted, gold, Green Published			2022-12-25	WOS:000265499900005
J	Smith, MI; Huang, YY; Deshmukh, M				Smith, Michelle I.; Huang, Yolanda Y.; Deshmukh, Mohanish			Skeletal Muscle Differentiation Evokes Endogenous XIAP to Restrict the Apoptotic Pathway	PLOS ONE			English	Article								Myotube apoptosis occurs normally during muscle development and aging but it can lead to destruction of skeletal muscle in neuromuscular diseases. Therefore, understanding how myotube apoptosis is regulated is important for developing novel strategies for treatment of muscle loss. We investigated the regulation of apoptosis in skeletal muscle and report a striking increase in resistance to apoptosis following differentiation. We find mitotic C2C12 cells (myoblast-like cells) are sensitive to cytosolic cytochrome c microinjection. However, differentiated C2C12 cells (myotube-like cells) and primary myotubes are markedly resistant. This resistance is due to endogenous X-linked inhibitor of apoptotic protein (XIAP). Importantly, the selective difference in the ability of XIAP to block myotube but not myoblast apoptosis is not due to a change in XIAP but rather a decrease in Apaf-1 expression. This decrease in Apaf-1 links XIAP to caspase activation and death. Our findings suggest that in order for myotubes to die, they may degrade XIAP, functionally inactivate XIAP or upregulate Apaf-1. Importantly, we identify a role for endogenous Smac in overcoming XIAP to allow myotube death. However, in postmitotic cardiomyocytes, where XIAP also restricts apoptosis, endogenous Smac was not capable of overcoming XIAP to cause death. These results show that as skeletal muscle differentiate, they become resistant to apoptosis because of the ability of XIAP to regulate caspase activation. The increased restriction of apoptosis in myotubes is presumably important to ensure the long term survival of these postmitotic cells as they play a vital role in the physiology of organisms.	[Smith, Michelle I.; Huang, Yolanda Y.; Deshmukh, Mohanish] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27515 USA; [Smith, Michelle I.; Huang, Yolanda Y.; Deshmukh, Mohanish] Univ N Carolina, Neurosci Ctr, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Smith, MI (corresponding author), Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27515 USA.	mohanish@med.unc.edu			National Institutes of Health (NIH) [GM078366]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078366] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant GM078366 to MD. NIH had no role in study design, data collection, decision to publish, or preparation of the manuscript.	Aure K, 2006, BRAIN, V129, P1249, DOI 10.1093/brain/awl061; Beauparlant P, 2003, CURR OPIN DRUG DISC, V6, P179; Bruusgaard JC, 2008, J CLIN INVEST, V118, P1450, DOI 10.1172/JCI34022; Burgess DH, 1999, CELL DEATH DIFFER, V6, P256, DOI 10.1038/sj.cdd.4400489; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Cook JG, 2002, P NATL ACAD SCI USA, V99, P1347, DOI 10.1073/pnas.032677499; Deshmukh M, 2000, J CELL BIOL, V150, P131, DOI 10.1083/jcb.150.1.131; Deshmukh M, 1998, NEURON, V21, P695, DOI 10.1016/S0896-6273(00)80587-5; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Ellerby HM, 1997, J NEUROSCI, V17, P6165; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; Fu WN, 2003, ONCOGENE, V22, P451, DOI 10.1038/sj.onc.1206147; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Furukawa Y, 2005, MOL CANCER RES, V3, P325, DOI 10.1158/1541-7786.MCR-04-0105; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Ho AT, 2007, MOL CELL BIOL, V27, P5673, DOI 10.1128/MCB.00188-07; Ho AT, 2004, CELL CYCLE, V3, P446; Ho AT, 2004, EMBO J, V23, P460, DOI 10.1038/sj.emboj.7600039; Ikezoe K, 2002, ACTA NEUROPATHOL, V103, P531, DOI 10.1007/s00401-001-0502-8; Li WY, 2002, NAT STRUCT BIOL, V9, P436, DOI 10.1038/nsb795; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Migheli A, 1997, NEUROGENETICS, V1, P81, DOI 10.1007/s100480050012; Mirabella M, 2000, BRAIN, V123, P93, DOI 10.1093/brain/123.1.93; Okada H, 2002, MOL CELL BIOL, V22, P3509, DOI 10.1128/MCB.22.10.3509-3517.2002; Potts MB, 2005, J CELL BIOL, V171, P925, DOI 10.1083/jcb.200504082; Potts PR, 2003, J CELL BIOL, V163, P789, DOI 10.1083/jcb.200307130; Sandri M, 1999, INT J BIOCHEM CELL B, V31, P1373, DOI 10.1016/S1357-2725(99)00063-1; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tews DS, 2008, APPL IMMUNOHISTO M M, V16, P66; Tews DS, 1997, J NEUROPATH EXP NEUR, V56, P150, DOI 10.1097/00005072-199702000-00005; Tews DS, 1996, NEUROMUSCULAR DISORD, V6, P265, DOI 10.1016/0960-8966(96)00018-1; Tews DS, 2002, NEUROMUSCULAR DISORD, V12, P613, DOI 10.1016/S0960-8966(02)00030-5; Van Loo G, 2002, CELL DEATH DIFFER, V9, P301, DOI 10.1038/sj.cdd.4400966; Vaughn AE, 2007, CELL DEATH DIFFER, V14, P973, DOI 10.1038/sj.cdd.4402084; Walsh K, 1997, CURR OPIN GENET DEV, V7, P597, DOI 10.1016/S0959-437X(97)80005-6; Wang XD, 2001, GENE DEV, V15, P2922; Wright KM, 2004, J CELL BIOL, V167, P303, DOI 10.1083/jcb.200406073	41	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e5097	10.1371/journal.pone.0005097	http://dx.doi.org/10.1371/journal.pone.0005097			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333375	Green Submitted, Green Published, gold			2022-12-25	WOS:000265499900027
J	Alard, JE; Dueymes, M; Mageed, RA; Saraux, A; Youinou, P; Jamin, C				Alard, Jean-Eric; Dueymes, Maryvonne; Mageed, Rizgar A.; Saraux, Alain; Youinou, Pierre; Jamin, Christophe			Mitochondrial heat shock protein (HSP) 70 synergizes with HSP60 in transducing endothelial cell apoptosis induced by anti-HSP60 autoantibody	FASEB JOURNAL			English	Article						antibodies; stress; endothelium; vasculitis; cell surface interaction; CCR5	SYSTEMIC-LUPUS-ERYTHEMATOSUS; TOLL-LIKE RECEPTOR-4; INNATE IMMUNE CELLS; EXTRACELLULAR HSP70; CHEMOKINE RECEPTORS; SIGNALING PATHWAY; MONONUCLEAR-CELLS; STRESS-PROTEINS; ANTIBODIES; BINDING	Heat shock protein (HSP) 60, up-regulated by endothelial cells (ECs) to resist stress, is the target of a subgroup of apoptosis-inducing anti-EC autoantibodies (Abs) in human vasculitides. Given that HSP60 is not a transmembrane protein, the mechanism by which these auto-Abs induces apoptosis is unclear. EC membrane proteins were analyzed using bidimensional electrophoresis and Far Western blot, and the HSP60 receptor was identified by mass spectrometry. Heat stress-dependent synthesis of HSP60 and receptor was examined by semiquantitative RT-PCR, and expression was examined by flow cytometry and indirect immunofluorescence. Interaction was demonstrated by coimmunoprecipitations. Lipid rafts were purified to evaluate specific localization, and the apoptotic response was investigated by blocking monoclonal Ab. Mitochondrial HSP70 (mtHSP70) was identified as an HSP60 receptor. Stress was required for ECs to up-regulate mRNA and express mtHSP70 on their surface. HSP60 and mtHSP70 colocalized and interacted within lipid rafts. They were associated with chemokine CC motif receptor 5 (CCR5), also induced at the mRNA and protein levels in stressed ECs. CCR5 was involved in the anti-HSP60-triggered apoptosis of ECs. These results provide new insights into the mechanism by which anti-EC auto-Abs from vasculitides induce apoptosis of ECs.-Alard, J.-E., Dueymes, M., Mageed, R. A., Saraux, A., Youinou, P., Jamin, C. Mitochondrial heat shock protein (HSP) 70 synergizes with HSP60 in transducing endothelial cell apoptosis induced by anti-HSP60 autoantibody. FASEB J. 23, 2772-2779 ( 2009)	[Alard, Jean-Eric; Dueymes, Maryvonne; Saraux, Alain; Youinou, Pierre; Jamin, Christophe] Univ Brest, EA Immunol & Pathol 2216, IFR ScInBioS 148, Brest, France; [Alard, Jean-Eric; Dueymes, Maryvonne; Saraux, Alain; Youinou, Pierre; Jamin, Christophe] Hop Morvan, CHU Brest, Brest, France; [Mageed, Rizgar A.] Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, Bone & Joint Res Unit, London, England	Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale; University of London; Queen Mary University London	Youinou, P (corresponding author), Brest Univ, Med Sch Hosp, Immunol Lab, 5 Av Foch,BP 824, F-29609 Brest, France.	youinou@univ-brest.fr	Dueymes, maryvonne/GMW-7826-2022		Conseil Regional de Bretagne	Conseil Regional de Bretagne(Region Bretagne)	This work was supported by a grant from the Conseil Regional de Bretagne. We gratefully thank the maternity staff at Clinique Pasteur and Clinique de Keraudren for their help with umbilical cord collecting over the years. We also appreciate the secretarial assistance of Simone Forest and Cindy Sene.	Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; Arispe N, 2004, FASEB J, V18, P1636, DOI 10.1096/fj.04-2088com; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Becker T, 2002, J CELL BIOL, V158, P1277, DOI 10.1083/jcb.200208083; Bordron A, 1998, J CLIN INVEST, V101, P2029, DOI 10.1172/JCI2261; Broquet AH, 2003, J BIOL CHEM, V278, P21601, DOI 10.1074/jbc.M302326200; Bulut Y, 2002, J IMMUNOL, V168, P1435, DOI 10.4049/jimmunol.168.3.1435; Calderwood SK, 2007, ANN NY ACAD SCI, V1113, P28, DOI 10.1196/annals.1391.019; DCRUZ DP, 1991, CLIN EXP IMMUNOL, V85, P254; Delneste Y, 2002, IMMUNITY, V17, P353, DOI 10.1016/S1074-7613(02)00388-6; DELPAPA N, 1992, CLIN IMMUNOL IMMUNOP, V63, P267, DOI 10.1016/0090-1229(92)90232-D; Dieude M, 2004, ARTHRITIS RHEUM-US, V50, P3221, DOI 10.1002/art.20564; Dugue C, 2004, INFECT IMMUN, V72, P301, DOI 10.1128/IAI.72.1.301-309.2004; Evdonin AL, 2006, EUR J CELL BIOL, V85, P443, DOI 10.1016/j.ejcb.2006.02.008; Fan J, 2003, J CLIN INVEST, V112, P1234, DOI 10.1172/JCI200318696; Fujieda M, 1997, CLIN EXP IMMUNOL, V107, P120, DOI 10.1046/j.1365-2249.1997.d01-894.x; Gehrmann M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001925; GILLARD BK, 1991, EXP CELL RES, V192, P433, DOI 10.1016/0014-4827(91)90062-Y; Gross C, 2003, BIOL CHEM, V384, P267, DOI 10.1515/BC.2003.030; Habich C, 2007, CELL MOL LIFE SCI, V64, P742, DOI 10.1007/s00018-007-6413-7; Habich C, 2002, J IMMUNOL, V168, P569, DOI 10.4049/jimmunol.168.2.569; Hillyer P, 2003, CLIN EXP IMMUNOL, V134, P431, DOI 10.1111/j.1365-2249.2003.02323.x; Huang MB, 2001, J ACQ IMMUN DEF SYND, V27, P213; Jamin C, 2005, ARTHRITIS RHEUM-US, V52, P4028, DOI 10.1002/art.21401; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kanda T, 2004, J NEUROSCI RES, V78, P141, DOI 10.1002/jnr.20228; Kol A, 2000, J IMMUNOL, V164, P13, DOI 10.4049/jimmunol.164.1.13; Manes S, 1999, EMBO J, V18, P6211, DOI 10.1093/emboj/18.22.6211; Meroni P, 2005, TRENDS IMMUNOL, V26, P275, DOI 10.1016/j.it.2005.03.006; Moroi Y, 2000, P NATL ACAD SCI USA, V97, P3485, DOI 10.1073/pnas.070550797; Nguyen DH, 2002, BLOOD, V99, P4298, DOI 10.1182/blood-2001-11-0087; Niu PY, 2006, CELL STRESS CHAPERON, V11, P162, DOI 10.1379/CSC-175R.1; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; PENNING CA, 1984, CLIN EXP IMMUNOL, V57, P548; Pockley AG, 2008, TRENDS BIOCHEM SCI, V33, P71, DOI 10.1016/j.tibs.2007.10.005; Salojin KV, 1997, AM J MED, V102, P178; Salojin KV, 1996, CLIN EXP RHEUMATOL, V14, P163; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; Sprenger RR, 2006, BIOCHEM J, V400, P401, DOI 10.1042/BJ20060355; Theriault JR, 2005, FEBS LETT, V579, P1951, DOI 10.1016/j.febslet.2005.02.046; Triantafilou M, 2002, J CELL SCI, V115, P2603; Tripathy NK, 2001, J RHEUMATOL, V28, P805; Tsan MF, 2004, AM J PHYSIOL-CELL PH, V286, pC739, DOI 10.1152/ajpcell.00364.2003; Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200; Wagner M, 1999, AM J PHYSIOL-LUNG C, V277, pL1026, DOI 10.1152/ajplung.1999.277.5.L1026; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8; Wang YF, 2001, IMMUNITY, V15, P971, DOI 10.1016/S1074-7613(01)00242-4; Whittall T, 2006, EUR J IMMUNOL, V36, P2304, DOI 10.1002/eji.200635953; Worda M, 2003, ARTHRITIS RHEUM-US, V48, P2605, DOI 10.1002/art.11179; YOUINOU P, 1995, IMMUNOL TODAY, V16, P363, DOI 10.1016/0167-5699(95)80001-8	52	16	16	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2772	2779		10.1096/fj.08-128785	http://dx.doi.org/10.1096/fj.08-128785			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19346294				2022-12-25	WOS:000268836700045
J	Johnston, RK; Balasubramanian, S; Kasiganesan, H; Baicu, CF; Zile, MR; Kuppuswamy, D				Johnston, Rebecca K.; Balasubramanian, Sundaravadivel; Kasiganesan, Harinath; Baicu, Catalin F.; Zile, Michael R.; Kuppuswamy, Dhandapani			beta(3) Integrin-mediated ubiquitination activates survival signaling during myocardial hypertrophy	FASEB JOURNAL			English	Article						NF-kappa B; cIAP1; pressure overload	NF-KAPPA-B; RAT VENTRICULAR MYOCYTES; FOCAL COMPLEX-FORMATION; CARDIAC-MUSCLE-CELLS; HEART-FAILURE; DILATED CARDIOMYOPATHY; PRESSURE-OVERLOAD; E3 LIGASES; IN-VIVO; C-SRC	Identifying the molecular mechanisms activated in compensatory hypertrophy and absent during decompensation will provide molecular targets for prevention of heart failure. We have previously shown enhanced ubiquitination (Ub) during the early growth period of pressure overload (PO) hypertrophy near intercalated discs of cardiomyocytes, where integrins are important for mechanotransduction. In this study, we tested the role of integrins upstream of Ub, whether enhanced Ub contributes to survival signaling in early PO, and if loss of this mechanism could lead to decreased ventricular function. The study used a beta(3) integrin (-/-) mouse and a wild-type mouse as a control for in vivo PO by transverse aortic constriction (TAC) and for cultured cardiomyocytes in vitro, stimulated with the integrin-activating peptide RGD. We demonstrate beta(3) integrin mediates transient Ub of targeted proteins during PO hypertrophy, which is necessary for cardiomyocyte survival and to maintain ventricular function. Prosurvival signaling proceeds by initiation of NF-kappa B transcription of the E3 ligase, cIAP1. In PO beta(-/-)(3) mice, absence of this mechanism correlates with increased TUNEL staining and decreased ventricular mass and function by 4 wk. This is the first study to show that a beta(3) integrin/Ub/NF-kappa B pathway contributes to compensatory hypertrophic growth.-Johnston, R. K., Balasubramanian, S., Kasiganesan, H., Baicu, C. F., Zile, M. R., Kuppuswamy, D. beta(3) Integrin-mediated ubiquitination activates survival signaling during myocardial hypertrophy. FASEB J. 23, 2759-2771 ( 2009)	[Johnston, Rebecca K.; Balasubramanian, Sundaravadivel; Kasiganesan, Harinath; Baicu, Catalin F.; Zile, Michael R.; Kuppuswamy, Dhandapani] Med Univ S Carolina, Gazes Cardiac Res Inst, Div Cardiol, Dept Med, Charleston, SC 29425 USA; [Zile, Michael R.; Kuppuswamy, Dhandapani] Ralph H Johnson Dept Vet Affairs Med Ctr, Charleston, SC USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Kuppuswamy, D (corresponding author), Med Univ S Carolina, Gazes Cardiac Res Inst, Div Cardiol, Dept Med, 114 Doughty St, Charleston, SC 29425 USA.	kuppusd@musc.edu		Zile, Michael/0000-0001-7076-221X	National Institutes of Health (NIH) [HL-48788, RO1 HL-092124, T32HL07260]; American Heart Association predoctoral fellowship [0615468U]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092124, P01HL048788, T32HL007260] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association predoctoral fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health (NIH) grant PPG HL-48788, by a Merit Award from the Research Service of the Department of Veterans Affairs, by NIH grant RO1 HL-092124 ( to D. K.), by American Heart Association predoctoral fellowship 0615468U ( to R. K. J.), and by NIH predoctoral fellowship NIH T32HL07260 ( to R. K. J.). We thank An Van Laer for proficiency with the TAC model. We also thank Dr. Robin Muise-Helmericks, Dr. Amy Bradshaw, and Phillip Moschella for thoughtful comments and useful discussions, and Dr. Francis G. Spinale for help with the measurement of myocyte cross-sectional area.	Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174; Balasubramanian S, 2003, J BIOL CHEM, V278, P42214, DOI 10.1074/jbc.M303428200; Balasubramanian S, 2006, J MOL CELL CARDIOL, V41, P669, DOI 10.1016/j.yjmcc.2006.04.022; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Birks EJ, 2008, CARDIOVASC RES, V79, P472, DOI 10.1093/cvr/cvn083; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Cheng G, 2008, AM J PHYSIOL-HEART C, V294, pH2231, DOI 10.1152/ajpheart.91515.2007; Courter DL, 2005, J BIOL CHEM, V280, P12145, DOI 10.1074/jbc.M412555200; DeGroff CG, 2000, PEDIATR CARDIOL, V21, P439, DOI 10.1007/s002460010104; Depre C, 2006, CIRCULATION, V114, P1821, DOI 10.1161/CIRCULATIONAHA.106.637827; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Ha TZ, 2005, FREE RADICAL BIO MED, V39, P1570, DOI 10.1016/j.freeradbiomed.2005.08.002; Hedhli N, 2005, CARDIOVASC RES, V68, P186, DOI 10.1016/j.cardiores.2005.06.025; Hu SM, 2003, J BIOL CHEM, V278, P10055, DOI 10.1074/jbc.M207197200; Iijima Y, 2002, J BIOL CHEM, V277, P23065, DOI 10.1074/jbc.M200328200; KENT RL, 1989, AM J PHYSIOL, V257, pH1717, DOI 10.1152/ajpheart.1989.257.5.H1717; Kostin S, 2003, CIRC RES, V92, P715, DOI 10.1161/01.RES.0000067471.95890.5C; Kuppuswamy D, 1997, J BIOL CHEM, V272, P4500, DOI 10.1074/jbc.272.7.4500; Laser M, 2000, J BIOL CHEM, V275, P35624, DOI 10.1074/jbc.M006124200; Lemler MS, 2000, AM J PHYSIOL-HEART C, V279, pH1365; Li HH, 2007, J CLIN INVEST, V117, P3211, DOI 10.1172/JCI31757; Li YH, 2004, AM J PHYSIOL-HEART C, V287, pH1712, DOI 10.1152/ajpheart.00124.2004; Lindsey ML, 2006, PROTEOMICS, V6, P2225, DOI 10.1002/pmic.200500013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Narula J, 1996, NEW ENGL J MED, V335, P1182, DOI 10.1056/NEJM199610173351603; Ogawa E, 2000, J MOL CELL CARDIOL, V32, P765, DOI 10.1006/jmcc.2000.1119; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Ren J, 2007, J MOL CELL CARDIOL, V42, P367, DOI 10.1016/j.yjmcc.2006.11.002; Ross RS, 1998, CIRC RES, V82, P1160, DOI 10.1161/01.RES.82.11.1160; Sadoshima J, 1997, ANNU REV PHYSIOL, V59, P551, DOI 10.1146/annurev.physiol.59.1.551; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Sambrano GR, 2002, NATURE, V420, P712, DOI 10.1038/nature01306; Sanlioglu S, 2001, J BIOL CHEM, V276, P30188, DOI 10.1074/jbc.M102061200; Sarkar S, 2004, J BIOL CHEM, V279, P52630, DOI 10.1074/jbc.M402037200; Scatena M, 1998, J CELL BIOL, V141, P1083, DOI 10.1083/jcb.141.4.1083; Spinale FG, 1998, CIRC RES, V82, P482, DOI 10.1161/01.RES.82.4.482; Spruill LS, 2008, J MOL CELL CARDIOL, V44, P69, DOI 10.1016/j.yjmcc.2007.10.011; Toruner M, 2006, J BIOL CHEM, V281, P8686, DOI 10.1074/jbc.M512178200; TRAENCKNER EBM, 1994, EMBO J, V13, P5433, DOI 10.1002/j.1460-2075.1994.tb06878.x; Tsukamoto O, 2006, BIOCHEM BIOPH RES CO, V340, P1125, DOI 10.1016/j.bbrc.2005.12.120; Tuxworth WJ, 2004, BIOCHEM J, V378, P73, DOI 10.1042/BJ20031027; Lipinski KV, 2006, CIRC RES, V98, P1490, DOI 10.1161/01.RES.0000229267.77982.0d; Weekes J, 2003, PROTEOMICS, V3, P208, DOI 10.1002/pmic.200390029; Wencker D, 2003, J CLIN INVEST, V111, P1497, DOI 10.1172/JCI200317664; Willey CD, 2003, J MOL CELL CARDIOL, V35, P671, DOI 10.1016/S0022-2828(03)00112-3; Willey CD, 2008, INT J BIOL SCI, V4, P184; Xi YT, 2006, EUR J HEART FAIL, V8, P16, DOI 10.1016/j.ejheart.2005.05.014; Zhang RQ, 2001, BIOCHEMISTRY-US, V40, P14898, DOI 10.1021/bi0107445	49	40	44	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2759	2771		10.1096/fj.08-127480	http://dx.doi.org/10.1096/fj.08-127480			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19364763	Green Published			2022-12-25	WOS:000268836700044
J	Corcoran, K; Wang, XL; Lybarger, L				Corcoran, Kathleen; Wang, Xiaoli; Lybarger, Lonnie			Adapter-mediated Substrate Selection for Endoplasmic Reticulum-associated Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; PEPTIDE-LOADING COMPLEX; CLASS-I MOLECULES; SARCOMA-ASSOCIATED HERPESVIRUS; ER-ASSOCIATED DEGRADATION; UBIQUITIN LIGASE COMPLEX; CD8(+) T-CELLS; MISFOLDED GLYCOPROTEINS; IMMUNE EVASION; ANTIGEN PRESENTATION	During endoplasmic reticulum (ER)-associated degradation (ERAD), a relatively small number of ubiquitin ligases (E3) must be capable of ubiquitinating an assortment of substrates diverse in both structure and location (ER lumen, membrane, and/or cytosol). Therefore, mechanisms that operate independently of primary sequence determinants must exist to ensure specificity during this process. Here we provide direct evidence for adapter-mediated substrate recruitment for a virus-encoded ERAD E3 ligase, mK3. Members of an ER membrane protein complex that normally functions during major histocompatibility complex class I biogenesis in the immune system are required for mK3 substrate selection. We demonstrate that heterologous substrates could be ubiquitinated by mK3 if they were recruited by these ER accessory molecules to the proper position relative to the ligase domain of mK3. This mechanism of substrate recruitment by adapter proteins may explain the ability of some E3 ligases, including cellular ERAD E3 ligases, to specifically target the ubiquitination of multiple substrates that are unrelated in sequence.	[Lybarger, Lonnie] Univ Arizona, Dept Cell Biol & Anat, Tucson, AZ 85724 USA; [Corcoran, Kathleen; Lybarger, Lonnie] Univ Arizona, Dept Immunobiol, Tucson, AZ 85724 USA; [Wang, Xiaoli] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	University of Arizona; University of Arizona; Washington University (WUSTL)	Lybarger, L (corresponding author), Univ Arizona, Dept Cell Biol & Anat, 1501 N Campbell Ave,LSN 444, Tucson, AZ 85724 USA.	lybarger@email.arizona.edu			National Institutes of Health [AI060723, AI19687]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019687, R01AI060723] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI060723 (to L. L.) and AI19687 (to X. W.).	Ballar P, 2007, J BIOL CHEM, V282, P33908, DOI 10.1074/jbc.M704446200; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Bartee E, 2006, PLOS PATHOG, V2, P975, DOI 10.1371/journal.ppat.0020107; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Boname JM, 2004, IMMUNITY, V20, P305, DOI 10.1016/S1074-7613(04)00047-0; Boname JM, 2001, IMMUNITY, V15, P627, DOI 10.1016/S1074-7613(01)00213-8; BRODSKY FM, 1979, EUR J IMMUNOL, V9, P536, DOI 10.1002/eji.1830090709; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Cadwell K, 2008, J VIROL, V82, P4184, DOI 10.1128/JVI.02264-07; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Coscoy L, 2007, NAT REV IMMUNOL, V7, P391, DOI 10.1038/nri2076; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Grandea AG, 2000, IMMUNITY, V13, P213, DOI 10.1016/S1074-7613(00)00021-2; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; Hughes EA, 1997, P NATL ACAD SCI USA, V94, P1896, DOI 10.1073/pnas.94.5.1896; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Lehner PJ, 2004, CURR OPIN IMMUNOL, V16, P82, DOI 10.1016/j.coi.2003.11.012; Lewis JW, 1996, CURR BIOL, V6, P873, DOI 10.1016/S0960-9822(02)00611-5; Lybarger L, 2003, IMMUNITY, V18, P121, DOI 10.1016/S1074-7613(02)00509-5; Margalit A, 2003, INT IMMUNOL, V15, P1379, DOI 10.1093/intimm/dxg136; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Ohmura-Hoshino M, 2006, J BIOCHEM, V140, P147, DOI 10.1093/jb/mvj160; Ohmura-Hoshino M, 2006, J IMMUNOL, V177, P341, DOI 10.4049/jimmunol.177.1.341; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Papadopoulos M, 2007, J BIOL CHEM, V282, P9401, DOI 10.1074/jbc.M610429200; PeaceBrewer AL, 1996, IMMUNITY, V4, P505, DOI 10.1016/S1074-7613(00)80416-1; Peaper DR, 2008, ANNU REV CELL DEV BI, V24, P343, DOI 10.1146/annurev.cellbio.24.110707.175347; PEDERSEN LO, 1995, EUR J IMMUNOL, V25, P1609, DOI 10.1002/eji.1830250621; Petersen JL, 2005, J IMMUNOL, V174, P962, DOI 10.4049/jimmunol.174.2.962; Plemper RK, 1999, J CELL SCI, V112, P4123; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; SCHMIDT W, 1981, IMMUNOGENETICS, V13, P483, DOI 10.1007/BF00343716; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Stevenson PG, 2000, P NATL ACAD SCI USA, V97, P8455, DOI 10.1073/pnas.150240097; Stevenson PG, 2002, NAT IMMUNOL, V3, P733, DOI 10.1038/ni818; STORKUS WJ, 1993, J IMMUNOTHER, V14, P94, DOI 10.1097/00002371-199308000-00003; Szathmary R, 2005, MOL CELL, V19, P765, DOI 10.1016/j.molcel.2005.08.015; Tan P, 2002, J IMMUNOL, V168, P1950, DOI 10.4049/jimmunol.168.4.1950; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Wang XL, 2006, J BIOL CHEM, V281, P8636, DOI 10.1074/jbc.M513920200; Wang XL, 2005, J VIROL, V79, P4099, DOI 10.1128/JVI.79.7.4099-4108.2005; Wang XL, 2004, J VIROL, V78, P8673, DOI 10.1128/JVI.78.16.8673-8686.2004; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Yu YYL, 1999, J IMMUNOL, V163, P4427; Yu YYL, 2002, J VIROL, V76, P2796, DOI 10.1128/JVI.76.6.2796-2803.2002; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhou PB, 2000, MOL CELL, V6, P751, DOI 10.1016/S1097-2765(00)00074-5	63	4	4	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17475	17487		10.1074/jbc.M808258200	http://dx.doi.org/10.1074/jbc.M808258200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19366690	Green Published, hybrid			2022-12-25	WOS:000267202500014
J	Alberts, SM; Sonntag, C; Schafer, A; Wolf, DH				Alberts, Sven M.; Sonntag, Caroline; Schaefer, Antje; Wolf, Dieter H.			Ubx4 Modulates Cdc48 Activity and Influences Degradation of Misfolded Proteins of the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; UBIQUITIN-PROTEASOME PATHWAY; AAA ATPASE CDC48/P97; SACCHAROMYCES-CEREVISIAE; LUMINAL PROTEIN; QUALITY-CONTROL; MEMBRANE; COMPLEX; YEAST; CHAPERONE	Misfolded proteins of the secretory pathway are recognized in the endoplasmic reticulum (ER), retrotranslocated into the cytoplasm, and degraded by the ubiquitin-proteasome system. Right after retrotranslocation and polyubiquitination, they are extracted from the cytosolic side of the ER membrane through a complex consisting of the AAA ATPase Cdc48 (p97 in mammals), Ufd1, and Npl4. This complex delivers misfolded proteins to the proteasome for final degradation. Extraction, delivery, and processing of ERAD (ER-associated degradation) substrates to the proteasome requires additional cofactors of Cdc48. Here we characterize the UBX domain containing protein Ubx4 (Cui1) as a crucial factor for the degradation of polyubiquitinated proteins via ERAD. Ubx4 modulates the Cdc48-Ufd1Npl4 complex to guarantee its correct function. Mutant variants of Ubx4 lead to defective degradation of misfolded proteins and accumulation of polyubiquitinated proteins bound to Cdc48. We show the requirement of the UBX domain of Ubx4 for its function in ERAD. The observation that Ubx2 and Ubx4 are not found together in one complex with Cdc48 suggests several distinct steps in modulating the activity and localization of Cdc48 in ERAD.	[Alberts, Sven M.; Sonntag, Caroline; Schaefer, Antje; Wolf, Dieter H.] Univ Stuttgart, Inst Biochem, D-70569 Stuttgart, Germany	University of Stuttgart	Wolf, DH (corresponding author), Univ Stuttgart, Inst Biochem, Pfaffenwaldring 55, D-70569 Stuttgart, Germany.	dieter.wolf@ibc.uni-stuttgart.de			European Network of Excellence RUBICON; Deutsche Forschungsgemeinschaft, Bonn	European Network of Excellence RUBICON; Deutsche Forschungsgemeinschaft, Bonn(German Research Foundation (DFG))	This work was supported by the European Network of Excellence RUBICON and the Deutsche Forschungsgemeinschaft, Bonn.	Ahner A, 2004, TRENDS CELL BIOL, V14, P474, DOI 10.1016/j.tcb.2004.07.013; Ausubel FM, 1994, CURRENT PROTOCOLS MO; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Biederer T, 1996, EMBO J, V15, P2069, DOI 10.1002/j.1460-2075.1996.tb00560.x; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Bruderer RM, 2004, J BIOL CHEM, V279, P49609, DOI 10.1074/jbc.M408695200; Buchberger A, 2001, J MOL BIOL, V307, P17, DOI 10.1006/jmbi.2000.4462; Buschhorn BA, 2004, FEBS LETT, V577, P422, DOI 10.1016/j.febslet.2004.10.039; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Decottignies A, 2004, YEAST, V21, P127, DOI 10.1002/yea.1071; Gauss R, 2005, YEAST, V22, P1, DOI 10.1002/yea.1187; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Guthrie C, 1991, METHODS ENZYMOLOGY; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Pye VE, 2007, P NATL ACAD SCI USA, V104, P467, DOI 10.1073/pnas.0603408104; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rabouille C, 1998, CELL, V92, P603, DOI 10.1016/S0092-8674(00)81128-9; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHAFER A, 2008, UBIQUITIN PROTEASOME, P123; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Schuberth C, 2004, EMBO REP, V5, P818, DOI 10.1038/sj.embor.7400203; SCHUBERTH C, 2006, THESIS L MAXIMILIANS; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005	45	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16082	16089		10.1074/jbc.M809282200	http://dx.doi.org/10.1074/jbc.M809282200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19359248	hybrid, Green Published			2022-12-25	WOS:000266730900004
J	Pinkse, MWH; Rijkers, DTS; Dostmann, WR; Heck, AJR				Pinkse, Martijn W. H.; Rijkers, Dirk T. S.; Dostmann, Wolfgang R.; Heck, Albert J. R.			Mode of Action of cGMP-dependent Protein Kinase-specific Inhibitors Probed by Photoaffinity Cross-linking Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I-ALPHA; DISSOCIATION-CONSTANTS; SUBSTRATE-SPECIFICITY; PEPTIDE LIBRARIES; COUPLING REAGENTS; BINDING-SITE; COMPLEXES; PHENYLALANINE; ACTIVATION; MECHANISMS	The inhibitor peptide DT-2 (YGRKKRRQRRRPPLRKKK-KKH) is the most potent and selective inhibitor of the cGMP-dependent protein kinase (PKG) known today. DT-2 is a construct of a PKG tight binding sequence (W45, LRKKKKKH, K-I = 0.8 mu M) and a membrane translocating sequence (DT-6, YGRKKRRQRRRPP, K-I = 1.1 mu M), that combined strongly inhibits PKG catalyzed phosphorylation (K-I = 12.5 nM) with similar to 1000-fold selectivity toward PKG over protein kinase A, the closest relative of PKG. However, the molecular mechanism behind this inhibition is not entirely understood. Using a combination of photoaffinity labeling, stable isotope labeling, and mass spectrometry, we have located the binding sites of PKG-specific substrate and inhibitor peptides. Covalent linkage of a PKG-specific substrate analogue was localized in the catalytic core on residues 356-372, also known as the glycine-rich loop, essential for ATP binding. By analogy, the individual inhibitor peptides W45 and DT-6 were also found to cross-link near the glycine-rich loop, suggesting these are both substrate competitive inhibitors. A bifunctional photoreactive analogue of DT-2 was found to generate dimers of PKG. This cross-linking induced covalent PKG dimerization was not observed for an N-terminal deletion mutant of PKG, which lacks the dimerization domain. In addition, non-covalent mass spectrometry was used to determine binding stoichiometry and binding order of the inhibitor peptides. Dimeric PKG binds two W45 and DT-6 peptides, whereas only one DT-2 molecule was observed to bind to the dimeric PKG. Taken together, these findings imply that (i) the two individual components making up DT-2 are both targeted against the substrate-binding site and (ii) binding of a single DT-2 molecule inactivates both PKG monomers simultaneously, which is an indication that (iii) in cGMP-activated PKG the catalytic centers of both subunits may be in each other's proximity.	[Pinkse, Martijn W. H.; Heck, Albert J. R.] Univ Utrecht, Biomol Mass Spectrometry & Prote Grp, Bijvoet Ctr Biomol Res, NL-3584 CA Utrecht, Netherlands; [Rijkers, Dirk T. S.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Pharmaceut Sci, Fac Sci, NL-3584 CA Utrecht, Netherlands; [Dostmann, Wolfgang R.] Univ Vermont, Dept Pharmacol, Coll Med, Burlington, VT 05405 USA; [Pinkse, Martijn W. H.] Delft Univ Technol, Dept Biotechnol, NL-2628 BC Delft, Netherlands	Utrecht University; Utrecht University; University of Vermont; Delft University of Technology	Heck, AJR (corresponding author), Sorbonnnelaan 16, NL-3584 CA Utrecht, Netherlands.	a.j.r.heck@uu.nl	Heck, Albert/D-7098-2011	Heck, Albert/0000-0002-2405-4404; Rijkers, Dirk T.S./0000-0002-8874-7576	National Institutes of Health [HL68891]; Netherlands Proteomics Centre; Totman Trust for Medical Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068891] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Proteomics Centre; Totman Trust for Medical Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant HL68891 (to W. R. D.). This work was also supported by the Netherlands Proteomics Centre and the Totman Trust for Medical Research.	Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Alverdi V, 2008, J MOL BIOL, V375, P1380, DOI 10.1016/j.jmb.2007.11.053; Bligh SWA, 2003, J MOL RECOGNIT, V16, P139, DOI 10.1002/jmr.622; Bove PF, 2007, AM J RESP CELL MOL, V36, P138, DOI 10.1165/rcmb.2006-0253SM; Brunner J, 1996, TRENDS CELL BIOL, V6, P154, DOI 10.1016/0962-8924(96)40001-0; CARPINO LA, 1994, J CHEM SOC CHEM COMM, P201, DOI 10.1039/c39940000201; COLBRAN JL, 1992, J BIOL CHEM, V267, P9589; Dey NB, 2005, J CARDIOVASC PHARM, V45, P404, DOI 10.1097/01.fjc.0000157455.38068.12; Dostmann WRG, 2002, PHARMACOL THERAPEUT, V93, P203, DOI 10.1016/S0163-7258(02)00189-4; Dostmann WRG, 1999, PHARMACOL THERAPEUT, V82, P373, DOI 10.1016/S0163-7258(98)00063-1; Dostmann WRG, 2000, P NATL ACAD SCI USA, V97, P14772, DOI 10.1073/pnas.97.26.14772; FIELDS C G, 1991, Peptide Research, V4, P95; Foley KF, 2005, FRONT BIOSCI-LANDMRK, V10, P1302, DOI 10.2741/1620; Francis S H, 1988, Second Messengers Phosphoproteins, V12, P301; FRANCIS SH, 1994, ANNU REV PHYSIOL, V56, P237, DOI 10.1146/annurev.ph.56.030194.001321; Francis SH, 2002, FRONT BIOSCI-LANDMRK, V7, pD580, DOI 10.2741/francis; GLASS DB, 1986, J BIOL CHEM, V261, P2987; GLASS DB, 1979, J BIOL CHEM, V254, P9728; Heck AJR, 2004, MASS SPECTROM REV, V23, P368, DOI 10.1002/mas.10081; HOFMANN F, 1992, BIOCHIM BIOPHYS ACTA, V1135, P51, DOI 10.1016/0167-4889(92)90165-8; Hou YL, 2006, CELL SIGNAL, V18, P882, DOI 10.1016/j.cellsig.2005.07.015; Jahn O, 2004, ANAL BIOANAL CHEM, V378, P1031, DOI 10.1007/s00216-003-2353-8; KAUER JC, 1986, J BIOL CHEM, V261, P695; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; KNORR R, 1989, TETRAHEDRON LETT, V30, P1927, DOI 10.1016/S0040-4039(00)99616-3; Krieg T, 2005, AM J PHYSIOL-HEART C, V288, pH1976, DOI 10.1152/ajpheart.00883.2004; Lohmann SM, 1997, TRENDS BIOCHEM SCI, V22, P307, DOI 10.1016/S0968-0004(97)01086-4; Loo JA, 1997, MASS SPECTROM REV, V16, P1; Meiring HD, 2002, J SEP SCI, V25, P557, DOI 10.1002/1615-9314(20020601)25:9<557::AID-JSSC557>3.0.CO;2-F; MILLER WT, 1988, P NATL ACAD SCI USA, V85, P5429, DOI 10.1073/pnas.85.15.5429; MITCHELL RD, 1995, BIOCHEMISTRY-US, V34, P528, DOI 10.1021/bi00002a018; NASSAL M, 1984, J AM CHEM SOC, V106, P7540, DOI 10.1021/ja00336a038; Pinkse MWH, 2004, J AM SOC MASS SPECTR, V15, P1392, DOI 10.1016/j.jasms.2004.06.015; Ploug M, 1998, BIOCHEMISTRY-US, V37, P3612, DOI 10.1021/bi972787k; Przybylski M, 1996, ANGEW CHEM INT EDIT, V35, P807; RINK H, 1987, TETRAHEDRON LETT, V28, P3787, DOI 10.1016/S0040-4039(00)96384-6; Rogniaux H, 2001, ANAL BIOCHEM, V291, P48, DOI 10.1006/abio.2000.4975; Samalikova M, 2004, ANAL BIOANAL CHEM, V378, P1112, DOI 10.1007/s00216-003-2339-6; Scholten A, 2008, MASS SPECTROM REV, V27, P331, DOI 10.1002/mas.20166; Sharon M, 2007, ANNU REV BIOCHEM, V76, P167, DOI 10.1146/annurev.biochem.76.061005.090816; Simmons DA, 2002, BIOCHEMISTRY-US, V41, P1906, DOI 10.1021/bi011697j; Tahallah N, 2001, RAPID COMMUN MASS SP, V15, P596, DOI 10.1002/rcm.275; TAKIO K, 1984, BIOCHEMISTRY-US, V23, P4207, DOI 10.1021/bi00313a030; Taylor MS, 2004, MOL PHARMACOL, V65, P1111, DOI 10.1124/mol.65.5.1111; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; TEGGE W, 1995, BIOCHEMISTRY-US, V34, P10569, DOI 10.1021/bi00033a032; TENKORTENAAR PBW, 1986, INT J PEPT PROT RES, V27, P398; THOMAS NE, 1987, BIOCHEMISTRY-US, V26, P4471, DOI 10.1021/bi00388a043; Tjernberg A, 2004, ANAL CHEM, V76, P4325, DOI 10.1021/ac0497914; van Duijn E, 2005, NAT METHODS, V2, P371, DOI 10.1038/nmeth753; Veenstra TD, 1998, J AM SOC MASS SPECTR, V9, P8, DOI 10.1016/S1044-0305(97)00229-8; Weber PJA, 1997, J PEPT RES, V49, P375; Wood JS, 1996, J BIOL CHEM, V271, P174, DOI 10.1074/jbc.271.1.174; Wu J, 2007, SCIENCE, V318, P274, DOI 10.1126/science.1146447; Yan XW, 1996, J BIOL CHEM, V271, P1845, DOI 10.1074/jbc.271.4.1845; Zhu CB, 2005, J BIOL CHEM, V280, P15649, DOI 10.1074/jbc.M410858200	57	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16354	16368		10.1074/jbc.M808521200	http://dx.doi.org/10.1074/jbc.M808521200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19369251	Green Published, hybrid			2022-12-25	WOS:000266730900033
J	Chen, YL; Cai, T; Wang, HJ; Li, ZC; Loreaux, E; Lingrel, JB; Xie, ZJ				Chen, Yiliang; Cai, Ting; Wang, Haojie; Li, Zhichuan; Loreaux, Elizabeth; Lingrel, Jerry B.; Xie, Zijian			Regulation of Intracellular Cholesterol Distribution by Na/K-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCING FUNCTION; ACTIVATED PROTEIN-KINASES; NA+/K+-ATPASE; CARDIAC MYOCYTES; PLASMA-MEMBRANES; CAVEOLAE; RECEPTOR; CELLS; COMPLEX; BINDING	Recent studies have ascribed many non-pumping functions to the Na/K-ATPase. We show here that graded knockdown of cellular Na/K-ATPase alpha 1 subunit produces a parallel decrease in both caveolin-1 and cholesterol in light fractions of LLC-PK1 cell lysates. This observation is further substantiated by imaging analyses, showing redistribution of cholesterol from the plasma membrane to intracellular compartments in the knockdown cells. Moreover, this regulation is confirmed in alpha 1(-/-) mouse liver. Functionally, the knockdown-induced redistribution appears to affect the cholesterol sensing in the endoplasmic reticulum, because it activates the sterol regulatory element-binding protein pathway and increases expression of hydroxym-ethylglutaryl-CoA reductase and low density lipoprotein receptor in the liver. Consistently, we detect a modest increase in hepatic cholesterol as well as a reduction in the plasma cholesterol. Mechanistically, alpha 1(-/-) livers show increases in cellular Src and ERK activity and redistribution of caveolin-1. Although activation of Src is not required in Na/K-ATPase-mediated regulation of cholesterol distribution, the interaction between the Na/K-ATPase and caveolin-1 is important for this regulation. Taken together, our new findings demonstrate a novel function of the Na/K-ATPase in control of the plasma membrane cholesterol distribution. Moreover, the data also suggest that the plasma membrane Na/K-ATPase-caveolin-1 interaction may represent an important sensing mechanism by which the cells regulate the sterol regulatory element-binding protein pathway.	[Xie, Zijian] Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Toledo, OH 43614 USA; [Loreaux, Elizabeth; Lingrel, Jerry B.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Cincinnati	Xie, ZJ (corresponding author), Univ Toledo, Coll Med, Dept Physiol & Pharmacol, 3000 Arlington Ave, Toledo, OH 43614 USA.	zi-jian.xie@utoledo.edu	Li, Zhichuan/Q-7379-2017	Chen, Yiliang/0000-0001-9786-8305; Edwards, Elizabeth/0000-0002-5983-4654; Edwards, Elizabeth/0000-0003-0770-1179	National Institutes of Health [HL-36573, HL-67963, GM 78565]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067963, P01HL036573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078565] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-36573, HL-67963, and GM 78565.	Abidi P, 2005, INT J MOL MED, V16, P779; Bist A, 1997, P NATL ACAD SCI USA, V94, P10693, DOI 10.1073/pnas.94.20.10693; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Cai T, 2008, J CELL BIOL, V182, P1153, DOI 10.1083/jcb.200712022; Carozzi AJ, 2000, TRAFFIC, V1, P326, DOI 10.1034/j.1600-0854.2000.010406.x; CHEN M, 1995, BBA-MOL BASIS DIS, V1272, P101, DOI 10.1016/0925-4439(95)00073-D; Chen Y, 2008, J BIOL CHEM, V283, P1128, DOI 10.1074/jbc.M708025200; CORNELIUS F, 1995, BBA-BIOMEMBRANES, V1235, P205, DOI 10.1016/0005-2736(95)80006-2; DELUISE M, 1980, NEW ENGL J MED, V303, P1017, DOI 10.1056/NEJM198010303031801; Djurhuus MS, 2001, J CLIN ENDOCR METAB, V86, P859, DOI 10.1210/jc.86.2.859; Fielding CJ, 2000, BBA-MOL CELL BIOL L, V1529, P210, DOI 10.1016/S1388-1981(00)00150-5; Frank PG, 2006, AM J PHYSIOL-HEART C, V291, pH677, DOI 10.1152/ajpheart.01092.2005; Garver WS, 2007, J CELL BIOCHEM, V101, P498, DOI 10.1002/jcb.21200; GIRAUD F, 1976, NATURE, V264, P646, DOI 10.1038/264646a0; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Haas A, 2002, J BIOL CHEM, V277, P18694, DOI 10.1074/jbc.M111357200; Haas M, 2000, J BIOL CHEM, V275, P27832; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; James PF, 1999, MOL CELL, V3, P555, DOI 10.1016/S1097-2765(00)80349-4; Kometiani P, 1998, J BIOL CHEM, V273, P15249, DOI 10.1074/jbc.273.24.15249; Lange Y, 2000, J BIOL CHEM, V275, P17468, DOI 10.1074/jbc.M000875200; Lange Y, 1999, J LIPID RES, V40, P2264; LANGE Y, 1989, J BIOL CHEM, V264, P3786; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Li SN, 1998, TOXICOL APPL PHARM, V151, P377, DOI 10.1006/taap.1998.8471; Liang M, 2007, J BIOL CHEM, V282, P10585, DOI 10.1074/jbc.M609181200; Liang M, 2006, J BIOL CHEM, V281, P19709, DOI 10.1074/jbc.M512240200; LINGREL JB, 1990, PROG NUCLEIC ACID RE, V38, P37; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; Liu LJ, 2003, AM J PHYSIOL-CELL PH, V284, pC1550, DOI 10.1152/ajpcell.00555.2002; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; NODA K, 1990, DIABETES RES CLIN PR, V8, P177, DOI 10.1016/0168-8227(90)90114-9; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pol A, 2001, J CELL BIOL, V152, P1057, DOI 10.1083/jcb.152.5.1057; Puri V, 2003, J BIOL CHEM, V278, P20961, DOI 10.1074/jbc.M300304200; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Sampson LJ, 2004, CIRC RES, V95, P1012, DOI 10.1161/01.RES.0000148634.47095.ab; SKOU JC, 1957, BIOCHIM BIOPHYS ACTA, V23, P394, DOI 10.1016/0006-3002(57)90343-8; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000851; Sun YT, 2005, BIOCHEMISTRY-US, V44, P14455, DOI 10.1021/bi0509090; SWEADNER KJ, 1989, BIOCHIM BIOPHYS ACTA, V988, P185, DOI 10.1016/0304-4157(89)90019-1; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Uittenbogaard A, 2002, J BIOL CHEM, V277, P4925, DOI 10.1074/jbc.M109278200; Uittenbogaard A, 1998, J BIOL CHEM, V273, P6525, DOI 10.1074/jbc.273.11.6525; Wang HJ, 2004, J BIOL CHEM, V279, P17250, DOI 10.1074/jbc.M313239200; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; Xie ZJ, 2001, CELL MOL BIOL, V47, P383; Xie ZJ, 1999, J BIOL CHEM, V274, P19323, DOI 10.1074/jbc.274.27.19323; YEAGLE PL, 1983, BIOCHIM BIOPHYS ACTA, V727, P39, DOI 10.1016/0005-2736(83)90366-8; Yuan ZK, 2005, MOL BIOL CELL, V16, P4034, DOI 10.1091/mbc.E05-04-0295	52	44	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14881	14890		10.1074/jbc.M109.003574	http://dx.doi.org/10.1074/jbc.M109.003574			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19363037	Green Published, hybrid			2022-12-25	WOS:000266288200024
J	Huang, SH; Zhao, L; Sun, ZP; Li, XZ; Geng, Z; Zhang, KD; Chao, MV; Chen, ZY				Huang, Shu-Hong; Zhao, Ling; Sun, Zong-Peng; Li, Xue-Zhi; Geng, Zhao; Zhang, Kai-Di; Chao, Moses V.; Chen, Zhe-Yu			Essential Role of Hrs in Endocytic Recycling of Full-length TrkB Receptor but Not Its Isoform TrkB.T1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; NEUROTROPHIN SIGNAL-TRANSDUCTION; ACTIVITY-DEPENDENT SECRETION; TYROSINE KINASE SUBSTRATE; PROTEIN-COUPLED RECEPTORS; ZINC-FINGER DOMAIN; EARLY ENDOSOMES; MULTIVESICULAR ENDOSOMES; TRUNCATED RECEPTORS; DENDRITIC GROWTH	Brain-derived neurotrophic factor (BDNF) signaling through its receptor, TrkB, modulates survival, differentiation, and synaptic activity of neurons. Both full-length TrkB (TrkB-FL) and its isoform T1 (TrkB.T1) receptors are expressed in neurons; however, whether they follow the same endocytic pathway after BDNF treatment is not known. In this study we report that TrkB-FL and TrkB.T1 receptors traverse divergent endocytic pathways after binding to BDNF. We provide evidence that in neurons TrkB.T1 receptors predominantly recycle back to the cell surface by a "default" mechanism. However, endocytosed TrkB-FL receptors recycle to a lesser extent in a hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs)-dependent manner which relies on its tyrosine kinase activity. The distinct role of Hrs in promoting recycling of internalized TrkB-FL receptors is independent of its ubiquitin-interacting motif. Moreover, Hrs-sensitive TrkB-FL recycling plays a role in BDNF-induced prolonged mitogen-activated protein kinase (MAPK) activation. These observations provide evidence for differential postendocytic sorting of TrkB-FL and TrkB.T1 receptors to alternate intracellular pathways.	[Huang, Shu-Hong; Zhao, Ling; Sun, Zong-Peng; Li, Xue-Zhi; Geng, Zhao; Zhang, Kai-Di; Chen, Zhe-Yu] Shandong Univ, Qilu Hosp, Dept Neurobiol, Key Lab Med Neurobiol,Sch Med, Jinan 250012, Shandong, Peoples R China; [Chen, Zhe-Yu] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan 250012, Shandong, Peoples R China; [Chen, Zhe-Yu] Shandong Univ, Qilu Hosp, Chinese Minist Hlth, Jinan 250012, Shandong, Peoples R China; [Chao, Moses V.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Chao, Moses V.] NYU, Sch Med, Dept Physiol, New York, NY 10016 USA; [Chao, Moses V.] NYU, Sch Med, Dept Neurosci, New York, NY 10016 USA; [Chao, Moses V.] NYU, Sch Med, Dept Psychiat, New York, NY 10016 USA	Shandong University; Shandong University; Shandong University; New York University; New York University; New York University; New York University	Chen, ZY (corresponding author), Shandong Univ, Dept Neurobiol, Sch Med, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.	zheyuchen@sdu.edu.cn	Li, Xuezhi/ABF-6626-2021; Huang, Shuhong/AAI-4151-2021	Chao, Moses/0000-0002-6969-3744; Li, Xuezhi/0000-0003-1030-9688	Natural Science Foundation of China [30671050, 30725020, 30700258, 90713016]; National 973 Basic Research Program of China [2009CB941403, 2009CB526507]; National High-Tech Research and Development Program of China [2006AA02A406]; Chinese Ministry of Education [707040]; Fok Ying Tong Education Foundation [111044]; China Postdoctoral Science Foundation [20070421083, 200702028, 200801406]; Research Fund for the Doctoral Program of Higher Education of China [200804221070]; National Alliance for Research on Schizophrenia and Depression	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Basic Research Program of China(National Basic Research Program of China); National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Chinese Ministry of Education(Ministry of Education, China); Fok Ying Tong Education Foundation(Fok Ying Tung Education Foundation); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Alliance for Research on Schizophrenia and Depression(NARSAD)	This work was supported by Natural Science Foundation of China Grants 30671050, 30725020, 30700258, and 90713016, National 973 Basic Research Program of China Grants 2009CB941403 and 2009CB526507, National High-Tech Research and Development Program of China Grant 2006AA02A406, Cultivation Fund of the Key Science and Technology Innovation Project from Chinese Ministry of Education Grant 707040, Fok Ying Tong Education Foundation Grant 111044, China Postdoctoral Science Foundation Grants 20070421083, 200702028, and 200801406, Research Fund for the Doctoral Program of Higher Education of China Grant 200804221070, and the National Alliance for Research on Schizophrenia and Depression.	Alderson RF, 2000, BRAIN RES, V871, P210, DOI 10.1016/S0006-8993(00)02428-8; ALLENDOERFER KL, 1994, J NEUROSCI, V14, P1795; Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; ARMANINI MP, 1995, EUR J NEUROSCI, V7, P1403, DOI 10.1111/j.1460-9568.1995.tb01132.x; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Baxter GT, 1997, J NEUROSCI, V17, P2683; BIFFO S, 1995, DEVELOPMENT, V121, P2461; Bilodeau PS, 2002, NAT CELL BIOL, V4, P534, DOI 10.1038/ncb815; Chao M, 1998, BRAIN RES REV, V26, P295, DOI 10.1016/S0165-0173(97)00036-2; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Chen ZY, 2005, MOL BIOL CELL, V16, P5761, DOI 10.1091/mbc.E05-07-0651; Chin LS, 2001, J BIOL CHEM, V276, P7069, DOI 10.1074/jbc.M004129200; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Cong M, 2001, J BIOL CHEM, V276, P45145, DOI 10.1074/jbc.M106087200; Dorsey SG, 2006, NEURON, V51, P21, DOI 10.1016/j.neuron.2006.06.009; Eide FF, 1996, J NEUROSCI, V16, P3123; ESCANDON E, 1994, J NEUROSCI, V14, P2054; FRISEN J, 1993, P NATL ACAD SCI USA, V90, P4971, DOI 10.1073/pnas.90.11.4971; Fryer RH, 1997, EXP NEUROL, V148, P616, DOI 10.1006/exnr.1997.6699; Fryer RH, 1996, J COMP NEUROL, V374, P21, DOI 10.1002/(SICI)1096-9861(19961007)374:1<21::AID-CNE2>3.0.CO;2-P; Gage RM, 2001, J BIOL CHEM, V276, P44712, DOI 10.1074/jbc.M107417200; Galet C, 2003, MOL ENDOCRINOL, V17, P411, DOI 10.1210/me.2002-0161; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; Ginty DD, 2002, CURR OPIN NEUROBIOL, V12, P268, DOI 10.1016/S0959-4388(02)00326-4; Grimes ML, 1997, P NATL ACAD SCI USA, V94, P9909, DOI 10.1073/pnas.94.18.9909; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Haapasalo A, 1999, ONCOGENE, V18, P1285, DOI 10.1038/sj.onc.1202401; Hanyaloglu AC, 2005, EMBO J, V24, P2265, DOI 10.1038/sj.emboj.7600688; Hanyaloglu AC, 2007, J BIOL CHEM, V282, P3095, DOI 10.1074/jbc.M605398200; Hasdemir B, 2007, J BIOL CHEM, V282, P29646, DOI 10.1074/jbc.M702974200; Heerssen HM, 2002, TRENDS NEUROSCI, V25, P160, DOI 10.1016/S0166-2236(02)02144-6; Hislop JN, 2004, J BIOL CHEM, V279, P22522, DOI 10.1074/jbc.M311062200; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Jadhav T, 2008, BIOCHEM BIOPH RES CO, V371, P521, DOI 10.1016/j.bbrc.2008.04.138; Jullien J, 2002, J BIOL CHEM, V277, P38700, DOI 10.1074/jbc.M202348200; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; KNUSEL B, 1994, J NEUROSCI, V14, P1542, DOI 10.1523/JNEUROSCI.14-03-01542.1994; KOMADA M, 1995, MOL CELL BIOL, V15, P6213; Komada M, 1997, J BIOL CHEM, V272, P20538, DOI 10.1074/jbc.272.33.20538; Kryl D, 1999, J NEUROSCI, V19, P5823, DOI 10.1523/JNEUROSCI.19-14-05823.1999; Li JG, 2002, J BIOL CHEM, V277, P27545, DOI 10.1074/jbc.M200058200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; Morino C, 2004, EXP CELL RES, V297, P380, DOI 10.1016/j.yexcr.2004.03.038; Ninkina N, 1996, EMBO J, V15, P6385, DOI 10.1002/j.1460-2075.1996.tb01029.x; Pornillos O, 2002, TRENDS CELL BIOL, V12, P569, DOI 10.1016/S0962-8924(02)02402-9; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; Raiborg C, 2001, J CELL SCI, V114, P2255; RUDGE JS, 1994, EUR J NEUROSCI, V6, P693, DOI 10.1111/j.1460-9568.1994.tb00981.x; Santi S, 2006, EMBO J, V25, P4372, DOI 10.1038/sj.emboj.7601303; Saxena S, 2005, MOL CELL NEUROSCI, V28, P571, DOI 10.1016/j.mcn.2004.11.011; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Sommerfeld MT, 2000, J BIOL CHEM, V275, P8982, DOI 10.1074/jbc.275.12.8982; Spellman DS, 2008, MOL CELL PROTEOMICS, V7, P1067, DOI 10.1074/mcp.M700387-MCP200; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048; Stoilov P, 2002, BIOCHEM BIOPH RES CO, V290, P1054, DOI 10.1006/bbrc.2001.6301; Tanowitz M, 2003, J BIOL CHEM, V278, P45978, DOI 10.1074/jbc.M304504200; Tessarollo L, 1998, CYTOKINE GROWTH F R, V9, P125, DOI 10.1016/S1359-6101(98)00003-3; Vargas GA, 2004, J BIOL CHEM, V279, P37461, DOI 10.1074/jbc.M401034200; WETMORE C, 1995, J COMP NEUROL, V353, P143, DOI 10.1002/cne.903530113; Yacoubian TA, 2000, NAT NEUROSCI, V3, P342, DOI 10.1038/73911; Zheng J, 2008, J BIOL CHEM, V283, P13280, DOI 10.1074/jbc.M709930200	68	44	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15126	15136		10.1074/jbc.M809763200	http://dx.doi.org/10.1074/jbc.M809763200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19351881	Green Published, hybrid			2022-12-25	WOS:000266288200048
J	Heuvelin, E; Lebreton, C; Grangette, C; Pot, B; Cerf-Bensussan, N; Heyman, M				Heuvelin, Elise; Lebreton, Corinne; Grangette, Corinne; Pot, Bruno; Cerf-Bensussan, Nadine; Heyman, Martine			Mechanisms Involved in Alleviation of Intestinal Inflammation by Bifidobacterium Breve Soluble Factors	PLOS ONE			English	Article								Objectives: Soluble factors released by Bifidobacterium breve C50 (Bb) alleviate the secretion of pro-inflammatory cytokines by immune cells, but their effect on intestinal epithelium remains elusive. To decipher the mechanisms accounting for the cross-talk between bacteria/soluble factors and intestinal epithelium, we measured the capacity of the bacteria, its conditioned medium (Bb-CM) and other Gram(+) commensal bacteria to dampen inflammatory chemokine secretion. Methods: TNF alpha-induced chemokine (CXCL8) secretion and alteration of NF-kappa B and AP-1 signalling pathways by Bb were studied by EMSA, confocal microscopy and western blotting. Anti-inflammatory capacity was also tested in vivo in a model of TNBS-induced colitis in mice. Results: Bb and Bb-CM, but not other commensal bacteria, induced a time and dose-dependent inhibition of CXCL8 secretion by epithelial cells driven by both AP-1 and NF-kappa B transcription pathways and implying decreased phosphorylation of p38-MAPK and IkB-alpha molecules. In TNBS-induced colitis in mice, Bb-CM decreased the colitis score and inflammatory cytokine expression, an effect reproduced by dendritic cell conditioning with Bb-CM. Conclusions: Bb and secreted soluble factors contribute positively to intestinal homeostasis by attenuating chemokine production. The results indicate that Bb down regulate inflammation at the epithelial level by inhibiting phosphorylations involved in inflammatory processes and by protective conditioning of dendritic cells.			Heuvelin, E (corresponding author), INSERM, U793, Paris, France.	martine.heyman@inserm.fr	Pot, Bruno DF/I-6645-2012; Cerf-Bensussan, nadine/H-9505-2017	Cerf-Bensussan, nadine/0000-0003-0665-1245				Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; Borruel N, 2002, GUT, V51, P659, DOI 10.1136/gut.51.5.659; Foligne B, 2006, DIGEST DIS SCI, V51, P390, DOI 10.1007/s10620-006-3143-x; Foligne B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000313; Gionchetti P, 2000, GASTROENTEROLOGY, V119, P305, DOI 10.1053/gast.2000.9370; Gribar SC, 2008, J LEUKOCYTE BIOL, V83, P493, DOI 10.1189/jlb.0607358; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; ISOLAURI E, 1995, VACCINE, V13, P310, DOI 10.1016/0264-410X(95)93319-5; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Ko JS, 2007, WORLD J GASTROENTERO, V13, P1962, DOI 10.3748/wjg.v13.i13.1962; Lee J, 2006, ANN NY ACAD SCI, V1072, P351, DOI 10.1196/annals.1326.022; Lee J, 2006, NAT CELL BIOL, V8, P1327, DOI 10.1038/ncb1500; Ma DL, 2004, INFECT IMMUN, V72, P5308, DOI 10.1128/IAI.72.9.5308-5314.2004; McCole DF, 2007, CURR OPIN GASTROEN, V23, P647, DOI 10.1097/MOG.0b013e3282f0153b; Menard S, 2004, GUT, V53, P821, DOI 10.1136/gut.2003.026252; MORRIS GP, 1989, GASTROENTEROLOGY, V96, P795, DOI 10.1016/0016-5085(89)90904-9; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Petrof EO, 2004, GASTROENTEROLOGY, V127, P1474, DOI 10.1053/j.gastro.2004.09.001; Rachmilewitz D, 2004, GASTROENTEROLOGY, V126, P520, DOI 10.1053/j.gastro.2003.11.019; Shibolet O, 2007, AM J PHYSIOL-GASTR L, V292, pG1469, DOI 10.1152/ajpgi.00531.2006; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; TEN RM, 1992, EMBO J, V11, P195, DOI 10.1002/j.1460-2075.1992.tb05042.x; Tien MT, 2006, J IMMUNOL, V176, P1228, DOI 10.4049/jimmunol.176.2.1228	23	82	110	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2009	4	4							e5184	10.1371/journal.pone.0005184	http://dx.doi.org/10.1371/journal.pone.0005184			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TW	19381276	Green Published, gold			2022-12-25	WOS:000265510800003
J	Bax, DA; Little, SE; Gaspar, N; Perryman, L; Marshall, L; Viana-Pereira, M; Jones, TA; Williams, RD; Grigoriadis, A; Vassal, G; Workman, P; Sheer, D; Reis, RM; Pearson, ADJ; Hargrave, D; Jones, C				Bax, Dorine A.; Little, Suzanne E.; Gaspar, Nathalie; Perryman, Lara; Marshall, Lynley; Viana-Pereira, Marta; Jones, Tania A.; Williams, Richard D.; Grigoriadis, Anita; Vassal, Gilles; Workman, Paul; Sheer, Denise; Reis, Rui M.; Pearson, Andrew D. J.; Hargrave, Darren; Jones, Chris			Molecular and Phenotypic Characterisation of Paediatric Glioma Cell Lines as Models for Preclinical Drug Development	PLOS ONE			English	Article								Background: Although paediatric high grade gliomas resemble their adult counterparts in many ways, there appear to be distinct clinical and biological differences. One important factor hampering the development of new targeted therapies is the relative lack of cell lines derived from childhood glioma patients, as it is unclear whether the well-established adult lines commonly used are representative of the underlying molecular genetics of childhood tumours. We have carried out a detailed molecular and phenotypic characterisation of a series of paediatric high grade glioma cell lines in comparison to routinely used adult lines. Principal Findings: All lines proliferate as adherent monolayers and express glial markers. Copy number profiling revealed complex genomes including amplification and deletions of genes known to be pivotal in core glioblastoma signalling pathways. Expression profiling identified 93 differentially expressed genes which were able to distinguish between the adult and paediatric high grade cell lines, including a number of kinases and co-ordinated sets of genes associated with DNA integrity and the immune response. Significance: These data demonstrate that glioma cell lines derived from paediatric patients show key molecular differences to those from adults, some of which are well known, whilst others may provide novel targets for evaluation in primary tumours. We thus provide the rationale and demonstrate the practicability of using paediatric glioma cell lines for preclinical and mechanistic studies.			Bax, DA (corresponding author), Inst Canc Res, Paediat Oncol, Sutton, Surrey, England.	chris.jones@icr.ac.uk	Reis, Rui M/C-2859-2009; Reis, Rui Manuel/B-1744-2018; Hargrave, Darren R/H-1066-2014; Corbett-Jones, Tania A/E-4891-2013; Jones, Chris/ABE-6059-2021; Sheer, Denise/C-6705-2011; Viana-Pereira, Marta/E-1317-2014; Jones, Tania/C-8912-2011; Reis, Rui Manuel/AAD-6470-2020	Reis, Rui M/0000-0002-9639-7940; Reis, Rui Manuel/0000-0002-9639-7940; Hargrave, Darren R/0000-0001-8219-9807; Corbett-Jones, Tania A/0000-0002-0067-3382; Jones, Chris/0000-0001-8118-2296; Sheer, Denise/0000-0001-9067-1796; Viana-Pereira, Marta/0000-0003-3087-0624; Jones, Tania/0000-0002-0067-3382; Reis, Rui Manuel/0000-0002-9639-7940; Grigoriadis, Anita/0000-0003-3434-201X	Cancer Research UK [A8318, C1178/A10294, C309/A8274, C309/A2187] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Bar EE, 2008, J NEUROPATH EXP NEUR, V67, P878, DOI 10.1097/NEN.0b013e3181845622; Bobola MS, 2005, CLIN CANCER RES, V11, P2747, DOI 10.1158/1078-0432.CCR-04-2045; Brantley EC, 2008, MOL CANCER RES, V6, P675, DOI 10.1158/1541-7786.MCR-07-2180; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Broniscer A, 2006, J NEURO-ONCOL, V76, P313, DOI 10.1007/s11060-005-7409-5; Broniscer A, 2007, J CLIN ONCOL, V25, P682, DOI 10.1200/JCO.2006.06.8213; Cheng Y, 1999, HUM PATHOL, V30, P1284, DOI 10.1016/S0046-8177(99)90057-6; Cloughesy TF, 2008, PLOS MED, V5, P139, DOI 10.1371/journal.pmed.0050008; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Eils R, 1998, CYTOGENET CELL GENET, V82, P160, DOI 10.1159/000015092; Faury D, 2007, J CLIN ONCOL, V25, P1196, DOI 10.1200/JCO.2006.07.8626; Fruehauf JP, 2006, CLIN CANCER RES, V12, P4523, DOI 10.1158/1078-0432.CCR-05-1830; GASPAR N, DIFFERENTIAL M UNPUB; Gaspar N, 2009, CANCER RES, V69, P1966, DOI 10.1158/0008-5472.CAN-08-3131; Gilles FH, 2000, CANCER-AM CANCER SOC, V88, P1477, DOI 10.1002/(SICI)1097-0142(20000315)88:6<1477::AID-CNCR28>3.3.CO;2-#; Hargrave Darren R, 2007, Expert Rev Neurother, V7, P1029, DOI 10.1586/14737175.7.8.1029; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Jeuken JW, 2007, LAB INVEST, V87, P1055, DOI 10.1038/labinvest.3700664; Johannessen TCA, 2008, CANCER TREAT REV, V34, P558, DOI 10.1016/j.ctrv.2008.03.125; Krupp W, 2004, CANCER GENET CYTOGEN, V153, P32, DOI 10.1016/j.cancergencyto.2003.12.017; Lambros MBK, 2006, LAB INVEST, V86, P398, DOI 10.1038/labinvest.3700390; Ma JG, 2002, BIOCHEM PHARMACOL, V63, P1219, DOI 10.1016/S0006-2952(02)00876-6; McLendon R, 2008, NATURE; Nakamura M, 2007, NEURO-ONCOLOGY, V9, P113, DOI 10.1215/15228517-2006-036; Nicholson HS, 2007, CANCER, V110, P1542, DOI 10.1002/cncr.22961; Nygren AOH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni127; Parkinson JF, 2008, J CLIN NEUROSCI, V15, P1, DOI 10.1016/j.jocn.2007.06.005; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pollack IF, 2006, J CLIN ONCOL, V24, P3431, DOI 10.1200/JCO.2006.05.7265; Potter N, 2008, NEOPLASIA, V10, P757, DOI 10.1593/neo.07914; Rebetz J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001936; Reddy A T, 2001, Curr Neurol Neurosci Rep, V1, P137, DOI 10.1007/s11910-001-0009-7; Rich JN, 2004, J CLIN ONCOL, V22, P133, DOI 10.1200/JCO.2004.08.110; Rickert CH, 2001, AM J PATHOL, V158, P1525, DOI 10.1016/S0002-9440(10)64103-X; Ruggiero A, 2006, J NEURO-ONCOL, V77, P89, DOI 10.1007/s11060-005-9011-2; Stone AR, 2004, AM J PATHOL, V165, P1151, DOI 10.1016/S0002-9440(10)63376-7; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tchirkov A, 2007, BRIT J CANCER, V96, P474, DOI 10.1038/sj.bjc.6603586; WASSON JC, 1990, CANCER RES, V50, P2987; Wen PY, 2006, CLIN CANCER RES, V12, P4899, DOI 10.1158/1078-0432.CCR-06-0773; Wick W, 2006, CURR PHARM DESIGN, V12, P341, DOI 10.2174/138161206775201901; Wong KK, 2006, CANCER RES, V66, P11172, DOI 10.1158/0008-5472.CAN-06-2438	42	89	92	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2009	4	4							e5209	10.1371/journal.pone.0005209	http://dx.doi.org/10.1371/journal.pone.0005209			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TO	19365568	Green Published, Green Submitted, gold			2022-12-25	WOS:000265510000004
J	Woods, DL; Stecker, GC; Rinne, T; Herron, TJ; Cate, AD; Yund, EW; Liao, I; Kang, XJ				Woods, David L.; Stecker, G. Christopher; Rinne, Teemu; Herron, Timothy J.; Cate, Anthony D.; Yund, E. William; Liao, Isaac; Kang, Xiaojian			Functional Maps of Human Auditory Cortex: Effects of Acoustic Features and Attention	PLOS ONE			English	Article								Background: While human auditory cortex is known to contain tonotopically organized auditory cortical fields (ACFs), little is known about how processing in these fields is modulated by other acoustic features or by attention. Methodology/Principal Findings: We used functional magnetic resonance imaging (fMRI) and population-based cortical surface analysis to characterize the tonotopic organization of human auditory cortex and analyze the influence of tone intensity, ear of delivery, scanner background noise, and intermodal selective attention on auditory cortex activations. Medial auditory cortex surrounding Heschl's gyrus showed large sensory (unattended) activations with two mirror-symmetric tonotopic fields similar to those observed in non-human primates. Sensory responses in medial regions had symmetrical distributions with respect to the left and right hemispheres, were enlarged for tones of increased intensity, and were enhanced when sparse image acquisition reduced scanner acoustic noise. Spatial distribution analysis suggested that changes in tone intensity shifted activation within isofrequency bands. Activations to monaural tones were enhanced over the hemisphere contralateral to stimulation, where they produced activations similar to those produced by binaural sounds. Lateral regions of auditory cortex showed small sensory responses that were larger in the right than left hemisphere, lacked tonotopic organization, and were uninfluenced by acoustic parameters. Sensory responses in both medial and lateral auditory cortex decreased in magnitude throughout stimulus blocks. Attention-related modulations (ARMs) were larger in lateral than medial regions of auditory cortex and appeared to arise primarily in belt and parabelt auditory fields. ARMs lacked tonotopic organization, were unaffected by acoustic parameters, and had distributions that were distinct from those of sensory responses. Unlike the gradual adaptation seen for sensory responses, ARMs increased in amplitude throughout stimulus blocks. Conclusions/Significance: The results are consistent with the view that medial regions of human auditory cortex contain tonotopically organized core and belt fields that map the basic acoustic features of sounds while surrounding higher-order parabelt regions are tuned to more abstract stimulus attributes. Intermodal selective attention enhances processing in neuronal populations that are partially distinct from those activated by unattended stimuli.			Woods, DL (corresponding author), VANCHCS, Human Cognit Neurophysiol Lab, Martinez, CA USA.	dlwoods@ucdavis.edu	Rinne, Teemu/A-6090-2009; Cate, Anthony/R-5104-2019	Rinne, Teemu/0000-0002-3142-9438; Cate, Anthony/0000-0003-0135-1622; Herron, Timothy/0000-0002-4297-014X; Woods, David/0000-0002-8804-3587; Yund, E./0000-0002-6833-0052	NIDCD NIH HHS [R01 DC005814] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Alho K, 1999, COGNITIVE BRAIN RES, V7, P335, DOI 10.1016/S0926-6410(98)00036-6; Baumgart F, 1999, NATURE, V400, P724, DOI 10.1038/23390; Behne N, 2005, J NEUROPHYSIOL, V93, P414, DOI 10.1152/jn.00568.2004; BENDOR D, 2008, J NEUROPHYSIOL; Bilecen D, 2002, NEUROIMAGE, V17, P710, DOI 10.1006/nimg.2002.1133; Bilecen D, 1998, HEARING RES, V126, P19, DOI 10.1016/S0378-5955(98)00139-7; Brechmann A, 2002, J NEUROPHYSIOL, V87, P423, DOI 10.1152/jn.00187.2001; Bunzeck N, 2005, NEUROIMAGE, V26, P1119, DOI 10.1016/j.neuroimage.2005.03.013; CASCIARO S, 2008, MAGN RESON IMAGING; Chung MK, 2005, NEUROIMAGE, V25, P1256, DOI 10.1016/j.neuroimage.2004.12.052; Ciaramitaro VM, 2007, J NEUROPHYSIOL, V98, P2399, DOI 10.1152/jn.00580.2007; Clare S, 1999, MAGNET RESON MED, V42, P1117, DOI 10.1002/(SICI)1522-2594(199912)42:6<1117::AID-MRM16>3.0.CO;2-J; Degerman A, 2006, BRAIN RES, V1077, P123, DOI 10.1016/j.brainres.2006.01.025; Desai R, 2005, NEUROIMAGE, V26, P1019, DOI 10.1016/j.neuroimage.2005.03.024; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; Devlin JT, 2003, J NEUROSCI, V23, P11516; Di Salle F, 2001, NEUROIMAGE, V13, P328, DOI 10.1006/nimg.2000.0683; Dorsaint-Pierre R, 2006, BRAIN, V129, P1164, DOI 10.1093/brain/awl055; EKMAN P, 1992, PSYCHOL REV, V99, P550, DOI 10.1037/0033-295X.99.3.550; Engelien A, 2002, NEUROIMAGE, V16, P944, DOI 10.1006/nimg.2002.1149; Formisano E, 2003, NEURON, V40, P859, DOI 10.1016/S0896-6273(03)00669-X; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Fritz JB, 2007, CURR OPIN NEUROBIOL, V17, P437, DOI 10.1016/j.conb.2007.07.011; Gaab N, 2007, HUM BRAIN MAPP, V28, P703, DOI 10.1002/hbm.20298; GALABURDA A, 1980, J COMP NEUROL, V190, P597, DOI 10.1002/cne.901900312; Hackett TA, 2001, J COMP NEUROL, V441, P197, DOI 10.1002/cne.1407; Haist F, 2001, BRAIN LANG, V76, P340, DOI 10.1006/brln.2000.2433; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; Hall DA, 2002, MAGN RESON IMAGING, V20, P695, DOI 10.1016/S0730-725X(02)00607-0; Halpern AR, 2004, NEUROPSYCHOLOGIA, V42, P1281, DOI 10.1016/j.neuropsychologia.2003.12.017; Harms MP, 2002, J NEUROPHYSIOL, V88, P1433, DOI 10.1152/jn.2002.88.3.1433; Hinds OP, 2008, NEUROIMAGE, V39, P1585, DOI 10.1016/j.neuroimage.2007.10.033; Hwang JH, 2005, ORL-J OTO-RHIN-LARYN, V67, P242, DOI 10.1159/000089501; Inan S, 2004, NEUROIMAGE, V21, P886, DOI 10.1016/j.neuroimage.2003.10.029; Jancke L, 1998, NEUROPSYCHOLOGIA, V36, P875, DOI 10.1016/S0028-3932(98)00019-0; Jancke L, 2003, COGNITIVE BRAIN RES, V16, P257, DOI 10.1016/S0926-6410(02)00281-1; Jancke L, 2001, BRAIN LANG, V78, P349, DOI 10.1006/brln.2000.2476; Jancke L, 2002, HEARING RES, V170, P166, DOI 10.1016/S0378-5955(02)00488-4; Johnson JA, 2006, NEUROIMAGE, V31, P1673, DOI 10.1016/j.neuroimage.2006.02.026; Johnsrude IS, 2000, BRAIN, V123, P155, DOI 10.1093/brain/123.1.155; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Kaas JH, 1999, CURR OPIN NEUROBIOL, V9, P164, DOI 10.1016/S0959-4388(99)80022-1; Kang XJ, 2007, MAGN RESON IMAGING, V25, P1070, DOI 10.1016/j.mri.2006.12.005; Kang XJ, 2004, NEUROIMAGE, V22, P1657, DOI 10.1016/j.neuroimage.2004.04.013; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kayser C, 2007, J NEUROSCI, V27, P1824, DOI 10.1523/JNEUROSCI.4737-06.2007; Langers DRM, 2007, NEUROIMAGE, V35, P709, DOI 10.1016/j.neuroimage.2006.12.013; Langers DRM, 2007, NEUROIMAGE, V34, P264, DOI 10.1016/j.neuroimage.2006.09.002; Lasota KJ, 2003, J COMPUT ASSIST TOMO, V27, P213, DOI 10.1097/00004728-200303000-00018; Laurienti PJ, 2002, J COGNITIVE NEUROSCI, V14, P420, DOI 10.1162/089892902317361930; Le TH, 2001, MAGNET RESON MED, V45, P254, DOI 10.1002/1522-2594(200102)45:2<254::AID-MRM1034>3.0.CO;2-J; Lehmann C, 2007, NEUROIMAGE, V34, P1637, DOI 10.1016/j.neuroimage.2006.11.011; Liebenthal E, 2005, CEREB CORTEX, V15, P1621, DOI 10.1093/cercor/bhi040; Lipschutz B, 2002, NEUROIMAGE, V17, P643, DOI 10.1006/nimg.2002.1184; MIDDLEBROOKS JC, 1981, J NEUROSCI, V1, P107, DOI 10.1523/JNEUROSCI.01-01-00107.1981; Mohr CM, 1999, J ACOUST SOC AM, V105, P2738, DOI 10.1121/1.426942; Morosan P, 2001, NEUROIMAGE, V13, P684, DOI 10.1006/nimg.2000.0715; Mozolic JL, 2008, EXP BRAIN RES, V184, P39, DOI 10.1007/s00221-007-1080-3; Mulert C, 2005, NEUROIMAGE, V28, P49, DOI 10.1016/j.neuroimage.2005.05.041; Murray SO, 2004, NAT NEUROSCI, V7, P70, DOI 10.1038/nn1161; Petkov CI, 2006, PLOS BIOL, V4, P1213, DOI 10.1371/journal.pbio.0040215; Petkov CI, 2004, NAT NEUROSCI, V7, P658, DOI 10.1038/nn1256; Powell HWR, 2006, NEUROIMAGE, V32, P388, DOI 10.1016/j.neuroimage.2006.03.011; Pugh KR, 1996, NEUROIMAGE, V4, P159, DOI 10.1006/nimg.1996.0067; Rademacher J, 2001, NEUROIMAGE, V13, P669, DOI 10.1006/nimg.2000.0714; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rauschecker JP, 1998, CURR OPIN NEUROBIOL, V8, P516, DOI 10.1016/S0959-4388(98)80040-8; Recanzone GH, 2008, ANNU REV PSYCHOL, V59, P119, DOI 10.1146/annurev.psych.59.103006.093544; Rinne T, 2005, HUM BRAIN MAPP, V26, P94, DOI 10.1002/hbm.20123; Rinne T, 2007, NEUROREPORT, V18, P1311, DOI 10.1097/WNR.0b013e32826fb3bb; Rinne T, 2007, NEUROSCI LETT, V416, P247, DOI 10.1016/j.neulet.2007.01.077; Sadagopan S, 2008, J NEUROSCI, V28, P3415, DOI 10.1523/JNEUROSCI.2743-07.2008; Scarff CJ, 2004, HUM BRAIN MAPP, V22, P341, DOI 10.1002/hbm.20043; Schmidt CF, 2008, HUM BRAIN MAPP, V29, P46, DOI 10.1002/hbm.20372; Schonwiesner M, 2007, CEREB CORTEX, V17, P492, DOI 10.1093/cercor/bhj165; Schonwiesner M, 2002, NEUROIMAGE, V17, P1144, DOI 10.1006/nimg.2002.1250; SCHREINER CE, 1992, EXP BRAIN RES, V92, P105; Schreiner CE, 2007, NEURON, V56, P356, DOI 10.1016/j.neuron.2007.10.013; Shah NJ, 2000, NEUROIMAGE, V12, P100, DOI 10.1006/nimg.2000.0588; Sigalovsky IS, 2006, NEUROIMAGE, V32, P1524, DOI 10.1016/j.neuroimage.2006.05.023; STUDEBAKER GA, 1987, J ACOUST SOC AM, V81, P1130, DOI 10.1121/1.394633; Sweet RA, 2005, J COMP NEUROL, V491, P270, DOI 10.1002/cne.20702; Talavage TM, 2004, J NEUROPHYSIOL, V91, P1282, DOI 10.1152/jn.01125.2002; Talavage TM, 2000, HEARING RES, V150, P225, DOI 10.1016/S0378-5955(00)00203-3; Tzourio N., 1993, Society for Neuroscience Abstracts, V19, P1285; Upadhyay J, 2007, CEREB CORTEX, V17, P2420, DOI 10.1093/cercor/bhl150; Wessinger CM, 1997, HUM BRAIN MAPP, V5, P18, DOI 10.1002/(SICI)1097-0193(1997)5:1<18::AID-HBM3>3.0.CO;2-Q; Woldorff MG, 1999, HUM BRAIN MAPP, V7, P49, DOI 10.1002/(SICI)1097-0193(1999)7:1<49::AID-HBM5>3.3.CO;2-A; Woodruff PWR, 1996, NEUROREPORT, V7, P1909, DOI 10.1097/00001756-199608120-00007; Yang YH, 2000, MAGNET RESON MED, V43, P185, DOI 10.1002/(SICI)1522-2594(200002)43:2<185::AID-MRM4>3.0.CO;2-3; Yetkin FZ, 2004, LARYNGOSCOPE, V114, P512, DOI 10.1097/00005537-200403000-00024; Yoo SS, 2005, NEUROSCI LETT, V383, P1, DOI 10.1016/j.neulet.2005.03.025; Zaehle T, 2007, RESTOR NEUROL NEUROS, V25, P251	93	112	113	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5183	10.1371/journal.pone.0005183	http://dx.doi.org/10.1371/journal.pone.0005183			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TN	19365552	gold, Green Published, Green Submitted			2022-12-25	WOS:000265509900012
J	Gruber, AJ; Hussain, RJ; O'Donnell, P				Gruber, Aaron J.; Hussain, Rifat J.; O'Donnell, Patricio			The Nucleus Accumbens: A Switchboard for Goal-Directed Behaviors	PLOS ONE			English	Article								Reward intake optimization requires a balance between exploiting known sources of rewards and exploring for new sources. The prefrontal cortex (PFC) and associated basal ganglia circuits are likely candidates as neural structures responsible for such balance, while the hippocampus may be responsible for spatial/contextual information. Although studies have assessed interactions between hippocampus and PFC, and between hippocampus and the nucleus accumbens (NA), it is not known whether 3-way interactions among these structures vary under different behavioral conditions. Here, we investigated these interactions with multichannel recordings while rats explored an operant chamber and while they performed a learned lever-pressing task for reward in the same chamber shortly afterward. Neural firing and local field potentials in the NA core synchronized with hippocampal activity during spatial exploration, but during lever pressing they instead synchronized more strongly with the PFC. The latter is likely due to transient drive of NA neurons by bursting prefrontal activation, as in vivo intracellular recordings in anesthetized rats revealed that NA up states can transiently synchronize with spontaneous PFC activity and PFC stimulation with a bursting pattern reliably evoked up states in NA neurons. Thus, the ability to switch synchronization in a task-dependent manner indicates that the NA core can dynamically select its inputs to suit environmental demands, thereby contributing to decision-making, a function that was thought to primarily depend on the PFC.			Gruber, AJ (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	podon002@umaryland.edu		O'Donnell, Patricio/0000-0001-7788-624X; Gruber, Aaron/0000-0003-2700-5429	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060131] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH060131, MH60131] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		[Anonymous], [No title captured]; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; BERENDSE HW, 1992, J COMP NEUROL, V316, P314, DOI 10.1002/cne.903160305; Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; Block AE, 2007, CEREB CORTEX, V17, P1625, DOI 10.1093/cercor/bhl073; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Carelli RM, 2002, PHYSIOL BEHAV, V76, P379, DOI 10.1016/S0031-9384(02)00760-6; Christakou A, 2004, J NEUROSCI, V24, P773, DOI 10.1523/JNEUROSCI.0949-03.2004; Collins P, 1998, J COGNITIVE NEUROSCI, V10, P332, DOI 10.1162/089892998562771; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; DeCoteau WE, 2007, P NATL ACAD SCI USA, V104, P5644, DOI 10.1073/pnas.0700818104; DeCoteau WE, 2007, J NEUROPHYSIOL, V97, P3800, DOI 10.1152/jn.00108.2007; Floresco SB, 2006, J NEUROSCI, V26, P2449, DOI 10.1523/JNEUROSCI.4431-05.2006; French SJ, 2002, J COMP NEUROL, V446, P151, DOI 10.1002/cne.10191; Fuster J. M., 2015, PREFRONTAL CORTEX, V5th; Gonzalez-Hernandez JA, 2002, HUM BRAIN MAPP, V17, P37, DOI 10.1002/hbm.10051; Goto Y, 2002, J NEUROSCI, V22, P9070; Goto Y, 2001, J NEUROSCI, V21, P4498, DOI 10.1523/JNEUROSCI.21-12-04498.2001; Goto Y, 2001, J NEUROSCI, V21; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; Groenewegen HJ, 1996, PROG BRAIN RES, V107, P485; GRUBER A, 2008, SYNAPSE IN PRESS; Haddon JE, 2006, J NEUROSCI, V26, P2933, DOI 10.1523/JNEUROSCI.3243-05.2006; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Kelley AE, 2004, NEUROSCI BIOBEHAV R, V27, P765, DOI 10.1016/j.neubiorev.2003.11.015; KELLEY AE, 1982, NEUROSCIENCE, V7, P2321, DOI 10.1016/0306-4522(82)90198-1; LEUNG LS, 1993, CAN J PHYSIOL PHARM, V71, P311, DOI 10.1139/y93-049; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Narayanan NS, 2008, J NEUROPHYSIOL, V100, P520, DOI 10.1152/jn.00035.2008; Narayanan NS, 2006, NEURON, V52, P921, DOI 10.1016/j.neuron.2006.10.021; O'Donnell P, 2003, EUR J NEUROSCI, V17, P429, DOI 10.1046/j.1460-9568.2003.02463.x; ODONNELL P, 1995, J NEUROSCI, V15, P3622; Ostlund SB, 2005, J NEUROSCI, V25, P7763, DOI 10.1523/JNEUROSCI.1921-05.2005; Perlstein WM, 2003, BIOL PSYCHIAT, V53, P25, DOI 10.1016/S0006-3223(02)01675-X; Peters YM, 2005, SYNAPSE, V56, P74, DOI 10.1002/syn.20129; Rickert J, 2005, J NEUROSCI, V25, P8815, DOI 10.1523/JNEUROSCI.0816-05.2005; Steriade M, 1998, Sleep Res Online, V1, P1; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Tabuchi ET, 2000, HIPPOCAMPUS, V10, P717, DOI 10.1002/1098-1063(2000)10:6<717::AID-HIPO1009>3.0.CO;2-3; Vertes RP, 2005, HIPPOCAMPUS, V15, P923, DOI 10.1002/hipo.20118	41	81	81	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2009	4	4							e5062	10.1371/journal.pone.0005062	http://dx.doi.org/10.1371/journal.pone.0005062			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RT	19352511	Green Submitted, Green Published, gold			2022-12-25	WOS:000265505300008
J	Hasan, Z; Jamil, B; Ashraf, M; Islam, M; Yusuf, MS; Khan, JA; Hussain, R				Hasan, Zahra; Jamil, Bushra; Ashraf, Mussarat; Islam, Muniba; Yusuf, Muhammad S.; Khan, Javaid A.; Hussain, Rabia			ESAT6-Induced IFN gamma and CXCL9 Can Differentiate Severity of Tuberculosis	PLOS ONE			English	Article								Background: Protective responses against Mycobacterium tuberculosis are dependent on appropriate T cell and macrophage activation. Mycobacterial antigen six kDa early secreted antigenic target (ESAT6) and culture filtrate protein 10 (CFP10) can detect M. tuberculosis specific IFN gamma responses. However, most studies have been performed in non-endemic regions and to study pulmonary tuberculosis (PTB). We have studied ESAT6 and CFP10 induced cytokine and chemokines responses in PTB and extrapulmonary (EPul) TB. Methodology: IFN gamma, IL10, CXCL9 and CCL2 responses were determined using an ex vivo whole blood assay system in PTB (n = 30) and EPulTB patients with limited (LNTB, n = 24) or severe (SevTB, n = 22) disease, and in healthy endemic controls (ECs). Responses to bacterial LPS were also determined. Principal Findings: ESAT6- and CFP10-induced IFN gamma was comparable between ECs and TB patients. Both ESAT6- and CFP10-induced IFN gamma secretion was greater in LNTB than PTB. ESAT6- induced CXCL9 was greater in EPulTB as compared with PTB, with an increase in SevTB as compared with LNTB. CFP10-induced CCL2 was higher in PTB than LNTB patients. LPS-stimulated CXCL9 was greatest in SevTB and LPS-induced CCL2 was increased in PTB as compared with LNTB patients. A positive correlation between ESAT6- induced IFN gamma and CXCL9 was present in all TB patients, but IFN gamma and CCL2 was only correlated in LNTB. ESAT-induced CCL2 and CXCL9 were significantly associated in LNTB while correlation in response to LPS was only present in SevTB. Conclusions: ESAT6 induced IFN gamma and CXCL9 can differentiate between limited and severe TB infections.	[Hasan, Zahra; Ashraf, Mussarat; Islam, Muniba; Yusuf, Muhammad S.; Hussain, Rabia] Aga Khan Univ, Dept Pathol & Microbiol, Karachi, Pakistan; [Jamil, Bushra; Khan, Javaid A.] Aga Khan Univ, Dept Med, Karachi, Pakistan	Aga Khan University; Aga Khan University	Hasan, Z (corresponding author), Aga Khan Univ, Dept Pathol & Microbiol, Karachi, Pakistan.	zahra.hasan@aku.edu	Hussain, Rabia/E-9982-2015; Hasan, Zahra/AAF-2191-2020; Hasan, Zahra/F-5111-2015	Hasan, Zahra/0000-0001-7580-372X; 	UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases; Third World Academy of Sciences for the Developing World (TWAS)	UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases; Third World Academy of Sciences for the Developing World (TWAS)	This investigation received financial support from the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR). The project was partially supported by Research Grant from the Third World Academy of Sciences for the Developing World (TWAS). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abramo C, 2006, MICROBES INFECT, V8, P45, DOI 10.1016/j.micinf.2005.05.019; Algood HMS, 2003, CYTOKINE GROWTH F R, V14, P467, DOI 10.1016/S1359-6101(03)00054-6; Berthet FX, 1998, MICROBIOL-UK, V144, P3195, DOI 10.1099/00221287-144-11-3195; Black GF, 2003, CLIN DIAGN LAB IMMUN, V10, P602, DOI 10.1128/CDLI.10.4.602-611.2003; Bonecini-Almeida MG, 2004, INFECT IMMUN, V72, P2628, DOI 10.1128/IAI.72.5.2628-2634.2004; Brice GT, 2001, J IMMUNOL METHODS, V257, P55, DOI 10.1016/S0022-1759(01)00446-X; Britton WJ, 2005, TUBERCULOSIS, V85, P137, DOI 10.1016/j.tube.2004.06.003; Brock I, 2001, INT J TUBERC LUNG D, V5, P462; Cagatay AA, 2004, SCAND J INFECT DIS, V36, P799, DOI 10.1080/00365540410025339; CHEE CBE, 2008, J CLIN MICROBIOL; Collins HL, 2001, IMMUNOLOGY, V103, P1, DOI 10.1046/j.1365-2567.2001.01236.x; CROFTON J, 1990, CROFTON DOUGLAS RESP, P395; Demissie A, 2006, INFECT IMMUN, V74, P2817, DOI 10.1128/IAI.74.5.2817-2822.2006; Dlugovitzky D, 1997, FEMS IMMUNOL MED MIC, V18, P203, DOI 10.1016/S0928-8244(97)00040-0; Ebdrup L, 2003, SCAND J INFECT DIS, V35, P244, DOI 10.1080/00365540310000274; Flynn JL, 2000, CURR OPIN IMMUNOL, V12, P432, DOI 10.1016/S0952-7915(00)00116-3; GONZALEZJUARRER.M, 2008, AM J RESP CELL M SEP; Harboe M, 1996, INFECT IMMUN, V64, P16, DOI 10.1128/IAI.64.1.16-22.1996; Hasan Z, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-14; Hasan Z, 2006, SCAND J IMMUNOL, V63, P241, DOI 10.1111/j.1365-3083.2006.01733.x; Hasan Z, 2009, SCAND J IMMUNOL, V69, P259, DOI 10.1111/j.1365-3083.2008.02217.x; Hussain R, 2002, J IMMUNOL METHODS, V264, P95, DOI 10.1016/S0022-1759(02)00092-3; HUSSAIN R, 1996, ASIAN J TROP MED PUB, V27, P1; Hussain R, 2007, CLIN VACCINE IMMUNOL, V14, P1578, DOI 10.1128/CVI.00289-07; Jamil B, 2007, TUBERCULOSIS, V87, P279, DOI 10.1016/j.tube.2007.03.004; Kobashi Y, 2008, CHEST, V7, P1995; Mastroianni CM, 1998, CLIN EXP IMMUNOL, V114, P210; Mazurek GH, 2007, CLIN INFECT DIS, V45, P837, DOI 10.1086/521107; Mendez-Samperio P, 2002, CLIN DIAGN LAB IMMUN, V9, P802, DOI 10.1128/CDLI.9.4.802-807.2002; Murray PJ, 1999, INFECT IMMUN, V67, P3087, DOI 10.1128/IAI.67.6.3087-3095.1999; Pathan AA, 2001, J IMMUNOL, V167, P5217, DOI 10.4049/jimmunol.167.9.5217; Ravn P, 2005, CLIN DIAGN LAB IMMUN, V12, P491, DOI 10.1128/CDLI.12.4.491-496.2005; Ruhwald M, 2008, EUR RESPIR J, V32, P1607, DOI 10.1183/09031936.00055508; Sahiratmadja E, 2007, INFECT IMMUN, V75, P820, DOI 10.1128/IAI.00602-06; Scott HM, 2002, INFECT IMMUN, V70, P5946, DOI 10.1128/IAI.70.11.5946-5954.2002; Sharma SK, 2002, J CLIN IMMUNOL, V22, P345, DOI 10.1023/A:1020604331886; Thwaites GE, 2003, J INFECT DIS, V188, P1105, DOI 10.1086/378642; Ulrichs T, 2005, J INFECT DIS, V192, P89, DOI 10.1086/430621; Ulrichs T, 2000, INFECT IMMUN, V68, P6073, DOI 10.1128/IAI.68.10.6073-6076.2000; Ulrichs T, 2000, INT J TUBERC LUNG D, V4, P1181; Walrath E, 2005, AM J RESP CELL MOL, V33, P48, DOI 10.1165/rcmb.2005-0060OC; Weir RE, 2004, INFECT IMMUN, V72, P1807, DOI 10.1128/IAI.72.3.1807-1811.2004; Weir RE, 2008, TUBERCULOSIS, V88, P31, DOI 10.1016/j.tube.2007.10.001; Whiting D, 2004, J IMMUNOL, V172, P7417, DOI 10.4049/jimmunol.172.12.7417; *WHO, 2008, COUNTR PROF PAK, P133	45	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5158	10.1371/journal.pone.0005158	http://dx.doi.org/10.1371/journal.pone.0005158			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340290	Green Submitted, Green Published, gold			2022-12-25	WOS:000265500700028
J	Faghiri, Z; Skelly, PJ				Faghiri, Zahra; Skelly, Patrick J.			The role of tegumental aquaporin from the human parasitic worm, Schistosoma mansoni, in osmoregulation and drug uptake	FASEB JOURNAL			English	Article						platyhelminth; RNAi; metabolite transport; antimonial; tegument	AMINO-ACID-TRANSPORT; GLUCOSE-TRANSPORTER; SURFACE; PROTEINS; PHOSPHOFRUCTOKINASE; ANTIMONIALS; SUPPRESSION; INHIBITION; APPEARANCE; EXPRESSION	Schistosomes are parasitic platyhelminths that constitute an important public health problem globally. Infection is characterized by the presence of adult worms within the vasculature of their hosts, where they can reside for many years. The worms are covered by an unusual dual lipid bilayer through which they import nutrients. How the parasites import other vital molecules, such as water, is not known. Recent proteomic analysis of the schistosome tegumental membranes revealed the presence of an aquaporin homologue at the host-interactive surface whose cDNA we have cloned and characterized. The cDNA encodes a predicted 304-aa protein (SmAQP) that is found largely in the parasite tegument by immunolocalization and is most highly expressed in the intravascular life stages. Treatment of parasites with short interfering RNAs targeting the SmAQP gene results in potent (>90%) suppression. These suppressed parasites resist swelling when placed in hypotonic medium, unlike their control counterparts, which rapidly double in volume. In addition, SmAQP-suppressed parasites, unlike controls, resist shrinkage when incubated in hyperosmotic solution. While suppressed parasites exhibit lower viability in culture relative to controls and exhibit a stunted appearance following prolonged suppression, they are nonetheless more resistant to killing by the drug potassium antimonyl tartrate (PAT). This is likely because SmAQP acts as a conduit for this drug, as is the case for aquaporins in other systems. These experiments reveal a heretofore unrecognized role of the schistosome tegument in controlling water and drug movement into the parasites and highlight the importance of the tegument in parasite osmoregulation and drug uptake.-Faghiri, Z., Skelly, P. J. The role of tegumental aquaporin from the human parasitic worm, Schistosoma mansoni, in osmoregulation and drug uptake. FASEB J. 23, 2780-2789 ( 2009)	[Faghiri, Zahra; Skelly, Patrick J.] Tufts Univ, Cummings Sch Vet Med, Mol Helminthol Lab, Div Infect Dis,Dept Biomed Sci, Grafton, MA USA	Tufts University	Skelly, PJ (corresponding author), Tufts Univ, Cummings Sch Vet Med, Dept Biomed Sci, 200 Westboro Rd, North Grafton, MA 01536 USA.	patrick.skelly@tufts.edu			NIH-NIAID [N01-AI-30026, AI-056273]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056273, R01AI030026] Funding Source: NIH RePORTER	NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr. Greice Krautz-Peterson and Dr. Chuck Shoemaker for helpful comments and David Ndegwa for technical assistance. Schistosome-infected snails were provided by the Biomedical Research Institute through National Institutes of Health-National Institute of Allergy and Infectious Diseases (NIH-NIAID) contract N01-AI-30026. This work was supported by NIH-NIAID grant AI-056273.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bienert GP, 2008, TRENDS BIOCHEM SCI, V33, P20, DOI 10.1016/j.tibs.2007.10.004; Braschi S, 2006, PROTEOMICS, V6, P1471, DOI 10.1002/pmic.200500368; Braschi S, 2006, MOL CELL PROTEOMICS, V5, P347, DOI 10.1074/mcp.M500287-MCP200; BUEDING E, 1957, BRIT J PHARM CHEMOTH, V12, P159, DOI 10.1111/j.1476-5381.1957.tb00114.x; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Correnti JA, 2005, MOL BIOCHEM PARASIT, V143, P209, DOI 10.1016/j.molbiopara.2005.06.007; Ghaleb H A, 1979, J Egypt Med Assoc, V62, P1; Gonen T, 2006, Q REV BIOPHYS, V39, P361, DOI 10.1017/S0033583506004458; Gourbal B, 2004, J BIOL CHEM, V279, P31010, DOI 10.1074/jbc.M403959200; Hackett F, 1993, Methods Mol Biol, V21, P89; HOCKLEY D J, 1973, International Journal for Parasitology, V3, P13, DOI 10.1016/0020-7519(73)90004-0; Jiang JW, 1996, EXP PARASITOL, V82, P201, DOI 10.1006/expr.1996.0025; JONES JT, 1988, MOL BIOCHEM PARASIT, V30, P35, DOI 10.1016/0166-6851(88)90130-2; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; King CH, 2008, CHRONIC ILLN, V4, P65, DOI 10.1177/1742395307084407; Koukounari A, 2007, J INFECT DIS, V196, P659, DOI 10.1086/520515; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Krautz-Peterson G, 2007, J BIOL CHEM, V282, P21767, DOI 10.1074/jbc.M703512200; Kuntz AN, 2007, PLOS MED, V4, P1071, DOI 10.1371/journal.pmed.0040206; Liu ZJ, 2002, P NATL ACAD SCI USA, V99, P6053, DOI 10.1073/pnas.092131899; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mastroberardino L, 1998, NATURE, V395, P288, DOI 10.1038/26246; MCLAREN DJ, 1977, NATURE, V269, P147, DOI 10.1038/269147a0; MORRIS GP, 1968, J PARASITOL, V54, P15, DOI 10.2307/3276867; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; RODRIGUEZMOLINA R, 1950, AM J TROP MED, V30, P881; Sanders OI, 1997, J BACTERIOL, V179, P3365, DOI 10.1128/jb.179.10.3365-3367.1997; Skelly PJ, 2006, ADV PARASIT, V63, P185, DOI 10.1016/S0065-308X(06)63003-0; Skelly PJ, 1996, P NATL ACAD SCI USA, V93, P3642, DOI 10.1073/pnas.93.8.3642; SKELLY PJ, 1994, J BIOL CHEM, V269, P4247; Skelly PJ, 2003, INT J PARASITOL, V33, P363, DOI 10.1016/S0020-7519(03)00030-4; Skelly PJ, 2001, PARASITOLOGY, V123, P277, DOI 10.1017/S0031182001008484; SMITH JH, 1969, AM J TROP MED HYG, V18, P28, DOI 10.4269/ajtmh.1969.18.28; Su JGJ, 1996, MOL BIOCHEM PARASIT, V81, P171, DOI 10.1016/0166-6851(96)02702-8; Threadgold L. T., 1984, Biology of the integument. 1. Invertebrates, P132; Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737; Tsukaguchi H, 1999, AM J PHYSIOL-RENAL, V277, pF685, DOI 10.1152/ajprenal.1999.277.5.F685; WILSON RA, 1974, PARASITOLOGY, V68, P239, DOI 10.1017/S0031182000045765; ZHONG C, 1995, PARASITOLOGY, V110, P383, DOI 10.1017/S0031182000064726	40	74	80	0	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2780	2789		10.1096/fj.09-130757	http://dx.doi.org/10.1096/fj.09-130757			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19364765	Green Published			2022-12-25	WOS:000268836700046
J	daCosta, CJB; Baenziger, JE				daCosta, Corrie J. B.; Baenziger, John E.			A Lipid-dependent Uncoupled Conformation of the Acetylcholine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION-CHANNEL; TORPEDO POSTSYNAPTIC MEMBRANES; X-RAY-STRUCTURE; TRYPTOPHAN SUBSTITUTIONS; TRANSMEMBRANE SEGMENT; BINDING-SITE; CALIFORNICA; LIGAND; M4; MUTATIONS	Lipids influence the ability of Cys-loop receptors to gate open in response to neurotransmitter binding, but the underlying mechanisms are poorly understood. With the nicotinic acetylcholine receptor (nAChR) from Torpedo, current models suggest that lipids modulate the natural equilibrium between resting and desensitized conformations. We show that the lipid-inactivated nAChR is not desensitized, instead it adopts a novel conformation where the allosteric coupling between its neuro-transmitter-binding sites and transmembrane pore is lost. The uncoupling is accompanied by an unmasking of previously buried residues, suggesting weakened association between structurally intact agonist-binding and transmembrane domains. These data combined with the extensive literature on Cys-loop receptor-lipid interactions suggest that the M4 transmembrane helix plays a key role as a lipid-sensor, translating bilayer properties into altered nAChR function.	[daCosta, Corrie J. B.; Baenziger, John E.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada	University of Ottawa	daCosta, CJB (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada.	corrie@dacosta.net; jebaenz@uottawa.ca		Baenziger, John/0000-0002-2888-5328	Canadian Institutes of Health Research; Canadian Graduate Scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Graduate Scholarship	This work was supported by the Canadian Institutes of Health Research and a Canadian Graduate Scholarship (to C. J. B. D.).	Arias HR, 2003, BIOCHEMISTRY-US, V42, P7358, DOI 10.1021/bi034052n; Baenziger JE, 2000, J BIOL CHEM, V275, P777, DOI 10.1074/jbc.275.2.777; Baenziger JE, 2008, MOL PHARMACOL, V73, P880, DOI 10.1124/mol.107.039008; Barrantes FJ, 2004, BRAIN RES REV, V47, P71, DOI 10.1016/j.brainresrev.2004.06.008; Bertrand D, 2007, BIOCHEM PHARMACOL, V74, P1155, DOI 10.1016/j.bcp.2007.07.011; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bouzat C, 1998, MOL PHARMACOL, V54, P146, DOI 10.1124/mol.54.1.146; BOYD ND, 1980, BIOCHEMISTRY-US, V19, P5344, DOI 10.1021/bi00564a031; BOYD ND, 1980, BIOCHEMISTRY-US, V19, P5353, DOI 10.1021/bi00564a032; Brannigan G, 2008, P NATL ACAD SCI USA, V105, P14418, DOI 10.1073/pnas.0803029105; CRIADO M, 1984, J BIOL CHEM, V259, P9188; daCosta C.J.B., 2006, THESIS U OTTAWA OTTA; daCosta CJB, 2005, BIOPHYS J, V88, P1755, DOI 10.1529/biophysj.104.052944; daCosta CJB, 2002, J BIOL CHEM, V277, P201, DOI 10.1074/jbc.M108341200; EPSTEIN M, 1978, J BIOL CHEM, V253, P6660; FONG TM, 1986, BIOCHEMISTRY-US, V25, P830, DOI 10.1021/bi00352a015; Hamouda AK, 2006, BIOCHEMISTRY-US, V45, P4327, DOI 10.1021/bi052281z; HEIDMANN T, 1980, EUR J BIOCHEM, V110, P35, DOI 10.1111/j.1432-1033.1980.tb04839.x; HERZ JM, 1987, J BIOL CHEM, V262, P7238; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Katz EJ, 1997, TOXICOL APPL PHARM, V146, P227, DOI 10.1006/taap.1997.8201; KRODEL EK, 1979, MOL PHARMACOL, V15, P294; Lasalde JA, 1996, BIOCHEMISTRY-US, V35, P14139, DOI 10.1021/bi961583l; LEE YH, 1994, BIOPHYS J, V66, P646, DOI 10.1016/S0006-3495(94)80838-0; LI L, 1992, BIOPHYS J, V62, P61, DOI 10.1016/S0006-3495(92)81779-4; MCCARTHY MP, 1992, J BIOL CHEM, V267, P7655; METHOT N, 1995, BIOCHEMISTRY-US, V34, P15142, DOI 10.1021/bi00046a021; Mitra A, 2004, STRUCTURE, V12, P1909, DOI 10.1016/j.str.2004.08.004; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Pagan OR, 2001, BIOCHEMISTRY-US, V40, P11121, DOI 10.1021/bi0112255; Paradiso K, 2001, J NEUROSCI, V21, P6561, DOI 10.1523/JNEUROSCI.21-17-06561.2001; Rankin SE, 1997, BIOPHYS J, V73, P2446, DOI 10.1016/S0006-3495(97)78273-0; Ridder A, 2005, J MOL BIOL, V354, P894, DOI 10.1016/j.jmb.2005.09.084; Ryan SE, 2002, J BIOL CHEM, V277, P10420, DOI 10.1074/jbc.M107412200; Ryan SE, 2001, J BIOL CHEM, V276, P4796, DOI 10.1074/jbc.M007063200; Ryan SE, 1999, MOL PHARMACOL, V55, P348, DOI 10.1124/mol.55.2.348; Shen XM, 2006, ANN NEUROL, V60, P128, DOI 10.1002/ana.20861; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Tamamizu S, 2000, BIOCHEMISTRY-US, V39, P4666, DOI 10.1021/bi992835w; TOBIMATSU T, 1987, FEBS LETT, V222, P56, DOI 10.1016/0014-5793(87)80191-6; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105	44	82	82	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17819	17825		10.1074/jbc.M900030200	http://dx.doi.org/10.1074/jbc.M900030200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19357079	Green Published, hybrid			2022-12-25	WOS:000267202500047
J	Huang, CC; Yoshino-Koh, K; Tesmer, JJG				Huang, Chih-chin; Yoshino-Koh, Kae; Tesmer, John J. G.			A Surface of the Kinase Domain Critical for the Allosteric Activation of G Protein-coupled Receptor Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; G-BETA-GAMMA; RHODOPSIN KINASE; BETA(2)-ADRENERGIC RECEPTOR; MOTIF PHOSPHORYLATION; CRYSTAL-STRUCTURE; TERMINAL TAIL; MECHANISM; IDENTIFICATION; COMPLEX	G protein-coupled receptor ( GPCR) kinases (GRKs) phosphorylate activated GPCRs and initiate their desensitization. Many prior studies suggest that activated GPCRs dock to an allosteric site on the GRKs and thereby stimulate kinase activity. The extreme N-terminal region of GRKs is clearly involved in this process, but its role is not understood. Using our recent structure of bovine GRK1 as a guide, we generated mutants of solvent-exposed residues in the GRK1 kinase domain that are conserved among GRKs but not in the extended protein kinase A, G, and C family and evaluated their catalytic activity. Mutation of select residues in strands beta 1 and beta 3 of the kinase small lobe, alpha D of the kinase large lobe, and the protein kinase A, G, and C kinase C-tail greatly impaired receptor phosphorylation. The most dramatic effect was observed for mutation of an invariant arginine on the beta 1-strand (similar to 1000-fold decrease in k(cat)/K-m). These residues form a continuous surface that is uniquely available in GRKs for protein-protein interactions. Surprisingly, these mutants, as well as a 19-amino acid N-terminal truncation of GRK1, also show decreased catalytic efficiency for peptide substrates, although to a lesser extent than for receptor phosphorylation. Our data suggest that the N-terminal region and the newly identified surface interact and stabilize the closed, active conformation of the kinase domain. Receptor binding is proposed to promote this interaction, thereby enhancing GRK activity.	[Huang, Chih-chin; Yoshino-Koh, Kae; Tesmer, John J. G.] Univ Michigan, Dept Pharmacol, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Tesmer, JJG (corresponding author), 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	johntesmer@umich.edu		Tesmer, John/0000-0003-1125-3727	National Institutes of Health [HL086865, HL071818]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086865, R01HL071818] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL086865 and HL071818 (to J.J.G.T.).	Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; Batkin M, 2000, BIOCHEMISTRY-US, V39, P5366, DOI 10.1021/bi000153z; CHEN CK, 1995, J BIOL CHEM, V270, P18060, DOI 10.1074/jbc.270.30.18060; CHEN CY, 1993, J BIOL CHEM, V268, P7825; DebBurman SK, 1996, J BIOL CHEM, V271, P22552, DOI 10.1074/jbc.271.37.22552; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FERGUSON SSG, 1995, J BIOL CHEM, V270, P24782, DOI 10.1074/jbc.270.42.24782; Gold MG, 2006, CURR OPIN STRUC BIOL, V16, P693, DOI 10.1016/j.sbi.2006.10.006; Goldsmith EJ, 2007, CHEM REV, V107, P5065, DOI 10.1021/cr068221w; Hauge C, 2007, EMBO J, V26, P2251, DOI 10.1038/sj.emboj.7601682; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; KIM CM, 1993, J BIOL CHEM, V268, P15412; KIM CM, 1993, RECEPTOR, V3, P39; Krasel C, 2008, J BIOL CHEM, V283, P31840, DOI 10.1074/jbc.M806086200; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; KUNAPULI P, 1994, J BIOL CHEM, V269, P1099; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lodowski DT, 2006, J BIOL CHEM, V281, P16785, DOI 10.1074/jbc.M601327200; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Lodowski DT, 2005, BIOCHEMISTRY-US, V44, P6958, DOI 10.1021/bi050119q; Madhusudan, 2002, NAT STRUCT BIOL, V9, P273, DOI 10.1038/nsb780; McCarthy NEM, 2002, BIOCHEM J, V363, P359, DOI 10.1042/0264-6021:3630359; Metaye T, 2005, CELL SIGNAL, V17, P917, DOI 10.1016/j.cellsig.2005.01.002; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Noble B, 2003, J BIOL CHEM, V278, P47466, DOI 10.1074/jbc.M308257200; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; ONORATO JJ, 1991, BIOCHEMISTRY-US, V30, P5118, DOI 10.1021/bi00235a002; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P12949; PALCZEWSKI K, 1993, J BIOL CHEM, V268, P6004; PALCZEWSKI K, 1988, BIOCHEMISTRY-US, V27, P2306, DOI 10.1021/bi00407a010; PALCZEWSKI K, 1991, TRENDS BIOCHEM SCI, V16, P387, DOI 10.1016/0968-0004(91)90157-Q; PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P240; Pellicena P, 2006, CURR OPIN STRUC BIOL, V16, P702, DOI 10.1016/j.sbi.2006.10.007; Pitcher JA, 1996, J BIOL CHEM, V271, P24907, DOI 10.1074/jbc.271.40.24907; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Seibold A, 2000, MOL PHARMACOL, V58, P1162, DOI 10.1124/mol.58.5.1162; Singh P, 2008, J BIOL CHEM, V283, P14053, DOI 10.1074/jbc.M708974200; Smith CM, 1997, TRENDS BIOCHEM SCI, V22, P444, DOI 10.1016/S0968-0004(97)01131-6; STERNEMARR R, 2009, BIOCHEMISTR IN PRESS; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tran TM, 2007, BIOCHEMISTRY-US, V46, P14438, DOI 10.1021/bi700922h; Vaughan DJ, 2006, J BIOL CHEM, V281, P7684, DOI 10.1074/jbc.M500328200; Whalen EJ, 2007, CELL, V129, P511, DOI 10.1016/j.cell.2007.02.046; Xu ZB, 2004, J BIOL CHEM, V279, P50401, DOI 10.1074/jbc.M409216200; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Yu QM, 1999, J NEUROCHEM, V73, P1222, DOI 10.1046/j.1471-4159.1999.0731222.x	49	52	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17206	17215		10.1074/jbc.M809544200	http://dx.doi.org/10.1074/jbc.M809544200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19364770	Green Published, hybrid			2022-12-25	WOS:000266962400058
J	Mi, LX; Gan, NQ; Cheema, A; Dakshanamurthy, S; Wang, XT; Yang, DCH; Chung, FL				Mi, Lixin; Gan, Nanqin; Cheema, Amrita; Dakshanamurthy, Sivanesan; Wang, Xiantao; Yang, David C. H.; Chung, Fung-Lung			Cancer Preventive Isothiocyanates Induce Selective Degradation of Cellular alpha- and beta-Tubulins by Proteasomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHENETHYL ISOTHIOCYANATE; GROWTH ARREST; APOPTOSIS; CELLS; SULFORAPHANE; PROTEINS; BINDING; MECHANISMS; MICROTUBULES; AUTOPHAGY	Although it is conceivable that cancer preventive isothiocyanates (ITCs), a family of compounds in cruciferous vegetables, induce cell cycle arrest and apoptosis through a mechanism involving oxidative stress, our study shows that binding to cellular proteins correlates with their potencies of apoptosis induction. More recently, we showed that ITCs bind selectively to tubulins. The differential binding affinities toward tubulin among benzyl isothiocyanate, phenethyl isothiocyanate, and sulforaphane correlate well with their potencies of inducing tubulin conformation changes, microtubule depolymerization, and eventual cell cycle arrest and apoptosis in human lung cancer A549 cells. These results support that tubulin binding by ITCs is an early event for cell growth inhibition. Here we demonstrate that ITCs can selectively induce degradation of both alpha- and beta-tubulins in a variety of human cancer cell lines in a dose- and time-dependent manner. The onset of degradation, a rapid and irreversible process, is initiated by tubulin aggregation, and the degradation is proteasome-dependent. Results indicate that the degradation is triggered by ITC binding to tubulin and is irrelevant to oxidative stress. This is the first report that tubulin, a stable and abundant cytoskeleton protein required for cell cycle progression, can be selectively degraded by a small molecule.	[Mi, Lixin; Gan, Nanqin; Cheema, Amrita; Dakshanamurthy, Sivanesan; Wang, Xiantao] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA; [Yang, David C. H.; Chung, Fung-Lung] Georgetown Univ, Dept Chem, Washington, DC 20057 USA	Georgetown University; Georgetown University	Mi, LX (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, 3800 Reservoir Rd,LL 129,Box 571465, Washington, DC 20057 USA.	lm293@georgetown.edu; flc6@georgetown.edu	Dakshanamurthy, Sivanesan/CAF-4258-2022; Yang, David/A-7294-2009	Dakshanamurthy, Sivanesan/0000-0003-3681-4121; 	National Institutes of Health; NCI [CA100853]; NATIONAL CANCER INSTITUTE [R01CA100853] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA100853 from NCI.	Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; BENZEEV A, 1979, CELL, V17, P319, DOI 10.1016/0092-8674(79)90157-0; Chen YR, 1998, J BIOL CHEM, V273, P1769, DOI 10.1074/jbc.273.3.1769; Chiao JW, 2002, INT J ONCOL, V20, P631; CLEVELAND DW, 1983, NATURE, V305, P738, DOI 10.1038/305738a0; CLEVELAND DW, 1981, CELL, V25, P537, DOI 10.1016/0092-8674(81)90072-6; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Downing KH, 1999, CELL STRUCT FUNCT, V24, P269; Ferrington DA, 2001, J BIOL CHEM, V276, P937, DOI 10.1074/jbc.M005356200; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Herman-Antosiewicz A, 2006, CANCER RES, V66, P5828, DOI 10.1158/0008-5472.CAN-06-0139; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Liu Y, 2007, CANCER RES, V67, P10207, DOI 10.1158/0008-5472.CAN-07-2574; Mi LX, 2008, J BIOL CHEM, V283, P22136, DOI 10.1074/jbc.M802330200; Mi LX, 2007, CANCER RES, V67, P6409, DOI 10.1158/0008-5472.CAN-07-0340; Nogales E, 2000, ANNU REV BIOCHEM, V69, P277, DOI 10.1146/annurev.biochem.69.1.277; NOGALES E, 1995, NATURE, V375, P424, DOI 10.1038/375424a0; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pierce A, 2008, MOL CELL PROTEOMICS, V7, P853, DOI 10.1074/mcp.M700251-MCP200; Salmeen A, 2005, ANTIOXID REDOX SIGN, V7, P560, DOI 10.1089/ars.2005.7.560; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Shringarpure R, 2003, J BIOL CHEM, V278, P311, DOI 10.1074/jbc.M206279200; Singh SV, 2005, J BIOL CHEM, V280, P19911, DOI 10.1074/jbc.M412443200; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; White E, 1996, GENE DEV, V10, P1, DOI 10.1101/gad.10.1.1; *WHO, 2004, IARC HDB CANC PREV, V9, P43; Xiao D, 2005, MOL CARCINOGEN, V43, P130, DOI 10.1002/mc.20099; Xirodimas D, 2001, ONCOGENE, V20, P4972, DOI 10.1038/sj.onc.1204656; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Yang YM, 2005, CANCER RES, V65, P8538, DOI 10.1158/0008-5472.CAN-05-0236; Zhang YS, 2005, FREE RADICAL BIO MED, V38, P70, DOI 10.1016/j.freeradbiomed.2004.09.033; Zhang YS, 1998, CANCER RES, V58, P4632	36	95	96	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17039	17051		10.1074/jbc.M901789200	http://dx.doi.org/10.1074/jbc.M901789200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19339240	Green Published, hybrid			2022-12-25	WOS:000266962400042
J	Hong, KU; Kim, HJ; Kim, HS; Seong, YS; Hong, KM; Bae, CD; Park, J				Hong, Kyung Uk; Kim, Hyun-Jun; Kim, Hyo-Sil; Seong, Yeon-Sun; Hong, Kyeong-Man; Bae, Chang-Dae; Park, Joobae			Cdk1-Cyclin B1-mediated Phosphorylation of Tumor-associated Microtubule-associated Protein/Cytoskeleton-associated Protein 2 in Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS EGG EXTRACTS; CYTOSKELETON-ASSOCIATED PROTEIN; DEPENDENT KINASE CDK1; MITOTIC SPINDLE; CELL-CYCLE; M-PHASE; CDC2 KINASE; HELA-CELLS; IN-VIVO; DYNAMICS	During mitosis, establishment of structurally and functionally sound bipolar spindles is necessary for maintaining the fidelity of chromosome segregation. Tumor-associated microtubule-associated protein (TMAP), also known as cytoskeleton-associated protein 2 (CKAP2), is a mitotic spindle-associated protein whose level is frequently up-regulated in various malignancies. Previous reports have suggested that TMAP is a potential regulator of mitotic spindle assembly and dynamics and that it is required for chromosome segregation to occur properly. So far, there have been no reports on how its mitosis-related functions are regulated. Here, we report that TMAP is hyper-phosphorylated at the C terminus specifically during mitosis. At least four different residues (Thr-578, Thr-596, Thr-622, and Ser-627) were responsible for the mitosis-specific phosphorylation of TMAP. Among these, Thr-622 was specifically phosphorylated by Cdk1-cyclin B1 both in vitro and in vivo. Interestingly, compared with the wild type, a phosphorylation-deficient mutant form of TMAP, in which Thr-622 had been replaced with an alanine (T622A), induced a significant increase in the frequency of metaphase cells with abnormal bipolar spindles, which often displayed disorganized, asymmetrical, or narrow and elongated morphologies. Formation of these abnormal bipolar spindles subsequently resulted in misalignment of metaphase chromosomes and ultimately caused a delay in the entry into anaphase. Moreover, such defects resulting from the T622A mutation were associated with a decrease in the rate of protein turnover at spindle microtubules. These findings suggest that Cdk1-cyclin B1-mediated phosphorylation of TMAP is important for and contributes to proper regulation of microtubule dynamics and establishment of functional bipolar spindles during mitosis.	[Hong, Kyung Uk; Kim, Hyun-Jun; Kim, Hyo-Sil; Bae, Chang-Dae; Park, Joobae] Sungkyunkwan Univ, Dept Mol Cell Biol, Sch Med, Suwon 440769, South Korea; [Hong, Kyung Uk; Kim, Hyun-Jun; Kim, Hyo-Sil; Bae, Chang-Dae; Park, Joobae] Sungkyunkwan Univ, Samsung Biomed Res Inst, Sch Med, Suwon 440769, South Korea; [Seong, Yeon-Sun] Dankook Univ, Dept Biochem, Coll Med, Cheonan 330714, Chungnam, South Korea; [Hong, Kyeong-Man] Natl Canc Ctr, Res Inst, Goyang Si 410769, South Korea	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Dankook University; National Cancer Center - Korea (NCC)	Bae, CD (corresponding author), Sungkyunkwan Univ, Dept Mol Cell Biol, Sch Med, 300 Chunchundong, Suwon 440746, South Korea.	cdbae@med.skku.ac.kr; jbpark@med.skku.ac.kr	Hong, Kyung Uk/G-7145-2011; SEONG, YEON-SUN/B-2485-2016	Hong, Kyung Uk/0000-0001-6700-9470; SEONG, YEON-SUN/0000-0002-4743-8048	Ministry of Health and Welfare, Republic of Korea [0720370]	Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by the National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea (Grant 0720370).	Bae CD, 2003, J CANCER RES CLIN, V129, P621, DOI 10.1007/s00432-003-0484-0; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Cha HJ, 2007, J BIOL CHEM, V282, P22984, DOI 10.1074/jbc.M700735200; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Draviam VM, 2006, EMBO J, V25, P2814, DOI 10.1038/sj.emboj.7601168; Eichmuller S, 2001, P NATL ACAD SCI USA, V98, P629, DOI 10.1073/pnas.021386498; Fourest-Lieuvin A, 2006, MOL BIOL CELL, V17, P1041, DOI 10.1091/mbc.E05-07-0621; Gadde S, 2004, CURR BIOL, V14, pR797, DOI 10.1016/j.cub.2004.09.021; Gergely F, 2003, GENE DEV, V17, P336, DOI 10.1101/gad.245603; Guadagno TM, 1998, SCIENCE, V282, P1312, DOI 10.1126/science.282.5392.1312; Hong KU, 2008, EXP MOL MED, V40, P377, DOI 10.3858/emm.2008.40.4.377; Hong KU, 2007, MOL CELL BIOL, V27, P3667, DOI 10.1128/MCB.01386-06; Hong KU, 2009, CELL CYCLE, V8, P314, DOI 10.4161/cc.8.2.7597; Jeon SM, 2006, BIOCHEM BIOPH RES CO, V348, P222, DOI 10.1016/j.bbrc.2006.07.046; Jin Y, 2004, CANCER SCI, V95, P815, DOI 10.1111/j.1349-7006.2004.tb02187.x; Kimura K, 2001, J BIOL CHEM, V276, P5417, DOI 10.1074/jbc.C000873200; Kline-Smith SL, 2004, MOL CELL, V15, P317, DOI 10.1016/j.molcel.2004.07.012; LIEUVIN A, 1994, J CELL BIOL, V124, P985, DOI 10.1083/jcb.124.6.985; Logarinho E, 2008, CELL CYCLE, V7, P1763, DOI 10.4161/cc.7.12.6180; Maouche-Chretien L, 1998, ONCOGENE, V17, P1245, DOI 10.1038/sj.onc.1202048; Meraldi P, 2001, J CELL SCI, V114, P3749; Mishima M, 2004, NATURE, V430, P908, DOI 10.1038/nature02767; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; North BJ, 2007, J BIOL CHEM, V282, P19546, DOI 10.1074/jbc.M702990200; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Ohsugi M, 2003, EMBO J, V22, P2091, DOI 10.1093/emboj/cdg208; Ookata K, 1997, BIOCHEMISTRY-US, V36, P15873, DOI 10.1021/bi971251w; OOKATA K, 1995, J CELL BIOL, V128, P849, DOI 10.1083/jcb.128.5.849; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; Raemaekers T, 2003, J CELL BIOL, V162, P1017, DOI 10.1083/jcb.200302129; Rudner AD, 2000, J CELL BIOL, V149, P1377, DOI 10.1083/jcb.149.7.1377; SAXTON WM, 1984, J CELL BIOL, V99, P2175, DOI 10.1083/jcb.99.6.2175; Tsuchihara K, 2005, CANCER RES, V65, P6685, DOI 10.1158/0008-5472.CAN-04-4223; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Vasquez RJ, 1999, CELL MOTIL CYTOSKEL, V43, P310, DOI 10.1002/(SICI)1097-0169(1999)43:4<310::AID-CM4>3.3.CO;2-A; VERDE F, 1992, J CELL BIOL, V118, P1097, DOI 10.1083/jcb.118.5.1097; VERDE F, 1990, NATURE, V343, P233, DOI 10.1038/343233a0; Wakefield JG, 2003, J CELL SCI, V116, P637, DOI 10.1242/jcs.00273; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wong J, 2008, MOL BIOL CELL, V19, P2083, DOI 10.1091/mbc.E07-10-1088; Yu LR, 2007, J PROTEOME RES, V6, P4150, DOI 10.1021/pr070152u; Zhai Y, 1996, J CELL BIOL, V135, P201, DOI 10.1083/jcb.135.1.201; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	49	15	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16501	16512		10.1074/jbc.M900257200	http://dx.doi.org/10.1074/jbc.M900257200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19369249	hybrid, Green Published			2022-12-25	WOS:000266730900047
J	Pu, MM; Fang, XM; Redfield, AG; Gershenson, A; Roberts, MF				Pu, Mingming; Fang, Xiaomin; Redfield, Alfred G.; Gershenson, Anne; Roberts, Mary F.			Correlation of Vesicle Binding and Phospholipid Dynamics with Phospholipase C Activity INSIGHTS INTO PHOSPHATIDYLCHOLINE ACTIVATION AND SURFACE DILUTION INHIBITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; FIELD-CYCLING NMR; INTERFACIAL BINDING; BACILLUS-CEREUS; INHALATION ANTHRAX; SIZE-DISTRIBUTION; MURINE MODEL; COMPLEX; THURINGIENSIS; SIMULATION	The enzymatic activity of the peripheral membrane protein, phosphatidylinositol-specific phospholipase C (PI-PLC), is increased by nonsubstrate phospholipids with the extent of enhancement tuned by the membrane lipid composition. For Bacillus thuringiensis PI-PLC, a small amount of phosphatidylcholine (PC) activates the enzyme toward its substrate PI; above 0.5 mol fraction PC (X-PC), enzyme activity decreases substantially. To provide a molecular basis for this PC-dependent behavior, we used fluorescence correlation spectroscopy to explore enzyme binding to multicomponent lipid vesicles composed of PC and anionic phospholipids (that bind to the active site as substrate analogues) and high resolution field cycling P-31 NMR methods to estimate internal correlation times (tau(c)) of phospholipid headgroup motions. PI-PLC binds poorly to pure anionic phospholipid vesicles, but 0.1 X-PC significantly enhances binding, increases PI-PLC activity, and slows nanosecond rotational/wobbling motions of both phospholipid headgroups, as indicated by increased tau(c). PI-PLC activity and phospholipid tau(c) are constant between 0.1 and 0.5 X-PC. Above this PC content, PI-PLC has little additional effect on the substrate analogue but further slows the PC tau(c), a motional change that correlates with the onset of reduced enzyme activity. For PC-rich bilayers, these changes, together with the reduced order parameter and enhanced lateral diffusion of the substrate analogue in the presence of PI-PLC, imply that at high X-PC, kinetic inhibition of PI-PLC results from intravesicle sequestration of the enzyme from the bulk of the substrate. Both methodologies provide a detailed view of protein-lipid interactions and can be readily adapted for other peripheral membrane proteins.	[Roberts, Mary F.] Boston Coll, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA; [Fang, Xiaomin; Redfield, Alfred G.; Gershenson, Anne] Brandeis Univ, Waltham, MA 02454 USA	Boston College; Brandeis University	Roberts, MF (corresponding author), Boston Coll, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA.	mary.roberts@bc.edu	Pu, Mingming/F-6760-2012	Gershenson, Anne/0000-0003-3124-9610	National Institutes of Health [GM60418, GM77974]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060418, R01GM077974] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM60418 (to M. F. R.) and GM77974 (to A. G. R.).	Berg OG, 2001, CHEM REV, V101, P2613, DOI 10.1021/cr990139w; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Downes CP, 2005, TRENDS CELL BIOL, V15, P259, DOI 10.1016/j.tcb.2005.03.008; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; Feng JW, 2003, J BIOL CHEM, V278, P24651, DOI 10.1074/jbc.M301207200; Feng JW, 2002, J BIOL CHEM, V277, P19867, DOI 10.1074/jbc.M200938200; Ghelardi E, 2007, MICROBES INFECT, V9, P591, DOI 10.1016/j.micinf.2007.02.001; Goni FM, 2000, BIOSCIENCE REP, V20, P443, DOI 10.1023/A:1010450702670; Guo S, 2008, BIOCHEMISTRY-US, V47, P4201, DOI 10.1021/bi702269u; Heffernan BJ, 2007, FEMS MICROBIOL LETT, V271, P98, DOI 10.1111/j.1574-6968.2007.00713.x; Heffernan BJ, 2006, INFECT IMMUN, V74, P3756, DOI 10.1128/IAI.00307-06; HEINZ DW, 1995, EMBO J, V14, P3855, DOI 10.1002/j.1460-2075.1995.tb00057.x; Klauda JB, 2008, BIOPHYS J, V94, P3074, DOI 10.1529/biophysj.107.121806; Liu L, 2006, BIOCHEMISTRY-US, V45, P10865, DOI 10.1021/bi0609568; MAGDE D, 1974, BIOPOLYMERS, V13, P29, DOI 10.1002/bip.1974.360130103; Maulucci G, 2005, BIOPHYS J, V88, P3545, DOI 10.1529/biophysj.104.048876; Mulgrew-Nesbitt A, 2006, BBA-MOL CELL BIOL L, V1761, P812, DOI 10.1016/j.bbalip.2006.07.002; Paulick MG, 2008, BIOCHEMISTRY-US, V47, P6991, DOI 10.1021/bi8006324; Qian XQ, 1998, BIOCHEMISTRY-US, V37, P6513, DOI 10.1021/bi972650u; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rhoades E, 2006, BIOPHYS J, V90, P4692, DOI 10.1529/biophysj.105.079251; Roberts MF, 2004, P NATL ACAD SCI USA, V101, P17066, DOI 10.1073/pnas.0407565101; Roberts MF, 2004, J AM CHEM SOC, V126, P13765, DOI 10.1021/ja046658k; Roberts MF, 2004, BIOCHEMISTRY-US, V43, P3637, DOI 10.1021/bi035979q; Rusu L, 2004, BIOPHYS J, V87, P1044, DOI 10.1529/biophysj.104.039958; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shao CH, 2007, J BIOL CHEM, V282, P9228, DOI 10.1074/jbc.M610918200; SWAIRJO MA, 1994, BBA-BIOMEMBRANES, V1191, P354, DOI 10.1016/0005-2736(94)90186-4; Takakuwa Y, 1999, BIOPHYS CHEM, V82, P149, DOI 10.1016/S0301-4622(99)00114-3; Thompson N. L., 1991, TOPICS FLUORESCENCE, V1, P337; VOLWERK JJ, 1994, BIOCHEMISTRY-US, V33, P3464, DOI 10.1021/bi00178a002; VOLWERK JJ, 1990, BIOCHEMISTRY-US, V29, P8056, DOI 10.1021/bi00487a010; Wehbi H, 2003, BIOCHEMISTRY-US, V42, P9374, DOI 10.1021/bi034195+; Zenewicz LA, 2005, J IMMUNOL, V174, P8011, DOI 10.4049/jimmunol.174.12.8011; ZHANG MY, 1993, INFECT IMMUN, V61, P4947, DOI 10.1128/IAI.61.12.4947-4954.1993; Zhou C, 1997, BIOCHEMISTRY-US, V36, P347, DOI 10.1021/bi960601w; Zhou C, 1997, BIOCHEMISTRY-US, V36, P10089, DOI 10.1021/bi970846o; Zhou C, 1998, BIOCHEMISTRY-US, V37, P16430, DOI 10.1021/bi980601r	38	25	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16099	16107		10.1074/jbc.M809600200	http://dx.doi.org/10.1074/jbc.M809600200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19336401	hybrid, Green Published			2022-12-25	WOS:000266730900006
J	Bayir, H; Kapralov, AA; Jiang, JF; Huang, ZT; Tyurina, YY; Tyurin, VA; Zhao, Q; Belikova, NA; Vlasova, II; Maeda, A; Zhu, JH; Na, HM; Mastroberardino, PG; Sparvero, LJ; Amoscato, AA; Chu, CT; Greenamyre, JT; Kagan, VE				Bayir, Huelya; Kapralov, Alexandr A.; Jiang, Janfei; Huang, Zhentai; Tyurina, Yulia Y.; Tyurin, Vladimir A.; Zhao, Qing; Belikova, Natalia A.; Vlasova, Irina I.; Maeda, Akihiro; Zhu, Jianhui; Na, Hye-Mee; Mastroberardino, Pier-Giorgio; Sparvero, Louis J.; Amoscato, Andrew A.; Chu, Charleen T.; Greenamyre, John T.; Kagan, Valerian E.			Peroxidase Mechanism of Lipid-dependent Cross-linking of Synuclein with Cytochrome c PROTECTION AGAINST APOPTOSIS VERSUS DELAYED OXIDATIVE STRESS IN PARKINSON DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTANT ALPHA-SYNUCLEIN; WILD-TYPE; NEURONAL CELLS; LEWY BODIES; AGGREGATION; MICE; CARDIOLIPIN; RESONANCE; NEURODEGENERATION; 6-HYDROXYDOPAMINE	Damage of presynaptic mitochondria could result in release of proapoptotic factors that threaten the integrity of the entire neuron. We discovered that alpha-synuclein (Syn) forms a triple complex with anionic lipids ( such as cardiolipin) and cytochrome c, which exerts a peroxidase activity. The latter catalyzes covalent hetero-oligomerization of Syn with cytochrome c into high molecular weight aggregates. Syn is a preferred substrate of this reaction and is oxidized more readily than cardiolipin, dopamine, and other phenolic substrates. Co-localization of Syn with cytochrome c was detected in aggregates formed upon proapoptotic stimulation of SH-SY5Y and HeLa cells and in dopaminergic substantia nigra neurons of rotenone-treated rats. Syn-cardiolipin exerted protection against cytochrome c-induced caspase-3 activation in a cell-free system, particularly in the presence of H2O2. Direct delivery of Syn into mouse embryonic cells conferred resistance to proapoptotic caspase-3 activation. Conversely, small interfering RNA depletion of Syn in HeLa cells made them more sensitive to dopamine-induced apoptosis. In human Parkinson disease substantia nigra neurons, two-thirds of co-localized Syn-cytochrome c complexes occurred in Lewy neurites. Taken together, these results indicate that Syn may prevent execution of apoptosis in neurons through covalent hetero-oligomerization of cytochrome c. This immediate protective function of Syn is associated with the formation of the peroxidase complex representing a source of oxidative stress and postponed damage.	[Bayir, Huelya; Kapralov, Alexandr A.; Jiang, Janfei; Huang, Zhentai; Tyurina, Yulia Y.; Tyurin, Vladimir A.; Zhao, Qing; Belikova, Natalia A.; Vlasova, Irina I.; Maeda, Akihiro; Kagan, Valerian E.] Univ Pittsburgh, Ctr Free Rad & Antioxidant Hlth, Pittsburgh, PA 15219 USA; [Bayir, Huelya] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15219 USA; [Bayir, Huelya; Kapralov, Alexandr A.; Jiang, Janfei; Huang, Zhentai; Tyurina, Yulia Y.; Tyurin, Vladimir A.; Zhao, Qing; Belikova, Natalia A.; Vlasova, Irina I.; Maeda, Akihiro] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15219 USA; [Zhu, Jianhui; Chu, Charleen T.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15219 USA; [Na, Hye-Mee; Mastroberardino, Pier-Giorgio; Greenamyre, John T.] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15219 USA; [Na, Hye-Mee; Sparvero, Louis J.; Amoscato, Andrew A.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15219 USA; [Mastroberardino, Pier-Giorgio; Greenamyre, John T.] Univ Pittsburgh, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15219 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bayir, H (corresponding author), CCM Off, 3705 5th Ave, Pittsburgh, PA 15213 USA.	bayihx@ccm.upmc.edu; kagan@pitt.edu	Greenamyre, J. Timothy/B-4049-2011; Mastroberardino, Pier/D-5623-2009; Maeda, Akihiro/K-5190-2015; Huang, Zhentai/C-6926-2012; Chu, Charleen T/B-1601-2008	Huang, Zhentai/0000-0002-8102-464X; Chu, Charleen T/0000-0002-5052-8271; Tyurin, Vladimir/0000-0002-3474-1697; Greenamyre, J. Timothy/0000-0003-3468-7878; Amoscato, Andrew/0000-0002-1340-9150; Kapralov, Oleksandr/0000-0002-3006-916X; Tyurina, Yulia/0000-0003-0287-2091; Kagan, Valerian E./0000-0002-7245-1885; MASTROBERARDINO, PIER GIORGIO/0000-0003-2364-4258	National Institutes of Health [U19 AIO68021, NS061817, HD057587, AG026389, ES012068]; Pennsylvania Department of Health [SAP 4100027294]; Picower Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD057587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI068021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U54ES012068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061817, P01NS059806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026389, P50AG005133] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; Picower Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants U19 AIO68021, NS061817, HD057587, AG026389, and ES012068 (NIEHS). This work was also supported by Pennsylvania Department of Health Grant SAP 4100027294 and The Picower Foundation.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Alakoskela JM, 2006, BIOCHEMISTRY-US, V45, P13447, DOI 10.1021/bi0611107; Anglade P, 1997, HISTOL HISTOPATHOL, V12, P603; Baba M, 1998, AM J PATHOL, V152, P879; Bayir H, 2006, BBA-BIOENERGETICS, V1757, P648, DOI 10.1016/j.bbabio.2006.03.002; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Betarbet R, 2002, BRAIN PATHOL, V12, P499; Borisenko GG, 2008, BIOCHEMISTRY-US, V47, P13699, DOI 10.1021/bi801507s; Burkitt M, 2004, BIOCHEM SOC SYMP, V71, P97; Callio J, 2005, J BIOL CHEM, V280, P18536, DOI 10.1074/jbc.M413224200; CASTNER TG, 1959, PHYS REV, V115, P1506, DOI 10.1103/PhysRev.115.1506; Chen YR, 2004, J BIOL CHEM, V279, P18054, DOI 10.1074/jbc.M307706200; Chu CT, 2006, J NEUROPATH EXP NEUR, V65, P423, DOI 10.1097/01.jnen.0000229233.75253.be; Chu CT, 2005, J NEUROCHEM, V94, P1685, DOI 10.1111/j.1471-4159.2005.03329.x; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; da Costa CA, 2000, J BIOL CHEM, V275, P24065, DOI 10.1074/jbc.M002413200; da Costa CA, 2002, J BIOL CHEM, V277, P50980, DOI 10.1074/jbc.M207825200; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dickson DW, 2001, CURR OPIN NEUROL, V14, P423, DOI 10.1097/00019052-200108000-00001; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Ellis CE, 2005, MOL CELL BIOL, V25, P10190, DOI 10.1128/MCB.25.22.10190-10201.2005; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fornai F, 2005, P NATL ACAD SCI USA, V102, P3413, DOI 10.1073/pnas.0409713102; Giannakis E, 2008, BBA-BIOMEMBRANES, V1778, P1112, DOI 10.1016/j.bbamem.2008.01.012; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966; Hashimoto M, 1999, J BIOL CHEM, V274, P28849, DOI 10.1074/jbc.274.41.28849; Horbinski C, 2005, FREE RADICAL BIO MED, V38, P2, DOI 10.1016/j.freeradbiomed.2004.09.030; Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1; Irizarry MC, 1998, J NEUROPATH EXP NEUR, V57, P334, DOI 10.1097/00005072-199804000-00005; Iwata A, 2001, J BIOL CHEM, V276, P45320, DOI 10.1074/jbc.M103736200; Jiang JF, 2004, LIPIDS, V39, P1133, DOI 10.1007/s11745-004-1340-1; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kaul S, 2005, MOL BRAIN RES, V139, P137, DOI 10.1016/j.molbrainres.2005.05.022; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Klivenyi P, 2006, NEUROBIOL DIS, V21, P541, DOI 10.1016/j.nbd.2005.08.018; LASSMANN G, 1991, J BIOL CHEM, V266, P20045; Lee M, 2001, J NEUROCHEM, V76, P998, DOI 10.1046/j.1471-4159.2001.00149.x; Lee SJ, 2003, ANTIOXID REDOX SIGN, V5, P337, DOI 10.1089/152308603322110904; Leng Y, 2006, J NEUROSCI, V26, P7502, DOI 10.1523/JNEUROSCI.0096-06.2006; Li K, 2000, CELL, V101, P389, DOI 10.1016/S0092-8674(00)80849-1; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Machida Y, 2005, BIOCHEM BIOPH RES CO, V332, P233, DOI 10.1016/j.bbrc.2005.04.124; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Matsuoka Y, 2001, NEUROBIOL DIS, V8, P535, DOI 10.1006/nbdi.2001.0392; Mattson MP, 2000, BRAIN PATHOL, V10, P300, DOI 10.1111/j.1750-3639.2000.tb00264.x; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Monti B, 2007, J NEUROCHEM, V103, P518, DOI 10.1111/j.1471-4159.2007.04778.x; Norris EH, 2005, ANTIOXID REDOX SIGN, V7, P673; Olteanu A, 2004, PROTEIN SCI, V13, P2852, DOI 10.1110/ps.04947204; PETIT JM, 1992, EUR J BIOCHEM, V209, P267, DOI 10.1111/j.1432-1033.1992.tb17285.x; Purring-Koch C, 2000, P NATL ACAD SCI USA, V97, P11928, DOI 10.1073/pnas.220416197; Qian SY, 2002, BIOCHEM J, V363, P281, DOI 10.1042/0264-6021:3630281; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P118, DOI 10.1016/0003-9861(91)90172-F; Ramirez DC, 2005, J BIOL CHEM, V280, P27402, DOI 10.1074/jbc.M504241200; Seo JH, 2002, FASEB J, V16, P1826, DOI 10.1096/fj.02-0041fje; Sherer TB, 2002, J NEUROSCI, V22, P7006; Shults CW, 2006, P NATL ACAD SCI USA, V103, P1661, DOI 10.1073/pnas.0509567103; Smith DP, 2008, BIOCHEMISTRY-US, V47, P1425, DOI 10.1021/bi701522m; Smith WW, 2005, HUM MOL GENET, V14, P3801, DOI 10.1093/hmg/ddi396; Souza JM, 2000, J BIOL CHEM, V275, P18344, DOI 10.1074/jbc.M000206200; Swerdlow RH, 1998, ANN NEUROL, V44, P873, DOI 10.1002/ana.410440605; Tyurin VA, 2008, METHOD ENZYMOL, V442, P375, DOI [10.1017/S0076-6879(08)01419-5, 10.1016/S0076-6879(08)01419-5]; Tyurina YY, 2006, MOL PHARMACOL, V70, P706, DOI 10.1124/mol.106.022731; Vlasova II, 2006, J BIOL CHEM, V281, P14554, DOI 10.1074/jbc.M509507200; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Zhu JH, 2003, BRAIN PATHOL, V13, P473; Zhu M, 2003, J BIOL CHEM, V278, P40186, DOI 10.1074/jbc.M305326200	73	85	87	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15951	15969		10.1074/jbc.M900418200	http://dx.doi.org/10.1074/jbc.M900418200			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19351880	Green Published, hybrid			2022-12-25	WOS:000266501000062
J	Jia, J; Maccarana, M; Zhang, X; Bespalov, M; Lindahl, U; Li, JP				Jia, Juan; Maccarana, Marco; Zhang, Xiao; Bespalov, Maxim; Lindahl, Ulf; Li, Jin-Ping			Lack of L-Iduronic Acid in Heparan Sulfate Affects Interaction with Growth Factors and Cell Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEONATAL LETHALITY; CRYSTAL-STRUCTURE; BINDING-SITES; PROTEOGLYCANS; MICE; BIOSYNTHESIS; C5-EPIMERASE; FGF; GLYCOSAMINOGLYCANS; OLIGOSACCHARIDES	HSEPI (glucuronyl C5-epimerase) catalyzes the conversion of D-glucuronic acid to L-iduronic acid in heparan sulfate (HS) biosynthesis. Disruption of the Hsepi gene in mice yielded a lethal phenotype with selective organ defects but had remarkably little effect on other organ systems. We have approached the underlying mechanisms by examining the course and effects of FGF2 signaling in a mouse embryonic fibroblast (MEF) cell line derived from the Hsepi(-/-) mouse. The HS produced by these cells is devoid of L-iduronic acid residues but shows up-regulated N- and 6-O-sulfation compared with wild type (WT) MEF HS. In medium fortified with 10% fetal calf serum, the Hsepi(-/-) MEFs proliferated and migrated similarly to WT cells. Under starvation conditions, both cell types showed attenuated proliferation and migration that could be restored by the addition of FGF2 to WT cells, whereas Hsepi(-/-) cells were resistant. Moreover, ERK phosphorylation following FGF2 stimulation was delayed in Hsepi(-/-) compared with WT cells. Assessment of HS-growth factor interaction by nitrocellulose filter trapping revealed a strikingly aberrant binding property of FGF2 and glia-derived neurotropic factor to Hsepi(-/-) but not to WT HS. glia-derived neurotropic factor has a key role in kidney development, defective in Hsepi(-/-) mice. By contrast, Hsepi(-/-) and WT HS interacted similarly and in conventional mode with FGF10. These findings correlate defective function of growth factors with their mode of HS interaction and may help explain the partly modest organ phenotypes observed after genetic ablation of selected enzymes in HS biosynthesis.	[Jia, Juan; Lindahl, Ulf; Li, Jin-Ping] Uppsala Univ, Biomed Ctr, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Maccarana, Marco] Lund Univ, Dept Expt Med Sci, BMC D12, SE-22184 Lund, Sweden; [Zhang, Xiao] Uppsala Univ, Dept Publ Hlth & Caring Sci, Rudbeck Lab, S-75185 Uppsala, Sweden; [Bespalov, Maxim] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland	Uppsala University; Lund University; Uppsala University; University of Helsinki	Li, JP (corresponding author), Uppsala Univ, Biomed Ctr, Dept Med Biochem & Microbiol, Box 582, SE-75123 Uppsala, Sweden.	Jin-Ping.Li@imbim.uu.se	Bespalov, Maxim/O-2817-2016; maccarana, marco/AAB-4764-2021	Bespalov, Maxim/0000-0002-8754-5753; Maccarana, Marco/0000-0003-3549-8921	Swedish Research Council [32X-15023, 2007-5985, K2009-67X-21128-01-3]; Polysackaridforskning AB (Uppsala, Sweden)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Polysackaridforskning AB (Uppsala, Sweden)	This work was supported by the Swedish Research Council (32X-15023, 2007-5985; K2009-67X-21128-01-3) and Polysackaridforskning AB (Uppsala, Sweden).	ABBONDANZO SJ, 1993, METHOD ENZYMOL, V225, P803; Abramsson A, 2007, GENE DEV, V21, P316, DOI 10.1101/gad.398207; Ashikari-Hada S, 2004, J BIOL CHEM, V279, P12346, DOI 10.1074/jbc.M313523200; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Casu B, 2001, ADV CARBOHYD CHEM BI, V57, P159, DOI 10.1016/S0065-2318(01)57017-1; Catlow KR, 2008, J BIOL CHEM, V283, P5235, DOI 10.1074/jbc.M706589200; Delehedde M, 2000, J BIOL CHEM, V275, P33905, DOI 10.1074/jbc.M005949200; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Feyzi E, 1998, J BIOL CHEM, V273, P13395, DOI 10.1074/jbc.273.22.13395; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Galvis MLE, 2007, NAT CHEM BIOL, V3, P773, DOI 10.1038/nchembio.2007.41; Goodger SJ, 2008, J BIOL CHEM, V283, P13001, DOI 10.1074/jbc.M704531200; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; HOOK GER, 1982, J BIOL CHEM, V257, P9211; Inatani M, 2003, SCIENCE, V302, P1044, DOI 10.1126/science.1090497; Jastrebova N, 2006, J BIOL CHEM, V281, P26884, DOI 10.1074/jbc.M600806200; JAT PS, 1986, MOL CELL BIOL, V6, P1204, DOI 10.1128/MCB.6.4.1204; Kreuger J, 2005, BIOCHEM J, V389, P145, DOI 10.1042/BJ20042129; Kreuger J, 2003, METHOD ENZYMOL, V363, P327; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Lauder RM, 2000, GLYCOBIOLOGY, V10, P393, DOI 10.1093/glycob/10.4.393; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Li JP, 2003, J BIOL CHEM, V278, P28363, DOI 10.1074/jbc.C300219200; Li JP, 2001, J BIOL CHEM, V276, P20069, DOI 10.1074/jbc.M011783200; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Lin XH, 1999, DEVELOPMENT, V126, P3715; Maccarana M, 2006, J BIOL CHEM, V281, P11560, DOI 10.1074/jbc.M513373200; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; Patel VN, 2008, J BIOL CHEM, V283, P9308, DOI 10.1074/jbc.M709995200; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Ringvall M, 2000, J BIOL CHEM, V275, P25926, DOI 10.1074/jbc.C000359200; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Sugaya N, 2008, J BIOL CHEM, V283, P10366, DOI 10.1074/jbc.M705948200; Tour E, 2005, DEVELOPMENT, V132, P5271, DOI 10.1242/dev.02138	37	51	54	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15942	15950		10.1074/jbc.M809577200	http://dx.doi.org/10.1074/jbc.M809577200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19336402	hybrid, Green Published			2022-12-25	WOS:000266501000061
J	Kotaka, M; Kong, R; Qureshi, I; Ho, QS; Sun, HH; Liew, CW; Goh, LP; Cheung, P; Mu, YG; Lescar, J; Liang, ZX				Kotaka, Masayo; Kong, Rong; Qureshi, Insaf; Ho, Qin Shi; Sun, Huihua; Liew, Chong Wai; Goh, Lan Pei; Cheung, Peter; Mu, Yuguang; Lescar, Julien; Liang, Zhao-Xun			Structure and Catalytic Mechanism of the Thioesterase CalE7 in Enediyne Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II THIOESTERASE; GENE-CLUSTER; 4-HYDROXYBENZOYL-COA THIOESTERASE; SUBSTRATE-SPECIFICITY; FUNCTIONAL-ANALYSIS; CRYSTAL-STRUCTURE; DOMAIN; DEHYDROGENASE; SUPERFAMILY; COMPLEXES	The biosynthesis of the enediyne moiety of the antitumor natural product calicheamicin involves an iterative polyketide synthase (CalE8) and other ancillary enzymes. In the proposed mechanism for the early stage of 10-membered enediyne biosynthesis, CalE8 produces a carbonyl-conjugated polyene with the assistance of a putative thioesterase (CalE7). We have determined the x-ray crystal structure of CalE7 and found that the subunit adopts a hotdog fold with an elongated and kinked substrate-binding channel embedded between two subunits. The 1.75-angstrom crystal structure revealed that CalE7 does not contain a critical catalytic residue (Glu or Asp) conserved in other hotdog fold thioesterases. Based on biochemical and site-directed mutagenesis studies, we proposed a catalytic mechanism in which the conserved Arg(37) plays a crucial role in the hydrolysis of the thioester bond, and that Tyr(29) and a hydrogen-bonded water network assist the decarboxylation of the beta-ketocarboxylic acid intermediate. Moreover, computational docking suggested that the substrate-binding channel binds a polyene substrate that contains a single cis double bond at the C4/C5 position, raising the possibility that the C4=C5 double bond in the enediyne moiety could be generated by the iterative polyketide synthase. Together, the results revealed a hotdog fold thioesterase distinct from the common type I and type II thioesterases associated with polyketide biosynthesis and provided interesting insight into the enediyne biosynthetic mechanism.	[Kotaka, Masayo; Kong, Rong; Qureshi, Insaf; Ho, Qin Shi; Sun, Huihua; Liew, Chong Wai; Goh, Lan Pei; Cheung, Peter; Mu, Yuguang; Lescar, Julien; Liang, Zhao-Xun] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Lescar, J (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	julien@ntu.edu.sg; zxliang@ntu.edu.sg	Liang, Zhao-Xun/A-2191-2011; Qureshi, Insaf Ahmed/W-1957-2019; Mu, Yuguang/A-9558-2010; Kotaka, Masayo/C-4483-2009	Qureshi, Insaf Ahmed/0000-0001-7720-7067; Kotaka, Masayo/0000-0001-9692-3843; Liang, Zhao-Xun/0000-0002-3128-1330; Sun, Huihua/0000-0002-0538-7553	Ministry of Education of Singapore through the Academic Research Council [RG60/06]; Biomedical Research Council [06/1/22/19/447, 05/1/22/19/405]	Ministry of Education of Singapore through the Academic Research Council(Ministry of Education, Singapore); Biomedical Research Council(Agency for Science Technology & Research (A*STAR))	This work was supported by the Ministry of Education of Singapore through the Academic Research Council (Grant RG60/06 to Z.-X.L.). The laboratory of J.L. is supported by Biomedical Research Council Grants 06/1/22/19/447 and 05/1/22/19/405.	Ahlert J, 2002, SCIENCE, V297, P1173, DOI 10.1126/science.1072105; Akey DL, 2006, NAT CHEM BIOL, V2, P537, DOI 10.1038/nchembio824; Ames BD, 2008, P NATL ACAD SCI USA, V105, P5349, DOI 10.1073/pnas.0709223105; Angelini A, 2008, PROTEINS, V72, P1212, DOI 10.1002/prot.22014; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benning MM, 1998, J BIOL CHEM, V273, P33572, DOI 10.1074/jbc.273.50.33572; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen DQ, 2009, BIOCHEMISTRY-US, V48, P511, DOI 10.1021/bi802207t; Cheng ZJ, 2006, BIOCHEM BIOPH RES CO, V349, P172, DOI 10.1016/j.bbrc.2006.08.025; Dillon SC, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-109; Fedoy AE, 2007, J MOL BIOL, V372, P130, DOI 10.1016/j.jmb.2007.06.040; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gachotte D, 1998, P NATL ACAD SCI USA, V95, P13794, DOI 10.1073/pnas.95.23.13794; Gao Q, 2008, FEMS MICROBIOL LETT, V282, P105, DOI 10.1111/j.1574-6968.2008.01112.x; Gigant B, 1997, P NATL ACAD SCI USA, V94, P7857, DOI 10.1073/pnas.94.15.7857; Guo ZF, 2009, BIOCHEMISTRY-US, V48, P1712, DOI 10.1021/bi802165x; Heathcole ML, 2001, CHEM BIOL, V8, P207, DOI 10.1016/S1074-5521(01)00002-3; Holm L, 1997, NUCLEIC ACIDS RES, V25, P231, DOI 10.1093/nar/25.1.231; Hu ZH, 2003, MICROBIOL-SGM, V149, P2213, DOI 10.1099/mic.0.26015-0; Itoh T, 2007, BIOCHEMISTRY-US, V46, P8181, DOI 10.1021/bi700190p; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Keegan RM, 2007, ACTA CRYSTALLOGR D, V63, P447, DOI 10.1107/S0907444907002661; Kim BS, 2002, J BIOL CHEM, V277, P48028, DOI 10.1074/jbc.M207770200; Koglin A, 2008, NATURE, V454, P907, DOI 10.1038/nature07161; Kong R, 2008, J AM CHEM SOC, V130, P8142, DOI 10.1021/ja8019643; Kotowska M, 2002, MICROBIOL-SGM, V148, P1777, DOI 10.1099/00221287-148-6-1777; Kunishima N, 2005, J MOL BIOL, V352, P212, DOI 10.1016/j.jmb.2005.07.008; LAM KS, 1993, J AM CHEM SOC, V115, P12340, DOI 10.1021/ja00079a014; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leduc D, 2007, J BACTERIOL, V189, P7112, DOI 10.1128/JB.00755-07; Linne U, 2004, EUR J BIOCHEM, V271, P1536, DOI 10.1111/j.1432-1033.2004.04063.x; Liu W, 2005, CHEM BIOL, V12, P293, DOI 10.1016/j.chembiol.2004.12.013; Liu W, 2002, SCIENCE, V297, P1170, DOI 10.1126/science.1072110; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murugan E, 2008, FEBS LETT, V582, P1097, DOI 10.1016/j.febslet.2008.02.061; NICOLAOU KC, 1993, P NATL ACAD SCI USA, V90, P5881, DOI 10.1073/pnas.90.13.5881; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Salas JJ, 2002, ARCH BIOCHEM BIOPHYS, V403, P25, DOI 10.1016/S0003-9861(02)00017-6; Shen B, 2003, CURR MED CHEM, V10, P2317, DOI 10.2174/0929867033456701; Thoden JB, 2003, J BIOL CHEM, V278, P43709, DOI 10.1074/jbc.M308198200; Thoden JB, 2002, J BIOL CHEM, V277, P27468, DOI 10.1074/jbc.M203904200; Thorson JS, 1999, BIOORG CHEM, V27, P172, DOI 10.1006/bioo.1998.1122; TOKIWA Y, 1992, J AM CHEM SOC, V114, P4107, DOI 10.1021/ja00037a011; Trauger JW, 2000, NATURE, V407, P215, DOI 10.1038/35025116; Van Lanen SG, 2007, J AM CHEM SOC, V129, P13082, DOI 10.1021/ja073275o; Wang F, 2007, CHEM BIOL, V14, P543, DOI 10.1016/j.chembiol.2007.04.005; Willis MA, 2008, BIOCHEMISTRY-US, V47, P2797, DOI 10.1021/bi702336d; Zazopoulos E, 2003, NAT BIOTECHNOL, V21, P187, DOI 10.1038/nbt784; Zhang J, 2008, P NATL ACAD SCI USA, V105, P1460, DOI 10.1073/pnas.0711625105	50	36	36	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15739	15749		10.1074/jbc.M809669200	http://dx.doi.org/10.1074/jbc.M809669200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19357082	Green Published, hybrid			2022-12-25	WOS:000266501000043
J	Scutt, PJ; Chu, MLH; Sloane, DA; Cherry, M; Bignell, CR; Williams, DH; Eyers, PA				Scutt, Paul J.; Chu, Matthew L. H.; Sloane, Dominic A.; Cherry, Mike; Bignell, Colin R.; Williams, David H.; Eyers, Patrick A.			Discovery and Exploitation of Inhibitor-resistant Aurora and Polo Kinase Mutants for the Analysis of Mitotic Networks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITOR; GROWTH IN-VIVO; DRUG-RESISTANT; ABL KINASE; B KINASE; CENTRIOLE DUPLICATION; SELECTIVE INHIBITOR; STRUCTURAL BASIS; TYROSINE KINASE; A ACTIVATION	The Aurora and Polo-like kinases are central components of mitotic signaling pathways, and recent evidence suggests that substantial cross-talk exists between Aurora A and Plk1. In addition to their validation as novel anticancer agents, small molecule kinase inhibitors are increasingly important tools to help dissect clinically relevant protein phosphorylation networks. However, one major problem associated with kinase inhibitors is their promiscuity toward "off-target" members of the kinome, which makes interpretation of data obtained from complex cellular systems challenging. Additionally, the emergence of inhibitor resistance in patients makes it clear that an understanding of resistance mechanisms is essential to inform drug design. In this study, we exploited structural knowledge of the binding modes of VX-680, an Aurora kinase inhibitor, and BI 2536, a Polo-like kinase inhibitor, to design and evaluate drug-resistant kinase mutants. Using inducible stable human cell lines, we authenticated mitotic targets for both compounds and demonstrated that Aurora A mutants exhibit differential cellular sensitivity toward the inhibitors VX-680 and MLN8054. In addition, we validated Aurora B as an important anti-proliferative target for VX-680 in model human cancer cells. Finally, this chemical genetic approach allowed us to prove that Aurora A activation loop phosphorylation is controlled by a Plk1-mediated pathway in human cells.	[Sloane, Dominic A.; Eyers, Patrick A.] Univ Sheffield, Yorkshire Canc Res Inst Canc Studies, Sheffield S10 2RX, S Yorkshire, England; [Scutt, Paul J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Chu, Matthew L. H.] Univ Manchester, Sch Pharm & Pharmaceut Sci, Manchester M13 9PT, Lancs, England; [Cherry, Mike] Accelrys, Cambridge CB4 0WN, England; [Bignell, Colin R.] ImmunoBiol Ltd, Cambridge CB22 3AT, England; [Williams, David H.] Summit Plc, Abingdon OX14 4RY, Oxon, England	University of Sheffield; University of Manchester; University of Manchester; BIOVIA	Eyers, PA (corresponding author), Univ Sheffield, Yorkshire Canc Res Inst Canc Studies, Sheffield S10 2RX, S Yorkshire, England.	p.eyers@sheffield.ac.uk			Cancer Research UK [A7778]; MRC [G120/1030] Funding Source: UKRI; Medical Research Council [G120/1030] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Recipient of a Medical Research Council career development fellowship and supported by Project Grant A7778 from Cancer Research UK.	Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bamborough P, 2008, J MED CHEM, V51, P7898, DOI 10.1021/jm8011036; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Blencke S, 2004, CHEM BIOL, V11, P691, DOI 10.1016/j.chembiol.2004.02.029; Carpinelli P, 2008, ADV EXP MED BIOL, V610, P54, DOI 10.1007/978-0-387-73898-7_5; Carter TA, 2005, P NATL ACAD SCI USA, V102, P11011, DOI 10.1073/pnas.0504952102; Chan EHY, 2008, CHROMOSOMA, V117, P457, DOI 10.1007/s00412-008-0165-5; Cheetham GMT, 2007, CANCER LETT, V251, P323, DOI 10.1016/j.canlet.2006.12.004; Cohen P, 2009, CURR OPIN CELL BIOL, V21, P317, DOI 10.1016/j.ceb.2009.01.015; De Luca M, 2006, CELL CYCLE, V5, P296; DeLano WL, 2005, DRUG DISCOV TODAY, V10, P213, DOI 10.1016/S1359-6446(04)03363-X; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Dreier MR, 2009, EXP CELL RES, V315, P1085, DOI 10.1016/j.yexcr.2009.02.008; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Eyers PA, 1999, FEBS LETT, V451, P191, DOI 10.1016/S0014-5793(99)00552-9; Eyers PA, 1998, CHEM BIOL, V5, P321, DOI 10.1016/S1074-5521(98)90170-3; Eyers PA, 2004, J BIOL CHEM, V279, P9008, DOI 10.1074/jbc.M312424200; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Giles FJ, 2007, BLOOD, V109, P500, DOI 10.1182/blood-2006-05-025049; Girdler F, 2008, CHEM BIOL, V15, P552, DOI 10.1016/j.chembiol.2008.04.013; Girdler F, 2006, J CELL SCI, V119, P3664, DOI 10.1242/jcs.03145; Guo J, 2009, PHARMACOGENOMICS J, V9, P90, DOI 10.1038/tpj.2008.20; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hanisch A, 2006, MOL BIOL CELL, V17, P448, DOI 10.1091/mbc.E05-08-0801; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Heron NM, 2006, BIOORG MED CHEM LETT, V16, P1320, DOI 10.1016/j.bmcl.2005.11.053; Howard S, 2009, J MED CHEM, V52, P379, DOI 10.1021/jm800984v; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; Johnson EF, 2007, BIOCHEMISTRY-US, V46, P9551, DOI 10.1021/bi7008745; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Kothe M, 2007, CHEM BIOL DRUG DES, V70, P540, DOI 10.1111/j.1747-0285.2007.00594.x; Krug M, 2008, MINI-REV MED CHEM, V8, P1312, DOI 10.2174/138955708786369591; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Lansing TJ, 2007, MOL CANCER THER, V6, P450, DOI 10.1158/1535-7163.MCT-06-0543; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Lin YG, 2008, CLIN CANCER RES, V14, P5437, DOI 10.1158/1078-0432.CCR-07-4922; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008; Manfredi MG, 2007, P NATL ACAD SCI USA, V104, P4106, DOI 10.1073/pnas.0608798104; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; O'Keefe SJ, 2007, J BIOL CHEM, V282, P34663, DOI 10.1074/jbc.M704236200; Plyte S, 2007, CURR BIOL, V17, pR280, DOI 10.1016/j.cub.2007.02.018; Qian YW, 1999, MOL CELL BIOL, V19, P8625; Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517; Saurin AT, 2008, NAT CELL BIOL, V10, P891, DOI 10.1038/ncb1749; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Taylor S, 2008, CURR OPIN CELL BIOL, V20, P77, DOI 10.1016/j.ceb.2007.11.008; Terada Y, 1998, EMBO J, V17, P667, DOI 10.1093/emboj/17.3.667; Tyler RK, 2007, CELL CYCLE, V6, P2846, DOI 10.4161/cc.6.22.4940; Wilkinson RW, 2007, CLIN CANCER RES, V13, P3682, DOI 10.1158/1078-0432.CCR-06-2979; Young MA, 2006, CANCER RES, V66, P1007, DOI 10.1158/0008-5472.CAN-05-2788; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhao BG, 2008, PROTEIN SCI, V17, P1791, DOI 10.1110/ps.036590.108; Zunder ER, 2008, CANCER CELL, V14, P180, DOI 10.1016/j.ccr.2008.06.014	63	61	61	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15880	15893		10.1074/jbc.M109.005694	http://dx.doi.org/10.1074/jbc.M109.005694			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19359241	Green Published, hybrid			2022-12-25	WOS:000266501000056
J	Takahashi, T; Inoue-Kashino, N; Ozawa, S; Takahashi, Y; Kashino, Y; Satoh, K				Takahashi, Takeshi; Inoue-Kashino, Natsuko; Ozawa, Shin-ichiro; Takahashi, Yuichiro; Kashino, Yasuhiro; Satoh, Kazuhiko			Photosystem II Complex in Vivo Is a Monomer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEIN COMPLEXES; SYNECHOCYSTIS SP PCC-6803; CYANOBACTERIUM SYNECHOCOCCUS SP; CYTOCHROME B(6)F COMPLEX; BLUE-GREEN-ALGA; RED ALGA; CYANIDIUM-CALDARIUM; REACTION CENTERS; LIGHT-INTENSITY; ENERGY-TRANSFER	Photosystem II (PS II) complexes are membrane protein complexes that are composed of >20 distinct subunit proteins. Similar to many other membrane protein complexes, two PS II complexes are believed to form a homo-dimer whose molecular mass is similar to 650 kDa. Contrary to this well known concept, we propose that the functional form of PS II in vivo is a monomer, based on the following observations. Deprivation of lipids caused the conversion of PS II from a monomeric form to a dimeric form. Only a monomeric PS II was detected in solubilized cyanobacterial and red algal thylakoids using blue-native polyacrylamide gel electrophoresis. Furthermore, energy transfer between PS II units, which was observed in the purified dimeric PS II, was not detected in vivo. Our proposal will lead to a re-evaluation of many crystallographic models of membrane protein complexes in terms of their oligomerization status.	[Takahashi, Takeshi; Inoue-Kashino, Natsuko; Kashino, Yasuhiro; Satoh, Kazuhiko] Hyogo Med Univ, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan; [Inoue-Kashino, Natsuko; Ozawa, Shin-ichiro; Takahashi, Yuichiro] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan	University of Hyogo; Okayama University	Kashino, Y (corresponding author), Hyogo Med Univ, Grad Sch Life Sci, 3-2-1 Kohto, Kamigori, Hyogo 6781297, Japan.	kashino@sci.u-hyogo.ac.jp	Takahashi, Yuichiro/B-2062-2011; Ozawa, Shin-Ichiro/O-7408-2015	Takahashi, Yuichiro/0000-0001-6410-0447; Ozawa, Shin-Ichiro/0000-0001-7698-5350	MEXT [20051021, 18GS0318]; Hyogo Science and Technology Association [20I107]; MEXT; Japan Science Society [17-166, 19-440]	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hyogo Science and Technology Association; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science Society	This work was supported by MEXT (Grant 20051021 to Y. K. and Grant 18GS0318 to Y. T.), from Hyogo Science and Technology Association (Grant 20I107 to Y. K.), GCOE Program from MEXT (to K. S.), and by Sasakawa Scientific Research Grants from The Japan Science Society (17-166 to T. T. and 19-440 to N.I.-K.).	ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Aro EM, 2005, J EXP BOT, V56, P347, DOI 10.1093/jxb/eri041; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Bricker TM, 1998, BBA-BIOENERGETICS, V1409, P50, DOI 10.1016/S0005-2728(98)00148-0; CUNNINGHAM FX, 1989, PLANT PHYSIOL, V91, P1179, DOI 10.1104/pp.91.3.1179; DINER BA, 1979, PLANT PHYSIOL, V63, P20, DOI 10.1104/pp.63.1.20; Dobakova M, 2007, PLANT PHYSIOL, V145, P1681, DOI 10.1104/pp.107.107805; DYER DL, 1961, SCIENCE, V134, P616, DOI 10.1126/science.134.3479.616; ENAMI I, 1975, PLANT CELL PHYSIOL, V16, P211; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; FORK DC, 1983, PHOTOCHEM PHOTOBIOL, V37, P421, DOI 10.1111/j.1751-1097.1983.tb04495.x; Furuya Ken, 1998, Journal of Oceanography, V54, P199, DOI 10.1007/BF02751695; GIDDINGS TH, 1983, PLANT PHYSIOL, V71, P409, DOI 10.1104/pp.71.2.409; GIDDINGS TH, 1979, BIOCHIM BIOPHYS ACTA, V546, P373, DOI 10.1016/0005-2728(79)90074-4; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hankamer B, 1997, ANNU REV PLANT PHYS, V48, P641, DOI 10.1146/annurev.arplant.48.1.641; Herranen M, 2004, PLANT PHYSIOL, V134, P470, DOI 10.1104/pp.103.032326; HIRANO M, 1980, Photosynthesis Research, V1, P149, DOI 10.1007/BF00020594; HOLZENBURG A, 1993, NATURE, V363, P470, DOI 10.1038/363470a0; HUANG D, 1994, BIOCHEMISTRY-US, V33, P4401, DOI 10.1021/bi00180a038; Inoue-Kashino N, 2005, BIOCHEMISTRY-US, V44, P12214, DOI 10.1021/bi047539k; Iwai M, 2004, PLANT CELL PHYSIOL, V45, P1809, DOI 10.1093/pcp/pch207; Iwai M, 2008, PLANT CELL, V20, P2177, DOI 10.1105/tpc.108.059352; JENNINGS RC, 1980, FEBS LETT, V117, P332, DOI 10.1016/0014-5793(80)80974-4; JOLIOT A, 1964, CR HEBD ACAD SCI, V258, P4622; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Kashino Y, 2003, J CHROMATOGR B, V797, P191, DOI 10.1016/S1570-0232(03)00428-8; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; KASHINO Y, 1990, PLANT CELL PHYSIOL, V31, P479; Kashino Y, 2001, ELECTROPHORESIS, V22, P1004, DOI 10.1002/1522-2683()22:6<1004::AID-ELPS1004>3.0.CO;2-Y; Kashino Y, 2007, J CHROMATOGR B, V849, P282, DOI 10.1016/j.jchromb.2006.10.067; Kashino Yasuhiro, 2003, Phycological Research, V51, P168, DOI 10.1111/j.1440-1835.2003.tb00184.x; Kashino Yasuhiro, 1992, P163; Komenda J, 2004, J BIOL CHEM, V279, P48620, DOI 10.1074/jbc.M405725200; Kuhl H, 2000, J BIOL CHEM, V275, P20652, DOI 10.1074/jbc.M001321200; KURAHOTTA M, 1986, ARCH BIOCHEM BIOPHYS, V249, P1, DOI 10.1016/0003-9861(86)90553-9; Kurisu G, 2003, SCIENCE, V302, P1009, DOI 10.1126/science.1090165; KURSAR TA, 1983, PLANT PHYSIOL, V72, P409, DOI 10.1104/pp.72.2.409; LEY AC, 1984, PLANT PHYSIOL, V74, P451, DOI 10.1104/pp.74.2.451; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Loll B, 2007, BBA-BIOENERGETICS, V1767, P509, DOI 10.1016/j.bbabio.2006.12.009; LYON MK, 1993, J STRUCT BIOL, V110, P133, DOI 10.1006/jsbi.1993.1014; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; MELIS A, 1979, PHOTOCHEM PHOTOBIOL, V29, P373, DOI 10.1111/j.1751-1097.1979.tb07061.x; MELIS A, 1976, PHOTOCHEM PHOTOBIOL, V23, P343, DOI 10.1111/j.1751-1097.1976.tb07259.x; MORSCHEL E, 1987, PLANTA, V172, P145, DOI 10.1007/BF00394582; Murata N., 1986, Light emission by plants and bacteria, P137; Nixon PJ, 2005, J EXP BOT, V56, P357, DOI 10.1093/jxb/eri021; OHKI K, 1987, PLANT CELL PHYSIOL, V28, P1219; Ohnishi N, 2007, J BIOL CHEM, V282, P7107, DOI 10.1074/jbc.M606763200; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Renger G, 2008, PHOTOSYNTH RES, V98, P53, DOI 10.1007/s11120-008-9345-7; Roose JL, 2008, J BIOL CHEM, V283, P4044, DOI 10.1074/jbc.M708960200; Sakurai I, 2007, PLANT PHYSIOL, V145, P1361, DOI 10.1104/pp.107.106781; SATOH K, 1983, BIOCHIM BIOPHYS ACTA, V722, P190, DOI 10.1016/0005-2728(83)90173-1; SATOH K, 1983, PLANT PHYSIOL, V71, P673, DOI 10.1104/pp.71.3.673; SATOH K, 1995, PLANT CELL PHYSIOL, V36, P597; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 2002, MEMBRANE PROTEIN PUR, P105; Simpson D. J., 1996, OXYGENIC PHOTOSYNTHE, P493; Siraki AG, 2004, TOXICOL SCI, V81, P148, DOI 10.1093/toxsci/kfh182; Stroebel D, 2003, NATURE, V426, P413, DOI 10.1038/nature02155; THIELEN APGM, 1981, BIOCHIM BIOPHYS ACTA, V637, P439, DOI 10.1016/0005-2728(81)90049-9; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; VARGAS C, 1993, ANAL BIOCHEM, V209, P323, DOI 10.1006/abio.1993.1127; WOLLMAN FA, 1979, PLANT PHYSIOL, V63, P375, DOI 10.1104/pp.63.2.375; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	68	51	52	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15598	15606		10.1074/jbc.M109.000372	http://dx.doi.org/10.1074/jbc.M109.000372			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19351885	hybrid, Green Published			2022-12-25	WOS:000266501000028
J	Kaysser, L; Lutsch, L; Siebenberg, S; Wemakor, E; Kammerer, B; Gust, B				Kaysser, Leonard; Lutsch, Liane; Siebenberg, Stefanie; Wemakor, Emmanuel; Kammerer, Bernd; Gust, Bertolt			Identification and Manipulation of the Caprazamycin Gene Cluster Lead to New Simplified Liponucleoside Antibiotics and Give Insights into the Biosynthetic Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLMURAMYL-PENTAPEPTIDE TRANSLOCASE; BACTERIAL PEPTIDOGLYCAN SYNTHESIS; ANTITUMOR POLYKETIDE ELLORAMYCIN; RIBOFURANOSYL NUCLEOSIDE MOIETY; STREPTOMYCES SP; SACCHAROPOLYSPORA-SPINOSA; HETEROLOGOUS EXPRESSION; ESCHERICHIA-COLI; FLEXIBLE GLYCOSYLTRANSFERASE; STRUCTURE ELUCIDATION	Caprazamycins are potent anti-mycobacterial liponucleoside antibiotics isolated from Streptomyces sp. MK730-62F2 and belong to the translocase I inhibitor family. Their complex structure is derived from 5'-(beta-O-aminoribosyl)-glycyluridine and comprises a unique N-methyldiazepanone ring. The biosynthetic gene cluster has been identified, cloned, and sequenced, representing the first gene cluster of a translocase I inhibitor. Sequence analysis revealed the presence of 23 open reading frames putatively involved in export, resistance, regulation, and biosynthesis of the caprazamycins. Heterologous expression of the gene cluster in Streptomyces coelicolor M512 led to the production of non-glycosylated bioactive caprazamycin derivatives. A set of gene deletions validated the boundaries of the cluster and inactivation of cpz21 resulted in the accumulation of novel simplified liponucleoside antibiotics that lack the 3-methylglutaryl moiety. Therefore, Cpz21 is assigned to act as an acyltransferase in caprazamycin biosynthesis. In vivo and in silico analysis of the caprazamycin biosynthetic gene cluster allows a first proposal of the biosynthetic pathway and provides insights into the biosynthesis of related uridyl-antibiotics.	[Kaysser, Leonard; Lutsch, Liane; Siebenberg, Stefanie; Wemakor, Emmanuel; Gust, Bertolt] Univ Tubingen, Inst Pharmazeut, D-72076 Tubingen, Germany; [Siebenberg, Stefanie; Kammerer, Bernd] Univ Tubingen, Inst Pharmakol & Toxikol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Gust, B (corresponding author), Univ Tubingen, Inst Pharmazeut, Morgenstelle 8, D-72076 Tubingen, Germany.	bertolt.gust@uni-tuebingen.de	Kaysser, Leonard/Q-2091-2019	Kaysser, Leonard/0000-0002-3943-993X	European Commission [IP005224]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported European Commission Grant IP005224 ActinoGEN.	Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Basnet DB, 2006, MOL CELLS, V22, P154; BIBB MJ, 1984, GENE, V30, P157, DOI 10.1016/0378-1119(84)90116-1; Blanco G, 2001, CHEM BIOL, V8, P253, DOI 10.1016/S1074-5521(01)00010-2; Brandish PE, 1996, ANTIMICROB AGENTS CH, V40, P1640, DOI 10.1128/AAC.40.7.1640; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Choi SS, 2007, MICROBIOL-SGM, V153, P1095, DOI 10.1099/mic.0.2006/003194-0; Dairi T, 2005, J ANTIBIOT, V58, P227, DOI 10.1038/ja.2005.27; Dini C, 2005, CURR TOP MED CHEM, V5, P1221, DOI 10.2174/156802605774463042; Dini C, 2001, BIOORG MED CHEM LETT, V11, P533, DOI 10.1016/S0960-894X(00)00714-9; Dini C, 2001, BIOORG MED CHEM LETT, V11, P529, DOI 10.1016/S0960-894X(00)00715-0; Doumith M, 2000, MOL GEN GENET, V264, P477, DOI 10.1007/s004380000329; Eustaquio AS, 2005, APPL ENVIRON MICROB, V71, P2452, DOI 10.1128/AEM.71.5.2452-2459.2005; Flett F, 1997, FEMS MICROBIOL LETT, V155, P223, DOI 10.1111/j.1574-6968.1997.tb13882.x; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Gao QJ, 2006, CHEM BIOL, V13, P733, DOI 10.1016/j.chembiol.2006.05.009; Gullon S, 2006, APPL ENVIRON MICROB, V72, P4172, DOI 10.1128/AEM.00734-06; Gunsior M, 2004, CHEM BIOL, V11, P927, DOI 10.1016/j.chembiol.2004.04.012; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Gust B, 2004, ADV APPL MICROBIOL, V54, P107, DOI 10.1016/S0065-2164(04)54004-2; Hirano S, 2005, ANGEW CHEM INT EDIT, V44, P1854, DOI 10.1002/anie.200462439; Hirano S, 2008, J ORG CHEM, V73, P569, DOI 10.1021/jo702264e; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Huang FL, 2006, CHEM BIOL, V13, P475, DOI 10.1016/j.chembiol.2006.02.014; Igarahi M, 2003, J ANTIBIOT, V56, P580, DOI 10.7164/antibiotics.56.580; Igarashi M, 2005, J ANTIBIOT, V58, P327, DOI 10.1038/ja.2005.41; Igarashi M., 2002, 42 INT C ANT AG CHEM, P232; ISONO K, 1985, J ANTIBIOT, V38, P1617, DOI 10.7164/antibiotics.38.1617; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kagami S, 2003, J ANTIBIOT, V56, P552, DOI 10.7164/antibiotics.56.552; Kapp U, 2008, ACTA CRYSTALLOGR F, V64, P479, DOI 10.1107/S1744309108011822; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kimura K, 2003, NAT PROD REP, V20, P252, DOI 10.1039/b202149h; Kimura K, 1998, J ANTIBIOT, V51, P647, DOI 10.7164/antibiotics.51.647; Kimura K, 1998, J ANTIBIOT, V51, P1099, DOI 10.7164/antibiotics.51.1099; Kudo F, 2007, BIOORGAN MED CHEM, V15, P4360, DOI 10.1016/j.bmc.2007.04.040; Li WL, 2008, J BIOL CHEM, V283, P28607, DOI 10.1074/jbc.M804279200; Luzhetskyy A, 2007, CHEMBIOCHEM, V8, P599, DOI 10.1002/cbic.200600529; MACNEIL DJ, 1988, J BACTERIOL, V170, P5607, DOI 10.1128/jb.170.12.5607-5612.1988; Madduri K, 2001, J BACTERIOL, V183, P5632, DOI 10.1128/JB.183.19.5632-5638.2001; Makart S, 2007, J BIOTECHNOL, V130, P402, DOI 10.1016/j.jbiotec.2007.05.008; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; McDonald LA, 2002, J AM CHEM SOC, V124, P10260, DOI 10.1021/ja017748h; OCHI K, 1989, Patent No. 4950605; Ohnuki T, 2003, J ANTIBIOT, V56, P268, DOI 10.7164/antibiotics.56.268; Patallo EP, 2001, J BIOL CHEM, V276, P18765, DOI 10.1074/jbc.M101225200; Price NPJ, 2007, J ANTIBIOT, V60, P485, DOI 10.1038/ja.2007.62; Ramos A, 2008, MICROBIOL-SGM, V154, P781, DOI 10.1099/mic.0.2007/014035-0; Reeve AM, 1998, J BIOL CHEM, V273, P30695, DOI 10.1074/jbc.273.46.30695; RODRIGUEZ AM, 1993, MOL MICROBIOL, V8, P571; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sinha SC, 2001, CURR OPIN STRUC BIOL, V11, P733, DOI 10.1016/S0959-440X(01)00274-3; STENFLO J, 1989, P NATL ACAD SCI USA, V86, P444, DOI 10.1073/pnas.86.2.444; STRUVE WG, 1966, BIOCHEMISTRY-US, V5, P82, DOI 10.1021/bi00865a012; TAKEUCHI T, 2002, Patent No. 6780616; Tsvetanova BC, 2002, J BIOL CHEM, V277, P35289, DOI 10.1074/jbc.M201345200; UBUKATA M, 1992, J ORG CHEM, V57, P6392, DOI 10.1021/jo00050a009; Waldron C, 2000, ANTON LEEUW INT J G, V78, P385, DOI 10.1023/A:1010289901631; Waldron C, 2001, CHEM BIOL, V8, P487, DOI 10.1016/S1074-5521(01)00029-1; Weitnauer G, 2001, CHEM BIOL, V8, P569, DOI 10.1016/S1074-5521(01)00040-0; Wu XM, 2009, CHEMBIOCHEM, V10, P304, DOI 10.1002/cbic.200800527	62	84	85	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14987	14996		10.1074/jbc.M901258200	http://dx.doi.org/10.1074/jbc.M901258200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19351877	hybrid, Green Published			2022-12-25	WOS:000266288200035
J	Drews-Elger, K; Ortells, MC; Rao, A; Lopez-Rodriguez, C; Aramburu, J				Drews-Elger, Katherine; Carmen Ortells, M.; Rao, Anjana; Lopez-Rodriguez, Cristina; Aramburu, Jose			The Transcription Factor NFAT5 Is Required for Cyclin Expression and Cell Cycle Progression in Cells Exposed to Hypertonic Stress	PLOS ONE			English	Article							ENHANCER-BINDING PROTEIN; RESPONSE ELEMENT; OSMOTIC-STRESS; STIMULATES TRANSCRIPTION; TARGETED DISRUPTION; FACTOR TONEBP; GENE; ACTIVATION; HYPERNATREMIA; CONTRIBUTES	Background: Hypertonicity can perturb cellular functions, induce DNA damage-like responses and inhibit proliferation. The transcription factor NFAT5 induces osmoprotective gene products that allow cells to adapt to sustained hypertonic conditions. Although it is known that NFAT5-deficient lymphocytes and renal medullary cells have reduced proliferative capacity and viability under hypertonic stress, less is understood about the contribution of this factor to DNA damage responses and cell cycle regulation. Methodology/Principal Findings: We have generated conditional knockout mice to obtain NFAT5(-/-) T lymphocytes, which we used as a model of proliferating cells to study NFAT5-dependent responses. We show that hypertonicity triggered an early, NFAT5-independent, genotoxic stress-like response with induction of p53, p21 and GADD45, downregulation of cyclins, and cell cycle arrest. This was followed by an NFAT5-dependent adaptive phase in wild-type cells, which induced an osmoprotective gene expression program, downregulated stress markers, resumed cyclin expression and proliferation, and displayed enhanced NFAT5 transcriptional activity in S and G2/M. In contrast, NFAT5(-/-) cells failed to induce osmoprotective genes and exhibited poorer viability. Although surviving NFAT5(-/-) cells downregulated genotoxic stress markers, they underwent cell cycle arrest in G1/S and G2/M, which was associated with reduced expression of cyclins E1, A2 and B1. We also show that pathologic hypertonicity levels, as occurring in plasma of patients and animal models of osmoregulatory disorders, inhibited the induction of cyclins and aurora B kinase in response to T cell receptor stimulation in fresh NFAT5(-/-) lymphocytes. Conclusions/Significance: We conclude that NFAT5 facilitates cell proliferation under hypertonic conditions by inducing an osmoadaptive response that enables cells to express fundamental regulators needed for cell cycle progression.			Drews-Elger, K (corresponding author), Univ Pompeu Fabra & Barcelona Biomed Res Pk PRBB, Dept Ciencies Expt & Salut, Barcelona, Spain.	cristina.lopez-rodriguez@upf.edu; jose.aramburu@upf.edu	Lopez-Rodriguez, C/G-4482-2014; Aramburu, J/G-8991-2014	Lopez-Rodriguez, C/0000-0002-2311-2406; Aramburu, J/0000-0001-9279-9523; Drews-Elger, Katherine/0000-0001-9540-0610				Aramburu J, 2006, BIOCHEM PHARMACOL, V72, P1597, DOI 10.1016/j.bcp.2006.07.002; Burg MB, 2008, J BIOL CHEM, V283, P7309, DOI 10.1074/jbc.R700042200; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Caetano MS, 2002, FASEB J, V16, P1940, DOI 10.1096/fj.02-0282fje; Carvalho LDS, 2007, CELL CYCLE, V6, P1789, DOI 10.4161/cc.6.14.4473; Chen Y, 2007, AM J PHYSIOL-RENAL, V292, pP981, DOI 10.1152/ajprenal.00493.2005; CHILTON LA, 1995, WESTERN J MED, V163, P74; COOKE CR, 1993, AM J KIDNEY DIS, V22, P44, DOI 10.1016/S0272-6386(12)70165-8; De Boer L, 2008, ONCOGENE, V27, P4261, DOI 10.1038/onc.2008.74; Dmitrieva N, 2000, J BIOL CHEM, V275, P18243, DOI 10.1074/jbc.M000522200; Dmitrieva NI, 2005, MUTAT RES-FUND MOL M, V569, P65, DOI 10.1016/j.mrfmmm.2004.06.053; Dogan E, 2005, ADV THER, V22, P429, DOI 10.1007/BF02849861; Go WY, 2004, P NATL ACAD SCI USA, V101, P10673, DOI 10.1073/pnas.0403139101; Held T, 2006, MOL CELL BIOL, V26, P8099, DOI 10.1128/MCB.01332-06; Huang Xuan, 2006, Methods Mol Biol, V314, P73; Irarrazabal CE, 2004, P NATL ACAD SCI USA, V101, P8809, DOI 10.1073/pnas.0403062101; Ito T, 2004, BIOCHEM J, V382, P177, DOI 10.1042/BJ20031838; Ito T, 2007, J BIOL CHEM, V282, P1152, DOI 10.1074/jbc.M609547200; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Ka T, 2003, DIABETES NUTR METAB, V16, P317; Kino T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000081; Ko BCB, 2002, J BIOL CHEM, V277, P46085, DOI 10.1074/jbc.M208138200; Kojima R, 2004, BIOCHEM J, V380, P783, DOI 10.1042/BJ20040313; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Lam AKM, 2004, J BIOL CHEM, V279, P48048, DOI 10.1074/jbc.M407224200; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Li SZ, 2007, AM J PHYSIOL-CELL PH, V292, pC1606, DOI 10.1152/ajpcell.00588.2005; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; Lopez-Rodriguez C, 2004, P NATL ACAD SCI USA, V101, P2392, DOI 10.1073/pnas.0308703100; Lopez-Rodriguez C, 2001, IMMUNITY, V15, P47, DOI 10.1016/S1074-7613(01)00165-0; Loyher ML, 2004, NEUROSCIENCE, V124, P89, DOI 10.1016/j.neuroscience.2003.10.025; Ma TH, 1998, J BIOL CHEM, V273, P4296, DOI 10.1074/jbc.273.8.4296; Maallem S, 2006, NEUROSCIENCE, V137, P51, DOI 10.1016/j.neuroscience.2005.07.037; Mak SK, 2004, J BIOL CHEM, V279, P39075, DOI 10.1074/jbc.M406643200; McDill BW, 2006, P NATL ACAD SCI USA, V103, P6952, DOI 10.1073/pnas.0602087103; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Morancho B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-13; Nakata Y, 2007, MOL CELL BIOL, V27, P2048, DOI 10.1128/MCB.01100-06; Nakayama Y, 2000, J BIOL CHEM, V275, P38275, DOI 10.1074/jbc.M004678200; Navarro P, 2008, BIOCHEM BIOPH RES CO, V372, P326, DOI 10.1016/j.bbrc.2008.05.067; O'Connor RS, 2007, J CELL SCI, V120, P149, DOI 10.1242/jcs.03307; Papadimitriou A, 1997, J PEDIATR ENDOCR MET, V10, P547; Paut O, 1999, PAEDIATR ANAESTH, V9, P171, DOI 10.1046/j.1460-9592.1999.9220325.x; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sasaki Y, 2004, J IMMUNOL, V173, P2245, DOI 10.4049/jimmunol.173.4.2245; SCHORN T, 1991, KLIN WOCHENSCHR, V69, P436, DOI 10.1007/BF01666829; Sheen MR, 2006, AM J PHYSIOL-RENAL, V291, pF1014, DOI 10.1152/ajprenal.00153.2006; Shim EH, 2002, EMBO REP, V3, P857, DOI 10.1093/embo-reports/kvf175; Song JX, 2007, NAT IMMUNOL, V8, P64, DOI 10.1038/ni1413; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Trama J, 2002, J IMMUNOL, V169, P5477, DOI 10.4049/jimmunol.169.10.5477; Wang DZ, 1995, ANN NY ACAD SCI, V766, P182, DOI 10.1111/j.1749-6632.1995.tb26661.x; Wang Y, 2005, J BIOL CHEM, V280, P19986, DOI 10.1074/jbc.M501689200; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Woo SK, 2002, MOL CELL BIOL, V22, P5753, DOI 10.1128/MCB.22.16.5753-5760.2002; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Yuan JP, 2004, ONCOGENE, V23, P5843, DOI 10.1038/sj.onc.1207757; Yun J, 2000, J CLIN INVEST, V106, P1361, DOI 10.1172/JCI9154	58	38	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2009	4	4							e5245	10.1371/journal.pone.0005245	http://dx.doi.org/10.1371/journal.pone.0005245			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VA	19381288	Green Published, gold, Green Submitted			2022-12-25	WOS:000265513800013
J	You, YN; Short, KR; Jourdan, M; Klaus, KA; Walrand, S; Nair, KS				You, Y. Nancy; Short, Kevin R.; Jourdan, Marion; Klaus, Katherine A.; Walrand, Stephane; Nair, K. Sreekumaran			The Effect of High Glucocorticoid Administration and Food Restriction on Rodent Skeletal Muscle Mitochondrial Function and Protein Metabolism	PLOS ONE			English	Article							MYOSIN HEAVY-CHAIN; SYNTHESIS RATES; OLD RATS; LEUCINE OXIDATION; ATP PRODUCTION; AMINO-ACIDS; STARVATION; TURNOVER; EXERCISE; HUMANS	Background: Glucocorticoids levels are high in catabolic conditions but it is unclear how much of the catabolic effects are due to negative energy balance versus glucocorticoids and whether there are distinct effects on metabolism and functions of specific muscle proteins. Methodology/Principal Findings: We determined whether 14 days of high dose methylprednisolone (MPred, 4 mg/kg/d) Vs food restriction (FR, food intake matched to MPred) in rats had different effects on muscle mitochondrial function and protein fractional synthesis rates (FSR). Lower weight loss (15%) occurred in FR than in MPred (30%) rats, while a 15% increase occurred saline-treated Controls. The per cent muscle loss was significantly greater for MPred than FR. Mitochondrial protein FSR in MPred rats was lower in soleus (51 and 43%, respectively) and plantaris (25 and 55%) than in FR, while similar decline in protein FSR of the mixed, sarcoplasmic, and myosin heavy chain occurred. Mitochondrial enzymatic activity and ATP production were unchanged in soleus while in plantaris cytochrome c oxidase activity was lower in FR than Control, and ATP production rate with pyruvate + malate in MPred plantaris was 28% lower in MPred. Branched-chain amino acid catabolic enzyme activities were higher in both FR and MPred rats indicating enhanced amino acid oxidation capacity. Conclusion/Significance: MPred and FR had little impact on mitochondrial function but reduction in muscle protein synthesis occurred in MPred that could be explained on the basis of reduced food intake. A greater decline in proteolysis may explain lesser muscle loss in FR than in MPred rats.			You, YN (corresponding author), Mayo Clin, Coll Med, Endocrine Res Unit, Rochester, MN 55905 USA.	nair.sree@mayo.edu	Short, Kevin R/AAC-2553-2020	Short, Kevin R/0000-0001-6704-9587	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041973, T32DK007352] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK41973, R01 DK041973, T32 DK007352, T32-DK07352] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AFTRING RP, 1988, AM J PHYSIOL, V254, pE292, DOI 10.1152/ajpendo.1988.254.3.E292; Balagopal P, 1997, AM J PHYSIOL-ENDOC M, V273, pE790, DOI 10.1152/ajpendo.1997.273.4.E790; BALAGOPAL P, 1994, ANAL BIOCHEM, V221, P72, DOI 10.1006/abio.1994.1381; Barazzoni R, 2005, ENDOCRINOLOGY, V146, P2098, DOI 10.1210/en.2004-1396; BEAUFRERE B, 1989, AM J PHYSIOL, V257, pE712, DOI 10.1152/ajpendo.1989.257.5.E712; Bezaire V, 2001, AM J PHYSIOL-ENDOC M, V281, pE975, DOI 10.1152/ajpendo.2001.281.5.E975; Boirie Y, 2001, DIABETES, V50, P2652, DOI 10.2337/diabetes.50.12.2652; Cooper AJL, 2002, ANAL BIOCHEM, V308, P100, DOI 10.1016/S0003-2697(02)00243-9; CZERWINSKI SM, 1989, J APPL PHYSIOL, V67, P2311, DOI 10.1152/jappl.1989.67.6.2311; CZERWINSKI SM, 1987, J APPL PHYSIOL, V63, P1504, DOI 10.1152/jappl.1987.63.4.1504; Dardevet D, 1998, J ENDOCRINOL, V156, P83, DOI 10.1677/joe.0.1560083; DARDEVET D, 1995, J CLIN INVEST, V96, P2113, DOI 10.1172/JCI118264; Duclos M, 2004, AM J PHYSIOL-ENDOC M, V286, pE159, DOI 10.1152/ajpendo.00281.2003; EMERY PW, 1995, CLIN SCI, V89, P383, DOI 10.1042/cs0890383; ESSEN P, 1992, CLIN PHYSIOL, V12, P287, DOI 10.1111/j.1475-097X.1992.tb00834.x; Fu AZ, 1998, AM J PHYSIOL-ENDOC M, V275, pE1023, DOI 10.1152/ajpendo.1998.275.6.E1023; HICKSON RC, 1995, AM J PHYSIOL-ENDOC M, V268, pE730, DOI 10.1152/ajpendo.1995.268.4.E730; KELLY FJ, 1986, MUSCLE NERVE, V9, P1, DOI 10.1002/mus.880090102; Koves TR, 2005, J BIOL CHEM, V280, P33588, DOI 10.1074/jbc.M507621200; LIEU FK, 1993, J APPL PHYSIOL, V75, P763, DOI 10.1152/jappl.1993.75.2.763; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Liu ZQ, 2001, J CLIN ENDOCR METAB, V86, P2136, DOI 10.1210/jc.86.5.2136; Ljungqvist OH, 1997, AM J PHYSIOL-ENDOC M, V273, pE564, DOI 10.1152/ajpendo.1997.273.3.E564; Lofberg E, 2002, EUR J CLIN INVEST, V32, P345, DOI 10.1046/j.1365-2362.2002.00993.x; LOUARD RJ, 1994, J CLIN ENDOCR METAB, V79, P278, DOI 10.1210/jc.79.1.278; MAGNUSSON K, 1990, METABOLISM, V39, P1113, DOI 10.1016/0026-0495(90)90080-V; MARONE JR, 1994, J APPL PHYSIOL, V77, P1685; Minet-Quinard R, 2000, JPEN-PARENTER ENTER, V24, P30, DOI 10.1177/014860710002400130; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; Mittendorfer B, 2005, J PHYSIOL-LONDON, V563, P203, DOI 10.1113/jphysiol.2004.077180; PAULSON JC, 1954, J AM CHEM SOC, V76, P6198, DOI 10.1021/ja01652a104; POLLA B, 1994, ACTA PHYSIOL SCAND, V151, P353, DOI 10.1111/j.1748-1716.1994.tb09754.x; QUAN ZY, 1991, METABOLISM, V40, P1263, DOI 10.1016/0026-0495(91)90026-S; Rieu I, 2004, EXP GERONTOL, V39, P1315, DOI 10.1016/j.exger.2004.06.005; Robinson JB., 1987, MITOCHONDRIA PRACTIC, P153, DOI DOI 10.1016/J.BBRC.2005.02.135; Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364; Rooyackers OE, 1997, MUSCLE NERVE, pS93; Savary I, 1998, BRIT J NUTR, V79, P297, DOI 10.1079/BJN19980047; SHERWIN RS, 1978, J CLIN INVEST, V61, P1471, DOI 10.1172/JCI109067; Shimomura Y, 2001, CURR OPIN CLIN NUTR, V4, P419, DOI 10.1097/00075197-200109000-00013; Short KR, 2007, AM J PHYSIOL-ENDOC M, V292, pE642, DOI 10.1152/ajpendo.00397.2006; Short KR, 2004, J CLIN ENDOCR METAB, V89, P6198, DOI 10.1210/jc.2004-0908; Short KR, 2001, AM J PHYSIOL-ENDOC M, V280, pE761, DOI 10.1152/ajpendo.2001.280.5.E761; Sreekumar R, 2002, AM J PHYSIOL-ENDOC M, V283, pE38, DOI 10.1152/ajpendo.00387.2001; Weber K, 2002, ENDOCRINOLOGY, V143, P177, DOI 10.1210/en.143.1.177; WIBOM R, 1990, SCAND J CLIN LAB INV, V50, P143, DOI 10.3109/00365519009089146; Wibom R, 2002, ANAL BIOCHEM, V311, P139, DOI 10.1016/S0003-2697(02)00424-4; WING SS, 1993, AM J PHYSIOL, V264, pE668, DOI 10.1152/ajpendo.1993.264.4.E668	48	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2009	4	4							e5283	10.1371/journal.pone.0005283	http://dx.doi.org/10.1371/journal.pone.0005283			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437UZ	19381333	Green Submitted, Green Published, gold			2022-12-25	WOS:000265513700003
J	Cundiff, P; Liu, LD; Wang, YP; Zou, JH; Pan, YW; Abel, G; Duan, X; Ming, GL; Englund, C; Hevner, R; Xia, ZG				Cundiff, Paige; Liu, Lidong; Wang, Yupeng; Zou, Junhui; Pan, Yung-Wei; Abel, Glen; Duan, Xin; Ming, Guo-Li; Englund, Chris; Hevner, Robert; Xia, Zhengui			ERK5 MAP Kinase Regulates Neurogenin1 during Cortical Neurogenesis	PLOS ONE			English	Article								The commitment of multi-potent cortical progenitors to a neuronal fate depends on the transient induction of the basic-helix-loop-helix (bHLH) family of transcription factors including Neurogenin 1 (Neurog1). Previous studies have focused on mechanisms that control the expression of these proteins while little is known about whether their pro-neural activities can be regulated by kinase signaling pathways. Using primary cultures and ex vivo slice cultures, here we report that both the transcriptional and pro-neural activities of Neurog1 are regulated by extracellular signal-regulated kinase (ERK) 5 signaling in cortical progenitors. Activation of ERK5 potentiated, while blocking ERK5 inhibited Neurog1-induced neurogenesis. Furthermore, endogenous ERK5 activity was required for Neurog1-initiated transcription. Interestingly, ERK5 activation was sufficient to induce Neurog1 phosphorylation and ERK5 directly phosphorylated Neurog1 in vitro. We identified S179/S208 as putative ERK5 phosphorylation sites in Neurog1. Mutations of S179/S208 to alanines inhibited the transcriptional and pro-neural activities of Neurog1. Our data identify ERK5 phosphorylation of Neurog1 as a novel mechanism regulating neuronal fate commitment of cortical progenitors.			Cundiff, P (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	zxia@u.washington.edu	Ming, Guo-li/J-7880-2013	Ming, Guo-li/0000-0002-2517-6075	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019193] Funding Source: NIH RePORTER; NIA NIH HHS [AG19193, R01 AG019193] Funding Source: Medline; NIDDK NIH HHS [P30 DK056465] Funding Source: Medline; NIGMS NIH HHS [T32GM07750, T32 GM007750] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barry SC, 2001, HUM GENE THER, V12, P1103, DOI 10.1089/104303401750214311; Britan A, 2006, SHOCK WAVES, V16, P1, DOI 10.1007/s00193-006-0019-0; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Cavanaugh JE, 2001, J NEUROSCI, V21, P434, DOI 10.1523/JNEUROSCI.21-02-00434.2001; Coyle-Rink J, 2002, CANCER BIOL THER, V1, P640, DOI 10.4161/cbt.313; Cude K, 2007, J CELL BIOL, V177, P253, DOI 10.1083/jcb.200609166; Dinev D, 2001, EMBO REP, V2, P829, DOI 10.1093/embo-reports/kve177; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; English JM, 1998, J BIOL CHEM, V273, P3854, DOI 10.1074/jbc.273.7.3854; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Farah MH, 2000, DEVELOPMENT, V127, P693; Fode C, 2000, GENE DEV, V14, P67; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Ge WH, 2006, P NATL ACAD SCI USA, V103, P1319, DOI 10.1073/pnas.0510419103; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Hayashi M, 2004, J MOL MED, V82, P800, DOI 10.1007/s00109-004-0602-8; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Irvin DK, 2003, DEV NEUROSCI-BASEL, V25, P162, DOI 10.1159/000072265; JAN YN, 1993, CELL, V75, P827, DOI 10.1016/0092-8674(93)90525-U; JOHNSON JE, 1992, P NATL ACAD SCI USA, V89, P3596, DOI 10.1073/pnas.89.8.3596; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kim S, 2002, EXP MOL MED, V34, P469, DOI 10.1038/emm.2002.65; Kolk SM, 2005, MOL CELL NEUROSCI, V30, P538, DOI 10.1016/j.mcn.2005.08.017; LI L, 1992, CELL, V71, P1181, DOI 10.1016/S0092-8674(05)80066-2; Liu LD, 2003, P NATL ACAD SCI USA, V100, P8532, DOI 10.1073/pnas.1332804100; Liu LD, 2006, P NATL ACAD SCI USA, V103, P9697, DOI 10.1073/pnas.0603373103; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Ma YC, 2008, NEURON, V58, P65, DOI 10.1016/j.neuron.2008.01.037; McCormick MB, 1996, MOL CELL BIOL, V16, P5792; Menard C, 2002, NEURON, V36, P597, DOI 10.1016/S0896-6273(02)01026-7; Moore KB, 2002, NEURON, V34, P183, DOI 10.1016/S0896-6273(02)00666-9; Morrow T, 2001, DEVELOPMENT, V128, P3585; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; Nadarajah B, 2002, NAT NEUROSCI, V5, P218, DOI 10.1038/nn813; Nelson BR, 2007, DEV BIOL, V304, P479, DOI 10.1016/j.ydbio.2007.01.001; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Olson JM, 2001, DEV BIOL, V234, P174, DOI 10.1006/dbio.2001.0245; Parras CM, 2002, GENE DEV, V16, P324, DOI 10.1101/gad.940902; Qian XM, 1997, NEURON, V18, P81, DOI 10.1016/S0896-6273(01)80048-9; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Samuels IS, 2008, J NEUROSCI, V28, P6983, DOI 10.1523/JNEUROSCI.0679-08.2008; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; SCHUURMANS C, 2004, EMBO J; Shen Q, 2002, DEVELOPMENT, V129, P4843; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Tang HB, 2004, CELL SIGNAL, V16, P551, DOI 10.1016/j.cellsig.2003.09.006; Tsai RYL, 2000, J NEUROSCI, V20, P3725, DOI 10.1523/JNEUROSCI.20-10-03725.2000; Vavvas D, 1997, J BIOL CHEM, V272, P13255, DOI 10.1074/jbc.272.20.13255; Vojtek AB, 2003, MOL CELL BIOL, V23, P4417, DOI 10.1128/MCB.23.13.4417-4427.2003; Vosper JMD, 2007, BIOCHEM J, V407, P277, DOI 10.1042/BJ20070064; Wang X, 2006, CELL SIGNAL, V18, P753, DOI 10.1016/j.cellsig.2005.11.003; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	58	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5204	10.1371/journal.pone.0005204	http://dx.doi.org/10.1371/journal.pone.0005204			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TN	19365559	Green Published, gold			2022-12-25	WOS:000265509900017
J	Elleuche, S; Poggeler, S				Elleuche, Skander; Poeggeler, Stefanie			beta-Carbonic Anhydrases Play a Role in Fruiting Body Development and Ascospore Germination in the Filamentous Fungus Sordaria macrospora	PLOS ONE			English	Article								Carbon dioxide (CO2) is among the most important gases for all organisms. Its reversible interconversion to bicarbonate (HCO3-) reaches equilibrium spontaneously, but slowly, and can be accelerated by a ubiquitous group of enzymes called carbonic anhydrases (CAs). These enzymes are grouped by their distinct structural features into alpha-, beta-, gamma-, delta-and zeta-classes. While physiological functions of mammalian, prokaryotic, plant and algal CAs have been extensively studied over the past years, the role of beta-CAs in yeasts and the human pathogen Cryptococcus neoformans has been elucidated only recently, and the function of CAs in multicellular filamentous ascomycetes is mostly unknown. To assess the role of CAs in the development of filamentous ascomycetes, the function of three genes, cas1, cas2 and cas3 (carbonic anhydrase of Sordaria) encoding beta-class carbonic anhydrases was characterized in the filamentous ascomycetous fungus Sordaria macrospora. Fluorescence microscopy was used to determine the localization of GFP- and DsRED-tagged CAs. While CAS1 and CAS3 are cytoplasmic enzymes, CAS2 is localized to the mitochondria. To assess the function of the three isoenzymes, we generated knock-out strains for all three cas genes (Delta cas1, Delta cas2, and Delta cas3) as well as all combinations of double mutants. No effect on vegetative growth, fruiting-body and ascospore development was seen in the single mutant strains lacking cas1 or cas3, while single mutant Delta cas2 was affected in vegetative growth, fruiting-body development and ascospore germination, and the double mutant strain Delta cas1/2 was completely sterile. Defects caused by the lack of cas2 could be partially complemented by elevated CO2 levels or overexpression of cas1, cas3, or a non-mitochondrial cas2 variant. The results suggest that CAs are required for sexual reproduction in filamentous ascomycetes and that the multiplicity of isoforms results in redundancy of specific and non-specific functions.			Elleuche, S (corresponding author), Univ Gottingen, Inst Microbiol & Genet, Dept Genet Eukaryot Microorganisms, Gottingen, Germany.	spoegge@gwdg.de		Elleuche, Skander/0000-0002-7259-9935				Aguilera J, 2005, FEMS YEAST RES, V5, P579, DOI 10.1016/j.femsyr.2004.09.009; Aguilera J, 2005, BIOCHEM J, V391, P311, DOI 10.1042/BJ20050556; Amoroso G, 2005, MOL MICROBIOL, V56, P549, DOI 10.1111/j.1365-2958.2005.04560.x; Bahn YS, 2006, CURR OPIN MICROBIOL, V9, P572, DOI 10.1016/j.mib.2006.09.003; Bahn YS, 2005, CURR BIOL, V15, P2013, DOI 10.1016/j.cub.2005.09.047; Casey JR, 2006, BIOCHEM CELL BIOL, V84, P930, DOI 10.1139/O06-184; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Clark D, 2004, BIOCHEM J, V379, P609, DOI 10.1042/BJ20031711; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Cronk JD, 2001, PROTEIN SCI, V10, P911, DOI 10.1110/ps.46301; ELLEUCHE S, 2009, CURR GENET IN PRESS; Elleuche S, 2008, BIOCHEM BIOPH RES CO, V366, P239, DOI 10.1016/j.bbrc.2007.11.126; Elleuche S, 2008, FUNGAL GENET BIOL, V45, P1458, DOI 10.1016/j.fgb.2008.08.005; Engh I, 2007, EUKARYOT CELL, V6, P831, DOI 10.1128/EC.00269-06; Eriksson M, 1996, P NATL ACAD SCI USA, V93, P12031, DOI 10.1073/pnas.93.21.12031; ESSER K, 1982, CRYPTOGAMS CYANAOBAC; Fabre N, 2007, PLANT CELL ENVIRON, V30, P617, DOI 10.1111/j.1365-3040.2007.01651.x; GIORDANO M, 2003, PLANT PHYSL, V132; Gotz R, 1999, YEAST, V15, P855, DOI 10.1002/(SICI)1097-0061(199907)15:10A<855::AID-YEA425>3.0.CO;2-C; GUILLOTON MB, 1993, J BACTERIOL, V175, P1443, DOI 10.1128/JB.175.5.1443-1451.1993; Henry RP, 1996, ANNU REV PHYSIOL, V58, P523, DOI 10.1146/annurev.ph.58.030196.002515; HewettEmmett D, 1996, MOL PHYLOGENET EVOL, V5, P50, DOI 10.1006/mpev.1996.0006; Innocenti A, 2008, BIOORG MED CHEM LETT, V18, P5066, DOI 10.1016/j.bmcl.2008.07.122; James P, 1996, GENETICS, V144, P1425; Janus D, 2007, APPL ENVIRON MICROB, V73, P962, DOI 10.1128/AEM.02127-06; Kamerewerd J, 2008, GENETICS, V180, P191, DOI 10.1534/genetics.108.091603; Kimber MS, 2000, EMBO J, V19, P1407, DOI 10.1093/emboj/19.7.1407; Klengel T, 2005, CURR BIOL, V15, P2021, DOI 10.1016/j.cub.2005.10.040; Kuck U, 2005, MOL GENET GENOMICS, V274, P307, DOI 10.1007/s00438-005-0021-8; KUCK U, 2005, PRODUCTION RECOMBINA, P215; Kusian B, 2002, J BACTERIOL, V184, P5018, DOI 10.1128/JB.184.18.5018-5026.2002; Levina NN, 2006, FUNGAL GENET BIOL, V43, P65, DOI 10.1016/j.fgb.2005.06.008; McGinn PJ, 2008, PHYSIOL PLANTARUM, V133, P78, DOI 10.1111/j.1399-3054.2007.01039.x; Missner A, 2008, J BIOL CHEM, V283, P25340, DOI 10.1074/jbc.M800096200; Mitsuhashi S, 2000, J BIOL CHEM, V275, P5521, DOI 10.1074/jbc.275.8.5521; Mitsuhashi S, 2004, APPL MICROBIOL BIOT, V63, P592, DOI 10.1007/s00253-003-1402-8; Mogensen EG, 2006, EUKARYOT CELL, V5, P103, DOI 10.1128/EC.5.1.103-111.2006; MOGENSEN EG, 2008, MYCOTA, V6, P83; NAGAO Y, 1994, P NATL ACAD SCI USA, V91, P10330, DOI 10.1073/pnas.91.22.10330; Nolting N, 2006, MOL MICROBIOL, V62, P853, DOI 10.1111/j.1365-2958.2006.05415.x; Nolting N, 2006, EUKARYOT CELL, V5, P1043, DOI 10.1128/EC.00086-06; Nowrousian M, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-64; Nowrousian M, 1999, MOL CELL BIOL, V19, P450; Nowrousian M, 2004, FUNGAL GENET BIOL, V41, P285, DOI 10.1016/j.fgb.2003.10.005; Nowrousian M, 2007, FUNGAL GENET BIOL, V44, P602, DOI 10.1016/j.fgb.2006.09.009; Parisi G, 2004, PLANT MOL BIOL, V55, P193, DOI 10.1007/s11103-004-0149-7; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Poggeler S, 2006, MOL GENET GENOMICS, V275, P492, DOI 10.1007/s00438-006-0107-y; Poggeler S, 2006, GENE, V378, P1, DOI 10.1016/j.gene.2006.03.020; Poggeler S, 1997, GENETICS, V147, P567; Poggeler S, 2003, CURR GENET, V43, P54, DOI 10.1007/s00294-003-0370-y; Poggeler S., 2008, FUNGAL GENET REP, V55, P8, DOI [10.4148/1941-4765.1083, DOI 10.4148/1941-4765.1083]; Poggeler S, 2006, MYCOTA, P325; Raven JA, 2001, PLANT CELL ENVIRON, V24, P261; Sambrook J, 2001, MOL CLONING LAB MANU; SCHLICKER C, 2008, J MOL BIOL; Slaymaker DH, 2002, P NATL ACAD SCI USA, V99, P11640, DOI 10.1073/pnas.182427699; Smith KS, 2002, J BACTERIOL, V184, P4240, DOI 10.1128/JB.184.15.4240-4245.2002; Smith KS, 1999, J BACTERIOL, V181, P6247, DOI 10.1128/JB.181.20.6247-6253.1999; Smith KS, 1999, P NATL ACAD SCI USA, V96, P15184, DOI 10.1073/pnas.96.26.15184; Strop P, 2001, J BIOL CHEM, V276, P10299, DOI 10.1074/jbc.M009182200; SUAREZ C, 2005, J BIOL CHEM, V0280; Subramani S, 1998, PHYSIOL REV, V78, P171, DOI 10.1152/physrev.1998.78.1.171; Sunderhaus S, 2006, J BIOL CHEM, V281, P6482, DOI 10.1074/jbc.M511542200; Supuran CT, 2008, CURR PHARM DESIGN, V14, P603, DOI 10.2174/138161208783877884; Tetu SG, 2007, PLANT PHYSIOL, V144, P1316, DOI 10.1104/pp.107.098152; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tripp BC, 2001, J BIOL CHEM, V276, P48615, DOI 10.1074/jbc.R100045200; Xu Y, 2008, NATURE, V452, P56, DOI 10.1038/nature06636	70	33	35	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5177	10.1371/journal.pone.0005177	http://dx.doi.org/10.1371/journal.pone.0005177			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TN	19365544	gold, Green Published, Green Submitted			2022-12-25	WOS:000265509900007
J	Nackley, AG; Shabalina, SA; Lambert, JE; Conrad, MS; Gibson, DG; Spiridonov, AN; Satterfield, SK; Diatchenko, L				Nackley, Andrea G.; Shabalina, Svetlana A.; Lambert, Jason E.; Conrad, Mathew S.; Gibson, Dustin G.; Spiridonov, Alexey N.; Satterfield, Sarah K.; Diatchenko, Luda			Low Enzymatic Activity Haplotypes of the Human Catechol-O-Methyltransferase Gene: Enrichment for Marker SNPs	PLOS ONE			English	Article								Catechol-O-methyltransferase (COMT) is an enzyme that plays a key role in the modulation of catechol-dependent functions such as cognition, cardiovascular function, and pain processing. Three common haplotypes of the human COMT gene, divergent in two synonymous and one nonsynonymous (val(158) met) position, designated as low (LPS), average (APS), and high pain sensitive (HPS), are associated with experimental pain sensitivity and risk of developing chronic musculoskeletal pain conditions. APS and HPS haplotypes produce significant functional effects, coding for 3- and 20-fold reductions in COMT enzymatic activity, respectively. In the present study, we investigated whether additional minor single nucleotide polymorphisms (SNPs), accruing in 1 to 5% of the population, situated in the COMT transcript region contribute to haplotype-dependent enzymatic activity. Computer analysis of COMT ESTs showed that one synonymous minor SNP (rs769224) is linked to the APS haplotype and three minor SNPs (two synonymous: rs6267, rs740602 and one nonsynonymous: rs8192488) are linked to the HPS haplotype. Results from in silico and in vitro experiments revealed that inclusion of allelic variants of these minor SNPs in APS or HPS haplotypes did not modify COMT function at the level of mRNA folding, RNA transcription, protein translation, or enzymatic activity. These data suggest that neutral variants are carried with APS and HPS haplotypes, while the high activity LPS haplotype displays less linked variation. Thus, both minor synonymous and nonsynonymous SNPs in the coding region are markers of functional APS and HPS haplotypes rather than independent contributors to COMT activity.			Nackley, AG (corresponding author), Univ N Carolina, Sch Dent, Ctr Neurosensory Disorders, Chapel Hill, NC 27515 USA.	lbdiatch@email.unc.edu	Shabalina, Svetlana/N-8939-2013	Shabalina, Svetlana/0000-0003-2272-7473; Gibson, Dustin/0000-0002-9073-3376	NCRR NIH HHS [KL2 RR025746, K12 KL2 RR025746] Funding Source: Medline; NIDCR NIH HHS [R01-DE016558, U01 DE017018, R01 DE016558, U01-DE017018] Funding Source: Medline; NIDDK NIH HHS [R24 DK067674] Funding Source: Medline; NINDS NIH HHS [P01-NS065685] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U01DE017018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK067674] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alsobrook JP, 2002, AM J MED GENET, V114, P116, DOI 10.1002/ajmg.10040; Bray NJ, 2003, AM J HUM GENET, V73, P152, DOI 10.1086/376578; Bubb KL, 2006, GENETICS, V173, P2165, DOI 10.1534/genetics.106.055715; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Chen RD, 1996, PROTEIN SCI, V5, P287; Devlin AM, 2000, HUM MOL GENET, V9, P2837, DOI 10.1093/hmg/9.19.2837; Diatchenko L, 2005, HUM MOL GENET, V14, P135, DOI 10.1093/hmg/ddi013; Diatchenko L, 2006, PAIN, V125, P216, DOI 10.1016/j.pain.2006.05.024; Diatchenko L, 2006, AM J MED GENET B, V141B, P449, DOI 10.1002/ajmg.b.30324; Domschke K, 2004, INT J NEUROPSYCHOPH, V7, P183, DOI 10.1017/s146114570400416X; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; ENGBERSEN AMT, 1995, AM J HUM GENET, V56, P142; Frisch A, 2001, MOL PSYCHIATR, V6, P243, DOI 10.1038/sj.mp.4000830; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Goldstein David S, 2003, Endocr Regul, V37, P69; Gursoy S, 2003, RHEUMATOL INT, V23, P104, DOI 10.1007/s00296-002-0260-5; Harden RN, 2004, ANESTH ANALG, V99, P1478, DOI 10.1213/01.ANE.0000132549.25154.ED; Hayden EP, 2006, GENES BRAIN BEHAV, V5, P85, DOI 10.1111/j.1601-183X.2005.00138.x; Hintsanen M, 2008, J OCCUP ENVIRON MED, V50, P649, DOI 10.1097/JOM.0b013e318165c7ec; Hong JP, 2008, AM J MED GENET B, V147B, P658, DOI 10.1002/ajmg.b.30649; Izumi T, 1999, J MOL BIOL, V287, P47, DOI 10.1006/jmbi.1999.2573; Kamide K, 2007, J HYPERTENS, V25, P103, DOI 10.1097/HJH.0b013e3280103a40; Kaplan N, 2001, GENET EPIDEMIOL, V20, P432, DOI 10.1002/gepi.1012; Karayiorgou M, 1997, P NATL ACAD SCI USA, V94, P4572, DOI 10.1073/pnas.94.9.4572; Kern AD, 2004, NAT GENET, V36, P1207, DOI 10.1038/ng1451; Kimura M., 1985, J GENET, V64, P7, DOI [10.1007/BF02923549, DOI 10.1007/BF02923549]; KIRBY DA, 1995, P NATL ACAD SCI USA, V92, P9047, DOI 10.1073/pnas.92.20.9047; Kondrashov AS, 2002, P NATL ACAD SCI USA, V99, P14878, DOI 10.1073/pnas.232565499; KREITMAN M, 1991, GENETICS, V127, P565; Kunugi H, 1997, NEUROSCI LETT, V221, P202, DOI 10.1016/S0304-3940(96)13289-4; Lavigne JA, 1997, CANCER RES, V57, P5493; Lee SG, 2005, HUM GENET, V116, P319, DOI 10.1007/s00439-004-1239-y; Lievers KJA, 2002, ATHEROSCLEROSIS, V164, P269, DOI 10.1016/S0021-9150(02)00065-5; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; LUNDSTROM K, 1991, DNA CELL BIOL, V10, P181, DOI 10.1089/dna.1991.10.181; MARBACH JJ, 1976, J DENT RES, V55, P711, DOI 10.1177/00220345760550043801; Masuda M, 2002, ANN CLIN BIOCHEM, V39, P589, DOI 10.1258/000456302760413379; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; MATVEEVA OV, 1993, NUCLEIC ACIDS RES, V21, P1007, DOI 10.1093/nar/21.4.1007; McGrath M, 2004, AM J PSYCHIAT, V161, P1703, DOI 10.1176/appi.ajp.161.9.1703; Michaelovsky E, 2008, INT J NEUROPSYCHOPH, V11, P351, DOI 10.1017/S1461145707008085; Muntjewerff JW, 2008, EUR NEUROPSYCHOPHARM, V18, P99, DOI 10.1016/j.euroneuro.2007.06.005; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; NACKLEY AG, 2005, COMT MODULATES PAIN; Nackley AG, 2007, PAIN, V128, P199, DOI 10.1016/j.pain.2006.09.022; NAZIPOVA NN, 1995, COMPUT APPL BIOSCI, V11, P423; Nielsen R, 2007, NAT REV GENET, V8, P857, DOI 10.1038/nrg2187; Nygard O, 1998, AM J CLIN NUTR, V67, P263, DOI 10.1093/ajcn/67.2.263; OGURTSOV AY, 2006, BIOINFORMATICS; Oroszi G, 2004, PHARMACOGENOMICS, V5, P1037, DOI 10.1517/14622416.5.8.1037; Palmatier MA, 2004, MOL PSYCHIATR, V9, P859, DOI 10.1038/sj.mp.4001496; Qian QJ, 2003, AM J MED GENET B, V118B, P103, DOI 10.1002/ajmg.b.10064; RAJA SN, 1995, ANN MED, V27, P241, DOI 10.3109/07853899509031966; Rakvag TT, 2005, PAIN, V116, P73, DOI 10.1016/j.pain.2005.03.032; Schulein R, 2001, J BIOL CHEM, V276, P8384, DOI 10.1074/jbc.M007045200; SENGUPTA S, 2008, NEUROPSYCHOPHARMACOL; Shabalina SA, 2006, NUCLEIC ACIDS RES, V34, P2428, DOI 10.1093/nar/gkl287; SHIBATA K, 2008, GENET EPIDEMIOL; Shifman S, 2002, AM J HUM GENET, V71, P1296, DOI 10.1086/344514; SIMMONS GM, 1994, MOL BIOL EVOL, V11, P666; Slade Gary D, 2008, Semin Orthod, V14, P146, DOI 10.1053/j.sodo.2008.02.005; TENHUNEN J, 1993, DNA CELL BIOL, V12, P253, DOI 10.1089/dna.1993.12.253; Thompson PA, 1998, CANCER RES, V58, P2107; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Tunbridge EM, 2006, BIOL PSYCHIAT, V60, P141, DOI 10.1016/j.biopsych.2005.10.024; Vargas-Alarcon G, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2316; Williams HJ, 2007, SCHIZOPHRENIA BULL, V33, P635, DOI 10.1093/schbul/sbm019; Woo JM, 2004, J PSYCHIATR RES, V38, P365, DOI 10.1016/j.jpsychires.2004.01.001; Yoritaka A, 1997, J NEURAL TRANSM, V104, P1313, DOI 10.1007/BF01294732; Zhu BT, 2002, HISTOL HISTOPATHOL, V17, P1283, DOI 10.14670/HH-17.1283; Zhu GS, 2004, PSYCHOPHARMACOLOGY, V177, P178, DOI 10.1007/s00213-004-1938-z; Zubieta JK, 2003, SCIENCE, V299, P1240, DOI 10.1126/science.1078546; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	74	41	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5237	10.1371/journal.pone.0005237	http://dx.doi.org/10.1371/journal.pone.0005237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TN	19365560	Green Published, Green Submitted, gold			2022-12-25	WOS:000265509900019
J	Varea, O; Garrido, JJ; Dopazo, A; Mendez, P; Garcia-Segura, LM; Wandosell, F				Varea, Olga; Garrido, Juan Jose; Dopazo, Ana; Mendez, Pablo; Garcia-Segura, Luis Miguel; Wandosell, Francisco			Estradiol Activates beta-Catenin Dependent Transcription in Neurons	PLOS ONE			English	Article								Estradiol may fulfill a plethora of functions in neurons, in which much of its activity is associated with its capacity to directly bind and dimerize estrogen receptors. This hormone-protein complex can either bind directly to estrogen response elements (ERE's) in gene promoters, or it may act as a cofactor at non-ERE sites interacting with other DNA-binding elements such as AP-1 or c-Jun. Many of the neuroprotective effects described for estrogen have been associated with this mode of action. However, recent evidence suggests that in addition to these "genomic effects", estrogen may also act as a more general "trophic factor" triggering cytoplasmic signals and extending the potential activity of this hormone. We demonstrated that estrogen receptor alpha associates with beta-catenin and glycogen synthase kinase 3 in the brain and in neurons, which has since been confirmed by others. Here, we show that the action of estradiol activates beta-catenin transcription in neuroblastoma cells and in primary cortical neurons. This activation is time and concentration-dependent, and it may be abolished by the estrogen receptor antagonist ICI 182780. The transcriptional activation of beta-catenin is dependent on lymphoid enhancer binding factor-1 (LEF-1) and a truncated-mutant of LEF-1 almost completely blocks estradiol TCF-mediated transcription. Transcription of a TCF-reporter in a transgenic mouse model is enhanced by estradiol in a similar fashion to that produced by Wnt3a. In addition, activation of a luciferase reporter driven by the engrailed promoter with three LEF-1 repeats was mediated by estradiol. We established a cell line that constitutively expresses a dominant-negative LEF-1 and it was used in a gene expression microarray analysis. In this way, genes that respond to estradiol or Wnt3a, sensitive to LEF-1, could be identified and validated. Together, these data demonstrate the existence of a new signaling pathway controlled by estradiol in neurons. This pathway shares some elements of the insulin-like growth factor-1/Insulin and Wnt signaling pathways, however, our data strongly suggest that it is different from that of both these ligands. These findings may reveal a set of new physiological roles for estrogens, at least in the Central Nervous System (CNS).	[Varea, Olga; Garrido, Juan Jose; Wandosell, Francisco] CSIC UAM, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Varea, Olga; Garrido, Juan Jose; Wandosell, Francisco] CSIC UAM, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Dopazo, Ana] Ctr Nacl Invest Cardiovasc, Genom Unit, Madrid, Spain; [Mendez, Pablo; Garcia-Segura, Luis Miguel] CSIC, Inst Cajal, Lab Neuroact Steroids, E-28002 Madrid, Spain; [Garrido, Juan Jose] CSIC, Inst Cajal, Lab Neuronal Polar, Madrid, Spain	CIBERNED; Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Centro Nacional de Investigaciones Cardiovasculares (CNIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Varea, O (corresponding author), CSIC UAM, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain.	fwandosell@cbm.uam.es	Garrido, Juan Jose/E-6782-2012; Dopazo, Ana/N-1159-2014; Wandosell, Francisco/AAV-6391-2020; Garcia-Segura, Luis M/U-3711-2017; Wandosell, Francisco/G-6105-2015; Mendez, Pablo/J-7552-2017	Garrido, Juan Jose/0000-0002-4499-4487; Dopazo, Ana/0000-0002-4910-1684; Garcia-Segura, Luis M/0000-0002-2450-2916; Wandosell, Francisco/0000-0001-6537-2321; , Olga/0000-0002-1408-495X; Varea, Olga/0000-0001-7425-6250; Mendez, Pablo/0000-0001-9862-6818				Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Barolo S, 2006, ONCOGENE, V25, P7505, DOI 10.1038/sj.onc.1210057; Beato M, 2000, HUM REPROD UPDATE, V6, P225, DOI 10.1093/humupd/6.3.225; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Belcher SM, 2001, J PHARMACOL EXP THER, V299, P408; Bienz M, 2005, CURR BIOL, V15, pR64, DOI 10.1016/j.cub.2004.12.058; Cardona-Gomez P, 2004, MOL CELL NEUROSCI, V25, P363, DOI 10.1016/j.mcn.2003.10.008; Cordey M, 2003, J NEUROCHEM, V84, P1340, DOI 10.1046/j.1471-4159.2003.01631.x; Culmsee C, 1999, J CEREBR BLOOD F MET, V19, P1263, DOI 10.1097/00004647-199911000-00011; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Demay F, 2001, ENDOCRINOLOGY, V142, P3340, DOI 10.1210/en.142.8.3340; Dubal DB, 1999, J NEUROSCI, V19, P6385; Filali M, 2002, J BIOL CHEM, V277, P33398, DOI 10.1074/jbc.M107977200; Flouriot G, 2000, EMBO J, V19, P4688, DOI 10.1093/emboj/19.17.4688; Galceran J, 2000, DEVELOPMENT, V127, P469; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Garcia C, 2007, J CELL BIOCHEM, V102, P665, DOI 10.1002/jcb.21324; Garcia-Segura LM, 2001, PROG NEUROBIOL, V63, P29, DOI 10.1016/S0301-0082(00)00025-3; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Honda K, 2000, J NEUROSCI RES, V60, P321, DOI 10.1002/(SICI)1097-4547(20000501)60:3<321::AID-JNR6>3.3.CO;2-K; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; Kenchappa RS, 2004, FASEB J, V18, P1102, DOI 10.1096/fj.03-1075fje; Kouzmenko AP, 2004, J BIOL CHEM, V279, P40255, DOI 10.1074/jbc.C400331200; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Li J, 2008, NAT CELL BIOL, V10, P160, DOI 10.1038/ncb1684; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; McCullough LD, 2003, TRENDS ENDOCRIN MET, V14, P228, DOI 10.1016/S1043-2760(03)00076-6; McGrew LL, 1999, MECH DEVELOP, V87, P21, DOI 10.1016/S0925-4773(99)00136-7; McKenna NJ, 2001, ANN NY ACAD SCI, V949, P3; Mendez P, 2003, MOL BRAIN RES, V112, P170, DOI 10.1016/S0169-328X(03)00088-3; Metivier R, 2004, EMBO J, V23, P3653, DOI 10.1038/sj.emboj.7600377; Miller DB, 1998, ANN NY ACAD SCI, V844, P153, DOI 10.1111/j.1749-6632.1998.tb08230.x; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morissette M, 2007, NEUROPHARMACOLOGY, V52, P1509, DOI 10.1016/j.neuropharm.2007.02.004; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Quintanilla RA, 2005, J BIOL CHEM, V280, P11615, DOI 10.1074/jbc.M411936200; Ray S, 2008, MOL ENDOCRINOL, V22, P1125, DOI 10.1210/me.2007-0445; Roose J, 1999, BBA-REV CANCER, V1424, pM23, DOI 10.1016/S0304-419X(99)00026-8; Sansom OJ, 2005, J BIOL CHEM, V280, P28463, DOI 10.1074/jbc.M500191200; Sawada H, 2000, FASEB J, V14, P1202, DOI 10.1096/fasebj.14.9.1202; Sawada H, 2002, NEUROPHARMACOLOGY, V42, P1056, DOI 10.1016/S0028-3908(02)00049-7; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Simpkins JW, 2004, STROKE, V35, P2648, DOI 10.1161/01.STR.0000143734.59507.88; Singh M, 1999, J NEUROSCI, V19, P1179; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; Toran-Allerand CD, 1999, FRONT NEUROENDOCRIN, V20, P97, DOI 10.1006/frne.1999.0177; TRUSS M, 1993, ENDOCR REV, V14, P459, DOI 10.1210/er.14.4.459; Wang CN, 2001, J BIOL CHEM, V276, P5287, DOI 10.1074/jbc.M006406200; Wise PM, 2003, ENDOCRINE, V21, P11, DOI 10.1385/ENDO:21:1:11; Wise PM, 2001, ENDOCRINOLOGY, V142, P969, DOI 10.1210/en.142.3.969; Wise PM, 2000, BIOL REPROD, V63, P982, DOI 10.1095/biolreprod63.4.982; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Xu HX, 1998, NAT MED, V4, P447, DOI 10.1038/nm0498-447; Yu XR, 2004, J BIOL CHEM, V279, P13086, DOI 10.1074/jbc.M313283200; Zhang QG, 2008, J NEUROSCI, V28, P8430, DOI 10.1523/JNEUROSCI.2752-08.2008	59	57	59	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2009	4	4							e5153	10.1371/journal.pone.0005153	http://dx.doi.org/10.1371/journal.pone.0005153			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437SB	19360103	Green Published, gold, Green Submitted			2022-12-25	WOS:000265506100001
J	Gawlik, K; Shiryaev, SA; Zhu, WH; Motamedchaboki, K; Desjardins, R; Day, R; Remacle, AG; Stec, B; Strongin, AY				Gawlik, Katarzyna; Shiryaev, Sergey A.; Zhu, Wenhong; Motamedchaboki, Khatereh; Desjardins, Roxane; Day, Robert; Remacle, Albert G.; Stec, Boguslaw; Strongin, Alex Y.			Autocatalytic Activation of the Furin Zymogen Requires Removal of the Emerging Enzyme's N-Terminus from the Active Site	PLOS ONE			English	Article								Background: Before furin can act on protein substrates, it must go through an ordered process of activation. Similar to many other proteinases, furin is synthesized as a zymogen (profurin) which becomes active only after the autocatalytic removal of its auto-inhibitory prodomain. We hypothesized that to activate profurin its prodomain had to be removed and, in addition, the emerging enzyme's N-terminus had to be ejected from the catalytic cleft. Methodology/Principal Findings: We constructed and analyzed the profurin mutants in which the egress of the emerging enzyme's N-terminus from the catalytic cleft was restricted. Mutants were autocatalytically processed at only the primary cleavage site Arg-Thr-Lys-Arg(107) down arrow Asp(108), but not at both the primary and the secondary (Arg-Gly-Val-Thr-Lys-Arg(75) down arrow Ser(76)) cleavage sites, yielding, as a result, the full-length prodomain and mature furins commencing from the N-terminal Asp108. These correctly processed furin mutants, however, remained self-inhibited by the constrained N-terminal sequence which continuously occupied the S' sub-sites of the catalytic cleft and interfered with the functional activity. Further, using the in vitro cleavage of the purified prodomain and the analyses of colon carcinoma LoVo cells with the reconstituted expression of the wild-type and mutant furins, we demonstrated that a three-step autocatalytic processing including the cleavage of the prodomain at the previously unidentified Arg-Leu-Gln-Arg(89) down arrow Glu(90) site, is required for the efficient activation of furin. Conclusions/Significance: Collectively, our results show the restrictive role of the enzyme's N-terminal region in the autocatalytic activation mechanisms. In a conceptual form, our data apply not only to profurin alone but also to a range of self-activated proteinases.	[Gawlik, Katarzyna; Shiryaev, Sergey A.; Zhu, Wenhong; Motamedchaboki, Khatereh; Remacle, Albert G.; Stec, Boguslaw; Strongin, Alex Y.] Burnham Inst Med Res, La Jolla, CA USA; [Desjardins, Roxane; Day, Robert] Univ Sherbrooke, Sherbrooke, PQ, Canada	Sanford Burnham Prebys Medical Discovery Institute; University of Sherbrooke	Gawlik, K (corresponding author), Burnham Inst Med Res, La Jolla, CA USA.	strongin@burnham.org	Strongin, Alex/R-6609-2019	Strongin, Alex/0000-0003-3765-3016; Stec, Boguslaw/0000-0002-8696-0349	National Institutes of Health [RR020843, CA83017, CA77470]; Susan G. Komen Breast Cancer Foundation [BCTR123106]; CIHR; NATIONAL CANCER INSTITUTE [R01CA083017, R01CA077470] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); CIHR(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the National Institutes of Health Grants RR020843, CA83017, and CA77470, and by the Susan G. Komen Breast Cancer Foundation Grant BCTR123106 (all to AYS), and CIHR grant to RD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ED, 1997, EMBO J, V16, P1508, DOI 10.1093/emboj/16.7.1508; Anderson ED, 2002, J BIOL CHEM, V277, P12879, DOI 10.1074/jbc.M108740200; ANDERSON ED, 1993, J BIOL CHEM, V268, P24887; Bassi DE, 2005, MOL CARCINOGEN, V44, P151, DOI 10.1002/mc.20134; Bhattacharjya S, 2007, BIOPOLYMERS, V86, P329, DOI 10.1002/bip.20748; Bissonnette L, 2004, BIOCHEM J, V379, P757, DOI 10.1042/BJ20031902; CREEMERS JWM, 1995, J BIOL CHEM, V270, P2695, DOI 10.1074/jbc.270.6.2695; Feliciangeli SF, 2006, J BIOL CHEM, V281, P16108, DOI 10.1074/jbc.M600760200; Fugere M, 2005, TRENDS PHARMACOL SCI, V26, P294, DOI 10.1016/j.tips.2005.04.006; Fugere M, 2002, J BIOL CHEM, V277, P7648, DOI 10.1074/jbc.M107467200; GALLAGHER T, 1995, STRUCTURE, V3, P907, DOI 10.1016/S0969-2126(01)00225-8; Henrich S, 2005, J MOL BIOL, V345, P211, DOI 10.1016/j.jmb.2004.10.050; Henrich S, 2003, NAT STRUCT BIOL, V10, P520, DOI 10.1038/nsb941; Jean F, 1998, P NATL ACAD SCI USA, V95, P7293, DOI 10.1073/pnas.95.13.7293; Khatib AM, 2002, AM J PATHOL, V160, P1921, DOI 10.1016/S0002-9440(10)61140-6; Lazure C, 2002, CURR PHARM DESIGN, V8, P511, DOI 10.2174/1381612023395691; LEDUC R, 1992, J BIOL CHEM, V267, P14304; LEWIS JH, 1978, BLOOD, V51, P129; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lopez-Otin C, 2008, J BIOL CHEM; Mayer G, 2008, J BIOL CHEM, V283, P2373, DOI 10.1074/jbc.M708763200; MOLLOY SS, 1994, EMBO J, V13, P18, DOI 10.1002/j.1460-2075.1994.tb06231.x; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Molloy SS, 1999, TRENDS CELL BIOL, V9, P28, DOI 10.1016/S0962-8924(98)01382-8; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; REHEMTULLA A, 1992, P NATL ACAD SCI USA, V89, P8235, DOI 10.1073/pnas.89.17.8235; Remacle AG, 2008, J BIOL CHEM, V283, P20897, DOI 10.1074/jbc.M803762200; Rockwell NC, 2004, TRENDS BIOCHEM SCI, V29, P80, DOI 10.1016/j.tibs.2003.12.006; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Siezen RJ, 1997, PROTEIN SCI, V6, P501; SIEZEN RJ, 1995, INTRAMOLECULAR CHAPE, P233; TAKAHASHI S, 1995, J BIOL CHEM, V270, P26565, DOI 10.1074/jbc.270.44.26565; Tangrea MA, 2002, J MOL BIOL, V320, P801, DOI 10.1016/S0022-2836(02)00543-0; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Zybailov B, 2005, ANAL CHEM, V77, P6218, DOI 10.1021/ac050846r	38	23	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2009	4	4							e5031	10.1371/journal.pone.0005031	http://dx.doi.org/10.1371/journal.pone.0005031			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RT	19352504	Green Published, Green Submitted, gold			2022-12-25	WOS:000265505300005
J	Rokka, A; Antonenkov, VD; Soininen, R; Immonen, HL; Pirila, PL; Bergmann, U; Sormunen, RT; Weckstrom, M; Benz, R; Hiltunen, JK				Rokka, Aare; Antonenkov, Vasily D.; Soininen, Raija; Immonen, Hanna L.; Pirila, Paivi L.; Bergmann, Ulrich; Sormunen, Raija T.; Weckstrom, Matti; Benz, Roland; Hiltunen, J. Kalervo			Pxmp2 Is a Channel-Forming Protein in Mammalian Peroxisomal Membrane	PLOS ONE			English	Article								Background: Peroxisomal metabolic machinery requires a continuous flow of organic and inorganic solutes across peroxisomal membrane. Concerning small solutes, the molecular nature of their traffic has remained an enigma. Methods/Principal Findings: In this study, we show that disruption in mice of the Pxmp2 gene encoding Pxmp2, which belongs to a family of integral membrane proteins with unknown function, leads to partial restriction of peroxisomal membrane permeability to solutes in vitro and in vivo. Multiple-channel recording of liver peroxisomal preparations reveals that the channel-forming components with a conductance of 1.3 nS in 1.0 M KCl were lost in Pxmp2(-/-) mice. The channel-forming properties of Pxmp2 were confirmed with recombinant protein expressed in insect cells and with native Pxmp2 purified from mouse liver. The Pxmp2 channel, with an estimated diameter of 1.4 nm, shows weak cation selectivity and no voltage dependence. The long-lasting open states of the channel indicate its functional role as a protein forming a general diffusion pore in the membrane. Conclusions/Significance: Pxmp2 is the first peroxisomal channel identified, and its existence leads to prediction that the mammalian peroxisomal membrane is permeable to small solutes while transfer of "bulky'' metabolites, e. g., cofactors (NAD/H, NADP/H, and CoA) and ATP, requires specific transporters.			Rokka, A (corresponding author), Univ Oulu, Dept Biochem, Bioctr Oulu, Oulu, Finland.	vasily.antonenkov@oulu.fi; kalervo.hiltunen@oulu.fi		Benz, Roland/0000-0002-9510-9265				Abdelraheim SR, 2003, BIOCHEM J, V374, P329, DOI 10.1042/BJ20030441; Antonenkov VD, 2006, BBA-MOL CELL RES, V1763, P1697, DOI 10.1016/j.bbamcr.2006.08.044; Antonenkov VD, 2005, CELL MOL LIFE SCI, V62, P2886, DOI 10.1007/s00018-005-5233-x; Antonenkov VD, 2004, J CELL SCI, V117, P5633, DOI 10.1242/jcs.01485; Antonenkov VD, 2004, AM J PHYSIOL-CELL PH, V287, pC1623, DOI 10.1152/ajpcell.00142.2004; Bakker BM, 2000, P NATL ACAD SCI USA, V97, P2087, DOI 10.1073/pnas.030539197; BAUDHUIN P, 1969, ANN NY ACAD SCI, V168, P214, DOI 10.1111/j.1749-6632.1969.tb43111.x; BENZ R, 1988, EUR J BIOCHEM, V176, P1, DOI 10.1111/j.1432-1033.1988.tb14245.x; Berthemy A, 1999, J PHARMACEUT BIOMED, V19, P429, DOI 10.1016/S0731-7085(98)00200-3; CHEN N, 1988, BIOCHIM BIOPHYS ACTA, V945, P135, DOI 10.1016/0005-2736(88)90476-2; Colasante C, 2006, PROTEOMICS, V6, P3275, DOI 10.1002/pmic.200500668; Dansen TB, 2000, NAT CELL BIOL, V2, P51, DOI 10.1038/71375; Drago I, 2008, J BIOL CHEM, V283, P14384, DOI 10.1074/jbc.M800600200; Gasmi L, 2001, BIOCHEM J, V357, P33, DOI 10.1042/0264-6021:3570033; Gouveia AMM, 1999, ANAL BIOCHEM, V274, P270, DOI 10.1006/abio.1999.4281; Iida R, 2003, J BIOL CHEM, V278, P6301, DOI 10.1074/jbc.M210886200; Jankowski A, 2001, J BIOL CHEM, V276, P48748, DOI 10.1074/jbc.M109003200; Kaulin YA, 1998, BIOPHYS J, V74, P2918, DOI 10.1016/S0006-3495(98)77999-8; Kunkele KP, 1998, CELL, V93, P1009, DOI 10.1016/S0092-8674(00)81206-4; Lasorsa FM, 2004, BIOCHEM J, V381, P581, DOI 10.1042/BJ20040856; Lasorsa FM, 2008, J BIOL CHEM, V283, P15300, DOI 10.1074/jbc.M800648200; Michels PAM, 2006, BBA-MOL CELL RES, V1763, P1463, DOI 10.1016/j.bbamcr.2006.08.019; MORIYAMA Y, 1992, FEBS LETT, V302, P18, DOI 10.1016/0014-5793(92)80274-K; Newberry EP, 2003, J BIOL CHEM, V278, P51664, DOI 10.1074/jbc.M309377200; Otte DM, 2003, GENE, V313, P119, DOI 10.1016/S0378-1119(03)00667-X; Palmieri L, 2001, EMBO J, V20, P5049, DOI 10.1093/emboj/20.18.5049; Porcelli AM, 2005, BIOCHEM BIOPH RES CO, V326, P799, DOI 10.1016/j.bbrc.2004.11.105; Price N., 2001, PRINCIPLES PROBLEMS; Qi C, 1999, J BIOL CHEM, V274, P15775, DOI 10.1074/jbc.274.22.15775; Reumann S, 1998, EUR J BIOCHEM, V251, P359, DOI 10.1046/j.1432-1327.1998.2510359.x; REUMANN S, 1995, J BIOL CHEM, V270, P17559, DOI 10.1074/jbc.270.29.17559; Savolainen K, 2004, HUM MOL GENET, V13, P955, DOI 10.1093/hmg/ddh107; Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765; Trott A, 2004, EUKARYOT CELL, V3, P620, DOI 10.1128/EC.3.3.620-631.2004; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; van Roermund CWT, 2004, J CELL SCI, V117, P4231, DOI 10.1242/jcs.01305; VANROERMUND CWT, 1995, EMBO J, V14, P3480, DOI 10.1002/j.1460-2075.1995.tb07354.x; VANVELDHOVEN PP, 1987, J BIOL CHEM, V262, P4310; VERLEUR N, 1993, EUR J BIOCHEM, V218, P75, DOI 10.1111/j.1432-1033.1993.tb18353.x; Visser WF, 2007, BIOCHEM J, V401, P365, DOI 10.1042/BJ20061352; Wanders RJA, 2007, PFLUG ARCH EUR J PHY, V453, P719, DOI 10.1007/s00424-006-0142-x; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; WU XW, 1994, P NATL ACAD SCI USA, V91, P742, DOI 10.1073/pnas.91.2.742; ZWACKA RM, 1994, EMBO J, V13, P5129, DOI 10.1002/j.1460-2075.1994.tb06842.x	44	101	103	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2009	4	4							e5090	10.1371/journal.pone.0005090	http://dx.doi.org/10.1371/journal.pone.0005090			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RT	19352492	Green Published, Green Submitted, gold			2022-12-25	WOS:000265505300013
J	Tian, WZ; Liou, HC				Tian, Wenzhi; Liou, Hsiou-Chi			RNAi-Mediated c-Rel Silencing Leads to Apoptosis of B Cell Tumor Cells and Suppresses Antigenic Immune Response In Vivo	PLOS ONE			English	Article							NF-KAPPA-B; TRANSCRIPTION FACTOR REL; CHICKEN SPLEEN-CELLS; T-CELLS; MULTIPLE-MYELOMA; CYCLE PROGRESSION; GENE-EXPRESSION; MICE LACKING; SPLENIC MICROARCHITECTURE; LYMPHOCYTE-PROLIFERATION	c-Rel is a member of the Rel/NF-kappa B transcription factor family and is predominantly expressed in lymphoid and myeloid cells, playing a critical role in lymphocyte proliferation and survival. Persistent activation of the c-Rel signal transduction pathway is associated with allergies, inflammation, autoimmune diseases, and a variety of human malignancies. To explore the potential of targeting c-Rel as a therapeutic agent for these disorders, we designed a small interfering RNA (siRNA) to silence c-Rel expression in vitro and in vivo. C-Rel-siRNA expression via a retroviral vector in a B cell tumor cell line leads to growth arrest and apoptosis of the tumor cells. Silencing c-Rel in primary B cells in vitro compromises their proliferative and survival response to CD40 activation signals, similar to the impaired response of c-Rel knockout B cells. Most important, in vivo silencing of c-Rel results in significant impairment in T cell-mediated immune responses to antigenic stimulation. Our study thus validates the efficacy of c-Rel-siRNA, and suggests the development of siRNA-based therapy, as well as small molecular inhibitors for the treatment of B cell tumors as well as autoimmune diseases.	[Tian, Wenzhi; Liou, Hsiou-Chi] Cornell Univ, Div Immunol, Dept Med, Weill Med Coll, New York, NY 10021 USA	Cornell University	Tian, WZ (corresponding author), Cornell Univ, Div Immunol, Dept Med, Weill Med Coll, New York, NY 10021 USA.	hcliou@med.cornell.edu			National Institutes of Health [CA68155, CA90405]; T32 postdoctoral fellowship; Leukemia & Lymphoma Society Scholar Award; NATIONAL CANCER INSTITUTE [R55CA068155, R01CA068155, R01CA090405] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T32 postdoctoral fellowship; Leukemia & Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants (CA68155, CA90405), T32 postdoctoral fellowship (W. Tian), and the Leukemia & Lymphoma Society Scholar Award (H.-C. Liou). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinc A, 2008, NAT BIOTECHNOL, V26, P561, DOI 10.1038/nbt1402; Andjelic S, 1998, EUR J IMMUNOL, V28, P570, DOI 10.1002/(SICI)1521-4141(199802)28:02<570::AID-IMMU570>3.0.CO;2-M; Andjelic S, 2000, J IMMUNOL, V165, P3860, DOI 10.4049/jimmunol.165.7.3860; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Banerjee D, 2005, IMMUNITY, V23, P445, DOI 10.1016/j.immuni.2005.09.012; Banerji L, 2001, ONCOGENE, V20, P7352, DOI 10.1038/sj.onc.1204951; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; BEG AA, 1996, SCIENCE, V274, P784; Bernal A, 2001, BLOOD, V98, P3050, DOI 10.1182/blood.V98.10.3050; Birmingham A, 2007, NAT PROTOC, V2, P2068, DOI 10.1038/nprot.2007.278; Bottero V, 2006, CELL DEATH DIFFER, V13, P785, DOI 10.1038/sj.cdd.4401888; Caamano JH, 1998, J EXP MED, V187, P185, DOI 10.1084/jem.187.2.185; Campbell IK, 2000, J CLIN INVEST, V105, P1799, DOI 10.1172/JCI8298; Carmody RJ, 2007, J IMMUNOL, V178, P186, DOI 10.4049/jimmunol.178.1.186; CHANG CC, 1994, ONCOGENE, V9, P923; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Chen XF, 2003, CANCER RES, V63, P1059; Cheng SH, 2003, ONCOGENE, V22, P8472, DOI 10.1038/sj.onc.1206917; Chiorazzi N, 2007, BEST PRACT RES CL HA, V20, P399, DOI 10.1016/j.beha.2007.03.007; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; Donjerkovic D, 2000, EUR J IMMUNOL, V30, P1154, DOI 10.1002/(SICI)1521-4141(200004)30:4<1154::AID-IMMU1154>3.0.CO;2-B; Donovan CE, 1999, J IMMUNOL, V163, P6827; Fan YJ, 2004, ONCOGENE, V23, P1030, DOI 10.1038/sj.onc.1207221; Fan YJ, 2008, ADV EXP MED BIOL, V615, P223, DOI 10.1007/978-1-4020-6554-5_11; FANG W, 1995, J IMMUNOL, V155, P66; Feng B, 2004, CELL IMMUNOL, V232, P9, DOI 10.1016/j.cellimm.2005.01.006; Feng Biao, 2004, Med Immunol, V3, P1, DOI 10.1186/1476-9433-3-1; Finn PW, 2002, J LEUKOCYTE BIOL, V72, P1054; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; Furman RR, 2000, J IMMUNOL, V164, P2200, DOI 10.4049/jimmunol.164.4.2200; Gerondakis S, 1998, CURR OPIN IMMUNOL, V10, P353, DOI 10.1016/S0952-7915(98)80175-1; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; GILMORE TD, 1992, CANCER SURV, V15, P69; Gilmore TD, 2004, ONCOGENE, V23, P2275, DOI 10.1038/sj.onc.1207410; Gilmore TD, 2001, ONCOGENE, V20, P7098, DOI 10.1038/sj.onc.1204898; Gilmore TD, 2007, CANCER CELL, V12, P95, DOI 10.1016/j.ccr.2007.07.010; Grossmann M, 1999, INT J BIOCHEM CELL B, V31, P1209, DOI 10.1016/S1357-2725(99)00068-0; Grumont R, 2001, J EXP MED, V194, P1021, DOI 10.1084/jem.194.8.1021; Grumont RJ, 2000, J EXP MED, V191, P1281, DOI 10.1084/jem.191.8.1281; Grumont RJ, 1998, J EXP MED, V187, P663, DOI 10.1084/jem.187.5.663; Grumont RJ, 2002, MOL CELL, V10, P1283, DOI 10.1016/S1097-2765(02)00779-7; Grumont RJ, 1999, GENE DEV, V13, P400, DOI 10.1101/gad.13.4.400; Harling-McNabb L, 1999, INT IMMUNOL, V11, P1431, DOI 10.1093/intimm/11.9.1431; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Henke E, 2008, NAT BIOTECHNOL, V26, P91, DOI 10.1038/nbt1366; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Hilliard BA, 2002, J CLIN INVEST, V110, P843, DOI 10.1172/JCI200215254; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Houldsworth J, 2004, BLOOD, V103, P1862, DOI 10.1182/blood-2003-04-1359; Hsia CY, 2002, INT IMMUNOL, V14, P905, DOI 10.1093/intimm/dxf055; Huang XG, 2004, P NATL ACAD SCI USA, V101, P17789, DOI 10.1073/pnas.0406111101; John M, 2007, NATURE, V449, P745, DOI 10.1038/nature06179; Karin M, 2008, CELL RES, V18, P334, DOI 10.1038/cr.2008.30; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901; Lam LT, 2005, CLIN CANCER RES, V11, P28; LAM LT, 2008, BLOOD; Lamhamedi-Cherradi SE, 2003, J IMMUNOL, V171, P4886, DOI 10.4049/jimmunol.171.9.4886; Lee H, 1995, Curr Top Microbiol Immunol, V194, P247; LEE HY, 1995, J EXP MED, V181, P1169, DOI 10.1084/jem.181.3.1169; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Liou HC, 2003, BIOESSAYS, V25, P767, DOI 10.1002/bies.10306; Liou HC, 1999, INT IMMUNOL, V11, P361, DOI 10.1093/intimm/11.3.361; LIOU HC, 1994, MOL CELL BIOL, V14, P5349, DOI 10.1128/MCB.14.8.5349; Mason N, 2002, J IMMUNOL, V168, P2590, DOI 10.4049/jimmunol.168.6.2590; Mason NJ, 2004, J IMMUNOL, V172, P3704, DOI 10.4049/jimmunol.172.6.3704; Mineva ND, 2007, J BIOL CHEM, V282, P17475, DOI 10.1074/jbc.M607313200; Mittal V, 2004, NAT REV GENET, V5, P355, DOI 10.1038/nrg1323; MIYAMOTO S, 1994, P NATL ACAD SCI USA, V91, P5056, DOI 10.1073/pnas.91.11.5056; Naito Y, 2004, NUCLEIC ACIDS RES, V32, pW124, DOI 10.1093/nar/gkh442; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; O'Connor S, 2004, MOL CELL BIOL, V24, P4895, DOI 10.1128/MCB.24.11.4895-4908.2004; Owyang AM, 2001, J IMMUNOL, V167, P4948, DOI 10.4049/jimmunol.167.9.4948; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Rao S, 2003, J IMMUNOL, V170, P3724, DOI 10.4049/jimmunol.170.7.3724; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Romano MF, 1998, BLOOD, V92, P990; Sanjabi S, 2000, P NATL ACAD SCI USA, V97, P12705, DOI 10.1073/pnas.230436397; Sanjabi S, 2005, GENE DEV, V19, P2138, DOI 10.1101/gad.1329805; Schauer SL, 1996, J IMMUNOL, V157, P81; Siebelt F, 1997, CELL IMMUNOL, V181, P13, DOI 10.1006/cimm.1997.1198; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; Starczynowski DT, 2005, ONCOGENE, V24, P7355, DOI 10.1038/sj.onc.1208902; Starczynowski DT, 2003, ONCOGENE, V22, P6928, DOI 10.1038/sj.onc.1206801; Strasser A, 1999, EUR J IMMUNOL, V29, P928, DOI 10.1002/(SICI)1521-4141(199903)29:03<928::AID-IMMU928>3.3.CO;2-G; Tian WZ, 2005, CELL IMMUNOL, V235, P72, DOI 10.1016/j.cellimm.2005.07.004; Tian WZ, 2005, CELL IMMUNOL, V234, P39, DOI 10.1016/j.cellimm.2005.04.021; Tumang JR, 1998, EUR J IMMUNOL, V28, P4299, DOI 10.1002/(SICI)1521-4141(199812)28:12<4299::AID-IMMU4299>3.0.CO;2-Y; Tumang JR, 2002, CELL IMMUNOL, V217, P47, DOI 10.1016/S0008-8749(02)00513-0; Venkataraman L, 1996, J IMMUNOL, V157, P1149; VENKATARAMAN L, 1995, J EXP MED, V181, P1091, DOI 10.1084/jem.181.3.1091; Wang WH, 1997, IMMUNITY, V6, P165, DOI 10.1016/S1074-7613(00)80423-9; WEIH F, 1994, ONCOGENE, V9, P3289; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Weinmann AS, 2001, NAT IMMUNOL, V2, P51, DOI 10.1038/83168; Wolfrum C, 2007, NAT BIOTECHNOL, V25, P1149, DOI 10.1038/nbt1339; Wu M, 1997, CURR TOP MICROBIOL, V224, P91; Wu M, 1996, MOL CELL BIOL, V16, P5015; Wu M, 1996, EMBO J, V15, P4682, DOI 10.1002/j.1460-2075.1996.tb00845.x; Yang H, 2002, TRANSPLANTATION, V74, P291, DOI 10.1097/00007890-200208150-00002	105	26	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2009	4	4							e5028	10.1371/journal.pone.0005028	http://dx.doi.org/10.1371/journal.pone.0005028			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RS	19347041	Green Submitted, Green Published, gold			2022-12-25	WOS:000265505200003
J	Zimmermann, G; Wang, LP; Vaughan, AG; Manoli, DS; Zhang, F; Deisseroth, K; Baker, BS; Scott, MP				Zimmermann, Gregor; Wang, Li-ping; Vaughan, Alexander G.; Manoli, Devanand S.; Zhang, Feng; Deisseroth, Karl; Baker, Bruce S.; Scott, Matthew P.			Manipulation of an Innate Escape Response in Drosophila: Photoexcitation of acj6 Neurons Induces the Escape Response	PLOS ONE			English	Article								Background: The genetic analysis of behavior in Drosophila melanogaster has linked genes controlling neuronal connectivity and physiology to specific neuronal circuits underlying a variety of innate behaviors. We investigated the circuitry underlying the adult startle response, using photoexcitation of neurons that produce the abnormal chemosensory jump 6 (acj6) transcription factor. This transcription factor has previously been shown to play a role in neuronal pathfinding and neurotransmitter modality, but the role of acj6 neurons in the adult startle response was largely unknown. Principal Findings: We show that the activity of these neurons is necessary for a wild-type startle response and that excitation is sufficient to generate a synthetic escape response. Further, we show that this synthetic response is still sensitive to the dose of acj6 suggesting that that acj6 mutation alters neuronal activity as well as connectivity and neurotransmitter production. Results/Significance: These results extend the understanding of the role of acj6 and of the adult startle response in general. They also demonstrate the usefulness of activity-dependent characterization of neuronal circuits underlying innate behaviors in Drosophila, and the utility of integrating genetic analysis into modern circuit analysis techniques.	[Zimmermann, Gregor; Scott, Matthew P.] Stanford Univ, Dept Dev Biol, Dept Genet, Dept Bioengn, Stanford, CA 94305 USA; [Wang, Li-ping; Zhang, Feng; Deisseroth, Karl] Stanford Univ, Dept Bioengn & Psychiat, Stanford, CA 94305 USA; [Vaughan, Alexander G.; Manoli, Devanand S.; Baker, Bruce S.] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Zimmermann, G (corresponding author), Stanford Univ, Dept Dev Biol, Dept Genet, Dept Bioengn, Stanford, CA 94305 USA.	mscott@stanford.edu	Wang, Liping/ABF-6317-2020; Wang, Liping/B-2827-2012; Macrae, Rhiannon/AAX-1536-2020	Wang, Liping/0000-0001-6893-3809; Manoli, Devanand/0000-0002-7238-2330	HHMI; NIH [RGM085818, Director's Pioneer Award Program]; California Institute of Regenerative Medicine; NARSAD; APIRE; Snyder Foundation; Culpeper Foundation; Coulter Foundation; Klingenstein Foundation; Whitehall Foundation; McKnight Foundation; Albert Yu and Mary Bechmann Foundation; NIDA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085818] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); NARSAD(NARSAD); APIRE; Snyder Foundation; Culpeper Foundation; Coulter Foundation; Klingenstein Foundation(Klingenstein Philanthropies); Whitehall Foundation; McKnight Foundation; Albert Yu and Mary Bechmann Foundation; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	GZ and MS were supported by HHMI. BB, DM and AV were supported by NIH RGM085818 and HHMI. LW was supported by the California Institute of Regenerative Medicine. FS was supported by the NIH. KD was supported by NARSAD, APIRE and the Snyder, Culpeper, Coulter, Klingenstein, Whitehall, McKnight, and Albert Yu and Mary Bechmann Foundations, as well as by NIMH, NIDA, and the NIH Director's Pioneer Award Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYER RK, 1991, P NATL ACAD SCI USA, V88, P5467, DOI 10.1073/pnas.88.12.5467; Bate Michael, 1993, P1013; Bourbon HM, 2002, MECH DEVELOP, V110, P71, DOI 10.1016/S0925-4773(01)00566-4; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brazier M A, 1993, J Hist Neurosci, V2, P53; Certel SJ, 2000, DEVELOPMENT, V127, P2395; Clyne PJ, 1999, NEURON, V22, P339, DOI 10.1016/S0896-6273(00)81094-6; Kitamoto T, 2002, P NATL ACAD SCI USA, V99, P13232, DOI 10.1073/pnas.202489099; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8; Lee MH, 2002, J NEUROSCI, V22, P5291; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Manoli DS, 2006, TRENDS NEUROSCI, V29, P444, DOI 10.1016/j.tins.2006.06.006; MCGUIRE SE, 2004, SCI STKE, P16; MCKENNA M, 1989, P NATL ACAD SCI USA, V86, P8118, DOI 10.1073/pnas.86.20.8118; Naderi Sait, 2004, Neurosurg Focus, V16, pE15; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Piccolino M, 2006, CR BIOL, V329, P303, DOI 10.1016/j.crvi.2006.03.002; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; SHIBATA S, 1984, BRAIN RES, V302, P83, DOI 10.1016/0006-8993(84)91287-3; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; SUH G, 2007, CURR BIOL; Suster ML, 2003, J NEUROBIOL, V55, P233, DOI 10.1002/neu.10202; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; YEH E, 1995, P NATL ACAD SCI USA, V92, P7036, DOI 10.1073/pnas.92.15.7036	31	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5100	10.1371/journal.pone.0005100	http://dx.doi.org/10.1371/journal.pone.0005100			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340304	Green Published, gold, Green Submitted			2022-12-25	WOS:000265500700013
J	Parvanova, I; Epiphanio, S; Fauq, A; Golde, TE; Prudencio, M; Mota, MM				Parvanova, Iana; Epiphanio, Sabrina; Fauq, Abdul; Golde, Todd E.; Prudencio, Miguel; Mota, Maria M.			A Small Molecule Inhibitor of Signal Peptide Peptidase Inhibits Plasmodium Development in the Liver and Decreases Malaria Severity	PLOS ONE			English	Article							GAMMA-SECRETASE INHIBITOR; IN-VITRO; INTRAMEMBRANE PROTEOLYSIS; CORE PROTEIN; FALCIPARUM; TARGETS; INFECTION; CELLS; IDENTIFICATION; SPOROZOITES	The liver stage of Plasmodium's life cycle is the first, obligatory step in malaria infection. Decreasing the hepatic burden of Plasmodium infection decreases the severity of disease and constitutes a promising strategy for malaria prophylaxis. The efficacy of the gamma-secretase and signal peptide peptidase inhibitor LY411,575 in targeting Plasmodium liver stages was evaluated both in human hepatoma cell lines and in mouse primary hepatocytes. LY411,575 was found to prevent Plasmodium's normal development in the liver, with an IC50 of approximately 80 nM, without affecting hepatocyte invasion by the parasite. In vivo results with a rodent model of malaria showed that LY411,575 decreases the parasite load in the liver and increases by 55% the resistance of mice to cerebral malaria, one of the most severe malaria-associated syndromes. Our data show that LY411,575 does not exert its effect via the Notch signaling pathway suggesting that it may interfere with Plasmodium development through an inhibition of the parasite's signal peptide peptidase. We therefore propose that selective signal peptide peptidase inhibitors could be potentially used for preventive treatment of malaria in humans.	[Parvanova, Iana; Epiphanio, Sabrina; Prudencio, Miguel; Mota, Maria M.] Univ Lisbon, Fac Med, Inst Med Mol, Unidade Malaria, P-1699 Lisbon, Portugal; [Fauq, Abdul; Golde, Todd E.] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL USA; [Prudencio, Miguel; Mota, Maria M.] Inst Gulbenkian Ciencias, Oeiras, Portugal	Universidade de Lisboa; Mayo Clinic; Instituto Gulbenkian de Ciencia	Parvanova, I (corresponding author), Vetsuisse Fac Bern, Dept Clin Res & VPH, Div Mol Pathobiol, Bern, Switzerland.	mmota@fm.ul.pt	Prudêncio, Miguel/D-2032-2012; Mota, Maria/AAF-2048-2019; Epiphanio, Sabrina/C-7572-2012; Prudêncio, Miguel/ABD-9282-2021	Prudêncio, Miguel/0000-0003-1746-6029; Epiphanio, Sabrina/0000-0001-6094-9750; Prudêncio, Miguel/0000-0003-1746-6029; Mota, Maria Manuel/0000-0002-2858-1041	Fundacao para a Ciencia e Tecnologia [SFRH/BPD/32284/2006, BPD/31598/2006, SFRH/BI/15849]; EMBO YIP; European Science Foundation [EURYI Award]; Howard Hughes Medical Institute [International Scholar]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); EMBO YIP(European Molecular Biology Organization (EMBO)); European Science Foundation(European Science Foundation (ESF)European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by Fundacao para a Ciencia e Tecnologia. I.P., S.E and M.P. were recipients of FCT fellowships (SFRH/BPD/32284/2006, BPD/31598/2006 and SFRH/BI/15849, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was performed in the scope of the FP6 BioMalPar Network of Excellence. M.M.M. is an EMBO YIP, is a recipient of a EURYI Award from European Science Foundation and is a Howard Hughes Medical Institute International Scholar.	Andrews KT, 2006, ANTIMICROB AGENTS CH, V50, P639, DOI 10.1128/AAC.50.2.639-648.2006; Baer K, 2007, PLOS PATHOG, V3, P1651, DOI 10.1371/journal.ppat.0030171; BAILLY E, 1992, J PROTOZOOL, V39, P593, DOI 10.1111/j.1550-7408.1992.tb04856.x; Bruna-Romero O, 2001, INT J PARASITOL, V31, P1499, DOI 10.1016/S0020-7519(01)00265-X; Casso DJ, 2005, GENETICS, V170, P139, DOI 10.1534/genetics.104.039933; Cunha-Rodrigues Margarido, 2006, Biotechnology Journal, V1, P321, DOI 10.1002/biot.200500038; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Ersmark K, 2006, MED RES REV, V26, P626, DOI 10.1002/med.20082; Fauq AH, 2007, BIOORG MED CHEM LETT, V17, P6392, DOI 10.1016/j.bmcl.2007.07.062; FRANCIS SE, 1994, EMBO J, V13, P306, DOI 10.1002/j.1460-2075.1994.tb06263.x; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Frevert U, 2005, PLOS BIOL, V3, P1034, DOI 10.1371/journal.pbio.0030192; Friedmann E, 2006, NAT CELL BIOL, V8, P843, DOI 10.1038/ncb1440; Fuwa H, 2007, ACS CHEM BIOL, V2, P408, DOI 10.1021/cb700073y; Golde TE, 2003, J CLIN INVEST, V111, P11, DOI 10.1172/JCI200317527; Golde TE, 2006, J NEUROCHEM, V99, P689, DOI 10.1111/j.1471-4159.2006.04211.x; Goncalves LA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-169; Grigorenko AP, 2004, P NATL ACAD SCI USA, V101, P14955, DOI 10.1073/pnas.0406462101; Haldar K, 2007, ANNU REV PATHOL-MECH, V2, P217, DOI 10.1146/annurev.pathol.2.010506.091913; Heimann M, 2006, J VIROL, V80, P1915, DOI 10.1128/JVI.80.4.1915-1921.2006; Hobbs CV, 2009, J INFECT DIS, V199, P134, DOI 10.1086/594369; Krawitz P, 2005, J BIOL CHEM, V280, P39515, DOI 10.1074/jbc.M501645200; Li XR, 2008, MOL BIOCHEM PARASIT, V158, P22, DOI 10.1016/j.molbiopara.2007.11.007; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Mota MM, 2002, BIOESSAYS, V24, P149, DOI 10.1002/bies.10050; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Nyborg AC, 2006, FASEB J, V20, P1671, DOI 10.1096/fj.06-5762com; Prudencio M, 2008, CELL MICROBIOL, V10, P218, DOI 10.1111/j.1462-5822.2007.01032.x; Prudencio M, 2006, NAT REV MICROBIOL, V4, P849, DOI 10.1038/nrmicro1529; Rosenthal PJ, 2002, CURR PHARM DESIGN, V8, P1659, DOI 10.2174/1381612023394197; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Siemers E, 2005, CLIN NEUROPHARMACOL, V28, P126, DOI 10.1097/01.wnf.0000167360.27670.29; Siemers ER, 2006, NEUROLOGY, V66, P602, DOI 10.1212/01.WNL.0000198762.41312.E1; Sturm A, 2006, SCIENCE, V313, P1287, DOI 10.1126/science.1129720; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925	37	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5078	10.1371/journal.pone.0005078	http://dx.doi.org/10.1371/journal.pone.0005078			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337374	Green Published, Green Submitted, gold			2022-12-25	WOS:000265500600020
J	Papadopoulos, A				Papadopoulos, Anthony			Hydrodynamics-Based Functional Forms of Activity Metabolism: A Case for the Power-Law Polynomial Function in Animal Swimming Energetics	PLOS ONE			English	Article								The first-degree power-law polynomial function is frequently used to describe activity metabolism for steady swimming animals. This function has been used in hydrodynamics-based metabolic studies to evaluate important parameters of energetic costs, such as the standard metabolic rate and the drag power indices. In theory, however, the power-law polynomial function of any degree greater than one can be used to describe activity metabolism for steady swimming animals. In fact, activity metabolism has been described by the conventional exponential function and the cubic polynomial function, although only the power-law polynomial function models drag power since it conforms to hydrodynamic laws. Consequently, the first-degree power-law polynomial function yields incorrect parameter values of energetic costs if activity metabolism is governed by the power-law polynomial function of any degree greater than one. This issue is important in bioenergetics because correct comparisons of energetic costs among different steady swimming animals cannot be made unless the degree of the power-law polynomial function derives from activity metabolism. In other words, a hydrodynamics-based functional form of activity metabolism is a power-law polynomial function of any degree greater than or equal to one. Therefore, the degree of the power-law polynomial function should be treated as a parameter, not as a constant. This new treatment not only conforms to hydrodynamic laws, but also ensures correct comparisons of energetic costs among different steady swimming animals. Furthermore, the exponential power-law function, which is a new hydrodynamics-based functional form of activity metabolism, is a special case of the power-law polynomial function. Hence, the link between the hydrodynamics of steady swimming and the exponential-based metabolic model is defined.	[Papadopoulos, Anthony] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University	Papadopoulos, A (corresponding author), Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA.	anthony.papadopoulos@ttu.edu			National Science Foundation [DEB-0616942]	National Science Foundation(National Science Foundation (NSF))	Support for this work was provided by National Science Foundation award DEB-0616942 to Sean H. Rice. NSF had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER DE, 1990, BIOL BULL, V179, P186, DOI 10.2307/1541768; Beamish F.W.H., 1978, FISH PHYSIOL, V7, P101; Behrens JW, 2006, J EXP MAR BIOL ECOL, V331, P208, DOI 10.1016/j.jembe.2005.10.012; BRETT JR, 1964, J FISH RES BOARD CAN, V21, P1183, DOI 10.1139/f64-103; Briggs CT, 1997, CAN J FISH AQUAT SCI, V54, P859, DOI 10.1139/cjfas-54-4-859; CULIK BM, 1994, J EXP BIOL, V197, P65; FINNEY RL, 1994, CALCULUS; Fish FE, 1999, J EXP BIOL, V202, P353; Fry FEJ, 1971, FISH PHYSIOL, VVI, P1, DOI DOI 10.1016/S1546-5098(08)60146-6; Fung YC, 1990, BIOMECHANICS MOTION; Goldstein S, 1929, P R SOC LOND A-CONTA, V123, P225, DOI 10.1098/rspa.1929.0067; GORDON MS, 1989, FISH PHYSIOL BIOCHEM, V6, P341, DOI 10.1007/BF01875604; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; KAUFMANN R, 1990, J EXP BIOL, V150, P343; Korsmeyer KE, 2002, J EXP BIOL, V205, P1253; METCALFE NB, 1995, ANIM BEHAV, V49, P431, DOI 10.1006/anbe.1995.0056; Ohlberger J, 2006, J COMP PHYSIOL B, V176, P17, DOI 10.1007/s00360-005-0024-0; Osler T. J, 2000, COLL MATH J, V31, P82, DOI DOI 10.1080/07468342.2000.11974118; Papadopoulos A, 2008, T AM FISH SOC, V137, P997, DOI 10.1577/T07-116.1; Pettersson LB, 1999, OECOLOGIA, V121, P12, DOI 10.1007/s004420050901; Pettersson LB, 2000, P ROY SOC B-BIOL SCI, V267, P759, DOI 10.1098/rspb.2000.1068; ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270; Schultz WW, 2002, INTEGR COMP BIOL, V42, P1018, DOI 10.1093/icb/42.5.1018; Speyer Edward, 1994, 6 ROADS NEWTON GREAT; TUCKER VA, 1970, COMP BIOCHEM PHYSIOL, V34, P841, DOI 10.1016/0010-406X(70)91006-6; Videler JJ, 1993, FISH SWIMMING, P1, DOI [10.1007/978-94-011-1580-3, DOI 10.1007/978-94-011-1580-3]; Wardle CS, 1996, J FISH BIOL, V49, P854, DOI 10.1111/j.1095-8649.1996.tb00084.x; Webb P. W., 1978, FISH PHYSIOL, VVII, P189; Webb P.W., 1975, B FISH RES BD CAN, V199, P109; Webb Paul W., 1993, P47; WEIHS D, 1973, NATURE, V245, P48, DOI 10.1038/245048a0; WEISENBORN AJ, 1995, SIAM J APPL MATH, V55, P577, DOI 10.1137/S0036139993260526; WEISENBORN AJ, 1993, SIAM J APPL MATH, V53, P601, DOI 10.1137/0153031; WIESER W, 1990, FUNCT ECOL, V4, P233, DOI 10.2307/2389342; Wu T. Y., 1977, SCALE EFFECTS ANIMAL, P203; WU TYT, 1971, J FLUID MECH, V46, P545, DOI 10.1017/S0022112071000697	36	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e4852	10.1371/journal.pone.0004852	http://dx.doi.org/10.1371/journal.pone.0004852			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333397	gold, Green Submitted, Green Published			2022-12-25	WOS:000265499900002
J	Eble, JA; Niland, S; Bracht, T; Mormann, M; Peter-Katalinic, J; Pohlentz, G; Stetefeld, J				Eble, Johannes A.; Niland, Stephan; Bracht, Thilo; Mormann, Michael; Peter-Katalinic, Jasna; Pohlentz, Gottfried; Stetefeld, Joerg			The alpha 2 beta 1 integrin-specific antagonist rhodocetin is a cruciform, heterotetrameric molecule	FASEB JOURNAL			English	Article						C-type lectin-like protein; integrin; snake venom; Calloselasma rhodostoma	IB-BINDING PROTEIN; MALAYAN PIT VIPER; CRYSTAL-STRUCTURE; FLAVOCETIN-A; VENOM; INHIBITOR; DOMAIN; POTENT; RECEPTORS; REVEALS	The integrin alpha 2 beta 1 plays an important role in various pathophysiological processes, such as thrombosis, wound healing, inflammation, and metastasis. Rhodocetin, a constituent of the venom of the hemorrhagic Malayan pit viper (Calloselasma rhodostoma), is a specific alpha 2 beta 1 integrin antagonist. To understand its molecular mode of action, its structure was studied by crystallography. Its quaternary structure in solution was also analyzed biochemically. Two novel subunits of rhodocetin were sequenced by mass spectrometry. Their integrin binding was measured by protein interaction ELISAs. Rhodocetin is a C-type lectinlike protein (CLP) consisting of four homologous, yet distinct, subunits, alpha, beta, gamma, and delta, the latter two of which have been unknown to date. With their CLP folds and loop-swapping motifs, the subunits alpha, beta and gamma, delta form two heterodimeric pairs. Uniquely, they arrange orthogonally and shape a cruciform molecule. Bearing a single unpaired cysteine residue, rhodocetin can only form covalent supramolecular complexes with a maximum aggregation number of 2, unlike many heterodimeric CLPs. Being the first heterotetrameric CLP to be crystallized, rhodocetin provides not only the prototypic molecular structure for heterotetrameric CLPs, but also a lead structure for pharmaceutical alpha 2 beta 1 integrin antagonists.-Eble, J. A., Niland, S., Bracht, T., Mormann, M., Peter-Katalinic, J., Pohlentz, G., Stetefeld, J. The alpha 2 beta 1 integrin-specific antagonist rhodocetin is a cruciform, heterotetrameric molecule. FASEB J. 23, 2917-2927 (2009). www.fasebj.org	[Eble, Johannes A.; Niland, Stephan; Bracht, Thilo] Frankfurt Univ Hosp, Ctr Mol Med, Dept Vasc Matrix Biol, Excellence Cluster Cardiopulm Syst, D-60590 Frankfurt, Germany; [Mormann, Michael; Peter-Katalinic, Jasna; Pohlentz, Gottfried] Univ Munster, Inst Med Phys & Biophys, Munster, Germany; [Stetefeld, Joerg] Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada; [Stetefeld, Joerg] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada	Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Munster; University of Manitoba; University of Manitoba	Eble, JA (corresponding author), Frankfurt Univ Hosp, Ctr Mol Med, Dept Vasc Matrix Biol, Excellence Cluster Cardiopulm Syst, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	eble@med.uni-frankfurt.de	Stetefeld, Joerg/H-7630-2017; Mormann, Michael/T-4860-2017; Bracht, Thilo/H-7258-2019	Stetefeld, Joerg/0000-0003-1478-3248; Mormann, Michael/0000-0002-7428-7329; Bracht, Thilo/0000-0002-1194-6614	Deutsche Forschungsgemeinschaft (DFG) [Eb177/5-1, STB492/Z2]; Canada Research Chair program	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Canada Research Chair program(Canada Research Chairs)	This work was financially supported by the Deutsche Forschungsgemeinschaft (DFG; grants Eb177/5-1 to J.A.E. and STB492/Z2 to J.P.K. and M.M.). J.S. is funded by the Canada Research Chair program.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arocas V, 1996, BIOCHEMISTRY-US, V35, P9083, DOI 10.1021/bi960043l; ATODA H, 1994, EUR J BIOCHEM, V224, P703, DOI 10.1111/j.1432-1033.1994.t01-1-00703.x; ATODA H, 1991, J BIOL CHEM, V266, P14903; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Batuwangala T, 2004, ACTA CRYSTALLOGR D, V60, P46, DOI 10.1107/S0907444903021620; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Curley GP, 1999, CELL MOL LIFE SCI, V56, P427, DOI 10.1007/s000180050443; Eble JA, 2003, BIOCHEM J, V376, P77, DOI 10.1042/BJ20030373; Eble JA, 2002, MATRIX BIOL, V21, P547, DOI 10.1016/S0945-053X(02)00068-9; Eble JA, 2001, J BIOL CHEM, V276, P12274, DOI 10.1074/jbc.M009338200; Emsley J, 1997, J BIOL CHEM, V272, P28512, DOI 10.1074/jbc.272.45.28512; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Fox JW, 2005, TOXICON, V45, P969, DOI 10.1016/j.toxicon.2005.02.012; Fukuda K, 2000, BIOCHEMISTRY-US, V39, P1915, DOI 10.1021/bi992134z; Fukuda K, 2005, NAT STRUCT MOL BIOL, V12, P152, DOI 10.1038/nsmb892; Horii K, 2004, J MOL BIOL, V341, P519, DOI 10.1016/j.jmb.2004.06.036; Horii K, 2003, BIOCHEMISTRY-US, V42, P12497, DOI 10.1021/bi034890h; Huang KF, 2004, BIOCHEM J, V378, P399, DOI 10.1042/BJ20031507; Kong CG, 2001, J PROTEIN CHEM, V20, P383, DOI 10.1023/A:1012280720595; Kowalska MA, 1998, THROMB HAEMOSTASIS, V79, P609; Leslie AGW, 1994, MOSFLM USERS GUIDE; Lu QM, 2005, TOXICON, V45, P1089, DOI 10.1016/j.toxicon.2005.02.022; Maita N, 2003, J BIOL CHEM, V278, P37777, DOI 10.1074/jbc.M305566200; Marcinkiewicz C, 2000, BIOCHEMISTRY-US, V39, P9859, DOI 10.1021/bi000428a; Matsui T, 2005, TOXICON, V45, P1075, DOI 10.1016/j.toxicon.2005.02.023; Mizuno H, 2001, P NATL ACAD SCI USA, V98, P7230, DOI 10.1073/pnas.131179698; Morita T, 2005, TOXICON, V45, P1099, DOI 10.1016/j.toxicon.2005.02.021; Mormann M, 2008, ANAL BIOANAL CHEM, V392, P831, DOI 10.1007/s00216-008-2258-7; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Paaventhan P, 2005, PROTEIN SCI, V14, P169, DOI 10.1110/ps.04945605; Polgar J, 1997, J BIOL CHEM, V272, P13576, DOI 10.1074/jbc.272.21.13576; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Rosenow Felix, 2008, Neoplasia, V10, P168, DOI 10.1593/neo.07898; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Shin Y, 2000, THROMB RES, V99, P239, DOI 10.1016/S0049-3848(00)00234-6; Wang RH, 1999, BIOCHEMISTRY-US, V38, P7584, DOI 10.1021/bi982132z; Wang WJ, 2003, THROMB HAEMOSTASIS, V90, P465, DOI 10.1160/TH03-02-0072; Yeates TO, 1997, METHOD ENZYMOL, V276, P344, DOI 10.1016/S0076-6879(97)76068-3; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zutter MM, 2007, IMMUNOBIOLOGY, V212, P343, DOI 10.1016/j.imbio.2006.11.013	41	24	28	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2009	23	9					2917	2927		10.1096/fj.08-126763	http://dx.doi.org/10.1096/fj.08-126763			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19369383				2022-12-25	WOS:000270241000015
J	Turu, G; Varnai, P; Gyombolai, P; Szidonya, L; Bagdy, G; Kunos, G; Hunyady, L				Turu, Gabor; Varnai, Peter; Gyombolai, Pal; Szidonya, Laszlo; Bagdy, Gyoergy; Kunos, George; Hunyady, Laszlo			Paracrine Transactivation of the CB1 Cannabinoid Receptor by AT(1) Angiotensin and Other G(q/11) Protein-coupled Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ARRESTIN BINDING; ENDOGENOUS CANNABINOIDS; ENDOCANNABINOID SYSTEM; ACTIVATION; 2-ARACHIDONOYLGLYCEROL; PHOSPHORYLATION; PHARMACOLOGY; PATHWAYS; RELEASE; SIGNAL	Intracellular signaling systems of G protein-coupled receptors are well established, but their role in paracrine regulation of adjacent cells is generally considered as a tissue-specific mechanism. We have shown previously that AT(1) receptor (AT(1)R) stimulation leads to diacylglycerol lipase-mediated transactivation of co-expressed CB(1)Rs in Chinese hamster ovary cells. In the present study we detected a paracrine effect of the endocannabinoid release from Chinese hamster ovary, COS7, and HEK293 cells during the stimulation of AT(1) angiotensin receptors by determining CB1 cannabinoid receptor activity with bioluminescence resonance energy transfer-based sensors of G protein activation expressed in separate cells. The angiotensin II-induced, paracrine activation of CB1 receptors was visualized by detecting translocation of green fluorescent protein-tagged beta-arrestin2. Mass spectrometry analyses have demonstrated angiotensin II-induced stimulation of 2-arachidonoylglycerol production, whereas no increase of anandamide levels was observed. Stimulation of G(q/11)-coupled M-1, M-3, M-5 muscarinic, V1 vasopressin, alpha(1a) adrenergic, B2 bradykinin receptors, but not G(i/o)-coupled M-2 and M-4 muscarinic receptors, also led to paracrine transactivation of CB1 receptors. These data suggest that, in addition to their retrograde neurotransmitter role, endocannabinoids have much broader paracrine mediator functions during activation of G(q/11)-coupled receptors.	[Hunyady, Laszlo] Semmelweis Univ, Dept Physiol, Fac Med, H-1444 Budapest, Hungary; [Bagdy, Gyoergy] Semmelweis Univ, Fac Pharm, Dept Pharmacodynam, H-1444 Budapest, Hungary; [Hunyady, Laszlo] Semmelweis Univ, Lab Neurobiochem & Mol Physiol, H-1444 Budapest, Hungary; [Bagdy, Gyoergy] Semmelweis Univ, Grp Neuropsychopharmacol, H-1444 Budapest, Hungary; [Bagdy, Gyoergy] Hungarian Acad Sci, Budapest, Hungary; [Szidonya, Laszlo; Kunos, George] NIAAA, Lab Psychol Studies, Bethesda, MD 20892 USA	Semmelweis University; Semmelweis University; Semmelweis University; Semmelweis University; Hungarian Academy of Sciences; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Hunyady, L (corresponding author), Semmelweis Univ, Dept Physiol, Fac Med, POB 259, H-1444 Budapest, Hungary.	Hunyady@eok.sote.hu	Szidonya, Laszlo/A-2271-2010; Bagdy, György/O-3893-2017	Bagdy, György/0000-0001-8141-3410; Gyombolai, Pal/0000-0001-7117-6351; Turu, Gabor/0000-0002-4421-3812	Hungarian Scientific Research Fund [NK-072661, NF-68563, M-045341, T-034606]; Agency for Research Fund Management and Research Exploitation, Hungary [NKFP1-010/2005]; Hungarian Ministry of Public Health [ETT 447/2006, 460/2006]; EC [LSHM-CT-2004-503474]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000350, ZIAAA000350] Funding Source: NIH RePORTER	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Agency for Research Fund Management and Research Exploitation, Hungary; Hungarian Ministry of Public Health; EC(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by grants from the Hungarian Scientific Research Fund (OTKA Grants NK-072661, NF-68563, M-045341 and T-034606), the Anyos Jedlik program by the Agency for Research Fund Management and Research Exploitation, Hungary (Grants NKFP1-010/2005), the Hungarian Ministry of Public Health (Grants ETT 447/2006 and 460/2006) and the EC (Grant LSHM-CT-2004-503474).	Azpiazu I, 2004, J BIOL CHEM, V279, P27709, DOI 10.1074/jbc.M403712200; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Barak LS, 2001, P NATL ACAD SCI USA, V98, P93, DOI 10.1073/pnas.011303698; Basavarajappa BS, 2007, PROTEIN PEPTIDE LETT, V14, P237, DOI 10.2174/092986607780090829; Bennett TA, 2000, J BIOL CHEM, V275, P24590, DOI 10.1074/jbc.C000314200; Berghuis P, 2007, SCIENCE, V316, P1212, DOI 10.1126/science.1137406; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Bisogno T, 1997, BIOCHEM J, V322, P671, DOI 10.1042/bj3220671; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Brown AJ, 2007, BRIT J PHARMACOL, V152, P567, DOI 10.1038/sj.bjp.0707481; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Ferguson Stephen S. G., 2003, V237, P121; Fredriksson R, 2005, ANN NY ACAD SCI, V1040, P89, DOI 10.1196/annals.1327.011; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Gaborik Z, 2003, ENDOCRINOLOGY, V144, P2220, DOI 10.1210/en.2002-0135; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Hanus L, 2001, P NATL ACAD SCI USA, V98, P3662, DOI 10.1073/pnas.061029898; Harkany T, 2007, TRENDS PHARMACOL SCI, V28, P83, DOI 10.1016/j.tips.2006.12.004; Hashimotodani Y, 2005, NEURON, V45, P257, DOI 10.1016/j.neuron.2005.01.004; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Huttenrauch F, 2002, J BIOL CHEM, V277, P30769, DOI 10.1074/jbc.M204033200; Jacoby E, 2006, CHEMMEDCHEM, V1, P760, DOI 10.1002/cmdc.200600134; Jeong WI, 2008, CELL METAB, V7, P227, DOI 10.1016/j.cmet.2007.12.007; Kim J, 2002, J NEUROSCI, V22, P10182; Kogan Natalya M, 2007, Dialogues Clin Neurosci, V9, P413; Kunos G, 2007, AM J MED, V120, P24; Lagane B, 2005, MOL PHARMACOL, V67, P1966, DOI 10.1124/mol.104.009779; Lefkowitz RJ, 2004, TRENDS PHARMACOL SCI, V25, P413, DOI 10.1016/j.tips.2004.06.006; Leterrier C, 2004, J BIOL CHEM, V279, P36013, DOI 10.1074/jbc.M403990200; Luttrell Louis M., 2006, V332, P3; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; McDonald NA, 2007, MOL PHARMACOL, V71, P976, DOI 10.1124/mol.106.029348; Mechoulam R, 2005, P NATL ACAD SCI USA, V102, P17541, DOI 10.1073/pnas.0508644102; Mhaouty-Kodja S, 1999, MOL PHARMACOL, V55, P339, DOI 10.1124/mol.55.2.339; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Pacher P, 2005, HANDB EXP PHARMACOL, V168, P599; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; SAVARESE TM, 1992, BIOCHEM J, V283, P1; SHENOY SK, 2005, SCI STKE, pCM14; Spat A, 2004, PHYSIOL REV, V84, P489, DOI 10.1152/physrev.00030.2003; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Sugiura T, 2006, PROG LIPID RES, V45, P405, DOI 10.1016/j.plipres.2006.03.003; Turu G, 2006, FEBS LETT, V580, P41, DOI 10.1016/j.febslet.2005.11.044; Turu G, 2007, J BIOL CHEM, V282, P7753, DOI 10.1074/jbc.C600318200; Tyndall JDA, 2005, MED CHEM, V1, P405, DOI 10.2174/1573406054368675; Wang L, 2003, P NATL ACAD SCI USA, V100, P1393, DOI 10.1073/pnas.0336351100; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5	53	51	52	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16914	16921		10.1074/jbc.M109.003681	http://dx.doi.org/10.1074/jbc.M109.003681			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19357084	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000266962400028
J	Hoosdally, SJ; Andress, EJ; Wooding, C; Martin, CA; Linton, KJ				Hoosdally, Sarah J.; Andress, Edward J.; Wooding, Carol; Martin, Catherine A.; Linton, Kenneth J.			The Human Scavenger Receptor CD36 GLYCOSYLATION STATUS AND ITS ROLE IN TRAFFICKING AND FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED OLIGOSACCHARIDES; MEMBRANE-PROTEIN; FATTY-ACIDS; SR-BI; GLYCOPROTEIN; EXPRESSION; BINDING; IDENTIFICATION; CLONING; DIFFERENTIATION	Human CD36 is a class B scavenger receptor expressed in a variety of cell types such as macrophage and adipocytes. This plasma membrane glycoprotein has a wide range of ligands including oxidized low density lipoprotein and long chain fatty acids which involves the receptor in diseases such as atherosclerosis and insulin resistance. CD36 is heavily modified post-translationally by N-linked glycosylation, and 10 putative glycosylation sites situated in the large extracellular loop of the protein have been identified; however, their utilization and role in the folding and function of the protein have not been characterized. Using mass spectrometry on purified and peptide N-glycosidase F-deglycosylated CD36 and also by comparing the electrophoretic mobility of different glycosylation site mutants, we have determined that 9 of the 10 sites can be modified by glycosylation. Flow cytometric analysis of the different glycosylation mutants expressed in mammalian cells established that glycosylation is necessary for trafficking to the plasma membrane. Minimally glycosylated mutants that supported trafficking were identified and indicated the importance of carboxyl-terminal sites Asn-247, Asn-321, and Asn-417. However, unlike SRBI, no individual site was found to be essential for proper trafficking of CD36. Surprisingly, these minimally glycosylated mutants appear to be predominantly core-glycosylated, indicating that mature glycosylation is not necessary for surface expression in mammalian cells. The data also show that neither the nature nor the pattern of glycosylation is relevant to binding of modified low density lipoprotein.	[Linton, Kenneth J.] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Cell & Mol Sci, London E1 2AT, England; [Hoosdally, Sarah J.; Andress, Edward J.; Wooding, Carol; Martin, Catherine A.; Linton, Kenneth J.] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, London W12 0NN, England	University of London; Queen Mary University London; Imperial College London	Linton, KJ (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Cell & Mol Sci, 4 Newark St, London E1 2AT, England.	kenneth.linton@ic.ac.uk		Martin, Catherine/0000-0001-7088-3441	Medical Research Council UK; British Heart Foundation [PG/03/044/15328]; Medical Research Council [MC_U120088463] Funding Source: researchfish; MRC [MC_U120088463] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council UK and also by British Heart Foundation Project Grant PG/03/044/15328 ( to C. A. M. and K. J. L.).	ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; ACTON SL, 1994, J BIOL CHEM, V269, P21003; Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; ALESSIO M, 1991, CELL IMMUNOL, V137, P487, DOI 10.1016/0008-8749(91)90096-T; ASCH AS, 1993, SCIENCE, V262, P1436, DOI 10.1126/science.7504322; Berglund L, 1996, BBA-GENE STRUCT EXPR, V1309, P63, DOI 10.1016/S0167-4781(96)00143-1; CALVO D, 1993, J BIOL CHEM, V268, P18929; Dixon PH, 2000, HUM MOL GENET, V9, P1209, DOI 10.1093/hmg/9.8.1209; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Franc NC, 1996, IMMUNITY, V4, P431, DOI 10.1016/S1074-7613(00)80410-0; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GREENWALT DE, 1990, BIOCHEMISTRY-US, V29, P7054, DOI 10.1021/bi00482a015; GREENWALT DE, 1992, BLOOD, V80, P1105; Gruarin P, 2000, BIOCHEM BIOPH RES CO, V275, P446, DOI 10.1006/bbrc.2000.3333; HARMON CM, 1993, J MEMBRANE BIOL, V133, P43; HART K, 1993, J MOL BIOL, V234, P249, DOI 10.1006/jmbi.1993.1580; Hebert DN, 1997, J CELL BIOL, V139, P613, DOI 10.1083/jcb.139.3.613; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; HSIEH P, 1984, J BIOL CHEM, V259, P2375; Hwang EH, 1998, J NUCL MED, V39, P1681; Jarvis DL, 2003, VIROLOGY, V310, P1, DOI 10.1016/S0042-6822(03)00120-X; Klinkenberg LG, 2006, EUKARYOT CELL, V5, P1007, DOI 10.1128/EC.00045-06; Koonen DPY, 2007, CIRCULATION, V116, P2139, DOI 10.1161/CIRCULATIONAHA.107.712901; Kulkarni KA, 2004, PROTEINS, V56, P821, DOI 10.1002/prot.20168; Love-Gregory L, 2008, HUM MOL GENET, V17, P1695, DOI 10.1093/hmg/ddn060; Ma XW, 2004, HUM MOL GENET, V13, P2197, DOI 10.1093/hmg/ddh233; Martin CA, 2007, PROTEIN SCI, V16, P2531, DOI 10.1110/ps.073007207; Mitra N, 2006, TRENDS BIOCHEM SCI, V31, P156, DOI 10.1016/j.tibs.2006.01.003; Nufer O, 2002, J CELL SCI, V115, P619; OConnor SE, 1996, CHEM BIOL, V3, P803, DOI 10.1016/S1074-5521(96)90064-2; OQUENDO P, 1989, CELL, V58, P95, DOI 10.1016/0092-8674(89)90406-6; PEARCE SFA, 1994, BLOOD, V84, P384; Peterman Scott M, 2005, J Biomol Tech, V16, P112; Rasmussen JT, 1998, EUR J BIOCHEM, V257, P488, DOI 10.1046/j.1432-1327.1998.2570488.x; Rutella S, 1997, EUR J HISTOCHEM, V41, P53; SCHINKEL AH, 1993, J BIOL CHEM, V268, P7474; Serghides L, 2003, TRENDS PARASITOL, V19, P461, DOI 10.1016/j.pt.2003.08.006; TANDON NN, 1989, J BIOL CHEM, V264, P7576; Tao NB, 1996, J BIOL CHEM, V271, P22315, DOI 10.1074/jbc.271.37.22315; Trombetta ES, 1998, CURR OPIN STRUC BIOL, V8, P587, DOI 10.1016/S0959-440X(98)80148-6; VEGA MA, 1991, J BIOL CHEM, V266, P16818; Vinals M, 2003, J BIOL CHEM, V278, P5325, DOI 10.1074/jbc.M211073200; Yamashita S, 2007, MOL CELL BIOCHEM, V299, P19, DOI 10.1007/s11010-005-9031-4; Zhou FF, 2005, MOL PHARMACOL, V67, P868, DOI 10.1124/mol.104.007583	46	76	79	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16277	16288		10.1074/jbc.M109.007849	http://dx.doi.org/10.1074/jbc.M109.007849			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19369259	Green Published, hybrid			2022-12-25	WOS:000266730900025
J	Ding, HL; Ryder, JW; Stull, JT; Kamm, KE				Ding, Hai-Lei; Ryder, Jeffrey W.; Stull, James T.; Kamm, Kristine E.			Signaling Processes for Initiating Smooth Muscle Contraction upon Neural Stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOSIN LIGHT-CHAIN; URINARY-BLADDER; PROTEIN-KINASE; CA2+ SENSITIVITY; RHO-KINASE; PHOSPHORYLATION; ACTIVATION; PAXILLIN; PHOSPHATASE; CALMODULIN	Relationships among biochemical signaling processes involved in Ca2+/calmodulin (CaM)-dependent phosphorylation of smooth muscle myosin regulatory light chain (RLC) by myosin light chain kinase (MLCK) were determined. A genetically-encoded biosensor MLCK for measuring Ca2+-dependent CaM binding and activation was expressed in smooth muscles of transgenic mice. We performed real-time evaluations of the relationships among [Ca2+](i), MLCK activation, and contraction in urinary bladder smooth muscle strips neurally stimulated for 3 s. Latencies for the onset of [Ca2+](i) and kinase activation were 55 +/- 8 and 65 +/- 6 ms, respectively. Both increased with RLC phosphorylation at 100 ms, whereas force latency was 109 +/- 3 ms. [Ca2+](i), kinase activation, and RLC phosphorylation responses were maximal by 1.2 s, whereas force increased more slowly to a maximal value at 3 s. A delayed temporal response between RLC phosphorylation and force is probably due to mechanical effects associated with elastic elements in the tissue. MLCK activation partially declined at 3 s of stimulation with no change in [Ca2+](i) and also declined more rapidly than [Ca2+](i) during relaxation. The apparent desensitization of MLCK to Ca2+ activation appears to be due to phosphorylation in its calmodulin binding segment. Phosphorylation of two myosin light chain phosphatase regulatory proteins (MYPT1 and CPI-17) or a protein implicated in strengthening membrane adhesion complexes for force transmission (paxillin) did not change during force development. Thus, neural stimulation leads to rapid increases in [Ca2+](i), MLCK activation, and RLC phosphorylation in phasic smooth muscle, showing a tightly coupled Ca2+ signaling complex as an elementary mechanism initiating contraction.	[Ding, Hai-Lei; Ryder, Jeffrey W.; Stull, James T.; Kamm, Kristine E.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Kamm, KE (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	kristine.kamm@utsouthwestern.edu			National Institutes of Health [HL26043]; Moss Heart Fund; Fouad A. and Val Imm Bashour Distinguished Chair in Physiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL026043, R37HL026043] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Moss Heart Fund; Fouad A. and Val Imm Bashour Distinguished Chair in Physiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL26043. This work was also supported by the Moss Heart Fund and the Fouad A. and Val Imm Bashour Distinguished Chair in Physiology ( to J. T. S.).	Agbulut O, 2007, J BIOL CHEM, V282, P10465, DOI 10.1074/jbc.M610418200; AKSOY MO, 1983, AM J PHYSIOL, V245, pC255, DOI 10.1152/ajpcell.1983.245.3.C255; BOWMAN BF, 1992, J BIOL CHEM, V267, P5346; Chen Q, 2005, J UROLOGY, V174, P370, DOI 10.1097/01.ju.0000161210.17365.cc; Deng JT, 2001, J BIOL CHEM, V276, P16365, DOI 10.1074/jbc.M011634200; Ekman M, 2006, EUR J PHARMACOL, V532, P99, DOI 10.1016/j.ejphar.2005.11.010; Geguchadze R, 2004, FEBS LETT, V557, P121, DOI 10.1016/S0014-5793(03)01456-X; Gomez-Pinilla PJ, 2008, J PINEAL RES, V44, P416, DOI 10.1111/j.1600-079X.2007.00544.x; Gunst SJ, 2003, RESP PHYSIOL NEUROBI, V137, P151, DOI 10.1016/S1569-9048(03)00144-7; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; He WQ, 2008, GASTROENTEROLOGY, V135, P610, DOI 10.1053/j.gastro.2008.05.032; Heppner TJ, 2005, J PHYSIOL-LONDON, V564, P201, DOI 10.1113/jphysiol.2004.077826; Hirano K, 2003, MOL CELL BIOCHEM, V248, P105, DOI 10.1023/A:1024180101032; Horman S, 2008, J BIOL CHEM, V283, P18505, DOI 10.1074/jbc.M802053200; Ihara E, 2007, AM J PHYSIOL-GASTR L, V293, pG699, DOI 10.1152/ajpgi.00214.2007; Ihara E, 2007, CAN J PHYSIOL PHARM, V85, P79, DOI 10.1139/Y06-103; Isotani E, 2004, P NATL ACAD SCI USA, V101, P6279, DOI 10.1073/pnas.0308742101; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; Ji GJ, 2004, J BIOL CHEM, V279, P21461, DOI 10.1074/jbc.M401084200; JOHNSON JD, 1981, J BIOL CHEM, V256, P2194; KAMM KE, 1985, AM J PHYSIOL, V249, pC238, DOI 10.1152/ajpcell.1985.249.3.C238; KAMM KE, 1989, J BIOL CHEM, V264, P21223; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; KENNEY RE, 1990, J BIOL CHEM, V265, P8642; Kitazawa T, 2000, J BIOL CHEM, V275, P9897, DOI 10.1074/jbc.275.14.9897; Mehta D, 1998, AM J PHYSIOL-CELL PH, V274, pC741, DOI 10.1152/ajpcell.1998.274.3.C741; Meng E, 2008, NEUROUROL URODYNAM, V27, P79, DOI 10.1002/nau.20456; Mizuno Y, 2008, AM J PHYSIOL-CELL PH, V295, pC358, DOI 10.1152/ajpcell.90645.2007; Murthy KS, 2006, ANNU REV PHYSIOL, V68, P345, DOI 10.1146/annurev.physiol.68.040504.094707; Pandita RK, 2000, J UROLOGY, V164, P1385, DOI 10.1016/S0022-5347(05)67204-7; PERSECHINI A, 1986, J BIOL CHEM, V261, P6293; Rembold CM, 2007, AM J PHYSIOL-CELL PH, V293, pC993, DOI 10.1152/ajpcell.00090.2007; Ryder JW, 2007, J BIOL CHEM, V282, P20447, DOI 10.1074/jbc.M702927200; Saez AO, 2004, AM J PHYSIOL-CELL PH, V286, pC433, DOI 10.1152/ajpcell.00030.2003; Silinsky EM, 1996, J PHYSIOL-LONDON, V492, P815, DOI 10.1113/jphysiol.1996.sp021348; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; STULL JT, 1990, J BIOL CHEM, V265, P16683; STULL JT, 1993, MOL CELL BIOCHEM, V128, P229, DOI 10.1007/BF01076774; STULL JT, 1986, ENZYMES, P113; TANSEY MG, 1992, J BIOL CHEM, V267, P12511; TANSEY MG, 1994, J BIOL CHEM, V269, P9912; THOMPSON CI, 1980, AM J PHYSIOL, V238, pH389, DOI 10.1152/ajpheart.1980.238.3.H389; TOROK K, 1994, BIOCHEMISTRY-US, V33, P12807, DOI 10.1021/bi00209a012; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Wang ZL, 1996, AM J PHYSIOL-CELL PH, V271, pC1594, DOI 10.1152/ajpcell.1996.271.5.C1594; Wegener JW, 2004, FASEB J, V18, P1159, DOI 10.1096/fj.04-1516fje; Werner ME, 2007, AM J PHYSIOL-REG I, V292, pR616, DOI 10.1152/ajpregu.00036.2006; Wibberley A, 2003, BRIT J PHARMACOL, V138, P757, DOI 10.1038/sj.bjp.0705109; ZIMMERMANN B, 1995, J BIOL CHEM, V270, P23966, DOI 10.1074/jbc.270.41.23966	51	50	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15541	15548		10.1074/jbc.M900888200	http://dx.doi.org/10.1074/jbc.M900888200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19349274	Green Published, hybrid			2022-12-25	WOS:000266501000022
J	Hatanaka, H; Omura, F; Kodama, Y; Ashikari, T				Hatanaka, Haruyo; Omura, Fumihiko; Kodama, Yukiko; Ashikari, Toshihiko			Gly-46 and His-50 of Yeast Maltose Transporter Mal21p Are Essential for Its Resistance against Glucose-induced Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID PERMEASE; TERMINAL CYTOPLASMIC DOMAIN; UBIQUITIN-PROTEIN LIGASE; PLASMA-MEMBRANE PROTEINS; PEST-LIKE SEQUENCE; SACCHAROMYCES-CEREVISIAE; CATABOLITE INACTIVATION; INDUCED PROTEOLYSIS; ENDOCYTIC PATHWAY; INTERNALIZATION	The maltose transporter gene is situated at the MAL locus, which consists of genes for a transporter, maltase, and transcriptional activator. Five unlinked MAL loci (MAL1, MAL2, MAL3, MAL4, and MAL6) constitute a gene family in Saccharomyces cerevisiae. The expression of the maltose transporter is induced by maltose and repressed by glucose. The activity of the maltose transporter is also regulated post-translationally; Mal61p is rapidly internalized from the plasma membrane and degraded by ubiquitin-mediated proteolysis in the presence of glucose. We found that S. cerevisiae strain ATCC20598 harboring MAL21 could grow in maltose supplemented with a non-assimilable glucose analogue, 2-deoxyglucose, whereas strain ATCC96955 harboring MAL61 and strain CB11 with MAL31 and AGT1 could not. These observations implied a Mal21p-specific resistance against glucose-induced degradation. Mal21p found in ATCC20598 has 10 amino acids, including Gly-46 and His-50, that are inconsistent with the corresponding residues in Mal61p. The half-life of Mal21p for glucose-induced degradation was 118 min when expressed using the constitutive TPI1 promoter, which was significantly longer than that of Mal61p (25 min). Studies with mutant cells that are defective in endocytosis or the ubiquitination process indicated that Mal21p was less ubiquitinated than Mal61p, suggesting that Mal21p remains on the plasma membrane because of poor susceptibility to ubiquitination. Mutational studies revealed that both residues Gly-46 and His-50 in Mal21p are essential for the full resistance of maltose transporters against glucose-induced degradation.	[Hatanaka, Haruyo; Omura, Fumihiko; Kodama, Yukiko] Suntory Res Ctr, Osaka 6188503, Japan	Suntory Holdings Ltd	Hatanaka, H (corresponding author), 1-1-1 Wakayamadai, Shimamoto, Osaka 6188503, Japan.	Haruyo_Hatanaka@suntory.co.jp						Brondijk THC, 1998, J BIOL CHEM, V273, P15352, DOI 10.1074/jbc.273.25.15352; Brondijk THC, 2001, ARCH MICROBIOL, V176, P96; CHENG Q, 1989, GENETICS, V123, P477; CLAIBORNE VC, 1998, PROG NUCL ACID RES M, V59, P95; Day RE, 2002, YEAST, V19, P1015, DOI 10.1002/yea.894; DEGRYSE E, 1995, YEAST, V11, P629, DOI 10.1002/yea.320110704; Dupre S, 2001, MOL CELL BIOL, V21, P4482, DOI 10.1128/MCB.21.14.4482-4494.2001; ENTIAN KD, 1990, J GEN MICROBIOL, V136, P855, DOI 10.1099/00221287-136-5-855; Gadura N, 2006, GENETICS, V172, P1427, DOI 10.1534/genetics.105.051698; Gadura N, 2006, CURR GENET, V50, P101, DOI 10.1007/s00294-006-0080-3; HAN EK, 1995, MOL MICROBIOL, V17, P1093, DOI 10.1111/j.1365-2958.1995.mmi_17061093.x; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; Hein C, 1997, MOL MICROBIOL, V24, P607, DOI 10.1046/j.1365-2958.1997.3771735.x; Hicke L, 1997, FASEB J, V11, P1215, DOI 10.1096/fasebj.11.14.9409540; Hicke L, 1998, J CELL BIOL, V141, P349, DOI 10.1083/jcb.141.2.349; HU Z, 1995, CURR GENET, V28, P258, DOI 10.1007/BF00309785; Hu Z, 1999, CURR GENET, V36, P1, DOI 10.1007/s002940050466; Jespersen L, 1999, APPL ENVIRON MICROB, V65, P450; Kodama Y, 2001, APPL ENVIRON MICROB, V67, P3455, DOI 10.1128/AEM.67.8.3455-3462.2001; LEVINE J, 1992, CURR GENET, V22, P181, DOI 10.1007/BF00351724; Lucero P, 1997, FEMS MICROBIOL LETT, V147, P273, DOI 10.1016/S0378-1097(96)00538-1; Madrid R, 2001, EMBO J, V20, P7008, DOI 10.1093/emboj/20.24.7008; Maeta K, 2005, FEMS MICROBIOL LETT, V243, P87, DOI 10.1016/j.femsle.2004.11.046; Maeta K, 2005, J BIOL CHEM, V280, P253, DOI 10.1074/jbc.M408061200; Marchal C, 1998, MOL CELL BIOL, V18, P314, DOI 10.1128/MCB.18.1.314; Medintz I, 2000, BIOCHEMISTRY-US, V39, P4518, DOI 10.1021/bi992455a; Medintz I, 1998, J BIOL CHEM, V273, P34454, DOI 10.1074/jbc.273.51.34454; Medintz I, 1996, J BACTERIOL, V178, P2245, DOI 10.1128/jb.178.8.2245-2254.1996; MORTIMER RK, 1986, GENETICS, V113, P35; NAUMOV GI, 1994, GENETICS, V136, P803; NI B, 1990, MOL CELL BIOL, V10, P3797, DOI 10.1128/MCB.10.7.3797; NISHIKAWA K, 1983, BIOCHIM BIOPHYS ACTA, V748, P285, DOI 10.1016/0167-4838(83)90306-0; Omura F, 2001, FEMS MICROBIOL LETT, V194, P207, DOI 10.1016/S0378-1097(00)00532-2; Omura F, 2001, BIOCHEM BIOPH RES CO, V287, P1045, DOI 10.1006/bbrc.2001.5697; POSTMA E, 1990, YEAST, V6, P149, DOI 10.1002/yea.320060209; Ramasamy R, 2006, CELL, V124, P258, DOI 10.1016/j.cell.2006.01.002; RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55; Rekha Nambudiry, 2003, BMC Struct Biol, V3, P4, DOI 10.1186/1472-6807-3-4; RIBALLO E, 1995, J BACTERIOL, V177, P5622, DOI 10.1128/jb.177.19.5622-5627.1995; ROSE MD, 1987, GENE, V60, P237, DOI 10.1016/0378-1119(87)90232-0; ROSE MD, 1990, METHODS YEAST GENETI, P179; Stolk M, 2005, BIOCHEM J, V386, P281, DOI 10.1042/BJ20041571; Vidgren V, 2005, APPL ENVIRON MICROB, V71, P7846, DOI 10.1128/AEM.71.12.7846-7857.2005; Wang GL, 2001, MOL CELL BIOL, V21, P3564, DOI 10.1128/MCB.21.10.3564-3575.2001; Wang JF, 1997, J BIOL CHEM, V272, P4613, DOI 10.1074/jbc.272.7.4613; Wesp A, 1997, MOL BIOL CELL, V8, P2291, DOI 10.1091/mbc.8.11.2291; YAO B, 1994, MOL GEN GENET, V243, P622, DOI 10.1007/BF00279571	47	11	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15448	15457		10.1074/jbc.M808151200	http://dx.doi.org/10.1074/jbc.M808151200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19359240	hybrid, Green Published			2022-12-25	WOS:000266501000013
J	Liu, ZM; Adams, HC; Whitehead, IP				Liu, Zhuoming; Adams, Homer C., III; Whitehead, Ian P.			The Rho-specific Guanine Nucleotide Exchange Factor Dbs Regulates Breast Cancer Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; MEDIATED TYROSINE PHOSPHORYLATION; BINDING PROTEIN; SIGNALING COMPLEX; UP-REGULATION; V-CRK; SRC; GROWTH; DOMAIN; ACTIVATION	Dbs is a Rho-specific guanine nucleotide exchange factor (RhoGEF) that regulates neurotrophin-3-induced cell migration in Schwann cells. Here we report that Dbs regulates cell motility in tumor-derived, human breast epithelial cells through activation of Cdc42 and Rac1. Cdc42 and Rac1 are activated in T47D cells that stably express onco- or proto-Dbs, and activation is dependent upon growth of the cells on collagen I. Transient suppression of expression of Cdc42 or Rac1 by small interfering RNAs attenuates Dbs-enhanced motility. Both onco- and proto-Dbs-enhanced motility correlates with an increase in tyrosine phosphorylation of focal adhesion kinase on Tyr-397 and p130(Cas) on Tyr-410 and an increase in the abundance of the Crk.p130(Cas) complex. Suppression of expression of Cdc42 or its effector, Ack1, reduces tyrosine phosphorylation of focal adhesion kinase and p130(Cas) and disrupts the Crk.p130(Cas) complex. We further determined that suppression of expression of Cdc42, Ack1, p130(Cas), or Crk reduces Rac1 activation and cell motility in Dbs-expressing cells to a level comparable with that in vector cells. Therefore, a cascade of activation of Cdc42 and Rac1 by Dbs through the Cdc42 effector Ack1 and the Crk.p130(Cas) complex is established. Suppression of the expression of endogenous Dbs reduces cell motility in both T47D cells and MDA-MB-231 cells, which correlates with the down-regulation of Cdc42 activity. This suggests that Dbs activates Cdc42 in these two human breast cancer cell lines and that the normal function of Dbs may be required to support cell movement.	Univ Med & Dent New Jersey, Dept Microbiol & Mol Genet, Newark, NJ 07101 USA; Univ Med & Dent New Jersey, Univ Hosp Canc Ctr, New Jersey Med Sch, Newark, NJ 07101 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Whitehead, IP (corresponding author), Canc Ctr H Level, 205 S Orange Ave, Newark, NJ 07101 USA.	whiteip@umdnj.edu	Liu, Zhuoming/I-6950-2013	Liu, Zhuoming/0000-0002-8466-3199	National Institutes of Health (NCI, to the United States Public Health Service) [CA97066]; American Cancer Society Research Scholar [RGS-04-199-01]; NATIONAL CANCER INSTITUTE [R01CA097066] Funding Source: NIH RePORTER	National Institutes of Health (NCI, to the United States Public Health Service)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society Research Scholar(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA97066 (NCI, to the United States Public Health Service). This work was also supported by American Cancer Society Research Scholar Grant RGS-04-199-01 (to I. P. W.).	Alowami S, 2003, BREAST CANCER RES, V5, pR129, DOI 10.1186/bcr622; BIRGE RB, 1993, MOL CELL BIOL, V13, P4648, DOI 10.1128/MCB.13.8.4648; Brown JL, 1997, GENE DEV, V11, P2972, DOI 10.1101/gad.11.22.2972; Cheng L, 2004, J BIOL CHEM, V279, P12786, DOI 10.1074/jbc.M313099200; Chodniewicz D, 2004, BBA-MOL CELL RES, V1692, P63, DOI 10.1016/j.bbamcr.2004.03.006; CHUANG TH, 1995, P NATL ACAD SCI USA, V92, P10282, DOI 10.1073/pnas.92.22.10282; GOTOH T, 1995, MOL CELL BIOL, V15, P6746; Hamasaki K, 1996, BIOCHEM BIOPH RES CO, V222, P338, DOI 10.1006/bbrc.1996.0745; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; HORII Y, 1994, EMBO J, V13, P4776, DOI 10.1002/j.1460-2075.1994.tb06803.x; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; KEELY PJ, 1995, J CELL SCI, V108, P595; Keely PJ, 2001, METHODS ENZYMOL, V333, P256; KEYDAR I, 1979, EUR J CANCER, V15, P659, DOI 10.1016/0014-2964(79)90139-7; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; KNUDSEN BS, 1994, J BIOL CHEM, V269, P32781; Kostenko EV, 2005, J BIOL CHEM, V280, P2807, DOI 10.1074/jbc.M411139200; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Liu ZM, 2006, J BIOL CHEM, V281, P16043, DOI 10.1074/jbc.M601823200; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; MATSUDA M, 1992, MOL CELL BIOL, V12, P3482, DOI 10.1128/MCB.12.8.3482; McSherry EA, 2007, CELL MOL LIFE SCI, V64, P3201, DOI 10.1007/s00018-007-7388-0; Minard ME, 2005, ONCOGENE, V24, P2568, DOI 10.1038/sj.onc.1208503; Modzelewska K, 2006, J BIOL CHEM, V281, P37527, DOI 10.1074/jbc.M604342200; Nakamoto T, 1996, J BIOL CHEM, V271, P8959, DOI 10.1074/jbc.271.15.8959; Nobes CD, 2000, METHOD ENZYMOL, V325, P441; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; Olabisi OO, 2006, CANCER RES, V66, P6250, DOI 10.1158/0008-5472.CAN-06-0536; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; ROSEN MK, 1995, NATURE, V374, P477, DOI 10.1038/374477a0; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schlaepfer DD, 1997, MOL CELL BIOL, V17, P1702, DOI 10.1128/MCB.17.3.1702; Shen F, 2007, MOL BIOL CELL, V18, P732, DOI 10.1091/mbc.E06-02-0142; Shin NY, 2004, J BIOL CHEM, V279, P38331, DOI 10.1074/jbc.M404675200; Shintani Y, 2008, J CELL BIOL, V180, P1277, DOI 10.1083/jcb.200708137; Shintani Y, 2008, AM J RESP CELL MOL, V38, P95, DOI 10.1165/rcmb.2007-0071OC; Shintani Y, 2006, MOL BIOL CELL, V17, P2963, DOI 10.1091/mbc.E05-12-1123; Shintani Y, 2006, CANCER RES, V66, P11745, DOI 10.1158/0008-5472.CAN-06-2322; Tachibana K, 1997, J BIOL CHEM, V272, P29083, DOI 10.1074/jbc.272.46.29083; TANAKA S, 1994, P NATL ACAD SCI USA, V91, P3443, DOI 10.1073/pnas.91.8.3443; Tolnai S., 1975, TCA MANUAL, V1, P37, DOI DOI 10.1007/BF00914435; Ueki K, 1998, FEBS LETT, V432, P197, DOI 10.1016/S0014-5793(98)00862-X; van der Horst EH, 2005, P NATL ACAD SCI USA, V102, P15901, DOI 10.1073/pnas.0508014102; Vuori K, 1996, MOL CELL BIOL, V16, P2606; WHITEHEAD I, 1995, ONCOGENE, V10, P713; Whitehead IP, 1997, BBA-REV CANCER, V1332, pF1, DOI 10.1016/S0304-419X(96)00040-6; Whitehead LP, 1999, MOL CELL BIOL, V19, P7759; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048; Worthylake RA, 2003, J BIOL CHEM, V278, P13578, DOI 10.1074/jbc.M211584200; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Yamauchi J, 2005, P NATL ACAD SCI USA, V102, P14889, DOI 10.1073/pnas.0507125102; Yamauchi J, 2005, P NATL ACAD SCI USA, V102, P5198, DOI 10.1073/pnas.0501160102; Yang WN, 1997, J BIOL CHEM, V272, P24819, DOI 10.1074/jbc.272.40.24819; Zeisberg M, 2001, AM J PATHOL, V159, P1313, DOI 10.1016/S0002-9440(10)62518-7	62	32	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15771	15780		10.1074/jbc.M901853200	http://dx.doi.org/10.1074/jbc.M901853200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19366686	Green Published, hybrid			2022-12-25	WOS:000266501000046
J	Vakonakis, I; Staunton, D; Ellis, IR; Sarkies, P; Flanagan, A; Schor, AM; Schor, SL; Campbell, ID				Vakonakis, Ioannis; Staunton, David; Ellis, Ian R.; Sarkies, Peter; Flanagan, Aleksandra; Schor, Ana M.; Schor, Seth L.; Campbell, Iain D.			Motogenic Sites in Human Fibronectin Are Masked by Long Range Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIGRATION-STIMULATING FACTOR; HUMAN-PLASMA FIBRONECTIN; GELATIN-BINDING DOMAIN; CRYSTAL-STRUCTURES; FRAGMENT; CONFORMATION; MODULES; SUPERFIBRONECTIN; TRANSGLUTAMINASE; IDENTIFICATION	Fibronectin (FN) is a large extracellular matrix glycoprotein important for development and wound healing in vertebrates. Recent work has focused on the ability of FN fragments and embryonic or tumorigenic splicing variants to stimulate fibroblast migration into collagen gels. This activity has been localized to specific sites and is not exhibited by full-length FN. Here we show that an N-terminal FN fragment, spanning the migration stimulation sites and including the first three type III FN domains, also lacks this activity. A screen for interdomain interactions by solution-state NMR spectroscopy revealed specific contacts between the Fn N terminus and two of the type III domains. A single amino acid substitution, R222A, disrupts the strongest interaction, between domains (4-5)FnI and (3)FnIII, and restores motogenic activity to the FN N-terminal fragment. Anastellin, which promotes fibril formation, destabilizes 3FnIII and disrupts the observed (4-5)FnI-(3)FnIII interaction. We discuss these findings in the context of the control of cellular activity through exposure of masked sites.	[Vakonakis, Ioannis; Staunton, David; Sarkies, Peter; Flanagan, Aleksandra; Campbell, Iain D.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Ellis, Ian R.; Schor, Ana M.; Schor, Seth L.] Univ Dundee, Unit Cell & Mol Biol, Dundee DD1 4HR, Scotland	University of Oxford; University of Dundee	Vakonakis, I (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	ioannis.vakonakis@bioch.ox.ac.uk	Ellis, Ian/AAM-9833-2021	Sarkies, Peter/0000-0003-0279-6199; Ellis, Ian/0000-0001-8035-6012	Marie Curie Fellowships program; Royal Society; Trinity College, Oxford, UK	Marie Curie Fellowships program(European Commission); Royal Society(Royal Society of London); Trinity College, Oxford, UK	Recipient of support from the Marie Curie Fellowships program, the Royal Society, and Trinity College, Oxford, UK.	Akimov SS, 2001, J CELL SCI, V114, P2989; ALEXANDER SS, 1979, J BIOL CHEM, V254, P1501; Altroff H, 2004, J BIOL CHEM, V279, P55995, DOI 10.1074/jbc.M406976200; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; Briknarova K, 2003, J MOL BIOL, V332, P205, DOI 10.1016/S0022-2836(03)00890-8; Copie V, 1998, J MOL BIOL, V277, P663; Erat MC, 2009, P NATL ACAD SCI USA, V106, P4195, DOI 10.1073/pnas.0812516106; HOCKING DC, 1994, J BIOL CHEM, V269, P19183; Houard X, 2005, INT J CANCER, V116, P378, DOI 10.1002/ijc.21053; Ingham KC, 2004, J BIOL CHEM, V279, P28132, DOI 10.1074/jbc.M312785200; Ingham KC, 1997, J BIOL CHEM, V272, P1718, DOI 10.1074/jbc.272.3.1718; Ingham KC, 2002, ARCH BIOCHEM BIOPHYS, V407, P217, DOI 10.1016/S0003-9861(02)00454-X; INGHAM KC, 1988, J BIOL CHEM, V263, P4624; Karuri NW, 2009, J BIOL CHEM, V284, P3445, DOI 10.1074/jbc.M805025200; LAI CS, 1993, J MOL BIOL, V230, P625, DOI 10.1006/jmbi.1993.1174; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; LITVINOVICH SV, 1995, J MOL BIOL, V248, P611, DOI 10.1006/jmbi.1995.0246; Liu XY, 2003, MATRIX BIOL, V22, P393, DOI 10.1016/S0945-053X(03)00071-4; Millard CJ, 2007, J BIOL CHEM, V282, P35530, DOI 10.1074/jbc.M707532200; MORLA A, 1992, J CELL BIOL, V118, P421, DOI 10.1083/jcb.118.2.421; MORLA A, 1994, NATURE, V367, P193, DOI 10.1038/367193a0; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Nelea V, 2008, PROTEIN J, V27, P223, DOI 10.1007/s10930-008-9128-1; Ohashi T, 2005, J BIOL CHEM, V280, P39143, DOI 10.1074/jbc.M509082200; Ozeri V, 1996, EMBO J, V15, P989, DOI 10.1002/j.1460-2075.1996.tb00435.x; Pelta J, 2000, BIOCHEMISTRY-US, V39, P5146, DOI 10.1021/bi992770x; Pickford AR, 2001, EMBO J, V20, P1519, DOI 10.1093/emboj/20.7.1519; RADEK JT, 1993, P NATL ACAD SCI USA, V90, P3152, DOI 10.1073/pnas.90.8.3152; Rudino-Pinera E, 2007, J MOL BIOL, V368, P833, DOI 10.1016/j.jmb.2007.02.061; Schor SL, 2003, CANCER RES, V63, P8827; Schor SL, 1999, J CELL SCI, V112, P3879; SCHOR SL, 1988, J CELL SCI, V90, P391; SCHOR SL, 1980, J CELL SCI, V41, P159; Schor SL, 1996, J CELL SCI, V109, P2581; Schreiber G, 2002, CURR OPIN STRUC BIOL, V12, P41, DOI 10.1016/S0959-440X(02)00287-7; SJOBERG B, 1987, ARCH BIOCHEM BIOPHYS, V255, P347, DOI 10.1016/0003-9861(87)90402-4; Spitzfaden C, 1997, J MOL BIOL, V265, P565, DOI 10.1006/jmbi.1996.0736; Talay SR, 2000, CELL MICROBIOL, V2, P521, DOI 10.1046/j.1462-5822.2000.00076.x; Tomasini-Johansson BR, 2006, MATRIX BIOL, V25, P282, DOI 10.1016/j.matbio.2006.02.002; UGAROVA TP, 1995, BIOCHEMISTRY-US, V34, P4457, DOI 10.1021/bi00013a039; Vakonakis I, 2008, STRUCTURE, V16, P944, DOI 10.1016/j.str.2008.02.020; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; Vakonakis L, 2007, CURR OPIN CELL BIOL, V19, P578, DOI 10.1016/j.ceb.2007.09.005; VUILLARD L, 1990, EUR J BIOCHEM, V191, P333, DOI 10.1111/j.1432-1033.1990.tb19127.x; WOLFF C, 1988, BIOCHEMISTRY-US, V27, P3483, DOI 10.1021/bi00409a053; Xu JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004113; Zaman MH, 2007, ANN BIOMED ENG, V35, P91, DOI 10.1007/s10439-006-9205-6; Zhao QS, 2001, EXP CELL RES, V268, P211, DOI 10.1006/excr.2001.5291	50	44	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15668	15675		10.1074/jbc.M109.003673	http://dx.doi.org/10.1074/jbc.M109.003673			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19366708	hybrid, Green Published			2022-12-25	WOS:000266501000035
J	Yang, HS; Kim, E; Lee, S; Park, HJ; Cooper, DS; Rajbhandari, I; Choi, I				Yang, Han Soo; Kim, Eunjin; Lee, Soojung; Park, Hae Jeong; Cooper, Deborah S.; Rajbhandari, Ira; Choi, Inyeong			Mutation of Aspartate 555 of the Sodium/Bicarbonate Transporter SLC4A4/NBCe1 Induces Chloride Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-BICARBONATE COTRANSPORTER; ELECTROGENIC NA+-HCO3-COTRANSPORTER; ERYTHROCYTE ANION-EXCHANGER; NA/HCO3 COTRANSPORTER; TUBULAR-ACIDOSIS; XENOPUS OOCYTES; RAT-KIDNEY; PROTEIN; AE1; HCO3	To understand the mechanism for ion transport through the sodium/bicarbonate transporter SLC4A4 (NBCe1), we examined amino acid residues, within transmembrane domains, that are conserved among electrogenic Na/HCO3 transporters but are substituted with residues at the corresponding site of all electroneutral Na/HCO3 transporters. Point mutants were constructed and expressed in Xenopus oocytes to assess function using two-electrode voltage clamp. Among the mutants, D555E (charge-conserved substitution of the aspartate at position 555 with a glutamate) produced decreasing HCO3- currents at more positive membrane voltages. Immunohistochemistry showed D555E protein expression in oocyte membranes. D555E induced Na/HCO3-dependent pH recovery from a CO2-induced acidification. Current-voltage relationships revealed that D555E produced an outwardly rectifying current in the nominally CO2/HCO3--free solution that was abolished by Cl- removal from the bath. In the presence of CO2/HCO3-, however, the outward current produced by D555E decreased only slightly after Cl- removal. Starting from a Cl--free condition, D555E produced dose-dependent outward currents in response to a series of chloride additions. The D555E-mediated chloride current decreased by 70% in the presence of CO2/HCO3-. The substitution of Asp(555) with an asparagine also produced a Cl- current. Anion selectivity experiments revealed that D555E was broadly permissive to other anions including NO3-. Fluorescence measurements of chloride transport were done with human embryonic kidney HEK 293 cells expressing NBCe1 and D555E. A marked increase in chloride transport was detected in cells expressing D555E. We conclude that Asp(555) plays a role in HCO3- selectivity.	[Yang, Han Soo; Kim, Eunjin; Lee, Soojung; Park, Hae Jeong; Cooper, Deborah S.; Rajbhandari, Ira; Choi, Inyeong] Emory Univ, Dept Physiol, Sch Med, Atlanta, GA 30322 USA	Emory University	Choi, I (corresponding author), Emory Univ, Dept Physiol, Sch Med, 615 Michael St, Atlanta, GA 30322 USA.	ichoi@emory.edu	Park, Hae Jeong/ABF-3130-2020; choi, inyeong/AAM-4826-2021		National Institutes of Health [GM078502]; National Kidney Foundation Young Investigator; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078502] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Kidney Foundation Young Investigator; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM078502. This work was also supported by a National Kidney Foundation Young Investigator Grant ( to I. C.).	Abuladze N, 2005, J PHYSIOL-LONDON, V565, P717, DOI 10.1113/jphysiol.2005.084988; Alper SL, 2006, EXP PHYSIOL, V91, P153, DOI 10.1113/expphysiol.2005.031765; Bernardo AA, 2006, SEMIN NEPHROL, V26, P352, DOI 10.1016/j.semnephrol.2006.07.008; Bevensee MO, 2000, AM J PHYSIOL-CELL PH, V278, pC1200, DOI 10.1152/ajpcell.2000.278.6.C1200; Boron WF, 1997, WIEN KLIN WOCHENSCHR, V109, P445; Boron WF, 1989, REGULATION ACID BASE, P33; Burnham CE, 1997, J BIOL CHEM, V272, P19111, DOI 10.1074/jbc.272.31.19111; CABANTCHIK ZI, 1974, J MEMBRANE BIOL, V15, P207, DOI 10.1007/BF01870088; Chang MH, 2008, J BIOL CHEM, V283, P18402, DOI 10.1074/jbc.M709819200; CHAO AC, 1989, BIOPHYS J, V56, P1071, DOI 10.1016/S0006-3495(89)82755-9; Choi I, 1997, FEBS LETT, V405, P133, DOI 10.1016/S0014-5793(97)00155-5; Choi I, 1999, AM J PHYSIOL-CELL PH, V276, pC576, DOI 10.1152/ajpcell.1999.276.3.C576; Choi I, 2000, NATURE, V405, P571, DOI 10.1038/35014615; Choi I, 2007, J PHYSIOL-LONDON, V578, P131, DOI 10.1113/jphysiol.2006.114959; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Dinour D, 2004, J BIOL CHEM, V279, P52238, DOI 10.1074/jbc.M406591200; Fujinaga J, 1999, J BIOL CHEM, V274, P6626, DOI 10.1074/jbc.274.10.6626; Gawenis LR, 2007, J BIOL CHEM, V282, P9042, DOI 10.1074/jbc.M607041200; Grichtchenko II, 2000, J GEN PHYSIOL, V115, P533, DOI 10.1085/jgp.115.5.533; Kao LY, 2008, J BIOL CHEM, V283, P26782, DOI 10.1074/jbc.M804006200; Kuma H, 2002, BIOCHEMISTRY-US, V41, P3380, DOI 10.1021/bi015879p; Lauger P., 1991, ELECTROGENIC ION PUM, P61; Li HC, 2005, AM J PHYSIOL-RENAL, V289, pF61, DOI 10.1152/ajprenal.00032.2005; Lu J, 2006, J BIOL CHEM, V281, P19241, DOI 10.1074/jbc.M602181200; McAlear SD, 2006, J BIOL CHEM, V281, P32417, DOI 10.1074/jbc.M607253200; McAlear SD, 2006, J GEN PHYSIOL, V127, P639, DOI 10.1085/jgp.200609520; OKUBO K, 1994, J BIOL CHEM, V269, P1918; Perry C, 2006, AM J PHYSIOL-RENAL, V290, pF417, DOI 10.1152/ajprenal.00395.2004; Popov M, 1999, BIOCHEM J, V339, P269, DOI 10.1042/0264-6021:3390269; Pushkin A, 2006, AM J PHYSIOL-RENAL, V290, pF580, DOI 10.1152/ajprenal.00252.2005; Qu ZQ, 2000, J GEN PHYSIOL, V116, P825, DOI 10.1085/jgp.116.6.825; Romero MF, 2004, PFLUG ARCH EUR J PHY, V447, P495, DOI 10.1007/s00424-003-1180-2; Sciortino CM, 1999, AM J PHYSIOL-RENAL, V277, pF611, DOI 10.1152/ajprenal.1999.277.4.F611; Shirakabe K, 2006, P NATL ACAD SCI USA, V103, P9542, DOI 10.1073/pnas.0602250103; SOLEIMANI M, 1987, J CLIN INVEST, V79, P1276, DOI 10.1172/JCI112948; Tang XB, 1998, J BIOL CHEM, V273, P22545, DOI 10.1074/jbc.273.35.22545; Weber WM, 1999, J MEMBRANE BIOL, V170, P1, DOI 10.1007/s002329900532; Zhu QS, 2004, J BIOL CHEM, V279, P23565, DOI 10.1074/jbc.M401380200; Zhu QS, 2009, J BIOL CHEM, V284, P8909, DOI 10.1074/jbc.M806674200	39	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15970	15979		10.1074/jbc.M109.001438	http://dx.doi.org/10.1074/jbc.M109.001438			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19336397	hybrid, Green Published			2022-12-25	WOS:000266501000063
J	Vega, VB; Cheung, E; Palanisamy, N; Sung, WK				Vega, Vinsensius B.; Cheung, Edwin; Palanisamy, Nallasivam; Sung, Wing-Kin			Inherent Signals in Sequencing-Based Chromatin-ImmunoPrecipitation Control Libraries	PLOS ONE			English	Article								Background: The growth of sequencing-based Chromatin Immuno-Precipitation studies call for a more in-depth understanding of the nature of the technology and of the resultant data to reduce false positives and false negatives. Control libraries are typically constructed to complement such studies in order to mitigate the effect of systematic biases that might be present in the data. In this study, we explored multiple control libraries to obtain better understanding of what they truly represent. Methodology: First, we analyzed the genome-wide profiles of various sequencing-based libraries at a low resolution of 1 Mbp, and compared them with each other as well as against aCGH data. We found that copy number plays a major influence in both ChIP-enriched as well as control libraries. Following that, we inspected the repeat regions to assess the extent of mapping bias. Next, significantly tag-rich 5 kbp regions were identified and they were associated with various genomic landmarks. For instance, we discovered that gene boundaries were surprisingly enriched with sequenced tags. Further, profiles between different cell types were noticeably distinct although the cell types were somewhat related and similar. Conclusions: We found that control libraries bear traces of systematic biases. The biases can be attributed to genomic copy number, inherent sequencing bias, plausible mapping ambiguity, and cell-type specific chromatin structure. Our results suggest careful analysis of control libraries can reveal promising biological insights.			Vega, VB (corresponding author), Genome Inst Singapore, Computat & Math Biol Grp, Singapore, Singapore.	sungk@gis.a-star.edu.sg	Palanisamy, Nallasivam/ABC-8844-2020	Palanisamy, Nallasivam/0000-0002-0633-9772; Sung, Wing-Kin/0000-0001-7806-7086				BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhinge AA, 2007, GENOME RES, V17, P910, DOI 10.1101/gr.5574907; Bourque G, 2008, GENOME RES, V18, P1752, DOI 10.1101/gr.080663.108; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Vega VB, 2008, LECT NOTES COMPUT SC, V5103, P130, DOI 10.1007/978-3-540-69389-5_16; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	16	33	35	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2009	4	4							e5241	10.1371/journal.pone.0005241	http://dx.doi.org/10.1371/journal.pone.0005241			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TS	19367334	Green Published, gold, Green Submitted			2022-12-25	WOS:000265510400008
J	Fritz, JA; Behm, CA				Fritz, Julie-Anne; Behm, Carolyn A.			CUTI-1: A Novel Tetraspan Protein Involved in C. elegans CUTicle Formation and Epithelial Integrity	PLOS ONE			English	Article								The nematode cuticle is a tough extracellular matrix composed primarily of cross-linked collagens and non-collagenous cuticulins. It is required for nematode motility and protection from the external environment. Little is known about how the complex process of cuticle formation has been adapted to the specialized requirements of the nematode cuticle, which is structurally and compositionally unique from other organisms. The C. elegans gene cuti-1 (CUTicle and epithelial Integrity) encodes a nematode-specific protein. We have shown that CUTI-1 is expressed in the epithelia and in seam cells. Within these tissues the expression of cuti-1 mRNA cycles throughout development in line with the molting cycle, a process that involves synthesis of a new cuticle. In addition, knockdown of cuti-1 by RNA interference (RNAi) results in worms that display post-embryonic phenotypes related to cuticle dysfunction and defects in epithelial integrity. This is one of the first reports of a nematode-specific protein involved in extracellular matrix formation. It provides further insight into how novel ways have evolved to regulate the formation of the cuticle, which is the primary protective barrier and skeletal component of nematodes.			Fritz, JA (corresponding author), Australian Natl Univ, Coll Med Biol & Environm, Sch Biol, Canberra, ACT, Australia.	Carolyn.Behm@anu.edu.au	Behm, Carolyn A/A-2102-2008	Behm, Carolyn A/0000-0002-0603-221X				Bercher M, 2001, J CELL BIOL, V154, P415, DOI 10.1083/jcb.200103035; Berezikov E, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh033; BIRD DM, 1989, MOL CELL BIOL, V9, P4119, DOI 10.1128/MCB.9.10.4119; BRENNER S, 1974, GENETICS, V77, P71; Caplan S, 2001, J CELL BIOL, V154, P109, DOI 10.1083/jcb.200102142; Cheong KH, 1999, P NATL ACAD SCI USA, V96, P6241, DOI 10.1073/pnas.96.11.6241; Costa M, 1997, DEV BIOL, V184, P373, DOI 10.1006/dbio.1997.8530; Dupuy D, 2004, GENOME RES, V14, P2169, DOI 10.1101/gr.2497604; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FRANCIS R, 1991, J CELL BIOL, V114, P465, DOI 10.1083/jcb.114.3.465; Gissendanner CR, 2004, DEV BIOL, V266, P399, DOI 10.1016/j.ydbio.2003.10.014; Hashmi S, 2004, J BIOL CHEM, V279, P6035, DOI 10.1074/jbc.M312346200; Hong L, 2001, J CELL BIOL, V154, P403, DOI 10.1083/jcb.200007075; Hresko MC, 1999, J CELL BIOL, V146, P659, DOI 10.1083/jcb.146.3.659; Johnstone IL, 2000, TRENDS GENET, V16, P21, DOI 10.1016/S0168-9525(99)01857-0; JOHNSTONE IL, 1994, BIOESSAYS, V16, P171, DOI 10.1002/bies.950160307; Johnstone IL, 1996, EMBO J, V15, P3633, DOI 10.1002/j.1460-2075.1996.tb00732.x; Johnstone IL, 1996, MOL BIOCHEM PARASIT, V80, P103, DOI 10.1016/0166-6851(96)02682-5; Koh K, 2001, DEVELOPMENT, V128, P2867; KRAMER JM, 1994, ANNU REV GENET, V28, P95; KRAMER JM, 1997, C ELEGANS, V2, P471; Lackner MR, 2005, CANCER CELL, V7, P325, DOI 10.1016/j.ccr.2005.03.024; McMahon L, 2001, J CELL SCI, V114, P2265; Michaux G, 2000, CURR BIOL, V10, P1098, DOI 10.1016/S0960-9822(00)00695-3; Moribe H, 2004, J CELL SCI, V117, P5209, DOI 10.1242/jcs.01403; Nakamura N, 1997, J BIOL CHEM, V272, P11344; PARK YS, 1994, DEV BIOL, V163, P112, DOI 10.1006/dbio.1994.1127; PODBILEWICZ B, 1994, DEV BIOL, V161, P408, DOI 10.1006/dbio.1994.1041; Praitis V, 2001, GENETICS, V157, P1217; Roberts B, 2003, MOL BIOL CELL, V14, P4414, DOI 10.1091/mbc.E03-03-0162; Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604; SINGH RN, 1978, NEMATOLOGICA, V24, P63, DOI 10.1163/187529278X00074; Thein MC, 2003, DEV DYNAM, V226, P523, DOI 10.1002/dvdy.10259; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190	36	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5117	10.1371/journal.pone.0005117	http://dx.doi.org/10.1371/journal.pone.0005117			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357781	Green Published, Green Submitted, gold			2022-12-25	WOS:000265505900003
J	Ou, HY; He, XY; Shao, YC; Tai, C; Rajakumar, K; Deng, ZX				Ou, Hong-Yu; He, Xinyi; Shao, Yucheng; Tai, Cui; Rajakumar, Kumar; Deng, Zixin			dndDB: A Database Focused on Phosphorothioation of the DNA Backbone	PLOS ONE			English	Article								Background: The Dnd DNA degradation phenotype was first observed during electrophoresis of genomic DNA from Streptomyces lividans more than 20 years ago. It was subsequently shown to be governed by the five-gene dnd cluster. Similar gene clusters have now been found to be widespread among many other distantly related bacteria. Recently the dnd cluster was shown to mediate the incorporation of sulphur into the DNA backbone via a sequence-selective, stereo-specific phosphorothioate modification in Escherichia coli B7A. Intriguingly, to date all identified dnd clusters lie within mobile genetic elements, the vast majority in laterally transferred genomic islands. Methodology: We organized available data from experimental and bioinformatics analyses about the DNA phosphorothioation phenomenon and associated documentation as a dndDB database. It contains the following detailed information: (i) Dnd phenotype; (ii) dnd gene clusters; (iii) genomic islands harbouring dnd genes; (iv) Dnd proteins and conserved domains. As of 25 December 2008, dndDB contained data corresponding to 24 bacterial species exhibiting the Dnd phenotype reported in the scientific literature. In addition, via in silico analysis, dndDB identified 26 syntenic dnd clusters from 25 species of Eubacteria and Archaea, 25 dnd-bearing genomic islands and one dnd plasmid containing 114 dnd genes. A further 397 other genes coding for proteins with varying levels of similarity to Dnd proteins were also included in dndDB. A broad range of similarity search, sequence alignment and phylogenetic tools are readily accessible to allow for to individualized directions of research focused on dnd genes. Conclusion: dndDB can facilitate efficient investigation of a wide range of aspects relating to dnd DNA modification and other island-encoded functions in host organisms. dndDB version 1.0 is freely available at http://mml.sjtu.edu.cn/dndDB/.			Ou, HY (corresponding author), Shanghai Jiao Tong Univ, Lab Microbial Metab, Shanghai 200030, Peoples R China.	zxdeng@sjtu.edu.cn	OU, Hong-Yu/O-5208-2019	OU, Hong-Yu/0000-0001-9439-1660				Abbott JC, 2005, BIOINFORMATICS, V21, P3665, DOI 10.1093/bioinformatics/bti601; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; He X, 2007, MOL MICROBIOL, V65, P1034, DOI 10.1111/j.1365-2958.2007.05846.x; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Liang JD, 2007, NUCLEIC ACIDS RES, V35, P2944, DOI 10.1093/nar/gkm176; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Ou HY, 2007, NUCLEIC ACIDS RES, V35, pW97, DOI 10.1093/nar/gkm380; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Wang HM, 2006, BIOINFORMATICS, V22, P2308, DOI 10.1093/bioinformatics/btl389; Wang LR, 2007, NAT CHEM BIOL, V3, P709, DOI 10.1038/nchembio.2007.39; You DL, 2008, CHEMBIOCHEM, V9, P1879, DOI 10.1002/cbic.200800033; You DL, 2007, BIOCHEMISTRY-US, V46, P6126, DOI 10.1021/bi602615k; Zhang CT, 2003, BIOINFORMATICS, V19, P593, DOI 10.1093/bioinformatics/btg041; ZHOU XF, 1988, NUCLEIC ACIDS RES, V16, P4341, DOI 10.1093/nar/16.10.4341; Zhou XF, 2005, MOL MICROBIOL, V57, P1428, DOI 10.1111/j.1365-2958.2005.04764.x; Zhou XF, 2004, APPL ENVIRON MICROB, V70, P7110, DOI 10.1128/AEM.70.12.7110-7118.2004	22	43	53	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5132	10.1371/journal.pone.0005132	http://dx.doi.org/10.1371/journal.pone.0005132			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357771	Green Published, gold, Green Submitted			2022-12-25	WOS:000265505900008
J	Tintu, A; Rouwet, E; Verlohren, S; Brinkmann, J; Ahmad, S; Crispi, F; van Bilsen, M; Carmeliet, P; Staff, AC; Tjwa, M; Cetin, I; Gratacos, E; Hernandez-Andrade, E; Hofstra, L; Jacobs, M; Lamers, WH; Morano, I; Safak, E; Ahmed, A; le Noble, F				Tintu, Andrei; Rouwet, Ellen; Verlohren, Stefan; Brinkmann, Joep; Ahmad, Shakil; Crispi, Fatima; van Bilsen, Marc; Carmeliet, Peter; Staff, Anne Cathrine; Tjwa, Marc; Cetin, Irene; Gratacos, Eduard; Hernandez-Andrade, Edgar; Hofstra, Leo; Jacobs, Michael; Lamers, Wouter H.; Morano, Ingo; Safak, Erdal; Ahmed, Asif; le Noble, Ferdinand			Hypoxia Induces Dilated Cardiomyopathy in the Chick Embryo: Mechanism, Intervention, and Long-Term Consequences	PLOS ONE			English	Article								Background: Intrauterine growth restriction is associated with an increased future risk for developing cardiovascular diseases. Hypoxia in utero is a common clinical cause of fetal growth restriction. We have previously shown that chronic hypoxia alters cardiovascular development in chick embryos. The aim of this study was to further characterize cardiac disease in hypoxic chick embryos. Methods: Chick embryos were exposed to hypoxia and cardiac structure was examined by histological methods one day prior to hatching (E20) and at adulthood. Cardiac function was assessed in vivo by echocardiography and ex vivo by contractility measurements in isolated heart muscle bundles and isolated cardiomyocytes. Chick embryos were exposed to vascular endothelial growth factor (VEGF) and its scavenger soluble VEGF receptor-1 (sFlt-1) to investigate the potential role of this hypoxia-regulated cytokine. Principal Findings: Growth restricted hypoxic chick embryos showed cardiomyopathy as evidenced by left ventricular (LV) dilatation, reduced ventricular wall mass and increased apoptosis. Hypoxic hearts displayed pump dysfunction with decreased LV ejection fractions, accompanied by signs of diastolic dysfunction. Cardiomyopathy caused by hypoxia persisted into adulthood. Hypoxic embryonic hearts showed increases in VEGF expression. Systemic administration of rhVEGF(165) to normoxic chick embryos resulted in LV dilatation and a dose-dependent loss of LV wall mass. Lowering VEGF levels in hypoxic embryonic chick hearts by systemic administration of sFlt-1 yielded an almost complete normalization of the phenotype. Conclusions/Significance: Our data show that hypoxia causes a decreased cardiac performance and cardiomyopathy in chick embryos, involving a significant VEGF-mediated component. This cardiomyopathy persists into adulthood.			Tintu, A (corresponding author), Max Delbruck Ctr Mol Med, Lab Angiogenesis & Cardiovasc Pathol, Berlin, Germany.	lenoble@mdc-berlin.de	van Bilsen, Marc/E-8342-2016; Ahmed, Asif/ABE-9544-2020; Gratacos, Eduard/AAR-4939-2020; Ahmed, Asif/A-7268-2010; cetin, irene/K-6112-2016; Carmeliet, Peter/AAQ-5140-2020; Ahmad, Shakil/A-9421-2008; le Noble, Ferdinand/L-7867-2017; Lamers, Wouter H./D-2965-2012	Ahmed, Asif/0000-0002-8755-8546; Gratacos, Eduard/0000-0002-7405-7224; cetin, irene/0000-0002-9217-3034; Carmeliet, Peter/0000-0001-7961-1821; Ahmad, Shakil/0000-0002-9294-0475; Verlohren, Stefan/0000-0003-3507-8636; Crispi, Fatima/0000-0002-7422-5240; Goswami, Kaushal/0000-0002-7052-4358	MRC [G0601295] Funding Source: UKRI; British Heart Foundation [RG/09/001/25940] Funding Source: Medline; Medical Research Council [G0601295] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Dor Y, 2001, DEVELOPMENT, V128, P1531; Dumont EA, 2001, NAT MED, V7, P1352, DOI 10.1038/nm1201-1352; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Feucht M, 1997, AM J PATHOL, V151, P1407; Fong TAT, 1999, CANCER RES, V59, P99; Gillman MW, 2005, NEW ENGL J MED, V353, P1848, DOI 10.1056/NEJMe058187; Giordano FJ, 2001, P NATL ACAD SCI USA, V98, P5780, DOI 10.1073/pnas.091415198; Gupta S, 2007, ANTIOXID REDOX SIGN, V9, P623, DOI 10.1089/ars.2007.1474; Haase H, 2006, FASEB J, V20, P865, DOI 10.1096/fj.05-5414com; Hein S, 2000, CARDIOVASC RES, V45, P273, DOI 10.1016/S0008-6363(99)00268-0; HEIN S, 1994, J MOL CELL CARDIOL, V26, P1291, DOI 10.1006/jmcc.1994.1148; Holubarsch C, 1996, CIRCULATION, V94, P683, DOI 10.1161/01.CIR.94.4.683; Ingelfinger JR, 2004, CURR OPIN NEPHROL HY, V13, P459, DOI 10.1097/01.mnh.0000133977.09688.2f; Katz AM, 2006, CIRCULATION, V113, P1922, DOI 10.1161/CIRCULATIONAHA.106.620765; Leeson CPM, 2001, CIRCULATION, V103, P1264; Louey S, 2005, EARLY HUM DEV, V81, P745, DOI 10.1016/j.earlhumdev.2005.07.001; Miao HQ, 1999, J CELL BIOL, V146, P233, DOI 10.1083/jcb.146.1.233; Miquerol L, 2000, DEVELOPMENT, V127, P3941; Morrison JL, 2007, AM J PHYSIOL-REG I, V293, pR306, DOI 10.1152/ajpregu.00798.2006; Nagueh SF, 2004, CIRCULATION, V110, P155, DOI 10.1161/01.CIR.0000135591.37759.AF; NICOLAIDES KH, 1989, AM J OBSTET GYNECOL, V161, P996, DOI 10.1016/0002-9378(89)90770-9; Nosek TM, 1997, AM J PHYSIOL-HEART C, V273, pH1464, DOI 10.1152/ajpheart.1997.273.3.H1464; PARDI G, 1993, NEW ENGL J MED, V328, P692, DOI 10.1056/NEJM199303113281004; Ream M, 2008, AM J PHYSIOL-REG I, V295, pR583, DOI 10.1152/ajpregu.00771.2007; Rouwet EV, 2002, CIRCULATION, V105, P2791, DOI 10.1161/01.CIR.0000017497.47084.06; SCHAPER J, 1991, CIRCULATION, V83, P504, DOI 10.1161/01.CIR.83.2.504; Sharma SK, 2006, PEDIATR RES, V59, P116, DOI 10.1203/01.pdr.0000191579.63339.90; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; STEWART DE, 1985, J MOL CELL CARDIOL, V17, P389, DOI 10.1016/S0022-2828(85)80138-3; Sugimoto H, 2003, J BIOL CHEM, V278, P12605, DOI 10.1074/jbc.C300012200; Sugishita Y, 2004, DEV BIOL, V267, P294, DOI 10.1016/j.ydbio.2003.11.017; TATSUMI R, 1995, ANAL BIOCHEM, V224, P28, DOI 10.1006/abio.1995.1004; Tintu AN, 2007, ENDOTHELIUM-J ENDOTH, V14, P353, DOI 10.1080/10623320701746347; van Heerebeek L, 2006, CIRCULATION, V113, P1966, DOI 10.1161/CIRCULATIONAHA.105.587519; Verburg BO, 2008, CIRCULATION, V117, P649, DOI 10.1161/CIRCULATIONAHA.107.709717; Villamor E, 2004, AM J PHYSIOL-REG I, V287, pR642, DOI 10.1152/ajpregu.00611.2003; Wu YM, 2002, CIRCULATION, V106, P1384, DOI 10.1161/01.CIR.0000029804.61510.02; Yue XP, 2001, AM J PHYSIOL-HEART C, V280, pH2240, DOI 10.1152/ajpheart.2001.280.5.H2240; Zile MR, 2002, CIRCULATION, V105, P1503, DOI 10.1161/hc1202.105290; Zile MR, 2002, CIRCULATION, V105, P1387, DOI 10.1161/hc1102.105289	42	95	97	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5155	10.1371/journal.pone.0005155	http://dx.doi.org/10.1371/journal.pone.0005155			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357774	Green Published, Green Accepted, gold			2022-12-25	WOS:000265505900015
J	Hashimoto, Y; Loftis, DW; Adams, JC				Hashimoto, Yosuke; Loftis, David W.; Adams, Josephine C.			Fascin-1 Promoter Activity Is Regulated by CREB and the Aryl Hydrocarbon Receptor in Human Carcinoma Cells	PLOS ONE			English	Article							ACTIN-BUNDLING PROTEIN; INDEPENDENT PROGNOSTIC VALUE; ELEMENT-BINDING PROTEIN; MATURE DENDRITIC CELLS; BREAST-CANCER; TRANSCRIPTIONAL ACTIVATION; GENOME SEQUENCE; COLON-CANCER; EXPRESSION; GENE	Background: Fascin is an actin-bundling protein that is absent from most normal epithelia yet is upregulated in multiple forms of human carcinoma, where its expression correlates clinically with a poor prognosis. How fascin-1 transcription is activated in carcinoma cells is largely unknown, although the hypothesis of regulation by beta-catenin signaling has received attention. The question is important because of the clinical significance of fascin expression in human carcinomas. Methodology/Principal Findings: Through comparative genomics we made an unbiased analysis of the DNA sequence of the fascin-1 promoter region from six mammalian species. We identified two regions in which highly conserved motifs are concentrated. Luciferase promoter reporter assays for the human fascin-1 promoter were carried out in fascin-positive and negative human breast and colon carcinoma cells, and in human dermal fibroblasts that are constitutively fascin-positive. In all fascin-positive cells, the region 2219/+114 that contains multiple highly conserved motifs had strong transcriptional activity. The region 22953/21582 appeared to contain repressor activity. By examining the effects of single or multiple point mutations of conserved motifs within the 2219/+114 region on transcriptional reporter activity, we identified for the first time that the conserved CREB and AhR binding motifs are major determinants of transcriptional activity in human colon carcinoma cells. Chromatin immunoprecipitations for CREB, AhR or beta-catenin from extracts from fascin-positive or -negative human colon carcinoma cells identified that CREB and AhR specifically associate with the 2219/+114 region of the FSCN1 promoter in fascin-positive colon carcinoma cells. An association of beta-catenin was not specific to fascin-positive cells. Conclusion: Upregulation of fascin-1 in aggressive human carcinomas appears to have a multi-factorial basis. The data identify novel roles for CREB and AhR as major, specific regulators of FSCN-1 transcription in human carcinoma cells but do not support the hypothesis that beta-catenin signaling has a central role.	[Hashimoto, Yosuke; Loftis, David W.; Adams, Josephine C.] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH USA; [Adams, Josephine C.] Cleveland Clin, Cleveland Clin Lerner Coll Med, Dept Mol Med, Cleveland, OH USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Hashimoto, Y (corresponding author), Shizuoka Canc Ctr, Shizuoka, Japan.	adamsj@ccf.org	Adams, Josephine C/B-1121-2009	Adams, Josephine C/0000-0002-2225-4947	Association for International Cancer Research [04-033]	Association for International Cancer Research	Supported by Association for International Cancer Research grant 04-033. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk John J. Jr., 2001, Journal of Insect Science (Tucson), V1, P1; Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Al-Alwan MM, 2001, J IMMUNOL, V166, P338, DOI 10.4049/jimmunol.166.1.338; Anilkumar N, 2003, EMBO J, V22, P5390, DOI 10.1093/emboj/cdg521; Barouki R, 2007, FEBS LETT, V581, P3608, DOI 10.1016/j.febslet.2007.03.046; Blanchette M, 2003, NUCLEIC ACIDS RES, V31, P3840, DOI 10.1093/nar/gkg606; Bros M, 2003, J IMMUNOL, V171, P1825, DOI 10.4049/jimmunol.171.4.1825; Bruce B, 2007, CLIN EXP METASTAS, V24, P69, DOI 10.1007/s10585-006-9050-x; De Arcangelis A, 2004, GENE EXPR PATTERNS, V4, P637, DOI 10.1016/j.modgep.2004.04.012; EDWARDS RA, 1995, CELL MOTIL CYTOSKEL, V32, P1, DOI 10.1002/cm.970320102; Fang M, 2006, EMBO J, V25, P2735, DOI 10.1038/sj.emboj.7601153; Gal-Yam EN, 2008, ANNU REV MED, V59, P267, DOI 10.1146/annurev.med.59.061606.095816; Geyeregger R, 2007, BLOOD, V109, P4288, DOI 10.1182/blood-2006-08-043422; Ghosh R, 2007, NEOPLASIA, V9, P893, DOI 10.1593/neo.07502; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Grothey A, 2000, ONCOGENE, V19, P4864, DOI 10.1038/sj.onc.1203838; Hashimoto Y, 2005, CLIN CANCER RES, V11, P2597, DOI 10.1158/1078-0432.CCR-04-1378; Hashimoto Y, 2005, INT J BIOCHEM CELL B, V37, P1787, DOI 10.1016/j.biocel.2005.05.004; Hashimoto Y, 2004, ONCOLOGY-BASEL, V67, P262, DOI 10.1159/000081327; Hashimoto Y, 2007, MOL BIOL CELL, V18, P4591, DOI 10.1091/mbc.E07-02-0157; Hashimoto Y, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-241; HORWITZ KB, 1978, CANCER RES, V38, P2434; Iacobuzio-Donahue CA, 2003, CANCER RES, V63, P8614; Ionov Y, 2004, P NATL ACAD SCI USA, V101, P1273, DOI 10.1073/pnas.0307276101; Jawhari AU, 2003, AM J PATHOL, V162, P69, DOI 10.1016/S0002-9440(10)63799-6; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Knuppel R, 1994, J Comput Biol, V1, P191, DOI 10.1089/cmb.1994.1.191; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Lambrechts A, 2004, INT J BIOCHEM CELL B, V36, P1890, DOI 10.1016/j.biocel.2004.01.024; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li J, 2007, EMBO J, V26, P2284, DOI 10.1038/sj.emboj.7601667; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Megiorni F, 2005, NEUROSCI LETT, V381, P169, DOI 10.1016/j.neulet.2005.02.027; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Min J, 2006, HYPERTENSION, V47, P1189, DOI 10.1161/01.HYP.0000222892.37375.4d; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mosialos G, 1996, AM J PATHOL, V148, P593; Pelosi G, 2003, BRIT J CANCER, V88, P537, DOI 10.1038/sj.bjc.6600731; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Puppa G, 2007, BRIT J CANCER, V96, P1118, DOI 10.1038/sj.bjc.6603690; Ross R, 2003, GENE THER, V10, P1035, DOI 10.1038/sj.gt.3301968; Ross R, 1998, J IMMUNOL, V160, P3776; Ross R, 2000, J INVEST DERMATOL, V115, P658, DOI 10.1046/j.1523-1747.2000.00112.x; Schlezinger JJ, 2006, BIOL CHEM, V387, P1175, DOI 10.1515/BC.2006.145; Shan ZT, 2008, ANAT REC, V291, P519, DOI 10.1002/ar.20686; Soshilov A, 2008, J BIOL CHEM, V283, P32995, DOI 10.1074/jbc.M802414200; Sosinsky A, 2003, NUCLEIC ACIDS RES, V31, P3589, DOI 10.1093/nar/gkg544; Vignjevic D, 2007, CANCER RES, V67, P6844, DOI 10.1158/0008-5472.CAN-07-0929; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Xie JJ, 2005, BIOCHEM BIOPH RES CO, V337, P355, DOI 10.1016/j.bbrc.2005.09.055; Yang F, 2004, J BIOL CHEM, V279, P35403, DOI 10.1074/jbc.M404055200; Yang XH, 2005, ONCOGENE, V24, P7869, DOI 10.1038/sj.onc.1208938; Yoder BJ, 2005, CLIN CANCER RES, V11, P186; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102; Zigeuner R, 2006, UROLOGY, V68, P518, DOI 10.1016/j.urology.2006.03.032	61	39	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5130	10.1371/journal.pone.0005130	http://dx.doi.org/10.1371/journal.pone.0005130			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340314	gold, Green Submitted, Green Published			2022-12-25	WOS:000265500700021
J	Hu, YM; Coates, ARM				Hu, Yanmin; Coates, Anthony R. M.			Acute and Persistent Mycobacterium tuberculosis Infections Depend on the Thiol Peroxidase TPX	PLOS ONE			English	Article								The macrophage is the natural niche of Mycobacterium tuberculosis infection. In order to combat oxidative and nitrosative stresses and persist in macrophages successfully, M. tuberculosis is endowed with a very efficient antioxidant complex. Amongst these antioxidant enzymes, TpX is the only one in M. tuberculosis with sequence homology to thiol peroxidase. Previous reports have demonstrated that the M. tuberculosis TpX protein functions as a peroxidase in vitro. It is the dominant antioxidant which protects M. tuberculosis against oxidative and nitrosative stresses. The level of the protein increases in oxidative stress. To determine the roles of tpx gene in M. tuberculosis survival and virulence in vivo, we constructed an M. tuberculosis strain lacking the gene. The characteristics of the mutant were examined in an in vitro stationary phase model, in response to stresses; in murine bone marrow derived macrophages and in an acute and an immune resistant model of murine tuberculosis. The tpx mutant became sensitive to H(2)O(2) and NO compared to the wild type strain. Enzymatic analysis using bacterial extracts from the WT and the tpx mutant demonstrated that the mutant contains reduced peroxidase activity. As a result of this, the mutant failed to grow and survive in macrophages. The growth deficiency in macrophages became more pronounced after interferon-gamma activation. In contrast, its growth was significantly restored in the macrophages of inducible nitric oxide synthase (iNOS or NOS2) knockout mice. Moreover, the tpx mutant was impaired in its ability to initiate an acute infection and to maintain a persistent infection. Its virulence was attenuated. Our results demonstrated that tpx is required for M. tuberculosis to deal with oxidative and nitrosative stresses, to survive in macrophages and to establish acute and persistent infections in animal tuberculosis models.	[Hu, Yanmin; Coates, Anthony R. M.] St Georges Univ London, Div Cellular & Mol Med, Ctr Infect, London, England	St Georges University London	Hu, YM (corresponding author), St Georges Univ London, Div Cellular & Mol Med, Ctr Infect, London, England.	acoates@sgul.ac.uk		Hu, Yanmin/0000-0003-0630-5342; Coates, Anthony/0000-0001-8052-3175	European Community's Sixth Framework Programme; Burton Medical Trust	European Community's Sixth Framework Programme; Burton Medical Trust	This research was supported by the European Community's Sixth Framework Programme to the project NEWTBDRUGS. The publication reflects only the author's views. The European Community is not liable for any use that may be made of the information herein. The financial support of the Burton Medical Trust is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P64, DOI 10.1016/S0952-7915(99)00052-7; Bogdan CT, 2000, IMMUNOL REV, V173, P17, DOI 10.1034/j.1600-065X.2000.917307.x; Cha MK, 1996, J BACTERIOL, V178, P5610, DOI 10.1128/jb.178.19.5610-5614.1996; Chen L, 1998, MOL CELL, V1, P795, DOI 10.1016/S1097-2765(00)80079-9; Chiavolini D, 2008, INFECT IMMUN, V76, P486, DOI 10.1128/IAI.00862-07; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Crawford RM, 1996, INFECT IMMUN, V64, P2188, DOI 10.1128/IAI.64.6.2188-2192.1996; DENIS M, 1991, CELL IMMUNOL, V132, P150, DOI 10.1016/0008-8749(91)90014-3; Dhandayuthapani S, 1996, J BACTERIOL, V178, P3641, DOI 10.1128/jb.178.12.3641-3649.1996; Dosanjh NS, 2005, FEMS MICROBIOL LETT, V249, P87, DOI 10.1016/j.femsle.2005.06.004; Dussurget O, 2001, INFECT IMMUN, V69, P529, DOI 10.1128/IAI.69.1.529-533.2001; Edwards KM, 2001, AM J RESP CRIT CARE, V164, P2213, DOI 10.1164/ajrccm.164.12.2106093; Ehlers S, 1999, IMMUNOLOGY, V98, P313; Hillas PJ, 2000, J BIOL CHEM, V275, P18801, DOI 10.1074/jbc.M001001200; Hu YM, 2008, INFECT IMMUN, V76, P1535, DOI 10.1128/IAI.01078-07; Hu YM, 2000, J BACTERIOL, V182, P6358, DOI 10.1128/JB.182.22.6358-6365.2000; Hu YM, 2006, INFECT IMMUN, V74, P861, DOI 10.1128/IAI.74.2.861-868.2006; Hu YM, 2004, FEMS MICROBIOL LETT, V237, P415, DOI 10.1016/j.femsle.2004.07.005; Jaeger T, 2004, ARCH BIOCHEM BIOPHYS, V423, P182, DOI 10.1016/j.abb.2003.11.021; Jaeger Timo, 2007, V44, P207; Kawahara M, 1996, MICROBIOL IMMUNOL, V40, P575, DOI 10.1111/j.1348-0421.1996.tb01111.x; Kim SY, 2002, REDOX REP, V7, P79, DOI 10.1179/135100002125000307; KUSUNOSE E, 1976, J BIOCHEM, V80, P1343, DOI 10.1093/oxfordjournals.jbchem.a131407; La Carbona S, 2007, MOL MICROBIOL, V66, P1148, DOI 10.1111/j.1365-2958.2007.05987.x; LEFFORD MJ, 1980, INFECT IMMUN, V28, P508; Manca C, 1999, INFECT IMMUN, V67, P74, DOI 10.1128/IAI.67.1.74-79.1999; Master SS, 2002, MICROBIOL-SGM, V148, P3139, DOI 10.1099/00221287-148-10-3139; Milano A, 1996, MOL MICROBIOL, V19, P113, DOI 10.1046/j.1365-2958.1996.352876.x; MORLEY D, 1993, J CARDIOVASC PHARM, V22, pS3, DOI 10.1097/00005344-199306227-00003; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Ng VH, 2004, MOL MICROBIOL, V52, P1291, DOI 10.1111/j.1365-2958.2004.04078.x; ORME IM, 1988, AM REV RESPIR DIS, V137, P716, DOI 10.1164/ajrccm/137.3.716; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; PARISH TSN, 1998, ELECTROPORATION MYCO; Piddington DL, 2001, INFECT IMMUN, V69, P4980, DOI 10.1128/IAI.69.8.4980-4987.2001; Rho BS, 2006, J MOL BIOL, V361, P850, DOI 10.1016/j.jmb.2006.05.076; Rouse DA, 1996, MOL MICROBIOL, V22, P583, DOI 10.1046/j.1365-2958.1996.00133.x; Sambrook J., 2002, MOL CLONING LAB MANU; Smith DA, 2001, INFECT IMMUN, V69, P1142, DOI 10.1128/IAI.69.2.1442-1150.2001; Springer B, 2001, INFECT IMMUN, V69, P5967, DOI 10.1128/IAI.69.10.5967-5973.2001; Stehr M, 2006, ACTA CRYSTALLOGR D, V62, P563, DOI 10.1107/S0907444906008249; Trujillo M, 2006, J BIOL CHEM, V281, P20555, DOI 10.1074/jbc.M601008200; WAYNE LG, 1988, INFECT IMMUN, V56, P936, DOI 10.1128/IAI.56.4.936-941.1988; Wengenack NL, 1999, BIOCHEM BIOPH RES CO, V256, P485, DOI 10.1006/bbrc.1999.0358; Zahrt TC, 2002, ANTIOXID REDOX SIGN, V4, P141, DOI 10.1089/152308602753625924	45	40	44	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5150	10.1371/journal.pone.0005150	http://dx.doi.org/10.1371/journal.pone.0005150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340292	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000265500700027
J	Thatte, HS; He, XD; Goyal, RK				Thatte, Hemant S.; He, Xue D.; Goyal, Raj K.			Imaging of Nitric Oxide in Nitrergic Neuromuscular Neurotransmission in the Gut	PLOS ONE			English	Article							PEPTIDE-VIP; 4,5-DIAMINOFLUORESCEIN; SYNTHASE	Background: Numerous functional studies have shown that nitrergic neurotransmission plays a central role in peristalsis and sphincter relaxation throughout the gut and impaired nitrergic neurotransmission has been implicated in clinical disorders of all parts of the gut. However, the role of nitric oxide (NO) as a neurotransmitter continues to be controversial because: 1) the cellular site of production during neurotransmission is not well established; 2) NO may interacts with other inhibitory neurotransmitter candidates, making it difficult to understand its precise role. Methodology/Principal Findings: Imaging NO can help resolve many of the controversies regarding the role of NO in nitrergic neurotransmission. Imaging of NO and its cellular site of production is now possible. NO forms quantifiable fluorescent compound with diaminofluorescein (DAF) and allows imaging of NO with good specificity and sensitivity in living cells. In this report we describe visualization and regulation of NO and calcium (Ca2+) in the myenteric nerve varicosities during neurotransmission using multiphoton microscopy. Our results in mice gastric muscle strips provide visual proof that NO is produced de novo in the nitrergic nerve varicosities upon nonadrenergic noncholinergic (NANC) nerve stimulation. These studies show that NO is a neurotransmitter rather than a mediator. Changes in NO production in response to various pharmacological treatments correlated well with changes in slow inhibitory junction potential of smooth muscles. Conclusions/Significance: Dual imaging and electrophysiologic studies provide visual proof that during nitrergic neurotransmission NO is produced in the nerve terminals. Such studies may help define whether NO production or its signaling pathway is responsible for impaired nitrergic neurotransmission in pathological states.	[Thatte, Hemant S.] VA Boston Hlth Care Syst, Cardiothorac Div, Dept Surg, Boston, MA USA; [Thatte, Hemant S.; He, Xue D.; Goyal, Raj K.] Harvard Univ, Sch Med, Boston, MA USA; [He, Xue D.; Goyal, Raj K.] VA Boston Hlth Care Syst, Ctr Swallow & Motil Disorders, Dept Med, Boston, MA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Thatte, HS (corresponding author), VA Boston Hlth Care Syst, Cardiothorac Div, Dept Surg, Boston, MA USA.	Raj_Goyal@hms.harvard.edu			NIDDK [DK 062867]; Office of Research and Development, Medical Research Service, Department of Veterans Affairs [VA Merit Review Award]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062867] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Office of Research and Development, Medical Research Service, Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported in parts by a research grant DK 062867 from the NIDDK and a VA Merit Review Award from the Office of Research and Development, Medical Research Service, Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BULT H, 1990, NATURE, V345, P346, DOI 10.1038/345346a0; Chaudhury A, 2008, AM J PHYSIOL-GASTR L, V295, pG442, DOI 10.1152/ajpgi.90280.2008; CRIST JR, 1992, J PHYSIOL-LONDON, V447, P119, DOI 10.1113/jphysiol.1992.sp018994; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Friebe A, 2007, P NATL ACAD SCI USA, V104, P7699, DOI 10.1073/pnas.0609778104; HE XD, 1993, J PHYSIOL-LONDON, V461, P485, DOI 10.1113/jphysiol.1993.sp019524; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; IGNARRO LJ, 1990, NATURE, V347, P131, DOI 10.1038/347131b0; Jourd'Heuil D, 2002, FREE RADICAL BIO MED, V33, P676, DOI 10.1016/S0891-5849(02)00955-3; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Mashimo H, 1996, J CLIN INVEST, V98, P8, DOI 10.1172/JCI118781; Murthy KS, 1998, AM J PHYSIOL-CELL PH, V275, pC1409, DOI 10.1152/ajpcell.1998.275.6.C1409; Pfeifer A, 1998, EMBO J, V17, P3045, DOI 10.1093/emboj/17.11.3045; Rao YM, 2008, AM J PHYSIOL-GASTR L, V294, pG627, DOI 10.1152/ajpgi.00519.2007; Sanders KM, 2007, J PHYSIOL-LONDON, V578, P33, DOI 10.1113/jphysiol.2006.122473; Suedof Thomas C., 2008, V184, P1; Sumiyoshi H, 2004, J CELL BIOL, V166, P591, DOI 10.1083/jcb.200402054; Suzuki N, 2002, J BIOL CHEM, V277, P47, DOI 10.1074/jbc.M108195200; Thatte HS, 2003, ANN THORAC SURG, V75, P1145, DOI 10.1016/S0003-4975(02)04705-7; Toda N, 2005, PHARMACOL REV, V57, P315, DOI 10.1124/pr.57.3.4; Toda N, 2003, PHARMACOL REV, V55, P271, DOI 10.1124/pr.55.2.3; Van Geldre LA, 2004, CURR PHARM DESIGN, V10, P2483; Vittal H, 2007, NAT CLIN PRACT GASTR, V4, P336, DOI 10.1038/ncpgasthep0838; Ye XY, 2004, ANALYST, V129, P1200, DOI 10.1039/b409394a	24	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e4990	10.1371/journal.pone.0004990	http://dx.doi.org/10.1371/journal.pone.0004990			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340298	Green Published, gold, Green Submitted			2022-12-25	WOS:000265500700005
J	Crill, WD; Hughes, HR; Delorey, MJ; Chang, GJJ				Crill, Wayne D.; Hughes, Holly R.; Delorey, Mark J.; Chang, Gwong-Jen J.			Humoral Immune Responses of Dengue Fever Patients Using Epitope-Specific Serotype-2 Virus-Like Particle Antigens	PLOS ONE			English	Article							WEST-NILE-VIRUS; ANTIBODY-DEPENDENT ENHANCEMENT; PROTEIN-DOMAIN-III; JAPANESE ENCEPHALITIS-VIRUS; LINKED-IMMUNOSORBENT-ASSAY; ENVELOPE-PROTEIN; NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES; FUSION LOOP; AMINO-ACID	Dengue virus (DENV) is a serious mosquito-borne pathogen causing significant global disease burden, either as classic dengue fever (DF) or in its most severe manifestation dengue hemorrhagic fever (DHF). Nearly half of the world's population is at risk of dengue disease and there are estimated to be millions of infections annually; a situation which will continue to worsen with increasing expansion of the mosquito vectors and epidemic DF/DHF. Currently there are no available licensed vaccines or antivirals for dengue, although significant effort has been directed toward the development of safe and efficacious dengue vaccines for over 30 years. Promising vaccine candidates are in development and testing phases, but a better understanding of immune responses to DENV infection and vaccination is needed. Humoral immune responses to DENV infection are complex and may exacerbate pathogenicity, yet are essential for immune protection. In this report, we develop DENV-2 envelope (E) protein epitope-specific antigens and measure immunoglobulin responses to three distinct epitopes in DENV-2 infected human serum samples. Immunoglobulin responses to DENV-2 infection exhibited significant levels of individual variation. Antibody populations targeting broadly cross-reactive epitopes centered on the fusion peptide in structural domain II were large, highly variable, and greater in primary than in secondary DENV-2 infected sera. E protein domain III cross-reactive immunoglobulin populations were similarly variable and much larger in IgM than in IgG. DENV-2 specific domain III IgG formed a very small proportion of the antibody response yet was significantly correlated with DENV-2 neutralization, suggesting that the highly protective IgG recognizing this epitope in murine studies plays a role in humans as well. This report begins to tease apart complex humoral immune responses to DENV infection and is thus important for improving our understanding of dengue disease and immunological correlates of protection, relevant to DENV vaccine development and testing.	[Crill, Wayne D.; Hughes, Holly R.; Delorey, Mark J.; Chang, Gwong-Jen J.] Ctr Dis Control & Prevent, Arbovirus Dis Branch, Div Vector Borne Infect Dis, Publ Hlth Serv,US Dept Hlth & Human Serv, Ft Collins, CO USA	Centers for Disease Control & Prevention - USA; United States Public Health Service	Crill, WD (corresponding author), Ctr Dis Control & Prevent, Arbovirus Dis Branch, Div Vector Borne Infect Dis, Publ Hlth Serv,US Dept Hlth & Human Serv, Ft Collins, CO USA.	wcrill@cdc.gov			CDC, DVBID	CDC, DVBID(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	CDC, DVBID is a federally funded national public health Lab (USCDC) and all funding for this work was supported by such federal funding. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The findings and conclusions in this manuscript are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.	Allison SL, 2001, J VIROL, V75, P4268, DOI 10.1128/JVI.75.9.4268-4275.2001; Barrera R, 2008, AM J TROP MED HYG, V78, P666, DOI 10.4269/ajtmh.2008.78.666; BLOK J, 1989, ARCH VIROL, V105, P39, DOI 10.1007/BF01311115; CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37; Casella G., 2021, STAT INFERENCE; Chang GJJ, 2000, J VIROL, V74, P4244, DOI 10.1128/JVI.74.9.4244-4252.2000; Chang GJJ, 2003, VIROLOGY, V306, P170, DOI 10.1016/S0042-6822(02)00028-4; Chang Gwong-Jen J, 2004, Expert Rev Vaccines, V3, P199, DOI 10.1586/14760584.3.2.199; Chiou SS, 2008, CLIN VACCINE IMMUNOL, V15, P825, DOI 10.1128/CVI.00004-08; Crill WD, 2007, J GEN VIROL, V88, P1169, DOI 10.1099/vir.0.82640-0; Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001; Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004; Farrar J, 2007, TROP MED INT HEALTH, V12, P695, DOI [10.1111/j.1365-3156.2007.01838, 10.1111/j.1365-3156.2007.01838.x]; Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104; Goncalvez AP, 2004, J VIROL, V78, P12919, DOI 10.1128/JVI.78.23.12919-12928.2004; Gonzalez D, 2005, INT J INFECT DIS, V9, P280, DOI 10.1016/j.ijid.2004.07.012; Gromowski GD, 2008, J VIROL, V82, P8828, DOI 10.1128/JVI.00606-08; Gromowski GD, 2007, VIROLOGY, V366, P349, DOI 10.1016/j.virol.2007.05.042; Gubler D.J., 2006, NOVART FDN SYMP, V277, P16, DOI DOI 10.1002/0470058005.CH2; Gubler Duane J, 2006, Novartis Found Symp, V277, P3, DOI 10.1002/0470058005.ch2; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Guzman MG, 2007, EMERG INFECT DIS, V13, P282, DOI 10.3201/eid1302.060539; HALSTEAD SB, 1989, REV INFECT DIS, V11, pS830; Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4; HENCHAL EA, 1985, AM J TROP MED HYG, V34, P162, DOI 10.4269/ajtmh.1985.34.162; Hiramatsu K, 1996, VIROLOGY, V224, P437, DOI 10.1006/viro.1996.0550; HOMBACH J, 2007, SCI CONSULTATION IMM; Johnson AJ, 2000, J CLIN MICROBIOL, V38, P1827, DOI 10.1128/JCM.38.5.1827-1831.2000; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Kuno G, 2001, AM J TROP MED HYG, V65, P671, DOI 10.4269/ajtmh.2001.65.671; Kuno Goro, 2003, Adv Virus Res, V61, P3, DOI 10.1016/S0065-3527(03)61001-8; Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08; Lai CJ, 2007, J VIROL, V81, P12766, DOI 10.1128/JVI.01420-07; Lehmann E. L., 1998, THEORY POINT ESTIMAT; LIN B, 1994, VIROLOGY, V202, P885, DOI 10.1006/viro.1994.1410; Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9; Lisova O, 2007, J GEN VIROL, V88, P2387, DOI 10.1099/vir.0.83028-0; Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382; Lok SM, 2001, J MED VIROL, V65, P315, DOI 10.1002/jmv.2036; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; Maillard RA, 2008, J BIOL CHEM, V283, P613, DOI 10.1074/jbc.M706031200; Martin DA, 2004, CLIN DIAGN LAB IMMUN, V11, P1130, DOI 10.1128/CDLI.11.6.1130-1133.2004; Martin DA, 2002, CLIN DIAGN LAB IMMUN, V9, P544, DOI 10.1128/CDLI.9.3.544-549.2002; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005; Monath TP, 2007, NEW ENGL J MED, V357, P2222, DOI 10.1056/NEJMp0707161; NITAYAPHAN S, 1990, VIROLOGY, V177, P541, DOI 10.1016/0042-6822(90)90519-W; Normile D, 2007, SCIENCE, V317, P1494, DOI 10.1126/science.317.5844.1494; Oliphant T, 2007, J VIROL, V81, P11828, DOI 10.1128/JVI.00643-07; Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06; Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Rigau-Perez JG, 2006, LANCET INFECT DIS, V6, P297, DOI 10.1016/S1473-3099(06)70465-0; Roberson JA, 2007, J CLIN MICROBIOL, V45, P3167, DOI 10.1128/JCM.01143-07; Roehrig JT, 1998, VIROLOGY, V246, P317, DOI 10.1006/viro.1998.9200; SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30; Senior K, 2007, LANCET INFECT DIS, V7, P636, DOI 10.1016/S1473-3099(07)70221-9; Shu PY, 2003, CLIN DIAGN LAB IMMUN, V10, P622, DOI 10.1128/CDLI.10.4.622-630.2003; Solomon T, 2001, J INFECTION, V42, P104, DOI 10.1053/jinf.2001.0802; Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06; Sukupolvi-Petty S, 2007, J VIROL, V81, P12816, DOI 10.1128/JVI.00432-07; Takada A, 2003, REV MED VIROL, V13, P387, DOI 10.1002/rmv.405; Tesh RB, 2002, EMERG INFECT DIS, V8, P245, DOI 10.3201/eid0803.010238; Throsby M, 2006, J VIROL, V80, P6982, DOI 10.1128/JVI.00551-06; Trainor NB, 2007, VIROLOGY, V360, P398, DOI 10.1016/j.virol.2006.10.033; TRIRAWATANAPONG T, 1992, GENE, V116, P139, DOI 10.1016/0378-1119(92)90509-N; Wallace MJ, 2003, J GEN VIROL, V84, P1723, DOI 10.1099/vir.0.18980-0; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; 2007, MMWR MORB MORTAL WKL, V57, P577	70	123	132	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e4991	10.1371/journal.pone.0004991	http://dx.doi.org/10.1371/journal.pone.0004991			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337372	Green Published, gold, Green Submitted			2022-12-25	WOS:000265500600005
J	Fels, D				Fels, Daniel			Cellular Communication through Light	PLOS ONE			English	Article							BIOPHOTON EMISSION; LUMINESCENCE; GROWTH	Information transfer is a fundamental of life. A few studies have reported that cells use photons (from an endogenous source) as information carriers. This study finds that cells can have an influence on other cells even when separated with a glass barrier, thereby disabling molecule diffusion through the cell-containing medium. As there is still very little known about the potential of photons for intercellular communication this study is designed to test for non-molecule-based triggering of two fundamental properties of life: cell division and energy uptake. The study was performed with a cellular organism, the ciliate Paramecium caudatum. Mutual exposure of cell populations occurred under conditions of darkness and separation with cuvettes (vials) allowing photon but not molecule transfer. The cell populations were separated either with glass allowing photon transmission from 340 nm to longer waves, or quartz being transmittable from 150 nm, i.e. from UV-light to longer waves. Even through glass, the cells affected cell division and energy uptake in neighboring cell populations. Depending on the cuvette material and the number of cells involved, these effects were positive or negative. Also, while paired populations with lower growth rates grew uncorrelated, growth of the better growing populations was correlated. As there were significant differences when separating the populations with glass or quartz, it is suggested that the cell populations use two (or more) frequencies for cellular information transfer, which influences at least energy uptake, cell division rate and growth correlation. Altogether the study strongly supports a cellular communication system, which is different from a molecule-receptor-based system and hints that photon-triggering is a fine tuning principle in cell chemistry.	[Fels, Daniel] Swiss Trop Inst, CH-4002 Basel, Switzerland; [Fels, Daniel] Univ Paris 06, Med Ctr, Lab Parasitol Evolut, UMR 7103, Paris, France	University of Basel; Swiss Tropical & Public Health Institute; UDICE-French Research Universities; Sorbonne Universite	Fels, D (corresponding author), Swiss Trop Inst, CH-4002 Basel, Switzerland.	daniel.fels@unibas.ch						ALBRECHTBUEHLER G, 1992, P NATURAL ACAD SCI, V89, P8299; Beloussov LV, 2007, BIOPHOTONICS AND COHERENT SYSTEMS IN BIOLOGY, P139; Chwirot W B, 1992, RECENT ADV BIOPHOTON, P259; Cohen S, 1997, Skin Res Technol, V3, P177, DOI 10.1111/j.1600-0846.1997.tb00184.x; COLLI L, 1955, EXPERIENTIA, V11, P479, DOI 10.1007/BF02166829; Fels D, 2006, P ROY SOC B-BIOL SCI, V273, P1031, DOI 10.1098/rspb.2005.3404; FENCHEL T, 1980, MICROBIAL ECOL, V6, P1, DOI 10.1007/BF02020370; GALANTSEV VP, 1993, EXPERIENTIA, V49, P870, DOI 10.1007/BF01952600; GALLE M, 1991, EXPERIENTIA, V47, P457, DOI 10.1007/BF01959943; GURWITSCH A, 1926, PROBLEM ZELLTEILUNG, P1; GURWITSCH A, 1923, ARCH ENTWICKLUNGSMEC, V52, P11; Ho M.W., 1992, RECENT ADV BIOPHOTON, P287; Ho M.-W., 1994, BIOELECTRODYNAMICS B; Ho M-W., 1999, RAINBOW WORM PHYS OR; Jaffe LF, 2005, LUMINESCENCE, V20, P414, DOI 10.1002/bio.866; Lambing K., 1992, RECENT ADV BIOPHOTON, P393; Levin M, 2003, BIOELECTROMAGNETICS, V24, P295, DOI 10.1002/bem.10104; Mei W. P., 1992, RECENT ADV BIOPHOTON, P243; MEI WP, 1994, BIOELECTRODYNAMICS B, P269; Musumeci F, 1999, EUROPHYS LETT, V47, P736, DOI 10.1209/epl/i1999-00452-6; NIGGLI HJ, 1992, J PHOTOCH PHOTOBIO B, V14, P144, DOI 10.1016/1011-1344(92)85090-H; POPOV G A, 1963, Biofizika, V8, P317; Popp FA, 2000, SCI CHINA SER C, V43, P507; POPP FA, 1988, EXPERIENTIA, V44, P543, DOI 10.1007/BF01953300; POPP FA, 2006, H FROHLICH FRS PHYS, P139; POPP FA, 1989, ELECTROMAGNETIC BIOI; Popp FA, 2007, BIOPHOTONICS AND COHERENT SYSTEMS IN BIOLOGY, P17; QUICKENDEN TI, 1976, PHOTOCHEM PHOTOBIOL, V23, P201, DOI 10.1111/j.1751-1097.1976.tb07242.x; SAS, 2003, JMP STAT GRAPH GUID; SHEN X, 1994, EXPERIENTIA, V50, P963, DOI 10.1007/BF01923488; STREHLER BL, 1951, J GEN PHYSIOL, V34, P809, DOI 10.1085/jgp.34.6.809; Takeda M, 2004, CANCER SCI, V95, P656, DOI 10.1111/j.1349-7006.2004.tb03325.x; Van Wijk R, 2007, BIOPHOTONICS AND COHERENT SYSTEMS IN BIOLOGY, P177; VANWIJK R, 1988, EXPERIENTIA, V44, P586	34	71	75	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5086	10.1371/journal.pone.0005086	http://dx.doi.org/10.1371/journal.pone.0005086			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19340303	Green Published, gold, Green Submitted			2022-12-25	WOS:000265500600022
J	Lu, J; Zhong, LW; Lonn, ME; Burk, RF; Hill, KE; Holmgren, A				Lu, Jun; Zhong, Liangwei; Lonn, Maria Elisabet; Burk, Raymond F.; Hill, Kristina E.; Holmgren, Arne			Penultimate selenocysteine residue replaced by cysteine in thioredoxin reductase from selenium-deficient rat liver	FASEB JOURNAL			English	Article						selenoprotein; UGA codon; glutaredoxin	MAMMALIAN THIOREDOXIN; ESCHERICHIA-COLI; CANCER-THERAPY; ACTIVE-SITE; AMINO-ACID; KAPPA-B; GLUTAREDOXIN; GENE; RNA; UGA	Selenium is an essential micronutrient for humans and animals, and its deficiency can predispose to the development of pathological conditions. This study evaluates the effect of selenium deficiency on the thioredoxin system, consisting of NADPH, selenoprotein thioredoxin reductase (TrxR), and thioredoxin (Trx); and the glutathione system, including NADPH, glutathione reductase, glutathione, and glutaredoxin coupled with selenoprotein glutathione peroxidase (GPx). We particularly investigate whether inactive truncated TrxR is present under selenium-starvation conditions due to reading of the UGA codon as stop. Feeding rats a selenium-deficient diet resulted in a large decrease in activity of TrxR and GPx in rat liver but not in the levels of Trx1 and Grx1. However, selenium deficiency induced mitochondrial Grx2 10-fold and markedly changed the expression of some flavoproteins that are involved in the cellular folate, glucose, and lipid metabolism. Liver TrxR mRNA was nearly unchanged, but no truncated enzyme was found. Instead, a low-activity form of TrxR with a cysteine substituted for the penultimate selenocysteine in the C-terminal active site was identified in selenium-deficient rat liver. These results show a novel mechanism for decoding the UGA stop codon, inserting cysteine to make a full-length enzyme that may be required for selenium assimilation.-Lu, J., Zhong, L., Lonn, M. E., Burk, R. F., Hill, K. E., Holmgren, A. Penultimate selenocysteine residue replaced by cysteine in thioredoxin reductase from selenium-deficient rat liver. FASEB J. 23, 2394-2402 (2009)	[Lu, Jun; Zhong, Liangwei; Lonn, Maria Elisabet; Holmgren, Arne] Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, SE-17177 Stockholm, Sweden; [Burk, Raymond F.; Hill, Kristina E.] Vanderbilt Univ, Sch Med, Div Gastroenterol, Dept Med, Nashville, TN 37212 USA; [Burk, Raymond F.; Hill, Kristina E.] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37212 USA	Karolinska Institutet; Vanderbilt University; Vanderbilt University	Lu, J (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, SE-17177 Stockholm, Sweden.	jun.lu@ki.se; arne.holmgren@ki.se	Lu, Jun/E-9701-2017	Lu, Jun/0000-0002-1699-8835	Swedish Cancer Society [961]; Swedish Research Council [3529]; U.S. National Institutes of Health [ES02497]; Swedish Hagelen Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES002497, R37ES002497] Funding Source: NIH RePORTER	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Hagelen Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Dr. Elias Arner and Mr. Qing Cheng (Department of Medical Biochemistry and Biophysics, Karolinska Institute) for kindly providing PAO Sepharose beads; R. Eliasson for the preparation of anti-rat TrxR antibodies; and Amy K. Motley and Marjan Hessam Amiri for technical assistance. This work was supported by the Swedish Cancer Society (grant 961), the Swedish Research Council (grant 3529), the U.S. National Institutes of Health (grant ES02497), and the K.A. Wallenberg foundation. L.Z. was supported in part by a fellowship from the Swedish Hagelen Foundation.	Anestal K, 2003, J BIOL CHEM, V278, P15966, DOI 10.1074/jbc.M210733200; Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Arner ESJ, 1999, J MOL BIOL, V292, P1003, DOI 10.1006/jmbi.1999.3085; Arner ESJ, 1999, METHOD ENZYMOL, V300, P226; BARON C, 1990, NUCLEIC ACIDS RES, V18, P6761, DOI 10.1093/nar/18.23.6761; Berggren MM, 1999, BIOCHEM PHARMACOL, V57, P187, DOI 10.1016/S0006-2952(98)00283-4; Bergman T, 2001, ANAL BIOCHEM, V290, P74, DOI 10.1006/abio.2000.4922; Brigelius-Flohe R, 1999, FREE RADICAL BIO MED, V27, P951, DOI 10.1016/S0891-5849(99)00173-2; Burk RF, 2008, FREE RADICAL BIO MED, V44, P1617, DOI 10.1016/j.freeradbiomed.2008.01.016; BURK RF, 1987, METHOD ENZYMOL, V143, P307; Castellano S, 2005, P NATL ACAD SCI USA, V102, P16188, DOI 10.1073/pnas.0505146102; Cheng Q, 2006, NAT PROTOC, V1, P604, DOI 10.1038/nprot.2006.87; Chew EH, 2008, FASEB J, V22, P2072, DOI 10.1096/fj.07-101477; Chittum HS, 1998, BIOCHEMISTRY-US, V37, P10866, DOI 10.1021/bi981042r; Conrad M, 2004, MOL CELL BIOL, V24, P9414, DOI 10.1128/MCB.24.21.9414-9423.2004; FENG YX, 1990, P NATL ACAD SCI USA, V87, P8860, DOI 10.1073/pnas.87.22.8860; Gladyshev VN, 1996, P NATL ACAD SCI USA, V93, P6146, DOI 10.1073/pnas.93.12.6146; HILL KE, 1992, BIOCHEM BIOPH RES CO, V185, P260, DOI 10.1016/S0006-291X(05)80984-2; Hill KE, 1997, BIOCHEM BIOPH RES CO, V234, P293, DOI 10.1006/bbrc.1997.6618; HILL KE, 1991, J BIOL CHEM, V266, P10050; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1979, J BIOL CHEM, V254, P3672; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P283; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Jakupoglu C, 2005, MOL CELL BIOL, V25, P1980, DOI 10.1128/MCB.25.5.1980-1988.2005; Johansson L, 2004, NAT METHODS, V1, P61, DOI 10.1038/NMETH707; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lacey BM, 2006, BIOCHEM BIOPH RES CO, V346, P629, DOI 10.1016/j.bbrc.2006.05.095; LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6; Lee SR, 2000, P NATL ACAD SCI USA, V97, P2521, DOI 10.1073/pnas.050579797; Lillig CH, 2004, P NATL ACAD SCI USA, V101, P13227, DOI 10.1073/pnas.0401896101; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Lu J, 2006, CANCER RES, V66, P4410, DOI 10.1158/0008-5472.CAN-05-3310; Lu J, 2009, J BIOL CHEM, V284, P723, DOI 10.1074/jbc.R800045200; Lu J, 2007, P NATL ACAD SCI USA, V104, P12288, DOI 10.1073/pnas.0701549104; Lundberg M, 2004, BIOCHEM BIOPH RES CO, V319, P801, DOI 10.1016/j.bbrc.2004.04.199; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; MEYER F, 1991, P NATL ACAD SCI USA, V88, P3758, DOI 10.1073/pnas.88.9.3758; Mostert V, 2003, FEBS LETT, V541, P85, DOI 10.1016/S0014-5793(03)00309-0; Mustacich D, 2000, BIOCHEM J, V346, P1, DOI 10.1042/0264-6021:3460001; Novoselov SV, 2005, ONCOGENE, V24, P8003, DOI 10.1038/sj.onc.1208940; PADILLA CA, 1995, EUR J BIOCHEM, V227, P27, DOI 10.1111/j.1432-1033.1995.tb20356.x; Prabhu KS, 2002, BIOCHEM J, V366, P203, DOI 10.1042/BJ20020256; Primiano T, 1998, CARCINOGENESIS, V19, P999, DOI 10.1093/carcin/19.6.999; REITER R, 1983, BIOCHEM PHARMACOL, V32, P3063, DOI 10.1016/0006-2952(83)90250-2; REN XL, 1993, BIOCHEMISTRY-US, V32, P9701, DOI 10.1021/bi00088a023; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; ROZELL B, 1985, EUR J CELL BIOL, V38, P79; Sandalova T, 2001, P NATL ACAD SCI USA, V98, P9533, DOI 10.1073/pnas.171178698; Savonet V, 1997, ANAL BIOCHEM, V247, P165, DOI 10.1006/abio.1997.2055; Shalini S, 2007, BIOMETALS, V20, P49, DOI 10.1007/s10534-006-9014-2; Suh JR, 2001, ANNU REV NUTR, V21, P255, DOI 10.1146/annurev.nutr.21.1.255; Suzuki T, 2008, J BIOL CHEM, V283, P2021, DOI 10.1074/jbc.M708352200; Takahata M, 2008, J BIOCHEM, V143, P467, DOI 10.1093/jb/mvm247; URBAN C, 1995, NUCLEIC ACIDS RES, V23, P4591, DOI 10.1093/nar/23.22.4591; Urig S, 2006, SEMIN CANCER BIOL, V16, P452, DOI 10.1016/j.semcancer.2006.09.004; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; YANG JG, 1989, J NUTR, V119, P1010, DOI 10.1093/jn/119.7.1010; Zhon LW, 1998, J BIOL CHEM, V273, P8581, DOI 10.1074/jbc.273.15.8581; Zhong LW, 2000, P NATL ACAD SCI USA, V97, P5854, DOI 10.1073/pnas.100114897; Zhong LW, 2000, J BIOL CHEM, V275, P18121, DOI 10.1074/jbc.M000690200	63	50	50	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	AUG	2009	23	8					2394	2402		10.1096/fj.08-127662	http://dx.doi.org/10.1096/fj.08-127662			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19351701	Green Published			2022-12-25	WOS:000268836700008
J	Middeldorp, J; Kamphuis, W; Sluijs, JA; Achoui, D; Leenaars, CHC; Feenstra, MGP; van Tijn, P; Fischer, DF; Berkers, C; Ovaa, H; Quinlan, RA; Hol, EM				Middeldorp, Jinte; Kamphuis, Willem; Sluijs, Jacqueline A.; Achoui, Dalila; Leenaars, Cathalijn H. C.; Feenstra, Matthijs G. P.; van Tijn, Paula; Fischer, David F.; Berkers, Celia; Ovaa, Huib; Quinlan, Roy A.; Hol, Elly M.			Intermediate filament transcription in astrocytes is repressed by proteasome inhibition	FASEB JOURNAL			English	Article						glial fibrillary acidic protein; astrogliosis; protein degradation; neurodegenerative diseases	FIBRILLARY ACIDIC PROTEIN; AGE-RELATED-CHANGES; REACTIVE ASTROCYTES; MESSENGER-RNA; NEURODEGENERATIVE DISORDERS; DEPENDENT PROTEOLYSIS; ALZHEIMERS-DISEASE; GENE-EXPRESSION; MICE DEFICIENT; UBIQUITIN	Increased expression of the astrocytic intermediate filament protein glial fibrillary acidic protein (GFAP) is a characteristic of astrogliosis. This process occurs in the brain during aging and neurodegeneration and coincides with impairment of the ubiquitin proteasome system. Inhibition of the proteasome impairs protein degradation; therefore, we hypothesized that the increase in GFAP may be the result of impaired proteasomal activity in astrocytes. We investigated the effect of proteasome inhibitors on GFAP expression and other intermediate filament proteins in human astrocytoma cells and in a rat brain model for astrogliosis. Extensive quantitative RT-PCR, immunocytochemistry, and Western blot analysis resulted unexpectedly in a strong decrease of GFAP mRNA to <4% of control levels [Control (DMSO) 100 +/- 19.2%; proteasome inhibitor (epoxomicin) 3.5 +/- 1.3%, n = 8; P<0.001] and a loss of GFAP protein in astrocytes in vitro. We show that the proteasome alters GFAP promoter activity, possibly mediated by transcription factors as demonstrated by a GFAP promoter-luciferase assay and RT2 Profiler PCR array for human transcription factors. Most important, we demonstrate that proteasome inhibitors also reduce GFAP and vimentin expression in a rat model for induced astrogliosis in vivo. Therefore, proteasome inhibitors could serve as a potential therapy to modulate astrogliosis associated with CNS injuries and disease.-Middeldorp, J., Kamphuis, W., Sluijs, J. A., Achoui, D., Leenaars, C. H. C., Feenstra, M. G. P., van Tijn, P., Fischer, D. F., Berkers, C., Ovaa, H., Quinlan, R. A., Hol, E. M. Intermediate filament transcription in astrocytes is repressed by proteasome inhibition. FASEB J. 23, 2710-2726 (2009)	[Middeldorp, Jinte; Kamphuis, Willem; Sluijs, Jacqueline A.; Achoui, Dalila; Leenaars, Cathalijn H. C.; Feenstra, Matthijs G. P.; van Tijn, Paula; Hol, Elly M.] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Dept Astrocyte Biol & Neurodegenerat, NL-1105 BA Amsterdam, Netherlands; [Fischer, David F.] BioFocus DPI, Leiden, Netherlands; [Berkers, Celia; Ovaa, Huib] Netherlands Canc Inst, Div Cellular Biochem, Tumor Biol & Immunol, NL-1066 CX Amsterdam, Netherlands; [Quinlan, Roy A.] Univ Durham, Sch Biol & Biomed Sci, Durham, England	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Netherlands Cancer Institute; Durham University	Hol, EM (corresponding author), Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Dept Astrocyte Biol & Neurodegenerat, Meibergdreef 47, NL-1105 BA Amsterdam, Netherlands.	e.hol@nin.knaw.nl	Middeldorp, Jinte/M-2352-2016; Quinlan, Roy/A-1348-2012; , Jinte/AHA-6575-2022; Hol, Elly/J-2025-2019; van Tijn, Paula/E-4866-2012; Berkers, Celia/I-3848-2016; Leenaars, Cathalijn/P-7211-2015; Hol, Elly M/F-1891-2013; ovaa, huib/M-2334-2016	Middeldorp, Jinte/0000-0002-9198-8020; Quinlan, Roy/0000-0003-0644-4123; , Jinte/0000-0002-9198-8020; Hol, Elly/0000-0001-5604-2603; Leenaars, Cathalijn/0000-0002-8212-7632; Hol, Elly M/0000-0001-5604-2603; ovaa, huib/0000-0002-0068-054X; Berkers, Celia/0000-0003-0746-8565; Fischer, David/0000-0002-6690-0197	Hersenstichting Nederland [13F05.08]; Internationale Stichting Alzheimer Onderzoek [04511]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS042803] Funding Source: NIH RePORTER	Hersenstichting Nederland; Internationale Stichting Alzheimer Onderzoek; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the Hersenstichting Nederland (13F05.08 to E. M. H.) and the Internationale Stichting Alzheimer Onderzoek (04511 to E. M. H.). We thank J. Rutka ( University of Toronto, Toronto, ON, Canada) for the U343 glioblastoma cells; B. de Leeuw (Erasmus University Medical Center, Rotterdam, The Netherlands) for kindly providing us with U251 and SNB19 glioblastoma cells; O. Meijer ( Leiden University Medical Center, Leiden, The Netherlands) for the Renilla construct; and M. Brenner ( University of Alabama at Birmingham, Birmingham, AL, USA) for the pGfa2-luciferase construct. We thank Lourens Nonkes, Laura Koster, and Rick Wassing for their technical assistance during cell culture, flow cytometric analysis, and animal surgery, respectively.	Auld KL, 2006, MOL CELL, V21, P861, DOI 10.1016/j.molcel.2006.02.020; Bae MH, 2002, BBA-MOL CELL RES, V1592, P163, DOI 10.1016/S0167-4889(02)00310-5; Beck H, 2008, AM J PATHOL, V173, P77, DOI 10.2353/ajpath.2008.070648; BENVENISTE H, 1987, ACTA NEUROPATHOL, V74, P234, DOI 10.1007/BF00688186; Berkers CR, 2007, MOL PHARM, V4, P739, DOI 10.1021/mp0700256; BESNARD F, 1991, J BIOL CHEM, V266, P18877; Bhat KP, 2008, MOL IMMUNOL, V45, P2214, DOI 10.1016/j.molimm.2007.12.001; Blechingberg J, 2007, GLIA, V55, P497, DOI 10.1002/glia.20475; BORRETT D, 1985, BRAIN, V108, P367, DOI 10.1093/brain/108.2.367; Bush KT, 1997, J BIOL CHEM, V272, P9086; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; CHIU FC, 1984, J NEUROCHEM, V42, P166, DOI 10.1111/j.1471-4159.1984.tb09713.x; Choi KS, 2007, FEBS LETT, V581, P4691, DOI 10.1016/j.febslet.2007.08.065; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Cotrina ML, 2002, J NEUROSCI RES, V67, P1; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; de Vrij FMS, 2004, PROG NEUROBIOL, V74, P249, DOI 10.1016/j.pneurobio.2004.10.001; Dembla-Rajpal N, 2004, BBA-GENE STRUCT EXPR, V1680, P34, DOI 10.1016/j.bbaexp.2004.08.008; Deroo BJ, 2002, J BIOL CHEM, V277, P20120, DOI 10.1074/jbc.C200173200; Desjardins S, 1997, NEUROBIOL AGING, V18, P37, DOI 10.1016/S0197-4580(96)00206-0; Dijk F, 2004, INVEST OPHTH VIS SCI, V45, P330, DOI 10.1167/iovs.03-0285; Ding QX, 2006, FASEB J, V20, P1055, DOI 10.1096/fj.05-5495com; Ding QX, 2005, J NEUROSCI, V25, P9171, DOI 10.1523/JNEUROSCI.3040-05.2005; Ding QX, 2001, J NEUROCHEM, V77, P1010, DOI 10.1046/j.1471-4159.2001.00302.x; DUCKETT S, 1992, PEDIATR NEUROSURG, V18, P134, DOI 10.1159/000120652; Ezhkova E, 2004, MOL CELL, V13, P435, DOI 10.1016/S1097-2765(04)00026-7; Fernandez S, 2008, BBA-MOL CELL RES, V1783, P803, DOI 10.1016/j.bbamcr.2007.10.020; Fleming JA, 2002, P NATL ACAD SCI USA, V99, P1461, DOI 10.1073/pnas.032516399; Gadea A, 2008, J NEUROSCI, V28, P2394, DOI 10.1523/JNEUROSCI.5652-07.2008; Geier E, 1999, SCIENCE, V283, P978, DOI 10.1126/science.283.5404.978; Glenn RJ, 2004, INT J ANTIMICROB AG, V24, P286, DOI 10.1016/j.ijantimicag.2004.02.023; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; GOSS JR, 1991, NEUROBIOL AGING, V12, P165, DOI 10.1016/0197-4580(91)90056-P; Hattori T, 2003, ONCOGENE, V22, P1273, DOI 10.1038/sj.onc.1206204; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hol EM, 2003, MOL PSYCHIATR, V8, P786, DOI 10.1038/sj.mp.4001379; Ingelsson M, 2004, NEUROLOGY, V62, P925, DOI 10.1212/01.WNL.0000115115.98960.37; James AB, 2006, J NEUROSCI, V26, P1624, DOI 10.1523/JNEUROSCI.4199-05.2006; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; Josefsberg LBY, 2000, BIOL REPROD, V62, P1270, DOI 10.1095/biolreprod62.5.1270; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kashon ML, 2004, J ALZHEIMERS DIS, V6, P595; Kawazoe Y, 1998, EUR J BIOCHEM, V255, P356, DOI 10.1046/j.1432-1327.1998.2550356.x; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; Kinouchi R, 2003, NAT NEUROSCI, V6, P863, DOI 10.1038/nn1088; Koues OI, 2008, MOL CELL BIOL, V28, P5837, DOI 10.1128/MCB.00535-08; Kubicek GJ, 2009, INT J RADIAT ONCOL, V74, P433, DOI 10.1016/j.ijrobp.2008.08.050; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Larsson A, 2004, NEUROCHEM RES, V29, P2069, DOI 10.1007/s11064-004-6880-2; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Layfield R, 2005, ESSAYS BIOCHEM, V41, P157, DOI 10.1042/EB0410157; Lee DY, 2005, CELL, V123, P423, DOI 10.1016/j.cell.2005.08.015; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Li R, 2005, ANN NEUROL, V57, P310, DOI 10.1002/ana.20406; Lim JH, 2004, BIOCHEM BIOPH RES CO, V318, P868, DOI 10.1016/j.bbrc.2004.04.103; Lindsten K, 2002, J CELL BIOL, V157, P417, DOI 10.1083/jcb.200111034; Lipford JR, 2003, NAT CELL BIOL, V5, P845, DOI 10.1038/ncb1003-845; LOWE J, 1988, J PATHOL, V155, P9, DOI 10.1002/path.1711550105; MACK KJ, 1994, MOL BRAIN RES, V23, P73, DOI 10.1016/0169-328X(94)90213-5; Mayer RJ, 1996, ADV EXP MED BIOL, V389, P261; McNaught KSP, 2004, ANN NEUROL, V56, P149, DOI 10.1002/ana.20186; Menet V, 2003, P NATL ACAD SCI USA, V100, P8999, DOI 10.1073/pnas.1533187100; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Miyajima M, 1996, J NEUROSCI RES, V46, P108, DOI 10.1002/(SICI)1097-4547(19961001)46:1<108::AID-JNR13>3.0.CO;2-1; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; NICHOLS NR, 1993, NEUROBIOL AGING, V14, P421, DOI 10.1016/0197-4580(93)90100-P; Nielsen AL, 2002, J BIOL CHEM, V277, P29983, DOI 10.1074/jbc.M112121200; Olanow CW, 2006, MOVEMENT DISORD, V21, P1806, DOI 10.1002/mds.21013; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Perng MD, 2008, MOL BIOL CELL, V19, P4521, DOI 10.1091/mbc.E08-03-0284; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Pihlaja R, 2008, GLIA, V56, P154, DOI 10.1002/glia.20599; Porchet R, 2003, PROTEOMICS, V3, P1476, DOI 10.1002/pmic.200300456; Prahlad V, 1998, J CELL BIOL, V143, P159, DOI 10.1083/jcb.143.1.159; Quinlan RA, 2007, EXP CELL RES, V313, P2077, DOI 10.1016/j.yexcr.2007.04.004; Rattan SIS, 1996, EXP GERONTOL, V31, P33, DOI 10.1016/0531-5565(95)02022-5; Riol H, 1997, J NEUROSCI RES, V48, P53; Roelofs RF, 2005, GLIA, V52, P289, DOI 10.1002/glia.20243; Rutka JT, 1999, INT J DEV NEUROSCI, V17, P503, DOI 10.1016/S0736-5748(99)00049-0; Sabbatini A, 1999, MECH AGEING DEV, V108, P165, DOI 10.1016/S0047-6374(99)00008-1; Sakurai K, 2008, J NEUROSCI, V28, P4604, DOI 10.1523/JNEUROSCI.5074-07.2008; Salon ML, 2000, J NEUROSCI RES, V62, P302, DOI 10.1002/1097-4547(20001015)62:2<302::AID-JNR15>3.0.CO;2-L; San Miguel JF, 2008, NEW ENGL J MED, V359, P906, DOI 10.1056/NEJMoa0801479; SHUAIB A, 1990, NEUROSCI LETT, V112, P149, DOI 10.1016/0304-3940(90)90194-E; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Sprangers R, 2008, BIOCHEMISTRY-US, V47, P6727, DOI 10.1021/bi8005913; Tang GM, 2006, J BIOL CHEM, V281, P38634, DOI 10.1074/jbc.M604942200; Thal DR, 2000, ACTA NEUROPATHOL, V100, P608, DOI 10.1007/s004010000242; van der Meulen JAJ, 2007, CEREB CORTEX, V17, P1444, DOI 10.1093/cercor/bhl057; van Tijn P, 2007, J CELL SCI, V120, P1615, DOI 10.1242/jcs.03438; Vesce S, 2007, INT REV NEUROBIOL, V82, P57, DOI 10.1016/S0074-7742(07)82003-4; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Yoshida T, 1996, NEUROSCI LETT, V215, P107, DOI 10.1016/0304-3940(96)12966-9; Zhu Q, 2007, ONCOGENE, V26, P4199, DOI 10.1038/sj.onc.1210191; Zimmermann J, 2000, ONCOGENE, V19, P2913, DOI 10.1038/sj.onc.1203606	98	32	32	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2710	2726		10.1096/fj.08-127696	http://dx.doi.org/10.1096/fj.08-127696			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19332645	Green Published			2022-12-25	WOS:000268836700039
J	Wang, JT; Sengupta, P; Guo, YJ; Golebiewska, U; Scarlata, S				Wang, Jingting; Sengupta, Parijat; Guo, Yuanjian; Golebiewska, Urszula; Scarlata, Suzanne			Evidence for a Second, High Affinity G beta gamma Binding Site on G alpha(i1)(GDP) Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; PHOSPHOLIPASE-C-BETA; GUANINE-NUCLEOTIDE-BINDING; LIVING CELLS; ADENYLYL-CYCLASE; TRANSMEMBRANE SIGNALS; COUPLED-RECEPTOR; ACTIVATION; MEMBRANE; STIMULATION	It is well known that G alpha(i1)(GDP) binds strongly to G beta gamma subunits to form the G alpha(i1)(GDP)-G beta gamma heterotrimer, and that activation to G alpha(i1)(GTP) results in conformational changes that reduces its affinity for G beta gamma subunits. Previous studies of G protein subunit interactions have used stoichiometric amounts of the proteins. Here, we have found that G alpha(i1)(GDP) can bind a second G beta gamma subunit with an affinity only 10-fold weaker than the primary site and close to the affinity between activated G alpha(i1) and G beta gamma subunits. Also, we find that phospholipase C beta 2, an effector of G beta gamma, does not compete with the second binding site implying that effectors can be bound to the G alpha(i1)(GDP)-(G beta gamma)2 complex. Biophysical measurements and molecular docking studies suggest that this second site is distant from the primary one. A synthetic peptide having a sequence identical to the putative second binding site on G alpha(i1) competes with binding of the second G beta gamma subunit. Injection of this peptide into cultured cells expressing eYFP-G alpha(i1)(GDP) and eCFP-G beta gamma reduces the overall association of the subunits suggesting this site is operative in cells. We propose that this second binding site serves to promote and stabilize G protein subunit interactions in the presence of competing cellular proteins.	[Wang, Jingting; Sengupta, Parijat; Guo, Yuanjian; Golebiewska, Urszula; Scarlata, Suzanne] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Scarlata, S (corresponding author), SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA.	Suzanne.Scarlata@sunysb.edu			National Institutes of Health [GM53132]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053132] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM53132.	ALBERTS B, 1994, MOL BIOL CELL, P734; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Birnbaumer L, 2007, BBA-BIOMEMBRANES, V1768, P772, DOI 10.1016/j.bbamem.2006.12.002; Buck E, 2002, J BIOL CHEM, V277, P49707, DOI 10.1074/jbc.M205553200; Buck E, 1999, SCIENCE, V283, P1332, DOI 10.1126/science.283.5406.1332; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Chen Y, 1999, BIOPHYS J, V77, P553, DOI 10.1016/S0006-3495(99)76912-2; Chidiac P, 1999, BIOCHEM PHARMACOL, V58, P39, DOI 10.1016/S0006-2952(99)00080-5; Diel S, 2006, J BIOL CHEM, V281, P288, DOI 10.1074/jbc.M511045200; Digby GJ, 2006, P NATL ACAD SCI USA, V103, P17789, DOI 10.1073/pnas.0607116103; Dowal L, 2006, J BIOL CHEM, V281, P23999, DOI 10.1074/jbc.M512330200; Drin G, 2007, CELL SIGNAL, V19, P1383, DOI 10.1016/j.cellsig.2007.04.006; Drin G, 2006, BIOCHEMISTRY-US, V45, P5712, DOI 10.1021/bi052317n; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; EXTON JH, 1994, ANNU REV PHYSIOL, V56, P349; Exton JH, 1997, EUR J BIOCHEM, V243, P10, DOI 10.1111/j.1432-1033.1997.t01-1-00010.x; Golebiewska U, 2008, BIOPHYS J, V95, P2575, DOI 10.1529/biophysj.108.129353; Hildebrandt JD, 1997, BIOCHEM PHARMACOL, V54, P325, DOI 10.1016/S0006-2952(97)00269-4; Hughes TE, 2001, J BIOL CHEM, V276, P4227, DOI 10.1074/jbc.M007608200; Hynes TR, 2004, J BIOL CHEM, V279, P44101, DOI 10.1074/jbc.M405151200; Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835; Li Y, 1998, J BIOL CHEM, V273, P16265, DOI 10.1074/jbc.273.26.16265; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Medkova M, 2002, BIOCHEMISTRY-US, V41, P9962, DOI 10.1021/bi0255726; Murray D, 2001, J BIOL CHEM, V276, P45153, DOI 10.1074/jbc.M101784200; NEER EJ, 1994, PROTEIN SCI, V3, P3; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Nobles M, 2005, P NATL ACAD SCI USA, V102, P18706, DOI 10.1073/pnas.0504778102; Panchenko MP, 1998, J BIOL CHEM, V273, P28298, DOI 10.1074/jbc.273.43.28298; Philip F, 2007, J BIOL CHEM, V282, P19203, DOI 10.1074/jbc.M701558200; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Runnels LW, 1999, BIOCHEMISTRY-US, V38, P1488, DOI 10.1021/bi9821519; Runnels LW, 1998, BIOCHEMISTRY-US, V37, P15563, DOI 10.1021/bi9811258; Sarvazyan NA, 2002, BIOCHEMISTRY-US, V41, P12858, DOI 10.1021/bi026212l; Schwille P, 2001, CELL BIOCHEM BIOPHYS, V34, P383, DOI 10.1385/CBB:34:3:383; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; VANDERMEER W, 1994, RESONANCE ENERGY TRA, P148; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wang JT, 2009, J MOL BIOL, V387, P92, DOI 10.1016/j.jmb.2009.01.051; WEDEGAERTNER PB, 1995, J BIOL CHEM, V270, P503, DOI 10.1074/jbc.270.2.503	44	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16906	16913		10.1074/jbc.M109.006585	http://dx.doi.org/10.1074/jbc.M109.006585			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19369247	hybrid, Green Published			2022-12-25	WOS:000266962400027
J	Derrien, B; Majeran, W; Wollman, FA; Vallon, O				Derrien, Benoit; Majeran, Wojciech; Wollman, Francis-Andre; Vallon, Olivier			Multistep Processing of an Insertion Sequence in an Essential Subunit of the Chloroplast ClpP Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CHLAMYDOMONAS-REINHARDTII; MESOSTIGMA-VIRIDE; GENOME SEQUENCE; DNA-SEQUENCE; PROTEASE; PROTEINS; GENE; TRANSFORMATION; ARCHITECTURE	In Chlamydomonas reinhardtii, the clpP1 chloroplast gene encoding one of the catalytic subunits of the ClpP protease complex contains a large in-frame insertion sequence (IS1). Based on the Escherichia coli ClpP structure, IS1 is predicted to protrude at the apical surface of the complex, likely influencing the interaction of the catalytic core with ClpC/HSP100 chaperones. Immunoblotting with an anti-ClpP1 antibody detected two immunoreactive forms of ClpP1: ClpP1(H) (59 kDa) and ClpP1(L) (25 kDa). It has been proposed that IS1 is a new type of protein intron (different from inteins). By studying transformants harboring mutations at the predicted borders of IS1 and tags at the C terminus of ClpP1 (tandem affinity purification tag, His tag, Strep.Tag) or within the IS1 sequence (3-hemagglutinin tag), we show that IS1 is not a protein intron and that ClpP1(L) results from endoproteolytic cleavage inside IS1. Processing sites have been identified in the middle of IS1 and near its C terminus. The sites can be mutated without abolishing processing.	[Derrien, Benoit; Wollman, Francis-Andre; Vallon, Olivier] Univ Paris 06, IBPC, UMR7141, CNRS, F-75005 Paris, France; [Majeran, Wojciech] Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Cornell University	Vallon, O (corresponding author), Univ Paris 06, IBPC, UMR7141, CNRS, 13 Rue Pierre & Marie Curie, F-75005 Paris, France.	ovallon@ibpc.fr	VALLON, Olivier/AAM-7737-2021		CNRS [UMR7141]; Universite Pierre et Marie Curie-Paris	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Pierre et Marie Curie-Paris	This work was supported by CNRS UMR7141 and the Universite Pierre et Marie Curie-Paris 6.	Belanger AS, 2006, MOL GENET GENOMICS, V276, P464, DOI 10.1007/s00438-006-0156-2; BOYNTON JE, 1988, SCIENCE, V240, P1534, DOI 10.1126/science.2897716; Brouard JS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-290; de Cambiaire JC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-213; de Cambiaire JC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-37; GOLDSCHMIDTCLERMONT M, 1991, NUCLEIC ACIDS RES, V19, P4083, DOI 10.1093/nar/19.15.4083; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; GOTTESMAN S, 1993, J BIOL CHEM, V268, P22618; Harris EH, 1989, CHLAMYDOMONAS SOURCE, P25, DOI [DOI 10.1016/B978-0-12-326880-8.50007-9, DOI 10.1126/SCIENCE.246.4936.1503-A]; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; Hoskins JR, 2000, J BIOL CHEM, V275, P35361, DOI 10.1074/jbc.M006288200; HUANG CZ, 1994, MOL GEN GENET, V244, P151, DOI 10.1007/BF00283516; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; KURAS R, 1994, EMBO J, V13, P1019, DOI 10.1002/j.1460-2075.1994.tb06350.x; Kuroda H, 2003, NATURE, V425, P86, DOI 10.1038/nature01909; Lemieux C, 2000, NATURE, V403, P649, DOI 10.1038/35001059; Lemieux C, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-2; Majeran W, 2005, FEBS J, V272, P5558, DOI 10.1111/j.1742-4658.2005.04951.x; Majeran W, 2000, PLANT CELL, V12, P137; MAURIZI MR, 1990, J BIOL CHEM, V265, P12536; Ortega J, 2004, J STRUCT BIOL, V146, P217, DOI 10.1016/j.jsb.2003.11.023; Peltier JB, 2004, J BIOL CHEM, V279, P4768, DOI 10.1074/jbc.M309212200; Perler FB, 2005, IUBMB LIFE, V57, P469, DOI 10.1080/15216540500163343; Perler FB, 2002, NUCLEIC ACIDS RES, V30, P383, DOI 10.1093/nar/30.1.383; PICCIONI RG, 1981, EUR J BIOCHEM, V117, P93; Pombert JF, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-3; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Shikanai T, 2001, PLANT CELL PHYSIOL, V42, P264, DOI 10.1093/pcp/pce031; Singh SK, 2000, P NATL ACAD SCI USA, V97, P8898, DOI 10.1073/pnas.97.16.8898; Sjogren LLE, 2006, PLANT CELL, V18, P2635, DOI 10.1105/tpc.106.044594; Stanne TM, 2007, J BIOL CHEM, V282, P14394, DOI 10.1074/jbc.M700275200; THOMPSON MW, 1994, J BIOL CHEM, V269, P18201; THOMPSON MW, 1994, J BIOL CHEM, V269, P18209; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Turmel M, 2008, J PHYCOL, V44, P739, DOI 10.1111/j.1529-8817.2008.00510.x; Wang SL, 1997, J BIOL CHEM, V272, P11869, DOI 10.1074/jbc.272.18.11869; Werner R, 1998, PLANT MOL BIOL REP, V16, P295, DOI 10.1023/A:1007583508766	39	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15408	15415		10.1074/jbc.M109.002733	http://dx.doi.org/10.1074/jbc.M109.002733			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19346247	Green Published, hybrid			2022-12-25	WOS:000266501000008
J	Vosper, JMD; McDowell, GS; Hindley, CJ; Fiore-Heriche, CS; Kucerova, R; Horan, I; Philpott, A				Vosper, Jonathan M. D.; McDowell, Gary S.; Hindley, Christopher J.; Fiore-Heriche, Christelle S.; Kucerova, Romana; Horan, Ian; Philpott, Anna			Ubiquitylation on Canonical and Non-canonical Sites Targets the Transcription Factor Neurogenin for Ubiquitin-mediated Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NH2-TERMINAL ACETYLATION; DEGRADATION; STABILITY; PROTEINS; MYOD; REQUIRES; NUCLEAR; PATHWAY	Polyubiquitylation targets multiple proteins for degradation by the proteasome. Typically, the first ubiquitin is linked to lysine residues in the substrate for degradation via an isopeptide bond, although rarely ubiquitin linkage to the N-terminal residue has also been observed. We have recently shown that Neurogenin (NGN), a basic helix-loop-helix transcription factor that plays a central role in regulating neuronal differentiation, is degraded by ubiquitin-mediated proteolysis. We have taken a biochemical and mutagenesis approach to investigate sites of ubiquitylation of NGN, initially using extracts of eggs from the frog Xenopus laevis as a source of ubiquitylation and degradation components. NGN can be targeted for destruction by ubiquitylation via lysines or the N terminus. However, we see that a modified NGN, where canonical lysine ubiquitylation and N-terminally linked ubiquitylation are prevented, is nevertheless ubiquitylated and degraded by the proteasome. We show that polyubiquitin chains covalently attach to non-canonical cysteine residues in NGN, and these non-canonical linkages alone are capable of targeting NGN protein for destruction. Importantly, canonical and non-canonical ubiquitylation occurs simultaneously in the native protein and may differ in importance for driving degradation in interphase and mitosis. We conclude that native NGN is ubiquitylated on multiple canonical and non-canonical sites by cellular ubiquitin ligases, and all types of linkage can contribute to protein turnover.	[Vosper, Jonathan M. D.; McDowell, Gary S.; Hindley, Christopher J.; Fiore-Heriche, Christelle S.; Kucerova, Romana; Horan, Ian; Philpott, Anna] Univ Cambridge, Addenbrookes Hosp, Dept Oncol, Hutchison Med Res Council MRC,Res Ctr, Cambridge CB2 0XZ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Philpott, A (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Oncol, Hutchison Med Res Council MRC,Res Ctr, Cambridge CB2 0XZ, England.	ap113@cam.ac.uk	McDowell, Gary/H-3382-2019	McDowell, Gary/0000-0002-9470-3799; Philpott, Anna/0000-0003-3789-2463	MRC [GO500101, G0700758]; Biotechnology and Biological Sciences Research Council [BB/C 004108/1]; Medical Research Council [G0700758, G0800784B, G0800784, G0300723] Funding Source: researchfish; MRC [G0300723, G0800784] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by training awards from the MRC (to J. V. and G. M.), MRC Grants GO500101 (to C. F.- H.) and G0700758 (R. K.), and Biotechnology and Biological Sciences Research Council Grant BB/C 004108/1.	Breitschopf K, 1998, EMBO J, V17, P5964, DOI 10.1093/emboj/17.20.5964; BUTT TR, 1988, J BIOL CHEM, V263, P16364; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Carvalho AF, 2007, J BIOL CHEM, V282, P31267, DOI 10.1074/jbc.M706325200; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Ciechanover Aaron, 2005, V301, P255; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; HERSHKO A, 1991, J BIOL CHEM, V266, P16376; Hoyt MA, 2004, CELL MOL LIFE SCI, V61, P1596, DOI 10.1007/s00018-004-4133-9; Kuo ML, 2004, GENE DEV, V18, P1862, DOI 10.1101/gad.1213904; Lindon C, 2000, MOL CELL BIOL, V20, P8923, DOI 10.1128/MCB.20.23.8923-8932.2000; Lingbeck JM, 2003, J BIOL CHEM, V278, P1817, DOI 10.1074/jbc.M208815200; Meinnel T, 2005, BIOCHIMIE, V87, P701, DOI 10.1016/j.biochi.2005.03.011; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; PALMITER RD, 1977, J BIOL CHEM, V252, P8781; Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198; Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X; Pollice A, 2008, FEBS LETT, V582, P3257, DOI 10.1016/j.febslet.2008.09.026; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Ravid T, 2007, NAT CELL BIOL, V9, P422, DOI 10.1038/ncb1558; Rodway H, 2004, ONCOGENE, V23, P6186, DOI 10.1038/sj.onc.1207854; RUBENSTEIN P, 1981, J BIOL CHEM, V256, P8149; Sadeh R, 2008, P NATL ACAD SCI USA, V105, P15690, DOI 10.1073/pnas.0808373105; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Tait SWG, 2007, J CELL BIOL, V179, P1453, DOI 10.1083/jcb.200707063; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; Vosper JMD, 2007, BIOCHEM J, V407, P277, DOI 10.1042/BJ20070064; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200	30	52	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15458	15468		10.1074/jbc.M809366200	http://dx.doi.org/10.1074/jbc.M809366200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19336407	Green Published, hybrid			2022-12-25	WOS:000266501000014
J	Gralle, M; Botelho, MG; Wouters, FS				Gralle, Matthias; Botelho, Michelle Gralle; Wouters, Fred S.			Neuroprotective Secreted Amyloid Precursor Protein Acts by Disrupting Amyloid Precursor Protein Dimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMAGING MOLECULAR-INTERACTIONS; FAMILIAL ALZHEIMERS-DISEASE; CELL-SURFACE PROTEINS; EXTRACELLULAR DOMAIN; ALPHA-SECRETASE; BETA-SECRETASE; FULL-LENGTH; HIPPOCAMPAL-NEURONS; FLUORESCENT PROTEIN; CYTOPLASMIC DOMAIN	The amyloid precursor protein (APP) is implied both in cell growth and differentiation and in neurodegenerative processes in Alzheimer disease. Regulated proteolysis of APP generates biologically active fragments such as the neuroprotective secreted ectodomain sAPP alpha and the neurotoxic beta-amyloid peptide. Furthermore, it has been suggested that the intact transmembrane APP plays a signaling role, which might be important for both normal synaptic plasticity and neuronal dysfunction in dementia. To understand APP signaling, we tracked single molecules of APP using quantum dots and quantitated APP homodimerization using fluorescence lifetime imaging microscopy for the detection of Forster resonance energy transfer in living neuroblastoma cells. Using selective labeling with synthetic fluorophores, we show that the dimerization of APP is considerably higher at the plasma membrane than in intracellular membranes. Heparan sulfate significantly contributes to the almost complete dimerization of APP at the plasma membrane. Importantly, this technique for the first time structurally defines the initiation of APP signaling by binding of a relevant physiological extracellular ligand; our results indicate APP as receptor for neuroprotective sAPP alpha, as sAPP alpha binding disrupts APP dimers, and this disruption of APP dimers by sAPP alpha is necessary for the protection of neuroblastoma cells against starvation-induced cell death. Only cells expressing reversibly dimerized wild-type, but not covalently dimerized mutant APP are protected by sAPP alpha. These findings suggest a potentially beneficial effect of increasing sAPP alpha production or disrupting APP dimers for neuronal survival.	[Gralle, Matthias; Wouters, Fred S.] Univ Gottingen, Lab Mol & Cellular Syst, Dept Neurophysiol & Sensory Physiol, D-37073 Gottingen, Germany; [Botelho, Michelle Gralle] Max Planck Inst Biophys Chem, Lab Cellular Dynam, D-37070 Gottingen, Germany	University of Gottingen; Max Planck Society	Gralle, M (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Mol Genet, Deutsch Pl 6, D-04103 Leipzig, Germany.	matthias.gralle@eva.mpg.de	Gralle, Matthias/B-9005-2014; Caarls, Michelle Botelho/T-7976-2019		German Federal Ministry for Education and Research (Bundesministerium fur Bildung und Forschung); European Neuroscience Institute Gottinge	German Federal Ministry for Education and Research (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); European Neuroscience Institute Gottinge	This work was supported by the German Federal Ministry for Education and Research (Bundesministerium fur Bildung und Forschung) for the project "FLI-Cam" in the Biophotonik III program and from the European Neuroscience Institute Gottinge.	BARGER SW, 1995, BIOCHEM J, V311, P45, DOI 10.1042/bj3110045; Bell KFS, 2008, NEUROBIOL AGING, V29, P554, DOI 10.1016/j.neurobiolaging.2006.11.004; Bouron A, 2004, EUR J NEUROSCI, V20, P2071, DOI 10.1111/j.1460-9568.2004.03680.x; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P3055, DOI 10.1073/pnas.89.7.3055; Chen CD, 2006, J NEUROCHEM, V97, P30, DOI 10.1111/j.1471-4159.2006.03705.x; Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006; Dulubova I, 2004, BIOCHEMISTRY-US, V43, P9583, DOI 10.1021/bi049041o; Esposito A, 2005, BIOPHYS J, V89, P4286, DOI 10.1529/biophysj.104.053397; Esposito A, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2208999; Ganesan S, 2006, P NATL ACAD SCI USA, V103, P4089, DOI 10.1073/pnas.0509922103; George N, 2004, J AM CHEM SOC, V126, P8896, DOI 10.1021/ja048396s; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Gorman PM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-17; Gralle M, 2006, J MOL BIOL, V357, P493, DOI 10.1016/j.jmb.2005.12.053; Gralle M, 2002, BIOPHYS J, V83, P3513, DOI 10.1016/S0006-3495(02)75351-4; Gralle M, 2007, PROG NEUROBIOL, V82, P11, DOI 10.1016/j.pneurobio.2007.02.001; HAASS C, 1995, J CELL BIOL, V128, P537, DOI 10.1083/jcb.128.4.537; HAGEN GM, 2007, P SPIE, V6441; Hashimoto Y, 2003, J PHARMACOL EXP THER, V306, P889, DOI 10.1124/jpet.103.051383; Heber S, 2000, J NEUROSCI, V20, P7951; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Hoffmann J, 1999, J HISTOCHEM CYTOCHEM, V47, P373, DOI 10.1177/002215549904700311; Hoyer S, 2000, EXP GERONTOL, V35, P1363, DOI 10.1016/S0531-5565(00)00156-X; Jares-Erijman EA, 2006, CURR OPIN CHEM BIOL, V10, P409, DOI 10.1016/j.cbpa.2006.08.021; Jung SS, 1999, NEUROBIOL AGING, V20, P249, DOI 10.1016/S0197-4580(99)00051-2; Jung SS, 1996, J NEUROSCI RES, V46, P336, DOI 10.1002/(SICI)1097-4547(19961101)46:3<336::AID-JNR7>3.3.CO;2-L; Kaden D, 2008, J BIOL CHEM, V283, P7271, DOI 10.1074/jbc.M708046200; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kienlen-Campard P, 2008, J BIOL CHEM, V283, P7733, DOI 10.1074/jbc.M707142200; KOO EH, 1994, J BIOL CHEM, V269, P17386; Kroenke CD, 1997, BIOCHEMISTRY-US, V36, P8145, DOI 10.1021/bi9705669; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; LANNFELT L, 1995, NAT MED, V1, P829, DOI 10.1038/nm0895-829; Leyssen M, 2005, EMBO J, V24, P2944, DOI 10.1038/sj.emboj.7600757; Lidke Diane S, 2007, Methods Mol Biol, V374, P69; Lidke DS, 2005, J CELL BIOL, V170, P619, DOI 10.1083/jcb.200503140; Lidke DS, 2003, BIOCHEM SOC T, V31, P1020; Lidke KA, 2005, OPT EXPRESS, V13, P7052, DOI 10.1364/OPEX.13.007052; Ma QH, 2008, NAT CELL BIOL, V10, P283, DOI 10.1038/ncb1690; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Mbebi C, 2002, J BIOL CHEM, V277, P20979, DOI 10.1074/jbc.M107948200; Meyer BH, 2006, FEBS LETT, V580, P1654, DOI 10.1016/j.febslet.2006.02.007; Meziane H, 1998, P NATL ACAD SCI USA, V95, P12683, DOI 10.1073/pnas.95.21.12683; MOYA KL, 1994, DEV BIOL, V161, P597, DOI 10.1006/dbio.1994.1055; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; NINOMIYA H, 1994, J NEUROCHEM, V63, P495; Park JH, 2006, J NEUROSCI, V26, P1386, DOI 10.1523/JNEUROSCI.3291-05.2006; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Postina R, 2008, CURR ALZHEIMER RES, V5, P179, DOI 10.2174/156720508783954668; Priller C, 2006, J NEUROSCI, V26, P7212, DOI 10.1523/JNEUROSCI.1450-06.2006; QIU WQ, 1995, J NEUROSCI, V15, P2157, DOI 10.1523/JNEUROSCI.15-03-02157.1995; Rohn TT, 2000, J NEUROCHEM, V74, P2331, DOI 10.1046/j.1471-4159.2000.0742331.x; Rossjohn J, 1999, NAT STRUCT BIOL, V6, P327; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Sato T, 2009, P NATL ACAD SCI USA, V106, P1421, DOI 10.1073/pnas.0812261106; Scheuermann S, 2001, J BIOL CHEM, V276, P33923, DOI 10.1074/jbc.M105410200; Schneider A, 2008, J NEUROSCI, V28, P2874, DOI 10.1523/JNEUROSCI.5345-07.2008; SCHUBERT D, 1993, BRAIN RES, V629, P275, DOI 10.1016/0006-8993(93)91331-L; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sennvik K, 2000, NEUROSCI LETT, V278, P169, DOI 10.1016/S0304-3940(99)00929-5; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Skovronsky DM, 2000, J BIOL CHEM, V275, P2568, DOI 10.1074/jbc.275.4.2568; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; Stein TD, 2004, J NEUROSCI, V24, P7707, DOI 10.1523/JNEUROSCI.2211-04.2004; Storey E, 1999, EUR J NEUROSCI, V11, P1779, DOI 10.1046/j.1460-9568.1999.00599.x; Sudo H, 2000, MOL CELL NEUROSCI, V16, P708, DOI 10.1006/mcne.2000.0910; Sudo H, 2001, BIOCHEM BIOPH RES CO, V282, P548, DOI 10.1006/bbrc.2001.4604; Tikkanen R, 2002, BIOL CHEM, V383, P1855, DOI 10.1515/BC.2002.209; Wang P, 2005, J NEUROSCI, V25, P1219, DOI 10.1523/JNEUROSCI.4660-04.2005; Wang YC, 2004, MOL CELL, V15, P343, DOI 10.1016/j.molcel.2004.06.037; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Young-Pearse TL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-15; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	75	110	114	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15016	15025		10.1074/jbc.M808755200	http://dx.doi.org/10.1074/jbc.M808755200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19336403	Green Published, hybrid			2022-12-25	WOS:000266288200038
J	Perreault, A; Gascon, S; D'Amours, A; Aletta, JM; Bachand, F				Perreault, Audrey; Gascon, Suzanne; D'Amours, Annie; Aletta, John M.; Bachand, Francois			A Methyltransferase-independent Function for Rmt3 in Ribosomal Subunit Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SET DOMAIN METHYLTRANSFERASE; PROTEIN ARGININE METHYLTRANSFERASES; MASS-SPECTROMETRIC ANALYSIS; RNA-POLYMERASE-II; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; POLY(A)-BINDING PROTEIN; DROSOPHILA-MELANOGASTER; ENVIRONMENTAL-CHANGES; PRE-40S SUBUNITS	Schizosaccharomyces pombe Rmt3 is a member of the protein-arginine methyltransferase (PRMT) family and is the homolog of human PRMT3. We previously characterized Rmt3 as a ribosomal protein methyltransferase based on the identification of the 40 S Rps2 (ribosomal protein S2) as a substrate of Rmt3. RMT3-null cells produce nonmethylated Rps2 and show mis-regulation of the 40 S/60 S ribosomal subunit ratio due to a small subunit deficit. For this study, we have generated a series of RMT3 alleles that express various amino acid substitutions to characterize the functional domains of Rmt3 in Rps2 binding, Rps2 arginine methylation, and small ribosomal subunit production. Notably, catalytically inactive versions of Rmt3 restored the ribosomal subunit imbalance detected in RMT3-null cells. Consistent with a methyltransferase-independent function for Rmt3 in small ribosomal subunit production, the expression of an Rps2 variant in which the identified methylarginine residues were substituted with lysines showed normal levels of 40 S subunit. Importantly, substitutions within the zinc finger domain of Rmt3 that abolished Rps2 binding did not rescue the 40 S ribosomal subunit deficit of RMT3-null cells. Our findings suggest that the Rmt3-Rps2 interaction, rather than Rps2 methylation, is important for the function of Rmt3 in the regulation of small ribosomal subunit production.	[Perreault, Audrey; Gascon, Suzanne; D'Amours, Annie; Bachand, Francois] Univ Sherbrooke, Dept Biochem, RNA Grp, Sherbrooke, PQ J1H 5N4, Canada; [Aletta, John M.] CH3 BioSyst LLC, New York State Ctr Excellence Bioinformat & Life, Buffalo, NY 14228 USA	University of Sherbrooke	Bachand, F (corresponding author), Univ Sherbrooke, Dept Biochem, RNA Grp, 5E Etage 3001,12E Av Nord, Sherbrooke, PQ J1H 5N4, Canada.	f.bachand@usherbrooke.ca			Canadian Institutes for Health Research (CIHR) [MOP-171704]	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes for Health Research (CIHR) Grant MOP-171704 (to F. B.).	Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; Bachand F, 2006, MOL CELL BIOL, V26, P1731, DOI 10.1128/MCB.26.5.1731-1742.2006; Bachand F, 2004, EMBO J, V23, P2641, DOI 10.1038/sj.emboj.7600265; Bachand F, 2007, EUKARYOT CELL, V6, P889, DOI 10.1128/EC.00099-07; Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; CHANG FN, 1976, ARCH BIOCHEM BIOPHYS, V172, P627, DOI 10.1016/0003-9861(76)90117-X; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Cheung N, 2007, NAT CELL BIOL, V9, P1208, DOI 10.1038/ncb1642; Choesmel V, 2008, HUM MOL GENET, V17, P1253, DOI 10.1093/hmg/ddn015; CRAMTON SE, 1994, GENETICS, V137, P1039; Duan P, 2007, J IMMUNOL METHODS, V320, P132, DOI 10.1016/j.jim.2007.01.006; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Frankel A, 2000, J BIOL CHEM, V275, P32974, DOI 10.1074/jbc.M006445200; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Godin KS, 2007, RNA BIOL, V4, P69, DOI 10.4161/rna.4.2.4869; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; KEENEY JB, 1994, GENETICS, V136, P849; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; KRUISWIJK T, 1978, BIOCHEM J, V175, P221, DOI 10.1042/bj1750221; Kwak YT, 2003, MOL CELL, V11, P1055, DOI 10.1016/S1097-2765(03)00101-1; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Lambertsson A, 1998, ADV GENET, V38, P69, DOI 10.1016/S0065-2660(08)60142-X; Lee J, 2002, EMBO REP, V3, P268, DOI 10.1093/embo-reports/kvf052; Lee SW, 2002, P NATL ACAD SCI USA, V99, P5942, DOI 10.1073/pnas.082119899; LHOEST J, 1984, EUR J BIOCHEM, V141, P585, DOI 10.1111/j.1432-1033.1984.tb08233.x; Liang XH, 2007, MOL CELL, V28, P965, DOI 10.1016/j.molcel.2007.10.012; Liu MF, 2004, RNA, V10, P1713, DOI 10.1261/rna.7820104; Louie DF, 1996, J BIOL CHEM, V271, P28189, DOI 10.1074/jbc.271.45.28189; Marygold SJ, 2005, GENETICS, V169, P683, DOI 10.1534/genetics.104.034124; Marygold SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r216; NAJBAUER J, 1993, J BIOL CHEM, V268, P10501; Odintsova TI, 2003, J PROTEIN CHEM, V22, P249, DOI 10.1023/A:1025068419698; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Pal S, 2007, J CELL PHYSIOL, V213, P306, DOI 10.1002/jcp.21180; Perreault A, 2008, NUCLEIC ACIDS RES, V36, P6132, DOI 10.1093/nar/gkn625; Perreault A, 2007, J BIOL CHEM, V282, P7552, DOI 10.1074/jbc.M610512200; Polevoda B, 2007, MOL MICROBIOL, V65, P590, DOI 10.1111/j.1365-2958.2007.05831.x; Porras-Yakushi TR, 2007, J BIOL CHEM, V282, P12368, DOI 10.1074/jbc.M611896200; Porras-Yakushi TR, 2006, J BIOL CHEM, V281, P35835, DOI 10.1074/jbc.M606578200; Porras-Yakushi TR, 2005, J BIOL CHEM, V280, P34590, DOI 10.1074/jbc.M507672200; RAMAGOPAL S, 1991, BIOCHEM CELL BIOL, V69, P263, DOI 10.1139/o91-040; Rappsilber J, 2003, ANAL CHEM, V75, P3107, DOI 10.1021/ac026283q; Rother S, 2007, GENE DEV, V21, P1409, DOI 10.1101/gad.428407; Rosado IV, 2007, NUCLEIC ACIDS RES, V35, P4203, DOI 10.1093/nar/gkm388; Roy-Chaudhuri B, 2008, MOL MICROBIOL, V68, P1547, DOI 10.1111/j.1365-2958.2008.06252.x; Sadaie M, 2008, J BIOL CHEM, V283, P7185, DOI 10.1074/jbc.M709429200; Smith JJ, 1999, J BIOL CHEM, V274, P13229, DOI 10.1074/jbc.274.19.13229; STEWART MJ, 1993, MOL CELL BIOL, V13, P2524, DOI 10.1128/MCB.13.4.2524; Sulic S, 2005, GENE DEV, V19, P3070, DOI 10.1101/gad.359305; SUZUKI K, 1991, J BIOL CHEM, V266, P20007; Swiercz R, 2005, BIOCHEM J, V386, P85, DOI 10.1042/BJ20041466; Swiercz R, 2007, J BIOL CHEM, V282, P16917, DOI 10.1074/jbc.M609778200; Torok I, 1999, MOL CELL BIOL, V19, P2308; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Volarevic S, 2000, SCIENCE, V288, P2045, DOI 10.1126/science.288.5473.2045; WATSON KL, 1992, P NATL ACAD SCI USA, V89, P11302, DOI 10.1073/pnas.89.23.11302; White J, 2008, MOL CELL BIOL, V28, P3151, DOI 10.1128/MCB.01674-07; Wysocka J, 2006, FRONT BIOSCI-LANDMRK, V11, P344, DOI 10.2741/1802; Xirodimas DP, 2008, EMBO REP, V9, P280, DOI 10.1038/embor.2008.10; Yu MC, 2004, GENE DEV, V18, P2024, DOI 10.1101/gad.1223204; Yu YH, 2005, PROTEIN SCI, V14, P1438, DOI 10.1110/ps.041293005; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509; Zhao X, 2008, GENE DEV, V22, P640, DOI 10.1101/gad.1632608	72	23	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15026	15037		10.1074/jbc.M109.004812	http://dx.doi.org/10.1074/jbc.M109.004812			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19359250	Green Published, hybrid			2022-12-25	WOS:000266288200039
J	Liu, HY; Yehuda-Shnaidman, E; Hong, T; Han, JM; Pi, JB; Liu, ZQ; Cao, WH				Liu, Hui-Yu; Yehuda-Shnaidman, Einav; Hong, Tao; Han, Jianmin; Pi, Jingbo; Liu, Zhenqi; Cao, Wenhong			Prolonged Exposure to Insulin Suppresses Mitochondrial Production in Primary Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; HUMAN SKELETAL-MUSCLE; GENE-EXPRESSION; ADIPOSE-TISSUE; HEPATIC GLUCONEOGENESIS; PYRUVATE-DEHYDROGENASE; METABOLIC SYNDROME; SIGNALING PATHWAY; OXIDATIVE STRESS; AMINO-ACIDS	Insulin is the central regulator of metabolism and is necessary for storing energy as fat efficiently. Mitochondria are primary sites of energy consumption of most cells. Increased plasma insulin level and mitochondrial dysfunction are features of insulin resistance. The exact role of insulin in regulation of mitochondrial production and function remains unestablished. In this study, we observed that mitochondrial production in liver and skeletal muscle gastrocnemius was increased in mice with insulin deficiency (streptozotocin-induced type 1 diabetes). In contrast, prolonged exposure (24 h) of isolated hepatocytes to insulin decreased mitochondrial mass, mitochondrial DNA (mtDNA), intracellular ATP content, and cellular O-2 consumption. Transcript levels of genes associated with mitochondrial production and beta oxidation were decreased, whereas those of lipogenic genes were increased by the prolonged exposure to insulin. Insulin-induced changes in mtDNA, mitochondrial mass, intracellular ATP content, and transcripts of mitochondrion-associated genes were prevented by blockade of Akt activation with the phosphatidylinositol 3-kinase inhibitor LY294002. Conversely, levels of mtDNA, intracellular ATP content, and expression of mitochondrion-associated genes were decreased by overexpression of the constitutively active Akt. Finally, insulin suppression of mtDNA, ATP production, and expression of mitochondrion-related genes was largely prevented by inhibition of cyclic nucleotide phosphodiesterase with isobutylmethylxanthine. Together, our results show prolonged exposure of isolated hepatocytes to insulin suppresses mitochondrial production and function through the classical Akt-dependent insulin signaling pathway.	[Cao, Wenhong] Duke Univ, Med Ctr, Dept Internal Med Endocrinol, Durham, NC 27705 USA; [Liu, Hui-Yu; Yehuda-Shnaidman, Einav; Hong, Tao; Han, Jianmin; Pi, Jingbo; Cao, Wenhong] Hamner Inst Hlth Sci, Res Triangle Pk, NC 27709 USA; [Liu, Zhenqi] Univ Virginia, Med Sci Ctr, Dept Med Endocrinol, Charlottesville, VA 22908 USA	Duke University; The Hamner Institutes for Health Sciences; University of Virginia	Cao, WH (corresponding author), Duke Univ, Med Ctr, Dept Internal Med Endocrinol, Durham, NC 27705 USA.	wcao@thehamner.org	PI, JINGBO/GWC-2514-2022	PI, JINGBO/0000-0003-0227-8041	National Institutes of Health [R01DK076039]; Investigator Development Fund from the Hamner Institutes for Health Sciences; American Heart Association [SDG-0530244N]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Investigator Development Fund from the Hamner Institutes for Health Sciences; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK076039 (to W. C.). This work was also supported by the Investigator Development Fund from the Hamner Institutes for Health Sciences (to W. C.) and American Heart Association Grant SDG-0530244N (to W. C.).	Accili D, 2004, DIABETES, V53, P1633, DOI 10.2337/diabetes.53.7.1633; Al-Regaiey KA, 2005, ENDOCRINOLOGY, V146, P851, DOI 10.1210/en.2004-1120; BEATTIE DS, 1967, J BIOL CHEM, V242, P4584; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Burns JM, 2007, NEUROLOGY, V69, P1094, DOI 10.1212/01.wnl.0000276952.91704.af; Cao WH, 2005, J BIOL CHEM, V280, P42731, DOI 10.1074/jbc.M506223200; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Cole GM, 2007, EXP GERONTOL, V42, P10, DOI 10.1016/j.exger.2006.08.009; Collins QF, 2007, J BIOL CHEM, V282, P30143, DOI 10.1074/jbc.M702390200; Collins QF, 2006, J BIOL CHEM, V281, P24336, DOI 10.1074/jbc.M602177200; Crowell JA, 2007, MOL CANCER THER, V6, P2139, DOI 10.1158/1535-7163.MCT-07-0120; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; DANFORD HG, 1956, J CLIN INVEST, V35, P1205, DOI 10.1172/JCI103375; Garcia-Roves P, 2007, P NATL ACAD SCI USA, V104, P10709, DOI 10.1073/pnas.0704024104; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Huang X, 1999, DIABETES, V48, P1508, DOI 10.2337/diabetes.48.8.1508; Katic M, 2007, AGING CELL, V6, P827, DOI 10.1111/j.1474-9726.2007.00346.x; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; KONES RJ, 1975, CARDIOLOGY, V60, P280, DOI 10.1159/000169727; Kumashiro N, 2008, DIABETES, V57, P2083, DOI 10.2337/db08-0144; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200; Liu HY, 2008, J BIOL CHEM, V283, P30642, DOI 10.1074/jbc.M803698200; Liu HY, 2008, J BIOL CHEM, V283, P12056, DOI 10.1074/jbc.M801033200; Liu HY, 2007, J BIOL CHEM, V282, P14205, DOI 10.1074/jbc.M609701200; Matthias A, 2000, J BIOL CHEM, V275, P25073, DOI 10.1074/jbc.M000547200; Meijer AJ, 2003, J NUTR, V133, p2057S, DOI 10.1093/jn/133.6.2057S; MENZIES RA, 1972, J NEUROCHEM, V19, P1671, DOI 10.1111/j.1471-4159.1972.tb06212.x; MENZIES RA, 1971, J BIOL CHEM, V246, P2425; Moreira PI, 2007, J NEUROL SCI, V257, P206, DOI 10.1016/j.jns.2007.01.017; MUKHERJEE C, 1975, BIOCHEM J, V148, P229, DOI 10.1042/bj1480229; Nishino Naonobu, 2007, Kobe J Med Sci, V53, P99; Nisoli E, 2008, AM J CARDIOL, V101, p22E, DOI 10.1016/j.amjcard.2008.02.077; Palmeira CM, 2007, TOXICOL APPL PHARM, V225, P214, DOI 10.1016/j.taap.2007.07.015; Pendergrass W, 2004, CYTOM PART A, V61A, P162, DOI 10.1002/cyto.a.20033; Petersen KF, 2005, PLOS MED, V2, P879, DOI 10.1371/journal.pmed.0020233; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; Southgate RJ, 2005, FASEB J, V19, P2072, DOI 10.1096/fj.05-3993fje; Stump CS, 2003, P NATL ACAD SCI USA, V100, P7996, DOI 10.1073/pnas.1332551100; Sugden M. C., 2002, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V2, P151, DOI 10.2174/1568008023340785; Tanaka T, 2003, P NATL ACAD SCI USA, V100, P15924, DOI 10.1073/pnas.0306981100; Turko IV, 2003, J BIOL CHEM, V278, P35844, DOI 10.1074/jbc.M303139200; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang MY, 2008, P NATL ACAD SCI USA, V105, P6139, DOI 10.1073/pnas.0801981105; Wijkander J, 1998, ENDOCRINOLOGY, V139, P219, DOI 10.1210/en.139.1.219; Xiong Y, 2007, J BIOL CHEM, V282, P4975, DOI 10.1074/jbc.M606742200; Yin XM, 2008, HEPATOLOGY, V47, P1773, DOI 10.1002/hep.22146	56	47	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14087	14095		10.1074/jbc.M807992200	http://dx.doi.org/10.1074/jbc.M807992200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19336408	Green Published, hybrid			2022-12-25	WOS:000266286100015
J	Lee, JB; Jang, JE; Song, MK; Chang, J				Lee, Jee-Boong; Jang, Ji-Eun; Song, Man Ki; Chang, Jun			Intranasal Delivery of Cholera Toxin Induces Th17-Dominated T-Cell Response to Bystander Antigens	PLOS ONE			English	Article								Cholera toxin (CT) is a potent vaccine adjuvant, which promotes mucosal immunity to protein antigen given by nasal route. It has been suggested that CT promotes T helper type 2 (Th2) response and suppresses Th1 response. We here report the induction of Th17-dominated responses in mice by intranasal delivery of CT. This dramatic Th17-driving effect of CT, which was dependent on the B subunit, was observed even in Th1 or Th2-favored conditions of respiratory virus infection. These dominating Th17 responses resulted in the significant neutrophil accumulation in the lungs of mice given CT. Both in vitro and in vivo treatment of CT induced strongly augmented IL-6 production, and Th17-driving ability of CT was completely abolished in IL-6 knockout mice, indicating a role of this cytokine in the Th17-dominated T-cell responses by CT. These data demonstrate a novel Th17-driving activity of CT, and help understand the mechanisms of CT adjuvanticity to demarcate T helper responses.			Lee, JB (corresponding author), Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul, South Korea.	tcell@ewha.ac.kr		CHANG, JUN/0000-0002-8423-5987				Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; BOGAERT D, 2009, INFECT IMMUN; Braun MC, 1999, J EXP MED, V189, P541, DOI 10.1084/jem.189.3.541; BROMANDER AK, 1993, SCAND J IMMUNOL, V37, P452, DOI 10.1111/j.1365-3083.1993.tb03318.x; Chang J, 2004, J IMMUNOL, V172, P2818, DOI 10.4049/jimmunol.172.5.2818; Chung DR, 2003, J IMMUNOL, V170, P1958, DOI 10.4049/jimmunol.170.4.1958; Cong YZ, 1996, EUR J IMMUNOL, V26, P2587, DOI 10.1002/eji.1830261108; Eriksson K, 2003, INFECT IMMUN, V71, P1740, DOI 10.1128/IAI.71.4.1740-1747.2003; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; FLEMING TJ, 1993, J IMMUNOL, V151, P2399; Gagliardi MC, 2000, EUR J IMMUNOL, V30, P2394, DOI 10.1002/1521-4141(2000)30:8<2394::AID-IMMU2394>3.0.CO;2-Y; Guinazu N, 2004, MICROBES INFECT, V6, P1250, DOI 10.1016/j.micinf.2004.07.010; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Harrington LE, 2006, CURR OPIN IMMUNOL, V18, P349, DOI 10.1016/j.coi.2006.03.017; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Imaoka K, 1998, J IMMUNOL, V161, P5952; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kawamura YI, 2003, EUR J IMMUNOL, V33, P3205, DOI 10.1002/eji.200324135; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Kurono Y, 1999, J INFECT DIS, V180, P122, DOI 10.1086/314827; Lavelle EC, 2003, J IMMUNOL, V171, P2384, DOI 10.4049/jimmunol.171.5.2384; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Liu SJ, 2007, J LEUKOCYTE BIOL, V82, P354, DOI 10.1189/jlb.0207111; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Lukens MV, 2006, VIROLOGY, V352, P157, DOI 10.1016/j.virol.2006.04.023; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; MARINARO M, 1995, J IMMUNOL, V155, P4621; MCGEE DW, 1993, INFECT IMMUN, V61, P4637, DOI 10.1128/IAI.61.11.4637-4644.1993; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Priebe GP, 2008, J IMMUNOL, V181, P4965, DOI 10.4049/jimmunol.181.7.4965; Ryan EJ, 2000, J IMMUNOL, V165, P5750, DOI 10.4049/jimmunol.165.10.5750; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Schaffeler MP, 1997, INT IMMUNOL, V9, P1555, DOI 10.1093/intimm/9.10.1555; Schwarzenberger P, 1998, J IMMUNOL, V161, P6383; Simecka JW, 2000, INFECT IMMUN, V68, P672, DOI 10.1128/IAI.68.2.672-679.2000; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Williams NA, 1999, IMMUNOL TODAY, V20, P95, DOI 10.1016/S0167-5699(98)01397-8; Witowski J, 2000, J IMMUNOL, V165, P5814, DOI 10.4049/jimmunol.165.10.5814; XUAMANO JC, 1993, J EXP MED, V178, P1309, DOI 10.1084/jem.178.4.1309; Yamamoto S, 1997, P NATL ACAD SCI USA, V94, P5267, DOI 10.1073/pnas.94.10.5267; Yanagita M, 1999, J IMMUNOL, V162, P3559	44	82	84	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2009	4	4							e5190	10.1371/journal.pone.0005190	http://dx.doi.org/10.1371/journal.pone.0005190			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437SB	19360100	Green Submitted, Green Published, gold			2022-12-25	WOS:000265506100005
J	Elvang, T; Christensen, JP; Billeskov, R; Hoang, TTKT; Holst, P; Thomsen, AR; Andersen, P; Dietrich, J				Elvang, Tara; Christensen, Jan P.; Billeskov, Rolf; Hoang, Truc Thi Kim Thanh; Holst, Peter; Thomsen, Allan Randrup; Andersen, Peter; Dietrich, Jes			CD4 and CD8 T Cell Responses to the M. tuberculosis Ag85B-TB10.4 Promoted by Adjuvanted Subunit, Adenovector or Heterologous Prime Boost Vaccination	PLOS ONE			English	Article								Background: Although CD4 T cells are crucial for defense against M. tb, it is still not clear whether the optimal response against M. tb in fact involves both CD4 and CD8 T cells. To test this, we used a new vaccine strategy that generated a strong balanced T cell response consisting of both CD4 and CD8 T cells. Methods and Findings: To compare CD4 and CD8 responses against Ag85B-TB10.4 (H4), H4 was delivered as a subunit vaccine in cationic liposomes (CAF01), expressed in Ad5 (Ad-H4) or as a heterologous prime boost vaccination. H4/CAF01 induced primarily CD4 T cells and Ad-H4 gave predominantly a CD8 T cell response. In contrast, the heterologous prime boost combination resulted in augmentation of both the CD4 and CD8 response. The majority (>40%) of the CD4 T cells induced by the heterologous prime boost protocol were polyfunctional, and expressed IFN-gamma(+), IL-2(+), and TNF-alpha(+), whereas most of the CD8 T cells expressed IFN-gamma(+) and TNF-alpha(+) and possessed strong cytotoxic potential. The heterologous prime boost protocol also gave an increase in protective efficacy against M. tb challenge compared to H4/CAF01 and Ad-H4. Both the H4 specific CD4 and CD8 T cells were recruited to the site of infection, at the onset of infection. However, compared to CD8 T cells, CD4 T cells showed more extensive recruitment and were the main T cell subset proliferating at the site of infection. Conclusions/Significance: Heterologous prime boost based on H4, produced an additive effect on the priming of CD4 and CD8 cells and in terms of the protective capacity of the vaccine, and therefore represent an interesting new vaccine strategy against M. tb. However, CD4 and CD8 T cells respond very differently to live M. tb challenge, in a manner which supports the consensus that CD4 T cells do play the major role during the early stages of an M. tb infection.			Elvang, T (corresponding author), Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark.	JDI@ssi.dk	Christensen, Jan Pravsgaard/I-4782-2017	Christensen, Jan Pravsgaard/0000-0002-4299-9479; Andersen, Peter/0000-0002-5869-2551; Billeskov, Rolf/0000-0003-4533-7304; Holst, Peter Johannes/0000-0002-1279-304X; Thomsen, Allan Randrup/0000-0002-2392-9803				Andersen P, 2005, MICROBES INFECT, V7, P911, DOI 10.1016/j.micinf.2005.03.013; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; Behar SM, 1999, J EXP MED, V189, P1973, DOI 10.1084/jem.189.12.1973; Bennekov T, 2006, EUR J IMMUNOL, V36, P3346, DOI 10.1002/eji.200636128; Billeskov R, 2007, J IMMUNOL, V179, P3973, DOI 10.4049/jimmunol.179.6.3973; Brodin P, 2004, J INFECT DIS, V190, P115, DOI 10.1086/421468; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Derrick SC, 2004, INFECT IMMUN, V72, P1685, DOI 10.1128/IAI.72.3.1685-1692.2004; Dietrich J, 2005, J IMMUNOL, V174, P6332, DOI 10.4049/jimmunol.174.10.6332; Dorman SE, 2000, CYTOKINE GROWTH F R, V11, P321, DOI 10.1016/S1359-6101(00)00010-1; Feng CG, 2001, INT IMMUNOL, V13, P451, DOI 10.1093/intimm/13.4.451; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; FLYNN JL, 1992, P NATL ACAD SCI USA, V89, P12013, DOI 10.1073/pnas.89.24.12013; Hervas-Stubbs S, 2006, INFECT IMMUN, V74, P3396, DOI 10.1128/IAI.02086-05; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Johansen P, 2004, EUR J IMMUNOL, V34, P91, DOI 10.1002/eji.200324231; Kristensen NN, 2002, J GEN VIROL, V83, P2123, DOI 10.1099/0022-1317-83-9-2123; Majlessi L, 2003, INFECT IMMUN, V71, P7173, DOI 10.1128/IAI.71.12.7173-7177.2003; McShane H, 2005, TUBERCULOSIS, V85, P47, DOI 10.1016/j.tube.2004.09.015; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; McShane H, 2002, INFECT IMMUN, V70, P1623, DOI 10.1128/IAI.70.3.1623-1626.2002; McShane H, 2001, INFECT IMMUN, V69, P681, DOI 10.1128/IAI.69.2.681-686.2001; MULLER I, 1987, INFECT IMMUN, V55, P2037; Novy P, 2007, J IMMUNOL, V179, P8243, DOI 10.4049/jimmunol.179.12.8243; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Radosevic K, 2007, INFECT IMMUN, V75, P4105, DOI 10.1128/IAI.00004-07; Santosuosso M, 2007, J IMMUNOL, V178, P2387, DOI 10.4049/jimmunol.178.4.2387; Santosuosso M, 2006, INFECT IMMUN, V74, P4634, DOI 10.1128/IAI.00517-06; Sauzet JP, 1996, INT IMMUNOL, V8, P457, DOI 10.1093/intimm/8.4.457; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Skjot RLV, 2002, INFECT IMMUN, V70, P5446, DOI 10.1128/IAI.70.10.5446-5453.2002; Skjot RLV, 2000, INFECT IMMUN, V68, P214, DOI 10.1128/IAI.68.1.214-220.2000; Tascon RE, 1998, INFECT IMMUN, V66, P830, DOI 10.1128/IAI.66.2.830-834.1998; Thomsen AR, 1996, J IMMUNOL, V157, P3074; Turner J, 2001, AM J RESP CELL MOL, V24, P203, DOI 10.1165/ajrcmb.24.2.4370; van Pinxteren LAH, 2000, EUR J IMMUNOL, V30, P3689, DOI 10.1002/1521-4141(200012)30:12<3689::AID-IMMU3689>3.3.CO;2-W; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; Wu Y, 2008, INFECT IMMUN, V76, P2249, DOI 10.1128/IAI.00024-08	41	56	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5139	10.1371/journal.pone.0005139	http://dx.doi.org/10.1371/journal.pone.0005139			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357780	Green Published, Green Submitted, gold			2022-12-25	WOS:000265505900009
J	de Mello, WA; de Paiva, TM; Ishida, MA; Benega, MA; dos Santos, MC; Viboud, C; Miller, MA; Alonso, WJ				de Mello, Wyller Alencar; de Paiva, Terezinha Maria; Ishida, Maria Akiko; Benega, Margarete Aparecida; dos Santos, Mirleide Cordeiro; Viboud, Cecile; Miller, Mark A.; Alonso, Wladimir J.			The Dilemma of Influenza Vaccine Recommendations when Applied to the Tropics: The Brazilian Case Examined Under Alternative Scenarios	PLOS ONE			English	Article								Since 1999 the World Health Organization issues annually an additional influenza vaccine composition recommendation. This initiative aimed to extend to the Southern Hemisphere (SH) the benefits-previously enjoyed only by the Northern Hemisphere (NH)-of a vaccine recommendation issued as close as possible to the moment just before the onset of the influenza epidemic season. A short time between the issue of the recommendation and vaccine delivery is needed to maximize the chances of correct matching between putative circulating strains and one of the three strains present in the vaccine composition. Here we compare the effectiveness of the SH influenza vaccination adopted in Brazil with hypothetical alternative scenarios defined by different timings of vaccine delivery and/or composition. Scores were based on the temporal overlap between vaccine-induced protection and circulating strains. Viral data were obtained between 1999 and 2007 from constant surveillance and strain characterization in two Brazilian cities: Belem, located at the Equatorial region, and Sao Paulo, at the limit between the tropical and subtropical regions. Our results show that, among currently feasible options, the best strategy for Brazil would be to adopt the NH composition and timing, as in such case protection would increase from 30% to 65% (p<.01) if past data can be used as a prediction of the future. The influenza season starts in Brazil (and in the equator virtually ends) well before the SH winter, making the current delivery of the SH vaccination in April too late to be effective. Since Brazil encompasses a large area of the Southern Hemisphere, our results point to the possibility of these conclusions being similarly valid for other tropical regions.			de Mello, WA (corresponding author), Brazilian Minist Hlth, Secretary Surveillance Hlth, WHO Global Influenza Surveillance Network, IEC, Ananindeua, Para, Brazil.	alonsow@mail.nih.gov	Alonso, Wladimir J./N-9223-2017	Alonso, Wladimir J./0000-0001-7038-0801				Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; Antunes JLF, 2007, INT J EPIDEMIOL, V36, P1319, DOI 10.1093/ije/dym208; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; CHAKRAVERTY P, 1986, J HYG-CAMBRIDGE, V97, P347, DOI 10.1017/S0022172400065438; CUNHA SS, 2005, REV SAUDE PUBL, V39, P129; Fedson DS, 2008, BIOLOGICALS, V36, P346, DOI 10.1016/j.biologicals.2008.07.001; Fisher NI, 1996, STAT ANAL CIRCULAR D; Forleo-Neto Eduardo, 2003, Rev. Soc. Bras. Med. Trop., V36, P267, DOI 10.1590/S0037-86822003000200011; Francisco PMSB, 2005, REV SAUDE PUBL, V39, P75, DOI 10.1590/S0034-89102005000100010; Gerdil C, 2003, VACCINE, V21, P1776, DOI 10.1016/S0264-410X(03)00071-9; Gross PA, 1997, CLIN DIAGN LAB IMMUN, V4, P491, DOI 10.1128/CDLI.4.4.491-492.1997; Hampson AW, 2008, ANN ACAD MED SINGAP, V37, P510; *INMET, 2008, CLIM GRAPH; Jones TA, 2006, COMPUT GEOSCI-UK, V32, P166, DOI 10.1016/j.cageo.2005.06.009; Kitler ME, 2002, VACCINE, V20, pS5, DOI 10.1016/S0264-410X(02)00121-4; MELLO WA, 2007, VIROLOGIC SURVEILLAN; MOURA FE, 2007, INFLUENZA INFECT NE; RAMBAUT A, 2008, NATURE; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Shek Lynette Pei-Chi, 2003, Paediatr Respir Rev, V4, P105, DOI 10.1016/S1526-0542(03)00024-1; Straliotto Selir M., 2002, Rev. Soc. Bras. Med. Trop., V35, P283, DOI 10.1590/S0037-86822002000400002; *SVS MS, 2005, BRAZ PREP PLAN CONFR; Tsuchiya LRRV, 2005, J INFECTION, V51, P401, DOI 10.1016/j.jinf.2004.12.002; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; *WHO, 2008, REC INFL VACC COMP; Wong CM, 2006, PLOS MED, V3, P485, DOI 10.1371/journal.pmed.0030121	26	54	56	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5095	10.1371/journal.pone.0005095	http://dx.doi.org/10.1371/journal.pone.0005095			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19352506	gold, Green Published			2022-12-25	WOS:000265505700009
J	Marrone, A; Ballantyne, J				Marrone, April; Ballantyne, Jack			Changes in Dry State Hemoglobin over Time Do Not Increase the Potential for Oxidative DNA Damage in Dried Blood	PLOS ONE			English	Article								Background: Hemoglobin (Hb) is the iron-containing oxygen transport protein present in the red blood cells of vertebrates. Ancient DNA and forensic scientists are particularly interested in Hb reactions in the dry state because both regularly encounter aged, dried bloodstains. The DNA in such stains may be oxidatively damaged and, in theory, may be deteriorated by the presence of Hb. To understand the nature of the oxidative systems potentially available to degrade DNA in the presence of dried Hb, we need to determine what molecular species Hb forms over time. These species will determine what type of iron (i.e. Fe2+/Fe3+/Fe4+) is available to participate in further chemical reactions. The availability of "free'' iron will affect the ability of the system to undergo Fenton-type reactions which generate the highly reactive hydroxyl radical (OH center dot). The OH center dot can directly damage DNA. Methodology/Principal Findings: Oxygenated Hb (oxyHb) converts over time to oxidized Hb (metHb), but this happens more quickly in the dry state than in the hydrated state, as shown by monitoring stabilized oxyHb. In addition, dry state oxyHb converts into at least one other unknown species other than metHb. Although "free'' iron was detectable as both Fe2+ and Fe3+ in dry and hydrated oxyHb and metHb, the amount of ions detected did not increase over time. There was no evidence that Hb becomes more prone to generating OH center dot as it ages in either the hydrated or dry states. Conclusions: The Hb molecule in the dried state undergoes oxidative changes and releases reactive Fe(II) cations. These changes, however, do not appear to increase the ability of Hb to act as a more aggressive Fenton reagent over time. Nevertheless, the presence of Hb in the vicinity of DNA in dried bloodstains creates the opportunity for OH center dot-induced oxidative damage to the deoxyribose sugar and the DNA nucleobases.			Marrone, A (corresponding author), Univ Cent Florida, Dept Chem, Grad Program Chem, Orlando, FL 32816 USA.	jballant@mail.ucf.edu						BUCKNALL T, 1978, CARBOHYD RES, V62, P49, DOI 10.1016/S0008-6215(00)83377-7; CARTER P, 1971, ANAL BIOCHEM, V40, P450, DOI 10.1016/0003-2697(71)90405-2; Emerit J, 2001, BIOMED PHARMACOTHER, V55, P333, DOI 10.1016/S0753-3322(01)00068-3; FATTORINI P, 2004, INT C SERIES PROGR F, P559; FLITTER W, 1983, FEBS LETT, V158, P310, DOI 10.1016/0014-5793(83)80602-4; FRENCH JK, 1978, BIOCHEM J, V173, P19, DOI 10.1042/bj1730019; Fujita N, 2007, FREE RADICAL BIO MED, V42, P353, DOI 10.1016/j.freeradbiomed.2006.11.001; GOLDSTEIN S, 1993, FREE RADICAL BIO MED, V15, P435, DOI 10.1016/0891-5849(93)90043-T; Goswami T, 2002, BIOCHEM CELL BIOL, V80, P679, DOI 10.1139/O02-159; Grootveld M, 1986, Free Radic Res Commun, V1, P243, DOI 10.3109/10715768609051634; Guclu K, 2005, TALANTA, V65, P1226, DOI 10.1016/j.talanta.2004.08.048; Gutteridge J M, 1986, Free Radic Res Commun, V1, P173, DOI 10.3109/10715768609083149; GUTTERIDGE JMC, 1978, ANAL BIOCHEM, V91, P250, DOI 10.1016/0003-2697(78)90838-2; GUTTERIDGE JMC, 1984, FEBS LETT, V172, P245, DOI 10.1016/0014-5793(84)81134-5; GUTTERIDGE JMC, 1984, BIOCHEM J, V224, P761, DOI 10.1042/bj2240761; GUTTERIDGE JMC, 1982, INT J BIOCHEM, V14, P891, DOI 10.1016/0020-711X(82)90071-4; GUTTERIDGE JMC, 1988, BIOCHEM J, V253, P932, DOI 10.1042/bj2530932; GUTTERIDGE JMC, 1984, BIOCHEM J, V224, P697, DOI 10.1042/bj2240697; GUTTERIDGE JMC, 1986, FEBS LETT, V201, P291, DOI 10.1016/0014-5793(86)80626-3; GUTTERIDGE JMC, 1981, BIOCHEM J, V199, P263, DOI 10.1042/bj1990263; GUTTERIDGE JMC, 1981, FEBS LETT, V128, P343, DOI 10.1016/0014-5793(81)80113-5; GUTTERIDGE JMC, 1987, BIOCHEM J, V243, P709, DOI 10.1042/bj2430709; GUTTERIDGE JMC, 1986, BIOCHEM J, V234, P225, DOI 10.1042/bj2340225; GUTTERIDGE JMC, 1990, BIOCHEM J, V269, P169, DOI 10.1042/bj2690169; GUTTERIDGE JMC, 1985, FEBS LETT, V185, P19, DOI 10.1016/0014-5793(85)80732-8; HALLIWELL B, 1978, FEBS LETT, V92, P321, DOI 10.1016/0014-5793(78)80779-0; HALLIWELL B, 1981, FEBS LETT, V128, P347, DOI 10.1016/0014-5793(81)80114-7; HALLIWELL B, 1987, ANAL BIOCHEM, V165, P215, DOI 10.1016/0003-2697(87)90222-3; MOORHOUSE CP, 1985, BIOCHIM BIOPHYS ACTA, V843, P261, DOI 10.1016/0304-4165(85)90147-3; NAIR V, 1984, LIPIDS, V19, P804, DOI 10.1007/BF02534475; OCONNELL M, 1986, BIOCHEM J, V234, P727, DOI 10.1042/bj2340727; ONORI N, 2006, INTERNALTION C SERIE, P510; PUPPO A, 1988, BIOCHEM J, V249, P185, DOI 10.1042/bj2490185; RACHMILEWITZ EA, 1971, J BIOL CHEM, V246, P3356; Riggs A., 1981, Methods in Enzymology, V76, P5; Sozgen K, 2006, TALANTA, V68, P1601, DOI 10.1016/j.talanta.2005.08.043; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; WHITBURN KD, 1982, J BIOL CHEM, V257, P1860; WINTERBOURN CC, 1976, BIOCHEM J, V155, P493, DOI 10.1042/bj1550493; WINTERBOURN CC, 1990, METHOD ENZYMOL, V186, P265	41	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5110	10.1371/journal.pone.0005110	http://dx.doi.org/10.1371/journal.pone.0005110			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19352435	Green Submitted, Green Published, gold			2022-12-25	WOS:000265505700014
J	Kajiwara, Y; Akram, A; Katsel, P; Haroutunian, V; Schmeidler, J; Beecham, G; Haines, JL; Pericak-Vance, MA; Buxbaum, JD				Kajiwara, Yuji; Akram, Afia; Katsel, Pavel; Haroutunian, Vahram; Schmeidler, James; Beecham, Gary; Haines, Jonathan L.; Pericak-Vance, Margaret A.; Buxbaum, Joseph D.			FE65 Binds Teashirt, Inhibiting Expression of the Primate-Specific Caspase-4	PLOS ONE			English	Article								The Alzheimer disease (AD) amyloid protein precursor (APP) can bind the FE65 adaptor protein and this complex can regulate gene expression. We carried out yeast two-hybrid studies with a PTB domain of FE65, focusing on those genes that might be involved in nuclear signaling, and identified and validated Teashirt proteins as FE65 interacting proteins in neurons. Using reporter systems, we observed that FE65 could simultaneously recruit SET, a component of the inhibitor of acetyl transferase, and Teashirt, which in turn recruited histone deacetylases, to produce a powerful gene-silencing complex. We screened stable cell lines with a macroarray focusing on AD-related genes and identified CASP4, encoding caspase-4, as a target of this silencing complex. Chromatin immunoprecipitation showed a direct interaction of FE65 and Teashirt3 with the promoter region of CASP4. Expression studies in postmortem samples demonstrated decreasing expression of Teashirt and increasing expression of caspase-4 with progressive cognitive decline. Importantly, there were significant increases in caspase-4 expression associated with even the earliest neuritic plaque changes in AD. We evaluated a case-control cohort and observed evidence for a genetic association between the Teashirt genes TSHZ1 and TSHZ3 and AD, with the TSHZ3 SNP genotype correlating with expression of Teashirt3. The results were consistent with a model in which reduced expression of Teashirt3, mediated by genetic or other causes, increases caspase-4 expression, leading to progression of AD. Thus the cell biological, gene expression and genetic data support a role for Teashirt/caspase-4 in AD biology. As caspase-4 shows evidence of being a primate-specific gene, current models of AD and other neurodegenerative conditions may be incomplete because of the absence of this gene in the murine genome.	[Kajiwara, Yuji; Akram, Afia; Buxbaum, Joseph D.] Mt Sinai Sch Med, Lab Mol Neuropsychiat, New York, NY USA; [Kajiwara, Yuji; Akram, Afia; Katsel, Pavel; Haroutunian, Vahram; Schmeidler, James; Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Kajiwara, Yuji; Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Beecham, Gary; Pericak-Vance, Margaret A.] Univ Miami, Miller Sch Med, Miami Inst Human Genom, Miami, FL USA; [Haines, Jonathan L.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Miami; Vanderbilt University	Kajiwara, Y (corresponding author), Mt Sinai Sch Med, Lab Mol Neuropsychiat, New York, NY USA.	joseph.buxbaum@mssm.edu	Haines, Jonathan/C-3374-2012; Buxbaum, Joseph D/G-6001-2010	Haines, Jonathan/0000-0002-4351-4728; Buxbaum, Joseph/0000-0001-8898-8313; kajiwara, yuji/0000-0002-9307-8215	National Institute of Health [AG021792, AG005138, AG010491, AG002219]; G. Harold and Leila Y. Mathers Research Professor of Geriatrics and Adult Development; NIH-NCI [CA095823]; NATIONAL CANCER INSTITUTE [R24CA095823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG002219, P01AG010491, R01AG021792, P50AG005138] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Research Professor of Geriatrics and Adult Development; NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute of Health Grants AG021792 (JDB, PI), AG005138 (Dr. M. Sano, PI; JDB, PL), AG010491 (Dr. S. E. Gandy, PI; JDB, PL), and AG002219 (VH, PI; JDB, PL). Dr. Buxbaum is the G. Harold and Leila Y. Mathers Research Professor of Geriatrics and Adult Development. The MS-MSRF was supported by an NIH-NCI shared resources grant (CA095823). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre E, 1996, MECH DEVELOP, V59, P191, DOI 10.1016/0925-4773(96)00594-1; Araki Y, 2003, J BIOL CHEM, V278, P49448, DOI 10.1074/jbc.M306024200; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; BARTLETT WP, 1984, J NEUROSCI, V4, P1944; Beecham GW, 2009, AM J HUM GENET, V84, P35, DOI 10.1016/j.ajhg.2008.12.008; Bruni P, 2002, J BIOL CHEM, V277, P35481, DOI 10.1074/jbc.M205227200; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Caubit X, 2005, J COMP NEUROL, V486, P76, DOI 10.1002/cne.20500; Caubit X, 2000, MECH DEVELOP, V91, P445, DOI 10.1016/S0925-4773(99)00318-4; Delacourte A, 1999, NEUROLOGY, V52, P1158, DOI 10.1212/WNL.52.6.1158; Dokmanovic M, 2005, J CELL BIOCHEM, V96, P293, DOI 10.1002/jcb.20532; Dracheva S, 2005, J NEUROSCI RES, V79, P868, DOI 10.1002/jnr.20423; Dracheva S, 2004, J NEUROSCI RES, V76, P581, DOI 10.1002/jnr.20122; Dracheva S, 2003, J NEUROCHEM, V87, P1402, DOI 10.1046/j.1471-4159.2003.02115.x; Dracheva S, 2001, AM J PSYCHIAT, V158, P1400, DOI 10.1176/appi.ajp.158.9.1400; DUILIO A, 1991, NUCLEIC ACIDS RES, V19, P5269, DOI 10.1093/nar/19.19.5269; Ebinu JO, 2002, NEURON, V34, P499, DOI 10.1016/S0896-6273(02)00704-3; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Fiore F, 1995, J BIOL CHEM, V270, P30853, DOI 10.1074/jbc.270.52.30853; Forman-Kay JD, 1999, CURR OPIN STRUC BIOL, V9, P690, DOI 10.1016/S0959-440X(99)00031-7; Friedlander RM, 1997, NATURE, V388, P31, DOI 10.1038/40299; Friedlander RM, 1997, J EXP MED, V185, P933, DOI 10.1084/jem.185.5.933; Furuya T, 2004, J NEUROSCI, V24, P1865, DOI 10.1523/JNEUROSCI.3309-03.2004; Gallet A, 1998, CURR BIOL, V8, P893, DOI 10.1016/S0960-9822(07)00369-7; Gallet A, 2000, DEVELOPMENT, V127, P5509; Gaughan L, 2002, J BIOL CHEM, V277, P25904, DOI 10.1074/jbc.M203423200; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Haroutunian V, 1998, ARCH NEUROL-CHICAGO, V55, P1185, DOI 10.1001/archneur.55.9.1185; HAROUTUNIAN V, 2007, NEUROBIOL AGING; Hass MR, 2005, J BIOL CHEM, V280, P36895, DOI 10.1074/jbc.M502861200; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kang SJ, 2003, J NEUROSCI, V23, P5455; Kordower JH, 2001, ANN NEUROL, V49, P202, DOI 10.1002/1531-8249(20010201)49:2<202::AID-ANA40>3.3.CO;2-V; Lee HJ, 2001, J BIOL CHEM, V276, P16597, DOI 10.1074/jbc.C000909200; LIN JZ, 2000, INT J NONLINEAR SCI, V1, P275; Manfroid I, 2004, DEVELOPMENT, V131, P1065, DOI 10.1242/dev.00977; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446; PALMERT MR, 1988, SCIENCE, V241, P1080, DOI 10.1126/science.2457949; Pompl PN, 2003, ARCH NEUROL-CHICAGO, V60, P369, DOI 10.1001/archneur.60.3.369; Pounds S, 2003, BIOINFORMATICS, V19, P1236, DOI 10.1093/bioinformatics/btg148; REINHARD C, 2005, EMBO J; Sabo SL, 1999, J BIOL CHEM, V274, P7952, DOI 10.1074/jbc.274.12.7952; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Taghli-Lamallem O, 2007, DEV BIOL, V307, P142, DOI 10.1016/j.ydbio.2007.04.028; Telese F, 2005, EMBO REP, V6, P77, DOI 10.1038/sj.embor.7400309; Waltzer L, 2001, EMBO J, V20, P137, DOI 10.1093/emboj/20.1.137; WANG LY, 1996, J POLYM RES, V3, P1; Xiao H, 2003, J BIOL CHEM, V278, P11197, DOI 10.1074/jbc.M210816200; Yang Z, 2006, J BIOL CHEM, V281, P4207, DOI 10.1074/jbc.M508445200; Zambrano N, 1998, J BIOL CHEM, V273, P20128, DOI 10.1074/jbc.273.32.20128; Zambrano N, 1997, J BIOL CHEM, V272, P6399, DOI 10.1074/jbc.272.10.6399	55	30	44	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2009	4	4							e5071	10.1371/journal.pone.0005071	http://dx.doi.org/10.1371/journal.pone.0005071			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437QA	19343227	Green Published, gold			2022-12-25	WOS:000265500800008
J	Singh, U; Bongcam-Rudloff, E; Westermark, B				Singh, Umashankar; Bongcam-Rudloff, Erik; Westermark, Bengt			A DNA Sequence Directed Mutual Transcription Regulation of HSF1 and NFIX Involves Novel Heat Sensitive Protein Interactions	PLOS ONE			English	Article							NUCLEAR-FACTOR-I; BINDING DOMAIN; SACCHAROMYCES-CEREVISIAE; BRAIN-DEVELOPMENT; GENE-EXPRESSION; MICROARRAY DATA; MESSENGER-RNA; SHOCK FACTOR; REPLICATION; IDENTIFICATION	Background: Though the Nuclear factor 1 family member NFIX has been strongly implicated in PDGFB-induced glioblastoma, its molecular mechanisms of action remain unknown. HSF1, a heat shock-related transcription factor is also a powerful modifier of carcinogenesis by several factors, including PDGFB. How HSF1 transcription is controlled has remained largely elusive. Methodology/Principal Findings: By combining microarray expression profiling and a yeast-two-hybrid screen, we identified that NFIX and its interactions with CGGBP1 and HMGN1 regulate expression of HSF1. We found that CGGBP1 organizes a bifunctional transcriptional complex at small CGG repeats in the HSF1 promoter. Under chronic heat shock, NFIX uses CGGBP1 and HMGN1 to get recruited to this promoter and in turn affects their binding to DNA. Results show that the interactions of NFIX with CGGBP1 and HMGN1 in the soluble fraction are heat shock sensitive due to preferential localization of CGGBP1 to heterochromatin after heat shock. HSF1 in turn was found to bind to the NFIX promoter and repress its expression in a heat shock sensitive manner. Conclusions/Significance: NFIX and HSF1 exert a mutual transcriptional repressive effect on each other which requires CGG repeat in HSF1 promoter and HSF1 binding site in NFIX promoter. We unravel a unique mechanism of heat shock sensitive DNA sequence-directed reciprocal transcriptional regulation between NFIX and HSF1. Our findings provide new insights into mechanisms of transcription regulation under stress.	[Singh, Umashankar; Westermark, Bengt] Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden; [Bongcam-Rudloff, Erik] Uppsala Univ, Linnaeus Ctr Bioinformat, Uppsala, Sweden	Uppsala University; Uppsala University	Singh, U (corresponding author), Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden.	umashankar.singh@genpat.uu.se; bengt.westermark@genpat.uu.se	Singh, Umashankar/ABE-3830-2020	Singh, Umashankar/0000-0001-8578-8201	Emil Ragna-Borjessons Minnesfond [postdoctoral fellowships]; Cancerfonden [UFV-PA 2008/2876, 070129]; Barncancerfonden [05/028]; Vetenskapradet [K2008-66X-20759-01-3, 521-2007-2033]	Emil Ragna-Borjessons Minnesfond; Cancerfonden(Swedish Cancer Society); Barncancerfonden; Vetenskapradet	Umashankar Singh was supported by postdoctoral fellowships from Emil Ragna-Borjessons Minnesfond and Cancerfonden (UFV-PA 2008/2876). This work was funded by grants to Bengt Westermark from Barncancerfonden (05/028), Cancerfonden (070129) and Vetenskapradet (K2008-66X-20759-01-3 and 521-2007-2033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alevizopoulos A, 1995, GENE DEV, V9, P3051, DOI 10.1101/gad.9.24.3051; Belova GI, 2008, J BIOL CHEM, V283, P8080, DOI 10.1074/jbc.M709782200; Blomquist P, 1996, J BIOL CHEM, V271, P153, DOI 10.1074/jbc.271.1.153; Campbell CE, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-52; Chaudhry AZ, 1999, J BIOL CHEM, V274, P7072, DOI 10.1074/jbc.274.11.7072; CHIANG CM, 1995, SCIENCE, V267, P531, DOI 10.1126/science.7824954; Clouaire T, 2008, CELL MOL LIFE SCI, V65, P1509, DOI 10.1007/s00018-008-7324-y; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Deissler H, 1997, J BIOL CHEM, V272, P16761, DOI 10.1074/jbc.272.27.16761; Driller K, 2007, MOL CELL BIOL, V27, P3855, DOI 10.1128/MCB.02293-06; Fletcher CF, 1999, MAMM GENOME, V10, P390, DOI 10.1007/s003359901008; Fujimura K, 2008, EXP CELL RES, V314, P543, DOI 10.1016/j.yexcr.2007.10.024; Gopalan SM, 2006, J BIOL CHEM, V281, P13126, DOI 10.1074/jbc.M601194200; Gottardo R, 2003, BIOSTATISTICS, V4, P597, DOI 10.1093/biostatistics/4.4.597; GOUNARI F, 1990, EMBO J, V9, P559, DOI 10.1002/j.1460-2075.1990.tb08143.x; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; HENNIGHAUSEN L, 1985, NATURE, V314, P289, DOI 10.1038/314289a0; Johansson FK, 2004, P NATL ACAD SCI USA, V101, P11334, DOI 10.1073/pnas.0402716101; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; KROEGER PE, 1994, MOL CELL BIOL, V14, P7592, DOI 10.1128/MCB.14.11.7592; LEEGWATER PAJ, 1985, EMBO J, V4, P1515, DOI 10.1002/j.1460-2075.1985.tb03811.x; Lonnstedt I, 2002, STAT SINICA, V12, P31; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; MERMOD N, 1989, CELL, V58, P741, DOI 10.1016/0092-8674(89)90108-6; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; Naumann F, 2004, GENOMICS, V83, P106, DOI 10.1016/S0888-7543(03)00212-X; NOWOCK J, 1985, NUCLEIC ACIDS RES, V13, P2045, DOI 10.1093/nar/13.6.2045; Ouellet S, 2006, NUCLEIC ACIDS RES, V34, P6472, DOI 10.1093/nar/gkl861; PERISIC O, 1989, CELL, V59, P797, DOI 10.1016/0092-8674(89)90603-X; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; SCHUUR ER, 1995, CELL GROWTH DIFFER, V6, P219; Shi Y, 2007, MOL CELL, V28, P79, DOI 10.1016/j.molcel.2007.08.028; Shu TZ, 2003, J NEUROSCI, V23, P203; SLATER MR, 1987, MOL CELL BIOL, V7, P1906, DOI 10.1128/MCB.7.5.1906; Steele-Perkins G, 2005, MOL CELL BIOL, V25, P685, DOI 10.1128/MCB.25.2.685-698.2005; Steele-Perkins G, 2003, MOL CELL BIOL, V23, P1075, DOI 10.1128/MCB.23.3.1075-1084.2003; Sun PQ, 1998, SCIENCE, V282, P2270, DOI 10.1126/science.282.5397.2270; TAMAI KT, 1994, MOL CELL BIOL, V14, P8155, DOI 10.1128/MCB.14.12.8155; Wendler WMF, 1997, J BIOL CHEM, V272, P8482, DOI 10.1074/jbc.272.13.8482; West KL, 2004, BIOCHEM SOC T, V32, P918, DOI 10.1042/BST0320918; WESTERMARK B, 1995, GLIA, V15, P257, DOI 10.1002/glia.440150307; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; XIAO H, 1991, CELL, V64, P585, DOI 10.1016/0092-8674(91)90242-Q; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Yamamoto A, 2005, J BIOL CHEM, V280, P11911, DOI 10.1074/jbc.M411256200; Yamamoto A, 2006, BIOCHEM BIOPH RES CO, V346, P1324, DOI 10.1016/j.bbrc.2006.06.057	46	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5050	10.1371/journal.pone.0005050	http://dx.doi.org/10.1371/journal.pone.0005050			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337383	Green Published, Green Submitted, gold			2022-12-25	WOS:000265500600014
J	Sandhya, S; Rani, SS; Pankaj, B; Govind, MK; Offmann, B; Srinivasan, N; Sowdhamini, R				Sandhya, Sankaran; Rani, Saane Sudha; Pankaj, Barah; Govind, Madabosse Kande; Offmann, Bernard; Srinivasan, Narayanaswamy; Sowdhamini, Ramanathan			Length Variations amongst Protein Domain Superfamilies and Consequences on Structure and Function	PLOS ONE			English	Article								Background: Related protein domains of a superfamily can be specified by proteins of diverse lengths. The structural and functional implications of indels in a domain scaffold have been examined. Methodology: In this study, domain superfamilies with large length variations (more than 30% difference from average domain size, referred as 'length-deviant' superfamilies and 'length-rigid' domain superfamilies (<10% length difference from average domain size) were analyzed for the functional impact of such structural differences. Our delineated dataset, derived from an objective algorithm, enables us to address indel roles in the presence of peculiar structural repeats, functional variation, protein-protein interactions and to examine 'domain contexts' of proteins tolerant to large length variations. Amongst the top-10 length-deviant superfamilies analyzed, we found that 80% of length-deviant superfamilies possess distant internal structural repeats and nearly half of them acquired diverse biological functions. In general, length-deviant superfamilies have higher chance, than length-rigid superfamilies, to be engaged in internal structural repeats. We also found that similar to 40% of length-deviant domains exist as multi-domain proteins involving interactions with domains from the same or other superfamilies. Indels, in diverse domain superfamilies, were found to participate in the accretion of structural and functional features amongst related domains. With specific examples, we discuss how indels are involved directly or indirectly in the generation of oligomerization interfaces, introduction of substrate specificity, regulation of protein function and stability. Conclusions: Our data suggests a multitude of roles for indels that are specialized for domain members of different domain superfamilies. These specialist roles that we observe and trends in the extent of length variation could influence decision making in modeling of new superfamily members. Likewise, the observed limits of length variation, specific for each domain superfamily would be particularly relevant in the choice of alignment length search filters commonly applied in protein sequence analysis.	[Sandhya, Sankaran; Rani, Saane Sudha; Pankaj, Barah; Govind, Madabosse Kande; Sowdhamini, Ramanathan] Natl Ctr Biol Sci TIFR, Bangalore, Karnataka, India; [Offmann, Bernard] Univ La Reunion, Lab Biochim Genet Mol, BP 7151, La Reunion, France; [Srinivasan, Narayanaswamy] Indian Inst Sci, Mol Biophys Unit, Bangalore, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of La Reunion; Indian Institute of Science (IISC) - Bangalore	Sandhya, S (corresponding author), Natl Ctr Biol Sci TIFR, GKVK Campus, Bangalore, Karnataka, India.	mini@ncbs.res.in	OFFMANN, Bernard/B-5901-2011	OFFMANN, Bernard/0000-0002-6845-5883; Sandhya, Sankaran/0000-0003-0055-302X; Barah, Pankaj/0000-0001-7039-7996	Department of Biotechnology, India	Department of Biotechnology, India(Department of Biotechnology (DBT) India)	R.S. was an International Senior Research Fellow of the Wellcome Trust, U.K.. S.S. thanks the Council of Scientific and Industrial Research, India for Ph.D research fellowship. We gratefully acknowledge NCBS-TIFR for infrastructural support. N.S. would like to thank Department of Biotechnology, India for financial support. We thank Profs. Saraswathi Vishweshwara and M.K. Mathew for useful discussions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apic G, 2001, Bioinformatics, V17 Suppl 1, pS83; Apic G, 2001, J MOL BIOL, V310, P311, DOI 10.1006/jmbi.2001.4776; BAIROCH A, 1991, NUCLEIC ACIDS RES, V19, P2247, DOI 10.1093/nar/19.suppl.2247; Benini S, 2000, BIOCHEMISTRY-US, V39, P13115, DOI 10.1021/bi000402j; Benson SD, 2002, ACTA CRYSTALLOGR D, V58, P39, DOI 10.1107/S0907444901017279; Benson SD, 1999, CELL, V98, P825, DOI 10.1016/S0092-8674(00)81516-0; Berman HM, 2000, NAT STRUCT BIOL, V7, P957, DOI 10.1038/80734; Bhaduri A, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-35; Bjorklund AK, 2006, PLOS COMPUT BIOL, V2, P959, DOI 10.1371/journal.pcbi.0020114; CHOTHIA C, 1992, NATURE, V357, P543, DOI 10.1038/357543a0; Cunane LM, 2000, J MOL BIOL, V295, P357, DOI 10.1006/jmbi.1999.3290; Ekman D, 2007, J MOL BIOL, V372, P1337, DOI 10.1016/j.jmb.2007.06.022; FLAHERTY KM, 1991, P NATL ACAD SCI USA, V88, P5041, DOI 10.1073/pnas.88.11.5041; Gough J, 2002, ACTA CRYSTALLOGR D, V58, P1897, DOI 10.1107/S0907444902015160; Heringa J, 1998, CURR OPIN STRUC BIOL, V8, P338, DOI 10.1016/S0959-440X(98)80068-7; Heringa J, 1997, CURR OPIN STRUC BIOL, V7, P416, DOI 10.1016/S0959-440X(97)80060-7; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; HUTCHINSON EG, 1990, PROTEINS, V8, P203, DOI 10.1002/prot.340080303; Jiang H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-444; KLEYWEGT GJ, 1994, CCP4 ESF EACBM NEWSL, V31, P9; Leiros I, 2000, STRUCTURE, V8, P655, DOI 10.1016/S0969-2126(00)00150-7; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Orengo CA, 2005, ANNU REV BIOCHEM, V74, P867, DOI 10.1146/annurev.biochem.74.082803.133029; ORENGO CA, 1994, NATURE, V372, P631, DOI 10.1038/372631a0; PASCARELLA S, 1992, J MOL BIOL, V224, P461, DOI 10.1016/0022-2836(92)91008-D; Pearl F, 2005, NUCLEIC ACIDS RES, V33, pD247, DOI 10.1093/nar/gki024; Quiocho FA, 2000, CURR OPIN STRUC BIOL, V10, P78, DOI 10.1016/S0959-440X(99)00053-6; Redfern OC, 2008, CURR OPIN STRUC BIOL, V18, P394, DOI 10.1016/j.sbi.2008.05.007; Reeves GA, 2006, J MOL BIOL, V360, P725, DOI 10.1016/j.jmb.2006.05.035; RUSSELL RB, 1994, J MOL BIOL, V244, P332, DOI 10.1006/jmbi.1994.1733; Rux JJ, 2003, J VIROL, V77, P9553, DOI 10.1128/JVI.77.17.9553-9566.2003; SALI A, 1990, J MOL BIOL, V212, P403, DOI 10.1016/0022-2836(90)90134-8; Sandhya S, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-28; Stuckey JA, 1999, NAT STRUCT BIOL, V6, P278; Szklarczyk R, 2004, BIOINFORMATICS, V20, P311, DOI 10.1093/bioinformatics/bth911; Than ME, 1997, J MOL BIOL, V271, P629, DOI 10.1006/jmbi.1997.1181; Todd AE, 2001, J MOL BIOL, V307, P1113, DOI 10.1006/jmbi.2001.4513; van Asselt EJ, 1999, STRUCT FOLD DES, V7, P1167, DOI 10.1016/S0969-2126(00)80051-9; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Wolf Y, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-19; Zhang JZ, 2000, TRENDS GENET, V16, P107, DOI 10.1016/S0168-9525(99)01922-8; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509	44	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e4981	10.1371/journal.pone.0004981	http://dx.doi.org/10.1371/journal.pone.0004981			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333395	Green Published, Green Submitted, gold			2022-12-25	WOS:000265499900008
J	Duka, T; Duka, V; Joyce, JN; Sidhu, A				Duka, Tetyana; Duka, Valeriy; Joyce, Jeffrey N.; Sidhu, Anita			alpha-Synuclein contributes to GSK-3 beta-catalyzed Tau phosphorylation in Parkinson's disease models	FASEB JOURNAL			English	Article						synucleopathies; tauopathies; neurodegeneration; Alzheimer's disease	GLYCOGEN-SYNTHASE KINASE-3-BETA; LEWY BODY PATHOLOGY; ALZHEIMERS-DISEASE; DOPAMINE TRANSPORTER; POSITIVE STRUCTURES; TRANSGENIC MICE; BODIES; LITHIUM; NEURONS; PROTEIN	We have shown in the parkinsonism-inducing neurotoxin MPP+/MPTP model that alpha-Synuclein (alpha-Syn), a presynaptic protein causal in Parkinson's disease (PD), contributes to hyperphosphorylation of Tau (p-Tau), a protein normally linked to tauopathies, such as Alzheimer's disease (AD). Here, we investigated the kinase involved and show that the Tau-specific kinase, glycogen synthase kinase 3 beta (GSK-3 beta), is robustly activated in various MPP+/MPTP models of Parkinsonism (SH-SY5Y cotransfected cells, mesencephalic neurons, transgenic mice overexpressing alpha-Syn, and postmortem striatum of PD patients). The activation of GSK-3 beta was absolutely dependent on the presence of alpha-Syn, as indexed by the absence of p-GSK-3 beta in cells lacking alpha-Syn and in alpha-Syn KO mice. MPP+ treatment induced translocation and accumulation of p-GSK-3 beta in nuclei of SH-SY5Y cells and mesencephalic neurons. Through coimmunoprecipitation (co-IP), we found that alpha-Syn, pSer396/404-Tau, and p-GSK-3 beta exist as a heterotrimeric complex in SH-SY5Y cells. GSK-3 beta inhibitors (lithium and TDZD-8) protected against MPP+-induced events in SH-SY5Y cells, preventing cell death and p-GSK-3 beta formation, by reversing increases in alpha-Syn accumulation and p-Tau formation. These data unveil a previously unappreciated role of alpha-Syn in the induction of p-GSK-3 beta, and demonstrate the importance of this kinase in the genesis and maintenance of neurodegenerative changes associated with PD.-Duka, T., Duka, V., Joyce, J. N., Sidhu, A. alpha-Synuclein contributes to GSK-3 beta-catalyzed Tau phosphorylation in Parkinson's disease models. FASEB J. 23, 2820-2830 (2009). www.fasebj.org	[Duka, Tetyana; Duka, Valeriy; Sidhu, Anita] Georgetown Univ, Dept Biochem Mol & Cellular Biol, Washington, DC USA; [Joyce, Jeffrey N.] Maricopa Integrated Hlth Syst, Dept Res, Phoenix, AZ USA	Georgetown University; Maricopa County General Hospital	Sidhu, A (corresponding author), Lab Mol Neurochem, Res Bldg,Rm W222,3970 Reservoir Rd NW, Washington, DC 20007 USA.	sidhua@georgetown.edu		Joyce, Jeffrey/0000-0002-0131-0946	National Institute of Aging [R01AG028108]; National Institutes of Neurological Disorders and Stroke [R01NS45326]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028108] Funding Source: NIH RePORTER	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to Dr. P. Davies (Albert Einstein College of Medicine, Bronx, NY, USA) for providing the antibodies PHF-1 and CP13 against Tau phosphorylated at Ser-396/404 and Ser-202. We thank Dr. John L. Goudreau (Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI, USA) for providing the striata from MPTP-treated alpha-Syn-knockout mice. We also thank Dr. Milan Rusnak for isolation of mesencephalic primary neurons. This work was supported in part by grants from the National Institute of Aging, R01AG028108, and National Institutes of Neurological Disorders and Stroke, R01NS45326, to A.S.	Agarwal-Mawal A, 2003, J BIOL CHEM, V278, P12722, DOI 10.1074/jbc.M211491200; Arai Y, 2001, BRAIN RES, V888, P287, DOI 10.1016/S0006-8993(00)03082-1; Arima K, 1999, BRAIN RES, V843, P53, DOI 10.1016/S0006-8993(99)01848-X; Bedford L, 2008, BBA-MOL BASIS DIS, V1782, P683, DOI 10.1016/j.bbadis.2008.10.009; Bhat RV, 2000, P NATL ACAD SCI USA, V97, P11074, DOI 10.1073/pnas.190297597; Bijur GN, 2000, J BIOL CHEM, V275, P7583, DOI 10.1074/jbc.275.11.7583; Bijur GN, 2001, J BIOL CHEM, V276, P37436, DOI 10.1074/jbc.M105725200; Caccamo A, 2007, AM J PATHOL, V170, P1669, DOI 10.2353/ajpath.2007.061178; Chen G, 2004, FASEB J, V18, P1162, DOI 10.1096/fj.04-1551fje; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Cole AR, 2004, J BIOL CHEM, V279, P50176, DOI 10.1074/jbc.C400412200; Dickson DW, 1999, BRAIN PATHOL, V9, P657; Drolet RE, 2004, NEUROTOXICOLOGY, V25, P761, DOI 10.1016/j.neuro.2004.05.002; Duka T, 2006, FASEB J, V20, P2302, DOI 10.1096/fj.06-6092com; Duka T, 2006, NEUROTOX RES, V10, P1, DOI 10.1007/BF03033329; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Frasier M, 2005, EXP NEUROL, V192, P274, DOI 10.1016/j.expneurol.2004.07.016; Frasier M, 2004, EXP NEUROL, V187, P235, DOI 10.1016/j.expneurol.2004.02.008; Geddes JW, 2005, EXP NEUROL, V192, P244, DOI 10.1016/j.expneurol.2004.12.002; Goers J, 2003, BIOCHEMISTRY-US, V42, P8465, DOI 10.1021/bi0341152; Gomez-Ramos A, 2004, BRAIN RES, V1007, P57, DOI 10.1016/j.brainres.2004.01.071; Habas A, 2006, J NEUROCHEM, V96, P335, DOI 10.1111/j.1471-4159.2005.03543.x; Hamilton RL, 2000, BRAIN PATHOL, V10, P378; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Hernandez F, 2002, J NEUROCHEM, V83, P1529, DOI 10.1046/j.1471-4159.2002.01269.x; Hetman M, 2000, J NEUROSCI, V20, P2567; Hishikawa N, 2003, NEUROPATH APPL NEURO, V29, P280, DOI 10.1046/j.1365-2990.2003.00470.x; Hong M, 1997, J BIOL CHEM, V272, P25326, DOI 10.1074/jbc.272.40.25326; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Ishizawa T, 2003, J NEUROPATH EXP NEUR, V62, P389, DOI 10.1093/jnen/62.4.389; Jeannotte AM, 2007, EUR J NEUROSCI, V26, P1509, DOI 10.1111/j.1460-9568.2007.05757.x; Joyce JN, 2003, EXP NEUROL, V184, P393, DOI 10.1016/S0014-4886(03)00353-4; Joyce JN, 2002, BRAIN RES, V955, P138, DOI 10.1016/S0006-8993(02)03396-6; Kawakami F, 2008, J BIOCHEM, V143, P359, DOI 10.1093/jb/mvm228; Kim JE, 2007, J CLIN NEUROL, V3, P9, DOI 10.3988/jcn.2007.3.1.9; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Kotzbauer PT, 2001, J MOL NEUROSCI, V17, P225, DOI 10.1385/JMN:17:2:225; Kozikowski AP, 2006, CHEMMEDCHEM, V1, P256, DOI 10.1002/cmdc.200500039; Kwok JBJ, 2005, ANN NEUROL, V58, P829, DOI 10.1002/ana.20691; Li BL, 2004, TRANSGENIC RES, V13, P385, DOI 10.1023/B:TRAG.0000040039.44899.6f; Lippa CF, 1999, ANN NEUROL, V45, P353, DOI 10.1002/1531-8249(199903)45:3<353::AID-ANA11>3.0.CO;2-4; Lippa Sara M, 2005, Am J Alzheimers Dis Other Demen, V20, P315, DOI 10.1177/153331750502000506; Lochhead PA, 2006, MOL CELL, V24, P627, DOI 10.1016/j.molcel.2006.10.009; Loo DT, 1998, METHOD CELL BIOL, V57, P251; LOVESTONE S, 1994, CURR BIOL, V4, P1077, DOI 10.1016/S0960-9822(00)00246-3; Luna-Munoz J, 2005, J ALZHEIMERS DIS, V8, P29; Martinez A, 2008, J ALZHEIMERS DIS, V15, P181; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; MunozMontano JR, 1997, FEBS LETT, V411, P183, DOI 10.1016/S0014-5793(97)00688-1; Muntane G, 2008, NEUROSCIENCE, V152, P913, DOI 10.1016/j.neuroscience.2008.01.030; Ostrerova N, 1999, J NEUROSCI, V19, P5782, DOI 10.1523/JNEUROSCI.19-14-05782.1999; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Popescu A, 2004, ARCH NEUROL-CHICAGO, V61, P1915, DOI 10.1001/archneur.61.12.1915; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Trembath Y, 2003, ACTA NEUROPATHOL, V105, P484, DOI 10.1007/s00401-003-0670-9; Vadivelan S, 2009, EUR J MED CHEM, V44, P2361, DOI 10.1016/j.ejmech.2008.08.012; Wang WY, 2007, NEUROPHARMACOLOGY, V52, P1678, DOI 10.1016/j.neuropharm.2007.03.017; Wersinger C, 2005, BIOCHEMISTRY-US, V44, P13612, DOI 10.1021/bi050402p; Wersinger C, 2003, FASEB J, V17, P2151, DOI 10.1096/fj.03-0152fje	59	191	196	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2009	23	9					2820	2830		10.1096/fj.08-120410	http://dx.doi.org/10.1096/fj.08-120410			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19369384	Green Published			2022-12-25	WOS:000270241000005
J	Ryan, RM; Compton, ELR; Mindell, JA				Ryan, Renae M.; Compton, Emma L. R.; Mindell, Joseph A.			Functional Characterization of a Na+-dependent Aspartate Transporter from Pyrococcus horikoshii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL GLUTAMATE TRANSPORTER; SCANNING MUTAGENESIS REVEALS; CHLORIDE PERMEATION PATHWAY; RAT-BRAIN; REENTRANT LOOP; SUBSTRATE-BINDING; ACID TRANSPORTER; ACTIVE-TRANSPORT; ION FLUXES; RECONSTITUTION	Excitatory amino acid transporters (EAATs) are crucial in maintaining extracellular levels of glutamate, the most abundant excitatory neurotransmitter, below toxic levels. The recent three-dimensional crystal structure of Glt(Ph), an archaeal homolog of the EAATs, provides elegant structural details of this family of proteins, yet we know little about the mechanism of the bacterial transporter. Conflicting reports in the literature have described Glt(Ph) as an aspartate transporter driven by Na+ or a glutamate transporter driven by either Na+ or H+. Here we use purified protein reconstituted into liposomes to thoroughly characterize the ion and substrate dependence of the Glt(Ph) transport. We confirm that Glt(Ph) is a Na+-dependent transporter that is highly selective for aspartate over other amino acids, and we show that transport is coupled to at least two Na+ ions. In contrast to the EAATs, transport via Glt(Ph) is independent of H+ and K+. We propose a kinetic model of transport in which at least two Na+ ions are coupled to the cotransport of each aspartate molecule by Glt(Ph), and where an ion-and substrate-free transporter reorients to complete the transport cycle.	[Ryan, Renae M.; Compton, Emma L. R.; Mindell, Joseph A.] NINDS, Membrane Transport Biophys Unit, Porter Neurosci Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Mindell, JA (corresponding author), 35 Convent Dr,Bldg 35,MSC 3701, Bethesda, MD 20892 USA.	mindellj@ninds.nih.gov	Mindell, Joseph/P-4461-2017; Ryan, Renae/AAC-3540-2021	Mindell, Joseph/0000-0002-6952-8247; Ryan, Renae/0000-0002-8680-4610; Compton-Daw, Emma/0000-0002-3832-7194	National Institutes of Health; Australian National Health and Medical Research Council [358779]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003014, Z01NS003014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole, or in part, by a National Institutes of Health grant from NINDS Intramural Program. This work was also supported by Australian National Health and Medical Research Council C. J. Martin Postdoctoral Fellowship 358779 (to R. M. R.).	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Billups B, 1996, J NEUROSCI, V16, P6722; Borre L, 2002, J BIOL CHEM, V277, P13501, DOI 10.1074/jbc.M110861200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DANBOLT NC, 1990, BIOCHEMISTRY-US, V29, P6734, DOI 10.1021/bi00480a025; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; FERSHT A, 1985, ENZYME STRUCTURE MEC, P101; Gaillard I, 1996, BIOCHEMISTRY-US, V35, P6150, DOI 10.1021/bi953005v; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Grewer C, 2003, J BIOL CHEM, V278, P2585, DOI 10.1074/jbc.M207956200; Grunewald M, 2002, J BIOL CHEM, V277, P26074, DOI 10.1074/jbc.M202248200; Grunewald M, 1998, NEURON, V21, P623, DOI 10.1016/S0896-6273(00)80572-3; Grunewald M, 2000, J BIOL CHEM, V275, P9684, DOI 10.1074/jbc.275.13.9684; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; KANNER BI, 1978, FEBS LETT, V94, P245, DOI 10.1016/0014-5793(78)80947-8; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; Leighton BH, 2002, J BIOL CHEM, V277, P29847, DOI 10.1074/jbc.M202508200; Raunser S, 2006, BIOCHEMISTRY-US, V45, P12796, DOI 10.1021/bi061008+; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; Ryan RM, 2007, NAT STRUCT MOL BIOL, V14, P365, DOI 10.1038/nsmb1230; Ryan RM, 2004, J BIOL CHEM, V279, P20742, DOI 10.1074/jbc.M304433200; Ryan RM, 2002, J BIOL CHEM, V277, P13494, DOI 10.1074/jbc.M109970200; Seal RP, 1998, NEURON, V21, P1487, DOI 10.1016/S0896-6273(00)80666-2; Slotboom DJ, 1999, MICROBIOL MOL BIOL R, V63, P293, DOI 10.1128/MMBR.63.2.293-307.1999; Slotboom DJ, 1999, P NATL ACAD SCI USA, V96, P14282, DOI 10.1073/pnas.96.25.14282; Slotboom DJ, 2001, J BIOL CHEM, V276, P10775, DOI 10.1074/jbc.M011064200; VANDENBERG RJ, 1995, J BIOL CHEM, V270, P17668, DOI 10.1074/jbc.270.30.17668; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	36	86	87	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17540	17548		10.1074/jbc.M109.005926	http://dx.doi.org/10.1074/jbc.M109.005926			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19380583	hybrid, Green Published			2022-12-25	WOS:000267202500020
J	Manna, T; Thrower, DA; Honnappa, S; Steinmetz, MO; Wilson, L				Manna, Tapas; Thrower, Douglas A.; Honnappa, Srinivas; Steinmetz, Michel O.; Wilson, Leslie			Regulation of Microtubule Dynamic Instability in Vitro by Differentially Phosphorylated Stathmin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; INTRACELLULAR PH; ONCOPROTEIN 18; MULTISITE PHOSPHORYLATION; DESTABILIZING ACTIVITY; PHOSPHOPROTEIN FAMILY; TUBULIN; OP18/STATHMIN; COMPLEX; CELLS	Stathmin is an important regulator of microtubule polymerization and dynamics. When unphosphorylated it destabilizes microtubules in two ways, by reducing the microtubule polymer mass through sequestration of soluble tubulin into an assembly-incompetent T2S complex (two alpha:beta tubulin dimers per molecule of stathmin), and by increasing the switching frequency (catastrophe frequency) from growth to shortening at plus and minus ends by binding directly to the microtubules. Phosphorylation of stathmin on one or more of its four serine residues (Ser(16), Ser(25), Ser(38), and Ser(63)) reduces its microtubule-destabilizing activity. However, the effects of phosphorylation of the individual serine residues of stathmin on microtubule dynamic instability have not been investigated systematically. Here we analyzed the effects of stathmin singly phosphorylated at Ser(16) or Ser(63), and doubly phosphorylated at Ser(25) and Ser(38), on its ability to modulate microtubule dynamic instability at steady-state in vitro. Phosphorylation at either Ser(16) or Ser(63) strongly reduced or abolished the ability of stathmin to bind to and sequester soluble tubulin and its ability to act as a catastrophe factor by directly binding to the microtubules. In contrast, double phosphorylation of Ser(25) and Ser(38) did not affect the binding of stathmin to tubulin or microtubules or its catastrophe-promoting activity. Our results indicate that the effects of stathmin on dynamic instability are strongly but differently attenuated by phosphorylation at Ser(16) and Ser(63) and support the hypothesis that selective targeting by Ser(16)-specific or Ser(63)-specific kinases provides complimentary mechanisms for regulating microtubule function.	[Manna, Tapas; Thrower, Douglas A.; Wilson, Leslie] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Manna, Tapas; Thrower, Douglas A.; Wilson, Leslie] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Honnappa, Srinivas; Steinmetz, Michel O.] Paul Scherrer Inst, CH-5232 Villigen, Switzerland	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Wilson, L (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	wilson@lifesci.ucsb.edu	Steinmetz, Michel O/AAA-3349-2022	Steinmetz, Michel O/0000-0001-6157-3687; Manna, Tapas/0000-0002-2213-6246	National Institutes of Health [NS13560]; USPHS; Swiss National Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS013560] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS13560 (to L.W.) from the USPHS. This work was also supported by the Swiss National Science Foundation (to M. O. S.).	Amayed P, 2002, J BIOL CHEM, V277, P22718, DOI 10.1074/jbc.M111605200; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; BERETTA L, 1993, J BIOL CHEM, V268, P20076; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRATTSAND G, 1994, EUR J BIOCHEM, V220, P359, DOI 10.1111/j.1432-1033.1994.tb18632.x; BUCKLER KJ, 1990, PFLUG ARCH EUR J PHY, V417, P234, DOI 10.1007/BF00370705; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; CHAILLET JR, 1986, P NATL ACAD SCI USA, V83, P522, DOI 10.1073/pnas.83.2.522; Curmi PA, 1997, J BIOL CHEM, V272, P25029, DOI 10.1074/jbc.272.40.25029; Curmi PA, 1999, CELL STRUCT FUNCT, V24, P345; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Gavet O, 1998, J CELL SCI, V111, P3333; GERBOTH GD, 1993, AM J PHYSIOL, V264, pL448, DOI 10.1152/ajplung.1993.264.5.L448; Gigant B, 2005, NATURE, V435, P519, DOI 10.1038/nature03566; Gradin HM, 1998, J CELL BIOL, V140, P131, DOI 10.1083/jcb.140.1.131; Holmfeldt P, 2006, MOL BIOL CELL, V17, P2921, DOI 10.1091/mbc.e06-02-0165; Honnappa S, 2003, J BIOL CHEM, V278, P38926, DOI 10.1074/jbc.M305546200; Honnappa S, 2006, J BIOL CHEM, V281, P16078, DOI 10.1074/jbc.M513524200; Horwitz SB, 1997, J BIOL CHEM, V272, P8129, DOI 10.1074/jbc.272.13.8129; Howell B, 1999, MOL BIOL CELL, V10, P105, DOI 10.1091/mbc.10.1.105; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Jourdain I, 2004, BIOCHEM J, V378, P877, DOI 10.1042/BJ20031413; Jourdain L, 1997, BIOCHEMISTRY-US, V36, P10817, DOI 10.1021/bi971491b; Kuntziger T, 2001, J BIOL CHEM, V276, P22979, DOI 10.1074/jbc.M101466200; LARSSON N, 1995, J BIOL CHEM, V270, P14175, DOI 10.1074/jbc.270.23.14175; Larsson N, 1997, MOL CELL BIOL, V17, P5530, DOI 10.1128/MCB.17.9.5530; Leem CH, 1999, J PHYSIOL-LONDON, V517, P159, DOI 10.1111/j.1469-7793.1999.0159z.x; Malinowska Iwona, 2002, Med Sci Monit, V8, pCR441; Manna T, 2006, J BIOL CHEM, V281, P2071, DOI 10.1074/jbc.M510661200; Manna T, 2007, BIOCHEMISTRY-US, V46, P3543, DOI 10.1021/bi061819d; MARKLUND U, 1993, J BIOL CHEM, V268, P15039; Marklund U, 1996, EMBO J, V15, P5290, DOI 10.1002/j.1460-2075.1996.tb00914.x; MARKLUND U, 1993, J BIOL CHEM, V268, P25671; MITCHISON TJ, 1989, J CELL BIOL, V109, P637, DOI 10.1083/jcb.109.2.637; Muller DR, 2001, ANAL CHEM, V73, P1927, DOI 10.1021/ac001379a; Muller-Borer BJ, 1998, AM J PHYSIOL-HEART C, V275, pH1937, DOI 10.1152/ajpheart.1998.275.6.H1937; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Ray A, 2007, CANCER RES, V67, P3767, DOI 10.1158/0008-5472.CAN-06-3065; Rodionov V, 1999, P NATL ACAD SCI USA, V96, P115, DOI 10.1073/pnas.96.1.115; Rogers GC, 2005, J CELL SCI, V118, P1105, DOI 10.1242/jcs.02284; Rogers GC, 2004, NATURE, V427, P364, DOI 10.1038/nature02256; Rubin CI, 2004, J CELL BIOCHEM, V93, P242, DOI 10.1002/jcb.20187; SAWIN KE, 1991, J CELL BIOL, V112, P941, DOI 10.1083/jcb.112.5.941; SCHUBART UK, 1992, DIFFERENTIATION, V51, P21, DOI 10.1111/j.1432-0436.1992.tb00676.x; SEKSEK O, 1991, ANAL BIOCHEM, V193, P49, DOI 10.1016/0003-2697(91)90042-R; SOBEL A, 1991, TRENDS BIOCHEM SCI, V16, P301, DOI 10.1016/0968-0004(91)90123-D; Srivastava A, 1997, ANAL BIOCHEM, V249, P140, DOI 10.1006/abio.1997.2164; Steinmetz MO, 2007, J STRUCT BIOL, V158, P137, DOI 10.1016/j.jsb.2006.07.018; Steinmetz MO, 2000, EMBO J, V19, P572, DOI 10.1093/emboj/19.4.572; Steinmetz MO, 2001, EMBO REP, V2, P505, DOI 10.1093/embo-reports/kve105; Stewart AK, 1999, J PHYSIOL-LONDON, V516, P209, DOI 10.1111/j.1469-7793.1999.209aa.x; Trzaskawka E, 2000, EUR J ORAL SCI, V108, P54, DOI 10.1034/j.1600-0722.2000.00670.x; Vorobjev IA, 1997, J CELL SCI, V110, P2635; Vorobjev IA, 1999, J CELL SCI, V112, P2277; Wilson L, 1999, CELL STRUCT FUNCT, V24, P329, DOI 10.1247/csf.24.329; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; Wong P, 2002, BRIT J CANCER, V87, P238, DOI 10.1038/sj.bjc.6600424	58	63	67	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15640	15649		10.1074/jbc.M900343200	http://dx.doi.org/10.1074/jbc.M900343200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19359244	hybrid, Green Published			2022-12-25	WOS:000266501000032
J	Thibault, J; Faudry, E; Ebel, C; Attree, I; Elsen, S				Thibault, Julie; Faudry, Eric; Ebel, Christine; Attree, Ina; Elsen, Sylvie			Anti-activator ExsD Forms a 1:1 Complex with ExsA to Inhibit Transcription of Type III Secretion Operons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTERICA SEROVAR TYPHIMURIUM; PSEUDOMONAS-AERUGINOSA; CYSTIC-FIBROSIS; EXOENZYME-S; REGULATORY PROTEIN; SHIGELLA-FLEXNERI; DNA-BINDING; SYSTEM; EXPRESSION; GENES	The ExsA protein is a Pseudomonas aeruginosa transcriptional regulator of the AraC/XylS family that is responsible for activating the type III secretion system operons upon host cell contact. Its activity is known to be controlled in vivo through interaction with its negative regulator ExsD. Using a heterologous expression system, we demonstrated that ExsD is sufficient to inhibit the transcriptional activity of ExsA. Gel shift assays with ExsA- and ExsD-containing cytosolic extracts revealed that ExsD does not block DNA target sites but affects the DNA binding activity of the transcriptional activator. The ExsA- ExsD complex was purified after coproduction of the two partners in Escherichia coli. Size exclusion chromatography and ultracentrifugation analysis revealed a homogeneous complex with a 1:1 ratio. When in interaction with ExsD, ExsA is not able to bind to its specific target any longer, as evidenced by gel shift assays. Size exclusion chromatography further showed a partial dissociation of the complex in the presence of a specific DNA sequence. A model of the molecular inhibitory role of ExsD toward ExsA is proposed, in which, under noninducing conditions, the anti-activator ExsD sequesters ExsA and hinders its binding to DNA sites, preventing the transcription of type III secretion genes.	[Thibault, Julie; Faudry, Eric; Attree, Ina; Elsen, Sylvie] Commissariat Energie Atom, LBBSI, iRTSV, F-38054 Grenoble 09, France; [Thibault, Julie; Faudry, Eric; Attree, Ina; Elsen, Sylvie] CNRS, UMR 5092, F-38054 Grenoble, France; [Thibault, Julie; Faudry, Eric; Ebel, Christine; Attree, Ina; Elsen, Sylvie] Univ Grenoble 1, F-38000 Grenoble, France; [Ebel, Christine] Commissariat Energie Atom, Inst Biol Struct, Lab Mol Biophys, F-38027 Grenoble, France; [Ebel, Christine] CNRS, UMR 5075, F-38027 Grenoble, France	CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Elsen, S (corresponding author), Commissariat Energie Atom, LBBSI, iRTSV, 17 Rue Martyrs, F-38054 Grenoble 09, France.	sylvie.elsen@cea.fr	Faudry, Eric/I-9154-2014	Faudry, Eric/0000-0001-9958-6029; Elsen, Sylvie/0000-0003-4611-4719; Ebel, Christine/0000-0002-6912-500X; Attree, Ina/0000-0002-2580-764X	CNRS; Commissariat a l'Energie Atomique; Universite Joseph Fourier; Region Rhone-Alpes	CNRS(Centre National de la Recherche Scientifique (CNRS)); Commissariat a l'Energie Atomique(French Atomic Energy Commission); Universite Joseph Fourier; Region Rhone-Alpes(Region Auvergne-Rhone-Alpes)	This work was supported in part by institutional grants from the CNRS, Commissariat a l'Energie Atomique, and Universite Joseph Fourier and a grant from Region Rhone-Alpes (Cluster 10 Infectiologie).	Banwart B, 2002, J INFECT DIS, V185, P269, DOI 10.1086/338197; Baxter MA, 2003, INFECT IMMUN, V71, P1295, DOI 10.1128/IAI.71.3.1295-1305.2003; BODEY GP, 1983, REV INFECT DIS, V5, P279; Brutinel ED, 2008, CURR OPIN MICROBIOL, V11, P128, DOI 10.1016/j.mib.2008.02.010; Brutinel ED, 2008, MOL MICROBIOL, V68, P657, DOI 10.1111/j.1365-2958.2008.06179.x; Chen GZ, 2004, MOL MICROBIOL, V52, P1641, DOI 10.1111/j.1365-2958.2004.04110.x; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Dacheux D, 2001, INFECT IMMUN, V69, P538, DOI 10.1128/IAI.69.1.538-542.2001; Darwin KH, 2001, EMBO J, V20, P1850, DOI 10.1093/emboj/20.8.1850; Dasgupta N, 2004, MOL MICROBIOL, V53, P297, DOI 10.1111/j.1365-2958.2004.04128.x; Dasgupta N, 2001, J BACTERIOL, V183, P6636, DOI 10.1128/JB.183.22.6636-6644.2001; Dominguez-Cuevas P, 2008, J BACTERIOL, V190, P3118, DOI 10.1128/JB.01784-07; Ebel C., 2007, PROTEIN STRUCTURES M, P229; Egan SM, 2002, J BACTERIOL, V184, P5529, DOI 10.1128/JB.184.20.5529-5532.2002; Engel J, 2009, CURR OPIN MICROBIOL, V12, P61, DOI 10.1016/j.mib.2008.12.007; Furukawa S, 2006, J BACTERIOL, V188, P1211, DOI 10.1128/JB.188.4.1211-1217.2006; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Ha UH, 2004, MOL MICROBIOL, V54, P307, DOI 10.1111/j.1365-2958.2004.04282.x; HOVEY AK, 1995, J BACTERIOL, V177, P4427, DOI 10.1128/jb.177.15.4427-4436.1995; Kipnis E, 2006, MED MALADIES INFECT, V36, P78, DOI 10.1016/j.medmal.2005.10.007; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Lykken GL, 2006, J BACTERIOL, V188, P6832, DOI 10.1128/JB.00884-06; Martin RG, 2001, CURR OPIN MICROBIOL, V4, P132, DOI 10.1016/S1369-5274(00)00178-8; Mavris M, 2002, MOL MICROBIOL, V43, P1543, DOI 10.1046/j.1365-2958.2002.02836.x; McCaw ML, 2002, MOL MICROBIOL, V46, P1123, DOI 10.1046/j.1365-2958.2002.03228.x; Miller JH., 1972, EXPT MOL GENETICS; Parsot C, 2005, MOL MICROBIOL, V56, P1627, DOI 10.1111/j.1365-2958.2005.04645.x; Pilonieta MC, 2008, J BACTERIOL, V190, P2249, DOI 10.1128/JB.01824-07; Plano GV, 2004, MOL MICROBIOL, V54, P287, DOI 10.1111/j.1365-2958.2004.04306.x; Qin YP, 2007, J BIOL CHEM, V282, P19979, DOI 10.1074/jbc.M703332200; Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102; Schleif R, 2003, BIOESSAYS, V25, P274, DOI 10.1002/bies.10237; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; TOUSSAINT B, 1993, BIOCHEM BIOPH RES CO, V196, P416, DOI 10.1006/bbrc.1993.2265; Urbanowski ML, 2005, P NATL ACAD SCI USA, V102, P9930, DOI 10.1073/pnas.0504405102; Yahr TL, 2006, MOL MICROBIOL, V62, P631, DOI 10.1111/j.1365-2958.2006.05412.x; YAHR TL, 1995, J BACTERIOL, V177, P1169, DOI 10.1128/jb.177.5.1169-1178.1995; Yamamoto S, 2006, J BACTERIOL, V188, P6703, DOI 10.1128/JB.00799-06; Yang J, 2008, MOL MICROBIOL, V68, P314, DOI 10.1111/j.1365-2958.2008.06171.x; Zheng ZD, 2007, J BIOL CHEM, V282, P6136, DOI 10.1074/jbc.M611664200; Zhou XH, 2008, MOL MICROBIOL, V69, P747, DOI 10.1111/j.1365-2958.2008.06326.x	43	43	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15762	15770		10.1074/jbc.M109.003533	http://dx.doi.org/10.1074/jbc.M109.003533			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19369699	hybrid, Green Published			2022-12-25	WOS:000266501000045
J	Olsson, M; Vakifahmetoglu, H; Abruzzo, PM; Hogstrand, K; Grandien, A; Zhivotovsky, B				Olsson, M.; Vakifahmetoglu, H.; Abruzzo, P. M.; Hogstrand, K.; Grandien, A.; Zhivotovsky, B.			DISC-mediated activation of caspase-2 in DNA damage-induced apoptosis	ONCOGENE			English	Article						apoptosis; caspase-2; caspase-8; DISC; DNA damage	CYTOCHROME-C RELEASE; CELL-DEATH; P53-INDUCED PROTEIN; GENOTOXIC STRESS; HCT116 CELLS; PIDD; P53; MITOCHONDRIAL; CLEAVAGE; PATHWAY	The tumor suppressor p53 protein supports growth arrest and is able to induce apoptosis, a signaling cascade regulated by sequential activation of caspases. Mechanisms that lead from p53 to activation of individual initiator caspases are still unclear. The present model for caspase-2 activation includes PIDDosome complex formation. However, in certain experimental models, elimination of complex constituents PIDD or RAIDD did not significantly influence caspase-2 activation, suggesting the existence of an alternative activation platform for caspase-2. Here we have investigated the link between p53 and caspase-2 in further detail and report that the latter is able to utilize the CD95 DISC as an activation platform. The recruitment of caspase-8 to this complex is required for activation of caspase-2. In the experimental system used, the DISC is formed through a distinct, p53-dependent upregulation of CD95. Moreover, we show that caspase-2 and -8 cleave Bid, and that both act simultaneously upstream of mitochondrial cytochrome c release. Finally, a direct interaction between the two caspases and the ability of caspase-8 to cleave caspase-2 are demonstrated. Thus, the observed functional link between caspase-8 and -2 within the DISC represents an alternative mechanism to the PIDDosome for caspase-2 activation in response to DNA damage. Oncogene (2009) 28, 1949-1959; doi:10.1038/onc.2009.36; published online 6 April 2009	[Olsson, M.; Vakifahmetoglu, H.; Abruzzo, P. M.; Zhivotovsky, B.] Karolinska Inst, Inst Environm Med, Div Toxicol, SE-17177 Stockholm, Sweden; [Hogstrand, K.; Grandien, A.] Karolinska Univ Hosp Huddinge, Karolinska Inst, Ctr Infect Med, Dept Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Zhivotovsky, B (corresponding author), Karolinska Inst, Inst Environm Med, Div Toxicol, SE-17177 Stockholm, Sweden.	Boris.Zhivotovsky@ki.se	Zhivotovsky, Boris/A-4346-2014; Olsson, Magnus/E-3140-2012; Abruzzo, Provvidenza Maria/G-7009-2015	Zhivotovsky, Boris/0000-0002-2238-3482; Olsson, Magnus/0000-0002-6370-8423; Abruzzo, Provvidenza Maria/0000-0001-5242-9448	Swedish Science Foundation; Swedish and Stockholm Cancer Societies; Swedish Childhood Cancer Foundation; Swedish Society of Medical Research; EC-FP-6; EC-FP-7	Swedish Science Foundation; Swedish and Stockholm Cancer Societies; Swedish Childhood Cancer Foundation(European Commission); Swedish Society of Medical Research; EC-FP-6(European CommissionEuropean Commission Joint Research Centre); EC-FP-7(European Commission)	We thank Professor PH Krammer and Dr IN Lavrik (German Cancer Research Center, Heidelberg, Germany) for Abs and Dr GP Nolan (Stanford University, Stanford, CA, USA) for the Phoenix-Ampho packaging cell line. We also thank Professor Sten Orrenius for critical review of the paper and permanent support. This study was supported by grants from the Swedish Science Foundation, the Swedish and Stockholm Cancer Societies, the Swedish Childhood Cancer Foundation and the EC-FP-6 (Oncodeath and Chemores) and EC-FP-7 (APO-SYS). MO is a fellow of the Swedish Society of Medical Research.	Baliga BC, 2004, CELL DEATH DIFFER, V11, P1234, DOI 10.1038/sj.cdd.4401492; Baptiste-Okoh N, 2008, P NATL ACAD SCI USA, V105, P1937, DOI 10.1073/pnas.0711800105; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Berube C, 2005, P NATL ACAD SCI USA, V102, P14314, DOI 10.1073/pnas.0506475102; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Borralho PM, 2007, BBA-MOL BASIS DIS, V1772, P40, DOI 10.1016/j.bbadis.2006.09.005; Cuenin S, 2008, ONCOGENE, V27, P387, DOI 10.1038/sj.onc.1210635; Dirsch VM, 2003, CANCER RES, V63, P8869; Djerbi M, 2001, SCAND J IMMUNOL, V54, P180, DOI 10.1046/j.1365-3083.2001.00941.x; Droin N, 2001, BLOOD, V97, P1835, DOI 10.1182/blood.V97.6.1835; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Galligan L, 2005, MOL CANCER THER, V4, P2026, DOI 10.1158/1535-7163.MCT-05-0262; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Guerrero AD, 2008, APOPTOSIS, V13, P177, DOI 10.1007/s10495-007-0139-8; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Harvey NL, 1996, GENES CELLS, V1, P673, DOI 10.1046/j.1365-2443.1996.00255.x; Janssens S, 2005, CELL, V123, P1079, DOI 10.1016/j.cell.2005.09.036; Lamkanfi M, 2005, J BIOL CHEM, V280, P6923, DOI 10.1074/jbc.M411180200; Lavrik IN, 2005, J CLIN INVEST, V115, P2665, DOI 10.1172/JCI26252; Lavrik IN, 2006, BLOOD, V108, P559, DOI 10.1182/blood-2005-07-007096; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Muller M, 1998, J EXP MED, V188, P2033, DOI 10.1084/jem.188.11.2033; Munsch D, 2000, J BIOL CHEM, V275, P3867, DOI 10.1074/jbc.275.6.3867; O'Reilly LA, 2002, CELL DEATH DIFFER, V9, P832, DOI 10.1038/sj.cdd.4401033; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Paroni G, 2001, J BIOL CHEM, V276, P21907, DOI 10.1074/jbc.M011565200; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Pop C, 2006, MOL CELL, V22, P269, DOI 10.1016/j.molcel.2006.03.009; Pop C, 2007, BIOCHEMISTRY-US, V46, P4398, DOI 10.1021/bi602623b; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Samraj AK, 2007, MOL BIOL CELL, V18, P84, DOI 10.1091/mbc.E06-04-0263; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Tinel A, 2007, EMBO J, V26, P197, DOI 10.1038/sj.emboj.7601473; Troy CM, 2003, CELL DEATH DIFFER, V10, P101, DOI 10.1038/sj.cdd.4401175; Troy CM, 2001, J NEUROSCI, V21, P5007, DOI 10.1523/JNEUROSCI.21-14-05007.2001; Vakifahmetoglu H, 2006, ONCOGENE, V25, P5683, DOI 10.1038/sj.onc.1209569; Van de Craen M, 1999, CELL DEATH DIFFER, V6, P1117, DOI 10.1038/sj.cdd.4400589; Wagner KW, 2004, J BIOL CHEM, V279, P35047, DOI 10.1074/jbc.M400708200; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Yamaguchi H, 2003, CANCER RES, V63, P1483; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Zhivotovsky B, 2005, BIOCHEM BIOPH RES CO, V331, P859, DOI 10.1016/j.bbrc.2005.03.191	43	63	66	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 7	2009	28	18					1949	1959		10.1038/onc.2009.36	http://dx.doi.org/10.1038/onc.2009.36			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	442DT	19347032				2022-12-25	WOS:000265820900002
J	Liu, LN; Aartsma, TJ; Thomas, JC; Zhou, BC; Zhang, YZ				Liu, Lu-Ning; Aartsma, Thijs J.; Thomas, Jean-Claude; Zhou, Bai-Cheng; Zhang, Yu-Zhong			FRAP Analysis on Red Alga Reveals the Fluorescence Recovery Is Ascribed to Intrinsic Photoprocesses of Phycobilisomes than Large-Scale Diffusion	PLOS ONE			English	Article							EXCITATION-ENERGY TRANSFER; LIGHT STATE TRANSITION; PORPHYRIDIUM-CRUENTUM; SUPRAMOLECULAR ARCHITECTURE; PHOTOSYNTHETIC MEMBRANE; THYLAKOID MEMBRANES; PROTEIN DIFFUSION; MOBILITY; PHYCOERYTHRIN; SPECTROSCOPY	Background: Phycobilisomes (PBsomes) are the extrinsic antenna complexes upon the photosynthetic membranes in red algae and most cyanobacteria. The PBsomes in the cyanobacteria has been proposed to present high lateral mobility on the thylakoid membrane surface. In contrast, direct measurement of PBsome motility in red algae has been lacking so far. Methodology/Principal Findings: In this work, we investigated the dynamics of PBsomes in the unicellular red alga Porphyridium cruentum in vivo and in vitro, using fluorescence recovery after photobleaching (FRAP). We found that part of the fluorescence recovery could be detected in both partially- and wholly-bleached wild-type and mutant F11 (UTEX 637) cells. Such partial fluorescence recovery was also observed in glutaraldehyde-treated and betaine-treated cells in which PBsome diffusion should be restricted by cross-linking effect, as well as in isolated PBsomes immobilized on the glass slide. Conclusions/Significance: On the basis of our previous structural results showing the PBsome crowding on the native photosynthetic membrane as well as the present FRAP data, we concluded that the fluorescence recovery observed during FRAP experiment in red algae is mainly ascribed to the intrinsic photoprocesses of the bleached PBsomes in situ, rather than the rapid diffusion of PBsomes on thylakoid membranes in vivo. Furthermore, direct observations of the fluorescence dynamics of phycoerythrins using FRAP demonstrated the energetic decoupling of phycoerythrins in PBsomes against strong excitation light in vivo, which is proposed as a photoprotective mechanism in red algae attributed by the PBsomes in response to excess light energy.			Liu, LN (corresponding author), Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	zhangyz@sdu.edu.cn	Liu, Lu-Ning/B-1460-2009	Liu, Lu-Ning/0000-0002-8884-4819				Adir N, 2005, PHOTOSYNTH RES, V85, P15, DOI 10.1007/s11120-004-2143-y; Arteni AA, 2008, PHOTOSYNTH RES, V95, P169, DOI 10.1007/s11120-007-9264-z; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bald D, 1996, PHOTOSYNTH RES, V49, P103, DOI 10.1007/BF00117661; BIGGINS J, 1989, PHOTOSYNTH RES, V20, P1, DOI 10.1007/BF00028620; BIGGINS J, 1983, BIOCHIM BIOPHYS ACTA, V724, P111, DOI 10.1016/0005-2728(83)90031-2; BRIMBLE S, 1989, BIOCHIM BIOPHYS ACTA, V973, P315, DOI 10.1016/S0005-2728(89)80438-4; BRUCE D, 1985, BIOCHIM BIOPHYS ACTA, V806, P237, DOI 10.1016/0005-2728(85)90101-X; BRUCE D, 1989, BIOCHIM BIOPHYS ACTA, V974, P66, DOI 10.1016/S0005-2728(89)80166-5; Colyer C, 2005, ANAL BIOANAL CHEM, V382, P559, DOI 10.1007/s00216-004-3020-4; DILWORTH MF, 1981, PLANT PHYSIOL, V67, P608, DOI 10.1104/pp.67.4.608; FICNER R, 1993, EUR J BIOCHEM, V218, P103, DOI 10.1111/j.1432-1033.1993.tb18356.x; GANTT E, 1974, BIOCHEMISTRY-US, V13, P2960, DOI 10.1021/bi00711a027; GANTT E, 1966, J CELL BIOL, V29, P423, DOI 10.1083/jcb.29.3.423; GANTT E, 1976, BIOCHIM BIOPHYS ACTA, V430, P375, DOI 10.1016/0005-2728(76)90093-1; GANTT E, 1965, J CELL BIOL, V26, P365, DOI 10.1083/jcb.26.2.365; Gantt E., 2003, LIGHT HARVESTING ANT, P307, DOI DOI 10.1007/978-94-017-2087-8_10; GLAZER AN, 1989, J BIOL CHEM, V264, P1; GROSSMAN AR, 1993, MICROBIOL REV, V57, P725, DOI 10.1128/MMBR.57.3.725-749.1993; JONES RF, 1963, PHYSIOL PLANTARUM, V16, P636, DOI 10.1111/j.1399-3054.1963.tb08342.x; Joshua S, 2004, PLANT PHYSIOL, V135, P2112, DOI 10.1104/pp.104.046110; Kana R, 2009, FEBS LETT, V583, P670, DOI 10.1016/j.febslet.2009.01.016; Kirchhoff H, 2008, TRENDS PLANT SCI, V13, P201, DOI 10.1016/j.tplants.2008.03.001; Kirchhoff H, 2008, PLANT PHYSIOL, V146, P1571, DOI 10.1104/pp.107.115170; Kondo K, 2009, PHOTOSYNTH RES, V99, P217, DOI 10.1007/s11120-008-9399-6; Li DH, 2004, BBA-BIOENERGETICS, V1608, P114, DOI 10.1016/j.bbabio.2003.11.002; Lippincott-Schwartz J, 2003, NAT CELL BIOL, pS7, DOI 10.1038/ncb1032; Liu LN, 2005, BBA-BIOENERGETICS, V1708, P133, DOI 10.1016/j.bbabio.2005.04.001; Liu LN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003134; Liu LN, 2008, J BIOL CHEM, V283, P34946, DOI 10.1074/jbc.M805114200; Loos D, 2004, BIOPHYS J, V87, P2598, DOI 10.1529/biophysj.104.046219; LUNDELL DJ, 1981, J BIOL CHEM, V256, P3580; LUNDELL DJ, 1984, J BIOL CHEM, V259, P5472; MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062; McConnell MD, 2002, PLANT PHYSIOL, V130, P1201, DOI 10.1104/pp.009845; Mullineaux CW, 2008, PHOTOSYNTH RES, V95, P175, DOI 10.1007/s11120-007-9249-y; Mullineaux CW, 2005, TRENDS PLANT SCI, V10, P521, DOI 10.1016/j.tplants.2005.09.001; Mullineaux CW, 2005, J EXP BOT, V56, P389, DOI 10.1093/jxb/eri064; Mullineaux CW, 2004, J EXP BOT, V55, P1207, DOI 10.1093/jxb/erh106; Mullineaux CW, 1997, NATURE, V390, P421, DOI 10.1038/37157; Mullineaux CW, 2002, TRENDS PLANT SCI, V7, P237, DOI 10.1016/S1360-1385(02)02283-5; MUSTARDY L, 1992, P NATL ACAD SCI USA, V89, P10021, DOI 10.1073/pnas.89.21.10021; Ray K, 2008, ANAL CHEM, V80, P6942, DOI 10.1021/ac800760z; REDLINGER T, 1981, PLANT PHYSIOL, V68, P1375, DOI 10.1104/pp.68.6.1375; Sarcina M, 2001, J BIOL CHEM, V276, P46830, DOI 10.1074/jbc.M107111200; Schluchter WM, 1996, PHOTOCHEM PHOTOBIOL, V64, P53, DOI 10.1111/j.1751-1097.1996.tb02421.x; SIVAN A, 1993, PHYCOLOGIA, V32, P68, DOI 10.2216/i0031-8884-32-1-68.1; SIVAN A, 1995, J PHYCOL, V31, P167, DOI 10.1111/j.0022-3646.1995.00167.x; Verkman AS, 2002, TRENDS BIOCHEM SCI, V27, P27, DOI 10.1016/S0968-0004(01)02003-5; Yang SZ, 2007, BBA-BIOENERGETICS, V1767, P15, DOI 10.1016/j.bbabio.2006.11.012; Zehetmayer P, 2004, BBA-BIOENERGETICS, V1608, P35, DOI 10.1016/j.bbabio.2003.10.003; Zehetmayer P, 2002, BIOPHYS J, V83, P407, DOI 10.1016/S0006-3495(02)75178-3; ZHANG F, 1993, BIOESSAYS, V15, P579, DOI 10.1002/bies.950150903; ZILINSKAS BA, 1986, PHOTOSYNTH RES, V10, P7, DOI 10.1007/BF00024183	54	20	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2009	4	4							e5295	10.1371/journal.pone.0005295	http://dx.doi.org/10.1371/journal.pone.0005295			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437UZ	19381335	Green Published, Green Submitted, gold			2022-12-25	WOS:000265513700004
J	Jain, D; Roy, N; Chattopadhyay, D				Jain, Deepti; Roy, Nilanjan; Chattopadhyay, Debasis			CaZF, a Plant Transcription Factor Functions through and Parallel to HOG and Calcineurin Pathways in Saccharomyces cerevisiae to Provide Osmotolerance	PLOS ONE			English	Article								Salt-sensitive yeast mutants were deployed to characterize a gene encoding a C2H2 zinc finger protein (CaZF) that is differentially expressed in a drought-tolerant variety of chickpea (Cicer arietinum) and provides salinity-tolerance in transgenic tobacco. In Saccharomyces cerevisiae most of the cellular responses to hyper-osmotic stress is regulated by two interconnected pathways involving high osmolarity glycerol mitogen-activated protein kinase (Hog1p) and Calcineurin (CAN), a Ca(2+)/calmodulin-regulated protein phosphatase 2B. In this study, we report that heterologous expression of CaZF provides osmotolerance in S. cerevisiae through Hog1p and Calcineurin dependent as well as independent pathways. CaZF partially suppresses salt-hypersensitive phenotypes of hog1, can and hog1can mutants and in conjunction, stimulates HOG and CAN pathway genes with subsequent accumulation of glycerol in absence of Hog1p and CAN. CaZF directly binds to stress response element (STRE) to activate STRE-containing promoter in yeast. Transactivation and salt tolerance assays of CaZF deletion mutants showed that other than the transactivation domain a C-terminal domain composed of acidic and basic amino acids is also required for its function. Altogether, results from this study suggests that CaZF is a potential plant salt-tolerance determinant and also provide evidence that in budding yeast expression of HOG and CAN pathway genes can be stimulated in absence of their regulatory enzymes to provide osmotolerance.			Jain, D (corresponding author), Natl Inst Plant Genome Res, Aruna Asaf Ali Marg, New Delhi, India.	debasis_chattopadhyay@nipgr.res.in	Roy, Nilanjan/I-5113-2014	Roy, Nilanjan/0000-0002-4888-2079; Chattopadhyay, Debasis/0000-0002-5754-4987; Roy, Nilanjan/0000-0001-8788-7350				ALBERTYN J, 1994, MOL CELL BIOL, V14, P4135, DOI 10.1128/MCB.14.6.4135; Alepuz PM, 2003, EMBO J, V22, P2433, DOI 10.1093/emboj/cdg243; Alepuz PM, 2001, MOL CELL, V7, P767, DOI 10.1016/S1097-2765(01)00221-0; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Bressan RA, 1998, TRENDS PLANT SCI, V3, P411, DOI 10.1016/S1360-1385(98)01331-4; BREUDER T, 1994, P NATL ACAD SCI USA, V91, P5372, DOI 10.1073/pnas.91.12.5372; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Cagney G, 2000, METHOD ENZYMOL, V328, P3, DOI 10.1016/S0076-6879(00)28386-9; Covic L, 1999, BBA-MOL CELL RES, V1451, P242, DOI 10.1016/S0167-4889(99)00096-8; CYERT MS, 1991, P NATL ACAD SCI USA, V88, P7376, DOI 10.1073/pnas.88.16.7376; Cyert MS, 2003, BIOCHEM BIOPH RES CO, V311, P1143, DOI 10.1016/S0006-291X(03)01552-3; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; Dreyer I, 1999, J EXP BOT, V50, P1073, DOI 10.1093/jexbot/50.suppl_1.1073; Eriksson P, 2000, J BIOL CHEM, V275, P29368, DOI 10.1074/jbc.M001663200; Estruch F, 2000, FEMS MICROBIOL REV, V24, P469, DOI 10.1016/S0168-6445(00)00035-8; Fan L, 1997, PLANT CELL, V9, P2183, DOI 10.1105/tpc.9.12.2183; FROMMER WB, 1995, ANNU REV PLANT PHYS, V46, P419, DOI 10.1146/annurev.pp.46.060195.002223; Ganster RW, 1998, GENETICS, V150, P31; Garcia-Gimeno MA, 2000, MOL CELL BIOL, V20, P4340, DOI 10.1128/MCB.20.12.4340-4349.2000; GARCIADEBLAS B, 1993, MOL GEN GENET, V236, P363, DOI 10.1007/BF00277134; GARRETTENGELE P, 1995, MOL CELL BIOL, V15, P4103; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; HARO R, 1993, PHYSIOL PLANTARUM, V89, P868, DOI 10.1111/j.1399-3054.1993.tb05298.x; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Kafadar KA, 2004, EUKARYOT CELL, V3, P1147, DOI 10.1128/EC.3.5.1147-1153.2004; Kim JC, 2001, PLANT J, V25, P247, DOI 10.1046/j.1365-313x.2001.00947.x; Lippuner V, 1996, J BIOL CHEM, V271, P12859, DOI 10.1074/jbc.271.22.12859; Liu JP, 1998, SCIENCE, V280, P1943, DOI 10.1126/science.280.5371.1943; LUAN S, 1993, P NATL ACAD SCI USA, V90, P2202, DOI 10.1073/pnas.90.6.2202; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; MAEDA T, 1995, SCIENCE, V269, P554, DOI 10.1126/science.7624781; Mager WH, 2002, FEMS YEAST RES, V2, P251, DOI 10.1016/S1567-1356(02)00116-2; MartinezPastor MT, 1996, EMBO J, V15, P2227, DOI 10.1002/j.1460-2075.1996.tb00576.x; Maskin L, 2007, BIOCHEM BIOPH RES CO, V352, P831, DOI 10.1016/j.bbrc.2006.11.115; Matheos DP, 1997, GENE DEV, V11, P3445, DOI 10.1101/gad.11.24.3445; Matsumoto TK, 2001, PLANT MOL BIOL, V45, P489, DOI 10.1023/A:1010659207604; Mendizabal I, 1998, FEBS LETT, V425, P323, DOI 10.1016/S0014-5793(98)00249-X; MENDOZA I, 1994, J BIOL CHEM, V269, P8792; Michael AJ, 1996, PLANT MOL BIOL, V30, P1051, DOI 10.1007/BF00020815; Moretti MB, 2006, PHYSIOL PLANTARUM, V127, P111, DOI 10.1111/j.1399-3054.2006.00664.x; Mulet JM, 1999, MOL CELL BIOL, V19, P3328; NAKAMURA T, 1993, EMBO J, V12, P4063, DOI 10.1002/j.1460-2075.1993.tb06090.x; NIU XM, 1995, PLANT PHYSIOL, V109, P735, DOI 10.1104/pp.109.3.735; Obata T, 2007, PLANT PHYSIOL, V144, P1978, DOI 10.1104/pp.107.101154; Ohkawa T, 2005, J VIROL, V79, P15258, DOI 10.1128/JVI.79.24.15258-15264.2005; Ohta M, 2001, PLANT CELL, V13, P1959, DOI 10.1105/tpc.13.8.1959; Pardo JM, 1998, P NATL ACAD SCI USA, V95, P9681, DOI 10.1073/pnas.95.16.9681; Platara M, 2006, J BIOL CHEM, V281, P36632, DOI 10.1074/jbc.M606483200; Posas F, 2000, J BIOL CHEM, V275, P17249, DOI 10.1074/jbc.M910016199; Proft M, 2004, CELL, V118, P351, DOI 10.1016/j.cell.2004.07.016; Proft M, 1999, MOL CELL BIOL, V19, P537; Proft M, 2002, MOL CELL, V9, P1307, DOI 10.1016/S1097-2765(02)00557-9; Proft M, 2001, EMBO J, V20, P1123, DOI 10.1093/emboj/20.5.1123; Proft M, 2006, MOL CELL, V23, P241, DOI 10.1016/j.molcel.2006.05.031; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Rep M, 1999, MOL CELL BIOL, V19, P5474; Ruiz A, 2007, EUKARYOT CELL, V6, P2175, DOI 10.1128/EC.00337-07; Sakamoto H, 2004, PLANT PHYSIOL, V136, P2734, DOI 10.1104/pp.104.046599; Schmitt AP, 1996, P NATL ACAD SCI USA, V93, P5777, DOI 10.1073/pnas.93.12.5777; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SCHULLER C, 1994, EMBO J, V13, P4382, DOI 10.1002/j.1460-2075.1994.tb06758.x; SERRANO R, 1994, CRIT REV PLANT SCI, V13, P121, DOI 10.1080/713608057; Shukla RK, 2006, PLANT PHYSIOL, V142, P113, DOI 10.1104/pp.106.081752; Smith A, 1998, EMBO J, V17, P3556, DOI 10.1093/emboj/17.13.3556; Soyano T, 2003, GENE DEV, V17, P1055, DOI 10.1101/gad.1071103; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; TAKATSUJI H, 1992, EMBO J, V11, P241, DOI 10.1002/j.1460-2075.1992.tb05047.x; TAKATSUJI H, 1994, PLANT CELL, V6, P947, DOI 10.1105/tpc.6.7.947; URAO T, 1993, PLANT CELL, V5, P1529, DOI 10.1105/tpc.5.11.1529; WACH A, 1994, YEAST, V10, P1808; Wilkinson MG, 1996, GENE DEV, V10, P2289, DOI 10.1101/gad.10.18.2289; Zakrzewska A, 2007, EUKARYOT CELL, V6, P600, DOI 10.1128/EC.00355-06; ZHAO S, 1994, GENE, V146, P215, DOI 10.1016/0378-1119(94)90295-X	76	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5154	10.1371/journal.pone.0005154	http://dx.doi.org/10.1371/journal.pone.0005154			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TN	19365545	Green Published, gold			2022-12-25	WOS:000265509900003
J	Wilson, CW; Chen, MH; Chuang, PT				Wilson, Christopher W.; Chen, Miao-Hsueh; Chuang, Pao-Tien			Smoothened Adopts Multiple Active and Inactive Conformations Capable of Trafficking to the Primary Cilium	PLOS ONE			English	Article								Activation of Hedgehog (Hh) signaling requires the transmembrane protein Smoothened (Smo), a member of the G-protein coupled receptor superfamily. In mammals, Smo translocates to the primary cilium upon binding of Hh ligands to their receptor, Patched (Ptch1), but it is unclear if ciliary trafficking of Smo is sufficient for pathway activation. Here, we demonstrate that cyclopamine and jervine, two structurally related inhibitors of Smo, force ciliary translocation of Smo. Treatment with SANT-1, an unrelated Smo antagonist, abrogates cyclopamine-and jervine-mediated Smo translocation. Further, activation of protein kinase A, either directly or through activation of Gas, causes Smo to translocate to a proximal region of the primary cilium. We propose that Smo adopts multiple inactive and active conformations, which influence its localization and trafficking on the primary cilium.			Wilson, CW (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.	pao-tien.chuang@ucsf.edu		Chen, Miao-Hsueh/0000-0002-9715-3067				Bijlsma MF, 2006, PLOS BIOL, V4, P1397, DOI 10.1371/journal.pbio.0040232; BROWN M, 1986, J VIROL, V60, P290, DOI 10.1128/JVI.60.1.290-293.1986; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; CODINA J, 1983, P NATL ACAD SCI-BIOL, V80, P4276, DOI 10.1073/pnas.80.14.4276; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Corcoran RB, 2006, P NATL ACAD SCI USA, V103, P8408, DOI 10.1073/pnas.0602852103; Davenport JR, 2005, AM J PHYSIOL-RENAL, V289, pF1159, DOI 10.1152/ajprenal.00118.2005; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Epstein DJ, 1996, DEVELOPMENT, V122, P2885; FAN CM, 1995, CELL, V81, P457, DOI 10.1016/0092-8674(95)90398-4; Gerber AN, 2007, ONCOGENE, V26, P1122, DOI 10.1038/sj.onc.1209891; GILL DM, 1978, P NATL ACAD SCI USA, V75, P3050, DOI 10.1073/pnas.75.7.3050; Hammerschmidt M, 1996, GENE DEV, V10, P647, DOI 10.1101/gad.10.6.647; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Koide T, 2006, DEVELOPMENT, V133, P2395, DOI 10.1242/dev.02393; Kovacs JJ, 2008, SCIENCE, V320, P1777, DOI 10.1126/science.1157983; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Low WC, 2008, DEV BIOL, V321, P188, DOI 10.1016/j.ydbio.2008.06.014; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Ocbina PJR, 2008, DEV DYNAM, V237, P2030, DOI 10.1002/dvdy.21551; Ogden SK, 2008, NATURE, V456, P967, DOI 10.1038/nature07459; Pan Y, 2009, DEV BIOL, V326, P177, DOI 10.1016/j.ydbio.2008.11.009; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Sasaki H, 1997, DEVELOPMENT, V124, P1313; SEAMON KB, 1981, J CYCLIC NUCL PROT, V7, P201; Shiba D, 2009, J CELL SCI, V122, P44, DOI 10.1242/jcs.037408; Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio753; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Zhao Y, 2007, NATURE, V450, P252, DOI 10.1038/nature06225; Zhu AJ, 2003, GENE DEV, V17, P1240, DOI 10.1101/gad.1080803	40	88	94	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5182	10.1371/journal.pone.0005182	http://dx.doi.org/10.1371/journal.pone.0005182			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TN	19365551	Green Published, gold, Green Submitted			2022-12-25	WOS:000265509900011
J	Kotnik, K; Popova, E; Todiras, M; Mori, MA; Alenina, N; Seibler, J; Bader, M				Kotnik, Katarina; Popova, Elena; Todiras, Mihail; Mori, Marcelo A.; Alenina, Natalia; Seibler, Jost; Bader, Michael			Inducible Transgenic Rat Model for Diabetes Mellitus Based on shRNA-Mediated Gene Knockdown	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; RNA INTERFERENCE; EXPRESSION; MICE; INDUCTION; PHENOTYPES; VECTORS	The rat is an important animal model in biomedical research, but gene targeting technology is not established for this species. Therefore, we aimed to produce transgenic knockdown rats using shRNA technology and pronuclear microinjection. To this purpose, we employed a tetracycline-inducible shRNA expression system targeting the insulin receptor (IR). Doxycycline (DOX) treatment of the resulting transgenic rats led to a dose-dependent and reversible increase in blood glucose caused by ubiquitous inhibition of IR expression and signalling. We could neither detect an interferon response nor disturbances in microRNA processing after DOX treatment excluding toxic effects of shRNA expression. Low dose DOX treatment induced a chronic state of diabetes mellitus. In conclusion, we have developed a technology which allows the specific, inducible, and reversible suppression of any gene of interest in the rat. Our first transgenic rat line generated with this method represents an inducible model for diabetes mellitus.	[Kotnik, Katarina; Popova, Elena; Todiras, Mihail; Mori, Marcelo A.; Alenina, Natalia; Seibler, Jost; Bader, Michael] Max Delbruck Ctr Mol Med MDC, Berlin, Germany; [Kotnik, Katarina] Free Univ Berlin, Dept Biol Chem & Pharm, D-1000 Berlin, Germany; [Seibler, Jost] TaconicArtemis Pharmaceut GmbH, Cologne, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin	Kotnik, K (corresponding author), Max Delbruck Ctr Mol Med MDC, Berlin, Germany.	mbader@mdc-berlin.de	Mori, Marcelo A/R-2881-2018; Bader, Michael/K-2124-2013; Todiras, Mihail/AAT-4426-2020	Mori, Marcelo A/0000-0001-7112-5263; Todiras, Mihail/0000-0002-9373-4753; Bader, Michael/0000-0003-4780-4164; Popova, Elena/0000-0002-3043-9650	German Ministry for Education and Research (RiNA-Network RNA Technologies, Berlin)	German Ministry for Education and Research (RiNA-Network RNA Technologies, Berlin)(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant of the German Ministry for Education and Research (RiNA-Network RNA Technologies, Berlin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2008, NAT GENET, V40, P516, DOI 10.1038/ng.147; Barbosa ME, 2005, METH MOLEC MED, V112, P339; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Cao Wen, 2005, Journal of Applied Genetics, V46, P217; Carmell MA, 2003, NAT STRUCT BIOL, V10, P91, DOI 10.1038/nsb896; Chen LG, 2005, INT J GREEN ENERGY, V2, P307, DOI 10.1080/01971520500198916; Coumoul X, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni100; Czauderna F, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng127; Dann CT, 2006, P NATL ACAD SCI USA, V103, P11246, DOI 10.1073/pnas.0604657103; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Dickins RA, 2007, NAT GENET, V39, P914, DOI 10.1038/ng2045; Fish RJ, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-9; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; GATZ C, 1988, P NATL ACAD SCI USA, V85, P1394, DOI 10.1073/pnas.85.5.1394; Gossen M, 2002, ANNU REV GENET, V36, P153, DOI 10.1146/annurev.genet.36.041002.120114; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Herold MJ, 2008, P NATL ACAD SCI USA, V105, P18507, DOI 10.1073/pnas.0806213105; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mansuy IM, 2000, CURR OPIN NEUROBIOL, V10, P593, DOI 10.1016/S0959-4388(00)00127-6; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Peng SH, 2006, P NATL ACAD SCI USA, V103, P2252, DOI 10.1073/pnas.0511034103; Popova E, 2005, TRANSGENIC RES, V14, P729, DOI 10.1007/s11248-005-7218-9; Rees DA, 2005, DIABETIC MED, V22, P359, DOI 10.1111/j.1464-5491.2005.01499.x; Reynolds A, 2006, RNA, V12, P988, DOI 10.1261/rna.2340906; Saito Y, 2005, J BIOL CHEM, V280, P42826, DOI 10.1074/jbc.M507685200; Seibler J, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni065; Seibler J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm122; Tofovic SP, 2003, METH MOLEC MED, V86, P29; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Xia XG, 2006, PLOS GENET, V2, P73, DOI 10.1371/journal.pgen.0020010; Xu P, 2008, HYPERTENSION, V51, P574, DOI 10.1161/HYPERTENSIONAHA.107.102764; Yu J, 2006, GENESIS, V44, P252, DOI 10.1002/dvg.20213	35	31	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5124	10.1371/journal.pone.0005124	http://dx.doi.org/10.1371/journal.pone.0005124			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340286	Green Accepted, Green Published, gold			2022-12-25	WOS:000265500700019
J	Wingo, SN; Gallardo, TD; Akbay, EA; Liang, MC; Contreras, CM; Boren, T; Shimamura, T; Miller, DS; Sharpless, NE; Bardeesy, N; Kwiatkowski, DJ; Schorge, JO; Wong, KK; Castrillon, DH				Wingo, Shana N.; Gallardo, Teresa D.; Akbay, Esra A.; Liang, Mei-Chi; Contreras, Cristina M.; Boren, Todd; Shimamura, Takeshi; Miller, David S.; Sharpless, Norman E.; Bardeesy, Nabeel; Kwiatkowski, David J.; Schorge, John O.; Wong, Kwok-Kin; Castrillon, Diego H.			Somatic LKB1 Mutations Promote Cervical Cancer Progression	PLOS ONE			English	Article								Human Papilloma Virus (HPV) is the etiologic agent for cervical cancer. Yet, infection with HPV is not sufficient to cause cervical cancer, because most infected women develop transient epithelial dysplasias that spontaneously regress. Progression to invasive cancer has been attributed to diverse host factors such as immune or hormonal status, as no recurrent genetic alterations have been identified in cervical cancers. Thus, the pressing question as to the biological basis of cervical cancer progression has remained unresolved, hampering the development of novel therapies and prognostic tests. Here we show that at least 20% of cervical cancers harbor somatically-acquired mutations in the LKB1 tumor suppressor. Approximately one-half of tumors with mutations harbored single nucleotide substitutions or microdeletions identifiable by exon sequencing, while the other half harbored larger monoallelic or biallelic deletions detectable by multiplex ligation probe amplification (MLPA). Biallelic mutations were identified in most cervical cancer cell lines; HeLa, the first human cell line, harbors a homozygous 25 kb deletion that occurred in vivo. LKB1 inactivation in primary tumors was associated with accelerated disease progression. Median survival was only 13 months for patients with LKB1-deficient tumors, but.100 months for patients with LKB1-wild type tumors (P = 0.015, log rank test; hazard ratio = 0.25, 95% CI = 0.083 to 0.77). LKB1 is thus a major cervical tumor suppressor, demonstrating that acquired genetic alterations drive progression of HPV-induced dysplasias to invasive, lethal cancers. Furthermore, LKB1 status can be exploited clinically to predict disease recurrence.	[Wingo, Shana N.; Boren, Todd] Univ Texas SW Med Ctr Dallas, Div Gynecol Oncol, Dallas, TX 75390 USA; [Gallardo, Teresa D.; Akbay, Esra A.; Contreras, Cristina M.; Miller, David S.; Castrillon, Diego H.] Univ Texas SW, Simmons Comprehensive Canc Ctr, Dept Pathol, Dallas, TX 75390 USA; [Liang, Mei-Chi; Shimamura, Takeshi; Wong, Kwok-Kin] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA; [Sharpless, Norman E.] Univ N Carolina, Sch Med, Lineberger Comprehensive Canc Ctr, Dept Med & Genet, Chapel Hill, NC USA; [Bardeesy, Nabeel] Massachusetts Gen Hosp, Canc Ctr, Boston, MA USA; [Kwiatkowski, David J.] Brigham and Womens Hosp, Dept Med, Boston, MA USA; [Schorge, John O.] Massachusetts Gen Hosp, Div Gynecol Oncol, Boston, MA USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Dana-Farber Cancer Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Wingo, SN (corresponding author), Univ Texas SW Med Ctr Dallas, Div Gynecol Oncol, Dallas, TX 75390 USA.	diego.castrillon@utsouthwestern.edu	Miller, David Scott/H-4604-2011	Miller, David Scott/0000-0002-8215-5887; Akbay, Esra/0000-0002-4149-2529; Sharpless, Norman/0000-0001-7078-9455; wong, kwok kin/0000-0001-6323-235X; Liang, Mei-Chih/0000-0002-7389-2455	Sidney Kimmel Translational Science Awards; NIH NRSA [fellowship]; American Cancer Society/UT Southwestern Simmons Comprehensive Cancer Center [Young Investigator Award]; National Center for Research Resources [K26RR024196]; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR024196] Funding Source: NIH RePORTER	Sidney Kimmel Translational Science Awards; NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society/UT Southwestern Simmons Comprehensive Cancer Center(American Cancer Society); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was funded through Sidney Kimmel Translational Science Awards to D.H.C., K.K.W., N.B., and N.E.S., an NIH NRSA F31 fellowship to C.M.C., a Young Investigator Award from the American Cancer Society/UT Southwestern Simmons Comprehensive Cancer Center to D.H.C, and the National Center for Research Resources (K26RR024196) (D.H.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Arbyn M, 2008, OBSTET GYNECOL, V111, P167, DOI 10.1097/01.AOG.0000296488.85807.b3; Avizienyte E, 1999, AM J PATHOL, V154, P677, DOI 10.1016/S0002-9440(10)65314-X; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Bonin S, 2005, J CLIN PATHOL, V58, P313, DOI 10.1136/jcp.2004.016477; BOSHART M, 1984, EMBO J, V3, P1151, DOI 10.1002/j.1460-2075.1984.tb01944.x; Boudeau J, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9112; Connolly DC, 2000, AM J PATHOL, V156, P339, DOI 10.1016/S0002-9440(10)64735-9; Contreras CM, 2008, CANCER RES, V68, P759, DOI 10.1158/0008-5472.CAN-07-5014; Crum CP, 2006, DIAGNOSTIC GYNECOLOG; Dall KL, 2008, CANCER RES, V68, P8249, DOI 10.1158/0008-5472.CAN-08-1741; Ellenson LH, 2004, CANCER CELL, V5, P533, DOI 10.1016/j.ccr.2004.05.029; Esteller M, 2000, ONCOGENE, V19, P164, DOI 10.1038/sj.onc.1203227; GEY GO, 1952, CANCER RES, V12, P264; Gurumurthy S, 2008, CANCER RES, V68, P55, DOI 10.1158/0008-5472.CAN-07-3225; Hearle N, 2006, CLIN CANCER RES, V12, P3209, DOI 10.1158/1078-0432.CCR-06-0083; Hezel AF, 2008, ONCOGENE, V27, P6908, DOI 10.1038/onc.2008.342; HSU SH, 1976, SCIENCE, V191, P392, DOI 10.1126/science.1246620; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; JONES HW, 1971, OBSTET GYNECOL, V38, P945; Jones HW, 1997, AM J OBSTET GYNECOL, V176, pS227, DOI 10.1016/S0002-9378(97)70379-X; Launonen V, 2000, CANCER RES, V60, P546; Masters JR, 2002, NAT REV CANCER, V2, P315, DOI 10.1038/nrc775; Matsumoto S, 2007, ONCOGENE, V26, P5911, DOI 10.1038/sj.onc.1210418; Nezu J, 1999, BIOCHEM BIOPH RES CO, V261, P750, DOI 10.1006/bbrc.1999.1047; Pearson HB, 2008, CANCER RES, V68, P2223, DOI 10.1158/0008-5472.CAN-07-5169; PUCK TT, 1955, P NATL ACAD SCI USA, V41, P432, DOI 10.1073/pnas.41.7.432; Schoell WMJ, 1999, SEMIN SURG ONCOL, V16, P203, DOI 10.1002/(SICI)1098-2388(199904/05)16:3<203::AID-SSU2>3.0.CO;2-C; Steben M, 2007, GYNECOL ONCOL, V107, pS2, DOI 10.1016/j.ygyno.2007.07.067; Tiainen M, 1999, P NATL ACAD SCI USA, V96, P9248, DOI 10.1073/pnas.96.16.9248; Young RH, 2002, HISTOPATHOLOGY, V41, P185, DOI 10.1046/j.1365-2559.2002.01462.x; ZURHAUSEN H, 1976, CANCER RES, V36, P794	32	202	224	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5137	10.1371/journal.pone.0005137	http://dx.doi.org/10.1371/journal.pone.0005137			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340305	Green Submitted, gold, Green Published			2022-12-25	WOS:000265500700022
J	Rohozinski, J; Anderson, ML; Broaddus, RE; Edwards, CL; Bishop, CE				Rohozinski, Jan; Anderson, Matthew L.; Broaddus, Russell E.; Edwards, Creighton L.; Bishop, Colin E.			Spermatogenesis Associated Retrogenes Are Expressed in the Human Ovary and Ovarian Cancers	PLOS ONE			English	Article								Background: Ovarian cancer is the second most prevalent gynecologic cancer in women. However, it is by far the most lethal. This is generally attributed to the absence of easily detectable markers specific to ovarian cancers that can be used for early diagnosis and specific therapeutic targets. Methodology/Principal Findings: Using end point PCR we have found that a family of retrogenes, previously thought to be expressed only in the male testis during spermatogenesis in man, are also expressed in normal ovarian tissue and a large percentage of ovarian cancers. In man there are at least eleven such autosomal retrogenes, which are intronless copies of genes on the X chromosome, essential for normal spermatogenesis and expressed specifically in the human testis. We tested for the expression of five of the known retrogenes, UTP14C, PGK2, RPL10L, RPL39L and UBL4B in normal human ovary and ovarian cancers. Conclusions/Significance: We propose that the activation of the testis specific retrogenes in the ovary and ovarian cancers is of biological significance in humans. Because these retrogenes are specifically expressed in the ovary and ovarian cancers in the female they may prove useful in developing new diagnostic and/or therapeutic targets for ovarian cancer.	[Rohozinski, Jan; Anderson, Matthew L.; Edwards, Creighton L.] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Rohozinski, Jan; Bishop, Colin E.] Wake Forest Univ, Inst Regenerat Med, Winston Salem, NC 27109 USA; [Broaddus, Russell E.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX USA	Baylor College of Medicine; Wake Forest University; University of Texas System; UTMD Anderson Cancer Center	Rohozinski, J (corresponding author), Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA.	janr@bcm.edu	Anderson, Matthew/C-4755-2019	Anderson, Matthew/0000-0002-2081-4672; Rohozinski, Jan/0000-0001-7872-2984	Saks Fifth Avenue Key to a Cure Foundations; Joann Rosenberg Fund for Ovarian Cancer Research; Ovarian Cancer Research Program of the Department of Obstetrics and Gynecology, Baylor College of Medicine; CLE	Saks Fifth Avenue Key to a Cure Foundations; Joann Rosenberg Fund for Ovarian Cancer Research; Ovarian Cancer Research Program of the Department of Obstetrics and Gynecology, Baylor College of Medicine; CLE	Funding for this work provided by Saks Fifth Avenue Key to a Cure Foundations, the Joann Rosenberg Fund for Ovarian Cancer Research and the Ovarian Cancer Research Program of the Department of Obstetrics and Gynecology, Baylor College of Medicine and an anonymous donation channeled through CLE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altinok G, 2006, PROSTATE CANCER P D, V9, P77, DOI 10.1038/sj.pcan.4500848; Betran E, 2004, CELL CYCLE, V3, P873; BLAKE CCF, 1981, PHILOS T ROY SOC B, V293, P93, DOI 10.1098/rstb.1981.0063; BOEL P, 1995, IMMUNITY, V2, P167, DOI 10.1016/S1074-7613(95)80053-0; Bradley J, 2004, NAT GENET, V36, P872, DOI 10.1038/ng1390; Brenner H, 2002, LANCET, V360, P1131, DOI 10.1016/S0140-6736(02)11199-8; Chan JK, 2006, OBSTET GYNECOL, V108, P521, DOI 10.1097/01.AOG.0000231680.58221.a7; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Dresios J, 2006, MOL MICROBIOL, V59, P1651, DOI 10.1111/j.1365-2958.2006.05054.x; Duan Z, 2002, ANTICANCER RES, V22, P1933; Edelson MI, 1998, ONCOGENE, V16, P197, DOI 10.1038/sj.onc.1201479; Emerson JJ, 2004, SCIENCE, V303, P537, DOI 10.1126/science.1090042; Ganesan S, 2002, CELL, V111, P393, DOI 10.1016/S0092-8674(02)01052-8; GAUGLER B, 1994, J EXP MED, V179, P921, DOI 10.1084/jem.179.3.921; Grizzi F, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-3; Handel MA, 2004, EXP CELL RES, V296, P57, DOI 10.1016/j.yexcr.2004.03.008; HENDRIKSEN PJM, 1995, DEV BIOL, V170, P730, DOI 10.1006/dbio.1995.1252; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Hogdall EVS, 2004, CANCER, V100, P2387, DOI 10.1002/cncr.20213; Hwang TL, 2006, PROTEOMICS, V6, P2259, DOI 10.1002/pmic.200500345; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Kleene KC, 2001, MECH DEVELOP, V106, P3, DOI 10.1016/S0925-4773(01)00413-0; Lay AJ, 2000, NATURE, V408, P869, DOI 10.1038/35048596; Leary DJ, 2004, MOL BIOL CELL, V15, P281, DOI 10.1091/mbc.e03-06-0363; Liao DZJ, 2003, CANCER INVEST, V21, P641, DOI 10.1081/CNV-120022385; MCCARREY JR, 1987, NATURE, V326, P501, DOI 10.1038/326501a0; Mo YY, 2005, ONCOGENE, V24, P2677, DOI 10.1038/sj.onc.1208210; Palma M, 2006, CRIT REV ONCOL HEMAT, V57, P1, DOI 10.1016/j.critrevonc.2005.05.003; Rohozinski J, 2006, BIOL REPROD, V74, P644, DOI 10.1095/biolreprod.105.046698; Rohozinski J, 2004, P NATL ACAD SCI USA, V101, P11695, DOI 10.1073/pnas.0401130101; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Shiao MS, 2007, MOL BIOL EVOL, V24, P2242, DOI 10.1093/molbev/msm153; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Spatz A, 2004, NAT REV CANCER, V4, P617, DOI 10.1038/nrc1413; Stalberg P, 2004, J CLIN ENDOCR METAB, V89, P2326, DOI 10.1210/jc.2003-031228; Suri A, 2006, EXPERT OPIN BIOL TH, V6, P379, DOI 10.1517/14712598.6.4.379; Thakur A, 2005, BREAST CANCER RES TR, V93, P135, DOI 10.1007/s10549-005-4516-0; Uechi T, 2002, NUCLEIC ACIDS RES, V30, P5369, DOI 10.1093/nar/gkf696; Uechi T, 2001, GENOMICS, V72, P223, DOI 10.1006/geno.2000.6470; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Vigodner M, 2006, AM J PHYSIOL-ENDOC M, V290, pE1022, DOI 10.1152/ajpendo.00527.2005; Wang PJ, 2004, TRENDS ENDOCRIN MET, V15, P79, DOI 10.1016/j.tem.2004.01.007; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wong YF, 2006, INT J CANCER, V118, P2461, DOI 10.1002/ijc.21660; Yang F, 2007, GENE EXPR PATTERNS, V7, P131, DOI 10.1016/j.modgep.2006.06.002; Zendman AJW, 2003, J CELL PHYSIOL, V194, P272, DOI 10.1002/jcp.10215	48	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e5064	10.1371/journal.pone.0005064	http://dx.doi.org/10.1371/journal.pone.0005064			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333399	gold, Green Submitted, Green Published			2022-12-25	WOS:000265499900016
J	McLeod, J; Curtis, N; Lewis, HD; Good, MA; Fagan, MJ; Genever, PG				McLeod, Jane; Curtis, Neil; Lewis, Huw D.; Good, Mark A.; Fagan, Michael J.; Genever, Paul G.			gamma-Secretase-dependent cleavage of amyloid precursor protein regulates osteoblast behavior	FASEB JOURNAL			English	Article						Alzheimer's disease; mesenchymal stem cell	MESENCHYMAL STEM-CELLS; RECEPTOR-RELATED PROTEIN; SMOOTH-MUSCLE-CELLS; ALZHEIMERS-DISEASE; TRANSGENIC MICE; INTRACELLULAR DOMAIN; BETA-PROTEIN; A-BETA; BASEMENT-MEMBRANE; BONE HOMEOSTASIS	gamma-Secretase cleaves amyloid precursor protein (APP) to generate amyloid-beta (A beta) peptides, which aggregate in the brain in Alzheimer's disease (AD). gamma-Secretase also cleaves molecules that regulate osteoblast activity, such as Notch and ephrinB2. However, the role of APP in bone is unknown. In this study, the expression, cleavage, and function of APP were investigated during osteogenesis in vitro and in vivo. Expression of all gamma-secretase subunits was confirmed in human primary osteoprogenitors cells, and a significant increase in enzyme activity was observed during osteogenic differentiation using a specific fluorimetric assay. Application of selective inhibitors confirmed gamma-secretase-dependent cleavage of APP within osteogenic cells, and secretion of A beta by mature osteoblasts was demonstrated with the use of a chemiluminescent immunoassay. Osteoprogenitors showed a selective and significant increase in adhesion to extracellular matrices containing aged A beta plaques compared with nonaged A beta peptide controls. A beta on the endosteal and periosteal surfaces of adult rat ulnae were identified by immunohistochemistry. MicroCT analysis of vertebrae from an AD mouse model, Tg2576, identified a decrease in bone volume, surface area, and thickness compared with wild-type controls. These findings indicate that APP functions as a novel regulator of osteoblast activity and suggest that the mechanisms underlying the pathogenesis of AD may also influence bone.-McLeod, J., Curtis, N., Lewis, H. D., Good, M. A., Fagan, M. J., Genever, P. G. gamma-Secretase-dependent cleavage of amyloid precursor protein regulates osteoblast behavior. FASEB J. 23, 2942- 2955 (2009). www.fasebj.org	[Genever, Paul G.] Univ York, Dept Biol, Area 9, York YO10 5YW, N Yorkshire, England; [Curtis, Neil; Fagan, Michael J.] Univ Hull, Dept Engn, Kingston Upon Hull HU6 7RX, N Humberside, England; [Lewis, Huw D.] Merck Sharp & Dohme Res Labs, Dept Mol & Cellular Neurosci, Harlow, Essex, England; [Good, Mark A.] Cardiff Univ, Sch Psychol, Cardiff, S Glam, Wales	University of York - UK; University of Hull; Merck & Company; Cardiff University	Genever, PG (corresponding author), Univ York, Dept Biol, Area 9, York YO10 5YW, N Yorkshire, England.	pg5@york.ac.uk		Genever, Paul/0000-0002-5730-8976	Medical Research Council [G9724886] Funding Source: Medline; MRC [G9724886] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adriani W, 2006, BEHAV PHARMACOL, V17, P525, DOI 10.1097/00008877-200609000-00019; Assis-Nascimento P, 2007, NEUROCHEM RES, V32, P1476, DOI 10.1007/s11064-007-9335-8; Best JD, 2005, J PHARMACOL EXP THER, V313, P902, DOI 10.1124/jpet.104.081174; BREEN KC, 1991, J NEUROSCI RES, V28, P90, DOI 10.1002/jnr.490280109; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; CHEN M, 1991, NEUROSCI LETT, V125, P223, DOI 10.1016/0304-3940(91)90034-Q; Churcher I, 2003, J MED CHEM, V46, P2275, DOI 10.1021/jm034058a; Churcher I, 2003, BIOORG MED CHEM LETT, V13, P179, DOI 10.1016/S0960-894X(02)00909-5; Compagni A, 2003, DEV CELL, V5, P217, DOI 10.1016/S1534-5807(03)00198-9; Coulson EJ, 1997, BRAIN RES, V770, P72, DOI 10.1016/S0006-8993(97)00757-9; Culvenor JG, 2000, EXP CELL RES, V255, P192, DOI 10.1006/excr.1999.4791; Cupers P, 2001, J NEUROCHEM, V78, P1168, DOI 10.1046/j.1471-4159.2001.00516.x; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Engin FZ, 2008, NAT MED, V14, P299, DOI 10.1038/nm1712; Etheridge SL, 2004, STEM CELLS, V22, P849, DOI 10.1634/stemcells.22-5-849; Farmery MR, 2003, J BIOL CHEM, V278, P24277, DOI 10.1074/jbc.M211992200; Frackowiak J, 2003, J NEUROPATH EXP NEUR, V62, P685, DOI 10.1093/jnen/62.6.685; Gillian AM, 1997, J NEUROSCI RES, V49, P154, DOI 10.1002/(SICI)1097-4547(19970715)49:2<154::AID-JNR4>3.0.CO;2-8; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Ho LB, 1996, J BIOL CHEM, V271, P30929, DOI 10.1074/jbc.271.48.30929; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Kim HS, 2003, FASEB J, V17, P1951, DOI 10.1096/fj.03-0106fje; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kinoshita A, 2003, J BIOL CHEM, V278, P41182, DOI 10.1074/jbc.M306403200; KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0; KNOPS J, 1992, J BIOL CHEM, V267, P16022; KOO EH, 1994, J BIOL CHEM, V269, P17386; KRAMER RH, 1984, JNCI-J NATL CANCER I, V72, P889; Legube G, 2002, EMBO J, V21, P1704, DOI 10.1093/emboj/21.7.1704; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; MELTON LJ, 1994, J AM GERIATR SOC, V42, P614, DOI 10.1111/j.1532-5415.1994.tb06859.x; Moir Robert D., 2005, Current Alzheimer Research, V2, P269, DOI 10.2174/1567205053585918; Mok SS, 2006, J NEUROCHEM, V96, P53, DOI 10.1111/j.1471-4159.2005.03539.x; Nguyen V, 2006, BRAIN RES, V1086, P76, DOI 10.1016/j.brainres.2006.02.122; Ognibene E, 2005, BEHAV BRAIN RES, V156, P225, DOI 10.1016/j.bbr.2004.05.028; Owens AP, 2003, BIOORG MED CHEM LETT, V13, P4143, DOI 10.1016/j.bmcl.2003.07.031; Pietrzik CU, 2004, J NEUROSCI, V24, P4259, DOI 10.1523/JNEUROSCI.5451-03.2004; PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D; PIKE CJ, 1993, J NEUROSCI, V13, P1676; PIKE CJ, 1991, EUR J PHARM-MOLEC PH, V207, P367, DOI 10.1016/0922-4106(91)90014-9; Postuma RB, 2000, J NEUROCHEM, V74, P1122; Prokop S, 2004, J BIOL CHEM, V279, P23255, DOI 10.1074/jbc.M401789200; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Roth AD, 2005, BIOL RES, V38, P381, DOI 10.4067/S0716-97602005000400011; Rozmahel R, 2002, NEUROBIOL AGING, V23, P187, DOI 10.1016/S0197-4580(01)00267-6; Sato Y, 1998, BONE, V23, P555, DOI 10.1016/S8756-3282(98)00134-3; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Sciaudone M, 2003, ENDOCRINOLOGY, V144, P5631, DOI 10.1210/en.2003-0463; SCOTT MR, 1992, PROTEIN SCI, V1, P986, DOI 10.1002/pro.5560010804; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Serneels L, 2005, P NATL ACAD SCI USA, V102, P1719, DOI 10.1073/pnas.0408901102; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Shindo K, 2003, EXP CELL RES, V290, P370, DOI 10.1016/S0014-4827(03)00349-5; Tropel P, 2004, EXP CELL RES, V295, P395, DOI 10.1016/j.yexcr.2003.12.030; TSUZUKI K, 1994, BRAIN RES, V659, P213, DOI 10.1016/0006-8993(94)90881-8; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Vujovic S, 2007, CELL PROLIFERAT, V40, P185, DOI 10.1111/j.1365-2184.2007.00426.x; Weller I, 2004, ANN EPIDEMIOL, V14, P319, DOI 10.1016/j.annepidem.2003.08.005; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; YANKNER BA, 1989, SCIENCE, V245, P417, DOI 10.1126/science.2474201; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	65	9	9	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2009	23	9					2942	2955		10.1096/fj.08-121657	http://dx.doi.org/10.1096/fj.08-121657			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19376818				2022-12-25	WOS:000270241000017
J	Medalia, N; Beer, A; Zwickl, P; Mihalache, O; Beck, M; Medalia, O; Navon, A				Medalia, Noa; Beer, Avital; Zwickl, Peter; Mihalache, Oana; Beck, Martin; Medalia, Ohad; Navon, Ami			Architecture and Molecular Mechanism of PAN, the Archaeal Proteasome Regulatory ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							20S PROTEASOME; DEPENDENT PROTEASE; ESCHERICHIA-COLI; 26S PROTEASOME; SUBSTRATE-BINDING; COMPLEX STRUCTURE; STRUCTURAL BASIS; GROEL; DEGRADATION; PROTEINS	In Archaea, an hexameric ATPase complex termed PAN promotes proteins unfolding and translocation into the 20 S proteasome. PAN is highly homologous to the six ATPases of the eukaryotic 19 S proteasome regulatory complex. Thus, insight into the mechanism of PAN function may reveal a general mode of action mutual to the eukaryotic 19 S proteasome regulatory complex. In this study we generated a three-dimensional model of PAN from tomographic reconstruction of negatively stained particles. Surprisingly, this reconstruction indicated that the hexameric complex assumes a two-ring structure enclosing a large cavity. Assessment of distinct three-dimensional functional states of PAN in the presence of adenosine 5'-O-(thiotriphosphate) and ADP and in the absence of nucleotides outlined a possible mechanism linking nucleotide binding and hydrolysis to substrate recognition, unfolding, and translocation. A novel feature of the ATPase complex revealed in this study is a gate controlling the "exit port" of the regulatory complex and, presumably, translocation into the 20 S proteasome. Based on our structural and biochemical findings, we propose a possible model in which substrate binding and unfolding are linked to structural transitions driven by nucleotide binding and hydrolysis, whereas translocation into the proteasome only depends upon the presence of an unfolded substrate and binding but not hydrolysis of nucleotide.	[Medalia, Noa; Beer, Avital; Navon, Ami] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Medalia, Noa; Medalia, Ohad] Ben Gurion Univ Negev, Dept Life Sci, IL-84195 Beer Sheva, Israel; [Medalia, Noa; Medalia, Ohad] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84195 Beer Sheva, Israel; [Zwickl, Peter; Mihalache, Oana; Medalia, Ohad] Max Planck Inst Biochem, Dept Mol Struct Biol, D-82152 Martinsried, Germany; [Beck, Martin] Swiss Fed Inst Technol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland	Weizmann Institute of Science; Ben Gurion University; Ben Gurion University; Max Planck Society; ETH Zurich	Navon, A (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	ami.navon@weizmann.ac.il	Beck, Martin/B-5589-2011	Beck, Martin/0000-0002-7397-1321; Medalia, Ohad/0000-0003-0994-2937	Israeli Science Foundation [ISF 802/04, ISF 794/02]; German Minerva Foundation [780040]; German-Israeli Foundation for Scientific Research and Development [GIF I-845-210.9/2004]; Rolando Uziel	Israeli Science Foundation(Israel Science Foundation); German Minerva Foundation; German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); Rolando Uziel	This work was supported in part by the Israeli Science Foundation Grants ISF 802/04 (to A.N.) and ISF 794/02 (to O.M.), German Minerva Foundation Grant 780040 (to A.N.), German-Israeli Foundation for Scientific Research and Development Grant GIF I-845-210.9/2004), and a special donation from Rolando Uziel (to A.N.).	Akopian TN, 1997, J BIOL CHEM, V272, P1791, DOI 10.1074/jbc.272.3.1791; Arighi CN, 1998, BIOCHEMISTRY-US, V37, P16802, DOI 10.1021/bi981827x; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Benaroudj N, 2003, MOL CELL, V11, P69, DOI 10.1016/S1097-2765(02)00775-X; Benaroudj N, 2000, NAT CELL BIOL, V2, P833, DOI 10.1038/35041081; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Forster F, 2005, P NATL ACAD SCI USA, V102, P4729, DOI 10.1073/pnas.0409178102; Gerega A, 2005, J BIOL CHEM, V280, P42856, DOI 10.1074/jbc.M510592200; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Golbik R, 1998, J MOL BIOL, V276, P505, DOI 10.1006/jmbi.1997.1538; Gottesman S, 1997, CELL, V91, P435, DOI 10.1016/S0092-8674(00)80428-6; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Harauz G, 1996, J STRUCT BIOL, V116, P290, DOI 10.1006/jsbi.1996.0044; Hartmann-Petersen R, 2001, ARCH BIOCHEM BIOPHYS, V386, P89, DOI 10.1006/abbi.2000.2178; Hendil KB, 2002, J MOL BIOL, V315, P627, DOI 10.1006/jmbi.2001.5285; Holzl H, 2000, J CELL BIOL, V150, P119, DOI 10.1083/jcb.150.1.119; Ishikawa T, 2004, J STRUCT BIOL, V146, P180, DOI 10.1016/j.jsb.2003.11.018; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; Kisselev AF, 1998, J BIOL CHEM, V273, P1982, DOI 10.1074/jbc.273.4.1982; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Kusmierczyk AR, 2000, J BIOL CHEM, V275, P33504, DOI 10.1074/jbc.M006256200; Larsen CN, 1997, CELL, V91, P431, DOI 10.1016/S0092-8674(00)80427-4; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Matouschek A, 2003, CURR OPIN STRUC BIOL, V13, P98, DOI 10.1016/S0959-440X(03)00010-1; Medalia N, 2006, J STRUCT BIOL, V156, P84, DOI 10.1016/j.jsb.2006.03.015; Navon A, 2001, MOL CELL, V8, P1339, DOI 10.1016/S1097-2765(01)00407-5; Nickell S, 2005, J STRUCT BIOL, V149, P227, DOI 10.1016/j.jsb.2004.10.006; Nickell S, 2007, BIOCHEM BIOPH RES CO, V353, P115, DOI 10.1016/j.bbrc.2006.11.141; Ortega J, 2000, MOL CELL, V6, P1515, DOI 10.1016/S1097-2765(00)00148-9; Pak M, 1997, P NATL ACAD SCI USA, V94, P4901, DOI 10.1073/pnas.94.10.4901; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Raha T, 1999, BIOCHEMISTRY-US, V38, P2110, DOI 10.1021/bi980734c; Ranson NA, 2006, NAT STRUCT MOL BIOL, V13, P147, DOI 10.1038/nsmb1046; Ranson NA, 2001, CELL, V107, P869, DOI 10.1016/S0092-8674(01)00617-1; Rohrwild M, 1996, P NATL ACAD SCI USA, V93, P5808, DOI 10.1073/pnas.93.12.5808; Rohrwild M, 1997, NAT STRUCT BIOL, V4, P133, DOI 10.1038/nsb0297-133; Schug ZT, 2008, J BIOL CHEM, V283, P2939, DOI [10.1074/jbc.M706645200, 10.1074/jbc.M802716200]; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Smoot AL, 2001, BIOCHEMISTRY-US, V40, P4484, DOI 10.1021/bi001822b; Song HK, 2000, P NATL ACAD SCI USA, V97, P14103, DOI 10.1073/pnas.250491797; Sousa MC, 2000, CELL, V103, P633, DOI 10.1016/S0092-8674(00)00166-5; Strickland E, 2000, J BIOL CHEM, V275, P5565, DOI 10.1074/jbc.275.8.5565; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Walz J, 1998, J STRUCT BIOL, V121, P19, DOI 10.1006/jsbi.1998.3958; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x; Wolf S, 1998, J MOL BIOL, V277, P13, DOI 10.1006/jmbi.1997.1589; Zwickl P, 1999, J BIOL CHEM, V274, P26008, DOI 10.1074/jbc.274.37.26008; Zwickl P, 2002, ADV PROTEIN CHEM, V59, P187	60	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22952	22960		10.1074/jbc.M809643200	http://dx.doi.org/10.1074/jbc.M809643200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19363223	Green Published, hybrid			2022-12-25	WOS:000268963100048
J	Nishijo, K; Hosoyama, T; Bjornson, CRR; Schaffer, BS; Prajapati, SI; Bahadur, AN; Hansen, MS; Blandford, MC; McCleish, AT; Rubin, BP; Epstein, JA; Rando, TA; Capecchi, MR; Keller, C				Nishijo, Koichi; Hosoyama, Tohru; Bjornson, Christopher R. R.; Schaffer, Beverly S.; Prajapati, Suresh I.; Bahadur, Ali N.; Hansen, Mark S.; Blandford, Mary C.; McCleish, Amanda T.; Rubin, Brian P.; Epstein, Jonathan A.; Rando, Thomas A.; Capecchi, Mario R.; Keller, Charles			Biomarker system for studying muscle, stem cells, and cancer in vivo	FASEB JOURNAL			English	Article						optical imaging; reporter gene; satellite cell	SECRETED ALKALINE-PHOSPHATASE; RED FLUORESCENT PROTEIN; GENE-EXPRESSION; SATELLITE CELLS; ALVEOLAR RHABDOMYOSARCOMA; LIVING SUBJECTS; TUMOR-GROWTH; MOUSE; REPORTER; CRE	Bioluminescent reporter genes are sensitive in situ tools for following disease progression in preclinical models, albeit they are subject to scattering and absorption in deep tissues. We have generated a bicistronic Cre/LoxP reporter mouse line that pairs the expression of firefly luciferase with quantifiable expression of a human placental alkaline phosphatase that is secreted into the serum (SeAP). With the use of this dual-modality bioreporter with a novel, inducible Pax7-CreER line for tracking muscle satellite cells, we demonstrate the longitudinal kinetics of muscle stem cell turnover, accounting for a doubling of the signal from satellite cell and progeny every 3.93 wk in the transition from adolescence to early adulthood. We also show that this dual-modality bioreporter can be incorporated in preclinical cancer models, whereby SeAP activity is reflective of tumor burden. Thus, this dual bioreporter permits both spatial localization and accurate quantification of biological processes in vivo even when the tissue of interest is deep within the animal.-Nishijo, K., Hosoyama, T., Bjornson, C. R. R., Schaffer, B. S., Prajapati, S. I., Bahadur, A. N., Hansen, M. S., Blandford, M. C., McCleish, A. T., Rubin, B. P., Epstein, J. A., Rando, T. A., Capecchi, M. R., Keller, C. Biomarker system for studying muscle, stem cells, and cancer in vivo. FASEB J. 23, 2681-2690 ( 2009)	[Nishijo, Koichi; Hosoyama, Tohru; Schaffer, Beverly S.; Prajapati, Suresh I.; Bahadur, Ali N.; McCleish, Amanda T.; Keller, Charles] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Nishijo, Koichi; Hosoyama, Tohru; Schaffer, Beverly S.; Prajapati, Suresh I.; Bahadur, Ali N.; McCleish, Amanda T.; Keller, Charles] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Nishijo, Koichi; Hosoyama, Tohru; Schaffer, Beverly S.; Prajapati, Suresh I.; Bahadur, Ali N.; McCleish, Amanda T.; Keller, Charles] Univ Texas Hlth Sci Ctr San Antonio, Dept Pediat, San Antonio, TX 78229 USA; [Bjornson, Christopher R. R.; Rando, Thomas A.] Stanford Univ, Dept Neurol & Neurol Sci, Palo Alto, CA 94304 USA; [Hansen, Mark S.; Blandford, Mary C.; Capecchi, Mario R.] Univ Utah, Dept Human Genet, Salt Lake City, UT USA; [Rubin, Brian P.] Cleveland Clin, Dept Anat Pathol, Taussig Canc Ctr, Cleveland, OH 44106 USA; [Rubin, Brian P.] Cleveland Clin, Dept Mol Genet, Taussig Canc Ctr, Cleveland, OH 44106 USA; [Rubin, Brian P.] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44106 USA; [Epstein, Jonathan A.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Stanford University; Utah System of Higher Education; University of Utah; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Pennsylvania	Keller, C (corresponding author), 8403 Floyd Curl Dr,MC-7784, San Antonio, TX 78229 USA.	kellerc2@uthscsa.edu	Hosoyama, Tohru/ABA-2797-2021	Rando, Thomas/0000-0001-5843-8564; Hosoyama, Tohru/0000-0002-1825-6923; Keller, Charles/0000-0003-2505-7487	National Institute of General Medical Sciences; NIGMS [GM-07717, GM-60655]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM007717, R25GM060655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG023806] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	An application of this reporter system for discovery of spontaneous biomarkers is being patented by University of Texas Health Science Center, San Antonio, and has been licensed for commercial distribution by Numira Biosciences (www.numirabio.com), of which C. K. is a cofounder. Numira Biosciences provided partial funding for these studies. A. T. M. was supported by National Institute of General Medical Sciences grants NIGMS MARC-U*STAR GM-07717 and NIGMS MBRS-RISE GM-60655.	ALLEN RE, 1991, J CELL PHYSIOL, V149, P525, DOI 10.1002/jcp.1041490323; Bao R, 2000, GYNECOL ONCOL, V78, P373, DOI 10.1006/gyno.2000.5925; Barton-Davis ER, 1998, P NATL ACAD SCI USA, V95, P15603, DOI 10.1073/pnas.95.26.15603; BISCHOFF R, 1986, DEV BIOL, V115, P129, DOI 10.1016/0012-1606(86)90234-4; Brown CB, 2005, GENESIS, V41, P202, DOI 10.1002/gene.20116; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chaudhuri TR, 2003, TECHNOL CANCER RES T, V2, P171, DOI 10.1177/153303460300200214; DEGREGORIO MW, 1989, CANCER CHEMOTH PHARM, V23, P68; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Keller C, 2004, GENE DEV, V18, P2614, DOI 10.1101/gad.1244004; Keller C, 2005, CANCER RES, V65, P7530, DOI 10.1158/0008-5472.CAN-05-0477; Keller C, 2004, GENE DEV, V18, P2608, DOI 10.1101/gad.1243904; LIEN EA, 1989, CANCER RES, V49, P2175; Louie AY, 2000, NAT BIOTECHNOL, V18, P321, DOI 10.1038/73780; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Lyons SK, 2003, CANCER RES, V63, P7042; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; MAXWELL IH, 1989, BIOTECHNIQUES, V7, P276; Nilsson EE, 2002, CANCER CHEMOTH PHARM, V49, P93, DOI 10.1007/s00280-001-0396-0; O'Neal WK, 2000, MOL THER, V2, P640, DOI 10.1006/mthe.2000.0198; Oumard A, 2000, MOL CELL BIOL, V20, P2755, DOI 10.1128/MCB.20.8.2755-2759.2000; Ray P, 2004, CANCER RES, V64, P1323, DOI 10.1158/0008-5472.CAN-03-1816; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Safran Michal, 2003, Mol Imaging, V2, P297, DOI 10.1162/153535003322750637; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stoller JZ, 2008, GENESIS, V46, P200, DOI 10.1002/dvg.20384; Tang SHE, 2002, GENESIS, V32, P199, DOI 10.1002/gene.10030; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Uhrbom L, 2004, NAT MED, V10, P1257, DOI 10.1038/nm1120; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Zolotukhin S, 1996, J VIROL, V70, P4646, DOI 10.1128/JVI.70.7.4646-4654.1996	35	104	109	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	AUG	2009	23	8					2681	2690		10.1096/fj.08-128116	http://dx.doi.org/10.1096/fj.08-128116			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19332644	Green Published			2022-12-25	WOS:000268836700036
J	Bains, J; Leon, R; Boulanger, MJ				Bains, Jasleen; Leon, Rafael; Boulanger, Martin J.			Structural and Biophysical Characterization of BoxC from Burkholderia xenovorans LB400 A NOVEL RING-CLEAVING ENZYME IN THE CROTONASE SUPERFAMILY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AEROBIC BENZOATE METABOLISM; 1.8 ANGSTROM RESOLUTION; COA CATABOLIC PATHWAY; CRYSTAL-STRUCTURE; COENZYME-A; AZOARCUS-EVANSII; DELTA(3)-DELTA(2)-ENOYL-COA ISOMERASE; RHODOPSEUDOMONAS-PALUSTRIS; AROMATIC-COMPOUNDS; CLEAVAGE ENZYME	The mineralization of aromatic compounds by microorganisms relies on a structurally and functionally diverse group of ring-cleaving enzymes. The recently discovered benzoate oxidation pathway in Burkholderia xenovorans LB400 encodes a novel such ring-cleaving enzyme, termed BoxC, that catalyzes the conversion of 2,3-dihydro-2,3-dihydroxybenzoyl-CoA to 3,4-dehydroadipyl-CoA without the requirement for molecular oxygen. Sequence analysis indicates that BoxC is a highly divergent member of the crotonase superfamily and nearly double the size of the average superfamily member. The structure of BoxC determined to 1.5 angstrom resolution reveals an intriguing structural demarcation. A highly divergent region in the C terminus probably serves as a structural scaffold for the conserved N terminus that encompasses the active site and, in conjunction with a conserved C-terminal helix, mediates dimer formation. Isothermal titration calorimetry and molecular docking simulations contribute to a detailed view of the active site, resulting in a compelling mechanistic model where a pair of conserved glutamate residues (Glu146 and Glu168) work in tandem to deprotonate the dihydroxylated ring substrate, leading to cleavage. A final deformylation step incorporating a water molecule and Cys(111) as a general base completes the formation of 3,4-dehydroadipyl-CoA product. Overall, this study establishes the basis for BoxC as one of the most divergent members of the crotonase superfamily and provides the first structural insight into the mechanism of this novel class of ring-cleaving enzymes.	[Bains, Jasleen; Boulanger, Martin J.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Leon, Rafael] Univ Victoria, Dept Chem, Victoria, BC V8W 3P6, Canada	University of Victoria; University of Victoria	Boulanger, MJ (corresponding author), Univ Victoria, Dept Biochem & Microbiol, POB 3055 STN CSC, Victoria, BC V8W 3P6, Canada.	mboulang@uvic.ca	León, Rafael/A-6997-2012; León, Rafael/AAE-4139-2019	León, Rafael/0000-0003-4017-5756; León, Rafael/0000-0003-4017-5756	Natural Sciences and Engineering Research Council of Canada; University of Victoria	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Victoria	This work was supported by a research grant from the Natural Sciences and Engineering Research Council of Canada (to M. J. B.).; Supported by a University of Victoria graduate award.	Babbitt PC, 1997, J BIOL CHEM, V272, P30591, DOI 10.1074/jbc.272.49.30591; Bains J, 2008, J MOL BIOL, V379, P597, DOI 10.1016/j.jmb.2008.04.031; Bains J, 2008, ACTA CRYSTALLOGR F, V64, P422, DOI 10.1107/S1744309108010919; Bains J, 2007, J MOL BIOL, V373, P965, DOI 10.1016/j.jmb.2007.08.008; Bennett JP, 2007, BIOCHEMISTRY-US, V46, P137, DOI 10.1021/bi061900g; Benning MM, 1996, BIOCHEMISTRY-US, V35, P8103, DOI 10.1021/bi960768p; Benning MM, 2000, BIOCHEMISTRY-US, V39, P4630, DOI 10.1021/bi9928896; Bugg TDH, 2003, TETRAHEDRON, V59, P7075, DOI 10.1016/S0040-4020(03)00944-X; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Denef VJ, 2006, APPL ENVIRON MICROB, V72, P585, DOI 10.1128/AEM.72.1.585-595.2006; Denef VJ, 2005, J BACTERIOL, V187, P7996, DOI 10.1128/JB.187.23.7996-8005.2005; Denef VJ, 2004, APPL ENVIRON MICROB, V70, P4961, DOI 10.1128/AEM.70.8.4961-4970.2004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel CK, 1996, EMBO J, V15, P5135, DOI 10.1002/j.1460-2075.1996.tb00897.x; EVANS WC, 1977, NATURE, V270, P17, DOI 10.1038/270017a0; EVANS WC, 1988, ANNU REV MICROBIOL, V42, P289, DOI 10.1146/annurev.mi.42.100188.001445; Frisch M.J., 2009, GAUSSIAN 09 LINUX VE; Gerber PR, 1998, J COMPUT AID MOL DES, V12, P37, DOI 10.1023/A:1007902804814; GERBER PR, 1995, J COMPUT AID MOL DES, V9, P251, DOI 10.1007/BF00124456; Gerlt JA, 2001, ANNU REV BIOCHEM, V70, P209, DOI 10.1146/annurev.biochem.70.1.209; Gescher J, 2006, J BACTERIOL, V188, P2919, DOI 10.1128/JB.188.8.2919-2927.2006; Gescher J, 2005, MOL MICROBIOL, V56, P1586, DOI 10.1111/j.1365-2958.2005.04637.x; Gescher J, 2002, J BACTERIOL, V184, P6301, DOI 10.1128/JB.184.22.6301-6315.2002; Gibson J, 2002, ANNU REV MICROBIOL, V56, P345, DOI 10.1146/annurev.micro.56.012302.160749; Hall PR, 2003, EMBO J, V22, P2334, DOI 10.1093/emboj/cdg244; Hamed RB, 2008, CELL MOL LIFE SCI, V65, P2507, DOI 10.1007/s00018-008-8082-6; HARWOOD CS, 1986, J BACTERIOL, V165, P504, DOI 10.1128/jb.165.2.504-509.1986; Harwood CS, 1996, ANNU REV MICROBIOL, V50, P553, DOI 10.1146/annurev.micro.50.1.553; Kurimoto K, 2001, STRUCTURE, V9, P1253, DOI 10.1016/S0969-2126(01)00686-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leonard PM, 2006, ACTA CRYSTALLOGR D, V62, P1494, DOI 10.1107/S0907444906039199; Leonard PM, 2004, J BIOL CHEM, V279, P31312, DOI 10.1074/jbc.M403514200; Modis Y, 1998, STRUCTURE, V6, P957, DOI 10.1016/S0969-2126(98)00098-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Mursula AM, 2001, J MOL BIOL, V309, P845, DOI 10.1006/jmbi.2001.4671; Partanen ST, 2004, J MOL BIOL, V342, P1197, DOI 10.1016/j.jmb.2004.07.039; Pelletier DA, 1998, J BACTERIOL, V180, P2330, DOI 10.1128/JB.180.9.2330-2336.1998; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sleeman MC, 2005, J BIOL CHEM, V280, P34956, DOI 10.1074/jbc.M507196200; Stanier R Y, 1973, Adv Microb Physiol, V9, P89; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Truglio JJ, 2003, J BIOL CHEM, V278, P42352, DOI 10.1074/jbc.M307399200; Ulaganathan V, 2007, ACTA CRYSTALLOGR F, V63, P908, DOI 10.1107/S1744309107047720; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wendt KS, 2003, EMBO J, V22, P3493, DOI 10.1093/emboj/cdg358; Whittingham JL, 2003, J BIOL CHEM, V278, P1744, DOI 10.1074/jbc.M211188200; Widboom PF, 2007, NATURE, V447, P342, DOI 10.1038/nature05702; Zaar A, 2004, MOL MICROBIOL, V54, P223, DOI 10.1111/j.1365-2958.2004.04263.x; Zhang HL, 2003, SCIENCE, V299, P2064, DOI 10.1126/science.1081366	54	10	11	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16377	16385		10.1074/jbc.M900226200	http://dx.doi.org/10.1074/jbc.M900226200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19369256	Green Published, hybrid			2022-12-25	WOS:000266730900035
J	Ortiz, D; Sanchez, MA; Koch, HP; Larsson, HP; Landfear, SM				Ortiz, Diana; Sanchez, Marco A.; Koch, Hans P.; Larsson, H. Peter; Landfear, Scott M.			An Acid-activated Nucleobase Transporter from Leishmania major	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-CHARACTERIZATION; DEFICIENT MUTANT; CLONING; GENE; PH; EXPRESSION; DONOVANI; RESCUE; FAMILY	Parasitic protozoa are unable to synthesize purines de novo and must import preformed purine nucleobases or nucleosides from their hosts. Leishmania major expresses two purine nucleobase transporters, LmaNT3 and LmaNT4. Previous studies revealed that at neutral pH, LmaNT3 is a broad specificity, high affinity nucleobase transporter, whereas LmaNT4 mediates the uptake of only adenine. Because LmaNT4 is required for optimal viability of the amastigote stage of the parasite that lives within acidified phagolysomal vesicles of mammalian macrophages, the function of this permease was examined under acidic pH conditions. At acidic pH, LmaNT4 acquires the ability to transport adenine, hypoxanthine, guanine, and xanthine with Km values in the micromolar range, indicating that this transporter is activated at low pH. Thus, LmaNT4 is an acid-activated purine nucleobase transporter that functions optimally under the physiological conditions the parasite is exposed to in the macrophage phagolysosome. In contrast, LmaNT3 functions optimally at neutral pH. Two-electrode voltage clamp experiments performed on LmaNT3 and LmaNT4 expressed in Xenopus oocytes revealed substrate-induced inward directed currents at acidic pH, and application of substrates induced acidification of the oocyte cytosol. These observations imply that LmaNT3 and LmaNT4 are nucleobase/proton symporters.	[Ortiz, Diana; Sanchez, Marco A.; Landfear, Scott M.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97239 USA; [Koch, Hans P.; Larsson, H. Peter] Oregon Hlth & Sci Univ, Inst Neurosci, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Landfear, SM (corresponding author), OR Hlth & Sci Univ, Dept Mol Microbiol & Immunol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	landfear@ohsu.edu		Landfear, Scott/0000-0002-1643-6664	National Institutes of Health [AI44138, NS051169]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051169] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI44138 ( to S. M. L.) and NS051169 ( to H. P. L.).	ANTOINE JC, 1990, INFECT IMMUN, V58, P779, DOI 10.1128/IAI.58.3.779-787.1990; ARRIZA JL, 1993, J BIOL CHEM, V268, P15329; Baldwin SA, 2005, J BIOL CHEM, V280, P15880, DOI 10.1074/jbc.M414337200; Barnes K, 2006, CIRC RES, V99, P510, DOI 10.1161/01.RES.0000238359.18495.42; Carter NS, 2000, J BIOL CHEM, V275, P20935, DOI 10.1074/jbc.M002418200; CARTER NS, 2003, MOL MED PARASITOLOGY, P197; Gontijo NF, 1998, EXP PARASITOL, V90, P212, DOI 10.1006/expr.1998.4336; Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; MARTINEZ S, 1992, NEW ENGL J MED, V326, P741, DOI 10.1056/NEJM199203123261105; Motulsky H., 1999, ANAL DATA GRAPHPAD P; Ortiz D, 2007, MOL MICROBIOL, V64, P1228, DOI 10.1111/j.1365-2958.2007.05730.x; Sanchez MA, 2004, MOL MEMBR BIOL, V21, P11, DOI 10.1080/0968768031000140845; Stein A, 2003, J BIOL CHEM, V278, P35127, DOI 10.1074/jbc.M306188200; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; ULLMAN B, 1984, PHARM RES-DORDR, P194, DOI 10.1023/A:1016365128531; Vasudevan G, 1998, P NATL ACAD SCI USA, V95, P9873, DOI 10.1073/pnas.95.17.9873	17	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16164	16169		10.1074/jbc.M109.006718	http://dx.doi.org/10.1074/jbc.M109.006718			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19366701	hybrid, Green Published			2022-12-25	WOS:000266730900013
J	Hsu, LJ; Schultz, L; Hong, QY; Van Moer, K; Heath, J; Li, MY; Lai, FJ; Lin, SR; Lee, MH; Lo, CP; Lin, YS; Chen, ST; Chang, NS				Hsu, Li-Jin; Schultz, Lori; Hong, Qunying; Van Moer, Kris; Heath, John; Li, Meng-Yen; Lai, Feng-Jie; Lin, Sing-Ru; Lee, Ming-Hui; Lo, Cheng-Peng; Lin, Yee-Shin; Chen, Shur-Tzu; Chang, Nan-Shan			Transforming Growth Factor beta 1 Signaling via Interaction with Cell Surface Hyal-2 and Recruitment of WWOX/WOX1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN-CONTAINING OXIDOREDUCTASE; WWOX TUMOR-SUPPRESSOR; NECROSIS-FACTOR CYTOTOXICITY; IN-VITRO; TYROSINE-33 PHOSPHORYLATION; NUCLEAR TRANSLOCATION; PHYSICALLY INTERACTS; BCL-2 EXPRESSION; PROSTATE-CANCER; POTENTIAL ROLE	Transforming growth factor beta(TGF-beta) initiates multiple signal pathways and activates many downstream kinases. Here, we determined that TGF-beta 1 bound cell surface hyaluronidase Hyal-2 on microvilli in type II TGF-beta receptor-deficient HCT116 cells, as determined by immunoelectron microscopy. This binding resulted in recruitment of proapoptotic WOX1 ( also named WWOX or FOR) and formation of Hyal-2 center dot WOX1 complexes for relocation to the nuclei. TGF-beta 1 strengthened the binding of the catalytic domain of Hyal-2 with the N-terminal Tyr-33-phosphorylated WW domain of WOX1, as determined by time lapse fluorescence resonance energy transfer analysis in live cells, co-immunoprecipitation, and yeast two-hybrid domain/domain mapping. In promoter activation assay, ectopic WOX1 or Hyal-2 alone increased the promoter activity driven by Smad. In combination, WOX1 and Hyal-2 dramatically enhanced the promoter activation (8-9-fold increases), which subsequently led to cell death (> 95% of promoter-activated cells). TGF-beta 1 supports L929 fibroblast growth. In contrast, transiently overexpressed WOX1 and Hyal-2 sensitized L929 to TGF-beta 1-induced apoptosis. Together, TGF-beta 1 invokes a novel signaling by engaging cell surface Hyal-2 and recruiting WOX1 for regulating the activation of Smad-driven promoter, thereby controlling cell growth and death.	[Lin, Sing-Ru; Lee, Ming-Hui; Chang, Nan-Shan] Natl Cheng Kung Univ, Coll Med, Inst Mol Med, Tainan 70101, Taiwan; [Hsu, Li-Jin; Lin, Yee-Shin] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 70101, Taiwan; [Hsu, Li-Jin; Lin, Yee-Shin; Chang, Nan-Shan] Natl Cheng Kung Univ, Coll Med, Ctr Gene Regulat & Signal Transduct Res, Tainan 70101, Taiwan; [Li, Meng-Yen; Lo, Cheng-Peng; Chen, Shur-Tzu] Natl Cheng Kung Univ, Coll Med, Dept Cell Biol & Anat, Tainan 70101, Taiwan; [Lai, Feng-Jie] Natl Cheng Kung Univ, Coll Med, Dept Dermatol, Tainan 70101, Taiwan; [Hsu, Li-Jin; Schultz, Lori; Hong, Qunying; Van Moer, Kris; Heath, John; Chang, Nan-Shan] Guthrie Res Inst, Lab Mol Immunol, Sayre, PA 18840 USA; [Chang, Nan-Shan] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Chang, NS (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Mol Med, Tainan 70101, Taiwan.	wox1world@gmail.com	Hsu, Li-Jin/G-7822-2011		American Heart Association; Department of Defense [DAMD17-03-1-0736, W81XWH-08-1-0682]; Guthrie Foundation for Education and Research; National Science Council, Taiwan [NSC96-2320-B-006-014, 96-2628-B-006-041-MY3, 96-2628-B-006-045-MY3]; National Health Research Institute, Taiwan [NHRI-EX97-9704BI]; National Cheng Kung University Landmark [C0167, R026]	American Heart Association(American Heart Association); Department of Defense(United States Department of Defense); Guthrie Foundation for Education and Research; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan); National Cheng Kung University Landmark	This research was supported in part by the American Heart Association, Department of Defense Grants DAMD17-03-1-0736 and W81XWH-08-1-0682, the Guthrie Foundation for Education and Research, the National Science Council, Taiwan Grants NSC96-2320-B-006-014, 96-2628-B-006-041-MY3, and 96-2628-B-006-045-MY3), the National Health Research Institute, Taiwan Grant NHRI-EX97-9704BI), and the National Cheng Kung University Landmark Projects C0167 and R026 ( to N.S.C.).	Aqeilan RI, 2008, J BIOL CHEM, V283, P21629, DOI 10.1074/jbc.M800855200; Aqeilan RI, 2007, J CELL PHYSIOL, V212, P307, DOI 10.1002/jcp.21099; Aqeilan RI, 2007, P NATL ACAD SCI USA, V104, P3949, DOI 10.1073/pnas.0609783104; Aqeilan RI, 2009, ENDOCRINOLOGY, V150, P1530, DOI 10.1210/en.2008-1087; Aqeilan RI, 2005, CANCER RES, V65, P6764, DOI 10.1158/0008-5472.CAN-05-1150; Aqeilan RI, 2004, P NATL ACAD SCI USA, V101, P4401, DOI 10.1073/pnas.0400805101; Aqeilan RI, 2004, CANCER RES, V64, P8256, DOI 10.1158/0008-5472.CAN-04-2055; Aqeilian RI, 2007, CANCER RES, V67, P9330, DOI 10.1158/0008-5472.CAN-07-2147; Atfi A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.126pe33; Bachman KE, 2005, CURR OPIN ONCOL, V17, P49, DOI 10.1097/01.cco.0000143682.45316.ae; Bednarek AK, 2001, CANCER RES, V61, P8068; Bourguignon LYW, 2002, J BIOL CHEM, V277, P39703, DOI 10.1074/jbc.M204320200; Cattaruzza S, 2005, MATRIX BIOL, V24, P400, DOI 10.1016/j.matbio.2005.06.005; Chang NS, 2007, TRENDS MOL MED, V13, P12, DOI 10.1016/j.molmed.2006.11.006; Chang NS, 1998, INT J MOL MED, V2, P653; Chang NS, 2005, J BIOL CHEM, V280, P43100, DOI 10.1074/jbc.M505590200; Chang NS, 2005, ONCOGENE, V24, P714, DOI 10.1038/sj.onc.1208124; Chang NS, 2003, J BIOL CHEM, V278, P9195, DOI 10.1074/jbc.M208373200; Chang NS, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-8; Chang NS, 2002, J BIOL CHEM, V277, P10323, DOI 10.1074/jbc.M106607200; Chang NS, 2001, J BIOL CHEM, V276, P3361, DOI 10.1074/jbc.M007140200; Chen ST, 2005, NEUROSCIENCE, V130, P397, DOI 10.1016/j.neuroscience.2004.07.054; Chen ST, 2004, NEUROSCIENCE, V124, P831, DOI 10.1016/j.neuroscience.2003.12.036; Chuang JI, 2001, J CHEM NEUROANAT, V21, P215, DOI 10.1016/S0891-0618(01)00109-0; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Driouch K, 2002, ONCOGENE, V21, P1832, DOI 10.1038/sj.onc.1205273; Fabbri M, 2005, P NATL ACAD SCI USA, V102, P15611, DOI 10.1073/pnas.0505485102; Guler G, 2004, CANCER, V100, P1605, DOI 10.1002/cncr.20137; Hong QY, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-50; Hsu LJ, 2008, CELL SIGNAL, V20, P1303, DOI 10.1016/j.cellsig.2008.02.018; Ilsley JL, 2002, CELL SIGNAL, V14, P183, DOI 10.1016/S0898-6568(01)00236-4; Ito T, 2004, AM J PATHOL, V164, P1979, DOI 10.1016/S0002-9440(10)63758-3; Jiang W, 1997, BIOCHEMISTRY-US, V36, P14786, DOI 10.1021/bi9717892; Jin CJ, 2006, BIOCHEM BIOPH RES CO, V341, P784, DOI 10.1016/j.bbrc.2006.01.023; Lai FJ, 2005, CLIN CANCER RES, V11, P5769, DOI 10.1158/1078-0432.CCR-04-2274; Lepperdinger G, 1998, J BIOL CHEM, V273, P22466, DOI 10.1074/jbc.273.35.22466; Lo CP, 2008, EUR J NEUROSCI, V27, P1634, DOI 10.1111/j.1460-9568.2008.06139.x; Lokeshwar VB, 2005, CANCER RES, V65, P7782, DOI 10.1158/0008-5472.CAN-05-1022; Ludes-Meyers JH, 2007, GENE CHROMOSOME CANC, V46, P1129, DOI 10.1002/gcc.20497; Mahajan NP, 2005, CANCER RES, V65, P10514, DOI 10.1158/0008-5472.CAN-05-1127; Muraoka-Cook RS, 2005, CLIN CANCER RES, V11, p937S; Okada T, 2007, TRENDS CELL BIOL, V17, P222, DOI 10.1016/j.tcb.2007.03.006; Pluciennik E, 2006, EJSO-EUR J SURG ONC, V32, P153, DOI 10.1016/j.ejso.2005.11.002; Qin HR, 2007, MOL CANCER RES, V5, P957, DOI 10.1158/1541-7786.MCR-07-0211; Qin HR, 2006, CANCER RES, V66, P6477, DOI 10.1158/0008-5472.CAN-06-0956; Rai SK, 2001, P NATL ACAD SCI USA, V98, P4443, DOI 10.1073/pnas.071572898; Ried K, 2000, HUM MOL GENET, V9, P1651, DOI 10.1093/hmg/9.11.1651; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Schultz L, 2004, DNA CELL BIOL, V23, P67, DOI 10.1089/104454904322745943; Smith DI, 2007, SEMIN CANCER BIOL, V17, P31, DOI 10.1016/j.semcancer.2006.10.003; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; Sze CI, 2004, J BIOL CHEM, V279, P30498, DOI 10.1074/jbc.M401399200; Udabage L, 2005, EXP CELL RES, V310, P205, DOI 10.1016/j.yexcr.2005.07.026; Wang J, 2004, J BIOL CHEM, V279, P40237, DOI 10.1074/jbc.M401665200; Watanabe A, 2003, CANCER RES, V63, P8629	55	61	67	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					16049	16059		10.1074/jbc.M806688200	http://dx.doi.org/10.1074/jbc.M806688200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19366691	Green Published, hybrid			2022-12-25	WOS:000266501000070
J	Nencioni, L; De Chiara, G; Sgarbanti, R; Amatore, D; Aquilano, K; Marcocci, ME; Serafino, A; Torcia, M; Cozzolino, F; Ciriolo, MR; Garaci, E; Palamara, AT				Nencioni, Lucia; De Chiara, Giovanna; Sgarbanti, Rossella; Amatore, Donatella; Aquilano, Katia; Marcocci, Maria E.; Serafino, Annalucia; Torcia, Maria; Cozzolino, Federico; Ciriolo, Maria R.; Garaci, Enrico; Palamara, Anna T.			Bcl-2 Expression and p38MAPK Activity in Cells Infected with Influenza A Virus IMPACT ON VIRALLY INDUCED APOPTOSIS AND VIRAL REPLICATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NUCLEAR EXPORT; AVIAN INFLUENZA; P38 MAPK; M1 PROTEIN; PHOSPHORYLATION; NUCLEOPROTEIN; INHIBITION; PATHWAY; DEATH	Previous reports have shown that various steps in the influenza A virus life cycle are impaired in cells expressing the antiapoptotic protein Bcl-2 (Bcl-2(+) cells). We demonstrated a direct link between Bcl-2 and the reduced nuclear export of viral ribonucleoprotein (vRNP) complexes in these cells. However, despite its negative impact on viral replication, Bcl-2 did not prevent host cells from undergoing virally triggered apoptosis. The protein's reduced antiapoptotic capacity was related to phosphorylation of its threonine 56 and serine 87 residues by virally activated p38MAPK. In infected Bcl-2(+) cells, activated p38MAPK was found predominantly in the cytoplasm, colocalized with Bcl-2, and both Bcl-2 phosphorylation and virally induced apoptosis were diminished by specific inhibition of p38MAPK activity. In contrast, in Bcl-2-negative (Bcl-2(-)) cells, which are fully permissive to viral infection, p38MAPK activity was predominantly nuclear, and its inhibition decreased vRNP traffic, phosphorylation of viral nucleoprotein, and virus titers in cell supernatants, suggesting that this kinase also contributes to the regulation of vRNP export and viral replication. This could explain why in Bcl-2(+) cells, where p38MAPK is active in the cytoplasm, phosphorylating Bcl-2, influenza viral replication is substantially reduced, whereas apoptosis proceeds at rates similar to those observed in Bcl-2(+) cells. Our findings suggest that the impact of p38MAPK on the influenza virus life cycle and the apoptotic response of host cells to infection depends on whether or not the cells express Bcl-2, highlighting the possibility that the pathological effects of the virus are partly determined by the cell type it targets.	[Nencioni, Lucia; Sgarbanti, Rossella; Amatore, Donatella; Marcocci, Maria E.; Palamara, Anna T.] Univ Roma La Sapienza, Dept Publ Hlth Sci, I-00185 Rome, Italy; [Palamara, Anna T.] Univ Roma La Sapienza, Ist Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy; [De Chiara, Giovanna] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Aquilano, Katia; Ciriolo, Maria R.] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; [Garaci, Enrico] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00133 Rome, Italy; [Serafino, Annalucia] CNR, Inst Neurobiol & Mol Med, I-00133 Rome, Italy; [Torcia, Maria; Cozzolino, Federico] Univ Florence, Dept Clin Physiopathol, I-50139 Florence, Italy; [Ciriolo, Maria R.; Palamara, Anna T.] Hosp & Hlth Care S Raffaele, Sci Inst Res, I-00100 Rome, Italy	Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; Istituto Superiore di Sanita (ISS); University of Rome Tor Vergata; University of Rome Tor Vergata; Consiglio Nazionale delle Ricerche (CNR); University of Florence; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Palamara, AT (corresponding author), Univ Roma La Sapienza, Dept Publ Hlth Sci, P le Aldo Moro 5, I-00185 Rome, Italy.	annateresa.palamara@uniroma1.it	Ciriolo, Maria Rosa/K-6572-2016; Serafino, Annalucia/AAC-1719-2019; Torcia, Maria Gabriella G/K-1840-2018; Elena, Marcocci Maria/I-9550-2014; AQUILANO, KATIA/K-8888-2016; Nencioni, Lucia/K-5988-2016; De Chiara, Giovanna/AAJ-7843-2021; GARACI, ENRICO/AAB-3349-2021; Sgarbanti, Rossella/D-8797-2011	Serafino, Annalucia/0000-0002-1142-4752; Torcia, Maria Gabriella G/0000-0003-4740-4646; Elena, Marcocci Maria/0000-0003-4751-4263; AQUILANO, KATIA/0000-0002-5905-9870; Nencioni, Lucia/0000-0003-4427-4823; De Chiara, Giovanna/0000-0002-2219-6097; AMATORE, DONATELLA/0000-0001-5701-9683; Ciriolo, Maria Rosa/0000-0002-7863-9029; Sgarbanti, Rossella/0000-0002-8028-0027; PALAMARA, ANNA TERESA/0000-0001-8330-4381; Cozzolino, Federico/0000-0002-2800-640X	Italian Ministry of Instruction, University and Research Special Project [FIRB RBIP067F9E, Reti FIRB RBPR05NWWC_006]; Progetto Ateneo	Italian Ministry of Instruction, University and Research Special Project; Progetto Ateneo	This work was supported in part by Italian Ministry of Instruction, University and Research Special Project "Fund for Investments on Basic Research" Grants FIRB RBIP067F9E and Reti FIRB RBPR05NWWC_006) and a grant from Progetto Ateneo.	Akarsu H, 2003, EMBO J, V22, P4646, DOI 10.1093/emboj/cdg449; Aquilano K, 2006, FASEB J, V20, P1683, DOI 10.1096/fj.05-5225fje; Blagosklonny MV, 2001, LEUKEMIA, V15, P869, DOI 10.1038/sj.leu.2402134; Boulo S, 2007, VIRUS RES, V124, P12, DOI 10.1016/j.virusres.2006.09.013; Bui M, 2000, J VIROL, V74, P1781, DOI 10.1128/JVI.74.4.1781-1786.2000; Bui M, 2002, VIRUS RES, V84, P37, DOI 10.1016/S0168-1702(01)00413-0; Bullido R, 2000, J GEN VIROL, V81, P135, DOI 10.1099/0022-1317-81-1-135; Cros JF, 2003, VIRUS RES, V95, P3, DOI 10.1016/S0168-1702(03)00159-X; De Chiara G, 2006, J BIOL CHEM, V281, P21353, DOI 10.1074/jbc.M511052200; DeSilva DR, 1998, J IMMUNOL, V160, P4175; Elton D, 2001, J VIROL, V75, P408, DOI 10.1128/JVI.75.1.408-419.2001; FIELDS BN, 2007, VIROLOGY, V2, P1647; Fremont L, 2000, LIFE SCI, V66, P663, DOI 10.1016/S0024-3205(99)00410-5; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; GARLAND LG, 1987, TRENDS PHARMACOL SCI, V8, P334, DOI 10.1016/0165-6147(87)90138-6; GAUSH CR, 1968, APPL MICROBIOL, V16, P588, DOI 10.1128/AEM.16.4.588-594.1968; GOMPEL A, 1994, AM J PATHOL, V144, P1195; HALDAR S, 1995, P NATL ACAD SCI USA, V92, P4507, DOI 10.1073/pnas.92.10.4507; Harris JF, 2005, AM J RESP CRIT CARE, V171, P764, DOI 10.1164/rccm.200408-1108OC; HINSHAW VS, 1994, J VIROL, V68, P3667, DOI 10.1128/JVI.68.6.3667-3673.1994; Hirayama E, 2004, J VIROL, V78, P1263, DOI 10.1128/JVI.78.3.1263-1270.2004; HOCKENBERY DM, 1991, P NATL ACAD SCI USA, V88, P6961, DOI 10.1073/pnas.88.16.6961; KISTNER O, 1989, J GEN VIROL, V70, P2421, DOI 10.1099/0022-1317-70-9-2421; Kristensson K, 2006, BRAIN RES BULL, V68, P406, DOI 10.1016/j.brainresbull.2005.11.022; Kujime K, 2000, J IMMUNOL, V164, P3222, DOI 10.4049/jimmunol.164.6.3222; Lee DCW, 2005, J VIROL, V79, P10147, DOI 10.1128/JVI.79.16.10147-10154.2005; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; LEVINE B, 1993, NATURE, V361, P739, DOI 10.1038/361739a0; Ludwig S, 2006, CELL MICROBIOL, V8, P375, DOI 10.1111/j.1462-5822.2005.00678.x; Ludwig S, 2003, TRENDS MOL MED, V9, P46, DOI 10.1016/S1471-4914(02)00010-2; MAHY BWJ, 1991, VIROLOGY PRACTICAL A, P119; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Maruoka S, 2003, BIOCHEM BIOPH RES CO, V307, P870, DOI 10.1016/S0006-291X(03)01283-X; Nencioni L, 2003, FASEB J, V17, P758, DOI 10.1096/fj.02-0508fje; Neumann G, 1997, J VIROL, V71, P9690, DOI 10.1128/JVI.71.12.9690-9700.1997; Neumann G, 2000, EMBO J, V19, P6751, DOI 10.1093/emboj/19.24.6751; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; O'Neill RE, 1998, EMBO J, V17, P288, DOI 10.1093/emboj/17.1.288; Olsen CW, 1996, J VIROL, V70, P663, DOI 10.1128/JVI.70.1.663-666.1996; Palamara AT, 2005, J INFECT DIS, V191, P1719, DOI 10.1086/429694; Pica F, 2000, ANTIMICROB AGENTS CH, V44, P200, DOI 10.1128/AAC.44.1.200-204.2000; Pleschka S, 2001, NAT CELL BIOL, V3, P301, DOI 10.1038/35060098; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; Rosini P, 2000, BIOCHEM BIOPH RES CO, V278, P753, DOI 10.1006/bbrc.2000.3871; Shin YK, 2007, J VIROL, V81, P12730, DOI 10.1128/JVI.01427-07; Tanaka H, 2003, VET MICROBIOL, V95, P1, DOI 10.1016/S0378-1135(03)00132-9; Tesfaigzi J, 1998, AM J RESP CELL MOL, V18, P794, DOI 10.1165/ajrcmb.18.6.3036; Tibbles LA, 1999, CELL MOL LIFE SCI, V55, P1230, DOI 10.1007/s000180050369; Torcia M, 2001, J BIOL CHEM, V276, P39027, DOI 10.1074/jbc.M102970200; Uchide N, 2007, INTERVIROLOGY, V50, P99, DOI 10.1159/000097396; Whittaker GR, 1998, VIROLOGY, V246, P1, DOI 10.1006/viro.1998.9165; Wurzer WJ, 2003, EMBO J, V22, P2717, DOI 10.1093/emboj/cdg279; Zachos G, 2001, J VIROL, V75, P2710, DOI 10.1128/JVI.75.6.2710-2728.2001	54	74	77	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					16004	16015		10.1074/jbc.M900146200	http://dx.doi.org/10.1074/jbc.M900146200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19336399	hybrid, Green Published			2022-12-25	WOS:000266501000066
J	Segal, E; Pan, HZ; Ofek, P; Udagawa, T; Kopeckova, P; Kopecek, J; Satchi-Fainaro, R				Segal, Ehud; Pan, Huaizhong; Ofek, Paula; Udagawa, Taturo; Kopeckova, Pavla; Kopecek, Jindrich; Satchi-Fainaro, Ronit			Targeting Angiogenesis-Dependent Calcified Neoplasms Using Combined Polymer Therapeutics	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR ANGIOGENESIS; DRUG-DELIVERY; COMBINATION CHEMOTHERAPY; ANTITUMOR-ACTIVITY; HPMA COPOLYMER; CATHEPSIN-K; PHASE-II; BONE; ALENDRONATE	Background: There is an immense clinical need for novel therapeutics for the treatment of angiogenesis-dependent calcified neoplasms such as osteosarcomas and bone metastases. We developed a new therapeutic strategy to target bone metastases and calcified neoplasms using combined polymer-bound angiogenesis inhibitors. Using an advanced "living polymerization'' technique, the reversible addition-fragmentation chain transfer (RAFT), we conjugated the aminobisphosphonate alendronate (ALN), and the potent anti-angiogenic agent TNP-470 with N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer through a Glycine-Glycine-Proline-Norleucine linker, cleaved by cathepsin K, a cysteine protease overexpressed at resorption sites in bone tissues. In this approach, dual targeting is achieved. Passive accumulation is possible due to the increase in molecular weight following polymer conjugation of the drugs, thus extravasating from the tumor leaky vessels and not from normal healthy vessels. Active targeting to the calcified tissues is achieved by ALN's affinity to bone mineral. Methods and Finding: The anti-angiogenic and antitumor potency of HPMA copolymer-ALN-TNP-470 conjugate was evaluated both in vitro and in vivo. We show that free and conjugated ALN-TNP-470 have synergistic anti-angiogenic and antitumor activity by inhibiting proliferation, migration and capillary-like tube formation of endothelial and human osteosarcoma cells in vitro. Evaluation of anti-angiogenic, antitumor activity and body distribution of HPMA copolymer-ALN-TNP470 conjugate was performed on severe combined immunodeficiency ( SCID) male mice inoculated with mCherry-labeled MG-63-Ras human osteosarcoma and by modified Miles permeability assay. Our targeted bi-specific conjugate reduced VEGF-induced vascular hyperpermeability by 92% and remarkably inhibited osteosarcoma growth in mice by 96%. Conclusions: This is the first report to describe a new concept of a narrowly-dispersed combined polymer therapeutic designed to target both tumor and endothelial compartments of bone metastases and calcified neoplasms at a single administration. This new approach of co-delivery of two synergistic drugs may have clinical utility as a potential therapy for angiogenesis-dependent cancers such as osteosarcoma and bone metastases.			Segal, E (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	ronitsf@post.tau.ac.il	Satchi-Fainaro, Ronit/F-9137-2011	Satchi-Fainaro, Ronit/0000-0002-7360-7837; Ofek, Paula/0000-0002-8516-1107	NIGMS NIH HHS [R01 GM069847] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069847] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bagi CM, 2005, ADV DRUG DELIVER REV, V57, P995, DOI 10.1016/j.addr.2004.12.014; Becker CM, 2006, AM J PATHOL, V168, P2074, DOI 10.2353/ajpath.2006.051133; Benny O, 2008, NAT BIOTECHNOL, V26, P799, DOI 10.1038/nbt1415; Berenson JR, 1999, ANNU REV MED, V50, P237; Bhargava P, 1999, CLIN CANCER RES, V5, P1989; Cheng YY, 2004, PEDIATR BLOOD CANCER, V42, P410, DOI 10.1002/pbc.20019; Chesler L, 2007, CANCER RES, V67, P9435, DOI 10.1158/0008-5472.CAN-07-1316; Chuman Hirokazu, 2004, Gan To Kagaku Ryoho, V31, P1331; Claffey KP, 1996, CANCER RES, V56, P172; DuBois S, 2007, CANCER-AM CANCER SOC, V109, P813, DOI 10.1002/cncr.22455; Duncan R, 2001, J CONTROL RELEASE, V74, P135, DOI 10.1016/S0168-3659(01)00328-5; Duncan R, 2006, J DRUG TARGET, V14, P337, DOI 10.1080/10611860600833856; DUNN D, 1977, CANCER-AM CANCER SOC, V40, P3054, DOI 10.1002/1097-0142(197712)40:6<3054::AID-CNCR2820400644>3.0.CO;2-A; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; El-Mabhouh AA, 2006, NUCL MED BIOL, V33, P715, DOI 10.1016/j.nucmedbio.2006.06.004; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Gittens SA, 2005, ADV DRUG DELIVER REV, V57, P1011, DOI 10.1016/j.addr.2004.12.015; Font RG, 2008, MED ORAL PATOL ORAL, V13, pE318; Greco F, 2007, J CONTROL RELEASE, V117, P28, DOI 10.1016/j.jconrel.2006.10.012; Haag R, 2006, ANGEW CHEM INT EDIT, V45, P1198, DOI 10.1002/anie.200502113; Hashimoto K, 2005, CANCER RES, V65, P540; Hashimoto K, 2007, BIOCHEM BIOPH RES CO, V354, P478, DOI 10.1016/j.bbrc.2007.01.014; Hering Flavio, 2003, Int. braz j urol., V29, P228, DOI 10.1590/S1677-55382003000300006; Hillner BE, 2000, SEMIN RADIAT ONCOL, V10, P250, DOI 10.1053/S1053-4296(00)80042-9; Hruby M, 2006, J APPL POLYM SCI, V101, P3192, DOI 10.1002/app.23446; Husmann K, 2008, MOL CARCINOGEN, V47, P66, DOI 10.1002/mc.20362; INGBER D, 1990, NATURE, V348, P555, DOI 10.1038/348555a0; Inoue R, 2005, BRIT J PHARMACOL, V146, P633, DOI 10.1038/sj.bjp.0706373; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kabbinavar F, 2003, J CLIN ONCOL, V21, P60, DOI 10.1200/JCO.2003.10.066; Kansara M, 2007, DNA CELL BIOL, V26, P1, DOI 10.1089/dna.2006.0505; KRINICK NL, 1994, J BIOMAT SCI-POLYM E, V5, P303, DOI 10.1163/156856294X00040; Kuljanin J, 2002, J PHARMACEUT BIOMED, V28, P1215, DOI 10.1016/S0731-7085(02)00021-3; Lipton A, 2002, CANCER INVEST, V20, P45, DOI 10.1081/CNV-120014886; Lipton A, 2008, CANCER TREAT REV, V34, pS25, DOI 10.1016/j.ctrv.2008.03.008; Marino JP, 2007, J MED CHEM, V50, P3777, DOI 10.1021/jm061182w; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Mercadante S, 1997, PAIN, V69, P1, DOI 10.1016/S0304-3959(96)03267-8; MILES AA, 1952, J PHYSIOL-LONDON, V118, P228, DOI 10.1113/jphysiol.1952.sp004789; MILLER K, 2008, WILEY ENCY CHEM BIOL; Molinuevo MS, 2007, EUR J PHARMACOL, V562, P28, DOI 10.1016/j.ejphar.2007.01.054; MORISHITA T, 1995, JPN J CLIN ONCOL, V25, P25; Motl S, 2005, AM J HEALTH-SYST PH, V62, P1021, DOI 10.1093/ajhp/62.10.1021; MOURAD JJ, 2007, ANN ONCOL; Pan HZ, 2008, MOL PHARMACEUT, V5, P548, DOI 10.1021/mp800003u; Pan HZ, 2006, J DRUG TARGET, V14, P425, DOI 10.1080/10611860600834219; Peterson CM, 1996, CANCER RES, V56, P3980; Quan GMY, 2006, CANCER METAST REV, V25, P707, DOI 10.1007/s10555-006-9031-1; Quattrocchi CC, 2007, RADIOL MED, V112, P1049, DOI 10.1007/s11547-007-0205-x; Russell RGG, 2007, PEDIATRICS, V119, pS150, DOI 10.1542/peds.2006-2023H; Russell RGG, 1999, BONE, V25, P97, DOI 10.1016/S8756-3282(99)00116-7; RUSSELL RGG, 1970, LANCET, V2, P899, DOI 10.1016/S0140-6736(70)92070-2; Sanfilippo NJ, 2008, J CLIN ONCOL, V26, P2973, DOI 10.1200/JCO.2007.14.4105; Santini D, 2007, CLIN CANCER RES, V13, P6850, DOI 10.1158/1078-0432.CCR-07-4408; Satchi-Fainaro R, 2006, ADV POLYM SCI, V193, P1, DOI 10.1007/12_024; Satchi-Fainaro R, 2005, CANCER CELL, V7, P251, DOI 10.1016/j.ccr.2005.02.007; Satchi-Fainaro R, 2004, NAT MED, V10, P255, DOI 10.1038/nm1002; Satchi-Fainaro R, 2002, J DRUG TARGET, V10, P529, DOI 10.1080/1061186021000051062; SATCHIFAINARO R, 2008, ANGIOGENESIS INTEGRA, P387; SEGAL E, 2009, PLOS ONE IN PRESS; Sevcik MA, 2004, PAIN, V111, P169, DOI 10.1016/j.pain.2004.06.015; Seymour LW, 2002, J CLIN ONCOL, V20, P1668, DOI 10.1200/JCO.2002.20.6.1668; Shiah JG, 2000, CLIN CANCER RES, V6, P1008; TOL J, 2008, ANN ONCOL; Traina TA, 2007, HEMATOL ONCOL CLIN N, V21, P303, DOI 10.1016/j.hoc.2007.03.006; Tucker LA, 2008, ONCOGENE, V27, P3967, DOI 10.1038/onc.2008.14; Tuomela JM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-81; Uludag H, 2002, CURR PHARM DESIGN, V8, P1929, DOI 10.2174/1381612023393585; Vicent MJ, 2005, ANGEW CHEM INT EDIT, V44, P4061, DOI 10.1002/anie.200462960; Wang D, 2003, BIOCONJUGATE CHEM, V14, P853, DOI 10.1021/bc034090j; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Wunder JS, 2007, LANCET ONCOL, V8, P513, DOI 10.1016/S1470-2045(07)70169-9; Zangari M, 2004, CLIN CANCER RES, V10, P88, DOI 10.1158/1078-0432.CCR-0221-3; Zhang Y, 2006, CHEM BIOL, V13, P1001, DOI 10.1016/j.chembiol.2006.07.010; Zhao YX, 2008, BIOORGAN MED CHEM, V16, P6333, DOI 10.1016/j.bmc.2008.05.012	75	98	107	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2009	4	4							e5233	10.1371/journal.pone.0005233	http://dx.doi.org/10.1371/journal.pone.0005233			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VA	19381291	gold, Green Published			2022-12-25	WOS:000265513800009
J	Carson, RG; Oytam, Y; Riek, S				Carson, Richard G.; Oytam, Yalchin; Riek, Stephan			Artificial Gravity Reveals that Economy of Action Determines the Stability of Sensorimotor Coordination	PLOS ONE			English	Article							MOTOR CORTEX; BIMANUAL COORDINATION; CEREBRAL ACTIVATION; MOVEMENT; PERCEPTION; DYNAMICS; REPRESENTATION; PET	Background: When we move along in time with a piece of music, we synchronise the downward phase of our gesture with the beat. While it is easy to demonstrate this tendency, there is considerable debate as to its neural origins. It may have a structural basis, whereby the gravitational field acts as an orientation reference that biases the formulation of motor commands. Alternatively, it may be functional, and related to the economy with which motion assisted by gravity can be generated by the motor system. Methodology/Principal Findings: We used a robotic system to generate a mathematical model of the gravitational forces acting upon the hand, and then to reverse the effect of gravity, and invert the weight of the limb. In these circumstances, patterns of coordination in which the upward phase of rhythmic hand movements coincided with the beat of a metronome were more stable than those in which downward movements were made on the beat. When a normal gravitational force was present, movements made down-on-the-beat were more stable than those made up-on-the-beat. Conclusions/Significance: The ubiquitous tendency to make a downward movement on a musical beat arises not from the perception of gravity, but as a result of the economy of action that derives from its exploitation.			Carson, RG (corresponding author), Queens Univ Belfast, Sch Psychol, Belfast BT7 1NN, Antrim, North Ireland.	r.g.carson@qub.ac.uk	Riek, Stephan/A-1506-2010	Riek, Stephan/0000-0002-8355-8426; Lauwereyns, Jan/0000-0003-0551-2550; Carson, Richard/0000-0002-1190-2814				ARNHEIM R, 1984, MUSIC QUART, V70, P295; BEEK PJ, 1979, JUGGLING DYNAMICS; BINDER JR, 1994, COGNITIVE BRAIN RES, V2, P31, DOI 10.1016/0926-6410(94)90018-3; Blinkenberg M, 1996, J CEREBR BLOOD F MET, V16, P794, DOI 10.1097/00004647-199609000-00004; BYBLOW WD, 1994, HUM MOVEMENT SCI, V13, P3, DOI 10.1016/0167-9457(94)90027-2; Carroll TJ, 2001, P ROY SOC B-BIOL SCI, V268, P221, DOI 10.1098/rspb.2000.1356; Carson RG, 1998, EXP BRAIN RES, V121, P103, DOI 10.1007/s002210050442; Carson RG, 1996, EXP BRAIN RES, V110, P99; Carson RG, 1999, P ROY SOC B-BIOL SCI, V266, P853, DOI 10.1098/rspb.1999.0715; Carson RG, 2006, J APPL PHYSIOL, V101, P1506, DOI 10.1152/japplphysiol.00544.2006; Gentili R, 2007, NEUROSCIENCE, V145, P20, DOI 10.1016/j.neuroscience.2006.11.035; GORDON AM, 1966, J PHYSIOL-LONDON, V184, P170, DOI 10.1113/jphysiol.1966.sp007909; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; HUFNAGEL A, 1990, J NEUROL, V237, P416, DOI 10.1007/BF00314732; HUMPHREY DR, 1986, FED PROC, V45, P2687; JANTZEN KJ, 2008, J COGN NEUROSCI; KELSO JAS, 1984, AM J PHYSIOL, V246, P1000; Lee DN, 1998, ECOL PSYCHOL, V10, P221, DOI 10.1207/s15326969eco103&4_4; LEMON R, 1988, TRENDS NEUROSCI, V11, P501, DOI 10.1016/0166-2236(88)90012-4; Luppino G, 2000, NEWS PHYSIOL SCI, V15, P219; Mayville JM, 2001, HUM BRAIN MAPP, V14, P65, DOI 10.1002/hbm.1042; McIntyre J, 2001, NAT NEUROSCI, V4, P693, DOI 10.1038/89477; Mechsner F, 2001, NATURE, V414, P69, DOI 10.1038/35102060; Pozzo T, 1998, BRAIN RES REV, V28, P92, DOI 10.1016/S0165-0173(98)00030-7; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Rathelot JA, 2006, P NATL ACAD SCI USA, V103, P8257, DOI 10.1073/pnas.0602933103; Riek S, 2004, HUM MOVEMENT SCI, V23, P431, DOI 10.1016/j.humov.2004.08.016; Schlaug G, 1996, NEUROREPORT, V7, P879, DOI 10.1097/00001756-199603220-00009; SCHMIDT RA, 1979, PSYCHOL REV, V86, P415, DOI 10.1037//0033-295X.86.5.415; Schneider C, 2002, EXP BRAIN RES, V146, P86, DOI 10.1007/s00221-002-1137-2; Turner RS, 1998, J NEUROPHYSIOL, V80, P2162, DOI 10.1152/jn.1998.80.4.2162	31	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5248	10.1371/journal.pone.0005248	http://dx.doi.org/10.1371/journal.pone.0005248			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437TN	19365561	Green Published, gold, Green Submitted			2022-12-25	WOS:000265509900020
J	Bunck, M; Czibere, L; Horvath, C; Graf, C; Frank, E; Kessler, MS; Murgatroyd, C; Muller-Myhsok, B; Gonik, M; Weber, P; Putz, B; Muigg, P; Panhuysen, M; Singewald, N; Bettecken, T; Deussing, JM; Holsboer, F; Spengler, D; Landgraf, R				Bunck, Mirjam; Czibere, Ludwig; Horvath, Charlotte; Graf, Cornelia; Frank, Elisabeth; Kessler, Melanie S.; Murgatroyd, Chris; Mueller-Myhsok, Bertram; Gonik, Mariya; Weber, Peter; Puetz, Benno; Muigg, Patrik; Panhuysen, Markus; Singewald, Nicolas; Bettecken, Thomas; Deussing, Jan M.; Holsboer, Florian; Spengler, Dietmar; Landgraf, Rainer			A Hypomorphic Vasopressin Allele Prevents Anxiety-Related Behavior	PLOS ONE			English	Article								Background: To investigate neurobiological correlates of trait anxiety, CD1 mice were selectively bred for extremes in anxiety-related behavior, with high (HAB) and low (LAB) anxiety-related behavior mice additionally differing in behavioral tests reflecting depression-like behavior. Methodology/Principal Findings: In this study, microarray analysis, in situ hybridization, quantitative real-time PCR and immunohistochemistry revealed decreased expression of the vasopressin gene (Avp) in the hypothalamic paraventricular (PVN) and supraoptic (SON) nuclei of adult LAB mice compared to HAB, NAB (normal anxiety-related behavior) and HABxLAB F1 intercross controls, without detecting differences in receptor expression or density. By sequencing the regions 2.5 kbp up-and downstream of the Avp gene locus, we could identify several polymorphic loci, differing between the HAB and LAB lines. In the gene promoter, a deletion of twelve bp D(22180-2191) is particularly likely to contribute to the reduced Avp expression detected in LAB animals under basal conditions. Indeed, allele-specific transcription analysis of F1 animals revealed a hypomorphic LAB-specific Avp allele with a reduced transcription rate by 75% compared to the HAB-specific allele, thus explaining line-specific Avp expression profiles and phenotypic features. Accordingly, intra-PVN Avp mRNA levels were found to correlate with anxiety-related and depression-like behaviors. In addition to this correlative evidence, a significant, though moderate, genotype/phenotype association was demonstrated in 258 male mice of a freely-segregating F2 panel, suggesting a causal contribution of the Avp promoter deletion to anxiety-related behavior. Discussion: Thus, the identification of polymorphisms in the Avp gene promoter explains gene expression differences in association with the observed phenotype, thus further strengthening the concept of the critical involvement of centrally released AVP in trait anxiety.			Bunck, M (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	czibere@mpipsykl.mpg.de	Pütz, Benno/P-2630-2016; Deussing, Jan M/ABB-5993-2021; Müller-Myhsok, Bertram/A-3289-2013	Pütz, Benno/0000-0002-2208-209X; Deussing, Jan/0000-0002-9329-5252; Murgatroyd, Chris/0000-0002-6885-7794; Czibere, Ludwig/0000-0002-7508-5841; Singewald, Nicolas/0000-0002-0166-3370				Alikhani-Koupaei R, 2007, FASEB J, V21, P3618, DOI 10.1096/fj.07-8140com; Bielsky IF, 2005, NEURON, V47, P503, DOI 10.1016/j.neuron.2005.06.031; Bielsky IF, 2004, NEUROPSYCHOPHARMACOL, V29, P483, DOI 10.1038/sj.npp.1300360; BIRKETT SD, 1993, ANN NY ACAD SCI, V689, P83, DOI 10.1111/j.1749-6632.1993.tb55539.x; Bohus B, 1998, PROG BRAIN RES, V119, P555; Bruins J, 2006, PSYCHONEUROENDOCRINO, V31, P80, DOI 10.1016/j.psyneuen.2005.06.001; Cervino AC, 2005, GENOMICS, V86, P505, DOI 10.1016/j.ygeno.2005.07.010; Chakrabarty A, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-14; Champagne FA, 2008, FRONT NEUROENDOCRIN, V29, P386, DOI 10.1016/j.yfrne.2008.03.003; Delaval K, 2004, CURR OPIN GENET DEV, V14, P188, DOI 10.1016/j.gde.2004.01.005; Deussing JM, 2007, J CEREBR BLOOD F MET, V27, P1476, DOI 10.1038/sj.jcbfm.9600451; Egashira N, 2007, BEHAV BRAIN RES, V178, P123, DOI 10.1016/j.bbr.2006.12.009; Engin E, 2008, NEUROPEPTIDES, V42, P411, DOI 10.1016/j.npep.2008.04.004; Fava M, 2000, NEURON, V28, P335, DOI 10.1016/S0896-6273(00)00112-4; Fields RL, 2003, J NEUROSCI, V23, P7801; Frank E, 2008, EUR J PHARMACOL, V583, P226, DOI 10.1016/j.ejphar.2007.11.063; Gillespie NA, 2004, TWIN RES, V7, P39, DOI 10.1375/13690520460741435; Griebel G, 2002, P NATL ACAD SCI USA, V99, P6370, DOI 10.1073/pnas.092012099; Hetzenauer A, 2006, NEUROSCIENCE, V139, P1005, DOI 10.1016/j.neuroscience.2006.01.059; IVELL R, 1984, P NATL ACAD SCI-BIOL, V81, P2006, DOI 10.1073/pnas.81.7.2006; Jacobi F, 2004, PSYCHOL MED, V34, P597, DOI 10.1017/S0033291703001399; Ji CH, 1999, ENDOCRINOLOGY, V140, P4564, DOI 10.1210/en.140.10.4564; Kas MJH, 2007, MOL PSYCHIATR, V12, P324, DOI 10.1038/sj.mp.4001979; Keck ME, 2003, NEUROPSYCHOPHARMACOL, V28, P235, DOI 10.1038/sj.npp.1300040; Kessler MS, 2007, EUR J NEUROSCI, V26, P2857, DOI 10.1111/j.1460-9568.2007.05917.x; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kraus RJ, 2001, VIROLOGY, V287, P89, DOI 10.1006/viro.2001.1024; Kromer SA, 2005, J NEUROSCI, V25, P4375, DOI 10.1523/JNEUROSCI.0115-05.2005; Landgraf R, 2001, ENDOCR J, V48, P517, DOI 10.1507/endocrj.48.517; LANDGRAF R, 1995, J NEUROSCI, V15, P4250; Landgraf R, 2007, NEUROSCI BIOBEHAV R, V31, P89, DOI 10.1016/j.neubiorev.2006.07.003; Landgraf Rainer, 2006, CNS & Neurological Disorders-Drug Targets, V5, P167, DOI 10.2174/187152706776359664; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mlynarik M, 2007, HORM BEHAV, V51, P395, DOI 10.1016/j.yhbeh.2006.12.007; Muller MB, 2003, NEUROPSYCHOPHARMACOL, V28, P1991, DOI 10.1038/sj.npp.1300257; Murgatroyd C, 2004, J NEUROSCI, V24, P7762, DOI 10.1523/JNEUROSCI.1614-04.2004; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; NEUMANN ID, 2008, PROG BRAIN RES, V170; PALKOVITS M, 1973, BRAIN RES, V59, P449, DOI 10.1016/0006-8993(73)90290-4; Paxinos G., 2001, MOUSE BRAIN STEREOTA; PORSOLT RD, 1978, EUR J PHARMACOL, V51, P291, DOI 10.1016/0014-2999(78)90414-4; Ressler KJ, 2000, DEPRESS ANXIETY, V12, P2, DOI 10.1002/1520-6394(2000)12:1+<2::AID-DA2>3.3.CO;2-W; Ring RH, 2005, CURR PHARM DESIGN, V11, P205, DOI 10.2174/1381612053382241; Sanders A. R., 1999, NEUROBIOLOGY MENTAL, P299; Scott LV, 2002, J AFFECT DISORDERS, V72, P113, DOI 10.1016/S0165-0327(02)00026-5; Shabalina SA, 2006, NUCLEIC ACIDS RES, V34, P2428, DOI 10.1093/nar/gkl287; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Touma C, 2008, PSYCHONEUROENDOCRINO, V33, P839, DOI 10.1016/j.psyneuen.2008.03.013; Tsolakidou A, 2008, MOL CELL NEUROSCI, V38, P444, DOI 10.1016/j.mcn.2008.04.005; Turri MG, 2004, MAMM GENOME, V15, P69, DOI [10.1007/S00335-003-3032-y, 10.1007/s00335-003-3032-y]; Ustun TB, 2004, BRIT J PSYCHIAT, V184, P386, DOI 10.1192/bjp.184.5.386; Veenema AH, 2008, PROG BRAIN RES, V170, P261, DOI 10.1016/S0079-6123(08)00422-6; Verbalis JG, 2003, REV ENDOCR METAB DIS, V4, P177, DOI 10.1023/A:1022946220908; VILLAR MJ, 1994, BRAIN RES, V644, P273, DOI 10.1016/0006-8993(94)91690-X; Waldherr M, 2007, P NATL ACAD SCI USA, V104, P16681, DOI 10.1073/pnas.0705860104; Wigger A, 2004, NEUROPSYCHOPHARMACOL, V29, P1, DOI 10.1038/sj.npp.1300290; Wilkins JF, 2003, NAT REV GENET, V4, P359, DOI 10.1038/nrg1062; Willis-Owen SAG, 2006, EUR J HUM GENET, V14, P721, DOI 10.1038/sj.ejhg.5201569; Young LJ, 2001, AM J MED GENET, V105, P53, DOI 10.1002/1096-8628(20010108)105:1<53::AID-AJMG1059>3.3.CO;2-L	60	47	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5129	10.1371/journal.pone.0005129	http://dx.doi.org/10.1371/journal.pone.0005129			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357765	Green Submitted, Green Published, gold			2022-12-25	WOS:000265505900007
J	Fitze, PS; Cote, J; San-Jose, LM; Meylan, S; Isaksson, C; Andersson, S; Rossi, JM; Clobert, J				Fitze, Patrick S.; Cote, Julien; San-Jose, Luis Martin; Meylan, Sandrine; Isaksson, Caroline; Andersson, Staffan; Rossi, Jean-Marc; Clobert, Jean			Carotenoid-Based Colours Reflect the Stress Response in the Common Lizard	PLOS ONE			English	Article							CORTICOSTERONE LEVELS; PLUMAGE COLORATION; IMMUNE FUNCTION; SEXUAL ATTRACTIVENESS; SOCIAL-DOMINANCE; OXIDATIVE STRESS; HORMONES; SURVIVAL; PIGMENTATION; REPRODUCTION	Under chronic stress, carotenoid-based colouration has often been shown to fade. However, the ecological and physiological mechanisms that govern colouration still remain largely unknown. Colour changes may be directly induced by the stressor (for example through reduced carotenoid intake) or due to the activation of the physiological stress response (PSR, e. g. due to increased blood corticosterone concentrations). Here, we tested whether blood corticosterone concentration affected carotenoid-based colouration, and whether a trade-off between colouration and PSR existed. Using the common lizard (Lacerta vivipara), we correlatively and experimentally showed that elevated blood corticosterone levels are associated with increased redness of the lizard's belly. In this study, the effects of corticosterone did not depend on carotenoid ingestion, indicating the absence of a trade-off between colouration and PSR for carotenoids. While carotenoid ingestion increased blood carotenoid concentration, colouration was not modified. This suggests that carotenoid-based colouration of common lizards is not severely limited by dietary carotenoid intake. Together with earlier studies, these findings suggest that the common lizard's carotenoid-based colouration may be a composite trait, consisting of fixed (e. g. genetic) and environmentally elements, the latter reflecting the lizard's PSR.	[Fitze, Patrick S.; San-Jose, Luis Martin] CSIC, Museo Nacl Ciencias Nat, E-28006 Madrid, Spain; [Fitze, Patrick S.; San-Jose, Luis Martin] IPE CSIC, Inst Pirenaico Ecol, Jaca, Huesca, Spain; [Cote, Julien; Meylan, Sandrine; Rossi, Jean-Marc; Clobert, Jean] Univ Paris 06, Lab Ecol, Paris, France; [Cote, Julien] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Isaksson, Caroline; Andersson, Staffan] Gothenburg Univ, Dept Zool, Gothenburg, Sweden; [Clobert, Jean] CNRS Moulis, Stn Ecol Expt, USR2936, Moulis, Saint Girons, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE); UDICE-French Research Universities; Sorbonne Universite; University of California System; University of California Davis; University of Gothenburg; Centre National de la Recherche Scientifique (CNRS)	Fitze, PS (corresponding author), CSIC, Museo Nacl Ciencias Nat, E-28006 Madrid, Spain.	patrick.fitze@mncn.csic.es	Cote, Julien/B-7809-2011; Fitze, Patrick S./C-1377-2011; Fitze, Patrick S/A-4719-2011; Garcia, Luis San-José/AAC-5620-2019; Andersson, Staffan/B-1534-2010; sandrine, MEYLAN/AAD-3073-2020; San-Jose, Luis/I-9433-2012	Cote, Julien/0000-0002-4453-5969; Fitze, Patrick S./0000-0002-6298-2471; Fitze, Patrick S/0000-0002-6298-2471; Garcia, Luis San-José/0000-0003-1351-4679; Andersson, Staffan/0000-0003-1474-3596; Sandrine, MEYLAN/0000-0002-0865-3335				Alonso-Alvarez C, 2004, AM NAT, V164, P651, DOI 10.1086/424971; AXELROD J, 1984, SCIENCE, V224, P452, DOI 10.1126/science.6143403; Bartolomucci A, 2005, NEUROSCI BIOBEHAV R, V29, P67, DOI 10.1016/j.neubiorev.2004.06.009; BAUWENS D, 1987, Amphibia-Reptilia, V8, P49, DOI 10.1163/156853887X00045; BELTHOFF JR, 1994, CONDOR, V96, P614, DOI 10.2307/1369464; BENDICH A, 1989, J NUTR, V119, P112, DOI 10.1093/jn/119.1.112; Bentley P., 1998, COMP VERTEBRATE ENDO; Blount JD, 2003, SCIENCE, V300, P125, DOI 10.1126/science.1082142; Blount JD, 2001, ECOL LETT, V4, P393, DOI 10.1046/j.1461-0248.2001.00255.x; Brawner WR, 2000, AUK, V117, P952, DOI 10.1642/0004-8038(2000)117[0952:EOCAMI]2.0.CO;2; Bremner JD, 1999, BIOL PSYCHIAT, V45, P797, DOI 10.1016/S0006-3223(99)00009-8; Breuner CW, 2003, HORM BEHAV, V43, P115, DOI 10.1016/S0018-506X(02)00020-X; Cabezas S, 2007, HORM BEHAV, V51, P313, DOI 10.1016/j.yhbeh.2006.11.004; Caesar S, 2007, BIOL J LINN SOC, V90, P491, DOI 10.1111/j.1095-8312.2007.00739.x; Calisi RM, 2007, J COMP PHYSIOL B, V177, P641, DOI 10.1007/s00360-007-0162-7; Cash WB, 1999, J EXP ZOOL, V284, P637, DOI 10.1002/(SICI)1097-010X(19991101)284:6<637::AID-JEZ5>3.0.CO;2-N; Chapple DG, 2002, AUSTRAL ECOL, V27, P565, DOI 10.1046/j.1442-9993.2002.01217.x; CLUTTONBROCK TH, 1984, AM NAT, V123, P212, DOI 10.1086/284198; Comendant T, 2003, J EVOLUTION BIOL, V16, P948, DOI 10.1046/j.1420-9101.2003.00598.x; Cooper WE, 1992, BIOL REPTILIA HORMON, V18, P298; Cote J, 2008, J EVOLUTION BIOL, V21, P1165, DOI 10.1111/j.1420-9101.2008.01534.x; Cote J, 2006, HORM BEHAV, V49, P320, DOI 10.1016/j.yhbeh.2005.08.004; Creel S, 2001, TRENDS ECOL EVOL, V16, P491, DOI 10.1016/S0169-5347(01)02227-3; CZECZUGA B, 1980, COMP BIOCHEM PHYS B, V65, P755, DOI 10.1016/0305-0491(80)90194-7; Dufty AM, 2002, TRENDS ECOL EVOL, V17, P190, DOI 10.1016/S0169-5347(02)02498-9; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; Fitze PS, 2008, J EVOLUTION BIOL, V21, P246, DOI 10.1111/j.1420-9101.2007.01447.x; Fitze PS, 2008, ECOL LETT, V11, P432, DOI 10.1111/j.1461-0248.2008.01158.x; Fitze PS, 2007, AM NAT, V169, pS137, DOI 10.1086/510094; Fitze PS, 2005, EVOLUTION, V59, P2451, DOI 10.1554/05-208.1; Fitze PS, 2003, OECOLOGIA, V137, P148, DOI 10.1007/s00442-003-1323-3; Fitze PS, 2003, EVOLUTION, V57, P144; GAVAUD J, 1986, GEN COMP ENDOCR, V63, P11, DOI 10.1016/0016-6480(86)90176-0; Goodwin T. W., 1984, BIOCH CAROTENOIDS; HILL GE, 1992, AUK, V109, P1; HILL GE, 1991, NATURE, V350, P337, DOI 10.1038/350337a0; Hill GE, 2006, DIGIT SIGNAL PROCESS; Hu Y, 2000, ENDOCRINE, V13, P123, DOI 10.1385/ENDO:13:1:123; Isaksson C, 2008, P ROY SOC B-BIOL SCI, V275, P309, DOI 10.1098/rspb.2007.1474; KODRICBROWN A, 1989, BEHAV ECOL SOCIOBIOL, V25, P393, DOI 10.1007/BF00300185; Landys MM, 2006, GEN COMP ENDOCR, V148, P132, DOI 10.1016/j.ygcen.2006.02.013; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Lin H, 2004, COMP BIOCHEM PHYS B, V139, P745, DOI 10.1016/j.cbpc.2004.09.014; Hai L, 2006, COMP BIOCHEM PHYS A, V144, P11, DOI 10.1016/j.cbpa.2006.01.032; Littell R. C, 1996, SAS SYSTEM MIXED MOD; McEwen BS, 1997, BRAIN RES REV, V23, P79, DOI 10.1016/S0165-0173(96)00012-4; McGraw KJ, 2006, BEHAV ECOL SOCIOBIOL, V60, P117, DOI 10.1007/s00265-005-0135-3; McGraw KJ, 2000, P ROY SOC B-BIOL SCI, V267, P1525, DOI 10.1098/rspb.2000.1174; McGraw KJ, 2004, CONDOR, V106, P390, DOI 10.1650/7384; McGraw KJ, 2003, AM NAT, V162, P704, DOI 10.1086/378904; Meylan S, 2005, HORM BEHAV, V48, P44, DOI 10.1016/j.yhbeh.2004.11.022; Meylan S, 2003, COMP BIOCHEM PHYS A, V134, P497, DOI 10.1016/S1095-6433(02)00343-4; Meylan S, 2007, OIKOS, V116, P650, DOI 10.1111/j.2007.0030-1299.15432.x; MILINSKI M, 1990, NATURE, V344, P330, DOI 10.1038/344330a0; Moore IT, 2003, HORM BEHAV, V43, P39, DOI 10.1016/S0018-506X(02)00038-7; Nelson RJ., 2005, INTRO BEHAV ENDOCRIN; PARTALLI V, 1987, COMP BIOCH PHYSL B, V82, P767; SAPOLSKY R M, 1992, P287; SERVATIUS RJ, 1994, LIFE SCI, V55, P1611, DOI 10.1016/0024-3205(94)00327-0; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Sinervo B, 2003, SCIENCE, V300, P1949, DOI 10.1126/science.1083109; Sinervo B, 2001, EVOLUTION, V55, P2040; Sinervo B, 2007, AM NAT, V170, P663, DOI 10.1086/522092; Tschirren B, 2003, J EVOLUTION BIOL, V16, P91, DOI 10.1046/j.1420-9101.2003.00483.x; Vercken E, 2007, J EVOLUTION BIOL, V20, P221, DOI 10.1111/j.1420-9101.2006.01208.x; Vercken E, 2008, ECOSCIENCE, V15, P320, DOI 10.2980/15-3-3135; Vercken E, 2007, HORM BEHAV, V51, P379, DOI 10.1016/j.yhbeh.2006.12.006; Wingfield JC, 2003, J NEUROENDOCRINOL, V15, P711, DOI 10.1046/j.1365-2826.2003.01033.x; Wingfield JC, 2002, INTEGR COMP BIOL, V42, P600, DOI 10.1093/icb/42.3.600; WINGFIELD JC, 1999, HORMONES BEHAV ECOLO, P1	70	79	80	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5111	10.1371/journal.pone.0005111	http://dx.doi.org/10.1371/journal.pone.0005111			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19352507	Green Published, Green Submitted, gold			2022-12-25	WOS:000265505700015
J	Lopez, MV; Viale, DL; Cafferata, EGA; Bravo, AI; Carbone, C; Gould, D; Chernajovsky, Y; Podhajcer, OL				Lopez, M. Veronica; Viale, Diego L.; Cafferata, Eduardo G. A.; Bravo, Alicia I.; Carbone, Cecilia; Gould, David; Chernajovsky, Yuti; Podhajcer, Osvaldo L.			Tumor Associated Stromal Cells Play a Critical Role on the Outcome of the Oncolytic Efficacy of Conditionally Replicative Adenoviruses	PLOS ONE			English	Article							SPARC EXPRESSION; GENE-EXPRESSION; CYSTEINE SPARC; NEOPLASTIC PROGRESSION; COLORECTAL-CANCER; VIRAL REPLICATION; UP-REGULATION; PROTEIN; PROMOTER; MELANOMA	The clinical efficacy of conditionally replicative oncolytic adenoviruses (CRAd) is still limited by the inefficient infection of the tumor mass. Since tumor growth is essentially the result of a continuous cross-talk between malignant and tumor-associated stromal cells, targeting both cell compartments may profoundly influence viral efficacy. Therefore, we developed SPARC promoter-based CRAds since the SPARC gene is expressed both in malignant cells and in tumor-associated stromal cells. These CRAds, expressing or not the Herpes Simplex thymidine kinase gene (Ad-F512 and Ad(I)-F512-TK, respectively) exerted a lytic effect on a panel of human melanoma cells expressing SPARC; but they were completely attenuated in normal cells of different origins, including fresh melanocytes, regardless of whether cells expressed or not SPARC. Interestingly, both CRAds displayed cytotoxic activity on SPARC positive-transformed human microendothelial HMEC-1 cells and WI-38 fetal fibroblasts. Both CRAds were therapeutically effective on SPARC positive-human melanoma tumors growing in nude mice but exhibited restricted efficacy in the presence of co-administered HMEC-1 or WI-38 cells. Conversely, co-administration of HMEC-1 cells enhanced the oncolytic efficacy of Ad(I)-F512-TK on SPARC-negative MIA PaCa-2 pancreatic cancer cells in vivo. Moreover, conditioned media produced by stromal cells pre-infected with the CRAds enhanced the in vitro viral oncolytic activity on pancreatic cancer cells, but not on melanoma cells. The whole data indicate that stromal cells might play an important role on the outcome of the oncolytic efficacy of conditionally replicative adenoviruses.			Lopez, MV (corresponding author), IIBBA CONICET, Inst Leloir, Lab Mol & Cellular Therapy, Buenos Aires, DF, Argentina.	opodhajcer@leloir.org.ar	Cafferata, Eduardo/AAY-1076-2021	podhajcer, osvaldo/0000-0002-6512-8553; Cafferata, Eduardo G/0000-0001-5089-3757	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Alemany R, 2007, MOL ASPECTS MED, V28, P42, DOI 10.1016/j.mam.2006.12.002; BELLAHCENE A, 1995, AM J PATHOL, V146, P95; BETT AJ, 1994, P NATL ACAD SCI USA, V91, P8802, DOI 10.1073/pnas.91.19.8802; Bilbao R, 2000, GENE THER, V7, P1824, DOI 10.1038/sj.gt.3301312; Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939; Briggs J, 2002, ONCOGENE, V21, P7077, DOI 10.1038/sj.onc.1205857; Chlenski A, 2007, ONCOGENE, V26, P4513, DOI 10.1038/sj.onc.1210247; CLARK CJ, 2008, J CELL BIOCH; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; DOMINGUEZ P, 1991, J BONE MINER RES, V6, P1127; Fisher K, 2006, CURR OPIN MOL THER, V8, P301; Gonzalez R, 2006, J VIROL, V80, P964, DOI 10.1128/JVI.80.2.964-974.2006; Goodrum FD, 1997, J VIROL, V71, P548, DOI 10.1128/JVI.71.1.548-561.1997; Gros A, 2008, CANCER RES, V68, P8928, DOI 10.1158/0008-5472.CAN-08-1145; Hafner M, 1995, MATRIX BIOL, V14, P733, DOI 10.1016/S0945-053X(05)80016-2; HEDLEY SJ, 2006, CANC IMMUNOL IMMUNOT; HODGE LD, 1969, VIROLOGY, V37, P554, DOI 10.1016/0042-6822(69)90273-6; Infante JR, 2007, J CLIN ONCOL, V25, P319, DOI 10.1200/JCO.2006.07.8824; Jakubczak JL, 2003, CANCER RES, V63, P1490; Kadonaga JT, 2002, EXP MOL MED, V34, P259, DOI 10.1038/emm.2002.36; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kato Y, 2001, BIOCHEM BIOPH RES CO, V287, P422, DOI 10.1006/bbrc.2001.5622; Kim JH, 2006, JNCI-J NATL CANCER I, V98, P1482, DOI 10.1093/jnci/djj397; Koukourakis MI, 2003, CANCER RES, V63, P5376; LANE TF, 1994, FASEB J, V8, P163, DOI 10.1096/fasebj.8.2.8119487; Ledda F, 1997, J INVEST DERMATOL, V108, P210, DOI 10.1111/1523-1747.ep12334263; Ledda MF, 1997, NAT MED, V3, P171, DOI 10.1038/nm0297-171; Lieber A, 1996, J VIROL, V70, P8944, DOI 10.1128/JVI.70.12.8944-8960.1996; Lopez MV, 2006, MOL CANCER THER, V5, P2503, DOI 10.1158/1535-7163.MCT-06-0286; Martin-Duque P, 2004, HUM GENE THER, V15, P995, DOI 10.1089/hum.2004.15.995; Marx J, 2008, SCIENCE, V320, P38, DOI 10.1126/science.320.5872.38; Mathis JM, 2005, ONCOGENE, V24, P7775, DOI 10.1038/sj.onc.1209044; Mok W, 2007, CANCER RES, V67, P10664, DOI 10.1158/0008-5472.CAN-07-3107; Nettelbeck DM, 2004, INT J CANCER, V108, P136, DOI 10.1002/ijc.11563; Petersen S, 2001, DIS COLON RECTUM, V44, P322, DOI 10.1007/BF02234727; PODHAJCER OL, 2008, CANC METASTASIS REV; Porte H, 1998, CLIN CANCER RES, V4, P1375; PORTE H, 1995, INT J CANCER, V64, P70, DOI 10.1002/ijc.2910640114; Rempel SA, 2001, J NEURO-ONCOL, V53, P149, DOI 10.1023/A:1012201300188; Rempel SA, 1999, CLIN CANCER RES, V5, P237; Rivera AA, 2004, GENE THER, V11, P1694, DOI 10.1038/sj.gt.3302346; RonnovJessen L, 1996, PHYSIOL REV, V76, P69, DOI 10.1152/physrev.1996.76.1.69; SAGE H, 1989, J HISTOCHEM CYTOCHEM, V37, P819, DOI 10.1177/37.6.2723400; Sakai N, 2001, HUM PATHOL, V32, P1064, DOI 10.1053/hupa.2001.28244; Sato N, 2003, ONCOGENE, V22, P5021, DOI 10.1038/sj.onc.1206807; Savontaus MJ, 2002, GENE THER, V9, P972, DOI 10.1038/sj.gt.3301747; Selden C, 2007, J GENE MED, V9, P67, DOI 10.1002/jgm.1000; Shi Q, 2004, J BIOL CHEM, V279, P52200, DOI 10.1074/jbc.M409630200; Sova P, 2004, MOL THER, V9, P496, DOI 10.1016/j.ymthe.2003.12.008; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; Thomas R, 2000, CLIN CANCER RES, V6, P1140; Vaha-Koskela MJV, 2007, CANCER LETT, V254, P178, DOI 10.1016/j.canlet.2007.02.002; VERNON RB, 1991, BIOL REPROD, V44, P157, DOI 10.1095/biolreprod44.1.157; Volk AL, 2003, CANCER BIOL THER, V2, P511, DOI 10.4161/cbt.2.5.440; Waehler R, 2007, NAT REV GENET, V8, P573, DOI 10.1038/nrg2141; Yamamoto M, 2003, GASTROENTEROLOGY, V125, P1203, DOI 10.1016/S0016-5085(03)01196-X; Yamanaka M, 2001, J UROLOGY, V166, P2495, DOI 10.1016/S0022-5347(05)65623-6; Yan Q, 1999, J HISTOCHEM CYTOCHEM, V47, P1495, DOI 10.1177/002215549904701201	59	30	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5119	10.1371/journal.pone.0005119	http://dx.doi.org/10.1371/journal.pone.0005119			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19337591	Green Published, Green Submitted, gold			2022-12-25	WOS:000265505700018
J	Moraes, JC; Coope, A; Morari, J; Cintra, DE; Roman, EA; Pauli, JR; Romanatto, T; Carvalheira, JB; Oliveira, ALR; Saad, MJ; Velloso, LA				Moraes, Juliana C.; Coope, Andressa; Morari, Joseane; Cintra, Dennys E.; Roman, Erika A.; Pauli, Jose R.; Romanatto, Talita; Carvalheira, Jose B.; Oliveira, Alexandre L. R.; Saad, Mario J.; Velloso, Licio A.			High-Fat Diet Induces Apoptosis of Hypothalamic Neurons	PLOS ONE			English	Article								Consumption of dietary fats is amongst the most important environmental factors leading to obesity. In rodents, the consumption of fat-rich diets blunts leptin and insulin anorexigenic signaling in the hypothalamus by a mechanism dependent on the in situ activation of inflammation. Since inflammatory signal transduction can lead to the activation of apoptotic signaling pathways, we evaluated the effect of high-fat feeding on the induction of apoptosis of hypothalamic cells. Here, we show that consumption of dietary fats induce apoptosis of neurons and a reduction of synaptic inputs in the arcuate nucleus and lateral hypothalamus. This effect is dependent upon diet composition, and not on caloric intake, since pair-feeding is not sufficient to reduce the expression of apoptotic markers. The presence of an intact TLR4 receptor, protects cells from further apoptotic signals. In diet-induced inflammation of the hypothalamus, TLR4 exerts a dual function, on one side activating pro-inflammatory pathways that play a central role in the development of resistance to leptin and insulin, and on the other side restraining further damage by controlling the apoptotic activity.	[Moraes, Juliana C.; Coope, Andressa; Morari, Joseane; Cintra, Dennys E.; Roman, Erika A.; Pauli, Jose R.; Romanatto, Talita; Carvalheira, Jose B.; Saad, Mario J.; Velloso, Licio A.] Univ Estadual Campinas, Dept Internal Med, Campinas, SP, Brazil; [Oliveira, Alexandre L. R.] Univ Estadual Campinas, Dept Anat, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas	Moraes, JC (corresponding author), Univ Estadual Campinas, Dept Internal Med, Campinas, SP, Brazil.	lavelloso@fcm.unicamp.br	Saad, Mario/ABD-8262-2020; Romanatto, Talita/D-7359-2012; Carvalheira, Jose B/H-8405-2012; Velloso, Licio/AAJ-3778-2020; Morari, Joseane/G-2568-2016; Cintra, Dennys E/N-7758-2017; Oliveira, Alexandre/AAI-6815-2020; Oliveira, Alexandre L. R./C-4436-2012; Pauli, José Rdrigo/AAD-2763-2021; Carvalheira, Jose Barreto Campello/E-8562-2013	Cintra, Dennys E/0000-0002-7954-5630; Oliveira, Alexandre/0000-0003-4224-4575; Oliveira, Alexandre L. R./0000-0003-4224-4575; Pauli, José Rdrigo/0000-0002-6129-1521; Carvalheira, Jose Barreto Campello/0000-0002-0136-0943; Coope, Andressa/0000-0002-7356-9690; Morari, Joseane/0000-0002-0728-4283; Contin Moraes Garotti, Juliana/0000-0002-7143-0644	Fundacao de 395 Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de 396 Desenvolvimento Cientifico e Tecnologico	Fundacao de 395 Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de 396 Desenvolvimento Cientifico e Tecnologico	This work was supported by grants from Fundacao de 395 Amparo a Pesquisa do Estado de Sao Paulo and Conselho Nacional de 396 Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Araujo EP, 2004, J ENDOCRINOL, V181, P25, DOI 10.1677/joe.0.1810025; Astrup A, 2008, OBES REV, V9, P1, DOI 10.1111/j.1467-789X.2007.00428.x; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Bertelli DF, 2006, ENDOCRINOLOGY, V147, P5385, DOI 10.1210/en.2006-0280; Carvalheira JBC, 2001, FEBS LETT, V500, P119, DOI 10.1016/S0014-5793(01)02591-1; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; De Souza CT, 2007, FASEB J, V21, P1153, DOI 10.1096/fj.06-7148com; De Souza CT, 2005, DIABETOLOGIA, V48, P1860, DOI 10.1007/s00125-005-1866-4; De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520; Degasperi GR, 2008, FEBS LETT, V582, P3103, DOI 10.1016/j.febslet.2008.08.006; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Hanisch UK, 2008, TRENDS NEUROSCI, V31, P176, DOI 10.1016/j.tins.2008.01.005; Howard JK, 2004, NAT MED, V10, P734, DOI 10.1038/nm1072; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Lu Y, 2006, J BIOL CHEM, V281, P36683, DOI 10.1074/jbc.M607374200; Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Muppidi JR, 2004, IMMUNITY, V21, P461, DOI 10.1016/j.immuni.2004.10.001; Pasinetti GM, 2008, J NEUROCHEM, V106, P1503, DOI 10.1111/j.1471-4159.2008.05454.x; PAXINOS G, 1980, J NEUROSCI METH, V3, P129, DOI 10.1016/0165-0270(80)90021-7; Picardi PK, 2008, ENDOCRINOLOGY, V149, P3870, DOI 10.1210/en.2007-1506; Rintamaki R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001482; Ryu KY, 2008, P NATL ACAD SCI USA, V105, P4016, DOI 10.1073/pnas.0800096105; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Siegel RM, 2003, IMMUNOL RES, V27, P499, DOI 10.1385/IR:27:2-3:499; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; WADE GN, 1982, PHYSIOL BEHAV, V29, P701, DOI 10.1016/0031-9384(82)90242-6; WEST DB, 1994, J CLIN INVEST, V94, P1410, DOI 10.1172/JCI117477; Xue B, 2007, J BIOL CHEM, V282, P23829, DOI 10.1074/jbc.M609680200	32	282	288	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5045	10.1371/journal.pone.0005045	http://dx.doi.org/10.1371/journal.pone.0005045			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340313	Green Submitted, Green Published, gold			2022-12-25	WOS:000265500700010
J	Kelly, H; Carville, K; Grant, K; Jacoby, P; Tran, T; Barr, I				Kelly, Heath; Carville, Kylie; Grant, Kristina; Jacoby, Peter; Tran, Thomas; Barr, Ian			Estimation of Influenza Vaccine Effectiveness from Routine Surveillance Data	PLOS ONE			English	Article								Background: Influenza vaccines are reviewed each year, and often changed, in an effort to maintain their effectiveness against drifted influenza viruses. There is however no regular review of influenza vaccine effectiveness during, or at the end of, Australian influenza seasons. It is possible to use a case control method to estimate vaccine effectiveness from surveillance data when all patients in a surveillance system are tested for influenza and their vaccination status is known. Methodology/Principal Findings: Influenza-like illness (ILI) surveillance is conducted during the influenza season in sentinel general practices scattered throughout Victoria, Australia. Over five seasons 2003-7, data on age, sex and vaccination status were collected and nose and throat swabs were offered to patients presenting within three days of the onset of their symptoms. Swabs were tested using a reverse transcriptase polymerase chain reaction (RT-PCR) test. Those positive for influenza were sent to the World Health Organization (WHO) Collaborating Centre for Reference and Research on Influenza where influenza virus culture and strain identification was attempted. We used a retrospective case control design in five consecutive influenza seasons, and estimated influenza vaccine effectiveness (VE) for patients of all ages to be 53% (95% CI 38-64), but 41% (95% CI 19-57) adjusted for age group and year. The adjusted VE for all adults aged at least 20 years, the age groups for whom a benefit of vaccination could be shown, was 51% (95% CI 34-63). Comparison of VE estimates with vaccine and circulating strain matches across the years did not reveal any significant differences. Conclusions/Significance: These estimates support other field studies of influenza vaccine effectiveness, given that theoretical considerations suggest that these values may underestimate true effectiveness, depending on test specificity and the ratio of the influenza ILI attack rate to the non-influenza ILI attack rate. Incomplete recording of vaccination status and under-representation of children in patients from whom a swab was collected limit the data. Improvements have been implemented for prospective studies.	[Kelly, Heath; Carville, Kylie; Grant, Kristina; Tran, Thomas] Victorian Infect Dis Reference Lab, Epidemiol Unit, Melbourne, Vic, Australia; [Kelly, Heath; Carville, Kylie; Grant, Kristina; Tran, Thomas] Victorian Infect Dis Reference Lab, Virus Identificat Lab, Melbourne, Vic, Australia; [Jacoby, Peter] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA, Australia; [Barr, Ian] World Hlth Org, Collaborating Ctr Reference & Res Influenza, Melbourne, FL USA	Victorian Infectious Diseases Reference Laboratory; Victorian Infectious Diseases Reference Laboratory; Telethon Kids Institute; University of Western Australia; World Health Organization	Kelly, H (corresponding author), Victorian Infect Dis Reference Lab, Epidemiol Unit, Melbourne, Vic, Australia.	Heath.kelly@mh.org.au		Barr, Ian/0000-0002-7351-418X; Carville, Kylie/0000-0002-3663-8802	Victorian Government Department of Human Services	Victorian Government Department of Human Services	This study was conducted as part of routine work funded in part by the Victorian Government Department of Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Melbourne WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health and Ageing. The sentinel influenza surveillance program receives support from the Victorian Department of Human Services.	Clothier H, 2006, AUST NZ J PUBL HEAL, V30, P337, DOI 10.1111/j.1467-842X.2006.tb00846.x; Druce J, 2005, J MED VIROL, V75, P122, DOI 10.1002/jmv.20246; GOVAERT TME, 1994, JAMA-J AM MED ASSOC, V272, P1661, DOI 10.1001/jama.272.21.1661; Jefferson T, 2005, LANCET, V366, P1165, DOI 10.1016/S0140-6736(05)67339-4; Jefferson TO, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001269.pub3; Kelly H, 2000, Commun Dis Intell, V24, P379; Legrand J, 2006, VACCINE, V24, P6605, DOI 10.1016/j.vaccine.2006.05.063; Monto AS, 2004, PEDIATR INFECT DIS J, V23, pS58, DOI 10.1097/01.inf.0000108193.91607.34; MONTO AS, 1985, AM J EPIDEMIOL, V121, P811, DOI 10.1093/oxfordjournals.aje.a114052; Newall AT, 2008, VACCINE, V26, P2142, DOI 10.1016/j.vaccine.2008.01.050; Orenstein EW, 2007, INT J EPIDEMIOL, V36, P623, DOI 10.1093/ije/dym021; ORENSTEIN WA, 1988, EPIDEMIOL REV, V10, P212, DOI 10.1093/oxfordjournals.epirev.a036023; *PAN AM HLTH ORG C, 1982, CONC PROC LAB BAS IN; Prosser LA, 2008, PHARMACOECONOMICS, V26, P163, DOI 10.2165/00019053-200826020-00006; Skowronski DM, 2007, VACCINE, V25, P2842, DOI 10.1016/j.vaccine.2006.10.002; StataCorp, 2008, STAT SOFTW REL 10 0; Thursky K, 2003, J CLIN VIROL, V27, P170, DOI 10.1016/S1386-6532(02)00172-5; Watts CG, 2003, AUST NZ J PUBL HEAL, V27, P409, DOI 10.1111/j.1467-842X.2003.tb00418.x; WRIGHT PF, 1980, AM J EPIDEMIOL, V112, P814, DOI 10.1093/oxfordjournals.aje.a113053; Zangwill KM, 2004, PEDIATR INFECT DIS J, V23, P189, DOI 10.1097/01.inf.0000116292.46143.d6	20	75	76	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e5079	10.1371/journal.pone.0005079	http://dx.doi.org/10.1371/journal.pone.0005079			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333374	Green Published, gold			2022-12-25	WOS:000265499900022
J	Wang, ZL; Shufesky, WJ; Montecalvo, A; Divito, SJ; Larregina, AT; Morelli, AE				Wang, Zhiliang; Shufesky, William J.; Montecalvo, Angela; Divito, Sherrie J.; Larregina, Adriana T.; Morelli, Adrian E.			In Situ-Targeting of Dendritic Cells with Donor-Derived Apoptotic Cells Restrains Indirect Allorecognition and Ameliorates Allograft Vasculopathy	PLOS ONE			English	Article								Chronic allograft vasculopathy (CAV) is an atheromatous-like lesion that affects vessels of transplanted organs. It is a component of chronic rejection that conventional immuno-suppression fails to prevent, and is a major cause of graft loss. Indirect allo-recognition through T cells and allo-Abs are critical during CAV pathogenesis. We tested whether the indirect allo-response and its impact on CAV is down-regulated by in situ-delivery of donor Ags to recipient's dendritic cells (DCs) in lymphoid organs in a pro-tolerogenic fashion, through administration of donor splenocytes undergoing early apoptosis. Following systemic injection, donor apoptotic cells were internalized by splenic CD11c(hi) CD8 alpha(+) and CD8(-) DCs, but not by CD11c(int) plasmacytoid DCs. Those DCs that phagocytosed apoptotic cells in vivo remained quiescent, resisted ex vivo-maturation, and presented allo-Ag for up to 3 days. Administration of donor apoptotic splenocytes, unlike cells alive, (i) promoted deletion, FoxP3 expression and IL-10 secretion, and decreased IFN-gamma-release in indirect pathway CD4 T cells; and (ii) reduced cross-priming of anti-donor CD8 T cells in vivo. Targeting recipient's DCs with donor apoptotic cells reduced significantly CAV in a fully-mismatched aortic allograft model. The effect was donor specific, dependent on the physical characteristics of the apoptotic cells, and was associated to down-regulation of the indirect type-1 T cell allo-response and secretion of allo-Abs, when compared to recipients treated with donor cells alive or necrotic. Down-regulation of indirect allo-recognition through in situ-delivery of donor-Ag to recipient's quiescent DCs constitutes a promising strategy to prevent/ameliorate indirect allorecognition and CAV.	[Wang, Zhiliang; Shufesky, William J.; Montecalvo, Angela; Divito, Sherrie J.; Morelli, Adrian E.] Univ Pittsburgh, Med Ctr, Thomas E Starzl Transplantat Inst, Pittsburgh, PA 15260 USA; [Wang, Zhiliang; Shufesky, William J.; Montecalvo, Angela; Divito, Sherrie J.; Morelli, Adrian E.] Univ Pittsburgh, Med Ctr, Dept Surg, Pittsburgh, PA 15260 USA; [Larregina, Adriana T.; Morelli, Adrian E.] Univ Pittsburgh, Med Ctr, Dept Dermatol, Pittsburgh, PA 15260 USA; [Larregina, Adriana T.] Univ Pittsburgh, Med Ctr, Dept Immunol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wang, ZL (corresponding author), Univ Pittsburgh, Med Ctr, Thomas E Starzl Transplantat Inst, Pittsburgh, PA 15260 USA.	morelli@imap.pitt.edu			National Institutes of Health [R01 HL075512, HL077545, R01 CA100893]; Therakos; NATIONAL CANCER INSTITUTE [R01CA100893] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075512, R01HL077545] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Therakos; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants from the National Institutes of Health R01 HL075512 and HL077545 (A.E.M), R01 CA100893 (A.T.L.), and a grant from Therakos (to A.E.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, AM J TRANSPLANT, V5, P1808, DOI 10.1111/j.1600-6143.2005.00954.x; Barr ML, 1998, NEW ENGL J MED, V339, P1744, DOI 10.1056/NEJM199812103392404; Benichou G, 1999, J IMMUNOL, V162, P352; Benitez-Ribas D, 2006, J EXP MED, V203, P1629, DOI 10.1084/jem.20052364; Bittencourt MD, 2001, BLOOD, V98, P224, DOI 10.1182/blood.V98.1.224; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Dalgaard J, 2005, J LEUKOCYTE BIOL, V77, P689, DOI 10.1189/jlb.1204711; Diao J, 2007, J IMMUNOL, V179, P2713, DOI 10.4049/jimmunol.179.5.2713; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Dzik S, 2002, TRANSFUSION, V42, P1221, DOI 10.1046/j.1537-2995.2002.00175.x; Dzionek A, 2001, J EXP MED, V194, P1823, DOI 10.1084/jem.194.12.1823; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fadok VA, 1998, BIOCHEM SOC T, V26, P653, DOI 10.1042/bst0260653; Ferguson TA, 2002, J IMMUNOL, V168, P5589, DOI 10.4049/jimmunol.168.11.5589; Fugier-Vivier IJ, 2005, J EXP MED, V201, P373, DOI 10.1084/jem.20041399; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Gatza E, 2008, BLOOD, V112, P1515, DOI 10.1182/blood-2007-11-125542; George JF, 2008, J HEART LUNG TRANSPL, V27, P616, DOI 10.1016/j.healun.2008.02.015; Gilliet M, 2002, J EXP MED, V195, P695, DOI 10.1084/jem.20011603; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hoeffel G, 2007, IMMUNITY, V27, P481, DOI 10.1016/j.immuni.2007.07.021; Hornick PI, 2000, CIRCULATION, V101, P2405, DOI 10.1161/01.CIR.101.20.2405; Illigens BM, 2002, HUM IMMUNOL, V63, P912, DOI 10.1016/S0198-8859(02)00449-4; Ito T, 2007, J EXP MED, V204, P105, DOI 10.1084/jem.20061660; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kamath AT, 2000, J IMMUNOL, V165, P6762, DOI 10.4049/jimmunol.165.12.6762; Kishimoto K, 2004, J AM SOC NEPHROL, V15, P2423, DOI 10.1097/01.ASN.0000137883.20961.2D; Kitchens WH, 2007, AM J TRANSPLANT, V7, P2675, DOI 10.1111/j.1600-6143.2007.01997.x; Kleinclauss F, 2006, CELL DEATH DIFFER, V13, P41, DOI 10.1038/sj.cdd.4401699; LECHLER RI, 1990, IMMUNOL TODAY, V11, P83, DOI 10.1016/0167-5699(90)90033-6; LEE RS, 1994, J EXP MED, V179, P865, DOI 10.1084/jem.179.3.865; Lee RS, 2001, P NATL ACAD SCI USA, V98, P3276, DOI 10.1073/pnas.051584498; Liu K, 2002, J EXP MED, V196, P1091, DOI 10.1084/jem.20021215; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Lorber MI, 1999, TRANSPLANTATION, V67, P897, DOI 10.1097/00007890-199903270-00018; Maeda A, 2005, J IMMUNOL, V174, P5968, DOI 10.4049/jimmunol.174.10.5968; Mahnke K, 2003, BLOOD, V101, P4862, DOI 10.1182/blood-2002-10-3229; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Morelli AE, 2006, AM J TRANSPLANT, V6, P254, DOI 10.1111/j.1600-6143.2005.01197.x; Morelli AE, 2003, BLOOD, V101, P611, DOI 10.1182/blood-2002-06-1769; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; Morelli AE, 2000, TRANSPLANTATION, V69, P2647, DOI 10.1097/00007890-200006270-00027; Moseman EA, 2004, J IMMUNOL, V173, P4433, DOI 10.4049/jimmunol.173.7.4433; Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333; Perruche S, 2004, AM J TRANSPLANT, V4, P1361, DOI 10.1111/j.1600-6143.2004.00509.x; Perruche S, 2008, NAT MED, V14, P528, DOI 10.1038/nm1749; Pietra BA, 2000, J CLIN INVEST, V106, P1003, DOI 10.1172/JCI10467; Quezada SA, 2003, BLOOD, V102, P1920, DOI 10.1182/blood-2003-02-0586; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Ren GW, 2008, J IMMUNOL, V181, P3277, DOI 10.4049/jimmunol.181.5.3277; Russell PS, 1997, TRANSPLANTATION, V64, P1531, DOI 10.1097/00007890-199712150-00005; Russell PS, 2001, J IMMUNOL, V167, P5731, DOI 10.4049/jimmunol.167.10.5731; RUSSELL PS, 1994, J IMMUNOL, V152, P5135; RUSSELL PS, 1994, AM J PATHOL, V144, P260; Sapoznikov A, 2007, J EXP MED, V204, P1923, DOI 10.1084/jem.20062373; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; SivaSai KSR, 1999, TRANSPLANTATION, V67, P1094, DOI 10.1097/00007890-199904270-00002; Speir JA, 1998, IMMUNITY, V8, P553, DOI 10.1016/S1074-7613(00)80560-9; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Stuart LM, 2002, J IMMUNOL, V168, P1627, DOI 10.4049/jimmunol.168.4.1627; Sun E, 2004, CELL DEATH DIFFER, V11, P1258, DOI 10.1038/sj.cdd.4401500; Sun H, 1998, MICROSURG, V18, P368, DOI 10.1002/(SICI)1098-2752(1998)18:6<368::AID-MICR5>3.0.CO;2-F; Uehara S, 2005, J IMMUNOL, V175, P3424, DOI 10.4049/jimmunol.175.5.3424; Urban BC, 2001, P NATL ACAD SCI USA, V98, P8750, DOI 10.1073/pnas.151028698; Vella JP, 1999, TRANSPLANTATION, V67, P1523, DOI 10.1097/00007890-199906270-00005; Verbovetski I, 2002, J EXP MED, V196, P1553, DOI 10.1084/jem.20020263; Viret C, 2000, J IMMUNOL, V164, P4627, DOI 10.4049/jimmunol.164.9.4627; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Wang Z, 2006, AM J TRANSPLANT, V6, P1297, DOI 10.1111/j.1600-6143.2006.01308.x; Wang ZL, 2005, TRANSPLANTATION, V79, P869, DOI 10.1097/01.TP.0000157120.43052.3A; Weiss MJ, 2008, FRONT BIOSCI-LANDMRK, V13, P2980, DOI 10.2741/2903; Wilson NS, 2003, BLOOD, V102, P2187, DOI 10.1182/blood-2003-02-0513; Yamada A, 2003, AM J TRANSPLANT, V3, P23, DOI 10.1034/j.1600-6143.2003.30105.x; Yu G, 2006, J EXP MED, V203, P1851, DOI 10.1084/jem.20060603	77	39	39	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e4940	10.1371/journal.pone.0004940	http://dx.doi.org/10.1371/journal.pone.0004940			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333400	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000265499900004
J	Zhu, Y; Vergote, D; Pardo, C; Noorbakhsh, F; McArthur, JC; Hollenberg, MD; Overall, CM; Power, C				Zhu, Yu; Vergote, David; Pardo, Carlos; Noorbakhsh, Farshid; McArthur, Justin C.; Hollenberg, Morley D.; Overall, Christopher M.; Power, Christopher			CXCR3 activation by lentivirus infection suppresses neuronal autophagy: neuroprotective effects of antiretroviral therapy	FASEB JOURNAL			English	Article						HIV; FIV; neuroinflammation; CXCL12	HUMAN-IMMUNODEFICIENCY-VIRUS; CENTRAL-NERVOUS-SYSTEM; HIV-INFECTION; FACTOR-I; MOLECULAR-MECHANISMS; ALZHEIMERS-DISEASE; TYPE-1 INFECTION; DEMENTIA; EXPRESSION; RECEPTOR	Previous studies have implicated CXCL12 in the neuropathogenesis of HIV infection. Proteolysis of CXCL12 generates a neurotoxic molecule, CXCL12(5-67), which engages and activates CXCR3, in addition to exhibiting increased expression in the brains of patients with HIV-associated dementia (HAD). Herein, we investigated CXCR3-mediated neuronal injury, particularly, its contribution to autophagy suppression and the concomitant effects of antiretroviral therapy using human brain samples and models of HIV neuropathogenesis. Neurons in the brains of HAD patients and feline immunodeficiency virus (FIV)-infected animals, as well as cultured human neurons, expressed CXCR3, which was modulated in a ligand-specific manner. Exposure of human neurons to CXCL12(5-67) caused a reduction in the autophagy-associated molecule LC3 (P<0.05) and neuronal survival (P<0.05), which recapitulated findings in FIV- and HIV-infected brains (P<0.05). Oral didanosine (ddI) treatment of FIV- infected animals reduced neurobehavioral abnormalities in conjunction with diminished plasma viral load ( P<0.05). F4/80 transcript abundance and CXCL12(5-67) immunoreactivity were reduced with restored neuronal LC3 expression in the brains of FIV-infected animals after ddI treatment (P<0.05). ddI treatment also prevented microglial activation and depletion of synaptic proteins in the cortex of FIV- infected animals (P<0.05). These findings indicate that the beneficial effects of ddI might be a consequence of a reduced systemic viral burden and concurrent leukocyte activation, leading to diminished neuroinflammation with preservation of neuronal autophagy by regulating CXCR3 activation.-Zhu, Y., Vergote, D., Pardo, C., Noorbakhsh, F., McArthur, J. C., Hollenberg, M. D., Overall, C. M., Power, C. CXCR3 activation by lentivirus infection suppresses neuronal autophagy: neuroprotective effects of antiretroviral therapy. FASEB J. 23, 2928-2941 (2009). www.fasebj.org	[Zhu, Yu; Vergote, David; Noorbakhsh, Farshid; Power, Christopher] Univ Alberta, Dept Med, Edmonton, AB T6G 2S2, Canada; [Pardo, Carlos; McArthur, Justin C.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA; [Hollenberg, Morley D.] Univ Calgary, Dept Pharmacol & Therapeut, Calgary, AB, Canada; [Overall, Christopher M.] Univ British Columbia, Dept Oral Biol & Med Sci, Ctr Blood Res, Vancouver, BC V5Z 1M9, Canada; [Overall, Christopher M.] Univ British Columbia, Dept Biochem & Mol Biol, Ctr Blood Res, Vancouver, BC V5Z 1M9, Canada	University of Alberta; Johns Hopkins University; University of Calgary; University of British Columbia; University of British Columbia	Power, C (corresponding author), Univ Alberta, Dept Med Neurol, 6-11 Heritage Med Res Ctr, Edmonton, AB T6G 2S2, Canada.	chris.power@ualberta.ca	Hollenberg, Morley/AFV-6966-2022; Pardo, Carlos A./A-5192-2008; Power, Christopher/C-7181-2013	Pardo, Carlos A./0000-0002-4128-5335; Power, Christopher/0000-0002-5131-9711; Vergote, David/0000-0002-1298-3783	Toupin Chair fellowship; CIHR; Alberta Heritage Foundation for Medical Research fellowships; U.S. National Institutes of Health-National Institute of Mental Health; NATIONAL INSTITUTE ON DRUG ABUSE [K08DA016160] Funding Source: NIH RePORTER	Toupin Chair fellowship; CIHR(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research fellowships; U.S. National Institutes of Health-National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Leah DeBlock for assistance with manuscript preparation. Y.Z. was a Canadian Institutes for Health Research (CIHR) fellow. D.V. was supported by a Toupin Chair fellowship. F.N. is supported by CIHR and Alberta Heritage Foundation for Medical Research fellowships. C.M.O. and C.P. hold Canada Research Chairs (tier 1) in metalloproteinases and systems biology and neurological infection and immunity, respectively. C.P. is an Alberta Heritage Foundation for Medical Research senior scholar. These studies were supported by the U.S. National Institutes of Health-National Institute of Mental Health and CIHR.	Adle-Biassette H, 1999, NEUROPATH APPL NEURO, V25, P123; Aksoy MO, 2006, AM J PHYSIOL-LUNG C, V290, pL909, DOI 10.1152/ajplung.00430.2005; Alirezaei M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002906; Anthony IC, 2008, INT REV PSYCHIATR, V20, P15, DOI 10.1080/09540260701862037; Antinori A, 2005, CLIN INFECT DIS, V41, P1787, DOI 10.1086/498310; Bellizzi MJ, 2006, J NEUROIMMUNE PHARM, V1, P20, DOI 10.1007/s11481-005-9006-y; Boisse L, 2008, NEUROL CLIN, V26, P799, DOI 10.1016/j.ncl.2008.04.002; Boven LA, 1999, FEMS IMMUNOL MED MIC, V26, P243, DOI 10.1111/j.1574-695X.1999.tb01395.x; Carloni S, 2008, NEUROBIOL DIS, V32, P329, DOI 10.1016/j.nbd.2008.07.022; ClarkLewis I, 1997, METHOD ENZYMOL, V287, P233; Conant K, 1999, ANN NEUROL, V46, P391, DOI 10.1002/1531-8249(199909)46:3<391::AID-ANA15>3.0.CO;2-0; Datta D, 2006, CANCER RES, V66, P9509, DOI 10.1158/0008-5472.CAN-05-4345; Ehlert JE, 2004, J IMMUNOL, V173, P6234, DOI 10.4049/jimmunol.173.10.6234; Elder JH, 2008, VET IMMUNOL IMMUNOP, V123, P3, DOI 10.1016/j.vetimm.2008.01.007; Everall IP, 1999, BRAIN PATHOL, V9, P209; EVERALL IP, 1994, ACTA NEUROPATHOL, V88, P538; Fehder W P, 2001, Semin Clin Neuropsychiatry, V6, P229; Feldman ED, 2006, ANN SURG ONCOL, V13, P125, DOI 10.1245/ASO.2006.03.038; Fletcher NF, 2008, VET IMMUNOL IMMUNOP, V123, P134, DOI 10.1016/j.vetimm.2008.01.028; Garg H, 2004, VIROLOGY, V321, P274, DOI 10.1016/j.virol.2004.01.006; Garin A, 2003, J IMMUNOL, V171, P5305, DOI 10.4049/jimmunol.171.10.5305; Gupta SK, 1999, J LEUKOCYTE BIOL, V66, P135, DOI 10.1002/jlb.66.1.135; HARTMANN K, 1992, VET IMMUNOL IMMUNOP, V35, P167, DOI 10.1016/0165-2427(92)90129-E; Hult B, 2008, INT REV PSYCHIATR, V20, P3, DOI 10.1080/09540260701862086; JANSSEN RS, 1992, NEUROLOGY, V42, P1472, DOI 10.1212/WNL.42.8.1472; Johnston JB, 2000, J VIROL, V74, P7211, DOI 10.1128/JVI.74.16.7211-7220.2000; Jones G, 2006, NEUROBIOL DIS, V21, P1, DOI 10.1016/j.nbd.2005.07.018; Kaul M, 2006, CURR HIV RES, V4, P307, DOI 10.2174/157016206777709384; Kennedy JM, 2004, AIDS, V18, P1241, DOI 10.1097/00002030-200406180-00002; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; KOENIG RE, 1986, LANCET, V2, P627; Langford D, 2006, J NEUROVIROL, V12, P100, DOI 10.1080/13550280600713932; Lasagni L, 2003, J EXP MED, V197, P1537, DOI 10.1084/jem.20021897; Letendre Scott, 2008, Top HIV Med, V16, P15; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2006, J CLIN INVEST, V116, P2078, DOI 10.1172/JCI29447; Masliah E, 1997, ANN NEUROL, V42, P963, DOI 10.1002/ana.410420618; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Muller T, 2008, PROG NEUROBIOL, V85, P393, DOI 10.1016/j.pneurobio.2008.05.002; Noorbakhsh F, 2006, J EXP MED, V203, P425, DOI 10.1084/jem.20052148; Noorbakhsh F, 2005, J IMMUNOL, V174, P7320, DOI 10.4049/jimmunol.174.11.7320; Noorbakhsh F, 2009, TRENDS NEUROSCI, V32, P88, DOI 10.1016/j.tins.2008.10.003; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Ohtani Y, 1998, NEUROSCI LETT, V249, P163, DOI 10.1016/S0304-3940(98)00425-X; Power C, 1998, J VIROL, V72, P9109, DOI 10.1128/JVI.72.11.9109-9115.1998; Power C, 2004, J NEUROVIROL, V10, P113, DOI 10.1080/13550280490270815; Price RW, 2008, J INFECT DIS, V197, pS294, DOI 10.1086/533419; Richardson J, 1999, J VIROL, V73, P3661, DOI 10.1128/JVI.73.5.3661-3671.1999; Rock RB, 2006, J NEUROIMMUNE PHARM, V1, P117, DOI 10.1007/s11481-006-9012-8; Roth JS, 1999, DRUG METAB DISPOS, V27, P1128; Rumbaugh JA, 2006, CURR PHARM DESIGN, V12, P1023, DOI 10.2174/138161206776055877; Ryan LA, 2002, CELL MOL BIOL, V48, P137; Sacktor N, 2002, J NEUROVIROL, V8, P115, DOI 10.1080/13550280290101094; Sarkar S, 2008, MOL BIOSYST, V4, P895, DOI 10.1039/b804606a; St Hillaire C, 2005, J NEUROVIROL, V11, P535, DOI 10.1080/13550280500385203; Tang GM, 2008, HUM MOL GENET, V17, P1540, DOI 10.1093/hmg/ddn042; Ventruti A, 2007, CURR NEUROL NEUROSCI, V7, P443, DOI 10.1007/s11910-007-0068-5; Vergote D, 2006, P NATL ACAD SCI USA, V103, P19182, DOI 10.1073/pnas.0604678103; Wynn HE, 2002, CNS DRUGS, V16, P595, DOI 10.2165/00023210-200216090-00002; Yang DS, 2008, AM J PATHOL, V173, P665, DOI 10.2353/ajpath.2008.071176; Zhang KY, 2003, NAT NEUROSCI, V6, P1064, DOI 10.1038/nn1127; Zhou DJ, 2008, AIDS, V22, P695, DOI 10.1097/QAD.0b013e3282f4a836; Zink MC, 2006, CURR HIV RES, V4, P293	64	34	35	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2009	23	9					2928	2941		10.1096/fj.08-128819	http://dx.doi.org/10.1096/fj.08-128819			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19380511	Green Published			2022-12-25	WOS:000270241000016
J	Dubois, V; Debreyer, C; Quentin, C; Parissi, V				Dubois, Veronique; Debreyer, Carole; Quentin, Claudine; Parissi, Vincent			In Vitro Recombination Catalyzed by Bacterial Class 1 Integron Integrase IntI1 Involves Cooperative Binding and Specific Oligomeric Intermediates	PLOS ONE			English	Article								Gene transfer via bacterial integrons is a major pathway for facilitating the spread of antibiotic resistance genes across bacteria. Recently the mechanism underlying the recombination catalyzed by class 1 integron recombinase (IntI1) between attC and attI1 was highlighted demonstrating the involvement of a single-stranded intermediary on the attC site. However, the process allowing the generation of this single-stranded substrate has not been determined, nor have the active IntI1.DNA complexes been identified. Using the in vitro strand transfer assay and a crosslink strategy we previously described we demonstrated that the single-stranded attC sequences could be generated in the absence of other bacterial proteins in addition to IntI. This suggests a possible role for this protein in stabilizing and/or generating this structure. The mechanism of folding of the active IntI.DNA complexes was further analyzed and we show here that it involves a cooperative binding of the protein to each recombination site and the emergence of different oligomeric species specific for each DNA substrate. These findings provide further insight into the recombination reaction catalyzed by IntI1.			Dubois, V (corresponding author), Univ Victor Segalen Bordeaux 2, CNRS, UMR 5097, Lab Cellular & Mol Microbiol & Pathogen MCMP, Bordeaux, France.	vincent.parissi@reger.u-bordeaux2.fr	QUENTIN, Claudine/A-9701-2012; Dubois, Veronique/F-9378-2011					Bouvier M, 2005, EMBO J, V24, P4356, DOI 10.1038/sj.emboj.7600898; Collis CM, 1998, MOL MICROBIOL, V29, P477, DOI 10.1046/j.1365-2958.1998.00936.x; COLLIS CM, 1995, ANTIMICROB AGENTS CH, V39, P155, DOI 10.1128/AAC.39.1.155; Collis CM, 2001, J BACTERIOL, V183, P2535, DOI 10.1128/JB.183.8.2535-2542.2001; Demarre G, 2007, NUCLEIC ACIDS RES, V35, P6475, DOI 10.1093/nar/gkm709; Dubois V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001315; Dubois W, 2002, ANTIMICROB AGENTS CH, V46, P638, DOI 10.1128/AAC.46.3.638-645.2002; Dufour E, 1999, J MOL BIOL, V285, P1339, DOI 10.1006/jmbi.1998.2430; Falbo V, 1999, ANTIMICROB AGENTS CH, V43, P693, DOI 10.1128/AAC.43.3.693; Faure A, 2005, NUCLEIC ACIDS RES, V33, P977, DOI 10.1093/nar/gki241; Francia MV, 1999, J BACTERIOL, V181, P6844, DOI 10.1128/JB.181.21.6844-6849.1999; HALL RM, 1991, MOL MICROBIOL, V5, P1941, DOI 10.1111/j.1365-2958.1991.tb00817.x; HALL RM, 1995, MOL MICROBIOL, V15, P593, DOI 10.1111/j.1365-2958.1995.tb02368.x; HALL RM, 1999, ANN N Y ACAD SCI, V870; Holmes AJ, 2003, ENVIRON MICROBIOL, V5, P383, DOI 10.1046/j.1462-2920.2003.00429.x; MacDonald D, 2006, NATURE, V440, P1157, DOI 10.1038/nature04643; PETSKO GA, 1985, METHOD ENZYMOL, V114, P147; RECCHIA GD, 1994, NUCLEIC ACIDS RES, V22, P2071, DOI 10.1093/nar/22.11.2071; Stokes HW, 1997, MOL MICROBIOL, V26, P731, DOI 10.1046/j.1365-2958.1997.6091980.x	19	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2009	4	4							e5228	10.1371/journal.pone.0005228	http://dx.doi.org/10.1371/journal.pone.0005228			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VA	19381299	Green Published, gold, Green Submitted			2022-12-25	WOS:000265513800008
J	Mohammad, KS; Chen, CG; Balooch, G; Stebbins, E; McKenna, CR; Davis, H; Niewolna, M; Peng, XH; Nguyen, DHN; Ionova-Martin, SS; Bracey, JW; Hogue, WR; Wong, DH; Ritchie, RO; Suva, LJ; Derynck, R; Guise, TA; Alliston, T				Mohammad, Khalid S.; Chen, Carol G.; Balooch, Guive; Stebbins, Elizabeth; McKenna, C. Ryan; Davis, Holly; Niewolna, Maria; Peng, Xiang Hong; Nguyen, Daniel H. N.; Ionova-Martin, Sophi S.; Bracey, John W.; Hogue, William R.; Wong, Darren H.; Ritchie, Robert O.; Suva, Larry J.; Derynck, Rik; Guise, Theresa A.; Alliston, Tamara			Pharmacologic Inhibition of the TGF-beta Type I Receptor Kinase Has Anabolic and Anti-Catabolic Effects on Bone	PLOS ONE			English	Article								During development, growth factors and hormones cooperate to establish the unique sizes, shapes and material properties of individual bones. Among these, TGF-beta has been shown to developmentally regulate bone mass and bone matrix properties. However, the mechanisms that control postnatal skeletal integrity in a dynamic biological and mechanical environment are distinct from those that regulate bone development. In addition, despite advances in understanding the roles of TGF-beta signaling in osteoblasts and osteoclasts, the net effects of altered postnatal TGF-beta signaling on bone remain unclear. To examine the role of TGF-beta in the maintenance of the postnatal skeleton, we evaluated the effects of pharmacological inhibition of the TGF-beta type I receptor (T beta RI) kinase on bone mass, architecture and material properties. Inhibition of T beta RI function increased bone mass and multiple aspects of bone quality, including trabecular bone architecture and macro-mechanical behavior of vertebral bone. T beta RI inhibitors achieved these effects by increasing osteoblast differentiation and bone formation, while reducing osteoclast differentiation and bone resorption. Furthermore, they induced the expression of Runx2 and EphB4, which promote osteoblast differentiation, and ephrinB2, which antagonizes osteoclast differentiation. Through these anabolic and anti-catabolic effects, T beta RI inhibitors coordinate changes in multiple bone parameters, including bone mass, architecture, matrix mineral concentration and material properties, that collectively increase bone fracture resistance. Therefore, T beta RI inhibitors may be effective in treating conditions of skeletal fragility.			Mohammad, KS (corresponding author), Univ Virginia, Div Endocrinol, Dept Internal Med, Charlottesville, VA 22903 USA.	tamara.alliston@ucsf.edu	Ritchie, Robert O/A-8066-2008; Mohammad, Khalid/AFE-4205-2022; Mohammad, Khalid/AAE-9569-2022	Ritchie, Robert O/0000-0002-0501-6998; Alliston, Tamara/0000-0001-9992-2897; Suva, Larry/0000-0002-2892-9757	NIDCR NIH HHS [R03 DE016868, R03 DE016868-02] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE016868] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Alliston Tamara, 2008, P667; [Anonymous], 1990, E399 ASTM; Arany PR, 2006, P NATL ACAD SCI USA, V103, P9250, DOI 10.1073/pnas.0602473103; *ASTM, 2006, E1820 ASTM; Balooch G, 2005, P NATL ACAD SCI USA, V102, P18813, DOI 10.1073/pnas.0507417102; Bonniaud P, 2005, AM J RESP CRIT CARE, V171, P889, DOI 10.1164/rccm.200405-612OC; Borton AJ, 2001, J BONE MINER RES, V16, P1754, DOI 10.1359/jbmr.2001.16.10.1754; CARCAMO J, 1994, MOL CELL BIOL, V14, P3810, DOI 10.1128/MCB.14.6.3810; CURREY JD, 1969, J BIOMECH, V2, P477, DOI 10.1016/0021-9290(69)90023-2; Currey JD, 1999, J EXP BIOL, V202, P3285; Dallas SL, 2002, J BIOL CHEM, V277, P21352, DOI 10.1074/jbc.M111663200; Derynck Rik, 2008, P613; Erlebacher A, 1998, MOL BIOL CELL, V9, P1903, DOI 10.1091/mbc.9.7.1903; Erlebacher A, 1996, J CELL BIOL, V132, P195, DOI 10.1083/jcb.132.1.195; Filvaroff E, 1999, DEVELOPMENT, V126, P4267; Fox SW, 2005, MOL CELL ENDOCRINOL, V243, P19, DOI 10.1016/j.mce.2005.09.008; Gaddy-Kurten D, 2002, ENDOCRINOLOGY, V143, P74, DOI 10.1210/en.143.1.74; Gaspar NJ, 2007, MOL PHARMACOL, V72, P152, DOI 10.1124/mol.106.029025; Geiser AG, 1998, BONE, V23, P87, DOI 10.1016/S8756-3282(98)00078-7; Giuliani N, 1998, BONE, V22, P455, DOI 10.1016/S8756-3282(98)00033-7; Hernandez CJ, 2006, BONE, V39, P1173, DOI 10.1016/j.bone.2006.06.001; Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167; Iida-Klein A, 2006, J BONE MINER RES, V21, P274, DOI 10.1359/JBMR.051017; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Kaneda T, 2000, J IMMUNOL, V165, P4254, DOI 10.4049/jimmunol.165.8.4254; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Kapoun AM, 2006, MOL PHARMACOL, V70, P518, DOI 10.1124/mol.105.021600; Karsdal MA, 2003, J BIOL CHEM, V278, P44975, DOI 10.1074/jbc.M303905200; Karst M, 2004, J CELL PHYSIOL, V200, P99, DOI 10.1002/jcp.20036; KINNEY JH, 1994, SCANNING MICROSCOPY, V8, P197; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Lin AH, 2005, J IMMUNOL, V175, P547, DOI 10.4049/jimmunol.175.1.547; Maeda S, 2004, EMBO J, V23, P552, DOI 10.1038/sj.emboj.7600067; Mei W, 2005, BIOCHEM BIOPH RES CO, V328, P651, DOI 10.1016/j.bbrc.2004.11.067; Murakami T, 1998, BIOCHEM BIOPH RES CO, V252, P747, DOI 10.1006/bbrc.1998.9723; Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3; OREFFO ROC, 1989, BIOCHEM BIOPH RES CO, V158, P817, DOI 10.1016/0006-291X(89)92795-2; OURSLER MJ, 1994, J BONE MINER RES, V9, P443; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Perrien DS, 2007, ENDOCRINOLOGY, V148, P1654, DOI 10.1210/en.2006-0848; Rho JY, 1997, BIOMATERIALS, V18, P1325, DOI 10.1016/S0142-9612(97)00073-2; RITCHIE RO, 2008, BONE; Stabnov L, 2002, BONE, V30, P909, DOI 10.1016/S8756-3282(02)00738-X; Suva LJ, 2008, AM J PATHOL, V172, P430, DOI 10.2353/ajpath.2008.070417; TAKAHASHI N, 2002, PRINCIPLES BONE BIOL, P109; THIRUNAVUKKARAS.K, 2001, J BIOL CHEM, V12, P12; Uhl M, 2004, CANCER RES, V64, P7954, DOI 10.1158/0008-5472.CAN-04-1013; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580; ZAHOOR A, 1989, ELECT POWER RES I; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012; Zysset PK, 1999, J BIOMECH, V32, P1005, DOI 10.1016/S0021-9290(99)00111-6	54	125	136	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2009	4	4							e5275	10.1371/journal.pone.0005275	http://dx.doi.org/10.1371/journal.pone.0005275			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TU	19357790	Green Published, Green Submitted, gold			2022-12-25	WOS:000265510600013
J	Webb, BT; McClay, JL; Vargas-Irwin, C; York, TP; van den Oord, EJCG				Webb, Bradley Todd; McClay, Joseph L.; Vargas-Irwin, Cristina; York, Timothy P.; van den Oord, Edwin J. C. G.			In Silico Whole Genome Association Scan for Murine Prepulse Inhibition	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; FALSE DISCOVERY RATE; ACOUSTIC STARTLE RESPONSE; EXPERIMENTAL UNIT LEADS; CHROMOGRANIN-B; DRAMATIC OVERESTIMATION; INAPPROPRIATE CHOICE; GENETIC-VARIATION; BIPOLAR DISORDER; SECRETOGRANIN-II	Background: The complex trait of prepulse inhibition (PPI) is a sensory gating measure related to schizophrenia and can be measured in mice. Large-scale public repositories of inbred mouse strain genotypes and phenotypes such as PPI can be used to detect Quantitative Trait Loci (QTLs) in silico. However, the method has been criticized for issues including insufficient number of strains, not controlling for false discoveries, the complex haplotype structure of inbred mice, and failing to account for genotypic and phenotypic subgroups. Methodology/Principal Findings: We have implemented a method that addresses these issues by incorporating phylogenetic analyses, multilevel regression with mixed effects, and false discovery rate (FDR) control. A genome-wide scan for PPI was conducted using over 17,000 single nucleotide polymorphisms (SNPs) in 37 strains phenotyped. Eighty-nine SNPs were significant at a false discovery rate (FDR) of 5%. After accounting for long-range linkage disequilibrium, we found 3 independent QTLs located on murine chromosomes 1 and 13. One of the PPI positives corresponds to a region of human chromosome 6p which includes DTNBP1, a gene implicated in schizophrenia. Another region includes the gene Tsn which alters PPI when knocked out. These genes also appear to have correlated expression with PPI. Conclusions/Significance: These results support the usefulness of using an improved in silico mapping method to identify QTLs for complex traits such as PPI which can be then be used for to help identify loci influencing schizophrenia in humans.			Webb, BT (corresponding author), Virginia Commonwealth Univ, Ctr Biomarker Res & Personalized Med, Richmond, VA 23284 USA.	btwebb@vcu.edu	McClay, Joseph/C-9931-2009; Webb, Bradley T/B-1459-2009	McClay, Joseph/0000-0002-3628-2447; Webb, Bradley T/0000-0002-0576-5366				Anokhin AP, 2003, NEUROSCI LETT, V353, P45, DOI 10.1016/j.neulet.2003.09.014; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Brown BW, 1997, STAT MED, V16, P2511, DOI 10.1002/(SICI)1097-0258(19971130)16:22<2511::AID-SIM693>3.0.CO;2-4; Cadenhead KS, 2000, AM J PSYCHIAT, V157, P1660, DOI 10.1176/appi.ajp.157.10.1660; Cannon TD, 2005, ARCH GEN PSYCHIAT, V62, P1205, DOI 10.1001/archpsyc.62.11.1205; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Chesler EJ, 2001, SCIENCE, V294; Cho YS, 2004, J BIOL CHEM, V279, P31514, DOI 10.1074/jbc.M401442200; Darvasi A, 2001, SCIENCE, V294; Fernando RL, 2004, GENETICS, V166, P611, DOI 10.1534/genetics.166.1.611; Funke B, 2004, AM J HUM GENET, V75, P891, DOI 10.1086/425279; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; Goldstein H, 1995, MULTILEVEL STAT MODE, DOI 10.1002/9780470973394; Grubb SC, 2004, BIOINFORMATICS, V20, P2857, DOI 10.1093/bioinformatics/bth299; Grupe A, 2001, SCIENCE, V292, P1915, DOI 10.1126/science.1058889; Guo AY, 2009, NUCLEIC ACIDS RES, V37, pD840, DOI 10.1093/nar/gkn816; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; Hinterhoelzl JK, 2003, J NEUROCHEM, V87, P13, DOI 10.1046/j.1471-4159.2003.01989.x; Hitzemann R, 2008, PHARMACOL BIOCHEM BE, V90, P525, DOI 10.1016/j.pbb.2008.04.004; Hsueh Huey-miin, 2003, J Biopharm Stat, V13, P675, DOI 10.1081/BIP-120024202; Iijima Y, 2004, BIOL PSYCHIAT, V56, P10, DOI 10.1016/j.biopsych.2004.03.012; Itokawa M, 2003, PHARMACOGENETICS, V13, P271, DOI 10.1097/00008571-200305000-00006; Iwayama-Shigeno Y, 2005, NEUROSCI LETT, V378, P102, DOI 10.1016/j.neulet.2004.12.013; Joober R, 2003, NEUROPSYCHOPHARMACOL, V28, P819, DOI 10.1038/sj.npp.1300065; Joober R, 2002, NEUROPSYCHOPHARMACOL, V27, P765, DOI 10.1016/S0893-133X(02)00333-0; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kirov G, 2004, BIOL PSYCHIAT, V55, P971, DOI 10.1016/j.biopsych.2004.01.025; Kline L, 1998, PSYCHOPHARMACOLOGY, V139, P322, DOI 10.1007/s002130050723; Korn EL, 2004, J STAT PLAN INFER, V124, P379, DOI 10.1016/S0378-3758(03)00211-8; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Li T, 2005, MOL PSYCHIATR, V10, P1037, DOI 10.1038/sj.mp.4001718; Liao GC, 2004, SCIENCE, V306, P690, DOI 10.1126/science.1100636; Marksteiner J, 2001, NEUROSCIENCE, V104, P325, DOI 10.1016/S0306-4522(01)00081-1; McCaughran J, 1999, BEHAV GENET, V29, P21, DOI 10.1023/A:1021433705004; McCaughran J, 1997, PSYCHOPHARMACOLOGY, V134, P131, DOI 10.1007/s002130050434; Mhyre TR, 2005, GENES BRAIN BEHAV, V4, P209, DOI 10.1111/j.1601-183X.2004.00102.x; Millar JK, 2000, GENOMICS, V67, P69, DOI 10.1006/geno.2000.6239; Myers KM, 2005, BIOL PSYCHIAT, V58, P67, DOI 10.1016/j.biopsych.2005.03.023; Palmer AA, 2003, NEUROPSYCHOPHARMACOL, V28, P818, DOI 10.1038/sj.npp.1300064; Palmer AA, 2003, PSYCHOPHARMACOLOGY, V165, P270, DOI 10.1007/s00213-002-1258-0; Park YG, 2003, GENOME RES, V13, P118, DOI 10.1101/gr.786403; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Petkov PM, 2004, GENOME RES, V14, P1806, DOI 10.1101/gr.2825804; Petryshen TL, 2005, GENETICS, V171, P1895, DOI 10.1534/genetics.105.045658; Pletcher MT, 2004, PLOS BIOL, V2, P2159, DOI 10.1371/journal.pbio.0020393; Sabatti C, 2003, GENETICS, V164, P829; Schwab SG, 2003, AM J HUM GENET, V72, P185, DOI 10.1086/345463; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Searle S., 1992, VARIANCE COMPONENTS; Smith JD, 2003, ARTERIOSCL THROM VAS, V23, P117, DOI 10.1161/01.ATV.0000047461.18902.80; Stein JM, 2006, J NEUROSCI, V26, P2184, DOI 10.1523/JNEUROSCI.4437-05.2006; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; TANG J, 2006, NEUROSCI LETT; Tang JX, 2003, MOL PSYCHIATR, V8, P717, DOI 10.1038/sj.mp.4001287; Thomas DC, 2004, JNCI-J NATL CANCER I, V96, P421, DOI 10.1093/jnci/djh094; Thomson PA, 2005, MOL PSYCHIATR, V10, P657, DOI 10.1038/sj.mp.4001669; Tian C, 2008, HUM MOL GENET, V17, pR143, DOI 10.1093/hmg/ddn268; Torkamanzehi A, 2008, J GENET GENOMICS, V35, P139, DOI 10.1016/S1673-8527(08)60020-X; Tsai CA, 2003, BIOMETRICS, V59, P1071, DOI 10.1111/j.0006-341X.2003.00123.x; Van Den Bogaert A, 2003, AM J HUM GENET, V73, P1438, DOI 10.1086/379928; van den Oord EJCG, 2005, MOL PSYCHIATR, V10, P230, DOI 10.1038/sj.mp.4001581; van den Oord EJCG, 2003, MOL PSYCHIATR, V8, P499, DOI 10.1038/sj.mp.4001263; van den Oord EJCG, 2003, TRENDS GENET, V19, P537, DOI 10.1016/j.tig.2003.08.003; van den Oord EJCG, 2001, STAT METHODS MED RES, V10, P393, DOI 10.1177/096228020101000603; Van Ooijen JW, 1999, HEREDITY, V83, P613, DOI 10.1038/sj.hdy.6886230; Vendruscolo Leandro Franco, 2006, Behav Brain Funct, V2, P21, DOI 10.1186/1744-9081-2-21; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252; Wang N, 2002, AM J HUM GENET, V71, P1227, DOI 10.1086/344398; Watanabe A, 2007, PLOS BIOL, V5, P2469, DOI 10.1371/journal.pbio.0050297; Webb BT, 2008, PHARMACOGENET GENOM, V18, P751, DOI 10.1097/FPC.0b013e32830162bc; Weickert CS, 2004, ARCH GEN PSYCHIAT, V61, P544, DOI 10.1001/archpsyc.61.6.544; Williams NM, 2004, ARCH GEN PSYCHIAT, V61, P336, DOI 10.1001/archpsyc.61.4.336; Williams RW, 2004, MAMM GENOME, V15, P637, DOI 10.1007/s00335-004-2380-6; Williams RW, 2001, GENOME BIOL, V2; Willott JF, 2003, BEHAV NEUROSCI, V117, P716, DOI 10.1037/0735-7044.117.4.716; Zhang BF, 2002, NEUROSCI LETT, V323, P229, DOI 10.1016/S0304-3940(02)00145-3	81	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2009	4	4							e5246	10.1371/journal.pone.0005246	http://dx.doi.org/10.1371/journal.pone.0005246			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TU	19370154	gold, Green Published, Green Submitted			2022-12-25	WOS:000265510600008
J	Verreck, FAW; Vervenne, RAW; Kondova, I; van Kralingen, KW; Remarque, EJ; Braskamp, G; van der Werff, NM; Kersbergen, A; Ottenhoff, THM; Heidt, PJ; Gilbert, SC; Gicquel, B; Hill, AVS; Martin, C; McShane, H; Thomas, AW				Verreck, Frank A. W.; Vervenne, Richard A. W.; Kondova, Ivanela; van Kralingen, Klaas W.; Remarque, Edmond J.; Braskamp, Gerco; van der Werff, Nicole M.; Kersbergen, Ariena; Ottenhoff, Tom H. M.; Heidt, Peter J.; Gilbert, Sarah C.; Gicquel, Brigitte; Hill, Adrian V. S.; Martin, Carlos; McShane, Helen; Thomas, Alan W.			MVA.85A Boosting of BCG and an Attenuated, phoP Deficient M. tuberculosis Vaccine Both Show Protective Efficacy Against Tuberculosis in Rhesus Macaques	PLOS ONE			English	Article							NONHUMAN PRIMATE MODEL; MYCOBACTERIUM-TUBERCULOSIS; ENHANCED IMMUNOGENICITY; SUBUNIT VACCINE; RECOMBINANT BCG; INFECTION; IMMUNITY; MVA85A; RESEMBLES; RESPONSES	Background: Continuous high global tuberculosis (TB) mortality rates and variable vaccine efficacy of Mycobacterium bovis Bacille Calmette-Guerin (BCG) motivate the search for better vaccine regimes. Relevant models are required to downselect the most promising vaccines entering clinical efficacy testing and to identify correlates of protection. Methods and Findings: Here, we evaluated immunogenicity and protection against Mycobacterium tuberculosis in rhesus monkeys with two novel strategies: BCG boosted by modified vaccinia virus Ankara expressing antigen 85A (MVA.85A), and attenuated M. tuberculosis with a disrupted phoP gene (SO2) as a single-dose vaccine. Both strategies were well tolerated, and immunogenic as evidenced by induction of specific IFN gamma responses. Antigen 85A-specific IFN gamma secretion was specifically increased by MVA.85A boosting. Importantly, both MVA. 85A and SO2 treatment significantly reduced pathology and chest X-ray scores upon infectious challenge with M. tuberculosis Erdman strain. MVA. 85A and SO2 treatment also showed reduced average lung bacterial counts (1.0 and 1.2 log respectively, compared with 0.4 log for BCG) and significant protective effect by reduction in C-reactive protein levels, body weight loss, and decrease of erythrocyte-associated hematologic parameters (MCV, MCH, Hb, Ht) as markers of inflammatory infection, all relative to non-vaccinated controls. Lymphocyte stimulation revealed Ag85A-induced IFN gamma levels post-infection as the strongest immunocorrelate for protection (spearman's rho: -0.60). Conclusions: Both the BCG/MVA.85A prime-boost regime and the novel live attenuated, phoP deficient TB vaccine candidate SO2 showed significant protective efficacy by various parameters in rhesus macaques. Considering the phylogenetic relationship between macaque and man and the similarity in manifestations of TB disease, these data support further development of these primary and combination TB vaccine candidates.			Verreck, FAW (corresponding author), Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands.	verreck@bprc.nl	Martin, Carlos/A-7283-2008; Heidt, Peter/GQQ-8459-2022; Remarque, Ed/AAE-8643-2020; Remarque, Edmond J/B-2217-2010; Gilbert, Sarah C./H-2857-2019	Martin, Carlos/0000-0003-2993-5478; Gilbert, Sarah C./0000-0002-6823-9750; McShane, Helen/0000-0002-2126-5142	Wellcome Trust [076943] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aguilar D, 2007, CLIN EXP IMMUNOL, V147, P330, DOI 10.1111/j.1365-2249.2006.03284.x; Asensio JAG, 2008, EXPERT OPIN BIOL TH, V8, P201, DOI 10.1517/14712598.8.2.201 ; Asensio JG, 2006, J BIOL CHEM, V281, P1313, DOI 10.1074/jbc.C500388200; Baumann S, 2006, CURR OPIN IMMUNOL, V18, P438, DOI 10.1016/j.coi.2006.05.016; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; Brosch R, 2007, P NATL ACAD SCI USA, V104, P5596, DOI 10.1073/pnas.0700869104; Capuano SV, 2003, INFECT IMMUN, V71, P5831, DOI 10.1128/IAI.71.10.5831-5844.2003; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Flynn JL, 2003, TUBERCULOSIS, V83, P116, DOI 10.1016/S1472-9792(02)00059-8; Frigui W, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040033; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Gonzalo-Asensio J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003496; Goonetilleke NP, 2003, J IMMUNOL, V171, P1602, DOI 10.4049/jimmunol.171.3.1602; Hussey G, 2007, PAEDIATR RESPIR REV, V8, P148, DOI 10.1016/j.prrv.2007.04.009; Ibango HB, 2006, LANCET INFECT DIS, V6, P522, DOI 10.1016/S1473-3099(06)70552-7; Kamath AT, 2005, VACCINE, V23, P3753, DOI 10.1016/j.vaccine.2005.03.001; Kita Y, 2005, VACCINE, V23, P2132, DOI 10.1016/j.vaccine.2005.01.057; Langermans JAM, 2005, VACCINE, V23, P2740, DOI 10.1016/j.vaccine.2004.11.051; Langermans JAM, 2001, P NATL ACAD SCI USA, V98, P11497, DOI 10.1073/pnas.201404898; Martin C, 2006, VACCINE, V24, P3408, DOI 10.1016/j.vaccine.2006.03.017; McMurray DN, 2000, CLIN INFECT DIS, V30, pS210, DOI 10.1086/313885; McShane H, 2005, TUBERCULOSIS, V85, P47, DOI 10.1016/j.tube.2004.09.015; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; McShane H, 2001, INFECT IMMUN, V69, P681, DOI 10.1128/IAI.69.2.681-686.2001; MLIKACABANNE N, 1995, AM J RESP CRIT CARE, V152, P786, DOI 10.1164/ajrccm.152.2.7633743; Pathan AA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001052; Perez E, 2001, MOL MICROBIOL, V41, P179, DOI 10.1046/j.1365-2958.2001.02500.x; Skeiky YAW, 2006, NAT REV MICROBIOL, V4, P469, DOI 10.1038/nrmicro1419; Sugawara I, 2007, TUBERCULOSIS, V87, P518, DOI 10.1016/j.tube.2007.06.002; Walsh GP, 1996, NAT MED, V2, P430, DOI 10.1038/nm0496-430; Williams A, 2005, TUBERCULOSIS, V85, P29, DOI 10.1016/j.tube.2004.09.009; World Health Organization, 2008, GLOB TUB CONTR SURV	33	163	174	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2009	4	4							e5264	10.1371/journal.pone.0005264	http://dx.doi.org/10.1371/journal.pone.0005264			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TS	19367339	Green Published, gold, Green Submitted			2022-12-25	WOS:000265510400009
J	Benachenhou, F; Jern, P; Oja, M; Sperber, G; Blikstad, V; Somervuo, P; Kaski, S; Blomberg, J				Benachenhou, Farid; Jern, Patric; Oja, Merja; Sperber, Goran; Blikstad, Vidar; Somervuo, Panu; Kaski, Samuel; Blomberg, Jonas			Evolutionary Conservation of Orthoretroviral Long Terminal Repeats (LTRs) and ab initio Detection of Single LTRs in Genomic Data	PLOS ONE			English	Article							ENDOGENOUS RETROVIRAL SEQUENCES; DE-NOVO IDENTIFICATION; MURINE LEUKEMIA-VIRUS; HIDDEN MARKOV-MODELS; R-REGION; TRANSCRIPTION INITIATION; ANTISENSE TRANSCRIPTS; TRANSPOSABLE ELEMENTS; PROVIRAL STRUCTURE; PROMOTER ACTIVITY	Background: Retroviral LTRs, paired or single, influence the transcription of both retroviral and non-retroviral genomic sequences. Vertebrate genomes contain many thousand endogenous retroviruses (ERVs) and their LTRs. Single LTRs are difficult to detect from genomic sequences without recourse to repetitiveness or presence in a proviral structure. Understanding of LTR structure increases understanding of LTR function, and of functional genomics. Here we develop models of orthoretroviral LTRs useful for detection in genomes and for structural analysis. Principal Findings: Although mutated, ERV LTRs are more numerous and diverse than exogenous retroviral (XRV) LTRs. Hidden Markov models (HMMs), and alignments based on them, were created for HML- (human MMTV-like), general-beta-, gamma-and lentiretroviruslike LTRs, plus a general-vertebrate LTR model. Training sets were XRV LTRs and RepBase LTR consensuses. The HML HMM was most sensitive and detected 87% of the HML LTRs in human chromosome 19 at 96% specificity. By combining all HMMs with a low cutoff, for screening, 71% of all LTRs found by RepeatMasker in chromosome 19 were found. HMM consensus sequences had a conserved modular LTR structure. Target site duplications (TG-CA), TATA (occasionally absent), an AATAAA box and a T-rich region were prominent features. Most of the conservation was located in, or adjacent to, R and U5, with evidence for stem loops. Several of the long HML LTRs contained long ORFs inserted after the second A rich module. HMM consensus alignment allowed comparison of functional features like transcriptional start sites (sense and antisense) between XRVs and ERVs. Conclusion: The modular conserved and redundant orthoretroviral LTR structure with three A-rich regions is reminiscent of structurally relaxed Giardia promoters. The five HMMs provided a novel broad range, repeat-independent, ab initio LTR detection, with prospects for greater generalisation, and insight into LTR structure, which may aid development of LTR-targeted pharmaceuticals.			Benachenhou, F (corresponding author), Uppsala Univ, Dept Med Sci, Virol Sect, Uppsala, Sweden.	Jonas.Blomberg@medsci.uu.se	Kaski, Samuel/B-6684-2008; Jern, Patric/AAR-2133-2021	Kaski, Samuel/0000-0003-1925-9154; Jern, Patric/0000-0003-3393-5825; Blomberg, Jonas/0000-0001-6492-2491				AHMED YF, 1991, CELL, V64, P727, DOI 10.1016/0092-8674(91)90502-P; Anderssen S, 1997, VIROLOGY, V234, P14, DOI 10.1006/viro.1997.8590; Andersson AC, 2005, J VIROL, V79, P9270, DOI 10.1128/JVI.79.14.9270-9284.2005; Andersson ML, 1999, J GEN VIROL, V80, P255, DOI 10.1099/0022-1317-80-1-255; ARMOUR JAL, 1989, NUCLEIC ACIDS RES, V17, P4925, DOI 10.1093/nar/17.13.4925; Bao ZR, 2002, GENOME RES, V12, P1269, DOI 10.1101/gr.88502; Barton N. H., 2007, EVOLUTION; Baust C, 2000, GENOMICS, V66, P98, DOI 10.1006/geno.2000.6175; Blikstad V, 2008, CELL MOL LIFE SCI, V65, P3348, DOI 10.1007/s00018-008-8495-2; Blusch JH, 1997, GENOMICS, V43, P52, DOI 10.1006/geno.1997.4790; Brand M, 1999, NEURAL COMPUT, V11, P1155, DOI 10.1162/089976699300016395; Briquet S, 2002, VIROLOGY, V292, P177, DOI 10.1006/viro.2001.1224; BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; Caspi A, 2006, GENOME RES, V16, P260, DOI 10.1101/gr.4361206; Cavanagh MH, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-15; CHANG NT, 2006, J BIOMED SCI; CHEN HR, 1984, NUCLEIC ACIDS RES, V12, P1767, DOI 10.1093/nar/12.4.1767; CHRISTY RJ, 1988, MOL CELL BIOL, V8, P1093, DOI 10.1128/MCB.8.3.1093; Coffin J, 1997, RETROVIRUSES; COFFIN J, 1997, RETROVIRUSES, P776; COFFIN JM, 1997, RETROVIRUSES, P225; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; Cupelli L, 1998, J VIROL, V72, P7807, DOI 10.1128/JVI.72.10.7807-7814.1998; CUPELLI LA, 1991, J VIROL, V65, P6961, DOI 10.1128/JVI.65.12.6961-6968.1991; Domansky AN, 2000, FEBS LETT, V472, P191, DOI 10.1016/S0014-5793(00)01460-5; Dunn CA, 2006, GENE, V366, P335, DOI 10.1016/j.gene.2005.09.003; Durbin R., 1998, BIOL SEQUENCE ANAL P; Edgar RC, 2005, BIOINFORMATICS, V21, pI152, DOI 10.1093/bioinformatics/bti1003; Elisaphenko EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002521; Ellinghaus D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-18; FEUCHTER A, 1990, NUCLEIC ACIDS RES, V18, P1261, DOI 10.1093/nar/18.5.1261; Frech K, 1997, J MOL BIOL, V270, P674, DOI 10.1006/jmbi.1997.1140; Frech K, 1996, VIROLOGY, V224, P256, DOI 10.1006/viro.1996.0527; Futuyma D. J., 2005, EVOLUTION; GUNTAKA RV, 1993, MICROBIOL REV, V57, P511, DOI 10.1128/MMBR.57.3.511-521.1993; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Heinemeyer T, 1999, NUCLEIC ACIDS RES, V27, P318, DOI 10.1093/nar/27.1.318; Jern P, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-50; Jern P, 2005, J VIROL, V79, P6325, DOI 10.1128/JVI.79.10.6325-6337.2005; Jern P, 2004, VIROLOGY, V327, P93, DOI 10.1016/j.virol.2004.06.023; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kalyanaraman Anantharaman, 2006, Journal of Bioinformatics and Computational Biology, V4, P197, DOI 10.1142/S021972000600203X; Karlin S, 2005, P NATL ACAD SCI USA, V102, P13355, DOI 10.1073/pnas.0501804102; Katzourakis A, 2007, P NATL ACAD SCI USA, V104, P6261, DOI 10.1073/pnas.0700471104; KELLY RG, 1994, GENOMICS, V24, P509, DOI 10.1006/geno.1994.1660; Kovalskaya E, 2006, VIROLOGY, V346, P373, DOI 10.1016/j.virol.2005.11.007; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; KROGH A, 1995, ISMB, V3, P215; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LAMANTIA G, 1992, NUCLEIC ACIDS RES, V20, P4129, DOI 10.1093/nar/20.16.4129; Lavrentieva I, 1998, HUM GENET, V102, P107, DOI 10.1007/s004390050662; Leib-Mosch CSW, 2005, INFLUENCE HUMAN ENDO; Leupin O, 2005, EMBO REP, V6, P956, DOI 10.1038/sj.embor.7400502; Ludwig LB, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-80; MAGER DL, 1989, VIROLOGY, V173, P591, DOI 10.1016/0042-6822(89)90570-9; MAGER DL, 2003, RETROVIRAL REPEAT SE; McCarthy EM, 2003, BIOINFORMATICS, V19, P362, DOI 10.1093/bioinformatics/btf878; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Nesterova TB, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-2; Oja M, 2005, INT J NEURAL SYST, V15, P163, DOI 10.1142/S0129065705000177; PIERCE J, 1993, J VIROL, V67, P415, DOI 10.1128/JVI.67.1.415-424.1993; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Quesneville H, 2005, PLOS COMPUT BIOL, V1, P166, DOI 10.1371/journal.pcbi.0010022; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Rho M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-90; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Seifarth W, 1998, J VIROL, V72, P8384, DOI 10.1128/JVI.72.10.8384-8391.1998; Sjottem E, 1996, J VIROL, V70, P188; SPERBER GO, 2007, NUCL ACIDS RES; Tek AL, 2005, GENETICS, V170, P1231, DOI 10.1534/genetics.105.041087; Teodorovic S, 2007, NUCLEIC ACIDS RES, V35, P2544, DOI 10.1093/nar/gkm105; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trubetskoy AM, 1999, J VIROL, V73, P3477, DOI 10.1128/JVI.73.4.3477-3483.1999; Wolgamot G, 1999, J VIROL, V73, P9803, DOI 10.1128/JVI.73.12.9803-9809.1999; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Zhang Z, 1999, J GEN VIROL, V80, P3065, DOI 10.1099/0022-1317-80-12-3065; ZUKER M, 1999, ALGORITHMS THERMODYN	79	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5179	10.1371/journal.pone.0005179	http://dx.doi.org/10.1371/journal.pone.0005179			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TN	19365549	Green Published, gold, Green Submitted			2022-12-25	WOS:000265509900009
J	Gile, GH; Faktorova, D; Castlejohn, CA; Burger, G; Lang, BF; Farmer, MA; Lukes, J; Keeling, PJ				Gile, Gillian H.; Faktorova, Drahomira; Castlejohn, Christina A.; Burger, Gertraud; Lang, B. Franz; Farmer, Mark A.; Lukes, Julius; Keeling, Patrick J.			Distribution and Phylogeny of EFL and EF-1 alpha in Euglenozoa Suggest Ancestral Co-Occurrence Followed by Differential Loss	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI; EARLY EVOLUTION; N.-SP.; GENOME; RNA; KINETOPLASTIDS; DIVERSITY; SEQUENCE; GENE; TREE	Background: The eukaryotic elongation factor EF-1 alpha (also known as EF1A) catalyzes aminoacyl-tRNA binding by the ribosome during translation. Homologs of this essential protein occur in all domains of life, and it was previously thought to be ubiquitous in eukaryotes. Recently, however, a number of eukaryotes were found to lack EF-1 alpha and instead encode a related protein called EFL (for EF-Like). EFL-encoding organisms are scattered widely across the tree of eukaryotes, and all have close relatives that encode EF-1 alpha. This intriguingly complex distribution has been attributed to multiple lateral transfers because EFL's near mutual exclusivity with EF-1 alpha makes an extended period of co-occurrence seem unlikely. However, differential loss may play a role in EFL evolution, and this possibility has been less widely discussed. Methodology/Principal Findings: We have undertaken an EST-and PCR-based survey to determine the distribution of these two proteins in a previously under-sampled group, the Euglenozoa. EF-1 alpha was found to be widespread and monophyletic, suggesting it is ancestral in this group. EFL was found in some species belonging to each of the three euglenozoan lineages, diplonemids, kinetoplastids, and euglenids. Conclusions/Significance: Interestingly, the kinetoplastid EFL sequences are specifically related despite the fact that the lineages in which they are found are not sisters to one another, suggesting that EFL and EF-1 alpha co-occurred in an early ancestor of kinetoplastids. This represents the strongest phylogenetic evidence to date that differential loss has contributed to the complex distribution of EFL and EF-1 alpha.			Gile, GH (corresponding author), Univ British Columbia, Canadian Inst Adv Res, Vancouver, BC, Canada.	ggile@interchange.ubc.ca	Faktorová, Drahomíra/G-7292-2014; Lukes, Julius/H-6760-2012	Faktorová, Drahomíra/0000-0001-9623-2233; Lukes, Julius/0000-0002-0578-6618; Keeling, Patrick/0000-0002-7644-0745				Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Andersen GR, 2001, NAT STRUCT BIOL, V8, P531, DOI 10.1038/88598; Atkins MS, 2000, J EUKARYOT MICROBIOL, V47, P400, DOI 10.1111/j.1550-7408.2000.tb00067.x; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Breglia SA, 2007, J EUKARYOT MICROBIOL, V54, P86, DOI 10.1111/j.1550-7408.2006.00233.x; Dimmic MW, 2002, J MOL EVOL, V55, P65, DOI 10.1007/s00239-001-2304-y; Dykova I, 2003, EUR J PROTISTOL, V39, P37, DOI 10.1078/0932-4739-00901; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Gile GH, 2006, PROTIST, V157, P435, DOI 10.1016/j.protis.2006.06.002; GONEN H, 1994, P NATL ACAD SCI USA, V91, P7648, DOI 10.1073/pnas.91.16.7648; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Kamikawa R, 2008, P NATL ACAD SCI USA, V105, P6965, DOI 10.1073/pnas.0711084105; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Keeling PJ, 2004, P NATL ACAD SCI USA, V101, P15380, DOI 10.1073/pnas.0404505101; Lai DH, 2008, P NATL ACAD SCI USA, V105, P1999, DOI 10.1073/pnas.0711799105; Lara E, 2009, ENVIRON MICROBIOL, V11, P47, DOI 10.1111/j.1462-2920.2008.01737.x; Lartillot N, 2006, SYST BIOL, V55, P195, DOI 10.1080/10635150500433722; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Leander BS, 2007, BIOESSAYS, V29, P987, DOI 10.1002/bies.20645; LUKES J, 1994, EMBO J, V13, P5086, DOI 10.1002/j.1460-2075.1994.tb06838.x; Lukes J, 2006, MOL BIOCHEM PARASIT, V148, P125, DOI 10.1016/j.molbiopara.2006.03.008; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Maddison D. R., 2003, MACCLADE 4 ANAL PHYL; Makiuchi T, 2008, PROTIST, V159, P459, DOI 10.1016/j.protis.2008.02.002; Marande W, 2005, EUKARYOT CELL, V4, P1137, DOI 10.1128/EC.4.6.1137-1146.2005; Marshall WL, 2008, PROTIST, V159, P415, DOI 10.1016/j.protis.2008.03.003; Maslov DA, 1999, PROTIST, V150, P33, DOI 10.1016/S1434-4610(99)70007-6; Moreira D, 1999, MOL BIOL EVOL, V16, P234, DOI 10.1093/oxfordjournals.molbev.a026105; Moreira D, 2004, INT J SYST EVOL MICR, V54, P1861, DOI 10.1099/ijs.0.63081-0; Negrutskii BS, 1998, PROG NUCLEIC ACID RE, V60, P47, DOI 10.1016/S0079-6603(08)60889-2; Noble GP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-82; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Podlipaev SA, 2004, J EUKARYOT MICROBIOL, V51, P283, DOI 10.1111/j.1550-7408.2004.tb00568.x; RIOU G, 1969, P NATL ACAD SCI USA, V62, P210, DOI 10.1073/pnas.62.1.210; Rodriguez-Ezpeleta N, 2007, CURR BIOL, V17, P1420, DOI 10.1016/j.cub.2007.07.036; RODRIGUEZEZPELE.N, 2009, GENERATION ANAL; Roy J, 2007, PROTIST, V158, P385, DOI 10.1016/j.protis.2007.03.002; Roy J, 2007, J EUKARYOT MICROBIOL, V54, P137, DOI 10.1111/j.1550-7408.2007.00244.x; Ruiz-Trillo I, 2006, J EUKARYOT MICROBIOL, V53, P379, DOI 10.1111/j.1550-7408.2006.00118.x; SAKAGUCHI M, 2008, GENE IN PRESS; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Simpson AGB, 2006, TRENDS PARASITOL, V22, P168, DOI 10.1016/j.pt.2006.02.006; Simpson AGB, 2004, PROTIST, V155, P407, DOI 10.1078/1434461042650389; Simpson AGB, 2004, MOL PHYLOGENET EVOL, V30, P201, DOI 10.1016/S1055-7903(03)00177-5; Simpson AGB, 2002, MOL BIOL EVOL, V19, P2071, DOI 10.1093/oxfordjournals.molbev.a004032; Simpson AGB, 2003, INT J SYST EVOL MICR, V53, P1759, DOI 10.1099/ijs.0.02578-0; Simpson AGB, 2006, MOL BIOL EVOL, V23, P615, DOI 10.1093/molbev/msj068; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; von der Heyden S, 2005, INT J SYST EVOL MICR, V55, P2605, DOI 10.1099/ijs.0.63606-0; von der Heyden S, 2004, J EUKARYOT MICROBIOL, V51, P402; Votypka J, 2002, PARASITOLOGY, V125, P253, DOI 10.1017/S0031182002002093; Yoon HS, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-14; Yurchenko V, 2006, J EUKARYOT MICROBIOL, V53, P103, DOI 10.1111/j.1550-7408.2005.00078.x; Yurchenko VY, 2006, PARASITOLOGY, V133, P537, DOI 10.1017/S0031182006000746; Yurchenko VY, 2008, PROTIST, V159, P99, DOI 10.1016/j.protis.2007.07.003	61	17	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5162	10.1371/journal.pone.0005162	http://dx.doi.org/10.1371/journal.pone.0005162			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357788	Green Published, gold, Green Submitted			2022-12-25	WOS:000265505900018
J	Gingras, MC; Zhang, YL; Kharitidi, D; Barr, AJ; Knapp, S; Tremblay, ML; Pause, A				Gingras, Marie-Claude; Zhang, Yu Ling; Kharitidi, Dmitri; Barr, Alastair J.; Knapp, Stefan; Tremblay, Michel L.; Pause, Arnim			HD-PTP Is a Catalytically Inactive Tyrosine Phosphatase Due to a Conserved Divergence in Its Phosphatase Domain	PLOS ONE			English	Article								Background: The HD-PTP protein has been described as a tumor suppressor candidate and based on its amino acid sequence, categorized as a classical non-transmembrane protein tyrosine phosphatase (PTP). To date, no HD-PTP phosphorylated substrate has been identified and controversial results concerning its catalytic activity have been recently reported. Methodology and Results: Here we report a rigorous enzymatic analysis demonstrating that the HD-PTP protein does not harbor tyrosine phosphatase or lipid phosphatase activity using the highly sensitive DiFMUP substrate and a panel of different phosphatidylinositol phosphates. We found that HD-PTP tyrosine phosphatase inactivity is caused by an evolutionary conserved amino acid divergence of a key residue located in the HD-PTP phosphatase domain since its back mutation is sufficient to restore the HD-PTP tyrosine phosphatase activity. Moreover, in agreement with a tumor suppressor activity, HD-PTP expression leads to colony growth reduction in human cancer cell lines, independently of its catalytic PTP activity status. Conclusion: In summary, we demonstrate that HD-PTP is a catalytically inactive protein tyrosine phosphatase. As such, we identify one residue involved in its inactivation and show that its colony growth reduction activity is independent of its PTP activity status in human cancer cell lines.	[Gingras, Marie-Claude; Zhang, Yu Ling; Kharitidi, Dmitri; Tremblay, Michel L.; Pause, Arnim] McGill Univ, Goodman Canc Ctr, Montreal, PQ, Canada; [Gingras, Marie-Claude; Zhang, Yu Ling; Kharitidi, Dmitri; Tremblay, Michel L.; Pause, Arnim] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Barr, Alastair J.; Knapp, Stefan] Univ Oxford, Nuffield Dept Med, Structur Genom Consortium, Oxford OX1 2JD, England	McGill University; McGill University; University of Oxford	Gingras, MC (corresponding author), McGill Univ, Goodman Canc Ctr, Montreal, PQ, Canada.	arnim.pause@mcgill.ca	Knapp, Stefan/AAG-2347-2019	Knapp, Stefan/0000-0001-5995-6494; Barr, Alastair/0000-0001-7738-8419	CIHR McGill University [fellowship, studentship]; Fond de la recherche en sante du Quebec (FRSQ) [fellowship]; Kidney Foundation of Canada [fellowship]; Maysie MacSporran graduate studentship award; Jeanne and Jean-Louis Levesque Chair in Cancer Research; NCIC/CCS; Canada Research Chair in Molecular Oncology	CIHR McGill University(Canadian Institutes of Health Research (CIHR)); Fond de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Kidney Foundation of Canada; Maysie MacSporran graduate studentship award; Jeanne and Jean-Louis Levesque Chair in Cancer Research; NCIC/CCS; Canada Research Chair in Molecular Oncology(Canada Research Chairs)	MCG was supported by a CIHR McGill University Cancer Consortium fellowship and a fellowship from Fond de la recherche en sante du Quebec (FRSQ) and holds a Kidney Foundation of Canada fellowship. YLZ holds a McGill Canderel studentship stipend award and DK holds a CIHR McGill University Cancer Consortium studentships and a Maysie MacSporran graduate studentship award. MLT holds a Jeanne and Jean-Louis Levesque Chair in Cancer Research and a NCIC/CCS operating grant and AP a Canada Research Chair in Molecular Oncology. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institute, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Blanchetot C, 2005, METHODS, V35, P44, DOI 10.1016/j.ymeth.2004.07.007; Cao LG, 1998, J BIOL CHEM, V273, P21077, DOI 10.1074/jbc.273.33.21077; Castiglioni S, 2007, BIOCHEM BIOPH RES CO, V364, P534, DOI 10.1016/j.bbrc.2007.10.022; Chiarugi P, 2005, CELL MOL LIFE SCI, V62, P931, DOI 10.1007/s00018-004-4448-1; Doyotte A, 2008, P NATL ACAD SCI USA, V105, P6308, DOI 10.1073/pnas.0707601105; Drake PG, 2003, BIOCHEM J, V373, P393, DOI 10.1042/BJ20021851; Fitzgerald LR, 1997, J NEUROCHEM, V68, P1820; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; HESSON LB, 2007, EVALUATION 3P21 3 TU; Imreh S, 2003, GENE CHROMOSOME CANC, V38, P307, DOI 10.1002/gcc.10271; Ji Lin, 2005, Future Oncol, V1, P79, DOI 10.1517/14796694.1.1.79; Jiang SX, 1998, GENE, V215, P345, DOI 10.1016/S0378-1119(98)00282-0; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Magistrelli G, 1996, BIOCHEM BIOPH RES CO, V227, P581, DOI 10.1006/bbrc.1996.1549; MARIOTTI M, 2008, INT BIOCH CELL BIOL; Miura GI, 2008, DEVELOPMENT, V135, P1913, DOI 10.1242/dev.017202; Montalibet J, 2005, METHODS, V35, P2, DOI 10.1016/j.ymeth.2004.07.002; Oganesian A, 2003, P NATL ACAD SCI USA, V100, P7563, DOI 10.1073/pnas.1336511100; Peters GH, 2003, BIOCHIMIE, V85, P527, DOI 10.1016/S0300-9084(03)00036-1; Peters KG, 2003, J INORG BIOCHEM, V96, P321, DOI 10.1016/S0162-0134(03)00236-8; Stuible M, 2007, CHEMBIOCHEM, V8, P179, DOI 10.1002/cbic.200600287; Tabernero L, 2008, FEBS J, V275, P867, DOI 10.1111/j.1742-4658.2008.06251.x; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Toyooka S, 2000, BIOCHEM BIOPH RES CO, V278, P671, DOI 10.1006/bbrc.2000.3870; Welbourn S, 2005, J BIOL CHEM, V280, P29604, DOI 10.1074/jbc.M505019200; Welte S, 2005, ANAL BIOCHEM, V338, P32, DOI 10.1016/j.ab.2004.11.047; Wishart MJ, 1998, TRENDS BIOCHEM SCI, V23, P301, DOI 10.1016/S0968-0004(98)01241-9; Wu Gen Sheng, 2003, Methods Mol Biol, V223, P207	33	45	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5105	10.1371/journal.pone.0005105	http://dx.doi.org/10.1371/journal.pone.0005105			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340315	Green Published, gold, Green Submitted			2022-12-25	WOS:000265500700015
J	Thomsen, PF; Elias, S; Gilbert, MTP; Haile, J; Munch, K; Kuzmina, S; Froese, DG; Sher, A; Holdaway, RN; Willerslev, E				Thomsen, Philip Francis; Elias, Scott; Gilbert, M. Thomas P.; Haile, James; Munch, Kasper; Kuzmina, Svetlana; Froese, Duane G.; Sher, Andrei; Holdaway, Richard N.; Willerslev, Eske			Non-Destructive Sampling of Ancient Insect DNA	PLOS ONE			English	Article							MUSEUM SPECIMENS; BONE GELATIN; NEW-ZEALAND; SEQUENCES; ICE; AGE; EXTRACTION; EVOLUTION; SEDIMENTS; DEPOSITS	Background: A major challenge for ancient DNA (aDNA) studies on insect remains is that sampling procedures involve at least partial destruction of the specimens. A recent extraction protocol reveals the possibility of obtaining DNA from past insect remains without causing visual morphological damage. We test the applicability of this protocol on historic museum beetle specimens dating back to AD 1820 and on ancient beetle chitin remains from permafrost (permanently frozen soil) dating back more than 47,000 years. Finally, we test the possibility of obtaining ancient insect DNA directly from non-frozen sediments deposited 3280-1800 years ago - an alternative approach that also does not involve destruction of valuable material. Methodology/Principal Findings: The success of the methodological approaches are tested by PCR and sequencing of COI and 16S mitochondrial DNA (mtDNA) fragments of 77-204 base pairs (-bp) in size using species-specific and general insect primers. Conclusion/Significance: The applied non-destructive DNA extraction method shows promising potential on insect museum specimens of historical age as far back as AD 1820, but less so on the ancient permafrost-preserved insect fossil remains tested, where DNA was obtained from samples up to ca. 26,000 years old. The non-frozen sediment DNA approach appears to have great potential for recording the former presence of insect taxa not normally preserved as macrofossils and opens new frontiers in research on ancient biodiversity.	[Thomsen, Philip Francis; Gilbert, M. Thomas P.; Willerslev, Eske] Univ Copenhagen, Nat Hist Museum, Ctr Ancient Genet & Environm, Copenhagen, Denmark; [Thomsen, Philip Francis; Gilbert, M. Thomas P.; Willerslev, Eske] Univ Copenhagen, Inst Biol, Copenhagen, Denmark; [Elias, Scott] Univ London, Geogr Dept, London WC1E 7HU, England; [Haile, James] Univ Oxford, Henry Wellcome Ancient Biomol Ctr, Dept Zool, Oxford OX1 2JD, England; [Munch, Kasper] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Kuzmina, Svetlana; Froese, Duane G.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2M7, Canada; [Sher, Andrei] Russian Acad Sci, Severtsov Inst Ecol & Evolut, Moscow 117901, Russia; [Holdaway, Richard N.] Palaecol Res Ltd, Christchurch, New Zealand; [Holdaway, Richard N.] Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand	University of Copenhagen; University of Copenhagen; University of London; University of Oxford; University of California System; University of California Berkeley; University of Alberta; Russian Academy of Sciences; Saratov Scientific Center of the Russian Academy of Sciences; Severtsov Institute of Ecology & Evolution; University of Canterbury	Thomsen, PF (corresponding author), Univ Copenhagen, Nat Hist Museum, Ctr Ancient Genet & Environm, Copenhagen, Denmark.	ewillerslev@snm.ku.dk	Thomsen, Philip Francis/AAE-9354-2019; Munch, Kasper/A-1434-2010; Willerslev, Eske/A-9619-2011; Gilbert, Marcus TP/A-8936-2013; Kuzmina, Svetlana/AAN-7520-2021; Willerslev, Eske/AAA-5686-2019	Thomsen, Philip Francis/0000-0002-9867-4366; Munch, Kasper/0000-0003-2880-6252; Willerslev, Eske/0000-0002-7081-6748; Gilbert, Marcus TP/0000-0002-5805-7195; Elias, Scott/0000-0002-1498-1060	Danish National Research Foundation; The Leverhulme Foundation [F/07 537/T]; Natural Science and Engineering Research Council of Canada; Alberta Ingenuity New Faculty Award; New Zealand Foundation for Research, Science and Technology; Marsden Fund of the Royal Society of New Zealand; The Lundbeck Foundation; Arts and Humanities Research Council	Danish National Research Foundation(Danmarks Grundforskningsfond); The Leverhulme Foundation; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Ingenuity New Faculty Award; New Zealand Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology); Marsden Fund of the Royal Society of New Zealand(Royal Society of New ZealandMarsden Fund (NZ)); The Lundbeck Foundation(Lundbeckfonden); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	EW and PFT were supported by the Danish National Research Foundation. SE was supported by The Leverhulme Foundation, F/07 537/T. DGF and SK were supported by grants from the Natural Science and Engineering Research Council of Canada and Alberta Ingenuity New Faculty Award. RNH was supported by New Zealand Foundation for Research, Science and Technology and the Marsden Fund of the Royal Society of New Zealand. KM was supported by The Lundbeck Foundation. JH was supported by the Arts and Humanities Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTIN JJ, 1997, P BIOL SCI, V22, P467; Binladen J, 2006, GENETICS, V172, P733, DOI 10.1534/genetics.105.049718; CANO R J, 1992, Medical Science Research, V20, P619; CANO R J, 1992, Medical Science Research, V20, P249; Chapco W, 2004, MOL PHYLOGENET EVOL, V30, P810, DOI 10.1016/S1055-7903(03)00209-4; DESALLE R, 1992, SCIENCE, V257, P1933, DOI 10.1126/science.1411508; FROGGATT PC, 1990, NEW ZEAL J GEOL GEOP, V33, P89, DOI 10.1080/00288306.1990.10427576; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000272; Goldstein PZ, 2003, MOL ECOL, V12, P1993, DOI 10.1046/j.1365-294X.2003.01860.x; Haile J, 2007, MOL BIOL EVOL, V24, P982, DOI 10.1093/molbev/msm016; Hansen AJ, 2001, MOL BIOL EVOL, V18, P262, DOI 10.1093/oxfordjournals.molbev.a003800; Hansen AJ, 2006, GENETICS, V173, P1175, DOI 10.1534/genetics.106.057349; Harper GL, 2006, BIOL J LINN SOC, V88, P447, DOI 10.1111/j.1095-8312.2006.00632.x; Hartley CJ, 2006, P NATL ACAD SCI USA, V103, P8757, DOI 10.1073/pnas.0509590103; Hebsgaard MB, 2005, TRENDS MICROBIOL, V13, P212, DOI 10.1016/j.tim.2005.03.010; Holdaway RN, 1999, J ROY SOC NEW ZEAL, V29, P185, DOI 10.1080/03014223.1999.9517592; Holdaway RN, 2002, J ROY SOC NEW ZEAL, V32, P463, DOI 10.1080/03014223.2002.9517705; Mandrioli M, 2008, MUS MANAGE CURATOR, V23, P193, DOI 10.1080/09647770802012375; Munch K, 2008, SYST BIOL, V57, P750, DOI 10.1080/10635150802422316; Reiss RA, 2006, QUATERNARY SCI REV, V25, P1877, DOI 10.1016/j.quascirev.2006.01.009; Rohland N, 2004, BIOTECHNIQUES, V36, P814, DOI 10.2144/04365ST05; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Watts PC, 2007, J INSECT CONSERV, V11, P195, DOI 10.1007/s10841-006-9024-y; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Willerslev E, 2004, TRENDS ECOL EVOL, V19, P141, DOI 10.1016/j.tree.2003.11.010; Willerslev E, 2003, SCIENCE, V300, P791, DOI 10.1126/science.1084114; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758	27	85	90	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5048	10.1371/journal.pone.0005048	http://dx.doi.org/10.1371/journal.pone.0005048			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337382	gold, Green Published, Green Submitted			2022-12-25	WOS:000265500600013
J	Bouguermouh, S; Fortin, G; Baba, N; Rubio, M; Sarfati, M				Bouguermouh, Salim; Fortin, Genevieve; Baba, Nobuyasu; Rubio, Manuel; Sarfati, Marika			CD28 Co-Stimulation Down Regulates Th17 Development	PLOS ONE			English	Article								Th17 cells are implicated in host defence and autoimmune diseases. CD28/B7 co-stimulation is involved in the induction and progression of autoimmune diseases, but its role in controlling murine Th17 cell fate remains to be clarified. We here report that soluble anti-CD28 mAb suppressed the differentiation of anti-CD3-stimulated naive CD4(+) T cells into IL-17-producing cells. CD28 co-stimulation reduced the frequency of proliferating cells that produce IL-17. We provide evidence for an IL-2 and IFN-gamma-dependent mechanism of CD28-mediated IL-17 suppression. CD28 blockade of Th17 development was correlated with a decrease rather than an increase in the percentage of Foxp3(+) T cells. In APC/T cell co-cultures, mature dendritic cells (DC) were less efficient than immature DC in their ability to support Th17 cell differentiation, while CTLA4-Ig, an agent blocking CD28/B7 and CTLA4/B7 interactions, facilitated both murine and human Th17 differentiation. This study identifies the importance of B7 co-stimulatory molecules in the negative regulation of Th17 development. These unexpected results caution targeting the CD28/B7 pathways in the treatment of human autoimmune diseases.	[Bouguermouh, Salim; Fortin, Genevieve; Baba, Nobuyasu; Rubio, Manuel; Sarfati, Marika] Univ Montreal, Notre Dame Hosp, CHUM Res Ctr, Immunoregulat Lab, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Bouguermouh, S (corresponding author), Univ Montreal, Notre Dame Hosp, CHUM Res Ctr, Immunoregulat Lab, Montreal, PQ H3C 3J7, Canada.	m.sarfati@umontreal.ca	Baba, Nobuyasu/AAF-8593-2019	Baba, Nobuyasu/0000-0001-9945-080X	Canadian Institute for Health and Research (CIHR) [MOP-53152, Canada Graduate Scholarships Doctoral Award]	Canadian Institute for Health and Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by grant from the Canadian Institute for Health and Research (CIHR Grant, MOP-53152). S.B. is a recipient of the Canadian Institutes for health Research/Canada Graduate Scholarships Doctoral Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams JR, 1999, J CLIN INVEST, V103, P1243, DOI 10.1172/JCI5857; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Amezcua-Guerra LM, 2006, GUT, V55, P1059, DOI 10.1136/gut.2006.095539; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Betti M, 2006, ANN ONCOL, V17, P235; Burchill MA, 2003, INFECT IMMUN, V71, P3437, DOI 10.1128/IAI.71.6.3437-3442.2003; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Egen JG, 2002, NAT IMMUNOL, V3, P611, DOI 10.1038/ni0702-611; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Iliopoulou BP, 2007, J IMMUNOL, V179, P8076, DOI 10.4049/jimmunol.179.12.8076; Jabs C, 2002, EUR J IMMUNOL, V32, P2687, DOI 10.1002/1521-4141(200209)32:9<2687::AID-IMMU2687>3.0.CO;2-1; JENKINS MK, 1991, J IMMUNOL, V147, P2461; Kim G, 2007, J IMMUNOL, V178, P5563, DOI 10.4049/jimmunol.178.9.5563; Kimura A, 2007, P NATL ACAD SCI USA, V104, P12099, DOI 10.1073/pnas.0705268104; KOLLOCH RE, 2004, PERFUSION-GERMANY, V17, P467; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kotloski NJ, 2008, CLIN VACCINE IMMUNOL, V15, P1199, DOI 10.1128/CVI.00129-08; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Lenschow DJ, 1996, IMMUNITY, V5, P285, DOI 10.1016/S1074-7613(00)80323-4; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Lohr J, 2003, NAT IMMUNOL, V4, P664, DOI 10.1038/ni939; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Matusevicius D, 1999, MULT SCLER J, V5, P101, DOI 10.1177/135245859900500206; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Perrin PJ, 1999, CLIN IMMUNOL, V91, P41, DOI 10.1006/clim.1998.4684; Perrin PJ, 1996, J NEUROIMMUNOL, V65, P31, DOI 10.1016/0165-5728(95)00172-7; RACKE MK, 1995, J CLIN INVEST, V96, P2195, DOI 10.1172/JCI118274; Radhakrishnan S, 2008, J IMMUNOL, V181, P3137, DOI 10.4049/jimmunol.181.5.3137; Salomon B, 2001, J EXP MED, V194, P677, DOI 10.1084/jem.194.5.677; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Schraven B, 2008, IMMUNITY, V28, P591, DOI 10.1016/j.immuni.2008.04.003; Sharpe AH, 2006, NEW ENGL J MED, V355, P973, DOI 10.1056/NEJMp068087; Shevach EM, 2006, IMMUNOL REV, V212, P60, DOI 10.1111/j.0105-2896.2006.00415.x; St Clair EW, 2008, J CLIN INVEST, V118, P1344, DOI 10.1172/JCI35382; Steinhaus M, 2008, OSTEOLOGIE, V17, P205; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; Van VQ, 2006, EMBO J, V25, P5560, DOI 10.1038/sj.emboj.7601415; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018; Ziolkowska N, 2000, J IMMUNOL, V164, P2832, DOI 10.4049/jimmunol.164.5.2832	52	82	86	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e5087	10.1371/journal.pone.0005087	http://dx.doi.org/10.1371/journal.pone.0005087			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333372	Green Published, gold, Green Submitted			2022-12-25	WOS:000265499900023
J	Kuiper, JWP; van Horssen, R; Oerlemans, F; Peters, W; van Dommelen, MMT; Lindert, MMT; ten Hagen, TLM; Janssen, E; Fransen, JAM; Wieringa, B				Kuiper, Jan W. P.; van Horssen, Remco; Oerlemans, Frank; Peters, Wilma; van Dommelen, Michiel M. T.; Lindert, Mariska M. te; ten Hagen, Timo L. M.; Janssen, Edwin; Fransen, Jack A. M.; Wieringa, Be			Local ATP Generation by Brain-Type Creatine Kinase (CK-B) Facilitates Cell Motility	PLOS ONE			English	Article								Background: Creatine Kinases (CK) catalyze the reversible transfer of high-energy phosphate groups between ATP and phosphocreatine, thereby playing a storage and distribution role in cellular energetics. Brain-type CK (CK-B) deficiency is coupled to loss of function in neural cell circuits, altered bone-remodeling by osteoclasts and complement-mediated phagocytotic activity of macrophages, processes sharing dependency on actomyosin dynamics. Methodology/Principal Findings: Here, we provide evidence for direct coupling between CK-B and actomyosin activities in cortical microdomains of astrocytes and fibroblasts during spreading and migration. CK-B transiently accumulates in membrane ruffles and ablation of CK-B activity affects spreading and migration performance. Complementation experiments in CK-B-deficient fibroblasts, using new strategies to force protein relocalization from cytosol to cortical sites at membranes, confirmed the contribution of compartmentalized CK-B to cell morphogenetic dynamics. Conclusion/Significance: Our results provide evidence that local cytoskeletal dynamics during cell motility is coupled to on-site availability of ATP generated by CK-B.	[Kuiper, Jan W. P.; van Horssen, Remco; Oerlemans, Frank; Peters, Wilma; van Dommelen, Michiel M. T.; Lindert, Mariska M. te; Janssen, Edwin; Fransen, Jack A. M.; Wieringa, Be] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Cell Biol, NL-6525 ED Nijmegen, Netherlands; [ten Hagen, Timo L. M.] Erasmus MC, Dept Surg Oncol, Rotterdam, Netherlands	Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC	Kuiper, JWP (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Cell Biol, NL-6525 ED Nijmegen, Netherlands.	b.wieringa@ncmls.ru.nl	Fransen, Jack/E-8924-2010; Wieringa, Berend/A-5346-2011	Fransen, Jack/0000-0002-0571-7639; Wieringa, Berend/0000-0001-9192-8020	Dutch Cancer Society [KUN-2002-1763]; Dutch Organization of Scientific Research (NWO-ZON-MW) [901-01-191]	Dutch Cancer Society(KWF Kankerbestrijding); Dutch Organization of Scientific Research (NWO-ZON-MW)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Dutch Cancer Society, Grant KUN-2002-1763 and the Dutch Organization of Scientific Research (NWO-ZON-MW), Grant 901-01-191 (to BW). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ames A, 2000, BRAIN RES REV, V34, P42, DOI 10.1016/S0165-0173(00)00038-2; Beckner ME, 2005, LAB INVEST, V85, P316, DOI 10.1038/labinvest.3700239; Bernstein BW, 2003, J NEUROSCI, V23, P1; Braissant O, 2001, MOL BRAIN RES, V86, P193, DOI 10.1016/S0169-328X(00)00269-2; Castellano F, 1999, CURR BIOL, V9, P351, DOI 10.1016/S0960-9822(99)80161-4; Chang EJ, 2008, NAT MED, V14, P966, DOI 10.1038/nm.1860; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Collavin L, 1999, ONCOGENE, V18, P5879, DOI 10.1038/sj.onc.1202970; Cougoule C, 2004, SEMIN CELL DEV BIOL, V15, P679, DOI 10.1016/j.semcdb.2004.09.001; CRAMER LP, 1995, J CELL BIOL, V131, P179, DOI 10.1083/jcb.131.1.179; Cuppen E, 1999, J CELL SCI, V112, P3299; Cuvelier D, 2007, CURR BIOL, V17, P694, DOI 10.1016/j.cub.2007.02.058; de Groof AJC, 2002, J BIOL CHEM, V277, P5275, DOI 10.1074/jbc.M108157200; de Hoog CL, 2004, CELL, V117, P649, DOI 10.1016/S0092-8674(04)00456-8; de Hoop MJ, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 1, P154; DEKOK YJM, 1995, MOL CELL BIOCHEM, V143, P59, DOI 10.1007/BF00925927; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Dringen R, 1998, J NEUROCHEM, V70, P835; Dzeja PP, 2004, MOL CELL BIOCHEM, V256, P13, DOI 10.1023/B:MCBI.0000009856.23646.38; Fournier HN, 2002, J BIOL CHEM, V277, P20895, DOI 10.1074/jbc.M200200200; Galbraith CG, 2007, SCIENCE, V315, P992, DOI 10.1126/science.1137904; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Haber M, 2006, J NEUROSCI, V26, P8881, DOI 10.1523/JNEUROSCI.1302-06.2006; Hertz L, 2007, J CEREBR BLOOD F MET, V27, P219, DOI 10.1038/sj.jcbfm.9600343; Hirrlinger J, 2004, EUR J NEUROSCI, V20, P2235, DOI 10.1111/j.1460-9568.2004.03689.x; Hornemann T, 2003, J MOL BIOL, V332, P877, DOI 10.1016/S0022-2836(03)00921-5; Huang TY, 2008, DEV CELL, V15, P691, DOI 10.1016/j.devcel.2008.09.017; Janssen E, 2000, EMBO J, V19, P6371, DOI 10.1093/emboj/19.23.6371; Janssen E, 2003, J BIOL CHEM, V278, P30441, DOI 10.1074/jbc.M303150200; Jost CR, 2002, EUR J NEUROSCI, V15, P1692, DOI 10.1046/j.1460-9568.2002.02001.x; Kraft T, 2000, J MUSCLE RES CELL M, V21, P691, DOI 10.1023/A:1005623002979; Kuiper JWP, 2008, PLOS BIOL, V6, P568, DOI 10.1371/journal.pbio.0060051; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Liu L, 2008, ONCOGENE, V27, P4998, DOI 10.1038/onc.2008.137; Mahajan VB, 2000, P NATL ACAD SCI USA, V97, P12062, DOI 10.1073/pnas.97.22.12062; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Michiels F, 2000, METHOD ENZYMOL, V325, P295; MOONEY DJ, 1995, J CELL SCI, V108, P2311; Mulvaney PT, 1998, INT J CANCER, V78, P46, DOI 10.1002/(SICI)1097-0215(19980925)78:1<46::AID-IJC9>3.0.CO;2-X; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Rittling SR, 1996, EXP CELL RES, V229, P7, DOI 10.1006/excr.1996.0337; Schliwa M, 2003, NATURE, V422, P759, DOI 10.1038/nature01601; Schmitz HD, 2002, CELL BIOL INT, V26, P155, DOI 10.1006/cbir.2001.0819; Shin JB, 2007, NEURON, V53, P371, DOI 10.1016/j.neuron.2006.12.021; SISTERMANS EA, 1995, CELL TISSUE RES, V280, P435, DOI 10.1007/s004410050372; Steeghs K, 1997, CELL, V89, P93, DOI 10.1016/S0092-8674(00)80186-5; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Tachikawa M, 2004, EUR J NEUROSCI, V20, P144, DOI 10.1111/j.1460-9568.2004.03478.x; van Horssen R, 2006, J CELL BIOCHEM, V99, P1536, DOI 10.1002/jcb.20994; van Horssen R, 2009, J BIOL CHEM, V284, P1620, DOI 10.1074/jbc.M806974200; Ventura-Clapier R, 2004, MOL CELL BIOCHEM, V256, P29, DOI 10.1023/B:MCBI.0000009857.69730.97; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Wallimann T, 1985, Cell Muscle Motil, V6, P239; Wang YME, 1998, J NEUROSCI, V18, P987; Wojtas K, 1997, MOL BIOL CELL, V8, P1665, DOI 10.1091/mbc.8.9.1665; Zhang HQ, 2004, NAT CELL BIOL, V6, P523, DOI 10.1038/ncb1136	58	43	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e5030	10.1371/journal.pone.0005030	http://dx.doi.org/10.1371/journal.pone.0005030			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333390	gold, Green Published, Green Submitted			2022-12-25	WOS:000265499900011
J	Nguyen, HG; Makitalo, M; Yang, D; Chinnappan, D; Hilaire, CS; Ravid, K				Nguyen, Hao G.; Makitalo, Maria; Yang, Dan; Chinnappan, Dharmaraj; Hilaire, Cynthia St.; Ravid, Katya			Deregulated Aurora-B induced tetraploidy promotes tumorigenesis	FASEB JOURNAL			English	Article						polyploidy; cancer; cell cycle; premature chromatid separation	PREMATURE CHROMATID SEPARATION; MOSAIC VARIEGATED ANEUPLOIDY; MAMMARY EPITHELIAL-CELLS; MITOTIC-SPINDLE CHECKPOINT; GENOMIC INSTABILITY; GROWTH-FACTOR; CHROMOSOMAL INSTABILITY; CANCER; POLYPLOIDY; ANAPHASE	High expression of Aurora-B has been observed in various cancers, and inhibition of this kinase has been shown to halt cellular proliferation. However, the mechanism of effect of Aurora-B on cellular transformation has not been fully explored. Here, we show that overexpression of Aurora-B in murine epithelial cells promotes generation of tetraploids. In search of a related mechanism, spectral karyotyping was carried out, showing premature chromatid separation (PCS). Of interest, PCS is a hallmark of Robert's syndrome, which also involves cellular polyploidy and aneuploidy. Sorted tetraploid Aurora-B-overexpressing cells promoted significant mammary epithelial cancers when injected into nude mice, as compared to injection of nonfractionated cells, suggesting that tetraploidy is an important mediator of Aurora-B-induced tumorigenesis. Comparative chromosome hybridization performed on DNA derived from tetraploid cell-induced tumors indicates amplifications and deletions of regions throughout the genome, which include tumor-promoting or tumor-suppressing genes, respectively. Thus, sustained expression of Aurora-B induces tetraploidy, which, in turn, facilitates genomic instability and tumor development in a xenograft model.-Nguyen, H. G., Makitalo, M., Yang, D., Chinnappan, D., St. Hilaire, C., Ravid, K. Deregulated Aurora-B induced tetraploidy promotes tumorigenesis. FASEB J. 23, 2741-2748 ( 2009)	[Ravid, Katya] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Boston University; Boston University	Ravid, K (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.	kravid@bu.edu	St. Hilaire, Cynthia/R-8205-2017; St. Hilaire, Cynthia/I-4713-2014	St. Hilaire, Cynthia/0000-0003-1871-6915; Nguyen, Hao/0000-0001-8275-5375; Ravid, Katya/0000-0002-9918-3024	National Cancer Institute seed funds to Boston University School of Medicine Cancer Center	National Cancer Institute seed funds to Boston University School of Medicine Cancer Center	This work was supported by National Cancer Institute seed funds to Boston University School of Medicine Cancer Center.	COLTRERA MD, 1995, CANCER RES, V55, P2703; Dai J, 2006, DEV CELL, V11, P741, DOI 10.1016/j.devcel.2006.09.018; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Dikovskaya D, 2007, J CELL BIOL, V176, P183, DOI 10.1083/jcb.200610099; Duesberg P, 2006, CONTRIB MICROBIOL, V13, P16, DOI 10.1159/000092963; Egler RA, 2005, ONCOGENE, V24, P8038, DOI 10.1038/sj.onc.1208821; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Furuta J, 2006, CANCER RES, V66, P6080, DOI 10.1158/0008-5472.CAN-06-0157; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; GERMAN J, 1979, CLIN GENET, V16, P441; Giet R, 2005, TRENDS CELL BIOL, V15, P241, DOI 10.1016/j.tcb.2005.03.004; Gimenez-Abian JF, 2004, CURR BIOL, V14, P1187, DOI 10.1016/j.cub.2004.06.052; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802; Jeon S, 2005, J NEUROCHEM, V95, P1608, DOI 10.1111/j.1471-4159.2005.03505.x; Kaitna S, 2002, CURR BIOL, V12, P798, DOI 10.1016/S0960-9822(02)00820-5; Kajii T, 1998, AM J MED GENET, V78, P245, DOI 10.1002/(SICI)1096-8628(19980707)78:3<245::AID-AJMG7>3.0.CO;2-O; Kajii T, 2001, AM J MED GENET, V104, P57, DOI 10.1002/ajmg.1580; Katayama Hiroshi, 2003, Cancer and Metastasis Reviews, V22, P451, DOI 10.1023/A:1023789416385; Kienitz A, 2005, ONCOGENE, V24, P4301, DOI 10.1038/sj.onc.1208589; Kimmins S, 2007, MOL ENDOCRINOL, V21, P726, DOI 10.1210/me.2006-0332; Klominek J, 1998, CLIN EXP METASTAS, V16, P529, DOI 10.1023/A:1006542301794; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Knippschild U, 2005, ONKOLOGIE, V28, P508, DOI 10.1159/000087137; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Li YJ, 2007, P NATL ACAD SCI USA, V104, P3490, DOI 10.1073/pnas.0610163104; Margolis RL, 2005, CANCER CELL, V8, P353, DOI 10.1016/j.ccr.2005.10.017; Matsuura S, 2000, AM J HUM GENET, V67, P483, DOI 10.1086/303022; Matsuura S, 2006, AM J MED GENET A, V140A, P358, DOI 10.1002/ajmg.a.31069; Mazzoni E, 2003, MOL CANCER RES, V1, P776; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Minoshima Y, 2005, MOL CELL BIOL, V25, P10315, DOI 10.1128/MCB.25.23.10315-10328.2005; Nguyen HG, 2006, J CELL PHYSIOL, V208, P12, DOI 10.1002/jcp.20565; Nguyen HG, 2005, MOL CELL BIOL, V25, P4977, DOI 10.1128/MCB.25.12.4977-4992.2005; Olaharski AJ, 2006, CARCINOGENESIS, V27, P337, DOI 10.1093/carcin/bgi218; Orr B, 2007, MOL BIOL CELL, V18, P850, DOI 10.1091/mbc.E06-07-0587; Rao CV, 2005, P NATL ACAD SCI USA, V102, P4365, DOI 10.1073/pnas.0407822102; Ravid K, 2002, J CELL PHYSIOL, V190, P7, DOI 10.1002/jcp.10035; Resnick TD, 2006, DEV CELL, V11, P57, DOI 10.1016/j.devcel.2006.04.021; SALOMON DS, 1987, J CELL PHYSIOL, V130, P397, DOI 10.1002/jcp.1041300313; Schlegel BP, 2003, ONCOGENE, V22, P983, DOI 10.1038/sj.onc.1206195; Sharpless NE, 2002, CELL, V110, P9, DOI 10.1016/S0092-8674(02)00818-8; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; VOGELSTEIN B, 1992, CELL, V70, P523, DOI 10.1016/0092-8674(92)90421-8; Wang XX, 2005, EXP CELL RES, V310, P1, DOI 10.1016/j.yexcr.2005.07.018; Zhang Y, 2004, BLOOD, V103, P3717, DOI 10.1182/blood-2003-09-3365; Zimmet J, 2000, EXP HEMATOL, V28, P3, DOI 10.1016/S0301-472X(99)00124-1	53	75	76	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2741	2748		10.1096/fj.09-130963	http://dx.doi.org/10.1096/fj.09-130963			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19332642	Green Published			2022-12-25	WOS:000268836700042
J	Tripathi, G; Salih, DAM; Drozd, AC; Cosgrove, RA; Cobb, LJ; Pell, JM				Tripathi, Gyanendra; Salih, Dervis A. M.; Drozd, Anja C.; Cosgrove, Ruth A.; Cobb, Laura J.; Pell, Jennifer M.			IGF-independent effects of insulin-like growth factor binding protein-5 (Igfbp5) in vivo	FASEB JOURNAL			English	Article						muscle; transgenic	BREAST-CANCER CELLS; TRANSGENIC MICE; TERMINAL DOMAINS; PROSTATE-CANCER; SMOOTH-MUSCLE; AMINO-ACIDS; RECEPTOR; INSULIN-LIKE-GROWTH-FACTOR-BINDING-PROTEIN-5; DIFFERENTIATION; EXPRESSION	IGF activity is regulated tightly by a family of IGF binding proteins (IGFBPs). IGFBP-5 is the most conserved of these and is up-regulated significantly during differentiation of several key lineages and in some cancers. The function of IGFBP-5 in these physiological and pathological situations is unclear, however, several IGFBP-5 sequence motifs and studies in vitro suggest IGF-independent actions. Therefore, we aimed to compare the phenotypes of mice overexpressing wild-type Igfbp5 or an N-terminal mutant Igfbp5 with negligible IGF binding affinity. Both significantly inhibited growth, even at low expression levels. Even though wild-type IGFBP-5 severely disrupted the IGF axis, we found no evidence for interaction of mutant IGFBP-5 with the IGF system. Further, overexpression of wildtype IGFBP-5 rescued the lethal phenotype induced by "excess" IGF-II in type 2 receptor-null mice; mutant IGFBP-5 overexpression could not. Therefore, wildtype IGFBP-5 provides a very effective mechanism for the inhibition of IGF activity and a powerful in vivo mechanism to inhibit IGF activity in pathologies such as cancer. This study is also the first to suggest significant IGF-independent actions for IGFBP-5 during development.-Tripathi, G., Salih, D. A. M., Drozd, A. C., Cosgrove, R. A., Cobb, L. J., Pell, J. M. IGF-independent effects of insulin-like growth factor binding protein-5 ( Igfbp5) in vivo. FASEB J. 23, 2616-2626 ( 2009)	[Tripathi, Gyanendra; Salih, Dervis A. M.; Drozd, Anja C.; Cosgrove, Ruth A.; Cobb, Laura J.; Pell, Jennifer M.] Babraham Inst, Mol Signalling Lab, Cambridge CB22 3AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Pell, JM (corresponding author), Babraham Inst, Mol Signalling Lab, Cambridge CB22 3AT, England.	jenny.pell@bbsrc.ac.uk	Tripathi, Gyanendra/C-8832-2011	Tripathi, Gyanendra/0000-0001-6889-706X; Salih, Dervis/0000-0001-7651-8998	Biotechnology and Biological Sciences Research Council via a competitive strategic grant to The Babraham Institute [202/S15716]	Biotechnology and Biological Sciences Research Council via a competitive strategic grant to The Babraham Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank The Babraham Institute Gene Targeting Facility/Small Animal Barrier Unit, Simon Walker from the Imaging Facility, and Anne Segonds-Pichon from Babraham Bioinformatics for their expert skills. This work was funded by the Biotechnology and Biological Sciences Research Council via a competitive strategic grant to The Babraham Institute and a responsive mode grant (202/S15716) to J.M.P.	Amaar YG, 2002, J BIOL CHEM, V277, P12053, DOI 10.1074/jbc.M110872200; Andress DL, 1998, AM J PHYSIOL-ENDOC M, V274, pE744, DOI 10.1152/ajpendo.1998.274.4.E744; Baserga R, 2003, INT J CANCER, V107, P873, DOI 10.1002/ijc.11487; Baxter RC, 2002, J CLIN ENDOCR METAB, V87, P271, DOI 10.1210/jc.87.1.271; Butt AJ, 2003, J BIOL CHEM, V278, P29676, DOI 10.1074/jbc.M301965200; Chan JM, 2002, J NATL CANCER I, V94, P1099; Clemmons D. R., 1995, Progress in Growth Factor Research, V6, P357, DOI 10.1016/0955-2235(95)00013-5; Cobb LJ, 2004, J CELL SCI, V117, P1737, DOI 10.1242/jcs.01028; Fernandez AM, 2002, J CLIN INVEST, V109, P347, DOI 10.1172/JCI200213503; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; Gonzalez I, 2004, MOL CELL BIOL, V24, P3607, DOI 10.1128/MCB.24.9.3607-3622.2004; GREEN BN, 1994, ENDOCRINOLOGY, V134, P954, DOI 10.1210/en.134.2.954; Imai Y, 2000, J BIOL CHEM, V275, P18188, DOI 10.1074/jbc.M000070200; Ishibashi J, 2005, J CELL BIOL, V171, P471, DOI 10.1083/jcb.200502101; James PL, 1996, J CELL BIOL, V133, P683, DOI 10.1083/jcb.133.3.683; Kawarabayashi T, 1996, NEUROBIOL AGING, V17, P215, DOI 10.1016/0197-4580(95)02061-6; Khan J, 1999, P NATL ACAD SCI USA, V96, P13264, DOI 10.1073/pnas.96.23.13264; Kuemmerle JF, 2002, J BIOL CHEM, V277, P20563, DOI 10.1074/jbc.M200885200; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; Leu JI, 2003, MOL CELL BIOL, V23, P1251, DOI 10.1128/MCB.23.4.1251-1259.2003; Li XQ, 2007, CANCER SCI, V98, P1592, DOI 10.1111/j.1349-7006.2007.00565.x; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Ludwig T, 1996, DEV BIOL, V177, P517, DOI 10.1006/dbio.1996.0182; Marshman E, 2003, J CELL SCI, V116, P675, DOI 10.1242/jcs.00263; Miyake H, 2000, CANCER RES, V60, P3058; Miyakoshi N, 2001, J CLIN INVEST, V107, P73, DOI 10.1172/JCI10459; Modric T, 2001, ENDOCRINOLOGY, V142, P1958, DOI 10.1210/en.142.5.1958; Ning Y, 2007, ENDOCRINOLOGY, V148, P2138, DOI 10.1210/en.2006-0041; Ning Y, 2006, MOL ENDOCRINOL, V20, P2173, DOI 10.1210/me.2005-0196; Parker A, 1996, J BIOL CHEM, V271, P13523, DOI 10.1074/jbc.271.23.13523; Perks CM, 2002, BIOCHEM BIOPH RES CO, V294, P995, DOI 10.1016/S0006-291X(02)00570-3; Perks CM, 2000, J CELL BIOCHEM, V80, P248; Salih DAM, 2004, P NATL ACAD SCI USA, V101, P4314, DOI 10.1073/pnas.0400230101; Schedlich LJ, 1998, J BIOL CHEM, V273, P18347, DOI 10.1074/jbc.273.29.18347; Schedlich LJ, 2007, MOL ENDOCRINOL, V21, P2378, DOI 10.1210/me.2006-0558; Shand JH, 2003, J BIOL CHEM, V278, P17859, DOI 10.1074/jbc.M300526200; Silha JV, 2006, ENDOCRINOLOGY, V147, P2112, DOI 10.1210/en.2005-1270; Silha JV, 2005, ENDOCRINOLOGY, V146, P1523, DOI 10.1210/en.2004-0905; Sorrell AM, 2006, J BIOL CHEM, V281, P10883, DOI 10.1074/jbc.M508505200; Stolf BS, 2003, CANCER LETT, V191, P193, DOI 10.1016/S0304-3835(02)00679-1; Tanno B, 2005, CELL DEATH DIFFER, V12, P213, DOI 10.1038/sj.cdd.4401546; Tonner E, 2002, DEVELOPMENT, V129, P4547; Tsibris JCM, 2002, FERTIL STERIL, V78, P114, DOI 10.1016/S0015-0282(02)03191-6; Wilson EM, 2004, MOL BIOL CELL, V15, P497, DOI 10.1091/mbc.E03-05-0351; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; Xu QJ, 2004, CIRC RES, V94, pE46, DOI 10.1161/01.RES.0000124761.62846.DF; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Yin P, 2004, J BIOL CHEM, V279, P32660, DOI 10.1074/jbc.M401378200; Zeslawski W, 2001, EMBO J, V20, P3638, DOI 10.1093/emboj/20.14.3638; Zhao Y, 2006, J BIOL CHEM, V281, P14184, DOI 10.1074/jbc.M506941200	50	55	56	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2616	2626		10.1096/fj.08-114124	http://dx.doi.org/10.1096/fj.08-114124			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19332648				2022-12-25	WOS:000268836700030
J	Yang, HB; Xiang, J; Wang, ND; Zhao, Y; Hyman, J; Li, S; Jiang, J; Chen, JK; Yang, Z; Lin, S				Yang, Hongbo; Xiang, Jing; Wang, Nengdong; Zhao, Yun; Hyman, Joel; Li, Song; Jiang, Jin; Chen, James K.; Yang, Zhen; Lin, Shuo			Converse Conformational Control of Smoothened Activity by Structurally Related Small Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEDGEHOG SIGNALING PATHWAY; BASAL-CELL CARCINOMA; SONIC HEDGEHOG; HUMAN HOMOLOG; BRAIN-TUMORS; FLOOR PLATE; MEDULLOBLASTOMA; INHIBITION; PROLIFERATION; CYCLOPAMINE	The seven-pass transmembrane protein Smoothened (Smo) is an essential component of the Hedgehog (Hh) signaling pathway that is critically involved in normal animal development as well as pathological malignancies. In studying Hh-related biological processes, it would be highly desirable if Smo activity could be instantly switched between activation and inhibition. Using Gli1-dependent GFP transgenic zebrafish and in vitro biochemical assays, we identified and characterized two potent Smo inhibitors, SANT74 and 75 (Smoothened antagonist 74 and 75), by screening a small molecule library designed based on the scaffold of Smo agonist SAG. These compounds are structural analogs of SAG with the methyl group substituted by a propyl or allyl group in SANTs. We show that SANTs and SAG exert opposite effects on Smo activity by regulating protein conformation. Our study represents the first demonstration of conformational regulation of Smo by small molecule analogs, and the combinational use of these Smo modulators in a temporal controlled fashion should be useful for studying Hh biology.	[Yang, Hongbo; Xiang, Jing; Yang, Zhen; Lin, Shuo] Peking Univ, Shenzhen Grad Sch, Lab Chem Genom, Shenzhen 518055, Peoples R China; [Yang, Hongbo; Lin, Shuo] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Xiang, Jing; Wang, Nengdong; Yang, Zhen] Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Zhao, Yun] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Zhao, Yun] Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Hyman, Joel; Jiang, Jin; Chen, James K.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Li, Song] Shenzhen Shengjie Biotech Co Ltd, Shenzhen 518055, Peoples R China; [Lin, Shuo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	Peking University; University Town of Shenzhen; Peking University; Peking University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Stanford University; University of California System; University of California Los Angeles	Yang, Z (corresponding author), Peking Univ, Shenzhen Grad Sch, Lab Chem Genom, Shenzhen 518055, Peoples R China.	zyang@pku.edu.cn; shuolin@ucla.edu	Yang, Zhen/J-6306-2015; Chen, James/G-9972-2011	Yang, Zhen/0000-0001-8036-934X; Chen, James/0000-0002-9220-8436	National Science Foundation of China [20325208, 20225318, 20521202, 20672004]; Ministry of Education of China Program 985; Shenzhen Science and Technology Key Laboratory Promotion Fund; Instrumental Analysis Fund of Peking University; Sidney Kimmel Foundation for Cancer Research; Astellas USA Foundation; Brain Tumor Society/ Rachel Molly Markoff Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061269, R01GM067045] Funding Source: NIH RePORTER	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China Program 985; Shenzhen Science and Technology Key Laboratory Promotion Fund; Instrumental Analysis Fund of Peking University; Sidney Kimmel Foundation for Cancer Research; Astellas USA Foundation(Astellas Pharmaceuticals); Brain Tumor Society/ Rachel Molly Markoff Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation of China Grants 20325208, 20225318, 20521202, and 20672004, Ministry of Education of China Program 985, the Shenzhen Science and Technology Key Laboratory Promotion Fund, the Instrumental Analysis Fund of Peking University, and funds from the Sidney Kimmel Foundation for Cancer Research (to J.K.C.), the Astellas USA Foundation (to J.K.C.), and the Brain Tumor Society/ Rachel Molly Markoff Foundation (to J.K.C.).	Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Corcoran RB, 2006, P NATL ACAD SCI USA, V103, P8408, DOI 10.1073/pnas.0602852103; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Dwyer JR, 2007, J BIOL CHEM, V282, P8959, DOI 10.1074/jbc.M611741200; FISCHER J, 2006, ANALOGUE BASED DRUG, pR31; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; Geng Ling, 2007, Angiogenesis, V10, P259, DOI 10.1007/s10456-007-9078-9; Gering M, 2005, DEV CELL, V8, P389, DOI 10.1016/j.devcel.2005.01.010; Hahn H, 1999, J MOL MED-JMM, V77, P459, DOI 10.1007/s001099900018; Jacob L, 2007, SCIENCE, V318, P66, DOI 10.1126/science.1147314; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Lee J, 2007, CHEMBIOCHEM, V8, P1916, DOI 10.1002/cbic.200700403; Lee Y, 2003, CANCER RES, V63, P5428; Nagase M, 2006, MICROVASC RES, V71, P85, DOI 10.1016/j.mvr.2005.11.006; Pepicelli CV, 1998, CURR BIOL, V8, P1083, DOI 10.1016/S0960-9822(98)70446-4; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; Rohatgi R, 2007, NAT CELL BIOL, V9, P1005, DOI 10.1038/ncb435; Romer JT, 2004, CANCER CELL, V6, P229, DOI 10.1016/j.ccr.2004.08.019; Sanchez P, 2005, MECH DEVELOP, V122, P223, DOI 10.1016/j.mod.2004.10.002; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Tas S, 2004, EUR J DERMATOL, V14, P96; Tostar U, 2006, J PATHOL, V208, P17, DOI 10.1002/path.1882; Wang ND, 2008, J COMB CHEM, V10, P825, DOI 10.1021/cc800025n; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Williams JA, 2003, P NATL ACAD SCI USA, V100, P4616, DOI 10.1073/pnas.0732813100; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Zhao Y, 2007, NATURE, V450, P252, DOI 10.1038/nature06225	36	49	56	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20876	20884		10.1074/jbc.M807648200	http://dx.doi.org/10.1074/jbc.M807648200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19366682	Green Published, hybrid			2022-12-25	WOS:000268316100051
J	Siu, KL; Kok, KH; Ng, MHJ; Poon, VKM; Yuen, KY; Zheng, BJ; Jin, DY				Siu, Kam-Leung; Kok, Kin-Hang; Ng, Ming-Him James; Poon, Vincent K. M.; Yuen, Kwok-Yung; Zheng, Bo-Jian; Jin, Dong-Yan			Severe Acute Respiratory Syndrome Coronavirus M Protein Inhibits Type I Interferon Production by Impeding the Formation of TRAF3 center dot TANK center dot TBK1/IKK epsilon Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLUENZA-A-VIRUS; HOST GENE-EXPRESSION; NF-KAPPA-B; MEMBRANE-PROTEIN; RIG-I; ANTIVIRAL RESPONSES; SARS-CORONAVIRUS; NS1 PROTEIN; INNATE IMMUNITY; ACTIVATION	Severe acute respiratory syndrome (SARS) coronavirus is highly pathogenic in humans and evades innate immunity at multiple levels. It has evolved various strategies to counteract the production and action of type I interferons, which mobilize the front-line defense against viral infection. In this study we demonstrate that SARS coronavirus M protein inhibits gene transcription of type I interferons. M protein potently antagonizes the activation of interferon-stimulated response element-dependent transcription by double-stranded RNA, RIG-I, MDA5, TBK1, IKK epsilon, and virus-induced signaling adaptor (VISA) but has no influence on the transcriptional activity of this element when IRF3 or IRF7 is overexpressed. M protein physically associates with RIG-I, TBK1, IKK epsilon, and TRAF3 and likely sequesters some of them in membrane-associated cytoplasmic compartments. Consequently, the expression of M protein prevents the formation of TRAF3 center dot TANK center dot TBK1/IKK epsilon complex and thereby inhibits TBK1/IKK epsilon-dependent activation of IRF3/IRF7 transcription factors. Taken together, our findings reveal a new mechanism by which SARS coronavirus circumvents the production of type I interferons.	[Siu, Kam-Leung; Kok, Kin-Hang; Ng, Ming-Him James; Jin, Dong-Yan] Univ Hong Kong, Dept Biochem, Pokfulam, Hong Kong, Peoples R China; [Poon, Vincent K. M.; Yuen, Kwok-Yung; Zheng, Bo-Jian] Univ Hong Kong, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Jin, DY (corresponding author), Univ Hong Kong, Dept Biochem, 21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	dyjin@hkucc.hku.hk	Kok, Kin-Hang/C-4184-2009	Yuen, Kwok-yung/0000-0002-2083-1552; Poon, Vincent kwok-man/0000-0002-7737-8912	Research Fund for the Control of Infectious Disease [04050052]; Research Council of Hong Kong Food and Health Bureau	Research Fund for the Control of Infectious Disease; Research Council of Hong Kong Food and Health Bureau	This work was supported by the Research Fund for the Control of Infectious Disease (Project 04050052) from the Research Council of Hong Kong Food and Health Bureau.	Alff PJ, 2008, J VIROL, V82, P9115, DOI 10.1128/JVI.00290-08; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Chan CM, 2007, ARCH BIOCHEM BIOPHYS, V459, P197, DOI 10.1016/j.abb.2007.01.012; Chan CP, 2006, J VIROL, V80, P9279, DOI 10.1128/JVI.00659-06; Cheng VCC, 2007, CLIN MICROBIOL REV, V20, P660, DOI 10.1128/CMR.00023-07; Chin KT, 2007, CANCER RES, V67, P1072, DOI 10.1158/0008-5472.CAN-06-3053; Ching YP, 2006, NAT CELL BIOL, V8, P717, DOI 10.1038/ncb1432; Choy EYW, 2008, J EXP MED, V205, P2551, DOI 10.1084/jem.20072581; Devaraj SG, 2007, J BIOL CHEM, V282, P32208, DOI 10.1074/jbc.M704870200; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Fang XN, 2007, J MED VIROL, V79, P1431, DOI 10.1002/jmv.20953; Frieman M, 2008, MICROBIOL MOL BIOL R, V72, P672, DOI 10.1128/MMBR.00015-08; Frieman M, 2007, J VIROL, V81, P9812, DOI 10.1128/JVI.01012-07; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hatakeyama S, 2008, VIROLOGY, V380, P99, DOI 10.1016/j.virol.2008.07.012; He LS, 2006, J BIOL CHEM, V281, P11235, DOI 10.1074/jbc.M508779200; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Hussain S, 2008, J VIROL, V82, P7212, DOI 10.1128/JVI.02406-07; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Kamitani W, 2006, P NATL ACAD SCI USA, V103, P12885, DOI 10.1073/pnas.0603144103; Kok KH, 2006, J GEN VIROL, V87, P2639, DOI 10.1099/vir.0.81764-0; Kopecky-Bromberg SA, 2007, J VIROL, V81, P548, DOI 10.1128/JVI.01782-06; LAUDE H, 1992, J VIROL, V66, P743, DOI 10.1128/JVI.66.2.743-749.1992; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Ma HC, 2008, J BIOMED SCI, V15, P301, DOI 10.1007/s11373-008-9235-1; Masters PS, 2006, ADV VIRUS RES, V66, P193, DOI 10.1016/S0065-3527(06)66005-3; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nal B, 2005, J GEN VIROL, V86, P1423, DOI 10.1099/vir.0.80671-0; Narayananj K, 2008, J VIROL, V82, P4471, DOI 10.1128/JVI.02472-07; Netland J, 2007, J VIROL, V81, P11520, DOI 10.1128/JVI.01308-07; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Oostra M, 2006, J VIROL, V80, P2326, DOI 10.1128/JVI.80.5.2326-2336.2006; Opitz B, 2007, CELL MICROBIOL, V9, P930, DOI 10.1111/j.1462-5822.2006.00841.x; Pacciarini F, 2008, J VIROL, V82, P5137, DOI 10.1128/JVI.00096-08; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Prins KC, 2009, J VIROL, V83, P3069, DOI 10.1128/JVI.01875-08; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Schafer SL, 1998, J BIOL CHEM, V273, P2714, DOI 10.1074/jbc.273.5.2714; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; SIU KL, 2009, J GEN VIROL IN PRESS; Siu YL, 2008, J VIROL, V82, P11318, DOI 10.1128/JVI.01052-08; Siu YT, 2008, MOL BIOL CELL, V19, P4750, DOI 10.1091/mbc.E08-04-0369; Siu YT, 2006, J VIROL, V80, P7052, DOI 10.1128/JVI.00103-06; Soulat D, 2008, EMBO J, V27, P2135, DOI 10.1038/emboj.2008.126; Tan YJ, 2007, CELL MICROBIOL, V9, P2552, DOI 10.1111/j.1462-5822.2007.01034.x; Thiel V, 2008, CYTOKINE GROWTH F R, V19, P121, DOI 10.1016/j.cytogfr.2008.01.001; Wathelet MG, 2007, J VIROL, V81, P11620, DOI 10.1128/JVI.00702-07; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2007, J BIOL CHEM, V282, P15315, DOI 10.1074/jbc.R700007200; Zhang LW, 2000, J VIROL, V74, P1061, DOI 10.1128/JVI.74.3.1061-1068.2000; Zust R, 2007, PLOS PATHOG, V3, P1062, DOI 10.1371/journal.ppat.0030109	59	223	240	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16202	16209		10.1074/jbc.M109.008227	http://dx.doi.org/10.1074/jbc.M109.008227			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19380580	Green Published, hybrid			2022-12-25	WOS:000266730900017
J	Dowen, RH; Engel, JL; Shao, F; Ecker, JR; Dixon, JE				Dowen, Robert H.; Engel, James L.; Shao, Feng; Ecker, Joseph R.; Dixon, Jack E.			A Family of Bacterial Cysteine Protease Type III Effectors Utilizes Acylation-dependent and -independent Strategies to Localize to Plasma Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANT IMMUNE-SYSTEM; SYRINGAE PV PHASEOLICOLA; DISEASE RESISTANCE GENE; PSEUDOMONAS-SYRINGAE; N-MYRISTOYLATION; INNATE IMMUNITY; TOMATO DC3000; ARABIDOPSIS-THALIANA; SIGNAL-TRANSDUCTION; AVIRULENCE GENES	Bacterial phytopathogens employ a type III secretion system to deliver effector proteins into the plant cell to suppress defense pathways; however, the molecular mechanisms and subcellular localization strategies that drive effector function largely remain a mystery. Here, we demonstrate that the plant plasma membrane is the primary site for subcellular localization of the Pseudomonas syringae effector AvrPphB and five additional cysteine protease family members. AvrPphB and two AvrPphB-like effectors, ORF4 and NopT, autoproteolytically process following delivery into the plant cell to expose embedded sites for fatty acylation. Host-dependent lipidation of these three effectors directs plasma membrane localization and is required for the avirulence activity of AvrPphB. Surprisingly, the AvrPphB-like effectors RipT, HopC1, and HopN1 utilize an acylation-independent mechanism to localize to the cellular plasma membrane. Although some AvrPphB-like effectors employ acylation-independent localization strategies, others hijack the eukaryotic lipidation machinery to ensure plasma membrane localization, illustrating the diverse tactics employed by type III effectors to target specific subcellular compartments.	[Ecker, Joseph R.] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Dowen, Robert H.; Engel, James L.; Shao, Feng; Dixon, Jack E.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Dowen, Robert H.; Engel, James L.; Shao, Feng; Dixon, Jack E.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Dowen, Robert H.; Engel, James L.; Shao, Feng; Dixon, Jack E.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Dowen, Robert H.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Dixon, Jack E.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Ecker, JR (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.	ecker@salk.edu; jedixon@ucsd.edu	Ecker, Joseph R/B-9144-2008	Ecker, Joseph R/0000-0001-5799-5895	National Institutes of Health [AI060662]; Pharmacology Training [2 T32 GM07752-25]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pharmacology Training; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI060662 ( to J.E.D.) and Pharmacology Training Grant 2 T32 GM07752-25 ( to R. H. D.).	Ade J, 2007, P NATL ACAD SCI USA, V104, P2531, DOI 10.1073/pnas.0608779104; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BERTHIAUME L, 1995, J BIOL CHEM, V270, P22399, DOI 10.1074/jbc.270.38.22399; BISGROVE SR, 1994, PLANT CELL, V6, P927, DOI 10.1105/tpc.6.7.927; Bologna G, 2004, PROTEOMICS, V4, P1626, DOI 10.1002/pmic.200300783; Chang JH, 2005, P NATL ACAD SCI USA, V102, P2549, DOI 10.1073/pnas.0409660102; Coaker G, 2005, SCIENCE, V308, P548, DOI 10.1126/science.1108633; Dai WJ, 2008, J BACTERIOL, V190, P5101, DOI 10.1128/JB.00306-08; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Dodds PN, 2006, P NATL ACAD SCI USA, V103, P8888, DOI 10.1073/pnas.0602577103; Dunphy JT, 1996, J BIOL CHEM, V271, P7154, DOI 10.1074/jbc.271.12.7154; Glover CJ, 1997, J BIOL CHEM, V272, P28680, DOI 10.1074/jbc.272.45.28680; Guttman DS, 2002, SCIENCE, V295, P1722, DOI 10.1126/science.295.5560.1722; Holt BF, 2005, SCIENCE, V309, P929, DOI 10.1126/science.1109977; HUYNH TV, 1989, SCIENCE, V245, P1374, DOI 10.1126/science.2781284; Jamir Y, 2004, PLANT J, V37, P554, DOI 10.1046/j.1365-313X.2003.01982.x; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Lewis JD, 2008, J BACTERIOL, V190, P2880, DOI 10.1128/JB.01702-07; Lopez-Solanilla E, 2004, MOL MICROBIOL, V54, P353, DOI 10.1111/j.1365-2958.2004.04285.x; Mackey D, 2006, MOL MICROBIOL, V61, P1365, DOI 10.1111/j.1365-2958.2006.05311.x; Maurer-Stroh S, 2004, TRENDS MICROBIOL, V12, P178, DOI 10.1016/j.tim.2004.02.006; Nimchuk Z, 2000, CELL, V101, P353, DOI 10.1016/S0092-8674(00)80846-6; Nimchuk Z, 2003, ANNU REV GENET, V37, P579, DOI 10.1146/annurev.genet.37.110801.142628; Nobuta K, 2007, PLANT PHYSIOL, V144, P1144, DOI [10.1104/pp.107.097691, 10.1104/PP.107.097691]; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; PERRET X, 1991, P NATL ACAD SCI USA, V88, P1923, DOI 10.1073/pnas.88.5.1923; Petnicki-Ocwieja T, 2002, P NATL ACAD SCI USA, V99, P7652, DOI 10.1073/pnas.112183899; Podell S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-37; Puri N, 1997, MOL PLANT MICROBE IN, V10, P247, DOI 10.1094/MPMI.1997.10.2.247; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Robert-Seilaniantz A, 2006, MOL PLANT MICROBE IN, V19, P130, DOI 10.1094/MPMI-19-0130; Roine E, 1997, P NATL ACAD SCI USA, V94, P3459, DOI 10.1073/pnas.94.7.3459; Scheel D, 1998, CURR OPIN PLANT BIOL, V1, P305, DOI 10.1016/1369-5266(88)80051-7; Shan LB, 2000, PLANT CELL, V12, P2323, DOI 10.1105/tpc.12.12.2323; Shan LB, 2008, CELL HOST MICROBE, V4, P17, DOI 10.1016/j.chom.2008.05.017; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; SIMONICH MT, 1995, MOL PLANT MICROBE IN, V8, P637, DOI 10.1094/MPMI-8-0637; Song JP, 1996, J BIOL CHEM, V271, P20273, DOI 10.1074/jbc.271.34.20273; Tampakaki AP, 2002, MOL PLANT MICROBE IN, V15, P292, DOI 10.1094/MPMI.2002.15.3.292; Thieme F, 2007, MOL PLANT MICROBE IN, V20, P1250, DOI 10.1094/MPMI-20-10-1250; Tornero P, 2001, PLANT J, V28, P475, DOI 10.1046/j.1365-313X.2001.01136.x; Utsumi T, 2001, J BIOL CHEM, V276, P10505, DOI 10.1074/jbc.M006134200; Wang XL, 2005, DEV CELL, V8, P855, DOI 10.1016/j.devcel.2005.05.001; Warren RF, 1999, GENETICS, V152, P401; Xiang TT, 2008, CURR BIOL, V18, P74, DOI 10.1016/j.cub.2007.12.020; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761; Zhu MF, 2004, P NATL ACAD SCI USA, V101, P302, DOI 10.1073/pnas.2036536100	50	75	75	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15867	15879		10.1074/jbc.M900519200	http://dx.doi.org/10.1074/jbc.M900519200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19346252	Green Published, hybrid			2022-12-25	WOS:000266501000055
J	Royer, MC; Lemaire-Ewing, S; Desrumaux, C; Monier, S; de Barros, JPP; Athias, A; Neel, D; Lagrost, L				Royer, Marie-Charlotte; Lemaire-Ewing, Stephanie; Desrumaux, Catherine; Monier, Serge; de Barros, Jean-Paul Pais; Athias, Anne; Neel, Dominique; Lagrost, Laurent			7-Ketocholesterol Incorporation into Sphingolipid/Cholesterol-enriched (Lipid Raft) Domains Is Impaired by Vitamin E A SPECIFIC ROLE FOR alpha-TOCOPHEROL WITH CONSEQUENCES ON CELL DEATH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; INDUCED APOPTOSIS; GAMMA-TOCOPHEROL; PHOSPHORYLATION; CHROMATOGRAPHY; TRANSDUCTION; ANTIOXIDANT; RECRUITMENT; INVOLVEMENT; ACTIVATION	Cholesterol oxides, in particular 7-ketocholesterol, are proatherogenic compounds that induce cell death in the vascular wall when localized in lipid raft domains of the cell membrane. Deleterious effects of 7-ketocholesterol can be prevented by vitamin E, but the molecular mechanism involved is unclear. In this study, unlike gamma-tocopherol, the alpha-tocopherol vitamin E form was found to prevent 7-ketocholesterol-mediated apoptosis of A7R5 smooth muscle cells. To be operative, alpha-tocopherol needed to be added to the cells before 7-ketocholesterol, and its anti-apoptotic effect was reduced and even suppressed when added together or after 7-ketocholesterol, respectively. Both pre- and co-treatment of the cells with alpha-tocopherol resulted in the redistribution of 7-ketocholesterol out of the sphingolipid/cholesterol-enriched ( lipid raft) domains. In turn, fewer amounts of alpha-tocopherol associated with lipid rafts on 7-ketocholesterol-pretreated cells compared with untreated cells, with no prevention of cell death in this case. In further support of the implication of lipid raft domains, the dephosphorylation/inactivation of Akt-PKB was involved in the 7-ketocholesterol-induced apoptosis. Akt-PKB dephosphorylation was prevented by alpha-tocopherol, but not gamma-tocopherol pretreatment.	[Neel, Dominique] INSERM, Ctr Rech, UMR866, Fac Med, F-21079 Dijon, France; Univ Bourgogne, F-21079 Dijon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Bourgogne	Neel, D (corresponding author), INSERM, Ctr Rech, UMR866, Fac Med, 7 Blvd Jeanne Arc,BP 87900, F-21079 Dijon, France.	dominique.neel@chu-dijon.fr; laurent.lagrost@u-bourgogne.fr	Desrumaux, Catherine/O-1925-2018	PAIS DE BARROS, Jean-Paul/0000-0002-5124-2283	Universite de Bourgogne; Centre Hospitalier Universitaire de Dijon; Conseil Regional de Bourgogne; INSERM; Agence Nationale de la Recherche; Fondation de France	Universite de Bourgogne; Centre Hospitalier Universitaire de Dijon; Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation de France(Fondation de France)	This work was supported by grants from the Universite de Bourgogne, the Centre Hospitalier Universitaire de Dijon, the Conseil Regional de Bourgogne, INSERM, the Agence Nationale de la Recherche, and the Fondation de France.	Azzi A, 2000, PROG LIPID RES, V39, P231, DOI 10.1016/S0163-7827(00)00006-0; Bauriedel G, 1999, CARDIOVASC RES, V41, P480, DOI 10.1016/S0008-6363(98)00318-6; BECART J, 1990, HRC-J HIGH RES CHROM, V13, P126; Berthier A, 2005, FEBS J, V272, P3093, DOI 10.1111/j.1742-4658.2005.04723.x; Berthier A, 2004, CELL DEATH DIFFER, V11, P897, DOI 10.1038/sj.cdd.4401434; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; CHATELAIN E, 1993, BIOCHIM BIOPHYS ACTA, V1176, P83, DOI 10.1016/0167-4889(93)90181-N; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; de Nigris F, 2000, BIOCHEM PHARMACOL, V59, P1477, DOI 10.1016/S0006-2952(00)00275-6; DEL PL, 1997, SCIENCE, V278, P687; Delmas D, 2003, J BIOL CHEM, V278, P41482, DOI 10.1074/jbc.M304896200; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; GAMBERT P, 1979, J CHROMATOGR, V162, P1, DOI 10.1016/S0378-4347(00)82057-5; Grazide S, 2002, FASEB J, V16, P1685, DOI 10.1096/fj.01-0794fje; Jessup W, 2005, REJUV RES, V8, P9, DOI 10.1089/rej.2005.8.9; Lasserre R, 2008, NAT CHEM BIOL, V4, P538, DOI 10.1038/nchembio.103; Lizard G, 1999, ARTERIOSCL THROM VAS, V19, P1190, DOI 10.1161/01.ATV.19.5.1190; Lyons NM, 2001, FREE RADICAL RES, V35, P329, DOI 10.1080/10715760100300861; Miguet C, 2001, CELL DEATH DIFFER, V8, P83, DOI 10.1038/sj.cdd.4400792; Munteanu A, 2004, J CELL MOL MED, V8, P59, DOI 10.1111/j.1582-4934.2004.tb00260.x; Munteanu A, 2007, MOL ASPECTS MED, V28, P538, DOI 10.1016/j.mam.2007.07.001; Princen K, 2003, CYTOM PART A, V51A, P35, DOI 10.1002/cyto.a.10008; Ricciarelli R, 1998, BIOCHEM J, V334, P243, DOI 10.1042/bj3340243; Scheid MP, 2003, FEBS LETT, V546, P108, DOI 10.1016/S0014-5793(03)00562-3; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; SMITH AJ, 1985, J IMMUNOL METHODS, V84, P125, DOI 10.1016/0022-1759(85)90421-1; Terasaka N, 2007, P NATL ACAD SCI USA, V104, P15093, DOI 10.1073/pnas.0704602104; Traber MG, 2007, FREE RADICAL BIO MED, V43, P4, DOI 10.1016/j.freeradbiomed.2007.03.024; TRABER MG, 1995, AM J CLIN NUTR, V62, P1501; Uemura M, 2002, EUR J PHARMACOL, V456, P29, DOI 10.1016/S0014-2999(02)02639-0; Vejux A, 2009, J NUTR BIOCHEM, V20, P45, DOI 10.1016/j.jnutbio.2007.12.001; Wang XY, 1999, PROG LIPID RES, V38, P309, DOI 10.1016/S0163-7827(99)00008-9; YEH CJG, 1981, J IMMUNOL METHODS, V43, P269, DOI 10.1016/0022-1759(81)90174-5	33	63	66	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15826	15834		10.1074/jbc.M808641200	http://dx.doi.org/10.1074/jbc.M808641200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19351882	hybrid, Green Published			2022-12-25	WOS:000266501000051
J	Zaks-Makhina, E; Li, H; Grishin, A; Salvador-Recatala, V; Levitan, ES				Zaks-Makhina, Elena; Li, Hui; Grishin, Anatoly; Salvador-Recatala, Vicenta; Levitan, Edwin S.			Specific and Slow Inhibition of the Kir2.1 K+ Channel by Gambogic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID RAFTS; POTASSIUM CHANNELS; ACTIVATION; BLOCKERS; ASSAY; RECTIFICATION; MECHANISM; APOPTOSIS; CAVEOLAE; YEAST	Although Kir2.1 channels are important in the heart and other excitable cells, there are virtually no specific drugs for this K+ channel. In search of Kir2.1 modulators, we screened a library of 720 naturally occurring compounds using a yeast strain in which mammalian Kir2.1 enables growth at low [K+]. One of the identified compounds, gambogic acid (GA), potently (EC50 <= 100 nM) inhibited Kir2.1 channels in mammalian cells when applied chronically for 3 h. This potent and slow inhibition was not seen with Kv2.1, HERG or Kir1.1 channels. However, ;acutely applied GA acted as a weak (EC50 = similar to 10 mu M) nonselective K+ channel blocker. Intracellular delivery of GA via a patch pipette did not potentiate the acute effect of GA on Kir2.1, showing that slow uptake is not responsible for the delayed, potent effect. Immunoblots showed that total Kir2.1 protein expression was not altered by GA. Similarly, immunostaining of intact cells expressing Kir2.1 with an extracellular epitope tag demonstrated that GA does not affect Kir2.1 surface expression. However, the 3-h treatment with GA caused redistribution of Kir2.1 and Kv2.1 from the Triton X-100-insoluble to the Triton X-100-soluble membrane fraction. Thus, GA changes the K+ channel membrane microenvironment resulting in potent, specific, and slow acting inhibition of Kir2.1 channels.	[Zaks-Makhina, Elena; Li, Hui; Grishin, Anatoly; Salvador-Recatala, Vicenta; Levitan, Edwin S.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Levitan, ES (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, E1351 BST,200 Lothrop St, Pittsburgh, PA 15261 USA.	elevitan@pitt.edu	Salvador, Vicenta/AAE-9733-2020	Salvador Recatala, Vicenta/0000-0002-6094-1422	National Institutes of Health [NSO48089-01, HL80632]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants NSO48089-01 ( to E. Z. M.) and HL80632 ( to E. S. L.).	FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; GHOSE AK, 1987, J CHEM INF COMP SCI, V27, P21, DOI 10.1021/ci00053a005; Hibino H, 2007, EUR J NEUROSCI, V26, P2539, DOI 10.1111/j.1460-9568.2007.05876.x; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Kasibhatla S, 2005, P NATL ACAD SCI USA, V102, P12095, DOI 10.1073/pnas.0406731102; Lingwood D, 2007, NAT PROTOC, V2, P2159, DOI 10.1038/nprot.2007.294; Liu H, 2007, J MED CHEM, V50, P83, DOI 10.1021/jm060414o; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Maguy A, 2006, CARDIOVASC RES, V69, P798, DOI 10.1016/j.cardiores.2005.11.013; Martens JR, 2000, J BIOL CHEM, V275, P7443, DOI 10.1074/jbc.275.11.7443; Martens JR, 2001, J BIOL CHEM, V276, P8409, DOI 10.1074/jbc.M009948200; MATSUDA H, 1987, NATURE, V325, P156, DOI 10.1038/325156a0; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Priori SG, 2005, CIRC RES, V96, P800, DOI 10.1161/01.RES.0000162101.76263.8c; Rapedius M, 2005, J BIOL CHEM, V280, P30760, DOI 10.1074/jbc.M503503200; Romanenko VG, 2004, BIOPHYS J, V87, P3850, DOI 10.1529/biophysj.104.043273; Sabirov RZ, 1997, J GEN PHYSIOL, V110, P665, DOI 10.1085/jgp.110.6.665; Slack M, 2006, J BIOMOL SCREEN, V11, P57, DOI 10.1177/1087057105282712; Sun HY, 2006, J BIOL CHEM, V281, P5877, DOI 10.1074/jbc.M600072200; TANG WM, 1995, MOL BIOL CELL, V6, P1231, DOI 10.1091/mbc.6.9.1231; Weaver AK, 2007, J BIOL CHEM, V282, P31558, DOI 10.1074/jbc.M702866200; Zaks-Makhina E, 2004, MOL PHARMACOL, V65, P214, DOI 10.1124/mol.65.1.214; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103; Zhang HZ, 2004, BIOORGAN MED CHEM, V12, P309, DOI 10.1016/j.bmc.2003.11.013	24	21	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15432	15438		10.1074/jbc.M901586200	http://dx.doi.org/10.1074/jbc.M901586200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19366693	Green Published, hybrid			2022-12-25	WOS:000266501000011
J	Wang, L; Lawrence, JC; Sturgill, TW; Harris, TE				Wang, Lifu; Lawrence, John C., Jr.; Sturgill, Thomas W.; Harris, Thurl E.			Mammalian Target of Rapamycin Complex 1 (mTORC1) Activity Is Associated with Phosphorylation of Raptor by mTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICH AKT SUBSTRATE; 40 KDA PRAS40; PROTEIN-KINASE; CELL-GROWTH; TOS MOTIF; BINDING; INSULIN; IDENTIFICATION; INHIBITOR; PARTNER	mTORC1 contains multiple proteins and plays a central role in cell growth and metabolism. Raptor (regulatory-associated protein of mammalian target of rapamycin (mTOR)), a constitutively binding protein of mTORC1, is essential for mTORC1 activity and critical for the regulation of mTORC1 activity in response to insulin signaling and nutrient and energy sufficiency. Herein we demonstrate that mTOR phosphorylates raptor in vitro and in vivo. The phosphorylated residues were identified by using phosphopeptide mapping and mutagenesis. The phosphorylation of raptor is stimulated by insulin and inhibited by rapamycin. Importantly, the site-directed mutation of raptor at one phosphorylation site, Ser(863), reduced mTORC1 activity both in vitro and in vivo. Moreover, the Ser863 mutant prevented small GTP-binding protein Rheb from enhancing the phosphorylation of S6 kinase (S6K) in cells. Therefore, our findings indicate that mTOR-mediated raptor phosphorylation plays an important role on activation of mTORC1.	[Wang, Lifu; Lawrence, John C., Jr.; Sturgill, Thomas W.; Harris, Thurl E.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA	University of Virginia	Wang, L (corresponding author), Univ Virginia Hlth Syst, Dept Pharmacol, POB 800735,1300 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	lw6j@virginia.edu	wang, lifu/E-1436-2012		National Institutes of Health [DK52753, DK28312]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629, R01DK052753, R01DK028312] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK52753 and DK28312 (to J.C.L.).	Adami A, 2007, MOL CELL, V27, P509, DOI 10.1016/j.molcel.2007.05.040; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Mothe-Satney I, 2000, J BIOL CHEM, V275, P33836, DOI 10.1074/jbc.M006005200; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; Peterson RT, 2000, J BIOL CHEM, V275, P7416, DOI 10.1074/jbc.275.10.7416; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wang L, 2008, J BIOL CHEM, V283, P15619, DOI 10.1074/jbc.M800723200; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Wang LF, 2006, J BIOL CHEM, V281, P24293, DOI 10.1074/jbc.M603566200; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	27	85	88	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14693	14697		10.1074/jbc.C109.002907	http://dx.doi.org/10.1074/jbc.C109.002907			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19346248	hybrid, Green Published			2022-12-25	WOS:000266288200005
J	Zhou, ZM; Hashimoto, Y; Kobayashi, M				Zhou, Zhemin; Hashimoto, Yoshiteru; Kobayashi, Michihiko			Self-subunit Swapping Chaperone Needed for the Maturation of Multimeric Metalloenzyme Nitrile Hydratase by a Subunit Exchange Mechanism Also Carries Out the Oxidation of the Metal Ligand Cysteine Residues and Insertion of Cobalt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODOCOCCUS-RHODOCHROUS J1; PROTEIN-SULFENIC ACIDS; ACYL-COA SYNTHETASE; POSTTRANSLATIONAL MODIFICATION; THIOCYANATE HYDROLASE; PEPTIDE DEFORMYLASE; CRYSTAL-STRUCTURE; FUNCTIONAL EXPRESSION; ESCHERICHIA-COLI; REACTION-PRODUCT	The incorporation of cobalt into low molecular mass nitrile hydratase (L-NHase) of Rhodococcus rhodochrous J1 has been found to depend on the alpha-subunit exchange between cobalt-free L-NHase (apo-L-NHase lacking oxidized cysteine residues) and its cobalt-containing mediator (holo-NhlAE containing Cys-SO2- and Cys-SO- metal ligands), this novel mode of post-translational maturation having been named self-subunit swapping, and NhlE having been recognized as a self-subunit swapping chaperone (Zhou, Z., Hashimoto, Y., Shiraki, K., and Kobayashi, M. (2008) Proc. Natl. Acad. Sci. U. S. A. 105, 14849-14854). We discovered here that cobalt was inserted into both the cobalt-free NhlAE (apo-NhlAE) and the cobalt-free alpha-subunit (apo-alpha-subunit) in an NhlE-dependent manner in the presence of cobalt and dithiothreitol in vitro. Matrix-assisted laser desorption ionization time-of-flight mass spectroscopy analysis revealed that the non-oxidized cysteine residues in apo-NhlAE were post-translationally oxidized after cobalt insertion. These findings suggested that NhlE has two activities, i.e. cobalt insertion and cysteine oxidation. NhlE not only functions as a self-subunit swapping chaperone but also a metallochaperone that includes a redox function. Cobalt insertion and cysteine oxidation occurred under both aerobic and anaerobic conditions when Co3+ was used as a cobalt donor, suggesting that the oxygen atoms in the oxidized cysteines were derived from water molecules but not from dissolved oxygen. Additionally, we isolated apo-NhlAE after the self-subunit swapping event and found that it was recycled for cobalt transfer into L-NHase.	[Kobayashi, Michihiko] Univ Tsukuba, Inst Appl Biochem, Tsukuba, Ibaraki 3058572, Japan; Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	University of Tsukuba; University of Tsukuba	Kobayashi, M (corresponding author), Univ Tsukuba, Inst Appl Biochem, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.				Ministry of Education, Culture, Sports, Science, and Technology	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology.	Abe T, 2008, J BIOL CHEM, V283, P11312, DOI 10.1074/jbc.M709654200; Arakawa T, 2007, J MOL BIOL, V366, P1497, DOI 10.1016/j.jmb.2006.12.011; Brennan BA, 1996, J AM CHEM SOC, V118, P9194, DOI 10.1021/ja961920d; Cai JH, 2006, PROTEIN SCI, V15, P2071, DOI 10.1110/ps.062238406; Chae PS, 2005, J AM CHEM SOC, V127, P2396, DOI 10.1021/ja044043h; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Deng H, 2002, BIOCHEMISTRY-US, V41, P10563, DOI 10.1021/bi026137e; Endo I, 1999, TRENDS BIOTECHNOL, V17, P244, DOI 10.1016/S0167-7799(99)01303-7; Greene SN, 2006, INORG CHEM, V45, P17, DOI 10.1021/ic050965p; Hashimoto Y, 2005, J BIOL CHEM, V280, P8660, DOI 10.1074/jbc.M405686200; HASHIMOTO Y, 1994, BIOSCI BIOTECH BIOCH, V58, P1859, DOI 10.1271/bbb.58.1859; Hourai S, 2003, BIOCHEM BIOPH RES CO, V312, P340, DOI 10.1016/j.bbrc.2003.10.124; Huang WJ, 1997, STRUCTURE, V5, P691, DOI 10.1016/S0969-2126(97)00223-2; Jonsson TJ, 2008, J BIOL CHEM, V283, P22890, DOI [10.1074/jbc.C800124200, 10.1074/jbc.M803244200]; Kataoka S, 2006, FEBS LETT, V580, P4667, DOI 10.1016/j.febslet.2006.07.051; Katayama Y, 2006, J AM CHEM SOC, V128, P728, DOI 10.1021/ja057010q; Kobayashi M, 1997, P NATL ACAD SCI USA, V94, P11986, DOI 10.1073/pnas.94.22.11986; Kobayashi M, 1999, EUR J BIOCHEM, V261, P1, DOI 10.1046/j.1432-1327.1999.00186.x; Kobayashi M, 1998, NAT BIOTECHNOL, V16, P733, DOI 10.1038/nbt0898-733; KOBAYASHI M, 1992, TRENDS BIOTECHNOL, V10, P402, DOI 10.1016/0167-7799(92)90283-2; Komeda H, 1996, P NATL ACAD SCI USA, V93, P4267, DOI 10.1073/pnas.93.9.4267; Komeda H, 1996, J BIOL CHEM, V271, P15796, DOI 10.1074/jbc.271.26.15796; Komeda H, 1997, P NATL ACAD SCI USA, V94, P36, DOI 10.1073/pnas.94.1.36; Kuchar J, 2004, CHEM REV, V104, P509, DOI 10.1021/cr020613p; Lu J, 2003, FEBS LETT, V553, P391, DOI 10.1016/S0014-5793(03)01070-6; Miyanaga A, 2004, EUR J BIOCHEM, V271, P429, DOI 10.1046/j.1432-1033.2003.03943.x; Miyanaga A, 2001, BIOCHEM BIOPH RES CO, V288, P1169, DOI 10.1006/bbrc.2001.5897; Murakami T, 2000, PROTEIN SCI, V9, P1024, DOI 10.1110/ps.9.5.1024; Nagashima S, 1998, NAT STRUCT BIOL, V5, P347, DOI 10.1038/nsb0598-347; Nakamura T, 2008, P NATL ACAD SCI USA, V105, P6238, DOI 10.1073/pnas.0709822105; Noguchi T, 2003, BIOCHEMISTRY-US, V42, P11642, DOI 10.1021/bi035260i; Nojiri M, 1999, J BIOCHEM-TOKYO, V125, P696, DOI 10.1093/oxfordjournals.jbchem.a022339; Ogata H, 2005, STRUCTURE, V13, P1635, DOI 10.1016/j.str.2005.07.018; Payne MS, 1997, BIOCHEMISTRY-US, V36, P5447, DOI 10.1021/bi962794t; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Stevens JM, 2003, J MASS SPECTROM, V38, P955, DOI 10.1002/jms.509; Tsujimura M, 2003, J AM CHEM SOC, V125, P11532, DOI 10.1021/ja035018z; Volbeda A, 2005, J BIOL INORG CHEM, V10, P239, DOI 10.1007/s00775-005-0632-x; Wu S, 1997, APPL MICROBIOL BIOT, V48, P704, DOI 10.1007/s002530051119; Zhou Z-M, 2005, ACTINOMYCETOLOGICA, V19, P18; Zhou Z, 2008, P NATL ACAD SCI USA, V105, P14849, DOI 10.1073/pnas.0803428105	41	42	44	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14930	14938		10.1074/jbc.M808464200	http://dx.doi.org/10.1074/jbc.M808464200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19346246	Green Published, hybrid			2022-12-25	WOS:000266288200029
J	Ordonez, L; Bernard, I; L'Faqihi-Olive, FE; Tervaert, JWC; Damoiseaux, J; Saoudi, A				Ordonez, Laurence; Bernard, Isabelle; L'Faqihi-Olive, Fatima-Ezzahra; Tervaert, Jan Willem Cohen; Damoiseaux, Jan; Saoudi, Abdelhadi			CD45RC Isoform Expression Identifies Functionally Distinct T Cell Subsets Differentially Distributed between Healthy Individuals and AAV Patients	PLOS ONE			English	Article								In animal models of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), the proportion of CD45RC T cell subsets is important for disease susceptibility. Their human counterparts are, however, functionally ill defined. In this report, we studied their distribution in healthy controls (HC), AAV patients and in Systemic lupus erythematous (SLE) patients as disease controls. We showed that CD45RC expression level on human CD4 and CD8 T cells identifies subsets that are highly variable among individuals. Interestingly, AAV patients exhibit an increased proportion of CD45RC low CD4 T cells as compared to HC and SLE patients. This increase is stable over time and independent of AAV subtype, ANCA specificity, disease duration, or number of relapses. We also analyzed the cytokine profile of purified CD4 and CD8 CD45RC T cell subsets from HC, after stimulation with anti-CD3 and anti-CD28 mAbs. The CD45RC subsets exhibit different cytokine profiles. Type-1 cytokines (IL-2, IFN-gamma and TNF-alpha) were produced by all CD45RC T cell subsets, while the production of IL-17, type-2 (IL-4, IL-5) and regulatory (IL-10) cytokines was restricted to the CD45RC low subset. In conclusion, we have shown that CD45RC expression divides human T cells in functionally distinct subsets that are imbalanced in AAV. Since this imbalance is stable over time and independent of several disease parameters, we hypothesize that this is a pre-existing immune abnormality involved in the etiology of AAV.			Ordonez, L (corresponding author), Hop Purpan, IFR 30, U563, INSERM, Toulouse, France.	abdelhadi.saoudi@inserm.fr	SAOUDI, Abdelhadi/K-6719-2014; Damoiseaux, Jan/B-8993-2009; tervaert, jan willem cohen/AAB-1111-2019	SAOUDI, Abdelhadi/0000-0001-7015-8178; Damoiseaux, Jan/0000-0003-4007-6985; Bernard, Isabelle/0000-0002-5847-1281				Abdulahad WH, 2006, KIDNEY INT, V70, P938, DOI 10.1038/sj.ki.5001670; Abdulahad WH, 2008, ARTHRITIS RHEUM-US, V58, P2196, DOI 10.1002/art.23557; Abdulahad WH, 2007, ANN NY ACAD SCI, V1107, P22, DOI 10.1196/annals.1381.003; Abdulahad WH, 2007, ARTHRITIS RHEUM, V56, P2080, DOI 10.1002/art.22692; Bernard I, 1998, EUR CYTOKINE NETW, V9, P613; BROUWER E, 1993, J EXP MED, V177, P905, DOI 10.1084/jem.177.4.905; Bunce C, 1997, J EXP MED, V185, P767, DOI 10.1084/jem.185.4.767; Csernok E, 1999, ARTHRITIS RHEUM, V42, P742, DOI 10.1002/1529-0131(199904)42:4<742::AID-ANR18>3.0.CO;2-I; ESNAULT VLM, 1992, LAB INVEST, V67, P114; Field AC, 2003, J IMMUNOL, V170, P2508, DOI 10.4049/jimmunol.170.5.2508; Fournie GJ, 2001, IMMUNOL REV, V184, P145, DOI 10.1034/j.1600-065x.2001.1840114.x; HAGEN EC, 1995, CLIN NEPHROL, V43, P351; Hargreaves M, 1997, IMMUNOLOGY, V91, P323, DOI 10.1046/j.1365-2567.1997.00267.x; Haubitz M, 1998, NEPHROL DIAL TRANSPL, V13, P2074, DOI 10.1093/ndt/13.8.2074; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; Jacobsen M, 2000, NAT GENET, V26, P495, DOI 10.1038/82659; Jagiello P, 2005, ARTHRITIS RHEUM-US, V52, P4039, DOI 10.1002/art.21487; Jennette JC, 1997, NEW ENGL J MED, V337, P1512, DOI 10.1056/NEJM199711203372106; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; Kiely PDW, 1997, J IMMUNOL, V159, P5100; Lamprecht P, 2007, ARTHRITIS RHEUM-US, V56, P1725, DOI 10.1002/art.22693; LOCKWOOD CM, 1993, LANCET, V341, P1620, DOI 10.1016/0140-6736(93)90759-A; Ludviksson BR, 1998, J IMMUNOL, V160, P3602; LUQMANI RA, 1994, Q J MED, V87, P671; Marinaki S, 2005, CLIN EXP IMMUNOL, V140, P181, DOI 10.1111/j.1365-2249.2005.02731.x; Mas M, 2004, J IMMUNOL, V172, P6354, DOI 10.4049/jimmunol.172.10.6354; MATHIESON PW, 1993, J EXP MED, V177, P1309, DOI 10.1084/jem.177.5.1309; MATHIESON PW, 1992, LAB INVEST, V67, P121; Mayet WJ, 1999, SCAND J IMMUNOL, V49, P585; MCKNIGHT AJ, 1991, EUR J IMMUNOL, V21, P1187, DOI 10.1002/eji.1830210514; Muller A, 2008, Z RHEUMATOL, V67, P72, DOI 10.1007/s00393-007-0236-7; Petricoin EF, 1997, NATURE, V390, P629, DOI 10.1038/37648; Popa ER, 1999, J ALLERGY CLIN IMMUN, V103, P885, DOI 10.1016/S0091-6749(99)70434-3; Popa ER, 2002, ARTHRITIS RHEUM, V46, P1894, DOI 10.1002/art.10384; Ruth AJ, 2006, J AM SOC NEPHROL, V17, P1940, DOI 10.1681/ASN.2006020108; SCHLESIER M, 1995, RHEUMATOL INT, V14, P213, DOI 10.1007/BF00262300; SCHMITT WH, 1992, ARTHRITIS RHEUM, V35, P1088, DOI 10.1002/art.1780350914; Schweickert R, 2003, HUM FACTORS, V45, P77, DOI 10.1518/hfes.45.1.77.27230; Slot MC, 2008, CLIN IMMUNOL, V128, P39, DOI 10.1016/j.clim.2008.03.506; STEGEMAN CA, 1993, CLIN EXP IMMUNOL, V91, P415; STREULI M, 1987, J EXP MED, V166, P1548, DOI 10.1084/jem.166.5.1548; Subra JF, 2001, J IMMUNOL, V166, P2944, DOI 10.4049/jimmunol.166.5.2944; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tchilian EZ, 2006, TRENDS IMMUNOL, V27, P146, DOI 10.1016/j.it.2006.01.001; van Wijngaarden RAFDL, 2008, CLIN J AM SOC NEPHRO, V3, P237, DOI 10.2215/CJN.03550807; Vorechovsky I, 2001, NAT GENET, V29, P22, DOI 10.1038/ng723; WILDE B, 2008, NEPHROL DIAL TRANSPL; Xystrakis E, 2004, BLOOD, V104, P3294, DOI 10.1182/blood-2004-03-1214; Xystrakis E, 2004, J IMMUNOL, V173, P3140, DOI 10.4049/jimmunol.173.5.3140	50	28	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2009	4	4							e5287	10.1371/journal.pone.0005287	http://dx.doi.org/10.1371/journal.pone.0005287			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VA	19381293	Green Published, gold, Green Submitted			2022-12-25	WOS:000265513800018
J	Randis, TM; Kulkarni, R; Aguilar, JL; Ratner, AJ				Randis, Tara M.; Kulkarni, Ritwij; Aguilar, Jorge L.; Ratner, Adam J.			Antibody-Based Detection and Inhibition of Vaginolysin, the Gardnerella vaginalis Cytolysin	PLOS ONE			English	Article								Bacterial vaginosis (BV) is the most common vaginal infection worldwide and is associated with significant adverse sequelae. We have recently characterized vaginolysin (VLY), the human-specific cytotoxin produced by Gardnerella vaginalis and believed to play a critical role in the pathogenesis of BV and its associated morbidities. We hypothesize that novel antibody-based strategies may be useful for detection of VLY and for inhibition of its toxic effects on human cells. Using purified toxin as an immunogen, we generated polyclonal rabbit immune serum (IS) against VLY. A western blot of G. vaginalis lysate was probed with IS and a single band (57 kD) identified. Immunofluorescence techniques using IS detected VLY production by G. vaginalis. In addition, we have developed a sandwich ELISA assay capable of VLY quantification at ng/ml concentrations in the supernatant of growing G. vaginalis. To investigate the potential inhibitory role of IS on VLY-mediated cell lysis, we exposed human erythrocytes to VLY or VLY pretreated with IS and determined the percent hemolysis. Pretreatment with IS resulted in a significant reduction in VLY-mediated lysis. Similarly, both human cervical carcinoma cells and vaginal epithelial cells exhibited reduced cytolysis following exposure to VLY with IS compared to VLY alone. These results confirm that antibody-based techniques are an effective means of VLY detection. Furthermore, VLY antiserum functions as an inhibitor of VLY-CD59 interaction, mitigating cell lysis. These strategies may have a potential role in the diagnosis and treatment of BV.			Randis, TM (corresponding author), Columbia Univ, Dept Pediat, New York, NY 10027 USA.	ar127@columbia.edu		Ratner, Adam/0000-0003-1761-794X; Randis, Tara/0000-0003-0348-6766	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI065450] Funding Source: NIH RePORTER; NIAID NIH HHS [AI065450, K08 AI065450] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; BRISELDEN AM, 1994, J CLIN MICROBIOL, V32, P148, DOI 10.1128/JCM.32.1.148-152.1994; Calderon E, 1997, Infect Dis Obstet Gynecol, V5, P226, DOI 10.1155/S1064744997000380; COHEN CR, 1995, AIDS, V9, P1093, DOI 10.1097/00002030-199509000-00017; Donders GGG, 2002, BJOG-INT J OBSTET GY, V109, P34, DOI 10.1016/S1470-0328(02)00432-9; Eschenbach D A, 1984, Scand J Urol Nephrol Suppl, V86, P213; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; FREDRICKS DN, 2009, J CLIN MICROBIOL; GARDNER HL, 1955, AM J OBSTET GYNECOL, V69, P962, DOI 10.1016/0002-9378(55)90095-8; Gelber SE, 2008, J BACTERIOL, V190, P3896, DOI 10.1128/JB.01965-07; Hedges SR, 2006, J INFECT DIS, V193, P556, DOI 10.1086/499824; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; Hogan VK, 2007, MATERN CHILD HLTH J, V11, P532, DOI 10.1007/s10995-007-0205-4; Josey WE, 2008, INT J STD AIDS, V19, P152, DOI 10.1258/ijsa.2007.007260; Keane FEA, 2005, SEX TRANSM INFECT, V81, P155, DOI 10.1136/sti.2004.009902; Klein LL, 2004, AM J OBSTET GYNECOL, V190, P1493, DOI 10.1016/j.ajog.2004.03.014; Koumans EH, 2001, SEX TRANSM DIS, V28, P292, DOI 10.1097/00007435-200105000-00011; Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127; McDonald HM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000262.pub3; Menard JP, 2008, CLIN INFECT DIS, V47, P33, DOI 10.1086/588661; Myziuk L, 2003, J CLIN MICROBIOL, V41, P1925, DOI 10.1128/JCM.41.5.1925-1928.2003; NELSON DB, 2008, J PERINAT MED; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; SCHWEBKE JR, 2008, SEX TRANSM DIS; Taha TE, 1998, AIDS, V12, P1699, DOI 10.1097/00002030-199813000-00019; Tam M T, 1998, Infect Dis Obstet Gynecol, V6, P204, DOI 10.1155/S1064744998000416; WATTS DH, 1989, OBSTET GYNECOL, V73, P52; West B, 2003, SEX TRANSM DIS, V30, P483, DOI 10.1097/00007435-200306000-00003	28	25	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2009	4	4							e5207	10.1371/journal.pone.0005207	http://dx.doi.org/10.1371/journal.pone.0005207			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TU	19370149	Green Published, gold, Green Submitted			2022-12-25	WOS:000265510600003
J	Worter, V; Schweigreiter, R; Kinzel, B; Mueller, M; Barske, C; Bock, G; Frentzel, S; Bandtlow, CE				Woerter, Verena; Schweigreiter, Ruediger; Kinzel, Bernd; Mueller, Matthias; Barske, Carmen; Boeck, Guenther; Frentzel, Stefan; Bandtlow, Christine E.			Inhibitory Activity of Myelin-Associated Glycoprotein on Sensory Neurons Is Largely Independent of NgR1 and NgR2 and Resides within Ig-Like Domains 4 and 5	PLOS ONE			English	Article								Myelin-associated glycoprotein (MAG) is a sialic acid binding Ig-like lectin (Siglec) which has been characterized as potent myelin-derived inhibitor of neurite outgrowth. Two members of the Nogo-receptor (NgR) family, NgR1 and NgR2, have been identified as neuronal binding proteins of MAG. In addition, gangliosides have been proposed to bind to and confer the inhibitory activity of MAG on neurons. In this study, we investigated the individual contribution of NgRs and gangliosides to MAG-mediated inhibition of sensory neurons derived from dorsal root ganglia (DRG) of ngr1, ngr2 or ngr1/ngr2 deletion mutants. We found no disinhibition of neurite growth in the absence of either NgR1 or NgR2. Sensory neurons deficient for both NgR proteins displayed only a moderate reduction of MAG-mediated inhibition of neurite growth. If treated with Vibrio cholerae neuraminidase (VCN), inhibition by MAG is further attenuated but still not annulled. Thus, disrupting all known protein and ganglioside receptors for MAG in sensory neurons does not fully abolish its inhibitory activity pointing to the existence of as yet unidentified receptors for MAG. Moreover, by employing a variety of protein mutants, we identified the Ig-like domains 4 or 5 of MAG as necessary and sufficient for growth arrest, whereas abolishing MAG's ability to bind to sialic acid did not interfere with its inhibitory activity. These findings provide new insights into the inhibitory function of MAG and suggest similarities but also major differences in MAG inhibition between sensory and central nervous system (CNS) neurons.			Worter, V (corresponding author), Innsbruck Med Univ, Div Neurobiochem, Bioctr, Innsbruck, Austria.	christine.bandtlow@i-med.ac.at						Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Barrette B, 2007, MOL CELL NEUROSCI, V34, P519, DOI 10.1016/j.mcn.2006.12.004; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Cao ZX, 2007, J NEUROSCI, V27, P9146, DOI 10.1523/JNEUROSCI.2404-07.2007; Chivatakarn O, 2007, J NEUROSCI, V27, P7117, DOI 10.1523/JNEUROSCI.1541-07.2007; Crocker PR, 2002, CURR OPIN STRUC BIOL, V12, P609, DOI 10.1016/S0959-440X(02)00375-5; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; FRUTTIGER M, 1995, EUR J NEUROSCI, V7, P511, DOI 10.1111/j.1460-9568.1995.tb00347.x; JOHNSON PW, 1989, NEURON, V3, P377, DOI 10.1016/0896-6273(89)90262-6; KELM S, 1994, CURR BIOL, V4, P965, DOI 10.1016/S0960-9822(00)00220-7; Lauren J, 2003, MOL CELL NEUROSCI, V24, P581, DOI 10.1016/S1044-7431(03)00199-4; Lauren J, 2007, J BIOL CHEM, V282, P5715, DOI 10.1074/jbc.M609797200; LEDERMANN B, 1991, EXP CELL RES, V197, P254, DOI 10.1016/0014-4827(91)90430-3; LI CM, 1994, NATURE, V369, P747, DOI 10.1038/369747a0; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Mehta NR, 2007, J BIOL CHEM, V282, P27875, DOI 10.1074/jbc.M704055200; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; MONTAG D, 1994, NEURON, V13, P229, DOI 10.1016/0896-6273(94)90472-3; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Niederost B, 2002, J NEUROSCI, V22, P10368; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Quarles RH, 2007, J NEUROCHEM, V100, P1431, DOI 10.1111/j.1471-4159.2006.04319.x; Schafer M, 1996, NEURON, V16, P1107, DOI 10.1016/S0896-6273(00)80137-3; Schweigreiter R, 2004, MOL CELL NEUROSCI, V27, P163, DOI 10.1016/j.mcn.2004.06.004; Schweigreiter R, 2007, PROTEOMICS, V7, P4457, DOI 10.1002/pmic.200700499; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Sicotte M, 2003, MOL CELL NEUROSCI, V23, P251, DOI 10.1016/S1044-7431(03)00053-8; Tang S, 1997, J CELL BIOL, V138, P1355, DOI 10.1083/jcb.138.6.1355; Turnley AM, 1998, NEUROREPORT, V9, P1987, DOI 10.1097/00001756-199806220-00013; Venkatesh K, 2005, J NEUROSCI, V25, P808, DOI 10.1523/JNEUROSCI.4464-04.2005; Venkatesh K, 2007, J CELL BIOL, V177, P393, DOI 10.1083/jcb.200702102; Vinson M, 2001, J BIOL CHEM, V276, P20280, DOI 10.1074/jbc.M100345200; Vyas AA, 2005, J BIOL CHEM, V280, P16305, DOI 10.1074/jbc.M500250200; Vyas AA, 2002, P NATL ACAD SCI USA, V99, P8412, DOI 10.1073/pnas.072211699; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Williams G, 2008, J BIOL CHEM, V283, P16641, DOI 10.1074/jbc.M802067200; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010; Yang HB, 1999, J NEUROSCI RES, V55, P687, DOI 10.1002/(SICI)1097-4547(19990315)55:6<687::AID-JNR4>3.0.CO;2-6; Zheng BH, 2005, P NATL ACAD SCI USA, V102, P1205, DOI 10.1073/pnas.0409026102	41	29	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2009	4	4							e5218	10.1371/journal.pone.0005218	http://dx.doi.org/10.1371/journal.pone.0005218			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TS	19367338	Green Published, Green Submitted, gold			2022-12-25	WOS:000265510400007
J	Aranko, AS; Zuger, S; Buchinger, E; Iwai, H				Aranko, A. Sesilja; Zuger, Sara; Buchinger, Edith; Iwai, Hideo			In Vivo and In Vitro Protein Ligation by Naturally Occurring and Engineered Split DnaE Inteins	PLOS ONE			English	Article								Background: Protein trans-splicing by naturally occurring split DnaE inteins is used for protein ligation of foreign peptide fragments. In order to widen biotechnological applications of protein trans-splicing, it is highly desirable to have split inteins with shorter C-terminal fragments, which can be chemically synthesized. Principal Findings: We report the identification of new functional split sites in DnaE inteins from Synechocystis sp. PCC6803 and from Nostoc punctiforme. One of the newly engineered split intein bearing C-terminal 15 residues showed more robust protein trans-splicing activity than naturally occurring split DnaE inteins in a foreign context. During the course of our experiments, we found that protein ligation by protein trans-splicing depended not only on the splicing junction sequences, but also on the foreign extein sequences. Furthermore, we could classify the protein trans-splicing reactions in foreign contexts with a simple kinetic model into three groups according to their kinetic parameters in the presence of various reducing agents. Conclusion: The shorter C-intein of the newly engineered split intein could be a useful tool for biotechnological applications including protein modification, incorporation of chemical probes, and segmental isotopic labelling. Based on kinetic analysis of the protein splicing reactions, we propose a general strategy to improve ligation yields by protein trans-splicing, which could significantly enhance the applications of protein ligation by protein trans-splicing.	[Buchinger, Edith] Aalborg Univ, Chem & Environm Engn, Dept Biotechnol, Aalborg, Denmark	Aalborg University	Aranko, AS (corresponding author), Univ Helsinki, Inst Biotechnol, Res Program Struct Biol & Biophys, Helsinki, Finland.	hideo.iwai@helsinki.fi	Aranko, Aino Sesilja/N-1224-2016; Iwaï, Hideo/A-6416-2009	Aranko, Aino Sesilja/0000-0001-9425-3524; Iwaï, Hideo/0000-0001-7376-5264				Buskirk AR, 2004, P NATL ACAD SCI USA, V101, P10505, DOI 10.1073/pnas.0402762101; Dassa B, 2007, BIOCHEMISTRY-US, V46, P322, DOI 10.1021/bi0611762; Derbyshire V, 1997, P NATL ACAD SCI USA, V94, P11466, DOI 10.1073/pnas.94.21.11466; Ding Y, 2003, J BIOL CHEM, V278, P39133, DOI 10.1074/jbc.M306197200; Evans TC, 2000, J BIOL CHEM, V275, P9091, DOI 10.1074/jbc.275.13.9091; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Forrer P, 1998, GENE, V224, P45, DOI 10.1016/S0378-1119(98)00538-1; Heinamaki K, 2009, BIOMOL NMR ASSIGN, V3, P41, DOI 10.1007/s12104-008-9137-1; Hiraga K, 2005, J MOL BIOL, V354, P916, DOI 10.1016/j.jmb.2005.09.088; HIRATA R, 1990, J BIOL CHEM, V265, P6726; Iwai H, 2006, FEBS LETT, V580, P1853, DOI 10.1016/j.febslet.2006.02.045; Iwai H, 2001, J BIOL CHEM, V276, P16548, DOI 10.1074/jbc.M011639200; Iwai H, 2008, J PEPT SCI, V14, P183; KANE PM, 1990, SCIENCE, V250, P651, DOI 10.1126/science.2146742; Kurpiers T, 2007, ANGEW CHEM INT EDIT, V46, P5234, DOI 10.1002/anie.200700719; Ludwig C, 2006, ANGEW CHEM INT EDIT, V45, P5218, DOI 10.1002/anie.200600570; Martin DD, 2001, BIOCHEMISTRY-US, V40, P1393, DOI 10.1021/bi001786g; Mills KV, 1998, P NATL ACAD SCI USA, V95, P3543, DOI 10.1073/pnas.95.7.3543; Mootz HD, 2003, J AM CHEM SOC, V125, P10561, DOI 10.1021/ja0362813; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Muona M, 2008, CHEMBIOCHEM, V9, P2958, DOI 10.1002/cbic.200800604; OEEMIG JS, 2009, SOLUTION STRUCTURE D, DOI DOI 10.1016/J.FEBSLET.2009.03.058; Otomo T, 1999, J BIOMOL NMR, V14, P105, DOI 10.1023/A:1008308128050; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; Perler FB, 1997, CURR OPIN CHEM BIOL, V1, P292, DOI 10.1016/S1367-5931(97)80065-8; REICHMAN CT, 1992, CELL GROWTH DIFFER, V3, P451; Schwartz EC, 2007, NAT CHEM BIOL, V3, P50, DOI 10.1038/nchembio832; Southworth MW, 1998, EMBO J, V17, P918, DOI 10.1093/emboj/17.4.918; Sun P, 2005, J MOL BIOL, V353, P1093, DOI 10.1016/j.jmb.2005.09.039; Sun WC, 2004, J BIOL CHEM, V279, P35281, DOI 10.1074/jbc.M405491200; Williams NK, 2002, J BIOL CHEM, V277, P7790, DOI 10.1074/jbc.M110303200; Wu H, 1998, BBA-PROTEIN STRUCT M, V1387, P422, DOI 10.1016/S0167-4838(98)00157-5; Wu H, 1998, P NATL ACAD SCI USA, V95, P9226, DOI 10.1073/pnas.95.16.9226; Xu MQ, 2005, CURR OPIN BIOTECH, V16, P440, DOI 10.1016/j.copbio.2005.06.012; Yamazaki T, 1998, J AM CHEM SOC, V120, P5591, DOI 10.1021/ja980776o; Zuger S, 2005, NAT BIOTECHNOL, V23, P736, DOI 10.1038/nbt1097	36	58	62	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2009	4	4							e5185	10.1371/journal.pone.0005185	http://dx.doi.org/10.1371/journal.pone.0005185			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TN	19365564	Green Published, gold			2022-12-25	WOS:000265509900013
J	Raz, S; Retzkin, S; Pavlicek, T; Hoffman, A; Kimchi, H; Zehavi, D; Beiles, A; Nevo, E				Raz, Shmuel; Retzkin, Sion; Pavlicek, Tomas; Hoffman, Adam; Kimchi, Hagay; Zehavi, Dan; Beiles, Avigdor; Nevo, Eviatar			Scorpion Biodiversity and Interslope Divergence at "Evolution Canyon'', Lower Nahal Oren Microsite, Mt. Carmel, Israel	PLOS ONE			English	Article							MOUNT-CARMEL; DIVERSITY; PLANTS	Background: Local natural laboratories, designated by us as the "Evolution Canyon'' model, are excellent tools to study regional and global ecological dynamics across life. They present abiotic and biotic contrasts locally, permitting the pursuit of observations and experiments across diverse taxa sharing sharp microecological subdivisions. Higher solar radiation received by the "African savannah-like'' south-facing slopes (AS) in canyons north of the equator than by the opposite "European maquis-like'' north-facing slopes (ES) is associated with higher abiotic stress. Scorpions are a suitable taxon to study interslope biodiversity differences, associated with the differences in abiotic factors (climate, drought), due to their ability to adapt to dry environments. Methodology/Principal Findings: Scorpions were studied by the turning stone method and by UV light methods. The pattern observed in scorpions was contrasted with similar patterns in several other taxa at the same place. As expected, the AS proved to be significantly more speciose regarding scorpions, paralleling the interslope patterns in taxa such as lizards and snakes, butterflies (Rhopalocera), beetles (families Tenebrionidae, Dermestidae, Chrysomelidae), and grasshoppers (Orthoptera). Conclusions/Significance: Our results support an earlier conclusion stating that the homogenizing effects of migration and stochasticity are not able to eliminate the interslope intra-and interspecific differences in biodiversity despite an interslope distance of only 100 m at the "EC'' valley bottom. In our opinion, the interslope microclimate selection, driven mainly by differences in insolance, could be the primary factor responsible for the observed interslope pattern.			Raz, S (corresponding author), Univ Haifa, Dept Environm & Evolutionary Biol, IL-31999 Haifa, Israel.	razshmu@gmail.com	Pavlicek, Tomas/C-4768-2008; רז, שמואל/ABD-3478-2021					Chikatunov V, 2000, BIOL J LINN SOC, V69, P139, DOI 10.1006/bijl.1999.0322; CLOUDSLEY-THOMPSON J. L., 1962, ENTOMOL EXPTL ET APPL, V5, P270; Fet V., 2000, Catalog of the scorpions of the world (1758-1998); Grishkan I, 2000, ISRAEL J PLANT SCI, V48, P297, DOI 10.1560/LAJV-KKNY-F0HD-59KG; HADLEY N F, 1974, Journal of Arachnology, V2, P11; HADLEY NF, 1972, AM SCI, V60, P338; HADLEY NF, 1970, J EXP BIOL, V53, P547; Harry M, 1999, BIOLOGIA, V54, P685; KARCZ Y., 1959, BULL RES COUNC ISRAEL SECT G GEO SCI, V8G, P119; Kravchenko Vasiliy, 2002, Ecologia Mediterranea, V28, P99; LEVY G, 1985, PLANTS ANIMALS LAND, V2, P17; Levy G., 1980, FAUNA PALAESTINA ARA; Melamud V, 2007, ACTA ZOOL ACAD SCI H, V53, P381; *MIN LAB EL PUBL C, 1970, ATL ISR; Nevo E, 1999, ISR J PLANT SCI, V47, P49, DOI 10.1080/07929978.1999.10676751; NEVO E, 1995, P ROY SOC B-BIOL SCI, V262, P149, DOI 10.1098/rspb.1995.0189; Nevo E, 1997, THEOR POPUL BIOL, V52, P231, DOI 10.1006/tpbi.1997.1330; Nevo E, 1996, ISR J ZOOL, V42, P395; Nevo E, 2001, P NATL ACAD SCI USA, V98, P6233, DOI 10.1073/pnas.101109298; Nevo E, 2006, ISR J ECOL EVOL, V52, P485; Palmer A. Richard, 2003, P279; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; Pavlicek T, 1996, ISR J ZOOL, V42, P449; PAVLICEK T, 2009, ECOL MED IN PRESS, V34; Pavlicek T, 2008, BIOL J LINN SOC, V93, P147; Pavlicek Tomas, 2002, Journal of the Entomological Research Society, V4, P25; Pavlicek Tomas, 2003, Israel Journal of Earth Sciences, V52, P1, DOI 10.1560/QD0A-9T22-4FGL-FGH6; Polis G.A., 1990, P247; Sissom W.D., 1990, P445; VANVALEN L, 1962, EVOLUTION, V16, P125; Vilenkin B, 2009, ECOL MODEL, V220, P657, DOI 10.1016/j.ecolmodel.2008.12.012; WARBURG MR, 1981, COMP BIOCHEM PHYS A, V68, P277, DOI 10.1016/0300-9629(81)90354-6; WARBURG MR, 1979, J ARID ENVIRON, V2, P339, DOI 10.1016/S0140-1963(18)31688-4; Warburg MR, 1997, BIODIVERS CONSERV, V6, P1377, DOI 10.1023/A:1018389730440; WARBURG MR, 1980, COMP BIOCHEM PHYS A, V67, P47, DOI 10.1016/0300-9629(80)90407-7; WARBURG MR, 1978, S ZOOL SOC LOND, V42, P161; Wasser SP, 1995, ISR J PLANT SCI, V43, P367, DOI 10.1080/07929978.1995.10676623	37	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5214	10.1371/journal.pone.0005214	http://dx.doi.org/10.1371/journal.pone.0005214			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357787	Green Published, gold, Green Submitted			2022-12-25	WOS:000265505900026
J	Maekawa, M; Takashima, N; Matsumata, M; Ikegami, S; Kontani, M; Hara, Y; Kawashima, H; Owada, Y; Kiso, Y; Yoshikawa, T; Inokuchi, K; Osumi, N				Maekawa, Motoko; Takashima, Noriko; Matsumata, Miho; Ikegami, Shiro; Kontani, Masanori; Hara, Yoshinobu; Kawashima, Hiroshi; Owada, Yuji; Kiso, Yoshinobu; Yoshikawa, Takeo; Inokuchi, Kaoru; Osumi, Noriko			Arachidonic Acid Drives Postnatal Neurogenesis and Elicits a Beneficial Effect on Prepulse Inhibition, a Biological Trait of Psychiatric Illnesses	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; BINDING PROTEINS; PRENATAL EXPOSURE; HIPPOCAMPAL NEUROGENESIS; EICOSAPENTAENOIC ACID; DENTATE GYRUS; SCHIZOPHRENIA; ADULT; RAT; STARTLE	Prepulse inhibition (PPI) is a compelling endophenotype (biological markers) for mental disorders including schizophrenia. In a previous study, we identified Fabp7, a fatty acid binding protein 7 as one of the genes controlling PPI in mice and showed that this gene was associated with schizophrenia. We also demonstrated that disrupting Fabp7 dampened hippocampal neurogenesis. In this study, we examined a link between neurogenesis and PPI using different animal models and exploring the possibility of postnatal manipulation of neurogenesis affecting PPI, since gene-deficient mice show biological disturbances from prenatal stages. In parallel, we tested the potential for dietary polyunsaturated fatty acids (PUFAs), arachidonic acid (ARA) and/or docosahexaenoic acid (DHA), to promote neurogenesis and improve PPI. PUFAs are ligands for Fabp members and are abundantly expressed in neural stem/progenitor cells in the hippocampus. Our results are: (1) an independent model animal, Pax6(+/-) rats, exhibited PPI deficits along with impaired postnatal neurogenesis; (2) methylazoxymethanol acetate (an anti-proliferative drug) elicited decreased neurogenesis even in postnatal period, and PPI defects in young adult rats (10 weeks) when the drug was given at the juvenile stage (4-5 weeks); (3) administering ARA for 4 weeks after birth promoted neurogenesis in wild type rats; (4) raising Pax6 (+/-) pups on an ARA-containing diet enhanced neurogenesis and partially improved PPI in adult animals. These results suggest the potential benefit of ARA in ameliorating PPI deficits relevant to psychiatric disorders and suggest that the effect may be correlated with augmented postnatal neurogenesis.			Maekawa, M (corresponding author), Tohoku Univ, Grad Sch Med, Dept Dev Neurobiol, Sendai, Miyagi 980, Japan.	osumi@mail.tains.tohoku.ac.jp	Inokuchi, Kaoru/AAI-9693-2020; Yoshikawa, Takeo/F-9599-2019; Kiso, Yoshinobu/D-5424-2012; Osumi, Noriko/T-2823-2019	Inokuchi, Kaoru/0000-0002-5393-3133; Osumi, Noriko/0000-0003-0548-6452; Kawashima, Hiroshi/0000-0003-4249-0426; hara, Yoshinobu/0000-0001-6339-5116; Owada, Yuji/0000-0002-5109-0531				Arai Y, 2005, J NEUROSCI, V25, P9752, DOI 10.1523/JNEUROSCI.2512-05.2005; BRAFF D, 1978, PSYCHOPHYSIOLOGY, V15, P339, DOI 10.1111/j.1469-8986.1978.tb01390.x; BRAFF DL, 1990, ARCH GEN PSYCHIAT, V47, P181; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Brunskill EW, 2005, EUR J NEUROSCI, V22, P1265, DOI 10.1111/j.1460-9568.2005.04291.x; Chen YJJ, 2008, J NEUROSCI, V28, P6872, DOI 10.1523/JNEUROSCI.1815-08.2008; DAS GD, 1970, BRAIN RES, V21, P122, DOI 10.1016/0006-8993(70)90026-0; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fukaya T, 2007, NEUROBIOL AGING, V28, P1179, DOI 10.1016/j.neurobiolaging.2006.05.023; Fukuda S, 2003, J NEUROSCI, V23, P9357; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Ghashghaei HT, 2006, P NATL ACAD SCI USA, V103, P1930, DOI 10.1073/pnas.0510410103; HACHEY DL, 1987, J LIPID RES, V28, P1185; Hanhoff T, 2002, MOL CELL BIOCHEM, V239, P45, DOI 10.1023/A:1020502624234; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Heird WC, 2001, PEDIATR CLIN N AM, V48, P173, DOI 10.1016/S0031-3955(05)70292-3; Horrobin DF, 2002, PROSTAG LEUKOTR ESS, V66, P83, DOI 10.1054/plef.2001.0338; Hyman SE, 2008, NATURE, V455, P890, DOI 10.1038/nature07454; Kamnasaran D, 2003, J MED GENET, V40, P325, DOI 10.1136/jmg.40.5.325; Kawakita E, 2006, NEUROSCIENCE, V139, P991, DOI 10.1016/j.neuroscience.2006.01.021; Koch M, 1999, PROG NEUROBIOL, V59, P107, DOI 10.1016/S0301-0082(98)00098-7; KURTZ A, 1994, DEVELOPMENT, V120, P2637; Le Pen G, 2006, NEUROSCIENCE, V143, P395, DOI 10.1016/j.neuroscience.2006.08.004; Lin SH, 2007, SCHIZOPHRENIA BULL, V33, P174, DOI 10.1093/schbul/sbl038; Lipska BK, 1995, PSYCHOPHARMACOLOGY, V122, P35, DOI 10.1007/BF02246439; Ludewig K, 2003, BIOL PSYCHIAT, V54, P121, DOI 10.1016/S0006-3223(02)01925-X; Maekawa M, 2005, GENES CELLS, V10, P1001, DOI 10.1111/j.1365-2443.2005.00893.x; Molina-Holgado F, 2007, EUR J NEUROSCI, V25, P629, DOI 10.1111/j.1460-9568.2007.05322.x; Muskiet FAJ, 2006, J NUTR BIOCHEM, V17, P717, DOI 10.1016/j.jnutbio.2006.02.001; Osumi N, 1997, DEVELOPMENT, V124, P2961; Owada Y, 1996, J CHEM NEUROANAT, V12, P113, DOI 10.1016/S0891-0618(96)00192-5; Peet M, 2001, SCHIZOPHR RES, V49, P243, DOI 10.1016/S0920-9964(00)00083-9; Pieper AA, 2005, P NATL ACAD SCI USA, V102, P14052, DOI 10.1073/pnas.0506713102; Sakuradani E, 1999, EUR J BIOCHEM, V260, P208, DOI 10.1046/j.1432-1327.1999.00131.x; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Smesny S, 2004, J PSYCHIAT RES, V38, P537, DOI 10.1016/j.jpsychires.2004.01.007; Smesny S, 2007, NEUROPSYCHOPHARMACOL, V32, P2067, DOI 10.1038/sj.npp.1301343; St Clair D, 2005, JAMA-J AM MED ASSOC, V294, P557, DOI 10.1001/jama.294.5.557; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Su KP, 2001, EUR NEUROPSYCHOPHARM, V11, P295, DOI 10.1016/S0924-977X(01)00098-0; SUSSER ES, 1992, ARCH GEN PSYCHIAT, V49, P983; Swerdlow NR, 2001, PSYCHOPHARMACOLOGY, V156, P194, DOI 10.1007/s002130100799; Uchida K, 2002, ZOOL SCI, V19, P1211, DOI 10.2108/zsj.19.1211; Veerkamp JH, 2001, J MOL NEUROSCI, V16, P133, DOI 10.1385/JMN:16:2-3:133; Venna VR, 2009, PSYCHONEUROENDOCRINO, V34, P199, DOI 10.1016/j.psyneuen.2008.08.025; Watanabe A, 2007, PLOS BIOL, V5, P2469, DOI 10.1371/journal.pbio.0050297	48	87	91	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5085	10.1371/journal.pone.0005085	http://dx.doi.org/10.1371/journal.pone.0005085			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437RX	19352438	Green Published, gold, Green Submitted			2022-12-25	WOS:000265505700008
J	Eme, L; Moreira, D; Talla, E; Brochier-Armanet, C				Eme, Laura; Moreira, David; Talla, Emmanuel; Brochier-Armanet, Celine			A Complex Cell Division Machinery Was Present in the Last Common Ancestor of Eukaryotes	PLOS ONE			English	Article								Background: The midbody is a transient complex structure containing proteins involved in cytokinesis. Up to now, it has been described only in Metazoa. Other eukaryotes present a variety of structures implied in the last steps of cell division, such as the septum in fungi or the phragmoplast in plants. However, it is unclear whether these structures are homologous (derive from a common ancestral structure) or analogous (have distinct evolutionary origins). Recently, the proteome of the hamster midbody has been characterized and 160 proteins identified. Methodology/Principal Findings: Using phylogenomic approaches, we show here that nearly all of these 160 proteins (95%) are conserved across metazoan lineages. More surprisingly, we show that a large part of the mammalian midbody components (91 proteins) were already present in the last common ancestor of all eukaryotes (LECA) and were most likely involved in the construction of a complex multi-protein assemblage acting in cell division. Conclusions/Significance: Our results indicate that the midbodies of non-mammalian metazoa are likely very similar to the mammalian one and that the ancestor of Metazoa possessed a nearly modern midbody. Moreover, our analyses support the hypothesis that the midbody and the structures involved in cytokinesis in other eukaryotes derive from a large and complex structure present in LECA, likely involved in cytokinesis. This is an additional argument in favour of the idea of a complex ancestor for all contemporary eukaryotes.	[Eme, Laura; Talla, Emmanuel; Brochier-Armanet, Celine] CNRS, Chim Bacterienne Lab, UPR 9043, F-13277 Marseille, France; [Moreira, David] Univ Paris 11, CNRS, UMR 8079, Unite Ecol Syst Evolut, Orsay, France; [Talla, Emmanuel] Univ Aix Marseille 2, Marseille, France; [Brochier-Armanet, Celine] Univ Aix Marseille 1, Marseille, France	Centre National de la Recherche Scientifique (CNRS); AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Eme, L (corresponding author), CNRS, Chim Bacterienne Lab, UPR 9043, F-13277 Marseille, France.	celine.brochier@ifr88.cnrs-mrs.fr	Moreira, David/F-7445-2012; Eme, Laura/G-8468-2015; Brochier-Armanet, Celine/B-7898-2011	Moreira, David/0000-0002-2064-5354; Eme, Laura/0000-0002-0510-8868; Brochier-Armanet, Celine/0000-0003-4669-3589; TALLA, Emmanuel/0000-0002-7775-8296	Ministre de l'Enseignement Superieur et de la Recherche; Action Thematique et Incitative sur Programme (ATIP) of the French Centre National de la Recherche Scientifique, CNRS; French Agence Nationale de la Recherche [JC05_44674]	Ministre de l'Enseignement Superieur et de la Recherche; Action Thematique et Incitative sur Programme (ATIP) of the French Centre National de la Recherche Scientifique, CNRS(Centre National de la Recherche Scientifique (CNRS)); French Agence Nationale de la Recherche(French National Research Agency (ANR))	LE is the recipient of a grant from the Ministre de l'Enseignement Superieur et de la Recherche. CBA is supported by an Action Thematique et Incitative sur Programme (ATIP) of the French Centre National de la Recherche Scientifique, CNRS. This work was supported by a grant from the French Agence Nationale de la Recherche (ANR JC05_44674). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bapteste E, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r85; Bischoff JR, 1999, TRENDS CELL BIOL, V9, P454, DOI 10.1016/S0962-8924(99)01658-X; Broadwater S.J., 1992, CYTOSKELETON ALGAE, P93; Collins L, 2005, MOL BIOL EVOL, V22, P1053, DOI 10.1093/molbev/msi091; Dacks JB, 2007, J CELL SCI, V120, P2977, DOI 10.1242/jcs.013250; Demidov D, 2005, PLANT CELL, V17, P836, DOI 10.1105/tpc.104.029710; DURBIN R, 1999, BIOL SEQUENCE ANAL; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Eisen JA, 2003, SCIENCE, V300, P1706, DOI 10.1126/science.1086292; Eisen JA, 1999, MUTAT RES-DNA REPAIR, V435, P171, DOI 10.1016/S0921-8777(99)00050-6; Field C, 1999, CURR OPIN CELL BIOL, V11, P68, DOI 10.1016/S0955-0674(99)80009-X; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Flemming W., 1891, ARCH MIKROSK ANAT, V37, P685, DOI [DOI 10.1007/BF02954311, 10.1007/BF02954311]; Fogel MA, 2006, GENE DEV, V20, P3269, DOI 10.1101/gad.1496506; FRANKE WW, 1970, Z ZELLFORSCH MIK ANA, V105, P405, DOI 10.1007/BF00335464; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; Guertin DA, 2002, MICROBIOL MOL BIOL R, V66, P155, DOI 10.1128/MMBR.66.2.155-178.2002; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Jurgens G, 2005, ANNU REV PLANT BIOL, V56, P281, DOI 10.1146/annurev.arplant.55.031903.141636; Jurgens G, 2005, TRENDS CELL BIOL, V15, P277, DOI 10.1016/j.tcb.2005.03.005; Kanoh J, 2003, CELL MOL LIFE SCI, V60, P2295, DOI 10.1007/s00018-003-3245-y; Ke YW, 2003, CELL RES, V13, P69, DOI 10.1038/sj.cr.7290152; Keith W Nicol, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402004507; Koumandou VL, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-29; LAMOND AI, 1993, BIOESSAYS, V15, P595, DOI 10.1002/bies.950150905; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Lopez-Bautista JM, 2003, INT J SYST EVOL MICR, V53, P1715, DOI 10.1099/ijs.0.02561-0; Makarova KS, 2005, NUCLEIC ACIDS RES, V33, P4626, DOI 10.1093/nar/gki775; Mans BJ, 2004, CELL CYCLE, V3, P1612; MULLINS JM, 1982, J CELL BIOL, V94, P654, DOI 10.1083/jcb.94.3.654; Neujahr R, 1998, J CELL SCI, V111, P1227; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Obuse C, 2004, GENES CELLS, V9, P105, DOI 10.1111/j.1365-2443.2004.00705.x; Ohno S., 1970, EVOLUTION GENE DUPLI; Otegui MS, 2005, TRENDS CELL BIOL, V15, P404, DOI 10.1016/j.tcb.2005.06.003; Pazour GJ, 2004, CURR BIOL, V14, pR575, DOI 10.1016/j.cub.2004.07.017; PHILIPPE H, 1993, NUCLEIC ACIDS RES, V21, P5264, DOI 10.1093/nar/21.22.5264; Pickett-Heaps JD, 1999, AM J BOT, V86, P153, DOI 10.2307/2656933; Robinson DN, 2000, TRENDS CELL BIOL, V10, P228, DOI 10.1016/S0962-8924(00)01747-5; SAWITZKY H, 1995, J CELL BIOL, V130, P1359, DOI 10.1083/jcb.130.6.1359; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Staub E, 2004, BIOESSAYS, V26, P567, DOI 10.1002/bies.20032; Striepen B, 2007, PLOS PATHOG, V3, P691, DOI 10.1371/journal.ppat.0030078; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; Terada Y, 2001, CELL STRUCT FUNCT, V26, P653, DOI 10.1247/csf.26.653; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Verma DPS, 2001, ANNU REV PLANT PHYS, V52, P751, DOI 10.1146/annurev.arplant.52.1.751; Walther A, 2003, FUNGAL GENET BIOL, V40, P187, DOI 10.1016/j.fgb.2003.08.005	50	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2009	4	4							e5021	10.1371/journal.pone.0005021	http://dx.doi.org/10.1371/journal.pone.0005021			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RT	19352429	Green Published, gold, Green Submitted			2022-12-25	WOS:000265505300004
J	Reffay, M; Gambin, Y; Benabdelhak, H; Phan, G; Taulier, N; Ducruix, A; Hodges, RS; Urbach, W				Reffay, Myriam; Gambin, Yann; Benabdelhak, Houssain; Phan, Gilles; Taulier, Nicolas; Ducruix, Arnaud; Hodges, Robert S.; Urbach, Wladimir			Tracking Membrane Protein Association in Model Membranes	PLOS ONE			English	Article							DILUTE SURFACTANT SOLUTIONS; BICONTINUOUS CUBIC PHASES; MULTIDRUG EFFLUX SYSTEM; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; FUSION PROTEIN; SPONGE PHASES; X-RAY; ANALYTICAL ULTRACENTRIFUGATION	Membrane proteins are essential in the exchange processes of cells. In spite of great breakthrough in soluble proteins studies, membrane proteins structures, functions and interactions are still a challenge because of the difficulties related to their hydrophobic properties. Most of the experiments are performed with detergent-solubilized membrane proteins. However widely used micellar systems are far from the biological two-dimensions membrane. The development of new biomimetic membrane systems is fundamental to tackle this issue. We present an original approach that combines the Fluorescence Recovery After fringe Pattern Photobleaching technique and the use of a versatile sponge phase that makes it possible to extract crucial informations about interactions between membrane proteins embedded in the bilayers of a sponge phase. The clear advantage lies in the ability to adjust at will the spacing between two adjacent bilayers. When the membranes are far apart, the only possible interactions occur laterally between proteins embedded within the same bilayer, whereas when membranes get closer to each other, interactions between proteins embedded in facing membranes may occur as well. After validating our approach on the streptavidin-biotinylated peptide complex, we study the interactions between two membrane proteins, MexA and OprM, from a Pseudomonas aeruginosa efflux pump. The mode of interaction, the size of the protein complex and its potential stoichiometry are determined. In particular, we demonstrate that: MexA is effectively embedded in the bilayer; MexA and OprM do not interact laterally but can form a complex if they are embedded in opposite bilayers; the population of bound proteins is at its maximum for bilayers separated by a distance of about 200 angstrom, which is the periplasmic thickness of Pseudomonas aeruginosa. We also show that the MexA-OprM association is enhanced when the position and orientation of the protein is restricted by the bilayers. We extract a stoichiometry for the complex that exhibits a strong pH dependance: from 2 to 6 MexA per OprM trimer when the pH decreases from 7.5 to 5.5. Our technique allows to study membrane protein associations in a membrane environment. It provides some challenging information about complexes such as geometry and stoichiometry.	[Reffay, Myriam; Gambin, Yann; Urbach, Wladimir] Univ Paris 06, CNRS, Phys Stat Lab, Ecole Normale Super,UMR 8550, Paris, France; [Benabdelhak, Houssain; Taulier, Nicolas; Urbach, Wladimir] Univ Paris 06, UPMC, Lab Imager Parametrique, UMR 7623, Paris, France; [Benabdelhak, Houssain; Taulier, Nicolas] CNRS, LIP, UMR 7623, Paris, France; [Phan, Gilles; Ducruix, Arnaud] Univ Paris 05, Lab Cristallograph RMN Biol, CNRS, UMR8015, Paris, France; [Hodges, Robert S.] Univ Colorado, Dept Biochem & Mol Genet, Denver, CO USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; University of Colorado System; University of Colorado Denver	Reffay, M (corresponding author), Univ Paris 06, CNRS, Phys Stat Lab, Ecole Normale Super,UMR 8550, Paris, France.	urbach@lps.ens.fr	GAMBIN, Yann/M-8799-2014; Taulier, Nicolas/C-3965-2011; URBACH, Wladimir/AAA-5969-2022; REFFAY, Myriam/D-3736-2018; GAMBIN, Yann/AAI-8501-2021; Urbach, Wladimir/AAG-9004-2019	Taulier, Nicolas/0000-0003-1017-1068; URBACH, Wladimir/0000-0002-1673-6923; Urbach, Wladimir/0000-0002-1673-6923; Reffay, Myriam/0000-0002-3695-2789; GAMBIN, Yann/0000-0001-7378-8976	Ministere de l'Education, de la Recherche et de la Technologie (MERT); ANR-BLANC eFFLUX [0263-01]	Ministere de l'Education, de la Recherche et de la Technologie (MERT); ANR-BLANC eFFLUX(French National Research Agency (ANR))	MR and GP were supported by a fellowship from the Ministere de l'Education, de la Recherche et de la Technologie (MERT). Financial support from ANR-BLANC eFFLUX 0263-01 is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akama H, 2004, J BIOL CHEM, V279, P52816, DOI 10.1074/jbc.C400445200; Akama H, 2004, J BIOL CHEM, V279, P25939, DOI 10.1074/jbc.C400164200; Andersen C, 2000, EMBO REP, V1, P313, DOI 10.1093/embo-reports/kvd075; ANDERSON DM, 1990, J PHYS CHEM-US, V94, P8683, DOI 10.1021/j100387a012; BALINOV B, 1991, J PHYS CHEM-US, V95, P5931, DOI 10.1021/j100168a041; Bokma E, 2006, FEBS LETT, V580, P5339, DOI 10.1016/j.febslet.2006.09.005; Broutin I, 2005, ACTA CRYSTALLOGR F, V61, P315, DOI 10.1107/S1744309105005014; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Camacho-Carvajal MM, 2004, MOL CELL PROTEOMICS, V3, P176, DOI 10.1074/mcp.T300010-MCP200; CATES ME, 1988, EUROPHYS LETT, V5, P733, DOI 10.1209/0295-5075/5/8/012; CATES ME, 1990, J PHYS-CONDENS MAT, V2, pSA339, DOI 10.1088/0953-8984/2/S/053; Cooper MA, 2007, J MOL RECOGNIT, V20, P154, DOI 10.1002/jmr.826; COULON C, 1991, PHYS REV LETT, V66, P1709, DOI 10.1103/PhysRevLett.66.1709; DAVOUST J, 1982, EMBO J, V1, P1233, DOI 10.1002/j.1460-2075.1982.tb00018.x; Ebel C, 2000, BIOPHYS J, V78, P385, DOI 10.1016/S0006-3495(00)76601-X; Fernandez-Recio J, 2004, FEBS LETT, V578, P5, DOI 10.1016/j.febslet.2004.10.097; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Freyssingeas E, 1996, LANGMUIR, V12, P6028, DOI 10.1021/la9605246; Gambin Y, 2006, P NATL ACAD SCI USA, V103, P2098, DOI 10.1073/pnas.0511026103; GAMBIN Y, 2006, THESIS UPMC PARIS; GRAHAM LL, 1991, TRENDS BIOCHEM SCI, V16, P328, DOI 10.1016/0968-0004(91)90135-I; HELM CA, 1991, P NATL ACAD SCI USA, V88, P8169, DOI 10.1073/pnas.88.18.8169; HENDRICKSON WA, 1989, P NATL ACAD SCI USA, V86, P2190, DOI 10.1073/pnas.86.7.2190; Higgins MK, 2004, P NATL ACAD SCI USA, V101, P9994, DOI 10.1073/pnas.0400375101; Ip H, 2003, J BIOL CHEM, V278, P50474, DOI 10.1074/jbc.M305152200; KALB E, 1992, THIN SOLID FILMS, V210, P763, DOI 10.1016/0040-6090(92)90397-T; Katsamba PS, 2002, METHODS, V26, P95, DOI 10.1016/S1046-2023(02)00012-9; Kleman M, 1999, PRAMANA-J PHYS, V53, P107, DOI 10.1007/s12043-999-0143-3; Kurtisovski E, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.258103; Lambert O, 2005, J STRUCT BIOL, V150, P50, DOI 10.1016/j.jsb.2005.01.001; Laurer JH, 1997, LANGMUIR, V13, P2177, DOI 10.1021/la9608876; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; LIVNAH O, 1993, P NATL ACAD SCI USA, V90, P5076, DOI 10.1073/pnas.90.11.5076; Lu JR, 1998, J PHYS CHEM B, V102, P5785, DOI 10.1021/jp973315i; Mahjoub HF, 1998, PHYS REV LETT, V81, P2076, DOI 10.1103/PhysRevLett.81.2076; Maldonado A, 2004, J PHYS CHEM B, V108, P2893, DOI 10.1021/jp0266751; Maldonado A, 1996, PHYS REV E, V54, P1774, DOI 10.1103/PhysRevE.54.1774; McKeegan KS, 2003, TRENDS MICROBIOL, V11, P21, DOI 10.1016/S0966-842X(02)00010-0; Mokhonov V, 2005, PROTEIN EXPRES PURIF, V40, P91, DOI 10.1016/j.pep.2004.10.002; Naji A, 2007, BIOPHYS J, V93, pL49, DOI 10.1529/biophysj.l07.119222; Narita S, 2003, BIOCHEM BIOPH RES CO, V308, P922, DOI 10.1016/S0006-291X(03)01512-2; Poole K, 2001, CURR OPIN MICROBIOL, V4, P500, DOI 10.1016/S1369-5274(00)00242-3; PORTE G, 1992, J PHYS-CONDENS MAT, V4, P8649, DOI 10.1088/0953-8984/4/45/002; PORTE G, 1989, J PHYS-PARIS, V50, P1335, DOI 10.1051/jphys:0198900500110133500; REFFAY M, 2007, THESIS UPMC PARIS; Rivas G, 1999, METHODS, V19, P194, DOI 10.1006/meth.1999.0851; ROUX D, 1992, J PHYS CHEM-US, V96, P4174, DOI 10.1021/j100190a017; Savage DF, 2003, PLOS BIOL, V1, P334, DOI 10.1371/journal.pbio.0000072; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SKOURI M, 1991, J PHYS II, V1, P1121, DOI 10.1051/jp2:1991208; Stone HA, 1998, J FLUID MECH, V369, P151, DOI 10.1017/S0022112098001980; STREY R, 1990, LANGMUIR, V6, P1635, DOI 10.1021/la00101a003; SWORDS NA, 1993, BIOCHEM J, V289, P215, DOI 10.1042/bj2890215; Touze T, 2004, MOL MICROBIOL, V53, P697, DOI 10.1111/j.1365-2958.2004.04158.x; Trepout S, 2007, LANGMUIR, V23, P2647, DOI 10.1021/la062227z; VANEDE J, 1989, J CHROMATOGR, V476, P319, DOI 10.1016/S0021-9673(01)93879-8; Wadsten P, 2006, J MOL BIOL, V364, P44, DOI 10.1016/j.jmb.2006.06.043; Yoneyama H, 2000, J BIOL CHEM, V275, P4628, DOI 10.1074/jbc.275.7.4628; Zgurskaya HI, 1999, P NATL ACAD SCI USA, V96, P7190, DOI 10.1073/pnas.96.13.7190	59	25	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5035	10.1371/journal.pone.0005035	http://dx.doi.org/10.1371/journal.pone.0005035			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337368	Green Published, gold			2022-12-25	WOS:000265500600011
J	Gomes, I; Grushko, JS; Golebiewska, U; Hoogendoorn, S; Gupta, A; Heimann, AS; Ferro, ES; Scarlata, S; Fricker, LD; Devi, LA				Gomes, Ivone; Grushko, Julia S.; Golebiewska, Urszula; Hoogendoorn, Sascha; Gupta, Achla; Heimann, Andrea S.; Ferro, Emer S.; Scarlata, Suzanne; Fricker, Lloyd D.; Devi, Lakshmi A.			Novel endogenous peptide agonists of cannabinoid receptors	FASEB JOURNAL			English	Article						G-protein-coupled receptors; pain; analgesia; drug abuse	INCREASES INTRACELLULAR CALCIUM; CPE(FAT/FAT) MOUSE HYPOTHALAMUS; DIAZEPAM BINDING INHIBITOR; STABLE ISOTOPIC TAGS; FUNCTIONAL-CHARACTERIZATION; QUANTITATIVE PEPTIDOMICS; NEURITE OUTGROWTH; AT(4) RECEPTOR; CB2 RECEPTORS; RAT-BRAIN	Hemopressin (Hp), a 9-residue alpha-hemoglobin-derived peptide, was previously reported to function as a CB1 cannabinoid receptor antagonist (1). In this study, we report that mass spectrometry (MS) data from peptidomics analyses of mouse brain extracts identified N-terminally extended forms of Hp containing either three (RVD-Hp alpha) or two (VD-Hp alpha) additional amino acids, as well as a beta-hemoglobinderived peptide with sequence similarity to that of hemopressin (VD-Hp beta). Characterization of the alpha-hemoglobin-derived peptides using binding and functional assays shows that in contrast to Hp, which functions as a CB1 cannabinoid receptor antagonist, both RVD-Hp alpha and VD-Hp alpha function as agonists. Studies examining the increase in the phosphorylation of ERK1/2 levels or release of intracellular Ca2+ indicate that these peptides activate a signal transduction pathway distinct from that activated by the endo-cannabinoid, 2-arachidonoylglycerol, or the classic CB1 agonist, Hu-210. This finding suggests an additional mode of regulation of endogenous cannabinoid receptor activity. Taken together, these results suggest that the CB1 receptor is involved in the integration of signals from both lipid-and peptide-derived signaling molecules.-Gomes, I., Grushko, J. S., Golebiewska, U., Hoogendoorn, S., Gupta, A., Heimann, A. S., Ferro, E. S., Scarlata, S., Fricker, L. D., Devi, L. A. Novel endogenous peptide agonists of cannabinoid receptors. FASEB J. 23, 3020-3029 (2009). www.fasebj.org	[Gomes, Ivone; Hoogendoorn, Sascha; Gupta, Achla; Devi, Lakshmi A.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Grushko, Julia S.; Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Mol Pharmacol, New York, NY USA; [Golebiewska, Urszula; Scarlata, Suzanne] SUNY Stony Brook, Dept Physiol & Biophys, Med Ctr, New York, NY USA; [Heimann, Andrea S.] Proteimax Biotechnol Ltd, Cotia, Brazil; [Ferro, Emer S.] Univ Sao Paulo, Dept Cell Biol & Dev, Inst Biomed Sci, Sao Paulo, Brazil	Icahn School of Medicine at Mount Sinai; Yeshiva University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Universidade de Sao Paulo	Devi, LA (corresponding author), Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, 1 Gustave L Levy Pl,Box 1603, New York, NY 10029 USA.	lakshmi.devi@mssm.edu	Ferro, Emer S/D-3908-2012; Devi P, Lakshmi/GXM-5982-2022	Ferro, Emer S/0000-0003-1651-9192; Devi P, Lakshmi/0000-0001-9274-4776; Hoogendoorn, Sascha/0000-0002-1155-8697	NIH [DA019521, GM05313, GM071558, DA04494, DK51271]; Zwanenberg Foundation Fellowship; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [04/04933-2, 04/14258-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA019521, R01DA004494] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Zwanenberg Foundation Fellowship; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants (DA019521 to L.A.D., GM05313 to S. S., GM071558 to L.A.D. and S.S., and DA04494 and DK51271 to L.D.F.), by a Zwanenberg Foundation Fellowship (to S.H.), by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Grants 04/04933-2 to E.S.F. and 04/14258-0 to A.S.H.), and by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (E.S.F.). Mass spectrometry was performed through Rede de Proteoma do Estado de Sao Paulo in the Laboratorio Nacional de Luz Sincrotron, Campinas, Sao Paulo, Brazil. We thank Dr. K. Mackie (Indiana University, Bloomington, IN, USA) for the plasmid cDNAs for CB1 cannabinoid and CB2 cannabinoid receptors and for GPR55. We also thank Emeline Maillet and Robert Margolskee for help with analysis using the FLEX Station.	Badamchian M, 2007, ANN NY ACAD SCI, V1112, P458, DOI 10.1196/annals.1415.046; Battista Natalia, 2006, Ital J Biochem, V55, P283; Bazinet RP, 2005, NEUROCHEM RES, V30, P597, DOI 10.1007/s11064-005-2746-5; Begg M, 2005, PHARMACOL THERAPEUT, V106, P133, DOI 10.1016/j.pharmthera.2004.11.005; Bhaskaran M, 2005, BIOCHEM BIOPH RES CO, V333, P1348, DOI 10.1016/j.bbrc.2005.06.042; Boyd ST, 2006, PHARMACOTHERAPY, V26, p218S, DOI 10.1592/phco.26.12part2.218S; BRANTL V, 1986, EUR J PHARMACOL, V125, P309, DOI 10.1016/0014-2999(86)90044-0; Che FY, 2007, J PROTEOME RES, V6, P4667, DOI 10.1021/pr060690r; Che FY, 2006, J MOL NEUROSCI, V28, P265, DOI 10.1385/JMN:28:3:265; Che FY, 2005, MOL CELL PROTEOMICS, V4, P1391, DOI 10.1074/mcp.T500010-MCP200; Che FY, 2005, J MASS SPECTROM, V40, P227, DOI 10.1002/jms.742; Che FY, 2005, J MASS SPECTROM, V40, P238, DOI 10.1002/jms.743; Che FY, 2005, J BIOL CHEM, V280, P4451, DOI 10.1074/jbc.M411178200; COSTA E, 1991, LIFE SCI, V49, P325, DOI 10.1016/0024-3205(91)90440-M; Coutts AA, 2001, J NEUROSCI, V21, P2425; Dassen H, 2008, HUM REPROD, V23, P635, DOI 10.1093/humrep/dem430; Decaillot FM, 2006, J MOL NEUROSCI, V28, P277, DOI 10.1385/JMN:28:3:277; Di Marzo V, 2007, CURR OPIN LIPIDOL, V18, P129, DOI 10.1097/MOL.0b013e32803dbdec; Drake MT, 2008, J BIOL CHEM, V283, P5669, DOI 10.1074/jbc.M708118200; Ferro ES, 2004, PROTEIN PEPTIDE LETT, V11, P415, DOI 10.2174/0929866043406706; Fricker LD, 2006, MASS SPECTROM REV, V25, P327, DOI 10.1002/mas.20079; Fricker LD, 2007, ENDOCRINOLOGY, V148, P4185, DOI 10.1210/en.2007-0123; FUKUI K, 1983, NEUROPHARMACOLOGY, V22, P191, DOI 10.1016/0028-3908(83)90008-4; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Goldstein AL, 2005, TRENDS MOL MED, V11, P421, DOI 10.1016/j.molmed.2005.07.004; Gomes I, 2003, METH MOLEC MED, V84, P157; Goumon Y, 2004, J BIOL CHEM, V279, P13054, DOI 10.1074/jbc.M308533200; He JCJ, 2005, J BIOL CHEM, V280, P33426, DOI 10.1074/jbc.M502812200; Heimann AS, 2007, P NATL ACAD SCI USA, V104, P20588, DOI 10.1073/pnas.0706980105; Howlett AC, 2000, CHEM PHYS LIPIDS, V108, P53, DOI 10.1016/S0009-3084(00)00187-0; Hsieh C, 1999, J NEUROCHEM, V73, P493, DOI 10.1046/j.1471-4159.1999.0730493.x; Iversen L, 2002, CURR OPIN PHARMACOL, V2, P50, DOI 10.1016/S1471-4892(01)00120-5; Jordan JD, 2005, J BIOL CHEM, V280, P11413, DOI 10.1074/jbc.M411521200; Lauckner JE, 2008, P NATL ACAD SCI USA, V105, P2699, DOI 10.1073/pnas.0711278105; Lauckner JE, 2005, P NATL ACAD SCI USA, V102, P19144, DOI 10.1073/pnas.0509588102; Lee J, 2003, J PHARMACOL EXP THER, V305, P205, DOI 10.1124/jpet.102.045492; LIEBMANN C, 1997, EUR J PHARMACOL, V166, P523; Lim J, 2006, J NEUROCHEM, V96, P1169, DOI 10.1111/j.1471-4159.2005.03614.x; Liu LM, 1999, P NATL ACAD SCI USA, V96, P6643, DOI 10.1073/pnas.96.12.6643; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; MILLINGTON WR, 1991, J NEUROCHEM, V57, P775, DOI 10.1111/j.1471-4159.1991.tb08219.x; Moeller I, 1997, J NEUROCHEM, V68, P2530; Mukai H, 2008, J BIOL CHEM, V283, P30596, DOI 10.1074/jbc.M803913200; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Newton DA, 2006, J BIOL CHEM, V281, P5668, DOI 10.1074/jbc.M509314200; Nishi H, 2008, J AM SOC NEPHROL, V19, P1500, DOI 10.1681/ASN.2007101085; Ojika K, 2000, PROG NEUROBIOL, V60, P37, DOI 10.1016/S0301-0082(99)00021-0; Pan H, 2005, BIOCHEMISTRY-US, V44, P4939, DOI 10.1021/bi047852m; Pan H, 2006, J NEUROCHEM, V98, P1763, DOI 10.1111/j.1471-4159.2006.04067.x; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; Pertwee RG, 2002, PROSTAG LEUKOTR ESS, V66, P101, DOI 10.1054/plef.2001.0341; Richter F, 2009, J COMP NEUROL, V515, P538, DOI 10.1002/cne.22062; Skold K, 2007, PROTEOMICS, V7, P4445, DOI 10.1002/pmic.200700142; SLOBODYANSKY E, 1989, J NEUROCHEM, V53, P1276, DOI 10.1111/j.1471-4159.1989.tb07425.x; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Wride MA, 2003, MOL VIS, V9, P360; Zhang J, 2003, EUR J NEUROSCI, V17, P2750, DOI 10.1046/j.1460-9568.2003.02704.x	57	113	126	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2009	23	9					3020	3029		10.1096/fj.09-132142	http://dx.doi.org/10.1096/fj.09-132142			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19380512	Green Published			2022-12-25	WOS:000270241000024
J	Leyris, JP; Gondeau, C; Charnet, A; Delattre, C; Rousset, M; Cens, T; Charnet, P				Leyris, J. -P.; Gondeau, C.; Charnet, A.; Delattre, C.; Rousset, M.; Cens, T.; Charnet, P.			RGK GTPase-dependent Ca(V)2.1 Ca2+ channel inhibition is independent of Ca-V beta-subunit-induced current potentiation	FASEB JOURNAL			English	Article						Gem; Rem; Rem2; Xenopus oocytes; GK domain	CALCIUM-CHANNEL; MOLECULAR DETERMINANTS; BINDING PROTEINS; ALPHA-SUBUNIT; KINASE DOMAIN; VOLTAGE; REM; CALMODULIN; EXPRESSION; COMPLEX	RGK (Rad-Gem-Rem) GTPases have been described as potent negative regulators of the Ca2+ influx via high-threshold voltage-activated Ca2+ channels. Recent work, mostly performed on Ca(V)1.2 Ca2+ channels, has highlighted the crucial role played by the channel auxiliary Ca-V beta subunits and identified several GTPase and beta-subunit protein domains involved in this regulation. We now extend these conclusions by producing the first complete characterization of the effects of Gem, Rem, and Rem2 on the neuronal Ca(V)2.1 Ca2+ channels expressed with Ca-V beta(1) or Ca-V beta(2) subunits. Current inhibition is limited to a decrease in amplitude with no modification in the voltage dependence or kinetics of the current. We demonstrate that this inhibition can occur for Ca-V beta constructs with impaired capacity to induce current potentiation, but that it is lost for Ca-V beta constructs deleted for their beta-interaction domain. The RGK C-terminal last similar to 80 amino acids are sufficient to allow potent current inhibition and in vivo beta-subunit/Gem interaction. Interestingly, although Gem and Gem carboxy-terminus induce a completely different pattern of beta-subunit cellular localization, they both potently inhibit CaV2.1 channels. These data therefore set the status of neuronal Ca(V)2.1 Ca2+ channel inhibition by RGK GTPases, emphasizing the role of short amino acid sequences of both proteins in beta-subunit binding and channel inhibition and revealing a new mechanism for channel inhibition.-Leyris, J.-P., Gondeau, C., Charnet, A., Delattre, C., Rousset, M., Cens, T., Charnet, P. RGK GTPase-dependent Ca(V)2.1 Ca2+ channel inhibition is independent of Ca-V beta-subunit-induced current potentiation. FASEB J. 23, 2627-2638 (2009)	[Charnet, P.] Univ Montpellier 1 & 2, CNRS, CRBM, UMR 5237, F-34293 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Charnet, P (corresponding author), Univ Montpellier 1 & 2, CNRS, CRBM, UMR 5237, 1919 Rte Mende, F-34293 Montpellier, France.	pierre.charnet@crbm.cnrs.fr	Cens, Thierry/M-3337-2017	Cens, Thierry/0000-0002-4109-2779; Rousset, Matthieu/0000-0003-2064-2791; Charnet, Pierre/0000-0003-4692-528X	CNRS; INSERM; Association pour la Recherche contre le Cancer; Fondation pour la Recherche sur le Cerveau; Fondation Simone et Cino del Duca; Agence Nationale de la Recherche	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Fondation pour la Recherche sur le Cerveau; Fondation Simone et Cino del Duca; Agence Nationale de la Recherche(French National Research Agency (ANR))	The authors thank Dr. D. Fesquet, P. Fort, and M. C. Morris (CRBM, Montpellier, France) and Dr. I. A. Lefevre (SanofiAventis, Montpellier, France) for helpful discussions and proofreading of the manuscript; J.-M. Donnay and J.-C. Mazure for oocyte preparation; and CNRS, INSERM, Association pour la Recherche contre le Cancer, Fondation pour la Recherche sur le Cerveau, Fondation Simone et Cino del Duca, and Agence Nationale de la Recherche for financial support.	Altier C, 2002, J BIOL CHEM, V277, P33598, DOI 10.1074/jbc.M202476200; Beguin P, 2005, J CELL SCI, V118, P1923, DOI 10.1242/jcs.02321; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Beguin P, 2007, J BIOL CHEM, V282, P11509, DOI 10.1074/jbc.M606423200; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; BOURINET E, 1992, FEBS LETT, V299, P5, DOI 10.1016/0014-5793(92)80087-W; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Cens T, 2005, MOL B INT U, P95; Cens T, 1998, J BIOL CHEM, V273, P18308, DOI 10.1074/jbc.273.29.18308; Cens T, 1998, PFLUG ARCH EUR J PHY, V435, P865, DOI 10.1007/s004240050595; Cens T, 1999, J BIOL CHEM, V274, P5483, DOI 10.1074/jbc.274.9.5483; Chen HM, 2005, J NEUROSCI, V25, P9762, DOI 10.1523/JNEUROSCI.3111-05.2005; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Correll RN, 2008, CELL SIGNAL, V20, P292, DOI 10.1016/j.cellsig.2007.10.028; Correll RN, 2007, J BIOL CHEM, V282, P28431, DOI 10.1074/jbc.M706176200; Crump SM, 2006, AM J PHYSIOL-HEART C, V291, pH1959, DOI 10.1152/ajpheart.00956.2005; DEWAARD M, 1994, NEURON, V13, P495, DOI 10.1016/0896-6273(94)90363-8; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Finlin BS, 2006, J BIOL CHEM, V281, P23557, DOI 10.1074/jbc.M604867200; Finlin BS, 2005, J BIOL CHEM, V280, P41864, DOI 10.1074/jbc.M414261200; Finlin BS, 2003, P NATL ACAD SCI USA, V100, P14469, DOI 10.1073/pnas.2437756100; Fischer R, 1996, J BIOL CHEM, V271, P25067, DOI 10.1074/jbc.271.41.25067; Flynn R, 2008, BIOCHEM BIOPH RES CO, V368, P827, DOI 10.1016/j.bbrc.2008.02.020; Gao TY, 2001, J BIOL CHEM, V276, P21089, DOI 10.1074/jbc.M008000200; Gerster U, 1999, J PHYSIOL-LONDON, V517, P353, DOI 10.1111/j.1469-7793.1999.0353t.x; Hanlon MR, 1999, FEBS LETT, V445, P366, DOI 10.1016/S0014-5793(99)00156-8; Hibino H, 2003, P NATL ACAD SCI USA, V100, P307, DOI 10.1073/pnas.0136791100; Hulme JT, 2006, J PHYSIOL-LONDON, V576, P87, DOI 10.1113/jphysiol.2006.111799; Iftinca M, 2007, NAT NEUROSCI, V10, P854, DOI 10.1038/nn1921; Kiyonaka S, 2007, NAT NEUROSCI, V10, P691, DOI 10.1038/nn1904; Kobayashi T, 2007, BIOCHEM BIOPH RES CO, V360, P679, DOI 10.1016/j.bbrc.2007.06.112; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leone A, 2001, ONCOGENE, V20, P3217, DOI 10.1038/sj.onc.1204420; Mahalakshmi RN, 2007, TRAFFIC, V8, P1150, DOI 10.1111/j.1600-0854.2007.00598.x; McGee AW, 2004, NEURON, V42, P89, DOI 10.1016/S0896-6273(04)00149-7; Murata M, 2004, CIRC RES, V95, P398, DOI 10.1161/01.RES.0000138449.85324.c5; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Paradis S, 2007, NEURON, V53, P217, DOI 10.1016/j.neuron.2006.12.012; Piccoli G, 2004, J NEUROSCI, V24, P10918, DOI 10.1523/JNEUROSCI.4020-04.2004; Restituito S, 2000, J NEUROSCI, V20, P9046; Sasaki T, 2005, J BIOL CHEM, V280, P9308, DOI 10.1074/jbc.M413773200; Seu L, 2006, J GEN PHYSIOL, V128, P605, DOI 10.1085/jgp.200609631; Splingard A, 2007, J BIOL CHEM, V282, P1905, DOI 10.1074/jbc.M604363200; STARR TVB, 1991, P NATL ACAD SCI USA, V88, P5621, DOI 10.1073/pnas.88.13.5621; Takahashi SX, 2005, J GEN PHYSIOL, V126, P365, DOI 10.1085/jgp.200509354; Tareilus E, 1997, P NATL ACAD SCI USA, V94, P1703, DOI 10.1073/pnas.94.5.1703; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Walker D, 1998, TRENDS NEUROSCI, V21, P148, DOI 10.1016/S0166-2236(97)01200-9; Walker D, 1998, J BIOL CHEM, V273, P2361, DOI 10.1074/jbc.273.4.2361; Ward Y, 2004, MOL CELL BIOL, V24, P651, DOI 10.1128/MCB.24.2.651-661.2004; WEI XY, 1994, J BIOL CHEM, V269, P1635; Yang T, 2007, NAT CHEM BIOL, V3, P795, DOI 10.1038/nchembio.2007.42; Yu K, 2008, J NEUROSCI, V28, P5660, DOI 10.1523/JNEUROSCI.0065-08.2008	54	20	20	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2627	2638		10.1096/fj.08-122135	http://dx.doi.org/10.1096/fj.08-122135			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19332647				2022-12-25	WOS:000268836700031
J	Nilsson, KE; Andren, M; de Stahl, TD; Kleinau, S				Nilsson, Kajsa E.; Andren, Maria; de Stahl, Teresita Diaz; Kleinau, Sandra			Enhanced susceptibility to low-dose collagen-induced arthritis in CR1/2-deficient female mice-possible role of estrogen on CR1 expression	FASEB JOURNAL			English	Article						complement receptor; B cells; knockout mice; autoimmunity	SYSTEMIC-LUPUS-ERYTHEMATOSUS; SOLUBLE COMPLEMENT RECEPTOR; B-CELL ACTIVATION; T-DEPENDENT ANTIGEN; FC-GAMMA-RIIB; II COLLAGEN; DBA/1 MICE; RHEUMATOID-ARTHRITIS; MONOCLONAL-ANTIBODY; INDUCED SUPPRESSION	The influence of complement receptor 1 and 2 (CR1/2) was investigated on the susceptibility to low-dose collagen-induced arthritis (CIA) in wild-type (WT) and CR1/2-deficient DBA/1 mice. Significantly enhanced CIA was observed in female CR1/2-deficient mice compared with WT female mice, while male mutant and WT mice showed similar arthritis development. The enhanced CIA was accompanied with higher complement levels and a prolonged IgM anti-collagen type II response. When investigating whether estrogen contributed to the different arthritis susceptibility, we found that ovariectomy rendered WT females more sensitive to low-dose CIA and to the same extent as CR1/2-deficient females, while CR1/2-deficient mice were unaffected by ovariectomy. Notably, the ovariectomized WT mice displayed reduced CR1(+) B220(+) B-cell numbers and CR1 expression compared with sham-operated WT mice, suggesting a stimulatory effect of estrogen on CR1. In accordance, a significant correlation was observed between reduced CR1 expression in B cells and increased age in healthy female blood donors but not in male donors. Our findings demonstrate an important role of CR1/2 in suppressing CIA in female mice under low-antigen conditions. The data suggest that estrogen promote CR1 expression in B cells. These findings provide insight to the increased frequency of rheumatoid arthritis in postmenopausal women.-Nilsson, K. E., Andren, M., Diaz de Stahl, T., Kleinau, S. Enhanced susceptibility to low-dose collagen-induced arthritis in CR1/2-deficient female mice-possible role of estrogen on CR1 expression. FASEB J. 23, 2450-2458 (2009)	[Nilsson, Kajsa E.; Andren, Maria; Kleinau, Sandra] Uppsala Univ, Dept Cell & Mol Biol, SE-75124 Uppsala, Sweden; [de Stahl, Teresita Diaz] Uppsala Univ, Dept Genet & Pathol, SE-75124 Uppsala, Sweden	Uppsala University; Uppsala University	Kleinau, S (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Box 596, SE-75124 Uppsala, Sweden.	sandra.kleinau@icm.uu.se	Kleinau, Sandra/C-9545-2013	Kleinau, Sandra/0000-0002-9729-2286; Diaz de Stahl, Teresita/0000-0001-5933-6623	Swedish Research Council; Swedish Rheumatism Association; King Gustaf V's 80-years foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Rheumatism Association; King Gustaf V's 80-years foundation	We thank Birgitta Heyman and Sofia Magnusson for critical reading of the manuscript and Dr. Inga Hansson for technical assistance. This work was supported by the Swedish Research Council, the Swedish Rheumatism Association, and the King Gustaf V's 80-years foundation.	Ahearn JM, 1996, IMMUNITY, V4, P251, DOI 10.1016/S1074-7613(00)80433-1; Andren M, 2005, EUR J IMMUNOL, V35, P3020, DOI 10.1002/eji.200526291; Applequist SE, 2000, J IMMUNOL, V165, P2398, DOI 10.4049/jimmunol.165.5.2398; ATKINSON JP, 1989, CLIN EXP RHEUMATOL, V7, pS95; Chakravarty L, 2002, INT IMMUNOL, V14, P139, DOI 10.1093/intimm/14.2.139; CORVETTA A, 1991, J RHEUMATOL, V18, P1021; COURTENAY JS, 1980, NATURE, V283, P666, DOI 10.1038/283666a0; CREAMER P, 1994, BRIT J RHEUMATOL, V33, P583; Croix DA, 1996, J EXP MED, V183, P1857, DOI 10.1084/jem.183.4.1857; de Stahl TD, 2003, J EXP MED, V197, P1183, DOI 10.1084/jem.20022232; Del Nagro CJ, 2005, J IMMUNOL, V175, P5379, DOI 10.4049/jimmunol.175.8.5379; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Dreja H, 2000, ARTHRITIS RHEUM-US, V43, P1698, DOI 10.1002/1529-0131(200008)43:8<1698::AID-ANR5>3.0.CO;2-8; Erdei A, 2003, CURR PHARM DESIGN, V9, P1849, DOI 10.2174/1381612033454351; ERICKSON RP, 1964, J IMMUNOL, V92, P611; Goodfellow RM, 2000, CLIN EXP IMMUNOL, V119, P210, DOI 10.1046/j.1365-2249.2000.01129.x; Grimaldi CM, 2006, CURR OPIN RHEUMATOL, V18, P456, DOI 10.1097/01.bor.0000240354.37927.dd; Grimaldi CM, 2005, MOL IMMUNOL, V42, P811, DOI 10.1016/j.molimm.2004.05.014; Grimaldi CM, 2002, J CLIN INVEST, V109, P1625, DOI 10.1172/JCI200214873; HEBELL T, 1991, SCIENCE, V254, P102, DOI 10.1126/science.1718035; HEYMAN B, 1990, J EXP MED, V172, P665, DOI 10.1084/jem.172.2.665; Hietala MA, 2002, J IMMUNOL, V169, P454, DOI 10.4049/jimmunol.169.1.454; HOLMDAHL R, 1985, CLIN EXP IMMUNOL, V62, P639; Jansson L, 1998, INFLAMM RES, V47, P290, DOI 10.1007/s000110050332; JANSSON L, 1992, CLIN EXP IMMUNOL, V89, P446; JANSSON L, 1990, J AUTOIMMUN, V3, P257, DOI 10.1016/0896-8411(90)90145-I; Jansson L, 2001, ARTHRITIS RHEUM, V44, P2168, DOI 10.1002/1529-0131(200109)44:9<2168::AID-ART370>3.0.CO;2-2; Jozsi M, 2002, J IMMUNOL, V168, P2782, DOI 10.4049/jimmunol.168.6.2782; KERWAR SS, 1983, ARTHRITIS RHEUM, V26, P1120, DOI 10.1002/art.1780260910; KERWAR SS, 1982, J IMMUNOPHARMACOL, V3, P323, DOI 10.3109/08923978109031065; KINOSHITA T, 1988, J IMMUNOL, V140, P3066; Kuhn KA, 2008, MOL IMMUNOL, V45, P2808, DOI 10.1016/j.molimm.2008.01.036; KUMAR A, 1994, IMMUNOBIOLOGY, V191, P9, DOI 10.1016/S0171-2985(11)80264-0; KURTZ CB, 1990, J IMMUNOL, V144, P3581; Linton SM, 1999, MOL IMMUNOL, V36, P905, DOI 10.1016/S0161-5890(99)00113-3; Magnusson SE, 2008, CLIN IMMUNOL, V127, P225, DOI 10.1016/j.clim.2008.02.002; MILLER EJ, 1972, BIOCHEMISTRY-US, V11, P4903, DOI 10.1021/bi00776a005; Molina H, 1996, P NATL ACAD SCI USA, V93, P3357, DOI 10.1073/pnas.93.8.3357; MOLINA H, 1994, J IMMUNOL, V153, P789; Mongini PKA, 1997, J IMMUNOL, V159, P3782; MUNSON LG, 1995, CLIN IMMUNOL IMMUNOP, V75, P20, DOI 10.1006/clin.1995.1047; Nandakumar KS, 2003, EUR J IMMUNOL, V33, P2269, DOI 10.1002/eji.200323810; Olsen Nancy J, 2002, J Gend Specif Med, V5, P28; PEPYS MB, 1974, J EXP MED, V140, P126, DOI 10.1084/jem.140.1.126; Prodeus AP, 1998, IMMUNITY, V9, P721, DOI 10.1016/S1074-7613(00)80669-X; Renaudineau Y, 2005, AUTOIMMUNITY, V38, P11, DOI 10.1080/08916930400022574; Sakiniene E, 1999, SCAND J IMMUNOL, V50, P250; SEKI N, 1988, J IMMUNOL, V140, P1477; STUART JM, 1983, J EXP MED, V158, P378, DOI 10.1084/jem.158.2.378; Svensson L, 1998, CLIN EXP IMMUNOL, V111, P521; Takahashi K, 1997, J IMMUNOL, V159, P1557; Walport MJ, 2002, ARTHRITIS RES THER, V4, pS279, DOI 10.1186/ar586; WANG Y, 1995, P NATL ACAD SCI USA, V92, P8955, DOI 10.1073/pnas.92.19.8955; Wang Y, 2000, J IMMUNOL, V164, P4340, DOI 10.4049/jimmunol.164.8.4340; WATSON WC, 1985, J EXP MED, V162, P1878, DOI 10.1084/jem.162.6.1878; WEISMAN HF, 1990, SCIENCE, V249, P146, DOI 10.1126/science.2371562; WILSON JG, 1986, ARTHRITIS RHEUM, V29, P739, DOI 10.1002/art.1780290606; WOOLEY PH, 1981, J EXP MED, V154, P688, DOI 10.1084/jem.154.3.688	58	12	13	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2450	2458		10.1096/fj.08-125849	http://dx.doi.org/10.1096/fj.08-125849			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19351702				2022-12-25	WOS:000268836700013
J	Kawahara, M; Morita, S; Takahashi, N; Kono, T				Kawahara, Manabu; Morita, Shinnosuke; Takahashi, Nozomi; Kono, Tomohiro			Defining Contributions of Paternally Methylated Imprinted Genes at the Igf2-H19 and Dlk1-Gtl2 Domains to Mouse Placentation by Transcriptomic Analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DE-NOVO METHYLATION; FETAL GROWTH; MICE; PROTEIN; EXPRESSION; DIFFERENTIATION; OVEREXPRESSION; PROLIFERATION; ACTIVATION; EMBRYOS	Parental genome functions in ontogeny are determined by interactions among transcripts from the maternal and paternal genomes, which contain many genes whose expression is strictly dependent on their parental origin as a result of genomic imprinting. Comprehensive recognition of the interactions between parental genomes is important for understanding genomic imprinting in mammalian development. The placenta is a key organ for exploring the biological significance of genomic imprinting. To decipher the unknown roles of paternally methylated imprinted genes on chromosomes 7 and 12 in mouse placentation, we performed a transcriptomic analysis on placentae in three types of bimaternal conceptuses that contained genomes derived from both non-growing and fully grown oocytes. Furthermore, we used the Ingenuity pathway analysis software to predict key networks and identify functions specific to paternally methylated imprinted genes regulated by the Igf2-H19 imprinting control region and Dlk1-Dio3 imprinting control region. The data suggested that dynamic conversion of the gene expression profile by restoring the expression of paternally methylated imprinted genes resulted in phenotypic improvements in bimaternal placentae. These results provide a framework to further explore the role of epigenetic modifications in paternal genome during mouse placentation.	[Kawahara, Manabu; Morita, Shinnosuke; Takahashi, Nozomi; Kono, Tomohiro] Tokyo Univ Agr, Dept Biosci, Setagaya Ku, Tokyo 1568502, Japan; [Kawahara, Manabu] Saga Univ, Fac Agr, Lab Anim Resource Dev, Saga 8408502, Japan	Tokyo University of Agriculture; Saga University	Kono, T (corresponding author), Tokyo Univ Agr, Dept Biosci, Setagaya Ku, Tokyo 1568502, Japan.	tomohiro@nodai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [18208024, 20780201]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Scientific Research 18208024 (to T. K.) and Young Scientists 20780201 (to M. K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	*AFF INC, 2009, GENECHIP EXPR AN TEC; Apel ED, 2000, J BIOL CHEM, V275, P31986, DOI 10.1074/jbc.M004775200; Arima T, 2006, DEV BIOL, V297, P361, DOI 10.1016/j.ydbio.2006.05.003; Baladron V, 2005, EXP CELL RES, V303, P343, DOI 10.1016/j.yexcr.2004.10.001; Bauer SR, 1998, MOL CELL BIOL, V18, P5247, DOI 10.1128/MCB.18.9.5247; Benarafa C, 2007, J EXP MED, V204, P1901, DOI 10.1084/jem.20070494; CHARD T, 1994, GROWTH REGULAT, V4, P91; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Coan PM, 2005, PLACENTA, V26, pS10, DOI 10.1016/j.placenta.2004.12.009; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Jincho Y, 2008, BIOL REPROD, V78, P568, DOI 10.1095/biolreprod.107.064634; Kawahara M, 2008, NAT PROTOC, V3, P197, DOI 10.1038/nprot.2007.531; Kawahara M, 2007, NAT BIOTECHNOL, V25, P1045, DOI 10.1038/nbt1331; Kawahara M, 2006, HUM MOL GENET, V15, P2869, DOI 10.1093/hmg/ddl228; Kono T, 2006, CYTOGENET GENOME RES, V113, P31, DOI 10.1159/000090812; Kono T, 1996, NAT GENET, V13, P91, DOI 10.1038/ng0596-91; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Lucifero D, 2004, HUM MOL GENET, V13, P839, DOI 10.1093/hmg/ddh104; Mann JR, 2001, STEM CELLS, V19, P287, DOI 10.1634/stemcells.19-4-287; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Nagpal ML, 2006, BBA-MOL BASIS DIS, V1762, P811, DOI 10.1016/j.bbadis.2006.06.017; Nagpal ML, 2004, J ENDOCRINOL, V183, P585, DOI 10.1677/joe.1.05795; Nagy A., 2002, MANIPULATING MOUSE E; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; SCROCCHI LA, 1993, ENDOCRINOLOGY, V132, P903, DOI 10.1210/en.132.2.903; Smas CM, 1997, CRIT REV EUKAR GENE, V7, P281, DOI 10.1615/CritRevEukarGeneExpr.v7.i4.10; Su YQ, 2007, DEV BIOL, V302, P104, DOI 10.1016/j.ydbio.2006.09.008; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; VANLIMPT VA, 2009, INT J CANCER, V105, P61; Yevtodiyenko A, 2006, DEV DYNAM, V235, P1115, DOI 10.1002/dvdy.20705; Zeng FY, 2005, DEV BIOL, V283, P40, DOI 10.1016/j.ydbio.2005.03.038; Zhang QP, 2005, J CELL SCI, V118, P673, DOI 10.1242/jcs.01642	34	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17751	17765		10.1074/jbc.M109.000299	http://dx.doi.org/10.1074/jbc.M109.000299			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19380578	Green Published, hybrid			2022-12-25	WOS:000267202500041
J	Meinild, AK; Loo, DDF; Skovstrup, S; Gether, U; MacAulay, N				Meinild, Anne-Kristine; Loo, Donald D. F.; Skovstrup, Soren; Gether, Ulrik; MacAulay, Nanna			Elucidating Conformational Changes in the gamma-Aminobutyric Acid Transporter-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE DOMAIN-I; GABA TRANSPORTER; VOLTAGE-CLAMP; FLUOROMETRIC MEASUREMENTS; SEROTONIN TRANSPORTER; ALTERNATING ACCESS; TRANSIENT CURRENTS; BACTERIAL HOMOLOG; CHARGE MOVEMENTS; ION-BINDING	The GABA transporter-1 (GAT-1) has three current-generating modes: GABA-coupled current, Li+-induced leak current, and Na+-dependent transient currents. We earlier hypothesized that Li+ is able to substitute for the first Na+ in the transport cycle and thereby induce a distinct conformation in GAT-1 and that the onset of the Li+-induced leak current at membrane potentials more negative than -50 mV was due to a voltage-dependent conformational change of the Li+-bound transporter. In this study, we set out to verify this hypothesis and seek insight into the structural dynamics underlying the leak current, as well as the sodium-dependent transient currents, by applying voltage clamp fluorometry to tetramethylrhodamine 6-maleimide-labeled GAT-1 expressed in Xenopus laevis oocytes. MTSET accessibility studies demonstrated the presence of two distinct conformations of GAT-1 in the presence of Na+ or Li+. The voltage-dependent fluorescence intensity changes obtained in Li+ buffer correlated with the Li+-induced leak currents, i.e. both were highly voltage-dependent and only present at hyperpolarized potentials (<-50 mV). The transient currents correlated directly with the voltage-dependent fluorescence data obtained in sodium buffer and the associated conformational changes were distinct from those associated with the Li+-induced leak current. The inhibitor potency of SKF89976A of the Li+-versus Na+-bound transporter confirmed the cationic dependence of the conformational occupancy. Our observations suggest that the microdomain situated at the external end of transmembrane I is involved in different conformational changes taking place either during the binding and release of sodium or during the initiation of the Li+-induced leak current.	[Meinild, Anne-Kristine] Univ Copenhagen, Dept Biol, DK-2100 Copenhagen, Denmark; [Skovstrup, Soren] Univ Copenhagen, Dept Med Chem, DK-2100 Copenhagen, Denmark; [Gether, Ulrik] Univ Copenhagen, Dept Neurosci & Pharmacol, DK-2100 Copenhagen, Denmark; [MacAulay, Nanna] Univ Copenhagen, Dept Cellular & Mol Med, DK-2100 Copenhagen, Denmark; [Loo, Donald D. F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Meinild, AK (corresponding author), August Krogh Bldg,Univ Pk 13, DK-2100 Copenhagen, Denmark.	smeinild@bio.ku.dk	MacAulay, Nanna/AER-7709-2022	MacAulay, Nanna/0000-0002-7800-6600; Gether, Ulrik/0000-0002-0020-3807	Danish Health Science Research Council; Novo Nordisk Foundation; Carlsberg Foundation; Lundbeck Foundation; John and Birthe Meyer Foundation	Danish Health Science Research Council; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Carlsberg Foundation(Carlsberg Foundation); Lundbeck Foundation(Lundbeckfonden); John and Birthe Meyer Foundation	The work was supported by the Danish Health Science Research Council, the Novo Nordisk Foundation, the Carlsberg Foundation, the Lundbeck Foundation, and the John and Birthe Meyer Foundation.	Bennett ER, 2000, J BIOL CHEM, V275, P34106, DOI 10.1074/jbc.M004229200; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bicho A, 2005, BIOPHYS J, V89, P211, DOI 10.1529/biophysj.105.061002; Bismuth Y, 1997, J BIOL CHEM, V272, P16096, DOI 10.1074/jbc.272.26.16096; Borden LA, 1996, NEUROCHEM INT, V29, P335, DOI 10.1016/0197-0186(95)00158-1; BORDEN LA, 1994, EUR J PHARM-MOLEC PH, V269, P219, DOI 10.1016/0922-4106(94)90089-2; Chen JG, 1997, BIOCHEMISTRY-US, V36, P1479, DOI 10.1021/bi962256g; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; GALLI A, 1995, J EXP BIOL, V198, P2197; Golovanevsky V, 1999, J BIOL CHEM, V274, P23020, DOI 10.1074/jbc.274.33.23020; Hazama A, 1997, J MEMBRANE BIOL, V155, P175, DOI 10.1007/s002329900169; Hilgemann DW, 1999, J GEN PHYSIOL, V114, P459, DOI 10.1085/jgp.114.3.459; Hirayama BA, 1997, J BIOL CHEM, V272, P2110; Kanner BI, 2003, J BIOL CHEM, V278, P3705, DOI 10.1074/jbc.M210525200; KEYNAN S, 1988, BIOCHEMISTRY-US, V27, P12, DOI 10.1021/bi00401a003; Larsson HP, 2004, P NATL ACAD SCI USA, V101, P3951, DOI 10.1073/pnas.0306737101; Li M, 2002, FEBS LETT, V513, P247, DOI 10.1016/S0014-5793(02)02322-0; Li M, 2000, J GEN PHYSIOL, V115, P491, DOI 10.1085/jgp.115.4.491; Lin F, 1996, BIOPHYS J, V71, P3126, DOI 10.1016/S0006-3495(96)79506-1; Liu YH, 1998, BBA-BIOMEMBRANES, V1415, P246, DOI 10.1016/S0005-2736(98)00200-4; Loo DDF, 1998, P NATL ACAD SCI USA, V95, P7789, DOI 10.1073/pnas.95.13.7789; LOO DDF, 1993, P NATL ACAD SCI USA, V90, P5767, DOI 10.1073/pnas.90.12.5767; Lopez-Corcuera B, 2001, J BIOL CHEM, V276, P43463, DOI 10.1074/jbc.M107438200; MacAulay N, 2003, J BIOL CHEM, V278, P28771, DOI 10.1074/jbc.M213023200; MacAulay N, 2002, J PHYSIOL-LONDON, V544, P447, DOI 10.1113/jphysiol.2002.022897; MacAulay N, 2001, J BIOL CHEM, V276, P40476, DOI 10.1074/jbc.M105578200; Mager S, 1996, J NEUROSCI, V16, P5405; MAGER S, 1994, NEURON, V12, P845, DOI 10.1016/0896-6273(94)90337-9; MAGER S, 1993, NEURON, V10, P177, DOI 10.1016/0896-6273(93)90309-F; Mannuzzu LM, 2000, J GEN PHYSIOL, V115, P257, DOI 10.1085/jgp.115.3.257; Meinild AK, 2002, BIOCHEMISTRY-US, V41, P1250, DOI 10.1021/bi011661r; Melamed N, 2004, MOL PHARMACOL, V65, P1452, DOI 10.1124/mol.65.6.1452; Ni YG, 2001, J BIOL CHEM, V276, P30942, DOI 10.1074/jbc.M104653200; RADIAN R, 1983, BIOCHEMISTRY-US, V22, P1236, DOI 10.1021/bi00274a038; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schrodinger LLC, 2008, SCHRODINGER SUITE 20; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Sonders MS, 1997, J NEUROSCI, V17, P960; UMBACH JA, 1990, BIOPHYS J, V57, P1217, DOI 10.1016/S0006-3495(90)82640-0; Virkki LV, 2006, J BIOL CHEM, V281, P28837, DOI 10.1074/jbc.M603861200; Virkki LV, 2006, J GEN PHYSIOL, V127, P539, DOI 10.1085/jgp.200609496; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yu N, 1998, FEBS LETT, V426, P174, DOI 10.1016/S0014-5793(98)00333-0; Zhang H, 1997, BIOCHEMISTRY-US, V36, P15856, DOI 10.1021/bi972357u; Zhou YG, 2005, J BIOL CHEM, V280, P20316, DOI 10.1074/jbc.M412937200; Zhou YG, 2004, J BIOL CHEM, V279, P13800, DOI 10.1074/jbc.M311579200; Zhou YG, 2006, J BIOL CHEM, V281, P22092, DOI 10.1074/jbc.M602319200; Zomot E, 2005, J BIOL CHEM, V280, P25512, DOI 10.1074/jbc.M503864200; Zomot E, 2003, J BIOL CHEM, V278, P42950, DOI 10.1074/jbc.M209307200	52	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16226	16235		10.1074/jbc.M109.003137	http://dx.doi.org/10.1074/jbc.M109.003137			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19363027	Green Published, hybrid			2022-12-25	WOS:000266730900020
J	Derler, I; Fahrner, M; Carugo, O; Muik, M; Bergsmann, J; Schindl, R; Frischauf, I; Eshaghi, S; Romanin, C				Derler, Isabella; Fahrner, Marc; Carugo, Oliviero; Muik, Martin; Bergsmann, Judith; Schindl, Rainer; Frischauf, Irene; Eshaghi, Said; Romanin, Christoph			Increased Hydrophobicity at the N Terminus/Membrane Interface Impairs Gating of the Severe Combined Immunodeficiency-related ORAI1 Mutant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; MECHANOSENSITIVE CHANNEL; MEMBRANE-PROTEIN; CA2+ RELEASE; CRAC CHANNEL; ION-CHANNEL; K+ CHANNEL; 2 SETS; CALCIUM; SELECTIVITY	Patients with severe combined immune deficiency (SCID) suffer from defective T-cell Ca2+ signaling. A loss of Ca2+ entry has been linked at the molecular level to single missense mutation R91W in the store-operated Ca2+ channel ORAI1. However, the mechanistic impact of this mutation on ORAI1 function remains unclear. Confocal Forster resonance energy transfer microscopy revealed that dynamic store-operated coupling of STIM1 to ORAI1 R91W was largely sustained similar to wild-type ORAI1. Characterization of various point mutants at position 91 by whole cell patch clamp recordings displayed that neutral or even negatively charged amino acids did not abolish ORAI1 function. However, substitution by hydrophobic leucine, valine, or phenylalanine resulted in non-functional ORAI1 channels, despite preserved STIM1 coupling. Besides conformational constraints at the N terminus/membrane interface predicted for the hydrophobic mutants, additional key factor(s) were suggested to determine ORAI1 functionality. Calculation of the probability for the 1st transmembrane domain and its hydrophobicity revealed a substantial increase for all hydrophobic substitutions that lead to non-functional ORAI1 R91X mutants in contrast to those with hydrophilic residues. Hence, increased hydrophobicity might lead to disrupted permeation/gating, as an ORAI1 channel with increased pore size and R91W mutation failed to recover activity. In conclusion, the increase in hydrophobicity at the N terminus/membrane interface represents the major cause for yielding nonfunctional ORAI1 channels.	[Derler, Isabella; Fahrner, Marc; Muik, Martin; Bergsmann, Judith; Schindl, Rainer; Frischauf, Irene; Romanin, Christoph] Univ Linz, Inst Biophys, A-4040 Linz, Austria; [Carugo, Oliviero] Vienna Bio Ctr, Max Perutz Labs, A-1030 Vienna, Austria; [Carugo, Oliviero] Univ Pavia, Dept Gen Chem, I-27100 Pavia, Italy; [Eshaghi, Said] Karolinska Inst, Div Biophys, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden	Johannes Kepler University Linz; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Pavia; Karolinska Institutet	Romanin, C (corresponding author), Univ Linz, Inst Biophys, Altenbergerstr 69, A-4040 Linz, Austria.	christoph.romanin@jku.at	Frischauf, Irene/AAG-2007-2019; Schindl, Rainer/V-4205-2019; Derler, Isabella/B-7871-2019; Romanin, Christoph/D-5399-2009; Schindl, Rainer/E-3959-2013; Fahrner, Marc/AAI-7927-2021	Frischauf, Irene/0000-0003-0661-2932; Derler, Isabella/0000-0002-4768-146X; Romanin, Christoph/0000-0003-3756-4136; Schindl, Rainer/0000-0003-0896-8887; Fahrner, Marc/0000-0002-2689-0158	Austrian Science Fund [P18169, P21118]	Austrian Science Fund(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund Projects P18169 and P21118 and Subproject 11 within W1201 ( to C. R.).	Beckstein O, 2006, PHYS BIOL, V3, P147, DOI 10.1088/1478-3975/3/2/007; Bergmeier W, 2009, BLOOD, V113, P675, DOI 10.1182/blood-2008-08-174516; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Buckley RH, 2004, J CLIN INVEST, V114, P1409, DOI 10.1172/JCI200423571; Carroll HR, 2006, MOL INTERV, V6, P253, DOI 10.1124/mi.6.5.6; Chakrabarti R, 2006, J CELL BIOCHEM, V99, P1503, DOI 10.1002/jcb.21102; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; Derler I, 2006, J PHYSIOL-LONDON, V577, P31, DOI 10.1113/jphysiol.2006.118661; Dutta D, 2000, J BIOSCIENCE, V25, P397, DOI 10.1007/BF02703793; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2005, J EXP MED, V202, P651, DOI 10.1084/jem.20050687; Frischauf I, 2008, CHANNELS, V2, P261, DOI 10.4161/chan.2.4.6705; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Gaspar HB, 2001, ARCH DIS CHILD, V84, P169, DOI 10.1136/adc.84.2.169; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; HARIS PI, 1994, FEBS LETT, V349, P371, DOI 10.1016/0014-5793(94)00704-7; Huang F, 2003, ANGEW CHEM INT EDIT, V42, P2269, DOI 10.1002/anie.200250684; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KABSCH W, 1978, ACTA CRYSTALLOGR A, V34, P827, DOI 10.1107/S0567739478001680; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuhn FJP, 2007, J BIOL CHEM, V282, P27598, DOI 10.1074/jbc.M702247200; Kuo AL, 2005, STRUCTURE, V13, P1463, DOI 10.1016/j.str.2005.07.011; Levin JM, 1997, PROTEIN ENG, V10, P771, DOI 10.1093/protein/10.7.771; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Micheletti C, 2000, PROTEINS, V40, P662, DOI 10.1002/1097-0134(20000901)40:4<662::AID-PROT90>3.0.CO;2-F; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Navarro-Borelly L, 2008, J PHYSIOL-LONDON, V586, P5383, DOI 10.1113/jphysiol.2008.162503; Nyholm TKM, 2007, BIOCHEMISTRY-US, V46, P1457, DOI 10.1021/bi061941c; Ozdirekcan S, 2005, BIOCHEMISTRY-US, V44, P1004, DOI 10.1021/bi0481242; Parekh AB, 2006, NATURE, V441, P163, DOI 10.1038/441163a; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Payandeh J, 2008, J BIOL CHEM, V283, P11721, DOI 10.1074/jbc.M707889200; PEINELT C, 2008, J PHYSL, V583, P3061; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Perozo E, 2006, NAT REV MOL CELL BIO, V7, P109, DOI 10.1038/nrm1833; Powl AM, 2005, BIOCHEMISTRY-US, V44, P5873, DOI 10.1021/bi047439e; Powl AM, 2003, BIOCHEMISTRY-US, V42, P14306, DOI 10.1021/bi034995k; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Raybaud A, 2007, J BIOL CHEM, V282, P27944, DOI 10.1074/jbc.M703895200; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; ROSE GD, 1985, SCIENCE, V229, P834, DOI 10.1126/science.4023714; Schindl R, 2008, J BIOL CHEM, V283, P20261, DOI 10.1074/jbc.M803101200; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Soboloff J, 2006, BBA-MOL CELL RES, V1763, P1161, DOI 10.1016/j.bbamcr.2006.09.023; Thompson JL, 2009, J BIOL CHEM, V284, P6620, DOI 10.1074/jbc.M808346200; THUNNISSEN MMGM, 1993, J MOL BIOL, V232, P839, DOI 10.1006/jmbi.1993.1435; TSONG TY, 1979, P NATL ACAD SCI USA, V76, P1109, DOI 10.1073/pnas.76.3.1109; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wieprecht T, 1999, J MOL BIOL, V294, P785, DOI 10.1006/jmbi.1999.3268; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Yamashita M, 2007, J GEN PHYSIOL, V130, P525, DOI 10.1085/jgp.200709872; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yoshimura K, 2001, BIOPHYS J, V80, P2198, DOI 10.1016/S0006-3495(01)76192-9; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200	61	68	71	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15903	15915		10.1074/jbc.M808312200	http://dx.doi.org/10.1074/jbc.M808312200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19366689	Green Published, hybrid			2022-12-25	WOS:000266501000058
J	Namkung, W; Song, Y; Mills, AD; Padmawar, P; Finkbeiner, WE; Verkman, AS				Namkung, Wan; Song, Yuanlin; Mills, Aaron D.; Padmawar, Prashant; Finkbeiner, Walter E.; Verkman, A. S.			In Situ Measurement of Airway Surface Liquid [K+] Using a Ratioable K+-sensitive Fluorescent Dye	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BRONCHIAL EPITHELIA; CELL-LINE CALU-3; CYSTIC-FIBROSIS; ANION SECRETION; POTASSIUM CHANNEL; ION COMPOSITION; NA+ ABSORPTION; CL-SECRETION; WILD-TYPE; DISEASE	The airway surface liquid (ASL) is the thin fluid layer lining airway surface epithelial cells, whose volume and composition are tightly regulated and may be abnormal in cystic fibrosis (CF). We synthesized a two-color fluorescent dextran to measure ASL [K+], TAC-Lime-dextran-TMR, consisting of a green-fluorescing triazacryptand K+ ionophore-Bodipy conjugate, coupled to dextran, together with a red fluorescing tetramethylrhodamine reference chromophore. TAC-Lime-dextran-TMR fluorescence was K+-selective, increasing >4-fold with increasing [K+] from 0 to 40 mM. In well differentiated human airway epithelial cells, ASL [K+] was 20.8 +/- 0.3 mM and decreased by inhibition of the Na+/K+ pump ( ouabain), ENaC ( amiloride), CF transmembrane conductance regulator (CFTRinh-172), or K+ channels ( TEA or XE991). ASL [K+] was increased by forskolin but not affected by Na+/K+/2Cl(-) cotransporter inhibition ( bumetanide). Functional and expression studies indicated the involvement of [K+] channels KCNQ1, KCNQ3, and KCNQ5 as determinants of ASL [K+]. [K+] in CF cultures was similar to that in non-CF cultures, suggesting that abnormal ASL [K+] is not a factor in CF lung disease. In intact airways, ASL [K+] was also well above extracellular [K+]: 22 +/- 1 mM in pig trachea ex vivo and 16 +/- 1 mM in mouse trachea in vivo. Our results provide the first noninvasive measurements of [K+] in the ASL and indicate the involvement of apical and basolateral membrane ion transporters in maintaining a high ASL [K+].	[Namkung, Wan; Mills, Aaron D.; Padmawar, Prashant; Verkman, A. S.] Univ Calif San Francisco, Dept Physiol & Med, San Francisco, CA 94143 USA; [Song, Yuanlin] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Finkbeiner, Walter E.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Verkman, AS (corresponding author), Univ Calif San Francisco, Dept Physiol & Med, San Francisco, CA 94143 USA.	Alan.Verkman@ucsf.edu			National Institutes of Health [HL73856, EB00415, DK72517, HL59198, DK35124, EY13574]; Cystic Fibrosis Foundation; Korean Government [KRF-2007-357-C00091]; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059198, R01HL073856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000415, R37EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK035124, R01DK035124, P30DK072517] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Korean Government(Korean Government); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL73856, EB00415, DK72517, HL59198, DK35124, and EY13574. This work was also supported by Research Development Program and Drug Discovery grants from the Cystic Fibrosis Foundation and Postdoctoral Fellowship Program of Korea Research Foundation Grant MOEHRD, KRF-2007-357-C00091 from the Korean Government ( to W. N.).	Boucher RC, 2007, ANNU REV MED, V58, P157, DOI 10.1146/annurev.med.58.071905.105316; Clarke LL, 1997, AM J PHYSIOL-LUNG C, V272, pL1084, DOI 10.1152/ajplung.1997.272.6.L1084; Coakley RD, 2003, P NATL ACAD SCI USA, V100, P16083, DOI 10.1073/pnas.2634339100; Cowley EA, 2002, J PHYSIOL-LONDON, V538, P747, DOI 10.1113/jphysiol.2001.013300; Davis KA, 2006, PFLUG ARCH EUR J PHY, V451, P631, DOI 10.1007/s00424-005-1505-4; De la Fuente R, 2008, MOL PHARMACOL, V73, P758, DOI 10.1124/mol.107.043208; Devor DC, 2000, AM J PHYSIOL-CELL PH, V279, pC461, DOI 10.1152/ajpcell.2000.279.2.C461; Devor DC, 1999, AM J PHYSIOL-CELL PH, V276, pC827, DOI 10.1152/ajpcell.1999.276.4.C827; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; HARTMANN T, 1990, BIOPHYS J, V58, P391, DOI 10.1016/S0006-3495(90)82385-7; He HR, 2003, J AM CHEM SOC, V125, P1468, DOI 10.1021/ja0284761; Jayaraman S, 2001, J GEN PHYSIOL, V117, P423, DOI 10.1085/jgp.117.5.423; Jayaraman S, 2001, J CLIN INVEST, V107, P317, DOI 10.1172/JCI11154; Knowles MR, 1997, J CLIN INVEST, V100, P2588, DOI 10.1172/JCI119802; KNOWLES MR, 1981, AM REV RESPIR DIS, V124, P484; Kozlova I, 2006, UPSALA J MED SCI, V111, P137, DOI 10.3109/2000-1967-016; Levin MH, 2006, INVEST OPHTH VIS SCI, V47, P306, DOI 10.1167/iovs.05-1082; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Magzoub M, 2006, J PHYS CHEM B, V110, P21216, DOI 10.1021/jp0633392; Mall M, 2003, PEDIATR RES, V53, P608, DOI 10.1203/01.PDR.0000057204.51420.DC; Mall M, 2000, AM J RESP CELL MOL, V23, P283, DOI 10.1165/ajrcmb.23.3.4060; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Moser SL, 2008, J MEMBRANE BIOL, V221, P153, DOI 10.1007/s00232-008-9093-9; Namkung W, 2008, J AM CHEM SOC, V130, P7794, DOI 10.1021/ja8014499; Padmawar P, 2005, NAT METHODS, V2, P825, DOI 10.1038/NMETH801; Smith JJ, 1996, CELL, V85, P229, DOI 10.1016/S0092-8674(00)81099-5; Song YL, 2003, J GEN PHYSIOL, V122, P511, DOI 10.1085/jgp.200308866; Tarran R, 2006, J GEN PHYSIOL, V127, P591, DOI 10.1085/jgp.200509468; Tarran R, 2006, ANNU REV PHYSIOL, V68, P543, DOI 10.1146/annurev.physiol.68.072304.112754; Verkman AS, 2003, AM J PHYSIOL-CELL PH, V284, pC2, DOI 10.1152/ajpcell.00417.2002; Wu JV, 2004, J BIOL CHEM, V279, P46558, DOI 10.1074/jbc.M406058200; YAMAYA M, 1992, AM J PHYSIOL, V262, pL713, DOI 10.1152/ajplung.1992.262.6.L713	32	36	39	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15916	15926		10.1074/jbc.M808021200	http://dx.doi.org/10.1074/jbc.M808021200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19364771	Green Published, hybrid			2022-12-25	WOS:000266501000059
J	Wiseman, RL; Chin, KT; Haynes, CM; Stanhill, A; Xu, CF; Roguev, A; Krogan, NJ; Neubert, TA; Ron, D				Wiseman, R. Luke; Chin, King-Tung; Haynes, Cole M.; Stanhill, Ariel; Xu, Chong-Feng; Roguev, Assen; Krogan, Nevan J.; Neubert, Thomas A.; Ron, David			Thioredoxin-related Protein 32 Is an Arsenite-regulated Thiol Reductase of the Proteasome 19 S Particle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHIZOSACCHAROMYCES-POMBE; UBIQUITINATED PROTEINS; MOLECULAR-CLONING; FISSION YEAST; CELLS; PROTEOTOXICITY; IDENTIFICATION; DESTRUCTION; DOMAIN; CUT8	Perturbation of the cytoplasmic protein folding environment by exposure to oxidative stress-inducing As(III)-containing compounds challenges the ubiquitin-proteasome system. Here we report on mass spectrometric analysis of As(III)-induced changes in the proteasome's composition in samples prepared by stable isotope labeling with amino acids in cell culture, using mammalian cells in which TRP32 (thioredoxin-related protein of 32 kDa; also referred to as TXNL1) was identified as a novel subunit of the 26 S proteasome. Quantitative genetic interaction mapping, using the epistatic miniarray profiling approach, identified a functional connection between TRP32 and the proteasome. Deletion of txl1, the Schizosaccharomyces pombe homolog of TRP32, results in a slow growth phenotype when combined with deletion of cut8, a gene required for normal proteasome localization. Deletion analysis in vivo, chemical crosslinking, and manipulation of the ATP concentration in vitro during proteasome immunopurification revealed that the C-terminal domain of mammalian TRP32 binds the 19 S regulatory particle in proximity to the proteasome substrate binding site. Thiol modification with polyethylene glycol-maleimide showed disulfide bond formation at the active site of TRP32 in cells exposed to As(III). Pulse-chase labeling showed that TRP32 is a stable protein whose half-life of >6 h is surprisingly reduced to 1 h upon exposure of cells to As(III). These findings reveal a previously undescribed thiol reductase at the proteasome's regulatory particle.	[Neubert, Thomas A.; Ron, David] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA; [Ron, David] NYU, Sch Med, Dept Med, New York, NY 10016 USA; [Ron, David] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Neubert, Thomas A.] NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA; [Roguev, Assen; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cell & Mol Pharmacol, San Francisco, CA 94158 USA; [Roguev, Assen; Krogan, Nevan J.] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA	New York University; New York University; New York University; New York University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ron, D (corresponding author), NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA.	david.ron@med.nyu.edu		Ron, David/0000-0002-3014-5636; stanhill, ariel/0000-0002-0318-2212; Wiseman, Luke/0000-0001-9287-6840	National Institutes of Health [RO1-ES08681, F32-ES014775, MC-IRG203123, P30-NS050276, F32-NS050901, RO1-GM084279]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F32ES014775, R01ES008681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS050276, F32NS050901] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-ES08681 (to D.R.), F32-ES014775 (to R.L.W.), MC-IRG203123 (to A.S.), P30-NS050276 (to T.A.N.), F32-NS050901 (to C.M.H.), and RO1-GM084279 (to N.J.K.).	Andersen KM, 2009, J BIOL CHEM, V284, P15246, DOI 10.1074/jbc.M900016200; Aposhian H, 1989, REV BIOCHEM TOXICOL, V10, P265; Appenzeller-Herzog C, 2008, ANTIOXID REDOX SIGN, V10, P55, DOI 10.1089/ars.2007.1837; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; BOND U, 1988, J BIOL CHEM, V263, P2384; DUNCAN RF, 1987, ARCH BIOCHEM BIOPHYS, V256, P651, DOI 10.1016/0003-9861(87)90622-9; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; EYTAN E, 1989, P NATL ACAD SCI USA, V86, P7751, DOI 10.1073/pnas.86.20.7751; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hanna J, 2007, FEBS LETT, V581, P2854, DOI 10.1016/j.febslet.2007.03.053; Ishii T, 2005, BIOCHEMISTRY-US, V44, P13893, DOI 10.1021/bi051336u; Jimenez A, 2006, FEBS LETT, V580, P960, DOI 10.1016/j.febslet.2006.01.025; Jimenez A, 2007, YEAST, V24, P481, DOI 10.1002/yea.1483; Jin J, 2002, EUR J BIOCHEM, V269, P2060, DOI 10.1046/j.1432-1033.2002.02844.x; JOHNSTON D, 1980, J BIOL CHEM, V255, P6975; Kirkpatrick DS, 2003, TOXICOL APPL PHARM, V186, P101, DOI 10.1016/S0041-008X(02)00019-4; Lee KK, 1998, J BIOL CHEM, V273, P19160, DOI 10.1074/jbc.273.30.19160; LEVINSON W, 1980, BIOCHIM BIOPHYS ACTA, V606, P170, DOI 10.1016/0005-2787(80)90108-2; Lu JL, 2001, BIOCHEMISTRY-US, V40, P13288, DOI 10.1021/bi0107647; Lundgren J, 2005, MOL CELL BIOL, V25, P4662, DOI 10.1128/MCB.25.11.4662-4675.2005; Miranda-Vizuete A, 1998, BIOCHEM BIOPH RES CO, V243, P284, DOI 10.1006/bbrc.1997.8003; ORINO E, 1991, FEBS LETT, V284, P206, DOI 10.1016/0014-5793(91)80686-W; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Roguev A, 2007, NAT METHODS, V4, P861, DOI 10.1038/NMETH1098; Rosenzweig R, 2008, NAT STRUCT MOL BIOL, V15, P573, DOI 10.1038/nsmb.1427; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Song JK, 2005, PROTEIN SCI, V14, P1059, DOI 10.1110/ps.041246805; Stanhill A, 2006, MOL CELL, V23, P875, DOI 10.1016/j.molcel.2006.07.023; Takeda K, 2005, CELL, V122, P393, DOI 10.1016/j.cell.2005.05.023; Tatebe H, 2000, CURR BIOL, V10, P1329, DOI 10.1016/S0960-9822(00)00773-9; Yun C, 2008, P NATL ACAD SCI USA, V105, P7094, DOI 10.1073/pnas.0707025105; Zheng PZ, 2005, P NATL ACAD SCI USA, V102, P7653, DOI 10.1073/pnas.0502825102	34	34	35	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15233	15245		10.1074/jbc.M109.002121	http://dx.doi.org/10.1074/jbc.M109.002121			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19349280	Green Published, hybrid			2022-12-25	WOS:000266288200058
J	Shi, B; Tran, T; Sobkoviak, R; Pope, RM				Shi, Bo; Tran, Tri; Sobkoviak, Rudina; Pope, Richard M.			Activation-induced Degradation of FLIPL Is Mediated via the Phosphatidylinositol 3-Kinase/Akt Signaling Pathway in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; FLICE-INHIBITORY PROTEIN; TRAIL-INDUCED APOPTOSIS; ARTHRITIS SYNOVIAL MACROPHAGES; INDUCED CELL-DEATH; C-FLIP; RHEUMATOID-ARTHRITIS; TUMOR-CELLS; CD95-INDUCED APOPTOSIS; CONFERS RESISTANCE	Cellular FLIP (Flice-like inhibitory protein) is critical for the protection against death receptor-mediated cell apoptosis. In macrophages, FLIP long (FLIPL) and FLIP short (FLIPS) mRNA was induced by tumor necrosis factor (TNF) alpha, mediated through NF-kappa B. However, we observed TNF alpha reduced the protein level of FLIPL, but not FLIPS, at 1 and 2 h. Similar results were observed with lipopolysaccharide. The reduction of FLIPL by TNF alpha was not mediated by caspase 8, or through JNK or Itch, but was suppressed by inhibition of the phosphatidylinositol 3-kinase/Akt pathway employing chemical inhibitors, a dominant negative Akt-1, or Akt-1 small interfering RNA. The reduction of FLIPL resulted in the short term induction of caspase 8-like activity, which augmented NF-kappa B activation. A co-immunoprecipitation assay demonstrated that Akt-1 physically interacts with FLIPL. Moreover, TNF alpha enhanced FLIPL serine phosphorylation, which was increased by activated Akt-1. Serine 273, a putative Akt-1 phosphorylation site in FLIPL, was critical for the activation-induced reduction of FLIPL. Thus, these observations document a novel mechanism where by TNF alpha facilitates the reduction of FLIPL protein, which is dependent on the phosphatidylinositol 3-kinase/Akt signaling.	[Shi, Bo; Tran, Tri; Sobkoviak, Rudina; Pope, Richard M.] Northwestern Univ, Feinberg Sch Med, Div Rheumatol, Chicago, IL 60611 USA; [Pope, Richard M.] Jesse Brown Vet Affairs Chicago Healthcare Syst, Chicago, IL 61612 USA	Northwestern University; Feinberg School of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Pope, RM (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Rheumatol, 240 E Huron,McGaw M300, Chicago, IL 60611 USA.	rmp158@northwestern.edu		Pope, Richard M./0000-0003-2416-8660; Shi, Bo/0000-0002-0780-0372	National Institutes of Health [AR049217, AR048269]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049217, R01AR048269] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR049217 and AR048269.	Albee L, 2006, INFLAMM RES, V55, P2, DOI 10.1007/s00011-005-0001-9; Bai SC, 2004, ARTHRITIS RHEUM-US, V50, P3844, DOI 10.1002/art.20680; Bannerman DD, 2001, J BIOL CHEM, V276, P14924, DOI 10.1074/jbc.M100819200; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chanvorachote P, 2005, J BIOL CHEM, V280, P42044, DOI 10.1074/jbc.M510080200; Davies CC, 2004, J BIOL CHEM, V279, P1010, DOI 10.1074/jbc.M303820200; Day TW, 2006, BIOCHEM PHARMACOL, V71, P1551, DOI 10.1016/j.bcp.2006.02.015; Djerbi M, 2001, SCAND J IMMUNOL, V54, P180, DOI 10.1046/j.1365-3083.2001.00941.x; Fujio Y, 1999, J BIOL CHEM, V274, P16349, DOI 10.1074/jbc.274.23.16349; Fukazawa T, 2001, ONCOGENE, V20, P5225, DOI 10.1038/sj.onc.1204673; Geisler F, 2007, GASTROENTEROLOGY, V132, P2489, DOI 10.1053/j.gastro.2007.03.033; Gordon S, 2007, J CLIN INVEST, V117, P89, DOI 10.1172/JCI30992; Haase R, 2003, J IMMUNOL, V171, P4294, DOI 10.4049/jimmunol.171.8.4294; Higuchi H, 2003, J BIOL CHEM, V278, P454, DOI 10.1074/jbc.M209387200; Inoue H, 2004, INT J MOL MED, V14, P271; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kang YC, 2004, CELL DEATH DIFFER, V11, P1287, DOI 10.1038/sj.cdd.4401489; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Keane J, 1997, INFECT IMMUN, V65, P298, DOI 10.1128/IAI.65.1.298-304.1997; Kim Y, 2002, J BIOL CHEM, V277, P22320, DOI 10.1074/jbc.M202458200; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; Liu HT, 2006, ARTHRITIS RHEUM-US, V54, P3174, DOI 10.1002/art.22132; Liu HT, 2005, J IMMUNOL, V175, P8337, DOI 10.4049/jimmunol.175.12.8337; Liu HT, 2004, J IMMUNOL, V172, P1907, DOI 10.4049/jimmunol.172.3.1907; Liu HT, 2003, BLOOD, V102, P344, DOI 10.1182/blood-2002-11-3396; Liu HT, 2001, J EXP MED, V194, P113, DOI 10.1084/jem.194.2.113; Longley DB, 2006, ONCOGENE, V25, P838, DOI 10.1038/sj.onc.1209122; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Ma YY, 2005, J BIOL CHEM, V280, P41827, DOI 10.1074/jbc.M510849200; Ma YY, 2005, CURR PHARM DESIGN, V11, P569, DOI 10.2174/1381612053381927; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Misra RS, 2007, J BIOL CHEM, V282, P19365, DOI 10.1074/jbc.M610610200; Nakajima A, 2006, EMBO J, V25, P5549, DOI 10.1038/sj.emboj.7601423; Nam SY, 2003, CANCER SCI, V94, P1066, DOI 10.1111/j.1349-7006.2003.tb01402.x; O'Donnell R, 2006, THORAX, V61, P448, DOI 10.1136/thx.2004.024463; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Oyarzo MP, 2006, BLOOD, V107, P2544, DOI 10.1182/blood-2005-06-2601; Ozes ON, 1999, NATURE, V401, P82; Pagliari LJ, 2000, MOL CELL BIOL, V20, P8855, DOI 10.1128/MCB.20.23.8855-8865.2000; Palacios C, 2006, CANCER RES, V66, P8858, DOI 10.1158/0008-5472.CAN-06-0808; Panka DJ, 2001, J BIOL CHEM, V276, P6893, DOI 10.1074/jbc.C000569200; Papa S, 2006, CELL DEATH DIFFER, V13, P712, DOI 10.1038/sj.cdd.4401865; Perlman H, 1999, J EXP MED, V190, P1679, DOI 10.1084/jem.190.11.1679; Perlman H, 2001, ARTHRITIS RHEUM, V44, P21, DOI 10.1002/1529-0131(200101)44:1<21::AID-ANR4>3.0.CO;2-8; Perlman H, 2001, EUR J IMMUNOL, V31, P2421, DOI 10.1002/1521-4141(200108)31:8<2421::AID-IMMU2421>3.0.CO;2-W; Poukkula M, 2005, J BIOL CHEM, V280, P27345, DOI 10.1074/jbc.M504019200; Rasper DM, 1998, CELL DEATH DIFFER, V5, P271, DOI 10.1038/sj.cdd.4400370; Rebe C, 2007, BLOOD, V109, P1442, DOI 10.1182/blood-2006-03-011585; Riendeau CJ, 2003, INFECT IMMUN, V71, P254, DOI 10.1128/IAI.71.1.254-259.2003; Sade H, 2004, J BIOL CHEM, V279, P2937, DOI 10.1074/jbc.M309924200; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Skurk C, 2004, J BIOL CHEM, V279, P1513, DOI 10.1074/jbc.M304736200; Sordet O, 2002, BLOOD, V100, P4446, DOI 10.1182/blood-2002-06-1778; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Suhara T, 2001, CIRC RES, V89, P13, DOI 10.1161/hh1301.092506; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Ueffing N, 2008, BLOOD, V112, P690, DOI 10.1182/blood-2008-02-141382; Uriarte SM, 2005, CELL DEATH DIFFER, V12, P233, DOI 10.1038/sj.cdd.4401549; Valente G, 2006, BRIT J HAEMATOL, V132, P560, DOI 10.1111/j.1365-2141.2005.05898.x; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Woo KJ, 2006, BIOCHEM BIOPH RES CO, V342, P1334, DOI 10.1016/j.bbrc.2006.02.105; Yang BF, 2003, J BIOL CHEM, V278, P7043, DOI 10.1074/jbc.M211278200; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Zhang SY, 2005, MOL CANCER THER, V4, P1972, DOI 10.1158/1535-7163.MCT-05-0249	67	17	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14513	14523		10.1074/jbc.M807918200	http://dx.doi.org/10.1074/jbc.M807918200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19339247	hybrid, Green Published			2022-12-25	WOS:000266286100058
J	Lau, LMS; Wolter, JK; Lau, JTML; Cheng, LS; Smith, KM; Hansford, LM; Zhang, L; Baruchel, S; Robinson, F; Irwin, MS				Lau, L. M. S.; Wolter, J. K.; Lau, J. T. M. L.; Cheng, L. S.; Smith, K. M.; Hansford, L. M.; Zhang, L.; Baruchel, S.; Robinson, F.; Irwin, M. S.			Cyclooxygenase inhibitors differentially modulate p73 isoforms in neuroblastoma	ONCOGENE			English	Article						neuroblastoma; COX inhibitor; celecoxib; p73; E2F-1	NONSTEROIDAL ANTIINFLAMMATORY DRUGS; IN-VIVO; UP-REGULATION; HUMAN TUMORS; P53 FAMILY; APOPTOSIS; CELECOXIB; CANCER; EXPRESSION; CELL	p73 encodes multiple functionally distinct isoforms. Proapoptotic TAp73 isoforms contain a transactivation (TA) domain, and like p53, have tumor suppressor properties and are activated by chemotherapies to induce cell death. In contrast, antiapoptotic Delta Np73 isoforms lack the TA domain and are dominant-negative inhibitors of p53 and TAp73. Delta Np73 proteins are overexpressed in a variety of tumors including neuroblastoma. Thus, identification of drugs that upregulate TAp73 and/or downregulate Delta Np73 represents a potential therapeutic strategy. Here, we report that cyclooxygenase (COX) inhibitors induce apoptosis independent of p53, and differentially modulate endogenous p73 isoforms in neuroblastoma and other tumors. COX inhibitor-mediated apoptosis is associated with the induction of TAp73 beta and its target genes. COX inhibitors also downregulate the alternative-spliced Delta Np73(AS) isoforms, Delta exon2 and Delta exon2/3. Furthermore, forced expression of Delta Np73(AS) results in diminished apoptosis in response to the selective COX-2 inhibitor celecoxib. Celecoxib-mediated downregulation of DNp73AS is associated with decreased E2F1 levels and diminished E2F1 activation of the p73 promoter. These results provide the first evidence that COX inhibitors differentially modulate p73 isoforms leading to enhanced apoptosis, and support the potential use of COX inhibitors as novel regulators of p73 to enhance chemosensitivity in tumors with deregulated E2F1 and in those with wild-type (wt) or mutant p53. Oncogene (2009) 28, 2024-2033; doi:10.1038/onc.2009.59; published online 13 April 2009	[Irwin, M. S.] Univ Toronto, MARS Ctr, Div Haematol Oncol, Hosp Sick Children, Toronto, ON M5G 1L7, Canada; [Lau, L. M. S.; Wolter, J. K.; Lau, J. T. M. L.; Cheng, L. S.; Smith, K. M.; Hansford, L. M.; Robinson, F.; Irwin, M. S.] Hosp Sick Children, Res Inst, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Zhang, L.; Baruchel, S.] Hosp Sick Children, Res Inst, Physiol & Expt Med Program, Toronto, ON M5G 1X8, Canada; [Irwin, M. S.] Univ Toronto, Dept Pediat, Inst Med Sci & Lab Med & Pathobiol, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Irwin, MS (corresponding author), Univ Toronto, MARS Ctr, Div Haematol Oncol, Hosp Sick Children, Toronto Med Discovery Tower,101 Coll St, Toronto, ON M5G 1L7, Canada.	meredith.irwin@sickkids.ca	Lau, Loretta MS/B-1565-2008	Lau, Loretta MS/0000-0002-3172-0970; Zhang, Libo/0000-0001-7072-4408; Smith, Kristen/0000-0003-0960-0937	Canadian Cancer Society; National Cancer Institute of Canada (CCS) [019274]; James Fund for Neuroblastoma Research at SickKids Foundation; Lloyd Carr-Harris Foundation; Terry Fox Foundation	Canadian Cancer Society(Canadian Cancer Society (CCS)); National Cancer Institute of Canada (CCS); James Fund for Neuroblastoma Research at SickKids Foundation; Lloyd Carr-Harris Foundation; Terry Fox Foundation	This study was supported by the Canadian Cancer Society and the National Cancer Institute of Canada (CCS Grant no. 019274, MS Irwin), the James Fund for Neuroblastoma Research at SickKids Foundation and Lloyd Carr-Harris Foundation. MS Irwin is a Canada Research Chair in Cancer Biology. L Lau was supported by the Terry Fox Foundation Clinical Research Fellowship (National Cancer Institute of Canada).	Amin ARMR, 2007, CANCER RES, V67, P5617, DOI 10.1158/0008-5472.CAN-07-0655; Balint E, 2002, P NATL ACAD SCI USA, V99, P3529, DOI 10.1073/pnas.062491899; Bock JM, 2007, CANCER RES, V67, P3801, DOI 10.1158/0008-5472.CAN-06-3780; Buhlmann S, 2008, BBA-REV CANCER, V1785, P207, DOI 10.1016/j.bbcan.2008.01.002; Casciano I, 2002, CELL DEATH DIFFER, V9, P246, DOI 10.1038/sj.cdd.4400993; Concin N, 2005, CLIN CANCER RES, V11, P8372, DOI 10.1158/1078-0432.CCR-05-0899; Dominguez G, 2006, J CLIN ONCOL, V24, P805, DOI 10.1200/JCO.2005.02.2350; Fillippovich I, 2001, ONCOGENE, V20, P514, DOI 10.1038/sj.onc.1204118; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Gonzalez S, 2005, CANCER RES, V65, P2186, DOI 10.1158/0008-5472.CAN-04-3047; Grosch S, 2006, JNCI-J NATL CANCER I, V98, P736, DOI 10.1093/jnci/djj206; Hansford LM, 2007, CANCER RES, V67, P11234, DOI 10.1158/0008-5472.CAN-07-0718; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; Irwin MS, 2004, CELL CYCLE, V3, P319; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Johnsen JI, 2004, CANCER RES, V64, P7210, DOI 10.1158/0008-5472.CAN-04-1795; Johnson AJ, 2005, BLOOD, V105, P2504, DOI 10.1182/blood-2004-05-1957; Kashfi K, 2005, BIOCHEM PHARMACOL, V70, P969, DOI 10.1016/j.bcp.2005.05.004; Lau L, 2007, ONCOGENE, V26, P1920, DOI 10.1038/sj.onc.1209981; Lau LMS, 2008, ONCOGENE, V27, P997, DOI 10.1038/sj.onc.1210707; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Muller M, 2005, CELL DEATH DIFFER, V12, P1564, DOI 10.1038/sj.cdd.4401774; Ponthan F, 2007, CLIN CANCER RES, V13, P1036, DOI 10.1158/1078-0432.CCR-06-1908; Pozniak CD, 2000, SCIENCE, V289, P304, DOI 10.1126/science.289.5477.304; Putzer BM, 2007, J CELL MOL MED, V11, P239, DOI 10.1111/j.1582-4934.2007.00030.x; Putzer B, 2003, CELL DEATH DIFFER, V10, P612, DOI 10.1038/sj.cdd.4401205; Sayan AE, 2005, BIOCHEM BIOPH RES CO, V330, P186, DOI 10.1016/j.bbrc.2005.02.145; Stempak D, 2002, CLIN PHARMACOL THER, V72, P490, DOI 10.1067/mcp.2002.129322; Stiewe T, 2002, J BIOL CHEM, V277, P14177, DOI 10.1074/jbc.M200480200; Stiewe T, 2000, NAT GENET, V26, P464, DOI 10.1038/82617; Thun MJ, 2002, JNCI-J NATL CANCER I, V94, P252, DOI 10.1093/jnci/94.4.252; Xue C, 2007, CANCER RES, V67, P10351, DOI 10.1158/0008-5472.CAN-06-4345; Zaika AI, 2002, J EXP MED, V196, P765, DOI 10.1084/jem.20020179; Zhu JX, 2004, CANCER RES, V64, P4309, DOI 10.1158/0008-5472.CAN-03-4063	34	36	41	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 14	2009	28	19					2024	2033		10.1038/onc.2009.59	http://dx.doi.org/10.1038/onc.2009.59			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	445BF	19363520				2022-12-25	WOS:000266023900003
J	Jordan, PW; Saunders, NJ				Jordan, Philip W.; Saunders, Nigel J.			Host Iron Binding Proteins Acting as Niche Indicators for Neisseria meningitidis	PLOS ONE			English	Article								Neisseria meningitidis requires iron, and in the absence of iron alters its gene expression to increase iron acquisition and to make the best use of the iron it has. During different stages of colonization and infection available iron sources differ, particularly the host iron-binding proteins haemoglobin, transferrin, and lactoferrin. This study compared the transcriptional responses of N. meningitidis, when grown in the presence of these iron donors and ferric iron, using microarrays. Specific transcriptional responses to the different iron sources were observed, including genes that are not part of the response to iron restriction. Comparisons between growth on haemoglobin and either transferrin or lactoferrin identified changes in 124 and 114 genes, respectively, and 33 genes differed between growth on transferrin or lactoferrin. Comparison of gene expression from growth on haemoglobin or ferric iron showed that transcription is also affected by the entry of either haem or ferric iron into the cytoplasm. This is consistent with a model in which N. meningitidis uses the relative availability of host iron donor proteins as niche indicators. Growth in the presence of haemoglobin is associated with a response likely to be adaptive to survival within the bloodstream, which is supported by serum killing assays that indicate growth on haemoglobin significantly increases survival, and the response to lactoferrin is associated with increased expression of epithelial cell adhesins and oxidative stress response molecules. The transferrin receptor is the most highly transcribed receptor and has the fewest genes specifically induced in its presence, suggesting this is the favoured iron source for the bacterium. Most strikingly, the responses to haemoglobin, which is associated with unrestricted growth, indicates a low iron transcriptional profile, associated with an aggressive phenotype that may be adaptive to access host iron sources but which may also underlie the lethal features of meningococcal septicaemia, when haemoglobin may become a major source of iron.			Jordan, PW (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, Bacterial Pathogenesis & Funct Genom Grp, S Parks Rd, Oxford OX1 3RE, England.	nigel.saunders@path.ox.ac.uk	Saunders, Nigel J/W-6745-2019	Saunders, Nigel/0000-0002-0160-4573				Adhikari P, 1996, J BACTERIOL, V178, P2145, DOI 10.1128/jb.178.7.2145-2149.1996; AHMED S, 2005, LPS MEDIATED SERUM R; ALAALDEEN DAA, 1993, INFECT IMMUN, V61, P751, DOI 10.1128/IAI.61.2.751-759.1993; ALAALDEEN DAA, 1993, J MED MICROBIOL, V38, P442, DOI 10.1099/00222615-38-6-442; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; APPELMELK BJ, 1994, INFECT IMMUN, V62, P2628, DOI 10.1128/IAI.62.6.2628-2632.1994; ARCHIBALD FS, 1979, FEMS MICROBIOL LETT, V6, P159; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Banerjee A, 1998, P NATL ACAD SCI USA, V95, P10872, DOI 10.1073/pnas.95.18.10872; BELLAMY W, 1992, J APPL BACTERIOL, V73, P472, DOI 10.1111/j.1365-2672.1992.tb05007.x; BIRCH HE, 1986, J BIOL CHEM, V261, P8077; Biswas GD, 1997, MOL MICROBIOL, V24, P169, DOI 10.1046/j.1365-2958.1997.3421692.x; Biville F, 2004, MOL MICROBIOL, V53, P1267, DOI 10.1111/j.1365-2958.2004.04207.x; BJERKNES R, 1995, INFECT IMMUN, V63, P160, DOI 10.1128/IAI.63.1.160-167.1995; Carbonnelle E, 2006, MOL MICROBIOL, V61, P1510, DOI 10.1111/j.1365-2958.2006.05341.x; Carson SDB, 1999, J BACTERIOL, V181, P2895, DOI 10.1128/JB.181.9.2895-2901.1999; CHEN CY, 1993, MOL MICROBIOL, V10, P311, DOI 10.1111/j.1365-2958.1993.tb01957.x; CHEN T, 1995, J EXP MED, V182, P511, DOI 10.1084/jem.182.2.511; Chipperfield JR, 2000, BIOMETALS, V13, P165, DOI 10.1023/A:1009227206890; Cornelissen CN, 1997, MOL MICROBIOL, V26, P25, DOI 10.1046/j.1365-2958.1997.5381914.x; Cotter SE, 2005, TRENDS MICROBIOL, V13, P199, DOI 10.1016/j.tim.2005.03.004; Delany I, 2006, J BACTERIOL, V188, P2483, DOI 10.1128/JB.188.7.2483-2492.2006; Delany I, 2003, J BACTERIOL, V185, P6032, DOI 10.1128/JB.185.20.6032-6041.2003; Drake SL, 1997, MOL MICROBIOL, V23, P657, DOI 10.1046/j.1365-2958.1997.2511618.x; Ducey TF, 2005, J BACTERIOL, V187, P4865, DOI 10.1128/JB.187.14.4865-4874.2005; DYER DW, 1988, INFECT IMMUN, V56, P977, DOI 10.1128/IAI.56.4.977-983.1988; ELLISON RT, 1988, INFECT IMMUN, V56, P2774, DOI 10.1128/IAI.56.11.2774-2781.1988; Enz S, 2000, J BACTERIOL, V182, P637, DOI 10.1128/JB.182.3.637-646.2000; Estabrook MM, 2004, J IMMUNOL, V172, P3784, DOI 10.4049/jimmunol.172.6.3784; Ferreiros CM, 1998, REV MED MICROBIOL, V9, P29; Grifantini R, 2003, P NATL ACAD SCI USA, V100, P9542, DOI 10.1073/pnas.1033001100; Griffiths E, 1999, IRON INFECT MOL PHYS, P1; Griffiths NJ, 2007, CELL MICROBIOL, V9, P2968, DOI 10.1111/j.1462-5822.2007.01038.x; Gunesekere IC, 2006, J BACTERIOL, V188, P4769, DOI 10.1128/JB.01807-05; Hagen TA, 2006, MOL MICROBIOL, V62, P1144, DOI 10.1111/j.1365-2958.2006.05429.x; Hauck CR, 1997, FEBS LETT, V405, P86, DOI 10.1016/S0014-5793(97)00163-4; Hendrixson DR, 2003, MOL MICROBIOL, V47, P607, DOI 10.1046/j.1365-2958.2003.03327.x; HOLBEIN BE, 1980, INFECT IMMUN, V29, P886; Holmes K, 2005, MICROBIOL-SGM, V151, P243, DOI 10.1099/mic.0.27412-0; HUSSEIN S, 1981, EUR J BIOCHEM, V117, P431, DOI 10.1111/j.1432-1033.1981.tb06357.x; Kahler CM, 2006, J BIOL CHEM, V281, P19939, DOI 10.1074/jbc.M601308200; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; Khun HH, 1998, INFECT IMMUN, V66, P2330, DOI 10.1128/IAI.66.5.2330-2336.1998; KING GJ, 1978, INFECT IMMUN, V21, P575, DOI 10.1128/IAI.21.2.575-584.1978; KLAUSNER RD, 1983, P NATL ACAD SCI-BIOL, V80, P2263, DOI 10.1073/pnas.80.8.2263; LAMBDEN PR, 1979, J GEN MICROBIOL, V114, P305, DOI 10.1099/00221287-114-2-305; Larson JA, 2004, MOL MICROBIOL, V53, P807, DOI 10.1111/j.1365-2958.2004.04169.x; Larson JA, 2002, INFECT IMMUN, V70, P1461, DOI 10.1128/IAI.70.3.1461-1467.2002; LETENDRE ED, 1983, INFECT IMMUN, V39, P50, DOI 10.1128/IAI.39.1.50-59.1983; LETOFFE S, 1994, P NATL ACAD SCI USA, V91, P9876, DOI 10.1073/pnas.91.21.9876; LEWIS LA, 1995, J BACTERIOL, V177, P1299, DOI 10.1128/jb.177.5.1299-1306.1995; Lewis LA, 1997, MOL MICROBIOL, V23, P737, DOI 10.1046/j.1365-2958.1997.2501619.x; Lin L, 1997, MOL MICROBIOL, V24, P1083, DOI 10.1046/j.1365-2958.1997.4191776.x; Lin W, 1999, P NATL ACAD SCI USA, V96, P1071, DOI 10.1073/pnas.96.3.1071; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahren S, 2003, J BACTERIOL, V185, P1796, DOI 10.1128/JB.185.6.1796-1802.2003; MASSON P, 1965, EXPERIENTIA, V21, P604, DOI 10.1007/BF02151559; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; MICKELSEN PA, 1981, INFECT IMMUN, V33, P555, DOI 10.1128/IAI.33.2.555-564.1981; MICKELSEN PA, 1982, INFECT IMMUN, V35, P915, DOI 10.1128/IAI.35.3.915-920.1982; Morelle S, 2005, MOL MICROBIOL, V55, P853, DOI 10.1111/j.1365-2958.2004.04426.x; OCHS M, 1995, MOL MICROBIOL, V15, P119, DOI 10.1111/j.1365-2958.1995.tb02226.x; Overton TW, 2006, J BIOL CHEM, V281, P33115, DOI 10.1074/jbc.M607056200; Padron J, 1999, FEMS IMMUNOL MED MIC, V25, P385, DOI 10.1016/S0928-8244(99)00113-3; PARUCHURI DK, 1990, P NATL ACAD SCI USA, V87, P333, DOI 10.1073/pnas.87.1.333; Paustian ML, 2002, J BACTERIOL, V184, P6714, DOI 10.1128/JB.184.23.6714-6720.2002; Peak IRA, 2000, FEMS IMMUNOL MED MIC, V28, P329, DOI 10.1111/j.1574-695X.2000.tb01494.x; PETTERSSON A, 1994, MICROB PATHOGENESIS, V17, P395, DOI 10.1006/mpat.1994.1085; PLAUT AG, 1975, SCIENCE, V190, P1103, DOI 10.1126/science.810892; Ram S, 2003, J BIOL CHEM, V278, P50853, DOI 10.1074/jbc.M308364200; Richardson AR, 1999, J BACTERIOL, V181, P2067, DOI 10.1128/JB.181.7.2067-2074.1999; Rohde KH, 2002, MOL MICROBIOL, V43, P335, DOI 10.1046/j.1365-2958.2002.02745.x; Rohde KH, 2004, INFECT IMMUN, V72, P2494, DOI 10.1128/IAI.72.5.2494-2506.2004; Rouse RJD, 2004, BIOTECHNIQUES, V36, P464, DOI 10.2144/04363RR02; Rowe HA, 2007, CELL MICROBIOL, V9, P154, DOI 10.1111/j.1462-5822.2006.00775.x; SAAL LH, 2002, GENOME BIOL, V3; Saunders NJ, 2000, MOL MICROBIOL, V37, P207, DOI 10.1046/j.1365-2958.2000.02000.x; Scarselli M, 2006, MOL MICROBIOL, V61, P631, DOI 10.1111/j.1365-2958.2006.05261.x; SCHREIBER G, 1986, INFLAMMATION, V10, P59, DOI 10.1007/BF00916041; Schryvers AB, 1999, MOL MICROBIOL, V32, P1117, DOI 10.1046/j.1365-2958.1999.01411.x; Singh PK, 2002, NATURE, V417, P552, DOI 10.1038/417552a; Snyder LAS, 2005, MICROBIOL-SGM, V151, P4005, DOI 10.1099/mic.0.27925-0; Stears RL, 2000, PHYSIOL GENOMICS, V3, P93, DOI 10.1152/physiolgenomics.2000.3.2.93; STEPHENS DS, 1981, J INFECT DIS, V143, P525, DOI 10.1093/infdis/143.4.525; Stohl EA, 2005, MOL MICROBIOL, V58, P520, DOI 10.1111/j.1365-2958.2005.04839.x; Stojiljkovic I, 1996, J BACTERIOL, V178, P4670, DOI 10.1128/jb.178.15.4670-4678.1996; Stojiljkovic I, 1997, J BACTERIOL, V179, P805, DOI 10.1128/jb.179.3.805-812.1997; Stojiljkovic I, 1997, FEMS MICROBIOL LETT, V151, P41, DOI 10.1016/S0378-1097(97)00135-3; THOMPSON SA, 1993, MOL MICROBIOL, V9, P85, DOI 10.1111/j.1365-2958.1993.tb01671.x; THOMPSON SA, 1993, INFECT IMMUN, V61, P2906, DOI 10.1128/IAI.61.7.2906-2911.1993; TSAI J, 1988, INFECT IMMUN, V56, P3132, DOI 10.1128/IAI.56.12.3132-3138.1988; UMEYAMA M, 2006, BIOCHIM BIOPHYS ACTA; van Putten JPM, 1998, J EXP MED, V188, P941, DOI 10.1084/jem.188.5.941; Virji M, 1996, MOL MICROBIOL, V22, P929, DOI 10.1046/j.1365-2958.1996.01548.x; Virji M, 1996, MOL MICROBIOL, V22, P941, DOI 10.1046/j.1365-2958.1996.01551.x; WALL RA, 1986, LANCET, V2, P624; Welch RA, 1995, INFECT AGENT DIS, V4, P254; Zhu WM, 2000, J BACTERIOL, V182, P6783, DOI 10.1128/JB.182.23.6783-6790.2000	99	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5198	10.1371/journal.pone.0005198	http://dx.doi.org/10.1371/journal.pone.0005198			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19352437	Green Submitted, gold, Green Published			2022-12-25	WOS:000265505700026
J	Placanica, L; Zhu, L; Li, YM				Placanica, Lisa; Zhu, Lei; Li, Yue-Ming			Gender- and Age-Dependent gamma-Secretase Activity in Mouse Brain and Its Implication in Sporadic Alzheimer Disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; ESTROGEN REPLACEMENT THERAPY; BETA-DEGRADING ENZYMES; POSTMENOPAUSAL WOMEN; CELL FATE; PRESENILIN-1; DEMENTIA; NOTCH; RISK; AD	Alzheimer disease (AD) is an age-related disorder. Aging and female gender are two important risk factors associated with sporadic AD. However, the mechanism by which aging and gender contribute to the pathogenesis of sporadic AD is unclear. It is well known that genetic mutations in gamma-secretase result in rare forms of early onset AD due to the aberrant production of A beta 42 peptides, which are the major constituents of senile plaques. However, the effect of age and gender on gamma-secretase has not been fully investigated. Here, using normal wild-type mice, we show mouse brain gamma-secretase exhibits gender-and age-dependent activity. Both male and female mice exhibit increased A beta 42:A beta 40 ratios in aged brain, which mimics the effect of familial mutations of Presenilin-1, Presenlin-2, and the amyloid precursor protein on A beta production. Additionally, female mice exhibit much higher gamma-secretase activity in aged brain compared to male mice. Furthermore, both male and female mice exhibit a steady decline in Notch1 gamma-secretase activity with aging. Using a small molecule affinity probe we demonstrate that male mice have less active gamma-secretase complexes than female mice, which may account for the gender-associated differences in activity in aged brain. These findings demonstrate that aging can affect gamma-secretase activity and specificity, suggesting a role for gamma-secretase in sporadic AD. Furthermore, the increased APP gamma-secretase activity seen in aged females may contribute to the increased incidence of sporadic AD in women and the aggressive A beta plaque pathology seen in female mouse models of AD. In addition, deceased Notch gamma-secretase activity may also contribute to neurodegeneration. Therefore, this study implicates altered gamma-secretase activity and specificity as a possible mechanism of sporadic AD during aging.			Placanica, L (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, 1275 York Ave, New York, NY 10021 USA.	liy2@mskcc.org	LI, Yue/GRS-8071-2022		NCI NIH HHS [T32 CA062948-11A, T32 CA062948] Funding Source: Medline; NIA NIH HHS [R01 AG026660, R01-AG026660] Funding Source: Medline; NIGMS NIH HHS [T32GM073546-01A1, T32 GM073546] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA062948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM073546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026660] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Allinson TMJ, 2003, J NEUROSCI RES, V74, P342, DOI 10.1002/jnr.10737; Andersen K, 1999, NEUROLOGY, V53, P1992, DOI 10.1212/WNL.53.9.1992; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Asthana S, 2001, NEUROLOGY, V57, P605, DOI 10.1212/WNL.57.4.605; Beher D, 2003, BIOCHEMISTRY-US, V42, P8133, DOI 10.1021/bi034045z; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Breunig JJ, 2007, P NATL ACAD SCI USA, V104, P20558, DOI 10.1073/pnas.0710156104; Caccamo A, 2005, NEUROBIOL AGING, V26, P645, DOI 10.1016/j.neurobiolaging.2004.06.013; Callahan MJ, 2001, AM J PATHOL, V158, P1173, DOI 10.1016/S0002-9440(10)64064-3; Deng Y, 2006, J NEUROSCI, V26, P3845, DOI 10.1523/JNEUROSCI.5384-05.2006; Eckman EA, 2005, BIOCHEM SOC T, V33, P1101, DOI 10.1042/BST0331101; Espeland MA, 2004, JAMA-J AM MED ASSOC, V291, P2959, DOI 10.1001/jama.291.24.2959; Fratiglioni L, 2000, NEUROLOGY, V54, pS10; Fratiglioni L, 1997, NEUROLOGY, V48, P132, DOI 10.1212/WNL.48.1.132; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Fukumoto H, 2004, AM J PATHOL, V164, P719, DOI 10.1016/S0002-9440(10)63159-8; Funalot B, 2004, MOL PSYCHIATR, V9, P1122, DOI 10.1038/sj.mp.4001584; Greenfield JP, 2000, FRONT BIOSCI, V5, pD72, DOI 10.2741/Greenfield; Handler M, 2000, DEVELOPMENT, V127, P2593; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hirata-Fukae C, 2008, BRAIN RES, V1216, P92, DOI 10.1016/j.brainres.2008.03.079; Hock B J Jr, 2001, Trends Genet, V17, pS7, DOI 10.1016/S0168-9525(01)02449-0; Howlett DR, 2004, BRAIN RES, V1017, P130, DOI 10.1016/j.brainres.2004.05.029; Hy LX, 2000, NEUROLOGY, V55, P198, DOI 10.1212/WNL.55.2.198; Iwata N, 2002, J NEUROSCI RES, V70, P493, DOI 10.1002/jnr.10390; JAFFE AB, 1994, J BIOL CHEM, V269, P13065; Jalbert JJ, 2008, EPIDEMIOL REV, V30, P15, DOI 10.1093/epirev/mxn008; Jan A, 2008, J BIOL CHEM, V283, P28176, DOI 10.1074/jbc.M803159200; JORM AF, 1987, ACTA PSYCHIAT SCAND, V76, P465, DOI 10.1111/j.1600-0447.1987.tb02906.x; Kern A, 2006, J BIOL CHEM, V281, P2405, DOI 10.1074/jbc.M505625200; Kim HJ, 2007, LIVER INT, V27, P633, DOI 10.1111/j.1478-3231.2007.01481.x; Kim WY, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-2; Kolovou GD, 2008, ANGIOLOGY, V59, p54S, DOI 10.1177/0003319708319645; Lai MT, 2003, J BIOL CHEM, V278, P22475, DOI 10.1074/jbc.M300974200; LaRosa J C, 1992, Womens Health Issues, V2, P102, DOI 10.1016/S1049-3867(05)80278-6; LAROSA JC, 1990, CAN J CARDIOL, V6, pB23; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Lukiw WL, 2005, CELL MOL NEUROBIOL, V25, P475, DOI 10.1007/s10571-005-4010-6; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; MOLSA PK, 1982, ACTA NEUROL SCAND, V65, P541; Mulnard RI, 2000, JAMA-J AM MED ASSOC, V283, P1007, DOI 10.1001/jama.283.8.1007; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; PaganiniHill A, 1996, ARCH INTERN MED, V156, P2213, DOI 10.1001/archinte.156.19.2213; Placanica L, 2009, J BIOL CHEM, V284, P2967, DOI 10.1074/jbc.M807269200; Postina R, 2008, CURR ALZHEIMER RES, V5, P179, DOI 10.2174/156720508783954668; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Schafer S, 2007, J NEURAL TRANSM, V114, P387, DOI 10.1007/s00702-006-0580-9; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Sennvik K, 2000, NEUROSCI LETT, V278, P169, DOI 10.1016/S0304-3940(99)00929-5; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Shumaker SA, 2003, JAMA-J AM MED ASSOC, V289, P2651, DOI 10.1001/jama.289.20.2651; Song WH, 1999, P NATL ACAD SCI USA, V96, P6959, DOI 10.1073/pnas.96.12.6959; Tang MX, 1996, LANCET, V348, P429, DOI 10.1016/S0140-6736(96)03356-9; Verhoeven MO, 2009, MENOPAUSE, V16, P37, DOI 10.1097/gme.0b013e31817c42d6; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Walker ES, 2005, J NEUROCHEM, V92, P294, DOI 10.1111/j.1471-4159.2004.02858.x; Wang J, 2003, NEUROBIOL DIS, V14, P318, DOI 10.1016/j.nbd.2003.08.009; Wang PN, 2000, NEUROLOGY, V54, P2061, DOI 10.1212/WNL.54.11.2061; Xu HX, 2006, ANN NY ACAD SCI, V1089, P324, DOI 10.1196/annals.1386.036; Xu HX, 1998, NAT MED, V4, P447, DOI 10.1038/nm0498-447; Yin YI, 2007, J BIOL CHEM, V282, P23639, DOI 10.1074/jbc.M704601200; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Yue X, 2005, P NATL ACAD SCI USA, V102, P19198, DOI 10.1073/pnas.0505203102	64	69	71	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2009	4	4							e5088	10.1371/journal.pone.0005088	http://dx.doi.org/10.1371/journal.pone.0005088			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RT	19352431	Green Submitted, gold, Green Published			2022-12-25	WOS:000265505300011
J	Pingitore, NE; Clague, JW; Amaya, MA; Maciejewska, B; Reynoso, JJ				Pingitore, Nicholas E., Jr.; Clague, Juan W.; Amaya, Maria A.; Maciejewska, Beata; Reynoso, Jesus J.			Urban Airborne Lead: X-Ray Absorption Spectroscopy Establishes Soil as Dominant Source	PLOS ONE			English	Article								Background: Despite the dramatic decrease in airborne lead over the past three decades, there are calls for regulatory limits on this potent pediatric neurotoxin lower even than the new (2008) US Environmental Protection Agency standard. To achieve further decreases in airborne lead, what sources would need to be decreased and what costs would ensue? Our aim was to identify and, if possible, quantify the major species (compounds) of lead in recent ambient airborne particulate matter collected in El Paso, TX, USA. Methodology/Principal Findings: We used synchrotron-based XAFS (x-ray absorption fine structure) to identify and quantify the major Pb species. XAFS provides molecular-level structural information about a specific element in a bulk sample. Pb-humate is the dominant form of lead in contemporary El Paso air. Pb-humate is a stable, sorbed complex produced exclusively in the humus fraction of Pb-contaminated soils; it also is the major lead species in El Paso soils. Thus such soil must be the dominant source, and its resuspension into the air, the transfer process, providing lead particles to the local air. Conclusions/Significance: Current industrial and commercial activity apparently is not a major source of airborne lead in El Paso, and presumably other locales that have eliminated such traditional sources as leaded gasoline. Instead, local contaminated soil, legacy of earlier anthropogenic Pb releases, serves as a long-term reservoir that gradually leaks particulate lead to the atmosphere. Given the difficulty and expense of large-scale soil remediation or removal, fugitive soil likely constrains a lower limit for airborne lead levels in many urban settings.	[Pingitore, Nicholas E., Jr.; Clague, Juan W.; Maciejewska, Beata] Univ Texas El Paso, Dept Geol Sci, El Paso, TX 79968 USA; [Pingitore, Nicholas E., Jr.; Amaya, Maria A.] Univ Texas El Paso, Sch Nurs, El Paso, TX 79968 USA	University of Texas System; University of Texas El Paso; University of Texas System; University of Texas El Paso	Pingitore, NE (corresponding author), Univ Texas El Paso, Dept Geol Sci, El Paso, TX 79968 USA.	nick@geo.utep.edu			National Institute of Environmental Health Sciences (NIEHS), NIH [1RO1-ES11367, 1 S11 ES013339-01A1]; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources, Biomedical Technology Program; SSRL-DOE-UTEP Gateway Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [S11ES013339, R01ES011367] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); SSRL-DOE-UTEP Gateway Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This publication was made possible by grant numbers 1RO1-ES11367 and 1 S11 ES013339-01A1 from the National Institute of Environmental Health Sciences (NIEHS), NIH. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIEHS, NIH. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a national user facility operated by Stanford University on behalf of the U.S. Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program. Partial travel and on-site support was provided by SSRL-DOE-UTEP Gateway Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNEST JL, 1983, NEW ENGL J MED, V308, P1373, DOI 10.1056/NEJM198306093082301; [Anonymous], 1988, NAT EXT LEAD POIS CH; Bargar JR, 1997, GEOCHIM COSMOCHIM AC, V61, P2639, DOI 10.1016/S0016-7037(97)00125-7; Bargar JR, 1997, GEOCHIM COSMOCHIM AC, V61, P2617, DOI 10.1016/S0016-7037(97)00124-5; Bargar JR, 1996, GEOCHIM COSMOCHIM AC, V60, P3541, DOI 10.1016/0016-7037(96)00222-0; BARGAR JR, 2007, MOL ENV INTERFACE SC; Casteel SW, 2006, ENVIRON HEALTH PERSP, V114, P1162, DOI 10.1289/ehp.8852; Charles D, 2007, SCIENCE, V316, P973; Choel M, 2006, ATMOS ENVIRON, V40, P4439, DOI 10.1016/j.atmosenv.2006.04.027; DAVIDSON CI, 1992, HUMAN LEAD EXPOSURE, P65; Elzinga EJ, 2002, ENVIRON SCI TECHNOL, V36, P4352, DOI 10.1021/es0158509; Gulson B, 2007, SCI TOTAL ENVIRON, V381, P169, DOI 10.1016/j.scitotenv.2007.03.018; Guo XY, 2006, ENVIRON TOXICOL CHEM, V25, P2366, DOI 10.1897/05-636R.1; Harris AR, 2005, ENVIRON SCI TECHNOL, V39, P7410, DOI 10.1021/es050642s; Huggins FE, 2000, J HAZARD MATER, V74, P1, DOI 10.1016/S0304-3894(99)00195-8; JAKLEVIC JM, 1980, ENVIRON SCI TECHNOL, V14, P437, DOI 10.1021/es60164a009; Kabata-Pendias A., 1992, TRACE ELEMENTS SOILS; Lankey RL, 1998, ENVIRON RES, V78, P86, DOI 10.1006/enrs.1998.3853; Manceau A, 1996, ENVIRON SCI TECHNOL, V30, P1540, DOI 10.1021/es9505154; McBride M. B., 1994, ENV CHEM SOILS; Mielke HW, 2008, ENVIRON GEOCHEM HLTH, V30, P231, DOI 10.1007/s10653-007-9111-3; Morin G, 1999, AM MINERAL, V84, P420; O'Day PA, 2004, AM MINERAL, V89, P572, DOI 10.2138/am-2004-0412; Ostergren JD, 1999, ENVIRON SCI TECHNOL, V33, P1627, DOI 10.1021/es980660s; Pingitore N. E., 2005, US MEXICAN BORDER EN, P131; RAO KJ, 1984, J CHEM PHYS, V81, P4832, DOI 10.1063/1.447509; ROE AL, 1991, LANGMUIR, V7, P367, DOI 10.1021/la00050a029; Sposito G, 1989, CHEM SOILS; Stokstad E, 2008, SCIENCE, V319, P146, DOI 10.1126/science.319.5860.146a; Trivedi P, 2003, ENVIRON SCI TECHNOL, V37, P908, DOI 10.1021/es0257927; U.S. Environmental Protection Agency, 2008, FIN NAT AMB AIR QUAL; *US EPA, 2008, FACT SHEET FIN REV N; Werner ML, 2007, ENVIRON SCI TECHNOL, V41, P4919, DOI 10.1021/es070430q; Xia K, 1997, GEOCHIM COSMOCHIM AC, V61, P2211, DOI 10.1016/S0016-7037(97)00079-3; Young TM, 2002, ENVIRON SCI TECHNOL, V36, P2484, DOI 10.1021/es015609u; 2007, CHEM ENG NEWS, V85, P39	36	24	24	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5019	10.1371/journal.pone.0005019	http://dx.doi.org/10.1371/journal.pone.0005019			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340295	Green Published, gold, Green Submitted			2022-12-25	WOS:000265500700007
J	Wagner, RN; Proell, M; Kufer, TA; Schwarzenbacher, R				Wagner, Roland N.; Proell, Martina; Kufer, Thomas A.; Schwarzenbacher, Robert			Evaluation of Nod-Like Receptor (NLR) Effector Domain Interactions	PLOS ONE			English	Article							NF-KAPPA-B; CONTAINING APAF1-LIKE PROTEIN; CASPASE-RECRUITMENT DOMAIN; FAMILY-MEMBER; NALP3 INFLAMMASOME; REGULATES ACTIVATION; CROHNS-DISEASE; CYTOCHROME-C; CARD PROTEIN; PYRIN DOMAIN	Members of the Nod-like receptor (NLR) family recognize intracellular pathogens and recruit a variety of effector molecules, including pro-caspases and kinases, which in turn are implicated in cytokine processing and NF-kappa B activation. In order to elucidate the intricate network of NLR signaling, which is still fragmentary in molecular terms, we applied comprehensive yeast two-hybrid analysis for unbiased evaluation of physical interactions between NLRs and their adaptors (ASC, CARD8) as well as kinase RIPK2 and inflammatory caspases (C1, C2, C4, C5) under identical conditions. Our results confirmed the interaction of NOD1 and NOD2 with RIPK2, and between NLRP3 and ASC, but most importantly, our studies revealed hitherto unrecognized interactions of NOD2 with members of the NLRP subfamily. We found that NOD2 specifically and directly interacts with NLRP1, NLRP3 and NLRP12. Furthermore, we observed homodimerization of the RIPK2 CARD domains and identified residues in NOD2 critical for interaction with RIPK2. In conclusion, our work provides further evidence for the complex network of protein-protein interactions underlying NLR function.	[Wagner, Roland N.; Proell, Martina; Schwarzenbacher, Robert] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Kufer, Thomas A.] Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-5000 Cologne, Germany	Salzburg University; University of Cologne	Wagner, RN (corresponding author), Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria.	robert.schwarzenbacher@sbg.ac.at	Kufer, Thomas A/I-5146-2015	Kufer, Thomas A/0000-0003-4563-0412	MCEXT [033534]; Deutsche Forschungsgemeinschaft [SFB 670]; Federation of European Biochemical Societies (FEBS); Austrian Academy of Sciences [DOC-FFORTE-fellowship]	MCEXT; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federation of European Biochemical Societies (FEBS); Austrian Academy of Sciences	This work was supported by MCEXT-033534 to RS and by funds from the Deutsche Forschungsgemeinschaft (SFB 670) and the Federation of European Biochemical Societies (FEBS) to TAK. MP was supported by a DOC-FFORTE-fellowship of the Austrian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bertin J, 1999, J BIOL CHEM, V274, P12955, DOI 10.1074/jbc.274.19.12955; Carneiro LAM, 2008, J PATHOL, V214, P136, DOI 10.1002/path.2271; Chu ZL, 2001, J BIOL CHEM, V276, P9239, DOI 10.1074/jbc.M006309200; Coussens NP, 2007, BIOCHEM BIOPH RES CO, V353, P1, DOI 10.1016/j.bbrc.2006.11.122; Damiano JS, 2004, BIOCHEM J, V381, P213, DOI 10.1042/BJ20031506; Damiano JS, 2001, GENOMICS, V75, P77, DOI 10.1006/geno.2001.6579; Dostert C, 2008, ADV DRUG DELIVER REV, V60, P830, DOI 10.1016/j.addr.2007.12.003; Eckmann L, 2005, IMMUNITY, V22, P661, DOI 10.1016/j.immuni.2005.06.004; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Faustin B, 2008, TRENDS CELL BIOL, V18, P4, DOI 10.1016/j.tcb.2007.10.004; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Geddes BJ, 2001, BIOCHEM BIOPH RES CO, V284, P77, DOI 10.1006/bbrc.2001.4928; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Hlaing T, 2001, J BIOL CHEM, V276, P9230, DOI 10.1074/jbc.M009853200; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Hu YM, 1998, P NATL ACAD SCI USA, V95, P4386, DOI 10.1073/pnas.95.8.4386; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2000, J BIOL CHEM, V275, P27823; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Jayapandian M, 2007, NUCLEIC ACIDS RES, V35, pD566, DOI 10.1093/nar/gkl859; Kinoshita T, 2006, INT IMMUNOL, V18, P1701, DOI 10.1093/intimm/dxl104; Kufer TA, 2008, MOL BIOSYST, V4, P380, DOI 10.1039/b718948f; Li HL, 1997, J BIOL CHEM, V272, P21010, DOI 10.1074/jbc.272.34.21010; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Manji GA, 2002, J BIOL CHEM, V277, P11570, DOI 10.1074/jbc.M112208200; Manon F, 2007, J MOL BIOL, V365, P160, DOI 10.1016/j.jmb.2006.09.067; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2001, CURR BIOL, V11, pR118, DOI 10.1016/S0960-9822(01)00056-2; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Masumoto J, 2003, BIOCHEM BIOPH RES CO, V303, P69, DOI 10.1016/S0006-291X(03)00309-7; Masumoto J, 2001, BIOCHEM BIOPH RES CO, V280, P652, DOI 10.1006/bbrc.2000.4190; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Pan QL, 2007, J LEUKOCYTE BIOL, V82, P177, DOI 10.1189/jlb.1006627; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Pathan N, 2001, J BIOL CHEM, V276, P32220, DOI 10.1074/jbc.M100433200; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Proell M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002119; Razmara M, 2002, J BIOL CHEM, V277, P13952, DOI 10.1074/jbc.M107811200; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Rosenstiel P, 2006, P NATL ACAD SCI USA, V103, P3280, DOI 10.1073/pnas.0505423103; Srimathi T, 2008, J BIOL CHEM, V283, P15390, DOI 10.1074/jbc.M801589200; Srimathi T, 2008, BIOCHEMISTRY-US, V47, P1319, DOI 10.1021/bi7016602; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Stehlik C, 2003, BIOCHEM J, V373, P101, DOI 10.1042/BJ20030304; Stehlik C, 2002, J EXP MED, V196, P1605, DOI 10.1084/jem.20021552; Stilo R, 2002, FEBS LETT, V521, P165, DOI 10.1016/S0014-5793(02)02869-7; Tanabe T, 2004, EMBO J, V23, P1587, DOI 10.1038/sj.emboj.7600175; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; YERETSSIAN G, 2008, CYTOKINE; Yoo NJ, 2002, BIOCHEM BIOPH RES CO, V299, P652, DOI 10.1016/S0006-291X(02)02714-6	66	47	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e4931	10.1371/journal.pone.0004931	http://dx.doi.org/10.1371/journal.pone.0004931			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337385	Green Published, gold, Green Submitted			2022-12-25	WOS:000265500600004
J	Claggett, SB; Plancher, M; Dunn, SD; Cain, BD				Claggett, Shane B.; Plancher, Mac O'Neil; Dunn, Stanley D.; Cain, Brian D.			The b Subunits in the Peripheral Stalk of F1F0 ATP Synthase Preferentially Adopt an Offset Relationship	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI F1F0-ATPASE; DIMERIZATION DOMAIN; STATOR STALK; 2ND STALK; F0F1-ATP SYNTHASE; DIMER; F-1; F-1-ATPASE; RESOLUTION; ACID	The peripheral stalk of F1F0 ATP synthase is essential for the binding of F-1 to F-0 and for proper transfer of energy between the two sectors of the enzyme. The peripheral stalk of Escherichia coli is composed of a dimer of identical b subunits. In contrast, photosynthetic organisms express two b-like genes that form a heterodimeric peripheral stalk. Previously we generated chimeric peripheral stalks in which a portion of the tether and dimerization domains of the E. coli b subunits were replaced with homologous sequences from the b and b' subunits of Thermosynechococcus elongatus (Claggett, S. B., Grabar, T. B., Dunn, S. D., and Cain, B. D. (2007) J. Bacteriol. 189, 5463-5471). The spatial arrangement of the chimeric b and b' subunits, abbreviated Tb and Tb', has been investigated by Cu2+-mediated disulfide cross-link formation. Disulfide formation was studied both in soluble model polypeptides and between full-length subunits within intact functional F1F0 ATP synthase complexes. In both cases, disulfides were preferentially formed between Tb-A83C and Tb'(A90C), indicating the existence of a staggered relationship between helices of the two chimeric subunits. Even under stringent conditions rapid formation of disulfides between these positions occurred. Importantly, formation of this cross-link had no detectable effect on ATP-driven proton pumping, indicating that the staggered conformation is compatible with normal enzymatic activity. Under less stringent reaction conditions, it was also possible to detect b subunits cross-linked through identical positions, suggesting that an in-register, non-staggered parallel conformation may also exist.	[Claggett, Shane B.; Plancher, Mac O'Neil; Cain, Brian D.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32605 USA; [Dunn, Stanley D.] Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada	State University System of Florida; University of Florida; Western University (University of Western Ontario)	Cain, BD (corresponding author), Univ Florida, Dept Biochem & Mol Biol, Box 100245, Gainesville, FL 32610 USA.	bcain@biochem.med.ufl.edu	Dunn, Stanley/D-3418-2013		United States Public Health Service [GM70978]; University of Florida; Canadian Institutes of Health [MOP-10237]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070978] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); University of Florida(University of Florida); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States Public Health Service Grant GM70978 (to B. D. C.), a University of Florida Alumni Fellowship (to S. B. C.), and Canadian Institutes of Health Grant MOP-10237 (to S. D. D.).	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Caviston TL, 1998, FEBS LETT, V429, P201, DOI 10.1016/S0014-5793(98)00597-3; Claggett SB, 2007, J BACTERIOL, V189, P5463, DOI 10.1128/JB.00191-07; Del Rizzo PA, 2002, BIOCHEMISTRY-US, V41, P6875, DOI 10.1021/bi025736i; Del Rizzo PA, 2006, J MOL BIOL, V364, P735, DOI 10.1016/j.jmb.2006.09.028; Devenish RJ, 2008, INT REV CEL MOL BIO, V267, P1, DOI 10.1016/S1937-6448(08)00601-1; Dimroth P, 2006, EMBO REP, V7, P276, DOI 10.1038/sj.embor.7400646; Dmitriev O, 1999, J BIOL CHEM, V274, P15598, DOI 10.1074/jbc.274.22.15598; Dunn SD, 1998, J BIOL CHEM, V273, P8646, DOI 10.1074/jbc.273.15.8646; Dykxhoorn DM, 1996, GENE, V177, P133, DOI 10.1016/0378-1119(96)00289-2; Gardner JL, 1999, ARCH BIOCHEM BIOPHYS, V361, P302, DOI 10.1006/abbi.1998.0995; Grabar TB, 2004, J BIOL CHEM, V279, P31205, DOI 10.1074/jbc.M404420200; Grabar TB, 2003, J BIOL CHEM, V278, P34751, DOI 10.1074/jbc.M303361200; Hornung T, 2008, BIOPHYS J, V94, P5053, DOI 10.1529/biophysj.107.121038; MCCORMICK KA, 1991, J BACTERIOL, V173, P7240, DOI 10.1128/jb.173.22.7240-7248.1991; McLachlin DT, 1997, J BIOL CHEM, V272, P21233, DOI 10.1074/jbc.272.34.21233; MESELSON M, 1968, NATURE, V217, P1110, DOI 10.1038/2171110a0; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; Priya R, 2008, J BIOENERG BIOMEMBR, V40, P245, DOI 10.1007/s10863-008-9154-x; Revington M, 1999, J BIOL CHEM, V274, P31094, DOI 10.1074/jbc.274.43.31094; Rodgers AJW, 1997, J BIOL CHEM, V272, P31058, DOI 10.1074/jbc.272.49.31058; Rodgers AJW, 1998, J BIOL CHEM, V273, P29406, DOI 10.1074/jbc.273.45.29406; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sorgen PL, 1998, BIOCHEMISTRY-US, V37, P923, DOI 10.1021/bi972309+; Sorgen PL, 1998, J BIOL CHEM, V273, P27873, DOI 10.1074/jbc.273.43.27873; Steigmiller S, 2005, BBA-BIOENERGETICS, V1708, P143, DOI 10.1016/j.bbabio.2005.03.013; von Ballmoos C, 2008, ANNU REV BIOPHYS, V37, P43, DOI 10.1146/annurev.biophys.37.032807.130018; Walker JE, 2006, BBA-BIOENERGETICS, V1757, P286, DOI 10.1016/j.bbabio.2006.01.001; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Weber J, 2007, TRENDS BIOCHEM SCI, V32, P53, DOI 10.1016/j.tibs.2006.12.006; Weber J, 2006, BBA-BIOENERGETICS, V1757, P1162, DOI 10.1016/j.bbabio.2006.04.007; Wise JG, 2008, BIOPHYS J, V94, P5040, DOI 10.1529/biophysj.107.121012; Wood KS, 2007, J BIOL CHEM, V282, P31920, DOI 10.1074/jbc.M706259200; Zaida TM, 2008, J BIOENERG BIOMEMBR, V40, P551, DOI 10.1007/s10863-008-9189-z	34	13	13	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16531	16540		10.1074/jbc.M109.002980	http://dx.doi.org/10.1074/jbc.M109.002980			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19369253	hybrid, Green Published			2022-12-25	WOS:000266730900050
J	Weaver, KL; Ivester, P; Seeds, M; Case, LD; Arm, JP; Chilton, FH				Weaver, Kelly L.; Ivester, Priscilla; Seeds, Michael; Case, L. Douglas; Arm, Jonathan P.; Chilton, Floyd H.			Effect of Dietary Fatty Acids on Inflammatory Gene Expression in Healthy Humans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-LINOLENIC ACID; PHOSPHATIDYLINOSITOL 3-KINASE-AKT PATHWAY; FISH-OIL; EICOSAPENTAENOIC ACID; RHEUMATOID-ARTHRITIS; VENTILATED PATIENTS; CONTROLLED-TRIAL; DOUBLE-BLIND; DISEASE; OMEGA-3-FATTY-ACIDS	Over the past 100 years, changes in the food supply in Western nations have resulted in alterations in dietary fatty acid consumption, leading to a dramatic increase in the ratio of omega-6 (omega 6) to omega 3 polyunsaturated fatty acids (PUFA) in circulation and in tissues. Increased omega 6/omega 3 ratios are hypothesized to increase inflammatory mediator production, leading to higher incidence of inflammatory diseases, and may impact inflammatory gene expression. To determine the effect of reducing the omega 6/omega 3 ratio on expression of inflammatory pathway genes in mononuclear cells, healthy humans were placed on a controlled diet for 1 week, then given fish oil and borage oil for an additional 4 weeks. Serum and neutrophil fatty acid composition and ex vivo leukotriene B-4 production from stimulated neutrophils were measured at the start and end of the supplementation period and after a 2-week washout. RNA was isolated from mononuclear cells and expression of PI3K, Akt, NF kappa B, and inflammatory cytokines was measured by real-time PCR. A marked increase was seen in serum and neutrophil levels of long-chain omega 3 PUFA concomitant with a reduction in the omega 6/omega 3 PUFA ratio (40%). The ex vivo capacity of stimulated neutrophils to produce leukotriene B-4 was decreased by 31%. Expression of PI3K alpha and PI3K gamma and the quantity of PI3K alpha protein in mononuclear cells was reduced after supplementation, as was the expression of several proinflammatory cytokines. These data reveal that PUFA may exert their clinical effects via their capacity to regulate the expression of signal transduction genes and genes for proinflammatory cytokines.	[Weaver, Kelly L.; Ivester, Priscilla; Chilton, Floyd H.] Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27157 USA; [Weaver, Kelly L.; Seeds, Michael] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC 27157 USA; [Case, L. Douglas] Wake Forest Univ, Bowman Gray Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27157 USA; [Arm, Jonathan P.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Arm, Jonathan P.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Ivester, P (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol & Pharmacol, Med Ctr Blvd, Winston Salem, NC 27157 USA.	ivester@wfubmc.edu		Chilton, Floyd/0000-0002-3686-0198; Weaver, Kelly/0000-0002-6826-0015	National Institutes of Health NCCAM [1P50AT0027820]; The GCRC at Wake Forest University Baptist Medical Center [M01-RR07122]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P50AT002782] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR007122] Funding Source: NIH RePORTER	National Institutes of Health NCCAM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); The GCRC at Wake Forest University Baptist Medical Center; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Institutes of Health NCCAM Grant 1P50AT0027820.; We thank B. Undem for critical editing of the manuscript, M. Wilson for technical support with FAME analysis, and M. Pace for administrative assistance. All authors discussed the results and commented on the manuscript. K. L. W. had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The GCRC at Wake Forest University Baptist Medical Center provided the diets and nutritional counseling to study participants and is supported by Grant Number M01-RR07122. Potential Conflicts of Interest: F. H. C. has published books Inflammation Nation, Win the War Within, and The Gene Smart Diet and is a founder and a consultant to Pilot Therapeutics Holdings, which may be partially related to his research. His conflict of interest has been disclosed to Wake Forest University Health Sciences and outside sponsors and is institutionally managed.	Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Barham JB, 2000, J NUTR, V130, P1925, DOI 10.1093/jn/130.8.1925; Calder PC, 2002, P NUTR SOC, V61, P345, DOI 10.1079/PNS2002166; Calder PC, 2001, LIPIDS, V36, P1007, DOI 10.1007/s11745-001-0812-7; CHILTON FH, 1993, J CLIN INVEST, V91, P115, DOI 10.1172/JCI116159; Christensen JH, 1996, BMJ-BRIT MED J, V312, P677, DOI 10.1136/bmj.312.7032.677; Cordain, 2002, PALEO DIET; Cordain L, 2002, EUR J CLIN NUTR, V56, P181, DOI 10.1038/sj.ejcn.1601307; Curtis CL, 2000, J BIOL CHEM, V275, P721, DOI 10.1074/jbc.275.2.721; FORTIN PR, 1995, J CLIN EPIDEMIOL, V48, P1379, DOI 10.1016/0895-4356(95)00028-3; Fukao T, 2002, NAT IMMUNOL, V3, P295, DOI 10.1038/ni768; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; HerreraVelit P, 1997, J BIOL CHEM, V272, P16445, DOI 10.1074/jbc.272.26.16445; High K P, 2003, J Nutr Health Aging, V7, P378; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Hughes-Fulford M, 2006, CANCER RES, V66, P1427, DOI 10.1158/0008-5472.CAN-05-0914; Johnson MM, 1997, J NUTR, V127, P1435, DOI 10.1093/jn/127.8.1435; KREMER JM, 1985, LANCET, V1, P184; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; METCALFE LD, 1966, ANAL CHEM, V38, P514, DOI 10.1021/ac60235a044; MILLER AM, 1993, PROSTAG LEUKOTR ESS, V49, P561, DOI 10.1016/0952-3278(93)90161-O; Monjazeb AM, 2006, CARCINOGENESIS, V27, P1950, DOI 10.1093/carcin/bgl023; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; Pontes-Arruda A, 2006, CRIT CARE MED, V34, P2325, DOI 10.1097/01.CCM.0000234033.65657.B6; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Simopoulos AP, 2002, J AM COLL NUTR, V21, P495, DOI 10.1080/07315724.2002.10719248; Singer P, 2006, CRIT CARE MED, V34, P1033, DOI 10.1097/01.CCM.0000206111.23629.0A; Su KP, 2003, EUR NEUROPSYCHOPHARM, V13, P267, DOI 10.1016/S0924-977X(03)00032-4; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.immunol.13.1.251; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839	33	113	183	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15400	15407		10.1074/jbc.M109.004861	http://dx.doi.org/10.1074/jbc.M109.004861			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19359242	hybrid, Green Published			2022-12-25	WOS:000266501000007
J	Saleh, O; Gust, B; Boll, B; Fiedler, HP; Heide, L				Saleh, Orwah; Gust, Bertolt; Boll, Bjoern; Fiedler, Hans-Peter; Heide, Lutz			Aromatic Prenylation in Phenazine Biosynthesis DIHYDROPHENAZINE-1-CARBOXYLATE DIMETHYLALLYLTRANSFERASE FROM STREPTOMYCES ANULATUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOMYCES-CINNAMONENSIS DSM-1042; SIMILAR-TO-D; GENE-CLUSTER; HETEROLOGOUS EXPRESSION; NATURAL-PRODUCTS; FURANONAPHTHOQUINONE; PRENYLTRANSFERASES; ANTIBIOTICS; DIVERSITY; CATALYZES	The bacterium Streptomyces anulatus 9663, isolated from the intestine of different arthropods, produces prenylated derivatives of phenazine 1-carboxylic acid. From this organism, we have identified the prenyltransferase gene PpzP. PpzP resides in a gene cluster containing orthologs of all genes known to be involved in phenazine 1-carboxylic acid biosynthesis in Pseudomonas strains as well as genes for the six enzymes required to generate dimethylallyl diphosphate via the mevalonate pathway. This is the first complete gene cluster of a phenazine natural compound from streptomycetes. Heterologous expression of this cluster in Streptomyces coelicolor M512 resulted in the formation of prenylated derivatives of phenazine 1-carboxylic acid. After inactivation of PpzP, only nonprenylated phenazine 1-carboxylic acid was formed. Cloning, overexpression, and purification of PpzP resulted in a 37-kDa soluble protein, which was identified as a 5,10-dihydrophenazine 1-carboxylate dimethylallyltransferase, forming a C-C bond between C-1 of the isoprenoid substrate and C-9 of the aromatic substrate. In contrast to many other prenyltransferases, the reaction of PpzP is independent of the presence of magnesium or other divalent cations. The K-m value for dimethylallyl diphosphate was determined as 116 mu M. For dihydro-PCA, half-maximal velocity was observed at 35 mu M. K-cat was calculated as 0.435 s(-1). PpzP shows obvious sequence similarity to a recently discovered family of prenyltransferases with aromatic substrates, the ABBA prenyltransferases. The present finding extends the substrate range of this family, previously limited to phenolic compounds, to include also phenazine derivatives.	[Saleh, Orwah; Gust, Bertolt; Boll, Bjoern; Heide, Lutz] Univ Tubingen, Inst Pharmazeut, D-72076 Tubingen, Germany; [Fiedler, Hans-Peter] Univ Tubingen, Inst Mikrobiol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen	Heide, L (corresponding author), Univ Tubingen, Inst Pharmazeut, Morgenstelle 8, D-72076 Tubingen, Germany.	heide@uni-tuebingen.de	Boll, Björn/AAJ-2892-2020	Heide, Lutz/0000-0001-7809-7453	Deutsche Forschungsgemeinschaft [1152]; Tishrin University, Syria	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tishrin University, Syria	This work was supported by Deutsche Forschungsgemeinschaft Grant SPP 1152 EVOMET (to L. H.) and by a scholarship from Tishrin University, Syria (to O.S.).	Ahuja EG, 2008, J AM CHEM SOC, V130, P17053, DOI 10.1021/ja806325k; Bringmann G, 2007, J ORG CHEM, V72, P4198, DOI 10.1021/jo0703404; Dairi T, 2005, J ANTIBIOT, V58, P227, DOI 10.1038/ja.2005.27; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Eustaquio AS, 2005, APPL ENVIRON MICROB, V71, P2452, DOI 10.1128/AEM.71.5.2452-2459.2005; Gebhardt K, 2002, J ANTIBIOT, V55, P794, DOI 10.7164/antibiotics.55.794; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Gust B, 2004, ADV APPL MICROBIOL, V54, P107, DOI 10.1016/S0065-2164(04)54004-2; Haagen Y, 2007, FEBS LETT, V581, P2889, DOI 10.1016/j.febslet.2007.05.031; Haagen Y, 2006, CHEMBIOCHEM, V7, P2016, DOI 10.1002/cbic.200600338; Hopwood DA, 2007, STREPTOMYCES NATURE; ISSHIKI K, 1986, J ANTIBIOT, V39, P1634, DOI 10.7164/antibiotics.39.1634; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; Kawasaki T, 2006, J BACTERIOL, V188, P1236, DOI 10.1128/JB.188.4.1236-1244.2006; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Krastel P, 2002, J ANTIBIOT, V55, P801, DOI 10.7164/antibiotics.55.801; Kumano T, 2008, BIOORGAN MED CHEM, V16, P8117, DOI 10.1016/j.bmc.2008.07.052; Kuzuyama T, 2003, NAT PROD REP, V20, P171, DOI 10.1039/b109860h; Kuzuyama T, 2005, NATURE, V435, P983, DOI 10.1038/nature03668; Laursen JB, 2004, CHEM REV, V104, P1663, DOI 10.1021/cr020473j; Mavrodi D.V., 2008, PSEUDOMONAS MODEL OR, P331; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; Pojer F, 2003, P NATL ACAD SCI USA, V100, P2316, DOI 10.1073/pnas.0337708100; Poulter C. Dale, 2006, Phytochemistry Reviews, V5, P17, DOI 10.1007/s11101-005-4887-1; Sambrook J, 2001, MOL CLONING LAB MANU; SEDMERA P, 1991, J NAT PROD, V54, P870, DOI 10.1021/np50075a022; Sigmund JM, 2003, MICROB ECOL, V46, P106, DOI 10.1007/s00248-002-2029-5; Takagi M, 2000, J BACTERIOL, V182, P4153, DOI 10.1128/JB.182.15.4153-4157.2000; TAX J, 1983, COLLECT CZECH CHEM C, V48, P527, DOI 10.1135/cccc19830527; Tello M, 2008, CELL MOL LIFE SCI, V65, P1459, DOI 10.1007/s00018-008-7579-3; WOODSIDE AB, 1988, ORG SYNTH, V66, P211	31	45	46	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14439	14447		10.1074/jbc.M901312200	http://dx.doi.org/10.1074/jbc.M901312200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19339241	hybrid, Green Published			2022-12-25	WOS:000266286100050
J	Wydau, S; van der Rest, G; Aubard, C; Plateau, P; Blanquet, S				Wydau, Sandra; van der Rest, Guillaume; Aubard, Caroline; Plateau, Pierre; Blanquet, Sylvain			Widespread Distribution of Cell Defense against D-Aminoacyl-tRNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RADICAL SAM SUPERFAMILY; ESCHERICHIA-COLI; D-TYR-TRNA(TYR) DEACYLASE; D-TYROSINE; SACCHAROMYCES-CEREVISIAE; PROTEIN-SYNTHESIS; CRYSTAL-STRUCTURE; ACTIVE-SITE; BINDING; SYNTHETASE	Several L-aminoacyl-tRNA synthetases can transfer a D-amino acid onto their cognate tRNA(s). This harmful reaction is counteracted by the enzyme D-aminoacyl-tRNA deacylase. Two distinct deacylases were already identified in bacteria (DTD1) and in archaea (DTD2), respectively. Evidence was given that DTD1 homologs also exist in nearly all eukaryotes, whereas DTD2 homologs occur in plants. On the other hand, several bacteria, including most cyanobacteria, lack genes encoding a DTD1 homolog. Here we show that Synechocystis sp. PCC6803 produces a third type of deacylase (DTD3). Inactivation of the corresponding gene (dtd3) renders the growth of Synechocystis sp. hypersensitive to the presence of D-tyrosine. Based on the available genomes, DTD3-like proteins are predicted to occur in all cyanobacteria. Moreover, one or several dtd3-like genes can be recognized in all cellular types, arguing in favor of the near-ubiquity of an enzymatic function involved in the defense of translational systems against invasion by D-amino acids.	[Wydau, Sandra; Aubard, Caroline; Plateau, Pierre; Blanquet, Sylvain] Ecole Polytech, CNRS, Biochim Lab, F-91128 Palaiseau, France; [van der Rest, Guillaume] Ecole Polytech, CNRS, Lab Mecanismes React, F-91128 Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris	Plateau, P (corresponding author), Ecole Polytech, CNRS, Biochim Lab, F-91128 Palaiseau, France.	pierre.plateau@polytechnique.edu	van der Rest, Guillaume/AAW-7349-2020	van der Rest, Guillaume/0000-0002-1176-620X; launay, caroline/0000-0002-6587-6631; Wydau-Dematteis, Sandra/0000-0003-2023-3656	Agence Nationale de la Recherche, 2005-2008	Agence Nationale de la Recherche, 2005-2008(French National Research Agency (ANR))	This work was supported by a grant from the Agence Nationale de la Recherche, 2005-2008.	CALENDAR R, 1966, BIOCHEMISTRY-US, V5, P1690, DOI 10.1021/bi00869a034; CALENDAR R, 1967, J MOL BIOL, V26, P39, DOI 10.1016/0022-2836(67)90259-8; Chong YE, 2008, J BIOL CHEM, V283, P30073, DOI 10.1074/jbc.M805943200; DARDEL F, 1994, COMPUT APPL BIOSCI, V10, P273; Ferri-Fioni ML, 2006, J BIOL CHEM, V281, P27575, DOI 10.1074/jbc.M605860200; Ferri-Fioni ML, 2001, J BIOL CHEM, V276, P47285, DOI 10.1074/jbc.M106550200; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; GomezOrtiz M, 1997, FEBS LETT, V400, P336, DOI 10.1016/S0014-5793(96)01412-3; Guillon L, 2005, BIOCHEMISTRY-US, V44, P15594, DOI 10.1021/bi051514j; HOLLAND DR, 1995, PROTEIN SCI, V4, P1955, DOI 10.1002/pro.5560041001; Holm L, 1997, PROTEINS, V28, P72, DOI 10.1002/(SICI)1097-0134(199705)28:1<72::AID-PROT7>3.0.CO;2-L; Kemp M, 2007, J BIOL CHEM, V282, P10441, DOI 10.1074/jbc.M609632200; Lai WL, 2004, J BIOL CHEM, V279, P13962, DOI 10.1074/jbc.M308849200; Liaw SH, 2003, J BIOL CHEM, V278, P4957, DOI 10.1074/jbc.M210795200; MENNINGER JR, 1976, J BIOL CHEM, V251, P3392; Nakabachi A, 2006, SCIENCE, V314, P267, DOI 10.1126/science.1134196; Qiu JZ, 2005, J BIOL CHEM, V280, P15370, DOI 10.1074/jbc.M413547200; Schmitt E, 1997, EMBO J, V16, P4760, DOI 10.1093/emboj/16.15.4760; Sheoran A, 2008, J BIOL CHEM, V283, P12971, DOI 10.1074/jbc.M801650200; Sheoran A, 2008, J BIOL CHEM, V283, P12960, DOI 10.1074/jbc.M801649200; Soutourina J, 2000, J BIOL CHEM, V275, P32535, DOI 10.1074/jbc.M005166200; Soutourina J, 1999, J BIOL CHEM, V274, P19109, DOI 10.1074/jbc.274.27.19109; Soutourina J, 2000, J BIOL CHEM, V275, P11626, DOI 10.1074/jbc.275.16.11626; Soutourina O, 2004, J BIOL CHEM, V279, P42560, DOI 10.1074/jbc.M402931200; Takayama T, 2005, BIOSCI BIOTECH BIOCH, V69, P1040, DOI 10.1271/bbb.69.1040; Tamames J, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-181; van den Bremer ETJ, 2002, PROTEIN SCI, V11, P1738, DOI 10.1110/ps.0200502; VIEIRA J, 1991, GENE, V100, P189, DOI 10.1016/0378-1119(91)90365-I; Wakayama M, 2000, BIOSCI BIOTECH BIOCH, V64, P1, DOI 10.1271/bbb.64.1; Wang SC, 2007, TRENDS BIOCHEM SCI, V32, P101, DOI 10.1016/j.tibs.2007.01.002; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Wydau S, 2007, NUCLEIC ACIDS RES, V35, P930, DOI 10.1093/nar/gkl1145; YAMANE T, 1981, BIOCHEMISTRY-US, V20, P7059, DOI 10.1021/bi00528a001; Yang HB, 2003, FEBS LETT, V552, P95, DOI 10.1016/S0014-5793(03)00858-5; YANG YB, 1992, BIOSCI BIOTECH BIOCH, V56, P1392, DOI 10.1271/bbb.56.1392; Zheng G, 2009, BIOCHEM J, V417, P85, DOI 10.1042/BJ20080617	36	30	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14096	14104		10.1074/jbc.M808173200	http://dx.doi.org/10.1074/jbc.M808173200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19332551	hybrid, Green Published			2022-12-25	WOS:000266286100016
J	Pasupuleti, M; Schmidtchen, A; Chalupka, A; Ringstad, L; Malmsten, M				Pasupuleti, Mukesh; Schmidtchen, Artur; Chalupka, Anna; Ringstad, Lovisa; Malmsten, Martin			End-Tagging of Ultra-Short Antimicrobial Peptides by W/F Stretches to Facilitate Bacterial Killing	PLOS ONE			English	Article								Background: Due to increasing resistance development among bacteria, antimicrobial peptides (AMPs), are receiving increased attention. Ideally, AMP should display high bactericidal potency, but low toxicity against (human) eukaryotic cells. Additionally, short and proteolytically stable AMPs are desired to maximize bioavailability and therapeutic versatility. Methodology and Principal Findings: A facile approach is demonstrated for reaching high potency of ultra-short antimicrobal peptides through end-tagging with W and F stretches. Focusing on a peptide derived from kininogen, KNKGKKNGKH (KNK10) and truncations thereof, end-tagging resulted in enhanced bactericidal effect against Gram-negative Escherichia coli and Gram-positive Staphylococcus aureus. Through end-tagging, potency and salt resistance could be maintained down to 4-7 amino acids in the hydrophilic template peptide. Although tagging resulted in increased eukaryotic cell permeabilization at low ionic strength, the latter was insignificant at physiological ionic strength and in the presence of serum. Quantitatively, the most potent peptides investigated displayed bactericidal effects comparable to, or in excess of, that of the benchmark antimicrobial peptide LL-37. The higher bactericidal potency of the tagged peptides correlated to a higher degree of binding to bacteria, and resulting bacterial wall rupture. Analogously, tagging enhanced peptide-induced rupture of liposomes, particularly anionic ones. Additionally, end-tagging facilitated binding to bacterial lipopolysaccharide, both effects probably contributing to the selectivity displayed by these peptides between bacteria and eukaryotic cells. Importantly, W-tagging resulted in peptides with maintained stability against proteolytic degradation by human leukocyte elastase, as well as staphylococcal aureolysin and V8 proteinase. The biological relevance of these findings was demonstrated ex vivo for pig skin infected by S. aureus and E. coli. Conclusions/Significance: End-tagging by hydrophobic amino acid stretches may be employed to enhance bactericidal potency also of ultra-short AMPs at maintained limited toxicity. The approach is of general applicability, and facilitates straightforward synthesis of hydrophobically modified AMPs without the need for post-peptide synthesis modifications.			Pasupuleti, M (corresponding author), Lund Univ, Dept Clin Sci, Sect Dermatol & Venereol, Lund, Sweden.	martin.malmsten@farmaci.uu.se	Pasupuleti, Mukesh/AAF-4066-2020; Pasupuleti, Mukesh/H-7605-2013; Schmidtchen, Artur/F-9507-2015; Pasupuleti, Mukesh/AAD-9977-2020	Pasupuleti, Mukesh/0000-0001-6337-6257; 				Andersson E, 2004, EUR J BIOCHEM, V271, P1219, DOI 10.1111/j.1432-1033.2004.04035.x; Avrahami D, 2004, J BIOL CHEM, V279, P12277, DOI 10.1074/jbc.M312260200; Avrahami D, 2003, BIOCHEMISTRY-US, V42, P14946, DOI 10.1021/bi035142v; Avrahami D, 2002, BIOCHEMISTRY-US, V41, P2254, DOI 10.1021/bi011549t; Bernard P, 2008, CURR OPIN INFECT DIS, V21, P122, DOI 10.1097/QCO.0b013e3282f44c63; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Chan DI, 2006, BBA-BIOMEMBRANES, V1758, P1184, DOI 10.1016/j.bbamem.2006.04.006; Chen FY, 2003, BIOPHYS J, V84, P3751, DOI 10.1016/S0006-3495(03)75103-0; Chen YX, 2005, J BIOL CHEM, V280, P12316, DOI 10.1074/jbc.M413406200; CHENG F, 1992, GLYCOBIOLOGY, V2, P553, DOI 10.1093/glycob/2.6.553; Costa MC, 2007, J CHEM ENG DATA, V52, P30, DOI 10.1021/je060146z; del Rio G, 2001, FEBS LETT, V494, P213, DOI 10.1016/S0014-5793(01)02348-1; Deslouches B, 2005, ANTIMICROB AGENTS CH, V49, P316, DOI 10.1128/AAC.49.1.316-322.2005; EMBER JA, 1991, BIOCHEMISTRY-US, V30, P3603, DOI 10.1021/bi00229a003; Glukhov E, 2005, J BIOL CHEM, V280, P33960, DOI 10.1074/jbc.M507042200; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Haney EF, 2007, BBA-BIOMEMBRANES, V1768, P2355, DOI 10.1016/j.bbamem.2007.04.018; Huang HW, 2006, BBA-BIOMEMBRANES, V1758, P1292, DOI 10.1016/j.bbamem.2006.02.001; Javadpour MM, 1996, J MED CHEM, V39, P3107, DOI 10.1021/jm9509410; Jenssen H, 2007, CHEM BIOL DRUG DES, V70, P134, DOI 10.1111/j.1747-0285.2007.00543.x; Jerala R, 2007, EXPERT OPIN INV DRUG, V16, P1159, DOI 10.1517/13543784.16.8.1159; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Li X, 2006, BBA-BIOMEMBRANES, V1758, P1203, DOI 10.1016/j.bbamem.2006.03.032; Lorenz D, 1998, J GEN PHYSIOL, V112, P577, DOI 10.1085/jgp.112.5.577; Makovitzki A, 2005, BIOCHEMISTRY-US, V44, P9775, DOI 10.1021/bi0502386; Makovitzki A, 2008, BIOCHEMISTRY-US, V47, P10630, DOI 10.1021/bi8011675; Malmsten M, 1996, J COLLOID INTERF SCI, V178, P160, DOI 10.1006/jcis.1996.0104; Malmsten M, 1998, J COLLOID INTERF SCI, V204, P104, DOI 10.1006/jcis.1998.5568; Malmsten M, 2007, GROWTH FACTORS, V25, P60, DOI 10.1080/08977190701344120; Malmsten M, 2006, MATRIX BIOL, V25, P294, DOI 10.1016/j.matbio.2006.04.003; Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006; McDonnell G, 1999, J MICROBIOL METH, V35, P31, DOI 10.1016/S0167-7012(98)00094-3; McInturff JE, 2005, J INVEST DERMATOL, V125, P256, DOI 10.1111/j.0022-202X.2005.23805.x; Nell MJ, 2006, PEPTIDES, V27, P649, DOI 10.1016/j.peptides.2005.09.016; Nizet V, 2006, CURR ISSUES MOL BIOL, V8, P11; Nordahl EA, 2004, P NATL ACAD SCI USA, V101, P16879, DOI 10.1073/pnas.0406678101; Nordahl EA, 2005, J BIOL CHEM, V280, P34832, DOI 10.1074/jbc.M507249200; Pasupuleti M, 2008, BIOCHEMISTRY-US, V47, P9057, DOI 10.1021/bi800991e; Pasupuleti M, 2007, J BIOL CHEM, V282, P2520, DOI 10.1074/jbc.M607848200; Petersen FNR, 2005, BIOPHYS J, V89, P3985, DOI 10.1529/biophysj.105.061804; Ramamoorthy A, 2006, BIOPHYS J, V91, P206, DOI 10.1529/biophysj.105.073890; Ringstad L, 2008, LANGMUIR, V24, P208, DOI 10.1021/la702538k; Ringstad L, 2007, BBA-BIOMEMBRANES, V1768, P715, DOI 10.1016/j.bbamem.2006.11.016; Ringstad L, 2006, LANGMUIR, V22, P5042, DOI 10.1021/la060317y; Ringstad L, 2007, BIOPHYS J, V92, P87, DOI 10.1529/biophysj.106.088161; Schmidtchen A, 2002, MOL MICROBIOL, V46, P157, DOI 10.1046/j.1365-2958.2002.03146.x; SCHMIDTCHEN A, 2008, J BIOL CHEM; Sonesson A, 2007, BBA-BIOMEMBRANES, V1768, P346, DOI 10.1016/j.bbamem.2006.10.017; Straus SK, 2006, BBA-BIOMEMBRANES, V1758, P1215, DOI 10.1016/j.bbamem.2006.02.009; Taboureau O, 2006, CHEM BIOL DRUG DES, V68, P48, DOI 10.1111/j.1747-0285.2006.00405.x; Toke O, 2005, BIOPOLYMERS, V80, P717, DOI 10.1002/bip.20286; Tossi A, 2000, BIOPOLYMERS, V55, P4; Tourmousoglou CE, 2008, J CHEMOTHERAPY, V20, P312, DOI 10.1179/joc.2008.20.3.312; ULEVITCH RJ, 1978, IMMUNOCHEMISTRY, V15, P157, DOI 10.1016/0161-5890(78)90144-X; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zelezetsky I, 2006, BBA-BIOMEMBRANES, V1758, P1436, DOI 10.1016/j.bbamem.2006.03.021; [No title captured]	57	83	86	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2009	4	4							e5285	10.1371/journal.pone.0005285	http://dx.doi.org/10.1371/journal.pone.0005285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TW	19381271	Green Published, Green Submitted, gold			2022-12-25	WOS:000265510800014
J	Kibuuka, H; Guwatudde, D; Kimutai, R; Maganga, L; Maboko, L; Watyema, C; Sawe, F; Shaffer, D; Matsiko, D; Millard, M; Michael, N; Wabwire-Mangen, F; Robb, M				Kibuuka, Hannah; Guwatudde, David; Kimutai, Robert; Maganga, Lucas; Maboko, Leonard; Watyema, Cecilia; Sawe, Fredrick; Shaffer, Douglas; Matsiko, Dickson; Millard, Monica; Michael, Nelson; Wabwire-Mangen, Fred; Robb, Merlin			Contraceptive Use in Women Enrolled into Preventive HIV Vaccine Trials: Experience from a Phase I/II Trial in East Africa	PLOS ONE			English	Article								Background: HIV vaccine trials generally require that pregnant women are excluded from participation, and contraceptive methods must be used to prevent pregnancy during the trial. However, access to quality services and misconceptions associated with contraceptive methods may impact on their effective use in developing countries. We describe the pattern of contraceptive use in a multi-site phase I/IIa HIV Vaccine trial in East Africa (Uganda, Kenya and Tanzania) and factors that may have influenced their use during the trial. Methods: Pregnancy prevention counseling was provided to female participants during informed consent process and at each study visit. Participants' methods of contraception used were documented. Methods of contraceptives were provided on site. Pregnancy testing was done at designated visits during the trial. Obstacles to contraceptive use were identified and addressed at each visit. Results: Overall, 103 (31.8%) of a total of 324 enrolled volunteers were females. Female participants were generally young with a mean age of 29(+/- 7.2), married (49.5%) and had less than high school education (62.1%). Hormonal contraceptives were the most common method of contraception (58.3%) followed by condom use (22.3%). The distribution of methods of contraception among the three sites was similar except for more condom use and less abstinence in Uganda. The majority of women (85.4%) reported to contraceptive use prior to screening. The reasons for not using contraception included access to quality services, insufficient knowledge of certain methods, and misconceptions. Conclusion: Although hormonal contraceptives were frequently used by females participating in the vaccine trial, misconceptions and their incorrect use might have led to inconsistent use resulting in undesired pregnancies. The study underscores the need for an integrated approach to pregnancy prevention counseling during HIV vaccine trials.			Kibuuka, H (corresponding author), Makerere Univ, Walter Reed Project, Kampala, Uganda.	hkibuuka@muwrp.org						AGYEI WKA, 1995, J BIOSOC SCI, V27, P47, DOI 10.1017/S0021932000006994; Biddlecom AE, 1998, STUD FAMILY PLANN, V29, P360, DOI 10.2307/172249; CAO H, JID, V15, P887; Guinan M E, 1995, J Am Med Womens Assoc (1972), V50, P74; *INT AIDS VACC IN, 2008, IAVI DAT PREV AIDS V; KAMAU RK, E AFRICAN MED J, V73, P651; Lande R, 2006, POPULATION REPORTS K; Lane T., 2004, INT FAMILY PLANNING, V30; MILLS E, PLOS MED, V3, pE94; NAKKAZI E, 2003, E AFRICAN       0804; RAYMOND EG, SEXUALLY TRANSMITTED, V34, P1035; SEIBER E, 2007, INT FAMILY PLANNING, V33, P177; Trussell J, 2004, CONTRACEPTIVE TECHNO; *UNAIDS WHO, 2006, AIDS EP UPD; WAKASIAKA S, 2005, AIDS VACCINE HDB GLO, P179; Wassenaar DR, 2005, HARVARD HLTH POLICY, V6, P124; Weidle PJ, 2002, LANCET, V359, P2261, DOI 10.1016/S0140-6736(02)09297-8; 2002, WOMEN HIDE CONTRACEP; 2006, FERTILITY RATES UGAN	19	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2009	4	4							e5164	10.1371/journal.pone.0005164	http://dx.doi.org/10.1371/journal.pone.0005164			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437SB	19360102	Green Published, gold, Green Submitted			2022-12-25	WOS:000265506100003
J	Winrow, CJ; Williams, DL; Kasarskis, A; Millstein, J; Laposky, AD; Yang, HS; Mrazek, K; Zhou, L; Owens, JR; Radzicki, D; Preuss, F; Schadt, EE; Shimomura, K; Vitaterna, MH; Zhang, C; Koblan, KS; Renger, JJ; Turek, FW				Winrow, Christopher J.; Williams, Deanna L.; Kasarskis, Andrew; Millstein, Joshua; Laposky, Aaron D.; Yang, He S.; Mrazek, Karrie; Zhou, Lili; Owens, Joseph R.; Radzicki, Daniel; Preuss, Fabian; Schadt, Eric E.; Shimomura, Kazuhiro; Vitaterna, Martha H.; Zhang, Chunsheng; Koblan, Kenneth S.; Renger, John J.; Turek, Fred W.			Uncovering the Genetic Landscape for Multiple Sleep-Wake Traits	PLOS ONE			English	Article							EYE-MOVEMENT SLEEP; MEMORY; REM	Despite decades of research in defining sleep-wake properties in mammals, little is known about the nature or identity of genes that regulate sleep, a fundamental behaviour that in humans occupies about one-third of the entire lifespan. While genome-wide association studies in humans and quantitative trait loci (QTL) analyses in mice have identified candidate genes for an increasing number of complex traits and genetic diseases, the resources and time-consuming process necessary for obtaining detailed quantitative data have made sleep seemingly intractable to similar large-scale genomic approaches. Here we describe analysis of 20 sleep-wake traits from 269 mice from a genetically segregating population that reveals 52 significant QTL representing a minimum of 20 genomic loci. While many (28) QTL affected a particular sleep-wake trait (e.g., amount of wake) across the full 24-hr day, other loci only affected a trait in the light or dark period while some loci had opposite effects on the trait during the light vs. dark. Analysis of a dataset for multiple sleep-wake traits led to previously undetected interactions (including the differential genetic control of number and duration of REM bouts), as well as possible shared genetic regulatory mechanisms for seemingly different unrelated sleep-wake traits (e.g., number of arousals and REM latency). Construction of a Bayesian network for sleep-wake traits and loci led to the identification of sub-networks of linkage not detectable in smaller data sets or limited single-trait analyses. For example, the network analyses revealed a novel chain of causal relationships between the chromosome 17@29cM QTL, total amount of wake, and duration of wake bouts in both light and dark periods that implies a mechanism whereby overall sleep need, mediated by this locus, in turn determines the length of each wake bout. Taken together, the present results reveal a complex genetic landscape underlying multiple sleep-wake traits and emphasize the need for a systems biology approach for elucidating the full extent of the genetic regulatory mechanisms of this complex and universal behavior.			Winrow, CJ (corresponding author), Merck Res Labs, Dept Depress & Circadian Rhythms, West Point, PA USA.	fturek@northwestern.edu	Koblan, Kenneth/GPX-3213-2022; Winrow, Christopher/K-1864-2014	Winrow, Christopher/0000-0001-8248-4157; Radzicki, Daniel/0000-0003-0675-2652				Benca RM, 2005, PRINCIPLES PRACTICE, P1311, DOI DOI 10.1016/B0.72.160797.7/50119.1; BOTTCHER SG, 2003, J STAT SOFTW, V8, P1; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Carskadon MA, 2005, PRINCIPLES PRACTICE, P13; Cureton E.E., 1983, FACTOR ANAL APPL APP; Franken P, 2001, J NEUROSCI, V21, P2610, DOI 10.1523/JNEUROSCI.21-08-02610.2001; Franken P, 1998, AM J PHYSIOL-REG I, V275, pR1127, DOI 10.1152/ajpregu.1998.275.4.R1127; Graves L, 2001, TRENDS NEUROSCI, V24, P237, DOI 10.1016/S0166-2236(00)01744-6; Huber R, 1999, J SLEEP RES, V8, P30; Kwong LN, 2007, GENETICS, V176, P1237, DOI 10.1534/genetics.107.071217; Laposky AD, 2006, AM J PHYSIOL-REG I, V290, pR894, DOI 10.1152/ajpregu.00304.2005; Lee J, 2004, P NATL ACAD SCI USA, V101, P18195, DOI 10.1073/pnas.0408089101; Li Y, 2006, J CHEM INF MODEL, V46, P1742, DOI 10.1021/ci050463u; Maret S, 2005, SCIENCE, V310, P111, DOI 10.1126/science.1117623; McCarley RW, 2007, SLEEP MED, V8, P302, DOI 10.1016/j.sleep.2007.03.005; O'Hara Bruce F., 2007, CNS & Neurological Disorders-Drug Targets, V6, P71, DOI 10.2174/187152707779940745; Peterson MJ, 2006, PSYCHIAT CLIN N AM, V29, P1009, DOI 10.1016/j.psc.2006.09.003; Smith CT, 2004, LEARN MEMORY, V11, P714, DOI 10.1101/lm.74904; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tafti M, 2003, NAT GENET, V34, P320, DOI 10.1038/ng1174; Tafti M, 2002, J APPL PHYSIOL, V92, P1339, DOI 10.1152/japplphysiol.00834.2001; Toth LA, 1999, BEHAV GENET, V29, P329, DOI 10.1023/A:1021609917126; Tucker AM, 2007, J SLEEP RES, V16, P170, DOI 10.1111/j.1365-2869.2007.00594.x; Zhu HQ, 2007, COMPUT BIOL MED, V37, P793, DOI 10.1016/j.compbiomed.2006.08.015	25	28	29	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2009	4	4							e5161	10.1371/journal.pone.0005161	http://dx.doi.org/10.1371/journal.pone.0005161			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437SB	19360106	Green Published, Green Submitted, gold			2022-12-25	WOS:000265506100002
J	Iorns, E; Lord, CJ; Grigoriadis, A; McDonald, S; Fenwick, K; MacKay, A; Mein, CA; Natrajan, R; Savage, K; Tamber, N; Reis, JS; Turner, NC; Ashworth, A				Iorns, Elizabeth; Lord, Christopher J.; Grigoriadis, Anita; McDonald, Sarah; Fenwick, Kerry; MacKay, Alan; Mein, Charles A.; Natrajan, Rachael; Savage, Kay; Tamber, Narinder; Reis-Filho, Jorge S.; Turner, Nicholas C.; Ashworth, Alan			Integrated Functional, Gene Expression and Genomic Analysis for the Identification of Cancer Targets	PLOS ONE			English	Article							BREAST-CANCER; ENDOCRINE THERAPY; BASAL-LIKE; ONCOGENE; PIK3CA; KINASE; AMPLIFICATION; ADDICTION; APOPTOSIS; ILLUMINA	The majority of new drug approvals for cancer are based on existing therapeutic targets. One approach to the identification of novel targets is to perform high-throughput RNA interference (RNAi) cellular viability screens. We describe a novel approach combining RNAi screening in multiple cell lines with gene expression and genomic profiling to identify novel cancer targets. We performed parallel RNAi screens in multiple cancer cell lines to identify genes that are essential for viability in some cell lines but not others, suggesting that these genes constitute key drivers of cellular survival in specific cancer cells. This approach was verified by the identification of PIK3CA, silencing of which was selectively lethal to the MCF7 cell line, which harbours an activating oncogenic PIK3CA mutation. We combined our functional RNAi approach with gene expression and genomic analysis, allowing the identification of several novel kinases, including WEE1, that are essential for viability only in cell lines that have an elevated level of expression of this kinase. Furthermore, we identified a subset of breast tumours that highly express WEE1 suggesting that WEE1 could be a novel therapeutic target in breast cancer. In conclusion, this strategy represents a novel and effective strategy for the identification of functionally important therapeutic targets in cancer.			Iorns, E (corresponding author), Inst Canc Res, Break Breast Canc Res Ctr, London SW3 6JB, England.	alan.ashworth@icr.ac.uk	Lord, Christopher J/B-3295-2012; Lord, Christopher/AAX-7130-2021	Lord, Christopher J/0000-0002-3226-0515; Mein, Charles/0000-0003-0811-9658; Natrajan, Rachael/0000-0002-9987-2946; Grigoriadis, Anita/0000-0003-3434-201X; Turner, Nicholas/0000-0001-8937-0873	Cancer Research UK [A8363] Funding Source: Medline; Breast Cancer Now [BREAST CANCER NOW RESEARCH CENTRE] Funding Source: Medline	Cancer Research UK(Cancer Research UK); Breast Cancer Now		Abdi H, 2007, ENCYCL MEASUR STATIS, V1; ARRIOLA E, 2008, LAB INVEST; ARRIOLA E, 2007, BREAST CANC RES TREA; Arriola E, 2007, LAB INVEST, V87, P75, DOI 10.1038/labinvest.3700495; Aza-Blanc P, 2003, MOL CELL, V12, P627, DOI 10.1016/S1097-2765(03)00348-4; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Collins I, 2006, NAT CHEM BIOL, V2, P689, DOI 10.1038/nchembio840; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Du P, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-16; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; HEALD R, 1993, CELL, V74, P463, DOI 10.1016/0092-8674(93)80048-J; Iorns E, 2008, CANCER CELL, V13, P91, DOI 10.1016/j.ccr.2008.01.001; Iorns E, 2007, NAT REV DRUG DISCOV, V6, P556, DOI 10.1038/nrd2355; Jonkers J, 2004, CANCER CELL, V6, P535, DOI 10.1016/j.ccr.2004.12.002; Karakas B, 2006, BRIT J CANCER, V94, P455, DOI 10.1038/sj.bjc.6602970; Kawabe T, 2004, MOL CANCER THER, V3, P513; Kuhn K, 2004, GENOME RES, V14, P2347, DOI 10.1101/gr.2739104; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Ma YY, 2000, ONCOGENE, V19, P2739, DOI 10.1038/sj.onc.1203597; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mukherji M, 2006, P NATL ACAD SCI USA, V103, P14819, DOI 10.1073/pnas.0604320103; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Palmer BD, 2006, J MED CHEM, V49, P4896, DOI 10.1021/jm0512591; Reis JS, 2005, J PATHOL, V207, P1, DOI 10.1002/path.1806; Rodriguez-Pinilla SM, 2007, J CLIN PATHOL, V60, P1017, DOI 10.1136/jcp.2006.043869; Savage K, 2007, CLIN CANCER RES, V13, P90, DOI 10.1158/1078-0432.CCR-06-1371; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Takeuchi O, 1999, GENE, V231, P59, DOI 10.1016/S0378-1119(99)00098-0; Watanabe N, 2005, P NATL ACAD SCI USA, V102, P11663, DOI 10.1073/pnas.0500410102; Wu GJ, 2005, BREAST CANCER RES, V7, pR609, DOI 10.1186/bcr1262	37	98	103	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5120	10.1371/journal.pone.0005120	http://dx.doi.org/10.1371/journal.pone.0005120			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357772	Green Submitted, gold, Green Published			2022-12-25	WOS:000265505900004
J	Kitamura, N; Araya, R; Kudoh, M; Kishida, H; Kimura, T; Murayama, M; Takashima, A; Sakamaki, Y; Hashikawa, T; Ito, S; Ohtsuki, S; Terasaki, T; Wess, J; Yamada, M				Kitamura, Naohito; Araya, Runa; Kudoh, Moeko; Kishida, Haruo; Kimura, Tetsuya; Murayama, Miyuki; Takashima, Akihiko; Sakamaki, Yuriko; Hashikawa, Tsutomu; Ito, Shingo; Ohtsuki, Sumio; Terasaki, Tetsuya; Wess, Juergen; Yamada, Masahisa			Beneficial Effects of Estrogen in a Mouse Model of Cerebrovascular Insufficiency	PLOS ONE			English	Article								Background: The M-5 muscarinic acetylcholine receptor is known to play a crucial role in mediating acetylcholine dependent dilation of cerebral blood vessels. Previously, we reported that male M-5 muscarinic acetylcholine knockout mice (M5R(-/-) mice) suffer from a constitutive constriction of cerebral arteries, reduced cerebral blood flow, dendritic atrophy, and short-term memory loss, without necrosis and/or inflammation in the brain. Methodology/Principal Findings: We employed the Magnetic Resonance Angiography to study the area of the basilar artery in male and female M5R(-/-) mice. Here we show that female M5R(-/-) mice did not show the reduction in vascular area observed in male M5R(-/-) mice. However, ovariectomized female M5R(-/-) mice displayed phenotypic changes similar to male M5R(-/-) mice, strongly suggesting that estrogen plays a key role in the observed gender differences. We found that 17 beta-estradiol (E2) induced nitric oxide release and ERK activation in a conditional immortalized mouse brain cerebrovascular endothelial cell line. Agonists of ER alpha, ER beta, and GPR30 promoted ERK activation in this cell line. Moreover, in vivo magnetic resonance imaging studies showed that the cross section of the basilar artery was restored to normal in male M5R(-/-) mice treated with E2. Treatment with E2 also improved the performance of male M5R(-/-) mice in a cognitive test and reduced the atrophy of neural dendrites in the cerebral cortex and hippocampus. M5R(-/-) mice also showed astrocyte swelling in cortex and hippocampus using the three-dimensional reconstruction of electron microscope images. This phenotype was reversed by E2 treatment, similar to the observed deficits in dendrite morphology and the number of synapses. Conclusions/Significance: Our findings indicate that M5R(-/-) mice represent an excellent novel model system to study the beneficial effects of estrogen on cerebrovascular function and cognition. E2 may offer new therapeutic perspectives for the treatment of cerebrovascular insufficiency related memory dysfunction.			Kitamura, N (corresponding author), RIKEN Brain Sci Inst, Yamada Res Unit, Saitama, Japan.	masahisa@brain.riken.jp	Terasaki, Tetsuya/K-6730-2012; Ohtsuki, Sumio/S-4360-2016	Terasaki, Tetsuya/0000-0002-6332-7575; Ohtsuki, Sumio/0000-0003-4634-7133	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075020] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Araya R, 2006, NEUROBIOL DIS, V24, P334, DOI 10.1016/j.nbd.2006.07.010; BONNER TI, 1988, NEURON, V1, P403, DOI 10.1016/0896-6273(88)90190-0; Chambliss KL, 2002, ENDOCR REV, V23, P665, DOI 10.1210/er.2001-0045; Chen Z, 1999, J CLIN INVEST, V103, P401, DOI 10.1172/JCI5347; Cooney JR, 2002, J NEUROSCI, V22, P2215, DOI 10.1523/JNEUROSCI.22-06-02215.2002; Dodel RC, 1999, J NEUROCHEM, V73, P1453, DOI 10.1046/j.1471-4159.1999.0731453.x; Dubal DB, 2001, P NATL ACAD SCI USA, V98, P1952, DOI 10.1073/pnas.98.4.1952; Eglen RM, 2000, BRIT J PHARMACOL, V130, P13, DOI 10.1038/sj.bjp.0703276; Faraci FM, 1999, CIRC RES, V85, P1214; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Gao X, 2001, NEUROSCIENCE, V103, P385, DOI 10.1016/S0306-4522(01)00014-8; Green PS, 1997, J NEUROSCI, V17, P511; Grossini E, 2008, ENDOCRINOLOGY, V149, P2678, DOI 10.1210/en.2007-1361; Guo XM, 2005, J BIOL CHEM, V280, P19704, DOI 10.1074/jbc.M501244200; Haas E, 2007, HYPERTENSION, V49, P1358, DOI 10.1161/HYPERTENSIONAHA.107.089995; Hamel E, 2004, PROG BRAIN RES, V145, P171, DOI 10.1016/S0079-6123(02)45012-7; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Haynes MP, 2000, CIRC RES, V87, P677, DOI 10.1161/01.RES.87.8.677; Hosoya K, 2000, AAPS PHARMSCI, V2; Hotta H, 2002, JPN J PHYSIOL, V52, P383, DOI 10.2170/jjphysiol.52.383; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Jia J, 2009, EXP NEUROL, V215, P48, DOI 10.1016/j.expneurol.2008.09.015; Jung YW, 2007, NEUROSCI RES, V59, P152, DOI 10.1016/j.neures.2007.06.1470; KARAS RH, 1994, CIRCULATION, V89, P1943, DOI 10.1161/01.CIR.89.5.1943; Khurana S, 2005, EUR J PHARMACOL, V517, P103, DOI 10.1016/j.ejphar.2005.05.037; Kim Jin Kyung, 2006, Nucl Recept Signal, V4, pe013; KimSchulze S, 1996, CIRCULATION, V94, P1402, DOI 10.1161/01.CIR.94.6.1402; Lamping KG, 2004, ARTERIOSCL THROM VAS, V24, P1253, DOI 10.1161/01.ATV.0000130661.82773.ca; LIAO CF, 1989, J BIOL CHEM, V264, P7328; Ma E, 1997, NEUROSCIENCE, V79, P591, DOI 10.1016/S0306-4522(96)00674-4; McCullough LD, 2001, STROKE, V32, P796, DOI 10.1161/01.STR.32.3.796; MELLERGARD P, 1993, EXP BRAIN RES, V95, P371; Meng W, 1996, AM J PHYSIOL-HEART C, V271, pH1145, DOI 10.1152/ajpheart.1996.271.3.H1145; Mor G, 1999, J NEUROBIOL, V40, P484, DOI 10.1002/(SICI)1097-4695(19990915)40:4<484::AID-NEU6>3.0.CO;2-C; Ohtsuki S, 2002, J CEREBR BLOOD F MET, V22, P1327, DOI 10.1097/01.WCB.0000033966.83623.7D; Oishi A, 2004, BIOCHEM BIOPH RES CO, V324, P193, DOI 10.1016/j.bbrc.2004.09.032; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Prossnitz ER, 2008, ANNU REV PHYSIOL, V70, P165, DOI 10.1146/annurev.physiol.70.113006.100518; Razandi M, 2004, MOL ENDOCRINOL, V18, P2854, DOI 10.1210/me.2004-0115; Reever CM, 1997, LIFE SCI, V60, P1105, DOI 10.1016/S0024-3205(97)00054-4; REHNCRONA S, 1985, ANN EMERG MED, V14, P770, DOI 10.1016/S0196-0644(85)80055-X; ROSENBLUM WI, 1986, STROKE, V17, P494, DOI 10.1161/01.STR.17.3.494; Santizo RA, 2000, STROKE, V31, P2231, DOI 10.1161/01.STR.31.9.2231; SARIA A, 1983, J NEUROSCI METH, V8, P41, DOI 10.1016/0165-0270(83)90050-X; Sato A, 2004, NEUROSCI LETT, V361, P90, DOI 10.1016/j.neulet.2004.01.004; Shibata M, 2004, STROKE, V35, P2598, DOI 10.1161/01.STR.0000143725.19053.60; Shibata M, 2007, STROKE, V38, P2826, DOI 10.1161/STROKEAHA.107.490151; Slezak M, 2003, TRENDS NEUROSCI, V26, P531, DOI 10.1016/j.tins.2003.08.005; Sobey CG, 1997, STROKE, V28, P837, DOI 10.1161/01.STR.28.4.837; Sykova E, 2002, HIPPOCAMPUS, V12, P269, DOI 10.1002/hipo.1101; Tayebati SK, 2003, NEUROSCIENCE, V122, P205, DOI 10.1016/S0306-4522(03)00513-X; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Vivacqua A, 2006, MOL ENDOCRINOL, V20, P631, DOI 10.1210/me.2005-0280; WANG SZ, 1994, J PHARMACOL EXP THER, V268, P552; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; WOOLLEY CS, 1994, J NEUROSCI, V14, P7680; Xia Y, 2004, ENDOCRINOLOGY, V145, P4550, DOI 10.1210/en.2004-0327; Yamada M, 2001, P NATL ACAD SCI USA, V98, P14096, DOI 10.1073/pnas.251542998; Yang SH, 2000, STROKE, V31, P745, DOI 10.1161/01.STR.31.3.745; YAO H, 1995, J CEREBR BLOOD F MET, V15, P398, DOI 10.1038/jcbfm.1995.50; Yong Y, 2005, BRAIN RES, V1054, P192, DOI 10.1016/j.brainres.2005.05.069; Zivadinovic D, 2005, BREAST CANCER RES, V7, pR130, DOI 10.1186/bcr959	62	25	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5159	10.1371/journal.pone.0005159	http://dx.doi.org/10.1371/journal.pone.0005159			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357782	Green Published, gold, Green Submitted			2022-12-25	WOS:000265505900017
J	Meiller, TF; Hube, B; Schild, L; Shirtliff, ME; Scheper, MA; Winkler, R; Ton, A; Jabra-Rizk, MA				Meiller, Timothy F.; Hube, Bernhard; Schild, Lydia; Shirtliff, Mark E.; Scheper, Mark A.; Winkler, Robert; Ton, Amy; Jabra-Rizk, Mary Ann			A Novel Immune Evasion Strategy of Candida albicans: Proteolytic Cleavage of a Salivary Antimicrobial Peptide	PLOS ONE			English	Article							SECRETED ASPARTYL PROTEINASES; ANTIFUNGAL ACTIVITY; GENE-EXPRESSION; HISTATIN 5; DEGRADATION; FAMILY; COLONIZATION; EPIDEMIOLOGY; ACTIVATION; VIRULENCE	Oropharyngeal candidiasis is an opportunistic infection considered to be a harbinger of AIDS. The etiologic agent Candida albicans is a fungal species commonly colonizing human mucosal surfaces. However, under conditions of immune dysfunction, colonizing C. albicans can become an opportunistic pathogen causing superficial or even life-threatening infections. The reasons behind this transition, however, are not clear. In the oral cavity, salivary antimicrobial peptides are considered to be an important part of the host innate defense system in the prevention of microbial colonization. Histatin-5 specifically has exhibited potent activity against C. albicans. Our previous studies have shown histatin-5 levels to be significantly reduced in the saliva of HIV+ individuals, indicating an important role for histatin-5 in keeping C. albicans in its commensal stage. The versatility in the pathogenic potential of C. albicans is the result of its ability to adapt through the regulation of virulence determinants, most notably of which are proteolytic enzymes (Saps), involved in tissue degradation. In this study, we show that C. albicans cells efficiently and rapidly degrade histatin-5, resulting in loss of its anti-candidal potency. In addition, we demonstrate that this cellular activity is due to proteolysis by a member of the secreted aspartic proteases (Sap) family involved in C. albicans pathogenesis. Specifically, the proteolysis was attributed to Sap9, in turn identifying histatin-5 as the first host-specific substrate for that isoenzyme. These findings demonstrate for the first time the ability of a specific C. albicans enzyme to degrade and deactivate a host antimicrobial peptide involved in the protection of the oral mucosa against C. albicans, thereby providing new insights into the factors directing the transition of C. albicans from commensal to pathogen, with important clinical implications for alternative therapy. This report characterizes the first defined mechanism behind the enhanced susceptibility of HIV+ individuals to oral candidiasis since the emergence of HIV.	[Meiller, Timothy F.; Scheper, Mark A.; Ton, Amy; Jabra-Rizk, Mary Ann] Univ Maryland, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA; [Meiller, Timothy F.; Scheper, Mark A.] Univ Maryland Med Syst, Marlene & Stewart Greenbaum Canc Ctr, Baltimore, MD USA; [Hube, Bernhard; Schild, Lydia] Hans Knoell Inst HKI, Leibniz Inst Nat Product Res & Infect Biol, Dept Microb Pathogen Mechanisms, Jena, Germany; [Hube, Bernhard] Univ Jena, Jena, Germany; [Shirtliff, Mark E.] Univ Maryland, Dental Sch, Dept Microb Pathogenesis, Baltimore, MD USA; [Shirtliff, Mark E.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD USA; [Winkler, Robert] Hans Knoell Inst HKI, Leibniz Inst Nat Product Res & Infect Biol, Dept Biomol Chem, Jena, Germany; [Jabra-Rizk, Mary Ann] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Hans Knoll Institute (HKI); University System of Maryland; University of Maryland Baltimore	Meiller, TF (corresponding author), Univ Maryland, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA.	mrizk@umaryland.edu	Winkler, Robert/A-1500-2009; Shirtliff, Mark E/H-2563-2017	Winkler, Robert/0000-0001-6732-1958; Shirtliff, Mark E/0000-0002-8913-3445; Hube, Bernhard/0000-0002-6028-0425	NIH [DE14424, DE016257]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K22DE014424, R03DE016257] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIH grants DE14424 and DE016257. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht A, 2006, J BIOL CHEM, V281, P688, DOI 10.1074/jbc.M509297200; Borg-von Zepelin M, 1998, MOL MICROBIOL, V28, P543, DOI 10.1046/j.1365-2958.1998.00815.x; Brown AJP, 2007, CURR OPIN MICROBIOL, V10, P307, DOI 10.1016/j.mib.2007.04.001; Calderone RA., 2002, CANDIDA CANDIDIASIS; Cannon RD, 1999, CRIT REV ORAL BIOL M, V10, P359, DOI 10.1177/10454411990100030701; Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001; De Bernardis F, 1999, J INFECT DIS, V179, P201, DOI 10.1086/314546; de Repentigny L, 2004, CLIN MICROBIOL REV, V17, P729, DOI 10.1128/CMR.17.4.729-759.2004; DeBernardis F, 1996, INFECT IMMUN, V64, P466, DOI 10.1128/IAI.64.2.466-471.1996; EDGAR WM, 1992, BRIT DENT J, V172, P305, DOI 10.1038/sj.bdj.4807861; Edgerton M, 1998, J BIOL CHEM, V273, P20438, DOI 10.1074/jbc.273.32.20438; Fidel P L Jr, 2006, Adv Dent Res, V19, P80; Gagnon-Arsenault I, 2008, MOL MICROBIOL, V69, P982, DOI 10.1111/j.1365-2958.2008.06339.x; Gyurko C, 2001, ANTON LEEUW INT J G, V79, P297, DOI 10.1023/A:1012070600340; Helmerhorst EJ, 2006, ARCH ORAL BIOL, V51, P1061, DOI 10.1016/j.archoralbio.2006.06.005; Helmerhorst EJ, 1999, J BIOL CHEM, V274, P7286, DOI 10.1074/jbc.274.11.7286; Helmerhorst EJ, 2001, P NATL ACAD SCI USA, V98, P14637, DOI 10.1073/pnas.141366998; Hube B, 1996, Curr Top Med Mycol, V7, P55; Hube B, 1997, INFECT IMMUN, V65, P3529, DOI 10.1128/IAI.65.9.3529-3538.1997; Hube B, 2006, FUTURE MICROBIOL, V1, P209, DOI 10.2217/17460913.1.2.209; Humphrey SP, 2001, J PROSTHET DENT, V85, P162, DOI 10.1067/mpr.2001.113778; Jainkittivong A, 1998, ORAL MICROBIOL IMMUN, V13, P181, DOI 10.1111/j.1399-302X.1998.tb00730.x; Jang WS, 2008, ANTIMICROB AGENTS CH, V52, P497, DOI 10.1128/AAC.01199-07; KLEIN RS, 1984, NEW ENGL J MED, V311, P354, DOI 10.1056/NEJM198408093110602; Koshlukova SE, 1999, J BIOL CHEM, V274, P18872, DOI 10.1074/jbc.274.27.18872; Koshlukova SE, 2000, INFECT IMMUN, V68, P6848, DOI 10.1128/IAI.68.12.6848-6856.2000; Kretschmar M, 2002, MICROB PATHOGENESIS, V32, P61, DOI 10.1006/mpat.2001.0478; Kumamoto CA, 2008, CURR OPIN MICROBIOL, V11, P325, DOI 10.1016/j.mib.2008.05.008; LAL K, 1992, J ACQ IMMUN DEF SYND, V5, P904; Li XWS, 2003, J BIOL CHEM, V278, P28553, DOI 10.1074/jbc.M300680200; MANDEL ID, 1992, J ORAL PATHOL MED, V21, P209, DOI 10.1111/j.1600-0714.1992.tb00103.x; Mochon AB, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000190; Munro CA, 2002, TRENDS MICROBIOL, V10, P173, DOI 10.1016/S0966-842X(02)02330-2; Naglik J, 2004, CELL MICROBIOL, V6, P915, DOI 10.1111/j.1462-5822.2004.00439.x; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Naglik JR, 2008, MICROBIOL-SGM, V154, P3266, DOI 10.1099/mic.0.2008/022293-0; OPPENHEIM FG, 1988, J BIOL CHEM, V263, P7472; Perlroth J, 2007, MED MYCOL, V45, P321, DOI 10.1080/13693780701218689; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Ruissen ALA, 2003, BIOL CHEM, V384, P183, DOI 10.1515/BC.2003.020; Sanglard D, 1997, INFECT IMMUN, V65, P3539, DOI 10.1128/IAI.65.9.3539-3546.1997; Staib P, 2000, P NATL ACAD SCI USA, V97, P6102, DOI 10.1073/pnas.110031497; Torres SR, 2009, MYCOSES, V52, P11, DOI 10.1111/j.1439-0507.2008.01602.x; Villar CC, 2007, INFECT IMMUN, V75, P2126, DOI 10.1128/IAI.00054-07; XU L, 1993, ARCH ORAL BIOL, V38, P277, DOI 10.1016/0003-9969(93)90133-7	45	93	95	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2009	4	4							e5039	10.1371/journal.pone.0005039	http://dx.doi.org/10.1371/journal.pone.0005039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RT	19352427	Green Published, gold, Green Submitted			2022-12-25	WOS:000265505300006
J	Gajendran, N; Vanhecke, D; Brinkmann, V; Kaufmann, SHE				Gajendran, Nadesan; Vanhecke, Dominique; Brinkmann, Volker; Kaufmann, Stefan H. E.			Identifying Activated T Cells in Reconstituted RAG Deficient Mice Using Retrovirally Transduced Pax5 Deficient Pro-B Cells	PLOS ONE			English	Article								Various methods have been used to identify activated T cells such as binding of MHC tetramers and expression of cell surface markers in addition to cytokine-based assays. In contrast to these published methods, we here describe a strategy to identify T cells that respond to any antigen and track the fate of these activated T cells. We constructed a retroviral double-reporter construct with enhanced green fluorescence protein (EGFP) and a far-red fluorescent protein from Heteractis crispa (HcRed). LTR-driven EGFP expression was used to enrich and identify transduced cells, while HcRed expression is driven by the CD40Ligand (CD40L) promoter, which is inducible and enables the identification and cell fate tracing of T cells that have responded to infection/inflammation. Pax5 deficient pro-B cells that can give rise to different hematopoietic cells like T cells, were retrovirally transduced with this double-reporter cassette and were used to reconstitute the T cell pool in RAG1 deifcient mice that lack T and B cells. By using flow cytometry and histology, we identified activated T cells that had developed from Pax5 deficient pro-B cells and responded to infection with the bacterial pathogen Listeria monocytogenes. Microscopic examination of organ sections allowed visual identification of HcRed-expressing cells. To further characterize the immune response to a given stimuli, this strategy can be easily adapted to identify other cells of the hematopoietic system that respond to infection/inflammation. This can be achieved by using an inducible reporter, choosing the appropriate promoter, and reconstituting mice lacking cells of interest by injecting gene-modified Pax5 deficient pro-B cells.	[Gajendran, Nadesan; Vanhecke, Dominique; Brinkmann, Volker; Kaufmann, Stefan H. E.] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany; [Vanhecke, Dominique] Max Planck Inst Mol Genet, Dept Vertebrate Genom, Berlin, Germany	Max Planck Society; Max Planck Society	Gajendran, N (corresponding author), Univ Basel, Inst Physiol, Basel, Switzerland.	N.Gajendran@unibas.ch; kaufmann@mpiib-berlin.mpg.de	Brinkmann, Volker/A-6015-2009; Kaufmann, Stefan HE/I-5454-2014	Kaufmann, Stefan HE/0000-0001-9866-8268; , Nadesan/0000-0002-7463-4220	Max Planck Society	Max Planck Society(Max Planck Society)	Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Goulder PJR, 2000, J EXP MED, V192, P1819, DOI 10.1084/jem.192.12.1819; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Marchant JS, 2001, NAT BIOTECHNOL, V19, P645, DOI 10.1038/90249; Maris CH, 2003, J IMMUNOL, V171, P2393, DOI 10.4049/jimmunol.171.5.2393; Ng LG, 2008, IMMUNOL REV, V221, P147, DOI 10.1111/j.1600-065X.2008.00596.x; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; ROLINK A, 1993, BLOOD, V81, P2290; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; Rolink AG, 2002, IMMUNOL LETT, V82, P35, DOI 10.1016/S0165-2478(02)00016-0; Schaniel C, 2002, BLOOD, V99, P472, DOI 10.1182/blood.V99.2.472; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5	14	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5115	10.1371/journal.pone.0005115	http://dx.doi.org/10.1371/journal.pone.0005115			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340306	Green Published, Green Submitted, gold			2022-12-25	WOS:000265500700018
J	Khan, A; Shover, W; Goodliffe, JM				Khan, Abid; Shover, Wesley; Goodliffe, Julie M.			Su(z)2 Antagonizes Auto-Repression of Myc in Drosophila, Increasing Myc Levels and Subsequent Trans-Activation	PLOS ONE			English	Article								All tumor cell lines that have been tested are defective for Myc auto-repression, and have high levels of Myc produced from wild type loci and re-arranged loci. Like mammalian Myc auto-repression, Myc protein represses the expression of its gene, dmyc, in Drosophila. This activity requires Polycomb (Pc), since RNAi for Pc in the embryo eliminates Myc auto-repression. We have observed that upon depletion of Polycomb in the embryo, levels of one of 18 different chromatin-binding genetic regulators, Su(z)2, rise dramatically. We pursued the possibility that increased levels of this protein, Su(z)2, interfere with Myc auto-repression, potentially explaining the loss of auto-repression upon Pc RNAi. We report that embryos expressing both ectopic Myc and ectopic Su(z)2 fail in Myc auto-repression. Surprisingly, histone H3K27 tri-methylation at the dmyc locus is inversely correlated with the presence of auto-repression. We show phenotypic consequences of potent dmyc auto-repression, and their complete reversal by ectopic Su(z)2: dmyc auto-repression induced a diminutive (dm) phenotype, and upon elimination of auto-repression by Su(z)2, overall levels of Myc increased and completely rescued the phenotype. We show that this increase in Myc levels caused dramatic activation of Myc activation targets. These data suggest that Su(z)2 is capable of increasing the potency of Myc activity by eliminating Myc's feedback regulation by auto-repression. Although Su(z) 2 eliminated Myc auto-repression, we found that Myc repression of other genes is not affected by Su(z)2. These data suggest a unique antagonistic role for Su(z)2 in Myc auto-repression, and a potential mechanism for cancer-cell specific loss of Myc auto-repression.	[Khan, Abid; Shover, Wesley; Goodliffe, Julie M.] Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA	University of North Carolina; University of North Carolina Charlotte	Khan, A (corresponding author), Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA.	jmgoodli@uncc.edu	Khan, Abid/Y-8454-2019	Khan, Abid/0000-0003-0968-8705	NIH [CA135481]; NATIONAL CANCER INSTITUTE [R15CA135481] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by a grant from the NIH to JMG: CA135481. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali JY, 2004, MOL CELL BIOL, V24, P7737, DOI 10.1128/MCB.24.17.7737-7747.2004; ALLIS C.D., 2007, EPIGENETICS; Barsyte-Lovejoy D, 2004, ONCOGENE, V23, P3481, DOI 10.1038/sj.onc.1207487; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Brown SJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-442; BRUNK BP, 1991, GENETICS, V128, P119; BRUNK BP, 1991, NATURE, V353, P351, DOI 10.1038/353351a0; BUNKER CA, 1994, MOL CELL BIOL, V14, P1721, DOI 10.1128/MCB.14.3.1721; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Cowling VH, 2008, ONCOGENE, V27, P1327, DOI 10.1038/sj.onc.1210734; Cowling VH, 2007, MOL CELL BIOL, V27, P2059, DOI 10.1128/MCB.01828-06; de la Cova C, 2006, SEMIN CANCER BIOL, V16, P303, DOI 10.1016/j.semcancer.2006.07.010; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Gallant P, 2006, CURR TOP MICROBIOL, V302, P235; Goodliffe JM, 2005, GENE DEV, V19, P2941, DOI 10.1101/gad.1352305; Goodliffe JM, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-40; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; GRIGNANI F, 1990, EMBO J, V9, P3913, DOI 10.1002/j.1460-2075.1990.tb07612.x; Guney I, 2006, P NATL ACAD SCI USA, V103, P3645, DOI 10.1073/pnas.0600069103; Guo WJ, 2007, CANCER RES, V67, P5083, DOI 10.1158/0008-5472.CAN-06-4368; Guo WJ, 2007, MOL BIOL CELL, V18, P536, DOI 10.1091/mbc.E06-05-0447; HAUPT Y, 1991, CELL, V65, P753, DOI 10.1016/0092-8674(91)90383-A; Kleine-Kohlbrecher D, 2006, CURR TOP MICROBIOL, V302, P51; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lo SM, 2009, MOL CELL BIOL, V29, P515, DOI 10.1128/MCB.01044-08; Maines JZ, 2004, DEVELOPMENT, V131, P775, DOI 10.1242/dev.00932; Mao DYL, 2004, NUCLEIC ACIDS RES, V32, P3462, DOI 10.1093/nar/gkh669; Mao DYL, 2003, CURR BIOL, V13, P882, DOI 10.1016/S0960-9822(03)00297-5; Mohd-Sarip A, 2005, GENE DEV, V19, P1755, DOI 10.1101/gad.347005; Mohd-Sarip A, 2002, MOL CELL BIOL, V22, P7473, DOI 10.1128/MCB.22.21.7473-7483.2002; Negre N, 2006, PLOS BIOL, V4, P917, DOI 10.1371/journal.pbio.0040170; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; PENN LJZ, 1990, EMBO J, V9, P1113, DOI 10.1002/j.1460-2075.1990.tb08217.x; RASTELLI L, 1993, EMBO J, V12, P1513, DOI 10.1002/j.1460-2075.1993.tb05795.x; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; Sauvageau M, 2008, PLOS BIOL, V6, P678, DOI 10.1371/journal.pbio.0060113; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Secombe J, 2007, GENE DEV, V21, P537, DOI 10.1101/gad.1523007; SHARP EJ, 1994, DEV BIOL, V161, P379, DOI 10.1006/dbio.1994.1039; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; VANLOHUIZEN M, 1991, NATURE, V353, P353, DOI 10.1038/353353a0; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; Wiederschain D, 2007, MOL CELL BIOL, V27, P4968, DOI 10.1128/MCB.02244-06; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Zaffran S, 1998, DEVELOPMENT, V125, P3571	53	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e5076	10.1371/journal.pone.0005076	http://dx.doi.org/10.1371/journal.pone.0005076			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333393	Green Published, gold, Green Submitted			2022-12-25	WOS:000265499900021
J	Tam, J; Duda, DG; Perentes, JY; Quadri, RS; Fukumura, D; Jain, RK				Tam, Joshua; Duda, Dan G.; Perentes, Jean Y.; Quadri, Rehan S.; Fukumura, Dai; Jain, Rakesh K.			Blockade of VEGFR2 and Not VEGFR1 Can Limit Diet-Induced Fat Tissue Expansion: Role of Local versus Bone Marrow-Derived Endothelial Cells	PLOS ONE			English	Article								Background: We investigated if new vessel formation in fat involves the contribution of local tissue-derived endothelial cells (i.e., angiogenesis) or bone marrow-derived cells (BMDCs, i.e. vasculogenesis) and if antiangiogenic treatment by blockade of vascular endothelial growth factor (VEGF) receptors can prevent diet-induced obesity (DIO). Methodology/Principal Findings: We performed restorative bone marrow transplantation into wild-type mice using transgenic mice expressing green fluorescent protein (GFP) constitutively (driven by beta-actin promoter) or selectively in endothelial cells (under Tie2 promoter activation) as donors. The presence of donor BMDCs in recipient mice was investigated in fat tissue vessels after DIO using in vivo and ex vivo fluorescence microscopy. We investigated the roles of VEGF receptors 1 and 2 (VEGFR1/VEGFR2) by inducing DIO in mice and treating them with blocking monoclonal antibodies. We found only marginal (less than 1%) incorporation of BMDCs in fat vessels during DIO. When angiogenesis was inhibited by blocking VEGFR2 in mice with DIO, treated mice had significantly lower body weights than control animals. In contrast, blocking VEGFR1 had no discernable effect on the weight gain during DIO. Conclusions/Significance: Formation of new vessels in fat tissues during DIO is largely due to angiogenesis rather than de novo vasculogenesis. Antiangiogenic treatment by blockade of VEGFR2 but not VEGFR1 may limit adipose tissue expansion.	[Tam, Joshua; Duda, Dan G.; Perentes, Jean Y.; Quadri, Rehan S.; Fukumura, Dai; Jain, Rakesh K.] Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab, Boston, MA 02114 USA; [Tam, Joshua; Duda, Dan G.; Perentes, Jean Y.; Quadri, Rehan S.; Fukumura, Dai; Jain, Rakesh K.] Harvard Univ, Sch Med, Boston, MA USA; [Tam, Joshua] Massachusetts Inst Technol, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Perentes, Jean Y.] Ctr Hosp Univ Vaudois CHUV, Div Thorac & Vasc Surg, Lausanne, Switzerland	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Tam, J (corresponding author), Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab, Boston, MA 02114 USA.	dai@steele.mgh.harvard.edu; jain@steele.mgh.harvard.edu	Jain, Rakesh K/I-1384-2017; Duda, Dan G/H-8523-2014	Jain, Rakesh K/0000-0001-7571-3548; Duda, Dan G/0000-0001-7065-8797; Perentes, Jean/0000-0001-7918-0793	National Institutes of Health [P01CA80124, R01CA96915, R01CA115767, R01CA85140, R01CA126642]; NATIONAL CANCER INSTITUTE [P01CA080124, R01CA096915, R01CA126642, R24CA085140, R01CA115767, T32CA073479, R01CA085140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was partially supported by National Institutes of Health grants P01CA80124, R01CA96915, R01CA115767, R01CA85140, and R01CA126642. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brakenhielm E, 2004, CIRC RES, V94, P1579, DOI 10.1161/01.RES.0000132745.76882.70; Brown EB, 2001, NAT MED, V7, P864, DOI 10.1038/89997; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JCI32239; CLAFFEY KP, 1992, J BIOL CHEM, V267, P16317; Duda DG, 2006, BLOOD, V107, P2774, DOI 10.1182/blood-2005-08-3210; Duda DG, 2004, CANCER RES, V64, P5920, DOI 10.1158/0008-5472.CAN-04-1268; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Fukumura D, 2003, CIRC RES, V93, pE88, DOI 10.1161/01.RES.0000099243.20096.FA; Gealekman O, 2008, AM J PHYSIOL-ENDOC M, V295, pE1056, DOI 10.1152/ajpendo.90345.2008; Hattori K, 2002, NAT MED, V8, P841, DOI 10.1038/nm740; Hausman GJ, 2004, J ANIM SCI, V82, P925; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Izumi Y, 2003, CANCER RES, V63, P747; Kamba T, 2006, AM J PHYSIOL-HEART C, V290, pH560, DOI 10.1152/ajpheart.00133.2005; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Lai N, 2009, TISSUE ENG PT A, V15, P1053, DOI 10.1089/ten.tea.2008.0101; Le Lay S, 2001, BIOCHEM BIOPH RES CO, V289, P564, DOI 10.1006/bbrc.2001.6015; Ledoux S, 2008, DIABETES, V57, P3247, DOI 10.2337/db07-1812; Li B, 2006, FASEB J, V20, P1495, DOI 10.1096/fj.05-5137fje; Lijnen HR, 2008, CARDIOVASC RES, V78, P286, DOI 10.1093/cvr/cvm007; Lijnen HR, 2006, DIABETES, V55, P2698, DOI 10.2337/db06-0526; Martin TL, 2006, J BIOL CHEM, V281, P18933, DOI 10.1074/jbc.M512831200; Miyazawa-Hoshimoto S, 2005, AM J PHYSIOL-ENDOC M, V288, pE1128, DOI 10.1152/ajpendo.00003.2004; Miyazawa-Hoshimoto S, 2003, DIABETOLOGIA, V46, P1483, DOI 10.1007/s00125-003-1221-6; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749; Rafii S, 2002, NAT REV CANCER, V2, P826, DOI 10.1038/nrc925; Rupnick MA, 2002, P NATL ACAD SCI USA, V99, P10730, DOI 10.1073/pnas.162349799; Shibuya M, 2006, J BIOCHEM MOL BIOL, V39, P469; Silha JV, 2005, INT J OBESITY, V29, P1308, DOI 10.1038/sj.ijo.0802987; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Voros G, 2005, ENDOCRINOLOGY, V146, P4545, DOI 10.1210/en.2005-0532; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zhang QX, 1997, J SURG RES, V67, P147, DOI 10.1006/jsre.1996.4983	36	71	76	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e4974	10.1371/journal.pone.0004974	http://dx.doi.org/10.1371/journal.pone.0004974			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333381	Green Published, Green Submitted, gold			2022-12-25	WOS:000265499900007
J	Dai, HM; Meng, XW; Lee, SH; Schneider, PA; Kaufmann, SH				Dai, Haiming; Meng, X. Wei; Lee, Sun-Hee; Schneider, Paula A.; Kaufmann, Scott H.			Context-dependent Bcl-2/Bak Interactions Regulate Lymphoid Cell Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE PERMEABILIZATION; BH3-ONLY PROTEINS; BH3 DOMAINS; MITOCHONDRIAL APOPTOSIS; MEDIATED APOPTOSIS; FAMILY-MEMBERS; LEUKEMIA-CELLS; DEATH DOMAIN; ANNEXIN-V; B-CELLS	The release of cytochrome c from mitochondria, which leads to activation of the intrinsic apoptotic pathway, is regulated by interactions of Bax and Bak with antiapoptotic Bcl-2 family members. The factors that regulate these interactions are, at the present time, incompletely understood. Recent studies showing preferences in binding between synthetic Bcl-2 homology domain 3 and antiapoptotic Bcl-2 family members in vitro have suggested that the antiapoptotic proteins Mcl-1 and Bcl-xL, but not Bcl-2, restrain proapoptotic Bak from inducing mitochondrial membrane permeabilization and apoptosis. Here we show that Bak protein has a much higher affinity than the 26-amino acid Bak Bcl-2 homology domain 3 for Bcl-2, that some naturally occurring Bcl-2 allelic variants have an affinity for full-length Bak that is only 3-fold lower than that of Mcl-1, and that endogenous levels of these Bcl-2 variants ( which are asmuchas 40-fold more abundant than Mcl-1) restrain part of the Bak in intact lymphoid cells. In addition, we demonstrate that Bcl-2 variants can, depending on their affinity for Bak, substitute for Mcl-1 in protecting cells. Thus, the ability of Bcl-2 to protect cells from activated Bak depends on two important contextual variables, the identity of the Bcl-2 present and the amount expressed.	[Dai, Haiming; Meng, X. Wei; Schneider, Paula A.; Kaufmann, Scott H.] Mayo Clin, Div Oncol Res, Rochester, MN 55905 USA; [Meng, X. Wei; Lee, Sun-Hee; Kaufmann, Scott H.] Mayo Clin, Dept Mol Pharmacol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Kaufmann, SH (corresponding author), Mayo Clin, Div Oncol Res, Gonda 19-212,200 1st St SW, Rochester, MN 55905 USA.	Kaufmann.scott@mayo.edu		Kaufmann, Scott/0000-0002-4900-7145; Dai, Haiming/0000-0002-0484-7407	National Institutes of Health [R01 CA69008]; Mayo Foundation for Education and Research; NATIONAL CANCER INSTITUTE [R01CA069008] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation for Education and Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA69008. This work was also supported by a Mayo Foundation for Education and Research predoctoral fellowship ( to S.-H. L.).	Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Adams KW, 2007, J BIOL CHEM, V282, P6192, DOI 10.1074/jbc.M610643200; Amundson SA, 2000, CANCER RES, V60, P6101; Berggard T, 2007, PROTEOMICS, V7, P2833, DOI 10.1002/pmic.200700131; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Brumatti G, 2008, METHODS, V44, P235, DOI 10.1016/j.ymeth.2007.11.010; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; Chittenden T, 2002, CANCER CELL, V2, P165, DOI 10.1016/S1535-6108(02)00128-9; CHITTENDEN T, 1995, EMBO J, V14, P5589, DOI 10.1002/j.1460-2075.1995.tb00246.x; CLEARY ML, 1986, CELL, V47, P19, DOI 10.1016/0092-8674(86)90362-4; Cliby WA, 2002, J BIOL CHEM, V277, P1599, DOI 10.1074/jbc.M106287200; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Fletchera JI, 2008, P NATL ACAD SCI USA, V105, P18081, DOI 10.1073/pnas.0808691105; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Gomez TS, 2006, IMMUNITY, V24, P741, DOI 10.1016/j.immuni.2006.03.022; Griffiths GJ, 2001, ONCOGENE, V20, P7668, DOI 10.1038/sj.onc.1204995; Hackbarth JS, 2004, BIOTECHNIQUES, V37, P835; Harlow E, 1988, ANTIBODIES LABORATOR, P521; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Jason-Moller L., 2006, CURRENT PROTOCOLS PR, DOI [10.1002/0471140864.ps1913-45, DOI 10.1002/0471140864.PS1913-45]; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Joseph MK, 2004, ONCOGENE, V23, P835, DOI 10.1038/sj.onc.1207141; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Lessene G, 2008, NAT REV DRUG DISCOV, V7, P989, DOI 10.1038/nrd2658; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; MAUNG ZT, 1994, BRIT J HAEMATOL, V88, P105, DOI 10.1111/j.1365-2141.1994.tb04984.x; Meng XW, 2007, J BIOL CHEM, V282, P29831, DOI 10.1074/jbc.M706110200; Meng XW, 2003, J BIOL CHEM, V278, P47326, DOI 10.1074/jbc.M304793200; Meng XW, 2002, J BIOL CHEM, V277, P3776, DOI 10.1074/jbc.M107218200; Mesa RA, 2005, BLOOD, V106, P318, DOI 10.1182/blood-2004-09-3523; MIYASHITA T, 1992, CANCER RES, V52, P5407; Moldoveanu T, 2006, MOL CELL, V24, P677, DOI 10.1016/j.molcel.2006.10.014; Moulding DA, 2000, BLOOD, V96, P1756, DOI 10.1182/blood.V96.5.1756.h8001756_1756_1763; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; SETO M, 1988, EMBO J, V7, P123, DOI 10.1002/j.1460-2075.1988.tb02791.x; Shivakumar L, 2006, CLIN LYMPHOMA MYELOM, V6, P455, DOI 10.3816/CLM.2006.n.025; STEVENSON R, 1991, AM BIOTECHNOL LAB, V9, P12; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; van Delft MF, 2006, CELL RES, V16, P203, DOI 10.1038/sj.cr.7310028; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhai DY, 2008, J BIOL CHEM, V283, P9580, DOI 10.1074/jbc.M708426200	63	39	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18311	18322		10.1074/jbc.M109.004770	http://dx.doi.org/10.1074/jbc.M109.004770			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19351886	Green Published, hybrid			2022-12-25	WOS:000267712400044
J	Kuhn, C; Frank, D; Will, R; Jaschinski, C; Frauen, R; Katus, HA; Frey, N				Kuhn, Christian; Frank, Derk; Will, Rainer; Jaschinski, Christoph; Frauen, Robert; Katus, Hugo A.; Frey, Norbert			DYRK1A Is a Novel Negative Regulator of Cardiomyocyte Hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC-HYPERTROPHY; IN-VIVO; PROTEIN-KINASE; PHOSPHORYLATION SITE; TARGETED INHIBITION; THERAPEUTIC TARGET; CALCINEURIN; HEART; SPECIFICITY; EXPRESSION	Activation of the phosphatase calcineurin and its downstream targets, transcription factors of the NFAT family, results in cardiomyocyte hypertrophy. Recently, it has been shown that the dual specificity tyrosine (Y) phosphorylation-regulated kinase 1A (DYRK1A) is able to antagonize calcineurin signaling by directly phosphorylating NFATs. We thus hypothesized that DYRK1A might modulate the hypertrophic response of cardiomyocytes. In a model of phenylephrine-induced hypertrophy, adenovirus-mediated overexpression of DYKR1A completely abrogated the hypertrophic response and significantly reduced the expression of the natriuretic peptides ANF and BNP. Furthermore, DYRK1A blunted cardiomyocyte hypertrophy induced by overexpression of constitutively active calcineurin and attenuated the induction of the hypertrophic gene program. Conversely, knockdown of DYRK1A, utilizing adenoviruses encoding for a specific synthetic miRNA, resulted in an increase in cell surface area accompanied by up-regulation of ANF-mRNA. Similarly, treatment of cardiomyocytes with harmine, a specific inhibitor of DYRK1A, revealed cardiomyocyte hypertrophy on morphological and molecular level. Moreover, constitutively active calcineurin led to robust induction of an NFAT-dependent luciferase reporter, whereas DYRK1A attenuated calcineurin-induced reporter activation in cardiomyocytes. Conversely, both knockdown and pharmacological inhibition of DYRK1A significantly augmented the effect of calcineurin in this assay. In summary, we identified DYRK1A as a novel negative regulator of cardiomyocyte hypertrophy. Mechanistically, this effect appears to be mediated via inhibition of NFAT transcription factors.	[Kuhn, Christian; Frey, Norbert] Univ Kiel, Dept Cardiol & Angiol, D-24105 Kiel, Germany; Univ Heidelberg Hosp, Dept Internal Med Cardiol Angiol & Pneumol 3, D-69120 Heidelberg, Germany	University of Kiel; Ruprecht Karls University Heidelberg	Frey, N (corresponding author), Univ Kiel, Dept Cardiol & Angiol, Schittenhelmstr 12, D-24105 Kiel, Germany.	norbert.frey@uk-sh.de	Frey, Norbert/A-9695-2010; Frey, Norbert/M-7749-2019	Frey, Norbert/0000-0001-7611-378X; Will, Rainer/0000-0001-6049-2690	Deutsche Forschungsgemeinschaft [FR1289/5-1]; Bundesministerium fur Bildung und Forschung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG, FR1289/5-1) as well as by a grant from the Bundesministerium fur Bildung und Forschung (Nationales Genomforschungsnetz: NGFNplus, Germany) (to N.F. and H.A.K.).	Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Becker W, 1998, J BIOL CHEM, V273, P25893, DOI 10.1074/jbc.273.40.25893; Branchi I, 2004, J NEUROPATH EXP NEUR, V63, P429, DOI 10.1093/jnen/63.5.429; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P4586, DOI 10.1073/pnas.072647999; Davies KJA, 2007, FASEB J, V21, P3023, DOI 10.1096/fj.06-7246com; De Windt LJ, 2000, CIRC RES, V86, P255, DOI 10.1161/01.RES.86.3.255; De Windt LJ, 2001, P NATL ACAD SCI USA, V98, P3322, DOI 10.1073/pnas.031371998; Frank D, 2007, CIRCULATION, V116, P2587, DOI 10.1161/CIRCULATIONAHA.107.711317; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Haq S, 2000, J CELL BIOL, V151, P117, DOI 10.1083/jcb.151.1.117; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Kentrup H, 1996, J BIOL CHEM, V271, P3488; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Mao JH, 2002, J BIOL CHEM, V277, P35156, DOI 10.1074/jbc.M206743200; Matsuo R, 2001, J IMMUNOL METHODS, V247, P141, DOI 10.1016/S0022-1759(00)00313-6; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Okui M, 1999, GENOMICS, V62, P165, DOI 10.1006/geno.1999.5998; Rothermel BA, 2001, P NATL ACAD SCI USA, V98, P3328, DOI 10.1073/pnas.041614798; Seifert A, 2008, FEBS J, V275, P6268, DOI 10.1111/j.1742-4658.2008.06751.x; Sitz JH, 2008, NEUROSCIENCE, V157, P596, DOI 10.1016/j.neuroscience.2008.09.034; Sugden PH, 2008, BRIT J PHARMACOL, V153, pS137, DOI 10.1038/sj.bjp.0707659; Taigen T, 2000, P NATL ACAD SCI USA, V97, P1196, DOI 10.1073/pnas.97.3.1196; Wilkins BJ, 2004, BIOCHEM BIOPH RES CO, V322, P1178, DOI 10.1016/j.bbrc.2004.07.121; Woods YL, 2001, BIOCHEM J, V355, P597, DOI 10.1042/bj3550597; Yang EJ, 2001, J BIOL CHEM, V276, P39819, DOI 10.1074/jbc.M104091200; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61	31	59	61	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17320	17327		10.1074/jbc.M109.006759	http://dx.doi.org/10.1074/jbc.M109.006759			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19372220	Green Published, hybrid			2022-12-25	WOS:000266962400067
J	Greig, SL; Radjainia, M; Mitra, AK				Greig, Sarah L.; Radjainia, Mazdak; Mitra, Alok K.			Oligomeric Structure of Colicin Ia Channel in Lipid Bilayer Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; FORMING DOMAIN; ION-CHANNEL; PROTEIN TRANSLOCATION; STATE; WATER; IDENTIFICATION; PURIFICATION; REFINEMENT; INSERTION	Colicin Ia is a soluble, harpoon-shaped bacteriocin which translocates across the periplasmic space of sensitive Escherichia coli cell by parasitizing an outer membrane receptor and forms voltage-gated ion channels in the inner membrane. This process leads to cell death, which has been thought to be caused by a single colicin Ia molecule. To directly visualize the three-dimensional structure of the channel, we generated two-dimensional crystals of colicin Ia inserted in lipid-bilayer membranes and determined a similar to 17 angstrom three-dimensional model by electron crystallography. Supported by velocity sedimentation, chemical cross-linking and single-particle image analysis, the three-dimensional structure is a crown-shaped oligomer enclosing a similar to 35 angstrom-wide extrabilayer vestibule. Our study suggests that lipid insertion instigates a global conformational change in colicin Ia and that more than one molecule participates in the channel architecture with the vestibule, possibly facilitating the known large scale peptide translocation upon channel opening.	[Greig, Sarah L.; Radjainia, Mazdak; Mitra, Alok K.] Univ Auckland, Sch Biol Sci, Auckland 1142, New Zealand	University of Auckland	Mitra, AK (corresponding author), Univ Auckland, Sch Biol Sci, Thomas Bldg,3A Symonds St, Auckland 1142, New Zealand.	a.mitra@auckland.ac.nz	Mitra, Alok/P-7800-2016	Mitra, Alok/0000-0003-0891-5697	National Institutes of Health [R21 DK060827]; Marsden Fund (New Zealand); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK060827] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marsden Fund (New Zealand)(Royal Society of New ZealandMarsden Fund (NZ)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R21 DK060827 (NIDDK). This work was also supported by a Marsden Fund (New Zealand) grant (to A. K. M.).	Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Buchanan SK, 2007, EMBO J, V26, P2594, DOI 10.1038/sj.emboj.7601693; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; CRAMER WA, 1995, ANNU REV BIOPH BIOM, V24, P611, DOI 10.1146/annurev.biophys.24.1.611; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; DUCHE D, 1994, J BIOL CHEM, V269, P6332; Dutzler R, 2007, FEBS LETT, V581, P2839, DOI 10.1016/j.febslet.2007.04.016; Elkins P, 1997, STRUCTURE, V5, P443, DOI 10.1016/S0969-2126(97)00200-1; Fivaz M, 2001, CURR TOP MICROBIOL, V257, P35; Hyun JK, 2007, J VIROL, V81, P11075, DOI 10.1128/JVI.00594-07; Jakes KS, 1999, Q REV BIOPHYS, V32, P189, DOI 10.1017/S0033583599003492; JARVIS LJ, 1995, CURR EYE RES, V14, P799, DOI 10.3109/02713689508995802; Kienker PK, 2008, J GEN PHYSIOL, V132, P693, DOI 10.1085/jgp.200810042; Kienker PK, 2000, J GEN PHYSIOL, V116, P587, DOI 10.1085/jgp.116.4.587; Kienker PK, 1997, J MEMBRANE BIOL, V157, P27, DOI 10.1007/s002329900213; Kienker PK, 2003, J GEN PHYSIOL, V122, P161, DOI 10.1085/jgp.200308852; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Krasilnikov OV, 1998, J MEMBRANE BIOL, V161, P83; KUHLBRANDT W, 1992, Q REV BIOPHYS, V25, P1; LEVINTHAL F, 1991, PROTEINS, V11, P254, DOI 10.1002/prot.340110404; Lindeberg M, 2000, J MOL BIOL, V295, P679, DOI 10.1006/jmbi.1999.3396; Luo WB, 2005, J AM CHEM SOC, V127, P6402, DOI 10.1021/ja0433121; MEL SF, 1993, BIOCHEMISTRY-US, V32, P2082, DOI 10.1021/bi00059a028; MIERCKE LJW, 1991, BIOCHEMISTRY-US, V30, P3088, DOI 10.1021/bi00226a016; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; Padmavathi PVL, 2008, J MOL BIOL, V378, P204, DOI 10.1016/j.jmb.2008.02.038; PARKER MW, 1992, J MOL BIOL, V224, P639, DOI 10.1016/0022-2836(92)90550-4; PARKER MW, 1993, TRENDS BIOCHEM SCI, V18, P391, DOI 10.1016/0968-0004(93)90096-6; Post PL, 2002, J BIOL CHEM, V277, P11679, DOI 10.1074/jbc.M111173200; Qiu XQ, 1996, J GEN PHYSIOL, V107, P313, DOI 10.1085/jgp.107.3.313; RADERMACHER M, 1987, J MICROSC-OXFORD, V146, P113, DOI 10.1111/j.1365-2818.1987.tb01333.x; Scheres SHW, 2005, BIOINFORMATICS, V21, P243, DOI 10.1093/bioinformatics/bti1140; Scheres SHW, 2005, J MOL BIOL, V348, P139, DOI 10.1016/j.jmb.2005.02.031; Scheres SHW, 2007, NAT METHODS, V4, P27, DOI 10.1038/NMETH992; SLATIN SL, 1988, INT J BIOCHEM, V20, P737, DOI 10.1016/0020-711X(88)90058-4; SLATIN SL, 1994, NATURE, V371, P158, DOI 10.1038/371158a0; Slatin SL, 2003, CEL MOL MEC TOX ACT, V5, P102; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Stroud RM, 1998, CURR OPIN STRUC BIOL, V8, P525, DOI 10.1016/S0959-440X(98)80132-2; Verkman AS, 2000, AM J PHYSIOL-RENAL, V278, pF13, DOI 10.1152/ajprenal.2000.278.1.F13; Vetter IR, 1998, STRUCTURE, V6, P863, DOI 10.1016/S0969-2126(98)00088-4; Vinothkumar KR, 2006, J BIOL CHEM, V281, P4795, DOI 10.1074/jbc.M508993200; Wei ZK, 2007, BIOCHEMISTRY-US, V46, P6074, DOI 10.1021/bi700317k; Wiener M, 1997, NATURE, V385, P461, DOI 10.1038/385461a0; Yao XL, 2006, BIOCHEMISTRY-US, V45, P289, DOI 10.1021/bi051540h; Yeager M, 1999, Methods Enzymol, V294, P135	47	13	13	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16126	16134		10.1074/jbc.M900292200	http://dx.doi.org/10.1074/jbc.M900292200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19357078	Green Published, hybrid			2022-12-25	WOS:000266730900009
J	Jacobson, MA; Ditmer, DP; Sinclair, E; Martin, JN; Deeks, SG; Hunt, P; Mocarski, ES; Shiboski, C				Jacobson, Mark A.; Ditmer, Dirk P.; Sinclair, Elizabeth; Martin, Jeffrey N.; Deeks, Steven G.; Hunt, Peter; Mocarski, Edward S.; Shiboski, Caroline			Human Herpesvirus Replication and Abnormal CD8+T Cell Activation and Low CD4+T Cell Counts in Antiretroviral-Suppressed HIV-Infected Patients	PLOS ONE			English	Article								Background: Most HIV-infected patients receiving virologically suppressive antiretroviral therapy continue to have abnormal, generalized T cell activation. We explored whether the degree of ongoing cytomegalovirus (CMV), Epstein-Barr virus (EBV) and Kaposi's sarcoma herpesvirus (KSHV) replication was associated with higher virus-specific T cell activation and the failure to achieve normal absolute CD4+ T cell counts in the face of long-term suppressive antiretroviral therapy. Methodology: Longitudinally collected PBMC and saliva specimens obtained from HIV-infected patients on effective antiretroviral therapy for at least one year (plasma HIV RNA <75 copies/mL) were examined using a multiplex CMV, EBV and KSHV DNA PCR assay. Eleven cases were chosen who had CD8+ T cell CD38+ HLA-DR+ expression >10% and plateau absolute CD4+ T cell counts <500 cells/mu L. Five controls from the same study had CD8+ T cell CD38 expression <10% and plateau absolute CD4+ T cell counts >500 cells/mu L. Results and Conclusions: Among all subjects combined, 18% of PMBC samples were positive for CMV DNA, and 27%, 73% and 24% of saliva samples were positive for CMV, EBV and KSHV DNA, respectively. No significant differences or trends were observed between cases and controls in proportions of all CMV, EBV or KSHV DNA positive specimens, proportions of subjects in each group that intermittently or continuously shed CMV, EBV or KSHV DNA in saliva, or the median number of genome copies of CMV, EBV and KSHV DNA in saliva. Overall, number of genome copies in saliva were lower for KSHV than for CMV and lower for CMV than for EBV. Although replication of CMV, EBV and KSHV persists in many antiretroviralsuppressed, HIV-infected patients, we observed no evidence in this pilot case-control study that the magnitude of such human herpesvirus replication is associated with abnormally increased CD8+ T cell activation and sub-normal plateau absolute CD4+ T cell counts following virologically suppressive antiretroviral therapy.			Jacobson, MA (corresponding author), Univ Calif San Francisco, Dept Med, Posit Hlth Program, San Francisco, CA 94143 USA.	mjacobson@php.ucsf.edu	Hunt, Peter W./P-2976-2017; Mocarski, Edward/ABC-2893-2020	Hunt, Peter W./0000-0002-4571-4870; dittmer, dirk/0000-0003-4968-5656	NCRR NIH HHS [UL1 RR024131] Funding Source: Medline; NIAID NIH HHS [U01 AI68636, U01 AI068636, P30 AI027763] Funding Source: Medline; NIDCR NIH HHS [R01 DE018304-01, R01 DE018304-02, DE018304, R01 DE018304-03, R01 DE018304] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, U01AI068636] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018304] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Boeckh M, 1997, TRANSPLANTATION, V64, P108, DOI 10.1097/00007890-199707150-00020; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Casper C, 2008, J INFECT DIS, V198, P23, DOI 10.1086/588820; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; HATANO H, 2009, 16 C RETR OPP INF MO; Havlir DV, 2003, J VIROL, V77, P11212, DOI 10.1128/JVI.77.20.11212-11219.2003; Hilscher C, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni181; Hsue PY, 2006, AIDS, V20, P2275, DOI 10.1097/QAD.0b013e3280108704; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Jacobson MA, 2002, JAIDS, V31, P472, DOI 10.1097/00126334-200212150-00003; Jebbink J, 2003, J MOL DIAGN, V5, P15, DOI 10.1016/S1525-1578(10)60446-1; JIANG W, 2009, J INFECT DIS    0305; JIAO Y, 2008, IMMUNOLOGY; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lim A, 2007, AIDS, V21, P1525, DOI 10.1097/QAD.0b013e32825eab8b; Liu ZY, 1997, J ACQ IMMUN DEF SYND, V16, P83, DOI 10.1097/00042560-199710010-00003; Maldarelli F, 2007, PLOS PATHOG, V3, P484, DOI 10.1371/journal.ppat.0030046; Mathotra U, 2006, CLIN IMMUNOL, V119, P95, DOI 10.1016/j.clim.2005.11.010; Miller CS, 2006, J CLIN MICROBIOL, V44, P2409, DOI 10.1128/JCM.00256-06; Ndhlovu LC, 2008, J LEUKOCYTE BIOL, V83, P254, DOI 10.1189/jlb.0507281; Nicastri E, 2008, CURR HIV RES, V6, P261, DOI 10.2174/157016208784325010; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Papagno L, 2004, PLOS BIOL, V2, P173, DOI 10.1371/journal.pbio.0020020; Potena L, 2007, J CLIN MICROBIOL, V45, P1804, DOI 10.1128/JCM.01362-06; Razonable RR, 2002, TRANSPLANTATION, V73, P968, DOI 10.1097/00007890-200203270-00025; van Baarle D, 2002, AIDS, V16, P2001, DOI 10.1097/00002030-200210180-00004	29	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2009	4	4							e5277	10.1371/journal.pone.0005277	http://dx.doi.org/10.1371/journal.pone.0005277			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TW	19381272	Green Published, Green Submitted, gold			2022-12-25	WOS:000265510800013
J	Logozzi, M; De Milito, A; Lugini, L; Borghi, M; Calabro, L; Spada, M; Perdicchio, M; Marino, ML; Federici, C; Iessi, E; Brambilla, D; Venturi, G; Lozupone, F; Santinami, M; Huber, V; Maio, M; Rivoltini, L; Fais, S				Logozzi, Mariantonia; De Milito, Angelo; Lugini, Luana; Borghi, Martina; Calabro, Luana; Spada, Massimo; Perdicchio, Maurizio; Marino, Maria Lucia; Federici, Cristina; Iessi, Elisabetta; Brambilla, Daria; Venturi, Giulietta; Lozupone, Francesco; Santinami, Mario; Huber, Veronica; Maio, Michele; Rivoltini, Licia; Fais, Stefano			High Levels of Exosomes Expressing CD63 and Caveolin-1 in Plasma of Melanoma Patients	PLOS ONE			English	Article								Background: Metastatic melanoma is an untreatable cancer lacking reliable and non-invasive markers of disease progression. Exosomes are small vesicles secreted by normal as well as tumor cells. Human tumor-derived exosomes are involved in malignant progression and we evaluated the presence of exosomes in plasma of melanoma patients as a potential tool for cancer screening and follow-up. Methodology/Principal Findings: We designed an in-house sandwich ELISA (Exotest) to capture and quantify exosomes in plasma based on expression of housekeeping proteins (CD63 and Rab-5b) and a tumor-associated marker (caveolin-1). Western blot and flow cytometry analysis of exosomes were used to confirm the Exotest-based findings. The Exotest allowed sensitive detection and quantification of exosomes purified from human tumor cell culture supernatants and plasma from SCID mice engrafted with human melanoma. Plasma levels of exosomes in melanoma-engrafted SCID mice correlated to tumor size. We evaluated the levels of plasma exosomes expressing CD63 and caveolin-1 in melanoma patients (n = 90) and healthy donors (n = 58). Consistently, plasma exosomes expressing CD63 (504 +/- 315) or caveolin-1 (619 +/- 310) were significantly increased in melanoma patients as compared to healthy donors (223 +/- 125 and 228 +/- 102, respectively). While the Exotest for CD63+ plasma exosomes had limited sensitivity (43%) the Exotest for detection of caveolin-1+ plasma exosomes showed a higher sensitivity (68%). Moreover, caveolin-1+ plasma exosomes were significantly increased with respect to CD63+ exosomes in the patients group. Conclusions/Significance: We describe a new non-invasive assay allowing detection and quantification of human exosomes in plasma of melanoma patients. Our results suggest that the Exotest for detection of plasma exosomes carrying tumor-associated antigens may represent a novel tool for clinical management of cancer patients.			Logozzi, M (corresponding author), Ist Super Sanita, Dept Therapeut Res & Med Evaluat, Unit Antitumor Drugs, Viale Regina Elena 299, I-00161 Rome, Italy.	stefano.fais@iss.it	Santinami, Mario/I-3795-2017; Federici, Cristina/O-4676-2016; Lugini, Luana/J-8672-2016; Huber, Veronica/D-1618-2017; Spada, Massimo/R-9563-2017; rivoltini, licia/I-2450-2012; BORGHI, MARTINA/M-4355-2015; Spada, Massimo/Z-1345-2019; Perdicchio, Maurizio/HGB-2966-2022; Calabrò, Luana/AAC-9920-2019; Lozupone, Francesco/H-2998-2016; VENTURI, GIULIETTA/O-8123-2015; Iessi, Elisabetta/O-2460-2017; Fais, Stefano/J-8638-2016	Santinami, Mario/0000-0001-8436-4757; Federici, Cristina/0000-0001-6366-0231; Lugini, Luana/0000-0002-8778-2601; Huber, Veronica/0000-0001-6304-3575; Spada, Massimo/0000-0003-0751-1893; rivoltini, licia/0000-0002-2409-6225; BORGHI, MARTINA/0000-0001-6313-0273; Spada, Massimo/0000-0003-0751-1893; Lozupone, Francesco/0000-0002-4959-9400; VENTURI, GIULIETTA/0000-0002-9078-8350; Iessi, Elisabetta/0000-0001-7221-9173; Fais, Stefano/0000-0001-9060-2766; coral, sandra/0000-0002-1308-3082; calabro', luana/0000-0002-3044-0889; Maio, Michele/0000-0002-0323-6321; De Milito, Angelo/0000-0003-2591-2914	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Andre F, 2002, LANCET, V360, P295, DOI 10.1016/S0140-6736(02)09552-1; Andreola G, 2002, J EXP MED, V195, P1303, DOI 10.1084/jem.20011624; Bard MP, 2004, AM J RESP CELL MOL, V31, P114, DOI 10.1165/rcmb.2003-0238OC; Bartalev SA, 2008, CONTEMP PROBL ECOL, V1, P1, DOI 10.1134/S1995425508010013; BERGMANN C, 2008, HEAD NECK       1215; Blanchard N, 2002, J IMMUNOL, V168, P3235, DOI 10.4049/jimmunol.168.7.3235; Brochez L, 2000, BRIT J DERMATOL, V143, P256, DOI 10.1046/j.1365-2133.2000.03649.x; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Cantiani L, 2007, CANCER RES, V67, P7675, DOI 10.1158/0008-5472.CAN-06-4697; Chaput N, 2003, ADV EXP MED BIOL, V532, P215; Clayton A, 2008, J IMMUNOL, V180, P7249, DOI 10.4049/jimmunol.180.11.7249; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; FERRONE S, 1995, IMMUNOL TODAY, V16, P487, DOI 10.1016/0167-5699(95)80033-6; Fine SW, 2001, AM J CLIN PATHOL, V115, P719; GERAN RI, 1972, CANC CHEMOTHER REP, V3, P1; Hauschild A, 2001, RECENT RESULTS CANC, V158, P169; Huber V, 2005, GASTROENTEROLOGY, V128, P1796, DOI 10.1053/j.gastro.2005.03.045; Huber V, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-63; Iero M, 2008, CELL DEATH DIFFER, V15, P80, DOI 10.1038/sj.cdd.4402237; Kim JW, 2005, CLIN CANCER RES, V11, P1010; Lamparski HG, 2002, J IMMUNOL METHODS, V270, P211, DOI 10.1016/S0022-1759(02)00330-7; Liu CR, 2006, J IMMUNOL, V176, P1375, DOI 10.4049/jimmunol.176.3.1375; Llorente A, 2004, J CELL SCI, V117, P5343, DOI 10.1242/jcs.01420; Lugini L, 2006, CANCER RES, V66, P3629, DOI 10.1158/0008-5472.CAN-05-3204; Maeurer MJ, 1996, J CLIN INVEST, V98, P1633, DOI 10.1172/JCI118958; Olver Christine, 2007, V43, P99, DOI 10.1007/978-1-4020-5943-8_7; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Raposo G, 1997, MOL BIOL CELL, V8, P2631, DOI 10.1091/mbc.8.12.2631; Soderberg A, 2007, FREE RADICAL BIO MED, V43, P90, DOI 10.1016/j.freeradbiomed.2007.03.026; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Tahir SA, 2003, CLIN CANCER RES, V9, P3653; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thompson JA, 2002, SEMIN ONCOL, V29, P361, DOI 10.1053/sonc.2002.34115; Valenti R, 2007, CANCER RES, V67, P2912, DOI 10.1158/0008-5472.CAN-07-0520; Valenti R, 2006, CANCER RES, V66, P9290, DOI 10.1158/0008-5472.CAN-06-1819; van Niel G, 2001, GASTROENTEROLOGY, V121, P337, DOI 10.1053/gast.2001.26263; Whiteside TL, 2005, BRIT J CANCER, V92, P209, DOI 10.1038/sj.bjc.6602360	38	640	690	7	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2009	4	4							e5219	10.1371/journal.pone.0005219	http://dx.doi.org/10.1371/journal.pone.0005219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TW	19381331	Green Submitted, Green Published, gold			2022-12-25	WOS:000265510800008
J	Kern, AD				Kern, Andrew D.			Correcting the Site Frequency Spectrum for Divergence-Based Ascertainment	PLOS ONE			English	Article							ULTRACONSERVED ELEMENTS; POPULATION-GENETICS; SELECTION; POLYMORPHISM	Comparative genomics based on sequenced referenced genomes is essential to hypothesis generation and testing within population genetics. However, selection of candidate regions for further study on the basis of elevated or depressed divergence between species leads to a divergence-based ascertainment bias in the site frequency spectrum within selected candidate loci. Here, a method to correct this problem is developed that obtains maximum-likelihood estimates of the unascertained allele frequency distribution using numerical optimization. I show how divergence-based ascertainment may mimic the effects of natural selection and offer correction formulae for performing proper estimation into the strength of selection in candidate regions in a maximum-likelihood setting.			Kern, AD (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.	andrew.d.kern@dartmouth.edu						Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Bustamante CD, 2001, GENETICS, V159, P1779; Drake JA, 2006, NAT GENET, V38, P223, DOI 10.1038/ng1710; Gillespie J. H., 1991, CAUSES MOL EVOLUTION; Gillespie JH, 1997, GENE, V205, P291, DOI 10.1016/S0378-1119(97)00470-8; HEY J, 1991, GENETICS, V128, P831; Katzman S, 2007, SCIENCE, V317, P915, DOI 10.1126/science.1142430; Kern AD, 2004, GENETICS, V167, P725, DOI 10.1534/genetics.103.020883; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Nielsen R, 2004, GENETICS, V168, P2373, DOI 10.1534/genetics.104.031039; Pollard KS, 2006, PLOS GENET, V2, P1599, DOI 10.1371/journal.pgen.0020168; Press W. H., 1992, ART SCI COMPUTING; SAWYER SA, 1992, GENETICS, V132, P1161; TAJIMA F, 1989, GENETICS, V123, P585; Williamson SH, 2005, P NATL ACAD SCI USA, V102, P7882, DOI 10.1073/pnas.0502300102	16	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2009	4	4							e5152	10.1371/journal.pone.0005152	http://dx.doi.org/10.1371/journal.pone.0005152			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TU	19370150	Green Published, gold, Green Submitted			2022-12-25	WOS:000265510600001
J	Mandolesi, G; Autuori, E; Cesa, R; Premoselli, F; Cesare, P; Strata, P				Mandolesi, Georgia; Autuori, Eleonora; Cesa, Roberta; Premoselli, Federica; Cesare, Paolo; Strata, Piergiorgio			GluR delta 2 Expression in the Mature Cerebellum of Hotfoot Mice Promotes Parallel Fiber Synaptogenesis and Axonal Competition	PLOS ONE			English	Article								Glutamate receptor delta 2 (GluR delta 2) is selectively expressed in the cerebellum, exclusively in the spines of the Purkinje cells (PCs) that are in contact with parallel fibers (PFs). Although its structure is similar to ionotropic glutamate receptors, it has no channel function and its ligand is unknown. The GluR delta 2-null mice, such as knockout and hotfoot have profoundly altered cerebellar circuitry, which causes ataxia and impaired motor learning. Notably, GluR delta 2 in PC-PF synapses regulates their maturation and strengthening and induces long term depression (LTD). In addition, GluR delta 2 participates in the highly territorial competition between the two excitatory inputs to the PC; the climbing fiber (CF), which innervates the proximal dendritic compartment, and the PF, which is connected to spiny distal branchlets. Recently, studies have suggested that GluR delta 2 acts as an adhesion molecule in PF synaptogenesis. Here, we provide in vivo and in vitro evidence that supports this hypothesis. Through lentiviral rescue in hotfoot mice, we noted a recovery of PC-PF contacts in the distal dendritic domain. In the proximal domain, we observed the formation of new spines that were innervated by PFs and a reduction in contact with the CF; ie, the pattern of innervation in the PC shifted to favor the PF input. Moreover, ectopic expression of GluR delta 2 in HEK293 cells that were cocultured with granule cells or in cerebellar Golgi cells in the mature brain induced the formation of new PF contacts. Collectively, our observations show that GluR delta 2 is an adhesion molecule that induces the formation of PF contacts independently of its cellular localization and promotes heterosynaptic competition in the PC proximal dendritic domain.			Mandolesi, G (corresponding author), IRCCS, EBRI Santa Lucia Fdn, Rome, Italy.	g.mandolesi@hsantalucia.it	Mandolesi, Georgia/G-6595-2011; Autuori, Eleonora/J-5868-2014	Mandolesi, Georgia/0000-0003-3612-6820; Cesare, Paolo/0000-0003-1324-5974				Andrasfalvy BK, 2001, J NEUROSCI, V21, P9151, DOI 10.1523/JNEUROSCI.21-23-09151.2001; Bravin M, 1999, P NATL ACAD SCI USA, V96, P1704, DOI 10.1073/pnas.96.4.1704; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Castejon OJ, 2000, BIOCELL, V24, P13; Cesa R, 2003, J NEUROSCI, V23, P2363; Cesa R, 2007, J NEUROSCI, V27, P4603, DOI 10.1523/JNEUROSCI.5617-06.2007; Cesa R, 2008, P NATL ACAD SCI USA, V105, P18988, DOI 10.1073/pnas.0806979105; Deglon N, 2005, J GENE MED, V7, P530, DOI 10.1002/jgm.707; Dieudonne S, 1998, J PHYSIOL-LONDON, V510, P845, DOI 10.1111/j.1469-7793.1998.845bj.x; ECCLES JC, 1967, EXP BRAIN RES, V3, P81; Eccles JC, 1967, CEREBELLUM NEURONAL; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Fu ZY, 2003, J NEUROPHYSIOL, V90, P3950, DOI 10.1152/jn.00647.2003; GUASTAVINO JM, 1990, BRAIN RES, V523, P199, DOI 10.1016/0006-8993(90)91488-3; HAMORI J, 1966, EXP BRAIN RES, V2, P35; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Ichikawa R, 2002, J NEUROSCI, V22, P8487; Jiang CG, 2002, TRENDS BIOCHEM SCI, V27, P506, DOI 10.1016/S0968-0004(02)02190-4; Kakegawa W, 2007, J PHYSIOL-LONDON, V584, P89, DOI 10.1113/jphysiol.2007.141291; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; Kirsch J, 1996, MOL CELL NEUROSCI, V8, P93, DOI 10.1006/mcne.1996.0048; Kohda K, 2003, MOL BRAIN RES, V110, P27, DOI 10.1016/S0169-328X(02)00561-2; Kohda K, 2007, EUR J NEUROSCI, V25, P1357, DOI 10.1111/j.1460-9568.2007.05412.x; Kurihara H, 1997, J NEUROSCI, V17, P9613; Lalouette A, 2001, NEUROSCIENCE, V105, P443, DOI 10.1016/S0306-4522(01)00193-2; Lalouette A, 1998, GENOMICS, V50, P9, DOI 10.1006/geno.1998.5314; Landsend AS, 1997, J NEUROSCI, V17, P834, DOI 10.1523/jneurosci.17-02-00834.1997; Lim ST, 2000, NEURON, V25, P385, DOI 10.1016/S0896-6273(00)80902-2; MANDOLESI G, NEUROSCIENCE; MASON CA, 1986, NEUROSCIENCE, V19, P1319, DOI 10.1016/0306-4522(86)90146-6; Matsuda S, 2002, EUR J NEUROSCI, V16, P1507, DOI 10.1046/j.1460-9568.2002.02219.x; Morando L, 2001, P NATL ACAD SCI USA, V98, P9954, DOI 10.1073/pnas.171098398; Nakagami Ryoichi, 2008, Keio Journal of Medicine, V57, P105, DOI 10.2302/kjm.57.105; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; NORDQUIST DT, 1988, J NEUROSCI, V8, P4780; OBERDICK J, 1990, SCIENCE, V248, P223, DOI 10.1126/science.2109351; OBERDICK J, 1988, NEURON, V1, P367, DOI 10.1016/0896-6273(88)90186-9; Palay S. L., 1974, CEREBELLAR CORTEX CY; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; ROSSI F, 1991, J COMP NEUROL, V308, P513, DOI 10.1002/cne.903080403; ROSSI F, 1991, J COMP NEUROL, V308, P536, DOI 10.1002/cne.903080404; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; SMEYNE RJ, 1995, MOL CELL NEUROSCI, V6, P230, DOI 10.1006/mcne.1995.1019; SOTELO C, 1975, BRAIN RES, V98, P574, DOI 10.1016/0006-8993(75)90374-1; Studler B, 2002, NEUROSCIENCE, V114, P123, DOI 10.1016/S0306-4522(02)00206-3; Takeuchi T, 2005, J NEUROSCI, V25, P2146, DOI 10.1523/JNEUROSCI.4740-04.2005; Uemura T, 2008, BIOCHEM BIOPH RES CO, V377, P1315, DOI 10.1016/j.bbrc.2008.10.170; Ultanir SK, 2007, P NATL ACAD SCI USA, V104, P19553, DOI 10.1073/pnas.0704031104; Watanabe M, 2008, TOHOKU J EXP MED, V214, P175, DOI 10.1620/tjem.214.175; Yuzaki M, 2004, CEREBELLUM, V3, P89, DOI 10.1080/14734220410028921; Yuzaki M, 2003, NEUROSCI RES, V46, P11, DOI 10.1016/S0168-0102(03)00036-1; Zhao HM, 1997, J NEUROCHEM, V68, P1041	53	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2009	4	4							e5243	10.1371/journal.pone.0005243	http://dx.doi.org/10.1371/journal.pone.0005243			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TU	19370152	Green Submitted, Green Published, gold			2022-12-25	WOS:000265510600007
J	Ahluwalia, TS; Khullar, M; Ahuja, M; Kohli, HS; Bhansali, A; Mohan, V; Venkatesan, R; Rai, TS; Sud, K; Singal, PK				Ahluwalia, Tarunveer Singh; Khullar, Madhu; Ahuja, Monica; Kohli, Harbir Singh; Bhansali, Anil; Mohan, Viswanathan; Venkatesan, Radha; Rai, Taranjit Singh; Sud, Kamal; Singal, Pawan K.			Common Variants of Inflammatory Cytokine Genes Are Associated with Risk of Nephropathy in Type 2 Diabetes among Asian Indians	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; PROMOTER POLYMORPHISM; RENAL-INSUFFICIENCY; CANDIDATE GENE; CCR5; DISEASE; EPIDEMIOLOGY; PROGRESSION; TGF-BETA-1; JAPANESE	Background: Inflammatory cytokine genes have been proposed as good candidate genes for conferring susceptibility to diabetic nephropathy. In the present study, we examined the combined effect of multiple alleles of pro inflammatory cytokine genes for determining the risk of nephropathy in type 2 diabetic patients. Methodology/Principal Findings: Eight single nucleotide polymorphisms (SNPs) of pro-inflammatory cytokine genes (CCL2, TGFB1, IL8, CCR5, and MMP9) were genotyped in two independently ascertained type 2 diabetic cohorts with (DN) and without nephropathy (DM); consisting of patients from North India (n = 495) and South India (n = 188). Genotyping was carried out using PCR, allele specific oligonucleotide-PCR (ASO-PCR), PCR-RFLP and TaqMan allelic discrimination assays and the gene-gene interaction among genetic variants were determined by multi dimensional reduction (MDR) software. Serum high sensitive CRP (hs-CRP) levels were measured by ELISA. The hs-CRP levels were significantly higher in DN as compared to the DM group (p < 0.05). The CCL2, IL8, CCR5 and MMP9 polymorphisms were found to be associated with the risk of diabetic nephropathy. Frequency of CCL2 II, IL8 -251AA, CCR5 59029AA and MMP9 279Gln/Gln genotypes were significantly higher in DN than in DM group (p < 0.05) and associated with an increased risk of nephropathy in both North and South Indian cohorts. CCR5 DD and IL8 -251AA genotypes were more prevalent in North Indian DN group only. The co-occurrence of risk associated genotypes (II, -2518GG (CCL2), DD (CCR5) and 279Gln/Gln (MMP9) conferred a tenfold increased risk of nephropathy among type 2 diabetics (p < 0.0002). Conclusion: The present study highlights that common variants of inflammatory cytokine genes exert a modest effect on risk of DN and a combination of risk alleles confer a substantial increased risk of nephropathy in type 2 diabetes among Asian Indians.			Ahluwalia, TS (corresponding author), Postgrad Inst Med Educ & Res, Dept Nephrol, Chandigarh 160012, India.	madhu.khullar@gmail.com	Ahluwalia, Tarunveer Singh/C-5549-2009; Rai, Taranjit Singh/A-3659-2012; KOHLI, HARBIR SINGH/AHA-5966-2022; Singh, Taranjit/ABE-8233-2020	Ahluwalia, Tarunveer Singh/0000-0002-7464-3354; Rai, Taranjit Singh/0000-0002-7276-7492; Singh, Taranjit/0000-0002-7276-7492; Kohli, Harbir/0000-0003-4806-2297; Khullar, Madhu/0000-0003-4461-2466				Ahluwalia TS, 2008, MOL CELL BIOCHEM, V314, P9, DOI 10.1007/s11010-008-9759-8; Ahluwalia TS, 2009, DNA CELL BIOL, V28, P141, DOI 10.1089/dna.2008.0810; Akai Y, 2001, AM J KIDNEY DIS, V38, pS182, DOI 10.1053/ajkd.2001.27439; Basu A, 2003, GENOME RES, V13, P2277, DOI 10.1101/gr.1413403; Chinoy H, 2007, RHEUMATOLOGY, V46, P604, DOI 10.1093/rheumatology/kel359; FALK RJ, 1983, DIABETES, V32, P34, DOI 10.2337/diab.32.2.S34; Gonzalez E, 2001, P NATL ACAD SCI USA, V98, P5199, DOI 10.1073/pnas.091056898; Gordon D, 2002, HUM HERED, V54, P22, DOI 10.1159/000066696; Gordon D, 2003, Pac Symp Biocomput, P490; Greene CN, 2008, HUM GENET, V124, P255, DOI 10.1007/s00439-008-0548-y; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hanson RL, 2007, DIABETES, V56, P975, DOI 10.2337/db06-1072; Hattersley AT, 2005, LANCET, V366, P1315, DOI 10.1016/S0140-6736(05)67531-9; Hirakawa S, 2003, AM J KIDNEY DIS, V42, P133, DOI 10.1016/S0272-6386(03)00416-5; Hull J, 2000, THORAX, V55, P1023, DOI 10.1136/thorax.55.12.1023; Ibrahim S, 2008, SAUDI J KIDNEY DIS T, V19, P911; Jacobsen P, 2003, J AM SOC NEPHROL, V14, P2843, DOI 10.1097/01.ASN.0000092139.19587.51; Lee SH, 2005, NEPHROLOGY, V10, pS32, DOI 10.1111/j.1440-1797.2005.00454.x; Maeda S, 2007, KIDNEY INT, V72, pS43, DOI 10.1038/sj.ki.5002385; Maeda S, 2001, KIDNEY INT, V60, P1428, DOI 10.1046/j.1523-1755.2001.00945.x; Maeda S, 2008, KIDNEY INT, V74, P413, DOI 10.1038/ki.2008.291; McDermott DH, 1998, LANCET, V352, P866, DOI 10.1016/S0140-6736(98)04158-0; Mlynarski WM, 2005, DIABETES, V54, P3331, DOI 10.2337/diabetes.54.11.3331; Mokubo A, 2006, DIABETES RES CLIN PR, V73, P89, DOI 10.1016/j.diabres.2005.12.006; Moon JY, 2007, J KOREAN MED SCI, V22, P810, DOI 10.3346/jkms.2007.22.5.810; Nakajima K, 2002, DIABETES, V51, P238, DOI 10.2337/diabetes.51.1.238; Navarro JF, 2006, NEPHROL DIAL TRANSPL, V21, P3428, DOI 10.1093/ndt/gfl469; Navarro-Gonzalez JF, 2008, J AM SOC NEPHROL, V19, P433, DOI 10.1681/ASN.2007091048; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; Pociot F, 1998, J AM SOC NEPHROL, V9, P2302; Prasad P, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-20; Prasad P, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-42; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Rivero A, 2009, CLIN SCI, V116, P479, DOI 10.1042/CS20080394; Rovin BH, 2002, KIDNEY INT, V62, P261, DOI 10.1046/j.1523-1755.2002.00438.x; Ruster C, 2008, FRONT BIOSCI-LANDMRK, V13, P944, DOI 10.2741/2734; Shipley JM, 1996, J BIOL CHEM, V271, P4335; SINGH S, 2002, PEOPLE INDIA INTRO N; Tashiro K, 2002, J CLIN LAB ANAL, V16, P1, DOI 10.1002/jcla.2057; Vielhauer V, 2001, J AM SOC NEPHROL, V12, P1173, DOI 10.1681/ASN.V1261173; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wong TYH, 2003, KIDNEY INT, V63, P1831, DOI 10.1046/j.1523-1755.2003.00919.x	43	59	61	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5168	10.1371/journal.pone.0005168	http://dx.doi.org/10.1371/journal.pone.0005168			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357773	Green Published, Green Submitted, gold			2022-12-25	WOS:000265505900021
J	Kita-Matsuo, H; Barcova, M; Prigozhina, N; Salomonis, N; Wei, K; Jacot, JG; Nelson, B; Spiering, S; Haverslag, R; Kim, C; Talantova, M; Bajpai, R; Calzolari, D; Terskikh, A; McCulloch, AD; Price, JH; Conklin, BR; Chen, HSV; Mercola, M				Kita-Matsuo, Hiroko; Barcova, Maria; Prigozhina, Natalie; Salomonis, Nathan; Wei, Karen; Jacot, Jeffrey G.; Nelson, Brandon; Spiering, Sean; Haverslag, Rene; Kim, Changsung; Talantova, Maria; Bajpai, Ruchi; Calzolari, Diego; Terskikh, Alexey; McCulloch, Andrew D.; Price, Jeffrey H.; Conklin, Bruce R.; Chen, H. S. Vincent; Mercola, Mark			Lentiviral Vectors and Protocols for Creation of Stable hESC Lines for Fluorescent Tracking and Drug Resistance Selection of Cardiomyocytes	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; SARCOPLASMIC-RETICULUM; IN-VITRO; GENE; ENRICHMENT; BRACHYURY; SURVIVAL; DIFFERENTIATION; FIBROBLASTS; EXPRESSION	Background: Developmental, physiological and tissue engineering studies critical to the development of successful myocardial regeneration therapies require new ways to effectively visualize and isolate large numbers of fluorescently labeled, functional cardiomyocytes. Methodology/Principal Findings: Here we describe methods for the clonal expansion of engineered hESCs and make available a suite of lentiviral vectors for that combine Blasticidin, Neomycin and Puromycin resistance based drug selection of pure populations of stem cells and cardiomyocytes with ubiquitous or lineage-specific promoters that direct expression of fluorescent proteins to visualize and track cardiomyocytes and their progenitors. The phospho-glycerate kinase (PGK) promoter was used to ubiquitously direct expression of histone-2B fused eGFP and mCherry proteins to the nucleus to monitor DNA content and enable tracking of cell migration and lineage. Vectors with T/Brachyury and alpha-myosin heavy chain (alpha MHC) promoters targeted fluorescent or drug-resistance proteins to early mesoderm and cardiomyocytes. The drug selection protocol yielded 96% pure cardiomyocytes that could be cultured for over 4 months. Puromycin-selected cardiomyocytes exhibited a gene expression profile similar to that of adult human cardiomyocytes and generated force and action potentials consistent with normal fetal cardiomyocytes, documenting these parameters in hESC-derived cardiomyocytes and validating that the selected cells retained normal differentiation and function. Conclusion/Significance: The protocols, vectors and gene expression data comprise tools to enhance cardiomyocyte production for large-scale applications.			Kita-Matsuo, H (corresponding author), Burnham Inst Med Res, La Jolla, CA USA.	mmercola@burnham.org	Conklin, Bruce/E-4738-2019; Terskikh, Alexey/U-8407-2019	Jacot, Jeffrey/0000-0002-1272-5055; Conklin, Bruce/0000-0003-1463-6061; Bajpai, Ruchi/0000-0001-7737-3567	NHGRI NIH HHS [R01 HG003053, HG003053] Funding Source: Medline; NHLBI NIH HHS [5P01HL46345-12, U01 HL066621, R37 HL059502, P01 HL046345, HL66621, R33HL088266, R33 HL088266, R37HL059502] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL046345, U01HL066621, R33HL088266, R37HL059502] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003053] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Anderson D, 2007, MOL THER, V15, P2027, DOI 10.1038/sj.mt.6300303; Arnold SJ, 2000, MECH DEVELOP, V91, P249, DOI 10.1016/S0925-4773(99)00309-3; Bajpai R, 2008, MOL REPROD DEV, V75, P818, DOI 10.1002/mrd.20809; Barcova M, 2007, HUMAN STEM CELL MANUAL: A LABORATORY GUIDE, P227, DOI 10.1016/B978-012370465-8/50022-3; Binah O, 2007, J ELECTROCARDIOL, V40, pS192, DOI 10.1016/j.jelectrocard.2007.05.035; BLUHM WF, 1995, J BIOMECH, V28, P1119, DOI 10.1016/0021-9290(94)00018-Y; Clements D, 1996, MECH DEVELOP, V56, P139, DOI 10.1016/0925-4773(96)00520-5; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Dolnikov K, 2006, STEM CELLS, V24, P236, DOI 10.1634/stemcells.2005-0036; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; HOSLER BA, 1993, MOL CELL BIOL, V13, P2919, DOI 10.1128/MCB.13.5.2919; Huber I, 2007, FASEB J, V21, P2551, DOI 10.1096/fj.05-5711com; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; JACOT JG, 2008, BIOPHYSICAL IN PRESS; Kehat I, 2002, CIRC RES, V91, P659, DOI 10.1161/01.RES.0000039084.30342.9B; KIM C, 2008, EXTRA CARDIAC UNPUB; Klug MG, 1996, J CLIN INVEST, V98, P216, DOI 10.1172/JCI118769; Laflamme MA, 2005, AM J PATHOL, V167, P663, DOI 10.1016/S0002-9440(10)62041-X; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Liu J, 2007, STEM CELLS, V25, P3038, DOI 10.1634/stemcells.2007-0549; Marganski WA, 2003, METHOD ENZYMOL, V361, P197; Muller M, 2000, FASEB J, V14, P2540, DOI 10.1096/fj.00-0002com; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Mummery Christine L, 2007, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01f02s2; Narmoneva DA, 2004, CIRCULATION, V110, P962, DOI 10.1161/01.CIR.0000140667.37070.07; Olson EN, 2003, GENE DEV, V17, P1937, DOI 10.1101/gad.1110103; Pertz O, 2004, J CELL SCI, V117, P1313, DOI 10.1242/jcs.01117; Salomonis N, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r12; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Shen FM, 2006, CYTOM PART A, V69A, P563, DOI 10.1002/cyto.a.20283; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Synnergren J, 2008, STEM CELLS, V26, P1831, DOI 10.1634/stemcells.2007-1033; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; van Laake LW, 2008, CIRC RES, V102, P1008, DOI 10.1161/CIRCRESAHA.108.175505; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91; Xu CH, 2006, STEM CELLS DEV, V15, P631, DOI 10.1089/scd.2006.15.631; Yamada S, 1999, LIVER, V19, P253, DOI 10.1111/j.1478-3231.1999.tb00043.x; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; Yeo GW, 2007, PLOS COMPUT BIOL, V3, P1951, DOI 10.1371/journal.pcbi.0030196; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	43	176	189	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5046	10.1371/journal.pone.0005046	http://dx.doi.org/10.1371/journal.pone.0005046			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19352491	gold, Green Published, Green Submitted			2022-12-25	WOS:000265505700004
J	Gajate, C; Gonzalez-Camacho, F; Mollinedo, F				Gajate, Consuelo; Gonzalez-Camacho, Fernando; Mollinedo, Faustino			Involvement of Raft Aggregates Enriched in Fas/CD95 Death-Inducing Signaling Complex in the Antileukemic Action of Edelfosine in Jurkat Cells	PLOS ONE			English	Article							LIPID RAFTS; SELECTIVE APOPTOSIS; MEMBRANE RAFTS; FAS; RECEPTOR; ET-18-OCH3; INDUCTION; LIGAND; REDISTRIBUTION; RECRUITMENT	Background: Recent evidence suggests that co-clustering of Fas/CD95 death receptor and lipid rafts plays a major role in death receptor-mediated apoptosis. Methodology/Principal Findings: By a combination of genetic, biochemical, and ultrastructural approaches, we provide here compelling evidence for the involvement of lipid raft aggregates containing recruited Fas/CD95 death receptor, Fas-associated death domain-containing protein (FADD), and procaspase-8 in the induction of apoptosis in human T-cell leukemia Jurkat cells by the antitumor drug edelfosine, the prototype compound of a promising family of synthetic antitumor lipids named as synthetic alkyl-lysophospholipid analogues. Co-immunoprecipitation assays revealed that edelfosine induced the generation of the so-called death-inducing signaling complex (DISC), made up of Fas/CD95, FADD, and procaspase-8, in lipid rafts. Electron microscopy analyses allowed to visualize the formation of raft clusters and their colocalization with DISC components Fas/CD95, FADD, and procaspase-8 following edelfosine treatment of Jurkat cells. Silencing of Fas/CD95 by RNA interference, transfection with a FADD dominant-negative mutant that blocks Fas/CD95 signaling, and specific inhibition of caspase-8 prevented the apoptotic response triggered by edelfosine, hence demonstrating the functional role of DISC in drug-induced apoptosis. By using radioactive labeled edelfosine and a fluorescent analogue, we found that edelfosine accumulated in lipid rafts, forming edelfosine-rich membrane raft clusters in Jurkat leukemic T-cells. Disruption of these membrane raft domains abrogated drug uptake and drug-induced DISC assembly and apoptosis. Thus, edelfosine uptake into lipid rafts was critical for the onset of both co-aggregation of DISC in membrane rafts and subsequent apoptotic cell death. Conclusions/Significance: This work shows the involvement of DISC clusters in lipid raft aggregates as a supramolecular and physical entity responsible for the induction of apoptosis in leukemic cells by the antitumor drug edelfosine. Our data set a novel framework and paradigm in leukemia therapy, as well as in death receptor-mediated apoptosis.	[Gajate, Consuelo; Gonzalez-Camacho, Fernando; Mollinedo, Faustino] Univ Salamanca, CSIC, Ctr Invest Canc, Inst Biol Mol & Celular Canc, E-37008 Salamanca, Spain; [Gajate, Consuelo] Hosp Univ Salamanca, Unidad Investigac, Campus Miguel Unamuno, Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca	Gajate, C (corresponding author), Univ Salamanca, CSIC, Ctr Invest Canc, Inst Biol Mol & Celular Canc, Campus Miguel Unamuno, E-37008 Salamanca, Spain.	cgajate@usal.es; fmollin@usal.es	González-Camacho, Fernando/P-1610-2014; 2009, Secribsal/A-1266-2012	Gajate, Consuelo/0000-0003-0604-6459; Gonzalez-Camacho, Fernando/0000-0003-3175-9004	Fondo de Investigacion Sanitaria and European Commission [06/0813]; Ministerio de Ciencia e Innovacion of Spain [SAF2008-02251, RD06/0020/1037]; Junta de Castilla y Leon [CSI01A08, SAN673/SA32/08]; Fundacion la Caixa [BM05-30-0]; Fundacion de Investigacion Medica Mutua Madrilena; Ramon y Cajal Program from the Ministerio de Ciencia e Innovacion of Spain	Fondo de Investigacion Sanitaria and European Commission(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon); Fundacion la Caixa(La Caixa Foundation); Fundacion de Investigacion Medica Mutua Madrilena; Ramon y Cajal Program from the Ministerio de Ciencia e Innovacion of Spain	This work was supported by grants from Fondo de Investigacion Sanitaria and European Commission (FIS-FEDER 06/0813), Ministerio de Ciencia e Innovacion of Spain (SAF2008-02251 and RD06/0020/1037 - Red Tematica de Investigacion Cooperativa en Cancer, Instituto de Salud Carlos III), Junta de Castilla y Leon (CSI01A08, SAN673/SA32/08, and GR15 - Experimental Therapeutics and Translational Oncology Program), Fundacion la Caixa (BM05-30-0), and Fundacion de Investigacion Medica Mutua Madrilena (FMM). CG is supported by the Ramon y Cajal Program from the Ministerio de Ciencia e Innovacion of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cabaner C, 1999, BRIT J PHARMACOL, V127, P813, DOI 10.1038/sj.bjp.0702606; Cheng PC, 1999, J EXP MED, V190, P1549, DOI 10.1084/jem.190.11.1549; Christian AE, 1997, J LIPID RES, V38, P2264; Delmas D, 2003, J BIOL CHEM, V278, P41482, DOI 10.1074/jbc.M304896200; Gajate C, 2000, INT J CANCER, V85, P674, DOI 10.1002/(SICI)1097-0215(20000301)85:5<674::AID-IJC13>3.0.CO;2-Z; Gajate C, 2005, J BIOL CHEM, V280, P11641, DOI 10.1074/jbc.M411781200; Gajate C, 2004, J EXP MED, V200, P353, DOI 10.1084/jem.20040213; Gajate C, 2000, INT J CANCER, V86, P208, DOI 10.1002/(SICI)1097-0215(20000415)86:2<208::AID-IJC10>3.0.CO;2-E; Gajate C, 2003, CLIN CANCER RES, V9, P1535; Gajate C, 2001, BLOOD, V98, P3860, DOI 10.1182/blood.V98.13.3860; Gajate C, 1998, MOL PHARMACOL, V53, P602, DOI 10.1124/mol.53.4.602; Gajate C, 2007, BLOOD, V109, P711, DOI 10.1182/blood-2006-04-016824; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hofmann TG, 2001, INT J CANCER, V93, P185, DOI 10.1002/ijc.1316; Hueber AO, 2002, EMBO REP, V3, P190, DOI 10.1093/embo-reports/kvf022; KELLEY EE, 1993, BIOCHEM PHARMACOL, V45, P2435, DOI 10.1016/0006-2952(93)90224-K; Lacour S, 2004, CANCER RES, V64, P3593, DOI 10.1158/0008-5472.CAN-03-2787; Mollinedo F, 2003, J IMMUNOL, V170, P1034, DOI 10.4049/jimmunol.170.2.1034; Mollinedo F, 1997, CANCER RES, V57, P1320; MOLLINEDO F, 1994, BIOCHEM J, V302, P325, DOI 10.1042/bj3020325; Mollinedo F, 2007, EXPERT OPIN THER PAT, V17, P385, DOI 10.1517/13543776.17.4.385; Mollinedo F, 2006, DRUG RESIST UPDATE, V9, P51, DOI 10.1016/j.drup.2006.04.002; Mollinedo Faustino, 2006, P13; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Nieto-Miguel T, 2007, CANCER RES, V67, P10368, DOI 10.1158/0008-5472.CAN-07-0278; Nieto-Miguel T, 2006, J BIOL CHEM, V281, P14833, DOI 10.1074/jbc.M511251200; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Ruiter GA, 1999, CANCER RES, V59, P2457; Scheel-Toellner D, 2002, BIOCHEM BIOPH RES CO, V297, P876, DOI 10.1016/S0006-291X(02)02311-2; SCHON A, 1989, BIOCHEMISTRY-US, V28, P5019, DOI 10.1021/bi00438a017; Tanaka M, 1997, J IMMUNOL, V158, P2303; Tsutsumi T, 1998, BBA-LIPID LIPID MET, V1390, P73, DOI 10.1016/S0005-2760(97)00171-9; van der Luit AH, 2007, MOL CANCER THER, V6, P2337, DOI 10.1158/1535-7163.MCT-07-0202; Zaremberg V, 2005, J BIOL CHEM, V280, P38047, DOI 10.1074/jbc.M502849200	36	90	91	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2009	4	4							e5044	10.1371/journal.pone.0005044	http://dx.doi.org/10.1371/journal.pone.0005044			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RT	19352436	Green Submitted, gold, Green Published			2022-12-25	WOS:000265505300007
J	Jobe, O; Donofrio, G; Sun, GP; Liepinsh, D; Schwenk, R; Krzych, U				Jobe, Ousman; Donofrio, Gina; Sun, Guangping; Liepinsh, Dmitry; Schwenk, Robert; Krzych, Urszula			Immunization with Radiation-Attenuated Plasmodium berghei Sporozoites Induces Liver cCD8 alpha+DC that Activate CD8(+)T Cells against Liver-Stage Malaria	PLOS ONE			English	Article							CD8-ALPHA(+) DENDRITIC CELLS; ANTIGEN-PRESENTING FUNCTIONS; CD8 T-CELLS; PROTECTIVE IMMUNITY; PROTRACTED PROTECTION; BACTERIAL-ANTIGENS; CROSS-PRESENTATION; CUTTING EDGE; IN-VITRO; SPLEEN	Immunization with radiation (gamma)-attenuated Plasmodia sporozoites (gamma-spz) confers sterile and long-lasting immunity against malaria liver-stage infection. In the P. berghei gamma-spz model, protection is linked to liver CD8(+) T cells that express an effector/memory (T-EM) phenotype, (CD(44hi)CD45RB(lo)CD62L(lo)), and produce IFN-gamma. However, neither the antigen presenting cells (APC) that activate these CD8(+) T-EM cells nor the site of their induction have been fully investigated. Because conventional (c) CD8 alpha(+) DC (a subset of CD11c(+) DC) are considered the major inducers of CD8(+) T cells, in this study we focused primarily on cCD8 alpha(+) DC from livers of mice immunized with Pb gamma-spz and asked whether the cCD8 alpha(+) DC might be involved in the activation of CD8(+) T-EM cells. We demonstrate that multiple exposures of mice to Pb gamma-spz lead to a progressive and nearly concurrent accumulation in the liver but not the spleen of both the CD11c(+)NK1.1(-) DC and CD8(+) T-EM cells. Upon adoptive transfer, liver CD11c(+)NK1.1(-) DC from Pb gamma-spz-immunized mice induced protective immunity against sporozoite challenge. Moreover, in an in vitro system, liver cCD8 alpha(+) DC induced naive CD8(+) T cells to express the CD8(+) T-EM phenotype and to secrete IFN-gamma. The in vitro induction of functional CD8(+) T-EM cells by cCD8 alpha(+) DC was inhibited by anti-MHC class I and anti-IL-12 mAbs. These data suggest that liver cCD8 alpha(+) DC present liver-stage antigens to activate CD8(+) T-EM cells, the pre-eminent effectors against pre-erythrocytic malaria. These results provide important implications towards a design of anti-malaria vaccines.	[Jobe, Ousman; Donofrio, Gina; Sun, Guangping; Liepinsh, Dmitry; Schwenk, Robert; Krzych, Urszula] Walter Reed Army Inst Res, Dept Cellular Immunol, Div Malaria Vaccine Dev, Silver Spring, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Jobe, O (corresponding author), Walter Reed Army Inst Res, Dept Cellular Immunol, Div Malaria Vaccine Dev, Silver Spring, MD USA.	urszula.krzych@.amedd.army.mil			NIH (UK) [AI43411]; US Medical Research and Materiel Command; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI043411, R01AI046438] Funding Source: NIH RePORTER	NIH (UK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by NIH grant AI43411 (UK) and US Medical Research and Materiel Command. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjuere F, 1999, BLOOD, V93, P590, DOI 10.1182/blood.V93.2.590.402k11_590_598; BACKER R, 2008, EUR J IMMUNOL; Belz GT, 2005, J IMMUNOL, V175, P196, DOI 10.4049/jimmunol.175.1.196; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Berenzon D, 2003, J IMMUNOL, V171, P2024, DOI 10.4049/jimmunol.171.4.2024; Bertolino P, 2001, J IMMUNOL, V166, P5430, DOI 10.4049/jimmunol.166.9.5430; Bruna-Romero O, 2001, INFECT IMMUN, V69, P5173, DOI 10.1128/IAI.69.8.5173-5176.2001; Chakravarty S, 2007, NAT MED, V13, P1035, DOI 10.1038/nm1628; Chen L, 2007, J LEUKOCYTE BIOL, V81, P1422, DOI 10.1189/jlb.1106674; Chung Y, 2007, EUR J IMMUNOL, V37, P1453, DOI 10.1002/eji.200636544; De Smedt T, 2001, J LEUKOCYTE BIOL, V69, P951; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Di Pucchio T, 2008, NAT IMMUNOL, V9, P551, DOI 10.1038/ni.1602; Doolan DL, 1999, J IMMUNOL, V163, P884; Garrigan K, 1996, BLOOD, V88, P3508, DOI 10.1182/blood.V88.9.3508.bloodjournal8893508; Grauer O, 2002, HISTOCHEM CELL BIOL, V117, P351, DOI 10.1007/s00418-002-0384-4; Hammad H, 2004, CLIN EXP ALLERGY, V34, P1834, DOI 10.1111/j.1365-2222.2004.02133.x; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Hoffman SL, 1997, NAT MED, V3, P80, DOI 10.1038/nm0197-80; Jewell NA, 2007, J VIROL, V81, P9790, DOI 10.1128/JVI.00530-07; Jobe O, 2007, J INFECT DIS, V196, P599, DOI 10.1086/519743; Johansson C, 2004, J IMMUNOL, V172, P2496, DOI 10.4049/jimmunol.172.4.2496; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kawamura K, 2006, BLOOD, V107, P1031, DOI 10.1182/blood-2005-04-1737; Klein I, 2006, J EXP MED, V203, P437, DOI 10.1084/jem.20051775; Leenen PJM, 1998, J IMMUNOL, V160, P2166; Leiriao P, 2005, J INFECT DIS, V191, P1576, DOI 10.1086/429635; Lian ZX, 2003, J IMMUNOL, V170, P2323, DOI 10.4049/jimmunol.170.5.2323; Matsuno K, 2000, INT REV CYTOL, V197, P83, DOI 10.1016/S0074-7696(00)97003-7; Matsuno Kenjiro, 2002, Dev Immunol, V9, P143, DOI 10.1080/1044667031000137610; McGill J, 2008, J EXP MED, V205, P1635, DOI 10.1084/jem.20080314; Mehal WZ, 1999, J IMMUNOL, V163, P3202; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Nardin E, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P397; O'Connell PJ, 2000, J IMMUNOL, V165, P795, DOI 10.4049/jimmunol.165.2.795; Pillarisetty VG, 2004, J IMMUNOL, V172, P1009, DOI 10.4049/jimmunol.172.2.1009; Plebanski M, 2005, IMMUNOL CELL BIOL, V83, P307, DOI 10.1111/j.1440-1711.2005.01325.x; Pooley JL, 2001, J IMMUNOL, V166, P5327, DOI 10.4049/jimmunol.166.9.5327; Pradel Gabriele, 2004, Comp Hepatol, V3 Suppl 1, pS47, DOI 10.1186/1476-5926-2-S1-S47; Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906; SCHELLER LF, 1995, P NATL ACAD SCI USA, V92, P4066, DOI 10.1073/pnas.92.9.4066; Schulz O, 2002, IMMUNOLOGY, V107, P183, DOI 10.1046/j.1365-2567.2002.01513.x; SEDEGAH M, 1994, P NATL ACAD SCI USA, V91, P10700, DOI 10.1073/pnas.91.22.10700; SHIN SCJ, 1982, J PROTOZOOL, V29, P448, DOI 10.1111/j.1550-7408.1982.tb05431.x; Shu SA, 2007, CLIN EXP IMMUNOL, V149, P335, DOI 10.1111/j.1365-2249.2007.03419.x; Steers N, 2005, EUR J IMMUNOL, V35, P2335, DOI 10.1002/eji.200425680; Sturm A, 2006, SCIENCE, V313, P1287, DOI 10.1126/science.1129720; Valenzuela J, 2002, J IMMUNOL, V169, P6842, DOI 10.4049/jimmunol.169.12.6842; van de Sand C, 2005, MOL MICROBIOL, V58, P731, DOI 10.1111/j.1365-2958.2005.04888.x; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; Villadangos JA, 2005, SEMIN IMMUNOL, V17, P262, DOI 10.1016/j.smim.2005.05.015; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; White KL, 1996, J IMMUNOL, V156, P3374; Wilson DC, 2008, J IMMUNOL, V180, P5935, DOI 10.4049/jimmunol.180.9.5935; Wilson NS, 2004, IMMUNOL CELL BIOL, V82, P91, DOI 10.1111/j.1440-1711.2004.01216.x; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001; Wuensch SA, 2006, J IMMUNOL, V177, P1689, DOI 10.4049/jimmunol.177.3.1689; Wykes MN, 2007, PLOS PATHOG, V3, P904, DOI 10.1371/journal.ppat.0030096	59	52	53	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2009	4	4							e5075	10.1371/journal.pone.0005075	http://dx.doi.org/10.1371/journal.pone.0005075			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437QB	19347042	Green Published, gold, Green Submitted			2022-12-25	WOS:000265500900003
J	Moroz, E; Carlin, S; Dyomina, K; Burke, S; Thaler, HT; Blasberg, R; Serganova, I				Moroz, Ekaterina; Carlin, Sean; Dyomina, Katerina; Burke, Sean; Thaler, Howard T.; Blasberg, Ronald; Serganova, Inna			Real-Time Imaging of HIF-1 alpha Stabilization and Degradation	PLOS ONE			English	Article								HIF-1 alpha is overexpressed in many human cancers compared to normal tissues due to the interaction of a multiplicity of factors and pathways that reflect specific genetic alterations and extracellular stimuli. We developed two HIF-1a chimeric reporter systems, HIF-1 alpha/FLuc and HIF-1 alpha(Delta ODDD)/FLuc, to investigate the tightly controlled level of HIF-1 alpha protein in normal (NIH3T3 and HEK293) and glioma (U87) cells. These reporter systems provided an opportunity to investigate the degradation of HIF-1 alpha in different cell lines, both in culture and in xenografts. Using immunofluorescence microscopy, we observed different patterns of subcellular localization of HIF-1 alpha/FLuc fusion protein between normal cells and cancer cells; similar differences were observed for HIF-1 alpha in non-transduced, wild-type cells. A dynamic cytoplasmic-nuclear exchange of the fusion protein and HIF-1 alpha was observed in NIH3T3 and HEK293 cells under different conditions (normoxia, CoCl(2) treatment and hypoxia). In contrast, U87 cells showed a more persistent nuclear localization pattern that was less affected by different growing conditions. Employing a kinetic model for protein degradation, we were able to distinguish two components of HIF-1 alpha/FLuc protein degradation and quantify the half-life of HIF-1 alpha fusion proteins. The rapid clearance component (t(1/2) similar to 4-6 min) was abolished by the hypoxia-mimetic CoCl(2), MG132 treatment and deletion of ODD domain, and reflects the oxygen/VHL-dependent degradation pathway. The slow clearance component (t(1/2) similar to 200 min) is consistent with other unidentified non-oxygen/VHL-dependent degradation pathways. Overall, the continuous bioluminescence readout of HIF-1 alpha/FLuc stabilization in vitro and in vivo will facilitate the development and validation of therapeutics that affect the stability and accumulation of HIF-1 alpha.	[Moroz, Ekaterina; Dyomina, Katerina; Blasberg, Ronald; Serganova, Inna] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10021 USA; [Carlin, Sean; Burke, Sean] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA; [Blasberg, Ronald] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA; [Thaler, Howard T.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Moroz, E (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Neurol, 1275 York Ave, New York, NY 10021 USA.	blasberg@neuro1.mskcc.org		Serganova, Inna/0000-0003-3561-8663; Carlin, Sean/0000-0002-5401-0648	NIH [P50 CA86438-01, PO1 CA115675, P30 CA08748]; Byrne Foundation; NIH Small-Animal Imaging Research Program (SAIRP) [R24 CA83084]; Flow Cytometry Facility; NATIONAL CANCER INSTITUTE [R24CA083084, P50CA086438, P01CA115675, P30CA008748] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Byrne Foundation; NIH Small-Animal Imaging Research Program (SAIRP)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flow Cytometry Facility; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grants P50 CA86438-01 and PO1 CA115675. The work of SC and SB is supported in part by the Byrne Foundation. Technical services were provided by the MSKCC Small-Animal Imaging Core Facility, supported in part by NIH Small-Animal Imaging Research Program (SAIRP) grant R24 CA83084 and NIH Center grant P30 CA08748 and Flow Cytometry Facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai R, 2001, PROTEIN ENG, V14, P529, DOI 10.1093/protein/14.8.529; Belozerov VE, 2005, ANTI-CANCER DRUG, V16, P901, DOI 10.1097/01.cad.0000180116.85912.69; Berra E, 2001, EMBO REP, V2, P615, DOI 10.1093/embo-reports/kve130; Brader P, 2007, MOL CANCER THER, V6, P2900, DOI 10.1158/1535-7163.MCT-07-0432; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Che Jiantu, 2005, Mol Imaging, V4, P128; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; Creighton-Gutteridge M, 2007, CLIN CANCER RES, V13, P1010, DOI 10.1158/1078-0432.CCR-06-2301; Dekanty A, 2005, J CELL SCI, V118, P5431, DOI 10.1242/jcs.02648; Demidenko ZN, 2005, ONCOGENE, V24, P4829, DOI 10.1038/sj.onc.1208636; Di Cristofano C, 2007, AM J SURG PATHOL, V31, P1875, DOI 10.1097/PAS.0b013e318094fed8; Escuin D, 2005, CANCER RES, V65, P9021, DOI 10.1158/0008-5472.CAN-04-4095; Feldser D, 1999, CANCER RES, V59, P3915; Frede S, 2005, CANCER RES, V65, P4690, DOI 10.1158/0008-5472.CAN-04-3877; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Generali D, 2006, ENDOCR-RELAT CANCER, V13, P921, DOI 10.1677/erc.1.01216; Giaccia A, 2003, NAT REV DRUG DISCOV, V2, P803, DOI 10.1038/nrd1199; Groulx I, 2002, MOL CELL BIOL, V22, P5319, DOI 10.1128/MCB.22.15.5319-5336.2002; HARADA H, 2008, J BIOL CHEM; Harada H, 2007, BIOCHEM BIOPH RES CO, V360, P791, DOI 10.1016/j.bbrc.2007.06.149; Harada H, 2005, MOL IMAGING, V4, P182; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Huang M, 2008, CIRCULATION, V118, pS226, DOI 10.1161/CIRCULATIONAHA.107.760785; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Kaelin WG, 2002, GENE DEV, V16, P1441, DOI 10.1101/gad.1003602; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Kallio PJ, 1999, J BIOL CHEM, V274, P6519, DOI 10.1074/jbc.274.10.6519; Kaper F, 2006, CANCER RES, V66, P1561, DOI 10.1158/0008-5472.CAN-05-3375; Katschinski DM, 2004, CELL PHYSIOL BIOCHEM, V14, P351, DOI 10.1159/000080345; Kong DH, 2005, CANCER RES, V65, P9047, DOI 10.1158/0008-5472.CAN-05-1235; Kong XG, 2007, J BIOL CHEM, V282, P15498, DOI 10.1074/jbc.M700704200; Krishnamachary B, 2003, CANCER RES, V63, P1138; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Lee S, 1999, MOL CELL BIOL, V19, P1486; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li YM, 2005, CANCER RES, V65, P3257, DOI 10.1158/0008-5472.CAN-04-1284; Liu Q, 2004, P NATL ACAD SCI USA, V101, P4302, DOI 10.1073/pnas.0400265101; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; Mabjeesh NJ, 2002, CANCER RES, V62, P2478; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Mylonis I, 2006, J BIOL CHEM, V281, P33095, DOI 10.1074/jbc.M605058200; Neckers Len, 2003, Current Opinion in Oncology, V15, P419, DOI 10.1097/00001622-200311000-00003; Ponomarev V, 2003, NEOPLASIA, V5, P245, DOI 10.1016/S1476-5586(03)80056-8; Pore N, 2006, MOL CANCER RES, V4, P471, DOI 10.1158/1541-7786.MCR-05-0234; Powis G, 2004, MOL CANCER THER, V3, P647; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Rapisarda A, 2002, CANCER RES, V62, P4316; Robey IF, 2005, NEOPLASIA, V7, P324, DOI 10.1593/neo.04430; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2006, EXPERT OPIN THER TAR, V10, P267, DOI 10.1517/14728222.10.2.267; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; SEMENZA GL, 2006, NOVART FDN SYMP, V272, P33, DOI DOI 10.1002/9780470035009.CH2; SEMENZA GL, 2006, NOVART FDN SYMP, V272, P8, DOI DOI 10.1002/9780470035009.CH2; Semenza Gregg L, 2006, Novartis Found Symp, V272, P2; Serganova I, 2004, CANCER RES, V64, P6101, DOI 10.1158/0008-5472.CAN-04-0842; Stolze I, 2002, BLOOD, V100, P2623, DOI 10.1182/blood-2001-12-0169; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Tan C, 2005, CANCER RES, V65, P605; Viola RJ, 2008, AM J ROENTGENOL, V191, P1779, DOI 10.2214/AJR.07.4060; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wiedmann MW, 2005, CURR CANCER DRUG TAR, V5, P171, DOI 10.2174/1568009053765771; Yeo EJ, 2003, J NATL CANCER I, V95, P516, DOI 10.1093/jnci/95.7.516; Yeom CJ, 2008, J NUCL MED, V49, P1489, DOI 10.2967/jnumed.107.044461; Zheng XW, 2006, MOL CELL BIOL, V26, P4628, DOI 10.1128/MCB.02236-05; Zhong H, 1999, CANCER RES, V59, P5830; Zhong H, 2000, CANCER RES, V60, P1541; Zundel W, 2000, GENE DEV, V14, P391	75	82	88	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2009	4	4							e5077	10.1371/journal.pone.0005077	http://dx.doi.org/10.1371/journal.pone.0005077			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437QB	19347037	gold, Green Submitted, Green Published			2022-12-25	WOS:000265500900004
J	Qutob, D; Tedman-Jones, J; Dong, SM; Kuflu, K; Pham, H; Wang, YC; Dou, DL; Kale, SD; Arredondo, FD; Tyler, BM; Gijzen, M				Qutob, Dinah; Tedman-Jones, Jennifer; Dong, Suomeng; Kuflu, Kuflom; Pham, Hai; Wang, Yuanchao; Dou, Daolong; Kale, Shiv D.; Arredondo, Felipe D.; Tyler, Brett M.; Gijzen, Mark			Copy Number Variation and Transcriptional Polymorphisms of Phytophthora sojae RXLR Effector Genes Avr1a and Avr3a	PLOS ONE			English	Article								The importance of segmental duplications and copy number variants as a source of genetic and phenotypic variation is gaining greater appreciation, in a variety of organisms. Now, we have identified the Phytophthora sojae avirulence genes Avr1a and Avr3a and demonstrate how each of these Avr genes display copy number variation in different strains of P. sojae. The Avr1a locus is a tandem array of four near-identical copies of a 5.2 kb DNA segment. Two copies encoding Avr1a are deleted in some P. sojae strains, causing changes in virulence. In other P. sojae strains, differences in transcription of Avr1a result in gain of virulence. For Avr3a, there are four copies or one copy of this gene, depending on the P. sojae strain. In P. sojae strains with multiple copies of Avr3a, this gene occurs within a 10.8 kb segmental duplication that includes four other genes. Transcriptional differences of the Avr3a gene among P. sojae strains cause changes in virulence. To determine the extent of duplication within the superfamily of secreted proteins that includes Avr1a and Avr3a, predicted RXLR effector genes from the P. sojae and the P. ramorum genomes were compared by counting trace file matches from whole genome shotgun sequences. The results indicate that multiple, near-identical copies of RXLR effector genes are prevalent in oomycete genomes. We propose that multiple copies of particular RXLR effectors may contribute to pathogen fitness. However, recognition of these effectors by plant immune systems results in selection for pathogen strains with deleted or transcriptionally silenced gene copies.	[Qutob, Dinah; Tedman-Jones, Jennifer; Dong, Suomeng; Kuflu, Kuflom; Pham, Hai; Gijzen, Mark] Agr & Agri Food Canada, London, ON, Canada; [Dong, Suomeng; Wang, Yuanchao; Dou, Daolong] Nanjing Agr Univ, Dept Plant Pathol, Nanjing, Peoples R China; [Dou, Daolong; Kale, Shiv D.; Arredondo, Felipe D.; Tyler, Brett M.] Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA USA	Agriculture & Agri Food Canada; Nanjing Agricultural University; Virginia Polytechnic Institute & State University	Qutob, D (corresponding author), Agr & Agri Food Canada, London, ON, Canada.	ark.gijzen@agr.gc.ca	Van Pham, Hai/AAA-5116-2022; Gijzen, Mark/C-6284-2011; Dou, Daolong/AAW-1678-2021; wang, yuanchao/G-9667-2011	Gijzen, Mark/0000-0002-3715-6389; Dou, Daolong/0000-0001-5226-6642; wang, yuanchao/0000-0001-5803-5343	Agriculture and Agri-Food Canada; Canadian Crop Genomics Initiative; National Research Initiative of the United States Department of Agriculture [2001-35319-14251, 2002-35600-12747, 2007-35319-18100, 2007-35600-18530]; United States National Science Foundation [MCB-0242131, MCB-0731969]	Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); Canadian Crop Genomics Initiative; National Research Initiative of the United States Department of Agriculture; United States National Science Foundation(National Science Foundation (NSF))	This research was supported by grants to MG from Agriculture and Agri-Food Canada, Canadian Crop Genomics Initiative, and to BMT from the National Research Initiative of the United States Department of Agriculture (2001-35319-14251, 2002-35600-12747, 2007-35319-18100 and 2007-35600-18530) and from the United States National Science Foundation (MCB-0242131 and MCB-0731969). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BHAT RG, 1993, EXP MYCOL, V17, P122, DOI 10.1006/emyc.1993.1011; Bhattacharjee Souvik, 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020050; Birch PRJ, 2006, TRENDS MICROBIOL, V14, P8, DOI 10.1016/j.tim.2005.11.007; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Burnham KD, 2003, CROP SCI, V43, P1610, DOI 10.2135/cropsci2003.1610; Catanzariti AM, 2007, FEMS MICROBIOL LETT, V269, P181, DOI 10.1111/j.1574-6968.2007.00684.x; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; CHURCHILL GA, 1993, P NATL ACAD SCI USA, V90, P16, DOI 10.1073/pnas.90.1.16; Dou DL, 2008, PLANT CELL, V20, P1930, DOI 10.1105/tpc.107.056093; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; FORSTER H, 1994, MOL PLANT MICROBE IN, V7, P780, DOI 10.1094/MPMI-7-0780; Gijzen M, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-6; Grouffaud S, 2008, MICROBIOL-SGM, V154, P3743, DOI 10.1099/mic.0.2008/021964-0; Jiang RHY, 2008, P NATL ACAD SCI USA, V105, P4874, DOI 10.1073/pnas.0709303105; Jiang RHY, 2006, GENOME RES, V16, P827, DOI 10.1101/gr.5193806; Jiang RHY, 2006, MOL PLANT MICROBE IN, V19, P1311, DOI 10.1094/MPMI-19-1311; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kamoun S, 2007, CURR OPIN PLANT BIOL, V10, P358, DOI 10.1016/j.pbi.2007.04.017; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Kasuga T, 1997, MOL PLANT MICROBE IN, V10, P1035, DOI 10.1094/MPMI.1997.10.9.1035; Korbel JO, 2008, CURR OPIN STRUC BIOL, V18, P366, DOI 10.1016/j.sbi.2008.02.005; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; MacGregor T, 2002, GENETICS, V160, P949; Mao YX, 1996, FUNGAL GENET BIOL, V20, P43, DOI 10.1006/fgbi.1996.0008; May KJ, 2002, FUNGAL GENET BIOL, V37, P1, DOI 10.1016/S1087-1845(02)00027-0; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Mideros S, 2007, PHYTOPATHOLOGY, V97, P655, DOI 10.1094/PHYTO-97-5-0655; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Qutob D, 2000, PLANT PHYSIOL, V123, P243, DOI 10.1104/pp.123.1.243; Qutob D, 2002, PLANT J, V32, P361, DOI 10.1046/j.1365-313X.2002.01439.x; Qutob D, 2006, PLANT CELL, V18, P3721, DOI 10.1105/tpc.106.044180; Qutob D, 2006, TRENDS MICROBIOL, V14, P470, DOI 10.1016/j.tim.2006.09.004; Ranathunge K, 2008, PHYTOPATHOLOGY, V98, P1179, DOI 10.1094/PHYTO-98-11-1179; Rehmany AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/tpc.105.031807; Rentel MC, 2008, P NATL ACAD SCI USA, V105, P1091, DOI 10.1073/pnas.0711215105; Sambrook J., 2002, MOL CLONING LAB MANU; Shan WX, 2004, MOL PLANT MICROBE IN, V17, P394, DOI 10.1094/MPMI.2004.17.4.394; Sohn KH, 2007, PLANT CELL, V19, P4077, DOI 10.1105/tpc.107.054262; Sokal R. R., 2012, BIOMETRY; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tyler BM, 2002, ANNU REV PHYTOPATHOL, V40, P137, DOI 10.1146/annurev.phyto.40.120601.125310; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van Poppel PMJA, 2008, MOL PLANT MICROBE IN, V21, P1460, DOI 10.1094/MPMI-21-11-1460; Vleeshouwers VGAA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002875; WARD EWB, 1979, PHYTOPATHOLOGY, V69, P951, DOI 10.1094/Phyto-69-951; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037; Wrather JA, 2006, J NEMATOL, V38, P173; Zhang X, 2006, MOL PLANT MICROBE IN, V19, P1302, DOI 10.1094/MPMI-19-1302	52	107	114	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2009	4	4							e5066	10.1371/journal.pone.0005066	http://dx.doi.org/10.1371/journal.pone.0005066			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437QA	19343173	Green Published, Green Submitted, gold			2022-12-25	WOS:000265500800007
J	Yan, YT; Dalmasso, G; Nguyen, HTT; Obertone, TS; Sitaraman, SV; Merlin, D				Yan, Yutao; Dalmasso, Guillaume; Nguyen, Hang Thi Thu; Obertone, Tracy S.; Sitaraman, Shanthi V.; Merlin, Didier			Ste20-Related Proline/Alanine-Rich Kinase (SPAK) Regulated Transcriptionally by Hyperosmolarity Is Involved in Intestinal Barrier Function	PLOS ONE			English	Article								The Ste20-related protein proline/alanine-rich kinase (SPAK) plays important roles in cellular functions such as cell differentiation and regulation of chloride transport, but its roles in pathogenesis of intestinal inflammation remain largely unknown. Here we report significantly increased SPAK expression levels in hyperosmotic environments, such as mucosal biopsy samples from patients with Crohn's disease, as well as colon tissues of C57BL/6 mice and Caco2-BBE cells treated with hyperosmotic medium. NF-kappa B and Sp1-binding sites in the SPAK TATA-less promoter are essential for SPAK mRNA transcription. Hyperosmolarity increases the ability of NF-kappa B and Sp1 to bind to their binding sites. Knock-down of either NF-kappa B or Sp1 by siRNA reduces the hyperosmolarity-induced SPAK expression levels. Furthermore, expression of NF-kappa B, but not Sp1, was upregulated by hyperosmolarity in vivo and in vitro. Nuclear run-on assays showed that hyperosmolarity increases SPAK expression levels at the transcriptional level, without affecting SPAK mRNA stability. Knockdown of SPAK expression by siRNA or overexpression of SPAK in cells and transgenic mice shows that SPAK is involved in intestinal permeability in vitro and in vivo. Together, our data suggest that SPAK, the transcription of which is regulated by hyperosmolarity, plays an important role in epithelial barrier function.	[Yan, Yutao; Dalmasso, Guillaume; Nguyen, Hang Thi Thu; Obertone, Tracy S.; Sitaraman, Shanthi V.; Merlin, Didier] Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA	Emory University	Yan, YT (corresponding author), Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA.	yyan2@emory.edu	Dalmasso, Guillaume/N-2443-2018; Nguyen, Hang/N-2441-2018	Dalmasso, Guillaume/0000-0002-3433-870X; Nguyen, Hang/0000-0001-7431-5126	National Institutes of Health of Diabetes and Digestive and Kidney Diseases [R24-DK-064399, RO1-DK-061941, RO1-DK55850]; Crohn's and Colitis Foundation of America [research fellowship]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064399, R01DK055850, R01DK061941] Funding Source: NIH RePORTER	National Institutes of Health of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health of Diabetes and Digestive and Kidney Diseases by grants R24-DK-064399 (center grant), RO1-DK-061941 (to D. Merlin), RO1-DK55850 (S. Sitaraman). Y. Yan is a recipient of a research fellowship award from the Crohn's and Colitis Foundation of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOLHASSANI M, 2008, INFLAMM RES; Asakawa H, 1997, J DIABETES COMPLICAT, V11, P176, DOI 10.1016/S1056-8727(97)00004-4; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; BAGNASCO SM, 1988, AM J PHYSIOL, V254, pC788, DOI 10.1152/ajpcell.1988.254.6.C788; Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; Baudouin-Legros M, 2000, AM J PHYSIOL-CELL PH, V278, pC49, DOI 10.1152/ajpcell.2000.278.1.C49; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; Carter AB, 1999, AM J RESP CELL MOL, V20, P751, DOI 10.1165/ajrcmb.20.4.3420; CHEROMCHA DP, 1988, DIGEST DIS SCI, V33, pS78, DOI 10.1007/BF01538135; Clayburgh DR, 2004, LAB INVEST, V84, P282, DOI 10.1038/labinvest.3700050; Craxton A, 1998, J IMMUNOL, V161, P3225; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Dignass AU, 2004, ALIMENT PHARM THER, V20, P9, DOI 10.1111/j.1365-2036.2004.02047.x; Dowd BFX, 2003, J BIOL CHEM, V278, P27347, DOI 10.1074/jbc.M301899200; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Duzgun SA, 2000, J CELL BIOCHEM, V76, P567, DOI 10.1002/(SICI)1097-4644(20000315)76:4<567::AID-JCB5>3.0.CO;2-W; El-Sherbeny A, 2004, INVEST OPHTH VIS SCI, V45, P694, DOI 10.1167/iovs.03-0503; Endo J, 2000, FEBS LETT, V468, P234, DOI 10.1016/S0014-5793(00)01219-9; Furuta GT, 2001, J EXP MED, V193, P1027, DOI 10.1084/jem.193.9.1027; Gagnon KBE, 2006, MOL CELL BIOL, V26, P689, DOI 10.1128/MCB.26.2.689-698.2006; Galvez AS, 2003, J BIOL CHEM, V278, P38484, DOI 10.1074/jbc.M211824200; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Garg P, 2006, J IMMUNOL, V177, P4103, DOI 10.4049/jimmunol.177.6.4103; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GNONI GV, 1985, BIOCHEM BIOPH RES CO, V128, P525, DOI 10.1016/0006-291X(85)90078-6; Gomez-Gonzalo M, 2001, J BIOL CHEM, V276, P35435, DOI 10.1074/jbc.M103020200; Goyette P, 2007, ANN MED, V39, P177, DOI 10.1080/07853890701197615; Hallows KR, 1996, J CELL PHYSIOL, V167, P60, DOI 10.1002/(SICI)1097-4652(199604)167:1<60::AID-JCP7>3.0.CO;2-A; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Hao CM, 2000, J CLIN INVEST, V106, P973, DOI 10.1172/JCI9956; Hashimoto S, 1999, AM J RESP CRIT CARE, V159, P634, DOI 10.1164/ajrccm.159.2.9712090; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hirano F, 1998, MOL CELL BIOL, V18, P1266, DOI 10.1128/MCB.18.3.1266; HIRAYAMA T, 1995, MOL GEN GENET, V249, P127, DOI 10.1007/BF00290358; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hollenbach E, 2004, FASEB J, V18, P1550, DOI 10.1096/fj.04-1642fje; Howe KL, 2005, AM J PATHOL, V167, P1587, DOI 10.1016/S0002-9440(10)61243-6; Hubert A, 2004, BIOCHIMIE, V86, P533, DOI 10.1016/j.biochi.2004.07.009; Ilic D, 2007, AM J PATHOL, V170, P2055, DOI 10.2353/ajpath.2007.061277; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Johnston AM, 2000, ONCOGENE, V19, P4290, DOI 10.1038/sj.onc.1203784; JONES KA, 1986, SCIENCE, V232, P755, DOI 10.1126/science.3008338; Katsuyama I, 2003, J OCUL PHARMACOL TH, V19, P281, DOI 10.1089/108076803321908400; KATZ KD, 1989, GASTROENTEROLOGY, V97, P927, DOI 10.1016/0016-5085(89)91499-6; KERR LD, 1993, NATURE, V365, P412, DOI 10.1038/365412a0; Klipp E, 2005, NAT BIOTECHNOL, V23, P975, DOI 10.1038/nbt1114; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; KUNSCH C, 1993, MOL CELL BIOL, V13, P6137, DOI 10.1128/MCB.13.10.6137; Kyriakis JM, 1999, J BIOL CHEM, V274, P5259, DOI 10.1074/jbc.274.9.5259; Lang KS, 2003, AM J PHYSIOL-CELL PH, V284, pC200, DOI 10.1152/ajpcell.00259.2002; LENARDO MJ, 1989, CELL, V57, P287, DOI 10.1016/0092-8674(89)90966-5; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; Li DQ, 2004, INVEST OPHTH VIS SCI, V45, P4302, DOI 10.1167/iovs.04-0299; Li DQ, 2006, EXP EYE RES, V82, P588, DOI 10.1016/j.exer.2005.08.019; Li YQ, 2004, EMBO J, V23, P1112, DOI 10.1038/sj.emboj.7600125; Loitsch SM, 2000, BIOCHEM BIOPH RES CO, V276, P571, DOI 10.1006/bbrc.2000.3504; Luo LH, 2007, CORNEA, V26, P452, DOI 10.1097/ICO.0b013e318030d259; Luo Lihui, 2005, Eye Contact Lens, V31, P186, DOI 10.1097/01.ICL.0000162759.79740.46; MORIYAMA T, 1989, J BIOL CHEM, V264, P16810; Mosser DD, 1997, MOL CELL BIOL, V17, P5317, DOI 10.1128/MCB.17.9.5317; NEISH AS, 1995, MOL CELL BIOL, V15, P2558; Nemeth ZH, 2002, AM J PATHOL, V161, P987, DOI 10.1016/S0002-9440(10)64259-9; Nguyen M, 2007, J EXP MED, V204, P1383, DOI 10.1084/jem.20061205; NWAGWU M, 1980, J EMBRYOL EXP MORPH, V56, P253; Ochi H, 2002, EUR J IMMUNOL, V32, P1821, DOI 10.1002/1521-4141(200207)32:7<1821::AID-IMMU1821>3.0.CO;2-A; Omori K, 2007, AM J PHYSIOL-CELL PH, V293, pC1523, DOI 10.1152/ajpcell.00524.2006; PERKINS ND, 1993, EMBO J, V12, P3551, DOI 10.1002/j.1460-2075.1993.tb06029.x; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Pinto D, 1999, J BIOL CHEM, V274, P6476, DOI 10.1074/jbc.274.10.6476; Poli A, 2002, MICROCIRCULATION, V9, P419, DOI 10.1038/sj.mn.7800149; Rizoli SB, 2000, AM J PHYSIOL-CELL PH, V279, pC619, DOI 10.1152/ajpcell.2000.279.3.C619; Safdar Z, 2003, J CLIN INVEST, V112, P1541, DOI 10.1172/JCI200318370; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; SANCEAU J, 1995, J BIOL CHEM, V270, P27920, DOI 10.1074/jbc.270.46.27920; SANDLE GI, 1990, GASTROENTEROLOGY, V99, P97, DOI 10.1016/0016-5085(90)91235-X; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; SCHILLI R, 1982, GUT, V23, P326, DOI 10.1136/gut.23.4.326; Schweigel M, 2005, J COMP PHYSIOL B, V175, P575, DOI 10.1007/s00360-005-0021-3; Shapiro L, 1997, EXP CELL RES, V231, P354, DOI 10.1006/excr.1997.3476; SHASBY DM, 1982, CIRC RES, V51, P657, DOI 10.1161/01.RES.51.5.657; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; SHU HB, 1993, MOL CELL BIOL, V13, P6283, DOI 10.1128/MCB.13.10.6283; So WV, 1997, EMBO J, V16, P7146, DOI 10.1093/emboj/16.23.7146; Stockton RA, 2004, J BIOL CHEM, V279, P46621, DOI 10.1074/jbc.M408877200; Stockton R, 2007, MOL BIOL CELL, V18, P2346, DOI 10.1091/mbc.E06-07-0584; Topper JN, 1997, J CLIN INVEST, V99, P2941, DOI 10.1172/JCI119489; VERNIA P, 1988, DIGEST DIS SCI, V33, P1353, DOI 10.1007/BF01536987; Visekruna A, 2006, J CLIN INVEST, V116, P3195, DOI 10.1172/JCI28804; Wagner S, 2002, J BIOL CHEM, V277, P37685, DOI 10.1074/jbc.M205899200; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Yan Y, 2007, BBA-GENE STRUCT EXPR, V1769, P106, DOI 10.1016/j.bbaexp.2007.01.003; Yan Y, 2008, AM J PATHOL, V173, P1013, DOI 10.2353/ajpath.2008.080339; Yujiri T, 1998, SCIENCE, V282, P1911, DOI 10.1126/science.282.5395.1911; ZENZIEGREGORY B, 1993, MOL CELL BIOL, V13, P3841, DOI 10.1128/MCB.13.7.3841; ZHANG DE, 1994, J BIOL CHEM, V269, P11425; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837	97	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2009	4	4							e5049	10.1371/journal.pone.0005049	http://dx.doi.org/10.1371/journal.pone.0005049			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437QA	19343169	gold, Green Submitted, Green Published			2022-12-25	WOS:000265500800006
J	Wang, Y; Amdam, GV; Rueppell, O; Wallrichs, MA; Fondrk, MK; Kaftanoglu, O; Page, RE				Wang, Ying; Amdam, Gro V.; Rueppell, Olav; Wallrichs, Megan A.; Fondrk, M. Kim; Kaftanoglu, Osman; Page, Robert E., Jr.			PDK1 and HR46 Gene Homologs Tie Social Behavior to Ovary Signals	PLOS ONE			English	Article							REPRODUCTIVE GROUND-PLAN; COLONY-LEVEL SELECTION; PROGRAMMED CELL-DEATH; APIS-MELLIFERA; HONEY-BEE; JUVENILE-HORMONE; EXPRESSION; RECEPTOR; DIFFERENTIATION; ARCHITECTURE	The genetic basis of division of labor in social insects is a central question in evolutionary and behavioral biology. The honey bee is a model for studying evolutionary behavioral genetics because of its well characterized age-correlated division of labor. After an initial period of within-nest tasks, 2-3 week-old worker bees begin foraging outside the nest. Individuals often specialize by biasing their foraging efforts toward collecting pollen or nectar. Efforts to explain the origins of foraging specialization suggest that division of labor between nectar and pollen foraging specialists is influenced by genes with effects on reproductive physiology. Quantitative trait loci (QTL) mapping of foraging behavior also reveals candidate genes for reproductive traits. Here, we address the linkage of reproductive anatomy to behavior, using backcross QTL analysis, behavioral and anatomical phenotyping, candidate gene expression studies, and backcross confirmation of gene-to-anatomical trait associations. Our data show for the first time that the activity of two positional candidate genes for behavior, PDK1 and HR46, have direct genetic relationships to ovary size, a central reproductive trait that correlates with the nectar and pollen foraging bias of workers. These findings implicate two genes that were not known previously to influence complex social behavior. Also, they outline how selection may have acted on gene networks that affect reproductive resource allocation and behavior to facilitate the evolution of social foraging in honey bees.	[Wang, Ying; Amdam, Gro V.; Fondrk, M. Kim; Kaftanoglu, Osman; Page, Robert E., Jr.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Amdam, Gro V.] Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway; [Rueppell, Olav; Wallrichs, Megan A.] Univ N Carolina Greensboro, Dept Biol, Greensboro, NC USA	Arizona State University; Arizona State University-Tempe; Norwegian University of Life Sciences; University of North Carolina; University of North Carolina Greensboro	Wang, Y (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	ying.wang.6@asu.edu	Wang, Ying/H-1172-2012; Rueppell, Olav/G-2679-2010	Rueppell, Olav/0000-0001-5370-4229	NIA [PO1 AG22500]; NSF [0615502]; Norwegian Research Council [175413, 180504, 185306]; PEW Foundation; NATIONAL INSTITUTE ON AGING [P01AG022500] Funding Source: NIH RePORTER	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NSF(National Science Foundation (NSF)); Norwegian Research Council(Research Council of NorwayEuropean Commission); PEW Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the NIA grant PO1 AG22500 to R. E. Page Jr., NSF grant #0615502 to O. Rueppell and G.V. Amdam, and Norwegian Research Council 175413, 180504 and 185306, and the PEW Foundation to G.V. Amdam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdam GV, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P1003; Amdam GV, 2006, NATURE, V439, P76, DOI 10.1038/nature04340; Amdam GV, 2004, P NATL ACAD SCI USA, V101, P11350, DOI 10.1073/pnas.0403073101; Amdam GV, 2003, J THEOR BIOL, V223, P451, DOI 10.1016/S0022-5193(03)00121-8; Barchuk Angel Roberto, 2002, Journal of Insect Science (Tucson), V2, P1; Brotherton PNM, 2001, BEHAV ECOL, V12, P590, DOI 10.1093/beheco/12.5.590; CALDERONE NW, 1992, BEHAV ECOL SOCIOBIOL, V30, P219, DOI 10.1007/BF00166706; Capella ICS, 1998, J INSECT PHYSIOL, V44, P385, DOI 10.1016/S0022-1910(98)00027-4; Capella ICS, 2002, CELL TISSUE RES, V307, P265, DOI 10.1007/s00441-001-0490-y; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; DEBORAHSMITHA, 1997, BEHAV ECOL, V8, P384; Drummond-Barbosa D, 2004, DEV BIOL, V266, P310, DOI 10.1016/j.ydbio.2003.10.028; FAULKES CG, 1991, J REPROD FERTIL, V93, P427; Goodson JL, 2005, HORM BEHAV, V48, P11, DOI 10.1016/j.yhbeh.2005.02.003; Hartfelder K, 1998, CURR TOP DEV BIOL, V40, P45, DOI 10.1016/S0070-2153(08)60364-6; Humphries MA, 2003, J COMP PHYSIOL A, V189, P555, DOI 10.1007/s00359-003-0433-z; HUNT GJ, 1995, GENETICS, V141, P1537; Hunt GJ, 2007, NATURWISSENSCHAFTEN, V94, P247, DOI 10.1007/s00114-006-0183-1; Jiang CA, 2000, MOL CELL, V5, P445, DOI 10.1016/S1097-2765(00)80439-6; Kapitskaya MZ, 2000, MOL CELL ENDOCRINOL, V160, P25, DOI 10.1016/S0303-7207(99)00253-1; Kethidi DR, 2005, J INSECT PHYSIOL, V51, P393, DOI 10.1016/j.jinsphys.2004.12.007; Labuhn M, 1997, GERONTOLOGY, V43, P261; Lam G, 1999, DEV BIOL, V212, P204, DOI 10.1006/dbio.1999.9343; Lam GT, 1997, DEVELOPMENT, V124, P1757; Lee CY, 2002, DEV BIOL, V252, P138, DOI 10.1006/dbio.2002.0838; Lindauer M., 1953, BEE WORLD, V34, P63, DOI [10.1080/0005772X.1953.11094788, DOI 10.1080/0005772X.1953.11094788]; Namiki T, 2005, BIOCHEM BIOPH RES CO, V337, P367, DOI 10.1016/j.bbrc.2005.09.043; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; NICOLE B, 2008, PHYSIOL BEHAV, V94, P349; Oldroyd BP, 2008, PLOS BIOL, V6, P463, DOI 10.1371/journal.pbio.0060056; Orgogozo V, 2006, GENETICS, V173, P197, DOI 10.1534/genetics.105.054098; PAGE RE, 1995, BEHAV ECOL SOCIOBIOL, V36, P135, DOI 10.1007/BF00170718; Page RE, 2000, J HERED, V91, P474, DOI 10.1093/jhered/91.6.474; Page RE, 2007, BIOESSAYS, V29, P334, DOI 10.1002/bies.20549; Page RE, 2006, CURR TOP DEV BIOL, V74, P253, DOI 10.1016/S0070-2153(06)74008-X; Page Robert E. Jr, 2009, P357; Pankiw T, 2003, J COMP PHYSIOL A, V189, P675, DOI 10.1007/s00359-003-0442-y; Pankiw T, 2001, BEHAV ECOL SOCIOBIOL, V51, P87, DOI 10.1007/s002650100408; Ragoussis J, 2006, PLOS GENET, V2, P920, DOI 10.1371/journal.pgen.0020100; Richard DS, 2005, J INSECT PHYSIOL, V51, P455, DOI 10.1016/j.jinsphys.2004.12.013; Rintelen F, 2001, P NATL ACAD SCI USA, V98, P15020, DOI 10.1073/pnas.011318098; ROBINSON GE, 1991, J INSECT PHYSIOL, V37, P929, DOI 10.1016/0022-1910(91)90008-N; Rueppell O, 2008, J INSECT BEHAV, V21, P317, DOI 10.1007/s10905-008-9135-2; Rueppell O, 2006, GENETICS, V172, P243, DOI 10.1534/genetics.105.046490; Rueppell O, 2004, GENETICS, V167, P1767, DOI 10.1534/genetics.103.021949; Ruppell O, 2004, J HERED, V95, P481, DOI 10.1093/jhered/esh072; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Schug MD, 2004, GENET RES, V83, P19, DOI 10.1017/S0016672303006542; Solignac M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r66; Sullivan AA, 2003, MOL ENDOCRINOL, V17, P2125, DOI 10.1210/me.2002-0430; Szathmary E, 1995, MAJOR TRANSITIONS EV; Takemoto K, 2007, P NATL ACAD SCI USA, V104, P13367, DOI 10.1073/pnas.0702733104; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024; Tsuruda JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003397; West-Eberhard M.J., 1987, P35; West-Eberhard Mary Jane, 1996, P290; Whitfield CW, 2006, SCIENCE, V314, P642, DOI 10.1126/science.1132772; WINSTON ML, 1987, BIOL HONEY BEE, P235; Wu Q, 2006, ANNU REV ENTOMOL, V51, P1, DOI 10.1146/annurev.ento.51.110104.151011	61	45	45	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e4899	10.1371/journal.pone.0004899	http://dx.doi.org/10.1371/journal.pone.0004899			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340296	Green Published, gold, Green Submitted			2022-12-25	WOS:000265500700002
J	Zvuloni, A; Artzy-Randrup, Y; Stone, L; Kramarsky-Winter, E; Barkan, R; Loya, Y				Zvuloni, Assaf; Artzy-Randrup, Yael; Stone, Lewi; Kramarsky-Winter, Esti; Barkan, Roy; Loya, Yossi			Spatio-Temporal Transmission Patterns of Black-Band Disease in a Coral Community	PLOS ONE			English	Article							REEF; SPREAD	Background: Transmission mechanisms of black-band disease (BBD) in coral reefs are poorly understood, although this disease is considered to be one of the most widespread and destructive coral infectious diseases. The major objective of this study was to assess transmission mechanisms of BBD in the field based on the spatio-temporal patterns of the disease. Methodology/Principal Findings: 3,175 susceptible and infected corals were mapped over an area of 10x10 m in Eilat (northern Gulf of Aqaba, Red Sea) and the distribution of the disease was examined monthly throughout almost two full disease cycles (June 2006-December 2007). Spatial and spatio-temporal analyses were applied to infer the transmission pattern of the disease and to calculate key epidemiological parameters such as R-0 (basic reproduction number). We show that the prevalence of the disease is strongly associated with high water temperature. When water temperatures rise and disease prevalence increases, infected corals exhibit aggregated distributions on small spatial scales of up to 1.9 m. Additionally, newly-infected corals clearly appear in proximity to existing infected corals and in a few cases in direct contact with them. We also present and test a model of water-borne infection, indicating that the likelihood of a susceptible coral becoming infected is defined by its spatial location and by the relative spatial distribution of nearby infected corals found in the site. Conclusions/Significance: Our results provide evidence that local transmission, but not necessarily by direct contact, is likely to be an important factor in the spread of the disease over the tested spatial scale. In the absence of potential disease vectors with limited mobility (e. g., snails, fireworms) in the studied site, water-borne infection is likely to be a significant transmission mechanism of BBD. Our suggested model of water-borne transmission supports this hypothesis. The spatio-temporal analysis also points out that infected corals surviving a disease season appear to play a major role in the reintroduction of the disease to the coral community in the following season.	[Zvuloni, Assaf; Kramarsky-Winter, Esti; Loya, Yossi] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Zvuloni, Assaf] Interuniv Inst Marine Sci Eilat, H Steinitz Marine Biol Lab, Elat, Israel; [Artzy-Randrup, Yael; Stone, Lewi] Tel Aviv Univ, Dept Zool, Biomathemat Unit, IL-69978 Tel Aviv, Israel; [Barkan, Roy] Tel Aviv Univ, Dept Geophys & Planet Sci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Tel Aviv University	Zvuloni, A (corresponding author), Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel.	zvolonia@post.tau.ac.il	Loya, Joseph/AAJ-9014-2020; Barkan, Roy/GZK-9665-2022; Loya, Yossi/J-3039-2012; Kramarsky-Winter, Esti/H-2205-2012	Loya, Yossi/0000-0001-6870-9444; Stone, Lewi/0000-0002-6465-579X	Israel Science Foundation (ISF); Tel Aviv University [Raynor Chair for Environmental Conservation Research]; World Bank and the Global Environmental Facility (GEF); Yeshaya Horowitz Center for Complexity Science; EU-ITC [EPIWORK]	Israel Science Foundation (ISF)(Israel Science Foundation); Tel Aviv University; World Bank and the Global Environmental Facility (GEF); Yeshaya Horowitz Center for Complexity Science; EU-ITC	This work was supported by: (1) the Israel Science Foundation (ISF) to YL and the Raynor Chair for Environmental Conservation Research Tel Aviv University to YL, and (2) the World Bank and the Global Environmental Facility (GEF) through the Coral Reef Targeted Research and Capacity Building for Management program, Coral Bleaching and Local Environmental Responses working group. YA-R was supported by the Yeshaya Horowitz Center for Complexity Science. LS acknowledges support from the EU-ITC grant EPIWORK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeby GS, 2006, MAR ECOL PROG SER, V318, P103, DOI 10.3354/meps318103; ANDERSON R M, 1991; Antonious A, 1973, ASS ISL MAR LAB CARI, V10, P3; Antonius A., 1988, P293; ANTONIUS A, 1985, PSZNI MAR ECOL, V6, P197; ANTONIUS A, 1981, 4TH P INT COR REEF S, V2, P3; BESAG J, 1977, J ROYAL STAT SOC B, V39, P193, DOI DOI 10.1016/J.FORECO.2009.04.009; Bruckner AW, 1997, B MAR SCI, V61, P919; Bruno JF, 2003, ECOL LETT, V6, P1056, DOI 10.1046/j.1461-0248.2003.00544.x; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Bunge J., J AM STAT ASSOC, V88, P364, DOI 10.2307/2290733; Diggle PJ, 1983, STAT ANAL SPATIAL PO; DINSDALE EA, 2002, P 9 INT COR REEF S B, V2, P1239; EDMUNDS PJ, 1991, CORAL REEFS, V10, P161, DOI 10.1007/BF00572175; Edmunds PJ, 2000, CORAL REEFS, V19, P69, DOI 10.1007/s003380050229; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Frias-Lopez J, 2002, APPL ENVIRON MICROB, V68, P2214, DOI 10.1128/AEM.68.5.2214-2228.2002; Garzon-Ferreira J, 2001, HYDROBIOLOGIA, V460, P65, DOI 10.1023/A:1013133818360; Gil-Agudelo DL, 2001, B MAR SCI, V69, P619; Goreau TJ, 1998, REV BIOL TROP, V46, P157; Green EP, 2000, BIOL CONSERV, V96, P347, DOI 10.1016/S0006-3207(00)00073-2; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Hayes RL, 1998, REV BIOL TROP, V46, P173; Jolles AE, 2002, ECOLOGY, V83, P2373, DOI 10.1890/0012-9658(2002)083[2373:DTOAIS]2.0.CO;2; Kuta KG, 1996, CORAL REEFS, V15, P219, DOI 10.1007/BF01787455; Kuta KG, 2002, CORAL REEFS, V21, P393, DOI 10.1007/s00338-002-0261-6; KUTA KG, 1997, P 8 INT COR REEF S, V1, P575; Mitchell R, 1975, MICROB ECOL, V2, P227, DOI 10.1007/BF02010442; Page C, 2006, DIS AQUAT ORGAN, V69, P41, DOI 10.3354/dao069041; Richardson LL, 1996, MICROBIAL ECOL, V32, P323; Richardson LL, 2004, CORAL HEALTH AND DISEASE, P325; Richardson LL, 1998, TRENDS ECOL EVOL, V13, P438, DOI 10.1016/S0169-5347(98)01460-8; RIPLEY BD, 1976, J APPL PROBAB, V13, P255, DOI 10.2307/3212829; Ritchie KB, 2001, HYDROBIOLOGIA, V460, P131, DOI 10.1023/A:1013181718805; Roberts MG, 2007, J MATH BIOL, V55, P803, DOI 10.1007/s00285-007-0112-8; Rodriguez S, 2008, CORAL REEFS, V27, P381, DOI 10.1007/s00338-007-0341-8; ROSENBLATT M, 1956, ANN MATH STAT, V27, P832, DOI 10.1214/aoms/1177728190; Rutzler K, 1983, PSZNI MAR ECOL, V4, P329, DOI DOI 10.1111/J.1439-0485.1983.TB00118.X; Santavy D.L., 1997, P607; Stone L, 2007, NATURE, V446, P533, DOI 10.1038/nature05638; Sussman M, 2003, ENVIRON MICROBIOL, V5, P250, DOI 10.1046/j.1462-2920.2003.00424.x; Sutherland KP, 2004, CORAL HEALTH AND DISEASE, P289; TAYLOR D, 1983, PSZNI MAR ECOL, V4, P320; Wand M. P., 1994, KERNEL SMOOTHING; Weil E, 2004, CORAL HEALTH AND DISEASE, P35; WEIL E, 2003, P 9 INT COR REEF S, V1, P1231; WEINBERG S, 1981, BIJDR DIERKD, V51, P199; Williams EH, 1990, ATOLL RES B, P330, DOI DOI 10.5479/SI.00775630.335.1; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69; Zvuloni A, 2008, LIMNOL OCEANOGR-METH, V6, P144, DOI 10.4319/lom.2008.6.144	50	56	56	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e4993	10.1371/journal.pone.0004993	http://dx.doi.org/10.1371/journal.pone.0004993			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337384	Green Published, Green Submitted, gold			2022-12-25	WOS:000265500600006
J	Sun, XL; Salih, E; Oppenheim, FG; Helmerhorst, EJ				Sun, Xiuli; Salih, Erdjan; Oppenheim, Frank G.; Helmerhorst, Eva J.			Kinetics of histatin proteolysis in whole saliva and the effect on bioactive domains with metal-binding, antifungal, and wound-healing properties	FASEB JOURNAL			English	Article						oral; proteolytic; enzymes; proteins; proteomics	HISTIDINE-RICH-POLYPEPTIDES; HUMAN-PAROTID SECRETION; PERIODONTAL-DISEASE; IDENTIFICATION; PELLICLE; ZINC; PROTEASES; PEPTIDES; PROTEOMICS; ENZYMES	The present study was undertaken to investigate the rate and mode of degradation of individual histatin proteins in whole saliva to establish the impact on its functional domains. Pure synthetic histatins 1, 3, and 5 were incubated with whole saliva supernatant as the enzyme source, and peptides in the resultant digests were separated by reverse-phase-HPLC and structurally characterized by electrospray ionization-tandem mass spectrometry. The overall V-max/K-m ratios, a measure of proteolytic efficiency, were on the order of histatin-5 > histatin-3 > histatin-1. Mathematical models predict that histatins 1, 3, and 5 levels in whole saliva stabilize at 5.1, 1.9, and 1.2 mu M, representing 59, 27, and 11% of glandular histatins 1, 3, and 5 levels, respectively. Monitoring of the appearance and disappearance of histatin fragments yielded the identification of the first targeted enzymatic cleavage sites as K-13 and K-17 in histatin 1, R-22, Y-24, and R-25 in histatin 3, and Y-10, K-11, R-12, K-13, H-15, E-16, K-17, and H-18 in histatin 5. The data indicate that metal-binding, antifungal, and wound-healing domains are largely unaffected by the primary cleavage events in whole saliva, suggesting a sustained functional activity of these proteins in the proteolytic environment of the oral cavity.-Sun, X., Salih, E., Oppenheim, F. G., Helmerhorst, E. J. Kinetics of histatin proteolysis in whole saliva and the effect on bioactive domains with metal-binding, antifungal, and wound-healing properties. FASEB J. 23, 2691-2701 ( 2009)	[Sun, Xiuli; Salih, Erdjan; Oppenheim, Frank G.; Helmerhorst, Eva J.] Boston Univ, Goldman Sch Dent Med, Dept Periodontol & Oral Biol, Boston, MA 02118 USA	Boston University	Helmerhorst, EJ (corresponding author), Boston Univ, Goldman Sch Dent Med, Dept Periodontol & Oral Biol, Boston, MA 02118 USA.	helmer@bu.edu		Helmerhorst, Eva/0000-0002-4803-3018; Salih, Erdjan/0000-0003-3322-2323	National Institutes of Health/National Institute of Dental and Craniofacial Research [DE05672, DE07652, DE18448, DE18132, DE16699]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE007652] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE018448, R01DE005672, R21DE018132, R03DE016699, R37DE005672] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by National Institutes of Health/National Institute of Dental and Craniofacial Research grants DE05672, DE07652, DE18448, DE18132, and DE16699.	Amerongen AVN, 2002, ORAL DIS, V8, P12, DOI 10.1034/j.1601-0825.2002.1o816.x; ARMSTRONG WG, 1968, P ROY SOC MED, V61, P923, DOI 10.1177/003591576806100929; BAUM BJ, 1977, J DENT RES, V56, P1115, DOI 10.1177/00220345770560091801; BAUM BJ, 1976, ARCH BIOCHEM BIOPHYS, V177, P427, DOI 10.1016/0003-9861(76)90455-0; Brewer D, 1998, BIOCHEM CELL BIOL, V76, P247, DOI 10.1139/bcb-76-2-3-247; Bruno LS, 2005, BBA-MOL CELL RES, V1746, P65, DOI 10.1016/j.bbamcr.2005.08.007; CAMPESE M, 2009, ARCH ORAL BIOL, DOI DOI 10.1016/J.ARCHORAL-BIO.2008.11.010; Castagnola M, 2004, J BIOL CHEM, V279, P41436, DOI 10.1074/jbc.M404322200; Dawes C, 2004, CARIES RES, V38, P236, DOI 10.1159/000077760; Flora B, 2001, PROTEIN EXPRES PURIF, V23, P198, DOI 10.1006/prep.2001.1493; Freedman A, 1996, LANCET, V348, P1592, DOI 10.1016/S0140-6736(05)66216-2; Germaine G R, 1978, Adv Exp Med Biol, V107, P849; Grogan J, 2001, FEBS LETT, V491, P76, DOI 10.1016/S0014-5793(01)02157-3; Gusman H, 2001, BBA-PROTEIN STRUCT M, V1545, P86, DOI 10.1016/S0167-4838(00)00265-X; Gusman H, 2004, ARCH ORAL BIOL, V49, P11, DOI 10.1016/S0003-9969(03)00182-1; Gusman H, 2001, INFECT IMMUN, V69, P1402, DOI 10.1128/IAI.69.3.1402-1408.2001; Helmerhorst EJ, 2007, J DENT RES, V86, P680, DOI 10.1177/154405910708600802; Helmerhorst EJ, 2006, ARCH ORAL BIOL, V51, P1061, DOI 10.1016/j.archoralbio.2006.06.005; Helmerhorst EJ, 2008, J BIOL CHEM, V283, P19957, DOI 10.1074/jbc.M708282200; Iontcheva I, 2000, J DENT RES, V79, P732; Li J, 2004, J DENT RES, V83, P60, DOI 10.1177/154405910408300112; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Melino S, 1999, BIOCHEMISTRY-US, V38, P9626, DOI 10.1021/bi990212c; Melino S, 2006, BIOCHEMISTRY-US, V45, P15373, DOI 10.1021/bi0615137; Messana I, 2008, MOL CELL PROTEOMICS, V7, P911, DOI 10.1074/mcp.M700501-MCP200; NAKAMURA M, 1983, J PERIODONTAL RES, V18, P559, DOI 10.1111/j.1600-0765.1983.tb00393.x; OPPENHEIM FG, 1988, J BIOL CHEM, V263, P7472; OPPENHEIM FG, 1986, J BIOL CHEM, V261, P1177; Oudhoff MJ, 2008, FASEB J, V22, P3805, DOI 10.1096/fj.08-112003; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; PAYNE JB, 1991, ORAL MICROBIOL IMMUN, V6, P169, DOI 10.1111/j.1399-302X.1991.tb00472.x; Rothstein David M, 2002, Expert Opin Emerg Drugs, V7, P47, DOI 10.1517/14728214.7.1.47; Rothstein DM, 2001, ANTIMICROB AGENTS CH, V45, P1367, DOI 10.1128/AAC.45.5.1367-1373.2001; RUDNEY JD, 1995, CRIT REV ORAL BIOL M, V6, P343, DOI 10.1177/10454411950060040501; Sorsa T, 2004, ORAL DIS, V10, P311, DOI 10.1111/j.1601-0825.2004.01038.x; SUN X, 2009, PROTEOMICS IN PRESS; Vitorino R, 2004, BIOMED CHROMATOGR, V18, P570, DOI 10.1002/bmc.358; Vitorino R, 2004, PROTEOMICS, V4, P1109, DOI 10.1002/pmic.200300638; Vitorino R, 2007, BIOMED CHROMATOGR, V21, P1107, DOI 10.1002/bmc.830; WATANABE T, 1981, J DENT RES, V60, P1039, DOI 10.1177/00220345810600060601; XU T, 1991, INFECT IMMUN, V59, P2549, DOI 10.1128/IAI.59.8.2549-2554.1991; ZAHRADNIK RT, 1976, J DENT RES, V55, P664, DOI 10.1177/00220345760550042101	42	40	44	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2691	2701		10.1096/fj.09-131045	http://dx.doi.org/10.1096/fj.09-131045			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19339663	Green Published			2022-12-25	WOS:000268836700037
J	Esteban, MA; Xu, JY; Yang, JY; Peng, MX; Qin, DJ; Li, W; Jiang, ZX; Chen, JK; Den, K; Zhong, M; Cai, JL; Lai, LX; Pei, DQ				Esteban, Miguel A.; Xu, Jianyong; Yang, Jiayin; Peng, Meixiu; Qin, Dajiang; Li, Wen; Jiang, Zhuoxin; Chen, Jiekai; Den, Kang; Zhong, Mei; Cai, Jinglei; Lai, Liangxue; Pei, Duanqing			Generation of Induced Pluripotent Stem Cell Lines from Tibetan Miniature Pig	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR TRANSFER; ADULT; FIBROBLASTS; EFFICIENCY; INDUCTION; SOX2	Induced pluripotent stem cell (iPS) technology appears to be a general strategy to generate pluripotent stem cells from any given mammalian species. So far, iPS cells have been reported for mouse, human, rat, and monkey. These four species have also established embryonic stem cell (ESC) lines that serve as the gold standard for pluripotency comparisons. Attempts have been made to generate porcine ESC by various means without success. Here we report the successful generation of pluripotent stem cells from fibroblasts isolated from the Tibetan miniature pig using a modified iPS protocol. The resulting iPS cell lines more closely resemble human ESC than cells from other species, have normal karyotype, stain positive for alkaline phosphatase, express high levels of ESC-like markers (Nanog, Rex1, Lin28, and SSEA4), and can differentiate into teratomas composed of the three germ layers. Because porcine physiology closely resembles human, the iPS cells reported here provide an attractive model to study certain human diseases or assess therapeutic applications of iPS in a large animal model.	[Cai, Jinglei; Lai, Liangxue; Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, S China Inst Stem Cell Biol & Regenerat Med, Stem Cell & Canc Biol Grp,Key Lab Regenerat Biol, Guangzhou 510663, Guangdong, Peoples R China; [Den, Kang; Zhong, Mei] Nanfang Hosp, Ctr Prenatal & Hereditary Dis Diag, Guangzhou 510515, Guangdong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Southern Medical University - China	Pei, DQ (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, S China Inst Stem Cell Biol & Regenerat Med, Stem Cell & Canc Biol Grp,Key Lab Regenerat Biol, Guangzhou 510663, Guangdong, Peoples R China.	pei_duanqing@gibh.ac.cn	zhou, xingru/G-4442-2012; Lai, Liangxue/H-4545-2011	Chen, Jiekai/0000-0001-5168-7074; Yang, Jiayin/0000-0001-9134-1959	National Natural Science Foundation of China [30725012, 30630039]; Chinese Academy of Sciences [KSCX2-YW-R-48]; Guangzhou Science and Technology [2006A50104002]; Ministry of Science and Technology 973 [2006CB701504, 2006CB943600, 2007CB948002, 2007CB947804, 2009CB941000]; National High Technology Project 863 [2005AA210930]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Guangzhou Science and Technology; Ministry of Science and Technology 973(National Basic Research Program of China); National High Technology Project 863(National High Technology Research and Development Program of China)	This work was supported by National Natural Science Foundation of China Grants 30725012 and 30630039, Chinese Academy of Sciences Grant KSCX2-YW-R-48, Guangzhou Science and Technology Grant 2006A50104002, Ministry of Science and Technology 973 Grants 2006CB701504, 2006CB943600, 2007CB948002, 2007CB947804, and 2009CB941000, and National High Technology Project 863 Grant 2005AA210930.	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; Hall V, 2008, STEM CELL REV, V4, P275, DOI 10.1007/s12015-008-9040-2; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hao YH, 2009, CLONING STEM CELLS, V11, P101, DOI 10.1089/clo.2008.0063; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kolber-Simonds D, 2004, P NATL ACAD SCI USA, V101, P7335, DOI 10.1073/pnas.0307819101; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Mali P, 2008, STEM CELLS, V26, P1998, DOI 10.1634/stemcells.2008-0346; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Pei DQ, 2008, CELL RES, V18, P221, DOI 10.1038/cr.2008.21; Qin DJ, 2008, J BIOL CHEM, V283, P33730, DOI 10.1074/jbc.M806788200; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Talbot NC, 2008, STEM CELL REV, V4, P235, DOI 10.1007/s12015-008-9026-0; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Tweedell KS, 2008, CURR STEM CELL RES T, V3, P151, DOI 10.2174/157488808785740361; Vackova I, 2007, J REPROD DEVELOP, V53, P1137, DOI 10.1262/jrd.19108; Wang XM, 2006, ANIM BIOTECHNOL, V17, P99, DOI 10.1080/10495390600608794; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	35	322	376	3	71	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17634	17640		10.1074/jbc.M109.008938	http://dx.doi.org/10.1074/jbc.M109.008938			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19376775	hybrid, Green Published			2022-12-25	WOS:000267202500029
J	Srinivasan, S; Mir, F; Huang, JS; Khasawneh, FT; Lam, SCT; Le Breton, GC				Srinivasan, Subhashini; Mir, Fozia; Huang, Jin-Sheng; Khasawneh, Fadi T.; Lam, Stephen C. -T.; Le Breton, Guy C.			The P2Y(12) Antagonists, 2-Methylthioadenosine 5 '-Monophosphate Triethylammonium Salt and Cangrelor (ARC69931MX), Can Inhibit Human Platelet Aggregation through a G(i)-independent Increase in cAMP Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTAGLANDIN DP-RECEPTORS; A(2A) ADENOSINE RECEPTORS; ADP RECEPTORS; INTEGRIN ALPHA(IIB)BETA(3); PROCOAGULANT ACTIVITY; ADENYLYL-CYCLASE; SHAPE CHANGE; G-PROTEINS; ACTIVATION; AGONISTS	ADP plays an integral role in the process of hemostasis by signaling through two platelet G-protein-coupled receptors, P2Y(1) and P2Y(12). The recent use of antagonists against these two receptors has contributed a substantial body of data characterizing the ADP signaling pathways in human platelets. Specifically, the results have indicated that although P2Y(1) receptors are involved in the initiation of platelet aggregation, P2Y(12) receptor activation appears to account for the bulk of the ADP-mediated effects. Based on this consideration, emphasis has been placed on the development of a new class of P2Y(12) antagonists (separate from clopidogrel and ticlopidine) as an approach to the treatment of thromboembolic disorders. The present work examined the molecular mechanisms by which two of these widely used adenosine-based P2Y(12) antagonists (2-methylthioadenosine 5'-monophosphate triethylammonium salt (2MeSAMP) and ARC69931MX), inhibit human platelet activation. It was found that both of these compounds raise platelet cAMP to levels that substantially inhibit platelet aggregation. Furthermore, the results demonstrated that this elevation of cAMP did not require G(i) signaling or functional P2Y(12) receptors but was mediated through activation of a separate G protein-coupled pathway, presumably involving G(s). However, additional experiments revealed that neither 2MeSAMP nor ARC69931MX (cangrelor) increased cAMP through activation of A2a, IP, DP, or EP2 receptors, which are known to couple to G(s). Collectively, these findings indicate that 2MeSAMP and ARC69931MX interact with an unidentified platelet G protein-coupled receptor that stimulates cAMP-mediated inhibition of platelet function. This inhibition is in addition to that derived from antagonism of P2Y(12) receptors.	[Le Breton, Guy C.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Le Breton, GC (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, 835 S Wolcott Ave M-C 868, Chicago, IL 60612 USA.	gcl@uic.edu			National Institutes of Health [HL23540-25]; American Heart Association [0815654G]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported, in whole or in part, by National Institutes of Health Grant HL23540-25 ( to G. C. L.).; Recipient of a predoctoral fellowship from the American Heart Association ( Grant 0815654G).	Baurand A, 2005, MOL PHARMACOL, V67, P721, DOI 10.1124/mol.104.004846; Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; BERTELE V, 1984, THROMB HAEMOSTASIS, V51, P125; BRASS LF, 1988, J BIOL CHEM, V263, P5348; Brass LF, 1997, THROMB HAEMOSTASIS, V78, P581; BRASS LF, 1986, J BIOL CHEM, V261, P6838; CHARO IF, 1977, J CLIN INVEST, V60, P866, DOI 10.1172/JCI108841; COLLER BS, 1990, NEW ENGL J MED, V322, P33, DOI 10.1056/NEJM199001043220107; Crider JY, 1999, BRIT J PHARMACOL, V127, P204, DOI 10.1038/sj.bjp.0702490; Daniel JL, 1998, J BIOL CHEM, V273, P2024, DOI 10.1074/jbc.273.4.2024; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Dionisotti S, 1996, J PHARMACOL EXP THER, V278, P1209; Dorsam RT, 2004, J CLIN INVEST, V113, P340, DOI 10.1172/JCI200420986; EVANS T, 1984, MOL PHARMACOL, V26, P395; Foster CJ, 2001, J CLIN INVEST, V107, P1591, DOI 10.1172/JCI12242; GILES H, 1989, BRIT J PHARMACOL, V96, P291, DOI 10.1111/j.1476-5381.1989.tb11816.x; GILMAN AG, 1970, P NATL ACAD SCI USA, V67, P305, DOI 10.1073/pnas.67.1.305; Hardy AR, 2005, BLOOD, V105, P3552, DOI 10.1182/blood-2004-07-2893; HIGGS EA, 1978, BRIT J PHARMACOL, V63, P535, DOI 10.1111/j.1476-5381.1978.tb07809.x; Jin JG, 2002, BLOOD, V99, P193, DOI 10.1182/blood.V99.1.193; Jung SM, 2001, EUR J BIOCHEM, V268, P3513, DOI 10.1046/j.1432-1327.2001.02252.x; Khasawneh FT, 2008, BIOCHEM PHARMACOL, V75, P2301, DOI 10.1016/j.bcp.2008.03.014; Kim S, 2002, BLOOD, V99, P3629, DOI 10.1182/blood.V99.10.3629; KINLOUGHRATHBONE RL, 1976, SCIENCE, V192, P1011, DOI 10.1126/science.1273582; Kunapuli SP, 2003, CURR PHARM DESIGN, V9, P2303, DOI 10.2174/1381612033453947; Le Breton G C, 1980, Adv Prostaglandin Thromboxane Res, V6, P497; Leon C, 2003, ARTERIOSCL THROM VAS, V23, P1941, DOI 10.1161/01.ATV.0000092127.16125.E6; MICHAL F, 1971, NATURE-NEW BIOL, V231, P220, DOI 10.1038/newbio231220a0; Nieswandt B, 2002, J BIOL CHEM, V277, P39493, DOI 10.1074/jbc.M207256200; Salomon Y, 1979, Adv Cyclic Nucleotide Res, V10, P35; Storey RF, 2000, BRIT J HAEMATOL, V110, P925, DOI 10.1046/j.1365-2141.2000.02208.x; Storey RF, 2001, PLATELETS, V12, P197, DOI 10.1080/09537100120058739; Storey RF, 2001, PLATELETS, V12, P443, DOI 10.1080/09537100120085450; TATESON JE, 1977, PROSTAGLANDINS, V13, P389, DOI 10.1016/0090-6980(77)90019-3; Trumel C, 1999, BLOOD, V94, P4156, DOI 10.1182/blood.V94.12.4156.424k29_4156_4165; Van Kolen K, 2004, J NEUROCHEM, V89, P442, DOI 10.1111/j.1471-4159.2004.02339.x; Varani K, 1999, CIRCULATION, V99, P2499, DOI 10.1161/01.CIR.99.19.2499; WOODWARD DF, 1995, BIOCHEM PHARMACOL, V50, P1731, DOI 10.1016/0006-2952(95)02035-7; Yang J, 2000, P NATL ACAD SCI USA, V97, P9984, DOI 10.1073/pnas.180194597; Yoneda K, 2004, BRIT J PHARMACOL, V142, P551, DOI 10.1038/sj.bjp.0705808; Yu HX, 1999, DRUG DEVELOP RES, V48, P84	41	43	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16108	16117		10.1074/jbc.M809780200	http://dx.doi.org/10.1074/jbc.M809780200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19346255	Green Published, hybrid			2022-12-25	WOS:000266730900007
J	Dutta, T; Deutscher, MP				Dutta, Tanmay; Deutscher, Murray P.			Catalytic Properties of RNase BN/RNase Z from Escherichia coli RNase BN IS BOTH AN EXO- AND ENDORIBONUCLEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRNASE-Z-FAMILY; SUBSTRATE; CCA; EXORIBONUCLEASES; PRECURSORS; MATURATION; PROTEINS; CLEAVAGE; GROWTH	Processing of the 3' terminus of tRNA in many organisms is carried out by an endoribonuclease termed RNase Z or 3'-tRNase, which cleaves after the discriminator nucleotide to allow addition of the universal -CCA sequence. In some eubacteria, such as Escherichia coli, the -CCA sequence is encoded in all known tRNA genes. Nevertheless, an RNase Z homologue (RNase BN) is still present, even though its action is not needed for tRNA maturation. To help identify which RNA molecules might be potential substrates for RNase BN, we carried out a detailed examination of its specificity and catalytic potential using a variety of synthetic substrates. We show here that RNase BN is active on both double-and single-stranded RNA but that duplex RNA is preferred. The enzyme displays a profound base specificity, showing no activity on runs of C residues. RNase BN is strongly inhibited by the presence of a 3'-CCA sequence or a 3'-phosphoryl group. Digestion by RNase BN leads to 3-mers as the limit products, but the rate slows on molecules shorter than 10 nucleotides in length. Most interestingly, RNase BN acts as a distributive exoribonuclease on some substrates, releasing mononucleotides and a ladder of digestion products. However, RNase BN also cleaves endonucleolytically, releasing 3' fragments as short as 4 nucleotides. Although the presence of a 3'-phosphoryl group abolishes exoribonuclease action, it has no effect on the endoribonucleolytic cleavages. These data suggest that RNase BN may differ from other members of the RNase Z family, and they provide important information to be considered in identifying a physiological role for this enzyme.	[Dutta, Tanmay; Deutscher, Murray P.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA	University of Miami	Deutscher, MP (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, POB 016129, Miami, FL 33101 USA.	mdeutsch@med.miami.edu	Dutta, Tanmay/ABH-2431-2021		National Institutes of Health [GM16317]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM016317, F32GM016317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM16317.	ASHA PK, 1983, P NATL ACAD SCI-BIOL, V80, P3301, DOI 10.1073/pnas.80.11.3301; de la Sierra-Gallay IL, 2006, NAT STRUCT MOL BIOL, V13, P376, DOI 10.1038/nsmb1066; de la Sierra-Gallay IL, 2005, NATURE, V433, P657, DOI 10.1038/nature03284; de la Sierra-Gallay IL, 2008, NAT STRUCT MOL BIOL, V15, P206, DOI 10.1038/nsmb.1376; DEUTSCHER MP, 1993, J BACTERIOL, V175, P4577, DOI 10.1128/JB.175.15.4577-4583.1993; Deutscher Murray P., 1995, P51; Elbarbary RA, 2008, BBA-PROTEINS PROTEOM, V1784, P2079, DOI 10.1016/j.bbapap.2008.08.019; Ezraty B, 2005, J BIOL CHEM, V280, P16542, DOI 10.1074/jbc.C500098200; KELLY KO, 1992, J BACTERIOL, V174, P6682, DOI 10.1128/JB.174.20.6682-6684.1992; Kostelecky B, 2006, J BACTERIOL, V188, P1607, DOI 10.1128/JB.188.4.1607-1614.2006; Li ZW, 1996, CELL, V86, P503, DOI 10.1016/S0092-8674(00)80123-3; Minagawa A, 2004, J BIOL CHEM, V279, P15688, DOI 10.1074/jbc.M313951200; Mohan A, 1999, RNA, V5, P245, DOI 10.1017/S1355838299981256; Pellegrini O, 2003, EMBO J, V22, P4534, DOI 10.1093/emboj/cdg435; Perwez T, 2006, MOL MICROBIOL, V60, P723, DOI 10.1111/j.1365-2958.2006.05124.x; Redko Y, 2007, NAT REV MICROBIOL, V5, P278, DOI 10.1038/nrmicro1622; REUVEN NB, 1993, FASEB J, V7, P143, DOI 10.1096/fasebj.7.1.8422961; Schierling K, 2002, J MOL BIOL, V316, P895, DOI 10.1006/jmbi.2001.5395; Schiffer S, 2003, BIOL CHEM, V384, P333, DOI 10.1515/BC.2003.039; Schiffer S, 2002, EMBO J, V21, P2769, DOI 10.1093/emboj/21.11.2769; Schilling O, 2005, J BIOL CHEM, V280, P17857, DOI 10.1074/jbc.M500591200; Schilling O, 2004, BIOCHEM BIOPH RES CO, V320, P1365, DOI 10.1016/j.bbrc.2004.05.227; SEIDMAN JG, 1975, CELL, V5, P389, DOI 10.1016/0092-8674(75)90058-6; Shibata HS, 2006, BIOCHEMISTRY-US, V45, P5486, DOI 10.1021/bi051972s; Takaku H, 2008, GENES CELLS, V13, P1087, DOI 10.1111/j.1365-2443.2008.01230.x; UZIEL M, 1973, BIOCHEMISTRY-US, V12, P938, DOI 10.1021/bi00729a023; Vogel A, 2005, BIOL CHEM, V386, P1253, DOI 10.1515/BC.2005.142; Vogel A, 2002, J BIOL CHEM, V277, P29078, DOI 10.1074/jbc.M112047200; Weiner AM, 2004, CURR BIOL, V14, pR883, DOI 10.1016/j.cub.2004.09.069; Yang XC, 2009, MOL CELL BIOL, V29, P31, DOI 10.1128/MCB.00776-08; Zareen N, 2006, RNA, V12, P1104, DOI 10.1261/rna.4206	32	24	25	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15425	15431		10.1074/jbc.M109.005462	http://dx.doi.org/10.1074/jbc.M109.005462			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19366704	Green Published, hybrid			2022-12-25	WOS:000266501000010
J	Minig, V; Kattan, Z; van Beeumen, J; Brunner, E; Becuwe, P				Minig, Vanessa; Kattan, Zilal; van Beeumen, Josef; Brunner, Emilie; Becuwe, Philippe			Identification of DDB2 Protein as a Transcriptional Regulator of Constitutive SOD2 Gene Expression in Human Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; DAMAGED DNA; MNSOD OVEREXPRESSION; GROWTH; GENERATION; PEROXIDE; PROMOTER; AP-2	Manganese superoxide dismutase plays a role in breast tumor cell growth, which depends on its constitutive expression. However, the mechanisms responsible for the regulation of constitutive SOD2 gene expression at different malignant phenotype in breast cancers remain to be determined. The present study reports the identification and characterization of a DNA sequence located in the proximal promoter of the SOD2 gene, which forms a complex with a nuclear protein from breast tumor MCF-7 cells. Purification of this complex showed that it contained DDB2 (damaged DNA binding 2), a well known protein involved in nucleotide excision DNA repair and cell cycle regulation. Functional analysis of the proximal promoter of the SOD2 gene or modulation of DDB2 expression allowed us to demonstrate that DDB2 regulates negatively the constitutive expression of the SOD2 gene in breast cancer cells. We demonstrate that the binding of DDB2 was associated with the loss of acetylated H3 histones and the decrease in the binding of Sp1 but not AP-2 alpha transcription factors to the SOD2 proximal promoter. In addition, we show that DDB2 exerts, at least in part, a control of breast cancer cell growth through its negative regulation of constitutive expression of the SOD2 gene. For the first time, these data give supporting evidence that DDB2 is a new transcriptional regulator, and they provide insight into the molecular function of breast cancer cell growth, which will have an important clinical interest.	[Minig, Vanessa; Kattan, Zilal; Brunner, Emilie; Becuwe, Philippe] Henri Poincare Univ Nancy 1, Canc Res Unit, EA SIGRETO, F-54506 Vandoeuvre Les Nancy, France; [van Beeumen, Josef] Univ Ghent, Lab Prot Biochem & Prot Engn, B-9000 Ghent, Belgium	Universite de Lorraine; Ghent University	Becuwe, P (corresponding author), BP 239, F-54506 Vandoeuvre Les Nancy, France.	becuwe@scbiol.uhp-nancy.fr			Ligue contre le Cancer (Comites Meuse and Meurthe et Moselle); Henri Poincare's Nancy University	Ligue contre le Cancer (Comites Meuse and Meurthe et Moselle); Henri Poincare's Nancy University	This work was supported by grants from the Ligue contre le Cancer (Comites Meuse and Meurthe et Moselle) and Henri Poincare's Nancy University.	Bevilacqua MA, 2005, J BIOL CHEM, V280, P31809, DOI 10.1074/jbc.M414677200; CHU G, 1988, SCIENCE, V242, P564, DOI 10.1126/science.3175673; Hayes S, 1998, MOL CELL BIOL, V18, P240, DOI 10.1128/MCB.18.1.240; Hitchiler MJ, 2008, FREE RADICAL BIO MED, V45, P1573, DOI 10.1016/j.freeradbiomed.2008.09.005; Hitchler MJ, 2006, EPIGENETICS-US, V1, P163, DOI 10.4161/epi.1.4.3401; Hodge DR, 2005, CANCER BIOL THER, V4, P585, DOI 10.4161/cbt.4.5.1704; Huang YH, 1999, DNA CELL BIOL, V18, P643, DOI 10.1089/104454999315051; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kattan Z, 2008, BREAST CANCER RES TR, V108, P203, DOI 10.1007/s10549-007-9597-5; Kattan Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002002; Kim HP, 1999, J BIOL CHEM, V274, P37455, DOI 10.1074/jbc.274.52.37455; Kim KH, 2001, ANTIOXID REDOX SIGN, V3, P361, DOI 10.1089/15230860152409013; Kiningham KK, 1999, FASEB J, V13, P1601, DOI 10.1096/fasebj.13.12.1601; Kiningham KK, 1997, CANCER RES, V57, P5265; Kinnula VL, 2004, FREE RADICAL BIO MED, V36, P718, DOI 10.1016/j.freeradbiomed.2003.12.010; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI JJ, 1995, ONCOGENE, V10, P1989; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maehara K, 2002, BIOCHEM BIOPH RES CO, V295, P187, DOI 10.1016/S0006-291X(02)00646-0; Martinez E, 2001, MOL CELL BIOL, V21, P6782, DOI 10.1128/MCB.21.20.6782-6795.2001; Mates JM, 2000, TOXICOLOGY, V153, P83, DOI 10.1016/S0300-483X(00)00306-1; MERRIL CR, 1981, SCIENCE, V211, P1437, DOI 10.1126/science.6162199; Nelson KK, 2003, CLIN CANCER RES, V9, P424; Oberley LW, 2005, BIOMED PHARMACOTHER, V59, P143, DOI 10.1016/j.biopha.2005.03.006; OLNES MJ, 1994, BIOTECHNIQUES, V17, P828; Pani G, 2004, CURR MED CHEM, V11, P1299, DOI 10.2174/0929867043365297; Ridnour LA, 2004, ANTIOXID REDOX SIGN, V6, P501, DOI 10.1089/152308604773934260; St Clair DK, 2002, METHOD ENZYMOL, V349, P306, DOI 10.1016/S0076-6879(02)49345-7; STCLAIR DK, 1992, MOL CARCINOGEN, V6, P238, DOI 10.1002/mc.2940060404; STCLAIR DK, 1991, CANCER RES, V51, P939; Tang J, 2002, DNA REPAIR, V1, P601, DOI 10.1016/S1568-7864(02)00052-6; Tsanou E, 2004, HISTOL HISTOPATHOL, V19, P807, DOI 10.14670/HH-19.807; Xu Y, 2002, BIOCHEM J, V362, P401, DOI 10.1042/0264-6021:3620401; Xu Y, 1999, ONCOGENE, V18, P93, DOI 10.1038/sj.onc.1202265; Yang JQ, 1999, MOL CARCINOGEN, V26, P180; Yeh CC, 1998, DNA CELL BIOL, V17, P921, DOI 10.1089/dna.1998.17.921; Zhu CH, 2001, J BIOL CHEM, V276, P14407, DOI 10.1074/jbc.M009708200	37	36	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14165	14176		10.1074/jbc.M808208200	http://dx.doi.org/10.1074/jbc.M808208200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19339246	hybrid, Green Published			2022-12-25	WOS:000266286100023
J	Zhou, J; Huang, W; Tao, R; Ibaragi, S; Lan, F; Ido, Y; Wu, X; Alekseyev, YO; Lenburg, ME; Hu, GF; Luo, Z				Zhou, J.; Huang, W.; Tao, R.; Ibaragi, S.; Lan, F.; Ido, Y.; Wu, X.; Alekseyev, Y. O.; Lenburg, M. E.; Hu, G-F; Luo, Z.			Inactivation of AMPK alters gene expression and promotes growth of prostate cancer cells	ONCOGENE			English	Article						AMPK; LKB1; cell proliferation; cell cycle; tumor suppressor	ACTIVATED PROTEIN-KINASE; FATTY-ACID SYNTHASE; METABOLIC CHECKPOINT; SOMATIC MUTATIONS; DIABETIC-PATIENTS; METFORMIN; LKB1; PHOSPHORYLATION; APOPTOSIS; TUMORIGENESIS	AMP-activated protein kinase (AMPK) serves as a fuel-sensing enzyme that is activated by binding of AMP and subsequent phophorylation by upstream kinases such as the tumor suppressor LKB1, when cells sense an increase in the ratio of AMP to ATP. Acute activation of AMPK stimulates fatty acid oxidation to generate more ATP and simultaneously inhibits ATP-consuming processes including fatty acid and protein syntheses, thereby preserving energy for acute cell-surviving program, whereas chronic activation leads to inhibition of cell growth. The goal of the present study is to explore the mechanisms by which AMPK regulates cell growth. Toward this end, we established stable cell lines by introducing a dominant-negative mutant of AMPK alpha 1 subunit or its shRNA into the prostate cancer C4-2 cells and other cells, or wild type LKB1 into the lung adenocarcinoma A549 and breast MB-MDA-231 cancer cells, both of which lack functional LKB1. Our results showed that the inhibition of AMPK accelerated cell proliferation and promoted malignant behavior such as increased cell migration and anchorage-independent growth. This was associated with decreased G1 population, downregulation of p53 and p21, and upregulation of S6K, IGF-1 and IGF1R. Conversely, treatment of the C4-2 cells with 5-aminoimidazole-4-carboxamide 1-D-ribonucleoside (AICAR), a prototypical AMPK activator, caused opposite changes. In addition, our study using microarray and RT-PCR revealed that AMPK regulated gene expression involved in tumor cell growth and survival. Thus, our study provides novel insights into the mechanisms of AMPK action in cancer cells and presents AMPK as an ideal drug target for cancer therapy. Oncogene (2009) 28, 1993-2002; doi:10.1038/onc.2009.63; published online 6 April 2009	[Zhou, J.; Huang, W.; Luo, Z.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Ibaragi, S.; Alekseyev, Y. O.; Hu, G-F] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Tao, R.; Lan, F.; Ido, Y.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Wu, X.] ADV Biosci LLC, Birmingham, AL USA; [Lenburg, M. E.; Luo, Z.] Boston Univ, Sch Med, Genome Sci Inst, Boston, MA 02118 USA; [Lenburg, M. E.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA	Boston University; Harvard University; Harvard Medical School; Boston University; Boston University; Boston University	Luo, Z (corresponding author), Boston Univ, Sch Med, Dept Biochem, 715 Albany St,E645, Boston, MA 02118 USA.	zluo@bu.edu	Luo, Zhijun/AAE-9302-2019; Lenburg, Marc/B-8027-2008	Luo, Zhijun/0000-0001-8105-5289; Lenburg, Marc/0000-0002-5760-4708; Ido, Yasuo/0000-0002-3036-9971; Alekseyev, Yuriy/0000-0001-6105-8861	NIH [R01 CA118918, GM 057959]; NATIONAL CANCER INSTITUTE [R01CA118918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057959] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project is supported by NIH R01 Grants, CA118918 and GM 057959 (to Z Luo). We thank Dr David Carling for providing us thecDNA construct for the dominant- negative mutant of AMPKa1 subunit.	Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Barb D, 2007, AM J CLIN NUTR, V86, p858S, DOI 10.1093/ajcn/86.3.858S; Baron A, 2004, J CELL BIOCHEM, V91, P47, DOI 10.1002/jcb.10708; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Carling D, 2006, TRENDS MOL MED, V12, P144, DOI 10.1016/j.molmed.2006.02.003; Chang CK, 2003, DIABETOLOGIA, V46, P595, DOI 10.1007/s00125-003-1109-5; De Schrijver E, 2003, CANCER RES, V63, P3799; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; GONG YF, 1993, MOL PHARMACOL, V44, P30; Grossmann ME, 2008, BRIT J CANCER, V98, P370, DOI 10.1038/sj.bjc.6604166; Gurumurthy S, 2008, CANCER RES, V68, P55, DOI 10.1158/0008-5472.CAN-07-3225; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Haheim LL, 2006, AM J EPIDEMIOL, V164, P769, DOI 10.1093/aje/kwj284; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; He GB, 2006, CANCER RES, V66, P1873, DOI 10.1158/0008-5472.CAN-05-3111; Horman S, 2006, J BIOL CHEM, V281, P5335, DOI 10.1074/jbc.M506850200; Huang X, 2008, BIOCHEM J, V412, P211, DOI 10.1042/BJ20080557; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Isakovic A, 2007, CELL MOL LIFE SCI, V64, P1290, DOI 10.1007/s00018-007-7080-4; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Jimenez AI, 2003, CANCER RES, V63, P1382; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; KLIPPERAURBACH Y, 1995, MED HYPOTHESES, V45, P486, DOI 10.1016/0306-9877(95)90228-7; Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X; Lee IM, 2003, MED SCI SPORT EXER, V35, P1823, DOI 10.1249/01.MSS.0000093620.27893.23; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; Majumder PK, 2005, ONCOGENE, V24, P7465, DOI 10.1038/sj.onc.1209096; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Ngo TH, 2003, ENDOCRINOLOGY, V144, P2319, DOI 10.1210/en.2003-221028; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; Sachdev D, 2007, MOL CANCER THER, V6, P1, DOI 10.1158/1535-7163.MCT-06-0080; Singh AP, 2008, CANCER LETT, V259, P28, DOI 10.1016/j.canlet.2007.09.018; Su GH, 1999, AM J PATHOL, V154, P1835, DOI 10.1016/S0002-9440(10)65440-5; Thupari JN, 2001, BIOCHEM BIOPH RES CO, V285, P217, DOI 10.1006/bbrc.2001.5146; Wu XY, 2000, MOL THER, V2, P47, DOI 10.1006/mthe.2000.0095; Xiang XQ, 2004, BIOCHEM BIOPH RES CO, V321, P161, DOI 10.1016/j.bbrc.2004.06.133	41	88	93	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 7	2009	28	18					1993	2002		10.1038/onc.2009.63	http://dx.doi.org/10.1038/onc.2009.63			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	442DT	19347029	Green Accepted			2022-12-25	WOS:000265820900006
J	Pecinka, A; Rosa, M; Schikora, A; Berlinger, M; Hirt, H; Luschnig, C; Scheid, OM				Pecinka, Ales; Rosa, Marisa; Schikora, Adam; Berlinger, Marc; Hirt, Heribert; Luschnig, Christian; Scheid, Ortrun Mittelsten			Transgenerational Stress Memory Is Not a General Response in Arabidopsis	PLOS ONE			English	Article								Adverse conditions can trigger DNA damage as well as DNA repair responses in plants. A variety of stress factors are known to stimulate homologous recombination, the most accurate repair pathway, by increasing the concentration of necessary enzymatic components and the frequency of events. This effect has been reported to last into subsequent generations not exposed to the stress. To establish a basis for a genetic analysis of this transgenerational stress memory, a broad range of treatments was tested for quantitative effects on homologous recombination in the progeny. Several Arabidopsis lines, transgenic for well-established recombination traps, were exposed to 10 different physical and chemical stress treatments, and scored for the number of somatic homologous recombination (SHR) events in the treated generation as well as in the two subsequent generations that were not treated. These numbers were related to the expression level of genes involved in homologous recombination and repair. SHR was enhanced after the majority of treatments, confirming previous data and adding new effective stress types, especially interference with chromatin. Compounds that directly modify DNA stimulated SHR to values exceeding previously described induction rates, concomitant with an induction of genes involved in SHR. In spite of the significant stimulation in the stressed generations, the two subsequent non-treated generations only showed a low and stochastic increase in SHR that did not correlate with the degree of stimulation in the parental plants. Transcripts coding for SHR enzymes generally returned to pre-treatment levels in the progeny. Thus, transgenerational effects on SHR frequency are not a general response to abiotic stress in Arabidopsis and may require special conditions.	[Pecinka, Ales; Rosa, Marisa; Scheid, Ortrun Mittelsten] Austrian Acad Sci, Gregor Mendel Inst Mol Plant Biol GMI, A-1010 Vienna, Austria; [Schikora, Adam; Hirt, Heribert] INRA URGV, Plant Genom Res Unit, Evry, France; [Berlinger, Marc; Luschnig, Christian] Univ Nat Resources & Appl Life Sci BOKU, Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Natural Resources & Life Sciences, Vienna	Pecinka, A (corresponding author), Austrian Acad Sci, Gregor Mendel Inst Mol Plant Biol GMI, A-1010 Vienna, Austria.	ortrun.mittelsten_scheid@gmi.oeaw.ac.at	Hirt, Heribert/A-2061-2013; Rosa, Marisa/R-4902-2019; Pecinka, Ales/T-9125-2017; Schikora, Adam/B-4842-2014	Rosa, Marisa/0000-0003-2793-8560; Pecinka, Ales/0000-0001-9277-1766; Schikora, Adam/0000-0002-0869-6423; Luschnig, Christian/0000-0003-2099-9280; Mittelsten Scheid, Ortrun/0000-0002-7757-4809				Ataian Y, 2006, BIOCHEM CELL BIOL, V84, P490, DOI 10.1139/O06-075; BABBS CF, 1989, PLANT PHYSIOL, V90, P1267, DOI 10.1104/pp.90.4.1267; BAUBEC T, 2008, PLANT J; BAUR M, 1990, MOL CELL BIOL, V10, P492, DOI 10.1128/MCB.10.2.492; Beemster GTS, 2002, PLANT PHYSIOL, V129, P854, DOI 10.1104/pp.002923; Bleuyard JY, 2005, PLANT J, V41, P533, DOI 10.1111/j.1365-313X.2004.02318.x; Boyko A, 2005, MUTAT RES-FUND MOL M, V572, P73, DOI 10.1016/j.mrfmmm.2004.12.011; Boyko A, 2006, MUTAT RES-FUND MOL M, V602, P100, DOI 10.1016/j.mrfmmm.2006.08.008; Boyko A, 2006, PLANT CELL PHYSIOL, V47, P736, DOI 10.1093/pcp/pcj045; Bray CM, 2005, NEW PHYTOL, V168, P511, DOI 10.1111/j.1469-8137.2005.01548.x; Britt AB, 1999, TRENDS PLANT SCI, V4, P20, DOI 10.1016/S1360-1385(98)01355-7; Chang S, 2005, J BIOL CHEM, V280, P796, DOI 10.1074/jbc.M409053200; Chen ZJ, 1997, GENE DEV, V11, P2124, DOI 10.1101/gad.11.16.2124; Claussen CA, 1999, CHEM REV, V99, P2797, DOI 10.1021/cr980449z; Culligan KM, 2006, PLANT J, V48, P947, DOI 10.1111/j.1365-313X.2006.02931.x; Day CD, 2000, GENE DEV, V14, P2869, DOI 10.1101/gad.849600; Endo M, 2006, EMBO J, V25, P5579, DOI 10.1038/sj.emboj.7601434; Filkowski J, 2004, PLANT J, V38, P1, DOI 10.1111/j.1365-313X.2004.02025.x; Friesner JD, 2005, MOL BIOL CELL, V16, P2566, DOI 10.1091/mbc.E04-10-0890; Fritsch O, 2004, MOL CELL, V16, P479, DOI 10.1016/j.molcel.2004.09.034; Gherbi H, 2001, EMBO REP, V2, P287, DOI 10.1093/embo-reports/kve069; Hanin M, 2000, PLANT J, V24, P183, DOI 10.1046/j.1365-313x.2000.00867.x; Hanin M, 2003, CURR OPIN PLANT BIOL, V6, P157, DOI 10.1016/S1369-5266(03)00016-5; Hasdai M, 2006, ANN APPL BIOL, V148, P113, DOI 10.1111/j.1744-7348.2006.00044.x; Kimura S, 2006, CHEM REV, V106, P753, DOI 10.1021/cr040482n; Kirik A, 2006, PLANT CELL, V18, P2431, DOI 10.1105/tpc.106.045088; Kovalchuk I, 2003, NATURE, V423, P760, DOI 10.1038/nature01683; Kunz BA, 2006, INT REV CYTOL, V255, P1, DOI 10.1016/S0074-7696(06)55001-6; Kurepa J, 1998, PLANT J, V14, P759, DOI 10.1046/j.1365-313x.1998.00168.x; Lafarge S, 2003, NUCLEIC ACIDS RES, V31, P1148, DOI 10.1093/nar/gkg202; LEBEL EG, 1993, P NATL ACAD SCI USA, V90, P422, DOI 10.1073/pnas.90.2.422; Li LL, 2004, PLANT J, V40, P1007, DOI 10.1111/j.1365-313X.2004.02270.x; Lucht JM, 2002, NAT GENET, V30, P311, DOI 10.1038/ng846; Madlung A, 2004, ANN BOT-LONDON, V94, P481, DOI 10.1093/aob/mch172; Mengiste T, 1999, EMBO J, V18, P4505, DOI 10.1093/emboj/18.16.4505; Molinier J, 2005, MUTAT RES-FUND MOL M, V571, P235, DOI 10.1016/j.mrfmmm.2004.09.016; Molinier J, 2004, PLANT CELL, V16, P342, DOI 10.1105/tpc.019042; Molinier J, 2006, NATURE, V442, P1046, DOI 10.1038/nature05022; Nabatiyan A, 2006, MOL CELL BIOL, V26, P1839, DOI 10.1128/MCB.26.5.1839-1849.2006; Preuss SB, 2003, GENETICS, V164, P323; PUCHTA H, 1991, NUCLEIC ACIDS RES, V19, P2693, DOI 10.1093/nar/19.10.2693; PUCHTA H, 1995, PLANT J, V7, P203, DOI 10.1046/j.1365-313X.1995.7020203.x; PUCHTA H, 1995, PLANT MOL BIOL, V28, P281, DOI 10.1007/BF00020247; Ricaud L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000430; Ridgway P, 2000, J CELL SCI, V113, P2647; Ries G, 2000, P NATL ACAD SCI USA, V97, P13425, DOI 10.1073/pnas.230251897; Ries G, 2000, NATURE, V406, P98, DOI 10.1038/35017595; Schuermann D, 2005, TRENDS GENET, V21, P172, DOI 10.1016/j.tig.2005.01.002; Shahrezaei V, 2008, CURR OPIN BIOTECH, V19, P369, DOI 10.1016/j.copbio.2008.06.011; Shaked H, 2006, GENETICS, V173, P985, DOI 10.1534/genetics.105.051664; SLOOTEN L, 1995, PLANT PHYSIOL, V107, P737, DOI 10.1104/pp.107.3.737; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; Sreenivasulu N, 2007, GENE, V388, P1, DOI 10.1016/j.gene.2006.10.009; Sun XQ, 2008, MOL BIOL EVOL, V25, P2079, DOI 10.1093/molbev/msn158; SWOBODA P, 1994, EMBO J, V13, P484, DOI 10.1002/j.1460-2075.1994.tb06283.x; Takeda S, 2004, GENE DEV, V18, P782, DOI 10.1101/gad.295404; TINLAND B, 1994, P NATL ACAD SCI USA, V91, P8000, DOI 10.1073/pnas.91.17.8000; van Attikum H, 2005, NAT REV MOL CELL BIO, V6, P757, DOI 10.1038/nrm1737; Young LW, 2005, GENOME, V48, P547, DOI 10.1139/G05-003; Zhou L, 2002, J MOL BIOL, V321, P591, DOI 10.1016/S0022-2836(02)00676-9	60	113	113	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2009	4	4							e5202	10.1371/journal.pone.0005202	http://dx.doi.org/10.1371/journal.pone.0005202			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VA	19381297	gold, Green Published			2022-12-25	WOS:000265513800002
J	Silva, RM; Duarte, ICN; Paredes, JA; Lima-Costa, T; Perrot, M; Boucherie, H; Goodfellow, BJ; Gomes, AC; Mateus, DD; Moura, GR; Santos, MAS				Silva, Raquel M.; Duarte, Iven C. N.; Paredes, Joao A.; Lima-Costa, Tatiana; Perrot, Michel; Boucherie, Helian; Goodfellow, Brian J.; Gomes, Ana C.; Mateus, Denisa D.; Moura, Gabriela R.; Santos, Manuel A. S.			The Yeast PNC1 Longevity Gene Is Up-Regulated by mRNA Mistranslation	PLOS ONE			English	Article								Translation fidelity is critical for protein synthesis and to ensure correct cell functioning. Mutations in the protein synthesis machinery or environmental factors that increase synthesis of mistranslated proteins result in cell death and degeneration and are associated with neurodegenerative diseases, cancer and with an increasing number of mitochondrial disorders. Remarkably, mRNA mistranslation plays critical roles in the evolution of the genetic code, can be beneficial under stress conditions in yeast and in Escherichia coli and is an important source of peptides for MHC class I complex in dendritic cells. Despite this, its biology has been overlooked over the years due to technical difficulties in its detection and quantification. In order to shed new light on the biological relevance of mistranslation we have generated codon misreading in Saccharomyces cerevisiae using drugs and tRNA engineering methodologies. Surprisingly, such mistranslation up-regulated the longevity gene PNC1. Similar results were also obtained in cells grown in the presence of amino acid analogues that promote protein misfolding. The overall data showed that PNC1 is a biomarker of mRNA mistranslation and protein misfolding and that PNC1-GFP fusions can be used to monitor these two important biological phenomena in vivo in an easy manner, thus opening new avenues to understand their biological relevance.			Silva, RM (corresponding author), Univ Porto, Inst Mol Pathol & Immunol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	msantos@ua.pt	Gomes, Ana Catarina/A-2628-2015; Silva, Raquel M/B-8337-2008; Moura, Gabriela R/E-6717-2010; Mateus, Denisa D/J-8827-2014; Moura, Gabriela/GPF-9079-2022; Goodfellow, Brian J/F-4638-2016; Santos, Manuel/E-6704-2010	Gomes, Ana Catarina/0000-0002-4989-6026; Silva, Raquel M/0000-0001-5926-8042; Moura, Gabriela R/0000-0003-2243-6123; Mateus, Denisa D/0000-0002-8665-5176; Moura, Gabriela/0000-0003-2243-6123; Goodfellow, Brian J/0000-0003-3191-7121; Santos, Manuel/0000-0002-0437-1146; Lima Costa, Tatiana/0000-0002-0675-8096; Paredes, Joao/0000-0002-7788-8939				Anderson RM, 2003, SCIENCE, V302, P2124, DOI 10.1126/science.1088697; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; BOUCHERIE H, 1995, YEAST, V11, P601, DOI 10.1002/yea.320110702; Boucherie H, 1996, ELECTROPHORESIS, V17, P1683, DOI 10.1002/elps.1150171106; BOUCHERIE H, 2005, YEAST PROTOCOLS, P47; EDELMANN P, 1977, CELL, V10, P131, DOI 10.1016/0092-8674(77)90147-7; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Farabaugh PJ, 1999, EMBO J, V18, P1427, DOI 10.1093/emboj/18.6.1427; Gallo CA, 2004, MOL CELL BIOL, V24, P1301, DOI 10.1128/MCB.24.3.1301-1312.2004; Ghislain M, 2002, YEAST, V19, P215, DOI 10.1002/yea.810; Gietz R.D., 1994, MOL GENETICS YEAST P, P121; Gomes AC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r206; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kimata Y, 2004, J CELL SCI, V117, P2283, DOI 10.1242/jcs.01078; Knight RD, 2001, J MOL EVOL, V53, P299, DOI 10.1007/s002390010220; Kramer EB, 2007, RNA, V13, P87, DOI 10.1261/rna.294907; Lahue E, 2005, YEAST, V22, P537, DOI 10.1002/yea.1231; Lamming DW, 2005, SCIENCE, V309, P1861, DOI 10.1126/science.1113611; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2003, CURR OPIN CELL BIOL, V15, P241, DOI 10.1016/S0955-0674(03)00006-1; Ling JQ, 2007, P NATL ACAD SCI USA, V104, P15299, DOI 10.1073/pnas.0704441104; Miranda I, 2006, YEAST, V23, P203, DOI 10.1002/yea.1350; Miranda I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000996; MURGOLA EJ, 1984, J MOL BIOL, V175, P19, DOI 10.1016/0022-2836(84)90442-X; Nangle LA, 2006, CHEM BIOL, V13, P1091, DOI 10.1016/j.chembiol.2006.08.011; Oberdoerffer P, 2007, NAT REV MOL CELL BIO, V8, P692, DOI 10.1038/nrm2238; Ortego BC, 2007, BIOCHEMISTRY-US, V46, P13864, DOI 10.1021/bi602660s; PARKER J, 1986, MOL GEN GENET, V204, P70, DOI 10.1007/BF00330189; Rabilloud T, 2002, BIOCHEMISTRY-US, V41, P144, DOI 10.1021/bi0114776; Reverter-Branchat G, 2004, J BIOL CHEM, V279, P31983, DOI 10.1074/jbc.M404849200; Santos MAS, 2004, TRENDS GENET, V20, P95, DOI 10.1016/j.tig.2003.12.009; Santos MAS, 1996, EMBO J, V15, P5060, DOI 10.1002/j.1460-2075.1996.tb00886.x; SCHULTZ DW, 1994, J MOL BIOL, V235, P1377, DOI 10.1006/jmbi.1994.1094; Silva RM, 2007, EMBO J, V26, P4555, DOI 10.1038/sj.emboj.7601876; Silva Raquel M., 2004, Briefings in Functional Genomics & Proteomics, V3, P35, DOI 10.1093/bfgp/3.1.35; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Sinclair DA, 2003, SCIENCE, V301, P1859, DOI 10.1126/science.1090465; Singer MS, 1998, GENETICS, V150, P613; Smith JS, 1998, GENETICS, V149, P1205; Stansfield I, 1998, J MOL BIOL, V282, P13, DOI 10.1006/jmbi.1998.1976; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Trotter EW, 2002, J BIOL CHEM, V277, P44817, DOI 10.1074/jbc.M204686200; Wilson FH, 2004, SCIENCE, V306, P1190, DOI 10.1126/science.1102521; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yang HY, 2006, EXP GERONTOL, V41, P718, DOI 10.1016/j.exger.2006.06.003; Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251; Yewdell JW, 1996, J IMMUNOL, V157, P1823; Yewdell JW, 2001, J CELL SCI, V114, P845	50	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2009	4	4							e5212	10.1371/journal.pone.0005212	http://dx.doi.org/10.1371/journal.pone.0005212			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TW	19381334	gold, Green Published, Green Submitted			2022-12-25	WOS:000265510800007
J	Subramanian, S; Hardt, M; Choe, Y; Niles, RK; Johansen, EB; Legac, J; Gut, J; Kerr, ID; Craik, CS; Rosenthal, PJ				Subramanian, Shoba; Hardt, Markus; Choe, Youngchool; Niles, Richard K.; Johansen, Eric B.; Legac, Jennifer; Gut, Jiri; Kerr, Iain D.; Craik, Charles S.; Rosenthal, Philip J.			Hemoglobin Cleavage Site-Specificity of the Plasmodium falciparum Cysteine Proteases Falcipain-2 and Falcipain-3	PLOS ONE			English	Article								The Plasmodium falciparum cysteine proteases falcipain-2 and falcipain-3 degrade host hemoglobin to provide free amino acids for parasite protein synthesis. Hemoglobin hydrolysis has been described as an ordered process initiated by aspartic proteases, but cysteine protease inhibitors completely block the process, suggesting that cysteine proteases can also initiate hemoglobin hydrolysis. To characterize the specific roles of falcipains, we used three approaches. First, using random P-1-P-4 amino acid substrate libraries, falcipain-2 and falcipain-3 demonstrated strong preference for cleavage sites with Leu at the P-2 position. Second, with overlapping peptides spanning alpha and beta globin and proteolysis-dependent O-18 labeling, hydrolysis was seen at many cleavage sites. Third, with intact hemoglobin, numerous cleavage products were identified. Our results suggest that hemoglobin hydrolysis by malaria parasites is not a highly ordered process, but rather proceeds with rapid cleavage by falcipains at multiple sites. However, falcipain-2 and falcipain-3 show strong specificity for P-2 Leu in small peptide substrates, in agreement with the specificity in optimized small molecule inhibitors that was identified previously. These results are consistent with a principal role of falcipain-2 and falcipain-3 in the hydrolysis of hemoglobin by P. falciparum and with the possibility of developing small molecule inhibitors with optimized specificity as antimalarial agents.			Subramanian, S (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	prosenthal@medsfgh.ucsf.edu	Hardt, Markus/M-8569-2019	Hardt, Markus/0000-0002-2300-216X; Subramanian, Shoba/0000-0002-4206-3400	NIAID NIH HHS [AI35707, R29 AI035800, R01 AI035800, P01 AI035707, R56 AI035800, AI AI035800] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035800, R56AI035800, R29AI035800, P01AI035707] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aidoo M, 2002, LANCET, V359, P1311, DOI 10.1016/S0140-6736(02)08273-9; Alker AP, 2007, AM J TROP MED HYG, V76, P641, DOI 10.4269/ajtmh.2007.76.641; Banerjee R, 2002, P NATL ACAD SCI USA, V99, P990, DOI 10.1073/pnas.022630099; Bennett TN, 2004, MOL BIOCHEM PARASIT, V133, P99, DOI 10.1016/j.molbiopara.2003.09.008; Bonilla JA, 2007, INT J PARASITOL, V37, P317, DOI 10.1016/j.ijpara.2006.11.008; Bonilla JA, 2007, MOL MICROBIOL, V65, P64, DOI 10.1111/j.1365-2958.2007.05768.x; Breman JG, 2001, AM J TROP MED HYG, V64, P1; Brindley PJ, 2001, MOL BIOCHEM PARASIT, V112, P103, DOI 10.1016/S0166-6851(00)00351-0; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Dahl EL, 2005, MOL BIOCHEM PARASIT, V139, P205, DOI 10.1016/j.molbiopara.2004.11.009; Dalal S, 2007, J BIOL CHEM, V282, P35978, DOI 10.1074/jbc.M703643200; Dasaradhi PVN, 2007, MOL BIOCHEM PARASIT, V156, P12, DOI 10.1016/j.molbiopara.2007.06.008; Dasaradhi PVN, 2005, BIOCHEM BIOPH RES CO, V336, P1062, DOI 10.1016/j.bbrc.2005.08.213; Debela M, 2006, J BIOL CHEM, V281, P25678, DOI 10.1074/jbc.M602372200; Dhawan S, 2003, J BIOL CHEM, V278, P30180, DOI 10.1074/jbc.M305132200; Drew ME, 2008, J BIOL CHEM, V283, P12870, DOI 10.1074/jbc.M708949200; Eggleson KK, 1999, J BIOL CHEM, V274, P32411, DOI 10.1074/jbc.274.45.32411; Fairhurst RM, 2003, BLOOD, V101, P3309, DOI 10.1182/blood-2002-10-3105; Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97; GAMBOADE DN, 1996, BLOOD, V87, P4448; Goetz DH, 2007, BIOCHEMISTRY-US, V46, P8744, DOI 10.1021/bi0621415; Hanspal M, 2002, BLOOD, V100, P1048, DOI 10.1182/blood-2002-01-0101; Harris JL, 1998, J BIOL CHEM, V273, P27364, DOI 10.1074/jbc.273.42.27364; Hogg T, 2006, J BIOL CHEM, V281, P25425, DOI 10.1074/jbc.M603776200; Kerr LD, 2009, J MED CHEM, V52, P852, DOI 10.1021/jm8013663; Klemba M, 2004, J BIOL CHEM, V279, P43000, DOI 10.1074/jbc.M408123200; Kolakovich KA, 1997, MOL BIOCHEM PARASIT, V87, P123, DOI 10.1016/S0166-6851(97)00062-5; KROGSTAD DJ, 1985, J CELL BIOL, V101, P2302, DOI 10.1083/jcb.101.6.2302; Kuhn Y, 2007, CELL MICROBIOL, V9, P1004, DOI 10.1111/j.1462-5822.2006.00847.x; Lee BJ, 2003, ANTIMICROB AGENTS CH, V47, P3810, DOI 10.1128/AAC.47.12.3810-3814.2003; Liu J, 2006, P NATL ACAD SCI USA, V103, P8840, DOI 10.1073/pnas.0601876103; May J, 2007, JAMA-J AM MED ASSOC, V297, P2220, DOI 10.1001/jama.297.20.2220; Miyagi M, 2007, MASS SPECTROM REV, V26, P121, DOI 10.1002/mas.20116; Modiano D, 2001, NATURE, V414, P305, DOI 10.1038/35104556; Murata CE, 2003, J BIOL CHEM, V278, P38022, DOI 10.1074/jbc.M306842200; Nosten F, 2007, AM J TROP MED HYG, V77, P181, DOI 10.4269/ajtmh.2007.77.181; Pandey KC, 2005, P NATL ACAD SCI USA, V102, P9138, DOI 10.1073/pnas.0502368102; Pandey KC, 2004, J BIOL CHEM, V279, P3484, DOI 10.1074/jbc.M310536200; Robinson S, 2008, PROTEOMICS, V8, P435, DOI 10.1002/pmic.200700680; Rosenthal PJ, 1996, ANTIMICROB AGENTS CH, V40, P1600, DOI 10.1128/AAC.40.7.1600; ROSENTHAL PJ, 1991, J CLIN INVEST, V88, P1467, DOI 10.1172/JCI115456; Rosenthal PJ, 2005, MOLECULAR APPROACHES TO MALARIA, P311; Rosenthal PJ, 2004, INT J PARASITOL, V34, P1489, DOI 10.1016/j.ijpara.2004.10.003; ROSENTHAL PJ, 1988, J CLIN INVEST, V82, P1560, DOI 10.1172/JCI113766; Rugles SW, 2004, J BIOL CHEM, V279, P30751, DOI 10.1074/jbc.M400949200; Shenai BR, 2000, J BIOL CHEM, V275, P29000, DOI 10.1074/jbc.M004459200; Shenai BR, 2002, MOL BIOCHEM PARASIT, V122, P99, DOI 10.1016/S0166-6851(02)00075-0; Sijwali PS, 2004, P NATL ACAD SCI USA, V101, P4384, DOI 10.1073/pnas.0307720101; Sijwali PS, 2002, J BIOL CHEM, V277, P14910, DOI 10.1074/jbc.M109680200; Sijwali PS, 2001, BIOCHEM J, V360, P481, DOI 10.1042/0264-6021:3600481; Sijwali PS, 2001, PROTEIN EXPRES PURIF, V22, P128, DOI 10.1006/prep.2001.1416; Sijwali PS, 2006, MOL BIOCHEM PARASIT, V150, P96, DOI 10.1016/j.molbiopara.2006.06.013; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Sojka D, 2007, INT J PARASITOL, V37, P713, DOI 10.1016/j.ijpara.2006.12.020; Subramanian S, 2007, J BIOL CHEM, V282, P24961, DOI 10.1074/jbc.M703316200; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Wang SX, 2006, P NATL ACAD SCI USA, V103, P11503, DOI 10.1073/pnas.0600489103; Williams TN, 2005, J INFECT DIS, V192, P178, DOI 10.1086/430744; Woessner JF, 2004, HDB PROTEOLYTIC ENZY; Wongsrichanalai C, 2002, LANCET INFECT DIS, V2, P209, DOI 10.1016/S1473-3099(02)00239-6; YAYON A, 1984, EMBO J, V3, P2695, DOI 10.1002/j.1460-2075.1984.tb02195.x	61	50	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5156	10.1371/journal.pone.0005156	http://dx.doi.org/10.1371/journal.pone.0005156			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357776	gold, Green Submitted, Green Published			2022-12-25	WOS:000265505900016
J	Charles, C; Pantalacci, S; Tafforeau, P; Headon, D; Laudet, V; Viriot, L				Charles, Cyril; Pantalacci, Sophie; Tafforeau, Paul; Headon, Denis; Laudet, Vincent; Viriot, Laurent			Distinct Impacts of Eda and Edar Loss of Function on the Mouse Dentition	PLOS ONE			English	Article								Background: The Eda-A1-Edar signaling pathway is involved in the development of organs with an ectodermal origin, including teeth. In mouse, mutants are known for both the ligand, Eda-A1 (Tabby), and the receptor, Edar (Downless). The adult dentitions of these two mutants have classically been considered to be similar. However, previous studies mentioned differences in embryonic dental development between Eda Ta and Edar dl-J mutants. A detailed study of tooth morphology in mutants bearing losses of functions of these two genes thus appears necessary to test the pattern variability induced by the developmental modifications. Methodology/Principal Findings: 3D-reconstructions of the cheek teeth have been performed at the ESRF (Grenoble, France) by X-ray synchrotron microtomography to assess dental morphology. The morphological variability observed in Eda Ta and Edar dl-J mutants have then been compared in detail. Despite patchy similarities, our detailed work on cheek teeth in Eda Ta and Edar dl-J mice show that all dental morphotypes defined in Edar dl-J mice resolutely differ from those of Eda Ta mice. This study reveals that losses of function of Eda and Edar have distinct impacts on the tooth size and morphology, contrary to what has previously been thought. Conclusion/Signifiance: The results indicate that unknown mechanisms of the Eda pathway are implicated in tooth morphogenesis. Three hypotheses could explain our results; an unexpected role of the Xedar pathway (which is influenced by the Eda gene product but not that of Edar), a more complex connection than has been appreciated between Edar and another protein, or a ligand-independent activity for Edar. Further work is necessary to test these hypotheses and improve our understanding of the mechanisms of development.	[Charles, Cyril] Univ Poitiers, Inst Int Paleoprimatol Paleontol Humaine Evolut, CNRS, UMR 6046, Poitiers, France; [Pantalacci, Sophie; Laudet, Vincent; Viriot, Laurent] Univ Lyon, Inst Genom Fonct Lyon, CNRS, Ecole Normale Superieure Lyon, UMR 5242, Lyon, France; [Tafforeau, Paul] European Synchrotron Radiat Facil, Grenoble, France; [Headon, Denis] Univ Edinburgh, Roslin Inst, Edinburgh EH8 9YL, Midlothian, Scotland; [Headon, Denis] Univ Edinburgh, Royal Dick Sch Vet Stud, Edinburgh EH8 9YL, Midlothian, Scotland	Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); European Synchrotron Radiation Facility (ESRF); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Charles, C (corresponding author), Univ Calif San Francisco, Dept Orofacial Sci, San Francisco, CA 94143 USA.	Laurent.Viriot@ens-lyon.fr	Charles, Cyril/E-7606-2011	Charles, Cyril/0000-0002-6930-039X; Viriot, Laurent/0000-0003-2092-588X; Tafforeau, Paul/0000-0002-5962-1683	ANR (Quenottes program).; Poitou-Charentes; Rhone-Alpes; Fondation pour la Recherche Medicale; Fondation Singer-Polignac; CNRS [fellowship]	ANR (Quenottes program).(French National Research Agency (ANR)); Poitou-Charentes(Region Nouvelle-Aquitaine); Rhone-Alpes(Region Auvergne-Rhone-Alpes); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation Singer-Polignac; CNRS(Centre National de la Recherche Scientifique (CNRS))	This study has been supported by the ANR (Quenottes program). Other supports have been provided by the regions Poitou-Charentes and Rhone-Alpes, the Fondation pour la Recherche Medicale, and the Fondation Singer-Polignac. SP holds a fellowship from CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHARLES C, 2007, EUR J ORAL SCI, V114, P1; Charles C, 2009, ANAT REC, V292, P299, DOI 10.1002/ar.20804; Courtney JM, 2005, ARCH ORAL BIOL, V50, P159, DOI 10.1016/j.archoralbio.2004.11.019; Drew CF, 2007, DEV BIOL, V305, P232, DOI 10.1016/j.ydbio.2007.02.011; GRUNEBERG H, 1971, PROC R SOC SER B-BIO, V179, P139, DOI 10.1098/rspb.1971.0086; GRUNEBERG H, 1966, J EMBRYOL EXP MORPH, V15, P223; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; Headon DJ, 2001, NATURE, V414, P913, DOI 10.1038/414913a; Jaskoll T, 2003, ANAT REC PART A, V271A, P322, DOI 10.1002/ar.a.10045; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P2641, DOI 10.1073/pnas.050586297; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Kristenova P, 2002, Orthod Craniofac Res, V5, P205, DOI 10.1034/j.1600-0544.2002.02225.x; Kumar A, 2001, J BIOL CHEM, V276, P2668, DOI 10.1074/jbc.M008356200; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; Mou C, 2006, P NATL ACAD SCI USA, V103, P9075, DOI 10.1073/pnas.0600825103; Mustonen T, 2003, DEV BIOL, V259, P123, DOI 10.1016/S0012-1606(03)00157-X; Newton K, 2004, MOL CELL BIOL, V24, P1608, DOI 10.1128/MCB.24.4.1608-1613.2004; Pantalacci S, 2008, MOL BIOL EVOL, V25, P912, DOI 10.1093/molbev/msn038; Peterkova R, 2005, ARCH ORAL BIOL, V50, P219, DOI 10.1016/j.archoralbio.2004.10.020; Peterson C., 2006, J POSIT PSYCHOL, V1, P17, DOI [10.1080/17439760500372739, DOI 10.1080/17439760500372739]; Pispa J, 1999, DEV BIOL, V216, P521, DOI 10.1006/dbio.1999.9514; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; SOFAER JA, 1977, ARCH ORAL BIOL, V22, P299, DOI 10.1016/0003-9969(77)90117-0; SOFAER JA, 1969, J EMBRYOL EXP MORPH, V22, P207; SOFAER JA, 1969, J EMBRYOL EXP MORPH, V22, P181; Tafforeau P, 2006, APPL PHYS A-MATER, V83, P195, DOI 10.1007/s00339-006-3507-2; Tucker AS, 2000, DEVELOPMENT, V127, P4691; Vaahtokari A, 1996, MECH DEVELOP, V54, P39, DOI 10.1016/0925-4773(95)00459-9; Yan MH, 2000, SCIENCE, V290, P523, DOI 10.1126/science.290.5491.523	30	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e4985	10.1371/journal.pone.0004985	http://dx.doi.org/10.1371/journal.pone.0004985			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340299	Green Published, gold			2022-12-25	WOS:000265500700004
J	Mattei, V; Barenco, MG; Tasciotti, V; Garofalo, T; Longo, A; Boller, K; Lower, J; Misasi, R; Montrasio, F; Sorice, M				Mattei, Vincenzo; Barenco, Maria Grazia; Tasciotti, Vincenzo; Garofalo, Tina; Longo, Agostina; Boller, Klaus; Loewer, Johannes; Misasi, Roberta; Montrasio, Fabio; Sorice, Maurizio			Paracrine Diffusion of PrPC and Propagation of Prion Infectivity by Plasma Membrane-Derived Microvesicles	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; PERIPHERAL NERVOUS-SYSTEM; SCRAPIE AGENT; ENDOTHELIAL MICROPARTICLES; SIGNALING COMPLEX; DENDRITIC CELLS; INCUBATION-TIME; CRUCIAL ROLE; PROTEIN PRP; B-CELLS	Cellular prion protein (PrPc) is a physiological constituent of eukaryotic cells. The cellular pathways underlying prions spread from the sites of prions infection/peripheral replication to the central nervous system are still not elucidated. Membrane-derived microvesicles (MVs) are submicron (0.1-1 mu m) particles, that are released by cells during plasma membrane shedding processes. They are usually liberated from different cell types, mainly upon activation as well as apoptosis, in this case, one of their hallmarks is the exposure of phosphatidylserine in the outer leaflet of the membrane. MVs are also characterized by the presence of adhesion molecules, MHC I molecules, as well as of membrane antigens typical of their cell of origin. Evidence exists that MVs shedding provide vehicles to transfer molecules among cells, and that MVs are important modulators of cell-to-cell communication. In this study we therefore analyzed the potential role of membrane-derived MVs in the mechanism(s) of PrPC diffusion and prion infectivity transmission. We first identified PrPC in association with the lipid raft components Fyn, flotillin-2, GM1 and GM3 in MVs from plasma of healthy human donors. Similar findings were found in MVs from cell culture supernatants of murine neuronal cells. Furthermore we demonstrated that PrPSc is released from infected murine neuronal cells in association with plasma membrane-derived MVs and that PrPSc-bearing MVs are infectious both in vitro and in vivo. The data suggest that MVs may contribute both to the intercellular mechanism(s) of PrPC diffusion and signaling as well as to the process of prion spread and neuroinvasion.	[Mattei, Vincenzo; Tasciotti, Vincenzo; Garofalo, Tina; Longo, Agostina; Misasi, Roberta; Sorice, Maurizio] Sapienza Univ, Dipartimento Med Sperimentale, Rome, Italy; [Mattei, Vincenzo; Tasciotti, Vincenzo; Sorice, Maurizio] Polo Univ Rieti Sabina Univ, Lab Med Sperimentale Patol Ambientale, Rieti, Italy; [Barenco, Maria Grazia; Boller, Klaus; Loewer, Johannes; Montrasio, Fabio] Paul Ehrlich Strasse, Paul Ehrlich Inst, Prion Res Grp, Langen, Germany	Sapienza University Rome; Paul Ehrlich Institute	Mattei, V (corresponding author), Sapienza Univ, Dipartimento Med Sperimentale, Rome, Italy.	maurizio.sorice@uniroma1.it	Sorice, Maurizio/Q-5079-2019; Sousa, Maria/HCI-9642-2022; Mattei, Vincenzo/AAQ-3667-2020	Mattei, Vincenzo/0000-0003-4677-088X; Garofalo, Tina/0000-0003-0645-2510; Sorice, Maurizio/0000-0003-3534-1502; Montrasio, Fabio/0000-0002-6069-1937	Sapienza University, Rome, Italy	Sapienza University, Rome, Italy	This work was supported by grants to Maurizio Sorice from Sapienza University, Rome, Italy. The funders had a role in data collection and analysis and in the preparation and publication of the manuscript.	Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; Aguzzi A, 2006, NAT REV MICROBIOL, V4, P765, DOI 10.1038/nrmicro1492; Alais S, 2008, BIOL CELL, V100, P603, DOI 10.1042/BC20080025; Baj-Krzyworzeka M, 2002, EXP HEMATOL, V30, P450, DOI 10.1016/S0301-472X(02)00791-9; Baron GS, 2002, EMBO J, V21, P1031, DOI 10.1093/emboj/21.5.1031; Beringue V, 2000, J PATHOL, V190, P495, DOI 10.1002/(SICI)1096-9896(200003)190:4&lt;495::AID-PATH535&gt;3.0.CO;2-T; Bishop MT, 2006, LANCET NEUROL, V5, P393, DOI 10.1016/S1474-4422(06)70413-6; Bons N, 2002, TRANSFUSION, V42, P513, DOI 10.1046/j.1537-2995.2002.00098.x; Brandner S, 1999, TRANSFUS CLIN BIOL, V6, P17, DOI 10.1016/S1246-7820(99)80007-X; BROWN KL, 2000, ARCH VIROL, V16, P13; Cervenakova L, 2003, TRANSFUSION, V43, P1687, DOI 10.1046/j.0041-1132.2003.00586.x; COHEN FE, 1994, SCIENCE, V264, P530, DOI 10.1126/science.7909169; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; Dignat-George F, 2004, THROMB HAEMOSTASIS, V91, P667, DOI 10.1160/TH03-07-0487; ENDO T, 1989, BIOCHEMISTRY-US, V28, P8380, DOI 10.1021/bi00447a017; Fagge T, 2005, TRANSFUSION, V45, P504, DOI 10.1111/j.0041-1132.2005.04342.x; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Favereaux A, 2004, ARCH NEUROL-CHICAGO, V61, P747, DOI 10.1001/archneur.61.5.747; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Garofalo T, 2003, J BIOL CHEM, V278, P8309, DOI 10.1074/jbc.M207618200; Geminard C, 2004, TRAFFIC, V5, P181, DOI 10.1111/j.1600-0854.2004.0167.x; Glatzel M, 2000, J GEN VIROL, V81, P2813, DOI 10.1099/0022-1317-81-11-2813; Glaysher BR, 2007, J IMMUNOL, V178, P3757, DOI 10.4049/jimmunol.178.6.3757; HEYNINGEN SV, 1974, SCIENCE, V183, P656, DOI DOI 10.1126/SCIENCE.183.4125.656; Huang FP, 2002, J GEN VIROL, V83, P267, DOI 10.1099/0022-1317-83-1-267; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; Joop K, 2001, THROMB HAEMOSTASIS, V85, P810; Klein MA, 1997, NATURE, V390, P687, DOI 10.1038/37789; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; KOTANI M, 1992, BIOCHIM BIOPHYS ACTA, V1117, P97, DOI 10.1016/0304-4165(92)90168-T; Lee CCM, 2005, J NEUROPATH EXP NEUR, V64, P716, DOI 10.1097/01.jnen.0000175330.66715.08; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Ludlam CA, 2006, BRIT J HAEMATOL, V132, P13, DOI 10.1111/j.1365-2141.2005.05796.x; Mabbott NA, 2003, J VIROL, V77, P6845, DOI 10.1128/JVI.77.12.6845-6854.2003; Mabbott N, 2005, HAEMATOLOGICA, V90, P542; MacGregor I, 1999, VOX SANG, V77, P88; Maignien T, 2005, INT J PHARMACEUT, V298, P293, DOI 10.1016/j.ijpharm.2005.02.042; Martinez MC, 2005, AM J PHYSIOL-HEART C, V288, pH1004, DOI 10.1152/ajpheart.00842.2004; Mattei V, 2004, FEBS LETT, V560, P14, DOI 10.1016/S0014-5793(04)00029-8; Mattei V, 2002, NEUROCHEM RES, V27, P743, DOI 10.1023/A:1020244621373; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; Montrasio F, 2001, P NATL ACAD SCI USA, V98, P4034, DOI 10.1073/pnas.051609398; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Naslavsky N, 1999, J BIOL CHEM, V274, P20763, DOI 10.1074/jbc.274.30.20763; Naslavsky N, 1997, J BIOL CHEM, V272, P6324, DOI 10.1074/jbc.272.10.6324; Pelchen-Matthews A, 2004, TRENDS MICROBIOL, V12, P310, DOI 10.1016/j.tim.2004.05.004; Prinz M, 2004, J NEUROSCI, V24, P5974, DOI 10.1523/JNEUROSCI.0122-04.2004; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Raymond CR, 2007, J NEUROIMMUNOL, V187, P114, DOI 10.1016/j.jneuroim.2007.05.006; Robertson C, 2006, BLOOD, V107, P3907, DOI 10.1182/blood-2005-02-0802; Rozmyslowicz T, 2003, AIDS, V17, P33, DOI 10.1097/00002030-200301030-00006; Sabatier F, 2002, BLOOD, V99, P3962, DOI 10.1182/blood.V99.11.3962; Sethi S, 2007, J VIROL, V81, P4877, DOI 10.1128/JVI.02345-06; Simak J, 2006, TRANSFUS MED REV, V20, P1, DOI 10.1016/j.tmrv.2005.08.001; Slaughter N, 2003, CLIN IMMUNOL, V108, P138, DOI 10.1016/S1521-6616(03)00097-4; SOMERVILLE RA, 1990, J GEN VIROL, V71, P833, DOI 10.1099/0022-1317-71-4-833; Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Stuermer CAO, 2004, FASEB J, V18, P1731, DOI 10.1096/fj.04-2150fje; SVENNERHOLM L, 1980, BIOCHIM BIOPHYS ACTA, V617, P97, DOI 10.1016/0005-2760(80)90227-1; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Towbin H, 1992, Biotechnology, V24, P145; Valaperta R, 2007, J NEUROCHEM, V100, P708, DOI 10.1111/j.1471-4159.2006.04279.x; Vella LJ, 2007, J PATHOL, V211, P582, DOI 10.1002/path.2145	70	35	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5057	10.1371/journal.pone.0005057	http://dx.doi.org/10.1371/journal.pone.0005057			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337375	gold, Green Published, Green Submitted			2022-12-25	WOS:000265500600016
J	Oulhen, N; Boulben, S; Bidinosti, M; Morales, J; Cormier, P; Cosson, B				Oulhen, Nathalie; Boulben, Sandrine; Bidinosti, Michael; Morales, Julia; Cormier, Patrick; Cosson, Bertrand			A Variant Mimicking Hyperphosphorylated 4E-BP Inhibits Protein Synthesis in a Sea Urchin Cell-Free, Cap-Dependent Translation System	PLOS ONE			English	Article							FACTOR 4E-BINDING PROTEIN-1; MESSENGER-RNA TRANSLATION; INITIATION-FACTOR 4E; EIF4E-BINDING PROTEINS; BINDING-PROTEIN; FERTILIZATION; PHOSPHORYLATION; EGGS; INSULIN; EIF4E	Background: 4E-BP is a translational inhibitor that binds to eIF4E to repress cap-dependent translation initiation. This critical protein: protein interaction is regulated by the phosphorylation of 4E-BP. Hypophosphorylated 4E-BP binds to eIF4E and inhibits cap-dependent translation, whereas hyperphosphorylated forms do not. While three 4E-BP proteins exist in mammals, only one gene encoding for 4E-BP is present in the sea urchin genome. The protein product has a highly conserved core domain containing the eIF4E-binding domain motif (YxxxxL Phi) and four of the regulatory phosphorylation sites. Methodology/Principal Findings: Using a sea urchin cell-free cap-dependent translation system prepared from fertilized eggs, we provide the first direct evidence that the sea urchin 4E-BP inhibits cap-dependent translation. We show here that a sea urchin 4E-BP variant, mimicking phosphorylation on four core residues required to abrogate binding to eIF4E, surprisingly maintains physical association to eIF4E and inhibits protein synthesis. Conclusions/Significance: Here, we examine the involvement of the evolutionarily conserved core domain and phosphorylation sites of sea urchin 4E-BP in the regulation of eIF4E-binding. These studies primarily demonstrate the conserved activity of the 4E-BP translational repressor and the importance of the eIF4E-binding domain in sea urchin. We also show that a variant mimicking hyperphosphorylation of the four regulatory phosphorylation sites common to sea urchin and human 4E-BP is not sufficient for release from eIF4E and translation promotion. Therefore, our results suggest that there are additional mechanisms to that of phosphorylation at the four critical sites of 4E-BP that are required to disrupt binding to eIF4E.	[Oulhen, Nathalie; Boulben, Sandrine; Morales, Julia; Cormier, Patrick; Cosson, Bertrand] Univ Paris 06, Equipe Traduct Cycle Cellulaire & Dev, Biol Stn, UMR 7150, Roscoff, France; [Oulhen, Nathalie; Boulben, Sandrine; Morales, Julia; Cormier, Patrick; Cosson, Bertrand] CNRS, Biol Stn, UMR 7150, Roscoff, France; [Oulhen, Nathalie; Boulben, Sandrine; Morales, Julia; Cormier, Patrick; Cosson, Bertrand] Univ Europeenne Bretagne, Bretagne, France; [Bidinosti, Michael] McGill Univ, Dept Biochem, Montreal, PQ H3A 2T5, Canada; [Bidinosti, Michael] McGill Univ, Rosalind & Morris Goodman Canc Ctr, Montreal, PQ H3A 2T5, Canada	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Universite de Bretagne Occidentale; McGill University; McGill University	Oulhen, N (corresponding author), Univ Paris 06, Equipe Traduct Cycle Cellulaire & Dev, Biol Stn, UMR 7150, Roscoff, France.	cosson@sb-roscoff.fr		Oulhen, NATHALIE/0000-0003-1046-360X; Cosson, Bertrand/0000-0003-3401-7137; Morales, Julia/0000-0003-1632-5419	Association pour la Recherche contre le Cancer (ARC, France) [4247, 3507]; Ligue Nationale contre le Cancer; Conseil Regional de Bretagne; Conseil General du Finistere	Association pour la Recherche contre le Cancer (ARC, France)(Fondation ARC pour la Recherche sur le Cancer); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Conseil Regional de Bretagne(Region Bretagne); Conseil General du Finistere(Region Bretagne)	This work was supported by Association pour la Recherche contre le Cancer (ARC, France; grants 4247 and 3507) to P.C., Ligue Nationale contre le Cancer (Delegations Departementales Finistere, Morbihan, Vendee et Cotes d'Armor) to P.C., Conseil Regional de Bretagne and Conseil General du Finistere. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRANDHORST BP, 1976, DEV BIOL, V52, P310, DOI 10.1016/0012-1606(76)90248-7; Carroll M, 2006, MOL CELL BIOL, V26, P8586, DOI 10.1128/MCB.00955-06; CLEMENS M, 1987, NATURE, V330, P699, DOI 10.1038/330699a0; COLIN AM, 1987, DEV BIOL, V123, P354, DOI 10.1016/0012-1606(87)90394-0; Cormier P, 2001, DEV BIOL, V232, P275, DOI 10.1006/dbio.2001.0206; Cormier Patrick, 2003, Prog Cell Cycle Res, V5, P469; DAVIDSON EH, 1982, SCIENCE, V217, P17, DOI 10.1126/science.6178156; Elia A, 2008, ONCOGENE, V27, P811, DOI 10.1038/sj.onc.1210678; EPEL D, 1990, CELL DIFFER DEV, V29, P1, DOI 10.1016/0922-3371(90)90019-S; EPEL D, 1967, P NATL ACAD SCI USA, V57, P899, DOI 10.1073/pnas.57.4.899; Fadden P, 1997, J BIOL CHEM, V272, P10240; FOERDER CA, 1977, P NATL ACAD SCI USA, V74, P4214, DOI 10.1073/pnas.74.10.4214; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gingras AC, 2001, GENE DEV, V15, P2852; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; GRAINGER JL, 1987, MOL CELL BIOL, V7, P3947, DOI 10.1128/MCB.7.11.3947; HAGHIGHAT A, 1995, EMBO J, V14, P5701, DOI 10.1002/j.1460-2075.1995.tb00257.x; Heesom KJ, 1998, BIOCHEM J, V336, P39, DOI 10.1042/bj3360039; HUANG WI, 1987, P NATL ACAD SCI USA, V84, P6359, DOI 10.1073/pnas.84.18.6359; HUMPHREYS T, 1971, DEV BIOL, V26, P201, DOI 10.1016/0012-1606(71)90122-9; JAGUS R, 1993, DEV GENET, V14, P412, DOI 10.1002/dvg.1020140603; JAGUS R, 1992, J BIOL CHEM, V267, P15530; Kahvejian A, 2005, GENE DEV, V19, P104, DOI 10.1101/gad.1262905; LAPASSET L, 2008, MOL REPROD DEV; Legagneux V, 1995, RNA, V1, P1001; LOPO AC, 1989, BIOCHEM J, V258, P553, DOI 10.1042/bj2580553; MADER S, 1995, MOL CELL BIOL, V15, P4990; Mamane Y, 2004, ONCOGENE, V23, P3172, DOI 10.1038/sj.onc.1207549; MATHEWS MB, 2007, TRANSLATIONAL CONTRO; Miron M, 2001, NAT CELL BIOL, V3, P596, DOI 10.1038/35078571; Morales J, 2006, DEV BIOL, V300, P293, DOI 10.1016/j.ydbio.2006.07.036; Oulhen N, 2007, J CELL SCI, V120, P425, DOI 10.1242/jcs.03339; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Poulin F, 1998, J BIOL CHEM, V273, P14002, DOI 10.1074/jbc.273.22.14002; Raught B., 2007, TRANSLATIONAL CONTRO; Rousseau D, 1996, ONCOGENE, V13, P2415; Salardi Silvana, 2003, Pediatr Diabetes, V4, P4, DOI 10.1034/j.1399-5448.2003.00028.x; Salaun P, 2005, J CELL SCI, V118, P1385, DOI 10.1242/jcs.01716; Salaun P, 2004, EXP CELL RES, V296, P347, DOI 10.1016/j.yexcr.2004.02.013; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Sivan G, 2008, CELL CYCLE, V7, P741, DOI 10.4161/cc.7.6.5596; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; SONENBERG N, 1979, P NATL ACAD SCI USA, V76, P4345, DOI 10.1073/pnas.76.9.4345; Tee AR, 2002, MOL CELL BIOL, V22, P1674, DOI 10.1128/MCB.22.6.1674-1683.2002; Thompson B., 2007, TRANSLATIONAL CONTRO; Tomoo K, 2005, BBA-PROTEINS PROTEOM, V1753, P191, DOI 10.1016/j.bbapap.2005.07.023; Tomoo K, 2006, J BIOCHEM, V140, P237, DOI 10.1093/jb/mvj143; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TV Pestova, 2007, TRANSLATIONAL CONTRO; Wang XM, 2003, MOL CELL BIOL, V23, P1546, DOI 10.1128/MCB.23.5.1546-1557.2003; WINKLER MM, 1981, DEV BIOL, V84, P432, DOI 10.1016/0012-1606(81)90412-7	52	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e5070	10.1371/journal.pone.0005070	http://dx.doi.org/10.1371/journal.pone.0005070			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333389	Green Submitted, Green Published, gold			2022-12-25	WOS:000265499900019
J	Savas, U; Machemer, DEW; Hsu, MH; Gaynor, P; Lasker, JM; Tukey, RH; Johnson, EF				Savas, Uezen; Machemer, Daniel E. W.; Hsu, Mei-Hui; Gaynor, Pryce; Lasker, Jerome M.; Tukey, Robert H.; Johnson, Eric F.			Opposing Roles of Peroxisome Proliferator-activated Receptor alpha and Growth Hormone in the Regulation of CYP4A11 Expression in a Transgenic Mouse Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC GENE-EXPRESSION; ACID OMEGA-HYDROXYLASE; HUMAN LIVER SLICES; PPAR-ALPHA; ARACHIDONIC-ACID; 20-HYDROXYEICOSATETRAENOIC ACID; ESSENTIAL-HYPERTENSION; ADAPTIVE RESPONSE; HUMAN HEPATOCYTES; CYTOCHROMES P450	CYP4A11 transgenic mice (CYP4A11 Tg) were generated to examine in vivo regulation of the human CYP4A11 gene. Expression of CYP4A11 in mice yields liver and kidney P450 4A11 levels similar to those found in the corresponding human tissues and leads to an increased microsomal capacity for omega-hydroxylation of lauric acid. Fasted CYP4A11 Tg mice exhibit 2-3-fold increases in hepatic CYP4A11 mRNA and protein, and this response is absent in peroxisome proliferator-activated receptor alpha (PPAR alpha) null mice. Dietary administration of either of the PPAR alpha agonists, fenofibrate or clofibric acid, increases hepatic and renal CYP4A11 levels by 2-3-fold, and these responses were also abrogated in PPAR alpha null mice. Basal liver CYP4A11 levels are reduced differentially in PPAR alpha(-/-) females (> 95%) and males (< 50%) compared with PPAR alpha(-/+) mice. Quantitative and temporal differences in growth hormone secretion are known to alter hepatic lipid metabolism and to underlie sexually dimorphic gene expression, respectively. Continuous infusion of low levels of growth hormone reduced CYP4A11 expression by 50% in PPAR alpha-proficient male and female transgenic mice. A larger decrease was observed for the expression of CYP4A11 in PPAR alpha(-/-) CYP4A11 Tg male mice to levels similar to that of female PPAR alpha-deficient mice. These results suggest that PPAR alpha contributes to the maintenance of basal CYP4A11 expression and mediates CYP4A11 induction in response to fibrates or fasting. In contrast, increased exposure to growth hormone down-regulates CYP4A11 expression in liver.	[Johnson, Eric F.] Scripps Res Inst, MEM 255, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Machemer, Daniel E. W.; Tukey, Robert H.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Gaynor, Pryce; Lasker, Jerome M.] Hackensack Univ, Med Ctr, Inst Biomed Res, Hackensack, NJ 07601 USA	Scripps Research Institute; University of California System; University of California San Diego; Hackensack University Medical Center	Johnson, EF (corresponding author), Scripps Res Inst, MEM 255, Dept Mol & Expt Med, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	johnson@scripps.edu			United States Public Health Service [HD 04445, GM 49135, AA07842]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD004445] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD004445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA007842] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by United States Public Health Service Grants HD 04445 (to E.F.J.), GM 49135 (to R.H.T.), and AA07842 (to J.M.L.).	Adas F, 1999, J LIPID RES, V40, P1990; Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Bell AR, 1998, BIOCHEM J, V332, P689, DOI 10.1042/bj3320689; Boucher JL, 1996, DRUG METAB DISPOS, V24, P462; Cheon YW, 2005, AM J PHYSIOL-REG I, V288, pR1525, DOI 10.1152/ajpregu.00751.2004; Corton JC, 2004, J BIOL CHEM, V279, P46204, DOI 10.1074/jbc.M406739200; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Duez H, 2005, ARTERIOSCL THROM VAS, V25, P585, DOI 10.1161/01.ATV.0000154140.73570.00; Edwards RJ, 2003, DRUG METAB DISPOS, V31, P282, DOI 10.1124/dmd.31.3.282; Fu Z, 2008, J HYPERTENS, V26, P453, DOI 10.1097/HJH.0b013e3282f2f10c; Gainer JV, 2005, CIRCULATION, V111, P63, DOI 10.1161/01.CIR.0000151309.82473.59; Graham RA, 2006, TOXICOL SCI, V92, P356, DOI 10.1093/toxsci/kfl009; Hardwick JP, 2008, BIOCHEM PHARMACOL, V75, P2263, DOI 10.1016/j.bcp.2008.03.004; Hashimoto T, 2000, J BIOL CHEM, V275, P28918, DOI 10.1074/jbc.M910350199; Heng YM, 1997, BIOCHEM J, V325, P741, DOI 10.1042/bj3250741; Holla VR, 2001, P NATL ACAD SCI USA, V98, P5211, DOI 10.1073/pnas.081627898; Holloway MG, 2006, MOL ENDOCRINOL, V20, P647, DOI 10.1210/me.2005-0328; Hsu MH, 2007, DRUG METAB REV, V39, P515, DOI 10.1080/03602530701468573; Hsu MH, 2001, J BIOL CHEM, V276, P27950, DOI 10.1074/jbc.M100258200; Jalouli M, 2003, ENDOCRINOLOGY, V144, P101, DOI 10.1210/en.2002-220630; Jeffery B, 2004, ARCH BIOCHEM BIOPHYS, V429, P231, DOI 10.1016/j.abb.2004.06.025; Johnson EF, 2002, TOXICOLOGY, V181, P203, DOI 10.1016/S0300-483X(02)00282-2; Johnson EF, 1996, FASEB J, V10, P1241, DOI 10.1096/fasebj.10.11.8836037; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kroetz DL, 1998, J BIOL CHEM, V273, P31581, DOI 10.1074/jbc.273.47.31581; LAETHEM RM, 1992, J BIOL CHEM, V267, P5552; Lake BG, 1996, XENOBIOTICA, V26, P297, DOI 10.3109/00498259609046709; Lasker JM, 2000, J BIOL CHEM, V275, P4118, DOI 10.1074/jbc.275.6.4118; Lawrence JW, 2001, J BIOL CHEM, V276, P31521, DOI 10.1074/jbc.M103306200; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Ljungberg A, 2007, GROWTH HORM IGF RES, V17, P154, DOI 10.1016/j.ghir.2007.01.003; Mayer B, 2005, HYPERTENSION, V46, P766, DOI 10.1161/01.HYP.0000182658.04299.15; Nakagawa K, 2003, AM J PHYSIOL-REG I, V284, pR1055, DOI 10.1152/ajpregu.00459.2002; Nakagawa K, 2006, J CLIN INVEST, V116, P1696, DOI 10.1172/JCI27546; Ngo SNT, 2006, GENE, V376, P123, DOI 10.1016/j.gene.2006.02.020; Okita RT, 2001, CURR DRUG METAB, V2, P265; Olsson B, 2003, AM J PHYSIOL-ENDOC M, V285, pE504, DOI 10.1152/ajpendo.00444.2002; Osoegawa K, 2001, GENOME RES, V11, P483, DOI 10.1101/gr.169601; PALMER CNA, 1993, BIOCHIM BIOPHYS ACTA, V1172, P161, DOI 10.1016/0167-4781(93)90285-L; Patsouris D, 2006, ENDOCRINOLOGY, V147, P1508, DOI 10.1210/en.2005-1132; Powell PK, 1996, ARCH BIOCHEM BIOPHYS, V335, P219, DOI 10.1006/abbi.1996.0501; Powell PK, 1998, J PHARMACOL EXP THER, V285, P1327; Raucy JL, 2004, TOXICOL SCI, V79, P233, DOI 10.1093/toxsci/kfh126; Richert L, 2003, TOXICOL APPL PHARM, V191, P130, DOI 10.1016/S0041-008X(03)00231-X; Roman RJ, 2002, PHYSIOL REV, V82, P131, DOI 10.1152/physrev.00021.2001; Sanguino E, 2004, BIOCHEM PHARMACOL, V67, P157, DOI 10.1016/j.bcp.2003.08.034; Savas U, 2003, ARCH BIOCHEM BIOPHYS, V409, P212, DOI 10.1016/S0003-9861(02)00499-X; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Wada F, 1977, Biochim Biophys Acta, V487, P361; Waring JF, 2008, J PHARMACOL EXP THER, V324, P507, DOI 10.1124/jpet.107.126938; Waxman DJ, 2006, MOL ENDOCRINOL, V20, P2613, DOI 10.1210/me.2006-0007	53	22	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16541	16552		10.1074/jbc.M902074200	http://dx.doi.org/10.1074/jbc.M902074200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19366684	Green Published, hybrid			2022-12-25	WOS:000266730900051
J	Hu, J; Sharma, M; Qin, HJ; Gao, FP; Cross, TA				Hu, Jian; Sharma, Mukesh; Qin, Huajun; Gao, Fei Philip; Cross, Timothy A.			Ligand Binding in the Conserved Interhelical Loop of CorA, a Magnesium Transporter from Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; FAMILY INTRAMEMBRANE PROTEASE; NUCLEAR-MAGNETIC-RESONANCE; CHEMICAL-SHIFT DATA; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; FUNCTIONAL DOMAINS; POTASSIUM CHANNEL; DIVALENT-CATIONS; LIPID-BILAYERS	CorA is a constitutively expressed magnesium transporter in many bacteria. The crystal structures of Thermotoga maritima CorA provide an excellent structural framework for continuing studies. Here, the ligand binding properties of the conserved interhelical loop, the only portion of the protein exposed to the periplasmic space, are characterized by solution nuclear magnetic resonance spectroscopy. Through titration experiments performed on the isolated transmembrane domain of Mycobacterium tuberculosis CorA, it was found that two CorA substrates (Mg2+ and Co2+) and the CorA-specific inhibitor (Co(III) hexamine chloride) bind in the loop at the same binding site. This site includes the glutamic acid residue from the conserved "MPEL" motif. The relatively large dissociation constants indicate that such interactions are weak but not atypical for channels. The present data support the hypothesis that the negatively charged loop could act as an electrostatic ring, increasing local substrate concentrations before transport across the membrane.	[Hu, Jian; Sharma, Mukesh; Qin, Huajun; Gao, Fei Philip; Cross, Timothy A.] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; [Hu, Jian; Sharma, Mukesh; Gao, Fei Philip; Cross, Timothy A.] Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Cross, Timothy A.] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Cross, TA (corresponding author), 1800 E Paul Dirac Dr, Tallahassee, FL 32310 USA.	cross@magnet.fsu.edu	Sharma, Mukesh/F-8328-2010; Smirnov, Alex I/Q-9818-2016	Sharma, Mukesh/0000-0003-3036-1846; Smirnov, Alex I/0000-0002-0037-2555; Cross, Timothy/0000-0002-9413-0505	National Institutes of Health [GM064676, AI073891]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM064676] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM064676 and AI073891.	BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Bonvin AMJJ, 2005, CURR OPIN CHEM BIOL, V9, P501, DOI 10.1016/j.cbpa.2005.08.011; Chill JH, 2006, PROTEIN SCI, V15, P684, DOI 10.1110/ps.051954706; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P8172, DOI 10.1021/bi00487a027; Doyle DA, 2004, EUR BIOPHYS J BIOPHY, V33, P175, DOI 10.1007/s00249-003-0382-z; DUFF KC, 1992, VIROLOGY, V190, P485, DOI 10.1016/0042-6822(92)91239-Q; Eshaghi S, 2006, SCIENCE, V313, P354, DOI 10.1126/science.1127121; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Franzin CM, 2007, METHODS, V41, P398, DOI 10.1016/j.ymeth.2006.08.011; Gelev V, 2006, J MOL BIOL, V364, P352, DOI 10.1016/j.jmb.2006.08.077; Hill AV, 1910, J PHYSIOL-LONDON, V40, P190; Hu J, 2006, P NATL ACAD SCI USA, V103, P6865, DOI 10.1073/pnas.0601944103; Hu J, 2007, PROTEIN SCI, V16, P2153, DOI 10.1110/ps.072996707; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Knoop V, 2005, MOL GENET GENOMICS, V274, P205, DOI 10.1007/s00438-005-0011-x; Kucharski LM, 2000, J BIOL CHEM, V275, P16767, DOI 10.1074/jbc.M001507200; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Lunin VV, 2006, NATURE, V440, P833, DOI 10.1038/nature04642; Ma C, 2002, PROTEIN SCI, V11, P546, DOI 10.1110/ps.37302; Maguire ME, 2006, CURR OPIN STRUC BIOL, V16, P432, DOI 10.1016/j.sbi.2006.06.006; Marassi FM, 1999, P NATL ACAD SCI USA, V96, P14336, DOI 10.1073/pnas.96.25.14336; MCLAUGHLIN A, 1978, BIOCHIM BIOPHYS ACTA, V513, P338, DOI 10.1016/0005-2736(78)90203-1; Moncrief MBC, 1999, J BIOL INORG CHEM, V4, P523, DOI 10.1007/s007750050374; Niegowski D, 2007, CELL MOL LIFE SCI, V64, P2564, DOI 10.1007/s00018-007-7174-z; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Page Richard C., 2006, Journal of Structural and Functional Genomics, V7, P51, DOI 10.1007/s10969-006-9009-9; Papp-Wallace KM, 2007, MOL MEMBR BIOL, V24, P351, DOI 10.1080/09687680701441883; Payandeh J, 2008, J BIOL CHEM, V283, P11721, DOI 10.1074/jbc.M707889200; Payandeh J, 2006, EMBO J, V25, P3762, DOI 10.1038/sj.emboj.7601269; Pfeiffer J, 2002, INFECT IMMUN, V70, P3930, DOI 10.1128/IAI.70.7.3930-3934.2002; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Schindl R, 2007, BIOPHYS J, V93, P3872, DOI 10.1529/biophysj.107.112318; Smith RL, 1998, J BACTERIOL, V180, P2788, DOI 10.1128/JB.180.10.2788-2791.1998; Takeuchi K, 2006, CURR OPIN STRUC BIOL, V16, P109, DOI 10.1016/j.sbi.2006.01.006; Tian CL, 2003, PROTEIN SCI, V12, P2597, DOI 10.1110/ps.03168503; Wachek M, 2006, FEBS J, V273, P4236, DOI 10.1111/j.1742-4658.2006.05424.x; Wang JF, 2001, PROTEIN SCI, V10, P2241, DOI 10.1110/ps.17901; Wang YJ, 2002, PROTEIN SCI, V11, P852, DOI 10.1110/ps.3180102; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Weghuber J, 2006, FEBS J, V273, P1198, DOI 10.1111/j.1742-4658.2006.05157.x; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179	44	17	17	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15619	15628		10.1074/jbc.M901581200	http://dx.doi.org/10.1074/jbc.M901581200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19346249	hybrid, Green Published			2022-12-25	WOS:000266501000030
J	Klein, G; Lindner, B; Brabetz, W; Brade, H; Raina, S				Klein, Gracjana; Lindner, Buko; Brabetz, Werner; Brade, Helmut; Raina, Satish			Escherichia coli K-12 Suppressor-free Mutants Lacking Early Glycosyltransferases and Late Acyltransferases MINIMAL LIPOPOLYSACCHARIDE STRUCTURE AND INDUCTION OF ENVELOPE STRESS RESPONSE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACYTOPLASMIC COMPARTMENTS; ACYL CHAINS; OUTER CORE; GENE; BIOSYNTHESIS; SHOCK; MSBA; MEMBRANE; EPITOPE; INNER	To elucidate the minimal lipopolysaccharide (LPS) structure needed for the viability of Escherichia coli, suppressor-free strains lacking either the 3-deoxy-D-manno-oct-2-ulosonic acid transferase waaA gene or derivatives of the heptosyltransferase I waaC deletion with lack of one or all late acyltransferases (lpxL/M/P) and/or various outer membrane biogenesis factors were constructed. Delta(waaC lpxL lpxM lpxP) and waaA mutants exhibited highly attenuated growth, whereas simultaneous deletion of waaC and surA was lethal. Analyses of LPS of suppressor-free waaA mutants grown at 21 degrees C, besides showing accumulation of free lipid IVA precursor, also revealed the presence of its pentaacylated and hexaacylated derivatives, indicating in vivo late acylation can occur without Kdo. In contrast, LPS of Delta(waaC lpxL lpxM lpxP) strains showed primarily Kdo(2)-lipid IVA, indicating that these minimal LPS structures are sufficient to support growth of E. coli under slow-growth conditions at 21/23 degrees C. These lipid IVA derivatives could be modified biosynthetically by phosphoethanolamine, but not by 4-amino-4-deoxy-L-arabinose, indicating export defects of such minimal LPS. Delta waaA and Delta(waaC lpxL lpxM lpxP) exhibited cell-division defects with a decrease in the levels of FtsZ and OMP-folding factor PpiD. These mutations led to strong constitutive additive induction of envelope responsive CpxR/A and sigma(E) signal transduction pathways. Delta(lpxL lpxM lpxP) mutant, with intact waaC, synthesized tetraacylated lipid A and constitutively incorporated a third Kdo in growth medium inducing synthesis of P-EtN and L-Ara4N. Overexpression of msbA restored growth of Delta(lpxL lpxM lpxP) under fast-growing conditions, but only partially that of the Delta(waaC lpxL lpxM lpxP) mutant. This suppression could be alleviated by overexpression of certain mutant msbA alleles or the single-copy chromosomal MsbA-498V variant in the vicinity of Walker-box II.	[Klein, Gracjana; Lindner, Buko; Brabetz, Werner; Brade, Helmut; Raina, Satish] Leibniz Ctr Med & Biosci, Res Ctr Borstel, D-23845 Borstel, Germany	Forschungszentrum Borstel	Raina, S (corresponding author), Leibniz Ctr Med & Biosci, Res Ctr Borstel, Parkallee 22, D-23845 Borstel, Germany.	sraina@fz-borstel.de	Raina, Satish/AAU-9550-2021; Lindner, Buko/G-9731-2014	Raina, Satish/0000-0003-3175-4932; Klein, Gracjana/0000-0001-8695-8065	Deutsche Forschungsgemeinschaft [448/4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by Deutsche Forschungsgemeinschaft Grant DFG LI 448/4 (to B. L.).	Antonoaea R, 2008, BIOCHEMISTRY-US, V47, P5649, DOI 10.1021/bi800233w; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BELUNIS CJ, 1992, J BIOL CHEM, V267, P9988; Bishop RE, 2000, EMBO J, V19, P5071, DOI 10.1093/emboj/19.19.5071; Brabetz W, 1997, EUR J BIOCHEM, V247, P716, DOI 10.1111/j.1432-1033.1997.00716.x; Carty SM, 1999, J BIOL CHEM, V274, P9677, DOI 10.1074/jbc.274.14.9677; Clementz T, 1996, J BIOL CHEM, V271, P12095, DOI 10.1074/jbc.271.20.12095; Clementz T, 1997, J BIOL CHEM, V272, P10353; Dartigalongue C, 1998, EMBO J, V17, P3968, DOI 10.1093/emboj/17.14.3968; Dartigalongue C, 2001, J BIOL CHEM, V276, P20866, DOI 10.1074/jbc.M100464200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeLasPenas A, 1997, MOL MICROBIOL, V24, P373, DOI 10.1046/j.1365-2958.1997.3611718.x; Doerrler WT, 2004, J BIOL CHEM, V279, P45102, DOI 10.1074/jbc.M408106200; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Frirdich E, 2003, J BACTERIOL, V185, P1659, DOI 10.1128/JB.185.5.1659-1671.2003; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; Gronow S, 2001, J ENDOTOXIN RES, V7, P3, DOI 10.1179/096805101101532468; Gronow S, 2000, EUR J BIOCHEM, V267, P6602, DOI 10.1046/j.1432-1327.2000.01754.x; Hagiwara D, 2004, BIOSCI BIOTECH BIOCH, V68, P1758, DOI 10.1271/bbb.68.1758; Kanipes MI, 2001, J BIOL CHEM, V276, P1156, DOI 10.1074/jbc.M009019200; KAROW M, 1991, RES MICROBIOL, V142, P289, DOI 10.1016/0923-2508(91)90043-A; KAROW M, 1991, J BACTERIOL, V173, P741, DOI 10.1128/jb.173.2.741-750.1991; Kondakov A, 2005, EUR J MASS SPECTROM, V11, P535, DOI 10.1255/ejms.721; KUHN HM, 1992, INFECT IMMUN, V60, P2201, DOI 10.1128/IAI.60.6.2201-2210.1992; LERNER CG, 1990, NUCLEIC ACIDS RES, V18, P4631, DOI 10.1093/nar/18.15.4631; Mamat U, 2008, MOL MICROBIOL, V67, P633, DOI 10.1111/j.1365-2958.2007.06074.x; Meredith TC, 2006, ACS CHEM BIOL, V1, P33, DOI 10.1021/cb0500015; Missiakas D, 1997, MOL MICROBIOL, V24, P355, DOI 10.1046/j.1365-2958.1997.3601713.x; Missiakas D, 1997, EMBO J, V16, P1670, DOI 10.1093/emboj/16.7.1670; Missiakas D, 1996, MOL MICROBIOL, V21, P871, DOI 10.1046/j.1365-2958.1996.561412.x; Muller-Loennies S, 2006, GLYCOBIOLOGY, V16, P184, DOI 10.1093/glycob/cwj055; Muller-Loennies S, 2003, J BIOL CHEM, V278, P34090, DOI 10.1074/jbc.M303985200; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RAINA S, 1995, EMBO J, V14, P1043, DOI 10.1002/j.1460-2075.1995.tb07085.x; RAINA S, 1991, NUCLEIC ACIDS RES, V19, P3811, DOI 10.1093/nar/19.14.3811; Reynolds CM, 2005, J BIOL CHEM, V280, P21202, DOI 10.1074/jbc.M500964200; ROZALSKI A, 1989, INFECT IMMUN, V57, P2645, DOI 10.1128/IAI.57.9.2645-2652.1989; SCHNAITMAN CA, 1993, MICROBIOL REV, V57, P655, DOI 10.1128/MMBR.57.3.655-682.1993; Tam C, 2005, MOL MICROBIOL, V55, P1403, DOI 10.1111/j.1365-2958.2005.04497.x; TORRIANI A, 1960, BIOCHIM BIOPHYS ACTA, V38, P460, DOI 10.1016/0006-3002(60)91281-6; Tran AX, 2005, J BIOL CHEM, V280, P28186, DOI 10.1074/jbc.M505020200; Vorachek-Warren MK, 2002, J BIOL CHEM, V277, P14194, DOI 10.1074/jbc.M200409200; Vorachek-Warren MK, 2002, J BIOL CHEM, V277, P14186, DOI 10.1074/jbc.M200408200; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Zhou ZM, 1998, J BIOL CHEM, V273, P12466, DOI 10.1074/jbc.273.20.12466	46	70	73	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15369	15389		10.1074/jbc.M900490200	http://dx.doi.org/10.1074/jbc.M900490200			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19346244	Green Published, hybrid			2022-12-25	WOS:000266501000005
J	Upton, PD; Davies, RJ; Trembath, RC; Morrell, NW				Upton, Paul D.; Davies, Rachel J.; Trembath, Richard C.; Morrell, Nicholas W.			Bone Morphogenetic Protein (BMP) and Activin Type II Receptors Balance BMP9 Signals Mediated by Activin Receptor-like Kinase-1 in Human Pulmonary Artery Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY HEMORRHAGIC TELANGIECTASIA; TGF-BETA; SMOOTH-MUSCLE; E-SELECTIN; HYPERTENSION; MUTATIONS; GROWTH; ALK1; ACTIVATION; GENE	Mutations in transforming growth factor-beta(TGF-beta) receptor superfamily members underlie conditions characterized by vascular dysplasia. Mutations in endoglin and activin-like kinase receptor 1 (ALK1) cause hereditary hemorrhagic telangiectasia, whereas bone morphogenetic protein type II receptor (BMPR-II) mutations underlie familial pulmonary arterial hypertension. To understand the functional roles of these receptors, we examined their relative contributions to BMP signaling in human pulmonary artery endothelial cells (HPAECs). BMP9 potently and selectively induced Smad1/5 phosphorylation and Id gene expression in HPAECs. Contrary to expectations, BMP9 also stimulated Smad2 activation. Furthermore, BMP9 induced the expression of interleukin 8 and E-selectin. Using small interfering RNA, we demonstrate that the type I receptor, ALK1, is essential for these responses. However, small interfering RNA and inhibitor studies showed no involvement of ALK5 or endoglin. We further demonstrate that, of the candidate type II receptors, BMPR-II predominantly mediated IL-8 and E-selectin induction and mitogenic inhibition by BMP9. Conversely, activin receptor type II (ActR-II) contributed more to BMP9-mediated Smad2 activation. Only abolition of both type II receptors significantly reduced the Smad1/5 and Id responses. Both ALK1 and BMPR-II contributed to growth inhibition of HPAECs, whereas ActR-II was not involved. Taken together, our findings demonstrate the critical role of type II receptors in balancing BMP9 signaling via ALK1 and emphasize the essential role for BMPR-II in a subset of BMP9 responses (interleukin 8, E-selectin, and proliferation). This differential signaling may contribute to the contrasting pathologies of hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension.	[Upton, Paul D.; Davies, Rachel J.; Morrell, Nicholas W.] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Dept Med, Cambridge CB2 2QQ, England; [Upton, Paul D.; Davies, Rachel J.; Morrell, Nicholas W.] Papworth Hosp, Cambridge CB2 2QQ, England; [Trembath, Richard C.] Kings Coll London, Guys Hosp, Dept Med & Mol Genet, London SE1 9RT, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Papworth Hospital; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Upton, PD (corresponding author), Dept Med, Div Resp Med, Box 157,Level 5,Hills Rd, Cambridge CB2 2QQ, England.	pdu21@medschl.cam.ac.uk	wei, wei/HHR-8613-2022	Trembath, Richard/0000-0003-0550-3400; Morrell, Nicholas/0000-0001-5700-9792	British Heart Foundation Programme Grant [RG/03/005]; Wellcome Trust Clinical Research Training Fellowship [GR077167MA]; British Heart Foundation [RG/08/002/24718] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10379] Funding Source: researchfish	British Heart Foundation Programme Grant; Wellcome Trust Clinical Research Training Fellowship(Wellcome Trust); British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by British Heart Foundation Programme Grant RG/03/005 (to N. W. M. and R. C. T.).; Supported by a Wellcome Trust Clinical Research Training Fellowship GR077167MA.	Abdalla SA, 2004, EUR RESPIR J, V23, P373, DOI 10.1183/09031936.04.00085504; Bullard DC, 1996, J EXP MED, V183, P2329, DOI 10.1084/jem.183.5.2329; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Chen YG, 1999, J BIOL CHEM, V274, P3672, DOI 10.1074/jbc.274.6.3672; Cottin V, 2004, AM J RESP CRIT CARE, V169, P994, DOI 10.1164/rccm.200310-1441OC; Cowburn AS, 2004, EUR J IMMUNOL, V34, P1733, DOI 10.1002/eji.200425091; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Ebisawa T, 1999, J CELL SCI, V112, P3519; Fernandez-L A, 2005, CARDIOVASC RES, V68, P235, DOI 10.1016/j.cardiores.2005.06.009; Gallione CJ, 2006, J MED GENET, V43, P793, DOI 10.1136/jmg.2006.041517; Gallione CJ, 2004, LANCET, V363, P852, DOI 10.1016/S0140-6736(04)15732-2; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Harrison RE, 2003, J MED GENET, V40, P865, DOI 10.1136/jmg.40.12.865; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Hoodless PA, 1999, DEV BIOL, V207, P364, DOI 10.1006/dbio.1998.9168; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Lamouille S, 2002, BLOOD, V100, P4495, DOI 10.1182/blood.V100.13.4495; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Lee NY, 2008, J BIOL CHEM, V283, P32527, DOI 10.1074/jbc.M803059200; Liu F, 1996, NATURE, V381, P620, DOI 10.1038/381620a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lux Andreas, 2006, BMC Cardiovasc Disord, V6, P13, DOI 10.1186/1471-2261-6-13; Machado RD, 2006, HUM MUTAT, V27, P121, DOI 10.1002/humu.20285; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; McClintock JY, 2005, J APPL PHYSIOL, V99, P861, DOI 10.1152/japplphysiol.00006.2005; Morrell NW, 1999, AM J PHYSIOL-LUNG C, V277, pL440, DOI 10.1152/ajplung.1999.277.3.L440; Morrell NW, 2001, CIRCULATION, V104, P790, DOI 10.1161/hc3201.094152; NGUYEN M, 1993, NATURE, V365, P267, DOI 10.1038/365267a0; Park SO, 2008, BLOOD, V111, P633, DOI 10.1182/blood-2007-08-107359; Pece-Barbara N, 2005, J BIOL CHEM, V280, P27800, DOI 10.1074/jbc.M503471200; Pepper Michael S., 1997, Cytokine and Growth Factor Reviews, V8, P21, DOI 10.1016/S1359-6101(96)00048-2; Sadick H, 2006, WIEN KLIN WOCHENSCHR, V118, P72, DOI 10.1007/s00508-006-0561-x; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Seki T, 2006, LAB INVEST, V86, P116, DOI 10.1038/labinvest.3700376; Sobolewski A, 2008, HUM MOL GENET, V17, P3180, DOI 10.1093/hmg/ddn214; Szekanecz Z, 2000, ARTHRITIS RES, V2, P368, DOI 10.1186/ar114; Trembath R. C., 2001, Journal of Heart and Lung Transplantation, V20, P175, DOI 10.1016/S1053-2498(00)00352-1; Trembath RC, 2001, NEW ENGL J MED, V345, P325, DOI 10.1056/NEJM200108023450503; Tuder RM, 2007, CLIN CHEST MED, V28, P23, DOI 10.1016/j.ccm.2006.11.010; Uhl M, 2004, CANCER RES, V64, P7954, DOI 10.1158/0008-5472.CAN-04-1013; Upton PD, 2008, MOL PHARMACOL, V73, P539, DOI 10.1124/mol.107.041673; Valdimarsdottir G, 2002, CIRCULATION, V106, P2263, DOI 10.1161/01.CIR.0000033830.36431.46; van den Driesche S, 2003, CARDIOVASC RES, V58, P20, DOI 10.1016/S0008-6363(02)00852-0; Verrecchia F, 2001, ONCOGENE, V20, P3332, DOI 10.1038/sj.onc.1204448; Yu Y, 2004, P NATL ACAD SCI USA, V101, P8005, DOI 10.1073/pnas.0402551101; YUE TL, 1994, CIRC RES, V75, P1, DOI 10.1161/01.RES.75.1.1	50	146	155	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15794	15804		10.1074/jbc.M109.002881	http://dx.doi.org/10.1074/jbc.M109.002881			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19366699	Green Published, hybrid			2022-12-25	WOS:000266501000048
J	Watzlich, D; Brocker, MJ; Uliczka, F; Ribbe, M; Virus, S; Jahn, D; Moser, J				Waetzlich, Denise; Broecker, Markus J.; Uliczka, Frank; Ribbe, Markus; Virus, Simone; Jahn, Dieter; Moser, Juergen			Chimeric Nitrogenase-like Enzymes of (Bacterio)chlorophyll Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATIVE PROTOCHLOROPHYLLIDE OXIDOREDUCTASE; RHODOBACTER-CAPSULATUS; KLEBSIELLA-PNEUMONIAE; BACTERIOCHLOROPHYLL BIOSYNTHESIS; AZOTOBACTER-VINELANDII; CHLOROBIUM-TEPIDUM; CROSS-REACTIONS; IRON PROTEIN; MOFE-PROTEIN; FE PROTEIN	Nitrogenase-like light-independent protochlorophyllide oxidoreductase (DPOR) is involved in chlorophyll biosynthesis. Bacteriochlorophyll formation additionally requires the structurally related chlorophyllide oxidoreductase (COR). During catalysis, homodimeric subunit BchL(2) or ChlL(2) of DPOR transfers electrons to the corresponding heterotetrameric catalytic subunit, (BchNB)(2) or (ChlNB)(2). Analogously, subunit BchX(2) of the COR enzymes delivers electrons to subunit (BchYZ)(2). Various chimeric DPOR enzymes formed between recombinant subunits (BchNB)(2) and BchL(2) from Chlorobaculum tepidum or (ChlNB)(2) and ChlL(2) from Prochlorococcus marinus and Thermosynechococcus elongatus were found to be enzymatically active, indicating a conserved docking surface for the interaction of both DPOR protein subunits. Biotin label transfer experiments revealed the interaction of P. marinus ChlL(2) with both subunits, ChlN and ChlB, of the (ChlNB)(2) tetramer. Based on these findings and on structural information from the homologous nitrogenase system, a site-directed mutagenesis approach yielded 10 DPOR mutants for the characterization of amino acid residues involved in protein-protein interaction. Surface-exposed residues Tyr(127) of subunit ChlL, Leu(70) and Val(107) of subunit ChlN, and Gly(66) of subunit ChlB were found essential for P. marinus DPOR activity. Next, the BchL(2) or ChlL(2) part of DPOR was exchanged with electron-transferring BchX(2) subunits of COR and NifH(2) of nitrogenase. Active chimeric DPOR was generated via a combination of BchX(2) from C. tepidum or Roseobacter denitrificans with (BchNB)(2) from C. tepidum. No DPOR activity was observed for the chimeric enzyme consisting of NifH(2) from Azotobacter vinelandii in combination with (BchNB)(2) from C. tepidum or (ChlNB)(2) from P. marinus and T. elongatus, respectively.	[Waetzlich, Denise; Broecker, Markus J.; Uliczka, Frank; Virus, Simone; Jahn, Dieter; Moser, Juergen] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany; [Ribbe, Markus] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	Braunschweig University of Technology; University of California System; University of California Irvine	Moser, J (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, Spielmannstr 7, D-38106 Braunschweig, Germany.	j.moser@tu-bs.de		Jahn, Dieter/0000-0002-4064-9205	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft.	BIGGINS DR, 1971, EUR J BIOCHEM, V20, P140, DOI 10.1111/j.1432-1033.1971.tb01371.x; BOLLIVAR DW, 1994, J MOL BIOL, V237, P622, DOI 10.1006/jmbi.1994.1260; Brocker MJ, 2008, J BIOL CHEM, V283, P29873, DOI 10.1074/jbc.M805206200; Brocker MJ, 2008, J BIOL CHEM, V283, P10559, DOI 10.1074/jbc.M708010200; BURKE DH, 1993, P NATL ACAD SCI USA, V90, P7134, DOI 10.1073/pnas.90.15.7134; BURKE DH, 1993, J BACTERIOL, V175, P2407, DOI 10.1128/JB.175.8.2407-2413.1993; Burris RH, 1971, CHEMISTRY BIOCHEMIST, P105; Bursey EH, 1998, J BIOL CHEM, V273, P29678, DOI 10.1074/jbc.273.45.29678; Chiu HJ, 2001, BIOCHEMISTRY-US, V40, P641, DOI 10.1021/bi001645e; DEAN DR, 1993, J BACTERIOL, V175, P6737, DOI 10.1128/jb.175.21.6737-6744.1993; EADY RR, 1974, NATURE, V249, P805, DOI 10.1038/249805a0; EMERICH DW, 1978, J BACTERIOL, V134, P936, DOI 10.1128/JB.134.3.936-943.1978; Fujita Y, 2000, J BIOL CHEM, V275, P23583, DOI 10.1074/jbc.M002904200; FUJITA Y, 1993, PLANT CELL PHYSIOL, V34, P305; GEORGIADIS MM, 1992, SCIENCE, V257, P1653, DOI 10.1126/science.1529353; Hu YL, 2006, P NATL ACAD SCI USA, V103, P17125, DOI 10.1073/pnas.0602651103; Jang SB, 2000, BIOCHEMISTRY-US, V39, P14745, DOI 10.1021/bi001705g; KELLY M, 1969, BIOCHIM BIOPHYS ACTA, V191, P527, DOI 10.1016/0005-2744(69)90346-5; Kim EJ, 2008, J BIOL CHEM, V283, P3718, DOI 10.1074/jbc.M707774200; LOVENBERG W, 1963, J BIOL CHEM, V238, P3899; MAY HD, 1991, BIOCHEM J, V277, P457, DOI 10.1042/bj2770457; MCFEETERS RF, 1971, PLANT PHYSIOL, V47, P609, DOI 10.1104/pp.47.5.609; MOORE LR, 1995, MAR ECOL PROG SER, V116, P259, DOI 10.3354/meps116259; Moss G P, 1988, Eur J Biochem, V178, P277, DOI 10.1111/j.1432-1033.1988.tb14453.x; MURPHY PM, 1971, BIOCHIM BIOPHYS ACTA, V253, P295, DOI 10.1016/0005-2728(71)90257-X; Nakamura Y, 2002, DNA RES, V9, P123, DOI 10.1093/dnares/9.4.123; Nomata J, 2008, FEBS LETT, V582, P1346, DOI 10.1016/j.febslet.2008.03.018; Nomata J, 2006, J BIOL CHEM, V281, P15021, DOI 10.1074/jbc.M601750200; PETERS JW, 1995, ANNU REV MICROBIOL, V49, P335, DOI 10.1146/annurev.mi.49.100195.002003; Rees D. C., 2005, PHILOS T A, V363; Rees DC, 2005, PHILOS T R SOC A, V363, P971, DOI 10.1098/rsta.2004.1539; Roe SM, 1997, ACTA CRYSTALLOGR D, V53, P227, DOI 10.1107/S0907444996012681; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Sambrook J, 2001, MOL CLONING LAB MANU; Sarma R, 2008, BIOCHEMISTRY-US, V47, P13004, DOI 10.1021/bi801058r; Schindelin N, 1997, NATURE, V387, P370, DOI 10.1038/387370a0; Schmid B, 2002, BIOCHEMISTRY-US, V41, P15557, DOI 10.1021/bi026642b; SMITH BE, 1976, BIOCHEM J, V157, P439, DOI 10.1042/bj1570439; Suzuki JY, 1997, ANNU REV GENET, V31, P61, DOI 10.1146/annurev.genet.31.1.61; Tezcan FA, 2005, SCIENCE, V309, P1377, DOI 10.1126/science.1115653; WAHLUND TM, 1993, J BACTERIOL, V175, P474, DOI 10.1128/JB.175.2.474-478.1993; WHERLAND S, 1981, BIOCHEMISTRY-US, V20, P5132, DOI 10.1021/bi00521a006	42	26	26	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15530	15540		10.1074/jbc.M901331200	http://dx.doi.org/10.1074/jbc.M901331200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19336405	hybrid, Green Published			2022-12-25	WOS:000266501000021
J	Zhang, ZH; Xu, XH; Zhang, Y; Zhou, JF; Yu, ZW; He, C				Zhang, Zhaohuan; Xu, Xiaohui; Zhang, Yong; Zhou, Jianfeng; Yu, Zhongwang; He, Cheng			LINGO-1 Interacts with WNK1 to Regulate Nogo-induced Inhibition of Neurite Extension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; RECEPTOR FAMILY-MEMBER; PROTEIN-KINASE; OUTGROWTH INHIBITOR; CL-COTRANSPORTER; CELL-ADHESION; RHO; IDENTIFICATION; REGENERATION; EXPRESSION	LINGO-1 is a component of the tripartite receptor complexes, which act as a convergent mediator of the intracellular signaling in response to myelin-associated inhibitors and lead to collapse of growth cone and inhibition of neurite extension. Although the function of LINGO-1 has been intensively studied, its downstream signaling remains elusive. In the present study, a novel interaction between LINGO-1 and a serine-threonine kinase WNK1 was identified by yeast two-hybrid screen. The interaction was further validated by fluorescence resonance energy transfer and co-immunoprecipitation, and this interaction was intensified by Nogo66 treatment. Morphological evidences showed that WNK1 and LINGO-1 were co-localized in cortical neurons. Furthermore, either suppressing WNK1 expression by RNA interference or overexpression of WNK1-(123-510) attenuated Nogo66-induced inhibition of neurite extension and inhibited the activation of RhoA. Moreover, WNK1 was identified to interact with Rho-GDI1, and this interaction was attenuated by Nogo66 treatment, further indicating its regulatory effect on RhoA activation. Taken together, our results suggest that WNK1 is a novel signaling molecule involved in regulation of LINGO-1 mediated inhibition of neurite extension.	Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, Minist Educ,Inst Neurosci, Shanghai 200433, Peoples R China; Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, Minist Educ,Key Lab Mol Neurobiol, Shanghai 200433, Peoples R China	Naval Medical University; Naval Medical University	He, C (corresponding author), 800 Xiangying Rd, Shanghai 200433, Peoples R China.	chenghe@smmu.edu.cn		Zhang, Zhaohuan/0000-0001-6882-9761	National Key Basic Research Program [2006CB500702]; Ministry of Science and Technology of China [2007CB947100]; National Natural Science Foundation [30500151, 30530240, 30770657]; National 863 Program [2006AA02A114]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0528]; Shanghai Metropolitan Fund for Research and Development [07DJ14005]	National Key Basic Research Program(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National 863 Program(National High Technology Research and Development Program of China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Shanghai Metropolitan Fund for Research and Development	This work was supported by National Key Basic Research Program 2006CB500702, Ministry of Science and Technology of China Grant 2007CB947100, National Natural Science Foundation Grants 30500151, 30530240, and 30770657, National 863 Program 2006AA02A114, Program for Changjiang Scholars and Innovative Research Team in University IRT0528, and Shanghai Metropolitan Fund for Research and Development Grant 07DJ14005	Anselmo AN, 2006, P NATL ACAD SCI USA, V103, P10883, DOI 10.1073/pnas.0604607103; Barker PA, 2004, NEURON, V42, P529, DOI 10.1016/j.neuron.2004.04.001; Barton WA, 2003, EMBO J, V22, P3291, DOI 10.1093/emboj/cdg325; BOKOCH GM, 1994, J BIOL CHEM, V269, P31674; Carim-Todd L, 2003, EUR J NEUROSCI, V18, P3167, DOI 10.1111/j.1460-9568.2003.03003.x; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Chen YN, 2006, BRAIN RES REV, V51, P265, DOI 10.1016/j.brainresrev.2005.11.005; Choate KA, 2003, P NATL ACAD SCI USA, V100, P663, DOI 10.1073/pnas.242728499; Cope G, 2005, PHARMACOL THERAPEUT, V106, P221, DOI 10.1016/j.pharmthera.2004.11.010; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Delaloy C, 2006, AM J PATHOL, V169, P105, DOI 10.2353/ajpath.2006.051290; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Fournier AE, 2003, J NEUROSCI, V23, P1416, DOI 10.1523/JNEUROSCI.23-04-01416.2003; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Fu G, 2006, BIOCHEM BIOPH RES CO, V351, P847, DOI 10.1016/j.bbrc.2006.10.127; Fu Y, 2006, AM J PHYSIOL-RENAL, V290, pF1305, DOI 10.1152/ajprenal.00391.2005; Golbang AP, 2005, HYPERTENSION, V46, P295, DOI 10.1161/01.HYP.0000174326.96918.d6; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Harrington AW, 2008, J BIOL CHEM, V283, P24690, DOI 10.1074/jbc.M802188200; Hong CB, 2007, P NATL ACAD SCI USA, V104, P10974, DOI 10.1073/pnas.0700683104; Inoue H, 2007, P NATL ACAD SCI USA, V104, P14430, DOI 10.1073/pnas.0700901104; Ji B, 2006, MOL CELL NEUROSCI, V33, P311, DOI 10.1016/j.mcn.2006.08.003; Kahle KT, 2008, ANNU REV PHYSIOL, V70, P329, DOI 10.1146/annurev.physiol.70.113006.100651; Kahle KT, 2006, PHYSIOLOGY, V21, P326, DOI 10.1152/physiol.00015.2006; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Llorens F, 2008, DEV NEUROBIOL, V68, P521, DOI 10.1002/dneu.20607; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Mi S, 2007, NAT MED, V13, P1228, DOI 10.1038/nm1664; Min XS, 2004, STRUCTURE, V12, P1303, DOI 10.1016/j.str.2004.04.014; Mosyak L, 2006, J BIOL CHEM, V281, P36378, DOI 10.1074/jbc.M607314200; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Niederost B, 2002, J NEUROSCI, V22, P10368; Niederost BP, 1999, J NEUROSCI, V19, P8979, DOI 10.1523/JNEUROSCI.19-20-08979.1999; Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Qiu J, 2000, GLIA, V29, P166, DOI 10.1002/(SICI)1098-1136(20000115)29:2<166::AID-GLIA10>3.0.CO;2-G; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Richardson C, 2008, J CELL SCI, V121, P675, DOI 10.1242/jcs.025312; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Shekarabi M, 2008, J CLIN INVEST, V118, P2496, DOI 10.1172/JCI34088; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Sun XT, 2006, J NEUROCHEM, V99, P1114, DOI 10.1111/j.1471-4159.2006.04159.x; Verissimo F, 2006, ONCOGENE, V25, P4172, DOI 10.1038/sj.onc.1209449; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; Wade JB, 2006, P NATL ACAD SCI USA, V103, P8558, DOI 10.1073/pnas.0603109103; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Xie J, 2006, PEDIATR NEPHROL, V21, P1231, DOI 10.1007/s00467-006-0106-6; Xu BE, 2005, P NATL ACAD SCI USA, V102, P10315, DOI 10.1073/pnas.0504422102; Xu BE, 2005, CELL RES, V15, P6, DOI 10.1038/sj.cr.7290256; Xu BE, 2004, J BIOL CHEM, V279, P7826, DOI 10.1074/jbc.M313465200; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Xu XH, 2006, J CELL SCI, V119, P452, DOI 10.1242/jcs.02750; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Yang CL, 2007, J CLIN INVEST, V117, P3403, DOI 10.1172/JCI32033; Zalcman G, 1999, Prog Mol Subcell Biol, V22, P85; ZHANG F, 2008, MOL IMAGING IN PRESS; Zhang Y, 2006, J CELL SCI, V119, P1666, DOI 10.1242/jcs.02845; Zhang Y, 2004, J MOL BIOL, V343, P1147, DOI 10.1016/j.jmb.2004.08.072	67	46	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15717	15728		10.1074/jbc.M808751200	http://dx.doi.org/10.1074/jbc.M808751200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19363035	Green Published, hybrid			2022-12-25	WOS:000266501000041
J	Dumas, JF; Argaud, L; Cottet-Rousselle, C; Vial, G; Gonzalez, C; Detaille, D; Leverve, X; Fontaine, E				Dumas, Jean Francois; Argaud, Laurent; Cottet-Rousselle, Cecile; Vial, Guillaume; Gonzalez, Cecile; Detaille, Dominique; Leverve, Xavier; Fontaine, Eric			Effect of Transient and Permanent Permeability Transition Pore Opening on NAD(P)H Localization in Intact Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLOPHILIN-D; BAX TRANSLOCATION; CYTOSOLIC NAD(+); MITOCHONDRIAL; DEATH; RELEASE; CALCIUM	To study the effect of mitochondrial permeability transition pore (PTP) opening on NAD(P)H localization, intact cells were exposed to the Ca2+ ionophore A23187. PTP opening, mitochondrial membrane potential, mitochondrial volume, and NAD(P)H localization were assessed by time-lapse laser confocal microscopy using the calcein-cobalt technique, tetramethylrhodamine methyl ester, MitoTracker, and NAD(P)H auto-fluorescence, respectively. Concomitant with PTP opening, NAD(P)H fluorescence increased outside mitochondria. These events occurred in all cells and were prevented by cyclosporin A. Mitochondrial membrane potential was not systematically collapsed, whereas mitochondrial volume did not change, confirming that A23187 induced transient PTP opening in a subpopulation of cells and suggesting that mitochondrial swelling did not immediately occur after PTP opening in intact cells. NAD(P)H autofluorescence remained elevated after PTP opening, particularly after membrane potential had been collapsed by an uncoupler. Extraction of nucleotide for NAD(P)H quantification confirmed that PTP opening led to an increase in NAD(P)H content. Because the oxygen consumption rate decreased, whereas the lactate/pyruvate ratio increased after PTP opening in intact cells, we conclude that PTP opening inhibits respiration and dramatically affects the cytosolic redox potential in intact cells.	[Dumas, Jean Francois; Argaud, Laurent; Cottet-Rousselle, Cecile; Vial, Guillaume; Gonzalez, Cecile; Detaille, Dominique; Leverve, Xavier; Fontaine, Eric] Univ Grenoble 1, INSERM, U884, F-38041 Grenoble, France; [Dumas, Jean Francois; Argaud, Laurent; Cottet-Rousselle, Cecile; Vial, Guillaume; Gonzalez, Cecile; Detaille, Dominique; Leverve, Xavier; Fontaine, Eric] Univ Grenoble 1, Lab Bioenerget Fondamentale & Appl, F-38041 Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Fontaine, E (corresponding author), Univ Grenoble 1, INSERM, U884, BP 53, F-38041 Grenoble, France.	eric.fontaine@ujf-grenoble.fr	Fontaine, Eric/ABA-8853-2020; Dumas, Jean-François/AAN-5035-2020; Dumas, Jean-François/S-7486-2017	Fontaine, Eric/0000-0002-5204-9477; Dumas, Jean-François/0000-0002-2293-6606; Dumas, Jean-François/0000-0002-2293-6606; COTTET-ROUSSELLE, Cecile/0000-0003-1208-8911; Vial, Guillaume/0000-0002-7333-8526	INSERM; Agence Nationale de la Recherche (PTPischemia); Ministere de l'Enseignement de la Recherche et de la Technologie; Nestle; AGIR a dom	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche (PTPischemia)(French National Research Agency (ANR)); Ministere de l'Enseignement de la Recherche et de la Technologie; Nestle(Nestle SA); AGIR a dom	This work was supported by grants from INSERM, Agence Nationale de la Recherche (PTPischemia), and the Ministere de l'Enseignement de la Recherche et de la Technologie.; Supported by fellowships from Nestle and AGIR a dom.	Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Batandier C, 2004, J BIOL CHEM, V279, P17197, DOI 10.1074/jbc.M310329200; Bergmeyer HU, 1974, METHODS ENZYMATIC AN; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Blinova K, 2005, BIOCHEMISTRY-US, V44, P2585, DOI 10.1021/bi0485124; CROMPTON M, 1987, BIOCHEM J, V245, P915, DOI 10.1042/bj2450915; De Giorgi F, 2002, FASEB J, V16, P607, DOI 10.1096/fj.01-0269fje; Detaille D, 2005, DIABETES, V54, P2179, DOI 10.2337/diabetes.54.7.2179; Devin A, 1997, FEBS LETT, V410, P329, DOI 10.1016/S0014-5793(97)00612-1; Di Lisa F, 2001, J BIOL CHEM, V276, P2571, DOI 10.1074/jbc.M006825200; Elmore SP, 2004, ARCH BIOCHEM BIOPHYS, V422, P145, DOI 10.1016/j.abb.2003.12.031; Fontaine E, 1998, J BIOL CHEM, V273, P12662, DOI 10.1074/jbc.273.20.12662; Friberg H, 1998, J NEUROSCI, V18, P5151, DOI 10.1523/JNEUROSCI.18-14-05151.1998; GROEN AK, 1982, EUR J BIOCHEM, V122, P87, DOI 10.1111/j.1432-1033.1982.tb05851.x; HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2; Huser J, 1999, BIOCHEM J, V343, P311, DOI 10.1042/0264-6021:3430311; Koopman WJH, 2008, METHODS, V46, P304, DOI 10.1016/j.ymeth.2008.09.018; MASSARI S, 1972, BIOCHIM BIOPHYS ACTA, V238, P23, DOI 10.1016/0005-2728(72)90094-1; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; NIEMINEN AL, 1995, BIOCHEM J, V307, P99, DOI 10.1042/bj3070099; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; PETRONILLI V, 1994, BBA-BIOENERGETICS, V1187, P255, DOI 10.1016/0005-2728(94)90122-8; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; Precht TA, 2005, CELL DEATH DIFFER, V12, P255, DOI 10.1038/sj.cdd.4401552; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; VINOGRADOV A, 1972, ARCH BIOCHEM BIOPHYS, V152, P646, DOI 10.1016/0003-9861(72)90261-5; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001; Zuurendonk P F, 1979, Methods Enzymol, V56, P207	31	42	43	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15117	15125		10.1074/jbc.M900926200	http://dx.doi.org/10.1074/jbc.M900926200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19346250	hybrid, Green Published			2022-12-25	WOS:000266288200047
J	Pujol, J; Lopez-Sola, M; Ortiz, H; Vilanova, JC; Harrison, BJ; Yucel, M; Soriano-Mas, C; Cardoner, N; Deus, J				Pujol, Jesus; Lopez-Sola, Marina; Ortiz, Hector; Carles Vilanova, Joan; Harrison, Ben J.; Yucel, Murat; Soriano-Mas, Carles; Cardoner, Narcis; Deus, Joan			Mapping Brain Response to Pain in Fibromyalgia Patients Using Temporal Analysis of fMRI	PLOS ONE			English	Article								Background: Nociceptive stimuli may evoke brain responses longer than the stimulus duration often partially detected by conventional neuroimaging. Fibromyalgia patients typically complain of severe pain from gentle stimuli. We aimed to characterize brain response to painful pressure in fibromyalgia patients by generating activation maps adjusted for the duration of brain responses. Methodology/Principal Findings: Twenty-seven women (mean age: 47.8 years) were assessed with fMRI. The sample included nine fibromyalgia patients and nine healthy subjects who received 4 kg/cm(2) of pressure on the thumb. Nine additional control subjects received 6.8 kg/cm(2) to match the patients for the severity of perceived pain. Independent Component Analysis characterized the temporal dynamics of the actual brain response to pressure. Statistical parametric maps were estimated using the obtained time courses. Brain response to pressure (18 seconds) consistently exceeded the stimulus application (9 seconds) in somatosensory regions in all groups. fMRI maps following such temporal dynamics showed a complete pain network response (sensory-motor cortices, operculo-insula, cingulate cortex, and basal ganglia) to 4 kg/cm(2) of pressure in fibromyalgia patients. In healthy subjects, response to this low intensity pressure involved mainly somatosensory cortices. When matched for perceived pain (6.8 kg/cm(2)), control subjects showed also comprehensive activation of pain-related regions, but fibromyalgia patients showed significantly larger activation in the anterior insulabasal ganglia complex and the cingulate cortex. Conclusions/Significance: The results suggest that data-driven fMRI assessments may complement conventional neuroimaging for characterizing pain responses and that enhancement of brain activation in fibromyalgia patients may be particularly relevant in emotion-related regions.			Pujol, J (corresponding author), CRC Corp Sanitaria, Inst Alta Tecnol PRBB, Barcelona, Spain.	jpujol@crccorp.es	Harrison, Ben J/I-2940-2014; Yücel, Murat/AAY-8124-2020; Soriano-Mas, Carles/E-4028-2019; Cardoner, Narcis/AAD-5449-2022; Cardoner, Narcis/H-8436-2015; Vilanova, Joan C/H-6104-2015; Yucel, Murat/I-3004-2014; Menchón, José Manuel/A-4656-2010; Yela, Joan Deus/F-3652-2011	Yücel, Murat/0000-0002-4705-452X; Soriano-Mas, Carles/0000-0003-4574-6597; Cardoner, Narcis/0000-0001-9633-0888; Vilanova, Joan C/0000-0003-2148-6751; Yucel, Murat/0000-0002-4705-452X; LOPEZ SOLA, MARINA/0000-0002-5517-2665				Anand A, 2007, J NEUROPSYCH CLIN N, V19, P274, DOI 10.1176/appi.neuropsych.19.3.274; Apkarian AV, 1999, J NEUROPHYSIOL, V81, P2956, DOI 10.1152/jn.1999.81.6.2956; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; BRETT M, 2007, MNI BRAIN TALAIRACH; BURCKHARDT CS, 1991, J RHEUMATOL, V18, P728; Burgmer M, 2009, NEUROIMAGE, V44, P502, DOI 10.1016/j.neuroimage.2008.09.008; Calhoun VD, 2004, MAGN RESON IMAGING, V22, P1181, DOI 10.1016/j.mri.2004.09.004; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Chen JI, 2002, J NEUROPHYSIOL, V88, P464, DOI 10.1152/jn.2002.88.1.464; Cook DB, 2004, J RHEUMATOL, V31, P364; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig AD, 1996, NATURE, V384, P258, DOI 10.1038/384258a0; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Damasio A.R., 1994, DESCARTES ERROR EMOT; Farrell MJ, 2001, ARTHRITIS RHEUM, V44, pS394; Giesecke T, 2005, ARTHRITIS RHEUM-US, V52, P1577, DOI 10.1002/art.21008; Giesecke T, 2004, ARTHRITIS RHEUM-US, V50, P613, DOI 10.1002/art.20063; Gracely RH, 2004, BRAIN, V127, P835, DOI 10.1093/brain/awh098; Gracely RH, 2002, ARTHRITIS RHEUM-US, V46, P1333, DOI 10.1002/art.10225; Hu DW, 2005, NEUROIMAGE, V25, P746, DOI 10.1016/j.neuroimage.2004.12.031; JAMES W, 1994, PSYCHOL REV, V101, P205, DOI 10.1037/0033-295X.101.2.205; Lorenz IH, 2008, BRIT J ANAESTH, V100, P827, DOI 10.1093/bja/aen082; McKeown MJ, 2000, NEUROIMAGE, V11, P24, DOI 10.1006/nimg.1999.0518; Niddam DM, 2002, NEUROIMAGE, V17, P1437, DOI 10.1006/nimg.2002.1270; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Phillips ML, 2008, AM J PSYCHIAT, V165, P313, DOI 10.1176/appi.ajp.2007.07071066; Pollatos O, 2007, BRAIN RES, V1141, P178, DOI 10.1016/j.brainres.2007.01.026; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Price DD, 2005, J RHEUMATOL, V32, P22; Quigley MA, 2002, AM J NEURORADIOL, V23, P49; Quintana JM, 2003, ACTA PSYCHIAT SCAND, V107, P216, DOI 10.1034/j.1600-0447.2003.00062.x; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Ringler R, 2003, PAIN, V105, P445, DOI 10.1016/S0304-3959(03)00258-6; Smythe H, 2000, J RHEUMATOL, V27, P2536; Staud R, 2008, EUR J PAIN, V12, P1078, DOI 10.1016/j.ejpain.2008.02.002; Staud R, 2007, PAIN, V129, P130, DOI 10.1016/j.pain.2006.10.010; Talairach J., 1988, COPLANAR STEREOTAXIC; Tolle TR, 1999, ANN NEUROL, V45, P40, DOI 10.1002/1531-8249(199901)45:1<40::AID-ART8>3.0.CO;2-L; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Williams DA, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2094; Wise RG, 2007, MAGN RESON IMAGING, V25, P801, DOI 10.1016/j.mri.2007.03.016; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	45	104	109	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2009	4	4							e5224	10.1371/journal.pone.0005224	http://dx.doi.org/10.1371/journal.pone.0005224			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VA	19381292	Green Published, gold			2022-12-25	WOS:000265513800005
J	Reynolds, MG; Holman, RC; Christensen, KLY; Cheek, JE; Damon, IK				Reynolds, Mary G.; Holman, Robert C.; Christensen, Krista L. Yorita; Cheek, James E.; Damon, Inger K.			The Incidence of Molluscum contagiosum among American Indians and Alaska Natives	PLOS ONE			English	Article								Background: The epidemiology of Molluscum contagiosum (MC) in the United States is largely unknown, despite the fact that the virus is directly communicable and large outbreaks occur. This study provides population-based estimates to describe the epidemiology of MC in the United States among American Indian and Alaska Native (AI/AN) persons. This population was selected because of the comprehensiveness and quality of available data describing utilization of outpatient services. Principal Findings: Outpatient visits listing MC as a diagnosis in the Indian Health Service National Patient Information Reporting System during 2001-2005 were analyzed to assess patient characteristics, visit frequency and concurrent skin conditions. Outpatient visit rates and incidence rates were calculated based on known population denominators (retrospective cohort). Overall outpatient visit rates were also calculated for the general US population using national data. The average annual rate of MC-associated outpatient visits was 20.15/10,000 AI/AN persons for 2001-2005 (13,711 total visits), which was similar to the rate for the general US population (22.0/10,000 [95% CI: 16.9-27.1]). The incidence of MC-associated visits was 15.34/10,000. AI/AN children 1-4 years old had the highest incidence (77.12), more than twice that for children 5-14 years old (30.79); the incidence for infants (< 1 year) was higher than that for adults. AI/AN persons living in the West region had the highest incidence, followed by those in the East and Alaska regions (26.96, 22.88 and 21.38, respectively). There were age-specific associations between MC and concurrent skin conditions (e.g., atopic dermatitis, eczema). Conclusions: This study highlights the need for periodic population-based measurements to assess trends in incidence and healthcare utilization for MC in the United States. High rates of MC were found among AI/AN persons, especially among children,15 years old. The AI/AN population would benefit from greater availability of effective strategies for prevention and treatment of MCV infection.			Reynolds, MG (corresponding author), Ctr Dis Control & Prevent CDC, Poxvirus & Rabies Branch, Atlanta, GA 30333 USA.	nzr6@cdc.gov		Reynolds, Mary/0000-0001-7882-4614; Christensen, Krista/0000-0003-4431-336X				[Anonymous], 2005, INT CLASS DIS 9 REV; Bikowski JB, 2004, CUTIS, V73, P202; Braue A, 2005, PEDIATR DERMATOL, V22, P287, DOI 10.1111/j.1525-1470.2005.22401.x; Choong K Y, 1999, Australas J Dermatol, V40, P89, DOI 10.1046/j.1440-0960.1999.00327.x; Czelusta A, 2000, J AM ACAD DERMATOL, V43, P409, DOI 10.1067/mjd.2000.105158; Dohil MA, 2006, J AM ACAD DERMATOL, V54, P47, DOI 10.1016/j.jaad.2005.08.035; Hanna D, 2006, PEDIATR DERMATOL, V23, P574, DOI 10.1111/j.1525-1470.2006.00313.x; *IND HLTH SERV, 2006, OUTP VIS DAT MOLL CO; Indian Health Service, 2004, TRENDS IND HLTH 2000; Kakourou T, 2005, INT J DERMATOL, V44, P221, DOI 10.1111/j.1365-4632.2004.02074.x; Kleinbaum DG, 1998, APPL REGRESSION ANAL; KONING S, 1994, BRIT J GEN PRACT, V44, P417; MAHE A, 1995, T ROY SOC TROP MED H, V89, P467, DOI 10.1016/0035-9203(95)90068-3; Molino AC, 2004, PEDIATR DERMATOL, V21, P628, DOI 10.1111/j.0736-8046.2004.21602.x; Montgomery LE, 1996, AM J PUBLIC HEALTH, V86, P1401, DOI 10.2105/AJPH.86.10.1401; *NAT CTR HLTH STAT, 2007, NAT HOSP AMB MED CAR; *NATL CTR HLTH SAT, 2007, NAT AMB MED CAR SURV; OREN B, 1991, INFECTION, V19, P159, DOI 10.1007/BF01643239; PAULY CR, 1978, ARCH DERMATOL, V114, P391, DOI 10.1001/archderm.114.3.391; Research Triangle Institute, 2001, SUDAAN US MAN REL 8; RHOADES DA, 2000, AM INDIAN HLTH INNOV, P93; SCHAUB N, 1996, SCHWEIZ RUNDSCH MED, V85, P1162; SOLOMON LM, 1966, CAN MED ASSOC J, V95, P978; Theos AU, 2004, CUTIS, V74, P134; *US BUR CENS, 2006, INT EST POP AG SEX R; *US CDCP, 1996, MMWR-MORBID MORTAL W, V45, P1; Wollenberg A, 2004, CURR OPIN ALLERGY CL, V4, P271, DOI 10.1097/01.all.0000136758.66442.28	27	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2009	4	4							e5255	10.1371/journal.pone.0005255	http://dx.doi.org/10.1371/journal.pone.0005255			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VA	19381289	gold, Green Published			2022-12-25	WOS:000265513800016
J	van den Berg, JM; van Koppen, E; Ahlin, A; Belohradsky, BH; Bernatowska, E; Corbeel, L; Espanol, T; Fischer, A; Kurenko-Deptuch, M; Mouy, R; Petropoulou, T; Roesler, J; Seger, R; Stasia, MJ; Valerius, NH; Weening, RS; Wolach, B; Roos, D; Kuijpers, TW				van den Berg, J. Merlijn; van Koppen, Elsbeth; Ahlin, Anders; Belohradsky, Bernd H.; Bernatowska, Ewa; Corbeel, Lucien; Espanol, Teresa; Fischer, Alain; Kurenko-Deptuch, Magdalena; Mouy, Richard; Petropoulou, Theoni; Roesler, Joachim; Seger, Reinhard; Stasia, Marie-Jose; Valerius, Niels H.; Weening, Ron S.; Wolach, Baruch; Roos, Dirk; Kuijpers, Taco W.			Chronic Granulomatous Disease: The European Experience	PLOS ONE			English	Article								CGD is an immunodeficiency caused by deletions or mutations in genes that encode subunits of the leukocyte NADPH oxidase complex. Normally, assembly of the NADPH oxidase complex in phagosomes of certain phagocytic cells leads to a "respiratory burst'', essential for the clearance of phagocytosed micro-organisms. CGD patients lack this mechanism, which leads to life-threatening infections and granuloma formation. However, a clear picture of the clinical course of CGD is hampered by its low prevalence (similar to 1:250,000). Therefore, extensive clinical data from 429 European patients were collected and analyzed. Of these patients 351 were males and 78 were females. X-linked (XL) CGD (gp91(phox) deficient) accounted for 67% of the cases, autosomal recessive (AR) inheritance for 33%. AR-CGD was diagnosed later in life, and the mean survival time was significantly better in AR patients (49.6 years) than in XL CGD (37.8 years), suggesting a milder disease course in AR patients. The disease manifested itself most frequently in the lungs (66% of patients), skin (53%), lymph nodes (50%), gastrointestinal tract (48%) and liver (32%). The most frequently cultured micro-organisms per episode were Staphylococcus aureus (30%), Aspergillus spp. (26%), and Salmonella spp. (16%). Surprisingly, Pseudomonas spp. (2%) and Burkholderia cepacia (< 1%) were found only sporadically. Lesions induced by inoculation with BCG occurred in 8% of the patients. Only 71% of the patients received antibiotic maintenance therapy, and 53% antifungal prophylaxis. 33% were treated with gamma-interferon. 24 patients (6%) had received a stem cell transplantation. The most prominent reason of death was pneumonia and pulmonary abscess (18/84 cases), septicemia (16/84) and brain abscess (4/84). These data provide further insight in the clinical course of CGD in Europe and hopefully can help to increase awareness and optimize the treatment of these patients.			van den Berg, JM (corresponding author), Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Sanquin Res & Landsteiner Lab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.m.vandenberg@amc.nl	STASIA, Marie José/M-7165-2014	STASIA, Marie jose/0000-0003-4466-4880; Bernatowska, Ewa/0000-0002-0125-266X; van den Berg, J.Merlijn/0000-0001-9431-5457				ALIABADI H, 1989, NEW ENGL J MED, V321, P706, DOI 10.1056/NEJM198909143211102; Bielorai B, 2000, BONE MARROW TRANSPL, V26, P1025, DOI 10.1038/sj.bmt.1702651; Bustamante J, 2007, J ALLERGY CLIN IMMUN, V120, P32, DOI 10.1016/j.jaci.2007.04.034; Cale CM, 2007, CLIN EXP IMMUNOL, V148, P79, DOI 10.1111/j.1365-2249.2007.03321.x; De Ravin SS, 2006, PEDIATRICS, V117, pE590, DOI 10.1542/peds.2005-1349; EMMENDORFFER A, 1994, CYTOMETRY, V18, P147, DOI 10.1002/cyto.990180306; Goldblatt D, 1999, J PEDIATR-US, V134, P780, DOI 10.1016/S0022-3476(99)70299-4; Heyworth PG, 2003, CURR OPIN IMMUNOL, V15, P578, DOI 10.1016/S0952-7915(03)00109-2; Jabado N, 1998, CLIN INFECT DIS, V27, P1437, DOI 10.1086/515015; Jones LBKR, 2008, CLIN EXP IMMUNOL, V152, P211, DOI 10.1111/j.1365-2249.2008.03644.x; Kobayashi SD, 2004, J IMMUNOL, V172, P636, DOI 10.4049/jimmunol.172.1.636; LACY DE, 1993, J INFECTION, V27, P301, DOI 10.1016/0163-4453(93)92271-W; LEE BW, 1994, ARTHRITIS RHEUM, V37, P773, DOI 10.1002/art.1780370524; Lee PPW, 2008, PEDIATR INFECT DIS J, V27, P224, DOI 10.1097/INF.0b013e31815b494c; Liese J, 2000, J PEDIATR-US, V137, P687, DOI 10.1067/mpd.2000.109112; MANZI S, 1991, ARTHRITIS RHEUM, V34, P101, DOI 10.1002/art.1780340116; Marciano BE, 2004, PEDIATRICS, V114, P462, DOI 10.1542/peds.114.2.462; Martire B, 2008, CLIN IMMUNOL, V126, P155, DOI 10.1016/j.clim.2007.09.008; Mauch L, 2007, CLIN CHEM, V53, P890, DOI 10.1373/clinchem.2006.083444; Meischl C, 1998, SPRINGER SEMIN IMMUN, V19, P417, DOI 10.1007/BF00792600; Ott MG, 2007, CURR GENE THER, V7, P155, DOI 10.2174/156652307780859044; Richardson MP, 1998, J IMMUNOL METHODS, V219, P187, DOI 10.1016/S0022-1759(98)00136-7; Roesler J, 2000, BLOOD, V95, P2150, DOI 10.1182/blood.V95.6.2150; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Roos D, 1996, BLOOD, V87, P1663; Segal BH, 2005, CLIN INFECT DIS, V40, P1684, DOI 10.1086/430068; Segal BH, 2000, MEDICINE, V79, P170, DOI 10.1097/00005792-200005000-00004; Seger RA, 2002, BLOOD, V100, P4344, DOI 10.1182/blood-2002-02-0583; Seger RA, 2008, BRIT J HAEMATOL, V140, P255, DOI 10.1111/j.1365-2141.2007.06880.x; Soler-Palacin P, 2007, ALLERGOL IMMUNOPATH, V35, P83, DOI 10.1157/13106774; Stein S, 2006, CURR OPIN MOL THER, V8, P415; THEK LG, 1998, AM J RESP CRIT CARE, V157, P1694; VOWELLS SJ, 1995, J IMMUNOL METHODS, V178, P89, DOI 10.1016/0022-1759(94)00247-T; Wang SM, 2005, DIAGN MICR INFEC DIS, V53, P149, DOI 10.1016/j.diagmicrobio.2005.04.015; WEENING RS, 1995, EUR J PEDIATR, V154, P295, DOI 10.1007/s004310050292; Winkelstein JA, 2000, MEDICINE, V79, P155, DOI 10.1097/00005792-200005000-00003; Wolach B, 2005, BLOOD, V105, P61, DOI 10.1182/blood-2004-02-0675	37	467	472	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2009	4	4							e5234	10.1371/journal.pone.0005234	http://dx.doi.org/10.1371/journal.pone.0005234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VA	19381301	Green Published, gold, Green Submitted			2022-12-25	WOS:000265513800010
J	Tanaka, MM; Kendal, JR; Laland, KN				Tanaka, Mark M.; Kendal, Jeremy R.; Laland, Kevin N.			From Traditional Medicine to Witchcraft: Why Medical Treatments Are Not Always Efficacious	PLOS ONE			English	Article							CHINESE MEDICINE; SEXUAL SELECTION; TRANSMISSION; EVOLUTION; HOMEOPATHY; BEHAVIOR; SAFETY; FADS	Complementary medicines, traditional remedies and home cures for medical ailments are used extensively world-wide, representing more than US$60 billion sales in the global market. With serious doubts about the efficacy and safety of many treatments, the industry remains steeped in controversy. Little is known about factors affecting the prevalence of efficacious and non-efficacious self-medicative treatments. Here we develop mathematical models which reveal that the most efficacious treatments are not necessarily those most likely to spread. Indeed, purely superstitious remedies, or even maladaptive practices, spread more readily than efficacious treatments under specified circumstances. Low-efficacy practices sometimes spread because their very ineffectiveness results in longer, more salient demonstration and a larger number of converts, which more than compensates for greater rates of abandonment. These models also illuminate a broader range of phenomena, including the spread of innovations, medical treatment of animals, foraging behaviour, and self-medication in non-human primates.			Tanaka, MM (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia.	m.tanaka@unsw.edu.au	Laland, Kevin N/C-9482-2011	Laland, Kevin/0000-0002-2457-0900; Kendal, Jeremy/0000-0001-8644-3117	Biotechnology and Biological Sciences Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Abbot NC, 1996, NATURE, V381, P361, DOI 10.1038/381361a0; Abbott A, 2005, NATURE, V436, P898, DOI 10.1038/436898b; Ang HH, 2006, FOOD CHEM TOXICOL, V44, P1245, DOI 10.1016/j.fct.2006.01.014; BECK M, 1989, J COMP PSYCHOL, V103, P132, DOI 10.1037/0735-7036.103.2.132; Bentley RA, 2007, EVOL HUM BEHAV, V28, P151, DOI 10.1016/j.evolhumbehav.2006.10.002; Bentley RA, 2004, P ROY SOC B-BIOL SCI, V271, P1443, DOI 10.1098/rspb.2004.2746; BIKHCHANDANI S, 1992, J POLIT ECON, V100, P992, DOI 10.1086/261849; Bikhchandani S, 1998, J ECON PERSPECT, V12, P151, DOI 10.1257/jep.12.3.151; Boyd R., 1985, CULTURE EVOLUTIONARY; Cavalli-Sforza Luigi L., 1981, CULTURAL TRANSMISSIO; Coultas JC, 2004, GROUP PROCESS INTERG, V7, P317, DOI 10.1177/1368430204046141; Dawkins R, 1976, SELFISH GENE; De Allegri M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-22; Ewens W.J., 1979, MATH POPULATION GENE, V9; Fiot J, 2006, J ETHNOPHARMACOL, V106, P173, DOI 10.1016/j.jep.2005.12.030; Garnier R, 2006, PRESSE MED, V35, P1177, DOI 10.1016/S0755-4982(06)74776-5; Giles J, 2007, NATURE, V446, P352, DOI 10.1038/446352a; Giraldeau LA, 2002, PHILOS T R SOC B, V357, P1559, DOI 10.1098/rstb.2002.1065; Hahn MW, 2003, P ROY SOC B-BIOL SCI, V270, pS120, DOI 10.1098/rsbl.2003.0045; Henrich J, 1998, EVOL HUM BEHAV, V19, P215, DOI 10.1016/S1090-5138(98)00018-X; Henrich J, 2001, EVOL HUM BEHAV, V22, P165, DOI 10.1016/S1090-5138(00)00071-4; HEYES CM, 1994, BIOL REV, V69, P207, DOI 10.1111/j.1469-185X.1994.tb01506.x; Hsieh SC, 2006, PHARMACOEPIDEM DR S, V15, P889, DOI 10.1002/pds.1340; Huffman MA, 2004, PRIMATES, V45, P113, DOI 10.1007/s10329-003-0065-5; HUFFMAN MA, 2003, P NUT SOC, V62, P113; Karlin S., 1975, 1 COURSE STOCHASTIC, V2; KIRKPATRICK M, 1982, EVOLUTION, V36, P1, DOI 10.1111/j.1558-5646.1982.tb05003.x; Laland KN, 1997, ANIM BEHAV, V53, P1161, DOI 10.1006/anbe.1996.0318; LALAND KN, 1994, THEOR POPUL BIOL, V45, P1, DOI 10.1006/tpbi.1994.1001; LEFEBVRE L, 1994, ANIM BEHAV, V47, P331, DOI 10.1006/anbe.1994.1046; LOSADA M, 2006, ECON BOT, V60, P374; Mace R, 2000, ANIM BEHAV, V59, P1, DOI 10.1006/anbe.1999.1287; Nesse R.M., 1994, WHY WE GET SICK NEW; Normile D, 2003, SCIENCE, V299, P188, DOI 10.1126/science.299.5604.188; Okeke TA, 2006, J BIOSOC SCI, V38, P491, DOI 10.1017/S002193200502660X; Pagel M, 2004, NATURE, V428, P275, DOI 10.1038/428275a; Palombo EA, 2006, PHYTOTHER RES, V20, P717, DOI 10.1002/ptr.1907; Patwardhan B, 2005, EVID-BASED COMPL ALT, V2, P465, DOI 10.1093/ecam/neh140; Reader S.M., 2003, ANIMAL INNOVATION; Shang AJ, 2005, LANCET, V366, P726, DOI 10.1016/S0140-6736(05)67177-2; SILVER IA, 1983, EQUINE VET J S, V1, P1; Tanaka MM, 2002, THEOR POPUL BIOL, V62, P111, DOI 10.1006/tpbi.2002.1585; WERNER D, 1983, WHERE THERE IS DOCTO; WHITEN A, 1992, ADV STUD BEHAV, V21, P239, DOI 10.1016/S0065-3454(08)60146-1; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; *WHO, 2002, WHO TRAD MED SURG 20	46	58	61	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2009	4	4							e5192	10.1371/journal.pone.0005192	http://dx.doi.org/10.1371/journal.pone.0005192			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437TS	19367333	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000265510400005
J	Bett, JS; Cook, C; Petrucelli, L; Bates, GP				Bett, John S.; Cook, Casey; Petrucelli, Leonard; Bates, Gillian P.			The Ubiquitin-Proteasome Reporter GFPu Does Not Accumulate in Neurons of the R6/2 Transgenic Mouse Model of Huntington's Disease	PLOS ONE			English	Article								Impairment of the ubiquitin-proteasome system (UPS) has long been considered an attractive hypothesis to explain the selective dysfunction and death of neurons in polyglutamine disorders such as Huntington's disease (HD). The fact that inclusion bodies in HD mouse models and patient brains are rich in ubiquitin and proteasome components suggests that the UPS may be hindered directly or indirectly by inclusion bodies or their misfolded monomeric or oligomeric precursors. However, studies into UPS function in various polyglutamine disease models have yielded conflicting results, suggesting mutant polyglutamine tracts may exert different effects on the UPS depending on protein context, expression level, subcellular localisation and cell-type. To investigate UPS function in a well-characterised mouse model of HD, we have crossed R6/2 HD mice with transgenic UPS reporter mice expressing the GFPu construct. The GFPu construct comprises GFP fused to a constitutive degradation signal (CL-1) that promotes its rapid degradation under conditions of a healthy UPS. Using a combination of immunoblot analysis, fluorescence and immunofluorescence microscopy studies, we found that steady-state GFPu levels were not detectably different between R6/2 and non-R6/2 brain. We observed no correlation between inclusion body formation and GFPu accumulation, suggesting no direct relationship between protein aggregation and global UPS inhibition in R6/2 mice. These findings suggest that while certain branches of the UPS can be impaired by mutant polyglutamine proteins, such proteins do not necessarily cause total blockade of UPS-dependent degradation. It is therefore likely that the relationship between mutant polyglutamine proteins and the UPS is more complex than originally anticipated.			Bett, JS (corresponding author), Kings Coll London, Sch Med, Dept Med & Mol Genet, London WC2R 2LS, England.	gillian.bates@kcl.ac.uk	Longo, Kenneth A/A-5631-2010; Bates, Gillian P/E-1146-2012	Bates, Gillian P/0000-0002-4041-6305	Wellcome Trust [66270] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bedford L, 2008, J NEUROSCI, V28, P8189, DOI 10.1523/JNEUROSCI.2218-08.2008; Bence NF, 2005, METHOD ENZYMOL, V399, P481, DOI 10.1016/S0076-6879(05)99033-2; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bett JS, 2006, HUM MOL GENET, V15, P33, DOI 10.1093/hmg/ddi423; BETT JS, 2009, J CELL MOL IN PRESS; Bove J, 2006, ANN NEUROL, V60, P260, DOI 10.1002/ana.20937; Bowman AB, 2005, HUM MOL GENET, V14, P679, DOI 10.1093/hmg/ddi064; Butler R, 2006, NAT REV NEUROSCI, V7, P784, DOI 10.1038/nrn1989; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Diaz-Hernandez M, 2003, J NEUROSCI, V23, P11653; Diaz-Hernandez M, 2006, J NEUROCHEM, V98, P1585, DOI 10.1111/j.1471-4159.2006.03968.x; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goellner GM, 2003, INT J BIOCHEM CELL B, V35, P562, DOI 10.1016/S1357-2725(02)00388-6; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Kaytor MD, 2004, J NEUROCHEM, V89, P962, DOI 10.1111/j.1471-4159.2004.02376.x; Khan LA, 2006, J NEUROCHEM, V98, P576, DOI 10.1111/j.1471-4159.2006.03895.x; Kim MO, 2008, J NEUROSCI, V28, P3947, DOI 10.1523/JNEUROSCI.5667-07.2008; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; LI X, 2008, BRAIN RES REV; Lindsten K, 2003, NAT BIOTECHNOL, V21, P897, DOI 10.1038/nbt851; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Menendez-Benito V, 2005, METHOD ENZYMOL, V399, P490, DOI 10.1016/S0076-6879(05)99034-4; Michalik A, 2004, NEUROBIOL DIS, V16, P202, DOI 10.1016/j.nbd.2003.12.020; Park Y, 2005, MOL CELLS, V19, P23; Pratt G, 2008, J BIOL CHEM, V283, P12919, DOI 10.1074/jbc.M709347200; Rusmini P, 2007, NEUROBIOL AGING, V28, P1099, DOI 10.1016/j.neurobiolaging.2006.05.015; Sathasivam K, 2001, HUM MOL GENET, V10, P2425, DOI 10.1093/hmg/10.21.2425; Seo H, 2004, ANN NEUROL, V56, P319, DOI 10.1002/ana.20207; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Verhoef LGGC, 2002, HUM MOL GENET, V11, P2689, DOI 10.1093/hmg/11.22.2689; Wang JJ, 2008, J CELL BIOL, V180, P1177, DOI 10.1083/jcb.200709080; Zhou H, 2003, J CELL BIOL, V163, P109, DOI 10.1083/jcb.200306038	39	40	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5128	10.1371/journal.pone.0005128	http://dx.doi.org/10.1371/journal.pone.0005128			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19352500	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000265505700021
J	Walshe, TE; Saint-Geniez, M; Maharaj, ASR; Sekiyama, E; Maldonado, AE; D'Amore, PA				Walshe, Tony E.; Saint-Geniez, Magali; Maharaj, Arindel S. R.; Sekiyama, Eiichi; Maldonado, Angel E.; D'Amore, Patricia A.			TGF-beta Is Required for Vascular Barrier Function, Endothelial Survival and Homeostasis of the Adult Microvasculature	PLOS ONE			English	Article								Pericyte-endothelial cell (EC) interactions are critical to both vascular development and vessel stability. We have previously shown that TGF-beta signaling between EC and mural cells participates in vessel stabilization in vitro. We therefore investigated the role of TGF-beta signaling in maintaining microvessel structure and function in the adult mouse retinal microvasculature. TGF-beta signaling was inhibited by systemic expression of soluble endoglin (sEng) and inhibition was demonstrated by reduced phospho-smad2 in the adult retina. Blockade of TGF-beta signaling led to increased vascular and neural cell apoptosis in the retina, which was associated with decreased retinal function, as measured by electroretinogram (ERG). Perfusion of the inner retinal vasculature was impaired and was accompanied by defective autoregulation and loss of capillary integrity. Fundus angiography and Evans blue permeability assay revealed a breakdown of the blood-retinal-barrier that was characterized by decreased association between the tight junction proteins zo-1 and occludin. Inhibition of TGF-beta signaling in cocultures of EC and 10T1/2 cells corroborated the in vivo findings, with impaired EC barrier function, dissociation of EC from 10T1/2 cells, and endothelial cell death, supporting the role of EC-mesenchymal interactions in TGF-beta signaling. These results implicate constitutive TGF-beta signaling in maintaining the integrity and function of the adult microvasculature and shed light on the potential role of TGF-beta signaling in vasoproliferative and vascular degenerative retinal diseases.	[Walshe, Tony E.; Saint-Geniez, Magali; Maharaj, Arindel S. R.; Sekiyama, Eiichi; Maldonado, Angel E.; D'Amore, Patricia A.] Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst, Boston, MA 02115 USA; [Walshe, Tony E.; Saint-Geniez, Magali; Maharaj, Arindel S. R.; Sekiyama, Eiichi; Maldonado, Angel E.; D'Amore, Patricia A.] Harvard Univ, Sch Med, Dept Pathol, Schepens Eye Res Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Harvard Medical School; Schepens Eye Research Institute	Walshe, TE (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst, Boston, MA 02115 USA.	patricia.damore@schepens.harvard.edu	D'Amore, Patricia A/G-5660-2017; SAINT-GENIEZ, MAGALI/P-3509-2019; Walshe, Tony/AAJ-8833-2020	D'Amore, Patricia A/0000-0001-9652-8974; SAINT-GENIEZ, MAGALI/0000-0001-9897-138X; 	 [EY05318];  [P30EY14104];  [Research to Prevent Blindness Senior Scientific Investigator]; NATIONAL EYE INSTITUTE [P30EY014104, R01EY005318] Funding Source: NIH RePORTER	; ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by EY05318 and by the Core grant for Vision Research P30EY14104. P.A.D. is a Research to Prevent Blindness Senior Scientific Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DH, 1995, J NEUROSCI RES, V42, P63, DOI 10.1002/jnr.490420108; ANTONELLIORLIDGE A, 1989, P NATL ACAD SCI USA, V86, P4544, DOI 10.1073/pnas.86.12.4544; BROWN MA, 1989, CLIN SCI, V77, P599, DOI 10.1042/cs0770599; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Collins NT, 2006, ARTERIOSCL THROM VAS, V26, P62, DOI 10.1161/01.ATV.0000194097.92824.b3; Darland D. C., 2001, Angiogenesis, V4, P11, DOI 10.1023/A:1016611824696; Darland DC, 2003, DEV BIOL, V264, P275, DOI 10.1016/j.ydbio.2003.08.015; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; ENGERMAN RL, 1967, LAB INVEST, V17, P738; Ferguson G, 2000, MOL PHARMACOL, V57, P546, DOI 10.1124/mol.57.3.546; Fernandez-Lopez A, 2007, HUM MOL GENET, V16, P1515, DOI 10.1093/hmg/ddm069; Frank R, 1996, J INVEST DERMATOL, V106, P36, DOI 10.1111/1523-1747.ep12327182; FURUKAWA H, 1987, INVEST OPHTH VIS SCI, V28, P1752; Gao W, 2007, J MOL CELL CARDIOL, V42, P609, DOI 10.1016/j.yjmcc.2006.12.006; Garcia CM, 2004, DEV BRAIN RES, V152, P25, DOI 10.1016/j.devbrainres.2004.05.008; Gordon-Thomson C, 1998, INVEST OPHTH VIS SCI, V39, P1399; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Guerin CJ, 2001, EXP EYE RES, V73, P753, DOI 10.1006/exer.2001.1095; GUTTMACHER AE, 1995, NEW ENGL J MED, V333, P918, DOI 10.1056/NEJM199510053331407; Hammes HP, 2005, HORM METAB RES, V37, pS39, DOI 10.1055/s-2005-861361; Henry E, 1999, INVEST OPHTH VIS SCI, V40, P1710; Hirschi KK, 1999, CIRC RES, V84, P298, DOI 10.1161/01.RES.84.3.298; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kano MR, 2007, P NATL ACAD SCI USA, V104, P3460, DOI 10.1073/pnas.0611660104; Lan Y, 2007, MOL CELL BIOL, V27, P7683, DOI 10.1128/MCB.00577-07; Larsson J, 2001, EMBO J, V20, P1663, DOI 10.1093/emboj/20.7.1663; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Li HG, 2002, NITRIC OXIDE-BIOL CH, V7, P132, DOI 10.1016/S1089-8603(02)00127-1; LU Q, 2008, AM J PHYSL LUNG CELL; LUTTY GA, 1993, INVEST OPHTH VIS SCI, V34, P477; Ma L, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-11; MERWIN JR, 1990, J CELL PHYSIOL, V142, P117, DOI 10.1002/jcp.1041420115; Mitic LL, 1999, J CELL BIOL, V146, P683, DOI 10.1083/jcb.146.3.683; Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5; Nagaoka T, 2002, INVEST OPHTH VIS SCI, V43, P3037; Neubauer K, 1999, J HEPATOL, V31, P692, DOI 10.1016/S0168-8278(99)80350-X; Pepper Michael S., 1997, Cytokine and Growth Factor Reviews, V8, P21, DOI 10.1016/S1359-6101(96)00048-2; Pfeiffer A, 1997, DIABETES, V46, pS26, DOI 10.2337/diab.46.2.S26; Ramsauer M, 2007, J CELL SCI, V120, P1810, DOI 10.1242/jcs.003533; SATO Y, 1989, J CELL BIOL, V109, P309, DOI 10.1083/jcb.109.1.309; Schonfelder U, 1998, MICROVASC RES, V56, P22, DOI 10.1006/mvre.1998.2086; Seki T, 2003, CIRC RES, V93, P682, DOI 10.1161/01.RES.0000095246.40391.3B; SHEPRO D, 1993, FASEB J, V7, P1031, DOI 10.1096/fasebj.7.11.8370472; STEWART PA, 1994, J COMP NEUROL, V340, P566, DOI 10.1002/cne.903400409; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Thorpe PE, 2004, CLIN CANCER RES, V10, P415, DOI 10.1158/1078-0432.CCR-0642-03; Urase K, 1999, DEV BRAIN RES, V116, P69, DOI 10.1016/S0165-3806(99)00076-0; van Royen N, 2002, FASEB J, V16, P432, DOI 10.1096/fj.01-0563fje; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; WACHTMEISTER L, 1978, INVEST OPHTH VIS SCI, V17, P1176; Watabe T, 2003, J CELL BIOL, V163, P1303, DOI 10.1083/jcb.200305147; Yamanaka R, 2002, JPN J OPHTHALMOL, V46, P525, DOI 10.1016/S0021-5155(02)00536-1	54	152	156	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2009	4	4							e5149	10.1371/journal.pone.0005149	http://dx.doi.org/10.1371/journal.pone.0005149			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PZ	19340291	Green Published, gold, Green Submitted			2022-12-25	WOS:000265500700026
J	Dahlem, MA; Hadjikhani, N				Dahlem, Markus A.; Hadjikhani, Nouchine			Migraine Aura: Retracting Particle-Like Waves in Weakly Susceptible Cortex	PLOS ONE			English	Article							CORTICAL SPREADING DEPRESSION; PRIMARY VISUAL-CORTEX; HUMAN STRIATE CORTEX; EXCITATION WAVES; MODEL; PROPAGATION; SCOTOMAS; PATTERNS; FMRI; REPRESENTATION	Cortical spreading depression (SD) has been suggested to underlie migraine aura. Despite a precise match in speed, the spatio-temporal patterns of SD observed in animal cortex and aura symptoms mapped to the cortical surface ordinarily differ in aspects of size and shape. We show that this mismatch is reconciled by utilizing that both pattern types bifurcate from an instability point of generic reaction-diffusion models. To classify these spatio-temporal pattern we suggest a susceptibility scale having the value sigma = 1 at the instability point. We predict that human cortex is only weakly susceptible to SD (sigma < 1), and support this prediction by directly matching visual aura symptoms with anatomical landmarks using fMRI retinotopic mapping. Moreover, we use retinal SD to give a proof of concept of the existence of this instability point and describe how cortical susceptibility to SD must be adjusted for migraine drug testing. Close to the instability point at sigma = 1 the dynamical repertoire of cortical tissue is increased. As a consequence, the picture of an engulfing SD that became paradigmatic for migraine with aura needs to be modified in most cases towards a more spatially confined pattern that remains within the originating major gyrus or sulcus. Furthermore, we discuss the resulting implications on migraine pharmacology that is hitherto tested in the regime (sigma > 1), and potentially silent aura occurring below a second bifurcation point at sigma = 0 on the susceptible scale.	[Dahlem, Markus A.] Tech Univ Berlin, Inst Theoret Phys, Berlin, Germany; [Dahlem, Markus A.] Otto Von Guericke Univ, Klin Neurol II, Magdeburg, Germany; [Dahlem, Markus A.] Leibniz Inst Neurobiol, Magdeburg, Germany; [Hadjikhani, Nouchine] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Martinos Ctr Biomed Imag, Charlestown, MA USA; [Hadjikhani, Nouchine] Brain Mind Inst, EPFL, Lausanne, Switzerland	Technical University of Berlin; Otto von Guericke University; Leibniz Institut fur Neurobiologie (LIN); Harvard University; Massachusetts General Hospital; Ecole Polytechnique Federale de Lausanne	Dahlem, MA (corresponding author), Tech Univ Berlin, Inst Theoret Phys, Berlin, Germany.	dahlem@physik.tu-berlin.de	Dahlem, Markus/A-8805-2008; Hadjikhani, Nouchine/C-2018-2008	Dahlem, Markus/0000-0002-7532-0127; Hadjikhani, Nouchine/0000-0003-4075-3106	Deutsche Forschungsgemeinschaft [DA 602/1-1, SFB 555]; NIH [5PO1NS 35611]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Deutsche Forschungsgemeinschaft DA 602/1-1 and SFB 555, and by an NIH grant 5PO1NS 35611. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews TJ, 1997, J NEUROSCI, V17, P2859; [Anonymous], 1988, EYE BRAIN VISION; Brand S, 1998, N-S ARCH PHARMACOL, V357, P419, DOI 10.1007/PL00005188; Dahlem MA, 2008, J THEOR BIOL, V251, P202, DOI 10.1016/j.jtbi.2007.11.019; Dahlem MA, 1997, EXP BRAIN RES, V115, P319, DOI 10.1007/PL00005700; Dahlem MA, 2000, EUR J NEUROSCI, V12, P767, DOI 10.1046/j.1460-9568.2000.00995.x; Dahlem MA, 2004, ANN PHYS-BERLIN, V13, P442, DOI 10.1002/andp.200410087; Dahlem MA, 2003, BIOL CYBERN, V88, P419, DOI 10.1007/s00422-003-0405-y; Davydov V. A., 1991, Soviet Physics - Uspekhi, V34, P665, DOI 10.1070/PU1991v034n08ABEH002462; Davydov VA, 2003, PHYS LETT A, V307, P265, DOI 10.1016/S0375-9601(02)01726-7; Davydov VA, 2002, EUROPHYS LETT, V59, P344, DOI 10.1209/epl/i2002-00200-6; Davydov VA, 2000, PHYS REV LETT, V85, P868, DOI 10.1103/PhysRevLett.85.868; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Farkas E, 2008, J CEREBR BLOOD F MET, V28, P251, DOI 10.1038/sj.jcbfm.9600569; ffytche DH, 1999, BRAIN, V122, P1247, DOI 10.1093/brain/122.7.1247; GaschlerMarkefski B, 1997, MAGN RESON MED, V38, P811, DOI 10.1002/mrm.1910380518; GORELOVA NA, 1983, J NEUROBIOL, V14, P353, DOI 10.1002/neu.480140503; GRAFSTEIN B, 1956, J NEUROPHYSIOL, V19, P308, DOI 10.1152/jn.1956.19.4.308; GRUSSER OJ, 1995, VISION RES, V35, P1125, DOI 10.1016/0042-6989(94)00187-Q; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Haken H., 1983, SYNERGETICS INTRO, DOI 10.1007/978-3-642-88338-5; Hakim V, 1999, PHYS REV E, V60, P5073, DOI 10.1103/PhysRevE.60.5073; Hanke W, 1999, RETINAL SPREADING DE; HORTON JC, 1991, ARCH OPHTHALMOL-CHIC, V109, P816, DOI 10.1001/archopht.1991.01080060080030; James MF, 1999, J PHYSIOL-LONDON, V519, P415, DOI 10.1111/j.1469-7793.1999.0415m.x; JUNG R, 1979, NEUROPSYCHOLOGIA, V17, P173, DOI 10.1016/0028-3932(79)90008-3; Kager H, 2000, J NEUROPHYSIOL, V84, P495, DOI 10.1152/jn.2000.84.1.495; KARMA A, 1991, PHYS REV LETT, V66, P2274, DOI 10.1103/PhysRevLett.66.2274; Lashley KS, 1941, ARCH NEURO PSYCHIATR, V46, P331, DOI 10.1001/archneurpsyc.1941.02280200137007; LAURITZEN M, 1987, TRENDS NEUROSCI, V10, P8, DOI 10.1016/0166-2236(87)90115-9; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Lehmenkuhler A, 1993, MIGRAINE BASIC MECH; Lotze M, 2000, NEUROIMAGE, V11, P473, DOI 10.1006/nimg.2000.0556; Makarova J, 2007, BIOPHYS J, V92, P4216, DOI 10.1529/biophysj.106.090332; MARTINSFERREIRA H, 1974, J NEUROPHYSIOL, V37, P773, DOI 10.1152/jn.1974.37.4.773; MASELKO J, 1989, NATURE, V339, P609, DOI 10.1038/339609a0; Mihaliuk E, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.065602; Mikhailov AS, 2006, PHYS REP, V425, P79, DOI 10.1016/j.physrep.2005.11.003; MILNER PM, 1958, ELECTROEN CLIN NEURO, V10, P705, DOI 10.1016/0013-4694(58)90073-7; Moskowitz MA, 2008, HEADACHE, V48, P688, DOI 10.1111/j.1526-4610.2008.01110.x; Muller M, 2000, J NEUROPHYSIOL, V84, P1869, DOI 10.1152/jn.2000.84.4.1869; Polimeni JR, 2006, VISION RES, V46, P3336, DOI 10.1016/j.visres.2006.03.006; POPPEL E, 1973, NATURWISSENSCHAFTEN, V60, P554; Qiu AQ, 2006, NEUROIMAGE, V31, P125, DOI 10.1016/j.neuroimage.2005.11.049; Rademacher J, 2001, NEUROIMAGE, V13, P669, DOI 10.1006/nimg.2000.0714; RICHARDS W, 1971, SCI AM, V224, P88, DOI 10.1038/scientificamerican0571-88; RODRIGUES PS, 1988, EXP BRAIN RES, V73, P659, DOI 10.1007/BF00406625; Roland PE, 1998, BRAIN RES REV, V26, P87, DOI 10.1016/S0165-0173(97)00058-1; Russell MB, 1996, BRAIN, V119, P355, DOI 10.1093/brain/119.2.355; Sakurai T, 2002, SCIENCE, V296, P2009, DOI 10.1126/science.1071265; Sanchez-del-Rio M, 2006, CURR OPIN NEUROL, V19, P294, DOI 10.1097/01.wco.0000227041.23694.5c; Scheller D, 1998, J NEUROSCI RES, V51, P85, DOI 10.1002/(SICI)1097-4547(19980101)51:1<85::AID-JNR9>3.0.CO;2-H; Schneider FM, 2009, CHAOS, V19, DOI 10.1063/1.3096411; SCHWARTZ EL, 1980, BIOL CYBERN, V37, P63, DOI 10.1007/BF00364246; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shepherd AJ, 2001, BRAIN, V124, P2310, DOI 10.1093/brain/124.11.2310; SHIBATA M, 1972, J NEUROPHYSIOL, V35, P381, DOI 10.1152/jn.1972.35.3.381; SILBERSTEIN SD, 2005, ATLAS MIGRAINE OTHER; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; STENSAAS SS, 1974, J NEUROSURG, V40, P747, DOI 10.3171/jns.1974.40.6.0747; Tootell RBH, 1998, TRENDS COGN SCI, V2, P174, DOI 10.1016/S1364-6613(98)01171-1; VANVALKENBURGH P, 2005, J VISION, V5, P90; Vincent MB, 2007, CEPHALALGIA, V27, P1368, DOI 10.1111/j.1468-2982.2007.01388.x; Watzlawick P., 1993, SITUATION IS HOPELES; Wiedemann M, 1996, N-S ARCH PHARMACOL, V353, P552, DOI 10.1007/BF00169175; Wilkinson F, 2003, PROG BRAIN RES, V144, P305, DOI 10.1016/S0079-6123(03)14402-1; Winfree AT, 1991, CHAOS, V1	68	43	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5007	10.1371/journal.pone.0005007	http://dx.doi.org/10.1371/journal.pone.0005007			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337363	Green Published, Green Submitted, gold			2022-12-25	WOS:000265500600008
J	Herfarth, HH; Grunert, M; Klebl, F; Strauch, U; Feuerbach, S; Scholmerich, J; Rogler, G; Schreyer, AG				Herfarth, Hans H.; Grunert, Michael; Klebl, Frank; Strauch, Ulrike; Feuerbach, Stefan; Schoelmerich, Juergen; Rogler, Gerhard; Schreyer, Andreas G.			Frequency and Nature of Incidental Extra-Enteric Lesions Found on Magnetic Resonance Enterography (MR-E) in Patients with Inflammatory Bowel Diseases (IBD)	PLOS ONE			English	Article							CROHNS-DISEASE; CT COLONOGRAPHY; CONVENTIONAL ENTEROCLYSIS; EXTRACOLONIC FINDINGS; VIRTUAL COLONOSCOPY; TREATMENT RESPONSE; ABDOMEN; PREVALENCE; ULTRASOUND; DISORDERS	Background: The aim of this study was to determine the occurrence of extra-enteric findings in a large cohort of patients undergoing magnetic resonance enterography (MR-E) and to classify the clinical significance of these findings. Materials and Methods: We retrospectively analyzed 1154 MR-E performed in 1006 patients referred to our radiological department between 1999-2005. The reasons for referral were suspected or proven inflammatory bowel diseases (IBD) (n = 710), further diagnostic work-up for small bowel disease because of non-specific abdominal symptoms (SBD; n = 182) or suspected small bowel malignancies (SBM; n = 114). All extra-enteric findings were reviewed by a radiologist and a gastroenterologist and were classified as having high, moderate, or low significance for further diagnostic or therapeutic procedures. Results: The average age of all patients was 40 +/- 16 (Mean +/- SD) years (y) (IBD 35 +/- 13 y; SBD 49 +/- 16 y; SBM 57 +/- 15 y). A total of 1113 extra-enteric findings were detected in 600 of 1006 patients (59.6%). Of these findings 180 (16.2%) were judged as having a high, 212 (19.0%) a moderate and 721 (64.8%) a low significance. On a per group basis in patients with IBD 12.0% of the findings were of major clinical significance compared to 13.7% and 33.3% in patients with SBD and SBM, respectively. The most common major findings were abscesses (69.9%) in the IBD group and extraintestinal tumors, metastases or masses in the SBD and SBM groups (41.9% and 74.2%, respectively). Conclusions: MR-E reveals a substantial number of extra-enteric findings, supporting the role of a cross-sectional imaging method for the evaluation of the small bowel.	[Herfarth, Hans H.; Grunert, Michael; Klebl, Frank; Strauch, Ulrike; Schoelmerich, Juergen; Rogler, Gerhard] Univ Regensburg, Dept Internal Med, D-8400 Regensburg, Germany; [Feuerbach, Stefan; Schreyer, Andreas G.] Univ Regensburg, Dept Radiol, D-8400 Regensburg, Germany	University of Regensburg; University of Regensburg	Herfarth, HH (corresponding author), Univ N Carolina, Sch Med, Div Gastroenterol & Hepatol, Chapel Hill, NC 27515 USA.	hherf@med.unc.edu	Herfarth, Hans/K-7547-2019; Schreyer, Andreas G/A-1797-2012; Rogler, Gerhard/O-5308-2015; Grunert, Michael/AAC-8233-2021	Schreyer, Andreas G/0000-0002-2449-4397; Rogler, Gerhard/0000-0002-1733-9188; Schreyer, Andreas/0000-0002-2539-059X	NIH [R21 DK080408-01]; CCFA [senior research award]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK080408] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CCFA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Hans Herfarth is supported in part by NIH R21 DK080408-01 and a senior research award of the CCFA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschoff AJ, 1997, ROFO-FORTSCHR RONTG, V167, P387, DOI 10.1055/s-2007-1015549; Bernstein CN, 2005, AM J GASTROENTEROL, V100, P2493, DOI 10.1111/j.1572-0241.2005.00239.x; BOOYA F, 2008, ABDOM IMAGING; Bruining DH, 2008, INFLAMM BOWEL DIS, V14, P1701, DOI 10.1002/ibd.20529; Debatin JF, 2003, GUT, V52, P17; FISHMAN EK, 1987, AM J ROENTGENOL, V148, P537, DOI 10.2214/ajr.148.3.537; Frokjaer JB, 2005, SCAND J GASTROENTERO, V40, P832, DOI 10.1080/00365520510015683; Gasche C, 1999, GUT, V44, P112, DOI 10.1136/gut.44.1.112; Gourtsoyiannis NC, 2006, EUR RADIOL, V16, P1915, DOI 10.1007/s00330-006-0248-8; Hara AK, 2000, RADIOLOGY, V215, P353, DOI 10.1148/radiology.215.2.r00ap33353; Hellstrom M, 2004, AM J ROENTGENOL, V182, P631, DOI 10.2214/ajr.182.3.1820631; Holzknecht N, 1998, RADIOLOGE, V38, P29, DOI 10.1007/s001170050320; Jamieson DH, 2003, AM J ROENTGENOL, V180, P1211, DOI 10.2214/ajr.180.5.1801211; KETTRITZ U, 1995, J CLIN GASTROENTEROL, V21, P249, DOI 10.1097/00004836-199510000-00018; Koh DM, 2001, AM J ROENTGENOL, V177, P1325, DOI 10.2214/ajr.177.6.1771325; Low RN, 2002, RADIOLOGY, V222, P652, DOI 10.1148/radiol.2223010811; Low RN, 2000, JMRI-J MAGN RESON IM, V11, P127, DOI 10.1002/(SICI)1522-2586(200002)11:2<127::AID-JMRI8>3.0.CO;2-G; Maccioni F, 2000, ABDOM IMAGING, V25, P219, DOI 10.1007/s002610000004; Maccioni F, 2002, ABDOM IMAGING, V27, P384, DOI 10.1007/s00261-001-0119-3; Madsen SM, 1997, ABDOM IMAGING, V22, P164, DOI 10.1007/s002619900163; Madsen SM, 1999, ABDOM IMAGING, V24, P232, DOI 10.1007/s002619900487; Maglinte DDT, 2006, EUR RADIOL, V16, P967, DOI 10.1007/s00330-005-0054-8; Mako EK, 2000, EUR J RADIOL, V35, P168, DOI 10.1016/S0720-048X(00)00239-4; Marcos HB, 2000, MAGN RESON IMAGING, V18, P263, DOI 10.1016/S0730-725X(99)00141-1; Ochsenkuhn T, 2004, SCAND J GASTROENTERO, V39, P953, DOI 10.1080/00365520410003218; Parente F, 2003, ALIMENT PHARM THER, V18, P1009, DOI 10.1046/j.1365-2036.2003.01796.x; Paulsen SR, 2006, RADIOGRAPHICS, V26, P641, DOI 10.1148/rg.263055162; Pickhardt PJ, 2003, NEW ENGL J MED, V349, P2191, DOI 10.1056/NEJMoa031618; Potthast S, 2002, EUR RADIOL, V12, P1416, DOI 10.1007/s00330-001-1191-3; Rieber A, 2000, INT J COLORECTAL DIS, V15, P176, DOI 10.1007/s003840000219; Rieber A, 1998, RADIOLOGE, V38, P23, DOI 10.1007/s001170050319; Sailer J, 2005, AM J ROENTGENOL, V185, P1575, DOI 10.2214/AJR.04.1534; Schreyer AG, 2004, INFLAMM BOWEL DIS, V10, P45, DOI 10.1097/00054725-200401000-00008; Schreyer AG, 2002, INVEST RADIOL, V37, P528, DOI 10.1097/00004424-200209000-00008; Schreyer AG, 2004, CLIN GASTROENTEROL H, V2, P491, DOI 10.1016/S1542-3565(04)00168-5; Schunk K, 2000, INVEST RADIOL, V35, P431, DOI 10.1097/00004424-200007000-00006; SHOENUT JP, 1994, J CLIN GASTROENTEROL, V19, P31, DOI 10.1097/00004836-199407000-00009; Small WC, 1999, J MAGN RESON IMAGING, V10, P15, DOI 10.1002/(SICI)1522-2586(199907)10:1<15::AID-JMRI3>3.3.CO;2-O; Stange EF, 2006, GUT, V55, DOI 10.1136/gut.2005.081950a; Wiarda BM, 2006, AM J ROENTGENOL, V187, P522, DOI 10.2214/AJR.05.0511; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; Xiong T, 2005, BRIT J RADIOL, V78, P22, DOI 10.1259/bjr/67998962	42	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e4863	10.1371/journal.pone.0004863	http://dx.doi.org/10.1371/journal.pone.0004863			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337373	Green Submitted, Green Published, gold			2022-12-25	WOS:000265500600003
J	Hosszu, LLP; Trevitt, CR; Jones, S; Batchelor, M; Scott, DJ; Jackson, GS; Collinge, J; Waltho, JP; Clarke, AR				Hosszu, Laszlo L. P.; Trevitt, Clare R.; Jones, Samantha; Batchelor, Mark; Scott, David J.; Jackson, Graham S.; Collinge, John; Waltho, Jonathan P.; Clarke, Anthony R.			Conformational Properties of beta-PrP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PRION PROTEIN; CHEMICAL-SHIFT; MOLTEN GLOBULE; INTERMEDIATE STATES; DOMAIN PRP(121-231); SECONDARY STRUCTURE; AMYLOID FORMATION; NMR-SPECTROSCOPY; FOLDING PATHWAY; COPPER-BINDING	Prion propagation involves a conformational transition of the cellular form of prion protein (PrPC) to a disease-specific isomer (PrPSc), shifting from a predominantly alpha-helical conformation to one dominated by beta-sheet structure. This conformational transition is of critical importance in understanding the molecular basis for prion disease. Here, we elucidate the conformational properties of a disulfide-reduced fragment of human PrP spanning residues 91-231 under acidic conditions, using a combination of heteronuclear NMR, analytical ultracentrifugation, and circular dichroism. We find that this form of the protein, which similarly to PrPSc, is a potent inhibitor of the 26 S proteasome, assembles into soluble oligomers that have significant beta-sheet content. The monomeric precursor to these oligomers exhibits many of the characteristics of a molten globule intermediate with some helical character in regions that form helices I and III in the PrPC conformation, whereas helix II exhibits little evidence for adopting a helical conformation, suggesting that this region is a likely source of interaction within the initial phases of the transformation to a beta-rich conformation. This precursor state is almost as compact as the folded PrPC structure and, as it assembles, only residues 126-227 are immobilized within the oligomeric structure, leaving the remainder in a mobile, random-coil state.	[Hosszu, Laszlo L. P.; Trevitt, Clare R.; Jones, Samantha; Batchelor, Mark; Jackson, Graham S.; Collinge, John; Clarke, Anthony R.] Inst Neurol, Dept Neurodegenerat Dis, MRC Prion Unit, London WC1N 3BG, England; [Hosszu, Laszlo L. P.; Waltho, Jonathan P.] Univ Sheffield, Krebs Inst Biomol Res, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Scott, David J.] Univ Nottingham, Sch Biosci, Natl Ctr Macromol Hydrodynam, Loughborough LE12 5RD, Leics, England	University of London; University College London; University of Sheffield; University of Nottingham	Clarke, AR (corresponding author), Inst Neurol, Dept Neurodegenerat Dis, MRC Prion Unit, Queen Sq, London WC1N 3BG, England.	a.r.clarke@prion.ucl.ac.uk		Scott, David/0000-0002-6726-2078; Jackson, Graham/0000-0002-3125-2011; Waltho, Jonathan/0000-0002-7402-5492	Medical Research Council; Biotechnology and Biological Sciences Research Council [B17948] Funding Source: researchfish; Medical Research Council [MC_U123160656, MC_U123192748, MC_U123170362] Funding Source: researchfish; MRC [MC_U123160656, MC_U123170362, MC_U123192748] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council.	Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Baskakov IV, 2004, PROTEIN SCI, V13, P586, DOI 10.1110/ps.03457204; BAX A, 1991, Journal of Biomolecular NMR, V1, P99, DOI 10.1007/BF01874573; BESSEN RA, 1995, NATURE, V375, P698, DOI 10.1038/375698a0; Brown DR, 1996, NATURE, V380, P345, DOI 10.1038/380345a0; BROWN P, 1990, P NATL ACAD SCI USA, V87, P7240, DOI 10.1073/pnas.87.18.7240; Calloni G, 2008, J AM CHEM SOC, V130, P13040, DOI 10.1021/ja8029224; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Cavagnero S, 2001, BIOCHEMISTRY-US, V40, P14459, DOI 10.1021/bi011500n; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Davies P, 2008, BIOCHEM J, V410, P237, DOI 10.1042/BJ20071477; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Fitzmaurice TJ, 2008, BIOCHEM J, V409, P367, DOI 10.1042/BJ20071122; Gerber R, 2008, PROTEIN SCI, V17, P537, DOI 10.1110/ps.073163308; Gerber R, 2007, J BIOL CHEM, V282, P6300, DOI 10.1074/jbc.M608926200; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Herrmann LM, 1998, NEUROREPORT, V9, P2457, DOI 10.1097/00001756-199808030-00006; HOMANS SW, 1989, DICT CONCEPTS NMR; Hornemann S, 1998, P NATL ACAD SCI USA, V95, P6010, DOI 10.1073/pnas.95.11.6010; Hosszu LLP, 2005, BIOCHEMISTRY-US, V44, P16649, DOI 10.1021/bi051277k; Hosszu LLP, 2004, J BIOL CHEM, V279, P28515, DOI 10.1074/jbc.M313762200; Hosszu LLP, 1999, NAT STRUCT BIOL, V6, P740, DOI 10.1038/11507; Hou LM, 2004, J AM CHEM SOC, V126, P1992, DOI 10.1021/ja036813f; Jackson GS, 2001, P NATL ACAD SCI USA, V98, P8531, DOI 10.1073/pnas.151038498; Jackson GS, 1999, BBA-PROTEIN STRUCT M, V1431, P1, DOI 10.1016/S0167-4838(99)00038-2; Jackson GS, 1999, SCIENCE, V283, P1935, DOI 10.1126/science.283.5409.1935; Kachel N, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-16; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; Khalili-Shirazi A, 2005, J IMMUNOL, V174, P3256, DOI 10.4049/jimmunol.174.6.3256; Khalill-Shirazi A, 2007, BBA-PROTEINS PROTEOM, V1774, P1438, DOI 10.1016/j.bbapap.2007.08.028; Klewpatinond M, 2008, J BIOL CHEM, V283, P1870, DOI 10.1074/jbc.M708472200; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Kuwata K, 2002, BIOCHEMISTRY-US, V41, P12277, DOI 10.1021/bi026129y; Lee S, 2003, NAT STRUCT BIOL, V10, P725, DOI 10.1038/nsb961; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Liu K, 2000, J MOL BIOL, V303, P555, DOI 10.1006/jmbi.2000.4164; Luhrs TT, 2006, J MOL BIOL, V357, P833, DOI 10.1016/j.jmb.2006.01.016; Maiti NR, 2001, J BIOL CHEM, V276, P2427, DOI 10.1074/jbc.M007862200; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; McParland VJ, 2002, NAT STRUCT BIOL, V9, P326, DOI 10.1038/nsb791; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Muramoto T, 1996, P NATL ACAD SCI USA, V93, P15457, DOI 10.1073/pnas.93.26.15457; Nandi PK, 2002, J MOL BIOL, V322, P153, DOI 10.1016/S0022-2836(02)00750-7; O'Sullivan DBD, 2007, BIOCHEM J, V401, P533, DOI 10.1042/BJ20060668; Paquet S, 2007, J GEN VIROL, V88, P706, DOI 10.1099/vir.0.82336-0; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Redfield C, 1999, NAT STRUCT BIOL, V6, P948, DOI 10.1038/13318; Redfield Christina, 2004, Methods Mol Biol, V278, P233; Reed MAC, 2003, J MOL BIOL, V330, P1189, DOI 10.1016/S0022-2836(03)00625-9; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Sasaki K, 2008, PRION, V2, P118, DOI 10.4161/pri.2.3.7148; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schulman BA, 1997, NAT STRUCT BIOL, V4, P630, DOI 10.1038/nsb0897-630; Schwarzinger S, 2008, PROTEIN SCI, V17, P313, DOI 10.1110/ps.073187208; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Supattapone S, 2004, J MOL MED, V82, P348, DOI 10.1007/s00109-004-0534-3; Suzuki T, 2002, BIOCHEM BIOPH RES CO, V294, P912, DOI 10.1016/S0006-291X(02)00546-6; Swietnicki W, 2000, BIOCHEMISTRY-US, V39, P424, DOI 10.1021/bi991967m; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Tattum MH, 2006, J MOL BIOL, V357, P975, DOI 10.1016/j.jmb.2006.01.052; TURK E, 1988, EUR J BIOCHEM, V176, P21, DOI 10.1111/j.1432-1033.1988.tb14246.x; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Walter ED, 2006, BIOCHEMISTRY-US, V45, P13083, DOI 10.1021/bi060948r; WANG Y, 1995, PHILOS T ROY SOC B, V348, P27, DOI 10.1098/rstb.1995.0042; Wells MA, 2006, BIOCHEM J, V400, P501, DOI 10.1042/BJ20060721; Wells MA, 2006, BIOCHEM J, V399, P435, DOI 10.1042/BJ20060458; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wishart DS, 1998, BIOCHEM CELL BIOL, V76, P153, DOI 10.1139/bcb-76-2-3-153; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Yao J, 1997, FEBS LETT, V419, P285, DOI 10.1016/S0014-5793(97)01474-9; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; Ziegler J, 2003, J BIOL CHEM, V278, P50175, DOI 10.1074/jbc.M305234200	84	28	29	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21981	21990		10.1074/jbc.M809173200	http://dx.doi.org/10.1074/jbc.M809173200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19369250	hybrid, Green Published			2022-12-25	WOS:000268783700022
J	Slugoski, MD; Ng, AML; Yao, SYM; Lin, CC; Mulinta, R; Cass, CE; Baldwin, SA; Young, JD				Slugoski, Melissa D.; Ng, Amy M. L.; Yao, Sylvia Y. M.; Lin, Colin C.; Mulinta, Ras; Cass, Carol E.; Baldwin, Stephen A.; Young, James D.			Substituted Cysteine Accessibility Method Analysis of Human Concentrative Nucleoside Transporter hCNT3 Reveals a Novel Discontinuous Region of Functional Importance within the CNT Family Motif (G/A)XKX(3)NEFVA(Y/M/F)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSERVED GLUTAMATE RESIDUES; NUCLEOBASE TRANSPORT; MECHANISTIC INSIGHTS; MOLECULAR-CLONING; RECOMBINANT HUMAN; CRYSTAL-STRUCTURE; NA+; IDENTIFICATION; EXPRESSION; PURINE	The human SLC28 family of integral membrane CNT (concentrative nucleoside transporter) proteins has three members, hCNT1, hCNT2, and hCNT3. Na+-coupled hCNT1 and hCNT2 transport pyrimidine and purine nucleosides, respectively, whereas hCNT3 mediates transport of both pyrimidine and purine nucleosides utilizing Na+ and/or H+ electrochemical gradients. These and other eukaryote CNTs are currently defined by a putative 13-transmembrane helix (TM) topology model with an intracellular N terminus and a glycosylated extracellular C terminus. Recent mutagenesis studies, however, have provided evidence supporting an alternative 15-TM membrane architecture. In the absence of CNT crystal structures, valuable information can be gained about residue localization and function using substituted cysteine accessibility method analysis with thiol-reactive reagents, such as p-chloromercuribenzene sulfonate. Using heterologous expression in Xenopus oocytes and the cysteineless hCNT3 protein hCNT3C-, substituted cysteine accessibility method analysis with p-chloromercuribenzene sulfonate was performed on the TM 11-13 region, including bridging extramembranous loops. The results identified residues of functional importance and, consistent with a new revised 15-TM CNT membrane architecture, suggest a novel membrane-associated topology for a region of the protein (TM 11A) that includes the highly conserved CNT family motif (G/A)XKX(3)NEFVA(Y/M/F).	[Slugoski, Melissa D.; Ng, Amy M. L.; Yao, Sylvia Y. M.; Lin, Colin C.; Mulinta, Ras; Young, James D.] Univ Alberta, Dept Physiol, Membrane Prot Res Grp, Edmonton, AB T6G 2H7, Canada; [Cass, Carol E.] Univ Alberta, Dept Oncol, Membrane Prot Res Grp, Edmonton, AB T6G 2H7, Canada; [Cass, Carol E.] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Baldwin, Stephen A.] Univ Leeds, Inst Membrane & Syst Biol, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England	University of Alberta; University of Alberta; University of Alberta; University of Leeds	Young, JD (corresponding author), Univ Alberta, Dept Physiol, Membrane Prot Res Grp, 7-55 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	james.young@ualberta.ca	Cass, Carol E/F-5861-2010		National Cancer Institute of Canada; Alberta Cancer Board, Canada	National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Alberta Cancer Board, Canada	This work was supported in part by the National Cancer Institute of Canada, with funds from the Canadian Cancer Society and the Alberta Cancer Board, Canada.	Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; CASS CE, 1995, DRUG TRANSPORT ANTIM, P403; CHE MX, 1995, J BIOL CHEM, V270, P13596, DOI 10.1074/jbc.270.23.13596; CRAIG JE, 1994, MOL MICROBIOL, V11, P1159, DOI 10.1111/j.1365-2958.1994.tb00392.x; Damaraju VL, 2007, AM J PHYSIOL-RENAL, V293, pF200, DOI 10.1152/ajprenal.00007.2007; Elwi AN, 2006, BIOCHEM CELL BIOL, V84, P844, DOI 10.1139/O06-198; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Gray JH, 2004, PFLUG ARCH EUR J PHY, V447, P728, DOI 10.1007/s00424-003-1107-y; Griffith DA, 1996, BBA-REV BIOMEMBRANES, V1286, P153, DOI 10.1016/S0304-4157(96)00008-1; Hamilton SR, 2001, J BIOL CHEM, V276, P27981, DOI 10.1074/jbc.M100518200; HUANG QQ, 1994, J BIOL CHEM, V269, P17757; King AE, 2006, TRENDS PHARMACOL SCI, V27, P416, DOI 10.1016/j.tips.2006.06.004; Latini S, 2001, J NEUROCHEM, V79, P463, DOI 10.1046/j.1471-4159.2001.00607.x; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Loewen SK, 2004, MOL MEMBR BIOL, V21, P1, DOI 10.1080/0968768031000140836; Ritzel MWL, 1998, MOL MEMBR BIOL, V15, P203; Ritzel MWL, 1997, AM J PHYSIOL-CELL PH, V272, pC707, DOI 10.1152/ajpcell.1997.272.2.C707; Ritzel MWL, 2001, J BIOL CHEM, V276, P2914, DOI 10.1074/jbc.M007746200; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Slugoski MD, 2008, J BIOL CHEM, V283, P24922, DOI 10.1074/jbc.M801793200; Slugoski MD, 2008, J BIOL CHEM, V283, P8496, DOI 10.1074/jbc.M710433200; Slugoski MD, 2007, BIOCHEMISTRY-US, V46, P1684, DOI 10.1021/bi061692s; Slugoski MD, 2009, J BIOL CHEM, V284, P17266, DOI 10.1074/jbc.M109.009613; Smith FM, 2007, MOL MEMBR BIOL, V24, P53, DOI 10.1080/09687860600942534; Smith KM, 2005, J BIOL CHEM, V280, P25436, DOI 10.1074/jbc.M409454200; Smith KM, 2004, J PHYSIOL-LONDON, V558, P807, DOI 10.1113/jphysiol.2004.068189; Wang J, 1997, AM J PHYSIOL-RENAL, V273, pF1058, DOI 10.1152/ajprenal.1997.273.6.F1058; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; YAN RT, 1993, CELL, V75, P37, DOI 10.1016/S0092-8674(05)80082-0; YAN RT, 1995, P NATL ACAD SCI USA, V92, P5973, DOI 10.1073/pnas.92.13.5973; Yao SY, 2002, AM J PHYSIOL-CELL PH, V283, pC155, DOI 10.1152/ajpcell.00587.2001; Yao SYM, 2007, J BIOL CHEM, V282, P30607, DOI 10.1074/jbc.M703285200; Yao SYM, 2000, PRACT APPROACH SER, P47; Yao SYM, 2002, J BIOL CHEM, V277, P24938, DOI 10.1074/jbc.M200966200; Yao SYM, 2001, BIOCHEM J, V353, P387, DOI 10.1042/0264-6021:3530387; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Young JD, 2008, XENOBIOTICA, V38, P995, DOI [10.1080/00498250801927427, 10.1080/00498250801927427 ]; Young JD, 2001, CURR TOP MEMBR, V50, P329; Zhang J, 2006, BIOCHEM J, V394, P389, DOI 10.1042/BJ20051476	41	14	14	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17281	17292		10.1074/jbc.M109.009704	http://dx.doi.org/10.1074/jbc.M109.009704			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19380585	Green Published, hybrid			2022-12-25	WOS:000266962400064
J	Antos, JM; Popp, MWL; Ernst, R; Chew, GL; Spooner, E; Ploegh, HL				Antos, John M.; Popp, Maximilian Wei-Lin; Ernst, Robert; Chew, Guo-Liang; Spooner, Eric; Ploegh, Hidde L.			A Straight Path to Circular Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN FLUORESCENT PROTEIN; CELL-WALL ANCHOR; STAPHYLOCOCCUS-AUREUS; SURFACE-PROTEINS; BACKBONE CYCLIZATION; IN-VIVO; CHEMICAL-SYNTHESIS; CYSTINE KNOT; SORTASE-A; KALATA B1	Folding and stability are parameters that control protein behavior. The possibility of conferring additional stability on proteins has implications for their use in vivo and for their structural analysis in the laboratory. Cyclic polypeptides ranging in size from 14 to 78 amino acids occur naturally and often show enhanced resistance toward denaturation and proteolysis when compared with their linear counterparts. Native chemical ligation and intein-based methods allow production of circular derivatives of larger proteins, resulting in improved stability and refolding properties. Here we show that circular proteins can be made reversibly with excellent efficiency by means of a sortase-catalyzed cyclization reaction, requiring only minimal modification of the protein to be circularized.	[Antos, John M.; Popp, Maximilian Wei-Lin; Ernst, Robert; Chew, Guo-Liang; Spooner, Eric; Ploegh, Hidde L.] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Popp, Maximilian Wei-Lin; Ploegh, Hidde L.] MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Ploegh, HL (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	ploegh@wi.mit.edu	Chew, Guo-Liang/R-9904-2019; Ernst, Robert/H-9513-2013	Chew, Guo-Liang/0000-0003-4357-1404; Ernst, Robert/0000-0001-5016-8694	National Institutes of Health [R21-EB008875]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB008875] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grant R21-EB008875.	Antos JM, 2008, J AM CHEM SOC, V130, P16338, DOI 10.1021/ja806779e; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Budzik JM, 2008, P NATL ACAD SCI USA, V105, P10215, DOI 10.1073/pnas.0803565105; Budzik JM, 2008, J BIOL CHEM, V283, P36676, DOI 10.1074/jbc.M806796200; Camarero JA, 1998, ANGEW CHEM INT EDIT, V37, P347, DOI 10.1002/(SICI)1521-3773(19980216)37:3<347::AID-ANIE347>3.0.CO;2-5; Camarero JA, 2001, J MOL BIOL, V308, P1045, DOI 10.1006/jmbi.2001.4631; Camarero JA, 1997, CHEM COMMUN, P1369, DOI 10.1039/a702083j; Camarero JA, 2007, CHEMBIOCHEM, V8, P1363, DOI 10.1002/cbic.200700183; Chan LY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001164; Clow F, 2008, BIOTECHNOL LETT, V30, P1603, DOI 10.1007/s10529-008-9718-1; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Craik DJ, 2006, SCIENCE, V311, P1563, DOI 10.1126/science.1125248; Daly NL, 1999, BIOCHEMISTRY-US, V38, P10606, DOI 10.1021/bi990605b; Davies JM, 2008, STRUCTURE, V16, P715, DOI 10.1016/j.str.2008.02.010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans TC, 2000, J BIOL CHEM, V275, P9091, DOI 10.1074/jbc.275.13.9091; Falker S, 2008, MOL MICROBIOL, V70, P595, DOI 10.1111/j.1365-2958.2008.06396.x; Gillon AD, 2008, PLANT J, V53, P505, DOI 10.1111/j.1365-313X.2007.03357.x; Hartgerink JD, 1996, J AM CHEM SOC, V118, P43, DOI 10.1021/ja953070s; Huang XY, 2003, BIOCHEMISTRY-US, V42, P11307, DOI 10.1021/bi034391g; Iwai H, 1999, FEBS LETT, V459, P166, DOI 10.1016/S0014-5793(99)01220-X; Iwai H, 2001, J BIOL CHEM, V276, P16548, DOI 10.1074/jbc.M011639200; JACKSON DY, 1995, J AM CHEM SOC, V117, P819, DOI 10.1021/ja00107a027; Kruger RG, 2004, BIOCHEMISTRY-US, V43, P1541, DOI 10.1021/bi035920j; Love KR, 2007, NAT CHEM BIOL, V3, P697, DOI 10.1038/nchembio.2007.43; Mao HY, 2004, PROTEIN EXPRES PURIF, V37, P253, DOI 10.1016/j.pep.2004.06.013; Mao HY, 2004, J AM CHEM SOC, V126, P2670, DOI 10.1021/ja039915e; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Martin SS, 2002, J MOL BIOL, V319, P107, DOI 10.1016/S0022-2836(02)00246-2; Misaghi S, 2005, J BIOL CHEM, V280, P1512, DOI 10.1074/jbc.M410770200; Pallen MJ, 2001, TRENDS MICROBIOL, V9, P97, DOI 10.1016/S0966-842X(01)01956-4; Parthasarathy R, 2007, BIOCONJUGATE CHEM, V18, P469, DOI 10.1021/bc060339w; Paterson GK, 2004, TRENDS MICROBIOL, V12, P89, DOI 10.1016/j.tim.2003.12.007; Peitz M, 2007, GENESIS, V45, P508, DOI 10.1002/dvg.20321; Popp MW, 2007, NAT CHEM BIOL, V3, P707, DOI 10.1038/nchembio.2007.31; Popp MW, 2009, J BIOL CHEM, V284, P3593, DOI 10.1074/jbc.M807172200; Pritz S, 2007, J ORG CHEM, V72, P3909, DOI 10.1021/jo062331l; Samantaray S, 2008, J AM CHEM SOC, V130, P2132, DOI 10.1021/ja077358g; Saska I, 2008, TRENDS BIOCHEM SCI, V33, P363, DOI 10.1016/j.tibs.2008.04.016; Saska I, 2007, J BIOL CHEM, V282, P29721, DOI 10.1074/jbc.M705185200; SCHNEEWIND O, 1995, SCIENCE, V268, P103, DOI 10.1126/science.7701329; Scott CP, 1999, P NATL ACAD SCI USA, V96, P13638, DOI 10.1073/pnas.96.24.13638; Tanaka T, 2008, CHEMBIOCHEM, V9, P802, DOI 10.1002/cbic.200700614; Ton-That H, 1999, J BIOL CHEM, V274, P24316, DOI 10.1074/jbc.274.34.24316; Ton-That H, 2000, J BIOL CHEM, V275, P9876, DOI 10.1074/jbc.275.13.9876; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; Trabi M, 2002, TRENDS BIOCHEM SCI, V27, P132, DOI 10.1016/S0968-0004(02)02057-1; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246	49	119	128	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					16028	16036		10.1074/jbc.M901752200	http://dx.doi.org/10.1074/jbc.M901752200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19359246	Green Published, hybrid			2022-12-25	WOS:000266501000068
J	Chen, PY; Simons, M; Friesel, R				Chen, Pei-Yu; Simons, Michael; Friesel, Robert			FRS2 via Fibroblast Growth Factor Receptor 1 Is Required for Platelet-derived Growth Factor Receptor beta-mediated Regulation of Vascular Smooth Muscle Marker Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL PROLIFERATION; HEPARAN-SULFATE; FGF; ASSOCIATION; ACTIVATION; BINDING; RECRUITMENT; ARTERIES; MUTATION; COMPLEX	Vascular smooth muscle cells (VSMC) exhibit phenotypic plasticity and change from a quiescent contractile phenotype to a proliferative synthetic phenotype during physiological arteriogenesis and pathological conditions such as atherosclerosis and restenosis. Platelet-derived growth factor (PDGF)-BB is a potent inducer of the VSMC synthetic phenotype; however, much less is known about the role of fibroblast growth factor-2 (FGF2) in this process. Here, we show using signal transduction mutants of FGF receptor 1 (FGFR1) expressed in rat VSMC that the adaptor protein FRS2 is essential for FGFR1-mediated phenotypic modulation and down-regulation of VSMC smooth muscle alpha-actin (SMA) gene expression. In addition, we show that PDGF-BB and FGF2 act synergistically to induce cell proliferation and down-regulate SMA and SM22 alpha in VSMC. Furthermore, we show that PDGF-BB induces tyrosine phosphorylation of FGFR1 and that this phosphorylation is mediated by PDGF receptor-beta (PDGFR beta), but not c-Src. We demonstrate that FRS2 co-immunoprecipitates with PDGFR beta in a complex that requires FGFR1 and that both the extracellular and the intracellular domains of FGFR1 are required for association with PDGFR beta, whereas the cytoplasmic domain of FGFR1 is required for FRS2 association with the FGFR1-PDGFR beta complex. Knockdown of FRS2 in VSMC by RNA interference inhibited PDGF-BB-mediated down-regulation of SMA and SM22 alpha without affecting PDGF-BB mediated cell proliferation or ERK activation. Together, these data support the notion that PDGFR beta down-regulates SMA and SM22 alpha through formation of a complex that requires FGFR1 and FRS2 and prove novel insight into VSMC phenotypic plasticity.	[Chen, Pei-Yu; Friesel, Robert] Maine Med Ctr, Ctr Mol Med, Res Inst, Scarborough, ME 04074 USA; [Chen, Pei-Yu] Univ Maine, Cooperat Grad Program Mol Genet & Cell Biol, Orono, ME 04469 USA; [Simons, Michael] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA	Maine Medical Center; University of Maine System; University of Maine Orono; Yale University	Chen, PY (corresponding author), 81 Res Dr, Scarborough, ME 04074 USA.	chenp@mmc.org; friesr@mmc.org	Chen, Pei-Yu/H-1669-2013; Simons, Michael/G-8553-2014	Simons, Michael/0000-0003-0348-7734	National Institutes of Health [R01-DK073871, R01-HL53793, P20 RR1555]; American Heart Association [0715788T]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018789, P40RR001555] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073871] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK073871 ( to R. F.), R01-HL53793 ( to M. S.), and P20 RR1555 ( to R. F.). This work was also supported by American Heart Association Founders Affiliate Predoctoral Fellowship 0715788T ( to P.-Y.C.).	Allen BL, 2001, J CELL BIOL, V155, P845, DOI 10.1083/jcb.200106075; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; BENJAMIN CW, 1994, J BIOL CHEM, V269, P30911; Burgar HR, 2002, J BIOL CHEM, V277, P4018, DOI 10.1074/jbc.M107785200; Chen PY, 2009, BIOCHEM BIOPH RES CO, V382, P424, DOI 10.1016/j.bbrc.2009.03.040; Chiara F, 2004, J BIOL CHEM, V279, P42516, DOI 10.1074/jbc.M406051200; Firulli AB, 1998, IN VITRO CELL DEV-AN, V34, P217; HOLYCROSS BJ, 1992, CIRC RES, V71, P1525, DOI 10.1161/01.RES.71.6.1525; Larsson H, 1999, J BIOL CHEM, V274, P25726, DOI 10.1074/jbc.274.36.25726; LINDNER V, 1991, P NATL ACAD SCI USA, V88, P3739, DOI 10.1073/pnas.88.9.3739; LINDNER V, 1993, CIRC RES, V73, P589, DOI 10.1161/01.RES.73.3.589; Lindner V, 1995, Z KARDIOL, V84, P137; Lundgren TK, 2006, J BIOL CHEM, V281, P29886, DOI 10.1074/jbc.M600473200; Mack CP, 1999, CIRC RES, V84, P852; Millette E, 2006, TRENDS CARDIOVAS MED, V16, P25, DOI 10.1016/j.tcm.2005.11.003; Millette E, 2005, CIRC RES, V96, P172, DOI 10.1161/01.RES.0000154595.87608.db; MOHAMMADI M, 1992, NATURE, V358, P681, DOI 10.1038/358681a0; Mood K, 2002, J BIOL CHEM, V277, P33196, DOI 10.1074/jbc.M203894200; Muto A, 2007, J VASC SURG, V45, p15A, DOI 10.1016/j.jvs.2007.02.061; Neilson KM, 1996, J BIOL CHEM, V271, P25049, DOI 10.1074/jbc.271.40.25049; Ong SH, 2001, P NATL ACAD SCI USA, V98, P6074, DOI 10.1073/pnas.111114298; Ong SH, 2000, MOL CELL BIOL, V20, P979, DOI 10.1128/MCB.20.3.979-989.2000; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; Owens Gary K, 2007, Novartis Found Symp, V283, P174; Rauch BH, 2005, J BIOL CHEM, V280, P17507, DOI 10.1074/jbc.M410848200; Rzucidlo EM, 2007, J VASC SURG, V45, p25A, DOI 10.1016/j.jvs.2007.03.001; Sachsenmaier C, 1999, ONCOGENE, V18, P3583, DOI 10.1038/sj.onc.1202694; Saito Y, 2001, MOL CELL BIOL, V21, P6387, DOI 10.1128/MCB.21.19.6387-6394.2001; Tanimoto T, 2004, CIRC RES, V94, P1050, DOI 10.1161/01.RES.0000126404.41421.BE; Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011; VAINIKKA S, 1994, J BIOL CHEM, V269, P18320; WANG JK, 1994, MOL CELL BIOL, V14, P181, DOI 10.1128/MCB.14.1.181; Xu H, 1998, J BIOL CHEM, V273, P17987, DOI 10.1074/jbc.273.29.17987; Yang X, 2006, CALCIFIED TISSUE INT, V78, P233, DOI 10.1007/s00223-005-0231-4; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09	36	41	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15980	15992		10.1074/jbc.M809399200	http://dx.doi.org/10.1074/jbc.M809399200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19339244	Green Published, hybrid			2022-12-25	WOS:000266501000064
J	Kim, TH; Kim, H; Park, JM; Im, SS; Bae, JS; Kim, MY; Yoon, HG; Cha, JY; Kim, KS; Ahn, YH				Kim, Tae-Hyun; Kim, Hail; Park, Joo-Man; Im, Seung-Soon; Bae, Jin-Sik; Kim, Mi-Young; Yoon, Ho-Geun; Cha, Ji-Young; Kim, Kyung-Sup; Ahn, Yong-Ho			Interrelationship between Liver X Receptor alpha, Sterol Regulatory Element-binding Protein-1c, Peroxisome Proliferator-activated Receptor gamma, and Small Heterodimer Partner in the Transcriptional Regulation of Glucokinase Gene Expression in Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORPHAN NUCLEAR RECEPTOR; ACID SYNTHASE GENE; LXR-ALPHA; HEPATIC GLUCOKINASE; GLUCOSE-METABOLISM; RESPONSE ELEMENT; TRANSGENIC MICE; GLUT2 PROMOTER; PPAR-GAMMA; CELL-LINE	Liver glucokinase (LGK) plays an essential role in controlling blood glucose levels and maintaining cellular metabolic functions. Expression of LGK is induced mainly regulated by insulin through sterol regulatory element-binding protein-1c (SREBP-1c) as a mediator. Since LGK expression is known to be decreased in the liver of liver X receptor (LXR) knockout mice, we have investigated whether LGK might be directly activated by LXR alpha. Furthermore, we have studied interrelationship between transcription factors that control gene expression of LGK. In the current studies, we demonstrated that LXR alpha increased LGK expression in primary hepatocytes and that there is a functional LXR response element in the LGK gene promoter as shown by electrophoretic mobility shift and chromatin precipitation assay. In addition, our studies demonstrate that LXR alpha and insulin activation of the LGK gene promoter occurs through a multifaceted indirect mechanism. LXR alpha increases SREBP-1c expression and then insulin stimulates the processing of the membrane-bound precursor SREBP-1c protein, and it activates LGK expression through SREBP sites in its promoter. LXR alpha also activates the LGK promoter by increasing the transcriptional activity and induction of peroxisome proliferator-activated receptor (PPAR)-gamma, which also stimulates LGK expression through a peroxisome proliferator-responsive element. This activation is tempered through a negative mechanism, where a small heterodimer partner (SHP) decreases LGK gene expression by inhibiting the transcriptional activity of LXR alpha and PPAR gamma by directly interacting with their common heterodimer partner RXR alpha. From these data, we propose a mechanism for LXR alpha in controlling the gene expression of LGK that involves activation through SREBP-1c and PPAR gamma and inhibition through SHP.	[Kim, Tae-Hyun; Kim, Hail; Park, Joo-Man; Im, Seung-Soon; Bae, Jin-Sik; Kim, Mi-Young; Yoon, Ho-Geun; Kim, Kyung-Sup; Ahn, Yong-Ho] Yonsei Univ, Dept Biochem & Mol Biol, Coll Med, Seoul 120752, South Korea; [Kim, Tae-Hyun; Park, Joo-Man; Yoon, Ho-Geun; Kim, Kyung-Sup; Ahn, Yong-Ho] Yonsei Univ, Brain Korea Project Med Sci 21, Coll Med, Seoul 120752, South Korea; [Kim, Tae-Hyun; Kim, Hail; Park, Joo-Man; Im, Seung-Soon; Bae, Jin-Sik; Kim, Mi-Young; Yoon, Ho-Geun; Kim, Kyung-Sup; Ahn, Yong-Ho] Yonsei Univ, Ctr Chron Metab Dis Res, Coll Med, Seoul 120752, South Korea; [Kim, Kyung-Sup] Yonsei Univ, Inst Genet Sci, Coll Med, Seoul 120752, South Korea; [Cha, Ji-Young] Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Inchon 406840, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Gachon University	Ahn, YH (corresponding author), Yonsei Univ, Dept Biochem & Mol Biol, Coll Med, 134 Shinchon Dong, Seoul 120752, South Korea.	yha111@yuhs.ac	Kim, Hail/C-1849-2011; AHN, Yong Ho/H-6712-2017; Kim, Hail/C-5608-2018	Kim, Hail/0000-0002-6652-1349; AHN, Yong Ho/0000-0002-4133-0757; Yoon, Ho-Geun Yoon/0000-0003-2718-3372; Kim, Kyung-sup/0000-0001-8483-8537	Korean government [R13-2002-054-03001-0]; Yonsei University College of Medicine [2005 6-2005-0047]; Yonsei University Research Fund [6-2005-0084]	Korean government(Korean Government); Yonsei University College of Medicine(General Electric); Yonsei University Research Fund	This work was supported by Korea Science and Engineering Foundation Grant R13-2002-054-03001-0 funded by the Korean government, Yonsei University College of Medicine faculty research grant for 2005 6-2005-0047, and Yonsei University Research Fund of 2005 Grant 6-2005-0084 (to H. K.). Downloaded from www.jbc.org at ISI, Thomson Scientific on May 26, 2009	Aiston S, 1999, J BIOL CHEM, V274, P24559, DOI 10.1074/jbc.274.35.24559; Brendel C, 2002, MOL ENDOCRINOL, V16, P2065, DOI 10.1210/me.2001-0194; Cao GQ, 2003, J BIOL CHEM, V278, P1131, DOI 10.1074/jbc.M210208200; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Dalen KT, 2003, J BIOL CHEM, V278, P48283, DOI 10.1074/jbc.M302287200; Ferre T, 1996, FASEB J, V10, P1213, DOI 10.1096/fasebj.10.10.8751724; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Goodwin B, 2003, MOL ENDOCRINOL, V17, P386, DOI 10.1210/me.2002-0246; Hariharan N, 1997, DIABETES, V46, P11, DOI 10.2337/diabetes.46.1.11; Hegarty BD, 2005, P NATL ACAD SCI USA, V102, P791, DOI 10.1073/pnas.0405067102; Im SS, 2005, EXP MOL MED, V37, P101, DOI 10.1038/emm.2005.14; IYNEDJIAN PB, 1989, P NATL ACAD SCI USA, V86, P7838, DOI 10.1073/pnas.86.20.7838; IYNEDJIAN PB, 1989, J BIOL CHEM, V264, P21824; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Kalaany NY, 2005, CELL METAB, V1, P231, DOI 10.1016/j.cmet.2005.03.001; Kim H, 2000, DIABETES, V49, P1517, DOI 10.2337/diabetes.49.9.1517; Kim HI, 2007, BIOCHEM BIOPH RES CO, V360, P301, DOI 10.1016/j.bbrc.2007.05.171; Kim HI, 2002, DIABETES, V51, P676, DOI 10.2337/diabetes.51.3.676; Kim JB, 1998, P NATL ACAD SCI USA, V95, P4333, DOI 10.1073/pnas.95.8.4333; Kim JY, 2004, MOL ENDOCRINOL, V18, P776, DOI 10.1210/me.2003-0311; Kim S, 2004, DIABETES, V53, pS66, DOI 10.2337/diabetes.53.2007.S66; Kim SY, 2004, J BIOL CHEM, V279, P30823, DOI 10.1074/jbc.M313223200; Kim YS, 2001, J BIOL CHEM, V276, P33736, DOI 10.1074/jbc.M101977200; Laffitte BA, 2003, P NATL ACAD SCI USA, V100, P5419, DOI 10.1073/pnas.0830671100; Latasa MJ, 2003, MOL CELL BIOL, V23, P5896, DOI 10.1128/MCB.23.16.5896-5907.2003; Lee HK, 1998, J BIOL CHEM, V273, P14398, DOI 10.1074/jbc.273.23.14398; Lee YK, 2000, MOL CELL BIOL, V20, P187, DOI 10.1128/MCB.20.1.187-195.2000; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; MAGNUSON MA, 1990, DIABETES, V39, P523, DOI 10.2337/diabetes.39.5.523; MAGNUSON MA, 1989, P NATL ACAD SCI USA, V86, P4838, DOI 10.1073/pnas.86.13.4838; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Nishizawa H, 2002, J BIOL CHEM, V277, P1586, DOI 10.1074/jbc.M104301200; Niswender KD, 1997, J BIOL CHEM, V272, P22570, DOI 10.1074/jbc.272.36.22570; Nordlie RC, 1999, ANNU REV NUTR, V19, P379, DOI 10.1146/annurev.nutr.19.1.379; Oosterveer MH, 2008, J BIOL CHEM, V283, P25437, DOI 10.1074/jbc.M801922200; Park KG, 2007, DIABETES, V56, P431, DOI 10.2337/db06-0753; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Repa JJ, 2002, NAT MED, V8, P1243, DOI 10.1038/nm1102-1243; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Seo JB, 2004, MOL CELL BIOL, V24, P3430, DOI 10.1128/MCB.24.8.3430-3444.2004; Seol W, 1996, SCIENCE, V272, P1336, DOI 10.1126/science.272.5266.1336; Shulman AI, 2005, NEW ENGL J MED, V353, P604, DOI 10.1056/NEJMra043590; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Tontonoz P, 2003, MOL ENDOCRINOL, V17, P985, DOI 10.1210/me.2003-0061; Wagner BL, 2003, MOL CELL BIOL, V23, P5780, DOI 10.1128/MCB.23.16.5780-5789.2003; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Yamagata K, 2004, J BIOL CHEM, V279, P23158, DOI 10.1074/jbc.M314322200; Zhang Y, 2004, VITAM HORM, V68, P1	50	68	70	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15071	15083		10.1074/jbc.M109.006742	http://dx.doi.org/10.1074/jbc.M109.006742			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19366697	Green Published, hybrid			2022-12-25	WOS:000266288200043
J	Usatyuk, PV; Gorshkova, IA; He, DH; Zhao, YT; Kalari, SK; Garcia, JGN; Natarajan, V				Usatyuk, Peter V.; Gorshkova, Irina A.; He, Donghong; Zhao, Yutong; Kalari, Satish K.; Garcia, Joe G. N.; Natarajan, Viswanathan			Phospholipase D-mediated Activation of IQGAP1 through Rac1 Regulates Hyperoxia-induced p47(phox) Translocation and Reactive Oxygen Species Generation in Lung Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; BRONCHIAL EPITHELIAL-CELLS; NADPH OXIDASE ACTIVATION; SMOOTH-MUSCLE-CELLS; PHOSPHATIDIC-ACID; NAD(P)H OXIDASE; ACTIN CYTOSKELETON; PLASMA-MEMBRANE; BINDING PROTEIN; ANGIOTENSIN-II	Phosphatidic acid generated by the activation of phospholipase D (PLD) functions as a second messenger and plays a vital role in cell signaling. Here we demonstrate that PLD-dependent generation of phosphatidic acid is critical for Rac1/IQGAP1 signal transduction, translocation of p47(phox) to cell periphery, and ROS production. Exposure of [P-32] orthophosphate-labeled human pulmonary artery endothelial cells (HPAECs) to hyperoxia (95% O-2 and 5% CO2) in the presence of 0.05% 1-butanol, but not tertiary-butanol, stimulated PLD as evidenced by accumulation of [P-32] phosphatidylbutanol. Infection of HPAECs with adenoviral constructs of PLD1 and PLD2 wild-type potentiated hyperoxia-induced PLD activation and accumulation of O-2(radical anion)/reactive oxygen species (ROS). Conversely, overexpression of catalytically inactive mutants of PLD (hPLD1-K898R or mPLD2-K758R) or down-regulation of expression of PLD with PLD1 or PLD2 siRNA did not augment hyperoxia-induced [P-32] phosphatidylbutanol accumulation and ROS generation. Hyperoxia caused rapid activation and redistribution of Rac1, and IQGAP1 to cell periphery, and down-regulation of Rac1, and IQGAP1 attenuated hyperoxia-induced tyrosine phosphorylation of Src and cortactin and ROS generation. Further, hyperoxia-mediated redistribution of Rac1, and IQGAP1 to membrane ruffles, was attenuated by PLD1 or PLD2 small interference RNA, suggesting that PLD is upstream of the Rac1/IQGAP1 signaling cascade. Finally, small interference RNA for PLD1 or PLD2 attenuated hyperoxia-induced cortactin tyrosine phosphorylation and abolished Src, cortactin, and p47(phox) redistribution to cell periphery. These results demonstrate a role of PLD in hyperoxia-mediated IQGAP1 activation through Rac1 in tyrosine phosphorylation of Src and cortactin, as well as in p47(phox) translocation and ROS formation in human lung endothelial cells.	[Usatyuk, Peter V.; Gorshkova, Irina A.; He, Donghong; Zhao, Yutong; Kalari, Satish K.; Garcia, Joe G. N.; Natarajan, Viswanathan] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago	Natarajan, V (corresponding author), Univ Chicago, Dept Med, CIS Bldg,Rm W408B,929 East 57th St, Chicago, IL 60637 USA.	vnataraj@medicine.bsd.uchicago.edu	Kalari, Satish/C-6967-2012; Garcia, Joe GN/E-8862-2010		National Institutes of Health [PO1 HL 58064]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL058064] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant PO1 HL 58064 (to V.N. and J.G.N.G.).	ABO A, 1994, BIOCHEM J, V298, P585, DOI 10.1042/bj2980585; Ago T, 2004, CIRCULATION, V109, P227, DOI 10.1161/01.CIR.0000105680.92873.70; AGWU DE, 1991, J CLIN INVEST, V88, P531, DOI 10.1172/JCI115336; Al-Mehdi AB, 1998, CIRC RES, V83, P730, DOI 10.1161/01.RES.83.7.730; Allen LAH, 1999, BLOOD, V93, P3521, DOI 10.1182/blood.V93.10.3521.410k21_3521_3530; ANDO S, 1992, J BIOL CHEM, V267, P25709; BENGISGARBER C, 1995, CELL SIGNAL, V7, P721, DOI 10.1016/0898-6568(95)00040-V; Bokoch GM, 2006, ANTIOXID REDOX SIGN, V8, P1533, DOI 10.1089/ars.2006.8.1533; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Brown HA, 2007, METHOD ENZYMOL, V434, P49, DOI 10.1016/S0076-6879(07)34004-4; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Brueckl C, 2006, AM J RESP CELL MOL, V34, P453, DOI 10.1165/rcmb.2005-0223OC; Cave AC, 2006, ANTIOXID REDOX SIGN, V8, P691, DOI 10.1089/ars.2006.8.691; Chae YC, 2008, MOL BIOL CELL, V19, P3111, DOI 10.1091/mbc.E07-04-0337; Chowdhury AK, 2005, J BIOL CHEM, V280, P20700, DOI 10.1074/jbc.M411722200; Clark RA, 1999, J INFECT DIS, V179, pS309, DOI 10.1086/513849; Cummings R, 2002, MOL CELL BIOCHEM, V234, P99, DOI 10.1023/A:1015944828973; Exton JH, 2002, REV PHYSIOL BIOCH P, V144, P1, DOI 10.1007/BFb0116585; Faraudo J, 2007, BIOPHYS J, V92, P2806, DOI 10.1529/biophysj.106.092015; Fontayne A, 2002, BIOCHEMISTRY-US, V41, P7743, DOI 10.1021/bi011953s; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; Frey RS, 2009, ANTIOXID REDOX SIGN, V11, P791, DOI [10.1089/ars.2008.2220, 10.1089/ARS.2008.2220]; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Fukata M, 2001, MOL CELL BIOL, V21, P2165, DOI 10.1128/MCB.21.6.2165-2183.2001; Gorshkova I, 2008, J BIOL CHEM, V283, P11794, DOI 10.1074/jbc.M800250200; Gorzalczany Y, 2000, J BIOL CHEM, V275, P40073, DOI 10.1074/jbc.M006013200; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Hammond SM, 1997, J BIOL CHEM, V272, P3860, DOI 10.1074/jbc.272.6.3860; Henderson LM, 1996, BBA-BIOENERGETICS, V1273, P87, DOI 10.1016/0005-2728(95)00140-9; HEYWORTH PG, 1994, J BIOL CHEM, V269, P30749; Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e; Ikeda S, 2005, ARTERIOSCL THROM VAS, V25, P2295, DOI 10.1161/01.ATV.0000187472.55437.af; Jadeski L, 2008, J BIOL CHEM, V283, P1008, DOI 10.1074/jbc.M708466200; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Kooijman EE, 2007, J BIOL CHEM, V282, P11356, DOI 10.1074/jbc.M609737200; Kuroda S, 1996, J BIOL CHEM, V271, P23363, DOI 10.1074/jbc.271.38.23363; Mataraza JM, 2007, CELL SIGNAL, V19, P1857, DOI 10.1016/j.cellsig.2007.04.011; McPhail LC, 1999, BBA-MOL CELL BIOL L, V1439, P277, DOI 10.1016/S1388-1981(99)00100-6; Morris AJ, 1997, ANAL BIOCHEM, V252, P1, DOI 10.1006/abio.1997.2299; Natarajan V, 1996, CHEM PHYS LIPIDS, V80, P103, DOI 10.1016/0009-3084(96)02548-0; Ohguchi K, 1997, J BIOL CHEM, V272, P1990, DOI 10.1074/jbc.272.3.1990; Owen D, 2008, J BIOL CHEM, V283, P1692, DOI 10.1074/jbc.M707257200; Palicz A, 2001, J BIOL CHEM, V276, P3090, DOI 10.1074/jbc.M007759200; Parinandi NL, 1999, ANTIOXID REDOX SIGN, V1, P193, DOI 10.1089/ars.1999.1.2-193; Parinandi NL, 2003, AM J PHYSIOL-LUNG C, V284, pL26, DOI 10.1152/ajplung.00123.2002; Parinandi NL, 2001, ARCH BIOCHEM BIOPHYS, V396, P231, DOI 10.1006/abbi.2001.2609; Pendyala S, 2008, ANTIOXID REDOX SIGNA; Pendyala S, 2009, ANTIOXID REDOX SIGN, V11, P747, DOI [10.1089/ars.2008.2203, 10.1089/ARS.2008.2203]; Pettitt TR, 2001, BIOCHEM J, V360, P707, DOI 10.1042/0264-6021:3600707; Powner DJ, 2002, MOL BIOL CELL, V13, P1252, DOI 10.1091/mbc.01-05-0235; QUINN MT, 1993, J BIOL CHEM, V268, P20983; Regier DS, 2000, J BIOL CHEM, V275, P28406, DOI 10.1074/jbc.M004703200; Regier DS, 1999, J BIOL CHEM, V274, P36601, DOI 10.1074/jbc.274.51.36601; Roy S, 2003, ANTIOXID REDOX SIGN, V5, P217, DOI 10.1089/152308603764816578; Sohn HY, 2000, J BIOL CHEM, V275, P18745, DOI 10.1074/jbc.M000026200; Tamura M, 2000, BIOCHEM BIOPH RES CO, V276, P1186, DOI 10.1006/bbrc.2000.3598; Touyz RM, 2005, ARTERIOSCL THROM VAS, V25, P512, DOI 10.1161/01.ATV.0000154141.66879.98; Touyz RM, 2003, ARTERIOSCL THROM VAS, V23, P981, DOI 10.1161/01.ATV.0000069236.27911.68; Ugolev Y, 2008, J BIOL CHEM, V283, P22257, DOI 10.1074/jbc.M800734200; Usatyuk PV, 2007, J BIOL CHEM, V282, P23284, DOI 10.1074/jbc.M700535200; Usatyuk PV, 2003, ANTIOXID REDOX SIGN, V5, P723, DOI 10.1089/152308603770380025; Ushio-Fukai M, 2006, CARDIOVASC RES, V71, P226, DOI 10.1016/j.cardiores.2006.04.015; Waite KA, 1997, J BIOL CHEM, V272, P15569, DOI 10.1074/jbc.272.24.15569; Wang LX, 2002, BIOCHEM J, V367, P751, DOI 10.1042/BJ20020586; Wang YP, 2008, EXP MOL PATHOL, V85, P122, DOI 10.1016/j.yexmp.2008.06.001; Wang YP, 2008, INT J MOL MED, V22, P79; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; WOLFSON M, 1985, J IMMUNOL, V135, P2057; Yamaoka-Tojo M, 2004, CIRC RES, V95, P276, DOI 10.1161/01.RES.0000136522.58649.60; Yamaoka-Tojo M, 2006, ARTERIOSCL THROM VAS, V26, P1991, DOI 10.1161/01.ATV.0000231524.14873.e7; Zhan Y, 2004, J CELL BIOCHEM, V92, P795, DOI 10.1002/jcb.20084; Zhao YT, 2000, BIOCHEM BIOPH RES CO, V278, P140, DOI 10.1006/bbrc.2000.3719	72	53	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15339	15352		10.1074/jbc.M109.005439	http://dx.doi.org/10.1074/jbc.M109.005439			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19366706	hybrid, Green Published			2022-12-25	WOS:000266288200068
J	Morgans, CW; Kensel-Hammes, P; Hurley, JB; Burton, K; Idzerda, R; McKnight, GS; Bajjalieh, SM				Morgans, Catherine W.; Kensel-Hammes, Patricia; Hurley, James B.; Burton, Kimberly; Idzerda, Rejean; McKnight, G. Stanley; Bajjalieh, Sandra M.			Loss of the Synaptic Vesicle Protein SV2B Results in Reduced Neurotransmission and Altered Synaptic Vesicle Protein Expression in the Retina	PLOS ONE			English	Article								The Synaptic Vesicle Protein 2 (SV2) family of transporter-like proteins is expressed exclusively in vesicles that undergo calcium-regulated exocytosis. Of the three isoforms expressed in mammals, SV2B is the most divergent. Here we report studies of SV2B location and function in the retina. Immunolabeling studies revealed that SV2B is detected in rod photoreceptor synaptic terminals where it is the primary isoform. In mice lacking SV2B, synaptic transmission at the synapse between photoreceptors and bipolar neurons was decreased, as evidenced by a significant reduction in the amplitude of the b-wave in electroretinogram recordings. Quantitative immunoblot analyses of whole eyes revealed that loss of SV2B was associated with reduced levels of synaptic vesicle proteins including synaptotagmin, VAMP, synaptophysin and the vesicular glutamate transporter V-GLUT1. Immunolabeling studies revealed that SV2B is detected in rod photoreceptor synaptic terminals where it is the primary isoform. Thus, SV2B contributes to the modulation of synaptic vesicle exocytosis and plays a significant role in regulating synaptic protein content.			Morgans, CW (corresponding author), Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA.	bajjalie@u.washington.edu		Morgans, Catherine/0000-0002-7287-3447	NATIONAL EYE INSTITUTE [R01EY018625, P30EY001730, R01EY014700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059842] Funding Source: NIH RePORTER; NEI NIH HHS [P30 EY001730, 5 P30 EY001730, R01 EY018625, R01 EY014700] Funding Source: Medline; NIMH NIH HHS [R01 MH059842, R01 MH59842] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BAJJALIEH SM, 1992, SCIENCE, V257, P1271, DOI 10.1126/science.1519064; BAJJALIEH SM, 1993, P NATL ACAD SCI USA, V90, P2150, DOI 10.1073/pnas.90.6.2150; BAJJALIEH SM, 1994, J NEUROSCI, V14, P5223, DOI 10.1523/jneurosci.14-09-05223.1994; Berntson AK, 2003, J VISION, V3, P274, DOI 10.1167/3.4.3; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; CALAKOS N, 1994, J BIOL CHEM, V269, P24534; Chang WP, 2009, J NEUROSCI, V29, P883, DOI 10.1523/JNEUROSCI.4521-08.2009; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; Crowder KM, 1999, P NATL ACAD SCI USA, V96, P15268, DOI 10.1073/pnas.96.26.15268; Custer KL, 2006, J NEUROSCI, V26, P1303, DOI 10.1523/JNEUROSCI.2699-05.2006; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; FEANY MB, 1992, CELL, V70, P861, DOI 10.1016/0092-8674(92)90319-8; Galli T, 1996, J BIOL CHEM, V271, P2193, DOI 10.1074/jbc.271.4.2193; Haucke V, 1999, SCIENCE, V285, P1268, DOI 10.1126/science.285.5431.1268; Hayashi T, 1998, J NEUROCHEM, V71, P356; Janz R, 1998, J NEUROSCI, V18, P9269; Janz R, 1999, NEURON, V24, P1003, DOI 10.1016/S0896-6273(00)81046-6; Kennedy MJ, 2001, NEURON, V31, P87, DOI 10.1016/S0896-6273(01)00340-3; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Lazzell DR, 2004, J BIOL CHEM, V279, P52124, DOI 10.1074/jbc.M407502200; Lynch BA, 2004, P NATL ACAD SCI USA, V101, P9861, DOI 10.1073/pnas.0308208101; MATTHEW WD, 1981, J CELL BIOL, V91, P257, DOI 10.1083/jcb.91.1.257; Morgans CW, 2005, VISUAL NEUROSCI, V22, P561, DOI 10.1017/S0952523805225038; Rao A, 2007, J NEUROSCI, V27, P14199, DOI 10.1523/JNEUROSCI.4934-07.2007; Rosenmund C, 2003, CURR OPIN NEUROBIOL, V13, P509, DOI 10.1016/j.conb.2003.09.011; Schivell AE, 2005, MOL CELL NEUROSCI, V29, P56, DOI 10.1016/j.mcn.2004.12.011; Schivell AE, 1996, J BIOL CHEM, V271, P27770, DOI 10.1074/jbc.271.44.27770; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Spiwoks-Becker I, 2001, NEUROSCIENCE, V107, P127, DOI 10.1016/S0306-4522(01)00345-1; Wang MM, 2003, J COMP NEUROL, V460, P106, DOI 10.1002/cne.10636; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Xu T, 2001, NAT CELL BIOL, V3, P691, DOI 10.1038/35087000	33	37	38	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2009	4	4							e5230	10.1371/journal.pone.0005230	http://dx.doi.org/10.1371/journal.pone.0005230			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TW	19381277	Green Published, gold, Green Submitted			2022-12-25	WOS:000265510800009
J	Gorski, L; Duhe, JM; Flaherty, D				Gorski, Lisa; Duhe, Jessica M.; Flaherty, Denise			The Use of Flagella and Motility for Plant Colonization and Fitness by Different Strains of the Foodborne Pathogen Listeria monocytogenes	PLOS ONE			English	Article							HOST-CELL INVASION; PSEUDOMONAS-FLUORESCENS; MOLECULAR DETERMINANTS; SALMONELLA-ENTERICA; ROOT COLONIZATION; BIOFILM FORMATION; ALFALFA SPROUTS; ATTACHMENT; VIRULENCE; FOOD	The role of flagella and motility in the attachment of the foodborne pathogen Listeria monocytogenes to various surfaces is mixed with some systems requiring flagella for an interaction and others needing only motility for cells to get to the surface. In nature this bacterium is a saprophyte and contaminated produce is an avenue for infection. Previous studies have documented the ability of this organism to attach to and colonize plant tissue. Motility mutants were generated in three wild type strains of L. monocytogenes by deleting either flaA, the gene encoding flagellin, or motAB, genes encoding part of the flagellar motor, and tested for both the ability to colonize sprouts and for the fitness of that colonization. The motAB mutants were not affected in the colonization of alfalfa, radish, and broccoli sprouts; however, some of the flaA mutants showed reduced colonization ability. The best colonizing wild type strain was reduced in colonization on all three sprout types as a result of a flaA deletion. A mutant in another background was only affected on alfalfa. The third, a poor alfalfa colonizer was not affected in colonization ability by any of the deletions. Fitness of colonization was measured in experiments of competition between mixtures of mutant and parent strains on sprouts. Here the flaA and motAB mutants of the three strain backgrounds were impaired in fitness of colonization of alfalfa and radish sprouts, and one strain background showed reduced fitness of both mutant types on broccoli sprouts. Together these data indicate a role for flagella for some strains to physically colonize some plants, while the fitness of that colonization is positively affected by motility in almost all cases.			Gorski, L (corresponding author), USDA ARS, Produce Safety & Microbiol Res Unit, Albany, CA USA.	lisa.gorski@ars.usda.gov		Gorski, Lisa/0000-0003-2387-1012				Berger CN, 2009, ISME J, V3, P261, DOI 10.1038/ismej.2008.95; Chin-A-Woeng TFC, 2000, MOL PLANT MICROBE IN, V13, P1340, DOI 10.1094/MPMI.2000.13.12.1340; CROES CL, 1993, J GEN MICROBIOL, V139, P2261, DOI 10.1099/00221287-139-9-2261; Dekkers LC, 1998, MOL PLANT MICROBE IN, V11, P763, DOI 10.1094/MPMI.1998.11.8.763; DEWEGER LA, 1987, J BACTERIOL, V169, P2769, DOI 10.1128/jb.169.6.2769-2773.1987; DONS L, 1992, MOL MICROBIOL, V6, P2919, DOI 10.1111/j.1365-2958.1992.tb01751.x; Dons L, 2004, INFECT IMMUN, V72, P3237, DOI 10.1128/IAI.72.6.3237-3244.2004; Dussurget O, 2004, ANNU REV MICROBIOL, V58, P587, DOI 10.1146/annurev.micro.57.030502.090934; FACINELLI B, 1994, J CLIN MICROBIOL, V32, P2929, DOI 10.1128/JCM.32.12.2929-2935.1994; Facinelli B, 1998, MICROBIOL-SGM, V144, P109, DOI 10.1099/00221287-144-1-109; FARBER JM, 1990, NEW ENGL J MED, V322, P338; Fernandez LA, 2000, FEMS MICROBIOL REV, V24, P21, DOI 10.1111/j.1574-6976.2000.tb00531.x; Glaser P, 2001, SCIENCE, V294, P849; Gorski L, 2004, J FOOD PROTECT, V67, P2488, DOI 10.4315/0362-028X-67.11.2488; Gorski L, 2003, APPL ENVIRON MICROB, V69, P258, DOI 10.1128/AEM.69.1.258-266.2003; Gorski L, 2008, J FOOD PROTECT, V71, P1556, DOI 10.4315/0362-028X-71.8.1556; HEISICK JE, 1989, APPL ENVIRON MICROB, V55, P1925, DOI 10.1128/AEM.55.8.1925-1927.1989; Hirsch AM, 1999, CURR OPIN PLANT BIOL, V2, P320, DOI 10.1016/S1369-5266(99)80056-9; HOWIE WJ, 1987, PHYTOPATHOLOGY, V77, P286, DOI 10.1094/Phyto-77-286; Klerks MM, 2007, ISME J, V1, P620, DOI 10.1038/ismej.2007.82; Lemon KP, 2007, J BACTERIOL, V189, P4418, DOI 10.1128/JB.01967-06; LINGNAU A, 1995, INFECT IMMUN, V63, P3896, DOI 10.1128/IAI.63.10.3896-3903.1995; Lugtenberg BJJ, 2001, ANNU REV PHYTOPATHOL, V39, P461, DOI 10.1146/annurev.phyto.39.1.461; Martinez-Granero F, 2006, APPL ENVIRON MICROB, V72, P3429, DOI 10.1128/AEM.72.5.3429-3434.2006; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Merritt PM, 2007, J BACTERIOL, V189, P8005, DOI 10.1128/JB.00566-07; Nelson KE, 2004, NUCLEIC ACIDS RES, V32, P2386, DOI 10.1093/nar/gkh562; O'Neil HS, 2006, INFECT IMMUN, V74, P6675, DOI 10.1128/IAI.00886-06; SCHAFERKORDT S, 1995, BIOTECHNIQUES, V19, P720; SCHER FM, 1988, PHYTOPATHOLOGY, V78, P1055, DOI 10.1094/Phyto-78-1055; Schirm M, 2004, J BACTERIOL, V186, P6721, DOI 10.1128/JB.186.20.6721-6727.2004; SCHLECH WF, 1983, NEW ENGL J MED, V308, P203, DOI 10.1056/NEJM198301273080407; Strapp CM, 2003, J FOOD PROTECT, V66, P182, DOI 10.4315/0362-028X-66.2.182; Todhanakasem T, 2008, J BACTERIOL, V190, P6030, DOI 10.1128/JB.00155-08; TRIUECUOT P, 1991, GENE, V102, P99; Vatanyoopaisarn S, 2000, APPL ENVIRON MICROB, V66, P860, DOI 10.1128/AEM.66.2.860-863.2000; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001	37	35	38	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5142	10.1371/journal.pone.0005142	http://dx.doi.org/10.1371/journal.pone.0005142			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19357783	Green Submitted, Green Published, gold			2022-12-25	WOS:000265505900011
J	Grandgeorge, M; Hausberger, M; Tordjman, S; Deleau, M; Lazartigues, A; Lemonnier, E				Grandgeorge, Marine; Hausberger, Martine; Tordjman, Sylvie; Deleau, Michel; Lazartigues, Alain; Lemonnier, Eric			Environmental Factors Influence Language Development in Children with Autism Spectrum Disorders	PLOS ONE			English	Article							CENTRAL AUDITORY AREA; YOUNG-CHILDREN; FOLLOW-UP; SCHIZOPHRENIA; INPUT; BIRDSONG; MOTHER; HORSES	Background: While it is clearly admitted that normal behavioural development is determined by the interplay of genetic and environmental influences, this is much less the case for psychiatric disorders for which more emphasis has been given in the past decades on biological determinism. Thus, previous studies have shown that Autistic Spectrum Disorders (ASD) were not affected by parental style. However, animal research suggests that different behavioural traits can be differentially affected by genetic/environmental factors. Methodology/Principal Findings: In the present study we hypothesized that amongst the ASD, language disorders may be more sensitive to social factors as language is a social act that develops under social influences. Using the Autism Diagnostic Interview-Revised, we compared the early characteristics of sensori-motor and language development in a large sample of children with ASD (n = 162) with parents belonging to different levels of education. The results showed that children raised by parents with a high level of education displayed earlier language development. Moreover, they showed earlier first words and phrases if their mother was at a high level of education, which reveals an additional gender effect. Conclusions/Significance: To our knowledge this study may trigger important new lines of thought and research, help equilibrate social and purely biological perspectives regarding ASD and bring new hopes for environmentally based therapies.			Grandgeorge, M (corresponding author), Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France.	marine.grandgeorge@univ-rennes1.fr	lemonnier, eric/K-1084-2016					*AM PSYCH ASS, DIAGN STAT MAN ME TR, V4; Bailey A, 1996, J CHILD PSYCHOL PSYC, V37, P89, DOI 10.1111/j.1469-7610.1996.tb01381.x; CHESS S, 1977, J AUTISM CHILD SCHIZ, V7, P69, DOI 10.1007/BF01531116; Cousillas H, 2004, EUR J NEUROSCI, V19, P3343, DOI 10.1111/j.0953-816X.2004.03376.x; Cousillas H, 2006, NATURWISSENSCHAFTEN, V93, P588, DOI 10.1007/s00114-006-0148-4; Cousillas H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002194; De Giacomo A, 1998, EUR CHILD ADOLES PSY, V7, P131, DOI 10.1007/s007870050058; DeMyer M. K., 1979, PARENTS CHILDREN AUT; Ensminger ME, 2003, MON PARENT, P13; Fletcher KL, 2005, DEV REV, V25, P64, DOI 10.1016/j.dr.2004.08.009; Fombonne E, 2003, J AUTISM DEV DISORD, V33, P365, DOI 10.1023/A:1025054610557; Franzek E, 1995, EUR PSYCHIAT, V10, P326, DOI 10.1016/0924-9338(96)80332-4; Gervais H, 2004, NAT NEUROSCI, V7, P801, DOI 10.1038/nn1291; GINSBERG EH, 2000, SPRACHENTWICKLUNG, P463; Goldstein MH, 2003, P NATL ACAD SCI USA, V100, P8030, DOI 10.1073/pnas.1332441100; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Hart B., 1995, MEANINGFUL DIFFERENC; Hausberger M, 2005, DOMESTIC HORSE: THE ORIGINS, DEVELOPMENT AND MANAGEMENT OF ITS BEHAVIOUR, P33; Hausberger M, 2004, J COMP PSYCHOL, V118, P434, DOI 10.1037/0735-7036.118.4.434; Hoff E, 2006, DEV REV, V26, P55, DOI 10.1016/j.dr.2005.11.002; Hoff E, 2003, CHILD DEV, V74, P1368, DOI 10.1111/1467-8624.00612; Hoff E, 2002, CHILD DEV, V73, P418, DOI 10.1111/1467-8624.00415; Hoff E., 2002, HDB PARENTING BIOL E, VVolume 2, P231, DOI DOI 10.4324/9780429401459-13; HOFFGINSBERG E, 1991, CHILD DEV, V62, P782, DOI 10.1111/j.1467-8624.1991.tb01569.x; Houpt KA, 2000, GENETICS OF THE HORSE, P281, DOI 10.1079/9780851994291.0281; Huttenlocher J, 2002, COGNITIVE PSYCHOL, V45, P337, DOI 10.1016/S0010-0285(02)00500-5; KANNER L, 1949, AM J ORTHOPSYCHIAT, V19, P416, DOI 10.1111/j.1939-0025.1949.tb05441.x; Kohn M. L., 1963, AM J SOCIOL, V68, P471, DOI [10.1086/223403, DOI 10.1086/223403]; Kuhl PK, 2003, P NATL ACAD SCI USA, V100, P9645, DOI 10.1073/pnas.1733998100; Locke John L., 1997, P274, DOI 10.1017/CBO9780511758843.014; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; LUESCHER VA, 1998, EQUINE VET J, V27, P14; MCGREEVY PD, 1995, VET REC, V137, P36, DOI 10.1136/vr.137.2.36; Muhle R, 2004, PEDIATRICS, V113, pE472, DOI 10.1542/peds.113.5.e472; Pancsofar N, 2006, J APPL DEV PSYCHOL, V27, P571, DOI 10.1016/j.appdev.2006.08.003; Pinker S., 2002, BLANK SLATE MODERN D; Plomin R, 2001, NAT REV NEUROSCI, V2, P136, DOI 10.1038/35053584; Rimland B, 1964, INFANTILE AUTISM SYN; Robert JS, 2000, THEOR MED BIOETH, V21, P191, DOI 10.1023/A:1009913618140; Sanders LD, 2006, NEUROPSYCHOLOGIA, V44, P2126, DOI 10.1016/j.neuropsychologia.2005.10.007; SNOWDON CT, 1997, SOCIAL INFLUENCES VO, P380; Stevens C, 2008, BRAIN RES, V1205, P55, DOI 10.1016/j.brainres.2007.10.108; Swensen LD, 2007, CHILD DEV, V78, P542, DOI 10.1111/j.1467-8624.2007.01022.x; Tager-Flusberg H, 2000, DEVELOPMENTAL SCI, V3, P33; Tamis-LeMonda CS, 2004, CHILD DEV, V75, P1806, DOI 10.1111/j.1467-8624.2004.00818.x; Tienari P, 2004, BRIT J PSYCHIAT, V184, P216, DOI 10.1192/bjp.184.3.216; TIENARI P, 1994, BRIT J PSYCHIAT, V164, P20, DOI 10.1192/S0007125000292696; World Health Organization, 1994, COMP INT DIAGN INT V	48	13	13	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e4683	10.1371/journal.pone.0004683	http://dx.doi.org/10.1371/journal.pone.0004683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437RZ	19357766	Green Submitted, Green Published, gold			2022-12-25	WOS:000265505900001
J	Serrano, A; Rodriguez-Corsino, M; Losada, A				Serrano, Angel; Rodriguez-Corsino, Miriam; Losada, Ana			Heterochromatin Protein 1 (HP1) Proteins Do Not Drive Pericentromeric Cohesin Enrichment in Human Cells	PLOS ONE			English	Article								Sister chromatid cohesion mediated by cohesin is essential for accurate chromosome segregation. Classical studies suggest that heterochromatin promotes cohesion, but whether this happens through regulation of cohesin remains to be determined. Heterochromatin protein 1 (HP1) is a major component of heterochromatin. In fission yeast, the HP1 homologue Swi6 interacts with cohesin and is required for proper targeting and/or stabilization of cohesin at the centromeric region. To test whether this pathway is conserved in human cells, we have examined the behavior of cohesin in cells in which the levels of HP1 alpha, beta or gamma (the three HP1 proteins present in mammalian organisms) have been reduced by siRNA. We have also studied the consequences of treating human cells with drugs that change the histone modification profile of heterochromatin and thereby affect HP1 localization. Our results show no evidence for a requirement of HP1 proteins for either loading of bulk cohesin onto chromatin in interphase or retention of cohesin at pericentric heterochromatin in mitosis. However, depletion of HP1gamma leads to defects in mitotic progression.			Serrano, A (corresponding author), Spanish Natl Canc Res Ctr CNIO, Mol Oncol Programme, Chromosome Dynam Grp, Madrid, Spain.	alosada@cnio.es	Rodriguez-Corsino, Miriam/AAD-7625-2022; Losada, Ana/H-5917-2015	Losada, Ana/0000-0001-5251-3383; Rodriguez-Corsino, Miriam/0000-0002-4028-5237				Aucott R, 2008, J CELL BIOL, V183, P597, DOI 10.1083/jcb.200804041; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; CLARKE DJ, 1993, J CELL SCI, V105, P563; Dai J, 2006, DEV CELL, V11, P741, DOI 10.1016/j.devcel.2006.09.018; De Lucia F, 2005, NUCLEIC ACIDS RES, V33, P2852, DOI 10.1093/nar/gki584; Eskeland R, 2007, MOL CELL BIOL, V27, P453, DOI 10.1128/MCB.01576-06; Fanti L, 2003, GENETICA, V117, P135, DOI 10.1023/A:1022971407290; Fanti L, 1998, MOL CELL, V2, P527, DOI 10.1016/S1097-2765(00)80152-5; Fanti L, 2008, CURR OPIN GENET DEV, V18, P169, DOI 10.1016/j.gde.2008.01.009; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; GATTI M, 1992, ANNU REV GENET, V26, P239, DOI 10.1146/annurev.ge.26.120192.001323; Glynn EF, 2004, PLOS BIOL, V2, P1325, DOI 10.1371/journal.pbio.0020259; GONZALEZ C, 1991, EXP CELL RES, V192, P10, DOI 10.1016/0014-4827(91)90150-S; Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hoque MT, 2001, J BIOL CHEM, V276, P5059, DOI 10.1074/jbc.M007809200; Inoue Y, 2008, PROC MONOGR ENG WATE, V1-2, P55; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kawashima SA, 2007, GENE DEV, V21, P420, DOI 10.1101/gad.1497307; Kellum R, 2003, CURR TOP MICROBIOL, V274, P53; KELLUM R, 1995, J CELL SCI, V108, P1419; Koch B, 2008, CHROMOSOMA, V117, P199, DOI 10.1007/s00412-007-0139-z; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lechner MS, 2005, BIOCHEM BIOPH RES CO, V331, P929, DOI 10.1016/j.bbrc.2005.04.016; Lee J, 2008, NAT CELL BIOL, V10, P42, DOI 10.1038/ncb1667; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Liu LP, 2005, NAT GENET, V37, P1361, DOI 10.1038/ng1662; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Losada A, 2002, GENE DEV, V16, P3004, DOI 10.1101/gad.249202; Losada A, 2005, J CELL SCI, V118, P2133, DOI 10.1242/jcs.02355; Losada A, 2008, BBA-REV CANCER, V1786, P41, DOI 10.1016/j.bbcan.2008.04.003; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Minc E, 1999, CHROMOSOMA, V108, P220, DOI 10.1007/s004120050372; Misulovin Z, 2008, CHROMOSOMA, V117, P89, DOI 10.1007/s00412-007-0129-1; MIYAZAKI WY, 1994, ANNU REV GENET, V28, P167, DOI 10.1146/annurev.ge.28.120194.001123; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; Onn I, 2008, ANNU REV CELL DEV BI, V24, P105, DOI 10.1146/annurev.cellbio.24.110707.175350; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; SHAMU CE, 1992, J CELL BIOL, V117, P921, DOI 10.1083/jcb.117.5.921; Taddei A, 2001, NAT CELL BIOL, V3, P114, DOI 10.1038/35055010; Takata H, 2007, CURR BIOL, V17, P1356, DOI 10.1016/j.cub.2007.07.009; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; VIG BK, 1981, CYTOGENET CELL GENET, V31, P129, DOI 10.1159/000131638; Warren WD, 2000, CURR BIOL, V10, P1463, DOI 10.1016/S0960-9822(00)00806-X; Watrin E, 2006, CURR BIOL, V16, P863, DOI 10.1016/j.cub.2006.03.049; Weber SA, 2004, PLOS BIOL, V2, P1340, DOI 10.1371/journal.pbio.0020260; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; White SA, 2004, NAT CELL BIOL, V6, P696, DOI 10.1038/ncb0804-696; Wirth KG, 2006, J CELL BIOL, V172, P847, DOI 10.1083/jcb.200506119; Yamagishi Y, 2008, NATURE, V455, P251, DOI 10.1038/nature07217; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016	66	32	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2009	4	4							e5118	10.1371/journal.pone.0005118	http://dx.doi.org/10.1371/journal.pone.0005118			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RX	19352502	Green Published, Green Submitted, gold			2022-12-25	WOS:000265505700017
J	Dey, R; Ji, KM; Liu, ZG; Chen, L				Dey, Raja; Ji, Kunmei; Liu, Zhigang; Chen, Lin			A Cytokine-Cytokine Interaction in the Assembly of Higher-Order Structure and Activation of the Interleukine-3:Receptor Complex	PLOS ONE			English	Article								Interleukine-3 (IL-3) binds its receptor and initiates a cascade of signaling processes that regulate the proliferation and differentiation of hematopoietic cells. To understand the detailed mechanisms of IL-3 induced receptor activation, we generated a homology model of the IL-3: receptor complex based on the closely related crystal structure of the GMCSF: receptor complex. Model-predicted interactions between IL-3 and its receptor are in excellent agreement with mutagenesis data, which validate the model and establish a detailed view of IL-3: receptor interaction. The homology structure reveals an IL-3: IL-3 interaction interface in a higher-order complex modeled after the dodecamer of the GMCSF:receptor complex wherein an analogous GM-CSF:GM-CSF interface is also identified. This interface is mediated by a proline-rich hydrophobic motif (PPLPLL) of the AA(loop that is highly exposed in the structure of isolated IL-3. Various experimental data suggest that this motif is required for IL-3 function through receptor-binding independent mechanisms. These observations are consistent with structure-function studies of the GM-CSF:receptor complex showing that formation of the higher-order cytokine: receptor complex is required for signaling. However, a key question not answered from previous studies is how cytokine binding facilitates the assembly of the higher-order complex. Our studies here reveal a potential cytokine-cytokine interaction that participates in the assembly of the dodecamer complex, thus linking cytokine binding to receptor activation.			Dey, R (corresponding author), Univ So Calif, Dept Biol Sci Mol & Computat Biol, Los Angeles, CA 90089 USA.	linchen@usc.edu	chen, Lin/A-3392-2008	chen, Lin/0000-0003-4798-6199; , Raja/0000-0002-1064-0824	NHLBI NIH HHS [R01 HL076334, HL076334] Funding Source: Medline; NIGMS NIH HHS [R01 GM064642, R01 GM077320] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077320, R01GM064642] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bagley CJ, 1996, J BIOL CHEM, V271, P31922, DOI 10.1074/jbc.271.50.31922; Barouch DH, 2002, J IMMUNOL, V168, P562, DOI 10.4049/jimmunol.168.2.562; BARRY SC, 1994, J BIOL CHEM, V269, P8488; BIESMA B, 1992, BLOOD, V80, P1141; Birnbaum RA, 2000, MOL CELL, V5, P189, DOI 10.1016/S1097-2765(00)80415-3; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; BRIZZI MF, 1994, J BIOL CHEM, V269, P31680; Carr PD, 2001, CELL, V104, P291, DOI 10.1016/S0092-8674(01)00213-6; Cook AD, 2001, ARTHRITIS RES, V3, P293, DOI 10.1186/ar318; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Dellisanti CD, 2007, CHANNELS, V1, P234, DOI 10.4161/chan.4909; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Dirksen U, 1998, BLOOD, V92, P1097; DORSSERS LCJ, 1994, GROWTH FACTORS, V11, P93, DOI 10.3109/08977199409001051; DORSSERS LCJ, 1991, J BIOL CHEM, V266, P21310; Fleetwood AJ, 2005, CRIT REV IMMUNOL, V25, P405, DOI 10.1615/CritRevImmunol.v25.i5.50; GIANNI AM, 1993, ANN ONCOL, V4, P759, DOI 10.1093/oxfordjournals.annonc.a058661; Guthridge MA, 1998, STEM CELLS, V16, P301, DOI 10.1002/stem.160301; Hansen G, 2008, CELL, V134, P496, DOI 10.1016/j.cell.2008.05.053; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAUSHANSKY K, 1992, J CLIN INVEST, V90, P1879, DOI 10.1172/JCI116065; Klein BK, 1997, J BIOL CHEM, V272, P22630, DOI 10.1074/jbc.272.36.22630; Korzenik JR, 2005, NEW ENGL J MED, V352, P2193, DOI 10.1056/NEJMoa041109; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Lilly MB, 2001, BLOOD, V97, P1662, DOI 10.1182/blood.V97.6.1662; LOKKER NA, 1991, EMBO J, V10, P2125, DOI 10.1002/j.1460-2075.1991.tb07746.x; LOKKER NA, 1991, J BIOL CHEM, V266, P10624; LOKKER NA, 1991, J IMMUNOL, V146, P893; LOPEZ AF, 1992, P NATL ACAD SCI USA, V89, P11842, DOI 10.1073/pnas.89.24.11842; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; MILBURN MV, 1993, NATURE, V363, P172, DOI 10.1038/363172a0; Murphy JM, 2004, J BIOL CHEM, V279, P26500, DOI 10.1074/jbc.M402705200; Murphy JM, 2003, J BIOL CHEM, V278, P10572, DOI 10.1074/jbc.M211664200; Muto A, 1995, J ALLERGY CLIN IMMUN, V96, P1100, DOI 10.1016/S0091-6749(95)70195-8; OLINS PO, 1995, J BIOL CHEM, V270, P23754, DOI 10.1074/jbc.270.40.23754; QUELLE FW, 1994, MOL CELL BIOL, V14, P4335, DOI 10.1128/MCB.14.7.4335; Ramshaw HS, 2002, EXP HEMATOL, V30, P1124, DOI 10.1016/S0301-472X(02)00903-7; Rozwarski DA, 1996, PROTEINS, V26, P304, DOI 10.1002/(SICI)1097-0134(199611)26:3<304::AID-PROT6>3.0.CO;2-D; SAKAMAKI K, 1992, EMBO J, V11, P3541, DOI 10.1002/j.1460-2075.1992.tb05437.x; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Stauber DJ, 2006, P NATL ACAD SCI USA, V103, P2788, DOI 10.1073/pnas.0511161103; Sun XL, 2002, VACCINE, V20, P1466, DOI 10.1016/S0264-410X(01)00476-5; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; WOODCOCK JM, 1994, EMBO J, V13, P5176, DOI 10.1002/j.1460-2075.1994.tb06848.x; Woodcock JM, 1996, J BIOL CHEM, V271, P25999, DOI 10.1074/jbc.271.42.25999	46	31	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2009	4	4							e5188	10.1371/journal.pone.0005188	http://dx.doi.org/10.1371/journal.pone.0005188			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RT	19352505	gold, Green Published, Green Submitted			2022-12-25	WOS:000265505300016
J	Ramduth, D; Day, CL; Thobakgale, CF; Mkhwanazi, NP; de Pierres, C; Reddy, S; van der Stok, M; Mncube, Z; Nair, K; Moodley, ES; Kaufmann, DE; Streeck, H; Coovadia, HM; Kiepiela, P; Goulder, PJR; Walker, BD				Ramduth, Danni; Day, Cheryl L.; Thobakgale, Christina F.; Mkhwanazi, Nompumelelo P.; de Pierres, Chantal; Reddy, Sharon; van der Stok, Mary; Mncube, Zenele; Nair, Kriebashne; Moodley, Eshia S.; Kaufmann, Daniel E.; Streeck, Hendrik; Coovadia, Hoosen M.; Kiepiela, Photini; Goulder, Philip J. R.; Walker, Bruce D.			Immunodominant HIV-1 Cd4+T Cell Epitopes in Chronic Untreated Clade C HIV-1 Infection	PLOS ONE			English	Article							CD4(+) T-CELLS; HIV-1-INFECTED SUBJECTS; COMPREHENSIVE ANALYSIS; DISEASE PROGRESSION; RESPONSES REVEALS; IMMUNE EVASION; GAG; PERSISTENCE; FREQUENCY; PROTEINS	Background: A dominance of Gag-specific CD8+ T cell responses is significantly associated with a lower viral load in individuals with chronic, untreated clade C human immunodeficiency virus type 1 (HIV-1) infection. This association has not been investigated in terms of Gag-specific CD4+ T cell responses, nor have clade C HIV-1-specific CD4+ T cell epitopes, likely a vital component of an effective global HIV-1 vaccine, been identified. Methodology/Principal Findings: Intracellular cytokine staining was conducted on 373 subjects with chronic, untreated clade C infection to assess interferon-gamma (IFN-gamma) responses by CD4+ T cells to pooled Gag peptides and to determine their association with viral load and CD4 count. Gag-specific IFN-gamma-producing CD4+ T cell responses were detected in 261/373 (70%) subjects, with the Gag responders having a significantly lower viral load and higher CD4 count than those with no detectable Gag response (p<0.0001 for both parameters). To identify individual peptides targeted by HIV-1-specific CD4+ T cells, separate ELISPOT screening was conducted on CD8-depleted PBMCs from 32 chronically infected untreated subjects, using pools of overlapping peptides that spanned the entire HIV-1 clade C consensus sequence, and reconfirmed by flow cytometry to be CD4+ mediated. The ELISPOT screening identified 33 CD4+ peptides targeted by 18/32 patients (56%), with 27 of the 33 peptides located in the Gag region. Although the breadth of the CD4+ responses correlated inversely with viral load (p = 0.015), the magnitude of the response was not significantly associated with viral load. Conclusions/Significance: These data indicate that in chronic untreated clade C HIV-1 infection, IFN-gamma-secreting Gag-specific CD4+ T cell responses are immunodominant, directed at multiple distinct epitopes, and associated with viral control.	[Ramduth, Danni; Day, Cheryl L.; Thobakgale, Christina F.; Mkhwanazi, Nompumelelo P.; de Pierres, Chantal; Reddy, Sharon; van der Stok, Mary; Mncube, Zenele; Nair, Kriebashne; Moodley, Eshia S.; Coovadia, Hoosen M.; Kiepiela, Photini; Goulder, Philip J. R.; Walker, Bruce D.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa; [Day, Cheryl L.; Kaufmann, Daniel E.; Streeck, Hendrik; Goulder, Philip J. R.; Walker, Bruce D.] Harvard Univ, MIT, Massachusetts Gen Hosp E, Ragon Inst MGH, Charlestown, MA USA; [Goulder, Philip J. R.] Univ Oxford, Peter Medawar Bldg Pathogen Res, Nuffield Dept Med, Dept Pediat, Oxford OX1 2JD, England; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Kwazulu Natal; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Oxford; Howard Hughes Medical Institute	Ramduth, D (corresponding author), Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa.	dramduth@gmail.com	Day, Cheryl/GQQ-9720-2022; Day, Cheryl L/J-9844-2012	Day, Cheryl L/0000-0002-6497-4846; Thobakgale-Tshabalala, Christina/0000-0001-5619-8894	US National Institute of Health [N01-A1-15422, 2 RO1AI46995-06, RO1AI067073]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046995, R01AI067073] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the US National Institute of Health (Contract N01-A1-15422, 2 RO1AI46995-06, and RO1AI067073). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Altfeld M, 2003, J VIROL, V77, P7330, DOI 10.1128/JVI.77.13.7330-7340.2003; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; Boaz MJ, 2002, J IMMUNOL, V169, P6376, DOI 10.4049/jimmunol.169.11.6376; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Day CL, 2003, J EXP MED, V198, P1773, DOI 10.1084/jem.20031947; Douek DC, 2002, J IMMUNOL, V168, P3099, DOI 10.4049/jimmunol.168.6.3099; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Duvall MG, 2006, J IMMUNOL, V176, P6973, DOI 10.4049/jimmunol.176.11.6973; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; Geldmacher C, 2007, AIDS, V21, P135, DOI 10.1097/01.aids.0000247589.77061.f7; Grakoui A, 2003, SCIENCE, V302, P659, DOI 10.1126/science.1088774; Harari A, 2005, J IMMUNOL, V174, P1037, DOI 10.4049/jimmunol.174.2.1037; Harari A, 2004, BLOOD, V103, P966, DOI 10.1182/blood-2003-04-1203; Harari A, 2002, BLOOD, V100, P1381, DOI 10.1182/blood-2001-11-0080; Iyasere C, 2003, J VIROL, V77, P10900, DOI 10.1128/JVI.77.20.10900-10909.2003; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Kaufmann DE, 2004, J VIROL, V78, P4463, DOI 10.1128/JVI.78.9.4463-4477.2004; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kurle S, 2004, AIDS RES HUM RETROV, V20, P1113, DOI 10.1089/aid.2004.20.1113; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Malhotra U, 2001, J CLIN INVEST, V107, P505, DOI 10.1172/JCI11275; Mattapallil JJ, 2006, J MED PRIMATOL, V35, P217, DOI 10.1111/j.1600-0684.2006.00170.x; McNeil AC, 2001, P NATL ACAD SCI USA, V98, P13878, DOI 10.1073/pnas.251539598; Ngumbela KC, 2008, AIDS RES HUM RETROV, V24, P72, DOI 10.1089/aid.2007.0124; Ondondo BO, 2008, EUR J IMMUNOL, V38, P3549, DOI 10.1002/eji.200838759; Palmer BE, 2002, J VIROL, V76, P5925, DOI 10.1128/JVI.76.12.5925-5936.2002; Pitcher CJ, 1999, NAT MED, V5, P518, DOI 10.1038/8400; Ramduth D, 2005, J INFECT DIS, V192, P1588, DOI 10.1086/496894; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; *UNAIDS, 2007, AIDS EP UP 07; Veazey RS, 2000, J VIROL, V74, P57, DOI 10.1128/JVI.74.1.57-64.2000; Younes SA, 2003, J EXP MED, V198, P1909, DOI 10.1084/jem.20031598; Yue FY, 2004, J IMMUNOL, V172, P2476, DOI 10.4049/jimmunol.172.4.2476; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	37	30	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2009	4	4							e5013	10.1371/journal.pone.0005013	http://dx.doi.org/10.1371/journal.pone.0005013			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RT	19352428	Green Published, Green Submitted, gold			2022-12-25	WOS:000265505300003
J	Lewis, MJ; Pelham, HRB				Lewis, Michael J.; Pelham, Hugh R. B.			Inefficient Quality Control of Thermosensitive Proteins on the Plasma Membrane	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM DEGRADATION; ER-ASSOCIATED DEGRADATION; UBIQUITIN LIGASE; SACCHAROMYCES-CEREVISIAE; MULTIVESICULAR BODIES; YEAST; SYSTEM; ENDOCYTOSIS; STABILITY; REQUIRES	Background: Misfolded proteins are generally recognised by cellular quality control machinery, which typically results in their ubiquitination and degradation. For soluble cytoplasmic proteins, degradation is mediated by the proteasome. Membrane proteins that fail to fold correctly are subject to ER associated degradation (ERAD), which involves their extraction from the membrane and subsequent proteasome-dependent destruction. Proteins with abnormal transmembrane domains can also be recognised in the Golgi or endosomal system and targeted for destruction in the vacuole/lysosome. It is much less clear what happens to membrane proteins that reach their destination, such as the cell surface, and then suffer damage. Methodology/Principal Findings: We have tested the ability of yeast cells to degrade membrane proteins to which temperature-sensitive cytoplasmic alleles of the Ura3 protein or of phage lambda repressor have been fused. In soluble form, these proteins are rapidly degraded upon temperature shift, in part due to the action of the Doa10 and San1 ubiquitin ligases and the proteasome. When tethered to the ER protein Use1, they are also degraded. However, when tethered to a plasma membrane protein such as Sso1 they escape degradation, either in the vacuole or by the proteasome. Conclusions/Significance: Membrane proteins with a misfolded cytoplasmic domain appear not to be efficiently recognised and degraded once they have escaped the ER, even though their defective domains are exposed to the cytoplasm and potentially to cytoplasmic quality controls. Membrane tethering may provide a way to reduce degradation of unstable proteins.	[Lewis, Michael J.; Pelham, Hugh R. B.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Lewis, MJ (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	hp@mrc-lmb.cam.ac.uk			UK Medical Research Council; Medical Research Council [MC_U105178788] Funding Source: researchfish; MRC [MC_U105178788] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the UK Medical Research Council (www.mrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Cohen MMJ, 2008, MOL BIOL CELL, V19, P2457, DOI 10.1091/mbc.E08-02-0227; Deak PM, 2001, J BIOL CHEM, V276, P10663, DOI 10.1074/jbc.M008608200; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Gilon T, 1998, EMBO J, V17, P2759, DOI 10.1093/emboj/17.10.2759; Gong XH, 2001, P NATL ACAD SCI USA, V98, P9104, DOI 10.1073/pnas.161282998; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hettema EH, 2004, EMBO J, V23, P1279, DOI 10.1038/sj.emboj.7600137; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Metzger MB, 2008, J BIOL CHEM, V283, P32302, DOI 10.1074/jbc.M806424200; Miller BG, 2000, P NATL ACAD SCI USA, V97, P2011, DOI 10.1073/pnas.030409797; MUHLRAD D, 1992, YEAST, V8, P79, DOI 10.1002/yea.320080202; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; PARSELL DA, 1989, J BIOL CHEM, V264, P7590; Pizzirusso M, 2004, MOL BIOL CELL, V15, P2401, DOI 10.1091/mbc.E03-10-0727; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Reggiori F, 2000, MOL BIOL CELL, V11, P3737, DOI 10.1091/mbc.11.11.3737; Reggiori F, 2001, EMBO J, V20, P5176, DOI 10.1093/emboj/20.18.5176; Reggiori F, 2002, NAT CELL BIOL, V4, P117, DOI 10.1038/ncb743; Sommer T, 1997, FASEB J, V11, P1227, DOI 10.1096/fasebj.11.14.9409541; SUSSMAN R, 1962, CR HEBD ACAD SCI, V254, P1517; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; VOLLAND C, 1994, J BIOL CHEM, V269, P9833	31	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e5038	10.1371/journal.pone.0005038	http://dx.doi.org/10.1371/journal.pone.0005038			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337370	Green Published, Green Submitted, gold			2022-12-25	WOS:000265500600012
J	Quaia, C; Ying, HS; Nichols, AM; Optican, LM				Quaia, Christian; Ying, Howard S.; Nichols, Altah M.; Optican, Lance M.			The Viscoelastic Properties of Passive Eye Muscle in Primates. I: Static Forces and Step Responses	PLOS ONE			English	Article							GENERATING LINE SPECTRA; SUPERIOR OBLIQUE PALSY; SKELETAL-MUSCLE; EXTRAOCULAR-MUSCLES; RESTING TENSION; RAT MUSCLE; FIBERS; MECHANICS; MODEL; FROG	The viscoelastic properties of passive eye muscles are prime determinants of the deficits observed following eye muscle paralysis, the root cause of several types of strabismus. Our limited knowledge about such properties is hindering the ability of eye plant models to assist in formulating a patient's diagnosis and prognosis. To investigate these properties we conducted an extensive in vivo study of the mechanics of passive eye muscles in deeply anesthetized and paralyzed monkeys. We describe here the static length-tension relationship and the transient forces elicited by small step-like elongations. We found that the static force increases nonlinearly with length, as previously shown. As expected, an elongation step induces a fast rise in force, followed by a prolonged decay. The time course of the decay is however considerably more complex than previously thought, indicating the presence of several relaxation processes, with time constants ranging from 1 ms to at least 40 s. The mechanical properties of passive eye muscles are thus similar to those of many other biological passive tissues. Eye plant models, which for lack of data had to rely on (erroneous) assumptions, will have to be updated to incorporate these properties.	[Quaia, Christian; Nichols, Altah M.; Optican, Lance M.] NEI, Sensorimotor Res Lab, Bethesda, MD 20892 USA; [Ying, Howard S.] Johns Hopkins Univ Hosp, Dept Neurol, Baltimore, MD 21287 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Johns Hopkins University; Johns Hopkins Medicine	Quaia, C (corresponding author), NEI, Sensorimotor Res Lab, Bldg 10, Bethesda, MD 20892 USA.	quaiac@nei.nih.gov			National Eye Institute; NIH [EY19347, EY15025]; Knights' Templar Eye Foundation [Young Investigator Award]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [ZIAEY000302, Z01EY000302, K12EY015025, R01EY019347] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Knights' Templar Eye Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the intramural research program of the National Eye Institute (CQ, AMN, LMO), by NIH grants NIH EY19347 and NIH EY15025 (HSY), the Knights' Templar Eye Foundation Young Investigator Award (HSY), and Research to Prevent Blindness Core Grant (HSY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACHYRITA P, 1966, J GEN PHYSIOL, V49, P1177, DOI 10.1085/jgp.0491177; BAGNI MA, 1992, BIOPHYS J, V63, P1412, DOI 10.1016/S0006-3495(92)81718-6; BAGNI MA, 1995, J PHYSIOL-LONDON, V482, P391, DOI 10.1113/jphysiol.1995.sp020526; BARMACK NH, 1976, J NEUROPHYSIOL, V39, P1009, DOI 10.1152/jn.1976.39.5.1009; BARMACK NH, 1971, J NEUROPHYSIOL, V34, P1072, DOI 10.1152/jn.1971.34.6.1072; Breinin GM, 1962, ELECTROPHYSIOLOGY EX; Brown IE, 1996, J MUSCLE RES CELL M, V17, P221, DOI 10.1007/BF00124244; Buchthal F., 1951, DAN VIDENS SELS BIOL, V21, P1; COLLINS CC, 1975, J PHYSIOL-LONDON, V245, P351, DOI 10.1113/jphysiol.1975.sp010850; Collins CC, 1971, CONTROL EYE MOVEMENT, P283, DOI DOI 10.1016/B978-0-12-071050-8.50015-X; Collins CC., 1975, BASIC MECH OCULAR MO, P145; Croes SA, 2007, J NEUROSCI METH, V166, P53, DOI 10.1016/j.jneumeth.2007.06.024; EMRI I, 1994, RHEOL ACTA, V33, P60, DOI 10.1007/BF00453464; EMRI I, 1993, RHEOL ACTA, V32, P311, DOI 10.1007/BF00434195; EMRI I, 1995, INT J SOLIDS STRUCT, V32, P817, DOI 10.1016/0020-7683(94)00162-P; FORD LE, 1977, J PHYSIOL-LONDON, V269, P441, DOI 10.1113/jphysiol.1977.sp011911; FUCHS AF, 1971, J PHYSIOL-LONDON, V219, P155, DOI 10.1113/jphysiol.1971.sp009655; Gardiner C W, 2004, HDB STOCHASTIC METHO; Goulding D, 1997, J MUSCLE RES CELL M, V18, P465, DOI 10.1023/A:1018650915751; Hakim OM, 2008, J AAPOS, V12, P62, DOI 10.1016/j.jaapos.2007.09.001; HILL AV, 1950, NATURE, V166, P415, DOI 10.1038/166415a0; HOROWITS R, 1987, J CELL BIOL, V105, P2217, DOI 10.1083/jcb.105.5.2217; HOROWITS R, 1986, NATURE, V323, P160, DOI 10.1038/323160a0; LINKE WA, 1994, BIOPHYS J, V67, P782, DOI 10.1016/S0006-3495(94)80538-7; MAGID A, 1985, SCIENCE, V230, P1280, DOI 10.1126/science.4071053; MILLER JM, 1984, COMPUT BIOMED RES, V17, P436, DOI 10.1016/0010-4809(84)90012-0; Mutungi G, 1996, J PHYSIOL-LONDON, V496, P827, DOI 10.1113/jphysiol.1996.sp021730; Mutungi G, 1996, J MUSCLE RES CELL M, V17, P357; Nekouzadeh A, 2005, P ROY SOC A-MATH PHY, V461, P1599, DOI 10.1098/rspa.2004.1437; NOLL W, 1961, REV MOD PHYS, V33, P239; Pinniger GJ, 2006, J PHYSIOL-LONDON, V573, P627, DOI 10.1113/jphysiol.2005.095448; Porter JD, 1996, NEUROLOGY, V46, P30, DOI 10.1212/WNL.46.1.30; Pryse KM, 2003, ANN BIOMED ENG, V31, P1287, DOI 10.1114/1.1615571; Puso MA, 1998, J BIOMECH ENG-T ASME, V120, P62, DOI 10.1115/1.2834308; Quaia C, 2008, PROG BRAIN RES, V171, P47, DOI 10.1016/S0079-6123(08)00607-9; Ramsey RW, 1940, J CELL COMPAR PHYSL, V15, P11, DOI 10.1002/jcp.1030150103; Robinson D.A., 1981, MODELS OCULOMOTOR BE, P21; ROBINSON DA, 1975, INVEST OPHTH VISUAL, V14, P801; ROBINSON DA, 1964, J PHYSIOL-LONDON, V174, P245, DOI 10.1113/jphysiol.1964.sp007485; ROBINSON DA, 1969, J APPL PHYSIOL, V26, P548, DOI 10.1152/jappl.1969.26.5.548; Scott AB, 1971, CONTROL EYE MOVEMENT, P327; Shan XY, 2007, INVEST OPHTH VIS SCI, V48, P2602, DOI 10.1167/iovs.06-1316; Shan XY, 2007, INVEST OPHTH VIS SCI, V48, P2612, DOI 10.1167/iovs.06-1318; Sklavos S, 2005, VISION RES, V45, P1525, DOI 10.1016/j.visres.2005.01.005; STONE SL, 1965, J PHYSIOL-LONDON, V181, P337, DOI 10.1113/jphysiol.1965.sp007765; Telley IA, 2007, J MUSCLE RES CELL M, V28, P89, DOI 10.1007/s10974-007-9107-8; Tschoegl N.W., 1989, PHENOMENOLOGICAL THE; TSCHOEGL NW, 1993, RHEOL ACTA, V32, P322, DOI 10.1007/BF00434196; Viidik A., 1980, BIOL COLLAGEN, P237; WANG K, 1991, P NATL ACAD SCI USA, V88, P7101, DOI 10.1073/pnas.88.16.7101; Wang K, 1996, ADV BIOPHYS, V33, P123; WILLETT JB, 1988, AM STAT, V42, P236, DOI 10.2307/2685031	52	27	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2009	4	4							e4850	10.1371/journal.pone.0004850	http://dx.doi.org/10.1371/journal.pone.0004850			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PY	19337381	Green Published, gold			2022-12-25	WOS:000265500600002
J	He, MA; Guo, H; Yang, XB; Zhang, XM; Zhou, L; Cheng, LX; Zeng, HS; Hu, FB; Tanguay, RM; Wu, TC				He, Meian; Guo, Huan; Yang, Xiaobo; Zhang, Xiaomin; Zhou, Li; Cheng, Longxian; Zeng, Hesong; Hu, Frank B.; Tanguay, Robert M.; Wu, Tangchun			Functional SNPs in HSPA1A Gene Predict Risk of Coronary Heart Disease	PLOS ONE			English	Article								Background: HSP70 plays crucial roles in endothelial cell apoptosis, which is involved in the early phase and progress of coronary heart disease (CHD). However, the association between polymorphisms of HSP70 genes and the risk of CHD still remains unclear. Our aim was to determine whether genetic variants in the HSPA1A gene are associated with the risk of CHD. Methodology/Principal Findings: By resequencing and genotyping, the associations of 2 single nucleotide polymorphisms (SNPs) + 190G/C (rs1043618) and -110A/C (rs1008438) in the HSPA1A gene with risk of CHD were determined in a 1,003 pairs case-control study. The SNP function was further analyzed using a luciferase reporter assay in two cell lines. The results indicated that +190CC genotype was associated with significantly higher risk of CHD when compared with +190GG genotype (OR = 1.56, 95% CI: 1.10-2.20, P = 0.012), while association between -110A/C polymorphism and CHD was not statistically significant (P>0.05). However, the -110C/+190C haplotype had a significantly higher risk of CHD when compared with the -110A/+190G haplotype (OR = 1.17, 95% CI: 1.01-1.34, P = 0.031). Luciferase reporter assays showed that the +190C allele resulted in 14%similar to 45% reduction in luciferase expression in endothelial and non-endothelial cells when compared with the +190G allele. Conclusions/Significance: The identified genetic variants in the HSPA1A gene combinatorially contribute towards the susceptibility to CHD likely by affecting the level of synthesis of HSP70. This study may provide useful markers for identification of subjects at risk for CHD.	[He, Meian; Guo, Huan; Yang, Xiaobo; Zhang, Xiaomin; Zhou, Li; Wu, Tangchun] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Inst Occupat Med, Wuhan, Hubei, Peoples R China; [He, Meian; Guo, Huan; Yang, Xiaobo; Zhang, Xiaomin; Zhou, Li; Wu, Tangchun] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Ministry of Ed Key Lab Environm & Hlth, Wuhan, Hubei, Peoples R China; [He, Meian; Cheng, Longxian] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Cardiol, Wuhan, Peoples R China; [Zeng, Hesong] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Cardiol, Wuhan, Peoples R China; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr & Epidemiol, Boston, MA 02138 USA; [Tanguay, Robert M.] Univ Laval, Fac Med, Dept Med, Lab Cellular & Dev Genet, Quebec City, PQ G1K 7P4, Canada; [Tanguay, Robert M.] Univ Laval, CREFSIP, Quebec City, PQ G1K 7P4, Canada	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Harvard University; Harvard T.H. Chan School of Public Health; Laval University; Laval University	He, MA (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Inst Occupat Med, Wuhan, Hubei, Peoples R China.	wut@mails.tjmu.edu.cn	Zhang, Xiaomin/GVT-8927-2022; Zhang, Xiaomin/F-3206-2018		National Natural Science Foundation of China [30525031, 30430590]; NSFC-CIHR [30711120579, CCI-85673]; American Heart Association [Established Investigator Award]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC-CIHR(Canadian Institutes of Health Research (CIHR)); American Heart Association(American Heart Association)	This study was supported by the National Natural Science Foundation of China (NSFC 30525031 and 30430590), NSFC-CIHR Collaborative Research Grant and NSFC (30711120579). Dr. Frank B. Hu's work was supported in part by the American Heart Association Established Investigator Award. TW and RMT also acknowledge support from a NNSFC-CIHR (Canadian Institutes of Health Research) collaborative research grant (CIHR CCI-85673). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolla MK, 1998, DIS MARKERS, V13, P227, DOI 10.1155/1998/235151; Brocchieri L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-19; Cines DB, 1998, BLOOD, V91, P3527; Clemons NJ, 2005, J BIOL CHEM, V280, P9005, DOI 10.1074/jbc.M414165200; CURRIE RW, 1993, CIRCULATION, V87, P963, DOI 10.1161/01.CIR.87.3.963; Das DK, 2006, CARDIOVASC RES, V70, P254, DOI 10.1016/j.cardiores.2006.02.023; Ding KY, 2003, BIOINFORMATICS, V19, P2147, DOI 10.1093/bioinformatics/btg276; Durand E, 2004, CIRCULATION, V109, P2503, DOI 10.1161/01.CIR.0000130172.62481.90; Favatier F, 1997, CELL STRESS CHAPERON, V2, P141, DOI 10.1379/1466-1268(1997)002<0141:VIHGEA>2.3.CO;2; Fraile A, 1998, TISSUE ANTIGENS, V51, P382; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; He MA, 2008, CELL STRESS CHAPERON, V13, P231, DOI 10.1007/s12192-008-0025-5; HUTTER MM, 1994, CIRCULATION, V89, P355, DOI 10.1161/01.CIR.89.1.355; Jarjour W, 1996, HUM IMMUNOL, V45, P59, DOI 10.1016/0198-8859(95)00153-0; JOHNSON AD, 1995, ARTERIOSCL THROM VAS, V15, P27, DOI 10.1161/01.ATV.15.1.27; Kabakov AE, 2003, CELL STRESS CHAPERON, V8, P335, DOI 10.1379/1466-1268(2003)008<0335:HSPOHS>2.0.CO;2; Li CY, 2000, J BIOL CHEM, V275, P25665, DOI 10.1074/jbc.M906383199; Mallat Z, 2000, CIRCULATION, V101, P841, DOI 10.1161/01.CIR.101.8.841; MARBER MS, 1995, J CLIN INVEST, V95, P1446, DOI 10.1172/JCI117815; MILNER CM, 1992, IMMUNOGENETICS, V36, P357; MILNER CM, 1990, IMMUNOGENETICS, V32, P242; Mosser DD, 2000, MOL CELL BIOL, V20, P7146, DOI 10.1128/MCB.20.19.7146-7159.2000; Organization W. H., 1992, WORLD HLTH STAT ANN; PUGLIESE A, 1992, DIABETES, V41, P788, DOI 10.2337/diabetes.41.7.788; Radford NB, 1996, P NATL ACAD SCI USA, V93, P2339, DOI 10.1073/pnas.93.6.2339; Rubtsova MP, 2003, J BIOL CHEM, V278, P22350, DOI 10.1074/jbc.M303213200; Steel R, 2004, J BIOL CHEM, V279, P51490, DOI 10.1074/jbc.M401314200; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Suzuki K, 2000, BASIC RES CARDIOL, V95, P397, DOI 10.1007/s003950070039; Vargas-Alarcon G, 2002, ANN RHEUM DIS, V61, P48, DOI 10.1136/ard.61.1.48; Vivinus S, 2001, EUR J BIOCHEM, V268, P1908, DOI 10.1046/j.1432-1327.2001.02064.x; Wu YF, 2006, CIRCULATION, V114, P2217, DOI 10.1161/CIRCULATIONAHA.105.607499; Wu YR, 2004, HUM GENET, V114, P236, DOI 10.1007/s00439-003-1050-1; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	34	47	51	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2009	4	3							e4851	10.1371/journal.pone.0004851	http://dx.doi.org/10.1371/journal.pone.0004851			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PR	19333379	Green Published, Green Submitted, gold			2022-12-25	WOS:000265499900001
